Citrus Sinensis ID: 047157
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 788 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.955 | 0.905 | 0.339 | 1e-121 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.945 | 0.854 | 0.302 | 2e-94 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.866 | 0.856 | 0.325 | 3e-92 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.911 | 0.867 | 0.318 | 2e-90 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.931 | 0.898 | 0.301 | 8e-89 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.866 | 0.823 | 0.313 | 8e-81 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.907 | 0.841 | 0.288 | 2e-74 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.901 | 0.828 | 0.301 | 7e-74 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.875 | 0.840 | 0.292 | 1e-73 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.897 | 0.810 | 0.295 | 2e-72 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 435 bits (1118), Expect = e-121, Method: Compositional matrix adjust.
Identities = 280/825 (33%), Positives = 423/825 (51%), Gaps = 72/825 (8%)
Query: 6 IVPCVLTLILKFYGLHGQTSPN--ISLGSSITAGSN----TSWLSPSGDFAFGFYSLF-G 58
I+ VL L L+ + + Q N + +G S+TA + +SW SPSGDFAFGF +
Sbjct: 8 IIHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFRKIQPN 67
Query: 59 GLYLLGIWFDKIPEKTLVWAADRDSPAEA----GSKITLTNDGKLLLTYFNGSV--QQIY 112
+ L IWFDKI +KT+VW A + GSK+TLT DG L++ G + +
Sbjct: 68 DGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRALS 127
Query: 113 SGAASLALMQNDGNFVLKNANSA----VVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTA 168
G+ S +DGNFVL S V+W SF+ PTDT+LP Q + G+ L S+ R
Sbjct: 128 GGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNL-SSRRTET 186
Query: 169 DYSTGNYTLEMQADGNLVLSAYHFADPG-------YWYTGTVTLNN--VSLIFNQSAFMY 219
+ G ++L ++ DGNL L + + Y+ + T NN + L+FNQS +Y
Sbjct: 187 SFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPNNPGIQLVFNQSGEIY 246
Query: 220 LINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKSTSSR--------WTRVW 271
++ R+ D+ A F + R R
Sbjct: 247 VLQRNNSRFVVKDRD-----PDFSIAAPFYISTGFLLSTIIPKEARRIVGGCLLGLCRDN 301
Query: 272 RAVNDPCIVNCICGVYGMCTSSDNETVTCNCIPGYTPLNPSDVSEGCHPETVVNYC-AET 330
D + N CG +C+ +N+ C C + +PS+ C P+ + C E
Sbjct: 302 MCSPDDALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPEN 361
Query: 331 SSKNFTVEVMDDAGFLFDN--FADLARVSNVDVEGCRKAVMDDCYSLGASLVGST----- 383
+ N V + + N F D +N D E C+ + + DC L A+++ T
Sbjct: 362 QTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDC--LCAAVIFGTNRDLK 419
Query: 384 CVKTRMPLLNARKSASTKGMKAIIKVPTKMSNPSNHEGKKKNNFNSRLLLKIGFIFSAIC 443
C K + PL + +S IKV + G + + ++ + ++
Sbjct: 420 CWKKKFPLSHGERSPRGDS-DTFIKVRNRSIADVPVTGNRAKKLDWLIIACSVLLGTSAF 478
Query: 444 ALLSGVAAIYYSPAARGLIKR------RNYFDPNSMEINFREFTFQELQEATKGFSKLVG 497
+ + + ++ ++K R + E+N R FT+ EL EAT+ F++ +G
Sbjct: 479 VIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELG 538
Query: 498 TGSSGKVYRGILRLKD-TQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFC 556
G+ G VY+G L + +++ +AVKKL++ +EF E+K+IG+ HHKNLVRL+GFC
Sbjct: 539 RGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFC 598
Query: 557 SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCD 616
+E +++VYE +P GTL+NFLF RP W R IA+ +ARG+LYLHEEC QIIHCD
Sbjct: 599 NEGQSQMIVYEFLPQGTLANFLFRR-PRPSWEDRKNIAVAIARGILYLHEECSEQIIHCD 657
Query: 617 IKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTT 676
IKPQN+LLD Y +ISDFG++KLL +QT T TN+RGT GYVAPEW RN P+T+
Sbjct: 658 IKPQNILLD-----EYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITS 712
Query: 677 KVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEV 736
KVDV+S+GVMLLEI+C ++ ++L E +++L +W C L+ L D E
Sbjct: 713 KVDVYSYGVMLLEIVCCKKAVDL--------EDNVILINWAYDCFRQGRLEDLTEDDSEA 764
Query: 737 LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPP 781
++D+E ER + +WC + +RP+M+ V MLEG ++V PP
Sbjct: 765 MNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPP 809
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (890), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 247/816 (30%), Positives = 409/816 (50%), Gaps = 71/816 (8%)
Query: 17 FYGLHGQTSPNISLGSSITAGS-NTSWLSPSGDFAFGFYSLF-GGLYLLGIWFDKIP-EK 73
F+ + T P+I LGS + A N +W+S +G FA GF +LL IWF ++P +
Sbjct: 19 FFLVSLATEPHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDRFLLSIWFAQLPGDP 78
Query: 74 TLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSV--QQIYSGAASLALMQNDGNFVLKN 131
T+VW+ +R+SP + + L G L+L+ N V + A+M GNF+L
Sbjct: 79 TIVWSPNRNSPVTKEAVLELEATGNLVLSDQNTVVWTSNTSNHGVESAVMSESGNFLLLG 138
Query: 132 AN---SAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEM-QADGNLVL 187
+W SF P+DT+LP Q L +L SN + G+Y+L+M Q +L L
Sbjct: 139 TEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRH---GHYSLKMLQQHTSLSL 195
Query: 188 SAYH------FADPGYW-------YTGTVTL-----NNVSLIFNQS---AFMYLINSTGD 226
+ A+ YW TG VT + +++ +S A N D
Sbjct: 196 GLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYKNPVDD 255
Query: 227 NI-FRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKST--SSRWTRVWRAVNDPCIVNCI 283
N + + N+ R ++ +GN + + + SS+W W AV++PC + I
Sbjct: 256 NRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSSQWVPEWAAVSNPCDIAGI 315
Query: 284 CGVYGMCT-SSDNETVTCNCIPGYTPLNPSDVSEGCHP-ETVVNYCAETSSKN--FTVEV 339
CG G+C + C C+PG L + ++ C ++V C ++N F +
Sbjct: 316 CG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQECESNINRNGSFKIST 374
Query: 340 MDDAGFLFDNFADLARVSNV-DVEGCRKAVMDDCYSLGASLVGSTCVKTRMPLLNA---- 394
+ + + F + + +S++ +V C + + DC + AS+ G K +L +
Sbjct: 375 VQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCV-ASVYGLDDEKPYCWILKSLNFG 433
Query: 395 --RKSASTKGMKAIIKVPTKMSNPSNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAI 452
R ST +K ++ +N +K++ + +L I + + + +
Sbjct: 434 GFRDPGSTLFVKTRANESYPSNSNNNDSKSRKSHGLRQKVLVIPIVVGMLVLVALLGMLL 493
Query: 453 YYSPAARGLIKRRNYFDPNSMEI--NFREFTFQELQEATKGFSKLVGTGSSGKVYRGILR 510
YY+ + +KR NS+ + + FT+++LQ T FS+L+G+G G VY+G +
Sbjct: 494 YYNLDRKRTLKRA---AKNSLILCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVA 550
Query: 511 LKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMP 570
+ +AVK+L++ + EF+TE+ IG HH NLVRL G+CSE+ RLLVYE M
Sbjct: 551 ---GETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMI 607
Query: 571 NGTLSNFLFHEGQRPG---WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK 627
NG+L ++F Q W R EIA+ A+G+ Y HE+C +IIHCDIKP+N+LLD
Sbjct: 608 NGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLD-- 665
Query: 628 TLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVML 687
N+ K+SDFG++K++ ++ + T +RGT GY+APEW+ N P+T K DV+S+G++L
Sbjct: 666 ---DNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLL 722
Query: 688 LEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA 747
LEI+ GRR++++S E D W + + V + +++ E +
Sbjct: 723 LEIVGGRRNLDMSYDAE-----DFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKAL 777
Query: 748 MVGLWCNHPDPNLRPSMKKVIHMLEGTL-EVGMPPL 782
V WC + ++RPSM +V+ +LEGT E+ +PP+
Sbjct: 778 KVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPM 813
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (872), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 255/783 (32%), Positives = 375/783 (47%), Gaps = 100/783 (12%)
Query: 29 SLGSSITAGSNTSWLSPSGDFAFGFYSLFGGL--YLLGIWFDKIPEKTLVWAADRDSPAE 86
S+ S + N + LS F GF+S G + LGI + +P T VW A+R P
Sbjct: 20 SVQSKVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVS 79
Query: 87 A--GSKITLTNDGKLLLTYF-NGSVQQIYSGAASLAL-MQNDGNFVLKNANSAVVWDSFD 142
S + LT+ G L+++ +G V Q + GN +L N + + VW SFD
Sbjct: 80 DPDSSTLELTSTGYLIVSNLRDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFD 139
Query: 143 FPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202
PTDT LPG + +TG ++ R D S G Y+L + N Y P YW TG
Sbjct: 140 NPTDTWLPG-MNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTP-YWSTGN 197
Query: 203 VTLNNVSLIFNQSAFMYLINSTGDNIFRLT-RNVMTPTEDYYH--------------RAT 247
T AF+ + T I+R N TPT +++ R
Sbjct: 198 WT---------GEAFVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFM 248
Query: 248 IDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTCNCIPGYT 307
+ +G +Q+ + T S W W DPC V +CG G C+S C CI G+
Sbjct: 249 VGANGQLKQYTWDPQTQS-WNMFWLQPEDPCRVYNLCGQLGFCSS--ELLKPCACIRGFR 305
Query: 308 PLNPS-----DVSEGCHPETVVNYCAETSSKNFTVEVMDDAGFLFDNFADLARVSNVDVE 362
P N + D S+GC E ++ K+ T E + D +D ++R+ V
Sbjct: 306 PRNDAAWRSDDYSDGCRREN-----GDSGEKSDTFEAVGD--LRYDGDVKMSRL-QVSKS 357
Query: 363 GCRKAVMDDCYSLGASLVGSTCVKTRMPLLNARKSASTKGMKAIIKVPTKMSNPSNHEGK 422
C K + + S+CV + KS K + + +P+N +
Sbjct: 358 SCAKTCLGN----------SSCVG----FYHKEKSNLCKIL---------LESPNNLKNS 394
Query: 423 KKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLI-------KRRNYFDPNSMEI 475
K N S ++L C+++ ++ + ++ ++ K+ D + +
Sbjct: 395 KGNISKSIIIL---------CSVVGSISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFAV 445
Query: 476 -NFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF 534
N + F+F+ELQ AT GFS VG G G V++G L + +AVK+LE+ EF
Sbjct: 446 LNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTL--PGSSTFVAVKRLERP-GSGESEF 502
Query: 535 MTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP-GWVQRVEI 593
E+ IG H NLVRL GFCSE RLLVY+ MP G+LS++L + W R I
Sbjct: 503 RAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRI 562
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653
ALG A+G+ YLHE C IIHCDIKP+N+LLD ++Y AK+SDFG++KLL +D +R
Sbjct: 563 ALGTAKGIAYLHEGCRDCIIHCDIKPENILLD-----SDYNAKVSDFGLAKLLGRDFSRV 617
Query: 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSR---VEEESEEVD 710
MRGT GYVAPEW+ +P+TTK DV+SFG+ LLE+I GRR++ ++ E+E+E
Sbjct: 618 LATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEK 677
Query: 711 IVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770
W ++ N+ +V + E RMA V +WC + +RP+M V+ M
Sbjct: 678 WFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKM 737
Query: 771 LEG 773
LEG
Sbjct: 738 LEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 333 bits (855), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 257/806 (31%), Positives = 388/806 (48%), Gaps = 88/806 (10%)
Query: 20 LHGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGL-YLLGIWFDKIPEKTLVWA 78
+HG ++ + G +G T +S G + GF+ + +G+W+ ++ + T++W
Sbjct: 17 IHGSSAVDTISGDFTLSGDQTI-VSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQ-TILWV 74
Query: 79 ADRDSP-AEAGSKITLTNDGKLLL-------TYFNGSVQQIYSGAASLALMQNDGNFVLK 130
A+RD ++ S + ++G L+L ++ + S +A A++Q+DGN VL+
Sbjct: 75 ANRDKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLR 134
Query: 131 NANSA----VVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTA-----DYSTGNYTLEMQA 181
S+ V+W SFD P DT LPG + K+ + R T+ D S G ++LE+
Sbjct: 135 TGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDE 194
Query: 182 DGNLVLSAYHFADPG---YWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTP 238
+AY G YW +G N S IF+ M L + F T +
Sbjct: 195 S-----TAYKILWNGSNEYWSSGP--WNPQSRIFDSVPEMRLNYIYNFSFFSNTTDSYFT 247
Query: 239 TEDYYH----RATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSD 294
Y R +D G +QF + + + W W C V CG +G+C SD
Sbjct: 248 YSIYNQLNVSRFVMDVSGQIKQFTWLEGNKA-WNLFWSQPRQQCQVYRYCGSFGIC--SD 304
Query: 295 NETVTCNCIPGYTPLNPSD-----VSEGCHPETVVNYCAETSSKNFTVEVMDDAGFLFDN 349
C C G+ P++ D S GC +T + ++ F + M L DN
Sbjct: 305 KSEPFCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMK----LADN 360
Query: 350 FADLARVSNVDVEGCRKAVMDDC------YSLGASLVGSTCVKTRMPLLNARKSASTKGM 403
L R S + C A DC Y G+S C+ +LN ++
Sbjct: 361 SEVLTRTS---LSICASACQGDCSCKAYAYDEGSS----KCLVWSKDVLNLQQLEDENSE 413
Query: 404 KAIIKVPTKMSNPSNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIK 463
I + S+ N K+N G IF A+ L + + +
Sbjct: 414 GNIFYLRLAASDVPNVGASGKSN-------NKGLIFGAVLGSLGVIVLVLLVVILILRYR 466
Query: 464 RRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKL 523
RR + F+++ELQ ATK FS +G G G V++G L D+ +IAVK+L
Sbjct: 467 RRKRMRGEKGDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGAL--PDSS-DIAVKRL 523
Query: 524 EKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLF---- 579
E I + ++F TE+ IG H NLVRL GFCSE K+LLVY+ MPNG+L + LF
Sbjct: 524 EG-ISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQV 582
Query: 580 HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639
E GW R +IALG ARGL YLH+EC IIHCDIKP+N+LLD + + K++D
Sbjct: 583 EEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLD-----SQFCPKVAD 637
Query: 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIEL 699
FG++KL+ +D +R T MRGT GY+APEW+ V +T K DV+S+G+ML E++ GRR+ E
Sbjct: 638 FGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTE- 696
Query: 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLS---DLERFERMAMVGLWCNHP 756
+ E+E+V S W + +L+++ + DP + D+E R V WC
Sbjct: 697 ---QSENEKVRFFPS-WAAT-ILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQD 751
Query: 757 DPNLRPSMKKVIHMLEGTLEVGMPPL 782
+ + RP+M +V+ +LEG LEV PP
Sbjct: 752 EESHRPAMSQVVQILEGVLEVNPPPF 777
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 328 bits (842), Expect = 8e-89, Method: Compositional matrix adjust.
Identities = 250/829 (30%), Positives = 397/829 (47%), Gaps = 95/829 (11%)
Query: 9 CVLTLILKFYGLHGQTSPNISLGSSITAGS--NTSWLSPSGDFAFGFYSLFGGLYLLGIW 66
C+L+ + + + + LGSS+ S +++ S G F+ GFY ++ + +W
Sbjct: 13 CILSFFIALFPRAASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEVYTHAFTFSVW 72
Query: 67 FDKIP-----EKTLVWAADRDSPAEAG-SKITLTNDGKLLLTYFNGSVQQIYSG----AA 116
+ K KT+VW+A+ D P A S +TL DG ++LT ++G+ G
Sbjct: 73 YSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNFTGV 132
Query: 117 SLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYT 176
A + + GN V++++ VW SFD PTDT LP Q++ +L T S GNY
Sbjct: 133 QRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPT---TQSRSPGNYI 189
Query: 177 LEMQADGNLVLSAYH--------FADP--GYWYTGTVTLNNVSLIFNQSAFMYLINSTGD 226
+D +++ YH + DP + G N+ L + + + D
Sbjct: 190 FRF-SDLSVLSLIYHVPQVSDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVLASSDFAD 248
Query: 227 NIFRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGV 286
+ +V + R T+D GN + ++ + S S W+ A+ PC ++ +CG
Sbjct: 249 GQALVASDVGPGVK---RRLTLDPDGNLRLYSMNDSDGS-WSVSMVAMTQPCNIHGLCGP 304
Query: 287 YGMCTSSDNETVTCNCIPGYTPLNPSDVSEGCHPETVVNY-CAETSSKNFTVEVMDDAGF 345
G+C S T TC+C PGY NP + +EGC +VN C ++ + + F
Sbjct: 305 NGICHYS--PTPTCSCPPGYATRNPGNWTEGCM--AIVNTTCDRYDKRSMRFVRLPNTDF 360
Query: 346 LFDNFADLARVSNVDVEGCRKAVMDDCYSLGASLV-GSTCVKTRMPLLNARKSASTKGMK 404
+D + +V + CR + DC G G+ + L + R ++
Sbjct: 361 WG---SDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFSGRTYPTSDVRT 417
Query: 405 AIIKVPTKMS------------------------NPSNHEG----KKKNNFNSRLLLKIG 436
+K+PT +S N S E K S+ G
Sbjct: 418 IYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGESKWFYFYG 477
Query: 437 FIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPN---SMEINFREFTFQELQEATKGFS 493
FI + +S ++ ++ R L + +M NFR ++++EL +AT+ F
Sbjct: 478 FIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTSNFRRYSYRELVKATRKFK 537
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G G SG VY+G+L + +AVKKLE ++ + E F EL +IGR +H NLVR+
Sbjct: 538 VELGRGESGTVYKGVL---EDDRHVAVKKLE-NVRQGKEVFQAELSVIGRINHMNLVRIW 593
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP--GWVQRVEIALGVARGLLYLHEECETQ 611
GFCSE RLLV E + NG+L+N LF EG W R IALGVA+GL YLH EC
Sbjct: 594 GFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHHECLEW 653
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK-DQTRTDTNMRGTMGYVAPEWLR 670
+IHCD+KP+N+L LD + KI+DFG+ KLLN+ T+ +++RGT+GY+APEW+
Sbjct: 654 VIHCDVKPENIL-----LDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVS 708
Query: 671 NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV--ISCMLSRNLQV 728
++P+T KVDV+S+GV+LLE++ G R +S + ++EV +L V +S L Q
Sbjct: 709 SLPITAKVDVYSYGVVLLELLTGTR---VSELVGGTDEVHSMLRKLVRMLSAKLEGEEQS 765
Query: 729 LVSHDPEVLSDLER------FERMAMVGLWCNHPDPNLRPSMKKVIHML 771
+ D + S L R + + + C D + RP+M+ + L
Sbjct: 766 WI--DGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 8e-81, Method: Compositional matrix adjust.
Identities = 254/809 (31%), Positives = 380/809 (46%), Gaps = 126/809 (15%)
Query: 28 ISLGSSITA-GSNTSWLSPSGDFAFGFY-SLFGGLYLLGIWF-DKIPEKTLVWAADRDSP 84
I LGS I A GSN +W SP+ F+ F S +L + F +P +W+A
Sbjct: 27 IPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVP----IWSA---GT 79
Query: 85 AEAGSKITLTNDGKLLLTYFNGSVQQIYSG-----AASLALMQNDGNFVLKNANSAVVWD 139
++ + L G L LT NGS ++ + +++ G F+L N S VW
Sbjct: 80 VDSRGSLRLHTSGSLRLT--NGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWS 137
Query: 140 SFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWY 199
SFD PTDTI+ Q GK L S G Y+ +++ GNL L A YW
Sbjct: 138 SFDNPTDTIVQSQNFTAGKILRS----------GLYSFQLERSGNLTLRWNTSAI--YWN 185
Query: 200 TG--------------TVTLNNVSLIFNQ-----SAFMYLINSTGDNIFRLTRNVMTPTE 240
G ++ N V IF + +Y + N FR +
Sbjct: 186 HGLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFLK------- 238
Query: 241 DYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTC 300
+D GN + ++ S W AV D C+V CG +G+C+ +D + C
Sbjct: 239 -------LDDDGNLRIYSSASRNSGPVNAHWSAV-DQCLVYGYCGNFGICSYNDTNPI-C 289
Query: 301 NCIP-GYTPLNPSDVSEGCHPETVVNYCAETS-------SKNFTVEVMDDAGFLFDNFAD 352
+C + ++ +D +GC + ++ C+ + ++ FT E DD N
Sbjct: 290 SCPSRNFDFVDVNDRRKGCKRKVELSDCSGNTTMLDLVHTRLFTYE--DDP-----NSES 342
Query: 353 LARVSNVDVEGCRKAVMDDCYSLGASLVGSTCVKTRMP--LLNARKSASTKGMKAIIKVP 410
S+ C +V+ C + + GS + P + S + +KV
Sbjct: 343 FFAGSSPCRANCLSSVL--CLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPST-SYVKVC 399
Query: 411 TKMSNPSNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGL----IKRRN 466
+ + K ++ NS++ L I + A+ A L G+ A+ GL ++
Sbjct: 400 GPVVANTLERATKGDDNNSKVHLWI--VAVAVIAGLLGLVAVEI-----GLWWCCCRKNP 452
Query: 467 YFDPNSMEINFREF--------TFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEI 518
F S E+ T++ELQ TK F + +G G G VYRG+L + +
Sbjct: 453 RFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVL---TNRTVV 509
Query: 519 AVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL 578
AVK+LE IE+ ++F E+ I THH NLVRL+GFCS+ RLLVYE M NG+L NFL
Sbjct: 510 AVKQLE-GIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFL 568
Query: 579 F--HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636
F + W R IALG A+G+ YLHEEC I+HCDIKP+N+L +D N+ AK
Sbjct: 569 FTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENIL-----VDDNFAAK 623
Query: 637 ISDFGISKLLN-KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR 695
+SDFG++KLLN KD +++RGT GY+APEWL N+P+T+K DV+S+G++LLE++ G+R
Sbjct: 624 VSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKR 683
Query: 696 HIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL----VSHDPEVLSDLERFERMAMVGL 751
+ ++S + S W N + + +S D V D+E+ RM
Sbjct: 684 NFDVSEKTNHKK-----FSIWAYEEFEKGNTKAILDTRLSEDQTV--DMEQVMRMVKTSF 736
Query: 752 WCNHPDPNLRPSMKKVIHMLEGTLEVGMP 780
WC P RP+M KV+ MLEG E+ P
Sbjct: 737 WCIQEQPLQRPTMGKVVQMLEGITEIKNP 765
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (718), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 230/798 (28%), Positives = 374/798 (46%), Gaps = 83/798 (10%)
Query: 28 ISLGSSITAGSNTSWLSPSGDFAFGFYSL-FGGLYLLGIWFDKIPEKTLVWAADRDSPAE 86
+S S+T SN + +SP F GF+ + LGIW+ I ++T VW A+RD+P
Sbjct: 32 LSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLS 91
Query: 87 AGSKITLTNDGKLLLTYFNGSVQQIYSGAAS--------LALMQNDGNFVLKNA-NSA-- 135
+ +D L++ + S ++S + +A + ++GNFVL+++ NSA
Sbjct: 92 SSIGTLKISDSNLVV--LDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPD 149
Query: 136 -VVWDSFDFPTDTILP----GQVLLTGKKLYSNS-RGTADYSTGNYTLEMQADGNLVLSA 189
V+W SFDFPTDT+LP G TG + S + D S+G+++ +++ +G +
Sbjct: 150 GVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFL 209
Query: 190 YHFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATID 249
++ Y +G S + F Y++ + + +T + D Y R +I
Sbjct: 210 WNRESRMY-RSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSIS 268
Query: 250 GHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTCNCIPGYTPL 309
G Q+F + + T+ W + W A D C CGVYG C S N + CNCI G+ P
Sbjct: 269 SSGLLQRFTWIE-TAQNWNQFWYAPKDQCDEYKECGVYGYCDS--NTSPVCNCIKGFKPR 325
Query: 310 NPS-----DVSEGCHPETVVNYCAETSSKNFTVEVMDDAGFLFDNFADLARVSNVDVEGC 364
NP D S+GC +T+++ + D A + R + V+ C
Sbjct: 326 NPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDT-----TTASVDR--GIGVKEC 378
Query: 365 RKAVMDDCYSLGASLV-----GSTCVKTRMPLLNARKSASTKGMKAIIKVPTKMSNPSNH 419
+ + DC + GS CV L + R A + T + + N
Sbjct: 379 EQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNR 438
Query: 420 EGK-KKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYF---------- 468
K ++ +LL + FI + + + +P ++ R+
Sbjct: 439 SAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRR 498
Query: 469 ----DPNSMEINFREFTFQELQEATKGFSKL--VGTGSSGKVYRGILRLKDTQIEIAVKK 522
+ N+ ++ F+E+ AT FS +G G G VY+G +L D Q E+AVK+
Sbjct: 499 HISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKG--KLLDGQ-EMAVKR 555
Query: 523 LEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEG 582
L K + +EF E+K+I R H NLVRLL C + +++L+YE + N +L + LF +
Sbjct: 556 LSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKS 615
Query: 583 Q--RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMA-KISD 639
+ + W R +I G+ARGLLYLH++ +IIH D+K N+LLD YM KISD
Sbjct: 616 RNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLD------KYMTPKISD 669
Query: 640 FGISKLLNKDQTRTDT-NMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIE 698
FG++++ +D+T +T + GT GY++PE+ + + K DVFSFGV+LLEII +R+
Sbjct: 670 FGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKG 729
Query: 699 LSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFE-----RMAMVGLWC 753
+ + + V +W + L+++ DP + F R +GL C
Sbjct: 730 FYNSDRDLNLLGCVWRNW----KEGKGLEII---DPIITDSSSTFRQHEILRCIQIGLLC 782
Query: 754 NHPDPNLRPSMKKVIHML 771
RP+M VI ML
Sbjct: 783 VQERAEDRPTMSLVILML 800
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 7e-74, Method: Compositional matrix adjust.
Identities = 243/805 (30%), Positives = 383/805 (47%), Gaps = 95/805 (11%)
Query: 28 ISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSP-AE 86
+S S+T SN + +SP F GF+ YL G+W+ K+ ++T VW A+RD+P +
Sbjct: 36 LSSTESLTISSNKTLVSPGSIFEVGFFRTNSRWYL-GMWYKKVSDRTYVWVANRDNPLSN 94
Query: 87 AGSKITLTNDGKLLLTYFNGSV--QQIYSG---AASLALMQNDGNFVLKNAN----SAVV 137
A + ++ + +LL + N V + G + +A + +GNFV+++++ S +
Sbjct: 95 AIGTLKISGNNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRDSSNNDASEYL 154
Query: 138 WDSFDFPTDTILP----GQVLLTG-KKLYSNSRGTADYSTGN--YTLEMQADGNLVLSAY 190
W SFD+PTDT+LP G L TG + ++ R + D S+GN Y LE Q+ LS
Sbjct: 155 WQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRE 214
Query: 191 HFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDN------IFRLTRNVMTPTEDYYH 244
+F P + +G S I Y++ + +N FR+T N +Y
Sbjct: 215 NF--PMH-RSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNN------SFYS 265
Query: 245 RATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDP-CIVNCICGVYGMCTSSDNETVTCNCI 303
R T+ G FQ+ ++ S W R W + DP C +CG Y C N + CNCI
Sbjct: 266 RLTLISEGYFQRLTWYPSIRI-WNRFWSSPVDPQCDTYIMCGPYAYCDV--NTSPVCNCI 322
Query: 304 PGYTPLNPSDVSE-----GCHPETVVNYCAETSSKNFTVEVMDDAGFLFDNFADLARVSN 358
G+ P N + GC T ++ S FT M A + R +
Sbjct: 323 QGFNPRNIQQWDQRVWAGGCIRRTQLS----CSGDGFT--RMKKMKLPETTMATVDR--S 374
Query: 359 VDVEGCRKAVMDDCYSLGASLV-----GSTCVKTRMPLLNARKSASTKGMKAIIKVPTKM 413
+ V+ C+K + DC + GS CV L + R A+ AI +
Sbjct: 375 IGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYAT----DAIDGQDLYV 430
Query: 414 SNPSNHEGKKKNNFNSRLLLKIG----FIFSAICALLSGVAAIYYSPAARGLIKRRNYFD 469
+ KK+N + L +G + C S + +R
Sbjct: 431 RLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNLP 490
Query: 470 PNSMEINFR-----EFTFQELQ----------EATKGFSKL--VGTGSSGKVYRGILRLK 512
N M ++ + E+ F+EL+ +AT+ FS +G G G VY+G RL
Sbjct: 491 MNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKG--RLL 548
Query: 513 DTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572
D + EIAVK+L K + +EFM E+ +I R H NLV++LG C E D+++L+YE + N
Sbjct: 549 DGK-EIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENL 607
Query: 573 TLSNFLFHEGQRP--GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD 630
+L ++LF + +R W +R +I GVARGLLYLH++ +IIH D+K N+L LD
Sbjct: 608 SLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNIL-----LD 662
Query: 631 TNYMAKISDFGISKLLNKDQTRTDT-NMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLE 689
N + KISDFG++++ +D+T +T + GT GY++PE+ + K DVFSFGV++LE
Sbjct: 663 KNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLE 722
Query: 690 IICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV---SHDPEVLSDLERFERM 746
I+ G+++ ++ E++ + V S W L V+V S P + E +
Sbjct: 723 IVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVL-KC 781
Query: 747 AMVGLWCNHPDPNLRPSMKKVIHML 771
+GL C RP+M V+ M
Sbjct: 782 IQIGLLCVQELAEHRPAMSSVVWMF 806
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 223/763 (29%), Positives = 344/763 (45%), Gaps = 73/763 (9%)
Query: 49 FAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSV 108
F FGF + + L + L+W+A+R SP K ++G +++
Sbjct: 55 FGFGFVTTQDSVTLFTLSIIHKSSTKLIWSANRASPVSNSDKFVFDDNGNVVMEGTEVWR 114
Query: 109 QQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTA 168
AS +++ GN V+ + + +W+SFD PTDT++ Q G KL S +
Sbjct: 115 LDNSGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTS----SP 170
Query: 169 DYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNI 228
S Y LE+++ G++VLS YW N I N+ + +S N
Sbjct: 171 SSSNMTYALEIKS-GDMVLSVNSLTPQVYWSMA----NARERIINKDGGVVTSSSLLGNS 225
Query: 229 FRL--TRNVM-------TPTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCI 279
+R + V+ +D + G+ F+ S +S + +D C
Sbjct: 226 WRFFDQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVISFSNLGSGASAADSSTKIPSDLCG 285
Query: 280 VNCICGVYGMCTSSDNETVTCNCIPGYTPLNPSDVSEGCHPETVVNYCAETSSKNFTVEV 339
CG Y +C+ S C C+ G + SD G + + C +T
Sbjct: 286 TPEPCGPYYVCSGSK----VCGCVSGLSRAR-SDCKTG-----ITSPCKKTKDNATLPLQ 335
Query: 340 MDDAGFLFDNFA---DLARVSNVDVEGCRKAVMDDCYSLGASLVGSTCVKTRMPLLNARK 396
+ AG D FA D++ C++ ++C LG S+ + + K
Sbjct: 336 LVSAGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLFFQNSSGNCFLFDYIGSFK 395
Query: 397 SAST--KGMKAIIKVPTKMSNPSNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYY 454
++ G + IK+ + S ++ +F +++ + +F +
Sbjct: 396 TSGNGGSGFVSYIKIASTGSGGGDNGEDDGKHFPYVVIIVVVTVFIIAVLIF-------- 447
Query: 455 SPAARGLIKRRNYF----DPNSMEINFRE--------FTFQELQEATKGFSKLVGTGSSG 502
A + KR+ +S E NF E F +++LQ AT FS +G G G
Sbjct: 448 --VAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFG 505
Query: 503 KVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562
VY G L +AVKKLE I + +EF E+ IIG HH +LVRL GFC+E R
Sbjct: 506 SVYEGTL---PDGSRLAVKKLE-GIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHR 561
Query: 563 LLVYELMPNGTLSNFLFHEGQRP---GWVQRVEIALGVARGLLYLHEECETQIIHCDIKP 619
LL YE + G+L ++F + W R IALG A+GL YLHE+C+ +I+HCDIKP
Sbjct: 562 LLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKP 621
Query: 620 QNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVD 679
+N+LLD N+ AK+SDFG++KL+ ++Q+ T MRGT GY+APEW+ N ++ K D
Sbjct: 622 ENILLD-----DNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSD 676
Query: 680 VFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD-PEVLS 738
V+S+G++LLE+I GR++ + S E+ + M L +V V
Sbjct: 677 VYSYGMVLLELIGGRKNYDPSETSEKCH-----FPSFAFKKMEEGKLMDIVDGKMKNVDV 731
Query: 739 DLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPP 781
ER +R LWC D RPSM KV+ MLEG V PP
Sbjct: 732 TDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPP 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 274 bits (700), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 234/793 (29%), Positives = 379/793 (47%), Gaps = 86/793 (10%)
Query: 43 LSPSGDFAFGFYSLFGGLYLLGIWFD--KIPEKTLVWAADRDSPAEAGSKITLT------ 94
LS + F G +S G G +F + + +W+++RDSP + + LT
Sbjct: 51 LSRNSIFKAGLFSPGGDDSSTGFYFSVVHVDSGSTIWSSNRDSPVSSSGTMNLTPQGISV 110
Query: 95 -NDGKLLLTYFNGSVQQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQV 153
DGK + ++ V + S SL L + GN +L + + +W+SFDFPTD+I+ GQ
Sbjct: 111 IEDGKSQIPVWSTPV--LASPVKSLRLT-DAGNLLLLDHLNVSLWESFDFPTDSIVLGQR 167
Query: 154 LLTGKKLYSNSRGTADYSTGNYT-LEMQADGNLVLSAYHFADPGYWYTGTVTLNNVSLIF 212
L G L S S +D+STG+Y L ++DG + + YW NV F
Sbjct: 168 LKLGMFL-SGSVSRSDFSTGDYKFLVGESDGLM-----QWRGQNYWKLRMHIRANVDSNF 221
Query: 213 N------QSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKSTSSR 266
++ + L+ G + + R + P+ D+ A +D G +F + +
Sbjct: 222 PVEYLTVTTSGLALMARNGTVV--VVRVALPPSSDF-RVAKMDSSG---KFIVSRFSGKN 275
Query: 267 WTRVWRAVNDPCIVNCICGVYGMCT---SSDNETVTCNCIPGYTPLNPSDVSEG-CHP-E 321
+ D C + +CG G+C +S+N++ +C P + D +G C P
Sbjct: 276 LVTEFSGPMDSCQIPFVCGKLGLCNLDNASENQSCSC---PDEMRM---DAGKGVCVPVS 329
Query: 322 TVVNYCAETSSKNFT-VEVMDDAGFLFDNFADLARVSNVDVEGCRKAVMDDCYSLGASL- 379
++ ++N + +E+ + +F D + + C +C LG
Sbjct: 330 QSLSLPVSCEARNISYLELGLGVSYFSTHFTDPVE-HGLPLLACHDICSKNCSCLGVFYE 388
Query: 380 -VGSTC--VKTRMPLLN-ARKSASTKGMKAIIKVPTKMSN--PSNHEGKKKNNFNSRLLL 433
+C VK L+ + S + +K+ + +N P + + ++F L+
Sbjct: 389 NTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRKTNAQPPGNNNRGGSSFPVIALV 448
Query: 434 KI---GFIFSAICALL--SGVAAIYYSPAARGLIKRRNYF---DPNSMEINF--REFTFQ 483
+ GF LL A + YS + R F D S I ++F F+
Sbjct: 449 LLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFE 508
Query: 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR 543
EL++AT+ F +G+G G VY+G L + IAVKK+ +EF TE+ IIG
Sbjct: 509 ELEQATENFKMQIGSGGFGSVYKGTL---PDETLIAVKKITNHGLHGRQEFCTEIAIIGN 565
Query: 544 THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP--GWVQRVEIALGVARGL 601
H NLV+L GFC+ + LLVYE M +G+L LF G P W +R +IALG ARGL
Sbjct: 566 IRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF-SGNGPVLEWQERFDIALGTARGL 624
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
YLH C+ +IIHCD+KP+N+LL ++ KISDFG+SKLLN++++ T MRGT
Sbjct: 625 AYLHSGCDQKIIHCDVKPENILLH-----DHFQPKISDFGLSKLLNQEESSLFTTMRGTR 679
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIEL-SRVEEESEE--VDIVLSDWVI 718
GY+APEW+ N ++ K DV+S+G++LLE++ GR++ SR +E+ + +
Sbjct: 680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTS 739
Query: 719 SCMLSRNLQVLVSH---------DPEVLSDL--ERFERMAMVGLWCNHPDPNLRPSMKKV 767
+ ++ L L H DP + + + E++ + L C H +P LRP+M V
Sbjct: 740 TGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAAV 799
Query: 768 IHMLEGTLEVGMP 780
+ M EG++ +G P
Sbjct: 800 VGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 788 | ||||||
| 147827610 | 785 | hypothetical protein VITISV_037411 [Viti | 0.988 | 0.992 | 0.672 | 0.0 | |
| 224123816 | 787 | predicted protein [Populus trichocarpa] | 0.991 | 0.992 | 0.680 | 0.0 | |
| 357480847 | 783 | Cysteine-rich receptor-like protein kina | 0.968 | 0.974 | 0.578 | 0.0 | |
| 224123812 | 789 | predicted protein [Populus trichocarpa] | 0.982 | 0.980 | 0.577 | 0.0 | |
| 225432626 | 785 | PREDICTED: G-type lectin S-receptor-like | 0.959 | 0.963 | 0.571 | 0.0 | |
| 225432630 | 782 | PREDICTED: G-type lectin S-receptor-like | 0.955 | 0.962 | 0.576 | 0.0 | |
| 225432634 | 787 | PREDICTED: G-type lectin S-receptor-like | 0.959 | 0.960 | 0.561 | 0.0 | |
| 225432640 | 770 | PREDICTED: G-type lectin S-receptor-like | 0.963 | 0.985 | 0.525 | 0.0 | |
| 359477337 | 749 | PREDICTED: G-type lectin S-receptor-like | 0.911 | 0.958 | 0.544 | 0.0 | |
| 147827611 | 800 | hypothetical protein VITISV_037412 [Viti | 0.939 | 0.925 | 0.533 | 0.0 |
| >gi|147827610|emb|CAN77456.1| hypothetical protein VITISV_037411 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1123 bits (2904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/790 (67%), Positives = 641/790 (81%), Gaps = 11/790 (1%)
Query: 1 MALKRIVPCVLTLILKFYGLHGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGL 60
MA+ ++ +L L F+G + Q NISLGSSITAGSN SW SPSGDFAFGFY L GL
Sbjct: 1 MAVALMISWLLVLFSSFHGFYAQIPQNISLGSSITAGSNASWRSPSGDFAFGFYHLTSGL 60
Query: 61 YLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSG--AASL 118
YL+GIWFD+I E+TLVW+A+RD PAE GS + LT+DG+L L+Y NGS Q IYSG AASL
Sbjct: 61 YLVGIWFDEISERTLVWSANRDKPAETGSTVQLTSDGQLELSYVNGSTQSIYSGSDAASL 120
Query: 119 ALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLE 178
MQ++GNFVLK+ANS +W SF FPTDT+LPGQV+ +KLYSN + + +YSTGN+ L
Sbjct: 121 GFMQDNGNFVLKDANSFDIWQSFSFPTDTLLPGQVVNQTQKLYSNEKESVNYSTGNFMLA 180
Query: 179 MQADGNLVLSAYHFADPGYWYTGTVTLNNVSLIFN-QSAFMYLINSTGDNIFRLTRNVMT 237
MQ+DGNLVLSAYHFADPGYW T T ++ VSL+F+ Q+A MYL+NS+ NI+ LT+N+ T
Sbjct: 181 MQSDGNLVLSAYHFADPGYWDTSTF-VSTVSLVFDEQTALMYLVNSSNVNIWPLTKNIST 239
Query: 238 PTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNET 297
P EDYYHRATID HGNFQQ+ Y K W RVWRAV +PC+VN ICGVYG CTS DNET
Sbjct: 240 PVEDYYHRATIDDHGNFQQYVYPKVNGRNWERVWRAVEEPCLVNSICGVYGFCTSPDNET 299
Query: 298 VTCNCIPGYTPLNPSDVSEGCHPETVVNYCAETSSKNFTVEVMDDAGFLFDNFADLARVS 357
V+C+C+PGY PL+P+D+S+GC PE V+NYCA+ S +NFTVEV+DDA F F+N ADLARV
Sbjct: 300 VSCSCLPGYIPLDPNDLSKGCRPEIVLNYCADPSMRNFTVEVIDDADFPFENSADLARVR 359
Query: 358 NVDVEGCRKAVMDDCYSLGASLVGSTCVKTRMPLLNARKSASTKGMKAIIKVPTKMSNPS 417
NVDVEGC+KAVMDDCY+L A+LV S C+K +MPLLNARKS STKG+KA+IKVP K+++P
Sbjct: 360 NVDVEGCKKAVMDDCYTLAAALVDSRCIKKKMPLLNARKSVSTKGIKALIKVPMKINDPG 419
Query: 418 NHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSMEINF 477
KK N N R+ L +GFI S + A+LS A+YY P AR L+KR+++ + N++ INF
Sbjct: 420 ML--PKKKNSNDRVYLTVGFITSGVLAVLSAAFAVYYHPVARRLVKRKHFQNANAIGINF 477
Query: 478 REFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTE 537
R+FTFQEL EAT GFSK +G GSSGKV+ GIL KD IEIAVKKLEK IEK +EF+TE
Sbjct: 478 RQFTFQELHEATNGFSKTIGRGSSGKVFSGILSSKDLHIEIAVKKLEKAIEKGEKEFVTE 537
Query: 538 LKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGV 597
LKIIGRTHHKNLVRLLGFC E+ +LLVYELM NGTLS+FLF + ++P W+QR E+ALG+
Sbjct: 538 LKIIGRTHHKNLVRLLGFCIEDGHQLLVYELMKNGTLSDFLFGKEEKPIWIQRAEMALGI 597
Query: 598 ARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNM 657
ARGLLYLHEECETQIIHCDIKPQNVL LD NY AKI+DFG+SKLLNKDQT+T TN+
Sbjct: 598 ARGLLYLHEECETQIIHCDIKPQNVL-----LDANYTAKIADFGLSKLLNKDQTKTITNI 652
Query: 658 RGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717
RGTMGY+APEWLRN VT KVD++SFGVMLLEIICGRRHIELSRVEEE+E+ D+V++DWV
Sbjct: 653 RGTMGYLAPEWLRNAAVTAKVDIYSFGVMLLEIICGRRHIELSRVEEETEDDDLVITDWV 712
Query: 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777
+SCM+SR L+ LV HD EVL D +RFERMA+VGLWC HPDP LRPS+KKV MLEGT+EV
Sbjct: 713 LSCMISRKLEKLVGHDSEVLDDFKRFERMALVGLWCVHPDPILRPSIKKVTQMLEGTVEV 772
Query: 778 GMPPLLHDQM 787
G+PPLL++ M
Sbjct: 773 GIPPLLYEHM 782
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123816|ref|XP_002319171.1| predicted protein [Populus trichocarpa] gi|222857547|gb|EEE95094.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1117 bits (2889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/791 (68%), Positives = 637/791 (80%), Gaps = 10/791 (1%)
Query: 1 MALKRIVPCVLTLILKFYGLHGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGL 60
M +++I+P +L L F+ LH Q PNISLGSSI AGS SW S S +FAFGFYSL L
Sbjct: 1 MTIQKILPFLLLQFLYFHELHAQIPPNISLGSSIKAGSGNSWRSLSDEFAFGFYSLPNNL 60
Query: 61 YLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSGA-ASLA 119
YL+GIWF+KIPEKTLVW+A+RDSPA AGS + LT DG+L LT+ NGS+Q IY G A L
Sbjct: 61 YLVGIWFNKIPEKTLVWSANRDSPAAAGSTVRLTFDGQLTLTHLNGSIQSIYRGRRAGLG 120
Query: 120 LMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEM 179
M NDGNFVL++ +S+V+W SF+ PTDTILPGQVL +KLYSN+ GT DYSTGN+ L+M
Sbjct: 121 FMLNDGNFVLRDDSSSVIWQSFNSPTDTILPGQVLSDDQKLYSNANGTVDYSTGNFMLQM 180
Query: 180 QADGNLVLSAYHFADPGYWYTGTVTLNNVSLIF-NQSAFMYLINSTGDNIFRLTRNVMTP 238
Q DGNLVLSAYHF+DPGYWYTGTV NNVSL+F N + FMYL+NSTGDNI+ LTRNV TP
Sbjct: 181 QFDGNLVLSAYHFSDPGYWYTGTVR-NNVSLVFSNHTFFMYLVNSTGDNIYPLTRNVSTP 239
Query: 239 TEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETV 298
DYYHRATI+ HG+FQQFAYHKS SS WTRVWRA+++PC+VN ICGVYGMC S +NET
Sbjct: 240 VGDYYHRATINDHGDFQQFAYHKSNSSGWTRVWRAIDEPCVVNAICGVYGMCFSLNNETA 299
Query: 299 TCNCIPGYTPLNPSDVSEGCHPETVVNYCAETSSKNFTVEVMDDAGFLFDNFADLARVSN 358
TC CIPGY PL+P+ VS+GC PETVVNYCA+ S +NFT+ V+DDA F F++ ADLARV N
Sbjct: 300 TCKCIPGYIPLDPNHVSKGCRPETVVNYCADPSMRNFTINVIDDADFPFESDADLARVKN 359
Query: 359 VDVEGCRKAVMDDCYSLGASLVGSTCVKTRMPLLNARKSASTKGMKAIIKVPTKMSNPSN 418
VD+EGC+KA+MDDCYSL ASLV S C+K RMPLLNARKS STKG +A++KVP K SNP
Sbjct: 360 VDLEGCKKALMDDCYSLSASLVDSRCIKKRMPLLNARKSFSTKGRQALVKVPMK-SNPGI 418
Query: 419 HEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSMEINFR 478
E KK N+F++R+ LKI I +A A GV+AIYY PA R IKR+ Y + NS+ INF+
Sbjct: 419 QEHKKNNDFDTRVFLKISLIVTATLAFCFGVSAIYYHPAPRRFIKRKRYSNANSIGINFQ 478
Query: 479 EFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTEL 538
EF + ELQ+AT GFSK +G GSS KVY GIL +KD QI+IAVK L K IEK +EFMTEL
Sbjct: 479 EFKYLELQKATNGFSKTLGRGSSAKVYSGILSMKDIQIDIAVKVLTKSIEKGEKEFMTEL 538
Query: 539 KIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGV 597
KIIGRT+HKNLVRLLGFC E D++LLVYELM NG+L+N LF +G +RP WV+R E+ L +
Sbjct: 539 KIIGRTYHKNLVRLLGFCVENDQQLLVYELMANGSLANLLFGKGSERPNWVRRAEMVLEI 598
Query: 598 ARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNM 657
ARGLLYLH+ECE QIIHCDIKP+NVL +D NY AK++DFG+SKLLNKDQTRTDTN+
Sbjct: 599 ARGLLYLHDECEAQIIHCDIKPENVL-----IDNNYTAKLADFGLSKLLNKDQTRTDTNL 653
Query: 658 RGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717
RGT+GY+APEW+RN VT+KVDV+SFGVMLLEI+C RRHIE SRVEEESEE D+VLSDWV
Sbjct: 654 RGTVGYLAPEWIRNERVTSKVDVYSFGVMLLEILCCRRHIEPSRVEEESEEDDLVLSDWV 713
Query: 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777
ISCM + L +V HDPEVLSD +RFERM +VGLWC HPD RPSMKKV MLEGT E+
Sbjct: 714 ISCMAAGKLGTVVGHDPEVLSDFKRFERMTLVGLWCIHPDAMSRPSMKKVTQMLEGTSEI 773
Query: 778 GMPPLLHDQMS 788
G+PP L DQMS
Sbjct: 774 GIPPSLSDQMS 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357480847|ref|XP_003610709.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355512044|gb|AES93667.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 938 bits (2425), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/798 (57%), Positives = 584/798 (73%), Gaps = 35/798 (4%)
Query: 1 MALKRIVPCV-LTLILKFYGLHGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGG 59
M+L +PC+ L LI L+ I L SSITAGSN++W SPSG F FGFY L G
Sbjct: 1 MSLAMFLPCIILVLISSLNVLYA-----IDLKSSITAGSNSTWKSPSGYFEFGFYPLPNG 55
Query: 60 LYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQI------YS 113
L+L GIWF KIP+KT VW + E S + LT++G LL+TY NG+ YS
Sbjct: 56 LFLPGIWFAKIPQKTFVWY--QTPSVETNSLLQLTSEGHLLITYPNGTTSHTIDNIGGYS 113
Query: 114 GAASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTG 173
AA+ A MQ+DGNFVLK++N VWDSF+ P++TILPGQ L + + LYS +G ++YS G
Sbjct: 114 EAANSAYMQDDGNFVLKDSNLRTVWDSFNSPSNTILPGQTLKSNQILYSKGKGDSNYSMG 173
Query: 174 NYTLEMQADGNLVLSAYHFADPGYWYTGTVTLNNVSLIFNQ-SAFMYLINSTGDNIFRLT 232
N+ LEMQADGNL+L A+ ++DP YWYT T+ ++N+SL+FN+ S+ +YL G+ I+ LT
Sbjct: 174 NFMLEMQADGNLILKAHQWSDPSYWYTSTL-VSNLSLVFNETSSLLYLATGIGNIIYSLT 232
Query: 233 RNVMTPTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTS 292
++ TP +DYYHRATID +GNFQQ+ YHK + W RVWRA++DPC V+ +CG+YG+CTS
Sbjct: 233 KSTPTPVKDYYHRATIDENGNFQQYVYHKRNGTNWERVWRAIDDPCRVDYVCGIYGLCTS 292
Query: 293 SDNETVTCNCIPGYTPLNPSDVSEGCHPETVVNYCAETSSKNFTVEVMDDAGFLFDNFAD 352
DNE+V C CI GY PL+ DVS+GC P+TV+NYC+ S NF + V DD F F + D
Sbjct: 293 PDNESVNCECIQGYIPLDQEDVSKGCRPKTVINYCSGPSMMNFELRVFDDTDFQF--YPD 350
Query: 353 LARVSNVDVEGCRKAVMDDCYSLGASLVG--STCVKTRMPLLNARKSASTKGMKAIIKVP 410
A +++VD+E C+K+V+DDC + A+ STC K RMPLLNAR S+S+KG KA++KVP
Sbjct: 351 FALINDVDLESCKKSVIDDCNIIAATYNSSTSTCAKKRMPLLNARNSSSSKGQKALLKVP 410
Query: 411 TKMSNPSNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRR-NYFD 469
+ + E K +FN R+ LK+ SA A G A YY P + LI RR Y +
Sbjct: 411 YSNNESNTIEVSKNKSFNVRVFLKVMVAISATLACFFGALAAYYHPFVKRLITRRKKYLN 470
Query: 470 PNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK 529
++ INFREFTFQEL EAT GFS+++G GSSGKVY G L + DT+I IAVKKLEK IEK
Sbjct: 471 ATAIGINFREFTFQELHEATDGFSRILGRGSSGKVYHGTLIIDDTEIGIAVKKLEKKIEK 530
Query: 530 TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQ 589
+ EFMTELKIIG THHKNLV+LLGFC E++ RLLVYELMPNG LS+ LF EG+RP W Q
Sbjct: 531 SENEFMTELKIIGLTHHKNLVKLLGFCMEDNHRLLVYELMPNGALSSLLFGEGERPQWSQ 590
Query: 590 RVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649
RVE+ALG+ARGLLYLHEECETQIIHCDIKPQNVL LD N++AKI+DFG+SKLLNKD
Sbjct: 591 RVEMALGIARGLLYLHEECETQIIHCDIKPQNVL-----LDANHIAKIADFGLSKLLNKD 645
Query: 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEV 709
QTRT TN RGT+GY+APEWLR+ P+T KVDVFS+GVMLLEIIC RR SE+
Sbjct: 646 QTRTSTNFRGTIGYIAPEWLRSAPITAKVDVFSYGVMLLEIICCRRG---------SEDD 696
Query: 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769
D+VL + V+ CM++R L+++VSHD EVL+D +RFE+MA+VGLWC HP+P LRPSMKKV
Sbjct: 697 DLVLVNLVLRCMVTRKLEIVVSHDLEVLNDFKRFEQMALVGLWCLHPNPTLRPSMKKVTQ 756
Query: 770 MLEGTLEVGMPPLLHDQM 787
MLEGT+EVG+PPLL+DQM
Sbjct: 757 MLEGTVEVGVPPLLYDQM 774
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123812|ref|XP_002319170.1| predicted protein [Populus trichocarpa] gi|222857546|gb|EEE95093.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2363), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/793 (57%), Positives = 574/793 (72%), Gaps = 19/793 (2%)
Query: 6 IVPCVLTLILKFYGLHGQ---TSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYL 62
IV L +L F Q T+ I+LG+SITAG+N+SW SPSGDFAFGFY L G++L
Sbjct: 4 IVLWCLPFVLSFLCSLAQPQITTNTINLGASITAGTNSSWRSPSGDFAFGFYPLLNGMFL 63
Query: 63 LGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSG--AASLAL 120
+GIWFDKIPE+TLVW+A+RD PA GS I T DG+L+LT+ NG+ IY+G AS AL
Sbjct: 64 VGIWFDKIPERTLVWSANRDDPARTGSTINFTLDGQLVLTHSNGTGYLIYNGTFGASSAL 123
Query: 121 MQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQ 180
MQNDGNFV+K +S V+W SFD PT+TIL GQVL+ GKKLYSN+ GT DYSTG Y LE+Q
Sbjct: 124 MQNDGNFVVKTNSSEVIWQSFDSPTNTILLGQVLVMGKKLYSNANGTVDYSTGQYMLELQ 183
Query: 181 ADGNLVLSAYHFADPGYWYTGTVTLNNVSLIFNQS-AFMYLINSTGDNIFRLTRNVMTPT 239
DGN+V+SAY FADPGYW+T T NVSLIFNQS AFMY++N T +R+T V TP
Sbjct: 184 MDGNVVMSAYKFADPGYWFTLTEGNQNVSLIFNQSTAFMYVVNHTSIT-YRMTSQVPTPI 242
Query: 240 EDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVN---DPCIVNCICGVYGMCTSSDNE 296
DYYHRATI+ HGN QQF YHK S WT VW + +PCI ICGVYG CTS DN
Sbjct: 243 GDYYHRATINDHGNLQQFVYHKENGSGWTVVWEPESIKAEPCIPFNICGVYGFCTSIDNT 302
Query: 297 TVTCNCIPGYTPLNPSDVSEGCHPETVVNYCAETSS-KNFTVEVMDDAGFLFDNFADLAR 355
T+ C+C+PGY+P +PS S+GC+P+TV+++CA SS NFT+E +D+A F FAD+AR
Sbjct: 303 TINCDCLPGYSPWDPSIPSKGCYPDTVIDFCAPNSSASNFTLEEIDNADFPNGAFADMAR 362
Query: 356 VSNVDVEGCRKAVMDDCYSLGASLVGSTCVKTRMPLLNARKS-ASTKGMKAIIKVPTKMS 414
V+ DVE CRKA+MDDC+++ LV S C K R PLLNAR+S ST + A IK+P +
Sbjct: 363 VTPADVEECRKAIMDDCFAVAGVLVESVCYKKRTPLLNARRSIPSTNNIVAFIKIPK--A 420
Query: 415 NPSNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSME 474
N +N K ++ S + L G + +I LL +IY+ P A+ I ++ P +E
Sbjct: 421 NNNNQIQDKDDDSPSWIALLAGLLLCSIMTLLFATISIYHHPLAQPYISKKQLPVPKPVE 480
Query: 475 INFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF 534
IN + F+FQEL +AT G +G G+ G VY G+L L+ ++EIAVKKLEK IE+ +EF
Sbjct: 481 INLKAFSFQELLQATNGLRNKLGRGAFGTVYSGVLTLEAEEVEIAVKKLEKVIEQGEKEF 540
Query: 535 MTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIA 594
+TE+++IG THHKNLVRL+GFC+E++ RLLVYEL+ NGTLS+FLF E +RP W QR E
Sbjct: 541 LTEVQVIGLTHHKNLVRLVGFCNEKNHRLLVYELVKNGTLSDFLFGEERRPSWDQRAETV 600
Query: 595 LGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD 654
G+ARGLLYLHEECETQIIHCDIKPQNVL LD NY AKI+DFG++KLL KDQTRT
Sbjct: 601 YGIARGLLYLHEECETQIIHCDIKPQNVL-----LDKNYTAKIADFGLAKLLKKDQTRTS 655
Query: 655 TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714
T +RGTMGY+APEWL+N PVTTKVDV+SFGV+LLEII R+HIEL +V E +E+ +++L
Sbjct: 656 TKVRGTMGYMAPEWLKNAPVTTKVDVYSFGVVLLEIIFCRKHIELHQVNESTEDNEMILI 715
Query: 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774
DWV+ + + NL +VSHD EVL D RFERM +VGLWC P+P LRPSM KV MLEGT
Sbjct: 716 DWVLCNVRAGNLHAIVSHDSEVLEDFCRFERMVLVGLWCICPNPTLRPSMNKVTQMLEGT 775
Query: 775 LEVGMPPLLHDQM 787
EV PPL+ Q+
Sbjct: 776 SEVDDPPLIDAQI 788
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432626|ref|XP_002278028.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2322), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/773 (57%), Positives = 571/773 (73%), Gaps = 17/773 (2%)
Query: 19 GLHGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWA 78
G H Q NISLGSS +N+SWLS SGDFAFGFY L GGL+LLGIWF+KIPEKT+VW+
Sbjct: 19 GSHAQVKGNISLGSSFDTHTNSSWLSLSGDFAFGFYPLPGGLFLLGIWFNKIPEKTVVWS 78
Query: 79 ADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSGA--ASLALMQNDGNFVLKNANSAV 136
A+RD+PA AGS + LT G L+LT+ NG+V QI +GA A+ A +QN+GN VL+N S+V
Sbjct: 79 ANRDAPAPAGSSVNLTLAGSLVLTFPNGTVSQISNGASAANSASLQNNGNLVLRNFVSSV 138
Query: 137 VWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPG 196
VW SFD PTDT+L GQ + +LYSN+ GT DYSTG + LE+ DGN+VL+ + +AD G
Sbjct: 139 VWQSFDNPTDTLLLGQKVPWDHRLYSNANGTVDYSTGKFMLEVGTDGNVVLATFRWADSG 198
Query: 197 YWYTGTVTLNNVSLIFNQS-AFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQ 255
YW+T T+ NVSL+FN+S A MY+ N T I+RLT NV TP + YYHRAT++ GNFQ
Sbjct: 199 YWWTDTIQ-PNVSLVFNESTALMYVTNLTSI-IYRLTTNVPTPVDRYYHRATVEDTGNFQ 256
Query: 256 QFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTCNCIPGYTPLNPSDVS 315
Q+ Y K S WT VW+A +PC VN ICGVYG CTS DN+ VTC+C+PGY+ ++P+ S
Sbjct: 257 QYIYPKVNGSGWTSVWKAATEPCSVNGICGVYGYCTSPDNQNVTCSCLPGYSLMDPNVPS 316
Query: 316 EGCHPETVVNYCAETSSK--NFTVEVMDDAGFLFDNFADLARVSNVDVEGCRKAVMDDCY 373
+GC+P C+++ S N+ +EV+D+A + + F ++ R+ N D+E CR+AVMDDCY
Sbjct: 317 KGCYPNVPPQQCSKSPSDVTNYNIEVIDNADIVNNLFTEMTRLYNSDLEKCREAVMDDCY 376
Query: 374 SLGASLVG-STCVKTRMPLLNARKSA-STKGMKAIIKVPTKMSNPSNHEGKKKNNFNSRL 431
+ A+L + C K R+P +NAR+S+ ST G++ IIKVP ++ K S++
Sbjct: 377 CMAATLTADNVCRKKRIPFMNARQSSPSTNGIQTIIKVPVVEQGKTDGLIAGKKEPRSQM 436
Query: 432 LLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEATKG 491
+LK+ S + ALL AIY +P AR + R F N EIN ++FT++EL EAT G
Sbjct: 437 ILKVCLSISTMLALLFAAFAIY-NPIAR--LSRARKFLANPAEINLKKFTYRELHEATDG 493
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
F +G GS G VY GIL L+D QI+IAVKKLE+ +E+ ++EF+TEL++IG+THHKNLV+
Sbjct: 494 FKNKIGRGSFGTVYSGILNLEDKQIKIAVKKLERVMEQGDKEFLTELRVIGQTHHKNLVK 553
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
LLGFC E+ RLLVYELM NGTLS FLF EG++P W R +I L +ARGL YLH+ECETQ
Sbjct: 554 LLGFCDEQSHRLLVYELMTNGTLSGFLFSEGEKPCWDHRAQIVLAIARGLSYLHDECETQ 613
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
IIHCDIKPQNVLLD + + KI++FG++KLL KDQTRT TN+RGTMGY+APEWL+N
Sbjct: 614 IIHCDIKPQNVLLD-----SQFNPKIAEFGLAKLLMKDQTRTSTNVRGTMGYMAPEWLKN 668
Query: 672 VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVS 731
VPVT KVDV+SFGV+LLEIIC R+HIEL+RVEEESEE D++L DWV++C+ L+ +V
Sbjct: 669 VPVTAKVDVYSFGVLLLEIICCRKHIELNRVEEESEEDDLILVDWVLTCVRKGKLEAVVK 728
Query: 732 HDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPPLLH 784
HDPEV D +RFERMAMVGLWC HPDP LRP+MKKVI MLEGT+EV +PPL+H
Sbjct: 729 HDPEVSDDFKRFERMAMVGLWCVHPDPVLRPTMKKVIQMLEGTVEVAVPPLVH 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432630|ref|XP_002278071.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2284), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/774 (57%), Positives = 569/774 (73%), Gaps = 21/774 (2%)
Query: 20 LHGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAA 79
L G + NISLGSS +N+SWLSPSG+FAFGFY L GGL+L+GIWFDKIPEKT+VW+A
Sbjct: 17 LLGSHAENISLGSSFDTNTNSSWLSPSGEFAFGFYPLAGGLFLVGIWFDKIPEKTVVWSA 76
Query: 80 DRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSG---AASLALMQNDGNFVLKNANSAV 136
+RD PA AGS I T G L++T NG+V QIY+G AA+ A +QN+GN VL ++ S V
Sbjct: 77 NRDDPAPAGSSINFTVAGSLVMTVPNGTVTQIYNGDTNAANSASLQNNGNLVLWSSVSRV 136
Query: 137 VWDSFDFPTDTILPGQVLLTGK-KLYSNSRGTADYSTGNYTLEMQA-DGNLVLSAYHFAD 194
+W SF+ PTDT+LPGQ + G +L+SN+ GT DYS GN+ LE+Q+ DGN+ L A+ F+D
Sbjct: 137 LWQSFEHPTDTLLPGQTIPAGDTRLFSNTNGTVDYSKGNFQLEVQSVDGNMGLFAFRFSD 196
Query: 195 PGYWYTGTVTLNNVSLIFNQS-AFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGN 253
GYW++ T NVSL+FN++ A MY+ N T IFR+TR+V TP YYHRATI+ GN
Sbjct: 197 SGYWWSNTTQQTNVSLVFNETTASMYMTNLTSI-IFRMTRDVPTPVNIYYHRATIEDTGN 255
Query: 254 FQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTCNCIPGYTPLNPSD 313
FQQ+ Y+K + W +WRA+ +PC VN ICGVYG CTS N+ TC+C+PGY+ ++P+
Sbjct: 256 FQQYVYNKVNGTGWRSIWRAIEEPCTVNGICGVYGYCTSPRNQNATCSCLPGYSLIDPNI 315
Query: 314 VSEGCHPETVVNYCAETSSK-NFTVEVMDDAGFLFDNFADLARVSNVDVEGCRKAVMDDC 372
S+GC P+ V CA T S+ + VEV+DDA D FA+L R+ D++GC KAV DDC
Sbjct: 316 PSKGCRPDVPVEQCANTPSETEYRVEVIDDADIKNDIFAELTRLYGYDLDGCIKAVQDDC 375
Query: 373 YSLGASLV-GSTCVKTRMPLLNARKSA-STKGMKAIIKVPTKMSNPSNHEGKKKNNFNSR 430
Y + A+ + C K R+P +NARKS+ ST G++AIIKVP K GKK+ S+
Sbjct: 376 YCVAATYTTDNVCRKKRIPFMNARKSSPSTDGIQAIIKVPVKTD--VQIAGKKEPR--SQ 431
Query: 431 LLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEATK 490
++LK+ SAI A L AAIY P AR R+ +P EIN +FT++EL EAT
Sbjct: 432 MILKVCLSISAILAFLFAAAAIYNHPIARRSRARKVLANP--AEINLNKFTYRELHEATD 489
Query: 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLV 550
GF +G GS G VY GIL L+D QI+IAVKKLE+ +E+ ++EF+TE+++IG+THHKNLV
Sbjct: 490 GFKNKIGRGSFGTVYSGILNLEDKQIKIAVKKLERVMEQGDKEFLTEVRVIGQTHHKNLV 549
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
+LLGFC E+ RLLVYELM NGTLS FLF EG++P W R +I L +ARGL YLH+ECET
Sbjct: 550 KLLGFCDEQSHRLLVYELMTNGTLSGFLFAEGEKPCWDHRAQIVLAIARGLSYLHDECET 609
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
QIIHCDIKPQNVLLD + + AKI+DFG++KLL KDQTRT TN+RGTMGY+APEWL+
Sbjct: 610 QIIHCDIKPQNVLLD-----SQFNAKIADFGLAKLLMKDQTRTSTNVRGTMGYMAPEWLK 664
Query: 671 NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730
N PVT KVDV+SFGV+LLEIIC RRHIEL+RVEEESEE D++L DWV++C+ L+ +V
Sbjct: 665 NAPVTAKVDVYSFGVLLLEIICCRRHIELNRVEEESEEDDLILMDWVLTCVRKGKLEAVV 724
Query: 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPPLLH 784
HDPEV D +RFERMAMVGLWC HPDP LRP+MKKVI MLEGT+EV +PPL+H
Sbjct: 725 KHDPEVSDDFKRFERMAMVGLWCVHPDPVLRPTMKKVIQMLEGTVEVAVPPLVH 778
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432634|ref|XP_002278198.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 874 bits (2258), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/773 (56%), Positives = 558/773 (72%), Gaps = 17/773 (2%)
Query: 21 HGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAAD 80
H QT NISLGS +T ++++WLSPSGDFAFGFY L GL+LLGIWF+KIPE+TLVW+A+
Sbjct: 23 HAQTPENISLGSGLTTTTDSTWLSPSGDFAFGFYPLDSGLFLLGIWFNKIPEETLVWSAN 82
Query: 81 RDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYS-GAASLALMQNDGNFVLKNANSAVVWD 139
RD+PA GS I LT G LLLTY NGS+ IY AAS A M ++GNFVL ++ S V+W
Sbjct: 83 RDNPAPEGSTINLTASGYLLLTYPNGSLDHIYEDAAASSASMLDNGNFVLWSSVSRVLWQ 142
Query: 140 SFDFPTDTILPGQVLLTGK-KLYSNSRGTADYSTGNYTLEMQA-DGNLVLSAYHFADPGY 197
SF+ PTDT+LPGQ + G +L+SN+ GT DYS GN+ LE+Q+ DGN+ L A+ F+D GY
Sbjct: 143 SFEHPTDTLLPGQTIPAGDTRLFSNTNGTVDYSKGNFQLEVQSVDGNMGLFAFRFSDSGY 202
Query: 198 WYTGTVTLNNVSLIFNQS-AFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQ 256
W++ T NVSL+FN++ A MY+ N T IFR+TR+V TP YYHRATI+ GNFQQ
Sbjct: 203 WWSNTTQQTNVSLVFNETTASMYMTNLTSI-IFRMTRDVPTPVNIYYHRATIEDTGNFQQ 261
Query: 257 FAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTCNCIPGYTPLNPSDVSE 316
+ Y+K + W +WRA+ +PC VN ICGVYG CTS N+ TC+C+PGY+ ++P+ S+
Sbjct: 262 YVYNKVNGTGWRSIWRAIEEPCTVNGICGVYGYCTSPRNQNATCSCLPGYSLIDPNIPSK 321
Query: 317 GCHPETVVNYCAETSSKN-FTVEVMDDAGFLFDNFADLARVSNVDVEGCRKAVMDDCYSL 375
GC P+ V CA T S+ + VEV+DDA D FA+L R+ D++GC KAV DDCY +
Sbjct: 322 GCRPDVPVEQCANTPSETEYRVEVIDDADIKNDIFAELTRLYGYDLDGCIKAVQDDCYCV 381
Query: 376 GASLV-GSTCVKTRMPLLNARKS-ASTKGMKAIIKVPTKMSNPSNHEGKKKNNFNSRLLL 433
A+ + C K R+P +NARKS ST G+KAIIKVP K+ +P K NN ++++
Sbjct: 382 AATYTTDNVCRKKRIPFMNARKSIPSTTGIKAIIKVPVKIEDPI----KGTNNSRPQVVV 437
Query: 434 KIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEATKGFS 493
+ + ALL IY + + S +IN R FT+QEL +AT GF
Sbjct: 438 LVCLSVVSFLALLFATIIIYQNLVVPRFGLSKLAPSTQSADINLRTFTYQELHKATDGFR 497
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G G+SG VY G LR +D ++EIAVKKLE+ IE+ + EF+ E++ IG+THH+NLVRLL
Sbjct: 498 NRLGRGASGSVYSGTLRFEDKEMEIAVKKLERVIEQGDREFLAEVRAIGQTHHRNLVRLL 557
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
GFC+E+ RLLVYELM NG LS+FLF +G++P W R EI L +ARGLLYLHEECET+II
Sbjct: 558 GFCNEQSHRLLVYELMKNGPLSSFLFSKGEKPCWDHRAEIVLAIARGLLYLHEECETRII 617
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVP 673
HCDIKPQNVLLD +Y AKI+DFG++KLL KDQTRT TN RGTMGY+APEWL+ P
Sbjct: 618 HCDIKPQNVLLD-----QHYNAKIADFGLAKLLRKDQTRTSTNARGTMGYMAPEWLKCAP 672
Query: 674 VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD 733
VT KVDV SFGVMLLEIIC RRHIEL R+EEE+E+ D++L+DWV++C+ L+V+V HD
Sbjct: 673 VTAKVDVHSFGVMLLEIICCRRHIELDRIEEETEDDDLILTDWVLNCLRLGKLEVVVKHD 732
Query: 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPPLLHDQ 786
PEVL D +RFERMAMVGLWC +PDP LRP+MK+VI MLEGT+E G+PPL+ Q
Sbjct: 733 PEVLGDFKRFERMAMVGLWCVNPDPILRPTMKRVIQMLEGTIEAGVPPLVTAQ 785
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432640|ref|XP_002278282.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 845 bits (2182), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/797 (52%), Positives = 556/797 (69%), Gaps = 38/797 (4%)
Query: 1 MALKRIVPCVLTLILKFYGLHGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGL 60
M ++ C L L + QT+ N +LGS ITAG+++SW SPSG FAFGFY L G
Sbjct: 1 MVAAGVLVCSLVFALSLFVCSAQTTSNKNLGSGITAGTDSSWKSPSGHFAFGFYRLDSGC 60
Query: 61 YLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSGA-ASLA 119
+L+GIWFDKI E TLVW+A+RD PA GS + LT G+L+LT+ NG+ IY+G AS A
Sbjct: 61 FLVGIWFDKIQENTLVWSANRDDPARIGSTVNLTLSGQLVLTHSNGTKLLIYNGTLASSA 120
Query: 120 LMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEM 179
M++DGNFVL++++S +VW SF FPTDT+LPGQVL+ G+KLYSN GT DYSTG + LE+
Sbjct: 121 SMEDDGNFVLRDSSSKIVWQSFAFPTDTVLPGQVLVMGQKLYSNINGTVDYSTGRFMLEL 180
Query: 180 QADGNLVLSAYHFADPGYWYTGTVTLNNVSLIFNQS-AFMYLINSTGDNI-FRLTRNVMT 237
Q DGN+V+S++ FADPGYW+T T N+SL+FN S AFMY++N+T + R V T
Sbjct: 181 QMDGNVVISSFQFADPGYWFTLTEGDKNISLVFNASTAFMYVMNTTSIRYRMGMEREVPT 240
Query: 238 PTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNET 297
P DYYHRA I+ +GN QQ Y K + RW VW AV +PCIV ICGVYG CTS DN+T
Sbjct: 241 PITDYYHRAVINDYGNLQQMVYKKGSVGRWKVVWEAVTEPCIVYNICGVYGFCTSPDNKT 300
Query: 298 VTCNCIPGYTPLNPSDVSEGCHPETVVNYCAETS-SKNFTVEVMDDAGFLFDNFADLARV 356
VTC C+ GY+P +P+ S+GC+P +V++CA S + + +E MD+ F F D+A+
Sbjct: 301 VTCTCLRGYSPWDPNVPSKGCYPNEMVDFCAPNSLASDLILEEMDNTDFPNGAFGDMAKS 360
Query: 357 SNVDVEGCRKAVMDDCYSLGASLVGSTCVKTRMPLLNARKSASTKGMKAIIKVPTKMSNP 416
+ D+ CRKAVMDDC + V S C K R+ ++ ++
Sbjct: 361 APSDLVSCRKAVMDDCSCMAGVWVESVCYKKRI----------------VVTSRVRLGIY 404
Query: 417 SNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSM--- 473
++E + SR +L G + +I A+L +AIY+ P A+ I++ P ++
Sbjct: 405 DHNESRAP----SRAVLLAGLLSCSILAVLFAASAIYHHPLAQPYIRKH---PPPTLKVP 457
Query: 474 -EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNE 532
EIN + F+FQEL+E T GF +G G+ G VY G+L ++D ++EIAVK+L+K I++ E
Sbjct: 458 VEINLKAFSFQELREGTNGFKNKLGGGAFGTVYGGVLTIEDEEVEIAVKQLDKVIDQQGE 517
Query: 533 -EFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV 591
EFM E+++IG THHKNLVRLLGFC++ + RLLVYELM NG LS+FLF EG++P W QR
Sbjct: 518 KEFMNEVRVIGLTHHKNLVRLLGFCNQHNHRLLVYELMKNGALSSFLFDEGKKPSWDQRA 577
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651
+I LG++RGLLYLHEECETQIIHCDIKPQNVL LD+NY AKI+DFG++KLL KDQT
Sbjct: 578 QIVLGISRGLLYLHEECETQIIHCDIKPQNVL-----LDSNYTAKIADFGLAKLLKKDQT 632
Query: 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVE-EESEEVD 710
RT TN+RGTMGY+APEWL+N PVTTKVDV+S+GVMLLEII R+H+EL R+E EE+ D
Sbjct: 633 RTSTNVRGTMGYMAPEWLKNAPVTTKVDVYSYGVMLLEIIFCRKHLELHRIEDEETGGDD 692
Query: 711 IVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770
++L DWV+ C+ L+ +VSHD E+L D +RFERMAMVGLWC P+P LRPSMK V+ M
Sbjct: 693 MILVDWVLCCVRDGKLEAVVSHDTELLCDYKRFERMAMVGLWCVCPNPTLRPSMKMVMQM 752
Query: 771 LEGTLEVGMPPLLHDQM 787
LEG+++VG+PPL+ M
Sbjct: 753 LEGSIDVGIPPLIETLM 769
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477337|ref|XP_002278047.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 843 bits (2179), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/775 (54%), Positives = 547/775 (70%), Gaps = 57/775 (7%)
Query: 19 GLHGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWA 78
G H Q NISLGSS +N+SWLSPSGDFAFGFY L GGL+LLGIWFDKI EKT+VW+
Sbjct: 19 GSHAQLQGNISLGSSFDTETNSSWLSPSGDFAFGFYPLPGGLFLLGIWFDKITEKTVVWS 78
Query: 79 ADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSGAASLALMQNDGNFVLKNANSAVVW 138
A+RD PA AGS + LT G L+LT+ NG+V QI+ GA + A N +F N+ ++W
Sbjct: 79 ANRDDPAPAGSSVNLTLTGSLVLTFPNGTVIQIHDGATNPA---NSASF----QNNGLLW 131
Query: 139 DSFDFPTDTILPG--QVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPG 196
+ PT ++ G Q + + ++LYSN+ GT DYSTG + LE+ DGN+VL+ + +AD G
Sbjct: 132 YLPNIPTAKLMSGLVQTVPSDRRLYSNANGTVDYSTGKFMLEVGTDGNVVLATFRWADSG 191
Query: 197 YWYTGTVTLNNVSLIFNQS-AFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQ 255
YW+T T+ NVSL+FN+S A MY+ N T I+RLT NV TP + YYHRAT++ GNFQ
Sbjct: 192 YWWTNTIQ-PNVSLVFNESTALMYVTNLTSI-IYRLTTNVSTPVDRYYHRATVEDTGNFQ 249
Query: 256 QFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTCNCIPGYTPLNPSDVS 315
Q+ Y K S WT VW+AV PC VN ICGVYG CTS+DN+ VTC+C+PGY+ ++P+ S
Sbjct: 250 QYIYPKVNGSGWTSVWKAVTQPCSVNGICGVYGYCTSADNQNVTCSCLPGYSLMDPNVPS 309
Query: 316 EGCHPETVVNYCAETSSK--NFTVEVMDDAGFLFDNFADLARVSNVDVEGCRKAVMDDCY 373
+GC+P C+++ S N+T+EV+ DA + + FA++ R+ N D+E CR++ MDDCY
Sbjct: 310 KGCYPNVPPQQCSKSPSNVTNYTIEVIGDADIVNNEFAEMTRLYNYDLEKCRQSCMDDCY 369
Query: 374 SLGASLVG-STCVKTRMPLLNARKSA-STKGMKAIIKVPTKMSNPSNH--EGKKKNNFNS 429
+ A+L + C K R+P +NAR+S+ ST G++ IIKVP ++ EGKK S
Sbjct: 370 CMAATLTADNVCRKKRIPFMNARQSSPSTNGIQTIIKVPVVEPGKTDGQIEGKKSEARRS 429
Query: 430 RLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEAT 489
R AR ++ N EIN ++FT++EL EAT
Sbjct: 430 R---------------------------ARKVLA-------NPAEINLKKFTYRELHEAT 455
Query: 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL 549
GF +G+GS G VY G+L +D +IEIAVKKL+K +E+ ++EF+TE+ +IG+THHKNL
Sbjct: 456 DGFKNKIGSGSFGTVYSGVLNFEDKEIEIAVKKLKKVMEQGDKEFLTEVMVIGQTHHKNL 515
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
V+LLGFC E+ RLLVYELM NGTLS FLF EG++P W R +I L VARGL YLH+ECE
Sbjct: 516 VKLLGFCDEQSHRLLVYELMTNGTLSGFLFAEGEKPCWDHRAQIVLAVARGLSYLHDECE 575
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
TQIIHCDIKPQNVLLD + + KI+DFG++KLL KDQTRT TN+RGTMGY+APEWL
Sbjct: 576 TQIIHCDIKPQNVLLD-----SQFNPKIADFGLAKLLMKDQTRTSTNVRGTMGYMAPEWL 630
Query: 670 RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729
+NVPVT KVDV+SFGV+LLEIIC RRHIEL+RVEEESEE D++L DWV++C++ L+ +
Sbjct: 631 KNVPVTAKVDVYSFGVLLLEIICCRRHIELNRVEEESEEDDLILVDWVLTCVIRGKLEAV 690
Query: 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPPLLH 784
V HDPEV D +RFERMAMVGLWC HPDP LRP+MKKVI MLEGT+EV +PPL H
Sbjct: 691 VKHDPEVSDDFKRFERMAMVGLWCVHPDPILRPTMKKVIQMLEGTVEVAVPPLAH 745
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147827611|emb|CAN77457.1| hypothetical protein VITISV_037412 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2131), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/783 (53%), Positives = 544/783 (69%), Gaps = 43/783 (5%)
Query: 13 LILKFYGLHGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPE 72
LI QT+ N +LGS ITAG+++SW SPSG FAFGFY L G +L+GIWFDKI E
Sbjct: 52 LICNRLDYQTQTTSNKNLGSGITAGTDSSWKSPSGHFAFGFYRLDSGCFLVGIWFDKIQE 111
Query: 73 KTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSGA-ASLALMQNDGNFVLKN 131
KTLVW+A+RD PA GS + LT G+L+LT+ NG+ IY+G A A M+++GNFVL+N
Sbjct: 112 KTLVWSANRDDPARIGSTVNLTLSGQLVLTHSNGTKLLIYNGTLARSASMEDNGNFVLRN 171
Query: 132 ANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQ-ADGNLVLSAY 190
++S ++W SFDFPTDTILPGQVL+ G+KLYSN+ GT DYSTG + LE+Q DGN+VLS++
Sbjct: 172 SSSKIIWQSFDFPTDTILPGQVLVMGQKLYSNTNGTVDYSTGRFMLEVQIMDGNVVLSSF 231
Query: 191 HFADPGYWYTGTVTLNNVSLIFNQS-AFMYLINSTGDNIFRLTRNVMTPTEDYYHRATID 249
FADPGYWYT T N+SL+FN S A MY++N+T + T DYYHRA I+
Sbjct: 232 RFADPGYWYTSTAGDKNISLVFNNSNALMYVMNTTSIRYNMSREELPTSITDYYHRAVIN 291
Query: 250 GHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTCNCIPGYTPL 309
+GN QQ Y K + +W VW A+ +PC VN ICGV+G CTS DN VTC C+PGY+P
Sbjct: 292 DYGNLQQMVYKKGSVGQWKVVWEAITEPCTVNNICGVFGFCTSPDNNIVTCTCLPGYSPW 351
Query: 310 NPSDVSEGCHPETVVNYCAETSS-KNFTVEVMDDAGFLFDNFADLARVSNVDVEGCRKAV 368
+P+ S+GC+P +V++CA SS +FT+E MD+ F +A+
Sbjct: 352 DPNVPSKGCYPNEMVDFCAPNSSASDFTLEEMDNTDFPNGEYAE---------------- 395
Query: 369 MDDCYSLGASLVGSTCVKTRMPLLNARKSASTKGMKAIIKVPTKMSNPSNHEGKKKNNFN 428
S C K RMPLLNAR S+ST A IKVP K++N + + K
Sbjct: 396 -------------SVCYKKRMPLLNARSSSSTNNRIAFIKVP-KVNNSWGIDDRPKRRTP 441
Query: 429 SRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPN-SMEINFREFTFQELQE 487
SR +L G + +I A+L +AIY+ P A+ I++ P +EIN + F+FQEL+
Sbjct: 442 SRGVLLAGLLSCSILAVLFAASAIYHHPLAQPYIRKHPPPTPKVPVEINLKAFSFQELRG 501
Query: 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNE-EFMTELKIIGRTHH 546
T GF +G G+ G VY G++ ++D ++EIAVK+L+K I++ E EFM E+++IG THH
Sbjct: 502 GTNGFKNKLGGGAFGTVYGGVITIEDEEVEIAVKQLDKVIDQQGEKEFMNEVRVIGLTHH 561
Query: 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
KNLVRLLGFC++ + RLLVYELM NG LS+FLF EG++P W QR +I LG+ARGLLYLHE
Sbjct: 562 KNLVRLLGFCNQHNHRLLVYELMNNGALSSFLFDEGKKPSWDQRAQIVLGIARGLLYLHE 621
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
ECETQIIHCDIKPQNVL LD+NY AKI+DFG++KLL KDQTRT+TN+RGTMGY+AP
Sbjct: 622 ECETQIIHCDIKPQNVL-----LDSNYTAKIADFGLAKLLKKDQTRTNTNVRGTMGYMAP 676
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVE-EESEEVDIVLSDWVISCMLSRN 725
EWL+N PVTTKVDV+SFGVM+LEII RRH+EL R+E EE+ D++L DWV+ C+
Sbjct: 677 EWLKNAPVTTKVDVYSFGVMMLEIIFCRRHLELHRIEDEETGGDDMILIDWVLCCVRDGK 736
Query: 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE-VGMPPLLH 784
L+ +VSHD E+L + FERMAMVGLWC P+P LRPSM V+ MLEG++E VG+PP +
Sbjct: 737 LEAVVSHDTELLCHYKMFERMAMVGLWCVCPNPTLRPSMNMVMKMLEGSIEVVGIPPPIE 796
Query: 785 DQM 787
QM
Sbjct: 797 TQM 799
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 788 | ||||||
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.925 | 0.880 | 0.307 | 2.5e-81 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.923 | 0.878 | 0.320 | 4.3e-77 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.845 | 0.811 | 0.304 | 6.7e-72 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.864 | 0.780 | 0.295 | 6.7e-72 | |
| TAIR|locus:2137010 | 849 | AT4G11900 [Arabidopsis thalian | 0.855 | 0.793 | 0.265 | 6.8e-65 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.861 | 0.841 | 0.281 | 4.2e-63 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.862 | 0.840 | 0.286 | 7.9e-62 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.388 | 0.362 | 0.347 | 9.9e-60 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.389 | 0.362 | 0.349 | 1.3e-59 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.371 | 0.374 | 0.371 | 1.7e-59 |
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 816 (292.3 bits), Expect = 2.5e-81, P = 2.5e-81
Identities = 244/793 (30%), Positives = 368/793 (46%)
Query: 20 LHGQTSPNISLGSSITAGSNTSWLSPSGDXXXXXXXXXXXXXXXXIWFDKIPEKTLVWAA 79
+HG ++ + G +G T S +W+ ++ + T++W A
Sbjct: 17 IHGSSAVDTISGDFTLSGDQTIVSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQ-TILWVA 75
Query: 80 DRDSP-AEAGSKITLTNDGKLLL---TY----FNGSVQQIYSGAASLALMQNDGNFVLKN 131
+RD ++ S + ++G L+L Y ++ + S +A A++Q+DGN VL+
Sbjct: 76 NRDKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRT 135
Query: 132 ANSA----VVWDSFDFPTDTILPG-QVLL---TGKKLYSNS-RGTADYSTGNYTLEMQAD 182
S+ V+W SFD P DT LPG ++ L TGK S + D S G ++LE+ D
Sbjct: 136 GGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLEL--D 193
Query: 183 GNLVLSAYHFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDY 242
+ YW +G N S IF+ M L + F T + Y
Sbjct: 194 ESTAYKILWNGSNEYWSSGP--WNPQSRIFDSVPEMRLNYIYNFSFFSNTTDSYFTYSIY 251
Query: 243 YH----RATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETV 298
R +D G +QF + + + W W C V CG +G+C SD
Sbjct: 252 NQLNVSRFVMDVSGQIKQFTWLEGNKA-WNLFWSQPRQQCQVYRYCGSFGIC--SDKSEP 308
Query: 299 TCNCIPGYTPLNPSDVSEGCHPETVVNYCAETSSKNFTVEVMDDAGF-LFDNFADLARVS 357
C C G+ P++ D + V S+ + L DN L R S
Sbjct: 309 FCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVLTRTS 368
Query: 358 NVDVEGCRKAVMDDCYSLGASL-VGST-CVKTRMPLLNARKSASTKGMKAIIKVPTKMSN 415
+ C A DC + GS+ C+ +LN ++ I + S+
Sbjct: 369 ---LSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASD 425
Query: 416 PSNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSMEI 475
N K+N N G IF A+ L + + +RR +
Sbjct: 426 VPNVGASGKSN-NK------GLIFGAVLGSLGVIVLVLLVVILILRYRRRKRMRGEKGDG 478
Query: 476 NFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFM 535
F+++ELQ ATK FS +G G G V++G L D+ +IAVK+LE I + ++F
Sbjct: 479 TLSAFSYRELQNATKNFSDKLGGGGFGSVFKGAL--PDSS-DIAVKRLE-GISQGEKQFR 534
Query: 536 TELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLF-HEGQRP---GWVQRV 591
TE+ IG H NLVRL GFCSE K+LLVY+ MPNG+L + LF ++ + GW R
Sbjct: 535 TEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRF 594
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651
+IALG ARGL YLH+EC IIHCDIKP+N+LLD + + K++DFG++KL+ +D +
Sbjct: 595 QIALGTARGLAYLHDECRDCIIHCDIKPENILLD-----SQFCPKVADFGLAKLVGRDFS 649
Query: 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHXXXXXXXXXXXXXXX 711
R T MRGT GY+APEW+ V +T K DV+S+G+ML E++ GRR+
Sbjct: 650 RVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPS- 708
Query: 712 XXXXWVISCMLSRNLQVLVSHDPEVLSD---LERFERMAMVGLWCNHPDPNLRPSMKKVI 768
W + +L+++ + DP + D +E R V WC + + RP+M +V+
Sbjct: 709 ----WAAT-ILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVV 763
Query: 769 HMLEGTLEVGMPP 781
+LEG LEV PP
Sbjct: 764 QILEGVLEVNPPP 776
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 776 (278.2 bits), Expect = 4.3e-77, P = 4.3e-77
Identities = 262/817 (32%), Positives = 384/817 (47%)
Query: 1 MALKRIVPCVLTLILKFYGLHGQTS-PNISLGSSITA-GSNTSWLSPSGDXXXXXXXXXX 58
MA+K +L L+L LH S I LGS I A GSN +W SP+
Sbjct: 1 MAVKTPFLKLLPLLLLL--LHFPFSFSTIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPS 58
Query: 59 -XXXXXXIWF-DKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSGAA 116
+ F +P +W+A ++ + L G L LT NGS ++
Sbjct: 59 PNSFLAAVSFAGSVP----IWSA---GTVDSRGSLRLHTSGSLRLT--NGSGTTVWDSKT 109
Query: 117 S-LAL----MQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYS 171
L + +++ G F+L N S VW SFD PTDTI+ Q GK L S
Sbjct: 110 DRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNPTDTIVQSQNFTAGKILRS--------- 160
Query: 172 TGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGD-NIFR 230
G Y+ +++ GNL L A YW G LN+ S N S+ + + G +IF
Sbjct: 161 -GLYSFQLERSGNLTLRWNTSAI--YWNHG---LNS-SFSSNLSSPRLSLQTNGVVSIFE 213
Query: 231 ---LTRNVMTPTEDYYHRAT-----IDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNC 282
L + + DY T +D GN + ++ S W AV D C+V
Sbjct: 214 SNLLGGAEIVYSGDYGDSNTFRFLKLDDDGNLRIYSSASRNSGPVNAHWSAV-DQCLVYG 272
Query: 283 ICGVYGMCTSSDNETVTCNCIP-GYTPLNPSDVSEGCHPETVVNYCAETSSKNFTVEVMD 341
CG +G+C+ +D + C+C + ++ +D +GC + ++ C S ++++
Sbjct: 273 YCGNFGICSYNDTNPI-CSCPSRNFDFVDVNDRRKGCKRKVELSDC---SGNTTMLDLVH 328
Query: 342 DAGFLFD---NFADLARVSNVDVEGCRKAVMDDCYSLGASLVGS-TCVKTRMPLLNARKS 397
F ++ N S+ C +V+ C + + GS C +
Sbjct: 329 TRLFTYEDDPNSESFFAGSSPCRANCLSSVL--CLASVSMSDGSGNCWQKHPGSFFTGYQ 386
Query: 398 ASTKGMKAIIKV--PTKMSNPSNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYS 455
+ + +KV P ++N K +N NS++ L I + A+ A L G+ A+
Sbjct: 387 WPSVPSTSYVKVCGPV-VANTLERATKGDDN-NSKVHLWI--VAVAVIAGLLGLVAVEIG 442
Query: 456 PAARGLIKRRN-YFDPNSMEINFRE--------FTFQELQEATKGFSKLVGTGSSGKVYR 506
R+N F S E FT++ELQ TK F + +G G G VYR
Sbjct: 443 --LWWCCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYR 500
Query: 507 GILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566
G+L + +AVK+LE IE+ ++F E+ I THH NLVRL+GFCS+ RLLVY
Sbjct: 501 GVLTNRTV---VAVKQLE-GIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVY 556
Query: 567 ELMPNGTLSNFLFHEGQRP--GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLL 624
E M NG+L NFLF W R IALG A+G+ YLHEEC I+HCDIKP+N+L+
Sbjct: 557 EFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILV 616
Query: 625 DLKTLDTNYMAKISDFGISKLLN-KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSF 683
D D N+ AK+SDFG++KLLN KD +++RGT GY+APEWL N+P+T+K DV+S+
Sbjct: 617 D----D-NFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSY 671
Query: 684 GVMLLEIICGRRHXXXXXXXXXXXXXXXXXXXWVISCMLSRNLQVLVSHDPEVLSDLERF 743
G++LLE++ G+R+ + L +S D V D+E+
Sbjct: 672 GMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKG-NTKAILDTRLSEDQTV--DMEQV 728
Query: 744 ERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMP 780
RM WC P RP+M KV+ MLEG E+ P
Sbjct: 729 MRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNP 765
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
Identities = 224/735 (30%), Positives = 349/735 (47%)
Query: 75 LVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQI-YSGA-ASLALMQNDGNFVLKNA 132
L+W+A+R SP K ++G +++ V ++ SG AS +++ GN V+ +
Sbjct: 81 LIWSANRASPVSNSDKFVFDDNGNVVME--GTEVWRLDNSGKNASRIELRDSGNLVVVSV 138
Query: 133 NSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHF 192
+ +W+SFD PTDT++ Q G KL S+ S Y LE+++ G++VLS
Sbjct: 139 DGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSS----SNMTYALEIKS-GDMVLSVNSL 193
Query: 193 ADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFR--------LTRNVMTPTEDYYH 244
YW N I N+ + +S N +R L + V + +D
Sbjct: 194 TPQVYWSMA----NARERIINKDGGVVTSSSLLGNSWRFFDQKQVLLWQFVFSDNKDDNT 249
Query: 245 R-ATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTCNCI 303
+ G+ F+ S +S + +D C CG Y +C+ S C C+
Sbjct: 250 TWIAVLGNNGVISFSNLGSGASAADSSTKIPSDLCGTPEPCGPYYVCSGSK----VCGCV 305
Query: 304 PGYTPLNPSDVSEGCHPETVVNYCAETSSKNFTVEV-MDDAGFLFDNFADLARV----SN 358
G + SD G + + C +T N T+ + + AG D FA L
Sbjct: 306 SGLSRAR-SDCKTG-----ITSPCKKTKD-NATLPLQLVSAGDGVDYFA-LGYAPPFSKK 357
Query: 359 VDVEGCRKAVMDDCYSLGASLVGSTCVKTRMPLLNARKSAST--KGMKAIIKVPTKMSNP 416
D++ C++ ++C LG S+ + + K++ G + IK+ + S
Sbjct: 358 TDLDSCKEFCHNNCSCLGLFFQNSSGNCFLFDYIGSFKTSGNGGSGFVSYIKIASTGSGG 417
Query: 417 SNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYS------PAARGLIKRRNYFDP 470
++ +F +++ + +F I A+L VA + A + + N+ +
Sbjct: 418 GDNGEDDGKHFPYVVIIVVVTVF--IIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLE- 474
Query: 471 NSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT 530
N + R F +++LQ AT FS +G G G VY G L D +AVKKLE I +
Sbjct: 475 NLSGMPIR-FAYKDLQSATNNFSVKLGQGGFGSVYEGTL--PDGS-RLAVKKLE-GIGQG 529
Query: 531 NEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP---GW 587
+EF E+ IIG HH +LVRL GFC+E RLL YE + G+L ++F + W
Sbjct: 530 KKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDW 589
Query: 588 VQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647
R IALG A+GL YLHE+C+ +I+HCDIKP+N+LLD N+ AK+SDFG++KL+
Sbjct: 590 DTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLD-----DNFNAKVSDFGLAKLMT 644
Query: 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHXXXXXXXXXXX 707
++Q+ T MRGT GY+APEW+ N ++ K DV+S+G++LLE+I GR++
Sbjct: 645 REQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCH 704
Query: 708 XXXXXXXXWVISCMLSRNLQVLVSHDPEVLSDL-ERFERMAMVGLWCNHPDPNLRPSMKK 766
+ M L +V + + ER +R LWC D RPSM K
Sbjct: 705 FPS-----FAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSK 759
Query: 767 VIHMLEGTLEVGMPP 781
V+ MLEG V PP
Sbjct: 760 VVQMLEGVFPVVQPP 774
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
Identities = 222/751 (29%), Positives = 361/751 (48%)
Query: 76 VWAADRDSPAEAGSKITLT-------NDGKLLLTYFNGSVQQIYSGAASLALMQNDGNFV 128
+W+++RDSP + + LT DGK + ++ V + S SL L + GN +
Sbjct: 86 IWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPV--LASPVKSLRLT-DAGNLL 142
Query: 129 LKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYT-LEMQADGNLVL 187
L + + +W+SFDFPTD+I+ GQ L G L S S +D+STG+Y L ++DG +
Sbjct: 143 LLDHLNVSLWESFDFPTDSIVLGQRLKLGMFL-SGSVSRSDFSTGDYKFLVGESDGLMQW 201
Query: 188 SAYHFADPGYWYTGTVTLN-NVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRA 246
++ V N V + ++ + L+ G + + R + P+ D+ A
Sbjct: 202 RGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVV--VVRVALPPSSDF-RVA 258
Query: 247 TIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSD-NETVTCNCIPG 305
+D G +F + + + D C + +CG G+C + +E +C+C P
Sbjct: 259 KMDSSG---KFIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLDNASENQSCSC-PD 314
Query: 306 YTPLNPSDVSEG-CHPETV-VNYCAETSSKNFT-VEVMDDAGFLFDNFADLARVSNVDVE 362
+ D +G C P + ++ ++N + +E+ + +F D + +
Sbjct: 315 EMRM---DAGKGVCVPVSQSLSLPVSCEARNISYLELGLGVSYFSTHFTDPVE-HGLPLL 370
Query: 363 GCRKAVMDDCYSLGASLVGST--C--VKTRMPLLN-ARKSASTKGMKAIIKVPTKMSN-- 415
C +C LG ++ C VK L+ + S + +K+ + +N
Sbjct: 371 ACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRKTNAQ 430
Query: 416 PSNHEGKKKNNFNSRLLLKI---GFIFSAICALL--SGVAAIYYSPAARGLIKRRNYF-- 468
P + + ++F L+ + GF LL A + YS + R F
Sbjct: 431 PPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQVTRPGSFES 490
Query: 469 -DPNSMEINF--REFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK 525
D S I ++F F+EL++AT+ F +G+G G VY+G L D + IAVKK+
Sbjct: 491 GDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTL--PDETL-IAVKKITN 547
Query: 526 DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP 585
+EF TE+ IIG H NLV+L GFC+ + LLVYE M +G+L LF G P
Sbjct: 548 HGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF-SGNGP 606
Query: 586 --GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643
W +R +IALG ARGL YLH C+ +IIHCD+KP+N+LL ++ KISDFG+S
Sbjct: 607 VLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLH-----DHFQPKISDFGLS 661
Query: 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHXXXXXXX 703
KLLN++++ T MRGT GY+APEW+ N ++ K DV+S+G++LLE++ GR++
Sbjct: 662 KLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRS 721
Query: 704 XXXXXXXX---XXXXWVISCMLSRNLQVLVSH---------DPEVLSDL--ERFERMAMV 749
+ ++ L L H DP + + + E++ +
Sbjct: 722 NSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRI 781
Query: 750 GLWCNHPDPNLRPSMKKVIHMLEGTLEVGMP 780
L C H +P LRP+M V+ M EG++ +G P
Sbjct: 782 ALCCVHEEPALRPTMAAVVGMFEGSIPLGNP 812
|
|
| TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 609 (219.4 bits), Expect = 6.8e-65, Sum P(2) = 6.8e-65
Identities = 196/738 (26%), Positives = 341/738 (46%)
Query: 78 AADRDSPAEAGSKIT--LTNDGKLLL--TYFNGSVQQIYSGAASLALMQNDGNFVLK--- 130
+A R S E S+ + ++G LL T ++ V S A++ + GN VL+
Sbjct: 113 SATRKSHTEGTSRRSPQKISEGNLLFHETVWSTGVNSSMSKDVQ-AVLFDSGNLVLRDGP 171
Query: 131 NANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAY 190
N+++AV+W SFD P+DT LPG + G +L+++ D S G Y+LE + +++ +
Sbjct: 172 NSSAAVLWQSFDHPSDTWLPGGKIRLGSQLFTSWESLIDPSPGRYSLEFDPKLHSLVTVW 231
Query: 191 HFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYY--HRATI 248
+ YW +G + + + F L + + + +T + D +R +
Sbjct: 232 N-RSKSYWSSGPL----YDWLQSFKGFPELQGTKLSFTLNMDESYITFSVDPQSRYRLVM 286
Query: 249 DGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTCNCIPGYTP 308
G F +H S W + ++ C V CG +G+C + + E C C+PG+
Sbjct: 287 GVSGQFMLQVWHVDLQS-WRVILSQPDNRCDVYNSCGSFGIC-NENREPPPCRCVPGFKR 344
Query: 309 L------NPSDVSEGCHPETVVNYCAETSSKNFTVEVMDDAGFLFDNFADLARVSNVDVE 362
+ +D S GC ET + +C + + + +E M L + + +++
Sbjct: 345 EFSQGSDDSNDYSGGCKRETYL-HCYKRNDEFLPIENMK----LATDPTTASVLTSGTFR 399
Query: 363 GCRKAVMDDCYSLGASLVGSTCVKTRMPLLNARKSASTKGMKAIIKVPTKMSNPSNHEGK 422
C + DC + G+ C+ N ++ + KG +++ + SN S +
Sbjct: 400 TCASRCVADCSCQAYANDGNKCLVWTKDAFNLQQLDANKGHTFFLRLAS--SNISTANNR 457
Query: 423 KKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSMEI------- 475
K + + ++ + + +++ A + +Y ++R K++ + +S E+
Sbjct: 458 KTEHSKGKSIV-LPLVLASLVATAACFVGLYCCISSRIRRKKKQRDEKHSRELLEGGLID 516
Query: 476 ----NFREFTFQELQEATKGFS--KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK 529
N ++ AT FS K +G G G VY+G L +E+A+K+L K +
Sbjct: 517 DAGENMCYLNLHDIMVATNSFSRKKKLGEGGFGPVYKGKL---PNGMEVAIKRLSKKSSQ 573
Query: 530 TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFH--EGQRPGW 587
EF E+ +I + HKNLVRLLG+C E D++LL+YE M N +L LF + + W
Sbjct: 574 GLTEFKNEVVLIIKLQHKNLVRLLGYCVEGDEKLLIYEYMSNKSLDGLLFDSLKSRELDW 633
Query: 588 VQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647
R++I G RGL YLHE +IIH D+K N+LLD + N KISDFG +++
Sbjct: 634 ETRMKIVNGTTRGLQYLHEYSRLRIIHRDLKASNILLDD---EMN--PKISDFGTARIFG 688
Query: 648 KDQTRTDTN-MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHXXXXXXXXXX 706
Q T + GT GY++PE+ ++ K D++SFGV+LLEII G++
Sbjct: 689 CKQIDDSTQRIVGTFGYMSPEYALGGVISEKSDIYSFGVLLLEIISGKKATRFVHNDQKH 748
Query: 707 XXXXXXXXXWVISCMLSRNLQVLVSHDPEVLS-DLERFERMAMVGLWCNHPDPNLRPSMK 765
W C ++ + ++ +P S LE R + L C P RP +
Sbjct: 749 SLIAYEWESW---CE-TKGVSII--DEPMCCSYSLEEAMRCIHIALLCVQDHPKDRPMIS 802
Query: 766 KVIHML--EGTLEVGMPP 781
++++ML + TL + P
Sbjct: 803 QIVYMLSNDNTLPIPKQP 820
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 644 (231.8 bits), Expect = 4.2e-63, P = 4.2e-63
Identities = 211/750 (28%), Positives = 349/750 (46%)
Query: 65 IWFDKIPEKTLVWAADRDSPA-EAGSKITLTNDGKLLLTYFNGSVQQIYSGAASL----- 118
IWF I + +VW A+R+ P ++ + + ++N+G LLL FNG +S +L
Sbjct: 62 IWFKGIIPRVVVWVANREKPVTDSTANLAISNNGSLLL--FNGKHGVAWSSGEALVSNGS 119
Query: 119 -ALMQNDGNF-VLKNANSAVVWDSFDFPTDTILPGQVL----LTGKK-LYSNSRGTADYS 171
A + + GN V+ N + +W SFD DT+LP L TG+K + S+ + D S
Sbjct: 120 RAELSDTGNLIVIDNFSGRTLWQSFDHLGDTMLPSSTLKYNLATGEKQVLSSWKSYTDPS 179
Query: 172 TGNYTLEM--QADGNLVLS--AYHFADPGYW----YTGTVTLNNVSLIFNQSAFMYLINS 223
G++ L++ Q ++++ + + G W +TG +++ + N
Sbjct: 180 VGDFVLQITPQVPTQVLVTKGSTPYYRSGPWAKTRFTGIPLMDDT--FTGPVSVQQDTNG 237
Query: 224 TGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCI 283
+G + L RN D R + G Q+ ++H T W + A C +
Sbjct: 238 SGSLTY-LNRN------DRLQRTMLTSKGT-QELSWHNGTD--WVLNFVAPEHSCDYYGV 287
Query: 284 CGVYGMCTSSDNETVTCNCIPGYTPL-----NPSDVSEGCHPETVVNYCAETSSKNFTVE 338
CG +G+C S C C G+ P + + GC T + YC S+ +
Sbjct: 288 CGPFGLCVKS--VPPKCTCFKGFVPKLIEEWKRGNWTGGCVRRTEL-YCQGNSTGKYANV 344
Query: 339 VMDDAGFLFDNFADLARVSNVDVEGCRKAVMDDCYSLGASLV-GSTCVKTRMPLLNARKS 397
A +F + A S V+VE C+K+ + +C L + + G C+ L++A +
Sbjct: 345 FHPVARIKPPDFYEFA--SFVNVEECQKSCLHNCSCLAFAYIDGIGCLMWNQDLMDAVQF 402
Query: 398 ASTKGMKAIIKVPTKMSNPSNHEGKKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPA 457
+ + +I +++ + + + L++ I F+ A C V
Sbjct: 403 SEGGELLSIRLARSELGGNKRKKAITASIVSLSLVVIIAFV--AFCFWRYRVKHNADITT 460
Query: 458 ARGLIKRRNYFDPNSME-INFREFTFQELQEATKGFS--KLVGTGSSGKVYRGILRLKDT 514
+ RN P + ++F F +Q AT FS +G G G VY+G +L+D
Sbjct: 461 DASQVSWRNDLKPQDVPGLDF--FDMHTIQTATNNFSISNKLGQGGFGPVYKG--KLQDG 516
Query: 515 QIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTL 574
+ EIAVK+L + EEFM E+ +I + HKNLVR+LG C E +++LL+YE M N +L
Sbjct: 517 K-EIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSL 575
Query: 575 SNFLFHEGQRP--GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632
FLF +R W +R++I G+ARG+ YLH + ++IH D+K N+LLD K N
Sbjct: 576 DTFLFDSRKRLEIDWPKRLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKM---N 632
Query: 633 YMAKISDFGISKLLNKDQTRTDTN-MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
KISDFG++++ + + +T + GT+GY+APE+ + K D++SFGV++LEII
Sbjct: 633 --PKISDFGLARMYQGTEYQDNTRRVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEII 690
Query: 692 CGRRHXXXXXXXXXXXXXXXXXXXWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGL 751
G + W C + +L + LE ER +GL
Sbjct: 691 SGEKISRFSYGKEEKTLIAYAWESW---CDTG-GIDLLDKDVADSCRPLE-VERCVQIGL 745
Query: 752 WCNHPDPNLRPSMKKVIHMLEGTLEVGMPP 781
C P RP+ +++ ML T + +PP
Sbjct: 746 LCVQHQPADRPNTLELLSMLTTTSD--LPP 773
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 632 (227.5 bits), Expect = 7.9e-62, P = 7.9e-62
Identities = 215/751 (28%), Positives = 353/751 (47%)
Query: 65 IWFDKIPEKTLVWAADRDSPA-EAGSKITLTNDGKLLLTYFNGSVQ----QIYSGAASLA 119
IWF I + +VW A+R+ P ++ + +T++++G LLL N SV + ++ S A
Sbjct: 62 IWFKGIIPRVVVWVANREKPVTDSAANLTISSNGSLLLFNENHSVVWSIGETFASNGSRA 121
Query: 120 LMQNDGNFVLKNANSA-VVWDSFDFPTDTILPGQVLL----TG-KKLYSNSRGTADYSTG 173
+ ++GN V+ + NS +W+SF+ DT+LP L+ TG K++ ++ + D S G
Sbjct: 122 ELTDNGNLVVIDNNSGRTLWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSPG 181
Query: 174 NYTLEMQADGNLVLSAYHFADPGYWYTGT---VTLNNVSLIFNQ--SAFMYLINSTGDNI 228
++T+++ YW +G + ++ + S F ++ G
Sbjct: 182 DFTVQITPQVPSQACTMR-GSKTYWRSGPWAKTRFTGIPVMDDTYTSPFSLQQDTNGSGS 240
Query: 229 FR-LTRNVMTPTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVY 287
F RN Y I G+ + F ++ W + A + C + CG +
Sbjct: 241 FTYFERNFKL---SYI---MITSEGSLKIFQHN---GMDWELNFEAPENSCDIYGFCGPF 291
Query: 288 GMCTSSDNETVTCNCIPGYTPLNPSDV-----SEGCHPETVVNYCAETSSKNFTVE-VMD 341
G+C S C C G+ P + + ++GC T ++ T+ K TV
Sbjct: 292 GICVMS--VPPKCKCFKGFVPKSIEEWKRGNWTDGCVRHTELHCQGNTNGK--TVNGFYH 347
Query: 342 DAGFLFDNFADLARVSNVDVEGCRKAVMDDCYSLGASLV-GSTCVKTRMPLLNARKSAST 400
A +F + A S VD EGC + + +C L + + G C+ L++A + S
Sbjct: 348 VANIKPPDFYEFA--SFVDAEGCYQICLHNCSCLAFAYINGIGCLMWNQDLMDAVQF-SA 404
Query: 401 KGMKAIIKVPTKMSNPSNHEGKKKNNFNSRLLLKIG-FI---FSAICALLSGVAAIYYSP 456
G I+ + ++++ S G K+N ++ + F+ F+A C L V +
Sbjct: 405 GG--EILSI--RLAS-SELGGNKRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAK 459
Query: 457 AARGLIKR--RNYFDPNSMEINFREFTFQELQEATKGFS--KLVGTGSSGKVYRGILRLK 512
++ K N +P + + F +Q AT FS +G G G VY+G +L+
Sbjct: 460 ISKIASKEAWNNDLEPQDVS-GLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKG--KLQ 516
Query: 513 DTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572
D + EIAVK+L + EEFM E+ +I + HKNLVR+LG C E ++RLLVYE + N
Sbjct: 517 DGK-EIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNK 575
Query: 573 TLSNFLFHEGQRP--GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD 630
+L FLF +R W +R I G+ARGL YLH + ++IH D+K N+LLD K
Sbjct: 576 SLDTFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKM-- 633
Query: 631 TNYMAKISDFGISKLLNKDQTRTDTN-MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLE 689
N KISDFG++++ + + +T + GT+GY+APE+ + K D++SFGV+LLE
Sbjct: 634 -N--PKISDFGLARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLE 690
Query: 690 IICGRRHXXXXXXXXXXXXXXXXXXXWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMV 749
II G + W C S + +L + LE ER +
Sbjct: 691 IITGEKISRFSYGRQGKTLLAYAWESW---CE-SGGIDLLDKDVADSCHPLE-VERCVQI 745
Query: 750 GLWCNHPDPNLRPSMKKVIHMLEGTLEVGMP 780
GL C P RP+ +++ ML T ++ P
Sbjct: 746 GLLCVQHQPADRPNTMELLSMLTTTSDLTSP 776
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 429 (156.1 bits), Expect = 9.9e-60, Sum P(2) = 9.9e-60
Identities = 115/331 (34%), Positives = 173/331 (52%)
Query: 461 LIKRRNYFDPNSMEINFREFTFQELQE---ATKGFSK--LVGTGSSGKVYRGILRLKDTQ 515
++ RR Y + E EL+ AT FS +G G G VY+G RL D +
Sbjct: 486 VVSRRGYTSKEKKS-EYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKG--RLLDGK 542
Query: 516 IEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLS 575
EIAVK+L K + +EFM E+++I + H NLVRLLG C ++ +++L+YE + N +L
Sbjct: 543 -EIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLD 601
Query: 576 NFLFHEGQRPG--WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNY 633
+ LF + + W +R +I G+ARGLLYLH++ +IIH D+K NVLLD N
Sbjct: 602 SHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLD-----KNM 656
Query: 634 MAKISDFGISKLLNKDQTRTDTN-MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC 692
KISDFG++++ +++T +T + GT GY++PE+ + + K DVFSFGV+LLEII
Sbjct: 657 TPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIIS 716
Query: 693 GRRHXXXXXXXXXXXXXXXXXXXWVISCMLSRNLQVLVSHDPEVLSD---LERFERMAMV 749
G+R+ W L+++ + + LS R +
Sbjct: 717 GKRNKGFYNSNRDLNLLGFVWRHW----KEGNELEIVDPINIDSLSSKFPTHEILRCIQI 772
Query: 750 GLWCNHPDPNLRPSMKKVIHMLEGTLEVGMP 780
GL C RP M V+ ML G+ +P
Sbjct: 773 GLLCVQERAEDRPVMSSVMVML-GSETTAIP 802
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 429 (156.1 bits), Expect = 1.3e-59, Sum P(2) = 1.3e-59
Identities = 116/332 (34%), Positives = 179/332 (53%)
Query: 457 AARGLIKRRNYFDPNSMEINFREFTFQELQEATKGFS--KLVGTGSSGKVYRGILRLKDT 514
A+R + N D +E+ E+ + L AT FS +G G G VY+G+L D
Sbjct: 492 ASRSYTSKENKTD--YLELPLMEW--KALAMATNNFSTDNKLGQGGFGIVYKGMLL--DG 545
Query: 515 QIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTL 574
+ EIAVK+L K + +EFM E+++I + H NLVRLLG C ++ +++L+YE + N +L
Sbjct: 546 K-EIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSL 604
Query: 575 SNFLFHEGQRPG--WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632
+ LF + + W +R +I G+ARGLLYLH++ +IIH D+K NVLLD N
Sbjct: 605 DSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLD-----KN 659
Query: 633 YMAKISDFGISKLLNKDQTRTDTN-MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
KISDFG++++ +++T +T + GT GY++PE+ + + K DVFSFGV+LLEII
Sbjct: 660 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 719
Query: 692 CGRRHXXXXXXXXXXXXXXXXXXXWVISCMLSRNLQVLVSHDPEVLS-DLERFE--RMAM 748
G+R+ W + L+++ + + LS + E R
Sbjct: 720 SGKRNKGFYNSNRDLNLLGFVWRHW----KEGKELEIVDPINIDALSSEFPTHEILRCIQ 775
Query: 749 VGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMP 780
+GL C RP M V+ ML G+ +P
Sbjct: 776 IGLLCVQERAEDRPVMSSVMVML-GSETTAIP 806
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 1.7e-59, Sum P(2) = 1.7e-59
Identities = 116/312 (37%), Positives = 177/312 (56%)
Query: 469 DPNSMEINFREFTFQELQEATKGFS--KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD 526
+ +E+ F + + EAT GFS +G G G VY+G L E+AVK+L +
Sbjct: 444 EEEDLELPFLDL--DTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQ---EVAVKRLSRT 498
Query: 527 IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP- 585
+ EEF E+K+I + H+NLV++LG+C +E++R+L+YE PN +L +F+F + +R
Sbjct: 499 SRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRE 558
Query: 586 -GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
W +RVEI G+ARG+LYLHE+ +IIH D+K NVLLD D N AKISDFG+++
Sbjct: 559 LDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDS---DMN--AKISDFGLAR 613
Query: 645 LLNKDQTRTDTN-MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHXXXXXXX 703
L D+T +T + GT GY++PE+ + + K DVFSFGV++LEI+ GRR+
Sbjct: 614 TLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEE 673
Query: 704 XXXXXXXXXXXXWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS 763
W + + +++ E +D+ R+ +GL C DP RP+
Sbjct: 674 HKLNLLGHA---WR-QFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPN 729
Query: 764 MKKVIHMLEGTL 775
M V+ ML +
Sbjct: 730 MSVVVLMLSSEM 741
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3393 | 0.9555 | 0.9050 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| eugene3.00130591 | hypothetical protein (787 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 788 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-23 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-22 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-21 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 8e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-17 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-15 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 6e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-09 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 0.004 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 1e-51
Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN-EEFMTELKIIGRTHHKNLVRLLG 554
+G G G VY R K T ++A+K ++K+ + EE + E++I+ + +H N+V+L G
Sbjct: 1 LGEGGFGTVYLA--RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIH 614
+E+ LV E G+L + L + + + I L + GL YLH IIH
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE-WLRNVP 673
D+KP+N+LLD N K++DFG+SKLL + GT Y+APE L
Sbjct: 116 RDLKPENILLD----SDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 674 VTTKVDVFSFGVMLLEI 690
+ K D++S GV+L E+
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 7e-50
Identities = 85/286 (29%), Positives = 132/286 (46%), Gaps = 44/286 (15%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVR 551
+ +G+GS G VY+ + K T +AVK L+K K ++ E++I+ R H N+VR
Sbjct: 5 RKLGSGSFGTVYKA--KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
L+ ++D LV E G L ++L G + +IAL + RGL YLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR- 670
IIH D+KP+N+L LD N + KI+DFG++K L K + T GT Y+APE L
Sbjct: 119 IIHRDLKPENIL-----LDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLG 172
Query: 671 NVPVTTKVDVFSFGVMLLEIICGR-------RHIELSRVEEESEEVDIVLSDWVISCMLS 723
KVDV+S GV+L E++ G+ +L + + D S
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGP--PLEFDEPKWSSGS 230
Query: 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769
+ L+ C + DP+ RP+ ++++
Sbjct: 231 EEAKDLIK--------------------KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRL 552
+ +G GS GKVY R K T +A+K ++K I+K E + E+KI+ + H N+VRL
Sbjct: 5 EKLGEGSFGKVYLA--RDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQI 612
+EDK LV E G L + L G+ R + L YLH + I
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-FYLRQILSALEYLHSK---GI 118
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
+H D+KP+N+LLD + K++DFG+++ L+ + T GT Y+APE L
Sbjct: 119 VHRDLKPENILLD-----EDGHVKLADFGLARQLDPGEKLTT--FVGTPEYMAPEVLLGK 171
Query: 673 PVTTKVDVFSFGVMLLEIICGR 694
VD++S GV+L E++ G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 87/294 (29%), Positives = 142/294 (48%), Gaps = 52/294 (17%)
Query: 492 FSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKN 548
K +G G+ G+VY+G L+ ++E+AVK L++D E+ EEF+ E +I+ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLHEE 607
+V+LLG C+EE+ ++V E MP G L ++L + + + AL +ARG+ YL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
IH D+ +N L + N + KISDFG+S+ L D + + ++APE
Sbjct: 123 ---NFIHRDLAARNCL-----VGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
L+ T+K DV+SFGV+L EI + EE +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEI--------FTLGEEPYPGMS----------------- 209
Query: 728 VLVSHDPEVLSDLERFERM----------AMVGLWCNHPDPNLRPSMKKVIHML 771
+ EVL L++ R+ + L C DP RP+ +++ +L
Sbjct: 210 -----NAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-47
Identities = 85/293 (29%), Positives = 138/293 (47%), Gaps = 51/293 (17%)
Query: 492 FSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKN 548
K +G G+ G+VY+G L+ ++E+AVK L++D E+ EEF+ E +I+ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+V+LLG C+EE+ +V E M G L ++L + + AL +ARG+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
IH D+ +N L + N + KISDFG+S+ L D + + ++APE
Sbjct: 122 --NFIHRDLAARNCL-----VGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728
L+ T+K DV+SFGV+L EI + E+ +
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEI--------FTLGEQPYPGMS------------------ 208
Query: 729 LVSHDPEVLSDLERFERM----------AMVGLWCNHPDPNLRPSMKKVIHML 771
+ EVL L+ R+ + L C DP RP+ +++ +L
Sbjct: 209 ----NEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 86/289 (29%), Positives = 142/289 (49%), Gaps = 42/289 (14%)
Query: 492 FSKLVGTGSSGKVYRGILRLKD--TQIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHKN 548
K +G G+ G+VY+G L+ T+ ++AVK L E E+ EEF+ E I+ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+VRLLG C++ + +V E MP G L +FL G++ +++AL +A+G+ YL +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL-NKDQTRTDTNMRGTMGYVAPE 667
+H D+ +N L + N + KISDFG+S+ + D R + + ++APE
Sbjct: 122 --NFVHRDLAARNCL-----VTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIIC-GRRH---IELSRVEEESEEVDIVLSDWVISCMLS 723
L++ T+K DV+SFGV+L EI G + + V E +L
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE----------------LLE 218
Query: 724 RNLQVLVSHD-PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771
++ + P+ L +L M C DP RP+ +++ L
Sbjct: 219 DGYRLPRPENCPDELYEL-----MLQ----CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 86/291 (29%), Positives = 143/291 (49%), Gaps = 41/291 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQ-IEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHKNLVR 551
K +G G+ G+VY+G L+ KD + E+AVK L E E+ ++F+ E +++ + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFL--------FHEGQRPGWVQRVEIALGVARGLLY 603
LLG C+EE+ LV E M G L ++L E + A+ +A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ-TRTDTNMRGTMG 662
L + + +H D+ +N L + + + KISDFG+S+ + D R T + +
Sbjct: 121 LASK---KFVHRDLAARNCL-----VGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD-IVLSDWVISCM 721
++APE L++ T+K DV+SFGV+L EI + + + +++
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIF--------TLGATPYPGLSNEEVLEYLRKG- 223
Query: 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
R + PE D E +E M L C DP RP+ +++ LE
Sbjct: 224 -YRLPK------PEYCPD-ELYELM----LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 28/217 (12%)
Query: 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHH 546
T+G +L+G GS G VY + KDT +AVK L D E+ E E++I+ H
Sbjct: 3 TRG--ELLGRGSFGSVYLAL--DKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH 58
Query: 547 KNLVRLLGFC-SEEDKRLLVY-ELMPNGTLSNFL-----FHEGQRPGWVQRVEIALGVAR 599
N+VR G EE L ++ E + G+LS+ L E +++ +
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKY--TRQILE 112
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN-MR 658
GL YLH I+H DIK N+L +D++ + K++DFG +K L +T T +R
Sbjct: 113 GLAYLHSN---GIVHRDIKGANIL-----VDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164
Query: 659 GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR 695
GT ++APE +R D++S G ++E+ G+
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 68/205 (33%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHKNLVRL 552
K++G GSSG VY+ R K T A+KK+ E+ ++ + ELK + +V+
Sbjct: 7 KVLGQGSSGVVYKV--RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 553 LG-FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV--EIALGVARGLLYLHEECE 609
G F E + + V E M G+L++ L + + V IA + +GL YLH +
Sbjct: 65 YGAFYKEGEISI-VLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHTK-- 118
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
IIH DIKP N+L++ K KI+DFGISK+L + +T + GT+ Y++PE +
Sbjct: 119 RHIIHRDIKPSNLLINSKG-----EVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERI 172
Query: 670 RNVPVTTKVDVFSFGVMLLEIICGR 694
+ + D++S G+ LLE G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (315), Expect = 3e-31
Identities = 75/290 (25%), Positives = 125/290 (43%), Gaps = 35/290 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE---FMTELKIIGR-THHKNL 549
+ +G GS G+VY R +A+K L K +E ++E F+ E++I+ H N+
Sbjct: 6 RKLGEGSFGEVYLARDRKL-----VALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWV--QRVEIALGVARGLLYLHEE 607
V+L F +E LV E + G+L + L G++ + + I + L YLH +
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR-----GTMG 662
IIH DIKP+N+LLD + K+ DFG++KLL + + GT G
Sbjct: 121 G---IIHRDIKPENILLD----RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 663 YVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS 719
Y+APE L ++ D++S G+ L E++ G E + + + ++ +
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
Query: 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769
+ S + SDL + DP R S +
Sbjct: 234 SLASPLSPSNPELISKAASDLLK---------KLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G G+VY+ R K T E+A+K ++ + ++ E+ + E++I+ + H N+V+ G
Sbjct: 8 IGKGGFGEVYKA--RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIA---LGVARGLLYLHEECETQI 612
++D+ +V E G+L + L Q + +IA + +GL YLH I
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSN---GI 119
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
IH DIK N+LL ++ K+ DFG+S L+ T+ M GT ++APE +
Sbjct: 120 IHRDIKAANILLT-----SDGEVKLIDFGLSAQLSD--TKARNTMVGTPYWMAPEVINGK 172
Query: 673 PVTTKVDVFSFGVMLLEIICGR 694
P K D++S G+ +E+ G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 75/207 (36%), Positives = 109/207 (52%), Gaps = 25/207 (12%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEE--FMTELKIIGRTHHKNLVRL 552
+G GS GKV ++R KDT A+K L+K I K E +TE I+ R +H +V+L
Sbjct: 1 LGKGSFGKVL--LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 553 LGFCS--EEDKRLLVYELMPNGTLSNFLFHEGQRP-GWVQR--VEIALGVARGLLYLHEE 607
+ E+K LV E P G L + L EG+ + EI L L YLH
Sbjct: 59 --HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLHSL 112
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
II+ D+KP+N+LLD + K++DFG++K L+ + +RT+T GT Y+APE
Sbjct: 113 ---GIIYRDLKPENILLD----ADGH-IKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPE 163
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGR 694
L VD +S GV+L E++ G+
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
K +G GS GKVY + R D ++ +K+ L EK E+ + E+KI+ + +H N+++
Sbjct: 6 KQIGKGSFGKVYL-VRRKSDGKL-YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPG----------WVQRVEIALGVARGL 601
E+ K +V E G LS + + ++ G W V++ L L
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKI-KKQKKEGKPFPEEQILDWF--VQLCLA----L 116
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
YLH +I+H DIKPQN+ L +N + K+ DFGISK+L+ T + GT
Sbjct: 117 KYLHSR---KILHRDIKPQNIFLT-----SNGLVKLGDFGISKVLSSTVDLAKT-VVGTP 167
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR 695
Y++PE +N P K D++S G +L E+ +
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+G G G V G R + ++AVK L KD + F+ E ++ H NLV+
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQ----KVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQ 64
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP-GWVQRVEIALGVARGLLYLHEECET 610
LLG + + +V E M G+L ++L G+ Q++ AL V G+ YL E+
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK--- 121
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
+H D+ +NVL+ + +AK+SDFG++K ++ Q ++ T APE LR
Sbjct: 122 NFVHRDLAARNVLVS----EDL-VAKVSDFGLAKEASQGQDSGKLPVKWT----APEALR 172
Query: 671 NVPVTTKVDVFSFGVMLLEI 690
+TK DV+SFG++L EI
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 64/202 (31%), Positives = 113/202 (55%), Gaps = 13/202 (6%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQ-IEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLV 550
K++G G G+V RG L+L + I++A+K L K +K +F+TE I+G+ H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
RL G ++ +++ E M NG+L FL + Q V + G+A G+ YL E
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL-NKDQTRTDTNMRGTMGYVAPEWL 669
+H D+ +N+L +++N + K+SDFG+S+ L + + T T + + + APE +
Sbjct: 127 -YVHRDLAARNIL-----VNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 670 RNVPVTTKVDVFSFGVMLLEII 691
T+ DV+SFG+++ E++
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 58/196 (29%), Positives = 108/196 (55%), Gaps = 13/196 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G+G G+V+ G+ + ++ +A+K L+ D ++F E++ + R HK+L+ L
Sbjct: 14 LGSGYFGEVWEGLWK---NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFH-EGQRPGWVQRVEIALGVARGLLYLHEECETQIIH 614
CS + ++ ELM G+L FL EGQ +++A VA G+ YL E+ IH
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIH 127
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPV 674
D+ +N+L + + + K++DFG+++L+ K+ ++ + + APE +
Sbjct: 128 RDLAARNIL-----VGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 675 TTKVDVFSFGVMLLEI 690
+TK DV+SFG++L E+
Sbjct: 182 STKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 20/201 (9%)
Query: 496 VGTGSSGKVYRGILRLKDT-QIEIAVKKLEKDIEKTNE-EFMTELKIIGRTHHKNLVRLL 553
+G G+ G V +G+ +K ++E+AVK L+++ + EF+ E ++ + H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI---ALGVARGLLYLHEECET 610
G C + + +LV EL P G L +L ++ + ++ A VA G+ YL E
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYL-ESK-- 114
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT--RTDTNMRGTMGYVAPEW 668
+H D+ +NVL L + AKISDFG+S+ L R T R + + APE
Sbjct: 115 HFVHRDLAARNVL-----LVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 669 LRNVPVTTKVDVFSFGVMLLE 689
+ ++K DV+S+GV L E
Sbjct: 170 INYGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 63/205 (30%), Positives = 108/205 (52%), Gaps = 20/205 (9%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHKNLVRL 552
L+G G+ G VY+G L L+ +A+K+ LEK E+ + M E+ ++ H N+V+
Sbjct: 7 LIGRGAFGVVYKG-LNLETGDF-VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVA---RGLLYLHEECE 609
+G D ++ E NG+L + ++ G +A+ V +GL YLHE+
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+IH DIK N+L T D K++DFG++ LN D ++ D ++ GT ++APE +
Sbjct: 119 -GVIHRDIKAANILT---TKDGV--VKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVI 171
Query: 670 RNVPVTTKVDVFSFGVMLLEIICGR 694
+T D++S G ++E++ G
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 64/203 (31%), Positives = 116/203 (57%), Gaps = 14/203 (6%)
Query: 494 KLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVR 551
K++G G G+V+RGIL++ ++ +A+K L+ EK ++F++E I+G+ H N++R
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLF-HEGQRPGWVQRVEIALGVARGLLYLHEECET 610
L G ++ +++ E M NG L +L H+G+ Q V + G+A G+ YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS-YQLVGMLRGIAAGMKYL---SDM 126
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG--YVAPEW 668
+H D+ +N+L +++N K+SDFG+S++L D T T G + + APE
Sbjct: 127 NYVHRDLAARNIL-----VNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 669 LRNVPVTTKVDVFSFGVMLLEII 691
+ T+ DV+SFG+++ E++
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 67/212 (31%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 493 SKLVGTGSSGKVYRGI-LRLKDTQIEIAVK--KLEKDIEKTNEEFMTELKIIGRTHHKNL 549
+G G+ GKVY + L DT +AVK +++ + KT +E E+K++ H NL
Sbjct: 5 GNKIGGGTFGKVYTAVNL---DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
V+ G +K + E GTL L H V RV L + GL YLH
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQLLEGLAYLHSH-- 118
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDT---NMRGTMGYVAP 666
I+H DIKP N+ LD N + K+ DFG + L + T ++ GT Y+AP
Sbjct: 119 -GIVHRDIKPANIF-----LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 667 EWLRNVPVTTK---VDVFSFGVMLLEIICGRR 695
E + D++S G ++LE+ G+R
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGR-THHK 547
F K++G GS V + K+T E A+K L+K EK + E +++ R H
Sbjct: 5 FGKIIGEGSFSTVVLA--KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR---VEIALGVARGLLYL 604
+++L +E+ V E PNG L ++ G R EI L + YL
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE----YL 118
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ-------------- 650
H + IIH D+KP+N+LLD + KI+DFG +K+L+ +
Sbjct: 119 HSK---GIIHRDLKPENILLD-----KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 651 -----TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
R + GT YV+PE L P D+++ G ++ +++ G+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 67/210 (31%), Positives = 112/210 (53%), Gaps = 15/210 (7%)
Query: 494 KLVGTGSSGKVYRG----ILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKN 548
+G+G+ G+VY G IL I +AVK L K ++ +EF+ E ++ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFL----FHEGQRPGW--VQRVEIALGVARGLL 602
+V+LLG C + + ++ ELM G L ++L P + ++I L VA+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK-DQTRTDTNMRGTM 661
YL + IH D+ +N L+ K D + + KI DFG+++ + K D R + +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
++APE L + TT+ DV+SFGV++ EI+
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+ +G G G+V+ G L + +AVK L+ ++F+ E +I+ + H L++
Sbjct: 10 LLRKLGAGQFGEVWEG---LWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQ 65
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWV-QRVEIALGVARGLLYLHEECET 610
L C+ E+ +V ELM G+L +L R + Q +++A VA G+ YL +
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ--- 122
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
IH D+ +NVL + N + K++DFG+++++ +D + + + APE
Sbjct: 123 NYIHRDLAARNVL-----VGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177
Query: 671 NVPVTTKVDVFSFGVMLLEII 691
+ K DV+SFG++L EI+
Sbjct: 178 YNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 78/267 (29%), Positives = 119/267 (44%), Gaps = 41/267 (15%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DIEKTNE--EFMTELKIIGRTHHKNLVRL 552
+G G+ GKV I++ +DT+ A+K + K + + E +I+ +H LV L
Sbjct: 8 IGKGAFGKVC--IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 553 -LGFCSEEDKRLLVYELMPNGTLSNFL-----FHEGQRPGWVQRVEIALGVARGLLYLHE 606
F EE+ L+V +L+ G L L F E Q W+ EI L + YLH
Sbjct: 66 WYSFQDEENMYLVV-DLLLGGDLRYHLSQKVKFSEEQVKFWI--CEIVLALE----YLHS 118
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
+ IIH DIKP N+LLD + I+DF I+ + D T T+ GT GY+AP
Sbjct: 119 K---GIIHRDIKPDNILLDEQG-----HVHITDFNIATKVTPDTLTTSTS--GTPGYMAP 168
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICGRR--HIELSRVEEE---SEEVDIVLS--DWVIS 719
E L + VD +S GV E + G+R + ++ +E VL W
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTE 228
Query: 720 CM------LSRNLQVLVSHDPEVLSDL 740
+ L R+ Q + + + L +
Sbjct: 229 AIDAINKLLERDPQKRLGDNLKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 64/221 (28%), Positives = 115/221 (52%), Gaps = 22/221 (9%)
Query: 484 ELQEATKGFSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDI-EKTNEEFMTELKI 540
L+E K++G+G+ G VY+G+ + +I +A+K L ++ K N+E + E +
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62
Query: 541 IGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARG 600
+ H ++VRLLG C + L+ +LMP G L +++ + G + + +A+G
Sbjct: 63 MASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT 660
+ YL E+ +++H D+ +NVL + T KI+DFG++KLL+ D +
Sbjct: 122 MSYLEEK---RLVHRDLAARNVL-----VKTPQHVKITDFGLAKLLDVD----EKEYHAE 169
Query: 661 MGYV-----APEWLRNVPVTTKVDVFSFGVMLLEIIC-GRR 695
G V A E + + T K DV+S+GV + E++ G +
Sbjct: 170 GGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHKNLVRL 552
+ +G G+ G VY+G+L+ E+AVK +F+ E +I+ + H N+V+L
Sbjct: 1 EKIGKGNFGDVYKGVLK---GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQI 612
+G C ++ +V EL+P G+L FL + R + ++++L A G+ YL +
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT-MGYVAPEWLRN 671
IH D+ +N L+ N + KISDFG+S+ ++ + + APE L
Sbjct: 115 IHRDLAARNCLVGE-----NNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 672 VPVTTKVDVFSFGVMLLEI 690
T++ DV+S+G++L E
Sbjct: 170 GRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+ +G+G G V+ G K ++A+K + + + E+F+ E +++ + H LV+
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKR---KVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQ 63
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR--VEIALGVARGLLYLHEECE 609
L G C+E LV+E M +G LS++L QR + Q + + L V G+ YL
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+IH D+ +N L + N + K+SDFG+++ + DQ + T + + + +PE
Sbjct: 121 --VIHRDLAARNCL-----VGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVF 173
Query: 670 RNVPVTTKVDVFSFGVMLLEI 690
++K DV+SFGV++ E+
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
F K +GTG G V G R Q ++A+K + K+ + +EF+ E K++ + H+ LV+
Sbjct: 8 FLKELGTGQFGVVKYGKWR---GQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
L G C+++ +V E M NG L N+L G+R Q +E+ V G+ YL + Q
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---Q 120
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
IH D+ +N L +D K+SDFG+S+ + D+ + + + + PE L
Sbjct: 121 FIHRDLAARNCL-----VDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY 175
Query: 672 VPVTTKVDVFSFGVMLLEI 690
++K DV++FGV++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 53/287 (18%)
Query: 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFC 556
G G G+V+ G ++AVK L K + E F+ E +I+ + H LV+L C
Sbjct: 15 GAGQFGEVWMGTWN---GTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 557 SEEDKRLLVYELMPNGTLSNFLFH-EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
SEE+ +V E M G+L +FL EG++ Q V++A +A G+ YL IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHR 127
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT 675
D+ +N+L + N + KI+DFG+++L+ D+ + + + APE T
Sbjct: 128 DLAARNIL-----VGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 676 TKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPE 735
K DV+SFG++L EI + RV M + E
Sbjct: 183 IKSDVWSFGILLTEI------VTYGRVPYPG--------------M----------TNRE 212
Query: 736 VLSDLERFERMAM----------VGLWCNHPDPNLRPSMKKVIHMLE 772
VL +ER RM + L C DP RP+ + + LE
Sbjct: 213 VLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 75/295 (25%), Positives = 137/295 (46%), Gaps = 50/295 (16%)
Query: 496 VGTGSSGKVYRGILR---LKDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+G GS G VY G+ + + + +A+K + E + EF+ E ++ + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP-----------GWVQRVEIALGVARG 600
LLG S L+V ELM G L ++L +RP + +++A +A G
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK-DQTRTDTNMRG 659
+ YL + +H D+ +N + + + KI DFG+++ + + D R
Sbjct: 132 MAYLA---AKKFVHRDLAARNCM-----VAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 660 TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI--ICGRRHIELSRVEEESEEVDIVLSDWV 717
+ ++APE L++ TTK DV+SFGV+L E+ + + + LS +EE V
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEE--------V 230
Query: 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
+ ++ L + P+ L +L M M C +P +RP+ +++ L+
Sbjct: 231 LKFVIDGGHLDLPENCPDKLLEL-----MRM----CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 72/212 (33%), Positives = 109/212 (51%), Gaps = 24/212 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKD---TQIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHKNL 549
+ +G G+ G+VY G+ R +D ++++AVK L E E+ +F+ E I+ + +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPG------WVQRVEIALGVARGLLY 603
VRL+G E R ++ ELM G L +FL RP + A VA+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG--TM 661
L E IH DI +N LL K +AKI+DFG++ +D R +G M
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGR--VAKIADFGMA----RDIYRASYYRKGGRAM 182
Query: 662 ---GYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
++ PE + T+K DV+SFGV+L EI
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G G+VY G+ K + +AVK L++D + EEF+ E ++ H NLV+LLG
Sbjct: 14 LGGGQYGEVYEGVW--KKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRP-GWVQRVEIALGVARGLLYLHEECETQIIH 614
C+ E ++ E M G L ++L ++ V + +A ++ + YL ++ IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 127
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPV 674
D+ +N L + N++ K++DFG+S+L+ D + + + APE L
Sbjct: 128 RDLAARNCL-----VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 675 TTKVDVFSFGVMLLEI 690
+ K DV++FGV+L EI
Sbjct: 183 SIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKL------EKDIEKTNEEFMTELKIIG 542
KG + +GTG+ Y+ R T +AVK++ + E+ E E++++
Sbjct: 3 LKG--QQLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMA 58
Query: 543 RTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIA--LGVARG 600
R +H +++R+LG E+ L E M G++S+ L G + + V I + RG
Sbjct: 59 RLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRG 115
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDT---NM 657
L YLHE QIIH D+K N+L+D T +I+DFG + L T +
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLID----STGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 658 RGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
GT+ ++APE LR DV+S G +++E+ +
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 60/197 (30%), Positives = 112/197 (56%), Gaps = 12/197 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT-NEEFMTELKIIGRTHHKNLVRLLG 554
+G+G+ G V +G+ +++ QI++A+K L+ + EK+ +E M E +I+ + + +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIH 614
C E + +LV E+ G L+ FL + VE+ V+ G+ YL + +H
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVH 118
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT--RTDTNMRGTMGYVAPEWLRNV 672
D+ +NVLL ++ +Y AKISDFG+SK L D + + + + + + APE +
Sbjct: 119 RDLAARNVLL----VNQHY-AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 673 PVTTKVDVFSFGVMLLE 689
+++ DV+S+G+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 34/209 (16%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFM-TELKIIGRTHHKNLVRLLG 554
+G G+SG+VY+ R T E+A+KK+ + K N+E + E+ I+ H N+V
Sbjct: 27 IGEGASGEVYKATDR--ATGKEVAIKKM--RLRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 555 FCSEEDKRL-LVYELMPNGTLSNFLFH------EGQRPGWVQRVEIA---LGVARGLLYL 604
L +V E M G+L++ + E Q IA V +GL YL
Sbjct: 83 -SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ---------IAYVCREVLQGLEYL 132
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
H +IH DIK N+LL + K++DFG + L K++++ ++ + GT ++
Sbjct: 133 HS---QNVIHRDIKSDNILLSK-----DGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWM 183
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICG 693
APE ++ KVD++S G+M +E+ G
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLG 554
++G G+ G VY R TQ+ IA+K++ + + + E+ + H+N+V+ LG
Sbjct: 15 VLGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGW--VQRVEIALG-----VARGLLYLHEE 607
SE + E +P G+LS L R W ++ E + + GL YLH+
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
QI+H DIK NVL++ + + KISDFG SK L T+T GT+ Y+APE
Sbjct: 128 ---QIVHRDIKGDNVLVNTYS----GVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPE 179
Query: 668 WLRNVP--VTTKVDVFSFGVMLLEIICGR 694
+ P D++S G ++E+ G+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGF 555
G G+SG V + + + T +AVK + +I E ++ + EL I+ + + +V G
Sbjct: 10 GAGNSGVVSK--VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
+ E M G+L L R +IA+ V +GL YLHE+ +IIH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHR 125
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT 675
D+KP N+L++ + K+ DFG+S L +T GT Y+APE ++ +
Sbjct: 126 DVKPSNILVNSRG-----QIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYS 177
Query: 676 TKVDVFSFGVMLLEIICGR 694
K D++S G+ L+E+ GR
Sbjct: 178 VKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 49/285 (17%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
K +G GS G VY+ + RL D Q A+K+ L +K E+ + E++I+ +H N++
Sbjct: 6 KKLGKGSYGSVYK-VKRLSDNQ-FYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIIS 63
Query: 552 -----LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI---ALGVARGLLY 603
L G +K +V E P G LS + ++ + EI + + RGL
Sbjct: 64 YKEAFLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
LHE+ +I+H D+K N+LL N + KI D GISK+L K+ +T GT Y
Sbjct: 119 LHEQ---KILHRDLKSANILLV-----ANDLVKIGDLGISKVLKKNMAKTQI---GTPHY 167
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723
+APE + P + K D++S G +L E+ E +++ +V I + S
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-PIPPIYS 226
Query: 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
++LQ + P LRP+ K++
Sbjct: 227 QDLQNFIR--------------------SMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 84/313 (26%), Positives = 136/313 (43%), Gaps = 58/313 (18%)
Query: 484 ELQEATKGFSKLVGTGSSGKVYRG---ILRLKDTQIEIAVKKL-EKDIEKTNEEFMTELK 539
+Q T + +G G+ GKV+ G L ++ + +AVK L E ++F E +
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 540 IIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEG-------------QRPG 586
++ H+N+V+ G C+E D ++V+E M +G L+ FL G
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 587 WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646
Q ++IA+ +A G++YL + +H D+ +N L + + + KI DFG+S
Sbjct: 121 LSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCL-----VGYDLVVKIGDFGMS--- 169
Query: 647 NKDQTRTDTNMRG--TM---GYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRR-HIEL 699
+D TD G TM ++ PE + TT+ DV+SFGV+L EI G++ L
Sbjct: 170 -RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228
Query: 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPN 759
S E VI C+ L P M+G W DP
Sbjct: 229 SNEE-------------VIECITQGRLL----QRPR---TCPSEVYDIMLGCW--KRDPQ 266
Query: 760 LRPSMKKVIHMLE 772
R ++K + L+
Sbjct: 267 QRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 63/207 (30%), Positives = 115/207 (55%), Gaps = 20/207 (9%)
Query: 494 KLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVR 551
+++G G G+V RG L+L +I +A+K L+ EK +F++E I+G+ H N++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
L G ++ +++ E M NG L +FL ++GQ +Q V + G+A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV-IQLVGMLRGIAAGMKYL---SEM 125
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG------YV 664
+H D+ +N+L +++N + K+SDFG+S+ L D +D ++G +
Sbjct: 126 NYVHRDLAARNIL-----VNSNLVCKVSDFGLSRFLEDD--TSDPTYTSSLGGKIPIRWT 178
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEII 691
APE + T+ DV+S+G+++ E++
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 72/229 (31%), Positives = 125/229 (54%), Gaps = 23/229 (10%)
Query: 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR 543
LQ+ T G +++G G G V +G + T ++AVK ++ D+ T + F+ E ++ +
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQG----EYTGQKVAVKNIKCDV--TAQAFLEETAVMTK 55
Query: 544 THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP-GWVQRVEIALGVARGLL 602
HHKNLVRLLG + V ELM G L NFL G+ +Q ++ +L VA G+
Sbjct: 56 LHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
YL + +++H D+ +N+L+ + +AK+SDFG++++ + N + +
Sbjct: 115 YLESK---KLVHRDLAARNILVS-----EDGVAKVSDFGLARV----GSMGVDNSKLPVK 162
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVD 710
+ APE L++ ++K DV+S+GV+L E+ GR ++E E V+
Sbjct: 163 WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 76/297 (25%), Positives = 134/297 (45%), Gaps = 39/297 (13%)
Query: 492 FSKLVGTGSSGKVYRGILR-LKDTQIE-IAVKKLEKDIEKTN-EEFMTELKIIGRTHHKN 548
F K +G G GKV L D E +AVK L E+ + +F E++I+ H+N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 549 LVRLLGFCSEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
+V+ G C + R L+ E +P+G+L ++L + + + + + +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT--MGYV 664
+ + IH D+ +N+L++ + + KISDFG++K+L +D+ G + +
Sbjct: 128 Q---RYIHRDLAARNILVE-----SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724
APE LR ++ DV+SFGV L E+ + + L +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYEL--------FTYGDPSQSPPAEFL-----RMIGIA 226
Query: 725 NLQVLVSHDPEVLSDLERFER---------MAMVGLWCNHPDPNLRPSMKKVIHMLE 772
Q++V+ E+L + ER R M W +P RPS +I +++
Sbjct: 227 QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCW--EAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-22
Identities = 78/262 (29%), Positives = 119/262 (45%), Gaps = 28/262 (10%)
Query: 513 DTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL-VYEL 568
T E+A+K L D E F E + R +H N+V LL L V+E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT 628
+P TL L +G P + + L V L H + I+H D+KPQN+++
Sbjct: 61 VPGRTLREVLAADGALPA-GETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 629 LDTNYMAKISDFGISKLL----NKDQTRT--DTNMRGTMGYVAPEWLRNVPVTTKVDVFS 682
+ + AK+ DFGI LL + D T + GT Y APE LR PVT D+++
Sbjct: 117 VRPH--AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 683 FGVMLLEIICGRRHIELSRVEE----ESEEVDIVLSDWVISCMLSRNLQVLVSHDPE--V 736
+G++ LE + G+R ++ + V E + VD+ L W+ L + L+ ++ DP
Sbjct: 175 WGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRA 234
Query: 737 LSDLERFERM------AMVGLW 752
S ER A+VG+
Sbjct: 235 ASAPALAERFRALELCALVGIL 256
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
F K +G+G G V+ G R +I++A+K + ++ + ++F+ E K++ + H NLV+
Sbjct: 8 FLKELGSGQFGVVHLGKWR---GKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQ 63
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
L G C+++ +V E M NG L N+L + G +++ V + YL
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--- 120
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
IH D+ +N L + + + K+SDFG+++ + DQ + + + + PE
Sbjct: 121 FIHRDLAARNCL-----VGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY 175
Query: 672 VPVTTKVDVFSFGVMLLEI 690
++K DV+SFGV++ E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 86/286 (30%), Positives = 139/286 (48%), Gaps = 36/286 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQ-IEIAVKKLEK--DIEKTNEEFMTELKIIGRTHHKNLV 550
+++G G G VY G L D Q I AVK L + D+E+ E+F+ E I+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV-EQFLKEGIIMKDFSHPNVL 59
Query: 551 RLLGFC-SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
LLG C E L+V M +G L NF+ E P + L VA+G+ YL +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-- 117
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNKD--QTRTDTNMRGTMGYVAP 666
+ +H D+ +N +LD ++ K++DFG+++ + +K+ T + + ++A
Sbjct: 118 -KFVHRDLAARNCMLD-----ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726
E L+ TTK DV+SFGV+L E+ ++R +VD D + + R L
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVDSF--DITVYLLQGRRL 221
Query: 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
PE D +E M L C HP P +RP+ +++ +E
Sbjct: 222 L-----QPEYCPD-PLYEVM----LSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 64/203 (31%), Positives = 113/203 (55%), Gaps = 14/203 (6%)
Query: 494 KLVGTGSSGKVYRGILRLKDT-QIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVR 551
K++G G G+V G L+L +I +A+K L+ EK +F++E I+G+ H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLF-HEGQRPGWVQRVEIALGVARGLLYLHEECET 610
L G ++ ++V E M NG+L FL H+GQ +Q V + G+A G+ YL +
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFT-VIQLVGMLRGIASGMKYL---SDM 125
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG--YVAPEW 668
+H D+ +N+L +++N + K+SDFG+S++L D T G + + APE
Sbjct: 126 GYVHRDLAARNIL-----VNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 669 LRNVPVTTKVDVFSFGVMLLEII 691
+ T+ DV+S+G+++ E++
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IE-KTNEEFMTELKIIGRTHHKN 548
F K +GTGS G+V ++R K + A+K L K ++ K E + E +I+ H
Sbjct: 5 FIKTLGTGSFGRVM--LVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLH 605
LV L G ++ LV E +P G L + L G+ P V R ++ L L YLH
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEYLH 118
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
I++ D+KP+N+LLD Y+ KI+DFG +K + + RT T + GT Y+A
Sbjct: 119 SL---DIVYRDLKPENLLLD----SDGYI-KITDFGFAKRV---KGRTYT-LCGTPEYLA 166
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICG 693
PE + + VD ++ G+++ E++ G
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 20/201 (9%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVK--KLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G+G+ G V +G+ ++K ++ +AVK K + + +E + E ++ + + +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR---VEIALGVARGLLYLHEECET 610
G C E + +LV EL G L+ FL Q+ V E+ V+ G+ YL E T
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEE---T 114
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT--RTDTNMRGTMGYVAPEW 668
+H D+ +NVLL T + AKISDFG+SK L D+ + T+ + + + APE
Sbjct: 115 NFVHRDLAARNVLLV-----TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 669 LRNVPVTTKVDVFSFGVMLLE 689
+ ++K DV+SFGV++ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 70/223 (31%), Positives = 113/223 (50%), Gaps = 37/223 (16%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQ---IEIAVKKLEKD-IEKTNEEFMTEL---KIIGRTHH 546
K +G G+ G+V + D +AVK L+ D EK + ++E+ K+IG+ H
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 75
Query: 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP-----------------GWVQ 589
KN++ LLG C++E +V E +G L +FL +RP
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL--RARRPPGEYASPDDPRPPEETLTQKD 133
Query: 590 RVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNK 648
V A VARG+ +L + + IH D+ +NVL+ +++ KI+DFG+++ + +
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT-----EDHVMKIADFGLARDIHHI 185
Query: 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
D R TN R + ++APE L + T + DV+SFGV+L EI
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 8e-21
Identities = 37/104 (35%), Positives = 62/104 (59%), Gaps = 10/104 (9%)
Query: 72 EKTLVWAADRDSPAEAGS-KITLTNDGKLLLTYFNGSVQQIYS------GAASLALMQND 124
+T+VW A+R +P S + L +DG L+L ++G+ + ++S G+ +A++Q+D
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVL--YDGNGRVVWSSNTSGKGSGCVAVLQDD 58
Query: 125 GNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTA 168
GN VL + + V+W SFD PTDT+LPGQ + + R T+
Sbjct: 59 GNLVLYDNSGKVLWQSFDHPTDTLLPGQK-DGNVVIGGSRRLTS 101
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 60/198 (30%), Positives = 110/198 (55%), Gaps = 14/198 (7%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRL 552
+L+G G+ G+V++G L+ K +AVK ++D+ ++ +F++E +I+ + H N+V+L
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTP---VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL 57
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQI 612
+G C++ +V EL+P G +FL + Q V+ AL A G+ YL +
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NC 114
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT-MGYVAPEWLRN 671
IH D+ +N L + N + KISDFG+S+ D + + ++ + + APE L
Sbjct: 115 IHRDLAARNCL-----VGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 672 VPVTTKVDVFSFGVMLLE 689
+++ DV+S+G++L E
Sbjct: 169 GRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT----ELKIIGRTHHKNLVRL 552
G G+ G V + RLK+T + A+K + D N + EL+I +V+
Sbjct: 10 GEGAGGSVTK--CRLKNTGMIFALKTITTD---PNPDLQKQILRELEINKSCKSPYIVKY 64
Query: 553 LG-FCSEEDKRL-LVYELMPNGTLSNF---LFHEGQRPGWVQRV--EIALGVARGLLYLH 605
G F E + + E G+L + + G R G ++V +IA V +GL YLH
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG--EKVLGKIAESVLKGLSYLH 122
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+IIH DIKP N+LL K K+ DFG+S L T T GT Y+A
Sbjct: 123 SR---KIIHRDIKPSNILLTRKG-----QVKLCDFGVSGELVNSLAGTFT---GTSFYMA 171
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
PE ++ P + DV+S G+ LLE+ R
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
K +G GS GK+Y + I L K K E E+ ++ + H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 554 GFCSEEDKRLLVYELMPNGTL-------SNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
E + +V E G L LF E Q W V+I+L GL ++H+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISL----GLKHIHD 119
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
+I+H DIK QN+ L +AK+ DFGI++ LN D GT Y++P
Sbjct: 120 R---KILHRDIKSQNIFLS----KNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSP 171
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696
E +N P K D++S G +L E +C +H
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYE-LCTLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF----MTELKIIGRTHHKNLVR 551
+G G+ G+VY+ R K T +A+KK+ + EK E F + E+K++ + H N+VR
Sbjct: 7 IGEGTYGQVYKA--RNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62
Query: 552 LLGFCSEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
L + + K +V+E M + L+ L + Q + GL YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN-- 119
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
I+H DIK N+L++ + + K++DFG+++ K + TN T+ Y PE L
Sbjct: 120 -GILHRDIKGSNILIN-----NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 670 ---RNVPVTTKVDVFSFGVMLLEIICGR 694
+VD++S G +L E+ G+
Sbjct: 174 LGATR--YGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 28/219 (12%)
Query: 492 FSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHK 547
F + +G G+ GKVY+G L + +A+K L+++ E K +EF E +++ H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLF----HEGQRPGWVQR-----------VE 592
N+V LLG C++E +++E + +G L FL H +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL-NKDQT 651
IA+ +A G+ YL +H D+ +N L+ KISDFG+S+ + + D
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG-----LTVKISDFGLSRDIYSADYY 180
Query: 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
R + + ++ PE + TT+ D++SFGV+L EI
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 13/211 (6%)
Query: 485 LQEATKGFSKLVGTGSSGKVYRGIL--RLKDTQIEIAVKKL-EKDIEKTNEEFMTELKII 541
L+E K++G+G+ G VY+GI + +I +A+K L E K N EFM E I+
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 542 GRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGL 601
H +LVRLLG C + LV +LMP+G L +++ G + + +A+G+
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM 122
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN-MRGT 660
+YL E +++H D+ +NVL+ N++ KI+DFG+++LL D+ + + +
Sbjct: 123 MYLEER---RLVHRDLAARNVLVK----SPNHV-KITDFGLARLLEGDEKEYNADGGKMP 174
Query: 661 MGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
+ ++A E + T + DV+S+GV + E++
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 37/232 (15%)
Query: 482 FQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNE-EFMTELKI 540
+ L+ F ++G G+ G+V + ++ +++ A+K++++ K + +F EL++
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 541 IGRT-HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL-----------FHEGQRPGWV 588
+ + HH N++ LLG C L E P+G L +FL F
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 589 ----QRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
Q + A VARG+ YL ++ Q IH D+ +N+L + NY+AKI+DFG+S+
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL-----VGENYVAKIADFGLSR 172
Query: 645 LLNKDQTRTDTNMRGTMGYVAPEWLR----NVPV-TTKVDVFSFGVMLLEII 691
+ ++ TMG + W+ N V TT DV+S+GV+L EI+
Sbjct: 173 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 494 KLVGTGSSGKVYRGI-LRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVR 551
K +G GS G V RG I +AVK L+ D + ++F+ E I+ H+NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV-EIALGVARGLLYLHEECET 610
L G ++V EL P G+L + L + + + + A+ +A G+ YL +
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL--NKDQTRTDTNMRGTMGYVAPEW 668
+ IH D+ +N+LL KI DFG+ + L N+D + +++ + APE
Sbjct: 117 RFIHRDLAARNILLASDDK-----VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 669 LRNVPVTTKVDVFSFGVMLLEI 690
LR + DV+ FGV L E+
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF----MTELKIIGRTH 545
+ KL +G G+ G VY+ R K T +A+KK+ ++ E + E+ ++
Sbjct: 1 YEKLEKLGEGTYGVVYKA--RDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELK 56
Query: 546 HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL--FHEGQRPGWVQRVEIALGVARGLLY 603
H N+V+LL E K LV+E L +L P ++ I + RGL Y
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAY 113
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
H +I+H D+KPQN+L ++ + + K++DFG+++ RT T+ T+ Y
Sbjct: 114 CHSH---RILHRDLKPQNIL-----INRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWY 164
Query: 664 VAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
APE L +T VD++S G + E+I G+
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 30/206 (14%)
Query: 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFC 556
G G+ GKVY+ + K+T + A K ++ + E+ E+FM E+ I+ H N+V L
Sbjct: 14 GDGAFGKVYKA--QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 557 SEEDKRLLVYELMPNGTLSNFL------FHEGQ-RPGWVQRVEIALGVARGLLYLHEECE 609
E+K ++ E G L + + E Q R + + L +LH
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEALNFLHSH-- 122
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
++IH D+K N+LL TLD + K++DFG+S + DT + GT ++APE +
Sbjct: 123 -KVIHRDLKAGNILL---TLDGD--VKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVV 175
Query: 670 -----RNVPVTTKVDVFSFGVMLLEI 690
++ P K D++S G+ L+E+
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 69/225 (30%), Positives = 115/225 (51%), Gaps = 44/225 (19%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIE-IAVKKLE----------KDIEKTNEEFMTELKIIG 542
+L+G G+ G+VY L L T E +AVK++E + + +E++ +
Sbjct: 7 ELIGKGTYGRVY---LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63
Query: 543 RTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL------G 596
H N+V+ LGF + E+ + E +P G++ + L + G R E L
Sbjct: 64 DLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYG---RFEEQLVRFFTEQ 116
Query: 597 VARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK----LLNKDQTR 652
V GL YLH + I+H D+K N+L+D + KISDFGISK + + DQ
Sbjct: 117 VLEGLAYLHSK---GILHRDLKADNLLVDADGI-----CKISDFGISKKSDDIYDNDQ-- 166
Query: 653 TDTNMRGTMGYVAPEWLRN--VPVTTKVDVFSFGVMLLEIICGRR 695
+ +M+G++ ++APE + + + KVD++S G ++LE+ GRR
Sbjct: 167 -NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 25/207 (12%)
Query: 499 GSSGKVYRGILRLKDTQIEIAVKKLEKD--IEK-TNEEFMTELKIIGRTHHKNLVRLLGF 555
G+ G+V+ + + K T A+K ++K I K ++ +TE I+ + +V+L +
Sbjct: 4 GAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--Y 59
Query: 556 CSEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
S + K+ LV E +P G L++ L + G V R+ IA V L YLH II
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVL-ALEYLHS---NGII 115
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKL-LNKDQTRTDTNMR------GTMGYVAP 666
H D+KP N+L+D +N K++DFG+SK+ L + Q + + + GT Y+AP
Sbjct: 116 HRDLKPDNILID-----SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICG 693
E + + VD +S G +L E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 475 INFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF 534
+N +E + +G G G V G R ++AVK ++ D T + F
Sbjct: 3 LNMKELKLLQT----------IGKGEFGDVMLGDYRGN----KVAVKCIKND--ATAQAF 46
Query: 535 MTELKIIGRTHHKNLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRP-GWVQRVE 592
+ E ++ + H NLV+LLG EE L +V E M G+L ++L G+ G ++
Sbjct: 47 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
+L V + YL +H D+ +NVL+ + +AK+SDFG L K+ +
Sbjct: 107 FSLDVCEAMEYLEA---NNFVHRDLAARNVLVS-----EDNVAKVSDFG----LTKEASS 154
Query: 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
T + + + APE LR +TK DV+SFG++L EI
Sbjct: 155 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G GS+G V I K T ++AVKK++ ++ E E+ I+ H N+V +
Sbjct: 27 IGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
D+ +V E + G L++ + H R Q + L V + L +LH + +IH
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHR 139
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT 675
DIK ++LL T D K+SDFG ++K+ R + + GT ++APE + +P
Sbjct: 140 DIKSDSILL---TSDGR--VKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPEVISRLPYG 193
Query: 676 TKVDVFSFGVMLLEIICG 693
T+VD++S G+M++E++ G
Sbjct: 194 TEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 71/227 (31%), Positives = 107/227 (47%), Gaps = 17/227 (7%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMT--ELKIIGRTHHKNLVRL 552
+G G G+V ++K T A KKL+K ++K E M E KI+ + + +V L
Sbjct: 1 LGKGGFGEVCA--CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI-ALGVARGLLYLHEECETQ 611
+D LV LM G L +++ G+ R A + GL +LH+ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---R 115
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
I++ D+KP+NVLLD D + +ISD G++ L K + GT GY+APE L+
Sbjct: 116 IVYRDLKPENVLLD----DHGNV-RISDLGLAVEL-KGGKKI-KGRAGTPGYMAPEVLQG 168
Query: 672 VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD-IVLSDWV 717
VD F+ G L E+I GR + + E EE+ L V
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 14/207 (6%)
Query: 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH 545
+E+ K KL G G G+V+ G + ++AVK L K + + F+ E ++
Sbjct: 5 RESIKLVKKL-GAGQFGEVWMGYY---NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQ 59
Query: 546 HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYL 604
H LVRL ++E+ ++ E M G+L +FL EG + + ++ + +A G+ Y+
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
+ IH D++ NVL+ + M KI+DFG+++++ ++ + + +
Sbjct: 120 ERK---NYIHRDLRAANVLVS-----ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEII 691
APE + T K DV+SFG++L EI+
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G GS+G V I K T ++AVKK++ ++ E E+ I+ HH+N+V +
Sbjct: 30 IGEGSTGIVC--IATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
D+ +V E + G L++ + H R Q + L V R L YLH + +IH
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQ---GVIHR 142
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT 675
DIK ++LL ++ K+SDFG ++K+ + + + GT ++APE + +P
Sbjct: 143 DIKSDSILLT-----SDGRIKLSDFGFCAQVSKEVPKRKS-LVGTPYWMAPEVISRLPYG 196
Query: 676 TKVDVFSFGVMLLEIICG 693
T+VD++S G+M++E+I G
Sbjct: 197 TEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLVRLLG 554
+G G+ G+V+ G LR +T + AVK + + +F+ E +I+ + H N+VRL+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPV--AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIH 614
C+++ +V EL+ G FL EG R + +++ A G+ YL + IH
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT-MGYVAPEWLRNVP 673
D+ +N L+ K + KISDFG+S+ + M+ + + APE L
Sbjct: 118 RDLAARNCLVTEKN-----VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 674 VTTKVDVFSFGVMLLE 689
+++ DV+SFG++L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 72/284 (25%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
F K +G+G G V+ G R QI++A+K + + + E+F+ E K++ + H LV+
Sbjct: 8 FMKELGSGQFGVVHLGKWR---AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQ 63
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR---VEIALGVARGLLYLHEEC 608
L G C+++ +V E M NG L N+L QR G + + + + V G+ YL
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLE--- 117
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
IH D+ +N L + + + K+SDFG+++ + D+ + + + + + PE
Sbjct: 118 RNSFIHRDLAARNCL-----VSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEV 172
Query: 669 LRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
++K DV+SFGV++ E+ G+ E S++ + M+SR +
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK-------------SNYEVVEMISRGFR 219
Query: 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771
+ L+ + +E M C H P RP+ +++ +
Sbjct: 220 LYRPK----LASMTVYEVMYS----CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 495 LVGTGSSGKVYRG-------ILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHK 547
L+G+GS G VY G ++ +K ++ + + E+ ++ H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
N+V+ LG + D + E +P G+++ L + G + R + +GL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLHNR 125
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN-----MRGTMG 662
IIH DIK N+L+D K KISDFGISK L + T TN ++G++
Sbjct: 126 ---GIIHRDIKGANILVDNKG-----GIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
++APE ++ T K D++S G +++E++ G+
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 37/222 (16%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGRT-HHKNL 549
F ++G G+ G+V R +++ ++ A+K L E E + +F EL+++ + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHE---GQRPGWV------------QRVEIA 594
+ LLG C + E P G L +FL P + Q ++ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 595 LGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD 654
VA G+ YL E+ Q IH D+ +NVL+ N +KI+DFG+S+ +
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVG-----ENLASKIADFGLSR-------GEE 170
Query: 655 TNMRGTMGYVAPEWLR----NVPV-TTKVDVFSFGVMLLEII 691
++ TMG + W+ N V TTK DV+SFGV+L EI+
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL--EKDIEKTNEEFMTELKIIGRTHHKNLVR 551
++VG G+ G V+ + R K Q + +K++ E+ + E +++ H N++
Sbjct: 6 RVVGRGAFGIVH--LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
E+ ++V E P GTL+ ++ + + + I + LL LH
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTKL 121
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL-NKDQTRTDTNMRGTMGYVAPEWLR 670
I+H D+K QN+LLD + + KI DFGISK+L +K + T + GT Y++PE
Sbjct: 122 ILHRDLKTQNILLDKHKM----VVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCE 174
Query: 671 NVPVTTKVDVFSFGVMLLEIICGRRHIE 698
P K D+++ G +L E+ +R E
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRT-HHKNL 549
K++G GS GKV + LK T AVK L+KD+ +++ MTE +++ H L
Sbjct: 1 KVLGKGSFGKVL--LAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
+L +D+ V E + G L F R + A + GL +LHE
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLM-FHIQRSGRFDEPRARFYAAEIVLGLQFLHER-- 115
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK--LLNKDQTRTDTNMRGTMGYVAPE 667
II+ D+K NVLLD + KI+DFG+ K +L T T GT Y+APE
Sbjct: 116 -GIIYRDLKLDNVLLD-----SEGHIKIADFGMCKEGILGGVTTST---FCGTPDYIAPE 166
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGR 694
L P VD ++ GV+L E++ G+
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 75/296 (25%), Positives = 140/296 (47%), Gaps = 37/296 (12%)
Query: 492 FSKLVGTGSSGKVYRGILR---LKDTQIE-IAVKKLEKDIEKTNEEFMTELKIIGRTHHK 547
F + +G G+ G V + R L+D E +AVKKL+ + +F E++I+ H
Sbjct: 8 FIQQLGKGNFGSVE--LCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 548 NLVRLLGFCSEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH 605
N+V+ G C +R LV E +P G+L ++L +R + + A + +G+ YL
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL--NKDQTRTDTNMRGTMGY 663
+ + +H D+ +N+L++ + KI DFG++K+L +K+ + + +
Sbjct: 126 SK---RYVHRDLATRNILVESENR-----VKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723
APE L + DV+SFGV+L E+ + + S +E + ++ +D
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT---YSDKSC-SPPAEFMRMMGND-------- 225
Query: 724 RNLQVLVSHDPEVLSDLERFER-------MAMVGLWCNHPDPNLRPSMKKVIHMLE 772
+ Q++V H E+L + R + + C + DP+ RPS ++ +E
Sbjct: 226 KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 72/236 (30%), Positives = 114/236 (48%), Gaps = 29/236 (12%)
Query: 467 YFDPNSMEINFR-EFTFQELQEATKGFSKLVGTGSSGKVYRGI---LRLKDTQIEIAVKK 522
Y DP + + + EF L F K +G G+ GKV L D +++AVK
Sbjct: 18 YIDPTQLPYDLKWEFPRNNLS-----FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKM 72
Query: 523 LEKDIEKTNEE-FMTELKIIGRTH---HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL 578
L+ + E M+ELKI+ +H H+N+V LLG C+ L++ E G L NFL
Sbjct: 73 LKPTAHSSEREALMSELKIM--SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL 130
Query: 579 FHEGQRPGWVQR--VEIALGVARGLLYL-HEECETQIIHCDIKPQNVLLDLKTLDTNYMA 635
+ + + VA+G+ +L + C IH D+ +NVLL +
Sbjct: 131 -RRKRESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLT-----HGKIV 180
Query: 636 KISDFGISK-LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
KI DFG+++ ++N N R + ++APE + N T + DV+S+G++L EI
Sbjct: 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 28/214 (13%)
Query: 496 VGTGSSGKVY----RGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+G G+ GKV+ +L +D + +AVK L++ E ++F E +++ H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKML-VAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFH-----------EGQRPGWV---QRVEIALGV 597
G C+E L+V+E M +G L+ FL E PG + Q + IA +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 598 ARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNKDQTRTDTN 656
A G++YL +H D+ +N L + + KI DFG+S+ + + D R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCL-----VGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183
Query: 657 MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ ++ PE + TT+ D++SFGV+L EI
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNE---EFMTELKIIGRTHH 546
KG +L+G+GS G VY G+ + L D + E + E+ ++ + H
Sbjct: 4 KG--ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLY 603
N+V+ LG EED + EL+P G+L+ L ++ G I L + GL Y
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEY 117
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
LH+ +H DIK N+L +DTN + K++DFG++K + + + +G+ +
Sbjct: 118 LHDR---NTVHRDIKGANIL-----VDTNGVVKLADFGMAKQVVE--FSFAKSFKGSPYW 167
Query: 664 VAPEWLRNV-PVTTKVDVFSFGVMLLEIICGR 694
+APE + D++S G +LE+ G+
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEE-FMTELKIIGRTHHKNLVRL 552
+G G G+V ++++K A+K ++K +E +E +E +I+ +H +V+L
Sbjct: 1 LGVGGFGRVE--LVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 553 LGFCSEEDKRLLVY---ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
+ + +DK+ +Y E G L L G + R IA V YLH
Sbjct: 59 --YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHNR-- 112
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
II+ D+KP+N+LLD +N K+ DFG +K L K +T T GT YVAPE +
Sbjct: 113 -GIIYRDLKPENLLLD-----SNGYVKLVDFGFAKKL-KSGQKTWT-FCGTPEYVAPEII 164
Query: 670 RNVPVTTKVDVFSFGVMLLEIICGR 694
N VD +S G++L E++ GR
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 58/202 (28%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 494 KLVGTGSSGKVYRG--ILRLKDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHKNLV 550
K++G+G+ G VY+G I + +I +A+K+L E K N+E + E ++ + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
RLLG C +L + +LMP G L +++ G + + +A+G+ YL E
Sbjct: 73 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER--- 128
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN-MRGTMGYVAPEWL 669
+++H D+ +NVL+ T KI+DFG++KLL D+ + + ++A E +
Sbjct: 129 RLVHRDLAARNVLVK-----TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 670 RNVPVTTKVDVFSFGVMLLEII 691
+ T + DV+S+GV + E++
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLG 554
+G GS G VY+ I K+T +A+K + +E+ +E + E+ I+ + +V+ G
Sbjct: 10 KLGEGSYGSVYKAIH--KETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYG 65
Query: 555 FCSEEDKRLLVYELMPNGTLSNFL------FHEGQRPGWVQRVEIAL---GVARGLLYLH 605
+ +V E G++S+ + E EIA +GL YLH
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTE---------EEIAAILYQTLKGLEYLH 116
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+ IH DIK N+LL+ + AK++DFG+S L + +T + GT ++A
Sbjct: 117 SN---KKIHRDIKAGNILLNEEGQ-----AKLADFGVSGQLTDTMAKRNT-VIGTPFWMA 167
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
PE ++ + K D++S G+ +E+ G+
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 11/201 (5%)
Query: 493 SKLVGTGSSGKVYRGI-LRLKDTQIEIAVKKLEKDIEKTN-EEFMTELKIIGRTHHKNLV 550
+ +G G G VY+G+ + ++ +I +AVK + + E+F+ E I+ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
+L+G E+ +V EL P G L ++L + + ++ L YL
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
+ +H DI +NVL + + K+ DFG+S+ L + + + + ++APE +
Sbjct: 127 RFVHRDIAARNVL-----VSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 671 NVPVTTKVDVFSFGVMLLEII 691
T+ DV+ FGV + EI+
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 74/269 (27%), Positives = 119/269 (44%), Gaps = 37/269 (13%)
Query: 518 IAVKKLEKDIEKT-NEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSN 576
+AVK L D+ KT +F+ E+KI+ R + N++RLLG C +D ++ E M NG L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 577 FLFHEGQRPGWVQRVEI-----------ALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625
FL + I A+ +A G+ YL +H D+ +N L
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL-- 161
Query: 626 LKTLDTNYMAKISDFGISK-LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFG 684
+ +Y KI+DFG+S+ L + D R + ++A E + TT DV++FG
Sbjct: 162 ---VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218
Query: 685 VMLLEI--ICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLER 742
V L E+ +C + L E+ E + + Q+ +S P S +
Sbjct: 219 VTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRN--------QGRQIYLSQTPLCPSPV-- 268
Query: 743 FERMAMVGLWCNHPDPNLRPSMKKVIHML 771
F+ M + C D RP+ K+ H L
Sbjct: 269 FKLM----MRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-17
Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 7/114 (6%)
Query: 35 TAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLT 94
T S + +S + F GF++L I + +T+VW A+RD+P +TL
Sbjct: 3 TLSSGQTLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQ 61
Query: 95 NDGKLLLTYFNGSV-----QQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDF 143
+DG L+L +G V +G L L +DGN V+ +++ +W SFD+
Sbjct: 62 SDGNLVLYDGDGRVVWSSNTTGANGNYVLVL-LDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 37/219 (16%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGRT-HHKNLVRL 552
++G G+ G+V + ++ +++ A+K++ E + + +F EL+++ + HH N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHE---GQRPGWV------------QRVEIALGV 597
LG C L E P+G L +FL P + Q + A V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 598 ARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNM 657
ARG+ YL ++ Q IH D+ +N+L + NY+AKI+DFG+S+ + +
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNIL-----VGENYVAKIADFGLSR-------GQEVYV 166
Query: 658 RGTMGYVAPEWLR----NVPV-TTKVDVFSFGVMLLEII 691
+ TMG + W+ N V TT DV+S+GV+L EI+
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 83/306 (27%), Positives = 141/306 (46%), Gaps = 49/306 (16%)
Query: 496 VGTGSSGKVYRGI---LRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRL 552
+G G+ GKV+ L + +I +AVK L+ + ++F E +++ H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNF---------LFHEGQRPGWV---QRVEIALGVARG 600
G C E D ++V+E M +G L+ F L EG RP + Q + IA +A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNKDQTRTDTNMRG 659
++YL + +H D+ +N L + N + KI DFG+S+ + + D R +
Sbjct: 133 MVYLASQ---HFVHRDLATRNCL-----VGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 660 TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRH--IELSRVEEESEEVDIVLSDWV 717
+ ++ PE + TT+ DV+S GV+L EI + +LS E V
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------------V 231
Query: 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777
I C+ + P+ + DL M+G W +P++R ++K+ IH L L
Sbjct: 232 IECITQGRVLQRPRTCPKEVYDL-------MLGCW--QREPHMRLNIKE-IHSLLQNLAK 281
Query: 778 GMPPLL 783
P L
Sbjct: 282 ASPVYL 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G GS+G V I +K + +AVKK++ ++ E E+ I+ H+N+V +
Sbjct: 28 IGEGSTGIVC--IATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
D+ +V E + G L++ + H R Q + L V + L LH + +IH
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHR 140
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT 675
DIK ++LL T D K+SDFG ++K+ R + + GT ++APE + +P
Sbjct: 141 DIKSDSILL---THDGR--VKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPELISRLPYG 194
Query: 676 TKVDVFSFGVMLLEIICG 693
+VD++S G+M++E++ G
Sbjct: 195 PEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 78/294 (26%), Positives = 130/294 (44%), Gaps = 50/294 (17%)
Query: 495 LVGTGSSGKVYR--------GILRLKDTQI-EIAVKKLEKDIEKTNEEFMTELKIIGRT- 544
+G+G+ G VY+ +L LK+ + A K +++ +K+ + ++E+ II
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 545 HHKNLVRLLGFCSEEDKRLLVYELM---PNGTLSNFLFHEGQRPG----WVQRVEIALGV 597
H N+VR E D+ +V +L+ P G N L + QR W V++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 598 ARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNM 657
L YLH+E +I+H D+ P N++L + I+DFG++K K T++
Sbjct: 126 ---LRYLHKE--KRIVHRDLTPNNIMLG-----EDDKVTITDFGLAK--QKQPESKLTSV 173
Query: 658 RGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717
GT+ Y PE ++N P K DV++FG +L ++ L +
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQM------CTLQPPFYSTN---------- 217
Query: 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771
MLS ++ V E L + E + V C PD RP + +V M+
Sbjct: 218 ---MLSLATKI-VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
K +G G G+V+ G + ++AVK L K + E F+ E +I+ + H LV+L
Sbjct: 12 KKLGNGQFGEVWMGTW---NGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLY 67
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFH-EGQRPGWVQRVEIALGVARGLLYLHEECETQI 612
SEE +V E M G+L +FL EG+ V++A VA G+ Y+
Sbjct: 68 AVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNY 123
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
IH D++ N+L + + KI+DFG+++L+ ++ + + + APE
Sbjct: 124 IHRDLRSANIL-----VGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 673 PVTTKVDVFSFGVMLLEIICGRR 695
T K DV+SFG++L E++ R
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-17
Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 35/286 (12%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLG 554
++ G G Y+G + ++ VK++ D+ + ++ G+ H N+V+L+G
Sbjct: 697 VISRGKKGASYKG--KSIKNGMQFVVKEI-NDVNSIPSSEIADM---GKLQHPNIVKLIG 750
Query: 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIH 614
C E L++E + LS L + W +R +IA+G+A+ L +LH C ++
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPV 674
++ P+ +++D K D ++ + LL TDT + YVAPE +
Sbjct: 807 GNLSPEKIIIDGK--DEPHLR----LSLPGLLC-----TDTKCFISSAYVAPETRETKDI 855
Query: 675 TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDP 734
T K D++ FG++L+E++ G+ S + E V + +W C +L + + DP
Sbjct: 856 TEKSDIYGFGLILIELLTGK-----SPADAEF-GVHGSIVEWARYCYSDCHLDMWI--DP 907
Query: 735 EVLSDL-----ERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775
+ D+ E E M + L C DP RP V+ LE
Sbjct: 908 SIRGDVSVNQNEIVEVMNL-ALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDIEKTN--EEFMTELKIIGRTHHKNLV 550
K++G G G V G L D +Q+++AVK ++ DI + EEF++E + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 551 RLLGFCSEEDKR------LLVYELMPNGTLSNFLFHE--GQRPGWV---QRVEIALGVAR 599
+L+G C E +++ M +G L +FL + G P + ++ + +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS-KLLNKDQTRTDTNMR 658
G+ YL IH D+ +N +L + ++DFG+S K+ + D R +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLR-----EDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 659 GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ ++A E L + T+K DV++FGV + EI
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN---EEFMTELKIIGRTHHKNLVR 551
+VG G+ G V + R K T +A+KK K+ E + + E+K++ + H+N+V
Sbjct: 8 VVGEGAYGVVLK--CRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFL--FHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
L + + LV+E + TL L G P V+ L + + Y H
Sbjct: 65 LKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCHSH-- 119
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
IIH DIKP+N+L+ + + K+ DFG ++ L T+ T Y APE L
Sbjct: 120 -NIIHRDIKPENILVSE-----SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173
Query: 670 -RNVPVTTKVDVFSFGVMLLEIICGR 694
+ VDV++ G ++ E++ G
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQ-IEIAVKKLEKDI-EKTNEEFMTELKII 541
EL + +++GTG G++ RG L+L + + +A+ L +K F+ E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 542 GRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLF-HEGQRPGWVQRVEIALGVARG 600
G+ H N+VRL G + + ++V E M NG L +FL HEGQ Q + + G+A G
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA-GQLMGMLPGLASG 119
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD-TNMRG 659
+ YL E +H + VL ++++ + KIS F L +D++ T M G
Sbjct: 120 MKYL---SEMGYVHKGLAAHKVL-----VNSDLVCKISGFR---RLQEDKSEAIYTTMSG 168
Query: 660 --TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
+ + APE ++ ++ DV+SFG+++ E++
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT---ELKIIGRTHH 546
F+ L +G GS G+VY+ I K T +A+K + D+E+ +E E++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAI--DKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRS 58
Query: 547 KNLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIA---LGVARGLL 602
+ + G + +L ++ E G+ + L +PG + IA V GL
Sbjct: 59 PYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLE 112
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
YLHEE IH DIK N+L L K++DFG+S L ++ +T GT
Sbjct: 113 YLHEE---GKIHRDIKAANIL-----LSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPF 163
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
++APE ++ K D++S G+ +E+ G
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD------IEKTNEEFMTELKI 540
E TKG +++G G+ G VY G L + IAVK++E D EK E+ E+ +
Sbjct: 1 EWTKG--EVLGKGAYGTVYCG---LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDL 55
Query: 541 IGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARG 600
+ H N+V+ LG C +++ + E +P G++S+ L G P V + + G
Sbjct: 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDG 114
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL-----NKDQTRTDT 655
+ YLH C ++H DIK NV+ L N + K+ DFG ++ L + +
Sbjct: 115 VAYLHNNC---VVHRDIKGNNVM-----LMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 656 NMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
+M GT ++APE + K D++S G + E+ G+
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G+ GKVY+ + K+T A K +E E+ E++M E++I+ +H +V+LLG
Sbjct: 20 LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
+ K ++ E P G + + + Q I + L YLH +IIH
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHR 134
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP-----EWLR 670
D+K NVLL TLD + K++DFG+S K R D+ + GT ++AP E ++
Sbjct: 135 DLKAGNVLL---TLDGD--IKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMK 188
Query: 671 NVPVTTKVDVFSFGVMLLEI 690
+ P K D++S G+ L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/226 (27%), Positives = 112/226 (49%), Gaps = 36/226 (15%)
Query: 494 KLVGTGSSGKVYRGI-LRLKDTQ--IEIAVKKLEKDIEKTN-EEFMTELKIIGRTHHKNL 549
K +G G GKV + RLK +AVK L+++ + + ++E ++ + +H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFL----------------------FHEGQRPGW 587
++L G CS++ LL+ E G+L +FL + +R
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 588 VQRV-EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-L 645
+ + A ++RG+ YL E +++H D+ +NVL+ + M KISDFG+S+ +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLV----AEGRKM-KISDFGLSRDV 177
Query: 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
+D + R + ++A E L + TT+ DV+SFGV+L EI+
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 27/210 (12%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN----EEFMTELKIIGRTHHKNLVR 551
+G GS G V++ ++R D ++ A+K++ D+ K N EE + E +++ + ++R
Sbjct: 8 IGKGSFGVVFK-VVRKADKRV-YAMKQI--DLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPG-----WVQRVEIALGVARGLLYLHE 606
++ K +V E NG L L + RP W ++I LG+A +LH
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HLHS 119
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
+ +I+H DIK N+ LD N KI D G++KLL+ D T + GT Y++P
Sbjct: 120 K---KILHRDIKSLNLFLDA---YDN--VKIGDLGVAKLLS-DNTNFANTIVGTPYYLSP 170
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696
E + P K DV++ GV+L E C +H
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYE-CCTGKH 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 59/185 (31%), Positives = 90/185 (48%), Gaps = 20/185 (10%)
Query: 518 IAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSN 576
+AVK L D + E+F+ E+KI+ R N+ RLLG C+ + ++ E M NG L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 577 FL-FHEGQRPGWVQR---------VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDL 626
FL H + G + +A +A G+ YL +H D+ +N L
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCL--- 162
Query: 627 KTLDTNYMAKISDFGISK-LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGV 685
+ NY KI+DFG+S+ L + D R + ++A E + TTK DV++FGV
Sbjct: 163 --VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 686 MLLEI 690
L EI
Sbjct: 221 TLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 36/222 (16%)
Query: 496 VGTGSSGKVYR----GILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLV 550
+G G+ G+V++ G+L + +AVK L+++ +F E ++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEP-FTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFH------------------EGQRP---GWVQ 589
+LLG C+ L++E M G L+ FL H G P +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 590 RVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS-KLLNK 648
++ IA VA G+ YL E + +H D+ +N L + N + KI+DFG+S + +
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCL-----VGENMVVKIADFGLSRNIYSA 183
Query: 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
D + N + ++ PE + TT+ DV+++GV+L EI
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 496 VGTGSSGKVYRGI---LRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRL 552
+G G+ GKV+ L ++ +AVK L+ ++F E +++ H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQ--------RP-------GWVQRVEIALGV 597
G C + D ++V+E M +G L+ FL G +P G Q + IA +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 598 ARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNKDQTRTDTN 656
A G++YL + +H D+ +N L + N + KI DFG+S+ + + D R +
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCL-----VGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 657 MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ ++ PE + TT+ DV+SFGV+L EI
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 68/227 (29%), Positives = 121/227 (53%), Gaps = 18/227 (7%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMT--ELKIIGRTHHKNLV 550
+++G G G+V +++ T A KKLEK I+K E M E +I+ + + + +V
Sbjct: 6 RVLGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVV 63
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI--ALGVARGLLYLHEEC 608
L +D LV LM G L ++H G+ G+ + + A + GL LH+E
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE- 121
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
+I++ D+KP+N+LLD D ++ +ISD G++ + + QT GT+GY+APE
Sbjct: 122 --RIVYRDLKPENILLD----DHGHI-RISDLGLAVHVPEGQTIK--GRVGTVGYMAPEV 172
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715
++N T D ++ G +L E+I G+ + + + + EEV+ ++ +
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 494 KLVGTGSSGKV--YRGILRLKDTQIEIAVKKLEKDIEKTNEE-FMTELKIIGRTHHKNLV 550
+++G G GKV Y T +AVK L+++ + N + E+ I+ +H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 551 RLLGFCSEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+ G CSE+ + L+ E +P G+L ++L + Q + A + G+ YLH +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT--RTDTNMRGTMGYVAP 666
IH D+ +NVLLD + + KI DFG++K + + R + + + A
Sbjct: 127 --HYIHRDLAARNVLLD-----NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEII 691
E L+ + DV+SFGV L E++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMT--ELKIIGRTHHKNLVRL 552
+G G G+V +++K+T A KKL+K ++K + E M E +I+ + + +V L
Sbjct: 1 LGKGGFGEVCA--VQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL 58
Query: 553 LGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRV-EIALGVARGLLYLHEECET 610
+ E L LV LM G L +++ G+R ++RV + + G+L+LH
Sbjct: 59 -AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
I++ D+KP+NVLLD ++SD G++ + +T T GT GY+APE L+
Sbjct: 115 DIVYRDMKPENVLLD-----DQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILK 167
Query: 671 NVPVTTKVDVFSFGVMLLEIICGR 694
P + VD F+ G + E++ GR
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN---EEFMTELKIIGRTHHKNLVRL 552
+G G++ VY I ++A+K++ D+EK +E E++ + + +H N+V+
Sbjct: 9 IGVGATAVVYAAIC--LPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEECE 609
D+ LV + G+L + + G + IA V +GL YLH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKS-SYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD---QTRTDTNMRGTMGYVAP 666
IH DIK N+L L + KI+DFG+S L + GT ++AP
Sbjct: 122 -GQIHRDIKAGNIL-----LGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 667 EWLRNVP-VTTKVDVFSFGVMLLEIICGR 694
E + V K D++SFG+ +E+ G
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVR 551
K +G G G V G L D+ +++AVK ++ I E+F++E + H N++R
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 552 LLGFCSEEDKR------LLVYELMPNGTLSNFLFHE--GQRPGWVQR---VEIALGVARG 600
L+G C + + +++ M +G L +FL + G P ++ V+ +A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNKDQTRTDTNMRG 659
+ YL + IH D+ +N +L+ N ++DFG+SK + N D R +
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLN-----ENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 660 TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ ++A E L + TTK DV+SFGV + EI
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 68/236 (28%), Positives = 104/236 (44%), Gaps = 52/236 (22%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DIEKTNEE--FMTELKIIGRTHHKNLV 550
K++G G+ G+V+ ++R KDT A+K L K D+ K N+ E I+ +V
Sbjct: 7 KVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 551 RLLGFCSEEDKRLL--VYELMPNGTLSNFLFHEGQ-RPGWVQ--RVEIALGVARGLLYLH 605
+L + S +D+ L V E MP G L N L + + E+ L + +H
Sbjct: 65 KL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD----SVH 118
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK-------------DQTR 652
+ IH DIKP N+L+D K++DFG+ K +NK R
Sbjct: 119 K---LGFIHRDIKPDNILIDADG-----HIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 653 TDTNMR---------------GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
+ +R GT Y+APE LR P + D +S GV+L E++ G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 71/224 (31%), Positives = 112/224 (50%), Gaps = 39/224 (17%)
Query: 494 KLVGTGSSGKVYR----GILRLK-DTQIEIAVKKL-----EKDIEKTNEEFMTELKIIGR 543
K +G G G+V R GI + + D + +AVK L +KD+ E M +K+IG+
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE-MELMKLIGK 76
Query: 544 THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL----------------FHEGQRPGW 587
HKN++ LLG C++E ++ E G L FL E Q +
Sbjct: 77 --HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL-SF 133
Query: 588 VQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647
V A VARG+ YL + IH D+ +NVL+ + N M KI+DFG+++ ++
Sbjct: 134 KDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT----EDNVM-KIADFGLARGVH 185
Query: 648 K-DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
D + +N R + ++APE L + T + DV+SFG+++ EI
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G+ GKVY+ + K+T + A K ++ E+ E++M E+ I+ H N+V+LL
Sbjct: 13 LGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALG-VARGLLYLHEECETQIIH 614
E+ ++ E G + + E +RP ++ + L YLH E +IIH
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLH---ENKIIH 126
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL----- 669
D+K N+L TLD + K++DFG+S + R D+ + GT ++APE +
Sbjct: 127 RDLKAGNILF---TLDGD--IKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETS 180
Query: 670 RNVPVTTKVDVFSFGVMLLEI 690
++ P K DV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 71/234 (30%), Positives = 119/234 (50%), Gaps = 39/234 (16%)
Query: 484 ELQEATKGFSKLVGTGSSGKVYR----GILRLKDTQI-EIAVKKLEKD-IEKTNEEFMTE 537
E+ K +G G G+V G+ + K ++ ++AVK L+ D EK + ++E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 538 L---KIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR---- 590
+ K+IG+ HKN++ LLG C+++ ++ E G L +L +RP ++
Sbjct: 74 MEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYCYNP 129
Query: 591 -------------VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637
V A VARG+ YL + + IH D+ +NVL+ + N M KI
Sbjct: 130 TQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT----EDNVM-KI 181
Query: 638 SDFGISKLLNK-DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+DFG+++ ++ D + TN R + ++APE L + T + DV+SFGV+L EI
Sbjct: 182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-16
Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 28/252 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLV 550
+++G GS GKV + RLK++ AVK L+KD+ + E MTE +I+ + +
Sbjct: 1 RVLGKGSFGKVM--LARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 58
Query: 551 RLLGFCSEEDKRLL-VYELMPNGTLSNFLFH--EGQRPGWVQRVEIALGVARGLLYLHEE 607
L C + RL V E + G L +FH + +R + A + L++LH++
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
II+ D+K NVLLD + K++DFG+ K + T T GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDHEG-----HCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPE 166
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI-SCMLSRN- 725
L+ + VD ++ GV+L E++CG E E E + + +L+D V+ LS++
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLFEAILNDEVVYPTWLSQDA 223
Query: 726 ---LQVLVSHDP 734
L+ ++ +P
Sbjct: 224 VDILKAFMTKNP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 480 FTFQELQEATKGFSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEK-DIEKTNEEFM 535
F LQE T +G G G+V+ + + + + VK L+K E EF
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 536 TELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLF-----HEGQRP---GW 587
EL + + HKN+VRLLG C E + ++ E G L FL E +P
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 588 VQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647
Q+V + +A G+ +L + +H D+ +N L + + K+S +SK +
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCL-----VSSQREVKVSLLSLSKDVY 168
Query: 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ N + ++APE ++ +TK DV+SFGV++ E+
Sbjct: 169 NSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 79/298 (26%), Positives = 146/298 (48%), Gaps = 50/298 (16%)
Query: 496 VGTGSSGKVYRGILR--LK-DTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLVR 551
+G GS G VY G R +K + + +AVK + + + EF+ E ++ ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLF--------HEGQRPGWVQR-VEIALGVARGLL 602
LLG S+ L+V ELM +G L ++L + G+ P +Q +++A +A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
YL+ + + +H D+ +N + + ++ KI DFG++ +D TD +G G
Sbjct: 134 YLNAK---KFVHRDLAARNCM-----VAHDFTVKIGDFGMT----RDIYETDYYRKGGKG 181
Query: 663 -----YVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717
++APE L++ TT D++SFGV+L EI S E+ + + ++ V
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT--------SLAEQPYQGLS---NEQV 230
Query: 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775
+ ++ + PE ++DL M M C +P +RP+ +++++L+ L
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDL-----MRM----CWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 79/298 (26%), Positives = 146/298 (48%), Gaps = 50/298 (16%)
Query: 493 SKLVGTGSSGKVYRGILR--LKDT-QIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHKN 548
S+ +G GS G VY GI + +KD + +A+K + E + EF+ E ++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLF--------HEGQRPGWVQR-VEIALGVAR 599
+VRLLG S+ L++ ELM G L ++L + Q P +++ +++A +A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG 659
G+ YL+ + +H D+ +N + + ++ KI DFG++ +D TD +G
Sbjct: 131 GMAYLN---ANKFVHRDLAARNCM-----VAEDFTVKIGDFGMT----RDIYETDYYRKG 178
Query: 660 TMG-----YVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714
G +++PE L++ TT DV+SFGV+L EI + E+ + + +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA--------TLAEQPYQGMS---N 227
Query: 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
+ V+ ++ L + P++L FE M M C +P +RPS ++I ++
Sbjct: 228 EQVLRFVMEGGLLDKPDNCPDML-----FELMRM----CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 58/202 (28%), Positives = 110/202 (54%), Gaps = 13/202 (6%)
Query: 494 KLVGTGSSGKVYRGILRL--KDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLV 550
K++G+G+ G VY+GI ++ +I +A+K L ++ K N+E + E ++ +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
RLLG C +L V +LMP G L +++ R G + + +A+G+ YL E
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EV 128
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN-MRGTMGYVAPEWL 669
+++H D+ +NVL+ KI+DFG+++LL+ D+T + + + ++A E +
Sbjct: 129 RLVHRDLAARNVLVKSPN-----HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 670 RNVPVTTKVDVFSFGVMLLEII 691
+ T + DV+S+GV + E++
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 18/198 (9%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G G+V+ G + +A+K L K + E F+ E +++ + H+ LV+L
Sbjct: 14 LGQGCFGEVWMGTW---NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWV---QRVEIALGVARGLLYLHEECETQI 612
SEE +V E M G+L +FL +G+ ++ Q V++A +A G+ Y+
Sbjct: 70 VSEE-PIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 123
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
+H D++ N+L+ N + K++DFG+++L+ ++ + + + APE
Sbjct: 124 VHRDLRAANILVG-----ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 673 PVTTKVDVFSFGVMLLEI 690
T K DV+SFG++L E+
Sbjct: 179 RFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 492 FSKLVGTGSSGKVY----RGILRLKDTQIE----------IAVKKLEKDIEKT-NEEFMT 536
F + +G G G+V+ G+ + D +AVK L +D K +F+
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 537 ELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLF-HEGQRPGWVQRVE--- 592
E+KI+ R N++RLL C D ++ E M NG L+ FL HE Q V
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 593 ------IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-L 645
+A +A G+ YL +H D+ +N L+ NY KI+DFG+S+ L
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK-----NYTIKIADFGMSRNL 180
Query: 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
+ D R + +++ E + TT DV++FGV L EI+
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G GS+G V I R K + ++AVK ++ ++ E E+ I+ H+N+V +
Sbjct: 29 IGEGSTGIVC--IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
++ ++ E + G L++ + R Q + V + L YLH + +IH
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHR 141
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT 675
DIK ++LL TLD K+SDFG ++KD + + + GT ++APE + P
Sbjct: 142 DIKSDSILL---TLDGR--VKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRTPYG 195
Query: 676 TKVDVFSFGVMLLEIICG 693
T+VD++S G+M++E++ G
Sbjct: 196 TEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 57/199 (28%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
K +G G G+V+ G + ++A+K L K + E F+ E ++ + H LVRL
Sbjct: 12 KKLGAGQFGEVWMG---YYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLHEECETQI 612
++E ++ E M NG+L +FL EG + + +++A +A G+ ++ +
Sbjct: 68 AVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
IH D++ N+L+ +TL KI+DFG+++L+ ++ + + + APE +
Sbjct: 124 IHRDLRAANILVS-ETL----CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178
Query: 673 PVTTKVDVFSFGVMLLEII 691
T K DV+SFG++L EI+
Sbjct: 179 TFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 73/234 (31%), Positives = 117/234 (50%), Gaps = 39/234 (16%)
Query: 484 ELQEATKGFSKLVGTGSSGKVYR----GILRLKDTQ-IEIAVKKLEKD-IEKTNEEFMTE 537
EL K +G G G+V GI + K + + +AVK L+ D +K + ++E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 538 L---KIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR---- 590
+ K+IG+ HKN++ LLG C+++ ++ E G L +L +RP +
Sbjct: 68 MEMMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYL--RARRPPGMDYSFDT 123
Query: 591 -------------VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637
V A VARG+ YL + + IH D+ +NVL+ + N M KI
Sbjct: 124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT----EDNVM-KI 175
Query: 638 SDFGISK-LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+DFG+++ + N D + TN R + ++APE L + T + DV+SFGV+L EI
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVK--KLEKDIEKTNEEFMTELKIIGR-THHKNLV 550
+++G G+ GKVY+ R K T +A+K + +D E EE E I+ + ++H N+
Sbjct: 12 EVIGEGTYGKVYKA--RHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKYSNHPNIA 66
Query: 551 RLLGF------CSEEDKRLLVYELMPNGT---LSNFLFHEGQRPGWVQRVEIALGVARGL 601
G +D+ LV EL G+ L L +G+R I RGL
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
YLHE ++IH DIK QN+L L N K+ DFG+S L+ R +T + GT
Sbjct: 127 AYLHEN---KVIHRDIKGQNIL-----LTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTP 177
Query: 662 GYVAPEWL-----RNVPVTTKVDVFSFGVMLLE 689
++APE + + + DV+S G+ +E
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 77/294 (26%), Positives = 133/294 (45%), Gaps = 43/294 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDIEKTN--EEFMTELKIIGRTHHKNLV 550
+++G G G V L+ +D + ++AVK L+ DI ++ EEF+ E + H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 551 RLLGFC--SEEDKRL----LVYELMPNGTLSNFLFHE--GQRPGWVQR---VEIALGVAR 599
+L+G S RL ++ M +G L FL G+ P + V + +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS-KLLNKDQTRTDTNMR 658
G+ YL + IH D+ +N +L+ N ++DFG+S K+ + D R +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLN-----ENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 659 GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718
+ ++A E L + TT DV++FGV + EI+ R + VE +
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT-RGQTPYAGVENSE----------IY 225
Query: 719 SCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
+ ++ N + P+ L D+ +E M C P+P RPS + + LE
Sbjct: 226 NYLIKGNR---LKQPPDCLEDV--YELMCQ----CWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 75/280 (26%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G G+V+ G + ++A+K L K E F+ E +I+ + H LV L
Sbjct: 14 LGQGCFGEVWMGTW---NGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFH-EGQRPGWVQRVEIALGVARGLLYLHEECETQIIH 614
SEE +V E M G+L +FL +G+ Q V++A +A G+ Y+ IH
Sbjct: 70 VSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIH 125
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPV 674
D++ N+L+ N + KI+DFG+++L+ ++ + + + APE
Sbjct: 126 RDLRAANILVG-----DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 675 TTKVDVFSFGVMLLEIICGRRHIELSRVEEES-EEVDIVLSDWVISCMLSRNLQVLVSHD 733
T K DV+SFG++L E++ R V E E+V+ R ++
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-------------RGYRMPCPQG 227
Query: 734 -PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
PE L +L + C DP+ RP+ + + LE
Sbjct: 228 CPESLHELMKL---------CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 70/224 (31%), Positives = 115/224 (51%), Gaps = 39/224 (17%)
Query: 494 KLVGTGSSGKVYR----GILRLKDTQ-IEIAVKKLEKD-IEKTNEEFMTEL---KIIGRT 544
K +G G G+V GI + K + + +AVK L+ D EK + ++E+ K+IG+
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 79
Query: 545 HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR-------------- 590
HKN++ LLG C+++ ++ E G L +L +RP ++
Sbjct: 80 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDIARVPDEQMTF 136
Query: 591 ---VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647
V VARG+ YL + + IH D+ +NVL+ + N M KI+DFG+++ +N
Sbjct: 137 KDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVT----ENNVM-KIADFGLARDVN 188
Query: 648 K-DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
D + TN R + ++APE L + T + DV+SFGV++ EI
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 75/296 (25%), Positives = 134/296 (45%), Gaps = 42/296 (14%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKK-LEKDIEK-TNEEFMTELKIIGRTHHKNLVRL 552
LVG GS G V + + K+T +A+KK LE + +K + M E++++ + H+NLV L
Sbjct: 8 LVGEGSYGMVMK--CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNF-LFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
+ + + LV+E + + L + + G V++ + RG+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK--YLFQILRGIEFCHSH---N 120
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
IIH DIKP+N+L+ + + K+ DFG ++ L T+ T Y APE L
Sbjct: 121 IIHRDIKPENILVSQ-----SGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVG 174
Query: 672 VPVTTK-VDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM--LSRNLQV 728
+ VD+++ G ++ E++ G + DI +I C+ L Q
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLF--------PGDSDIDQLYHIIKCLGNLIPRHQE 226
Query: 729 LVSHDP-----------EVLSDLERFERMAMVGL----WCNHPDPNLRPSMKKVIH 769
+ +P E+ +RF +++ + L C DP+ RPS +++H
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 41/234 (17%)
Query: 486 QEATKGFSKL-----VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT-NEEFMTELK 539
A K S+L +G+G+ G VY+ I R T A+K + + E T + E++
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHR--PTGRLYALKVIYGNHEDTVRRQICREIE 124
Query: 540 IIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSN-FLFHEGQRPGWVQRVEIALGVA 598
I+ +H N+V+ + ++ E M G+L + E ++A +
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFL------ADVARQIL 178
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR 658
G+ YLH I+H DIKP N+L++ KI+DFG+S++L QT N
Sbjct: 179 SGIAYLHRR---HIVHRDIKPSNLLINSAK-----NVKIADFGVSRILA--QTMDPCNSS 228
Query: 659 -GTMGYVAPEWLRNVPVTTKV----------DVFSFGVMLLEIICGRRHIELSR 701
GT+ Y++PE + T + D++S GV +LE GR + R
Sbjct: 229 VGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 28/194 (14%)
Query: 518 IAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSN 576
+AVK L D K +F+ E+KI+ R N++RLLG C +ED ++ E M NG L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 577 FLFH----EGQRPG--------------WVQRVEIALGVARGLLYLHEECETQIIHCDIK 618
FL + + G + + +AL +A G+ YL +H D+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 619 PQNVLLDLKTLDTNYMAKISDFGISK-LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTK 677
+N L + N KI+DFG+S+ L D R + ++A E + TT
Sbjct: 166 TRNCL-----VGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 678 VDVFSFGVMLLEII 691
DV++FGV L EI+
Sbjct: 221 SDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-15
Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 8/114 (7%)
Query: 37 GSNTSWLSPSGDFAFGFYSL-FGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTN 95
S + +S F GF+ L I + +T+VW A+RD+P+ + +TL +
Sbjct: 5 SSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQS 63
Query: 96 DGKLLLTYFNGSV-----QQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDFP 144
DG L++ +G+V +G L L +DGN VL +++ +W SFD+P
Sbjct: 64 DGNLVIYDGSGTVVWSSNTTRVNGNYVLVL-LDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKNLVRL 552
+G G G+V +++ T A KKL K K + + M E +I+ + H + +V L
Sbjct: 1 LGKGGFGEVS--ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFH-EGQRPGWVQRVEI--ALGVARGLLYLHEECE 609
+ LV +M G L +++ + + PG+ + + GL +LH+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+II+ D+KP+NVLLD D N +ISD G++ L Q++T GT G++APE L
Sbjct: 117 -RIIYRDLKPENVLLDN---DGN--VRISDLGLAVELKDGQSKT-KGYAGTPGFMAPELL 169
Query: 670 RNVPVTTKVDVFSFGVMLLEIICGR 694
+ VD F+ GV L E+I R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 8e-15
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G+SG VY I T E+A+K++ + E + E+ ++ H N+V L
Sbjct: 27 IGQGASGTVYTAID--VATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
D+ +V E + G+L++ + G Q + + L +LH Q+IH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSN---QVIHR 139
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT 675
DIK N+LL + + K++DFG + +Q++ T M GT ++APE +
Sbjct: 140 DIKSDNILLGM-----DGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYG 193
Query: 676 TKVDVFSFGVMLLEIICG 693
KVD++S G+M +E++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 52/209 (24%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR 543
E+ + K +G G G+V+ + + ++AVK + K + E F+ E ++
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVW---MATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKT 57
Query: 544 THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLL 602
H LV+L ++E ++ E M G+L +FL EG + + ++ + +A G+
Sbjct: 58 LQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
++ + IH D++ N+L+ +L + KI+DFG+++++ ++ + +
Sbjct: 117 FIEQR---NYIHRDLRAANILVS-ASL----VCKIADFGLARVIEDNEYTAREGAKFPIK 168
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
+ APE + T K DV+SFG++L+EI+
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G G+ G V++ + ++T +A+KK L + + + E+K + H +V+LL
Sbjct: 8 IGEGAHGIVFKA--KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVE-IALGVARGLLYLHEECETQI 612
+LV E MP LS L E +RP +V+ + +G+ Y+H I
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHAN---GI 120
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
+H D+KP N+L+ + KI+DFG+++L ++++ R ++ T Y APE L
Sbjct: 121 MHRDLKPANLLISADG-----VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 673 P-VTTKVDVFSFGVMLLEIICGR 694
VD+++ G + E++ G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLE-----KDIEKTNEEFMTELKIIGRTHHKN 548
KL+G G+ G+VY + DT E+AVK++ + +K E++++ H+
Sbjct: 8 KLLGQGAFGRVY--LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 549 LVRLLGFCSEEDKRLLVY-ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
+V+ G C +D+ L ++ E MP G++ + L G V R + + G+ YLH
Sbjct: 66 IVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSN 123
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR---GTMGYV 664
I+H DIK N+L D K+ DFG SK L + T M+ GT ++
Sbjct: 124 ---MIVHRDIKGANILRDS-----AGNVKLGDFGASKRLQTICSSG-TGMKSVTGTPYWM 174
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEII 691
+PE + K DV+S G ++E++
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL 549
F+KL +G GS G+VY+GI + I + LE + E E+ E+ ++ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYI 64
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHE 606
R G + K ++ E + G+ + L +PG ++ IA + +GL YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS 119
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
E + IH DIK NVLL + K++DFG++ L Q + +T + GT ++AP
Sbjct: 120 E---RKIHRDIKAANVLLSEQG-----DVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICG 693
E ++ K D++S G+ +E+ G
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 78/308 (25%), Positives = 139/308 (45%), Gaps = 66/308 (21%)
Query: 478 REFTFQELQEATKGFSKLVGTGSSGKVYRGI-LRLKDT-QIEIAVKKLE-KDIEKTNEEF 534
R EL++ KL+G+G G V++GI + D+ +I +A+K ++ + +T +E
Sbjct: 2 RILKETELRKL-----KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI 56
Query: 535 MTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWV--QRV- 591
+ +G H +VRLLG C +L V +L P G+L L H Q + QR+
Sbjct: 57 TDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSL---LDHVRQHRDSLDPQRLL 112
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651
+ +A+G+ YL E ++H ++ +N+LL ++ + +I+DFG++ LL D
Sbjct: 113 NWCVQIAKGMYYLEEHR---MVHRNLAARNILLK-----SDSIVQIADFGVADLLYPDDK 164
Query: 652 RTDTN-MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD 710
+ + + + ++A E + T + DV+S+GV + E
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWE--------------------- 203
Query: 711 IVLSDWVISCMLSRNLQVLVS-HDPEVLSDLERFERMA----------MVGLWCNHPDPN 759
M+S + EV LE+ ER+A MV + C D N
Sbjct: 204 ----------MMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDEN 253
Query: 760 LRPSMKKV 767
+RP+ K++
Sbjct: 254 VRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKNLVRL 552
+G GS GKV + +R +DTQ A+K + K + E + E ++ + + +V L
Sbjct: 1 IGKGSFGKVMQ--VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 553 -LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
F S E K LV + G L FH QR G A L L +
Sbjct: 59 KFSFQSPE-KLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHKFN 113
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKIS--DFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+I+ D+KP+N+LLD Y I+ DFG+ KL KD +T+T GT Y+APE L
Sbjct: 114 VIYRDLKPENILLD-------YQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELL 165
Query: 670 RNVPVTTKVDVFSFGVMLLEIICG 693
T VD ++ GV+L E++ G
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 69/222 (31%), Positives = 111/222 (50%), Gaps = 44/222 (19%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF----MTELKIIGRTHHKNLVR 551
+G G+ G+VY+ R KDT +A+KK+ D EK E F + E+KI+ + +H+N+V
Sbjct: 15 IGEGTYGQVYKA--RDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVN 70
Query: 552 L----------LGFCSEEDKRLLVYELMPN---GTLSNFL--FHEGQRPGWVQRVEIALG 596
L L F ++ LV+E M + G L + L F E +++++
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125
Query: 597 VARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN 656
GL Y H+ +H DIK N+LL+ K K++DFG+++L N +++R TN
Sbjct: 126 -LEGLNYCHK---KNFLHRDIKCSNILLNNKG-----QIKLADFGLARLYNSEESRPYTN 176
Query: 657 MRGTMGYVAPEWL----RNVPVTTKVDVFSFGVMLLEIICGR 694
T+ Y PE L R P +DV+S G +L E+ +
Sbjct: 177 KVITLWYRPPELLLGEERYGPA---IDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVRLL 553
+G G+ G VY+ R K T +A+KK++ E E+K++ +H N+++LL
Sbjct: 7 IGEGTYGVVYKA--RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVE-IALGVARGLLYLHEECETQI 612
+ LV+E M + L + QR ++ + +GL + H I
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
+H D+KP+N+L ++T + K++DFG+++ R T+ T Y APE L
Sbjct: 120 LHRDLKPENLL-----INTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGD 173
Query: 673 PV-TTKVDVFSFGVMLLEIICGR 694
+T VD++S G + E++ R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 72/206 (34%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRL 552
+G G+ G+VY+ +R KDT+ A+K L K +K + E I+ RT +
Sbjct: 1 IGKGTFGQVYQ--VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFI 58
Query: 553 LG--FCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
+G F + D L LV + M G L L EG+ + IA V L +LH+
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL-ALEHLHKY-- 115
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL-LNKDQTRTDTNMRGTMGYVAPEW 668
I++ D+KP+N+LLD T ++A + DFG+SK L ++T T+T GT Y+APE
Sbjct: 116 -DIVYRDLKPENILLDA----TGHIA-LCDFGLSKANLTDNKT-TNT-FCGTTEYLAPEV 167
Query: 669 LRNVPVTTK-VDVFSFGVMLLEIICG 693
L + TK VD +S GV++ E+ CG
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 31/217 (14%)
Query: 500 SSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMT--ELKIIGRTHHKNLVRLLGFC 556
++GK+Y A KKLEK I+K E M E +I+ + + + +V L
Sbjct: 23 ATGKMY-------------ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 69
Query: 557 SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR--VEIALGVARGLLYLHEECETQIIH 614
+D LV LM G L +++ G PG+ + V A + GL LH E +I++
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRE---RIVY 125
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGIS-KLLNKDQTRTDTNMRGTMGYVAPEWLRNVP 673
D+KP+N+LLD D ++ +ISD G++ ++ + R GT+GY+APE ++N
Sbjct: 126 RDLKPENILLD----DYGHI-RISDLGLAVEIPEGETIRGRV---GTVGYMAPEVVKNER 177
Query: 674 VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD 710
T D + G ++ E+I G+ + + + EEV+
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVR 551
+ +G GS G V + + R D +I + K+++ EK ++ ++E+ I+ H N+VR
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKI-LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 552 LLG-FCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC- 608
++ L +V E G L+ + + +++ E + LL EC
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEE-EFIWRILTQLLLALYECH 122
Query: 609 -----ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
++H D+KP N+ LD N K+ DFG++K+L D + T + GT Y
Sbjct: 123 NRSDPGNTVLHRDLKPANIF-----LDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYY 176
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIIC-------GRRHIELSR 701
++PE L ++ K D++S G ++ E +C R ++L+
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYE-LCALSPPFTARNQLQLAS 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 484 ELQEATKGFSKLVGTGSSGKVYRGILRLK--DTQIEIAVKKLEKDIEKTNE--EFMTELK 539
EL + F + +G + GK+Y+G L L D +A+K L KDI + EF E
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEAS 59
Query: 540 IIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHE---------GQRPGWVQR 590
++ HH N+V LLG ++E +++E + G L FL G V+
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 591 -------VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643
+ IA+ +A G+ YL +H D+ +N+L + KISD G+S
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL-----IGEQLHVKISDLGLS 171
Query: 644 K-LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ + + D R + ++ PE + ++ D++SFGV+L EI
Sbjct: 172 REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 30/226 (13%)
Query: 480 FTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTEL 538
FT ++L++ G +G G+ G V + + K + +AVK++ EK + + +L
Sbjct: 1 FTAEDLKD--LG---EIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 539 KIIGRTHH-KNLVRLLGFCSEEDKRLLVYELMPNGTLSNF--LFHEGQRPGWVQRV--EI 593
++ R+ +V+ G E + ELM + +L F +E + + + +I
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKI 112
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS-KLLNK-DQT 651
A+ + L YL EE +IIH D+KP N+LLD N K+ DFGIS +L++ +T
Sbjct: 113 AVATVKALNYLKEE--LKIIHRDVKPSNILLDR-----NGNIKLCDFGISGQLVDSIAKT 165
Query: 652 RTDTNMRGTMGYVAPEWL---RNVPVTTKVDVFSFGVMLLEIICGR 694
R D G Y+APE + + DV+S G+ L E+ G+
Sbjct: 166 R-DA---GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 497 GTGSSGKVYRGILR------LKDTQIEIAV--KKLEKDIEKTNEEFMTELKIIGRTHHKN 548
G G+ +Y+G+LR + E++V K L D + F ++ + HK+
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-DSLAFFETASLMSQLSHKH 62
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
LV+L G C D+ ++V E + G L FL E ++++A +A L YL ++
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK- 120
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNY--MAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
+++H ++ +N+L+ L+ Y K+SD GI + + R + + ++AP
Sbjct: 121 --KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWIAP 173
Query: 667 EWLRNVPV--TTKVDVFSFGVMLLEIICG 693
E +RN T D +SFG LLEI
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKN 548
F ++G GS GKV K T A+K L+KD+ +++ M E +++
Sbjct: 4 FLMVLGKGSFGKVMLA--ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 549 LVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEI--ALGVARGLLYLH 605
+ L C + RL V E + G L ++H Q + + + A +A GL +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK--LLNKDQTRTDTNMRGTMGY 663
+ II+ D+K NV+LD KI+DFG+ K + TRT GT Y
Sbjct: 119 SK---GIIYRDLKLDNVMLD-----AEGHIKIADFGMCKENIFGGKTTRT---FCGTPDY 167
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
+APE + P VD ++FGV+L E++ G+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 47/224 (20%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF--MTELKIIGRTHHK 547
F KL +G G+ G VYR R + +A+KK+ D E+ + E+ ++ H
Sbjct: 9 FEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 548 NLVRLL---------------GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVE 592
N+V L +C ++ LL + MP F E Q
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTP------FSESQVKC------ 112
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL-NKDQT 651
+ L + RGL YLHE IIH D+K N+LL K KI+DFG+++ +
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGC-----LKIADFGLARTYGLPAKP 164
Query: 652 RTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
T + T+ Y APE L TT +D+++ G +L E++ +
Sbjct: 165 MTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G+SG VY + + Q E+A+K++ + E + E+ ++ + N+V L
Sbjct: 27 IGQGASGTVYTA-IDIATGQ-EVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
D+ +V E + G+L++ + G Q + + L +LH Q+IH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALDFLHS---NQVIHR 139
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT 675
DIK N+LL + + K++DFG + +Q++ T M GT ++APE +
Sbjct: 140 DIKSDNILLGM-----DGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYG 193
Query: 676 TKVDVFSFGVMLLEIICG 693
KVD++S G+M +E++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL 549
F+KL +G GS G+V++GI + I + LE + E E+ E+ ++ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYV 64
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHE 606
+ G ++ K ++ E + G+ + L PG + +IA + +GL YLH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 119
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
E + IH DIK NVLL + K++DFG++ L Q + +T + GT ++AP
Sbjct: 120 E---KKIHRDIKAANVLLS-----EHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICGR-RHIEL 699
E ++ +K D++S G+ +E+ G H EL
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVK--KLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G G+ G VY+ + + T + +A+K +LE D K N+ M EL I+ + +V
Sbjct: 9 LGKGNYGSVYK--VLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVDFY 65
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWV---QRVEIALGVARGLLYLHEECET 610
G E + E M G+L L+ G + I V +GL +L EE
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--H 122
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
IIH D+KP NVL ++ N K+ DFG+S L +T+ G Y+APE ++
Sbjct: 123 NIIHRDVKPTNVL-----VNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIK 174
Query: 671 ------NVPVTTKVDVFSFGVMLLEIICGR 694
N T + DV+S G+ +LE+ GR
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLE-----KDIEKTNEEFMTELKIIGRTHHKNLV 550
+G+G+ G VY+ + I V KLE + I++ E+ ++ H N+V
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ-------EISMLKECRHPNIV 63
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVAR----GLLYLHE 606
G DK +V E G+L + ++ + P + ++IA V R GL YLHE
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGP--LSELQIAY-VCRETLKGLAYLHE 119
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
T IH DIK N+LL T D + K++DFG+S L + + + GT ++AP
Sbjct: 120 ---TGKIHRDIKGANILL---TEDGD--VKLADFGVSAQLTATIAKRKSFI-GTPYWMAP 170
Query: 667 EWL---RNVPVTTKVDVFSFGVMLLE 689
E R K D+++ G+ +E
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 60/226 (26%), Positives = 110/226 (48%), Gaps = 29/226 (12%)
Query: 478 REFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DIEKTNEEFMT 536
+L+ +G+G+ G+VY+ +R K T +AVK++ + ++ N+ +
Sbjct: 10 YPADLNDLE-----NLGEIGSGTCGQVYK--MRFKKTGHVMAVKQMRRTGNKEENKRILM 62
Query: 537 ELKIIGRTHH-KNLVRLLG-FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV--E 592
+L ++ ++H +V+ G F ++ D + + ELM T + L Q P + + +
Sbjct: 63 DLDVVLKSHDCPYIVKCYGYFITDSDVFICM-ELM--STCLDKLLKRIQGP-IPEDILGK 118
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
+ + + + L YL E+ +IH D+KP N+LLD K+ DFGIS L + +
Sbjct: 119 MTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASG-----NVKLCDFGISGRLVDSKAK 171
Query: 653 TDTNMRGTMGYVAPEWLRNVPVTTK----VDVFSFGVMLLEIICGR 694
T + G Y+APE + K DV+S G+ L+E+ G+
Sbjct: 172 TRS--AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 20/223 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMT--ELKIIGRTHHKNLV 550
+++G G G+V +++ T A K+LEK I+K E M E +I+ + + + +V
Sbjct: 6 RVLGKGGFGEVC--ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVV 63
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR--VEIALGVARGLLYLHEEC 608
L +D LV +M G L +++ G PG+ + + A + GL LH E
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE- 121
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS-KLLNKDQTRTDTNMRGTMGYVAPE 667
++ D+KP+N+LLD D ++ +ISD G++ K+ + R GT+GY+APE
Sbjct: 122 --NTVYRDLKPENILLD----DYGHI-RISDLGLAVKIPEGESIRGRV---GTVGYMAPE 171
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD 710
L N T D + G ++ E+I G+ + + + EEVD
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIG-RTHHKNL 549
K++G GS GKV + LK T A+K L+KD+ + E M E +++ H L
Sbjct: 1 KVLGKGSFGKVM--LAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 550 VRLLGFCSEEDKRLL--VYELMPNGTLSNFLFH--EGQRPGWVQRVEIALGVARGLLYLH 605
L FC+ + K L V E + G L +FH R + A + GL +LH
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
++ II+ D+K NVLLD + KI+DFG+ K + + T GT Y+A
Sbjct: 114 KK---GIIYRDLKLDNVLLD-----KDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
PE L+ VD +SFGV+L E++ G+
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 66/204 (32%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEE--FMTELKI-IGRTHHKNL 549
K++G GS GKV + + K AVK L+K I K E+ M E + + H L
Sbjct: 1 KVIGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
V L DK V + + G L L E P R A +A L YLH
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS--- 114
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
II+ D+KP+N+LLD ++ ++DFG+ K + ++T + GT Y+APE L
Sbjct: 115 LNIIYRDLKPENILLD----SQGHVV-LTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVL 168
Query: 670 RNVPVTTKVDVFSFGVMLLEIICG 693
R P VD + G +L E++ G
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLE-KDIEKTNEEFMTELKIIGRTHHKN 548
F+KL +G GS G+V++GI TQ +A+K ++ ++ E E+ E+ ++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGID--NRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLH 605
+ + G + K ++ E + G+ + L R G +IA + +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLH 118
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
E + IH DIK NVLL K++DFG++ L Q + +T + GT ++A
Sbjct: 119 SE---KKIHRDIKAANVLLS-----EQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMA 169
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICG 693
PE ++ +K D++S G+ +E+ G
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKNLV 550
KL+G G+ GKV ++R K T A+K L+K++ +E +TE +++ T H L
Sbjct: 1 KLLGKGTFGKVI--LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR---VEIALGVARGLLYLHEE 607
L D+ V E G L L E R EI L YLH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LGYLHSC 114
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
+++ D+K +N++LD + KI+DFG+ K D T GT Y+APE
Sbjct: 115 ---DVVYRDLKLENLMLD-----KDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE 165
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGR 694
L + VD + GV++ E++CGR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKN 548
F + +GTGS G+V + +D +A+K+ EK +K + +E KI+ +H
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFP-PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
V L G +E LV E + G FL + P ++ A ++ + E
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-----DVGCFYAAQIVLIFEYL 147
Query: 609 ET-QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
++ I++ D+KP+N+LLD + K++DFG +K++ TRT T + GT Y+APE
Sbjct: 148 QSLNIVYRDLKPENLLLD-----KDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPE 198
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICG 693
L NV D ++ G+ + EI+ G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 496 VGTGSSGKVY--RGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRL 552
+G G GKV R +T ++AVK L+ + + E++I+ +H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 553 LGFCSEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
G C+E+ L+ E +P+G+L +L + Q+++ A+ + +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR--- 128
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL--NKDQTRTDTNMRGTMGYVAPEW 668
Q +H D+ +NVL +++ + KI DFG++K + +K+ ++ + + APE
Sbjct: 129 QYVHRDLAARNVL-----VESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 669 LRNVPVTTKVDVFSFGVMLLEII 691
L DV+SFGV L E++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 8e-13
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G+SG VY + T E+A++++ + E + E+ ++ + N+V L
Sbjct: 28 IGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
D+ +V E + G+L++ + G Q + + L +LH Q+IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHS---NQVIHR 140
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT 675
DIK N+LL + + K++DFG + +Q++ + M GT ++APE +
Sbjct: 141 DIKSDNILLGM-----DGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYG 194
Query: 676 TKVDVFSFGVMLLEIICG 693
KVD++S G+M +E+I G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHK 547
F ++G GS GKV + K T A+K L+KD+ +++ M E +++
Sbjct: 3 NFLMVLGKGSFGKVM--LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 548 NLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWV---QRVEIALGVARGLLY 603
+ L C + RL V E + G L ++H Q+ G Q V A ++ GL +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHI-QQVGKFKEPQAVFYAAEISVGLFF 116
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK--LLNKDQTRTDTNMRGTM 661
LH II+ D+K NV+LD + KI+DFG+ K +++ TRT GT
Sbjct: 117 LHRR---GIIYRDLKLDNVMLDSEG-----HIKIADFGMCKEHMVDGVTTRT---FCGTP 165
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y+APE + P VD +++GV+L E++ G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G G+ G VY+ R + T IA+KK LE++ E + E+ ++ H N+VRL
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIA----LGVARGLLYLHEECE 609
E + LV+E + + H P + + + + RG+ Y H
Sbjct: 68 DVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE-W 668
+++H D+KPQN+L+D + TN + K++DFG+++ RT T+ T+ Y APE
Sbjct: 122 -RVLHRDLKPQNLLIDRR---TNAL-KLADFGLARAFGI-PVRTFTHEVVTLWYRAPEIL 175
Query: 669 LRNVPVTTKVDVFSFGVMLLEII 691
L + +T VD++S G + E++
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DI--EKTNEEFMTELKIIGRTHHKNLVRL 552
+GTGS G+V I + K T A+K L+K +I K + E I+ H +V +
Sbjct: 26 LGTGSFGRVR--IAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR---VEIALGVARGLLYLHEECE 609
+ +E++ + E + G L L G+ P V + E+ L YLH +
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE----YLHSK-- 137
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
II+ D+KP+N+LLD K K++DFG +K K RT T + GT Y+APE +
Sbjct: 138 -DIIYRDLKPENLLLDNKG-----HVKVTDFGFAK---KVPDRTFT-LCGTPEYLAPEVI 187
Query: 670 RNVPVTTKVDVFSFGVMLLEIICG 693
++ VD ++ GV+L E I G
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE--FMTELKIIGRTHHKNLVRLL 553
+G G GKV G ++ + VK+L + +E+ F+ E++ +H N+++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFL----FHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
G C E LLV E P G L N+L Q +A VA GLL+LH +
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---Q 118
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS-KLLNKDQTRTDTNMRGTMGYVAPEW 668
IH D+ +N L T D + KI D+G++ + +D T + ++APE
Sbjct: 119 ADFIHSDLALRNCQL---TADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 669 -------LRNVPVTTKVDVFSFGVMLLEI 690
L T K +++S GV + E+
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 496 VGTGSSGKVYRGILRLKDTQI--EIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G G+SG V+ D E+A+K++ + E + E+ ++ + N+V L
Sbjct: 27 IGQGASGTVFTA----IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
D+ +V E + G+L++ + Q + + L +LH Q+I
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA--QIAAVCRECLQALEFLHA---NQVI 137
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVP 673
H DIK NVLL + K++DFG + +Q++ T M GT ++APE +
Sbjct: 138 HRDIKSDNVLLGMDG-----SVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKA 191
Query: 674 VTTKVDVFSFGVMLLEIICG 693
KVD++S G+M +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 496 VGTGSSGKVYRGILR-LKDT----QIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLV 550
+G G+ K+++GI R + D + E+ +K L+K +E F ++ + HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
G C D+ ++V E + G+L +L ++E+A +A L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK--- 119
Query: 611 QIIHCDIKPQNVLL----DLKTLDTNYMAKISDFGIS-KLLNKDQTRTDTNMRGTMGYVA 665
+ H ++ +NVLL D KT + ++ K+SD GIS +L K+ + + +V
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKEI------LLERIPWVP 172
Query: 666 PEWLRNVP-VTTKVDVFSFGVMLLEIICG 693
PE + N ++ D +SFG L EI G
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 54/219 (24%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 494 KLVGTGSSGK--VYRGILRLKDTQI----EIAVKKLEKDIEKTNEEFMTELKIIGRTHHK 547
+++G G+ G+ +YR R +D + E+ + +L EK + + E+ I+ H
Sbjct: 6 RVLGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHP 59
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQR------PGWVQRVEIALGVARGL 601
N++ +++ L+ E GTL + + + + W +I V+
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL-FQIVSAVS--- 115
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
Y+H+ I+H DIK N+ L L K+ DFGISK+L + + +T + GT
Sbjct: 116 -YIHKA---GILHRDIKTLNIFLTKAGL-----IKLGDFGISKILGSEYSMAETVV-GTP 165
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELS 700
Y++PE + V K D+++ G +L E++ +R + +
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFM--------TELKIIGRTHH 546
+G G+ G VY+ R +T +A+KK+ + +EE + LK + H
Sbjct: 6 EIGEGAYGTVYKA--RDLNTGRFVALKKVR--VP-LSEEGIPLSTLREIALLKQLESFEH 60
Query: 547 KNLVRLLGFC-----SEEDKRLLVYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVA 598
N+VRLL C E K LV+E + + L+ +L G P ++ + L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQL--L 117
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLL--DLKTLDTNYMAKISDFGISKLLNKDQTRTDTN 656
RG+ +LH I+H D+KPQN+L+ D + KI+DFG++++ + + T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQV-------KIADFGLARIYSFEMALTSVV 167
Query: 657 MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ T+ Y APE L T VD++S G + E+
Sbjct: 168 V--TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 32/216 (14%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHK 547
F K+ +G G+ G VY+ R K T +A+KK L+ + E + E+ ++ +H
Sbjct: 2 FQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 59
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVAR-------- 599
N+V+LL E+K LV+E + + L F+ + I L + +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASPLS-----GIPLPLIKSYLFQLLQ 111
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG 659
GL + H +++H D+KPQN+L ++T K++DFG+++ RT T+
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLL-----INTEGAIKLADFGLARAFGV-PVRTYTHEVV 162
Query: 660 TMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
T+ Y APE L +T VD++S G + E++ R
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 59/206 (28%), Positives = 110/206 (53%), Gaps = 22/206 (10%)
Query: 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLE-KDI--EKTNEEFMTELKIIGRTHHKNL 549
K VGTG+ G+V+ ++R + ++ A+K + ++ K + E +++ H +
Sbjct: 6 IKTVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFI 63
Query: 550 VRLLGFCSEEDKRLL--VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
+RL F +E D+R L + E +P G L ++L + G+ + V L YLH +
Sbjct: 64 IRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC-ALEYLHSK 120
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
+I++ D+KP+N+LLD K++DFG +K L +D+T T + GT Y+APE
Sbjct: 121 ---EIVYRDLKPENILLD-----KEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLAPE 168
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICG 693
+++ VD ++ G+++ E++ G
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKL---EKDIEKTNEE--FMTELKIIGRTHHKNL 549
L+G G+ G VYRG + + + L + D+ E +++L+ ++ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLR---QSQPPNI 64
Query: 550 VRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLL----YL 604
+ G + RL ++ E G++ + + G + I++ + R +L Y+
Sbjct: 65 TKYYG-SYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISV-IIREVLVALKYI 117
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
H+ +IH DIK N+L+ T N + DFG++ LLN++ ++ T GT ++
Sbjct: 118 HK---VGVIHRDIKAANILV---TNTGNVK--LCDFGVAALLNQNSSKRST-FVGTPYWM 168
Query: 665 APEWLRNVPV-TTKVDVFSFGVMLLEIICG 693
APE + TK D++S G+ + E+ G
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 73/273 (26%), Positives = 123/273 (45%), Gaps = 32/273 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLV 550
+ +++G G+ G VY+ L T+ +AVK + DI + ++ M+EL+I+ + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLL--TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYII 62
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
G E++ + E M G+L + + P V IA+ V +GL YL
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLG-RIAVAVVKGLTYL---WSL 114
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
+I+H D+KP N+L ++T K+ DFG+S L +T GT Y+APE +
Sbjct: 115 KILHRDVKPSNML-----VNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERIS 166
Query: 671 NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730
DV+S G+ +E+ GR ++++ S M + LQ +V
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR--FPYPQIQKNQG-----------SLMPLQLLQCIV 213
Query: 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS 763
DP VL + E+ C P RP+
Sbjct: 214 DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 29/279 (10%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLG 554
+G G+ G V + + + T +A K + ++ + EL+I+ +V G
Sbjct: 13 LGAGNGGSVSK-VKHIP-TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV-EIALGVARGLLYLHEECETQII 613
E+ + E M G+L G P V+ + +IA+ V GL YL+ +I+
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNV--HRIM 126
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGIS-KLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
H DIKP N+L++ + K+ DFG+S +L+N + DT + GT Y++PE ++
Sbjct: 127 HRDIKPSNILVN-----SRGQIKLCDFGVSGELIN---SIADTFV-GTSTYMSPERIQGG 177
Query: 673 PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSH 732
T K DV+S G+ ++E+ G+ S ++++ ++ + + D ++ ++ L S
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-LLQQIVQEPPPRLPSS 236
Query: 733 D-PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770
D PE L D V C DP RP+ +++ M
Sbjct: 237 DFPEDLRD--------FVDA-CLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 70/232 (30%), Positives = 103/232 (44%), Gaps = 53/232 (22%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF----MTELKIIGRTHHKNL 549
KL G G+ G+VY+ R T +A+KK+ EK + F + E+KI+ + H N+
Sbjct: 15 KL-GEGTFGEVYKA--RQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNV 69
Query: 550 VRLLGFCSEE-----DKRLLVYELMP------NGTLSN--FLFHEGQRPGWV-QRVEIAL 595
V L+ E KR VY + P +G L N E Q ++ Q +E
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE--- 126
Query: 596 GVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ----- 650
G+ YLHE I+H DIK N+L +D + KI+DFG+++ +
Sbjct: 127 ----GINYLHEN---HILHRDIKAANIL-----IDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 651 -----TRTDTNMRGTMGYVAPEWL---RNVPVTTKVDVFSFGVMLLEIICGR 694
TR TN+ T Y PE L R TT VD++ G + E+ R
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERR--YTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 18/222 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMT--ELKIIGRTHHKNLV 550
+++G G G+V +++ T A KKLEK I+K E M E +I+ + + + +V
Sbjct: 6 RVLGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVV 63
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI--ALGVARGLLYLHEEC 608
L +D LV +M G L +++ G PG+ ++ I A + GL L E
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE- 121
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
+I++ D+KP+N+LLD D ++ +ISD G++ + + +T GT+GY+APE
Sbjct: 122 --RIVYRDLKPENILLD----DRGHI-RISDLGLAVQIPEGETVR--GRVGTVGYMAPEV 172
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD 710
+ N T D + G ++ E+I G+ + + EEVD
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRT-HHKNL 549
K++G GS GKV+ + LK T A+K L+KD+ +++ M E +++ H L
Sbjct: 1 KMLGKGSFGKVF--LAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 58
Query: 550 VRLLGFCSEEDKRLL--VYELMPNGTLSNFLFH--EGQRPGWVQRVEIALGVARGLLYLH 605
L +C+ + K L V E + G L +FH + + A + GL +LH
Sbjct: 59 THL--YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+ I++ D+K N+LLD T+ KI+DFG+ K +T T GT Y+A
Sbjct: 114 SK---GIVYRDLKLDNILLD-----TDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIA 164
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
PE L T VD +SFGV+L E++ G+
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL---EKDIEKTNEEFMTELKIIGRTHHKNLV 550
K +G G VY+ I L + A+KK+ E K ++ + E+ ++ + H N++
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVV--ALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFL--FHEGQRP-----GWVQRVEIALGVARGLLY 603
+ L E ++ +V EL G LS + F + +R W V++ L +
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEH 121
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
+H + +I+H DIKP NV + + K+ D G+ + + +T ++ GT Y
Sbjct: 122 MHSK---RIMHRDIKPANVFIT-----ATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYY 172
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIIC 692
++PE + K D++S G +L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 23/222 (10%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKN 548
F ++G GS GKV + K T A+K L+KD+ +++ M E +++ +
Sbjct: 4 FLMVLGKGSFGKVM--LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 549 LVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQ--RPGWVQRVEIALGVARGLLYLH 605
+ L C + RL V E + G L ++ Q R V A +A GL +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+ II+ D+K NV+LD + KI+DFG+ K D T T GT Y+A
Sbjct: 119 SK---GIIYRDLKLDNVMLD-----SEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIA 169
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESE 707
PE + P VD ++FGV+L E++ G+ E E+E E
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 54/203 (26%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT-NEEFMTELKIIGRTHHKNLVRLLG 554
+G G+ G V + ++ K + + +A K + +I+ + + EL+++ + +V G
Sbjct: 13 LGAGNGGVVTK--VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIH 614
+ + + E M G+L L E +R ++++ V RGL YL E+ QI+H
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMH 127
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPV 674
D+KP N+L++ + K+ DFG+S L + GT Y++PE L+
Sbjct: 128 RDVKPSNILVNSRG-----EIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHY 179
Query: 675 TTKVDVFSFGVMLLEIICGRRHI 697
+ + D++S G+ L+E+ GR I
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKII-GRTHHKNLVRLLG 554
+G G+ GKVY+ + KD + AVK L+ I +EE E I+ +H N+V+ G
Sbjct: 30 IGKGTYGKVYK-VTNKKDGSLA-AVKILDP-ISDVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 555 FCSEEDKRL-----LVYELMPNGTLSNF---LFHEGQRPGWVQRVEIALGVARGLLYLHE 606
+ DK + LV EL G+++ L GQR I G GL +LH
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
+IIH D+K N+L L T K+ DFG+S L + R +T++ GT ++AP
Sbjct: 147 ---NRIIHRDVKGNNIL-----LTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAP 197
Query: 667 EWLR-----NVPVTTKVDVFSFGVMLLEI 690
E + + + DV+S G+ +E+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 69/266 (25%), Positives = 123/266 (46%), Gaps = 44/266 (16%)
Query: 448 GVAAIYY---SPAARGLIKRRNY---FDPNSMEINFREFTFQELQEATKGFS--KLVGTG 499
V A+ Y PA R N+ ++ + +I +L+ + F K++G G
Sbjct: 2 TVTALVYDCDIPALRKNKNIDNFLSRYEKAAEKIT-------KLRMKAEDFDVIKVIGRG 54
Query: 500 SSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELK-IIGRTHHKNLVRLLGFC 556
+ G+V ++R K ++ A+K L K I++++ F E + I+ + + +V+L
Sbjct: 55 AFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL--HY 110
Query: 557 SEEDKRLL--VYELMPNGTLSNFLFHEGQRPGWVQ--RVEIALGVARGLLYLHEECETQI 612
+ +D + L V E MP G L N + + W + E+ L + +H
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDA----IHS---MGF 163
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD-QTRTDTNMRGTMGYVAPEWLRN 671
IH D+KP N+LLD + K++DFG ++ + R DT + GT Y++PE L++
Sbjct: 164 IHRDVKPDNMLLD-----KSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKS 217
Query: 672 VPVTT----KVDVFSFGVMLLEIICG 693
+ D +S GV L E++ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 73/259 (28%), Positives = 123/259 (47%), Gaps = 29/259 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGR-THHKNL 549
+++G GS KV ++RLK T+ A+K ++K++ +E+ TE + + ++H L
Sbjct: 1 RVIGRGSYAKVL--LVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 58
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR---VEIALGVARGLLYLHE 606
V L E + V E + G L + + + P R EI+L L YLHE
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHE 114
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK--LLNKDQTRTDTNMRGTMGYV 664
II+ D+K NVLLD + K++D+G+ K L D T + GT Y+
Sbjct: 115 R---GIIYRDLKLDNVLLD-----SEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYI 163
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724
APE LR VD ++ GV++ E++ GR + + S+ D D++ +L +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD---IVGSSDNPDQNTEDYLFQVILEK 220
Query: 725 NLQVLVSHDPEVLSDLERF 743
+++ S + S L+ F
Sbjct: 221 QIRIPRSLSVKAASVLKSF 239
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTE--LKIIGRTHHKNL 549
F ++VG GS G+V ++R + + +KKL E E +++ + H N+
Sbjct: 4 FVRVVGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 550 VRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEE 607
V ED L +V G L + L + G+ Q VE + +A L YLHE+
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
I+H D+K QNV L TN + K+ D GI+++L ++Q + + GT Y++PE
Sbjct: 122 ---HILHRDLKTQNVFLT----RTN-IIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPE 172
Query: 668 WLRNVPVTTKVDVFSFGVMLLEI 690
N P K DV++ G + E+
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 49/225 (21%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHK 547
++K+ +G G+ G VY+G R K T +A+KK LE + E + E+ ++ H
Sbjct: 2 YTKIEKIGEGTYGVVYKG--RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHP 59
Query: 548 NLVRLLGFCSEEDKRLLVYEL-----------------MPNGTLSNFLFHEGQRPGWVQR 590
N+V L +E + L++E M + ++L+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ---------- 109
Query: 591 VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650
+ +G+L+ H +++H D+KPQN+L+D K + K++DFG+++
Sbjct: 110 ------ILQGILFCHSR---RVLHRDLKPQNLLIDNKGV-----IKLADFGLARAFGI-P 154
Query: 651 TRTDTNMRGTMGYVAPEWLRNVP-VTTKVDVFSFGVMLLEIICGR 694
R T+ T+ Y APE L P +T VD++S G + E+ +
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 67/216 (31%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIE-IAVKKLEKDIEKTNEEFMTELKIIGR-THHKNLVR 551
+LVG G+ G+VY+G +K Q+ I V + D E EE E+ ++ + +HH+N+
Sbjct: 12 ELVGNGTYGQVYKG-RHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRNIAT 67
Query: 552 LLG-FCSE-----EDKRLLVYELMPNGTLSNFLFH-EGQ--RPGWVQRVEIALGVARGLL 602
G F + +D+ LV E G++++ + + +G + W+ I + RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLS 125
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
+LH+ ++IH DIK QNVL L N K+ DFG+S L++ R +T + GT
Sbjct: 126 HLHQH---KVIHRDIKGQNVL-----LTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 176
Query: 663 YVAPEWL---RNVPVTT--KVDVFSFGVMLLEIICG 693
++APE + N T K D++S G+ +E+ G
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 20/205 (9%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLG 554
+G G+ VY+G R + T +A+K++ D E+ T + E+ ++ H+N+VRL
Sbjct: 8 LGEGTYATVYKG--RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQR----PGWVQRVEIALGVARGLLYLHEECET 610
E+K +LV+E M + L ++ G R P V+ L +G+ + HE
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCHEN--- 119
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
+++H D+KPQN+L++ + K++DFG+++ T +N T+ Y AP+ L
Sbjct: 120 RVLHRDLKPQNLLINKRG-----ELKLADFGLARAFGI-PVNTFSNEVVTLWYRAPDVLL 173
Query: 671 NVPV-TTKVDVFSFGVMLLEIICGR 694
+T +D++S G ++ E+I GR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 75/252 (29%), Positives = 108/252 (42%), Gaps = 31/252 (12%)
Query: 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE---FMTELKI---IGRTHHKNLV 550
G G GKV + K T A+K L+K +E M E +I H LV
Sbjct: 8 GRGHFGKVL--LAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
L ED V E G L + H + V A V GL YLHE
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSE-PRAVFYAACVVLGLQYLHEN--- 120
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK--LLNKDQTRTDTNMRGTMGYVAPEW 668
+I++ D+K N+LLD + KI+DFG+ K + D+T T GT ++APE
Sbjct: 121 KIVYRDLKLDNLLLDTEG-----FVKIADFGLCKEGMGFGDRTST---FCGTPEFLAPEV 172
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI-SCMLSRN-- 725
L T VD + GV++ E++ G ++E E D +++D V LSR
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPF---PGDDEEEVFDSIVNDEVRYPRFLSREAI 229
Query: 726 --LQVLVSHDPE 735
++ L+ +PE
Sbjct: 230 SIMRRLLRRNPE 241
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--KTNEE---FMTELKIIGRTHHKN 548
KL+G G+ G+VY + DT E+AVK+++ D E +T++E E++++ H+
Sbjct: 8 KLLGQGAFGRVY--LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 549 LVRLLGFCSEEDKRLL--VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
+V+ G + +R L E MP G++ + L G V R + + G+ YLH
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHS 124
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT--RTDTNMR---GTM 661
I+H DIK N+L D+ K+ DFG SK L QT + T M+ GT
Sbjct: 125 ---NMIVHRDIKGANIL-----RDSVGNVKLGDFGASKRL---QTICLSGTGMKSVTGTP 173
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
+++PE + K D++S G ++E++ +
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 42/216 (19%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT----ELKIIGRTHHKNLVR 551
VG+G+ G+V T ++A+KKL + + + EL+++ H+N++
Sbjct: 23 VGSGAYGQVCSAFDTK--TGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIG 78
Query: 552 LLG-FC---SEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH 605
LL F S ED + LV LM L+N + Q+ + + RGL Y+H
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH 135
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
IIH D+KP N+ ++ + KI DFG+++ + + T GYVA
Sbjct: 136 S---AGIIHRDLKPSNI-----AVNEDCELKILDFGLARHTDDEMT----------GYVA 177
Query: 666 PEWLRNVPV-------TTKVDVFSFGVMLLEIICGR 694
W R + VD++S G ++ E++ G+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKNLV 550
KL+G G+ GKV ++R K T A+K L K++ +E +TE +++ T H L
Sbjct: 1 KLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALG--VARGLLYLHEEC 608
L D+ V E G L FH + + + G + L YLH
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSR- 114
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR---GTMGYVA 665
+++ DIK +N++LD + KI+DFG L K+ M+ GT Y+A
Sbjct: 115 --DVVYRDIKLENLMLD-----KDGHIKITDFG----LCKEGISDGATMKTFCGTPEYLA 163
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
PE L + VD + GV++ E++CGR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 29/215 (13%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR-THHKNLVRL 552
++VG G+ G+VY+G +K Q+ A K+ E EE E+ ++ + +HH+N+
Sbjct: 22 EVVGNGTYGQVYKG-RHVKTGQL--AAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATY 78
Query: 553 LGF------CSEEDKRLLVYELMPNGTLSNFLFH-EGQ--RPGWVQRVEIALGVARGLLY 603
G +D+ LV E G++++ + + +G + W+ I + RGL +
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREILRGLAH 136
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
LH ++IH DIK QNVL L N K+ DFG+S L++ R +T + GT +
Sbjct: 137 LHAH---KVIHRDIKGQNVL-----LTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYW 187
Query: 664 VAPEWL--RNVPVTT---KVDVFSFGVMLLEIICG 693
+APE + P T + D++S G+ +E+ G
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNE--EFMTELKIIGRTHHKNLVRL 552
VG G G+V+ + + KDT +A+K+++K + K NE +TE I+ T + LV+L
Sbjct: 9 VGQGGYGQVF--LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFL-----FHEGQRPGWVQRVEIALGVARGLLYLHEE 607
L +++ L E +P G L E ++ E+ V LHE
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM--AEMFEAVDA----LHE- 119
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNKDQTRTDTNMRGTMGYVAP 666
IH D+KP+N L+D K++DFG+SK ++ + + G+ Y+AP
Sbjct: 120 --LGYIHRDLKPENFLIDASG-----HIKLTDFGLSKGIVTYANS-----VVGSPDYMAP 167
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICG 693
E LR VD +S G ML E +CG
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE-FMTELKIIGRTHH-KNLVRLLG 554
G G+ G V + +R T +AVK++ + ++ + +L I R+ V G
Sbjct: 10 GRGAYGVVDK--MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 555 FCSEEDKRLLVYELMPNGTLSNF---LFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
E + E+M + +L F ++ +G +IA+ + + L YLH +
Sbjct: 68 ALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LS 124
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
+IH D+KP NVL ++ N K+ DFGIS L +T G Y+APE R
Sbjct: 125 VIHRDVKPSNVL-----INRNGQVKLCDFGISGYLVDSVAKTID--AGCKPYMAPE--RI 175
Query: 672 VPVTT------KVDVFSFGVMLLEIICGR 694
P K DV+S G+ ++E+ GR
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 41/108 (37%), Positives = 58/108 (53%), Gaps = 12/108 (11%)
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL----LNKDQTRTDTN 656
LL +H +IH DIK N+LL +N + K+ DFG SK+ ++ D RT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLC-----SNGLVKLGDFGFSKMYAATVSDDVGRT--- 204
Query: 657 MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEE 704
GT YVAPE R P + K D+FS GV+L E++ +R + +EE
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE 252
|
Length = 496 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKNLV 550
KL+G G+ GKV +++ K T A+K L+K++ +E +TE +++ + H L
Sbjct: 1 KLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALG--VARGLLYLHEEC 608
L D+ V E G L FH + + + G + L YLH E
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
+++ D+K +N++LD + KI+DFG+ K KD T GT Y+APE
Sbjct: 116 N--VVYRDLKLENLMLD-----KDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEV 167
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICGR 694
L + VD + GV++ E++CGR
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 10/103 (9%)
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651
+I++ V RGL YL E+ +I+H D+KP N+L++ + K+ DFG+S L
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVN-----SRGEIKLCDFGVSGQLIDSMA 155
Query: 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
+ GT Y++PE L+ T + D++S G+ L+E+ GR
Sbjct: 156 NS---FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 6e-11
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 43/218 (19%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGR-THHKNLV 550
K +G G+ G VY R K+T +A+KK++K EE M E+K + + H N+V
Sbjct: 5 KQLGDGTFGSVYLA--RNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIV 61
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
+L E D+ V+E M G L + +P + V R ++Y
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKP-------FSESVIRSIIY------- 106
Query: 611 QII------------HCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNKDQTRTDTNM 657
QI+ H D+KP+N+L + + KI+DFG+++ + ++ T+
Sbjct: 107 QILQGLAHIHKHGFFHRDLKPENLL-----VSGPEVVKIADFGLAREIRSRP---PYTDY 158
Query: 658 RGTMGYVAPE-WLRNVPVTTKVDVFSFGVMLLEIICGR 694
T Y APE LR+ ++ VD+++ G ++ E+ R
Sbjct: 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 494 KLVGTGSSGKVY--RGILRLKDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRTHHK 547
+++GTG+ GKV+ R + D A+K L+K KT E TE +++
Sbjct: 6 RVLGTGAYGKVFLVRKVGG-HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC 64
Query: 548 NLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
+ L + + D +L L+ + + G L L+ RV IA + L +LH+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ 123
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
II+ DIK +N+LLD + ++DFG+SK ++ + GT+ Y+AP
Sbjct: 124 ---LGIIYRDIKLENILLD-----SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 667 EWLRNVPV--TTKVDVFSFGVMLLEIICG 693
E +R VD +S GV+ E++ G
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DIEKTNEEFMTELKIIGRTHH-----K 547
K + G+ G VY + + + T A+K L+K D+ N+ +T +K
Sbjct: 2 KPISKGAFGSVY--LAKKRSTGDYFAIKVLKKSDMIAKNQ--VTNVKAERAIMMIQGESP 57
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP-GWVQR--VEIALGVARGLLYL 604
+ +L +D LV E + G ++ + G P W ++ E+ LGV L
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVE----DL 113
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK--LLNKDQTRTDTNMRGTMG 662
H+ IIH DIKP+N+L+D T ++ K++DFG+S+ L NK GT
Sbjct: 114 HQR---GIIHRDIKPENLLID----QTGHL-KLTDFGLSRNGLENKK-------FVGTPD 158
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEE 704
Y+APE + V D +S G ++ E + G +
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 19/229 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIG-RTHHKNL 549
K++G GS GKV LK T A+K L+KD+ +++ MTE +I+ H L
Sbjct: 1 KVLGKGSFGKVMLA--ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
L +D+ V E + G L F ++ + A V L++LH
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLM-FQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+I+ D+K N+LLD K++DFG+ K T T GT Y+APE L
Sbjct: 116 -GVIYRDLKLDNILLD-----AEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEIL 168
Query: 670 RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718
+ + VD ++ GV++ E++ G+ E + E + + +L D V+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFE---ADNEDDLFESILHDDVL 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 85/295 (28%), Positives = 123/295 (41%), Gaps = 45/295 (15%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRT-HHKNL 549
K++G GS GKV LK AVK L+KD I+ E M E +++ + L
Sbjct: 1 KVLGKGSFGKVLLA--ELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFH--EGQRPGWVQRVEIALGVARGLLYLHEE 607
L ++ V E + G L +FH + R + A + GL +LH +
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
II+ D+K NV+LD + KI+DFG+ K R T GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVMLD-----RDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPE 166
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEE--ESEEVDIVLSDWVISCMLSRN 725
L+ + T VD +SFGV+L E++ G+ +E ES VD I+
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDI 226
Query: 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHP---------------DPNLRPSMK 765
L+ L DP R+ +VG HP DP +P +K
Sbjct: 227 LEKLFERDP--------TRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVK 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 30/226 (13%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGR-THHKNL 549
+++G GS KV ++ LK T+ A+K ++K++ +E+ TE + ++H L
Sbjct: 1 RVIGRGSYAKVL--LVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFL 58
Query: 550 VRLLGFCSEEDKRL-LVYELMPNGTLSNFLFH-EGQR--PGWVQR---VEIALGVARGLL 602
V L C + + RL V E + G L +FH + QR P R EI+L L
Sbjct: 59 VGLHS-CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLA----LN 110
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
+LHE II+ D+K NVLLD K++D+G+ K + T T GT
Sbjct: 111 FLHER---GIIYRDLKLDNVLLD-----AEGHIKLTDYGMCKEGIRPGDTTST-FCGTPN 161
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEE 708
Y+APE LR VD ++ GV++ E++ GR ++ + + ++
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEK--DIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G+G+ G V I + ++A+KK+ D+ + + ELKI+ H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTR--SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 554 GFCSEEDKRL----LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALG-VARGLLYLHEEC 608
+V +LM + + + H Q P + + L + RGL Y+H
Sbjct: 71 DILRPPGADFKDVYVVMDLMESDL--HHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSAN 127
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR---GTMGYVA 665
+IH D+KP N+L ++ + +I DFG+++ L+ T M T Y A
Sbjct: 128 ---VIHRDLKPSNLL-----VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 666 PEWLRNVP-VTTKVDVFSFGVMLLEIICGRRHI 697
PE L ++P TT +D++S G + E++ GRR +
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 494 KLVGTGSSGKVY--RGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNL 549
K++G GS GKV+ R I D A+K L+K K + T E I+ +H +
Sbjct: 2 KVLGQGSFGKVFLVRKITG-PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTL-----SNFLFHEGQRPGWVQRVEIALGVARGLLYL 604
V+L E K L+ + + G L +F E ++ E+AL L +L
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL--AELALA----LDHL 114
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
H II+ D+KP+N+LLD + ++ K++DFG+SK + D + + GT+ Y+
Sbjct: 115 HS---LGIIYRDLKPENILLD----EEGHI-KLTDFGLSKE-SIDHEKKAYSFCGTVEYM 165
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICG 693
APE + T D +SFGV++ E++ G
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 9e-11
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKNLV 550
KL+G G+ GKV ++R K + A+K L+K++ +E +TE +++ T H L
Sbjct: 1 KLLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALG--VARGLLYLHEEC 608
L +D+ V E + G L FH + + + G + L YLH
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHS-- 113
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
+I++ D+K +N++LD + KI+DFG+ K D T GT Y+APE
Sbjct: 114 -GKIVYRDLKLENLMLD-----KDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEV 166
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICGR 694
L + VD + GV++ E++CGR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNE-EFMTELKIIGRTHHKNLVRL 552
K +G G GKV G + T ++ VK+L + +F+ E + H NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQR--------PGWVQRVEIALGVARGLLYL 604
LG C+E LLV E P G L +L R P +QR +A +A GLL+L
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQR--MACEIALGLLHL 116
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK-DQTRTDTNMRGTMGY 663
H+ IH D+ +N L L + KI D+G+S K D T + + +
Sbjct: 117 HKN---NFIHSDLALRNCL-----LTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 664 VAPEWLRNV-------PVTTKVDVFSFGVMLLEI 690
+APE + V T + +V+S GV + E+
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNL 549
K++G GS GKV R D + AVK L+K I K + M E ++ + H L
Sbjct: 1 KVIGKGSFGKVLLA-KRKLDGKC-YAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL 58
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
V L +K V + + G L L E P R A +A L YLH
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS--- 114
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
I++ D+KP+N+LLD + ++DFG+ K Q+ T T GT Y+APE +
Sbjct: 115 INIVYRDLKPENILLD-----SQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVI 168
Query: 670 RNVPVTTKVDVFSFGVMLLEIICG 693
R P VD + G +L E++ G
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 38/222 (17%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKNLV 550
KL+ G+ G VY ++R K+T+ A+KK+ K + ++ E I+ + +V
Sbjct: 7 KLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVV 64
Query: 551 RLLGFCSEEDKRLL--VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+ FCS E KR L V E + G + L + G P + R+ A V L YLH
Sbjct: 65 SM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLHN-- 119
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMA--KISDFGISKL-------------LNKDQTR- 652
I+H D+KP N+L+ M K++DFG+SK+ + KD TR
Sbjct: 120 -YGIVHRDLKPDNLLI-------TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD-TRE 170
Query: 653 -TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
D + GT Y+APE + VD ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL--EKDIEKTNEEFMTELKIIGRTHHKNLVR 551
K +G GS GK +++ K+ + +K++ K K EE E+ ++ H N+V+
Sbjct: 6 KKIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 552 LLGFCSEEDKRLLVYELMPNGTL-------SNFLFHEGQRPGWVQRVEIALGVARGLLYL 604
E +V + G L LF E Q W V+I L L ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICLA----LKHV 117
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
H+ +I+H DIK QN+ L T D K+ DFGI+++LN T + GT Y+
Sbjct: 118 HDR---KILHRDIKSQNIFL---TKDG--TIKLGDFGIARVLNSTVELARTCI-GTPYYL 168
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696
+PE N P K D+++ G +L E +C +H
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYE-MCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 53/206 (25%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT-NEEFMTELKIIGRTHHKN 548
F K+ +G G+ G V++ + K + + +A K + +I+ + + EL+++ +
Sbjct: 7 FEKISELGAGNGGVVFK--VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+V G + + + E M G+L L G+ P + ++++ V +GL YL E+
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREK- 122
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
+I+H D+KP N+L++ + K+ DFG+S L + GT Y++PE
Sbjct: 123 -HKIMHRDVKPSNILVNSRG-----EIKLCDFGVSGQLIDSMANS---FVGTRSYMSPER 173
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICGR 694
L+ + + D++S G+ L+E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLE--KDIEKTNEEFMTELKIIGRTHHKNLVRL 552
+VG G+ G V + R K+T+ +A+KK + ++ E+ E + ELK++ +N+V L
Sbjct: 8 VVGEGAYGVVLK--CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECE 609
K LV+E + L L E G P V+ L + + + H+
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQL--IKAIHWCHK--- 118
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
I+H DIKP+N+L+ N + K+ DFG ++ L++ T T Y +PE L
Sbjct: 119 NDIVHRDIKPENLLIS-----HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 670 RNVPVTTKVDVFSFGVMLLEIICGR 694
P VD++S G +L E+ G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 76/299 (25%), Positives = 128/299 (42%), Gaps = 56/299 (18%)
Query: 493 SKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDIEKTN-EEFMTE-LKIIGRTHHKN 548
S L+ G+ G+++ GIL + E+ VK ++ + + E + G H+N
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG-LSHQN 69
Query: 549 LVRLLGFCSEE-DKRLLVYELMPNGTLSNFL----FHEGQRPGWV---QRVEIALGVARG 600
++ +L C E+ + ++Y M G L FL E P + Q V +A+ +A G
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNKDQTRTDTNMRG 659
+ YLH+ +IH DI +N ++D KI+D +S+ L D N
Sbjct: 130 MSYLHKR---GVIHKDIAARNCVID-----EELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 660 TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC--GRRHIELSRVEEESEEVDIVLSDWV 717
+ ++A E L N ++ DV+SFGV+L E++ ++E+ + E+ L D
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-----DPFEMAAYLKDGY 236
Query: 718 -----ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771
I+C P+ E F MA C DP RPS +++ L
Sbjct: 237 RLAQPINC-------------PD-----ELFAVMA----CCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 59/228 (25%), Positives = 94/228 (41%), Gaps = 40/228 (17%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLV 550
+L+G G G+VY +A+KK+ +D+ + F+ E KI H +V
Sbjct: 8 RLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 551 RLLGFCSEEDKRLLVYELMP---NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
+ CS+ D VY MP TL + L Q+ + + V L H+
Sbjct: 66 PVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 608 CET-------QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN---KDQTRTDTNM 657
C T ++H D+KP N+LL L I D+G + +D D +
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFG-----EVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 658 R--------------GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
R GT Y+APE L VP + D+++ GV+L +++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 491 GFSKL--------VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIG 542
GF KL +G G+ VY+G +L D + + +LE + E + E+ ++
Sbjct: 1 GFGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLK 59
Query: 543 RTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL-GVARGL 601
H N+V L E LV+E + + L +L G + V++ L + RGL
Sbjct: 60 DLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSIN-MHNVKLFLFQLLRGL 117
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
Y H +++H D+KPQN+L++ + K++DFG+++ T+T +N T+
Sbjct: 118 NYCHRR---KVLHRDLKPQNLLINERG-----ELKLADFGLAR-AKSIPTKTYSNEVVTL 168
Query: 662 GYVAPE-WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEE 705
Y P+ L + +T++D++ G + E+ GR S VEE+
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--DIEKTNEEFMTELKIIGRTHHKNLVR 551
K++G G+ G+V ++R K T+ A+K L K I++++ F E + I + V
Sbjct: 49 KVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 552 LLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
L + ++D+ L +V E MP G L N + + W + A +L L
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAR-----FYTAEVVLALDAIHSM 161
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD-QTRTDTNMRGTMGYVAPEWL 669
IH D+KP N+LLD + ++ K++DFG +NK+ R DT + GT Y++PE L
Sbjct: 162 GFIHRDVKPDNMLLD----KSGHL-KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 215
Query: 670 RNVP----VTTKVDVFSFGVMLLEIICG 693
++ + D +S GV L E++ G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 26/210 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--KTNEEFMT---ELKIIGRTHHKN 548
KL+G G+ G+VY + DT E+A K+++ D E +T++E E++++ H+
Sbjct: 8 KLLGQGAFGRVY--LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 549 LVRLLGFCSEEDKRLLV--YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
+V+ G + ++ L E MP G++ + L G V R + + G+ YLH
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHS 124
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT--RTDTNMR---GTM 661
I+H DIK N+L D + K+ DFG SK L QT + T +R GT
Sbjct: 125 ---NMIVHRDIKGANILRD-----SAGNVKLGDFGASKRL---QTICMSGTGIRSVTGTP 173
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
+++PE + K DV+S G ++E++
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 494 KLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRTHH 546
K++GTG+ GKV+ ++R D+ A+K L+K KT E TE +++
Sbjct: 6 KVLGTGAYGKVF--LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 547 KNLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH 605
+ L + + D +L L+ + + G L H QR + ++ E+ + +L L
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYINGGEL---FTHLSQRERFKEQ-EVQIYSGEIVLALE 119
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+ II+ DIK +N+LLD +N ++DFG+SK ++D+ + GT+ Y+A
Sbjct: 120 HLHKLGIIYRDIKLENILLD-----SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 666 PEWLR--NVPVTTKVDVFSFGVMLLEIICG 693
P+ +R + VD +S GV++ E++ G
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKII-GRTHHKNLVRLLG 554
+G G+ GKV++ +L K+ + AVK L+ I +EE E I+ + H N+V+ G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGS-KAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 555 FCSEEDKR-----LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
++D + LV EL G++++ + +R ++ IA + L+ L
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+ IH D+K N+L L T K+ DFG+S L + R +T++ GT ++APE +
Sbjct: 143 NKTIHRDVKGNNIL-----LTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 196
Query: 670 R-----NVPVTTKVDVFSFGVMLLEI 690
+ + DV+S G+ +E+
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 45/220 (20%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKL------EKDIEKTNEE--FMTELKIIGRTHHK 547
+G G+ G V++ I R T+ +A+KK+ D ++T E F+ EL H
Sbjct: 15 LGKGAYGIVWKAIDR--RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHP 67
Query: 548 NLVRLLG-FCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVE---IALGVARGLL 602
N+V+LL +E DK + LV+E M H R ++ V I + + L
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETD------LHAVIRANILEDVHKRYIMYQLLKALK 121
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
Y+H +IH D+KP N+L L+++ K++DFG+++ L+ + +
Sbjct: 122 YIHS---GNVIHRDLKPSNIL-----LNSDCRVKLADFGLARSLS---ELEENPENPVLT 170
Query: 663 -YVAPEWLRNVPV-------TTKVDVFSFGVMLLEIICGR 694
YVA W R + T VD++S G +L E++ G+
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRL--- 552
+G GS+G V+ + D +AVKK+ ++ + + E+KII R H N+V++
Sbjct: 13 LGCGSNGLVFSAVDS--DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 553 -----------LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGL 601
+G +E + +V E M L+N L G R+ + RGL
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLSEEHARL-FMYQLLRGL 127
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG-- 659
Y+H ++H D+KP NV ++ + L + KI DFG++++++ + G
Sbjct: 128 KYIHS---ANVLHRDLKPANVFINTEDL----VLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 660 TMGYVAPEWLRNVPVTTK-VDVFSFGVMLLEIICGR 694
T Y +P L + TK +D+++ G + E++ G+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 64/236 (27%), Positives = 101/236 (42%), Gaps = 48/236 (20%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DIEKTNE--EFMTELKIIGRTHHKNLV 550
KL+G G G+V+ ++RLK T A+K L+K ++ K N+ +TE +I+ H L
Sbjct: 7 KLLGKGDVGRVF--LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI----ALGVARGLLYLHE 606
L E LV + P G L L ++PG E+ A V L YLH
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK----------DQTRTDTN 656
I++ D+KP+N+LL + M +SDF +SK + +R +
Sbjct: 122 L---GIVYRDLKPENILL---HESGHIM--LSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 657 MR------------------GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
GT Y+APE + + VD ++ G++L E++ G
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHK 547
+ K+ +G G+ G VY+ R K T +A+KK LE + E + E+ ++ +H
Sbjct: 1 YQKVEKIGEGTYGVVYKA--RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHP 58
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL-GVARGLLYLHE 606
N+VRLL E+K LV+E + + L ++ ++ L + +G+ Y H
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
+++H D+KPQN+L +D K++DFG+++ RT T+ T+ Y AP
Sbjct: 118 H---RVLHRDLKPQNLL-----IDREGALKLADFGLARAFGV-PVRTYTHEVVTLWYRAP 168
Query: 667 EWLRNVP-VTTKVDVFSFGVMLLEIICGR 694
E L +T VD++S G + E++ R
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKL---EKD--IEKTNEEFMTELKIIGRTHHKNLV 550
+G GS G V++ R ++T +A+KK E D I+K + E++++ + H NLV
Sbjct: 9 IGEGSYGVVFK--CRNRETGQIVAIKKFVESEDDPVIKKIA---LREIRMLKQLKHPNLV 63
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHE-GQRPGWV---QRVEIALGVARGLLYLHE 606
L+ + K LV+E + + +E + P V +I + + + H+
Sbjct: 64 NLIEVFRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN-KDQTRTDTNMRGTMGYVA 665
IH D+KP+N+L + K+ DFG +++L TD YVA
Sbjct: 119 H---NCIHRDVKPENIL-----ITKQGQIKLCDFGFARILTGPGDDYTD--------YVA 162
Query: 666 PEWLR-------NVPVTTKVDVFSFGVMLLEIICG 693
W R + VDV++ G + E++ G
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 36/221 (16%)
Query: 479 EFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---M 535
E F +L+E +G GS G VY R T +A+KK+ +++NE++ +
Sbjct: 14 EKLFTDLRE--------IGHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNEKWQDII 63
Query: 536 TELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIA- 594
E++ + + H N + G E LV E G+ S+ L E + +Q VEIA
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDIL--EVHKKP-LQEVEIAA 119
Query: 595 --LGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
G +GL YLH IH DIK N+L L K++DFG + L++ +
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNIL-----LTEPGTVKLADFGSASLVSPANS- 170
Query: 653 TDTNMRGTMGYVAPEWLRNV---PVTTKVDVFSFGVMLLEI 690
GT ++APE + + KVDV+S G+ +E+
Sbjct: 171 ----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 70/266 (26%), Positives = 107/266 (40%), Gaps = 78/266 (29%)
Query: 494 KLVGTGSSGKVYR----GILRLKDTQIEIAVKKL-EKDIEKTNEEFMTELKI-IGRTHHK 547
K++G G+ GKV GI + K + +AVK L E ++ M+ELKI I +H
Sbjct: 13 KVLGHGAFGKVVEASAFGIDK-KSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHL 71
Query: 548 NLVRLLGFCSEEDKRLLV-YELMPNGTLSN------------------------------ 576
N+V LLG C++ + L+V E G LSN
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131
Query: 577 -----------------FLFHEGQRPGWVQRVE--------------IALGVARGLLYLH 605
F Q + + VARG+ +L
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL- 190
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYV 664
+ IH D+ +N+LL N + KI DFG+++ + KD + R + ++
Sbjct: 191 --ASRKCIHRDLAARNILLS-----ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEI 690
APE + + TT+ DV+SFGV+L EI
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 14/212 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G+ V++G +L + + + +LE + E + E+ ++ H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL-GVARGLLYLHEECETQIIH 614
E LV+E + + L +L + G + V+I + + RGL Y H+ +I+H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMS-MHNVKIFMFQLLRGLSYCHKR---KILH 126
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE-WLRNVP 673
D+KPQN+L++ K K++DFG+++ T+T +N T+ Y P+ L +
Sbjct: 127 RDLKPQNLLINEKG-----ELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 674 VTTKVDVFSFGVMLLEIICGRRHIELSRVEEE 705
+T +D++ G +L E+ GR S V+EE
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 52/224 (23%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVRL 552
+G G+ G V + T +++A+KK+ E T E+KI+ R H+N++ +
Sbjct: 12 YIGEGAYGMVCSATHKP--TGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKHENIIGI 68
Query: 553 L------GFCSEEDKRLLVYELMPNG--------TLSN-----FLFHEGQRPGWVQRVEI 593
L F S D +V ELM LSN FL+
Sbjct: 69 LDIIRPPSFESFNDV-YIVQELMETDLYKLIKTQHLSNDHIQYFLYQ------------- 114
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL--LNKDQT 651
+ RGL Y+H ++H D+KP N+L L+TN KI DFG++++ D T
Sbjct: 115 ---ILRGLKYIHS---ANVLHRDLKPSNLL-----LNTNCDLKICDFGLARIADPEHDHT 163
Query: 652 RTDTNMRGTMGYVAPEWLRNVPVTTK-VDVFSFGVMLLEIICGR 694
T T Y APE + N TK +D++S G +L E++ R
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEE--FMTELKIIGRT-HHKNL 549
K++G GS GKV + R K + AVK L+K I K EE M+E ++ + H L
Sbjct: 1 KVIGKGSFGKVL--LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI-ALGVARGLLYLHEEC 608
V L DK V + + G L F + +R R A +A L YLH
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHS-- 114
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
I++ D+KP+N+LLD + ++DFG+ K N + T + GT Y+APE
Sbjct: 115 -LNIVYRDLKPENILLD-----SQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEV 167
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICG 693
L P VD + G +L E++ G
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 31/210 (14%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFM--------TELKIIGRTHHK 547
+G G+ GKV++ LK+ +A+K++ +T EE M L+ + H
Sbjct: 9 IGEGAYGKVFKA-RDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 548 NLVRLLGFCS-----EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV--EIALGVARG 600
N+VRL C+ E K LV+E + + L+ +L + PG ++ + RG
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRG 122
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT 660
L +LH +++H D+KPQN+L+ ++ K++DFG++++ + T + T
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVT-----SSGQIKLADFGLARIYSFQMALTSVVV--T 172
Query: 661 MGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ Y APE L T VD++S G + E+
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 40/217 (18%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT----ELKIIGRTHHKNL 549
K VG+G+ G V + R T ++A+KKL + + +E F EL+++ H+N+
Sbjct: 21 KQVGSGAYGTVCSALDR--RTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENV 76
Query: 550 VRLLG-FCSEE--DKRLLVYELMP-NGT-LSNFLFHEGQRPGWVQRVEIALGVARGLLYL 604
+ LL F + D+ Y +MP GT L + HE +Q + + +GL Y+
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF--LVYQMLKGLKYI 134
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG---TM 661
H IIH D+KP N+ ++ + KI DFG+++ +TD+ M G T
Sbjct: 135 HA---AGIIHRDLKPGNL-----AVNEDCELKILDFGLAR-------QTDSEMTGYVVTR 179
Query: 662 GYVAPE----WLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y APE W+ T VD++S G ++ E++ G+
Sbjct: 180 WYRAPEVILNWMH---YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 5e-10
Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 65/235 (27%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF----MTELKIIGRTHHKNL 549
K +G+G+ G V + K T ++A+KK+ + + + E+K++ H+N+
Sbjct: 6 KPIGSGAYGVVCSAVD--KRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENI 61
Query: 550 VRLLGF----CSEEDKRL-LVYELMP---------NGTLSN-----FLFHEGQRPGWVQR 590
+ LL E+ + +V ELM L++ FL+
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQ---------- 111
Query: 591 VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650
+ RGL YLH +IH D+KP N+L +++N KI DFG+++ ++
Sbjct: 112 ------ILRGLKYLHS---ANVIHRDLKPSNIL-----VNSNCDLKICDFGLARGVD--- 154
Query: 651 TRTDTNMRGTM-GYVAPEWLRNVPV-------TTKVDVFSFGVMLLEIICGRRHI 697
D + +G + YV W R + T +D++S G + E++ R+ +
Sbjct: 155 --PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVR 551
LVG G G+V ++R K T A+K ++K + ++T F E I+ ++ + +
Sbjct: 8 LVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLF-HEGQRPGWVQRVEIALGVARGLLYLHEECET 610
L ++D LV E P G L + L +E Q + + +A V L +H +
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV----LAIHSVHQM 121
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
+H DIKP+NVL+D T ++ K++DFG + L ++ GT Y+APE L
Sbjct: 122 GYVHRDIKPENVLID----RTGHI-KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 671 NVPVTTK------VDVFSFGVMLLEIICGR 694
+ K D +S GV+ E+I GR
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNL 549
K++G GS GKV + + K AVK L+K +K M E ++ + H L
Sbjct: 1 KVIGKGSFGKVL--LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI-ALGVARGLLYLHEEC 608
V L +K V + + G L F + +R R A VA + YLH
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLHSL- 115
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
II+ D+KP+N+LLD + ++DFG+ K + + T T GT Y+APE
Sbjct: 116 --NIIYRDLKPENILLDSQG-----HVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEV 167
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICG 693
LR P VD + G +L E++ G
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLG 554
++G GS G VY I DT ++A+KK+ +D + N E + I+ +H N++ L
Sbjct: 73 IIGNGSFGVVYEAICI--DTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKD 126
Query: 555 FCSEEDKRL--------LVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLY 603
+ E + +V E +P T+ ++ H + + + L + R L Y
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
+H + I H D+KPQN+L+D T + K+ DFG +K L Q + + Y
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNT----HTLKLCDFGSAKNLLAGQ--RSVSYICSRFY 236
Query: 664 VAPE-WLRNVPVTTKVDVFSFGVMLLEIICG 693
APE L TT +D++S G ++ E+I G
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 36/213 (16%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAV-KKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVRL 552
+G GS G VY + + + V K++ NE E +++ + H +V+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 553 LG-------------FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVAR 599
+C D + EL G E Q W +++ LGV
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT----LSENQVCEWF--IQLLLGVH- 120
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG 659
Y+H+ +I+H D+K +N+ L N + KI DFG+S+LL T G
Sbjct: 121 ---YMHQR---RILHRDLKAKNIFL------KNNLLKIGDFGVSRLL-MGSCDLATTFTG 167
Query: 660 TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC 692
T Y++PE L++ +K D++S G +L E+ C
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR 658
RGL YLH I+H DIKP N+L++ +N + KI DFG++++ D+++ T
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVN-----SNCVLKICDFGLARVEEPDESKHMTQEV 165
Query: 659 GTMGYVAPEWLRNVP-VTTKVDVFSFGVMLLEIICGR 694
T Y APE L T+ VD++S G + E++ R
Sbjct: 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 65/241 (26%), Positives = 113/241 (46%), Gaps = 25/241 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKNLV 550
+++G GS KV ++RLK A+K ++K++ +E+ TE + + +
Sbjct: 1 RVIGRGSYAKVL--LVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFL 58
Query: 551 RLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
L C + RL LV E + G L + + + P R A + L +LHE
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHER-- 115
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK--LLNKDQTRTDTNMRGTMGYVAPE 667
II+ D+K NVLLD + K++D+G+ K L D T T GT Y+APE
Sbjct: 116 -GIIYRDLKLDNVLLD-----ADGHIKLTDYGMCKEGLGPGDTTST---FCGTPNYIAPE 166
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
LR VD ++ GV++ E++ GR ++ ++ D+ D++ +L + ++
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII-----TDNPDMNTEDYLFQVILEKPIR 221
Query: 728 V 728
+
Sbjct: 222 I 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 487 EATKGFSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT--NEEFMTELKIIG 542
E T + L VG G+ G V +L T +A+KK+ K + ELK++
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQL--TGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64
Query: 543 RTHHKNLVRLLG-FCSEEDKRLLVYELMPNGT-LSNFLFHEGQRPGWVQRVEIALGVARG 600
H+N++ L F S + V EL+ GT L L ++Q + RG
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQY--FLYQILRG 120
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG- 659
L Y+H ++H D+KP N+L ++ N KI DFG++++ D M G
Sbjct: 121 LKYVHS---AGVVHRDLKPSNIL-----INENCDLKICDFGLARI-------QDPQMTGY 165
Query: 660 --TMGYVAPE----WLR-NVPVTTKVDVFSFGVMLLEIICGR 694
T Y APE W + +V +VD++S G + E++ G+
Sbjct: 166 VSTRYYRAPEIMLTWQKYDV----EVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 491 GFSKL--------VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIG 542
GF K+ +G G+ V++G +L + + + +LE + E + E+ ++
Sbjct: 1 GFGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLK 59
Query: 543 RTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL-GVARGL 601
H N+V L + LV+E + + L ++ G + V+I L + RGL
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMS-MHNVKIFLYQILRGL 117
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
Y H +++H D+KPQN+L++ + K++DFG+++ T+T +N T+
Sbjct: 118 AYCHRR---KVLHRDLKPQNLLINERG-----ELKLADFGLAR-AKSVPTKTYSNEVVTL 168
Query: 662 GYVAPE-WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEE 705
Y P+ L + +T++D++ G + E+ GR S VE+E
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--DIEKTNEEFMTELK-IIGRTHHKNLV 550
K++G G+ G+V ++R K +Q A+K L K I++++ F E + I+ + +V
Sbjct: 49 KVIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 551 RLLGFCSEEDKRLL--VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+L FC+ +D + L V E MP G L N + + W + A +L L
Sbjct: 107 QL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYTAEVVLALDAIH 159
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT---RTDTNMRGTMGYVA 665
+IH D+KP N+L LD + K++DFG + D+T R DT + GT Y++
Sbjct: 160 SMGLIHRDVKPDNML-----LDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYIS 211
Query: 666 PEWLRNVP----VTTKVDVFSFGVMLLEIICG 693
PE L++ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 42/216 (19%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE--FMT---ELKIIGRTHHKN 548
K +G G+ VY+ R K+T +A+KK++ K ++ T E+K++ H N
Sbjct: 6 KKLGEGTYAVVYKA--RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVA---------- 598
++ LL + LV+E M L ++ I L A
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKV----------IKDKSIVLTPADIKSYMLMTL 112
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR 658
RGL YLH I+H D+KP N+L + ++ + K++DFG+++ + T+
Sbjct: 113 RGLEYLHSN---WILHRDLKPNNLL-----IASDGVLKLADFGLARSFGSPNRKM-THQV 163
Query: 659 GTMGYVAPEWL---RNVPVTTKVDVFSFGVMLLEII 691
T Y APE L R+ VD++S G + E++
Sbjct: 164 VTRWYRAPELLFGARH--YGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 26/210 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL--EKDIEKTNEE---FMTELKIIGRTHHKN 548
KL+G G+ G+VY + DT E+AVK++ + D ++T++E E++++ H
Sbjct: 8 KLLGRGAFGEVY--LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 549 LVRLLGFCSE-EDKRLLVY-ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
+V+ G + E+K+L ++ E MP G++ + L G V R + +G+ YLH
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLHS 124
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT--RTDTNMR---GTM 661
I+H DIK N+L D+ K+ DFG SK + QT + T ++ GT
Sbjct: 125 ---NMIVHRDIKGANIL-----RDSAGNVKLGDFGASKRI---QTICMSGTGIKSVTGTP 173
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
+++PE + K DV+S ++E++
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 70/244 (28%), Positives = 111/244 (45%), Gaps = 44/244 (18%)
Query: 459 RGLIKRRNYFDPNSMEINFR---EFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQ 515
+G++K DP ++ ++ E F L E +G GS G VY T
Sbjct: 2 KGVVK-----DPEIADLFYKDDPEEIFVGLHE--------IGHGSFGAVY--FATNSHTN 46
Query: 516 IEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572
+AVKK+ ++TNE++ + E+K + + H N + G +E LV E G
Sbjct: 47 EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105
Query: 573 TLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL 629
+ S+ L ++P +Q VEIA G +GL YLH +IH DIK N+LL
Sbjct: 106 SASDLL-EVHKKP--LQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPG- 158
Query: 630 DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV---PVTTKVDVFSFGVM 686
K++DFG + + + GT ++APE + + KVDV+S G+
Sbjct: 159 ----QVKLADFGSASKSSPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 209
Query: 687 LLEI 690
+E+
Sbjct: 210 CIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 26/212 (12%)
Query: 494 KLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEK----DIEKTNEEFMTELKIIGRTHH 546
K++GTG+ GKV+ ++R DT A+K L+K KT E TE ++
Sbjct: 6 KVLGTGAYGKVF--LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ 63
Query: 547 KNLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQ-RVEIALG-VARGLLY 603
+ L + + + +L L+ + + G + L+ QR + + V G + L +
Sbjct: 64 SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEH 120
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNKDQTRTDTNMRGTMG 662
LH+ I++ DIK +N+LLD + ++DFG+SK L++++ RT + GT+
Sbjct: 121 LHK---LGIVYRDIKLENILLD-----SEGHVVLTDFGLSKEFLSEEKERT-YSFCGTIE 171
Query: 663 YVAPEWLRNVPVTTK-VDVFSFGVMLLEIICG 693
Y+APE +R K VD +S G+++ E++ G
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 64/231 (27%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVR 551
K +G G+ G V +T ++A+KK+ + + T E+K++ H+N++
Sbjct: 11 KPIGRGAYGIVCSAKNS--ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 552 LLGFCSEEDKR-----LLVYELM---------PNGTLSN-----FLFHEGQRPGWVQRVE 592
+ + +VYELM + TLS+ FL+
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ------------ 116
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
+ RGL Y+H ++H D+KP N+L L+ N KI DFG++ R
Sbjct: 117 ----LLRGLKYIHS---ANVLHRDLKPSNLL-----LNANCDLKICDFGLA--------R 156
Query: 653 TDTNMRGTMG-YVAPEWLRNVPV-------TTKVDVFSFGVMLLEIICGRR 695
T + M YV W R + TT +DV+S G + E++ GR+
Sbjct: 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-09
Identities = 27/82 (32%), Positives = 37/82 (45%), Gaps = 9/82 (10%)
Query: 229 FRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYG 288
+R+T N Y R T+ G+ ++F + S W W A D C V CG YG
Sbjct: 38 YRMTNN------SIYSRLTLSSEGSLERFTWIP-NSQDWNLFWSAPKDQCDVYGRCGPYG 90
Query: 289 MCTSSDNETVTCNCIPGYTPLN 310
C + + CNCI G+ P N
Sbjct: 91 YCDVNTSP--KCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIA-VKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRL 552
K +G G +VYR L + + V+ E K ++ + E+ ++ + +H N+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEG-------QRPGWVQRVEIALGVARGLLYLH 605
L E+++ +V EL G LS + + +R W V++ V ++H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE----HMH 123
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+++H DIKP NV + + K+ D G+ + + T + + GT Y++
Sbjct: 124 SR---RVMHRDIKPANVFIT-----ATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMS 174
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEI 690
PE + K D++S G +L E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 64/287 (22%), Positives = 120/287 (41%), Gaps = 43/287 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DI--EKTNEEFMTELKIIGRTHHKNLV 550
K +G G +VYR L + A+KK++ D+ K + + E+ ++ + +H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPV--ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEG-------QRPGWVQRVEIALGVARGLLY 603
+ E+++ +V EL G LS + H ++ W V++ L +
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL----CSALEH 121
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
+H +++H DIKP NV + + K+ D G+ + + T + + GT Y
Sbjct: 122 MHSR---RVMHRDIKPANVF-----ITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYY 172
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723
++PE + K D++S G +L E+ + ++ S I D+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY------- 225
Query: 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770
P + SD E +V + C +PDP RP + V +
Sbjct: 226 ----------PPLPSDHYSEELRQLVNM-CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQI---EIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLV 550
++VG GS G+ D + EI + K +E + +E + ++ + H N+V
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV----LLAKMKHPNIV 61
Query: 551 RLLGFCSEEDKRLLVYELMPNGTL-------SNFLFHEGQRPGWVQRVEIALGVARGLLY 603
+ +V E G L LF E W V++ LGV +
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF--VQMCLGVQ----H 115
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
+HE+ +++H DIK +N+ L N K+ DFG ++LL T + GT Y
Sbjct: 116 IHEK---RVLHRDIKSKNIFLT-----QNGKVKLGDFGSARLLTSPGAYACTYV-GTPYY 166
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696
V PE N+P K D++S G +L E +C +H
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYE-LCTLKH 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFM--------TELKIIGRTHHK 547
+G G+ G VY+ R + +A+K + +TNE+ + LK + H
Sbjct: 8 IGVGAYGTVYKA--RDPHSGHFVALKSVRV---QTNEDGLPLSTVREVALLKRLEAFDHP 62
Query: 548 NLVRLLGFCS-----EEDKRLLVYELMPNGTLSNFLFHEGQRPGW-VQRV-EIALGVARG 600
N+VRL+ C+ E K LV+E + + L +L + PG + + ++ RG
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRG 120
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT 660
L +LH C I+H D+KP+N+L+ + K++DFG++++ + T + T
Sbjct: 121 LDFLHANC---IVHRDLKPENILVT-----SGGQVKLADFGLARIYSCQMALTPVVV--T 170
Query: 661 MGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ Y APE L T VD++S G + E+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 42/230 (18%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNE-------------EFMT--EL 538
+G G+ GKV + L +A+KK+ K IE +N+ F T EL
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGK--IVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 539 KIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVA 598
KI+ H+N++ L+ E D LV ++M L + R Q I L +
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQIL 129
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI-------------SKL 645
GL LH + +H D+ P N+ ++ K + KI+DFG+ SK
Sbjct: 130 NGLNVLH---KWYFMHRDLSPANIFINSKGI-----CKIADFGLARRYGYPPYSDTLSKD 181
Query: 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVP-VTTKVDVFSFGVMLLEIICGR 694
+ T+ T+ Y APE L VD++S G + E++ G+
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 41/123 (33%), Positives = 58/123 (47%), Gaps = 11/123 (8%)
Query: 467 YFDPNSMEINFR-EFTFQELQEATKGFSKLVGTGSSGKVYRGI---LRLKDTQIEIAVKK 522
+ DP + N + EF LQ F K +G G+ GKV L +D + +AVK
Sbjct: 21 FIDPTQLPYNEKWEFPRDNLQ-----FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKM 75
Query: 523 LEKDIEKTNEE-FMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFH 580
L+ E M+ELKI+ HKN+V LLG C+ L++ E G L NFL
Sbjct: 76 LKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
Query: 581 EGQ 583
+ +
Sbjct: 136 KAE 138
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G G+ G V++ + ++T +A+K+ L+ D E + E+ ++ HKN+VRL
Sbjct: 8 IGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQ-RPGWVQRVEIALGVARGLLYLHEECETQI 612
+ K LV+E F G P V+ L +GL + H +
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL--LKGLAFCHSH---NV 120
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
+H D+KPQN+L ++ N K++DFG+++ R + T+ Y P+ L
Sbjct: 121 LHRDLKPQNLL-----INKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGA 174
Query: 673 PV-TTKVDVFSFGVMLLEI 690
+ +T +D++S G + E+
Sbjct: 175 KLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 55/223 (24%), Positives = 111/223 (49%), Gaps = 19/223 (8%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G GS VY+G ++ + + V +L+++ E T + E ++ H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEECETQI 612
++ LV+E + ++ + + PG + + L + RGL Y+H+ I
Sbjct: 72 IHTKETLTLVFEYVH----TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YI 124
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE-WLRN 671
+H D+KPQN+L+ DT + K++DFG+++ + T +N T+ Y P+ L +
Sbjct: 125 LHRDLKPQNLLIS----DTGEL-KLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 672 VPVTTKVDVFSFGVMLLEIICGRRHIE-LSRVEEESEEVDIVL 713
+T +D++ G + +E+I G + ++++ E + +VL
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVRLL 553
VG+G+ G V T + +AVKKL + + T EL+++ H+N++ LL
Sbjct: 25 VGSGAYGSVCAAFD--TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 554 GFCS------EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
+ E + LV LM L+N + + VQ + + RGL Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF--LIYQILRGLKYIHS- 138
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG---TMGYV 664
IIH D+KP N+ ++ + KI DFG+++ TD M G T Y
Sbjct: 139 --ADIIHRDLKPSNL-----AVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYR 184
Query: 665 APEWLRN-VPVTTKVDVFSFGVMLLEIICGR 694
APE + N + VD++S G ++ E++ GR
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 496 VGTGSSGKVYRGILRLKD----------TQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH 545
+G G+ ++Y GIL KD +I++ +K L+ + F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 546 HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH 605
HK++V L G C + + ++V E + G L F+ + + ++A +A L YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNY--MAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
++ ++H ++ +N+LL + +D K+SD GI + Q + + +
Sbjct: 123 DK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----RIPW 174
Query: 664 VAPEWLRNVPV-TTKVDVFSFGVMLLEI 690
+APE + + + D +SFG L EI
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 48/206 (23%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLG 554
L+ +Y+GI K+ I KK K + + E+K + R N++++ G
Sbjct: 27 LIKENDQNSIYKGIFNNKEVIIR-TFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 555 FCSEEDKRL----LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
F + L L+ E G L L E + + ++++A+ +GL L++
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNK 144
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
+ ++ + L+ NY KI G+ K+L+ + + N M Y + + L
Sbjct: 145 P--YKNLTSVSFLVT-----ENYKLKIICHGLEKILSSPPFK-NVNF---MVYFSYKMLN 193
Query: 671 NV--PVTTKVDVFSFGVMLLEIICGR 694
++ T K D++S GV+L EI G+
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 69/259 (26%), Positives = 109/259 (42%), Gaps = 40/259 (15%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT--------NEEFMTELKIIGRTHH 546
++G G G+VY R DT A+K L+K K NE M L G
Sbjct: 1 IIGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEG---QRPGWVQRVEIALGVARGLLY 603
+V + DK + +LM G L L G ++ EI LG L +
Sbjct: 59 --IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG----LEH 112
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
+H +++ D+KP N+L LD + +ISD G++ +K + GT GY
Sbjct: 113 MHNRF---VVYRDLKPANIL-----LDEHGHVRISDLGLACDFSKKKPHASV---GTHGY 161
Query: 664 VAPEWL-RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722
+APE L + + D FS G ML +++ G + +++ E + L
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---------IDRMTL 212
Query: 723 SRNLQVLVSHDPEVLSDLE 741
+ N+++ S PE+ S LE
Sbjct: 213 TVNVELPDSFSPELKSLLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 55/223 (24%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF----MTELKIIGRTHHKNLVR 551
+G G+ G+V++ R K T+ +A+KK+ + EK E F + E+KI+ H+N+V
Sbjct: 20 IGQGTFGEVFKA--RHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVN 75
Query: 552 LLGFCSEEDKR--------LLVYELMPN---GTLSNFLFHEGQRPGWVQRVEIALGVAR- 599
L+ C + LV+E + G LSN + V+ L +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN------------KNVKFTLSEIKK 123
Query: 600 -------GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK---LLNKD 649
GL Y+H +I+H D+K N+L + + + K++DFG+++ L
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANIL-----ITKDGILKLADFGLARAFSLSKNS 175
Query: 650 QTRTDTNMRGTMGYVAPEWL---RNVPVTTKVDVFSFGVMLLE 689
+ TN T+ Y PE L R+ +D++ G ++ E
Sbjct: 176 KPNRYTNRVVTLWYRPPELLLGERD--YGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHKN-LVRL 552
+G G+ GKVY+ R K+T +A+KK LE D E + E+ ++ +VRL
Sbjct: 9 IGEGTYGKVYKA--RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 553 LGFCSEEDKR-----LLVYELMPNGTLSNFLFHEGQRPG------WVQRVEIALGVARGL 601
L E+K LV+E + + L F+ G+ PG ++ L +G+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--LKGV 123
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
+ H+ ++H D+KPQN+L+D + KI+D G+ + + ++ T+ T+
Sbjct: 124 AHCHKH---GVMHRDLKPQNLLVD----KQKGLLKIADLGLGRAFSI-PVKSYTHEIVTL 175
Query: 662 GYVAPE-WLRNVPVTTKVDVFSFGVMLLEII 691
Y APE L + +T VD++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+ +G GS VY+GI R+ + + V ++ + E + E ++ H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLH 69
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEECET 610
++ V+E M + L+ ++ Q PG + + L + RGL Y+H +
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAYIHGQ--- 122
Query: 611 QIIHCDIKPQNVLLD-LKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
I+H D+KPQN+L+ L L K++DFG+++ ++T ++ T+ Y P+ L
Sbjct: 123 HILHRDLKPQNLLISYLGEL------KLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVL 175
Query: 670 RN-VPVTTKVDVFSFGVMLLEIICGR 694
++ +D++ G + +E++ G+
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 66/248 (26%), Positives = 103/248 (41%), Gaps = 60/248 (24%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DIEKTNE--EFMTELKIIGRTHHKNLV 550
K +G G+ G+V ++R DT A+K L K D+ N+ E I+ ++ +V
Sbjct: 7 KTIGIGAFGEVC--LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVV 64
Query: 551 RLLGFCSEEDKRLL--VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+L + S +DK L V + +P G + + L G + R IA + + +H+
Sbjct: 65 KL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHK-- 119
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI---------SKLLNK-DQTRTDT--- 655
IH DIKP N+L+D + K++DFG+ SK K D R D+
Sbjct: 120 -MGFIHRDIKPDNILIDR-----DGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173
Query: 656 ------------------NMR-----------GTMGYVAPEWLRNVPVTTKVDVFSFGVM 686
R GT Y+APE L T D +S GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233
Query: 687 LLEIICGR 694
L E++ G+
Sbjct: 234 LYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 29/100 (29%), Positives = 49/100 (49%), Gaps = 12/100 (12%)
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD---T 655
GL Y+H ++H D+KP N+L++ + KI DFG+++ +++ T
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNA-----DCELKICDFGLARGFSENPGENAGFMT 167
Query: 656 NMRGTMGYVAPE-WLRNVPVTTKVDVFSFGVMLLEIICGR 694
T Y APE L T +DV+S G +L E++ +
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN----EEFMTELKIIGRTH------ 545
+G G+ +Y G LR++ + ++D E LK++ +H
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 546 ------------HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHE-GQRP-GWVQRV 591
H +L + G C + ++V E + +G L L E G+ P W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL--DTNYMAKISDFGISKLLNKD 649
+A +A L YL ++ ++H ++ +N+LL L T+ K+SD G+S
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 650 QTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEI 690
+ R + + ++APE + ++T D +SFG LLEI
Sbjct: 178 EERVER-----IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DIEKTNEE--FMTELKIIGRTHHKNLV 550
K++G G+ G+V ++++K T+ A+K L K ++ K E F E ++ + +
Sbjct: 7 KVIGRGAFGEV--AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWIT 64
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFH-EGQRPGWVQRVEIALGVARGLLYLHEECE 609
L +E+ LV + G L L E + P + R IA V L +H +
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV----LAIHSIHQ 120
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+H DIKP NVLLD+ N +++DFG +N+D T + GT Y++PE L
Sbjct: 121 LHYVHRDIKPDNVLLDM-----NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 670 RNV-----PVTTKVDVFSFGVMLLEIICG 693
+ + + D +S GV + E++ G
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 18/199 (9%)
Query: 499 GSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE 558
GS G+V+ + + ++ VK + KT E+ I+ H+ ++ L+
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPG---REIDILKTISHRAIINLIHAYRW 157
Query: 559 EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV-EIALGVARGLLYLHEECETQIIHCDI 617
+ V +MP F + + P +++ I + L YLH IIH D+
Sbjct: 158 KS---TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDV 211
Query: 618 KPQNVLLDLKTLDTNYMAKISDFGIS-KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTT 676
K +N+ LD A + DFG + KL T GT+ +PE L P
Sbjct: 212 KTENIFLDEPE-----NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA 266
Query: 677 KVDVFSFGVMLLEIICGRR 695
K D++S G++L E+
Sbjct: 267 KTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 65/236 (27%), Positives = 100/236 (42%), Gaps = 31/236 (13%)
Query: 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT--------NEEFMTELKIIGRTHH 546
++G G G+VY R DT A+K L+K K NE M L G
Sbjct: 1 IIGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
+V + DK + +LM G L +H Q G E+ A +L L
Sbjct: 59 --IVCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQH-GVFSEAEMRFYAAEIILGLEH 112
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
+++ D+KP N+L LD + +ISD G++ +K + GT GY+AP
Sbjct: 113 MHNRFVVYRDLKPANIL-----LDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 667 EWL-RNVPVTTKVDVFSFGVMLLEIICG----RRHIELSRVEEE--SEEVDIVLSD 715
E L + V + D FS G ML +++ G R+H + E + + + + L D
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 496 VGTGSSGKV---YRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLV 550
VG+G+ G V Y LR K +AVKKL + + T EL+++ H+N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK-----VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI 77
Query: 551 RLLGF----CSEED--KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYL 604
LL S E+ + LV LM L+N + + VQ + L RGL Y+
Sbjct: 78 GLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQL--LRGLKYI 134
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG---TM 661
H IIH D+KP NV ++ + +I DFG+++ + D M G T
Sbjct: 135 HS---AGIIHRDLKPSNV-----AVNEDCELRILDFGLAR-------QADDEMTGYVATR 179
Query: 662 GYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGR 694
Y APE + N + VD++S G ++ E++ G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 30/228 (13%)
Query: 484 ELQEATKGFSKLVGTGSSGKVYRGIL----RLKDTQIEIAVKKLEKDIEKT-NEEFMTEL 538
E+ +T F + +G GKVY+G L + TQ +A+K L+ E EEF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQ-AVAIKTLKDKAEGPLREEFKHEA 59
Query: 539 KIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGW----------- 587
+ R H N+V LLG ++E +++ + L FL
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 588 ----VQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI- 642
V I +A G+ +L ++H D+ +NVL+ K KISD G+
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK-----LNVKISDLGLF 171
Query: 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
++ D + N + +++PE + + D++S+GV+L E+
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 39/118 (33%), Positives = 55/118 (46%), Gaps = 11/118 (9%)
Query: 467 YFDPNSMEINFR-EFTFQELQEATKGFSKLVGTGSSGKVYRGI---LRLKDTQIEIAVKK 522
Y DP + + + EF L F K +G G+ GKV L D + +AVK
Sbjct: 18 YIDPTQLPYDHKWEFPRNRLS-----FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKM 72
Query: 523 LEKDIEKTNEE-FMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL 578
L+ T E M+ELK++ +H N+V LLG C+ L++ E G L NFL
Sbjct: 73 LKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653
+ VARG+ +L + IH D+ +N+LL N + KI DFG+++ + KD
Sbjct: 179 SFQVARGMEFLASR---KCIHRDLAARNILLS-----ENNVVKICDFGLARDIYKDPDYV 230
Query: 654 DT-NMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ R + ++APE + + TT+ DV+SFGV+L EI
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 9e-07
Identities = 54/240 (22%), Positives = 91/240 (37%), Gaps = 69/240 (28%)
Query: 481 TFQELQEATKGFSKL----VGTGSSGKVYRGILRLKDTQ---------------IEIAVK 521
+ EL + K + + G GKV +L+ K TQ IE V
Sbjct: 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAIEPMVH 62
Query: 522 KLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHE 581
+L KD + N ++L + +L+ + + +G L + L E
Sbjct: 63 QLMKD-------------------NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE 103
Query: 582 GQRPGWVQRVE------IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMA 635
G ++ I + L LH+ IIH DIK +NVL D
Sbjct: 104 G-------KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYD------RAKD 147
Query: 636 KI--SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
+I D+G+ K++ T + GT+ Y +PE ++ D ++ GV+ E++ G
Sbjct: 148 RIYLCDYGLCKIIG-----TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 41/217 (18%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT----ELKIIGRTHHKNL 549
K VG+G+ G V I K T ++A+KKL + + +E F EL ++ H+N+
Sbjct: 21 KQVGSGAYGSVCSAID--KRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENV 76
Query: 550 VRLLG-FCSEEDKRLL--VYELMPNGTLSNFLFHEGQR----PGWVQRVE-IALGVARGL 601
+ LL F S Y +MP ++ + Q+ P +V+ + + GL
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMP------YMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG-- 659
Y+H IIH D+KP N+ ++ + KI DFG+++ D M G
Sbjct: 131 KYIHS---AGIIHRDLKPGNL-----AVNEDCELKILDFGLAR-------HADAEMTGYV 175
Query: 660 -TMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGR 694
T Y APE + N + VD++S G ++ E++ G+
Sbjct: 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 56/225 (24%)
Query: 494 KLVGTGSSGKV---YRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKN 548
K +G+G+ G V Y + T +A+KKL + + EL ++ +HKN
Sbjct: 22 KPIGSGAQGIVCAAYDTV-----TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN 76
Query: 549 LVRLLGFCSEEDKRL-------LVYELMP------------NGTLSNFLFHEGQRPGWVQ 589
++ LL K L LV ELM + +S L+
Sbjct: 77 IIGLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ--------- 126
Query: 590 RVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649
+ G+ +LH IIH D+KP N+++ ++ KI DFG+++
Sbjct: 127 -------MLCGIKHLHS---AGIIHRDLKPSNIVVK-----SDCTLKILDFGLARTAGTS 171
Query: 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
T + T Y APE + + VD++S G ++ E+I G
Sbjct: 172 FMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT---ELKIIGRTHHKNLVRL 552
+G G+ G+VY+ + E A+KK + D E+ + E+ ++ H+N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 553 LG-FCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQR--VEIAL-GVARGLLYLHEE 607
+ F DK + L+++ + FH + + V+ L + G+ YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-- 125
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648
++H D+KP N+L+ + + KI D G+++L N
Sbjct: 126 -SNWVLHRDLKPANILV-MGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 30/182 (16%)
Query: 597 VARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDT- 655
VA+G+ +L + IH D+ +N+LL N + KI DFG+++ + KD
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLS-----ENNVVKICDFGLARDIYKDPDYVRKG 239
Query: 656 NMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLS 714
+ R + ++APE + + T + DV+SFGV+L EI G +++EE
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--------- 290
Query: 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774
L ++ P+ + E ++ M L C H +P+ RP+ +++ L
Sbjct: 291 ---FCRRLKEGTRM---RAPDYTTP-EMYQTM----LDCWHGEPSQRPTFSELVEHLGNL 339
Query: 775 LE 776
L+
Sbjct: 340 LQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 62/248 (25%), Positives = 96/248 (38%), Gaps = 67/248 (27%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFM-TELKIIGRTHHKNLV 550
K++G G+ G+V +++ KDT A+KKL K +EK + E I+ + +V
Sbjct: 7 KVIGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 551 RLLGFCSEEDKR--LLVYELMPNGTLSNFLF------HEGQRPGWVQRVEIALGVARGLL 602
+L + S +D+ L+ E +P G + L E R +A +L
Sbjct: 65 KL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR----------FYIAETIL 112
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD-------- 654
+ + IH DIKP N+LLD K K+SDFG+ L K
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKG-----HIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 655 ----------------------TNMR-------GTMGYVAPEWLRNVPVTTKVDVFSFGV 685
N R GT Y+APE + D +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 686 MLLEIICG 693
++ E++ G
Sbjct: 228 IMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 31/205 (15%)
Query: 499 GSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF-MT---ELKIIGRTHHKNLVRL-- 552
G+ G VYR R K T +A+KKL+ +EK E F +T E+ I+ + H N+V +
Sbjct: 16 GTYGVVYRA--RDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 553 --LGFCSEEDKRLLVYELMPN---GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
+G S DK +V E + + + + V+ + + L G+ +LH+
Sbjct: 72 VVVG--SNLDKIYMVMEYVEHDLKSLMETM--KQPFLQSEVKCLMLQL--LSGVAHLHDN 125
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
I+H D+K N+LL+ + + KI DFG+++ + T + T+ Y APE
Sbjct: 126 ---WILHRDLKTSNLLLNNRGI-----LKICDFGLAREYG-SPLKPYTQLVVTLWYRAPE 176
Query: 668 WLRNVPV-TTKVDVFSFGVMLLEII 691
L +T +D++S G + E++
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 494 KLVGTGSSGKVYR-GILRLKDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRTHHKN 548
K++G G GKV++ + DT A+K L+K +K E I+ H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFL-----FHEGQRPGWVQRVEIALGVARGLLY 603
+V L+ K L+ E + G L L F E ++ + +AL +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------H 115
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
LH++ II+ D+KP+N+L LD K++DFG+ K + T T T GT+ Y
Sbjct: 116 LHQQ---GIIYRDLKPENIL-----LDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEY 166
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
+APE L VD +S G ++ +++ G
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 38/164 (23%), Positives = 72/164 (43%), Gaps = 25/164 (15%)
Query: 535 MTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE-----LMP--NGTLSNFLFHEGQRPGW 587
+ E ++ +H +++R+ K LV ++P + L +L +
Sbjct: 105 LIEAMLLQNVNHPSVIRM--------KDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPI 156
Query: 588 VQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647
Q + I + GL YLH + +IIH D+K +N+ ++ +D I D G ++
Sbjct: 157 DQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFIN--DVDQ---VCIGDLGAAQFPV 208
Query: 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
+ GT+ APE L +K D++S G++L E++
Sbjct: 209 VAPA--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLVRLLG 554
+G G GKV + + VK+L+ + K EF+ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI---ALGVARGLLYLHEECETQ 611
C E LLV+E G L ++L E Q + + A +A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK-DQTRTDTNMRGTMGYVAPEW-- 668
+H D+ +N L T D K+ D+GI K D T+ + + ++APE
Sbjct: 120 FLHSDLALRNCFL---TSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 669 -----LRNVPVTTKVDVFSFGVMLLEI 690
L T +V++ GV L E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEKDIEKTN--EEFMTELKIIGRTHHKNL 549
K +G+G+ G V DT I +AVKKL + + + EL ++ +HKN+
Sbjct: 27 KPIGSGAQGIVCAAF----DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 550 VRLLGFCS-----EEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL-GVARGLL 602
+ LL + EE + + LV ELM + L + E +R+ L + G+
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDH----ERMSYLLYQMLCGIK 137
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
+LH IIH D+KP N+++ ++ KI DFG+++ + T + T
Sbjct: 138 HLHS---AGIIHRDLKPSNIVVK-----SDCTLKILDFGLARTACTNFMMTPYVV--TRY 187
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
Y APE + + VD++S G ++ E++ G
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 57/230 (24%), Positives = 105/230 (45%), Gaps = 37/230 (16%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQ-----IEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN 548
K +G G G+V+ +++ K TQ I+ + L+ E+ + + E+ ++ HKN
Sbjct: 19 KKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLK---EREKSQLVIEVNVMRELKHKN 73
Query: 549 LVRLLG-FCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
+VR + F ++ +++L ++ E G LS + + G ++ I + + R LL+
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-VDITRQLLHALA 132
Query: 607 ECET--------QIIHCDIKPQNVLLDL------------KTLDTNYMAKISDFGISKLL 646
C +++H D+KPQN+ L L+ +AKI DFG+SK
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-- 190
Query: 647 NKDQTRTDTNMRGTMGYVAPEWL--RNVPVTTKVDVFSFGVMLLEIICGR 694
N + GT Y +PE L K D+++ G ++ E+ G+
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 63/250 (25%), Positives = 98/250 (39%), Gaps = 60/250 (24%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL-EKDIEKTNE--EFMTELKIIGRTHHKNLV 550
K +G G+ G+V + DT A+K L +KD+ N+ E I+ ++ +V
Sbjct: 7 KTLGIGAFGEVC--LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVV 64
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
+L ++D V + +P G + + L P + R IA L + +
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA----ELTLAIESVHKM 120
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI---------SKLLNK-DQTRTD------ 654
IH DIKP N+L+DL + K++DFG+ SK K R D
Sbjct: 121 GFIHRDIKPDNILIDL-----DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 655 -----TNMR-------------------------GTMGYVAPEWLRNVPVTTKVDVFSFG 684
+N R GT Y+APE L T D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 685 VMLLEIICGR 694
V+L E++ G+
Sbjct: 236 VILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 63/240 (26%), Positives = 96/240 (40%), Gaps = 54/240 (22%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTN-EEFMTELKIIGRTHHKNLV 550
K++G G+ G+V +++ KDT A+K L K +EK E I+ +V
Sbjct: 7 KVIGRGAFGEVR--LVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 551 RLLGFCSEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
++ F S +DKR L+ E +P G + L + + +A +L +
Sbjct: 65 KM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT----LSEEATQFYIAETVLAIDAIH 118
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD-------------- 654
+ IH DIKP N+LLD K K+SDFG+ L K RT+
Sbjct: 119 QLGFIHRDIKPDNLLLDAKG-----HVKLSDFGLCTGLKKAH-RTEFYRNLTHNPPSDFS 172
Query: 655 -TNMR--------------------GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
NM GT Y+APE D +S GV++ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 29/263 (11%)
Query: 509 LRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568
R D + ++ K + + E+ +EL + H +V+ +DK LL+ E
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT 628
G L+ + + Q E+ L + +L L E +++H D+K N+ L
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---- 202
Query: 629 LDTNYMAKISDFGISKLLNKDQTRTD--TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVM 686
+ T + K+ DFG SK + D D ++ GT Y+APE + K D++S GV+
Sbjct: 203 MPTG-IIKLGDFGFSKQYS-DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVI 260
Query: 687 LLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERM 746
L E++ R + E ++V D C +S ++ L+ DP +LS
Sbjct: 261 LYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALL--DP-LLSK------- 309
Query: 747 AMVGLWCNHPDPNLRPSMKKVIH 769
+P LRP+ ++++H
Sbjct: 310 ----------NPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 11/96 (11%)
Query: 597 VARGLLYL-HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK-LLNKDQTRTD 654
VA+G+ +L + C IH D+ +NVLL +AKI DFG+++ ++N
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLT-----DGRVAKICDFGLARDIMNDSNYVVK 271
Query: 655 TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
N R + ++APE + + T + DV+S+G++L EI
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 49/206 (23%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLG- 554
VG G+ G VY+ + + A+K++E + E+ ++ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEG--TGISMSACREIALLRELKHPNVISLQKV 66
Query: 555 FCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLY-----LHEEC 608
F S D+++ L+++ + FH + + V++ G+ + LLY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD-QTRTDTN-MRGTMGYVAP 666
++H D+KP N+L+ + + + KI+D G ++L N + D + + T Y AP
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 667 EWLRNVPVTTK-VDVFSFGVMLLEII 691
E L TK +D+++ G + E++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 68/248 (27%), Positives = 112/248 (45%), Gaps = 46/248 (18%)
Query: 463 KRRNYFDPNSMEINFREFT----FQELQEATKGFSKLVGTGSSGKV---YRGILRLKDTQ 515
KR N F S+EI FT +Q L K +G+G+ G V Y IL +
Sbjct: 5 KRDNNF--YSVEIGDSTFTVLKRYQNL--------KPIGSGAQGIVCAAYDAIL-----E 49
Query: 516 IEIAVKKLEKDIEKTN--EEFMTELKIIGRTHHKNLVRLLGFCS-----EEDKRL-LVYE 567
+A+KKL + + + EL ++ +HKN++ LL + EE + + +V E
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 568 LMPNGTLSNFLFHEGQRPGWVQRVEIAL-GVARGLLYLHEECETQIIHCDIKPQNVLLDL 626
LM + L + E +R+ L + G+ +LH IIH D+KP N+++
Sbjct: 110 LM-DANLCQVIQMELDH----ERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK- 160
Query: 627 KTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVM 686
++ KI DFG+++ T + T Y APE + + VD++S G +
Sbjct: 161 ----SDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCI 214
Query: 687 LLEIICGR 694
+ E+I G
Sbjct: 215 MGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH 545
E K KL G GS VY+G +L + + +LE + E + E ++
Sbjct: 4 LETYKKLDKL-GEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLK 61
Query: 546 HKNLVRLLGFCSEEDKRLLVYELM-----------PNG-TLSN---FLFHEGQRPGWVQR 590
H N+V L + LV+E + G ++ N FLF
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ---------- 111
Query: 591 VEIALGVARGLLYLHEECETQIIHCDIKPQNVLL-DLKTLDTNYMAKISDFGISKLLNKD 649
+ RGL Y H+ +++H D+KPQN+L+ + L K++DFG+++
Sbjct: 112 ------LLRGLAYCHQR---RVLHRDLKPQNLLISERGEL------KLADFGLAR-AKSV 155
Query: 650 QTRTDTNMRGTMGYVAPE-WLRNVPVTTKVDVFSFGVMLLEIICGR 694
++T +N T+ Y P+ L + +T +D++ G + E+ GR
Sbjct: 156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 63/250 (25%), Positives = 102/250 (40%), Gaps = 60/250 (24%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL-EKDIEKTNE--EFMTELKIIGRTHHKNLV 550
K +G G+ G+V + R DT+ A+K L +KD+ N+ E I+ ++ +V
Sbjct: 7 KTLGIGAFGEVC--LARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVV 64
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
RL ++D V + +P G + + L G P + R IA + + +H+
Sbjct: 65 RLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHK---M 120
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI---------SKLLNK-DQTRTDT----- 655
IH DIKP N+L +D + K++DFG+ SK D R D+
Sbjct: 121 GFIHRDIKPDNIL-----IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 656 -------------------------------NMRGTMGYVAPEWLRNVPVTTKVDVFSFG 684
++ GT Y+APE L T D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 685 VMLLEIICGR 694
V+L E++ G+
Sbjct: 236 VILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DIEKTNEE--FMTELKIIGRTHHKNLV 550
K++G G+ G+V +++LK+ A+K L K ++ K E F E ++ ++ +
Sbjct: 7 KVIGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWIT 64
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFH-EGQRPGWVQRVEIALGVARGLLYLHEECE 609
L +E+ LV + G L L E + P + R +A V + + +
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV----IAIDSVHQ 120
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+H DIKP N+L+D+ N +++DFG L +D T + GT Y++PE L
Sbjct: 121 LHYVHRDIKPDNILMDM-----NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 670 RNVP-----VTTKVDVFSFGVMLLEIICG 693
+ + + D +S GV + E++ G
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 48/206 (23%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLG- 554
VG G+ G VY+ + + E A+K++E + E+ ++ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEG--TGISMSACREIALLRELKHPNVIALQKV 66
Query: 555 FCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLY-----LHEEC 608
F S D+++ L+++ + FH + + +++ + + LLY +H
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD-QTRTDTN-MRGTMGYVAP 666
++H D+KP N+L+ + KI+D G ++L N + D + + T Y AP
Sbjct: 126 ANWVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 667 EWLRNVPVTTK-VDVFSFGVMLLEII 691
E L TK +D+++ G + E++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 59/230 (25%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNE--EFMTELKIIGRTHHKNLVR 551
+++G GS G V I T ++A+KK+ E ++ + E+K++ H ++V
Sbjct: 6 EVIGKGSYGVVCSAIDTH--TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 63
Query: 552 LLGFCSEEDKR-----LLVYELM---------PNGTLSN-----FLFHEGQRPGWVQRVE 592
+ +R +V+ELM N L+ FL+
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQ------------ 111
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
+ R L Y+H + H D+KP+N+L + + KI DFG++++ D
Sbjct: 112 ----LLRALKYIHT---ANVFHRDLKPKNIL-----ANADCKLKICDFGLARVAFND--- 156
Query: 653 TDTNMRGTMGYVAPEWLRNVPV--------TTKVDVFSFGVMLLEIICGR 694
T T + T YVA W R + T +D++S G + E++ G+
Sbjct: 157 TPTAIFWT-DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 28/180 (15%)
Query: 597 VARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT-DT 655
VA+G+ +L + IH D+ +N+LL + KI DFG+++ + D
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLT-----HGRITKICDFGLARDIRNDSNYVVKG 274
Query: 656 NMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715
N R + ++APE + N T + DV+S+G++L EI L VD
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI------FSLGSSPYPGMPVDSKFYK 328
Query: 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775
M+ ++L PE + E ++ M C DP RP+ K+++ ++E L
Sbjct: 329 -----MIKEGYRML---SPE-CAPSEMYDIMKS----CWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 14/97 (14%)
Query: 492 FSKLVGTGSSGKVYR----GILRLKDTQIEIAVKKLEKDIEKTNEE--FMTELKI---IG 542
K +G G+ GKV + GI + + +AVK L K+ +E MTELKI IG
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRT-VAVKML-KEGATASEYKALMTELKILIHIG 68
Query: 543 RTHHKNLVRLLGFCSEEDKRLLV-YELMPNGTLSNFL 578
HH N+V LLG C++ L+V E G LSN+L
Sbjct: 69 --HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 51/221 (23%), Positives = 95/221 (42%), Gaps = 61/221 (27%)
Query: 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEK---DIEKTNEEFMTELKIIGR-THHKNLVRL 552
G G+ +V + + + T A+K ++K +E+ N + E++ + R + H N++RL
Sbjct: 8 GEGTFSEVLKA--QSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRL 63
Query: 553 LGFCSEE-DKRL-LVYELM---------------PNGTLSNFLFHEGQRPGWVQRVEIAL 595
+ + RL LV+ELM P + ++++
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQ--------------- 108
Query: 596 GVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDT 655
+ + L ++H I H DIKP+N+L+ L K++DFG + + T+
Sbjct: 109 -LLKSLDHMHRN---GIFHRDIKPENILIKDDIL------KLADFGSCRGIYSKPPYTE- 157
Query: 656 NMRGTMGYVAPEWLRNVPVTT-----KVDVFSFGVMLLEII 691
T Y APE L +T K+D+++ G + EI+
Sbjct: 158 -YISTRWYRAPECL----LTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DIEKTNEE--FMTELKIIGRTHHKNLV 550
K++G G+ G+V ++++K+T A+K L K ++ K E F E ++ + +
Sbjct: 7 KVIGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWIT 64
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQR-PGWVQRVEIALGVARGLLYLHEECE 609
L +E+ LV + G L L R P + R +A V L + +
Sbjct: 65 NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV----LAIDSVHQ 120
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+H DIKP NVLLD N +++DFG L D T GT Y++PE L
Sbjct: 121 LGYVHRDIKPDNVLLDK-----NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 670 RNVP-----VTTKVDVFSFGVMLLEIICG 693
+ + + D +S GV + E++ G
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 52/239 (21%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE---FMTELKIIGRTHHKNLV 550
K++G G+ G+V +++ KDT A+K L K E+ E I+ +V
Sbjct: 7 KVIGRGAFGEVR--LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 551 RLLGFCSEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
++ F S +DK L+ E +P G + L + + E +A +L +
Sbjct: 65 KM--FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT----LTEEETQFYIAETVLAIDSIH 118
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK----------------DQTR 652
+ IH DIKP N+LLD K K+SDFG+ L K D T
Sbjct: 119 QLGFIHRDIKPDNLLLDSKG-----HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 653 TDTNMR------------------GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
+ N + GT Y+APE D +S GV++ E++ G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN--EEFMTELKIIGRTHHKNLVR 551
K +G+G+ G V + D + A+KKL + + + EL ++ +HKN++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNF----LFHEGQRPGWVQRVEIALGVAR-------- 599
LL P +L F L E Q +++ L R
Sbjct: 81 LLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128
Query: 600 --GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNM 657
G+ +LH IIH D+KP N+++ ++ KI DFG+++ T +
Sbjct: 129 LCGIKHLHS---AGIIHRDLKPSNIVVK-----SDCTLKILDFGLARTAGTSFMMTPYVV 180
Query: 658 RGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696
T Y APE + + VD++S G ++ E++ RH
Sbjct: 181 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV---RH 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 14/113 (12%)
Query: 582 GQRPGWVQRVEIALGVARGLL----YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637
G R + ++ VAR LL Y+H E IIH DIK +NVL++ +
Sbjct: 251 GARLRPLGLAQVT-AVARQLLSAIDYIHGE---GIIHRDIKTENVLVN-----GPEDICL 301
Query: 638 SDFGISKLLNKD-QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLE 689
DFG + T + GT+ APE L P T VD++S G+++ E
Sbjct: 302 GDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 36/125 (28%), Positives = 62/125 (49%), Gaps = 15/125 (12%)
Query: 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL 629
P T + L +E ++ V + VA G+ +L + +H D+ +NVL+ L
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKL 277
Query: 630 DTNYMAKISDFGISKLLNKDQTRTDTNMRGT----MGYVAPEWLRNVPVTTKVDVFSFGV 685
KI DFG+++ + +D +G+ + ++APE + N TT DV+SFG+
Sbjct: 278 -----VKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329
Query: 686 MLLEI 690
+L EI
Sbjct: 330 LLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 467 YFDPNSMEINFR-EFTFQELQEATKGFSKLVGTGSSGKVYRGI---LRLKDTQIEIAVKK 522
Y DP + + R EF L +++G+G+ GKV G L +++AVK
Sbjct: 20 YVDPMQLPYDSRWEFPRDGLV-----LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKM 74
Query: 523 LEKDIEKTNEE-FMTELKIIGRTH---HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL 578
L+ + ++ M+ELKI+ TH H N+V LLG C++ ++ E G L N+L
Sbjct: 75 LKPTARSSEKQALMSELKIM--THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.004
Identities = 13/39 (33%), Positives = 19/39 (48%), Gaps = 2/39 (5%)
Query: 171 STGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTLNNVS 209
+ +YTL +Q+DGNLVL Y W + T +
Sbjct: 15 TDSSYTLILQSDGNLVL--YDGNGRVVWSSNTSGKGSGC 51
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 31/104 (29%), Positives = 45/104 (43%), Gaps = 12/104 (11%)
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI--SDFGISKLLNKDQ 650
I V R + YLHE +IIH DIK +N+ + N+ + DFG +
Sbjct: 187 IERSVLRAIQYLHE---NRIIHRDIKAENIFI-------NHPGDVCLGDFGAACFPVDIN 236
Query: 651 TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
GT+ APE L P VD++S G++L E+
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 788 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.91 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.48 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.44 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.15 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.04 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.04 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.98 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.97 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.91 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.7 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.24 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.14 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.85 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.84 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.8 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.75 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.71 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.69 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 97.6 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.56 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.56 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.52 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.42 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.26 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.13 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.08 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.04 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 96.93 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.83 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.32 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.11 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.1 | |
| PLN02236 | 344 | choline kinase | 95.98 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 95.92 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.8 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.47 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.41 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.27 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.11 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.79 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.66 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.45 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.4 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=432.17 Aligned_cols=288 Identities=42% Similarity=0.748 Sum_probs=249.2
Q ss_pred CCcccCHHHHHHHhhccc--ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEe
Q 047157 476 NFREFTFQELQEATKGFS--KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553 (788)
Q Consensus 476 ~~~~~~~~~l~~~t~~~~--~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 553 (788)
..+.|++.+|.++|.+|+ ..||+|+||.||+|.+. ++..||||++........++|.+|++++.+++|||||+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~---~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS---DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC---CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence 578899999999999998 69999999999999995 4479999988765432155699999999999999999999
Q ss_pred eEEecCC-eEEEEEecCCCCCHhHhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCC
Q 047157 554 GFCSEED-KRLLVYELMPNGTLSNFLFHEGQ-RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT 631 (788)
Q Consensus 554 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~ 631 (788)
|||.+.+ +.+||||||++|+|.++|+.... .++|..|++|+.++|+||+|||+.+.+.||||||||+||||| +
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-----~ 212 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-----E 212 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-----C
Confidence 9999998 59999999999999999988766 889999999999999999999999888999999999999999 8
Q ss_pred CCcEEEeecCCccccCCCCCcccccc-cCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccch
Q 047157 632 NYMAKISDFGISKLLNKDQTRTDTNM-RGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD 710 (788)
Q Consensus 632 ~~~~kL~Dfg~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~ 710 (788)
++++||+|||+|+....... ..... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.... ...
T Consensus 213 ~~~aKlsDFGLa~~~~~~~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-----~~~ 286 (361)
T KOG1187|consen 213 DFNAKLSDFGLAKLGPEGDT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-----RGE 286 (361)
T ss_pred CCCEEccCccCcccCCcccc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-----ccc
Confidence 99999999999976543111 11112 799999999999999999999999999999999999988875431 122
Q ss_pred hhhHHHHHHHhhcccccccccCCCC-CcccH-HHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 711 IVLSDWVISCMLSRNLQVLVSHDPE-VLSDL-ERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
..+.+|++..+..+.+.+++++... ..... +...++.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus 287 ~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 287 LSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 3378899999999999999988865 33333 6888999999999999999999999999999765543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=363.54 Aligned_cols=257 Identities=28% Similarity=0.403 Sum_probs=213.7
Q ss_pred cCHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEec
Q 047157 480 FTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE 558 (788)
Q Consensus 480 ~~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 558 (788)
++..||+. .+.||+|..|+||+++++ .+++.+|+|.+... .....+++.+|+++++..+||+||++||.|..
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk--~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHK--PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEc--CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 45555543 468999999999999998 88899999999433 35667899999999999999999999999999
Q ss_pred CC-eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 559 ED-KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 559 ~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
.. ...|+||||++|+|++++... ++.++...-+|+.++++||.|||+ + +||||||||+|||++ ..+.+|
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvN-----skGeVK 219 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVN-----SKGEVK 219 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeec-----cCCCEE
Confidence 88 599999999999999999654 668899999999999999999996 5 999999999999998 889999
Q ss_pred EeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
|+|||.+..+.+. ....+.||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...... ......+
T Consensus 220 icDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~---~~~~~~L--- 290 (364)
T KOG0581|consen 220 ICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP---YLDIFEL--- 290 (364)
T ss_pred eccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC---CCCHHHH---
Confidence 9999999987654 334578999999999999999999999999999999999999999764110 0000111
Q ss_pred HHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+..++...+.........+++..++..||+.||.+||+++|++++
T Consensus 291 ---------l~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 291 ---------LCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---------HHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122333233333333677889999999999999999999999863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=381.49 Aligned_cols=252 Identities=32% Similarity=0.507 Sum_probs=206.9
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCC-eEEEEEecC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED-KRLLVYELM 569 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lV~e~~ 569 (788)
.+.||+|+||+||+|.++ ....||||++.... ....++|.+|+.+|.+++|||||+++|+|.+.. ..+|||||+
T Consensus 46 ~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 456999999999999985 44349999997543 222679999999999999999999999999988 799999999
Q ss_pred CCCCHhHhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhccCCc-eEecCCCCCcEEeccCCCCCCC-cEEEeecCCcccc
Q 047157 570 PNGTLSNFLFH-EGQRPGWVQRVEIALGVARGLLYLHEECETQ-IIHCDIKPQNVLLDLKTLDTNY-MAKISDFGISKLL 646 (788)
Q Consensus 570 ~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~-ivH~dlkp~NIll~~~~~~~~~-~~kL~Dfg~a~~~ 646 (788)
++|+|.++++. ....+++..+++++.|||+||.|||++ + ||||||||+|||++ .+. ++||+|||+++..
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~-----~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVD-----LKGKTLKIADFGLSREK 194 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEc-----CCCCEEEECCCccceee
Confidence 99999999988 478899999999999999999999999 7 99999999999999 665 9999999999876
Q ss_pred CCCCCcccccccCCccccCccccc--CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLR--NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.... ...+...||+.|||||++. ..+++.|+|||||||++|||+||+.||....... . +.......
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--------~---~~~v~~~~ 262 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--------V---ASAVVVGG 262 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--------H---HHHHHhcC
Confidence 5432 2333468999999999999 6699999999999999999999999998653211 0 11111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.....+......+..++.+||+.||++||++.+++..|+.+..
T Consensus 263 ---------~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 263 ---------LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ---------CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1111111256678889999999999999999999999986654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=382.97 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=212.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
.+|...+.||+|||+.+|+++.. .++..||+|++.+.. ....+.+.+|+++.+.|+|||||+++++|++.+..||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~--~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL--DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc--CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 45677899999999999999886 678899999997643 4567789999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+|+|++++|.++++ ..+.+++.++..+++||+.||.|||++ +|+|||||..|++++ ++.++||+|||+|.
T Consensus 96 vLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~-----~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLN-----ENMNVKIGDFGLAT 166 (592)
T ss_pred EEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc---Cceecccchhheeec-----CcCcEEecccceee
Confidence 999999999999996 568899999999999999999999999 999999999999998 89999999999999
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.+..+.... .+.+||+.|+|||++.....+..+||||+||++|.||+|++||+.....+....+. ..
T Consensus 167 ~le~~~Erk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik------------~~ 233 (592)
T KOG0575|consen 167 QLEYDGERK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK------------LN 233 (592)
T ss_pred eecCccccc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH------------hc
Confidence 887665444 34899999999999999999999999999999999999999998765443322111 00
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
+...+.....+..+||..+|++||.+|||+++|+.
T Consensus 234 ----------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 ----------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111133456678999999999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=362.61 Aligned_cols=206 Identities=31% Similarity=0.496 Sum_probs=182.6
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|+|++||+|+++ ..+..||||.+.+. ..+..+.+..|+.+|+.++|||||++++++..++..+||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~--~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHK--KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ceehhhccCcceEEEEEeEec--cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 455677999999999999998 56689999999776 56777889999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCC-CCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT-LDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~~~~~~kL~Dfg~a~~~ 646 (788)
||.+|+|.+|++.+ ..+++.....++.|||.||++||++ +||||||||+||||+... ......+||+|||+|+.+
T Consensus 90 yC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999766 4789999999999999999999999 999999999999998542 111268999999999988
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVE 703 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~ 703 (788)
.... ...+.+|++-|||||++...+|+.|+|+||+|+|||++++|+.||+.....
T Consensus 166 ~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 166 QPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred Cchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 7433 334579999999999999999999999999999999999999999865443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=364.02 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=207.1
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHH-------HHHHHHHHHHHhcCCCccccceEeeEEec
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK-------TNEEFMTELKIIGRTHHKNLVRLLGFCSE 558 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 558 (788)
.+..|-+.+.||+|+||.|-+|..+ .+++.||||++.+.... ......+|+++|++|+|||||+++++++.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~--~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEK--KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEc--ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 3455677899999999999999887 78889999999754321 22346799999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 559 EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
.+..|+||||++||.|.+.+..+ +.+.+.....++.|++.|+.|||++ ||+||||||+|||+..+. ++..+||+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~--e~~llKIt 321 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDA--EDCLLKIT 321 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCC--cceEEEec
Confidence 99999999999999999999665 5566777788999999999999999 999999999999998554 56899999
Q ss_pred ecCCccccCCCCCcccccccCCccccCcccccCCC--CC-ccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVP--VT-TKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s-~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
|||+|+.... ...+.+.+||+.|.|||++.++. +. .|.|+||+||+||-+++|..||........
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---------- 389 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---------- 389 (475)
T ss_pred ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----------
Confidence 9999998763 33445689999999999997654 33 378999999999999999999975432221
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...++..+.+. .......+..++..++|.+||..||++|||+.|+++
T Consensus 390 -l~eQI~~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 -LKEQILKGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -HHHHHhcCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11111122111 011223456788999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=346.38 Aligned_cols=259 Identities=23% Similarity=0.320 Sum_probs=212.0
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEee-EEecCCe-E
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLG-FCSEEDK-R 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~~~~-~ 562 (788)
.+.|.+.++||+|.||+||++... .++..||.|.+.-. ..+....+..|+.+|++|+|||||++++ -+.++++ +
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~--~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCL--LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeec--cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 345677899999999999999887 67889999988632 3556778999999999999999999998 4555555 8
Q ss_pred EEEEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCC-ceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 563 LLVYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECET-QIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
+||||++..|+|.+.+++ .++.+++..+++++.|+++||.++|.+... -|+||||||.||+|+ .++.+||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-----~~gvvKLG 170 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-----ANGVVKLG 170 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-----CCCceeec
Confidence 999999999999999853 456789999999999999999999993221 399999999999999 88999999
Q ss_pred ecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
|||+++.+....... ...+|||.||+||.+.+.+|+.|+||||+||++|||+.-++||.+....+...
T Consensus 171 DfGL~r~l~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~----------- 238 (375)
T KOG0591|consen 171 DFGLGRFLSSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCK----------- 238 (375)
T ss_pred cchhHhHhcchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHH-----------
Confidence 999999987655433 45789999999999999999999999999999999999999998763322111
Q ss_pred HHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 719 SCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
.+..++. ....+..+...+..|+..|+..||+.||+...+++.+..
T Consensus 239 -KI~qgd~--------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 239 -KIEQGDY--------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -HHHcCCC--------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1112211 112335677888999999999999999997666666654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=372.38 Aligned_cols=262 Identities=28% Similarity=0.473 Sum_probs=219.9
Q ss_pred HHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
++......+.+.||+|-||.||.|.+. ....||+|.+... .-..+.|.+|+++|++|+|+|||+++++|..++.++
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~---~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWN---GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEc---CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 445555667899999999999999995 5558999998764 333468889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 564 LVYELMPNGTLSNFLFH-EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
||||||+.|+|.++|++ .+..+...+.+.++.|||+|++||+++ ++|||||.++||||+ ++..+||+|||+
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~-----~~~~vKIsDFGL 349 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVD-----EDLVVKISDFGL 349 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---Cccchhhhhhheeec-----cCceEEEccccc
Confidence 99999999999999986 567889999999999999999999999 999999999999999 888999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
|+....+.........-...|.|||.+....++.|||||||||+||||+| |+.|+......+.
T Consensus 350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev---------------- 413 (468)
T KOG0197|consen 350 ARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV---------------- 413 (468)
T ss_pred ccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH----------------
Confidence 99666555544444556778999999999999999999999999999997 7777765533221
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVG 778 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 778 (788)
-+.++..-+...+...+..+.+|+..||+.+|++|||++.+...|+.+....
T Consensus 414 -----~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 414 -----LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -----HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 1122223344445556778889999999999999999999999998776543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=327.53 Aligned_cols=265 Identities=23% Similarity=0.293 Sum_probs=210.2
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeeccc--chHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
..++|+|+||+||+++++ ++++.||||++-. +.+...+-.++|+++|++++|+|+|.++++|.....++||+||++
T Consensus 7 LgkvGEGSYGvV~KCrnk--~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d 84 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNK--DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD 84 (396)
T ss_pred hhccccCcceEEEEeccC--CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence 457899999999999887 8999999999843 235566778999999999999999999999999999999999997
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
..-| +-|.......+...+.+++.|+++|+.|+|++ ++|||||||+||||+ .++.+||+|||+|+.+.. .
T Consensus 85 hTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit-----~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 85 HTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILIT-----QNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred hHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEe-----cCCcEEeccchhhHhhcC-C
Confidence 6444 44556667788899999999999999999999 999999999999999 889999999999998874 2
Q ss_pred CcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH---HHh-hccc
Q 047157 651 TRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI---SCM-LSRN 725 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~ 725 (788)
....+..+.|..|+|||.+.+ .+|.+..||||+||++.||++|.+.|.+.+..++...+...+..... ..+ ..+.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 334456788999999999977 78999999999999999999999999887654443322222222111 111 1222
Q ss_pred ccccccCCCCCcccH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDL-----ERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
+..+.-+.++...+. ....-+++++..||+.||++|++.+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 233333333333332 23457889999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=349.36 Aligned_cols=271 Identities=21% Similarity=0.269 Sum_probs=215.6
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHH-HHHHHHHHhcCCC-ccccceEeeEEecCC-eEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNE-EFMTELKIIGRTH-HKNLVRLLGFCSEED-KRL 563 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~-~~~~E~~~l~~l~-hpniv~~~~~~~~~~-~~~ 563 (788)
...|...++||.|.||.||+|+.. ..+..||||++++......+ .-.+|+..|++|+ ||||+++.+++.+.+ .++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~--~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSK--ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeec--CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 456778899999999999999877 66778999999876544333 3468999999998 999999999998888 999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||| ..+|.++++++++.+++..+..|+.||++||+|+|.+ |++|||+||+|||+. ....+||+|||+|
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~-----~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILIS-----GNDVIKIADFGLA 157 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEec-----ccceeEecccccc
Confidence 999999 5699999999989999999999999999999999999 999999999999997 6789999999999
Q ss_pred cccCCCCCcccccccCCccccCcccc-cCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWL-RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+.+.... ..+..+.|..|+|||++ +..-|+.+.|+||+|||++|+.+-+..|.+.+..++..++...+.......+.
T Consensus 158 Rev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 158 REVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 9875433 34566789999999987 56789999999999999999999999998876655443333322221111111
Q ss_pred c---------ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 723 S---------RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 723 ~---------~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
+ -.+............. ....++++++.+|++.||.+||||+|++++-
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1 1111111111111112 2567889999999999999999999999853
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=334.99 Aligned_cols=247 Identities=28% Similarity=0.326 Sum_probs=202.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
...+.++||+|+||+||+++.+ ++++.+|+|.+++.. ....+...+|..+|.+++||.||+++-.|++.+.+|||
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~--dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKK--DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred heeeeeeeeccCCceEEEEEEc--ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4456799999999999999877 888999999997654 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+||+.||.|.-+|.++ ..+++..+.-++..|+.||.|||++ +||||||||+||||| .+++++|+|||+++.
T Consensus 104 ld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd-----~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLD-----EQGHIKLTDFGLCKE 174 (357)
T ss_pred EeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeec-----CCCcEEEeccccchh
Confidence 9999999999999655 5677777778889999999999999 999999999999999 899999999999996
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... ...+++||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+..+..+ .+....
T Consensus 175 ~~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~------------~I~~~k 241 (357)
T KOG0598|consen 175 DLKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD------------KILKGK 241 (357)
T ss_pred cccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH------------HHhcCc
Confidence 544333 2344899999999999999999999999999999999999999998764332211 111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC----CHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP----SMKKVI 768 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~evl 768 (788)
+ ...+.-...+..+++..+|+.||++|. .+++|.
T Consensus 242 ~---------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 242 L---------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred C---------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 0 001111235667888999999999995 455544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=342.87 Aligned_cols=269 Identities=24% Similarity=0.281 Sum_probs=212.9
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC--CeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lV 565 (788)
|.-.++||+|.||.||+|+.. .++..||+|+++.+. .....-..+||.+|++|+||||+++.+...+. ..+|||
T Consensus 119 feki~kIGeGTyg~VYkAr~~--~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDL--ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHhcCcchhheeEeeec--ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 333578999999999999887 788899999997654 34445678999999999999999999988776 689999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+|||+. +|..++...+-.++..++..++.||+.||.|+|.+ +|+|||||.+||||| .++.+||+|||+|+.
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLid-----n~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILID-----NNGVLKIADFGLARF 267 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEc-----CCCCEEeccccceee
Confidence 999965 89999988888999999999999999999999999 999999999999999 889999999999999
Q ss_pred cCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
+........+..+-|..|+|||++.+. .|+.+.|+||.||||.||++|+..|.+....++...+...........+...
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 888777777888889999999998765 7999999999999999999999999887665544332211111111111111
Q ss_pred cccccccCCCCCcc--cH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 725 NLQVLVSHDPEVLS--DL-----ERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 725 ~~~~l~~~~~~~~~--~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.+.......+.... .. ......++|+..+|..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111111111111 11 12345678889999999999999999885
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=346.64 Aligned_cols=250 Identities=26% Similarity=0.310 Sum_probs=207.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 564 (788)
.+.|.+.||.|+|++|++|+.+ .+++.+|||++.+.. +...+.+..|-.+|.+| .||.|++++-.|+++..+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~--~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREK--ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hcchhheeccccceeEEEeeec--CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4567899999999999999887 788899999997653 33445678899999999 89999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+||+++|+|.++|.+. ..+++.....++.+|+.||+|||++ |||||||||+||||| .++++||+|||.|+
T Consensus 152 vLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd-----~dmhikITDFGsAK 222 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLD-----KDGHIKITDFGSAK 222 (604)
T ss_pred EEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEc-----CCCcEEEeeccccc
Confidence 99999999999999766 6688888889999999999999999 999999999999999 99999999999999
Q ss_pred ccCCCCCc------------ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh
Q 047157 645 LLNKDQTR------------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 645 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 712 (788)
.+...... ....++||..|.+||++.....++.+|||+||||||+|+.|++||...+....-+
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq----- 297 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ----- 297 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH-----
Confidence 88543221 1145889999999999999999999999999999999999999998653221111
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
.+. ..+........+...+|+.+.|..||.+|+|++||.++.
T Consensus 298 -------kI~----------~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 298 -------KIQ----------ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -------HHH----------HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 110 011111112235677889999999999999999998864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=366.64 Aligned_cols=266 Identities=30% Similarity=0.457 Sum_probs=219.2
Q ss_pred HHHHHHhhcccccccccccceEEEEEEec---cCcceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEec
Q 047157 483 QELQEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSE 558 (788)
Q Consensus 483 ~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 558 (788)
.++......+.+.||+|.||.||+|+... ......||||.+++.... .+++|++|++++..|+|||||+++|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 34455555677899999999999998652 244568999999877655 78899999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHhhhcc---------CCC----CCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 559 EDKRLLVYELMPNGTLSNFLFHE---------GQR----PGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~~---------~~~----~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
++..++|+|||..|+|.++|... +.. ++..+.+.|+.|||.|+.||-++ .+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 99999999999999999999542 122 78889999999999999999999 999999999999998
Q ss_pred cCCCCCCCcEEEeecCCccccC-CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccc
Q 047157 626 LKTLDTNYMAKISDFGISKLLN-KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVE 703 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~ 703 (788)
++..|||+|||+++..= .+......+..-..+|||||.+..++||.+||||||||+|||+++ |+.|+.+...+
T Consensus 638 -----e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 638 -----ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred -----cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 89999999999998652 222222223345678999999999999999999999999999996 88899876443
Q ss_pred cccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
+ +...+..+.+ ...+...+.++..|+..||+.+|++||+++||-..|+...+.
T Consensus 713 E------------VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 713 E------------VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred H------------HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 3 2333333333 223345677889999999999999999999999999875543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.28 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=202.6
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCC--eEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED--KRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lV~e 567 (788)
....+.||+|+||+||++... +++...|||..........+.+.+|+++|.+++|||||+++|.....+ .+++.||
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~--~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNK--KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhccccCccceEEEEEEec--CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 344688999999999999987 557799999987654333677899999999999999999999855544 6899999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCC-CCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT-NYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~-~~~~kL~Dfg~a~~~ 646 (788)
|+++|+|.+++...+..+++..+..+.+||++||+|||++ +|+||||||+|||++ . ++.+||+|||++...
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~-----~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLD-----PSNGDVKLADFGLAKKL 168 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEe-----CCCCeEEeccCcccccc
Confidence 9999999999987766789999999999999999999999 999999999999998 6 689999999999877
Q ss_pred CC--CCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 647 NK--DQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 647 ~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
.. ..........||+.|||||++..+ ...+++|||||||++.||+||+.||... . ....+.......
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~--------~~~~~~~~ig~~ 238 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--F--------EEAEALLLIGRE 238 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--c--------chHHHHHHHhcc
Confidence 63 222334457899999999999853 3345999999999999999999999753 0 011111111112
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
.....+ +.....+..+++..|++.||++||||++++++.-
T Consensus 239 ~~~P~i---------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 239 DSLPEI---------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCCC---------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 211111 1123456778899999999999999999998763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=329.42 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=209.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchH-HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
..|.+.++||.|.-++||+|+.. ..+..||||++.-+.. ...+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~--p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCI--PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred cceeEEEEEeccceeEeeeeeec--ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45777899999999999999988 5668999999965442 33588999999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
.||.+||+.++++.. ...+++..+..|++++++||.|||.+ |.||||||+.||||+ .+|.|||+|||....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~-----~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILID-----SDGTVKLADFGVSAS 175 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEc-----CCCcEEEcCceeeee
Confidence 999999999999654 45689999999999999999999999 999999999999999 999999999998877
Q ss_pred cCCCCCccc---ccccCCccccCccccc--CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 646 LNKDQTRTD---TNMRGTMGYVAPEWLR--NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 646 ~~~~~~~~~---~~~~gt~~y~aPE~~~--~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
+.....+.. ..+.||+.|||||++. ...|+.|+|||||||+..||.+|..||......+. . -.
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-----------L-l~ 243 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-----------L-LL 243 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----------H-HH
Confidence 654443322 4568999999999953 34699999999999999999999999975432110 0 01
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...+....+................+.+++..||+.||.+|||++++++
T Consensus 244 tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 244 TLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111111112222333445567889999999999999999999986
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=362.67 Aligned_cols=272 Identities=26% Similarity=0.492 Sum_probs=228.4
Q ss_pred CCcccCHHHHHHH-----------hhcccccccccccceEEEEEEeccC-cceeeeeeecccch-HHHHHHHHHHHHHhc
Q 047157 476 NFREFTFQELQEA-----------TKGFSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDI-EKTNEEFMTELKIIG 542 (788)
Q Consensus 476 ~~~~~~~~~l~~~-----------t~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~ 542 (788)
-.+.++|++=.++ ...+.++||.|.||.|++|.++... ....||||.++... ++.+.+|+.|..||.
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG 685 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG 685 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence 3556777654333 3445578999999999999998533 44689999998654 566789999999999
Q ss_pred CCCccccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 543 RTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 543 ~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
+++||||+++.|+.......+||+|||++|+|+.+|+++...+++.+..-++++||.|++||.+. ++|||||.++||
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNI 762 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNI 762 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhe
Confidence 99999999999999999999999999999999999999888899999999999999999999998 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCCcccccccC--CccccCcccccCCCCCccCcchhhHHHHHHHH-hCCCCCCc
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG--TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII-CGRRHIEL 699 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~k~DVwSlGvil~ell-tg~~p~~~ 699 (788)
|++ .+...|++|||+++.+..+.....+...| ..+|.|||.+...++|.++|||||||++||.+ .|.+|+..
T Consensus 763 LVN-----snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 763 LVN-----SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred eec-----cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 998 99999999999999886665333333333 46899999999999999999999999999987 48899865
Q ss_pred cccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
...++..+ -+...-....+++.+..|.+|+++|||.|-.+||.+.+|+.+|+++..
T Consensus 838 mSNQdVIk---------------------aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 838 MSNQDVIK---------------------AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred cchHHHHH---------------------HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 43332211 122344555667788899999999999999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.04 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=210.8
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGT 573 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 573 (788)
++||+|+.|.||.+... ..+..||||++....+...+-+.+|+.+|+..+|+|||++++.|...+++++|||||++|+
T Consensus 279 ~kigqgaSG~vy~A~~~--~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKI--STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred hhhccccccceeeeeec--cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 67999999999999876 6777899999988777778889999999999999999999999999999999999999999
Q ss_pred HhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcc
Q 047157 574 LSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653 (788)
Q Consensus 574 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 653 (788)
|.+.+.+ ..+++.++..|++++++||+|||.+ +|+|||||.+|||++ .++.+||+|||++..+..... .
T Consensus 357 LTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~-----~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 357 LTDVVTK--TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLT-----MDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred hhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEec-----cCCcEEEeeeeeeeccccccC-c
Confidence 9999844 3589999999999999999999999 999999999999998 788899999999998876554 4
Q ss_pred cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCC
Q 047157 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD 733 (788)
Q Consensus 654 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 733 (788)
....+||+.|||||+...+.|.+|.||||||+++.||+-|++||-..+.... -| .+. ....
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA---------ly---LIa-------~ng~ 486 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---------LY---LIA-------TNGT 486 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH---------HH---HHh-------hcCC
Confidence 4557899999999999999999999999999999999999999965322110 00 011 1123
Q ss_pred CCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 734 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
++..........+.+++.+||+.||++||++.|+|++
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 4444455667788999999999999999999999974
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=345.82 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=204.6
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccc----hH-HHHHHHHHHHHHhcCCC-ccccceEeeEEecCC
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD----IE-KTNEEFMTELKIIGRTH-HKNLVRLLGFCSEED 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 560 (788)
...|.+.+.||+|+||+|+.|.+. .++..||+|.+.+. .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~--~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHR--LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeec--cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 445777899999999999999887 56689999977653 12 34567778999999998 999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC-CcEEEee
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN-YMAKISD 639 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~-~~~kL~D 639 (788)
..++||||+.+|+|.+++.+ ..++.+.....+++||+.|++|||++ +|+||||||+|||++ .+ +++||+|
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld-----~~~~~~Kl~D 164 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLD-----GNEGNLKLSD 164 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEec-----CCCCCEEEec
Confidence 99999999999999999988 67788899999999999999999999 999999999999999 66 8999999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccCCC-CC-ccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVP-VT-TKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
||++.... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.......
T Consensus 165 FG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l------------ 231 (370)
T KOG0583|consen 165 FGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL------------ 231 (370)
T ss_pred cccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH------------
Confidence 99999874 2223344578999999999999987 87 789999999999999999999986321110
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 768 (788)
...+..+ ......... ..++..++.+||+.||.+|+|+.+|+
T Consensus 232 ~~ki~~~--------~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 232 YRKIRKG--------EFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHhcC--------CccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0111111 111111111 56778899999999999999999999
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=341.78 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=209.7
Q ss_pred HHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCe
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 561 (788)
||......+.+.||+|.||+||+|.+. | .||||.+.-. ..+..+.|++|+..+++.+|.||+-+.|+|.....
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh----G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH----G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc----c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 344444456789999999999999884 3 7999988643 35678899999999999999999999999988877
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.||+.+|+|-+|..+|+....+++..+.+.|++||++|+.|||.+ +|||||||..||++. ++++|||+|||
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~-----~~~kVkIgDFG 533 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLH-----EDLKVKIGDFG 533 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEc-----cCCcEEEeccc
Confidence 999999999999999988888899999999999999999999999 999999999999998 77999999999
Q ss_pred CccccCCC-CCcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 642 ISKLLNKD-QTRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 642 ~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
++..-..- .........|...|||||+++ ..+|++.+||||||+++|||++|..||.....+.......
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG------- 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG------- 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec-------
Confidence 99754322 222233456788999999985 4589999999999999999999999997432222111000
Q ss_pred HHHhhcccccccccCCCCCcc-cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 718 ISCMLSRNLQVLVSHDPEVLS-DLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.+ .+ .++... .....+++.+|+..||..++++||++.+|+..|+.++.
T Consensus 607 -----rG----~l--~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 607 -----RG----YL--MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -----cc----cc--CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 00 00 011111 22445678889999999999999999999999887765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.59 Aligned_cols=262 Identities=29% Similarity=0.428 Sum_probs=202.8
Q ss_pred HHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCC-
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED- 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~- 560 (788)
...+.+.++||+|+||.||+|.+.. ...+..||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 4557788999999999999997531 2344689999986533 33456789999999999 8999999999887644
Q ss_pred eEEEEEecCCCCCHhHhhhccC----------------------------------------------------------
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG---------------------------------------------------------- 582 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 582 (788)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6889999999999999986431
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc-cccccc
Q 047157 583 ---QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMR 658 (788)
Q Consensus 583 ---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~ 658 (788)
..+++..+..++.||++||+|||++ +|+||||||+|||++ .++.+||+|||+++........ ......
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~-----~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLS-----ENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEc-----CCCcEEEeecccccccccCcchhcccCCC
Confidence 2367788899999999999999998 999999999999998 7789999999999865432221 122234
Q ss_pred CCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCc
Q 047157 659 GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVL 737 (788)
Q Consensus 659 gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 737 (788)
++..|+|||++.+..++.++||||||+++|||++ |..||......+. .......+... .
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----------~~~~~~~~~~~---------~ 297 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----------FCQRLKDGTRM---------R 297 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----------HHHHHhcCCCC---------C
Confidence 5678999999999999999999999999999997 9999975422110 00111111100 0
Q ss_pred ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 738 SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 738 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
......+.+.+++.+||+.||++|||+.||+++|++++.
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011234567889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=342.67 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=205.2
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
+++.+.||+|+-|.|-+|++. .+|+.+|||++.+.. ......+.+|+.+|+.+.|||++++++++++..++|+|.
T Consensus 14 wkLgkTLG~Gstg~vrlakh~--~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHA--ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred eeccccccCCCCceehhhhcc--cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 456788999999999999887 889999999997652 334557889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|-|.+++..++ .+.+.+..+++.||+.|+.|+|.. +|+||||||+|+||| ...++||+|||+|.+-
T Consensus 92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd-----~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLD-----VKNNIKIADFGMASLE 162 (786)
T ss_pred EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhh-----cccCEeeeccceeecc
Confidence 9999999999997774 456677778999999999999999 999999999999999 6667999999999875
Q ss_pred CCCCCcccccccCCccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVT-TKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
..+.. ..+.+|++.|.|||++.+.+|. .++||||.|||||.||||+.||+..+... ....+..+.
T Consensus 163 ~~gkl--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~------------LLlKV~~G~ 228 (786)
T KOG0588|consen 163 VPGKL--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV------------LLLKVQRGV 228 (786)
T ss_pred cCCcc--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH------------HHHHHHcCc
Confidence 54433 3346899999999999999987 68999999999999999999998543221 111122222
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
++ .+.....+..+|+.+|+..||++|.|++||+++-
T Consensus 229 f~----------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 FE----------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cc----------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 11 1123455677899999999999999999999864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=346.24 Aligned_cols=260 Identities=29% Similarity=0.417 Sum_probs=210.0
Q ss_pred cccccccccccceEEEEEEeccCc--ceeeeeeeccc---chHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEK---DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.+.++||+|+||.||+|.++..+. ...||||.... ......++|.+|.++|++++|||||+++|++..+..++||
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 345899999999999999986544 22389999875 3367788999999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+|.||+|.++|.+.+..++..+++.++.+.|.||+|||++ +++||||..+|+|++ ....+||+|||+++.
T Consensus 240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~-----~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYS-----KKGVVKISDFGLSRA 311 (474)
T ss_pred EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheec-----CCCeEEeCccccccC
Confidence 999999999999998888899999999999999999999999 999999999999998 667789999999876
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... ......-...|+|||.+....+++++|||||||++||+.+ |..||.+....+.. ..+...
T Consensus 312 ~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~------------~kI~~~ 378 (474)
T KOG0194|consen 312 GSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK------------AKIVKN 378 (474)
T ss_pred Ccceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH------------HHHHhc
Confidence 431111 1111234678999999999999999999999999999998 78898765432211 111011
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCCC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGM 779 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 779 (788)
.-....+...+..+..++..||..||++||+|.++.+.|+.+.....
T Consensus 379 --------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 379 --------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11111122445667778889999999999999999999987765443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=328.89 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=208.0
Q ss_pred HHHHhhcccccccccccceEEEEEEec-cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
+....+.+.+.||+|+||.||+|.+.. ......||+|.++... ....+.+.+|+.++++++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 445677888999999999999998753 2345689999987543 34456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++++|.+++......+++..++.++.||+.||+|||++ +++||||||+||+++ .++.+|++|||.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~-----~~~~~~l~dfg~ 153 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVN-----SDLVCKISGFRR 153 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEc-----CCCcEEECCCcc
Confidence 999999999999999977666789999999999999999999999 999999999999998 788999999998
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+...............++..|+|||.+.+..++.++||||||+++||+++ |+.||......+. . ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--------~----~~~ 221 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--------I----KAV 221 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--------H----HHH
Confidence 76543222222222345678999999999999999999999999999775 9999965422110 0 111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
..... ..........+.+++..||+.+|++||++++|++.|+++
T Consensus 222 ~~~~~---------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 EDGFR---------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HCCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11100 001122345678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=306.38 Aligned_cols=270 Identities=20% Similarity=0.246 Sum_probs=207.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
+|.-.++||+|.||.||+|+.. .+++.||||+++... ........+|++.|+.++|+||+.++++|.+.+...||+
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~--~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDT--ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEec--CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 3445678999999999999987 788899999997543 223456789999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|||+ .+|+..++++...+...++..++.++++||+|||.+ .|+||||||.|+|++ +++.+||+|||+++.+
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis-----~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLIS-----SDGQLKIADFGLARFF 151 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEc-----CCCcEEeecccchhcc
Confidence 9995 599999999989999999999999999999999999 999999999999998 8999999999999988
Q ss_pred CCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc-c
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS-R 724 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 724 (788)
........ ..+-|..|+|||.+.+ +.|+...|+||.|||+.||+-|.+-|.+.+..++...+-..+.......+.+ .
T Consensus 152 ~~p~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 152 GSPNRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred CCCCcccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 75544332 2367889999998876 4799999999999999999999988877654333221111110000000000 0
Q ss_pred cccccc----cCCCCCc-ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLV----SHDPEVL-SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~----~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+.+.. -+.+... .-....+..++++..|+..||.+|+|+.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000000 0000000 112334566899999999999999999999865
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=363.84 Aligned_cols=262 Identities=28% Similarity=0.441 Sum_probs=214.4
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCc---ceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDT---QIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
+....-.+.+.||+|.||.||.|.....+. ...||||.+.+.. .+...+|.+|..+|+.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 334445566889999999999999875443 4569999997653 556779999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhcc------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCc
Q 047157 561 KRLLVYELMPNGTLSNFLFHE------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM 634 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~ 634 (788)
..+|++|||++|+|..+|++. ...+.....+.++.|||+|+.||+++ ++|||||..+|+||+ ....
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~-----~~r~ 840 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLD-----ERRV 840 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeec-----ccCc
Confidence 999999999999999999887 67789999999999999999999999 999999999999999 7789
Q ss_pred EEEeecCCccccCC-CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhh
Q 047157 635 AKISDFGISKLLNK-DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 635 ~kL~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 712 (788)
+||+|||+|+.+-. +.........-...|||||.+....++.|+|||||||+|||++| |..||...+..+.
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------- 913 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------- 913 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-------
Confidence 99999999995433 22222222244578999999999999999999999999999997 7788875532221
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
+.. ....+ +...+...++.+.+|+..||+.+|++||++..|++.++.+.
T Consensus 914 ~~~----~~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 914 LLD----VLEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred HHH----HHhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 111 11111 33334456778889999999999999999999999887664
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.36 Aligned_cols=247 Identities=30% Similarity=0.475 Sum_probs=202.1
Q ss_pred ccCHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec
Q 047157 479 EFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE 558 (788)
Q Consensus 479 ~~~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 558 (788)
++.|++|.+. +-||.|+.|.||+|+++ +..||||+++... ..+|+.|++|+||||+.+.|+|..
T Consensus 120 eiPFe~IsEL-----eWlGSGaQGAVF~Grl~----netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 120 EIPFEEISEL-----EWLGSGAQGAVFLGRLH----NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred cCCHHHhhhh-----hhhccCcccceeeeecc----CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence 4555665442 56999999999999984 4589999885432 257888999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 559 EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
...++||||||..|.|.+.|+.. +.+.......+..+||.|+.|||.+ .|||||||.-||||. .+..+||+
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs-----~~d~VKIs 254 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILIS-----YDDVVKIS 254 (904)
T ss_pred CceeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEee-----ccceEEec
Confidence 99999999999999999999554 6677788889999999999999999 999999999999998 67789999
Q ss_pred ecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
|||-++..... .....+.||..|||||++++.+.++|+|||||||+|||||||..||...+.....-..
T Consensus 255 DFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV--------- 323 (904)
T KOG4721|consen 255 DFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV--------- 323 (904)
T ss_pred cccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec---------
Confidence 99999876544 3344589999999999999999999999999999999999999999754332221110
Q ss_pred HHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 719 SCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
-.. .+...-+...++-+.-|+++||+..|..||++++|+.+|+
T Consensus 324 ---GsN--------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 324 ---GSN--------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ---cCC--------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 000 1112223344566777889999999999999999999996
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=301.89 Aligned_cols=264 Identities=23% Similarity=0.283 Sum_probs=211.7
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCC-----
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED----- 560 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 560 (788)
...+|++.++||+|||+-||++..- .++..+|+|++.....+..+..++|++..++++|||+++++++...+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~--s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGL--STGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeeccc--CcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3456788899999999999999865 667799999998877788899999999999999999999999875433
Q ss_pred eEEEEEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 561 KRLLVYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
+.||+++|...|+|.+.+.. ++..+++.+++.|+.+|++||.+||+. .++++||||||.|||+. +.+.++|
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls-----~~~~~vl 170 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLS-----DSGLPVL 170 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEec-----CCCceEE
Confidence 58999999999999999854 355789999999999999999999997 33599999999999998 7889999
Q ss_pred eecCCccccCCCCC--------cccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCcccccccc
Q 047157 638 SDFGISKLLNKDQT--------RTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES 706 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~ 706 (788)
.|||.+........ +.......|..|+|||.+. +..+++++|||||||+||+|+.|..||+..-.....
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 99999886532111 1112345789999999984 567889999999999999999999999753221100
Q ss_pred ccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 707 EEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
- .-....+....+....+.+.+.+++++|++.||.+||++.+++..++.+.
T Consensus 251 l------------------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 L------------------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred E------------------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0 00111112222333347888999999999999999999999999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.31 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=208.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||.||+|+-+ .+.+.||+|.+.+.. .+..+.+.+|++++++++||||+.++++|+...+.++|+
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK--~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRK--YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred chhHHHHhcCCccceeeecccc--cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 3556789999999999999776 788899999997543 455678999999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+.| +|..+|... ..++++.+..|+.|++.||.|||+. +|+|||+||+|||++ ..+.+|++|||+|+.+
T Consensus 81 e~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~-----~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLE-----KGGTLKLCDFGLARAM 150 (808)
T ss_pred hhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeec-----CCCceeechhhhhhhc
Confidence 99977 999999655 5688899999999999999999999 999999999999998 8999999999999987
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
.. .....+...||+.|||||...+.+|+..+|+||+|||+||+.+|++||....... .+..
T Consensus 151 ~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-----------Lv~~------- 211 (808)
T KOG0597|consen 151 ST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-----------LVKS------- 211 (808)
T ss_pred cc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-----------HHHH-------
Confidence 65 3344556889999999999999999999999999999999999999997542211 1111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+. .++ ...+......+..++...|+.||.+|.|..+++.+
T Consensus 212 --I~-~d~-v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 212 --IL-KDP-VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --Hh-cCC-CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11 111 11122556778889999999999999999998863
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=317.91 Aligned_cols=249 Identities=21% Similarity=0.364 Sum_probs=209.9
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
+..|.|.+.||+|.||.|-++... ..++.||||.++++. ++..-.+.+|+++|..|+||||+.++++|+..+.+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~--~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEH--KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhc--cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 456778899999999999999775 677899999997654 344557899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
|||||..+|.|.+|+... ..+++.+...+++||..|+.|+|.+ +++|||||.+|||+| .++++||+|||++
T Consensus 130 ivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD-----~N~NiKIADFGLS 200 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLD-----QNNNIKIADFGLS 200 (668)
T ss_pred EEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeec-----CCCCeeeeccchh
Confidence 999999999999999655 6788899999999999999999999 999999999999999 9999999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT-TKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
..+..... ...++|++-|.+||++.+.+|. +..|-|||||+||.|+.|..||++.+... ....+.
T Consensus 201 Nly~~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~------------lvrQIs 266 (668)
T KOG0611|consen 201 NLYADKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR------------LVRQIS 266 (668)
T ss_pred hhhccccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH------------HHHHhh
Confidence 88755433 3468999999999999999986 78999999999999999999998864321 111122
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
.+...+. +.+....-||+|||-.+|++|-|+++|..+.
T Consensus 267 ~GaYrEP-----------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 267 RGAYREP-----------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccccCC-----------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2222211 1223445689999999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.27 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=202.7
Q ss_pred HHhhcccccccccccceEEEEEEe---ccCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCe
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 561 (788)
...+.+.+.||+|+||.||+|... ..+.+..||||+++... ....+.+.+|++++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 345677899999999999999753 23456689999986432 33456788999999999 89999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccC-----------------------------------------------------------
Q 047157 562 RLLVYELMPNGTLSNFLFHEG----------------------------------------------------------- 582 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 582 (788)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999985432
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 583 ---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 583 ---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
..+++..+..++.||+.||.|||++ +|+||||||+|||++ .+..+||+|||++....
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~-----~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLT-----HGRITKICDFGLARDIR 265 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEE-----CCCcEEEecCccceecc
Confidence 1467888999999999999999998 999999999999998 77889999999998664
Q ss_pred CCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 648 KDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 648 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..... ...+.
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------~~~~~----~~~~~ 334 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------KFYKM----IKEGY 334 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------HHHHH----HHhCc
Confidence 432211 122345677999999999999999999999999999998 888886432111 01111 11110
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
... .+ .....++.+++.+||+.||++|||+.||+++|++.
T Consensus 335 -~~~---~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 -RML---SP-----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -cCC---CC-----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 000 01 11235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.22 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=203.2
Q ss_pred CCcccCHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceE
Q 047157 476 NFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 476 ~~~~~~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~ 552 (788)
+.+.++.++++..+ ...|++|+++.||+|.. ++..||||.++.... ...+.+.+|+.++++++||||+++
T Consensus 11 ~~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 11 DIKCIESDDIDKYT---SVLIKENDQNSIYKGIF----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred cceecCHHHcCCCC---CeEEeeCCceEEEEEEE----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 34455566653221 24689999999999987 356899999875432 225678899999999999999999
Q ss_pred eeEEec----CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCC
Q 047157 553 LGFCSE----EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT 628 (788)
Q Consensus 553 ~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 628 (788)
++++.+ ....++||||+++|+|.+++.+. ..+++.....++.|++.||.|||+. .+++||||||+|||++
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~--- 157 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVT--- 157 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEEC---
Confidence 999876 35789999999999999999654 5688999999999999999999973 2788999999999998
Q ss_pred CCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCcccccccc
Q 047157 629 LDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN--VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES 706 (788)
Q Consensus 629 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~ 706 (788)
.++.+||+|||++....... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.
T Consensus 158 --~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~- 230 (283)
T PHA02988 158 --ENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI- 230 (283)
T ss_pred --CCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-
Confidence 78899999999988654322 22457889999999976 6899999999999999999999999975422110
Q ss_pred ccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 707 EEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.. ...... .....+....+.+.+++.+||+.||++|||++||++.|+...
T Consensus 231 -------~~----~i~~~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 231 -------YD----LIINKN--------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -------HH----HHHhcC--------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 00 110010 001111123557889999999999999999999999998654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=329.20 Aligned_cols=265 Identities=27% Similarity=0.361 Sum_probs=201.8
Q ss_pred HHhhcccccccccccceEEEEEEec--------------cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccce
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRL--------------KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVR 551 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~--------------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~ 551 (788)
...+.+.++||+|+||.||++.+.. ...+..||+|.+.... .....++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3456778999999999999998642 1234579999887543 344668999999999999999999
Q ss_pred EeeEEecCCeEEEEEecCCCCCHhHhhhccC------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceE
Q 047157 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEG------------------QRPGWVQRVEIALGVARGLLYLHEECETQII 613 (788)
Q Consensus 552 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 613 (788)
+++++.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999999985421 2357788999999999999999999 999
Q ss_pred ecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh
Q 047157 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC 692 (788)
Q Consensus 614 H~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 692 (788)
||||||+|||++ .++.+||+|||++......... ......++..|+|||++....++.++||||||+++|||++
T Consensus 161 H~dlkp~Nill~-----~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 161 HRDLATRNCLVG-----ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred ccCcchhheEEc-----CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 999999999998 7889999999999865433221 1223445788999999988899999999999999999987
Q ss_pred --CCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 693 --GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 693 --g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+..||......+. .................. ........+.+++.+||+.||++|||++||.+.
T Consensus 236 ~~~~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~ 301 (304)
T cd05096 236 LCKEQPYGELTDEQV--------IENAGEFFRDQGRQVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301 (304)
T ss_pred ccCCCCCCcCCHHHH--------HHHHHHHhhhcccccccc------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 4566654322111 111111111111000000 011234578899999999999999999999999
Q ss_pred hhc
Q 047157 771 LEG 773 (788)
Q Consensus 771 L~~ 773 (788)
|++
T Consensus 302 l~~ 304 (304)
T cd05096 302 LTE 304 (304)
T ss_pred HhC
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.76 Aligned_cols=251 Identities=25% Similarity=0.293 Sum_probs=200.2
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|...+.||+|+||.||++... .++..||+|.+.... ......+.+|++++.+++|+||+++++.+.+.+..++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe--cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 455688999999999999887 567799999886532 223346789999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||++..
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~-----~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLD-----DRGHIRISDLGLAVQ 151 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEEC-----CCCCEEEeeCCCcEE
Confidence 999999999888654 34678999999999999999999999 999999999999998 778999999999986
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... .....|+..|+|||++.+..++.++|||||||++|||++|+.||........... ........
T Consensus 152 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--------~~~~~~~~- 220 (285)
T cd05631 152 IPEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE--------VDRRVKED- 220 (285)
T ss_pred cCCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH--------HHHHhhcc-
Confidence 543221 2235689999999999999999999999999999999999999976432111000 00000000
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 770 (788)
...........+.+|+.+||+.||++||+ +++++++
T Consensus 221 ---------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 ---------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 00111123456788999999999999997 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.04 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=206.7
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
...+.||+|.||.||+|... .+++.||+|.+.-+. ....+++.+|+.++..++|+||.++|+.+..+..++++|||+
T Consensus 16 ~~~~~IgrGsfG~Vyk~~d~--~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 16 TKLELIGRGSFGEVYKAIDN--KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccchhccccccceeeeeeec--cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 33478999999999999987 788899999997544 344678899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
.+|++.+.|... ..+.+..+.-++++++.||.|||.+ +.+|||||+.|||+. .++.+||+|||.+..+...
T Consensus 94 ~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s-----~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 94 GGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLS-----ESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEe-----ccCcEEEEecceeeeeech
Confidence 999999999543 4447778888999999999999999 999999999999998 7799999999999988765
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.... ..++||+.|||||+++...|+.|+||||||++.+||.+|.+|+........ +..+
T Consensus 165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--------------------lflI 223 (467)
T KOG0201|consen 165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--------------------LFLI 223 (467)
T ss_pred hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--------------------EEec
Confidence 5554 568999999999999988999999999999999999999999865432111 1111
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
....|..... .....+.+++..||+.||+.||+|.+++++
T Consensus 224 pk~~PP~L~~-~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 224 PKSAPPRLDG-DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCCCCCcccc-ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1112222222 556678889999999999999999999863
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=301.75 Aligned_cols=234 Identities=26% Similarity=0.291 Sum_probs=195.8
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.+.+.||.|+||.|.+++.+ .++..+|+|++++.. -+..+...+|..+|+.+.||+++++++.+.+.+..++|||
T Consensus 47 e~~~tlGtGSFGrV~LVr~k--~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREK--HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hheeeeccCccceEEEEEEc--cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 45688999999999999887 667899999998754 2345677899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|++||.|..++++. +++++....-++.||+.||+|||+. +|++|||||+|||+| .++.+||+|||+|+.+.
T Consensus 125 yv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD-----~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 125 YVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLD-----QNGHIKITDFGFAKRVS 195 (355)
T ss_pred ccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeec-----cCCcEEEEeccceEEec
Confidence 99999999999765 5678888889999999999999999 999999999999999 99999999999999765
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
.. .-+.+||+.|+|||++..+.+..++|.|||||++|||+.|..||...+.... ...+.++++.
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i------------Y~KI~~~~v~ 259 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI------------YEKILEGKVK 259 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH------------HHHHHhCccc
Confidence 43 3357899999999999999999999999999999999999999987643221 1222222211
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCC
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLR 761 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 761 (788)
.+.-....+.+|+...|+.|-.+|
T Consensus 260 ----------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 ----------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 111223456677888888888888
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=297.47 Aligned_cols=246 Identities=25% Similarity=0.336 Sum_probs=205.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.++.+.||+|.||.||.|+.+ .+.-.||+|++.+.. ....+++.+|+++-..|+||||++++++|.+....||++
T Consensus 24 feigr~LgkgkFG~vYlarek--ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREK--KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred ccccccccCCccccEeEeeec--cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 346789999999999999887 777799999997653 344578999999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||.++|+|...|+.. ..++++.....++.|+|.||.|+|.+ +|+||||||+|+|++ ..+..||+|||-+..
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg-----~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLG-----SAGELKIADFGWSVH 173 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccC-----CCCCeeccCCCceee
Confidence 999999999999744 45678888899999999999999999 999999999999998 888999999999886
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.. .......+||..|.|||...+..++.+.|+|++|++.||++.|.+||+.....+...+ +..
T Consensus 174 ~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr------------I~k-- 236 (281)
T KOG0580|consen 174 AP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR------------IRK-- 236 (281)
T ss_pred cC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH------------HHH--
Confidence 43 2334457899999999999999999999999999999999999999986542221111 100
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+...+........++|.+|+..+|.+|.+..|++++
T Consensus 237 --------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 --------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 0111112334567789999999999999999999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=338.65 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=203.4
Q ss_pred HHHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCC
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED 560 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 560 (788)
....+.+.+.||+|+||.||+|+... ......||+|.+.... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 34456778999999999999998642 2334579999986532 33456788999999999 8999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccC----------------------------------------------------------
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG---------------------------------------------------------- 582 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 582 (788)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999985421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC
Q 047157 583 -----------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651 (788)
Q Consensus 583 -----------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~ 651 (788)
..+++..+..++.||+.||.|||++ +|+||||||+|||++ ++..+||+|||++........
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~-----~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLT-----DGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEe-----CCCeEEEeeceeeeeccCCcc
Confidence 2367788899999999999999998 999999999999998 778999999999986543322
Q ss_pred cc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 652 RT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 652 ~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.. .....++..|+|||++.+..++.++||||||+++|||++ |+.||....... .... ....+ ...
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~----~~~~~-~~~- 334 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYK----MVKRG-YQM- 334 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHH----HHHcc-cCc-
Confidence 11 122335668999999998899999999999999999997 999996532111 0000 01000 000
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.........+.+++.+||+.||++|||+.+|+++|+++.
T Consensus 335 -------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 -------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 000112356888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=344.12 Aligned_cols=257 Identities=21% Similarity=0.255 Sum_probs=210.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeE-Eec------CCe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGF-CSE------EDK 561 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-~~~------~~~ 561 (788)
..+.++|.+|||+.||.|... ..+..+|+|++-...+...+.+.+|+++|++|. |+|||.+++. ... .-+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~--~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDV--KGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEccCCcEEEEEEEec--CCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 456789999999999999986 444799999987777888899999999999996 9999999993 211 236
Q ss_pred EEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 562 RLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
.+|.||||.+|.|-+++..+ ...+++.++++|+.|+++|+++||.. +++|||||||-+||||. .+++.||+||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls-----~~g~~KLCDF 190 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLS-----ADGNYKLCDF 190 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEc-----CCCCEEeCcc
Confidence 78999999999999999654 45599999999999999999999985 77899999999999998 8889999999
Q ss_pred CCccccCCCCCcc--------cccccCCccccCcccc---cCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccc
Q 047157 641 GISKLLNKDQTRT--------DTNMRGTMGYVAPEWL---RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEV 709 (788)
Q Consensus 641 g~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~ 709 (788)
|.+.......... .-...-|+.|+|||.+ .+.++++|+|||+|||+||-|+....||+......
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----- 265 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----- 265 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----
Confidence 9987543222110 1113468999999987 67899999999999999999999999998653222
Q ss_pred hhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCC
Q 047157 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVG 778 (788)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 778 (788)
++...-.......+..+|.+||..||++||.+||++-+|+..+.++...+
T Consensus 266 -------------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 -------------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 22223333334578899999999999999999999999999998776543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.34 Aligned_cols=251 Identities=34% Similarity=0.566 Sum_probs=196.9
Q ss_pred ccccccccccceEEEEEEe--ccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 492 FSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 492 ~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.+.||.|.||.||+|.+. ....+..|+||.+.... ....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999998 45567789999996432 44578999999999999999999999999988889999999
Q ss_pred CCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 569 MPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 569 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
+++|+|.++|... ...+++..++.|+.||++||.|||++ +++|++|+++||+++ .++.+||+|||++....
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~-----~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLD-----SNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEE-----TTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccc-----ccccccccccccccccc
Confidence 9999999999876 67789999999999999999999999 999999999999999 88899999999998763
Q ss_pred CCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 648 KDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 648 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.... ...........|+|||.+....++.++||||||+++|||++ |+.||......+ .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------------~~~~~~~~~ 222 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------------IIEKLKQGQ 222 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------------HHHHHHTTE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------------ccccccccc
Confidence 2222 22233456778999999998889999999999999999999 678876442211 111111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
. ..........+.+++..||+.||++|||++++++.|
T Consensus 223 ~---------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 R---------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp E---------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred c---------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 011112345678899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=331.26 Aligned_cols=243 Identities=26% Similarity=0.289 Sum_probs=196.6
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
+.||+|+||.||++... .++..||+|.+.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREK--ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 46899999999999876 667799999987543 2334567899999999999999999999999999999999999
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
+++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++......
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~-----~~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLD-----KDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEEC-----CCCCEEEeeCCCCcccccCC
Confidence 99999998654 5678999999999999999999999 999999999999998 78899999999987532221
Q ss_pred CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccc
Q 047157 651 TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 730 (788)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------------~~~~~~~~----- 211 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------------FELILMEE----- 211 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH------------HHHHHcCC-----
Confidence 122345689999999999999999999999999999999999999965422110 01111111
Q ss_pred cCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 731 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
... .......+.+++.+||+.||++|| ++.+++++
T Consensus 212 ---~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 ---IRF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---CCC--CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 000 112345678899999999999999 79998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.02 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=207.0
Q ss_pred HhhcccccccccccceEEEEEEecc-Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..+.+.+.||+|+||+||+|.++.. .....|++|.+.... .....++.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 4567789999999999999988643 235689999886543 34456889999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++......+++..+..++.|++.||.|||++ +|+|+||||+||+++ +++.+||+|||++..
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~-----~~~~~~l~dfg~~~~ 155 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVN-----SNLVCKVSDFGLSRR 155 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEc-----CCCCEEECccchhhc
Confidence 999999999999977666789999999999999999999998 999999999999998 788999999999987
Q ss_pred cCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 646 LNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 646 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ . ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--------~----~~~~~~ 223 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--------V----IKAVED 223 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--------H----HHHHHc
Confidence 752221 11122334678999999998899999999999999999998 999985432111 0 011111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
... ........+.+.+++.+||+.+|++||+++||+++|+++
T Consensus 224 ~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 GYR---------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 000112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=319.19 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=205.8
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...+.+.+.||+|+||.||+|... ..+..|++|.+... ....+++.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEe--cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 344667789999999999999987 56778999998754 334567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++... ...+++..++.++.|+++||+|||++ +++||||||+||+++ +++.+||+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~-----~~~~~kl~df~~~~~ 153 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVG-----ENHLVKVADFGLSRL 153 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEc-----CCCcEEeCCCccccc
Confidence 999999999999654 34578999999999999999999998 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..............+..|+|||.+.+..++.++||||||+++|||++ |..||......+. .......
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------------~~~~~~~ 221 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------------YELLEKG 221 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------------HHHHHCC
Confidence 65433222222334568999999999999999999999999999998 8899865422111 0111110
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
. ...........+.+++.+||+.||++||++.+++++|+.+
T Consensus 222 -~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 -Y--------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -C--------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0 0001112346788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=331.08 Aligned_cols=252 Identities=25% Similarity=0.287 Sum_probs=202.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|+||.||+|... .++..||+|++.... ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKK--DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred cEEEEEEeecCCeEEEEEEEC--CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 567789999999999999886 567799999987543 234467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~-----~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLID-----ASGHIKLTDFGLSKGI 151 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEC-----CCCCEEEEeCcCCccc
Confidence 999999999999644 4678889999999999999999999 999999999999998 7889999999999865
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+... .+..+
T Consensus 152 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~----~i~~~---------- 213 (333)
T cd05600 152 VT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE----NLKYW---------- 213 (333)
T ss_pred cc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH----HHHhc----------
Confidence 43 2234568999999999999999999999999999999999999997643221110 00000
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...+...............+.+++.+||+.+|++||+++|++++
T Consensus 214 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 214 KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000000000012235677889999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=331.64 Aligned_cols=272 Identities=22% Similarity=0.325 Sum_probs=204.4
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
...|.+.+.||+|+||.||++... .++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHK--PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEEC--CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 345667789999999999999886 667789999887542 34456899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++..+..++.|++.||.|||++ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 82 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~-----~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 82 MEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVN-----SRGEIKLCDFGVSGQ 153 (331)
T ss_pred eecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEc-----CCCcEEEccCccccc
Confidence 9999999999998654 4678899999999999999999985 2599999999999998 778999999999876
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH-------HHHH
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS-------DWVI 718 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~ 718 (788)
..... .....|+..|+|||++.+..++.++||||||+++|||++|+.||......+.......... ....
T Consensus 154 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 154 LIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred ccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 54322 2235689999999999999999999999999999999999999965432111000000000 0000
Q ss_pred HH-------------------hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 719 SC-------------------MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 719 ~~-------------------~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
.. ........+...............++.+++.+||+.||++|||++|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00 000000000000011111112456788999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.74 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=201.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..+.+.+.||+|+||.||++..+ .+..+++|.+... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~---~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR---AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec---cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 34567789999999999999874 3457999987643 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++......+++..+..++.|++.||.|||++ +|+|+||||+||+++ .++.+||+|||.+....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~-----~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVS-----STGVVKVSDFGMTRYVL 151 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEc-----CCCeEEECCCCCccccC
Confidence 9999999999976555689999999999999999999999 999999999999998 77899999999988654
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. .......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~--------~~----~i~~~~~ 219 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV--------VE----MISRGFR 219 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--------HH----HHHCCCC
Confidence 332222222345668999999998899999999999999999999 8899865422111 00 0111100
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
. ..+ ......+.+++.+||+.+|++||+++|+++.|.
T Consensus 220 --~--~~~-----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 --L--YRP-----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --C--CCC-----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 011 112356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=319.31 Aligned_cols=254 Identities=26% Similarity=0.273 Sum_probs=200.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchH--------------HHHHHHHHHHHHhcCCCccccceEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--------------KTNEEFMTELKIIGRTHHKNLVRLL 553 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~hpniv~~~ 553 (788)
.+|.+.+.||+|.||.|-+|... ..++.||||++.+... ...+...+|+.+|++++|||||+++
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~--~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDE--VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred hheehhhhhcCCccceEEEEeec--CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 45777899999999999999887 6777999999965321 1125788999999999999999999
Q ss_pred eEEec--CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCC
Q 047157 554 GFCSE--EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT 631 (788)
Q Consensus 554 ~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~ 631 (788)
++..+ .+.+|||+|||..|.+...-. ....++..+..++++++..||+|||.+ +||||||||+|+||+ +
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~-----~ 245 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS-----S 245 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc-----C
Confidence 99976 458999999999888764331 122388999999999999999999999 999999999999999 8
Q ss_pred CCcEEEeecCCccccCCCC----CcccccccCCccccCcccccCCC----CCccCcchhhHHHHHHHHhCCCCCCccccc
Q 047157 632 NYMAKISDFGISKLLNKDQ----TRTDTNMRGTMGYVAPEWLRNVP----VTTKVDVFSFGVMLLEIICGRRHIELSRVE 703 (788)
Q Consensus 632 ~~~~kL~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltg~~p~~~~~~~ 703 (788)
++++||+|||.+....... ........||+.|+|||...++. .+.+.||||+||+||-|+.|+.||......
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 8999999999998763321 11223468999999999886632 346899999999999999999999765322
Q ss_pred cccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
+. . ..++...+......+..+.+.+|++++|+.||++|.+..+|..+.-
T Consensus 326 ~l------------~--------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 EL------------F--------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HH------------H--------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 11 1 1122222333333356678889999999999999999999987663
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.53 Aligned_cols=270 Identities=20% Similarity=0.221 Sum_probs=202.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||.||+++.+ .++..+|+|++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHK--ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CceEEEEecccCCEEEEEEEEC--CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 3567789999999999999886 667789999886432 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||++++.|..+. .....+++..+..++.||+.||.|||+. +|+||||||+||+++ .++.+||+|||++...
T Consensus 80 e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~-----~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 80 EYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLIS-----HNDVLKLCDFGFARNL 150 (287)
T ss_pred ecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc-----CCCcEEEeeccCcccc
Confidence 999987776544 3445688999999999999999999998 999999999999998 7789999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh----hHHHHHHHhh
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV----LSDWVISCML 722 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~ 722 (788)
............+++.|+|||++.+..++.++|||||||++|||++|+.||......+........ ..........
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 151 SEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred cccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 543333333456899999999999889999999999999999999999999764322111000000 0000000000
Q ss_pred cccccccccCCCCCcc------cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLS------DLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.........+...... .......+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111000000000 0112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=322.39 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=200.7
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.+.++||+|+||.||+++-+ +++..+|+|++++.. ....+.++.|-.+|...++|.||+++-.|++.+.+|||||
T Consensus 144 e~Lk~IgkGAfGeVrLarKk--~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKK--DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred hhheeeccccceeEEEEEEc--cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence 34588999999999999876 889999999998754 3445678899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|++||++..+|... ..+++.....++.+++-|+..||+. |+|||||||+|+||| ..|++||+|||++.-+.
T Consensus 222 ylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD-----~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLID-----AKGHIKLSDFGLSTGLD 292 (550)
T ss_pred ecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeec-----CCCCEeeccccccchhh
Confidence 99999999999665 5677777788889999999999999 999999999999999 89999999999986431
Q ss_pred C-----------------------CCC-----c-c-----------------cccccCCccccCcccccCCCCCccCcch
Q 047157 648 K-----------------------DQT-----R-T-----------------DTNMRGTMGYVAPEWLRNVPVTTKVDVF 681 (788)
Q Consensus 648 ~-----------------------~~~-----~-~-----------------~~~~~gt~~y~aPE~~~~~~~s~k~DVw 681 (788)
. +.. . . ....+|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 000 0 0 0124599999999999999999999999
Q ss_pred hhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCC
Q 047157 682 SFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLR 761 (788)
Q Consensus 682 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 761 (788)
|||||+||||.|-+||......+... .+..|... .....+.....+..+||.+|+. ||++|
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~r----kI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYR----KIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHH----HHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 99999999999999998775544322 22222211 1111122223677889999998 99999
Q ss_pred C---CHHHHHHH
Q 047157 762 P---SMKKVIHM 770 (788)
Q Consensus 762 P---t~~evl~~ 770 (788)
. .++||.++
T Consensus 434 LG~~G~~EIK~H 445 (550)
T KOG0605|consen 434 LGSKGAEEIKKH 445 (550)
T ss_pred cCcccHHHHhcC
Confidence 6 47777663
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.65 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=204.6
Q ss_pred hhcccccccccccceEEEEEEeccC---cceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKD---TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
.+.+.+.||+|+||.||+|...... ....|++|.+.... .....++.+|++++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4567789999999999999876322 23579999886433 3455678999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC
Q 047157 565 VYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL 629 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 629 (788)
+|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~---- 158 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG---- 158 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc----
Confidence 999999999999996431 3567889999999999999999999 999999999999998
Q ss_pred CCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccc
Q 047157 630 DTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESE 707 (788)
Q Consensus 630 ~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~ 707 (788)
+++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 159 -~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~-- 235 (283)
T cd05048 159 -EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV-- 235 (283)
T ss_pred -CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 778999999999986533221 12223456788999999988899999999999999999998 9999875432111
Q ss_pred cchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 708 EVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
...+..+... ......+.++.+|+.+||+.||++||+++||+++|++
T Consensus 236 ----------~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 ----------IEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----------HHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111111 1122345778899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.59 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=205.4
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
+....+.+.+.||+|++|.||+|... .+..|++|.++... ...+++.+|++++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN---NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec---CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 44566788899999999999999874 34579999986543 235678899999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 565 VYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++ .++.+||+|||++
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~-----~~~~~~l~dfg~~ 150 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVG-----ENNICKVADFGLA 150 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEc-----CCCCEEECCcceE
Confidence 999999999999996543 5689999999999999999999998 999999999999998 7889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
................+..|+|||.+.+..++.++||||||+++|||++ |+.||....... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------------~~~~~~ 218 (261)
T cd05068 151 RVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------------VLQQVD 218 (261)
T ss_pred EEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------------HHHHHH
Confidence 8765332222222233467999999999899999999999999999999 998986532111 011111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
.. .. ........+.+.+++.+|++.+|++||++.++++.|++.
T Consensus 219 ~~-~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 219 QG-YR--------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred cC-CC--------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11 00 001112346788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=325.65 Aligned_cols=244 Identities=23% Similarity=0.243 Sum_probs=199.1
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|+||.||++... .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDR--ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEc--CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 566789999999999999886 567799999986432 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~-----~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLD-----KEGHIKLTDFGFAKKL 151 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEEC-----CCCCEEEEecCcchhc
Confidence 999999999999654 4678889999999999999999999 999999999999998 7789999999999865
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
.... ....|++.|+|||++.+..++.++||||||+++|||++|+.||......+. ........
T Consensus 152 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------------~~~i~~~~- 214 (291)
T cd05612 152 RDRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------------YEKILAGK- 214 (291)
T ss_pred cCCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------------HHHHHhCC-
Confidence 4321 234689999999999998999999999999999999999999975432111 01111111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIHM 770 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 770 (788)
... +......+.+++.+||+.||.+||+ ++|++++
T Consensus 215 -------~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 -------LEF--PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------cCC--CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 110 0112346788999999999999995 8888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=329.87 Aligned_cols=246 Identities=24% Similarity=0.246 Sum_probs=200.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..|.+.+.||+|+||.||+|... .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHK--GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEEC--CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 34677899999999999999886 667799999986542 2344678899999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 96 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~-----~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLD-----NKGHVKVTDFGFAK 166 (329)
T ss_pred EEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEC-----CCCCEEEeeccCce
Confidence 99999999999999654 4678888889999999999999999 999999999999998 78899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... ....|++.|+|||++.+..++.++|||||||++|||++|+.||........ ......+
T Consensus 167 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------~~~i~~~ 230 (329)
T PTZ00263 167 KVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI------------YEKILAG 230 (329)
T ss_pred EcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH------------HHHHhcC
Confidence 654322 235689999999999999999999999999999999999999965422110 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 770 (788)
.. .. +.....++.+++.+||+.||++||+ +++++.+
T Consensus 231 ~~--------~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 RL--------KF--PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred Cc--------CC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 00 0112346778999999999999997 6888754
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=331.29 Aligned_cols=265 Identities=20% Similarity=0.207 Sum_probs=197.0
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...|.+.++||+|+||.||++... .++..||+|.... ..+.+|++++++++||||+++++++......++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~--~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDN--KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEEC--CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 345777899999999999999886 6777999997542 35678999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|++. ++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 163 e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~-----~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 163 PRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFIN-----HPGDVCLGDFGAACFP 232 (391)
T ss_pred ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEc-----CCCCEEEEeCCccccc
Confidence 9985 7888888554 5678999999999999999999999 999999999999998 7789999999999754
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHH-------
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS------- 719 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 719 (788)
............||+.|+|||++.+..++.++|||||||++|||++|+.||...............+......
T Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 3322222334578999999999999999999999999999999999998875432111000000000000000
Q ss_pred ----------Hhhcccccccc---cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 720 ----------CMLSRNLQVLV---SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 720 ----------~~~~~~~~~l~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
........... ...+...........+.+++.+||+.||++|||++|+++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 000000111233457889999999999999999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.09 Aligned_cols=240 Identities=26% Similarity=0.285 Sum_probs=193.4
Q ss_pred ccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 496 lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
||+|+||.||++... .++..||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKR--DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 699999999999886 567789999986532 334567889999999999999999999999999999999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++....... .
T Consensus 79 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~-----~~~~~kl~Dfg~~~~~~~~~-~ 148 (312)
T cd05585 79 ELFHHLQRE-GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLD-----YQGHIALCDFGLCKLNMKDD-D 148 (312)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEEC-----CCCcEEEEECcccccCccCC-C
Confidence 999999654 5688899999999999999999999 999999999999998 78899999999987543222 1
Q ss_pred ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccC
Q 047157 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSH 732 (788)
Q Consensus 653 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 732 (788)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. . ......
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-----------~-~~~~~~-------- 208 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-----------Y-RKILQE-------- 208 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-----------H-HHHHcC--------
Confidence 22345689999999999999999999999999999999999999975422110 0 011111
Q ss_pred CCCCcccHHHHHHHHHHHhHccCCCCCCCCC---HHHHHH
Q 047157 733 DPEVLSDLERFERMAMVGLWCNHPDPNLRPS---MKKVIH 769 (788)
Q Consensus 733 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 769 (788)
.... +......+.+++.+||+.||++||+ +.|++.
T Consensus 209 ~~~~--~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 209 PLRF--PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCC--CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 1111 1123456788999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.09 Aligned_cols=243 Identities=27% Similarity=0.299 Sum_probs=196.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
+.||+|+||.||++... .++..||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREK--ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 46899999999999876 667799999987542 2345678899999999999999999999999999999999999
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
+++|..++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++.......
T Consensus 79 ~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~-----~~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 79 GGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLD-----KDGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEEC-----CCCcEEEecCcCCccCCCcc
Confidence 99999888554 5688999999999999999999999 999999999999998 78899999999987543221
Q ss_pred CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccc
Q 047157 651 TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 730 (788)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ......
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~------------~~~~~~------ 210 (328)
T cd05593 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------------ELILME------ 210 (328)
T ss_pred -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH------------HHhccC------
Confidence 1223356899999999999989999999999999999999999999754221110 001000
Q ss_pred cCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 731 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
.... +......+.+++.+||+.||++|| +++|++++
T Consensus 211 --~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 211 --DIKF--PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --CccC--CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0000 112245678899999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=324.28 Aligned_cols=270 Identities=21% Similarity=0.255 Sum_probs=199.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.++||+|+||+||+|... .++..||+|.++... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSK--LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEEC--CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 3667789999999999999876 567799999886432 2234567899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++ +|.+++...+..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~-----~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLIN-----EKGELKLADFGLARAKS 154 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEC-----CCCCEEECcCcceeecc
Confidence 9974 99999877666788999999999999999999999 999999999999998 77899999999987643
Q ss_pred CCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH---HHHHHHhh-
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS---DWVISCML- 722 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~- 722 (788)
.... ......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+.......... .-.+....
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 155 VPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred CCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 2221 2233467899999998865 5689999999999999999999999976543221110000000 00000000
Q ss_pred cccccccccCCCCCcc----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLS----DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.........+...... .......+.+++.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000000 01123467899999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.72 Aligned_cols=248 Identities=26% Similarity=0.411 Sum_probs=198.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
+.||+|+||.||+|... .++..+++|.+.... ......+.+|++++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR--ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEe--cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999886 567789999876433 445568999999999999999999999999999999999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
+|.+++......+++..++.++.|++.||.|||++ +|+|+||||+||+++ .++.+||+|||++.........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~-----~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVT-----EKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEc-----CCCcEEECccccCccccccccc
Confidence 99999976666789999999999999999999999 999999999999998 7788999999998765432111
Q ss_pred cc-ccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccccc
Q 047157 653 TD-TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730 (788)
Q Consensus 653 ~~-~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 730 (788)
.. .....+..|+|||.+.+..++.++||||||+++|||++ |..||....... ........
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------------~~~~~~~~------ 212 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------------TREAIEQG------ 212 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------------HHHHHHcC------
Confidence 11 11123457999999998899999999999999999997 888886432111 00001000
Q ss_pred cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 731 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
............+.+++.+||+.+|++|||+.+|+++|+
T Consensus 213 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 213 ---VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 000111123457888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.43 Aligned_cols=255 Identities=23% Similarity=0.400 Sum_probs=204.1
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...+.+.++||+|+||.||+|... .+..|++|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN---NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec---CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 445677899999999999999864 44579999886532 23568899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++ .++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~-----~~~~~~l~dfg~~~~ 152 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVS-----ESLMCKIADFGLARV 152 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEec-----CCCcEEECCCcccee
Confidence 999999999999654 45678899999999999999999998 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.............++..|+|||.+....++.++||||||+++|+|++ |+.||........ .. .....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--------~~----~~~~~ 220 (261)
T cd05072 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV--------MS----ALQRG 220 (261)
T ss_pred cCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH--------HH----HHHcC
Confidence 65433222233345678999999988899999999999999999998 9999864321110 01 01111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
. .. .........+.+++.+||+.+|++||+++++.+.|+..
T Consensus 221 ~-------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 221 Y-------RM--PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C-------CC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 00 00112345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.25 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=206.0
Q ss_pred HHhhcccccccccccceEEEEEEecc---CcceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
..++.+.+.||+|+||.||+|..... .....||+|.+...... ..+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 45677789999999999999987532 34568999998765433 567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccC-------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC
Q 047157 563 LLVYELMPNGTLSNFLFHEG-------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL 629 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 629 (788)
++||||+++++|.+++...+ ..+++..+..++.||+.||.|||++ +++||||||+||+++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~---- 156 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVG---- 156 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEc----
Confidence 99999999999999996542 3467889999999999999999999 999999999999998
Q ss_pred CCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccc
Q 047157 630 DTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESE 707 (788)
Q Consensus 630 ~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~ 707 (788)
.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 157 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-- 233 (280)
T cd05049 157 -YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-- 233 (280)
T ss_pred -CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--
Confidence 788999999999876533221 11223345678999999999999999999999999999998 9999865422111
Q ss_pred cchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 708 EVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
......+.... ........+.+++.+||+.||++||++.||++.|++
T Consensus 234 ----------~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 ----------IECITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----------HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 01111111111 011234567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=314.61 Aligned_cols=261 Identities=30% Similarity=0.349 Sum_probs=196.0
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCC-----eEEEEEe
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED-----KRLLVYE 567 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~lV~e 567 (788)
.+++|.|+||.||+|+.. .+...||||+.-.+..- --+|+++|+++.|||||+++-+|.... ...+|||
T Consensus 29 ~~liG~GsFg~Vyq~~~~--e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLR--ETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred eEEEeecccceEEEEEEc--CCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 478999999999999998 55679999988654322 127999999999999999998885432 3358999
Q ss_pred cCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 568 LMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 568 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||+. +|.+++++ .+.+++...+.-+..||.+||+|||+. +|+||||||+|+|+|. +.+.+||+|||.|+
T Consensus 103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~----~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDP----DTGVLKICDFGSAK 174 (364)
T ss_pred hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcC----CCCeEEeccCCcce
Confidence 9975 88888864 356778888888999999999999998 9999999999999994 56899999999999
Q ss_pred ccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
.+...... .....|..|+|||.+.+ ..|+.+.||||.||++.||+-|+..|.+.+..++..++-..+.....+.+..
T Consensus 175 ~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 175 VLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 88765544 23456889999998865 4799999999999999999999999988755444333222221111111111
Q ss_pred c-------cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 724 R-------NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 724 ~-------~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. ....+...............+.++++.++|+.+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1 111111111101112233467889999999999999999999985
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.99 Aligned_cols=252 Identities=28% Similarity=0.444 Sum_probs=202.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..+.+.+.||+|+||+||+|... .+..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~---~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec---CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 45677889999999999999774 34469999887542 234678999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++......+++..++.++.||+.||.|||+. +++|+||||+||+++ .++.+||+|||.++...
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~-----~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVD-----DQGCVKVSDFGLSRYVL 151 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEc-----CCCCEEECCCccceecC
Confidence 9999999999977656789999999999999999999999 999999999999998 77899999999988654
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . .........
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~----~~~~~~~~~ 219 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------T----VEKVSQGLR 219 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------H----HHHHhcCCC
Confidence 433222222345678999999988889999999999999999998 999986432111 0 011111100
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
. .. .....+.+.+++.+||+.||++||++.+|++.|+
T Consensus 220 ~----~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 L----YR-----PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C----CC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 00 1112467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.96 Aligned_cols=262 Identities=26% Similarity=0.453 Sum_probs=209.0
Q ss_pred HHHhhcccccccccccceEEEEEEec---cCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
+...+.+.+.||+|+||.||++.... ...+..+++|.+........+.+.+|++++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 44566778999999999999997632 234567999999876666677899999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccC------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCC
Q 047157 563 LLVYELMPNGTLSNFLFHEG------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD 630 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 630 (788)
++||||+++++|.+++...+ ..+++..++.++.|++.||+|||++ +++||||||+||+++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~----- 154 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG----- 154 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc-----
Confidence 99999999999999986432 2478999999999999999999998 999999999999998
Q ss_pred CCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcccccccccc
Q 047157 631 TNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEE 708 (788)
Q Consensus 631 ~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~ 708 (788)
+++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---- 230 (288)
T cd05093 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---- 230 (288)
T ss_pred cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 788999999999986543221 11222345778999999998899999999999999999998 888886542211
Q ss_pred chhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 709 VDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.......+..... + ......+.+++.+||+.||.+|||+.||++.|+.+..
T Consensus 231 --------~~~~i~~~~~~~~----~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 231 --------VIECITQGRVLQR----P-----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --------HHHHHHcCCcCCC----C-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 0111111111110 0 1123568899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=326.33 Aligned_cols=243 Identities=27% Similarity=0.301 Sum_probs=195.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
+.||+|+||.||++... .++..||+|.+.... ......+.+|++++++++||||+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 46899999999999876 667799999987543 2344567889999999999999999999999999999999999
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
+++|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.......
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~-----~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 79 GGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLD-----KDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEc-----CCCCEEecccHHhccccCCC
Confidence 99999888554 5688999999999999999999999 999999999999998 78899999999987532221
Q ss_pred CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccc
Q 047157 651 TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 730 (788)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||........ .........
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------------~~~~~~~~~---- 212 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------------FELILMEEI---- 212 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------------HHHHhcCCC----
Confidence 122235689999999999999999999999999999999999999965422111 000111110
Q ss_pred cCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 731 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
.. +......+.+++.+||+.||++|| ++.+++++
T Consensus 213 ----~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 ----RF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ----CC--CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 00 112245677899999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.78 Aligned_cols=254 Identities=27% Similarity=0.462 Sum_probs=207.3
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..|.+.++||.|+||.||+|... . +..+++|.+..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~--~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWK--N-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEec--C-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45677899999999999999986 3 67899999987666567789999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+++++|.+++.+. +..+++..+..++.||+.||.|||++ +|+|+||||+||+++ .++.+||+|||.+...
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~-----~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVG-----EDLVCKVADFGLARLI 154 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEc-----CCceEEEccccchhhc
Confidence 99999999999764 45679999999999999999999998 999999999999998 7889999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
....... ....++..|+|||.+....++.++||||||+++|+|++ |+.||......+ .... ....
T Consensus 155 ~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--------~~~~----~~~~- 220 (261)
T cd05148 155 KEDVYLS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------VYDQ----ITAG- 220 (261)
T ss_pred CCccccc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--------HHHH----HHhC-
Confidence 4332222 23345678999999988899999999999999999998 889986543111 0011 1100
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
..........+.+.+++.+||+.||++|||++++++.|+.+
T Consensus 221 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 --------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00011123345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=371.08 Aligned_cols=270 Identities=24% Similarity=0.471 Sum_probs=207.2
Q ss_pred ccCHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec
Q 047157 479 EFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE 558 (788)
Q Consensus 479 ~~~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 558 (788)
.++++++... +...++||+|+||.||+|... ..+..||||++..... ....|++.+++++||||++++++|.+
T Consensus 682 ~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 682 SITINDILSS-LKEENVISRGKKGASYKGKSI--KNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhhHHHHHhh-CCcccEEccCCCeeEEEEEEC--CCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc
Confidence 3455555443 344578999999999999876 5677999999865322 12356888999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 559 EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
.+..++||||+++|+|.+++. .++|..+.+++.||++||+|||..+.++|+||||||+||+++ .+..+++.
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-----~~~~~~~~ 825 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-----GKDEPHLR 825 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-----CCCceEEE
Confidence 999999999999999999994 478999999999999999999976667999999999999998 56666665
Q ss_pred ecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
|+........ ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+|..
T Consensus 826 -~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~------~~~~~~~~~~ 893 (968)
T PLN00113 826 -LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG------VHGSIVEWAR 893 (968)
T ss_pred -eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC------CCCcHHHHHH
Confidence 5554432211 123578899999999999999999999999999999999999853211 1112334443
Q ss_pred HHhhcccccccccCCCC--CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 719 SCMLSRNLQVLVSHDPE--VLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
...........+++... ...+.+...++.+++.+||+.||++||||+||+++|+++..
T Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 33333333333333221 12344566788999999999999999999999999998754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.78 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=204.3
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCc--ceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCe
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 561 (788)
+....+...+.||+|+||.||+|.+...+. ...||+|.+.... ....+++.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 344556777899999999999998753222 3358999986443 44567899999999999999999999998764 5
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++|+||+++|+|.+++......+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~-----~~~~~kl~DfG 154 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVK-----TPQHVKITDFG 154 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEec-----CCCcEEEcccc
Confidence 7799999999999999987767789999999999999999999999 999999999999998 77899999999
Q ss_pred CccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHH
Q 047157 642 ISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 642 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
+++......... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . .
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--------~----~ 222 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------S----S 222 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--------H----H
Confidence 998765433221 112234668999999999999999999999999999997 9999865422110 0 0
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
...... ...........+.+++.+||+.||++||++.+++..|..+.
T Consensus 223 ~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 223 ILEKGE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HHhCCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011100 00001112345778999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=317.59 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=208.4
Q ss_pred HhhcccccccccccceEEEEEEec---cCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..+.+.+.||+|+||.||++.... ......+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 445667899999999999997642 23455799999877666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC
Q 047157 565 VYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL 629 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 629 (788)
||||+++++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~---- 157 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG---- 157 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc----
Confidence 999999999999996432 3478999999999999999999999 999999999999998
Q ss_pred CCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccc
Q 047157 630 DTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESE 707 (788)
Q Consensus 630 ~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~ 707 (788)
.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 158 -~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 233 (291)
T cd05094 158 -ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--- 233 (291)
T ss_pred -cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 788999999999976543221 12223456788999999999999999999999999999998 999986542211
Q ss_pred cchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 708 EVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.......+..... ....+..+.+++.+||+.||++|||+++|+++|+.+..
T Consensus 234 ---------~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 ---------VIECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---------HHHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111111111110 11234568899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=297.74 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=204.7
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..|.+.++||+|.|+.||+..+. .+++..|+|.+... .....+++.+|+++-+.|+||||+++.+.+.+....|||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~--~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHK--TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhc--cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 45667789999999999998876 77788888887532 344677899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+|+|+|++|..-+..+ ...++...-..++||+++|.|+|.+ +|||||+||+|+|+..+. ..-.+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~--~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKA--KGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeecc--CCCceeecccceEEE
Confidence 9999999998776544 4457778888999999999999999 999999999999997554 556799999999998
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
+. .......+.||++|||||+++..+|+..+|||+.|||||-|+.|..||.+.+..... +.+..+.
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly------------e~I~~g~ 228 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY------------EQIKAGA 228 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH------------HHHhccc
Confidence 87 223334578999999999999999999999999999999999999999874332211 1111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.+-++... ....++..+|+.+||..||++|.|+.|.+.
T Consensus 229 ----yd~~~~~w--~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 ----YDYPSPEW--DTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----cCCCCccc--CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11111111 123456778999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=331.69 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=202.8
Q ss_pred HhhcccccccccccceEEEEEEecc---Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 562 (788)
..+.+.++||+|+||.||+|..... .....||||++.... ....+.+.+|+++++++. ||||+++++++.+.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 3456678999999999999986421 223479999996433 334567999999999996 99999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccC------------------------------------------------------------
Q 047157 563 LLVYELMPNGTLSNFLFHEG------------------------------------------------------------ 582 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 582 (788)
+|||||+++|+|.+++.+..
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 99999999999999885421
Q ss_pred -----------------------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccC
Q 047157 583 -----------------------------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK 627 (788)
Q Consensus 583 -----------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 627 (788)
..+++..+..++.||+.||.|||+. +|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~-- 271 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA-- 271 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe--
Confidence 2367778889999999999999998 999999999999998
Q ss_pred CCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccc
Q 047157 628 TLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEE 705 (788)
Q Consensus 628 ~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~ 705 (788)
.+..+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 272 ---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 272 ---QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred ---CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 7788999999999865432221 1222346778999999998899999999999999999997 8899864321110
Q ss_pred cccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 706 SEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.......+. ...........+.+++.+||+.||++||++.+|.++|+.+.+
T Consensus 349 -----------~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 -----------FYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -----------HHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 001111110 000112234678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=326.90 Aligned_cols=249 Identities=25% Similarity=0.300 Sum_probs=200.8
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
....|.+.+.||+|+||.||+|.... .....||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKN-EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEEC-CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 34457788999999999999998752 223589999886532 23456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~-----~~~~ikL~DFG~ 177 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLD-----KDGFIKMTDFGF 177 (340)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEEC-----CCCCEEEecCCC
Confidence 9999999999999999654 4688899999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 178 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------------~~~~i~ 241 (340)
T PTZ00426 178 AKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------------IYQKIL 241 (340)
T ss_pred CeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------------HHHHHh
Confidence 9865432 123568999999999999889999999999999999999999997542211 011111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
..... .+ ......+.+++.+||+.||++|+ ++++++++
T Consensus 242 ~~~~~-----~p-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 EGIIY-----FP-----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred cCCCC-----CC-----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11110 01 11234567899999999999995 89998875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.36 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=204.0
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEec-----CCeEEEE
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-----EDKRLLV 565 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~lV 565 (788)
.+.||+|+||.|..+..+ .++..||||++... .....++..+|+++|+.++|+||+.+++++.. -+..|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~--~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV 104 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDK--RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLV 104 (359)
T ss_pred cccccCcceeeEEEEEEc--CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEe
Confidence 467999999999999988 66789999999733 34456788999999999999999999998855 4578999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+|+| ..+|.+.++.. +.++...+..++.||++||.|+|+. +|+||||||+|+|++ .+..+||+|||+|+.
T Consensus 105 ~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n-----~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 105 FELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLN-----ADCDLKICDFGLARY 174 (359)
T ss_pred hhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeec-----cCCCEEeccccceee
Confidence 9999 66888888544 5588889999999999999999999 999999999999998 888899999999998
Q ss_pred cCCC-CCcccccccCCccccCcccc-cCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHH
Q 047157 646 LNKD-QTRTDTNMRGTMGYVAPEWL-RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISC 720 (788)
Q Consensus 646 ~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 720 (788)
.... .....+..+.|..|.|||++ ....|+.+.||||.|||+.||++|+..|.+.+...+.......+ .+.....
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 7543 12233567789999999987 45689999999999999999999999998875543322211110 0111112
Q ss_pred hhcccccccccCCCCCcc------cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLS------DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+.+......+...+.... -.......++|+.+||..||.+|+|++|++++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 222222222222221111 11234567899999999999999999999874
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=320.01 Aligned_cols=260 Identities=28% Similarity=0.394 Sum_probs=202.4
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e 567 (788)
+.+.++||+|+||.||+|..........+++|.++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 5667899999999999998874444446788887642 234456789999999999 79999999999999999999999
Q ss_pred cCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC
Q 047157 568 LMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~ 632 (788)
|+++++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~-----~~ 155 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG-----EN 155 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC-----CC
Confidence 999999999996532 2478899999999999999999998 999999999999998 77
Q ss_pred CcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchh
Q 047157 633 YMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDI 711 (788)
Q Consensus 633 ~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 711 (788)
..+||+|||++....... .......+..|+|||.+....++.++||||||+++|||++ |..||......+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------ 227 (297)
T cd05089 156 LASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------ 227 (297)
T ss_pred CeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 899999999986432111 1111223457999999998899999999999999999997 9999965422110
Q ss_pred hhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCCCC
Q 047157 712 VLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMP 780 (788)
Q Consensus 712 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p 780 (788)
......+. ...........+.+++.+||+.+|.+||+++++++.|+.+.+...+
T Consensus 228 ------~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 228 ------YEKLPQGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred ------HHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 01111110 0001112345678899999999999999999999999887765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=325.48 Aligned_cols=203 Identities=25% Similarity=0.423 Sum_probs=174.8
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
+....|.+.+.||+|+||.||++... .++..+++|.+.... ....+.+.+|++++++++||||+++++++.+++..+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHK--PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEEC--CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34566778899999999999999886 567789999876542 344567899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. .+|+|+||||+|||++ .++.+||+|||++
T Consensus 80 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~-----~~~~~kL~Dfg~~ 151 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVN-----SRGEIKLCDFGVS 151 (333)
T ss_pred EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEc-----CCCCEEEeeCCcc
Confidence 999999999999999654 4578889999999999999999974 2699999999999998 7788999999998
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELS 700 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~ 700 (788)
....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 152 GQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhhhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 7653221 12346889999999999989999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=312.69 Aligned_cols=251 Identities=26% Similarity=0.446 Sum_probs=200.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.+.+.+.||+|+||.||++..+ .+..+++|.+.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR---GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEec---CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3557789999999999999874 34579999886432 2345688899999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++......+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.+||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~-----~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVG-----EDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEEC-----CCCcEEECCcccceeccc
Confidence 999999999977666789999999999999999999999 999999999999998 788999999999876543
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ...... .
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------------~~~~~~-~- 218 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV------------ESVSAG-Y- 218 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH------------HHHHcC-C-
Confidence 22222222234467999999998899999999999999999999 78888654221110 001100 0
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
...........+.+++.+||+.+|++|||+.|+++.|.
T Consensus 219 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 219 -------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 00011123567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=338.60 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=200.9
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
|.+.+.||+|++|.||+|..... .+..|++|.+..........+.+|+.+++.++||||+++++++..++..+|||||+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~-~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSD-PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCC-CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 66789999999999999986522 25578888776555555667889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 570 PNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 570 ~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
++|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-----~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLM-----PTGIIKLGDFGFSKQY 219 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEEC-----CCCcEEEEeCcCceec
Confidence 999999988542 34578899999999999999999999 999999999999998 7889999999999876
Q ss_pred CCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 647 NKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 647 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+.
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------------~~~~~~~~~ 287 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------------IMQQVLYGK 287 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------------HHHHHHhCC
Confidence 44322 12334568999999999999999999999999999999999999996542211 001111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.... .......+.+++.+||+.||++||++++++.
T Consensus 288 ~~~~---------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 YDPF---------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCC---------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1100 1122356788999999999999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.41 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=208.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeeccc--chHHHHHHHHHHHHHhcCCCccccceEeeEEecCCe-EEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK-RLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lV 565 (788)
.|...+++|+|+||.++..+++ .....+++|.+.- .....++...+|+.++++++|||||.+.+.+.+++. .+||
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk--~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHK--SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred hhhhhhhcCccccchhhhhhhc--cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 4666789999999999999887 4455788887753 334555678899999999999999999999998887 9999
Q ss_pred EecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 566 YELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+|++||+|.+.+...+ ..++++.+..++.||+.|+.|||++ .|+|||||+.||+++ .+..|||+|||+|+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Niflt-----k~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLT-----KDKKVKLGDFGLAK 154 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhcc-----ccCceeecchhhhh
Confidence 99999999999997654 6789999999999999999999998 999999999999998 77889999999999
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.+..+... .....||+.|+.||++.+.+|..|+|||||||++|||++-+++|...+...... .....
T Consensus 155 ~l~~~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~------------ki~~~ 221 (426)
T KOG0589|consen 155 ILNPEDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL------------KINRG 221 (426)
T ss_pred hcCCchhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH------------HHhhc
Confidence 98766522 345789999999999999999999999999999999999999998764332211 11111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. ...+..+..++..++..|++.+|..||++.+++.+
T Consensus 222 ----~~-----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 ----LY-----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----cC-----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 11223456677888999999999999999999875
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.44 Aligned_cols=252 Identities=22% Similarity=0.228 Sum_probs=202.2
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|+||+||++... .++..||+|.++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREK--ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred ceEEEEEEeccCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 567789999999999999876 667799999987543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++......+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~-----~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLID-----RTGHIKLADFGSAARL 152 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEEC-----CCCCEEeccCCCCeEC
Confidence 99999999999977667789999999999999999999999 999999999999998 7889999999999876
Q ss_pred CCCCCcccccccCCccccCccccc------CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLR------NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
............||+.|+|||++. ...++.++||||||+++|||++|+.||........ . ..
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----------~-~~ 220 (330)
T cd05601 153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----------Y-NN 220 (330)
T ss_pred CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----------H-HH
Confidence 544433333456899999999986 45678999999999999999999999975422111 0 00
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.... ...+ ...........+.+++..|++ +|++|||+++++++
T Consensus 221 i~~~--~~~~----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 221 IMNF--QRFL----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHcC--CCcc----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1100 0000 111111234567788889997 99999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.46 Aligned_cols=260 Identities=30% Similarity=0.389 Sum_probs=211.7
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCCH
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTL 574 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL 574 (788)
+||+|.||+||.|++. .+++.+|||.+........+.+..|+.+.+.|+|.|||+++|.+.+++..-|.||.++||+|
T Consensus 582 VLGKGTYG~VYA~RD~--~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM--DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccc--cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 6999999999999887 88999999999877666777889999999999999999999999999999999999999999
Q ss_pred hHhhhccCCCC--CHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 575 SNFLFHEGQRP--GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 575 ~~~l~~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
.++|+.+-.++ ++.++-.+.+||++||.|||++ .|||||||-+|||++ .-.+.+||+|||-++.+..-. .
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvN----TySGvlKISDFGTsKRLAgin-P 731 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVN----TYSGVLKISDFGTSKRLAGIN-P 731 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEe----eccceEEecccccchhhccCC-c
Confidence 99998875555 7888888999999999999999 999999999999997 267899999999998775433 3
Q ss_pred ccccccCCccccCcccccCC--CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccc
Q 047157 653 TDTNMRGTMGYVAPEWLRNV--PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730 (788)
Q Consensus 653 ~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 730 (788)
....+.||..|||||++..+ .|.+++|||||||++.||.||++||--..... .+.. . ..+.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-----------AAMF--k----VGmy 794 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-----------AAMF--K----VGMY 794 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-----------Hhhh--h----hcce
Confidence 44568899999999999765 48899999999999999999999995321110 0000 0 0111
Q ss_pred cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH--HhhcCcCCCCCCCC
Q 047157 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH--MLEGTLEVGMPPLL 783 (788)
Q Consensus 731 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~~~pp~p 783 (788)
+..| ..+.+...+...++++|+.+||.+||+++++++ .|+--...+.||++
T Consensus 795 KvHP--~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls 847 (1226)
T KOG4279|consen 795 KVHP--PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS 847 (1226)
T ss_pred ecCC--CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence 1222 234455677888999999999999999999985 45444344555554
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=314.48 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=200.7
Q ss_pred hhcccccccccccceEEEEEEeccCc--ceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.+.+.+.||+|+||+||+|.....+. ...+++|.+.... .....++..|+..+++++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 44566899999999999998753222 2358888876433 2344678889999999999999999998754 557889
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+||+++|+|.+++......+++..+..++.||+.||.|||++ +++|+||||+|||++ .++.+||+|||+++.
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~-----~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLK-----SDSIVQIADFGVADL 158 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEc-----CCCcEEEcCCcccee
Confidence 999999999999987777889999999999999999999998 999999999999998 788999999999986
Q ss_pred cCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 646 LNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 646 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..+. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------~~~~----~~~ 226 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--------VPDL----LEK 226 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHH----HHC
Confidence 543222 12223456778999999998899999999999999999998 999986542211 1111 111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
+.... .+. .....+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 227 ~~~~~----~~~-----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 227 GERLA----QPQ-----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCcCC----CCC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11000 011 123456778899999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=324.83 Aligned_cols=261 Identities=29% Similarity=0.435 Sum_probs=202.6
Q ss_pred HhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEec-CCe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSE-EDK 561 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~ 561 (788)
..+.+.++||+|+||.||+|.... ..++..||+|+++... ....+.+.+|++++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 457778999999999999997542 1234689999986432 33446788999999999 89999999998865 457
Q ss_pred EEEEEecCCCCCHhHhhhccC-----------------------------------------------------------
Q 047157 562 RLLVYELMPNGTLSNFLFHEG----------------------------------------------------------- 582 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 582 (788)
.++++||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999985421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCC
Q 047157 583 -QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGT 660 (788)
Q Consensus 583 -~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt 660 (788)
..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++..+...... ......++
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~-----~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLS-----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEe-----CCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 2568899999999999999999999 999999999999998 7789999999999876433221 12234556
Q ss_pred ccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCccc
Q 047157 661 MGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSD 739 (788)
Q Consensus 661 ~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 739 (788)
..|+|||++.+..++.++|||||||++|||++ |+.||......+. +. ....... .. ..+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-------~~----~~~~~~~-~~--------~~~ 298 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-------FC----RRLKEGT-RM--------RAP 298 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-------HH----HHHhccC-CC--------CCC
Confidence 78999999999999999999999999999998 9999865321110 00 1111110 00 011
Q ss_pred HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 740 LERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 740 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
......+.+++.+||+.+|++||++.||+++|+.+++
T Consensus 299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1234578899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=317.64 Aligned_cols=269 Identities=24% Similarity=0.358 Sum_probs=203.8
Q ss_pred hhcccccccccccceEEEEEEe--ccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec--CCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--EDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 564 (788)
.+.+.+.||+|+||.||++... ....+..|++|.+........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4567789999999999999753 234567899999877666667789999999999999999999998754 346899
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+||+++++|.+++......+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~-----~~~~~~l~dfg~~~ 156 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVE-----SENRVKIGDFGLTK 156 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEEC-----CCCeEEECCCcccc
Confidence 9999999999999976666789999999999999999999999 999999999999998 77899999999998
Q ss_pred ccCCCCCcc--cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccc--ccc-h-hhhHHHHH
Q 047157 645 LLNKDQTRT--DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES--EEV-D-IVLSDWVI 718 (788)
Q Consensus 645 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~--~~~-~-~~~~~~~~ 718 (788)
......... .....++..|+|||.+.+..++.++||||||+++|||++|..++......... ... . ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 764432211 11122345699999999889999999999999999999988765432211000 000 0 00000000
Q ss_pred HHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 719 SCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
..... .............+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 237 ~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKN---------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhc---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111 111111122345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.26 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=198.9
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCC
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGT 573 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 573 (788)
.||+|+||.||+|.+.....+..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 489999999999988755666789999886553 334567999999999999999999999885 457899999999999
Q ss_pred HhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcc
Q 047157 574 LSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653 (788)
Q Consensus 574 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 653 (788)
|.+++......+++..++.++.||+.||.|||++ +++||||||+||+++ .+..+||+|||++..........
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~-----~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLV-----NQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEc-----CCCcEEeccCCccccccCCccce
Confidence 9999976667789999999999999999999998 999999999999998 77899999999998654332221
Q ss_pred --cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccccc
Q 047157 654 --DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730 (788)
Q Consensus 654 --~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 730 (788)
.....++..|+|||.+....++.++||||||+++||+++ |+.||......+. ......+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------------~~~~~~~~~---- 216 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV------------MSFIEQGKR---- 216 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH------------HHHHHCCCC----
Confidence 111223568999999988889999999999999999996 9999965422110 011111110
Q ss_pred cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 731 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
...+....+.+.+++..||+.||++||++.+|.+.|+..
T Consensus 217 -----~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 -----LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 001112346777899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.16 Aligned_cols=258 Identities=27% Similarity=0.487 Sum_probs=204.8
Q ss_pred HhhcccccccccccceEEEEEEeccC-cceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..+...+.||+|+||.||+|...... ....+++|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 34566789999999999999986322 23479999886542 44466889999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++......+++.++..++.|++.||.|||+. +++|+||||+||+++ .++.+||+|||++..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~-----~~~~~kl~dfg~~~~ 156 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVN-----SNLECKVSDFGLSRV 156 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEc-----CCCcEEECCCcccee
Confidence 999999999999977667789999999999999999999999 999999999999998 788999999999986
Q ss_pred cCCCCCcccc--cccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 646 LNKDQTRTDT--NMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 646 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
.......... ....+..|+|||.+....++.++||||||+++|||++ |+.||......+ . .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--------~----~~~i~ 224 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--------V----MKAIN 224 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--------H----HHHHh
Confidence 6433222111 1223457999999988889999999999999999997 999986432111 0 01111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
... ...........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 225 ~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 DGF---------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 0001112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.62 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=202.2
Q ss_pred HhhcccccccccccceEEEEEEeccC---cceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKD---TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
..+.+.+.||+|++|.||+|.+.... ....|++|.+.... ......+.+|+.++++++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 44566789999999999999987321 56789999886443 334567899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccC------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 564 LVYELMPNGTLSNFLFHEG------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++... ....+||
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~--~~~~~kl 160 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKG--PGRVAKI 160 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccC--CCcceEe
Confidence 9999999999999986543 2578999999999999999999999 999999999999998432 3457999
Q ss_pred eecCCccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHH
Q 047157 638 SDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--------~~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--------ME 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------HH
Confidence 9999998763322111 112233567999999998899999999999999999997 9999875432111 11
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
. ..... .. .........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 233 ~----~~~~~-------~~--~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 233 F----VTGGG-------RL--DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred H----HHcCC-------cC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 0 10000 00 0111224578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.24 Aligned_cols=248 Identities=29% Similarity=0.434 Sum_probs=197.6
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
+||+|+||.||+|.++...++..+|+|.++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999987655677899999886432 345678999999999999999999999885 45678999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||++.........
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~-----~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLV-----TQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEc-----CCCeEEECCCccccccCCCCCe
Confidence 999999644 4688999999999999999999998 999999999999998 7788999999999876543322
Q ss_pred c--cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 653 T--DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 653 ~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .....++..|+|||.+....++.++||||||+++|||++ |+.||......+ .. .........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~----~~i~~~~~~-- 217 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------VT----QMIESGERM-- 217 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HH----HHHHCCCCC--
Confidence 1 112234578999999988889999999999999999998 999997542211 11 111111100
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
. ........+.+++.+||+.||++||++.+|.+.|++
T Consensus 218 -----~--~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 -----E--CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -----C--CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 0 011234567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.03 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=201.7
Q ss_pred HhhcccccccccccceEEEEEEec--cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRL--KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..+.+.+.||+|+||.||+|.... ...+..+++|.+.... ......+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 456677899999999999998642 2355789999987433 3445688999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhcc----------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCC
Q 047157 565 VYELMPNGTLSNFLFHE----------------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT 628 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~----------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 628 (788)
||||+++++|.+++... ...+++.+...++.|++.||.|||++ +|+|+||||+||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~--- 158 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG--- 158 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc---
Confidence 99999999999998532 12467888999999999999999999 999999999999998
Q ss_pred CCCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcccccccc
Q 047157 629 LDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEES 706 (788)
Q Consensus 629 ~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~ 706 (788)
.+..+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 159 --~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~- 235 (283)
T cd05090 159 --EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV- 235 (283)
T ss_pred --CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 778899999999986543221 11223345678999999988889999999999999999998 8889865321110
Q ss_pred ccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 707 EEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
........... .......++.+++.+||+.||++||++.+|+++|..
T Consensus 236 -----------~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 -----------IEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----------HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111100 111224567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=320.06 Aligned_cols=258 Identities=29% Similarity=0.433 Sum_probs=201.3
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV 565 (788)
..+.+.+.||+|+||.||+|.+...+....+++|.+... .....+.+.+|++++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 456678999999999999999864444456788877643 244556888999999999 899999999999999999999
Q ss_pred EecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCC
Q 047157 566 YELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD 630 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 630 (788)
+||+++++|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~----- 158 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG----- 158 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEec-----
Confidence 99999999999996432 2568899999999999999999998 999999999999998
Q ss_pred CCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccc
Q 047157 631 TNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEV 709 (788)
Q Consensus 631 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 709 (788)
.++.+||+|||++...... ........+..|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---- 232 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---- 232 (303)
T ss_pred CCCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH----
Confidence 7789999999998643211 11111234567999999988889999999999999999998 9999864422110
Q ss_pred hhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.. ...... .+. ........+.+++.+||+.+|++||++++++++|+.+.+
T Consensus 233 ----~~----~~~~~~-------~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 233 ----YE----KLPQGY-------RLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred ----HH----HHhcCC-------cCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 010000 000 011123567889999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=324.97 Aligned_cols=243 Identities=26% Similarity=0.301 Sum_probs=195.3
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
+.||+|+||.||++... .++..||+|.+.... ......+.+|++++..++||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEK--ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46899999999999876 667799999987542 2334567889999999999999999999999999999999999
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
+++|..++... ..+++..+..++.||+.||.|||+ . +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~-----~~~~~kL~Dfg~~~~~~~~ 149 (325)
T cd05594 79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLD-----KDGHIKITDFGLCKEGIKD 149 (325)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEEC-----CCCCEEEecCCCCeecCCC
Confidence 99999888544 568899999999999999999997 6 999999999999998 7889999999998754322
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.. ......|++.|+|||++.+..++.++||||||+++|||++|+.||......... ........
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~------------~~i~~~~~--- 213 (325)
T cd05594 150 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------------ELILMEEI--- 213 (325)
T ss_pred Cc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH------------HHHhcCCC---
Confidence 21 122356899999999999999999999999999999999999999754321110 00100100
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
.. +......+.+++.+||+.||++|+ ++++++++
T Consensus 214 -----~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 -----RF--PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -----CC--CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00 111235677899999999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.98 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=201.8
Q ss_pred HHHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCe
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 561 (788)
....+.+.+.||+|+||.||+|.... ...+..||+|.+.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34567778999999999999998642 2345679999885432 3345678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccC---------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC
Q 047157 562 RLLVYELMPNGTLSNFLFHEG---------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~ 632 (788)
.++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++ ++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~-----~~ 155 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA-----ED 155 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEc-----CC
Confidence 999999999999999986532 2357788899999999999999998 999999999999998 78
Q ss_pred CcEEEeecCCccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccch
Q 047157 633 YMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVD 710 (788)
Q Consensus 633 ~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 710 (788)
+.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------ 229 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------ 229 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 899999999987654322211 112345678999999998899999999999999999999 688886542211
Q ss_pred hhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 711 IVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
.. ........... .......+.+++.+||+.||++|||+.|++++|++
T Consensus 230 --~~----~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 230 --VL----RFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --HH----HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00 11111111111 11223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.70 Aligned_cols=252 Identities=25% Similarity=0.309 Sum_probs=203.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||+||+|... .++..||+|++.... ......+.+|++++..++||||+++++++.+++..++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDK--DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEEC--CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 3567789999999999999886 567799999987543 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~-----~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILID-----ADGHIKLADFGLCKK 150 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEEC-----CCCCEEeecCCCCcc
Confidence 9999999999999765 6788999999999999999999998 999999999999998 788999999999987
Q ss_pred cCCCC----------------------------CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCC
Q 047157 646 LNKDQ----------------------------TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHI 697 (788)
Q Consensus 646 ~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~ 697 (788)
..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence 64433 11223356899999999999999999999999999999999999999
Q ss_pred CccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-HHHHHHH
Q 047157 698 ELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-MKKVIHM 770 (788)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~ 770 (788)
......+.. ...... . ............+.+.+++..|++ ||.+||+ ++|++++
T Consensus 231 ~~~~~~~~~------------~~i~~~--~----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 231 YSDTLQETY------------NKIINW--K----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCHHHHH------------HHHhcc--C----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 765321110 001000 0 000011111135667888999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.88 Aligned_cols=259 Identities=26% Similarity=0.473 Sum_probs=206.1
Q ss_pred HHhhcccccccccccceEEEEEEeccC-cceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
...+.+.+.||+|+||.||+|.....+ ....+++|.++... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 345677899999999999999875332 34579999886532 3446789999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++......+++.++..++.|++.||.|||+. +++|+||||+|||++ .++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~-----~~~~~~l~dfg~~~ 154 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVN-----SNLVCKVSDFGLSR 154 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEEC-----CCCeEEeCCCCccc
Confidence 9999999999999987766789999999999999999999999 999999999999998 78899999999998
Q ss_pred ccCCCCCccc--ccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHh
Q 047157 645 LLNKDQTRTD--TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 645 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
.......... ....++..|+|||.+.+..++.++||||||+++||+++ |+.||......+. .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--------~~----~~ 222 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--------IK----AI 222 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--------HH----HH
Confidence 7654332211 11223567999999998899999999999999999886 9999865422110 00 01
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
... . ........+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 223 ~~~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 EEG-Y--------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred hCC-C--------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111 0 0001112345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.88 Aligned_cols=258 Identities=27% Similarity=0.493 Sum_probs=204.6
Q ss_pred HhhcccccccccccceEEEEEEeccC-cceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..+.+.+.||+|+||.||+|...... ....|+||.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45678899999999999999986432 2347999998754 344567899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++......+++.++..++.|++.||.|||++ +++|+||||+||+++ .+..+||+|||++..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~-----~~~~~kl~dfg~~~~ 155 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVN-----SNLVCKVSDFGLSRF 155 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEc-----CCCcEEECCCccccc
Confidence 999999999999977667789999999999999999999998 999999999999998 778999999999876
Q ss_pred cCCCCCcc-ccc-c--cCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHH
Q 047157 646 LNKDQTRT-DTN-M--RGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 646 ~~~~~~~~-~~~-~--~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
........ ... . ..+..|+|||.+.+..++.++||||||+++||+++ |..||......+ .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--------~~~~i--- 224 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VINAI--- 224 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--------HHHHH---
Confidence 54322211 111 1 12457999999999999999999999999999886 999986542211 11111
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
... . ......+.+..+.+++.+||+.+|++||++++|+++|+++
T Consensus 225 -~~~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 -EQD-Y--------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -HcC-C--------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0 0001112345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=328.41 Aligned_cols=255 Identities=21% Similarity=0.230 Sum_probs=201.7
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
....|.+.+.||+|+||.||++... .++..+|+|.+.+.. ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHK--SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3456777899999999999999886 667799999986532 23345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++|+|.+++... .++...+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~-----~~~~~kL~DfG~ 188 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD-----KSGHLKLADFGT 188 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEc-----CCCCEEEEeccc
Confidence 9999999999999998543 577888889999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCC----CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNV----PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
+...............||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ .
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------------~ 256 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------------Y 256 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------------H
Confidence 987654333233345789999999998653 478899999999999999999999976432110 0
Q ss_pred HHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 047157 719 SCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNL--RPSMKKVIHM 770 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 770 (788)
........ .............+.+++..||+.+|++ ||+++|++++
T Consensus 257 ~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 SKIMDHKN------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHcCCC------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111000 0111111223567788999999999988 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=328.55 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=194.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
+.+.+.||+|+||+||+|... .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKV--DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred ceEEEEEeecCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 456789999999999999886 677799999996532 334567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++..+
T Consensus 81 E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~-----~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 81 DYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILID-----LDGHIKLTDFGLCTGF 151 (381)
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEEC-----CCCCEEEeeCcCCccc
Confidence 999999999998654 4578888889999999999999998 999999999999998 7789999999997643
Q ss_pred CCCCC----------------------------------------------cccccccCCccccCcccccCCCCCccCcc
Q 047157 647 NKDQT----------------------------------------------RTDTNMRGTMGYVAPEWLRNVPVTTKVDV 680 (788)
Q Consensus 647 ~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV 680 (788)
..... .......||+.|+|||.+.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence 21000 00123468999999999998899999999
Q ss_pred hhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhH--ccCCCC
Q 047157 681 FSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLW--CNHPDP 758 (788)
Q Consensus 681 wSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP 758 (788)
|||||++|||++|+.||......+... . .... .. ............++.+++.+ |+..+|
T Consensus 232 wSlG~il~elltG~~Pf~~~~~~~~~~-----------~-i~~~--~~----~~~~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAPTPTETQL-----------K-VINW--EN----TLHIPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred eehhhHHHHHHhCCCCCcCCCHHHHHH-----------H-HHcc--cc----ccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence 999999999999999997643211100 0 0000 00 00111111123455566655 566777
Q ss_pred CCCCCHHHHHHH
Q 047157 759 NLRPSMKKVIHM 770 (788)
Q Consensus 759 ~~RPt~~evl~~ 770 (788)
..||+++|++++
T Consensus 294 ~~R~~~~~~l~h 305 (381)
T cd05626 294 LGRNGADDIKAH 305 (381)
T ss_pred cCCCCHHHHhcC
Confidence 779999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.85 Aligned_cols=269 Identities=24% Similarity=0.363 Sum_probs=201.0
Q ss_pred cccccccccccceEEEEEEe--ccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecC--CeEEEE
Q 047157 491 GFSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DKRLLV 565 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lV 565 (788)
.+.+.||+|+||+||++... ....+..||+|.+.... ....+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 66789999999999887643 22456689999987543 34567888999999999999999999988653 468899
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... .+++.++..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~-----~~~~~~l~dfg~~~~ 156 (283)
T cd05080 87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLD-----NDRLVKIGDFGLAKA 156 (283)
T ss_pred ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEc-----CCCcEEEeecccccc
Confidence 9999999999998543 589999999999999999999999 999999999999998 778999999999987
Q ss_pred cCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 646 LNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 646 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .. .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~-----~~~~~~~~~ 230 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MI-----GPKQGQMTV 230 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hh-----cccccccch
Confidence 6433221 112234566799999998889999999999999999999999998643211000 00 000000000
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
..+...+...............+.+++..||+.||++|||+++|+++|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0001111111111111223467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=317.47 Aligned_cols=263 Identities=25% Similarity=0.427 Sum_probs=220.6
Q ss_pred HHHHHhhcccccccccccceEEEEEEec--cCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRL--KDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~--~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
+|.++.....+.||.|-||.||+|++.. ++....||||..+.+ ..+..+.|+.|..+|++++||||++++|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 3444555566899999999999999874 345567999998763 45567899999999999999999999999965 5
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..+||||.++-|.|..||+.+...++......++.||..||+|||+. ..|||||..+|||+. ...-+||+||
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVs-----Sp~CVKLaDF 535 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVS-----SPQCVKLADF 535 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeec-----Ccceeeeccc
Confidence 78999999999999999999989999999999999999999999999 999999999999998 7778999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHH-hCCCCCCccccccccccchhhhHHHHHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII-CGRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
|+++.+..+.....+...-...|||||-+.-..++.++|||-|||.+||++ .|..||.+....+...
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~------------ 603 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG------------ 603 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE------------
Confidence 999998877766666556678899999999999999999999999999988 5899998754332211
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.+....+...+...+..+.-|+.+||+.||.+||.+.|+...|..+++
T Consensus 604 ---------~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 ---------HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---------EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 122233334455667788899999999999999999999888865543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=325.35 Aligned_cols=242 Identities=27% Similarity=0.303 Sum_probs=201.5
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 563 (788)
....+.++||+|.||+|+++..+ .+++.+|||.+++.. .+..+..+.|.+++... +||.|++++..|+..+++|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k--~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELK--GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEc--CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 34567799999999999999988 677799999998764 44556778888888877 5999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+.||++..+ .....+++..+.-++..|+.||.|||++ +||+||||.+||||| .+|++||+|||++
T Consensus 446 fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD-----~eGh~kiADFGlc 515 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLD-----TEGHVKIADFGLC 515 (694)
T ss_pred EEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEc-----ccCcEEecccccc
Confidence 99999999994333 3446788999999999999999999999 999999999999999 8999999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
+....... ...+++||+.|||||++.+..|+.++|.|||||+||||+.|..||.+.+.++.- ..+..
T Consensus 516 Ke~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F------------dsI~~ 582 (694)
T KOG0694|consen 516 KEGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF------------DSIVN 582 (694)
T ss_pred cccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------------HHHhc
Confidence 97543333 445699999999999999999999999999999999999999999987544321 11111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM 764 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 764 (788)
.+...+.....+.+.++.++|..+|++|--+
T Consensus 583 ----------d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 ----------DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----------CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1222333445678889999999999999865
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.93 Aligned_cols=246 Identities=24% Similarity=0.388 Sum_probs=191.6
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
.+.++||+|+||+||++... .+++.||||.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHR--PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred hhhhhccCCCCeEEEEEEEC--CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 34578999999999999876 567799999986432 344568899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+.. ...+..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..+...
T Consensus 155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~-----~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 155 DGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLIN-----SAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEc-----CCCCEEEcccccceecccc
Confidence 999986532 346677889999999999999999 999999999999998 7889999999999876433
Q ss_pred CCcccccccCCccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRN-----VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.. ......|+..|+|||.+.. ...+.++|||||||++|||++|+.||......+. ......... .
T Consensus 222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--------~~~~~~~~~-~ 291 (353)
T PLN00034 222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--------ASLMCAICM-S 291 (353)
T ss_pred cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--------HHHHHHHhc-c
Confidence 22 1223568999999998743 2345689999999999999999999973321110 000000000 0
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..+. .......++.+++.+||+.||++|||+.|++++
T Consensus 292 -------~~~~--~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 -------QPPE--APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------CCCC--CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 111234578899999999999999999999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.65 Aligned_cols=262 Identities=22% Similarity=0.280 Sum_probs=196.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.+.||+|+||.||+|... .++..||+|.+.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSK--VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cceEeeeEEecCCEEEEEEEEC--CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4667789999999999999886 567789999986443 2233467889999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|++ ++|.+++......++...+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~-----~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLIS-----DTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC-----CCCCEEECCCCcceecc
Confidence 995 688888876666788899999999999999999999 999999999999998 77899999999987543
Q ss_pred CCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc-
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN- 725 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 725 (788)
... .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+.. .........
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------~~~~-~~~~~~~~~~ 226 (303)
T cd07869 155 VPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD------QLER-IFLVLGTPNE 226 (303)
T ss_pred CCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH------HHHH-HHHHhCCCCh
Confidence 222 12233567899999998865 4578899999999999999999999975421110 0000 000000000
Q ss_pred --------ccccccC-----CCCCc----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 --------LQVLVSH-----DPEVL----SDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 --------~~~l~~~-----~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
....... .+... ........+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 00000 00012246778999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.23 Aligned_cols=261 Identities=23% Similarity=0.377 Sum_probs=206.3
Q ss_pred HHHhhcccccccccccceEEEEEEecc-Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
...++.+.++||+|+||.||+|..... .....|++|...... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 345567789999999999999987533 334578999887654 4556789999999999999999999998875 5578
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++++|.+++......+++..+..++.|++.||.|||+. +++|+||||+||+++ .++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~-----~~~~~~l~d~g~~ 154 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVS-----SPDCVKLGDFGLS 154 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEe-----cCCCeEEccCcee
Confidence 99999999999999977666789999999999999999999998 999999999999998 7789999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
...............++..|+|||.+....++.++||||||+++||+++ |+.||......+.. . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--------~----~~~ 222 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI--------G----RIE 222 (270)
T ss_pred eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--------H----HHH
Confidence 8665443222222334568999999988889999999999999999986 99999654321110 0 010
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
... .+. ........+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 223 ~~~-------~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 223 NGE-------RLP--MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred cCC-------cCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 100 000 011224578889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=321.36 Aligned_cols=243 Identities=26% Similarity=0.339 Sum_probs=194.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
++||+|+||.||+|... .++..||+|.+.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELK--GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEEC--CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 46899999999999876 667799999987542 23345677888888865 7999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~-----~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 79 NGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLD-----AEGHCKLADFGMCKEGILN 149 (321)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEEC-----CCCCEEEeecccceecccC
Confidence 999999988654 5678889999999999999999999 999999999999998 7889999999998754322
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.. ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+.. ........
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~------------~~i~~~~~--- 213 (321)
T cd05591 150 GV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF------------ESILHDDV--- 213 (321)
T ss_pred Cc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH------------HHHHcCCC---
Confidence 21 223456899999999999999999999999999999999999999765322110 11111110
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-------CHHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-------SMKKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~evl~~ 770 (788)
. .+......+.+++..||+.||++|| ++++++++
T Consensus 214 -----~--~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 -----L--YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -----C--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0 0111235678899999999999999 88888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.62 Aligned_cols=245 Identities=25% Similarity=0.281 Sum_probs=194.9
Q ss_pred ccccccccceEEEEEEec-cCcceeeeeeecccch----HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 494 KLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.||+|+||.||++.... ...+..||+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 579999999999998642 2456789999987532 23345678899999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++... ..+.+..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~-----~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLD-----AQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEC-----CCCCEEEeeCcCCeeccc
Confidence 9999999998654 4567888888999999999999999 999999999999998 788999999999875432
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 153 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------------~~~~~~~~~~-- 217 (323)
T cd05584 153 EGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------------TIDKILKGKL-- 217 (323)
T ss_pred CCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------------HHHHHHcCCC--
Confidence 222 2223568999999999998889999999999999999999999997542211 0111111110
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
.. +......+.+++.+||+.||++|| ++++++++
T Consensus 218 ------~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 ------NL--PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ------CC--CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 00 111235678899999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.07 Aligned_cols=246 Identities=27% Similarity=0.322 Sum_probs=195.2
Q ss_pred ccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 496 lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
||+|+||+||++... .++..+|+|.+..... ...+.+..|++++++++||||+++.+++..+...++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMR--ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEc--cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 699999999999876 5677999999865422 23356788999999999999999999999999999999999999
Q ss_pred CHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 573 TLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 573 sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
+|..++.. ....+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~-----~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLD-----NDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC-----CCCCEEEeeCccceecCCC
Confidence 99988753 335688999999999999999999999 999999999999998 7788999999999765433
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... . ......
T Consensus 151 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-------~-~~~~~~------- 214 (280)
T cd05608 151 QSK-TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-------E-LKQRIL------- 214 (280)
T ss_pred Ccc-ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-------H-HHHhhc-------
Confidence 221 223568999999999999999999999999999999999999997542211000 0 000000
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
.... .........+.+++.+||+.||++|| ++++++++
T Consensus 215 -~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 -NDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -ccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0000 11122345678899999999999999 78888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=321.36 Aligned_cols=242 Identities=27% Similarity=0.387 Sum_probs=193.5
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
++||+|+||+||++..+ .++..||+|.+.+.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLK--ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEc--CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 46899999999999876 567799999987542 23445677888888776 7999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~-----~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 79 NGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLD-----HEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred CCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEEC-----CCCcEEEeeCCCCeecCcC
Confidence 999999988654 5688899999999999999999999 999999999999998 7889999999998754222
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. .........
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------------~~~i~~~~~--- 213 (320)
T cd05590 150 G-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------------FEAILNDEV--- 213 (320)
T ss_pred C-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------------HHHHhcCCC---
Confidence 1 122335689999999999999999999999999999999999999975432111 111111110
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH------HHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM------KKVIH 769 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 769 (788)
. ........+.+++.+||+.||++||++ +++++
T Consensus 214 -----~--~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 214 -----V--YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred -----C--CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 0 011124567889999999999999998 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.68 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=198.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
++||+|+||.||+|... .+..+++|.+.... ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK---DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec---CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999863 45689999886543 334457899999999999999999999999999999999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
+|.+++......+++..+..++.|++.||.|||++ +++|+||||+||+++ .++.+||+|||++.........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~-----~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVG-----ENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEc-----CCCeEEECCCccceeccccccc
Confidence 99999976666789999999999999999999998 999999999999998 7889999999998754433222
Q ss_pred ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccccccccc
Q 047157 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVS 731 (788)
Q Consensus 653 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 731 (788)
......++..|+|||++....++.++||||||+++||+++ |..||........ ........
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------------~~~~~~~~------ 211 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------------REQVEKGY------ 211 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------------HHHHHcCC------
Confidence 2222334667999999998899999999999999999998 8889864422110 01111110
Q ss_pred CCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 732 HDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 732 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
.. .........+.+++.+|++.+|++||++.|+++.|.
T Consensus 212 -~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 -RM--SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -CC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00 011123467888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.52 Aligned_cols=246 Identities=26% Similarity=0.295 Sum_probs=193.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHh---cCCCccccceEeeEEecCCeEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKII---GRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~ 563 (788)
|.+.+.||+|+||.||++... .++..||||.++... ....+.+.+|++++ ++++||||+++++++.+.+..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK--KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 356789999999999999886 667799999987542 22334566666554 5678999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++++|..++.. ..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++
T Consensus 79 lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~-----~~~~~kL~Dfg~~ 148 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLD-----TEGFVKIADFGLC 148 (324)
T ss_pred EEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEEC-----CCCcEEeCcccCC
Confidence 99999999999988843 4689999999999999999999999 999999999999998 7889999999998
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
....... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.. .....
T Consensus 149 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------------~~i~~ 215 (324)
T cd05589 149 KEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------------DSIVN 215 (324)
T ss_pred ccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------------HHHHh
Confidence 7543222 1223457899999999999999999999999999999999999999754321110 01111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
.. +.. .......+.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~--------~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 216 DE--------VRY--PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CC--------CCC--CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 11 110 111245677899999999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.55 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=202.7
Q ss_pred HHhhcccccccccccceEEEEEEecc---Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
...+.+.+.||+|+||.||+|..... ..+..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 34566778999999999999987532 235689999997543 33456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccC
Q 047157 563 LLVYELMPNGTLSNFLFHE---------------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK 627 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 627 (788)
++++||+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~-- 158 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF-- 158 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec--
Confidence 9999999999999998532 23467888999999999999999998 999999999999998
Q ss_pred CCCCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccc
Q 047157 628 TLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEE 705 (788)
Q Consensus 628 ~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~ 705 (788)
++..+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 159 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 234 (283)
T cd05091 159 ---DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD- 234 (283)
T ss_pred ---CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 778899999999886543222 11223345778999999988889999999999999999998 778886532211
Q ss_pred cccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 706 SEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
............ ........+.+++..||+.+|++||++++|++.|+.
T Consensus 235 -----------~~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 -----------VIEMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----------HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111111110 111234567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.09 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=201.5
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...|.+.++||+|+||.||+|... +. ..|++|.++.... ..+.+.+|++++++++||||+++++++.+ ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWN--GT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEec--CC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 456788899999999999999874 33 4699999875322 34578999999999999999999998754 5679999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++... +..+++..+..++.|++.||+|||+. +|+|+||||+||+++ +++.+||+|||.+..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~-----~~~~~~L~dfg~~~~ 151 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG-----ENLVCKVADFGLARL 151 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEc-----CCCcEEeccCCceee
Confidence 999999999999753 34578999999999999999999998 999999999999998 788999999999986
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.............++..|+|||...+..++.++||||||+++|||++ |+.||......+. .......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------------~~~~~~~ 219 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------------LDQVERG 219 (262)
T ss_pred ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------------HHHHhcC
Confidence 65433222223446678999999988899999999999999999999 7888864421110 0111110
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
. ......+..+.+.+++.+|++.||++||+++++++.|+..
T Consensus 220 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 Y---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred C---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 0011123456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.22 Aligned_cols=256 Identities=25% Similarity=0.293 Sum_probs=212.4
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHH---HHHHHHHHHHHhcCCC-ccccceEeeEEecCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK---TNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 562 (788)
...|.+.+.||+|.||.||+++.+ .++..+|+|.+.+.... ..+.+.+|+++|+++. |||||.+++++++....
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~--~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREK--STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEec--CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 445777799999999999999987 66889999999765432 3468999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++|||++.||.|.+.+.+. .+++.....++.||+.++.|||+. +|+||||||+|+|+..... .++.+|++|||+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~-~~~~ik~~DFGl 185 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDE-GSGRIKLIDFGL 185 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccC-CCCcEEEeeCCC
Confidence 9999999999999999776 399999999999999999999998 9999999999999985431 246899999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... .+.
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------------~i~ 251 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------------AIL 251 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------------HHH
Confidence 998776 334556899999999999999999999999999999999999999998764322111 111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+.. ......-....+.+.+++..|+..||.+|+|+.+++++
T Consensus 252 ~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 RGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1211 11111112335677889999999999999999999985
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=310.61 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=209.6
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|-|+.|-+|++. -++..||||++.+.. .-....+.+|++.|+.++|||||++|++......+|||+|
T Consensus 20 YDLekTlG~GHFAVVKLArHV--FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHV--FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred ehhhhhhcCCceehhhhhhhh--cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 556788999999999999887 678899999997643 2334578899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
.-++|+|.+|+.+....+.+....+++.||+.|+.|+|+. .+|||||||+||.+. ..-+-+||.|||++..+.
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFF----EKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFF----EKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEe----eecCceEeeeccccccCC
Confidence 9999999999999889999999999999999999999999 999999999999986 267899999999998876
Q ss_pred CCCCcccccccCCccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVT-TKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
+.... +..+|+..|.|||++.+..|+ ++.||||||||||.|++|+.||+..+..+..
T Consensus 171 PG~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-------------------- 228 (864)
T KOG4717|consen 171 PGKKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-------------------- 228 (864)
T ss_pred Ccchh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh--------------------
Confidence 65443 456899999999999999987 6899999999999999999999754332211
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..++ +-...-+.....++.+||..||..||.+|-+.+||+.
T Consensus 229 TmIm--DCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 229 TMIM--DCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhh--cccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1111 1112223455678999999999999999999999975
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.66 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=203.3
Q ss_pred HhhcccccccccccceEEEEEEec---cCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..+.+.++||+|+||.||++.... ...+..+++|.+........+.+.+|++++++++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 345567899999999999997531 23456899999887666677889999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCC
Q 047157 565 VYELMPNGTLSNFLFHEG--------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD 630 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 630 (788)
|+||+++++|.+++.... ..+++..++.++.||+.||+|||+. +++||||||+|||++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~----- 156 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG----- 156 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc-----
Confidence 999999999999986542 2478899999999999999999998 999999999999998
Q ss_pred CCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcccccccccc
Q 047157 631 TNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEE 708 (788)
Q Consensus 631 ~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~ 708 (788)
+++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--- 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---
Confidence 788999999999876533221 11122335678999999999999999999999999999998 8888854321110
Q ss_pred chhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 709 VDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
......+.. . .........+.+++.+||+.||++||+++||++.|++
T Consensus 234 ---------~~~~~~~~~-------~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 ---------IECITQGRE-------L--ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ---------HHHHHcCcc-------C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000111100 0 0011223567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.87 Aligned_cols=261 Identities=28% Similarity=0.409 Sum_probs=205.4
Q ss_pred HHHhhcccccccccccceEEEEEEecc---Ccceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCC
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED 560 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 560 (788)
....+.+.+.||+|+||.||++..... .....+++|.+.... .....++.+|++++.++ +||||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 344566778999999999999987632 234689999887532 34456788999999999 8999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 561 KRLLVYELMPNGTLSNFLFHE---------------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
..+++|||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999998532 34678999999999999999999998 999999999999998
Q ss_pred cCCCCCCCcEEEeecCCccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccc
Q 047157 626 LKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVE 703 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~ 703 (788)
.++.+||+|||++..+....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 167 -----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 167 -----EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred -----CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 78899999999998765432211 122335678999999988899999999999999999997 88888654221
Q ss_pred cccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
+. ........ ...........+.+++.+||+.||++|||++|+++.|+++.
T Consensus 242 ~~------------~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 EL------------FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH------------HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 01111110 00111123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.45 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=216.5
Q ss_pred HHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 483 QELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 483 ~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
-|+++......++||-|.||.||.|+++ .-...||||.++.+.- ..++|++|..+|+.++|||+|+++|+|..+...
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWK--kyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeee--ccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3455555566789999999999999998 6667899999986643 457999999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQ-RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
|||+|||..|+|.+||+...+ ..+....+.++.||+.|+.||..+ ++|||||..+|.|+. ++..+|++|||
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVg-----EnhiVKvADFG 410 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVG-----ENHIVKVADFG 410 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhcccc-----ccceEEeeccc
Confidence 999999999999999987644 456677789999999999999999 999999999999998 88899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHH
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
+++++..+.........-.+.|.|||-+....++.|+|||+|||+||||.| |-.||.+.+... +.
T Consensus 411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq------------VY-- 476 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------VY-- 476 (1157)
T ss_pred hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH------------HH--
Confidence 999987665544444455778999999999999999999999999999997 667887643211 11
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.++...-....+..+++.+.+|++.||+.+|.+||++.|+-+.+|.+.
T Consensus 477 -------~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 477 -------GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -------HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 122222333334456678889999999999999999999999887654
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.67 Aligned_cols=242 Identities=28% Similarity=0.351 Sum_probs=190.4
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcC-CCccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGR-THHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
++||+|+||.||+|... .++..||+|.+.... ....+.+..|..++.. .+||||+++++++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELK--GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46899999999999886 667789999987543 2233455667777764 48999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~-----~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 79 NGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLD-----KDGHIKIADFGMCKENMNG 149 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEEC-----CCCCEEEccCcCCeECCCC
Confidence 999999988654 4688889999999999999999998 999999999999998 7789999999999754322
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. . ......
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-----------~-~~i~~~----- 211 (316)
T cd05592 150 E-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-----------F-DSILND----- 211 (316)
T ss_pred C-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-----------H-HHHHcC-----
Confidence 2 222345689999999999999999999999999999999999999975432111 0 001100
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMK-KVIH 769 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 769 (788)
.+.. +......+.+++.+||+.||++||++. ++++
T Consensus 212 ---~~~~--~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 ---RPHF--PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ---CCCC--CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0000 111234567889999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.35 Aligned_cols=254 Identities=25% Similarity=0.271 Sum_probs=198.1
Q ss_pred hcccccccccccceEEEEEEec-cCcceeeeeeecccch----HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 563 (788)
|.+.+.||+|+||.||++.... ...+..||+|.+.+.. ....+.+.+|+.++..+ +||||+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 5567899999999999987642 2456789999986532 23345678899999999 5999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 82 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~-----~~~~~kl~DfG~~ 152 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLD-----SEGHVVLTDFGLS 152 (332)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEEC-----CCCCEEEeeCcCC
Confidence 999999999999998654 5678899999999999999999999 999999999999998 7789999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
...............||+.|+|||.+.+. .++.++||||||+++|||++|+.||.......... .......
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--------~~~~~~~ 224 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--------EVSRRIL 224 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--------HHHHHHh
Confidence 86544333333346789999999999765 47889999999999999999999996532211100 0111111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
. ..+.. .......+.+++.+||+.||++|| ++++++++
T Consensus 225 ~--------~~~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 225 K--------CDPPF--PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred c--------CCCCC--CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0 01111 112245677899999999999999 77788754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=302.76 Aligned_cols=265 Identities=25% Similarity=0.304 Sum_probs=202.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchH--HHHHHHHHHHHHhcCCCccc-cceEeeEEecCC------
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--KTNEEFMTELKIIGRTHHKN-LVRLLGFCSEED------ 560 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~------ 560 (788)
+...++||+|.||+||+|+.+ .++..||+|+++-... ..-....+|+.++++++|+| |+++++++...+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~--~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSK--RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEe--cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 333467999999999999988 5667999999875533 23345689999999999999 999999998877
Q ss_pred eEEEEEecCCCCCHhHhhhccC---CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG---QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
..++|+||+ .-+|..++.... ...+...+..++.||++||+|||++ +|+||||||+||||+ +.+.+||
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~-----~~G~lKl 161 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLIS-----SSGVLKL 161 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEEC-----CCCcEee
Confidence 889999999 569999997665 3577788999999999999999999 999999999999999 7899999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
+|||+|+...-.. ...+....|..|+|||++.+. .|+...||||+|||+.||++++..|.+....++...
T Consensus 162 aDFGlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~-------- 232 (323)
T KOG0594|consen 162 ADFGLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR-------- 232 (323)
T ss_pred eccchHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH--------
Confidence 9999999654322 224456789999999999876 799999999999999999999999987654322211
Q ss_pred HHHHhhcc---cc---cccccCC--------CCCccc--HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcC
Q 047157 717 VISCMLSR---NL---QVLVSHD--------PEVLSD--LERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGT 774 (788)
Q Consensus 717 ~~~~~~~~---~~---~~l~~~~--------~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~ 774 (788)
+...+..+ .. ..+.+.. +..... ........+++.+||+.+|++|.|++.++.+ +..+
T Consensus 233 If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 233 IFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11111110 00 0000111 000000 0111467889999999999999999999986 5443
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.75 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=194.9
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
+.||+|+||.||++... .++..+|+|.+.+.. ....+.+..|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK--KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 46899999999999886 667789999987542 23445678888888776 8999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|..++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++......
T Consensus 79 ~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~-----~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 79 NGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLD-----SEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEC-----CCCCEEEeeCCccccccCC
Confidence 999999888544 5688999999999999999999999 999999999999998 7889999999998753222
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .....+..........
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~---~~~~~~~~~~i~~~~~--- 222 (329)
T cd05618 150 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---QNTEDYLFQVILEKQI--- 222 (329)
T ss_pred CC-ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc---cccHHHHHHHHhcCCC---
Confidence 11 2234578999999999999999999999999999999999999996422111100 0111122222211111
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC------HHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS------MKKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~~ 770 (788)
.. +......+.+++.+||+.||++||+ +.+++++
T Consensus 223 -----~~--p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 -----RI--PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -----CC--CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11 1122356778999999999999998 4676543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.42 Aligned_cols=254 Identities=22% Similarity=0.243 Sum_probs=198.7
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
...|.+.+.||+|+||.||++... .++..+|+|.+.+.. ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHK--SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 355777889999999999999886 667789999986432 223456789999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~-----~~~~~kL~DFG~a 189 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLD-----KHGHLKLADFGTC 189 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEC-----CCCCEEEEecccc
Confidence 999999999999998543 578888999999999999999999 999999999999998 7889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCC----CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHH
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVP----VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
...............||+.|+|||++.+.. ++.++||||+||++|||++|+.||........ ..
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------------~~ 257 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------------YS 257 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------------HH
Confidence 876543332333467999999999986543 78899999999999999999999975432111 00
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNL--RPSMKKVIHM 770 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 770 (788)
....... .............+.+++..|++.+|.+ ||+++|++++
T Consensus 258 ~i~~~~~------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 KIMDHKN------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHhCCc------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111000 0111112233456677888898755543 8999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.36 Aligned_cols=251 Identities=29% Similarity=0.435 Sum_probs=196.5
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
+.||+|+||.||+|.....+....+++|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 4689999999999998744344567889887432 44556889999999999 799999999999999999999999999
Q ss_pred CCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 572 GTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 572 gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
++|.+++.... ..+++.++..++.|++.||+|||+. +++|+||||+||+++ .++.+|
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~-----~~~~~k 152 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG-----ENYVAK 152 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEc-----CCCeEE
Confidence 99999986432 2468899999999999999999998 999999999999998 788999
Q ss_pred EeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHH
Q 047157 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
|+|||++...... ........+..|+|||++....++.++||||||+++|||++ |..||......+.
T Consensus 153 l~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---------- 220 (270)
T cd05047 153 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---------- 220 (270)
T ss_pred ECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH----------
Confidence 9999998632211 11111233567999999988899999999999999999997 9999864321110
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
........ ... ........+.+++.+||+.||.+|||+.++++.|++++
T Consensus 221 --~~~~~~~~-------~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 221 --YEKLPQGY-------RLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --HHHHhCCC-------CCC--CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00111110 000 01122356789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.89 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=205.1
Q ss_pred HHHhhcccccccccccceEEEEEEe---ccCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCC
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED 560 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 560 (788)
....+.+.+.||+|+||.||++... .......||+|.++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3445677899999999999999753 12345689999887543 34456789999999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
..++||||+++++|.+++.... ..+++.++..++.||+.||.|||++ +|+|+||||+|||++ .+..+||+|
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~-----~~~~~~l~d 184 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLT-----HGKIVKICD 184 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEc-----CCCeEEECC
Confidence 9999999999999999996543 3479999999999999999999998 999999999999998 778999999
Q ss_pred cCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHH
Q 047157 640 FGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 640 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-------~~~-- 255 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-------FYK-- 255 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-------HHH--
Confidence 9999866443221 1222345678999999998899999999999999999998 9999864322110 000
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
....+ .. ........+++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 256 --~~~~~-~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 --LIKEG-YR--------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --HHHcC-Cc--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111 00 000111245788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.69 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=196.5
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
++||+|+||.||++... .++..||+|.++... ....+.+..|..++.++ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELK--KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 46899999999999886 667799999997542 23345678899999888 7999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~-----~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 79 SGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLD-----AEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEC-----CCCCEEECcCccccccccC
Confidence 999999888544 5789999999999999999999999 999999999999998 7889999999998753221
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+... ....++..........
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~--- 222 (329)
T cd05588 150 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD---QNTEDYLFQVILEKQI--- 222 (329)
T ss_pred C-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc---ccchHHHHHHHHcCCC---
Confidence 1 12233578999999999999999999999999999999999999997432221100 0111122222222111
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC------HHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS------MKKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~~ 770 (788)
.. +......+.+++.+||+.||.+||+ +++++++
T Consensus 223 -----~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 -----RI--PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -----CC--CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11 0112346788999999999999997 6777653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.28 Aligned_cols=251 Identities=29% Similarity=0.433 Sum_probs=198.7
Q ss_pred ccccccccceEEEEEEeccC-cceeeeeeecccchH-HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
++||+|+||.||+|...... ....+++|.+..... ...+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876433 447899999875443 35668999999999999999999999876 4568999999999
Q ss_pred CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC
Q 047157 572 GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651 (788)
Q Consensus 572 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~ 651 (788)
++|.+++.... .+++..+..++.|++.||+|||.. +++|+||||+||+++ .++.+||+|||++........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~-----~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLV-----NRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEc-----CCCcEEeccccccceeecCCc
Confidence 99999997654 789999999999999999999998 999999999999998 788999999999987644332
Q ss_pred ccc--ccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 652 RTD--TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 652 ~~~--~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... ....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..... .... .
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--------~~~~~----~~~~--~ 216 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--------VIAML----ESGE--R 216 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHH----HcCC--c
Confidence 211 11223567999999998899999999999999999998 999986532111 11111 1110 0
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
..........+.+++.+||+.+|++||++.+|++.|++..
T Consensus 217 -------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 -------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0011123457788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.75 Aligned_cols=266 Identities=23% Similarity=0.304 Sum_probs=191.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCC---CccccceEeeEEe-----c
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRT---HHKNLVRLLGFCS-----E 558 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~-----~ 558 (788)
.|.+.+.||+|+||.||+|.... .++..||+|.+.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcC-CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36677899999999999998742 245689999886432 22234556677666654 7999999999885 3
Q ss_pred CCeEEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 559 EDKRLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
....++||||++ ++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~-----~~~~~kl 151 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVT-----SSGQIKL 151 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEc-----CCCCEEE
Confidence 456899999996 6899988654 34578999999999999999999999 999999999999998 7889999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh-----
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV----- 712 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----- 712 (788)
+|||++...... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+........
T Consensus 152 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 152 ADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred ccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 999999865433 2223456899999999998889999999999999999999999999765332211100000
Q ss_pred hHHHHHHHhhcccccccccCCCCCcc---cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLS---DLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...|...... ............. .....+.+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVAL---PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcc---cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000 0000000000000 0112356678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.19 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=204.0
Q ss_pred HHhhcccccccccccceEEEEEEeccCc--ceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
...+.+.+.||+|+||+||+|.+...+. ...||+|.+... .....+++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 3455667899999999999998763322 235899988643 34456788999999999999999999999875 4578
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+++||+++|+|.+++......+++..++.++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||++
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~-----~~~~~kL~dfG~~ 156 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVK-----SPNHVKITDFGLA 156 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc-----CCCcEEECCCCce
Confidence 99999999999999977667789999999999999999999999 999999999999998 7778999999999
Q ss_pred cccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHh
Q 047157 644 KLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 644 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~----~ 224 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--------IPDL----L 224 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHH----H
Confidence 8765332211 112234678999999998899999999999999999998 888986432111 1111 1
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVG 778 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 778 (788)
.... ...........+.+++..||+.||++||++.++++.|+.+...+
T Consensus 225 ~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 225 EKGE---------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HCCC---------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1110 00011123456788999999999999999999999998775544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=308.53 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=199.8
Q ss_pred cccccccccccceEEEEEEeccC-cceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCe------
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK------ 561 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------ 561 (788)
.+.+.||+|+||.||+|....+. ....||+|+++... ....+.+.+|++.++.++||||+++++++.+.+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 45688999999999999886332 34689999886432 3445688999999999999999999998866554
Q ss_pred EEEEEecCCCCCHhHhhhcc-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 562 RLLVYELMPNGTLSNFLFHE-----GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
.++|+||+++++|..++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++ +++.+|
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~-----~~~~~k 153 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLR-----EDMTVC 153 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEEC-----CCCeEE
Confidence 79999999999999998542 24578999999999999999999998 999999999999998 778999
Q ss_pred EeecCCccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhH
Q 047157 637 ISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 714 (788)
|+|||+++......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--------~~ 225 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------IY 225 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------HH
Confidence 99999998664432221 112234678999999988899999999999999999999 888886432111 11
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
+ ....+... .........+.+++.+||+.||++|||+.||++.|+++
T Consensus 226 ~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 226 D----YLRHGNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred H----HHHcCCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 11111100 11122356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=307.97 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=203.5
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
+...++.+.++||+|+||.||+|... .+..+|+|.+..... ..+.+.+|+.++++++||||+++++++. .+..++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN---GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC---CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 45677888999999999999999864 456899998875432 3467889999999999999999999874 467899
Q ss_pred EEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 565 VYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+|||+++++|.+++... +..+++.++..++.|++.||+|||+. +++|+||||+||+++ .++.++|+|||++
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~-----~~~~~~l~dfg~~ 149 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVS-----ETLCCKIADFGLA 149 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEc-----CCCCEEEccCcce
Confidence 99999999999998654 45678999999999999999999998 999999999999998 7889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
...............++..|+|||.+....++.++||||||+++|||++ |+.||......+. .. ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~----~~~ 217 (260)
T cd05067 150 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--------IQ----NLE 217 (260)
T ss_pred eecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--------HH----HHH
Confidence 8765333222223445678999999998899999999999999999999 9999965422110 00 010
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
.. . ..........++.+++.+||+.+|++||+++++++.|+.
T Consensus 218 ~~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 RG-Y--------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred cC-C--------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00 0 000111224578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=309.07 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=197.0
Q ss_pred ccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecC------CeEE
Q 047157 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------DKRL 563 (788)
Q Consensus 492 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~ 563 (788)
+.++||+|+||.||+|..........+|+|.++.. .....+.+.+|++++++++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 56889999999999999864443347899987643 244567889999999999999999999987432 2568
Q ss_pred EEEecCCCCCHhHhhhc-----cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 564 LVYELMPNGTLSNFLFH-----EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
+++||+++++|.+++.. ....+++.....++.||+.||+|||++ +|+||||||+|||++ .++.+||+
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~-----~~~~~kl~ 154 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLN-----ENMNVCVA 154 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEc-----CCCCEEEC
Confidence 99999999999998742 224478999999999999999999998 999999999999998 78899999
Q ss_pred ecCCccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHH
Q 047157 639 DFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------------ 222 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------------ 222 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------------
Confidence 999998764332211 122345678999999999999999999999999999999 788886432111
Q ss_pred HHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 717 VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
.......+.... ........+.+++.+||+.||++|||+.++++.|+++
T Consensus 223 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 223 IYDYLRQGNRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111111100 0112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.41 Aligned_cols=252 Identities=26% Similarity=0.311 Sum_probs=200.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
+|...++||+|+||+||++... .++..||+|.+.... ......+.+|++++++++||||+++++.+..++..++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc--CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 3556789999999999999876 567799999986532 22335678899999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 566 YELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++ +++.++|+|||++.
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~-----~~~~~~l~Dfg~~~ 150 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLD-----DYGHIRISDLGLAV 150 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEEC-----CCCCEEEeeCCCce
Confidence 9999999999988654 34689999999999999999999999 999999999999998 77899999999988
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
....... .....|+..|+|||.+.+..++.++||||+|+++|||++|+.||.......... . ........
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~-------~-~~~~~~~~ 220 (285)
T cd05605 151 EIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE-------E-VERRVKED 220 (285)
T ss_pred ecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH-------H-HHHHhhhc
Confidence 6543222 123468899999999998899999999999999999999999997543211100 0 00000000
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
.. .........+.+++..||+.||++|| ++++++++
T Consensus 221 --------~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 --------QE--EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --------cc--ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00 01122345678899999999999999 88899764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=307.69 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=204.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeeccc---chHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK---DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.++||+|+||.||+|... .++..|+||.+.. ........+.+|+++++.++||||+++++++.+.+..++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCL--LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEe--CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 3567789999999999999886 5667899997753 2234456789999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 566 YELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
+||+++++|.+++.. ....++...+..++.||+.||.|||++ +++|+||||+||+++ .++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~-----~~~~~~l~d~g~ 152 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFIT-----ATGVVKLGDLGL 152 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEc-----CCCCEEECcccc
Confidence 999999999988853 234578899999999999999999999 999999999999998 778899999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ..+. ....
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---------~~~~-~~~~ 221 (267)
T cd08228 153 GRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---------FSLC-QKIE 221 (267)
T ss_pred ceeccchhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---------HHHH-HHHh
Confidence 8876433221 123467889999999988889999999999999999999999986432110 0111 1111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
.... +. .........+.+++.+||+.+|++||++++|++.|+++
T Consensus 222 ~~~~-------~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 222 QCDY-------PP-LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred cCCC-------CC-CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1000 00 11123446788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=296.31 Aligned_cols=265 Identities=22% Similarity=0.234 Sum_probs=200.6
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHH--HHHHHHHHHHHhcCCCccccceEeeEEec--CCeEEEEEec
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK--TNEEFMTELKIIGRTHHKNLVRLLGFCSE--EDKRLLVYEL 568 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lV~e~ 568 (788)
...|++|.||.||+|+++ .+...||+|+++-+.+. .--.-++|+.+|.+++|||||.+-.+... -+.+||||||
T Consensus 81 lnrI~EGtyGiVYRakdk--~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDK--KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HhhcccCcceeEEEeccC--CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 467999999999999887 77889999999754321 11245799999999999999999988754 4579999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
|+. +|..++....+++...++..++.|+++||+|||.+ .|+|||||++|+|+. ..+.+||+|||+|+.++.
T Consensus 159 ~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~-----~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 159 VEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLS-----HKGILKIADFGLAREYGS 229 (419)
T ss_pred HHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeec-----cCCcEEecccchhhhhcC
Confidence 965 89999988888999999999999999999999999 999999999999998 888999999999998876
Q ss_pred CCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH---HHHHhhcc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW---VISCMLSR 724 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 724 (788)
.. ...+..+-|..|+|||.+.+. .|+.+.|+||+|||+.||+++++.|.+....++...+...+... .|+.+..-
T Consensus 230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 53 234556779999999998764 69999999999999999999999998775544332221111100 11100000
Q ss_pred cccccccCCCCCcc-----cH---HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLS-----DL---ERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~-----~~---~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.....+. .+.... .. ...+.-.+|+..+|..||.+|.|++|.+++
T Consensus 309 p~~k~~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000000 000000 00 123566788889999999999999998864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=323.81 Aligned_cols=200 Identities=25% Similarity=0.312 Sum_probs=173.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
+.+.+.||+|+||+||++... .++..||+|.+.+.. ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKK--DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEEC--CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 456789999999999999876 667799999987542 233457888999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++..+
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~-----~~~~vkL~DFGla~~~ 151 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLD-----SKGHVKLSDFGLCTGL 151 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEEC-----CCCCEEEeeccCcccc
Confidence 999999999999654 5688999999999999999999999 999999999999998 7789999999998754
Q ss_pred CCCCC----------------------------------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh
Q 047157 647 NKDQT----------------------------------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC 692 (788)
Q Consensus 647 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 692 (788)
..... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 32110 00123479999999999999999999999999999999999
Q ss_pred CCCCCCcc
Q 047157 693 GRRHIELS 700 (788)
Q Consensus 693 g~~p~~~~ 700 (788)
|+.||...
T Consensus 232 G~~Pf~~~ 239 (363)
T cd05628 232 GYPPFCSE 239 (363)
T ss_pred CCCCCCCC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.21 Aligned_cols=251 Identities=22% Similarity=0.255 Sum_probs=197.6
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|+||+||++... .++..||||.+.... ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKK--DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred ceEEEEEEecCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 556789999999999999886 567799999997532 234456889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++..+
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~-----~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLD-----AKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEEC-----CCCCEEEeecccceec
Confidence 999999999999654 4688999999999999999999999 999999999999998 7889999999998754
Q ss_pred CCCCCc-------------------------------------ccccccCCccccCcccccCCCCCccCcchhhHHHHHH
Q 047157 647 NKDQTR-------------------------------------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLE 689 (788)
Q Consensus 647 ~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~e 689 (788)
...... ......||+.|+|||++....++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 321100 0112458999999999999999999999999999999
Q ss_pred HHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC---HHH
Q 047157 690 IICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS---MKK 766 (788)
Q Consensus 690 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~e 766 (788)
|++|..||......+.. ...... .. ...........+.+.+++.+|+. +|.+|++ ++|
T Consensus 232 l~~G~~Pf~~~~~~~~~------------~~i~~~--~~----~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 232 MLVGYPPFCSDNPQETY------------RKIINW--KE----TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred hhcCCCCCCCCCHHHHH------------HHHHcC--CC----ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 99999999754321110 000000 00 00111111223466778888886 9999998 998
Q ss_pred HHHH
Q 047157 767 VIHM 770 (788)
Q Consensus 767 vl~~ 770 (788)
++++
T Consensus 293 ll~h 296 (364)
T cd05599 293 IKSH 296 (364)
T ss_pred HhcC
Confidence 8774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=314.86 Aligned_cols=269 Identities=27% Similarity=0.411 Sum_probs=211.9
Q ss_pred CHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEecC
Q 047157 481 TFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEE 559 (788)
Q Consensus 481 ~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 559 (788)
..+|+.+..-.|.++||+|.||.|.++... ....||||.++..... ..++|.+|+++|.+++||||++++|+|..+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeve---g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVE---GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEec---CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 344555555667899999999999999884 5789999999876544 458999999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhccCCC-CCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEGQR-PGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
+.+++|+|||++|+|.+++.++... ..-.....|+.||+.|++||.+. ++|||||.++|+|++ .++++||+
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~-----~e~~iKia 679 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVD-----GEFTIKIA 679 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeec-----CcccEEec
Confidence 9999999999999999999766333 35556678999999999999999 999999999999999 99999999
Q ss_pred ecCCccccCC-CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHH--hCCCCCCccccccccccchhhhHH
Q 047157 639 DFGISKLLNK-DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII--CGRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 639 Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ell--tg~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
|||+++.+-. +........+-..+|||||.+..++++.++|||+||+++||++ +...||.....+... +
T Consensus 680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv--------e 751 (807)
T KOG1094|consen 680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV--------E 751 (807)
T ss_pred CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH--------H
Confidence 9999995533 3333333455678999999999999999999999999999986 566787644222111 1
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
-..........+..+ ..+.-....+.+++++||..|-++||+++++...|++.
T Consensus 752 n~~~~~~~~~~~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 752 NAGEFFRDQGRQVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhhhcCCCCcceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111111111111111 12234456778999999999999999999999998764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=304.87 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=201.2
Q ss_pred ccccccccceEEEEEEec-cCcceeeeeeecccchH-HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
++||+|++|.||+|.+.. ......||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999864 23344799999987655 667789999999999999999999999988 899999999999
Q ss_pred CCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 572 GTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 572 gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
++|.+++.+.. ..+++..++.++.|++.||.|||++ +++|+||||+||+++ .++.+||+|||++.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~-----~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLA-----SDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEe-----cCCEEEeccccccccccccc
Confidence 99999997654 5689999999999999999999999 999999999999998 77899999999998764422
Q ss_pred Cc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 651 TR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 651 ~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ... .... .
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~--------~~~---~~~~--~ 218 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL--------KKI---DKEG--E 218 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH--------HHH---HhcC--C
Confidence 11 1122456788999999998899999999999999999998 99998643221110 000 0000 0
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
........+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 219 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 -------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00011123467888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=310.48 Aligned_cols=266 Identities=26% Similarity=0.371 Sum_probs=201.6
Q ss_pred HHHhhcccccccccccceEEEEEEecc------------Ccceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceE
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLK------------DTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~------------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~ 552 (788)
....+.+.+.||+|+||.||++..... .....||+|.+... .......+.+|++++++++||||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 345677889999999999999876421 22346899998654 23445679999999999999999999
Q ss_pred eeEEecCCeEEEEEecCCCCCHhHhhhccC-----------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCc
Q 047157 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEG-----------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQN 621 (788)
Q Consensus 553 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~N 621 (788)
++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 999999999999999999999999985432 2357889999999999999999999 99999999999
Q ss_pred EEeccCCCCCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh--CCCCCC
Q 047157 622 VLLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC--GRRHIE 698 (788)
Q Consensus 622 Ill~~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--g~~p~~ 698 (788)
|+++ .++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ +..||.
T Consensus 160 ill~-----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 160 CLVG-----NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred EEEc-----CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 9998 777899999999976533221 11122345678999999988899999999999999999998 556775
Q ss_pred ccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 699 LSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
.....+... ................ ........+.+++.+||+.||++|||+.+|++.|+.
T Consensus 235 ~~~~~~~~~--------~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 235 LLSDEQVIE--------NTGEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ccChHHHHH--------HHHHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 432211100 0000011100000000 011124578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=306.72 Aligned_cols=248 Identities=23% Similarity=0.410 Sum_probs=193.0
Q ss_pred ccccccccceEEEEEEecc----------CcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 494 KLVGTGSSGKVYRGILRLK----------DTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~----------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
+.||+|+||.||+|....+ .....|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986422 123468999887665666678899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCC--CCCcEEEeecC
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD--TNYMAKISDFG 641 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~--~~~~~kL~Dfg 641 (788)
+||||+++++|..++......+++..++.++.||++||+|||++ +|+||||||+|||++..... ....++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999876666789999999999999999999999 99999999999999743211 12248999999
Q ss_pred CccccCCCCCcccccccCCccccCccccc-CCCCCccCcchhhHHHHHHHH-hCCCCCCccccccccccchhhhHHHHHH
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLR-NVPVTTKVDVFSFGVMLLEII-CGRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+. .
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------------~ 219 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------------E 219 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------------H
Confidence 98755322 1235678899999886 567899999999999999998 57777754321110 0
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
........ . .......+.+++.+||+.||.+||++.+|++.|+
T Consensus 220 ~~~~~~~~-~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEGQCM-L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhcCcc-C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00011000 0 0012356788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=307.18 Aligned_cols=253 Identities=27% Similarity=0.427 Sum_probs=199.8
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...+.+.++||+|+||.||+|... .+..+++|.+..... ..+.+.+|+.++++++|||++++++++. ....+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN---GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec---CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 345677889999999999999774 445799998875432 3457899999999999999999999885 45689999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++ +++.++|+|||.+..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~-----~~~~~~l~dfg~~~~ 151 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVG-----DGLVCKIADFGLARL 151 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEe-----CCceEEeCCceeeee
Confidence 999999999999654 34579999999999999999999999 999999999999998 778999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..+ .....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~----~~~~~ 219 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--------VLE----QVERG 219 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--------HHH----HHHcC
Confidence 64433222222345668999999988899999999999999999999 888886432111 001 11100
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
.....+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 220 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 ---------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.51 Aligned_cols=275 Identities=21% Similarity=0.282 Sum_probs=197.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC-----CeE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE-----DKR 562 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 562 (788)
|.+.++||+|+||.||+|... .++..||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDT--HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred eEEEEEEeecCCeEEEEEEEC--CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 566789999999999999876 667799999886432 23345788999999999999999999988543 357
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+. ++|.+++... ..+++..+..++.||++||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 80 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~-----~~~~~kL~Dfg~ 149 (338)
T cd07859 80 YVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILAN-----ADCKLKICDFGL 149 (338)
T ss_pred EEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEC-----CCCcEEEccCcc
Confidence 99999995 6898888544 4688999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCC--cccccccCCccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh---hHH
Q 047157 643 SKLLNKDQT--RTDTNMRGTMGYVAPEWLRN--VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV---LSD 715 (788)
Q Consensus 643 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~ 715 (788)
+........ .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||............... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 986532221 11234568999999999865 67899999999999999999999999754321110000000 000
Q ss_pred HHHHHhhcccccc----cccCCCCCc--ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCcC
Q 047157 716 WVISCMLSRNLQV----LVSHDPEVL--SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTLE 776 (788)
Q Consensus 716 ~~~~~~~~~~~~~----l~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~ 776 (788)
............. +....+... ........+.+++.+||+.||++|||++|++++ +++...
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000000000000 000000000 000123457889999999999999999999964 444433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.18 Aligned_cols=263 Identities=23% Similarity=0.399 Sum_probs=203.4
Q ss_pred HHHHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCC-ccccceEeeEEecC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEE 559 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 559 (788)
+....+.+.++||+|+||.||+|.+.. ...+..||+|++.... ....+.+.+|++++.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 444456667899999999999998752 2345689999997543 333457889999999997 99999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhccC---------------------------------------------------------
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEG--------------------------------------------------------- 582 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 582 (788)
+..++|+||+++|+|.++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999996432
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 583 ----------------------------------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 583 ----------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
..+++..+..++.||+.||.|||+. +|+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 1346677889999999999999998 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcc
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELS 700 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~ 700 (788)
|++ .+..+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 271 Ll~-----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 271 LIC-----EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred EEe-----CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 998 778999999999986533221 11222356788999999998889999999999999999998 88898643
Q ss_pred ccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
...+. .......+ . .+. .+......+.+++..||+.+|++||+++||++.|+++.
T Consensus 346 ~~~~~-----------~~~~~~~~-~------~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 346 PMNEQ-----------FYNAIKRG-Y------RMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CchHH-----------HHHHHHcC-C------CCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 21110 00111111 0 000 01112457888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.23 Aligned_cols=270 Identities=22% Similarity=0.347 Sum_probs=205.2
Q ss_pred HHhhcccccccccccceEEEEEEe--ccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecC--Ce
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DK 561 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 561 (788)
+.++.+.+.||+|+||.||++... ....+..|++|.+.... ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 445667789999999999999754 23456789999986443 34456899999999999999999999998775 57
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++||||+++++|.+++.+....+++..+..++.||+.||+|||++ +|+||||||+||+++ .++.+||+|||
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~-----~~~~~~l~dfg 154 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE-----SEHQVKIGDFG 154 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEc-----CCCCEEECCCc
Confidence 8999999999999999976656789999999999999999999999 999999999999998 77889999999
Q ss_pred CccccCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccc----ccchhhhHH
Q 047157 642 ISKLLNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES----EEVDIVLSD 715 (788)
Q Consensus 642 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~----~~~~~~~~~ 715 (788)
++......... ......++..|+|||.+.+..++.++||||||+++|||++++.|.......... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 99876433221 112345677899999998889999999999999999999987765322110000 000000000
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
......... ...........+.+++.+||+.||++|||++++++.|+.+
T Consensus 235 -~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 -LVRVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHHHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 011111110 0001112356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.06 Aligned_cols=241 Identities=27% Similarity=0.331 Sum_probs=191.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcC-CCccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGR-THHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
++||+|+||.||+|... .++..||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELK--GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 46999999999999886 667799999987543 2234566778888775 48999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~-----~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 79 NGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLD-----RDGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEC-----CCCCEEeCccCCCeecccC
Confidence 999999988654 5678899999999999999999999 999999999999998 7789999999998743221
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. .......
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~------------~~~~~~~----- 211 (316)
T cd05620 150 D-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL------------FESIRVD----- 211 (316)
T ss_pred C-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------------HHHHHhC-----
Confidence 1 122345689999999999999999999999999999999999999975432111 0111100
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMK-KVI 768 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 768 (788)
.+... ......+.+++.+||+.||++||++. +++
T Consensus 212 ---~~~~~--~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 ---TPHYP--RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCCCC--CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00000 01234677899999999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.63 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=201.5
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...|.+.+.||+|+||.||+|... .++..|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~--~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNL--HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEEC--CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 345677899999999999999876 567789999987554445567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||++...
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~-----~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 86 EYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLT-----DNGDVKLADFGVAAKI 156 (267)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEC-----CCCCEEECcCccceee
Confidence 999999999998644 4678999999999999999999998 999999999999998 7788999999999866
Q ss_pred CCCCCcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
..... ......++..|+|||.+. ...++.++||||||+++|||++|+.||......+.... ...
T Consensus 157 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~------------~~~ 223 (267)
T cd06646 157 TATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------------MSK 223 (267)
T ss_pred ccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee------------eec
Confidence 43221 122346788999999874 44578899999999999999999999854321110000 000
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
.... .+...........+.+++.+||+.||++|||++++++.|
T Consensus 224 ~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 224 SNFQ-----PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCC-----CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000 011111122346788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.43 Aligned_cols=265 Identities=28% Similarity=0.413 Sum_probs=207.8
Q ss_pred HHHHhhcccccccccccceEEEEEEec-----cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEe
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRL-----KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCS 557 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 557 (788)
+....+.+.+.||+|+||.||++.... ......|++|.+.... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 455667788999999999999997532 1234579999886543 34457889999999999 8999999999999
Q ss_pred cCCeEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 558 EEDKRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 558 ~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
.....++||||+++++|.+++.... ..+++.++..++.||+.||.|||++ +|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 9999999999999999999996532 3467888999999999999999999 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcc
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELS 700 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~ 700 (788)
+++ .++.+||+|||.+.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 169 li~-----~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 169 LVT-----ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EEc-----CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 998 77899999999998764432221 222345678999999988899999999999999999998 77887543
Q ss_pred ccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCC
Q 047157 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVG 778 (788)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 778 (788)
...+. ......... ..........+.+++.+||+.+|++|||+.||++.|+++....
T Consensus 244 ~~~~~------------~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 244 PVEEL------------FKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred CHHHH------------HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 22111 111111110 0011123467888999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=299.63 Aligned_cols=265 Identities=26% Similarity=0.315 Sum_probs=216.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.++.+.||+|.-|+||++.++ +.....|+|++.+.. .+...+...|-+||+.++||.++.+|+.++.++..++||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~--~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELR--GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHcCCCCceeEEEEEec--CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345688999999999999987 666899999998764 334457788999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+||+|..+++++ ++.+++..+.-++..++-||+|||-. |||.|||||+||||. +++++.|+||.++..
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvr-----edGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVR-----EDGHIMLSDFDLSLR 228 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEe-----cCCcEEeeecccccc
Confidence 999999999998765 56789999999999999999999999 999999999999998 999999999998764
Q ss_pred cCC---------------------------------CCC----------------------cccccccCCccccCccccc
Q 047157 646 LNK---------------------------------DQT----------------------RTDTNMRGTMGYVAPEWLR 670 (788)
Q Consensus 646 ~~~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~ 670 (788)
... ... .....++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 310 000 0011356999999999999
Q ss_pred CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHH
Q 047157 671 NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVG 750 (788)
Q Consensus 671 ~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~ 750 (788)
+...+.++|.|+|||+||||+.|+.||.+....+. +..++...+......+....+.+||
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--------------------l~NIv~~~l~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--------------------LRNIVGQPLKFPEEPEVSSAAKDLI 368 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--------------------HHHHhcCCCcCCCCCcchhHHHHHH
Confidence 99999999999999999999999999988754332 2233444455555556677888999
Q ss_pred hHccCCCCCCCCC----HHHHHHH--hhcC----cCCCCCCCCC
Q 047157 751 LWCNHPDPNLRPS----MKKVIHM--LEGT----LEVGMPPLLH 784 (788)
Q Consensus 751 ~~cl~~dP~~RPt----~~evl~~--L~~~----~~~~~pp~p~ 784 (788)
+..|..||++|.- +.||.++ ++++ .....||..|
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP 412 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIP 412 (459)
T ss_pred HHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCC
Confidence 9999999999998 8888763 4544 3445666543
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.29 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=192.4
Q ss_pred cccccccceEEEEEEec----------------------cCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceE
Q 047157 495 LVGTGSSGKVYRGILRL----------------------KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~----------------------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 552 (788)
.||+|+||.||+|.+.. ......|++|.+.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998642 12234689999876555556788899999999999999999
Q ss_pred eeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC--C
Q 047157 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL--D 630 (788)
Q Consensus 553 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--~ 630 (788)
++++.+....++||||+++++|..++......+++..+..++.||++||+|||++ +|+||||||+|||++.... .
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999977667789999999999999999999998 9999999999999974321 1
Q ss_pred CCCcEEEeecCCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHH-hCCCCCCcccccccccc
Q 047157 631 TNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEII-CGRRHIELSRVEEESEE 708 (788)
Q Consensus 631 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~ell-tg~~p~~~~~~~~~~~~ 708 (788)
....+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--- 230 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---
Confidence 2335899999987643221 12346788999998865 56899999999999999995 78888865422110
Q ss_pred chhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 709 VDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
.... . . ...... .....+.+++.+||+.+|++|||+.+|++.|.
T Consensus 231 -----~~~~-~----~--------~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 -----ERFY-E----K--------KHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -----HHHH-H----h--------ccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0000 0 0 000000 11235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=308.66 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=201.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
|.+.+.||+|+||.||+|... .++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK--ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC--CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 556788999999999999886 667789999987665666778899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|..++......+++..+..++.||+.||.|||+. +|+||||||+||+++ .++.+||+|||++......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~-----~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFT-----LDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEc-----cCCCEEEcccccccccccc
Confidence 99999998876666789999999999999999999999 999999999999998 7789999999998765332
Q ss_pred CCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.. ......++..|+|||.+. +..++.++|||||||++|||++|+.||......+. ...... .
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----------~~~~~~-~ 223 (282)
T cd06643 157 IQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-----------LLKIAK-S 223 (282)
T ss_pred cc-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-----------HHHHhh-c
Confidence 21 222356889999999973 45678899999999999999999999864321110 000000 0
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
. .+....+......+.+++.+||+.||.+||++.+++++-
T Consensus 224 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 224 E-------PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred C-------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0 001111112345788999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.02 Aligned_cols=242 Identities=27% Similarity=0.339 Sum_probs=191.4
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcC-CCccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGR-THHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
+.||+|+||.||+|... .++..||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELK--GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 46899999999999886 667789999987542 2334556778888875 48999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++|+|.+++... ..+++.++..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~-----~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 79 NGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLD-----TDGHIKIADFGMCKENMLG 149 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEEC-----CCCCEEEccCCcceECCCC
Confidence 999999998653 5678889999999999999999999 999999999999998 7789999999998753221
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||......+. .. .....
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--------~~----~i~~~----- 211 (316)
T cd05619 150 D-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL--------FQ----SIRMD----- 211 (316)
T ss_pred C-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH--------HH----HHHhC-----
Confidence 1 122335689999999999999999999999999999999999999975432111 00 00000
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMK-KVIH 769 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 769 (788)
.+.. +......+.+++.+||+.||++||++. ++++
T Consensus 212 ---~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 ---NPCY--PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---CCCC--CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0000 111234677899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=306.30 Aligned_cols=257 Identities=21% Similarity=0.330 Sum_probs=204.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc---hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|++|.||++... .++..++||.+... .....+++.+|+.+++.++||||+++++++.+++..+++
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCL--LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeec--CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 3566789999999999999876 56678999987542 233456889999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 566 YELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
|||+++++|.+++.. ....+++..++.++.||+.||.|||++ +++|+||||+||+++ .++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~-----~~~~~~l~dfg~ 152 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFIT-----ATGVVKLGDLGL 152 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc-----CCCCEEECcchh
Confidence 999999999998853 234678999999999999999999999 999999999999998 778999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ... ....
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------~~~-~~~~ 221 (267)
T cd08229 153 GRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---------SLC-KKIE 221 (267)
T ss_pred hhccccCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH---------HHh-hhhh
Confidence 8766433221 2234678899999999988999999999999999999999999864321100 000 0000
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
.. ...........+.+.+++.+||+.||++||||.+|+++++++
T Consensus 222 ~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 222 QC--------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cC--------CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00 000011123456788999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.95 Aligned_cols=243 Identities=29% Similarity=0.344 Sum_probs=194.8
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
+.||+|+||+||++... .++..||+|.+.+.. ......+..|.+++..+ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELK--GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46899999999999886 567789999987543 23345677888888877 7999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~-----~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 79 NGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLD-----SEGHIKIADFGMCKEGILG 149 (318)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEEC-----CCCcEEecccCCCeecCcC
Confidence 999999988654 4688999999999999999999999 999999999999998 7889999999998753222
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||........ ........
T Consensus 150 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~------------~~~i~~~~---- 212 (318)
T cd05570 150 GV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL------------FQSILEDE---- 212 (318)
T ss_pred CC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH------------HHHHHcCC----
Confidence 11 12234689999999999999999999999999999999999999975432110 01111111
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM-----KKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~ 770 (788)
... +......+.+++.+||+.||++||++ .++++.
T Consensus 213 ----~~~--~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 213 ----VRY--PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----CCC--CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 000 11224567889999999999999999 888753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=309.24 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=192.2
Q ss_pred ccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 496 lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
||+|+||.||++..+ .++..+|+|.+.... ....+.+..|++++++++||||+++++++.++...++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVK--NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEc--cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 699999999999886 567799999886432 122345667999999999999999999999999999999999999
Q ss_pred CHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC
Q 047157 573 TLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651 (788)
Q Consensus 573 sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~ 651 (788)
+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.++|+|||++........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~-----~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLD-----DQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEc-----CCCCEEEeeceeeeecCCCce
Confidence 9998886543 4578899999999999999999998 999999999999998 778999999999886643221
Q ss_pred cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccccc
Q 047157 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVS 731 (788)
Q Consensus 652 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 731 (788)
.....++..|+|||++.+..++.++|||||||++|||++|+.||........ ... ...........
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-------~~~-~~~~~~~~~~~---- 216 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-------KEE-LKRRTLEDEVK---- 216 (277)
T ss_pred --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-------HHH-HHHHhhccccc----
Confidence 2234688999999999988899999999999999999999999964321110 000 00111111100
Q ss_pred CCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 732 HDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 732 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. .......++.+++..||+.||++||+++|+++
T Consensus 217 ----~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 217 ----F-EHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ----c-ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 0 00123456788999999999999999976553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.15 Aligned_cols=246 Identities=26% Similarity=0.322 Sum_probs=194.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCc-cccceEeeEEecCCeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHH-KNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lV 565 (788)
|.+.+.||+|+||.||+|... .++..||+|.+.... ....+.+..|.+++..++| ++|+++++++.+.+..++|
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERK--GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred ceEEEEEeeccCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 566789999999999999876 667789999987542 2345677889999998876 5688899999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 80 ~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~-----~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 80 MEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLD-----AEGHIKIADFGMCKE 150 (324)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEc-----CCCCEEEeecCccee
Confidence 9999999999998654 4678899999999999999999999 999999999999998 778999999999874
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
..... .......|++.|+|||++.+..++.++||||||+++|||++|+.||......+.. .......
T Consensus 151 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~------------~~i~~~~ 217 (324)
T cd05587 151 NIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------------QSIMEHN 217 (324)
T ss_pred cCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------------HHHHcCC
Confidence 32211 1222356899999999999999999999999999999999999999754321110 0011110
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM-----KKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 769 (788)
+.. +......+.+++.+||+.||++||+. +++++
T Consensus 218 --------~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 218 --------VSY--PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred --------CCC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 000 11124567889999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.39 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=203.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|++|.||++... .++..+++|.+... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRK--ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEc--CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 456788999999999999886 56778999987642 24556789999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++ .++.++|+|||++...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~-----~~~~~~l~df~~~~~~ 151 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLD-----AYDNVKIGDLGVAKLL 151 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEe-----CCCCEEEcccccceec
Confidence 99999999999764 56788999999999999999999998 999999999999998 7789999999998876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
...... .....+++.|+|||++.+..++.++||||||+++|||++|+.||....... . .........
T Consensus 152 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~----~~~~~~~~~ 218 (256)
T cd08529 152 SDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--------L----ILKIIRGVF 218 (256)
T ss_pred cCccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------H----HHHHHcCCC
Confidence 543222 223467889999999999899999999999999999999999997543111 0 001111111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. ........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PP---------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CC---------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 10 011334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=308.67 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=205.0
Q ss_pred HHHHhhcccccccccccceEEEEEEecc---Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
+....+.+.+.||+|+||.||+|..... ..+..|++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 3445667789999999999999987631 234689999986543 344567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccC---------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCC
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG---------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT 631 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~ 631 (788)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+. +|+|+||||+||+++ .
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~-----~ 154 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVA-----E 154 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEc-----C
Confidence 9999999999999999986432 2467889999999999999999998 999999999999998 7
Q ss_pred CCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccc
Q 047157 632 NYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEV 709 (788)
Q Consensus 632 ~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 709 (788)
++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----- 229 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----- 229 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-----
Confidence 88999999999886543322 12223446788999999988889999999999999999998 888986432211
Q ss_pred hhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
... ....+..... +......+.+++.+||+.+|++|||+.++++.|++
T Consensus 230 ---~~~----~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 230 ---VLK----FVIDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---HHH----HHhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111 1111111110 11125678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=311.12 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=201.5
Q ss_pred hcccccccccccceEEEEEEecc---Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
+.+.+.||+|+||.||+|..... .....+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 34568899999999999987521 223578888876543 33456789999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhcc-----------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 566 YELMPNGTLSNFLFHE-----------------------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
+||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence 9999999999998532 13467889999999999999999998 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcc
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELS 700 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~ 700 (788)
|++ +++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ll~-----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 159 LVA-----EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEc-----CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 998 7789999999999865332221 1122345678999999988889999999999999999998 99998654
Q ss_pred ccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
...+ + +...... . ...........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 234 ~~~~--------~----~~~~~~~-~--------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 234 APER--------L----FNLLKTG-Y--------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CHHH--------H----HHHHhCC-C--------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 2111 1 1111111 0 000111234578899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=310.26 Aligned_cols=267 Identities=25% Similarity=0.392 Sum_probs=199.7
Q ss_pred ccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhc--CCCccccceEeeEEecCC----eEEEE
Q 047157 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIG--RTHHKNLVRLLGFCSEED----KRLLV 565 (788)
Q Consensus 492 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~hpniv~~~~~~~~~~----~~~lV 565 (788)
+.++||+|+||.||+|.+. ++.||||++.. +..+.|.+|-++.+ .++|+||+++++.-.... +++||
T Consensus 214 l~eli~~Grfg~V~KaqL~----~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD----NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hHHHhhcCccceeehhhcc----CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 4578999999999999984 36999999964 44567788888776 468999999999876655 89999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc------cCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE------CETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~------~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
+||.++|+|.++|.. ...+|....+|+..+++||+|||+. ++++|+|||||.+||||. .+++..|+|
T Consensus 287 t~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-----~DlTccIaD 359 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-----NDLTCCIAD 359 (534)
T ss_pred eeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-----cCCcEEeec
Confidence 999999999999954 4789999999999999999999975 567899999999999998 899999999
Q ss_pred cCCccccCCCCCccc-ccccCCccccCcccccCCC-CC-----ccCcchhhHHHHHHHHhCCCCCCcccccccc------
Q 047157 640 FGISKLLNKDQTRTD-TNMRGTMGYVAPEWLRNVP-VT-----TKVDVFSFGVMLLEIICGRRHIELSRVEEES------ 706 (788)
Q Consensus 640 fg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~-~s-----~k~DVwSlGvil~elltg~~p~~~~~~~~~~------ 706 (788)
||+|..+........ ...+||.+|||||++.+.. +. .+.||||+|.+||||++...-+......+.+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999998876544432 3478999999999997642 22 3699999999999999865544321111111
Q ss_pred ccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 707 EEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
-..+..+.+ .+......+.+..+ +........+..+.+.+..||+.||+.|.|+.=|.+++.++.-
T Consensus 440 vG~hPt~e~-mq~~VV~kK~RP~~---p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 440 VGNHPTLEE-MQELVVRKKQRPKI---PDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred hcCCCCHHH-HHHHHHhhccCCCC---hhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 011111111 11111111111111 1122233567788899999999999999999999888876553
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.75 Aligned_cols=238 Identities=28% Similarity=0.308 Sum_probs=188.6
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHH-HhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELK-IIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
++||+|+||+||+|... .++..||+|.+.... ....+++..|.. +++.++||||+++++.+.+.+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK--ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 46899999999999886 667799999987542 222344555554 567899999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~-----~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLD-----SQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEEC-----CCCcEEEeccCCCcccccC
Confidence 999999988654 5678889999999999999999999 999999999999998 7889999999998754222
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. ........
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------------~~~i~~~~---- 212 (323)
T cd05575 150 S-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------------YDNILNKP---- 212 (323)
T ss_pred C-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------------HHHHHcCC----
Confidence 1 222345689999999999999999999999999999999999999975432111 00111111
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMK 765 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 765 (788)
.... ......+.+++.+||+.||++||++.
T Consensus 213 ----~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 ----LRLK--PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CCCC--CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1111 11245678899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.92 Aligned_cols=241 Identities=26% Similarity=0.268 Sum_probs=192.5
Q ss_pred ccccccccceEEEEEEec-cCcceeeeeeecccchH--HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDIE--KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
+.||+|+||.||++.... ...+..+|+|.+..... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 579999999999987642 24677999999875432 234567789999999999999999999999999999999999
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
+++|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~-----~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLD-----EEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEEC-----CCCcEEEeeccCCcccCCCC
Confidence 99999998554 5689999999999999999999999 999999999999998 77899999999988654332
Q ss_pred CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccc
Q 047157 651 TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 730 (788)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. .........
T Consensus 153 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------------~~~i~~~~~---- 215 (318)
T cd05582 153 K-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------------MTMILKAKL---- 215 (318)
T ss_pred C-ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------------HHHHHcCCC----
Confidence 2 22345789999999999988899999999999999999999999975422111 001111110
Q ss_pred cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 047157 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKK 766 (788)
Q Consensus 731 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 766 (788)
.. +......+.+++.+||+.||++||++.+
T Consensus 216 ----~~--p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ----GM--PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----CC--CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00 1112356778999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=325.15 Aligned_cols=251 Identities=22% Similarity=0.239 Sum_probs=193.1
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
+.+.++||+|+||+||+|... .++..+|+|.+.... ....+.+.+|++++++++||||+++++.+.+.+..++||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKV--DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEEC--CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 456789999999999999886 667799999987542 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..+
T Consensus 81 E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~-----~~g~~kL~DFGla~~~ 151 (382)
T cd05625 81 DYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILID-----RDGHIKLTDFGLCTGF 151 (382)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC-----CCCCEEEeECCCCccc
Confidence 999999999998654 4578888889999999999999999 999999999999998 7889999999997533
Q ss_pred CCCC----------------------------------------------CcccccccCCccccCcccccCCCCCccCcc
Q 047157 647 NKDQ----------------------------------------------TRTDTNMRGTMGYVAPEWLRNVPVTTKVDV 680 (788)
Q Consensus 647 ~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV 680 (788)
.... ........||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (382)
T cd05625 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence 1100 000112468999999999999999999999
Q ss_pred hhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCC
Q 047157 681 FSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNL 760 (788)
Q Consensus 681 wSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 760 (788)
|||||++|||++|+.||......+... . .... . ..............+.+++.+|+ .+|++
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~~~-----------~-i~~~--~----~~~~~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLAQTPLETQM-----------K-VINW--Q----TSLHIPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred EechHHHHHHHhCCCCCCCCCHHHHHH-----------H-HHcc--C----CCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence 999999999999999997543211100 0 0000 0 00011111122344556666665 49999
Q ss_pred CCC---HHHHHHH
Q 047157 761 RPS---MKKVIHM 770 (788)
Q Consensus 761 RPt---~~evl~~ 770 (788)
|++ ++|++++
T Consensus 293 R~~~~~~~ei~~h 305 (382)
T cd05625 293 RLGKNGADEIKAH 305 (382)
T ss_pred cCCCCCHHHHhcC
Confidence 997 8888763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=304.78 Aligned_cols=255 Identities=22% Similarity=0.430 Sum_probs=202.5
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
+....+.+.+.||+|+||.||++... .+..+++|.+... ....+.+.+|++++++++|+||+++++++.+ ...++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~---~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN---KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec---CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 34556778899999999999999764 3447999988654 2345678899999999999999999999887 77899
Q ss_pred EEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 565 VYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+|||+++++|.+++.+. ...+++..+..++.|++.||.|||+. +++|+||||+||+++ .++.+||+|||.+
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~-----~~~~~~l~d~~~~ 149 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS-----ASLVCKIADFGLA 149 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEc-----CCCcEEECCCcce
Confidence 99999999999999653 45678889999999999999999998 999999999999998 7889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
...............++..|+|||.+....++.++||||||+++|++++ |+.||........ .. ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--------~~----~~~ 217 (260)
T cd05073 150 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--------IR----ALE 217 (260)
T ss_pred eeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH--------HH----HHh
Confidence 8664433222223345678999999998889999999999999999998 8889865321110 00 011
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
.. ............+.+++.+|++.+|++||++.++++.|+.
T Consensus 218 ~~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 RG---------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CC---------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 0001111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=304.67 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=199.3
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...+.+.+.||+|++|.||++... . ...+++|.+.... ...+.+.+|++++++++|||++++++++. .+..++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~--~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWN--G-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEc--C-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 345777889999999999999875 3 3468999876532 23467889999999999999999999875 45688999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++ +++.++|+|||.+..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~-----~~~~~~l~dfg~~~~ 151 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVG-----DNLVCKIADFGLARL 151 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEc-----CCCeEEECCCccceE
Confidence 999999999999654 34578999999999999999999998 999999999999998 788999999999986
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.............++..|+|||...+..++.++||||||+++|||++ |+.||......+ ... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~----~~~~~ 219 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--------VLE----QVERG 219 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHH----HHHcC
Confidence 64332222222345678999999988899999999999999999999 888986532111 001 11110
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
.. ..........+.+++.+||+.||++||++++|++.|+.
T Consensus 220 -~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 -YR--------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CC--------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 00111234678889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=313.47 Aligned_cols=269 Identities=21% Similarity=0.278 Sum_probs=198.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
+|.+.+.||+|+||.||+|... .++..||+|.++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSK--LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred ceEEEEEecccCCEEEEEEEec--CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 4667789999999999999876 566789999886433 2233467789999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++ +|.+++...+..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++....
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~-----~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLIN-----ERGELKLADFGLARAKS 155 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC-----CCCCEEECccccceecC
Confidence 9975 88888877667789999999999999999999999 999999999999998 77899999999987643
Q ss_pred CCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHHhhc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISCMLS 723 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 723 (788)
.... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... ....+.....
T Consensus 156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 156 VPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 3221 1223457889999998865 468899999999999999999999997654322111100000 0000000000
Q ss_pred c-cccc--cccCCCCC--cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 724 R-NLQV--LVSHDPEV--LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 724 ~-~~~~--l~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. .... .....+.. .........+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 0000 00000000 000112356788999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.15 Aligned_cols=246 Identities=27% Similarity=0.333 Sum_probs=195.1
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV 565 (788)
|.+.+.||+|+||.||+|... .++..||+|.+.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++|
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERK--GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 456789999999999999886 667799999987543 22334567788888777 689999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 80 ~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~-----~~~~~kL~DfG~~~~ 150 (323)
T cd05616 80 MEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLD-----SEGHIKIADFGMCKE 150 (323)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEEC-----CCCcEEEccCCCcee
Confidence 9999999999988654 4678899999999999999999999 999999999999998 788999999999875
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . .......
T Consensus 151 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--------~----~~i~~~~ 217 (323)
T cd05616 151 NMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--------F----QSIMEHN 217 (323)
T ss_pred cCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--------H----HHHHhCC
Confidence 432221 22345689999999999999999999999999999999999999975432111 0 1111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM-----KKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 769 (788)
.. .+.....++.+++.+||+.||++|++. +++++
T Consensus 218 --------~~--~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 218 --------VA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --------CC--CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 00 011234567889999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=303.27 Aligned_cols=250 Identities=32% Similarity=0.524 Sum_probs=203.4
Q ss_pred ccccccccceEEEEEEecc-CcceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
+.||+|+||.||++..... ..+..+++|.+...... ..+.+.+|++.+.+++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999998732 23678999998765433 367899999999999999999999999999999999999999
Q ss_pred CCHhHhhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 572 GTLSNFLFHE--------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 572 gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
++|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||+++ .++.+||+|||.+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~-----~~~~~~l~dfg~~ 152 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVG-----EDLVVKISDFGLS 152 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEEC-----CCCcEEEcccccc
Confidence 9999999775 47789999999999999999999998 999999999999998 7789999999999
Q ss_pred cccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHh
Q 047157 644 KLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 644 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
........ .......++..|+|||.+....++.++||||||+++|||++ |..||......+ .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------~~~~~ 220 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------------VLEYL 220 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------------HHHHH
Confidence 87754331 12233457889999999988899999999999999999999 589987542211 01111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
.... ..........++.+++.+||+.+|++|||++|++++|+
T Consensus 221 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 RKGY---------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HcCC---------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1110 00111122567889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=323.34 Aligned_cols=251 Identities=20% Similarity=0.215 Sum_probs=194.6
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|+||+||++... .++..||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKK--DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred ceEeEEEeecCCEEEEEEEEC--CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 556789999999999999876 667799999886532 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~-----~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILID-----RGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEC-----CCCCEEEeeccccccc
Confidence 999999999998654 5678888889999999999999999 999999999999998 7889999999998643
Q ss_pred CCCCCc----------------------------------------------ccccccCCccccCcccccCCCCCccCcc
Q 047157 647 NKDQTR----------------------------------------------TDTNMRGTMGYVAPEWLRNVPVTTKVDV 680 (788)
Q Consensus 647 ~~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DV 680 (788)
...... ......||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 210000 0012468999999999999999999999
Q ss_pred hhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCC
Q 047157 681 FSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNL 760 (788)
Q Consensus 681 wSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 760 (788)
|||||++|||++|+.||......+.. ...... .. .............+.+++.+|++ +|.+
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~~------------~~i~~~--~~----~~~~p~~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHETY------------RKIINW--RE----TLYFPDDIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHHHH------------HHHHcc--CC----ccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence 99999999999999999754321110 000000 00 00011111223567788888997 6666
Q ss_pred C---CCHHHHHHH
Q 047157 761 R---PSMKKVIHM 770 (788)
Q Consensus 761 R---Pt~~evl~~ 770 (788)
| +++.|++++
T Consensus 293 r~~r~~~~~~l~h 305 (377)
T cd05629 293 RLGRGGAHEIKSH 305 (377)
T ss_pred cCCCCCHHHHhcC
Confidence 5 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.36 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=191.6
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
+.||+|+||.||+|..........+++|.++... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 4689999999999987655566789999886543 234457889999999999999999999999999999999999999
Q ss_pred CHhHhhhccC----CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 573 TLSNFLFHEG----QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 573 sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+|.+++.... ...++..+..++.|++.||+|||+. +++|+||||+||+++ .++.+||+|||.+.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~-----~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLT-----ADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEc-----CCCcEEECCccccccccC
Confidence 9999996432 2456778889999999999999999 999999999999998 778999999999875433
Q ss_pred CCCcc-cccccCCccccCcccccCC-------CCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHH
Q 047157 649 DQTRT-DTNMRGTMGYVAPEWLRNV-------PVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 649 ~~~~~-~~~~~gt~~y~aPE~~~~~-------~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
..... .....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+. ....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--------~~~~-- 222 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--------LTYT-- 222 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--------HHHH--
Confidence 22211 1234567889999988542 35789999999999999996 9999965422111 0000
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
.. ........ +.. .....+.+.+++..|+ .+|++|||++||++.|+
T Consensus 223 -~~-~~~~~~~~--~~~--~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 -VR-EQQLKLPK--PRL--KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -hh-cccCCCCC--Ccc--CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00 00011111 111 1112345667888898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=305.64 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=204.4
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
+....+.+.++||+|+||.||+|... ....++||.+.... ...+++.+|+.++++++||||+++++++......++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~---~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN---GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc---CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 34556777899999999999999874 34679999887543 234678999999999999999999999999899999
Q ss_pred EEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 565 VYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++ +++.+||+|||.+
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~-----~~~~~~l~d~g~~ 150 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVG-----ENLVCKIADFGLA 150 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEc-----CCCCEEECccccc
Confidence 999999999999997643 5689999999999999999999999 999999999999998 7889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
................+..|+|||.+.+..++.++||||||+++|||++ |+.||........ .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~------------~~~~~ 218 (261)
T cd05034 151 RLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV------------LEQVE 218 (261)
T ss_pred eeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------------HHHHH
Confidence 8765432222222334568999999998899999999999999999998 9999864321110 01111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
.. .. ...+......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 219 ~~-~~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 RG-YR--------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred cC-CC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 00 00011124578889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=315.33 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=195.1
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
++||+|+||.||++... .++..+|+|.+++.. ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK--KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 46999999999999886 667799999997543 23345688999999888 6999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~-----~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 79 NGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLD-----ADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEe-----CCCCEEEeccccceeccCC
Confidence 999999888544 5689999999999999999999999 999999999999998 7889999999998753221
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..............
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~~~--- 220 (327)
T cd05617 150 G-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-----TEDYLFQVILEKPI--- 220 (327)
T ss_pred C-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-----cHHHHHHHHHhCCC---
Confidence 1 12234578999999999999999999999999999999999999996532221111 11111111111111
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM------KKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~ 770 (788)
.. +......+.+++.+||+.||++||++ ++++++
T Consensus 221 -----~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 221 -----RI--PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -----CC--CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 10 11123557789999999999999984 566553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.48 Aligned_cols=257 Identities=22% Similarity=0.242 Sum_probs=199.8
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCe
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 561 (788)
+....|.+.+.||+|+||.||++... .++..+|+|.+.+.. ....+.+.+|+.+++.++||||+++++.+.+++.
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHK--STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEEC--CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34466778899999999999999886 677799999986432 2334567889999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++||||+++++|.+++... .++...+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~-----~~~~ikL~DfG 187 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD-----KSGHLKLADFG 187 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEC-----CCCCEEEEeCC
Confidence 99999999999999998543 578888889999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCC----CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV----PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
++...............||+.|+|||++... .++.++|||||||++|||++|+.||........
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------------ 255 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------------ 255 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------------
Confidence 9987654433333446799999999998654 378899999999999999999999975432110
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHHh
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNL--RPSMKKVIHML 771 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~L 771 (788)
...+.... . .............+.+++..||+.++.+ ||+++|++++.
T Consensus 256 ~~~i~~~~-~-----~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 256 YSKIMNHK-N-----SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHHHcCC-C-----cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 01111100 0 0011111233456778888999844433 78999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=317.33 Aligned_cols=255 Identities=21% Similarity=0.220 Sum_probs=197.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||++... .++..||+|.+.+.. ......+.+|..++..++|+||+++++++.+++..++|
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMK--HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 3567789999999999999876 567789999986532 23345678899999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~-----~~~~~kl~DfG~a~~ 151 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLD-----MNGHIRLADFGSCLK 151 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEc-----CCCCEEEEeccceee
Confidence 999999999999977666788999999999999999999999 999999999999998 778999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRN-----VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
.............|++.|+|||++.+ ..++.++||||||+++|||++|+.||......+. ...
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------------~~~ 219 (331)
T cd05624 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------------YGK 219 (331)
T ss_pred ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------------HHH
Confidence 65444333334568999999999865 4678999999999999999999999975422111 001
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNL--RPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 770 (788)
......... .+... ....+++.+++.+|+..++++ |+++++++++
T Consensus 220 i~~~~~~~~---~p~~~--~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 220 IMNHEERFQ---FPSHI--TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHcCCCccc---CCCcc--ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111000000 00000 112456777888888765544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=303.50 Aligned_cols=250 Identities=29% Similarity=0.432 Sum_probs=202.9
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...+.+.+.||+|+||.||+|... +..|++|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~----~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR----GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec----CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 345667889999999999999763 56899999976644 5678999999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++ .++.+||+|||.+..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~-----~~~~~~l~d~g~~~~ 151 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVS-----EDLVAKVSDFGLAKE 151 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEe-----CCCCEEEcccccccc
Confidence 9999999999996553 3689999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... ....+..|+|||.+....++.++||||||+++||+++ |+.||......+ + .......
T Consensus 152 ~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~----~~~~~~~ 215 (256)
T cd05039 152 ASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------V----VPHVEKG 215 (256)
T ss_pred cccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--------H----HHHHhcC
Confidence 633222 2234567999999988899999999999999999997 999986442211 0 0111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
. .. .......+.+.+++.+||+.+|++|||++|++++|+++
T Consensus 216 ~-------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 Y-------RM--EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred C-------CC--CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 00 00112346788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=303.71 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=195.2
Q ss_pred ccccccccceEEEEEEec-cCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEe-cCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCS-EEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lV~e~~~ 570 (788)
+.||+|+||.||+|.... ......+|+|.+... .....+.+.+|+.+++.++||||+++++++. .+...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998752 234568999988543 2345678889999999999999999999875 4556899999999
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
+++|.+++.......++..+..++.||+.||.|||+. +++||||||+|||++ .++.+||+|||++.......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~-----~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLD-----ESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEc-----CCCcEEECCccccccccCCc
Confidence 9999999977666678888899999999999999998 999999999999998 77899999999997653322
Q ss_pred Cc---ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCC-CCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 651 TR---TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR-RHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 651 ~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
.. ......++..|+|||.+.+..++.++||||||+++|||++|. .||...... ..... ...+.
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------~~~~~----~~~~~- 219 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--------DITVY----LLQGR- 219 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHH----HhcCC-
Confidence 11 111234567899999998889999999999999999999964 555432111 11111 11110
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.+. .....+..+.+++..||+.+|++||++.||++.|+++.
T Consensus 220 ------~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 ------RLL--QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ------CCC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 000 01112356888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.26 Aligned_cols=263 Identities=28% Similarity=0.407 Sum_probs=204.6
Q ss_pred HHHHhhcccccccccccceEEEEEEeccC-----cceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEe
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKD-----TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCS 557 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 557 (788)
+....|.+.+.||+|+||.||++.....+ ....+|+|.+.... .....++.+|+++++++ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33456788899999999999999864211 23469999987542 34456788999999999 7999999999999
Q ss_pred cCCeEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 558 EEDKRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 558 ~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
..+..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++ +++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 9999999999999999999996532 2478899999999999999999998 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcc
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELS 700 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~ 700 (788)
+++ .++.+||+|||.+.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 172 ll~-----~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 172 LVT-----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred EEc-----CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 998 77899999999987654322111 111234568999999998899999999999999999998 88888643
Q ss_pred ccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
...+. ......... . .........+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus 247 ~~~~~------------~~~~~~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 247 PVEEL------------FKLLKEGHR-------M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred CHHHH------------HHHHHcCCC-------C--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 22110 001111100 0 0111234577889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.63 Aligned_cols=251 Identities=21% Similarity=0.227 Sum_probs=194.2
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|+||.||++... .++..||+|.+.+.. ....+.+.+|++++++++||||+++++.+.+++..++||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKV--DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEEC--CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 567789999999999999876 567799999986532 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++..+
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~-----~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILID-----RDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEEC-----CCCCEEEEeCCCCccc
Confidence 999999999999654 4578888889999999999999999 999999999999998 7889999999997533
Q ss_pred CCCC------------------------------------------CcccccccCCccccCcccccCCCCCccCcchhhH
Q 047157 647 NKDQ------------------------------------------TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFG 684 (788)
Q Consensus 647 ~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlG 684 (788)
.... ........||+.|+|||++.+..++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 1000 0001134689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC--
Q 047157 685 VMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-- 762 (788)
Q Consensus 685 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-- 762 (788)
|++|||++|+.||......+... ...... . .............+.+++.+|+ .+|.+|+
T Consensus 232 vilyell~G~~Pf~~~~~~~~~~------------~i~~~~--~----~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 232 VILYEMLVGQPPFLADTPAETQL------------KVINWE--T----TLHIPSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred ceeeehhhCCCCCCCCCHHHHHH------------HHhccC--c----cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 99999999999997653221100 000000 0 0000001112344556666665 5999999
Q ss_pred -CHHHHHHH
Q 047157 763 -SMKKVIHM 770 (788)
Q Consensus 763 -t~~evl~~ 770 (788)
++.|++++
T Consensus 293 ~t~~ell~h 301 (376)
T cd05598 293 NGADEIKAH 301 (376)
T ss_pred CCHHHHhCC
Confidence 89999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.20 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=193.0
Q ss_pred ccccccccceEEEEEEeccC-----cceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 494 KLVGTGSSGKVYRGILRLKD-----TQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.||+|+||.||+|...... ....+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46899999999999875321 2345888988766556667889999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC---CCCCcEEEeecCCccc
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL---DTNYMAKISDFGISKL 645 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---~~~~~~kL~Dfg~a~~ 645 (788)
+++|+|.+++...+..+++..++.++.||+.||+|||++ +|+||||||+||+++.++. .....++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999987766789999999999999999999999 9999999999999984321 1123479999999875
Q ss_pred cCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCC-CCCCccccccccccchhhhHHHHHHHhhc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGR-RHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
.... ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+....... ... .. .
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~----~~-~ 219 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQ----FY-E 219 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHH----HH-H
Confidence 4322 22457889999999976 45789999999999999999995 5554321110 000 00 0
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
. ..... ......+.+++.+||+.||++|||++++++.|+
T Consensus 220 ~--------~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 D--------RHQLP--APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c--------cccCC--CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00000 012246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=303.27 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=203.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||.||+|... .++..+++|.+..... .+++.+|++++++++||||+++++.+.+....++++||
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHK--ETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEc--CCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4566788999999999999886 4567899999875433 67899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++......+++..+..++.|++.||.|||+. +++|+||+|+||+++ .++.+||+|||++.....
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~-----~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLN-----EEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEC-----CCCcEEEcccccchhccc
Confidence 999999999977777889999999999999999999999 999999999999998 778999999999987654
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......... .....
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------------~~~~~----- 213 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------------FMIPN----- 213 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------------hhhcc-----
Confidence 322 222345788999999999989999999999999999999999999753221100 00000
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...............+.+++.+||+.||++|||++||++
T Consensus 214 --~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 214 --KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 001111112233467888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=305.71 Aligned_cols=253 Identities=30% Similarity=0.479 Sum_probs=199.9
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHH--HHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN--EEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|+||+||++... .++..+|+|.+........ ....+|+.++++++||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK--KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET--TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC--CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 467789999999999999887 6777999999976543332 234569999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
++++++|.+++. ....+++..+..++.||++||.+||+. +|+|+||||+||+++ .++.++|+|||.+....
T Consensus 79 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~-----~~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 79 YCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLD-----ENGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEES-----TTSEEEESSGTTTEEST
T ss_pred cccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccc-----ccccccccccccccccc
Confidence 999999999997 346779999999999999999999999 999999999999998 88899999999998642
Q ss_pred CCCCcccccccCCccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLR-NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
..........++..|+|||++. +...+.++||||+|+++|+|++|..||........... ... ......
T Consensus 150 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~----~~~-----~~~~~~ 219 (260)
T PF00069_consen 150 -ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI----IEK-----ILKRPL 219 (260)
T ss_dssp -STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH----HHH-----HHHTHH
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh----hhh-----cccccc
Confidence 1222333466889999999998 88999999999999999999999999976511111000 000 000000
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.... . ........+.+++..||+.||++||++.++++
T Consensus 220 ~~~~---~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSS---Q---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHT---T---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccc---c---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0 00001268889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.36 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=202.6
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..|.+.++||+|+||.||+|... .++..+++|.+........+.+.+|+++++.++||||+++++.+..+...++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNK--ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEEC--CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 34667789999999999999886 5677999999987766677889999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|..++.+....+++..+..++.|++.+|.|||+. +++||||||+||+++ .++.+||+|||++....
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~-----~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLT-----LDGDIKLADFGVSAKNV 161 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEc-----CCCCEEEccCccceecc
Confidence 9999999998876667789999999999999999999998 999999999999998 77899999999987543
Q ss_pred CCCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
... .......++..|+|||++. ...++.++||||||+++|||++|+.||....... . . ....
T Consensus 162 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~----~-~~~~ 228 (292)
T cd06644 162 KTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------V----L-LKIA 228 (292)
T ss_pred ccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-------H----H-HHHh
Confidence 221 1122345788999999884 4457889999999999999999999986532111 0 0 0000
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... .+...........+.+++.+||+.||++||+++++++.
T Consensus 229 ~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 229 KSE-------PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cCC-------CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 11111112334567889999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.62 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=198.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch-----HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-----EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
+...+.||+|++|.||++... .++..+++|.+.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~--~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDV--DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred ccccceecCCCceEEEEEEEc--CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 556789999999999999876 567799999875331 2234578899999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+||+++++|.+++... ..++...+..++.|++.||.|||+. +|+|+||+|+||+++ .++.++|+|||++.
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~-----~~~~~~l~dfg~~~ 152 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRD-----SAGNVKLGDFGASK 152 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc-----CCCCEEEeecccce
Confidence 99999999999998654 4578888899999999999999999 999999999999998 77899999999987
Q ss_pred ccCCCCCccc--ccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 645 LLNKDQTRTD--TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 645 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
.......... ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----------~~~~~~ 221 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-----------IFKIAT 221 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-----------HHHHhc
Confidence 6543222111 234577899999999998999999999999999999999999864321110 000000
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. .....+......+.+++.+||+.+|++|||++|++++
T Consensus 222 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 QP---------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cC---------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 0001111234567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=332.17 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=200.6
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCC-----
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED----- 560 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 560 (788)
..|.+.+.||+|+||+||++... .++..||||.+... .......+.+|+..+..++|+||+++++.+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRV--SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEc--CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 36777899999999999999876 56779999998643 2445567889999999999999999988765432
Q ss_pred ---eEEEEEecCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCc
Q 047157 561 ---KRLLVYELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM 634 (788)
Q Consensus 561 ---~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~ 634 (788)
..++||||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~-----~~~~ 181 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLC-----SNGL 181 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEe-----CCCC
Confidence 368999999999999998643 34678999999999999999999999 999999999999998 7889
Q ss_pred EEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh
Q 047157 635 AKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL 713 (788)
Q Consensus 635 ~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 713 (788)
+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~-------- 253 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-------- 253 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--------
Confidence 99999999986643222 222346789999999999999999999999999999999999999975422110
Q ss_pred HHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 714 SDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 714 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
......+....+ +......+.+++..||+.||++||++.+++++
T Consensus 254 ----~~~~~~~~~~~~---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 254 ----MHKTLAGRYDPL---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----HHHHhcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111111110 11234568889999999999999999999864
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.13 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=196.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.+.++||+|+||.||+|... .++..||+|.+... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHL--LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred chheeeeccCCCeEEEEEEEc--CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 345688999999999999876 56778999988654 244556799999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++ .++.+||+|||++.....
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~-----~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVN-----TRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEEC-----CCCCEEEeeCCcceeccc
Confidence 9999997653 467888889999999999999999 999999999999998 788999999999976543
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||............ .. ........
T Consensus 148 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~----~~-~~~~~~~~---- 215 (279)
T cd06619 148 SI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP----LQ-LLQCIVDE---- 215 (279)
T ss_pred cc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch----HH-HHHHHhcc----
Confidence 21 22356889999999999989999999999999999999999999653221111000 00 00111111
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
............++.+++.+||+.||++||+++|++++
T Consensus 216 ----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 216 ----DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ----CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111111234567889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.63 Aligned_cols=248 Identities=28% Similarity=0.445 Sum_probs=199.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchH-HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
++||+|+||.||++... + +..|++|.+..... ...+.+.+|++++++++||||+++++++.+....++|+||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~--~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK--G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEe--C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 46899999999999875 4 67999998875433 35678999999999999999999999999999999999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
+|.+++......+++..+..++.+++.||.|||++ +++||||||+||+++ .++.+||+|||.+.........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~-----~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVG-----ENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEc-----CCCcEEEeeccccccccCCcce
Confidence 99999977666788999999999999999999999 999999999999998 7789999999999865422211
Q ss_pred cc-ccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccccc
Q 047157 653 TD-TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730 (788)
Q Consensus 653 ~~-~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 730 (788)
.. .....+..|+|||.+.+..++.++||||||+++|||++ |..||........ .. .....
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--------~~----~~~~~------ 211 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--------RE----RIESG------ 211 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--------HH----HHhcC------
Confidence 11 11233567999999988899999999999999999999 7888865422110 00 00000
Q ss_pred cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 731 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
............+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 212 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 212 ---YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ---CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 0001111234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=316.71 Aligned_cols=242 Identities=26% Similarity=0.300 Sum_probs=188.6
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHH-HhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELK-IIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
+.||+|+||+||++... .++..+|+|.+.... ......+..|.. +++.++||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHK--AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 46899999999999886 566789999987532 122334445544 567889999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++... ..+....+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~-----~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 79 NGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLD-----SQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEC-----CCCCEEEccCCCCcccccC
Confidence 999999998654 4567788888999999999999999 999999999999998 7789999999998754322
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. ........
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------------~~~i~~~~---- 212 (325)
T cd05602 150 N-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------------YDNILNKP---- 212 (325)
T ss_pred C-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------------HHHHHhCC----
Confidence 1 122345689999999999999999999999999999999999999975432111 00011110
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
... .......+.+++.+||+.||.+||++.+.+.
T Consensus 213 ----~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 213 ----LQL--KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ----cCC--CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 000 1122456778999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.88 Aligned_cols=262 Identities=25% Similarity=0.422 Sum_probs=202.9
Q ss_pred HHHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCe
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 561 (788)
....|.+.++||+|+||.||+|..+. ...+..||+|.+.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34567778999999999999997652 1234589999876433 2334568899999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccC---------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC
Q 047157 562 RLLVYELMPNGTLSNFLFHEG---------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~ 632 (788)
.++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++ .+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~-----~~ 155 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVA-----HD 155 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEc-----CC
Confidence 999999999999999996432 2346778889999999999999999 999999999999998 78
Q ss_pred CcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccch
Q 047157 633 YMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVD 710 (788)
Q Consensus 633 ~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 710 (788)
+.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------ 229 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------ 229 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 89999999998865332221 1122345678999999998899999999999999999998 778886432111
Q ss_pred hhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 711 IVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
. . .....+..... .......+.+++.+||+.||++|||+.++++.|++...
T Consensus 230 --~---~-~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 230 --V---L-KFVMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred --H---H-HHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 0 0 11111111100 11223678899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.58 Aligned_cols=264 Identities=26% Similarity=0.377 Sum_probs=203.3
Q ss_pred HhhcccccccccccceEEEEEEeccC--------------cceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKD--------------TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~--------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~ 552 (788)
..+.+.++||+|+||.||++...... ....|++|.+.... ....+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 45677899999999999999875322 23468999987543 3456789999999999999999999
Q ss_pred eeEEecCCeEEEEEecCCCCCHhHhhhccC----------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEG----------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 553 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
++++..++..++|+|++++++|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 999999999999999999999999996543 2678999999999999999999998 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh--CCCCCCc
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC--GRRHIEL 699 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--g~~p~~~ 699 (788)
+++ .++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ +..||..
T Consensus 162 li~-----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 162 LVG-----KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eec-----CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 998 778999999999876533221 12223456778999999988889999999999999999998 6677754
Q ss_pred cccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
..... ................. .......++++.+++.+||+.||++|||+.||++.|+.
T Consensus 237 ~~~~~--------~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 237 LTDQQ--------VIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred cChHH--------HHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 32111 11111111111111110 01111234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=315.73 Aligned_cols=255 Identities=20% Similarity=0.202 Sum_probs=196.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.++||+|+||.||++..+ ..+..+|+|.+.+.. ......+.+|+.++..++|+||+++++.+.+.+..++|
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLK--NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEEC--CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 3566789999999999999886 667789999986432 22344588899999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++.+....+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~-----~~~~~kL~DfG~a~~ 151 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMD-----MNGHIRLADFGSCLK 151 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEC-----CCCCEEEeecchhee
Confidence 999999999999977667789999999999999999999999 999999999999998 788999999999876
Q ss_pred cCCCCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
.............||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. ..
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------------~~ 219 (332)
T cd05623 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------------GK 219 (332)
T ss_pred cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------------HH
Confidence 5443333333457899999999986 346889999999999999999999999754321110 00
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCC--CCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDP--NLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP--~~RPt~~evl~~ 770 (788)
......... .+.. .......+.+++.+|+..++ ..|++++|++++
T Consensus 220 i~~~~~~~~---~p~~--~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 220 IMNHKERFQ---FPAQ--VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HhCCCcccc---CCCc--cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111000000 0000 01223556677777775544 447899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=337.77 Aligned_cols=259 Identities=23% Similarity=0.330 Sum_probs=201.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.++||+|+||.||+|... .++..||+|++.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~--~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDP--VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEEC--CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 3566789999999999999876 567799999986532 34456899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhcc----------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcE
Q 047157 566 YELMPNGTLSNFLFHE----------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMA 635 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~ 635 (788)
|||+++++|.+++... ....++..++.++.||++||+|||++ +|+||||||+|||++ .++.+
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd-----~dg~v 152 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLG-----LFGEV 152 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEc-----CCCCE
Confidence 9999999999998532 12345677889999999999999999 999999999999998 78899
Q ss_pred EEeecCCccccCCCCC-----------------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCC
Q 047157 636 KISDFGISKLLNKDQT-----------------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIE 698 (788)
Q Consensus 636 kL~Dfg~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~ 698 (788)
||+|||++........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 9999999986521110 01112468999999999999999999999999999999999999996
Q ss_pred ccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHhhcCcC
Q 047157 699 LSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-SMKKVIHMLEGTLE 776 (788)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~ 776 (788)
......... . . .+............+..+.+++.+|++.||++|| +++++++.|+....
T Consensus 233 ~~~~~ki~~-----------~----~----~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 233 RKKGRKISY-----------R----D----VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred Ccchhhhhh-----------h----h----hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 532111100 0 0 0000000011112345678899999999999996 67777777766543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.69 Aligned_cols=241 Identities=28% Similarity=0.303 Sum_probs=189.6
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHH-HhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELK-IIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
++||+|+||.||++... .++..+|+|.+.... ....+.+..|.. +++.++||||+++++.+...+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK--LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 46899999999999876 667799999986542 223345566655 467789999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~-----~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLD-----SQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEEC-----CCCCEEEeecCCcccCCCC
Confidence 999999888644 5688999999999999999999999 999999999999998 7889999999998753221
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. ........+
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------------~~~~~~~~~--- 213 (325)
T cd05604 150 S-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------------YDNILHKPL--- 213 (325)
T ss_pred C-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------------HHHHHcCCc---
Confidence 1 122345689999999999999999999999999999999999999975432111 011111110
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 768 (788)
... ......+.+++.+|++.||.+||++++.+
T Consensus 214 -----~~~--~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 214 -----VLR--PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -----cCC--CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 000 11235677899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=307.11 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=205.6
Q ss_pred HHHHhhcccccccccccceEEEEEEeccC--cceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEec-CC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKD--TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-ED 560 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 560 (788)
+....+.+.++||+|+||.||+|...... ....|++|.+.... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34556778899999999999999986321 35789999886542 4446778999999999999999999998766 56
Q ss_pred eEEEEEecCCCCCHhHhhhccC-------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCC
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG-------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNY 633 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~ 633 (788)
..++++||+++++|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||+++ +++
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~-----~~~ 154 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVID-----EEL 154 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEc-----CCC
Confidence 7899999999999999986532 4578999999999999999999998 999999999999998 778
Q ss_pred cEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchh
Q 047157 634 MAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDI 711 (788)
Q Consensus 634 ~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 711 (788)
.+||+|||+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------- 227 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------- 227 (280)
T ss_pred cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------
Confidence 9999999999865432221 1122345678999999998899999999999999999998 999986532211
Q ss_pred hhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 712 VLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 712 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
...+ ...+ . .+. ......+.+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 228 -~~~~----~~~~-~------~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 228 -MAAY----LKDG-Y------RLA--QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred -HHHH----HHcC-C------CCC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111 1111 0 000 01122456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.81 Aligned_cols=202 Identities=25% Similarity=0.274 Sum_probs=174.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||++... .++..||+|.+.+.. ....+.+.+|+.++..++|+||+++++++.+++..++|
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMK--NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CceEEEEEEecCCeEEEEEEEC--CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 3567789999999999999886 567799999986422 23345688999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++.+....+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~-----~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLD-----KNGHIRLADFGSCLR 151 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEEC-----CCCCEEEEECCceee
Confidence 999999999999976667789999999999999999999999 999999999999998 788999999999876
Q ss_pred cCCCCCcccccccCCccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRN-----VPVTTKVDVFSFGVMLLEIICGRRHIELS 700 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltg~~p~~~~ 700 (788)
.............||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 54433333333568999999999863 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=321.47 Aligned_cols=266 Identities=23% Similarity=0.265 Sum_probs=197.3
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCC-----eEE
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED-----KRL 563 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~ 563 (788)
.+.+.||+|+||.||++... .++..||+|++.... ....+++.+|+++++.++||||+++++++...+ ..+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDP--RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred cccceeeeCCCEEEEEEEEC--CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 45688999999999999876 567799999886432 234567889999999999999999999998776 789
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+|+||+. ++|.+.+.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~-----~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVN-----SNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEEC-----CCCCEEeccccce
Confidence 9999996 578887744 35688999999999999999999999 999999999999998 7889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh-----hHH--
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV-----LSD-- 715 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-----~~~-- 715 (788)
...............++..|+|||.+.+. .++.++|||||||++|||++|+.||............... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 86544333333345678899999998764 5789999999999999999999999765432211100000 000
Q ss_pred ----HHHHHhhcccccc-cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 716 ----WVISCMLSRNLQV-LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 716 ----~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
............. .... .........+.+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPV--LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHH--hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000 0000 000001124578899999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.34 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=201.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+|.+.+.||+|++|.||+|... ..+..|++|.+........+.+.+|+.+++.++||||+++++.+......++||||
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDV--ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEEC--CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4556688999999999999875 56678999998765555567889999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++.. ..+++.++..++.|++.||.|||+. +|+|+||||+||+++ .++.+||+|||++.....
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~-----~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLG-----MDGSVKLTDFGFCAQITP 168 (296)
T ss_pred cCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEc-----CCCCEEECccccchhccc
Confidence 999999999853 3578899999999999999999999 999999999999998 778999999999876543
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ +. .....
T Consensus 169 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~----------~~-~~~~~----- 231 (296)
T cd06654 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----------LY-LIATN----- 231 (296)
T ss_pred ccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh----------HH-HHhcC-----
Confidence 221 12234678899999999988899999999999999999999999965422110 00 00000
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..+...........+.+++.+||+.||++|||++|+++.
T Consensus 232 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 232 ---GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 001111112334567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=308.13 Aligned_cols=269 Identities=24% Similarity=0.390 Sum_probs=207.1
Q ss_pred HhhcccccccccccceEEEEEEec--cCcceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEec--CCeE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRL--KDTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSE--EDKR 562 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~--~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 562 (788)
..+.+.+.||+|+||.||++.+.. ...+..+|||.+...... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 345567899999999999998752 245678999998765443 56789999999999999999999999877 5688
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++++|.+++......+++..+..++.|++.||+|||+. +++|+||||+||+++ .++.++|+|||.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~-----~~~~~~l~dfg~ 155 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVE-----SEDLVKISDFGL 155 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEc-----CCCCEEEccccc
Confidence 999999999999999977666789999999999999999999998 999999999999998 778999999999
Q ss_pred ccccCCCCCcc--cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccc----ccchhhhHHH
Q 047157 643 SKLLNKDQTRT--DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES----EEVDIVLSDW 716 (788)
Q Consensus 643 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~----~~~~~~~~~~ 716 (788)
+.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 98765332211 11223456799999998889999999999999999999999998643221100 0000000010
Q ss_pred HHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 717 VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
..... .............++.+++.+||+.+|++||||.||+++|+++
T Consensus 236 -~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 -LELLK---------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -HHHHH---------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 01111 1111111122336788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.36 Aligned_cols=201 Identities=21% Similarity=0.309 Sum_probs=162.7
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec--CCeEEEEEecCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--EDKRLLVYELMP 570 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lV~e~~~ 570 (788)
.++||+|+||+||+|.......+..+|+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 36899999999999987644566789999986532 23457789999999999999999998854 456899999985
Q ss_pred CCCHhHhhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 571 NGTLSNFLFHE--------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 571 ~gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++... ...+.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~-~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG-PERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCC-CCcCcEEEeecCc
Confidence 5888776422 23478889999999999999999999 999999999999995321 1567899999999
Q ss_pred ccccCCCCC--cccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCcc
Q 047157 643 SKLLNKDQT--RTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELS 700 (788)
Q Consensus 643 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~ 700 (788)
+........ .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 987643322 12234568999999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=315.70 Aligned_cols=238 Identities=28% Similarity=0.314 Sum_probs=187.4
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHH-HhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELK-IIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
++||+|+||.||+|... .++..||+|.+.+.. ......+..|.. +++.++||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK--SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46899999999999886 667799999986542 223345555654 578899999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|...+... ..+.+..+..++.||+.||.|||+. +|+||||||+||+++ .++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~-----~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 79 NGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLD-----SQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEEC-----CCCCEEEccCCCCccCCCC
Confidence 999999888544 5677888889999999999999998 999999999999998 7889999999998753222
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.... ........
T Consensus 150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------------~~~i~~~~---- 212 (321)
T cd05603 150 E-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------------YDNILHKP---- 212 (321)
T ss_pred C-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------------HHHHhcCC----
Confidence 1 122345689999999999998999999999999999999999999975422110 01111111
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMK 765 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 765 (788)
... +......+.+++.+||+.||++||++.
T Consensus 213 ----~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 ----LQL--PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ----CCC--CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111 112245678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.95 Aligned_cols=269 Identities=24% Similarity=0.331 Sum_probs=200.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.+.+.||+|+||.||++... .++..+++|.+... .....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHR--PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEc--CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 556789999999999999876 56778999988644 234456788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++.+. ..+++..+..++.||++||.|||+. .+++|+||||+|||++ .++.+||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~-----~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVN-----SRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEe-----cCCcEEEccCCCcccccc
Confidence 9999999999655 5678899999999999999999973 2899999999999998 778899999999876533
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHH---------
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS--------- 719 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 719 (788)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......................
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 153 SM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred cc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 21 123567899999999988889999999999999999999999986443211100000000000000
Q ss_pred -------HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 720 -------CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 720 -------~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
..........................+.+++.+||+.||++|||++||+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000000000011111345688999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=286.77 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=200.9
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc--------hHHHHHHHHHHHHHhcCC-CccccceEeeEEecCC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--------IEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED 560 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--------~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 560 (788)
|.-.+.||+|..++|-+..++ .++...|+|++... .....++-.+|+.+|+++ .||+|+++.++++.+.
T Consensus 19 y~pkeilgrgvss~vrRci~k--~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHK--ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred cChHHHhcccchhhhhhhhhc--ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 444678999999999999887 67778999988532 234556778899999998 6999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++|+|.|+.|.|.++|... -.++++...+|++|+.+|+.|||.+ +||||||||+|||++ ++.++||+||
T Consensus 97 F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILld-----dn~~i~isDF 167 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLD-----DNMNIKISDF 167 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeec-----cccceEEecc
Confidence 999999999999999999544 6788899999999999999999999 999999999999999 9999999999
Q ss_pred CCccccCCCCCcccccccCCccccCccccc------CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLR------NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 714 (788)
|++..+.+.... ...+||++|+|||.++ ...|+...|+|++|||+|.|+.|..||..... +.+
T Consensus 168 GFa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------mlM- 236 (411)
T KOG0599|consen 168 GFACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------MLM- 236 (411)
T ss_pred ceeeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HHH-
Confidence 999988765433 3579999999999884 23578899999999999999999999964311 111
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...+.++..+- ... .=.+......+|+.+||+.||.+|.|++|+++
T Consensus 237 ---LR~ImeGkyqF----~sp--eWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 ---LRMIMEGKYQF----RSP--EWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---HHHHHhccccc----CCc--chhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11122222111 000 11234456778999999999999999999986
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=317.08 Aligned_cols=262 Identities=28% Similarity=0.427 Sum_probs=200.1
Q ss_pred HHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecC-C
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE-D 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~ 560 (788)
...+.+.+.||+|+||.||+|.... ...++.||||.++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 4567788999999999999997531 2346689999987533 33456788999999999 689999999988654 5
Q ss_pred eEEEEEecCCCCCHhHhhhccC----------------------------------------------------------
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG---------------------------------------------------------- 582 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 582 (788)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc-c
Q 047157 583 --------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR-T 653 (788)
Q Consensus 583 --------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~ 653 (788)
..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++......... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~-----~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS-----ENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEc-----CCCcEEEEecccccccccCcchhh
Confidence 2357788889999999999999999 999999999999998 7789999999999865332211 1
Q ss_pred cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccccccC
Q 047157 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSH 732 (788)
Q Consensus 654 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 732 (788)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||........ . ......+....
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~----~~~~~~~~~~~---- 302 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------F----CRRLKEGTRMR---- 302 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-------H----HHHHhccCCCC----
Confidence 122345678999999988899999999999999999997 8888864321110 0 00111111000
Q ss_pred CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 733 DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 733 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.+. .....+.+++..||+.||++|||+.||+++|+.+.+
T Consensus 303 ~~~-----~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 APD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011 123467889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.93 Aligned_cols=249 Identities=27% Similarity=0.377 Sum_probs=196.3
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
...||+|+||.||+|... .++..|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||++++
T Consensus 13 ~~~lg~g~~g~v~~~~~~--~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 13 RVVLGKGTYGIVYAARDL--STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred eEEEecCCceEEEEeEec--CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 368999999999999876 567789999987666666778999999999999999999999999999999999999999
Q ss_pred CHhHhhhccCCCC--CHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 573 TLSNFLFHEGQRP--GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 573 sL~~~l~~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
+|.+++......+ ++..+..++.||+.||+|||++ +|+||||||+||+++. ..+.++|+|||.+.......
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~----~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNT----YSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcC----CCCeEEEecchhheecccCC
Confidence 9999997654444 7888889999999999999998 9999999999999972 35689999999987654322
Q ss_pred CcccccccCCccccCcccccCC--CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 651 TRTDTNMRGTMGYVAPEWLRNV--PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
. ......++..|+|||++... .++.++||||||+++|+|++|+.||........ ..+...
T Consensus 164 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--------~~~~~~--------- 225 (268)
T cd06624 164 P-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--------AMFKVG--------- 225 (268)
T ss_pred C-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--------hHhhhh---------
Confidence 2 12234578899999998654 378899999999999999999999864311100 000000
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.....+. .+....+++.+++.+||+.+|++|||+.|++++
T Consensus 226 ~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 226 MFKIHPE--IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhccCCC--CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000011 111234567889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=323.91 Aligned_cols=193 Identities=24% Similarity=0.293 Sum_probs=166.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||.||++.+. ..+..||||.... ..+.+|++++++++||||+++++++..++..++|||+
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~--~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHP--DYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEEC--CCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4666789999999999999886 5667899996432 3456899999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+ .++|.+++......+++.+++.|+.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++....
T Consensus 242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~-----~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVN-----GPEDICLGDFGAACFARG 312 (461)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEEC-----CCCCEEEcccCCceeccc
Confidence 9 4789998876666799999999999999999999999 999999999999998 778899999999986543
Q ss_pred CCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCC
Q 047157 649 DQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIE 698 (788)
Q Consensus 649 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~ 698 (788)
.... ......||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2221 1223568999999999999999999999999999999999887653
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.07 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=202.5
Q ss_pred HHhhcccccccccccceEEEEEEec-----cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecC
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRL-----KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE 559 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 559 (788)
...+.+.+.||+|+||.||++.... ......+++|.+.... ......+.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 3456678999999999999997531 1234578999887532 34456788999999999 699999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEe
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLL 624 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 624 (788)
...++||||+++++|.+++.... ..+++.++..++.||+.||.|||++ +|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999996532 3478899999999999999999998 99999999999999
Q ss_pred ccCCCCCCCcEEEeecCCccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcccc
Q 047157 625 DLKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRV 702 (788)
Q Consensus 625 ~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~ 702 (788)
+ .++.+||+|||.++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 168 ~-----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 168 T-----EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred c-----CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 8 77899999999998664322211 111234467999999998899999999999999999999 8888865422
Q ss_pred ccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 703 EEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.+. ......... .. ........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 243 ~~~------------~~~~~~~~~-------~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 EEL------------FKLLREGHR-------MD--KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHH------------HHHHHcCCC-------CC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 111111110 00 01122456778999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.55 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=205.1
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.+.+.+.||+|+||.||++... .++..+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDI--ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ceEEEEEecCCCceEEEEeEec--CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4567789999999999999886 45668999998766555678899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++......+++.++..++.|++.||.|||++ +|+|+||+|+||+++ .++.+||+|||.+.....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~-----~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLT-----EDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEEC-----CCCCEEECccccchhhhh
Confidence 999999999877656789999999999999999999998 999999999999998 778899999999886543
Q ss_pred CCCcccccccCCccccCcccccCC---CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNV---PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
... ......++..|+|||.+... .++.++||||||+++|||++|+.||......... .. .....
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-------~~-----~~~~~ 220 (262)
T cd06613 154 TIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-------FL-----ISKSN 220 (262)
T ss_pred hhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------HH-----HHhcc
Confidence 221 12234678899999999776 8899999999999999999999999654211100 00 00000
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
+ ..+...........+.+++.+||+.+|.+|||+++|+.
T Consensus 221 ~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 F-----PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred C-----CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 01111122344567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=303.41 Aligned_cols=251 Identities=27% Similarity=0.477 Sum_probs=200.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.+.+.+.||+|+||.||++... .+..+++|.+.... .....+.+|++++++++||||+++++++......++|+||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL---EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe---CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 4566789999999999999874 34579999886542 2345788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++......+++..+..++.|++.||+|||+. +++|+||||+||+++ .++.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~-----~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVG-----ENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEc-----CCCeEEECCCcceeeccc
Confidence 999999999977666788999999999999999999998 999999999999998 778999999999876543
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . ...... ..
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-----------~-~~~~~~-~~ 219 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-----------V-ETINAG-FR 219 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH-----------H-HHHhCC-CC
Confidence 32222222335678999999998899999999999999999998 8999864321110 0 001110 00
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
.. .+. ...+.+.+++.+||+.+|++|||+.|++++|.
T Consensus 220 -~~--~~~-----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 220 -LY--KPR-----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CC--CCC-----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 00 011 12467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.87 Aligned_cols=264 Identities=25% Similarity=0.348 Sum_probs=200.6
Q ss_pred HhhcccccccccccceEEEEEEec--------------cCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRL--------------KDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~--------------~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~ 552 (788)
..+.+.+.||+|+||.||++.... ......+|+|.+... .....+++.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 446778899999999999985431 123457999998754 24456789999999999999999999
Q ss_pred eeEEecCCeEEEEEecCCCCCHhHhhhccC----------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEG----------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 553 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
++++...+..++||||+++++|.+++.... ..+++.++..++.||+.||+|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 999999999999999999999999986532 2356788999999999999999999 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh--CCCCCCc
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC--GRRHIEL 699 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--g~~p~~~ 699 (788)
|++ .++.++|+|||++..+....... .....++..|+|||......++.++||||||+++|||++ |..||..
T Consensus 162 li~-----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 162 LVG-----KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEc-----CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 998 77899999999998654332211 122334678999999888889999999999999999998 6678764
Q ss_pred cccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
....+... ............... +. .......+.+++.+||+.||++||++.||++.|+.
T Consensus 237 ~~~~~~~~--------~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 237 LSDEQVIE--------NTGEFFRDQGRQVYL-PK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred cChHHHHH--------HHHHHHhhccccccC-CC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 32221110 000111111000000 00 11223678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.62 Aligned_cols=258 Identities=22% Similarity=0.335 Sum_probs=205.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc---hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||+|... .++..+++|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICL--LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEc--CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4667889999999999999886 56778999987532 233467889999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 566 YELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
|||+++++|.+++.. ....+++.+++.++.|++.||.|||+. +|+|+||+|+||+++ .++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~-----~~~~~~l~d~~~ 152 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFIT-----ATGVVKLGDLGL 152 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEEC-----CCCcEEEeccce
Confidence 999999999999854 234578999999999999999999999 999999999999998 778999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+. .....
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~-~~~~~ 221 (267)
T cd08224 153 GRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LYSL-CKKIE 221 (267)
T ss_pred eeeccCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---------HHHH-Hhhhh
Confidence 8765433221 22345788999999999889999999999999999999999998643211 0010 01111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.+... ..........+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 222 ~~~~~--------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 KCDYP--------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cCCCC--------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11110 0111134457788999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.24 Aligned_cols=265 Identities=24% Similarity=0.342 Sum_probs=206.1
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
+....+.+.+.||+|+||+||++... ..+..+++|.+.... ....+.+.+|+++++.++||||+++++++...+..+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHI--PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEc--CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 34456777899999999999999876 567789999876432 445678999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++++|.+++... ..+++..+..++.+++.||.|||+. .+++|+||||+||+++ .++.++|+|||++
T Consensus 80 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~-----~~~~~~l~d~gl~ 151 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVN-----SRGQIKLCDFGVS 151 (284)
T ss_pred EEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEEC-----CCCcEEEccCCcc
Confidence 999999999999988653 4688999999999999999999973 2899999999999998 7789999999998
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......+.................
T Consensus 152 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 226 (284)
T cd06620 152 GELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-- 226 (284)
T ss_pred cchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh--
Confidence 7543221 12346889999999998889999999999999999999999999754332111111111111111111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
...+...........+.+++.+||+.||++|||++||+++.
T Consensus 227 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 -------QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -------hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111111122445688899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=313.67 Aligned_cols=241 Identities=27% Similarity=0.342 Sum_probs=191.9
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV 565 (788)
+++.+.||+|+||+||++... .++..||+|.+.+.. ....+.+..|..++..+. |++|+++++++.+.+..++|
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERK--GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred ceEEEEEEecCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 456789999999999999876 667799999987542 233456778888888875 67888999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++.++..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 80 ~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~-----~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 80 MEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLD-----SEGHIKIADFGMCKE 150 (323)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEEC-----CCCCEEEeccccccc
Confidence 9999999999998654 4688999999999999999999999 999999999999998 788999999999875
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... ......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ........
T Consensus 151 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------------~~~i~~~~ 217 (323)
T cd05615 151 HMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL------------FQSIMEHN 217 (323)
T ss_pred cCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH------------HHHHHhCC
Confidence 432221 12235689999999999999999999999999999999999999975432110 01111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM 764 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 764 (788)
. .. .......+.+++.+||+.||++|++.
T Consensus 218 ~--------~~--p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 V--------SY--PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C--------CC--CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1 00 01123567889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=317.24 Aligned_cols=203 Identities=26% Similarity=0.389 Sum_probs=175.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-c-----cccceEeeEEecCCeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-H-----KNLVRLLGFCSEEDKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~~~~~~~~~ 562 (788)
+|.+.+.||+|.||.|.++... .+++.||||+++.. ..-..+...|+.+|..|+ | -|+|+++++|...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~--~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH--KTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEec--CCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 5677899999999999999987 78889999999875 445567778999999986 4 4899999999999999
Q ss_pred EEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 563 LLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
|||+|.+ ..+|.++|+.+ ...++...+..|+.||+.||.+||+. +|||+||||+||||... ....+||+|||
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~---~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDP---KRSRIKVIDFG 336 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccC---CcCceeEEecc
Confidence 9999999 56999999765 35678999999999999999999998 99999999999999743 34589999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccc
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEE 705 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~ 705 (788)
.+........ ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..++
T Consensus 337 SSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 337 SSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred cccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 9987543322 35668899999999999999999999999999999999988877655443
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.14 Aligned_cols=264 Identities=28% Similarity=0.428 Sum_probs=205.6
Q ss_pred HHHHHhhcccccccccccceEEEEEEecc-----Ccceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEE
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLK-----DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFC 556 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 556 (788)
++....+.+.+.||+|+||.||++..... .....|++|.+.... ....+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 34455678889999999999999976421 123478999887543 34457899999999999 799999999999
Q ss_pred ecCCeEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCc
Q 047157 557 SEEDKRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQN 621 (788)
Q Consensus 557 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~N 621 (788)
.+.+..++++||+++++|.+++.... ..+++.++..++.||+.||.|||++ +|+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999986532 3467889999999999999999998 99999999999
Q ss_pred EEeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCc
Q 047157 622 VLLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIEL 699 (788)
Q Consensus 622 Ill~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~ 699 (788)
||++ .++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 165 ill~-----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 165 VLVT-----EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred EEEc-----CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 9998 7789999999999865432211 1122234567999999999999999999999999999998 8888865
Q ss_pred cccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
....+. .......... . ........+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 240 ~~~~~~------------~~~~~~~~~~-------~--~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 240 IPVEEL------------FKLLKEGHRM-------D--KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCHHHH------------HHHHHcCCCC-------C--CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 422111 0111111100 0 011234578899999999999999999999999997763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.17 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=200.9
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
+....|.+.+.||+|+||.||++.......+..|++|.+... +...+|++++++++||||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 334567888999999999999998765556678999988653 234589999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|||++. ++|.+++ .....+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 164 v~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~-----~~~~~~l~DfG~a~ 233 (392)
T PHA03207 164 VMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLD-----EPENAVLGDFGAAC 233 (392)
T ss_pred EehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEc-----CCCCEEEccCcccc
Confidence 999985 6888888 3446789999999999999999999999 999999999999998 78899999999997
Q ss_pred ccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 645 LLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 645 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... +.. +......
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~----l~~-i~~~~~~ 308 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ----LRS-IIRCMQV 308 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHH----HHH-HHHHhcc
Confidence 65443222 22345789999999999999999999999999999999999999976543211100 000 0000000
Q ss_pred cc-----------------ccccccC---CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 724 RN-----------------LQVLVSH---DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 724 ~~-----------------~~~l~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. +.....+ .+...........+.+++.+||+.||++|||+.|++.+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000 00000011123467788999999999999999999875
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.17 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=203.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||.|+||.||++... .++..+++|.+........+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHK--ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEc--CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 3666788999999999999886 46678999998766666677899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++.+.+..+++..+..++.|++.||.|||++ +|+|+||||+||+++ .++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~-----~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLT-----LDGDVKLADFGVSAKNKS 155 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEC-----CCCCEEEccCccchhhcc
Confidence 999999999977667789999999999999999999999 999999999999998 788999999998876533
Q ss_pred CCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
... ......++..|+|||.+. ...++.++||||||+++|||++|+.||........ . .....
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-------~-----~~~~~ 222 (280)
T cd06611 156 TLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-------L-----LKILK 222 (280)
T ss_pred ccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-------H-----HHHhc
Confidence 221 122346788999999874 34577899999999999999999999975421110 0 00111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. .+....+......+.+++..||+.+|++||++++|++.
T Consensus 223 ~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 SE-------PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CC-------CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 10 01111112234567889999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.95 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=201.6
Q ss_pred HHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
...+.+.+.||+|+||.||++.... ...+..|++|.+.... ....+++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3446667899999999999998642 2345689999987543 34456799999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccC---------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCc
Q 047157 563 LLVYELMPNGTLSNFLFHEG---------------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQN 621 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~N 621 (788)
++|+||+++++|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999996421 2467888899999999999999998 99999999999
Q ss_pred EEeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCc
Q 047157 622 VLLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIEL 699 (788)
Q Consensus 622 Ill~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~ 699 (788)
|+++ .++.++|+|||++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 161 il~~-----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLVG-----ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEec-----CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998 7889999999998765332211 1122234667999999998899999999999999999997 8788854
Q ss_pred cccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
....+ . ........... .......++.+++.+||+.||++|||+.|+++.|++
T Consensus 236 ~~~~~-----------~-~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 236 MAHEE-----------V-IYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCHHH-----------H-HHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 32211 0 01111111110 011234678889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=301.56 Aligned_cols=254 Identities=27% Similarity=0.368 Sum_probs=188.9
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
++||+|+||.||+|..........+++|.+.... ......+.+|+++++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3689999999999976544455678999876433 344567889999999999999999999999999999999999999
Q ss_pred CHhHhhhccC----CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 573 TLSNFLFHEG----QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 573 sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+|.+++.... ...++.....++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~-----~~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLT-----ADLSVKIGDYGLALEQYP 152 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEec-----CCCcEEEecccccccccc
Confidence 9999996543 2346778889999999999999999 999999999999998 788999999999875433
Q ss_pred CCCc-ccccccCCccccCccccc-------CCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHH
Q 047157 649 DQTR-TDTNMRGTMGYVAPEWLR-------NVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 649 ~~~~-~~~~~~gt~~y~aPE~~~-------~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
.... ......++..|+|||++. ...++.++||||||+++|||++ |..||......+. + ..
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~----~~ 221 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-------L----KQ 221 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-------H----HH
Confidence 2211 112234567899999874 3456889999999999999999 7778764321110 0 00
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
..... ...+.. + .........+.+++..|+ .||++|||++||++.|.
T Consensus 222 ~~~~~-~~~~~~--~--~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 222 VVREQ-DIKLPK--P--QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred Hhhcc-CccCCC--C--cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 01111 011111 1 111123345566777788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.96 Aligned_cols=248 Identities=29% Similarity=0.411 Sum_probs=196.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEe-cCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCS-EEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lV~ 566 (788)
..+.+.+.||+|+||.||++... +..+++|.++... ..+.+.+|+.++++++|+|++++++++. +++..++|+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc----CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 45677899999999999999763 4578999886532 3567899999999999999999999764 556789999
Q ss_pred ecCCCCCHhHhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHEGQ-RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++.+... .+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~-----~~~~~kl~dfg~~~~ 151 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVS-----EDNVAKVSDFGLTKE 151 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEc-----CCCcEEecCCcccee
Confidence 99999999999976543 478999999999999999999999 999999999999998 788999999999875
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..... .....+..|+|||++.+..++.++||||||+++|||++ |+.||......+. . ......
T Consensus 152 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~-----------~-~~~~~~ 215 (256)
T cd05082 152 ASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----------V-PRVEKG 215 (256)
T ss_pred ccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-----------H-HHHhcC
Confidence 43322 12234568999999998899999999999999999997 8988864321110 0 001111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
. . + .........+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 216 ~-~------~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 Y-K------M--DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred C-C------C--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0 0 0 00112345678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.17 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=200.1
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..|.+.+.||+|+||.||+|... .++..+++|.++.........+.+|+.+++.++||||+++++.+...+..++|+|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNV--NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEc--CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 35667789999999999999876 5677899999876555555678899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++... ..+++.++..++.|++.||.|||+. +++|+||||+||+++ .++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~-----~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 87 FCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLT-----DNGHVKLADFGVSAQIT 157 (267)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC-----CCCCEEECcceeeeEcc
Confidence 99999999998654 4688999999999999999999999 999999999999998 77889999999987654
Q ss_pred CCCCcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
... .......|+..|+|||.+. ...++.++||||||+++|||++|+.||........ . . .....
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~----~-~~~~~ 224 (267)
T cd06645 158 ATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------L----F-LMTKS 224 (267)
T ss_pred Ccc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------H----H-hhhcc
Confidence 322 2223356889999999874 45688999999999999999999999854321110 0 0 00000
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... .+.........+.+.+++.+||+.||++||++++|+++
T Consensus 225 ~~~-----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 NFQ-----PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCC-----CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 00000111223567889999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.95 Aligned_cols=246 Identities=26% Similarity=0.462 Sum_probs=190.6
Q ss_pred ccccccccceEEEEEEeccC--------cceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKD--------TQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~--------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
+.||+|+||.||+|.+.... ....+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999987322 1145788877654333 6788999999999999999999999988 778999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCC--CCCcEEEeecCCc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD--TNYMAKISDFGIS 643 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~--~~~~~kL~Dfg~a 643 (788)
+||+++++|.+++......+++..+..++.||+.||+|||++ +|+||||||+||+++.+... ....+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999987666789999999999999999999998 99999999999999832200 1127999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCC--CCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHH
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNV--PVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
..... .....++..|+|||++... .++.++||||||+++|||++ |..|+......+. ..+
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--------~~~---- 218 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--------ERF---- 218 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--------HHH----
Confidence 86543 1123466789999999776 78999999999999999999 4667654321110 000
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
..... .. +.+ ....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 219 ~~~~~--~~--~~~-------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQH--RL--PMP-------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCC--CC--CCC-------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 00 000 1167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.85 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=204.6
Q ss_pred HHhhcccccccccccceEEEEEEeccCc--ceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
...+.+.+.||+|+||.||+|.....+. ...+++|.+.... .....++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3456677899999999999998763222 3468999886553 3455788999999999999999999999987 7889
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+|+||+++++|.+++......+++..+..++.||+.||+|||++ +|+|+||||+||+++ .++.+||+|||.+
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~-----~~~~~kL~dfg~~ 156 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVK-----TPQHVKITDFGLA 156 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEc-----CCCeEEECCCccc
Confidence 99999999999999987766789999999999999999999998 999999999999998 7789999999999
Q ss_pred cccCCCCCccc-ccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHh
Q 047157 644 KLLNKDQTRTD-TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 644 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
........... ....++..|+|||.+....++.++||||||+++||+++ |+.||......+. .. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~----~~ 224 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--------PD----LL 224 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--------HH----HH
Confidence 87653322111 11223567999999988899999999999999999998 9999975432111 11 11
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
..... . ..+ ......+.+++.+||..||++||++.++++.|+.+..
T Consensus 225 ~~~~~---~-~~~-----~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 225 EKGER---L-PQP-----PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred hCCCC---C-CCC-----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11100 0 001 1122457788999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.83 Aligned_cols=194 Identities=22% Similarity=0.306 Sum_probs=166.3
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
+....|.+.+.||+|+||.||+|... ..+..||+|..... ....|+.++++++||||+++++++.+.+..++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKP--GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEEC--CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 33445778899999999999999886 56678999975432 23468999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+|++ .++|.+++......+++..+..|+.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 135 v~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~-----~~~~~kl~DfG~a~ 205 (357)
T PHA03209 135 VLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFIN-----DVDQVCIGDLGAAQ 205 (357)
T ss_pred EEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC-----CCCCEEEecCcccc
Confidence 99999 4689998877777889999999999999999999999 999999999999998 77899999999987
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCC
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHI 697 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~ 697 (788)
...... ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 206 FPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 533221 122356899999999999999999999999999999999876554
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=327.46 Aligned_cols=266 Identities=24% Similarity=0.275 Sum_probs=189.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecC--------C
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--------D 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~ 560 (788)
.|.+.++||+|+||.||+|... .++..||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~--~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICI--DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEEC--CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 4677899999999999999886 667799999885432 2234799999999999999999876432 2
Q ss_pred eEEEEEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 561 KRLLVYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
..++||||+++ +|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++. ....+||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~----~~~~vkL 212 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDP----NTHTLKL 212 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcC----CCCceee
Confidence 46799999975 77776642 346788999999999999999999999 9999999999999972 2347999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
+|||+++.+..... .....+++.|+|||++.+ ..++.++|||||||++|||++|..||......+........+...
T Consensus 213 ~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 213 CDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred eccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999986643222 223467899999998865 468999999999999999999999997653322111100000000
Q ss_pred HHHHh--hcccccccccCCC-----CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCM--LSRNLQVLVSHDP-----EVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~--~~~~~~~l~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... .......+.-+.. ....+.....++.+|+.+||+.||.+|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 0000000000000 000011123578899999999999999999999853
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=304.62 Aligned_cols=251 Identities=24% Similarity=0.289 Sum_probs=197.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
+...+.||+|+||+||++... .++..+|+|.+.... ......+.+|++++++++|+||+++++.+..++..++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR--ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC--CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 445678999999999999886 567799999986542 223346788999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||++..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~-----~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLD-----DYGHIRISDLGLAVK 151 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEC-----CCCCEEEecCCccee
Confidence 999999999988654 34689999999999999999999998 999999999999998 778899999999876
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ...........
T Consensus 152 ~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--------~~~~~~~~~~~ 221 (285)
T cd05632 152 IPEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--------EEVDRRVLETE 221 (285)
T ss_pred cCCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--------HHHHHhhhccc
Confidence 533221 12346899999999999889999999999999999999999999754221110 00000011000
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 770 (788)
..........+.+++..||+.||++||+ +++++.+
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 ----------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0011122345678999999999999999 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.32 Aligned_cols=250 Identities=27% Similarity=0.325 Sum_probs=197.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
+...++||+|+||+||++... .+++.+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEc--CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 445678999999999999887 677799999886432 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.++|+|||++..
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~-----~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLD-----DHGHIRISDLGLAVH 151 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEEC-----CCCCEEEeeccceee
Confidence 999999999998654 34588999999999999999999998 999999999999998 778899999999876
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... .... ....
T Consensus 152 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~----~~~~-----~~~~- 219 (285)
T cd05630 152 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EVER-----LVKE- 219 (285)
T ss_pred cCCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH----HHHh-----hhhh-
Confidence 543222 123468999999999999999999999999999999999999997542111000 0000 0000
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 769 (788)
.... ........+.+++..||+.||++||| ++|+++
T Consensus 220 ~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 VQEE--------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhh--------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0000 00112345778999999999999999 889887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.51 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=197.1
Q ss_pred ccccccccceEEEEEEec----cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 494 KLVGTGSSGKVYRGILRL----KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.||+|+||.||+|.... ...+..+++|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998752 1233689999886543 34566889999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhcc------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 569 MPNGTLSNFLFHE------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 569 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
+++++|.+++... ...+++.++..++.|++.||.|||+. +++|+||||+||+++.........++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999642 23468899999999999999999998 99999999999999843222233899999999
Q ss_pred ccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHH
Q 047157 643 SKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 643 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
+........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~---- 225 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQH---- 225 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHH----
Confidence 876533221 11122345678999999999999999999999999999998 999986432111 0010
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
..... ...........+.+++.+||+.+|++||++.+|++.|++
T Consensus 226 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 VTAGG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HhcCC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000 001111234678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=299.51 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=200.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
|.+.+.||+|+||.||++... .++..+++|.++.. .....+.+.+|+.++++++||||+++++.+.+++..++||||
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHV--NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEc--CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 456789999999999999876 56678999987542 234456788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 569 MPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 569 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
+++++|.+++... ...++...+..++.||+.||.|||++ +|+|+||||+||+++ +++.++|+|||.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~-----~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLT-----QNGKVKLGDFGSARLLT 151 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEC-----CCCcEEEcccCcceeec
Confidence 9999999988653 45578899999999999999999999 999999999999998 78899999999987664
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ . .....+...
T Consensus 152 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----------~-~~~~~~~~~ 218 (255)
T cd08219 152 SPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-----------I-LKVCQGSYK 218 (255)
T ss_pred cccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-----------H-HHHhcCCCC
Confidence 3222 12235678899999999988999999999999999999999999965321110 0 011111111
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+ .......+.+++.+||+.||++||++.|++..
T Consensus 219 ~~---------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PL---------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC---------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 11233467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.24 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=191.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCC---CccccceEeeEEec-----C
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRT---HHKNLVRLLGFCSE-----E 559 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~-----~ 559 (788)
|.+.+.||+|+||+||+|... .++..||+|.+.... ......+.+|+++++++ +||||+++++++.. .
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDP--HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred ceEeeEEeecCCeEEEEEEEC--CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 556789999999999999886 667799999886432 12223455677776655 79999999998864 3
Q ss_pred CeEEEEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
...++|+||++ ++|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~-----~~~~~kl~ 150 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVT-----SGGQVKLA 150 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC-----CCCCEEEC
Confidence 45799999997 48888886543 4579999999999999999999999 999999999999998 78899999
Q ss_pred ecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh-----h
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV-----L 713 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-----~ 713 (788)
|||++........ .....++..|+|||.+.+..++.++|||||||++|||++|+.||............... .
T Consensus 151 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 151 DFGLARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred ccCccccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 9999986643221 22346788999999999889999999999999999999999999654322111000000 0
Q ss_pred HHHHHHHhhcccccccccCCCCCc--ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 714 SDWVISCMLSRNLQVLVSHDPEVL--SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 714 ~~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..|.... ......+........ ......+.+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDV--TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccc--cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 000000000000000 001234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.82 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=199.6
Q ss_pred HhhcccccccccccceEEEEEEeccCcc--eeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQ--IEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..+...+.||+|+||.||+|.....+.. ..+++|.+.... .....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 3445568899999999999987633222 357889886543 23345788999999999999999999998754 4679
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
++||+++|+|.+++......+++..++.++.|++.||.|||++ +|+|+||||+||+++ .++.+||+|||++.
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~-----~~~~~kL~Dfg~~~ 157 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVK-----SPNHVKITDFGLAR 157 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---Ceeccccccceeeec-----CCCceEEccccccc
Confidence 9999999999999977766789999999999999999999999 999999999999998 77789999999998
Q ss_pred ccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 645 LLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 645 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..++ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--------~~~~----~~ 225 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDL----LE 225 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHH----HH
Confidence 764332211 112335678999999999999999999999999999997 889986532111 1111 11
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
... ...........+.+++..||..+|++||+++++++.|+.+.
T Consensus 226 ~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 226 KGE---------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 00001112346778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.81 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=187.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
+.||+|+||.||+|..........+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3689999999999986544444466777765433 345678999999999999999999999999999999999999999
Q ss_pred CHhHhhhccC---CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 573 TLSNFLFHEG---QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 573 sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
+|.+++.+.. ...+...+..++.||++||.|||+. +++||||||+|||++ .++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~-----~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLT-----SDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEc-----CCccEEecccccccccCcc
Confidence 9999996542 3456677889999999999999998 999999999999998 7789999999998643221
Q ss_pred -CCcccccccCCccccCcccccC-------CCCCccCcchhhHHHHHHHHhC-CCCCCccccccccccchhhhHHHHHHH
Q 047157 650 -QTRTDTNMRGTMGYVAPEWLRN-------VPVTTKVDVFSFGVMLLEIICG-RRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 650 -~~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
.........++..|+|||++.. ..++.++||||||+++|||+++ ..||......+. . ..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-----------~-~~ 220 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-----------L-NH 220 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH-----------H-HH
Confidence 1112223467889999998743 2457899999999999999974 567754321110 0 01
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
...+....+.++.... ...+++.+++..|| .+|++||+++||++.|.
T Consensus 221 ~~~~~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 221 VIKDQQVKLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHhhcccccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111111111111111 13345667888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.06 Aligned_cols=242 Identities=24% Similarity=0.341 Sum_probs=204.4
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeeccc---chHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK---DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
+.||.|+||.||.+... .+...||||++.- .......++++|+..|.+++|||++.+.|+|..+...+||||||
T Consensus 32 rEIGHGSFGAVYfArd~--~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC- 108 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDV--RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC- 108 (948)
T ss_pred HHhcCCccceeEEeecc--CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-
Confidence 57999999999999887 6777999999863 34556679999999999999999999999999999999999999
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
-|+-.+++.-..+++.+.++..|..+.+.||+|||+. +.||||||..|||++ +.+.|||+|||.|.+..+.
T Consensus 109 lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLs-----e~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 109 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLS-----EPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEec-----CCCeeeeccccchhhcCch-
Confidence 5688888877778899999999999999999999999 999999999999998 8899999999999876543
Q ss_pred CcccccccCCccccCcccc---cCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 651 TRTDTNMRGTMGYVAPEWL---RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~---~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
..++||+.|||||++ ..+.|+-|+|||||||+..||.-.++|....+.... . ..
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-----------L-YH------- 236 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------L-YH------- 236 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-----------H-HH-------
Confidence 347899999999987 467899999999999999999999998754321100 0 00
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
+-...+......+..+.+..++..||+.-|.+|||.++++.+-
T Consensus 237 -IAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 237 -IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred -HHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 0111333344667888999999999999999999999998753
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.66 Aligned_cols=258 Identities=25% Similarity=0.354 Sum_probs=202.1
Q ss_pred HhhcccccccccccceEEEEEEecc---CcceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
..+...+.||+|+||.||+|..+.. .....+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 3455668899999999999987532 23457999988654433 5678999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccC--------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcE
Q 047157 564 LVYELMPNGTLSNFLFHEG--------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMA 635 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~ 635 (788)
+||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++ .++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~-----~~~~~ 156 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVS-----SQREV 156 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEe-----CCCcE
Confidence 9999999999999996543 1578999999999999999999999 999999999999998 77899
Q ss_pred EEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhH
Q 047157 636 KISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 636 kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 714 (788)
+|+|||++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||.......
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---------- 226 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---------- 226 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH----------
Confidence 999999987543332222233455678999999988889999999999999999998 778885432111
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
............. ........+.+++.+||+.+|++||++.|++++|.+
T Consensus 227 --~~~~~~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 227 --VLNRLQAGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred --HHHHHHcCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0011111111110 011234578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=302.26 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=199.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
+.|...+.||+|+||.||+|.+. .++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDN--RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEc--CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 34555678999999999999876 567789999886433 345568899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++.. ..+++..+..++.||++||.|||++ +++|+||+|+||+++ .++.++|+|||++..+
T Consensus 82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~-----~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 82 EYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLS-----EQGDVKLADFGVAGQL 151 (277)
T ss_pred EccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEe-----CCCCEEEccccccccc
Confidence 99999999998853 4678899999999999999999998 999999999999998 7789999999999765
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ . .......
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----------~-~~~~~~~- 217 (277)
T cd06642 152 TDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----------L-FLIPKNS- 217 (277)
T ss_pred cCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----------H-hhhhcCC-
Confidence 43221 12234578899999999998999999999999999999999999864321110 0 0000000
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+. ........+.+++.+||+.+|++||++.+|+++
T Consensus 218 ------~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 ------PPT--LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ------CCC--CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000 111234567889999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.64 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=200.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
|.+.+.||.|++|.||+|... .++..|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDV--ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEc--CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 456688999999999999876 567799999887655555678899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++.. ..+++.++..++.|++.||.|||+. +++|+||||+||+++ .++.+||+|||++......
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~-----~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLG-----MDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC-----CCCCEEEccCccchhcccc
Confidence 99999998854 3578999999999999999999999 999999999999998 7789999999998865433
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......... . ......
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~----------~--~~~~~~---- 231 (296)
T cd06655 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----------Y--LIATNG---- 231 (296)
T ss_pred cc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------H--HHHhcC----
Confidence 22 122346788999999999888999999999999999999999999764321110 0 000000
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.+...........+.+++.+||+.||++||++.++++
T Consensus 232 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 232 ---TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ---CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0001111123456778999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.30 Aligned_cols=199 Identities=17% Similarity=0.232 Sum_probs=166.3
Q ss_pred cccccccc--ccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 492 FSKLVGTG--SSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 492 ~~~~lg~G--~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
+.++||+| +|++||++..+ .++..||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK--PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeec--ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 45789999 68899999887 678899999987542 3445677889999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+++++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.++++||+.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~-----~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILIS-----VDGKVYLSGLRSNLSM 151 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEe-----cCCcEEEcccchhhcc
Confidence 99999999999654 34588999999999999999999998 999999999999998 7789999999876543
Q ss_pred CCCCCc------ccccccCCccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCcc
Q 047157 647 NKDQTR------TDTNMRGTMGYVAPEWLRN--VPVTTKVDVFSFGVMLLEIICGRRHIELS 700 (788)
Q Consensus 647 ~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltg~~p~~~~ 700 (788)
...... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 221110 0112346778999999875 46899999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.71 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=202.1
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..|.+.+.||+|+||.||++... ..+..|++|.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDI--ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEEC--CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 45666789999999999999875 5677999999876555556778999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++.+ ..+++.++..++.|++.||.|||+. +|+||||||+||+++ .++.++|+|||.+....
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~-----~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLG-----MDGSVKLTDFGFCAQIT 166 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC-----CCCCEEECcCccceEcc
Confidence 9999999999854 4578889999999999999999998 999999999999998 77899999999987654
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------------------- 226 (297)
T cd06656 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------------------- 226 (297)
T ss_pred CCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------------------
Confidence 3322 12234678899999999998899999999999999999999999965432111000
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
......+...........+.+++.+||+.||++||++++|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000001111112223456778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=291.91 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=213.6
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
..+.++||+|+||.||++.++ ..+..||||++.-+ ...+++.+|+.++++...|++|++||.+.....+++|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~--EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHR--ESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHh--ccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 445688999999999999988 78889999998753 45678999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
..|+..+.++.+.+.+.+.++..+++..++||.|||.. .-+|||||..|||++ .++.+||+|||.+-.+...
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLN-----T~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLN-----TDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEc-----ccchhhhhhccccchhhhh
Confidence 99999999999999999999999999999999999998 889999999999998 8899999999999876432
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
- .......||+-|||||++..-.|+.++||||||+...||..|++|+......... +--.
T Consensus 183 M-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-------------------FMIP 242 (502)
T KOG0574|consen 183 M-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-------------------FMIP 242 (502)
T ss_pred H-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-------------------Eecc
Confidence 2 2234578999999999999999999999999999999999999999643211110 0011
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..+.|....+.+...++-++++.||-..|++|-|+.+++++
T Consensus 243 T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 243 TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12345555677888999999999999999999999888764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.83 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=194.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCC-----
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED----- 560 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 560 (788)
..|.+.+.||+|+||.||++... ..+..||+|.+... .....+.+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDT--VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEc--CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45677899999999999999876 66779999998643 2344567889999999999999999999986543
Q ss_pred -eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 561 -KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 561 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
..++||||+++ +|.+.+. ..++...+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~-----~~~~~kl~D 166 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK-----SDCTLKILD 166 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEC-----CCCCEEEec
Confidence 57999999965 5666553 3477888899999999999999999 999999999999998 788999999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccch-------hh
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD-------IV 712 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~-------~~ 712 (788)
||++....... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...+......... ..
T Consensus 167 fg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 167 FGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred CCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 99997643322 2233568899999999999999999999999999999999999997653221100000 00
Q ss_pred hHH----HHHHHhhc-cccc-----ccccC---CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 713 LSD----WVISCMLS-RNLQ-----VLVSH---DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 713 ~~~----~~~~~~~~-~~~~-----~l~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... ........ .... ++... .............+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00000000 0000 00000 00000011123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.74 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=194.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecC------Ce
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE------DK 561 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~------~~ 561 (788)
.|.+.+.||+|+||.||+|... ..+..||+|.+.... .....+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~--~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHV--KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEc--CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 3556688999999999999886 667799999986542 3446788999999998 799999999998653 46
Q ss_pred EEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 562 RLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+|+||||+||+++ +++.+||+||
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~-----~~~~~~l~Df 155 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT-----ENAEVKLVDF 155 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEEC-----CCCCEEEccC
Confidence 89999999999999999764 35678999999999999999999999 999999999999998 7788999999
Q ss_pred CCccccCCCCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
|++........ ......|+..|+|||++. ...++.++||||||+++|||++|+.||....... .
T Consensus 156 g~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----------~ 224 (272)
T cd06637 156 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----------A 224 (272)
T ss_pred CCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----------H
Confidence 99986543221 223356889999999985 3468889999999999999999999996432110 0
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.. ......... .........+.+++.+||+.||.+|||+.|+++
T Consensus 225 ~~--~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 225 LF--LIPRNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HH--HHhcCCCCC--------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 000000000 111123356788999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.50 Aligned_cols=200 Identities=25% Similarity=0.316 Sum_probs=172.4
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
+.+.+.||+|+||+||++... .++..||+|.+.... ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKK--DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 456689999999999999886 667799999986532 334567888999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..+
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~-----~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLD-----AKGHVKLSDFGLCTGL 151 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEEC-----CCCCEEEeeccCCccc
Confidence 999999999998654 5678899999999999999999999 999999999999998 7889999999998754
Q ss_pred CCCCC----------------------------------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh
Q 047157 647 NKDQT----------------------------------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC 692 (788)
Q Consensus 647 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 692 (788)
..... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 32110 00113468999999999999999999999999999999999
Q ss_pred CCCCCCcc
Q 047157 693 GRRHIELS 700 (788)
Q Consensus 693 g~~p~~~~ 700 (788)
|+.||...
T Consensus 232 G~~Pf~~~ 239 (360)
T cd05627 232 GYPPFCSE 239 (360)
T ss_pred CCCCCCCC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.60 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=197.9
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeeccc--chHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--DIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 563 (788)
...|.+.++||+||.+.||++... +...+|+|++.. ...+...-|.+|+..|.+| .|.+||++++|-..++.+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s---~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS---DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC---CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 344566789999999999999763 445777776642 3356677899999999999 5999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||- ..+|...|.+....++...+..+..||+.|+.++|++ +|||.||||.|+|+ ..|.+||+|||+|
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl------VkG~LKLIDFGIA 506 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL------VKGRLKLIDFGIA 506 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE------EeeeEEeeeechh
Confidence 999996 6699999987766665447788999999999999999 99999999999999 6789999999999
Q ss_pred cccCCCCCcc-cccccCCccccCcccccCC-----------CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh
Q 047157 644 KLLNKDQTRT-DTNMRGTMGYVAPEWLRNV-----------PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI 711 (788)
Q Consensus 644 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 711 (788)
..+..+.... ....+||+.||+||.+... +.+.++||||||||||+|+.|+.||.....
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------- 577 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------- 577 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------
Confidence 9887765543 3457899999999988432 366899999999999999999999964311
Q ss_pred hhHHHHHHHhhcccccccccCCCCCcc-cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 712 VLSDWVISCMLSRNLQVLVSHDPEVLS-DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 712 ~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.|. .+..+.++.-+... +.....+++++++.||+.||.+|||+.|+|++
T Consensus 578 ---~~a-------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 ---QIA-------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHH-------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 011 12223322221111 11112238999999999999999999999864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.15 Aligned_cols=267 Identities=21% Similarity=0.235 Sum_probs=195.4
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecC------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------ 559 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 559 (788)
..|.+.+.||+|+||.||++... ..+..||||.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDA--VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEec--CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 35667789999999999999876 56778999998653 233456788999999999999999999988543
Q ss_pred CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
...++||||+++ +|.+.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~-----~~~~~kl~D 162 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK-----SDCTLKILD 162 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEC-----CCCCEEEee
Confidence 357999999965 6666663 3478888999999999999999999 999999999999998 788999999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh--------
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI-------- 711 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~-------- 711 (788)
||+++...... ......++..|+|||++.+..++.++||||||+++|||++|+.||......+.......
T Consensus 163 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred CcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99998654322 22335689999999999999999999999999999999999999976532211100000
Q ss_pred ---hhHHHHHHHhhc-cccccc-----ccCC---CCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 712 ---VLSDWVISCMLS-RNLQVL-----VSHD---PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 712 ---~~~~~~~~~~~~-~~~~~l-----~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+.......... .....+ .... ............+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000 000000 0000 0000111224567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=300.73 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=201.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
|.+.+.||.|++|.||+|... .++..+++|.+.... ......+.+|+++++.++||||+++++++.++...++|+||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDK--RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEEC--CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 556688999999999999886 567799999986543 34456788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++... .+++..+..++.|++.||.|||++ +++|+||+|+||+++ .++.++|+|||++.....
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~-----~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLS-----EEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEC-----CCCCEEEcccccceeecc
Confidence 9999999998654 789999999999999999999998 999999999999998 788999999999987654
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ..........
T Consensus 151 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------------~~~~~~~~~~- 216 (274)
T cd06609 151 TMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------------LFLIPKNNPP- 216 (274)
T ss_pred ccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------------HHHhhhcCCC-
Confidence 322 22335678899999999988899999999999999999999999965421110 0001011000
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. .........+.+++.+||+.||++|||+++++++
T Consensus 217 ------~-~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 217 ------S-LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ------C-CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 0111134567889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=296.01 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=203.2
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.++||+|+||.||.+... .++..+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred ceEeeEecccCCceEEEEEEc--CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 566789999999999998876 56678999987643 34556788999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+++++|.+++... ...+++.++..++.|++.+|.|||+. +++|+||+|+||+++ .++.+||+|||.+...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~-----~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLT-----KAGLIKLGDFGISKIL 151 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEe-----CCCCEEECcCcceEEc
Confidence 99999999999765 45679999999999999999999998 999999999999998 7788999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
..... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+. .. ....+..
T Consensus 152 ~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-----------~~-~~~~~~~ 218 (256)
T cd08221 152 GSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-----------VV-KIVQGNY 218 (256)
T ss_pred ccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-----------HH-HHHcCCC
Confidence 44332 22335688999999999888899999999999999999999999965422110 00 1111111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
.. ........+.+++.+||+.+|++||+++++++++
T Consensus 219 ~~---------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 TP---------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CC---------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11 0122345688899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.61 Aligned_cols=251 Identities=32% Similarity=0.532 Sum_probs=200.7
Q ss_pred ccccccccccceEEEEEEeccC--cceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 492 FSKLVGTGSSGKVYRGILRLKD--TQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 492 ~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.+.||+|+||.||++...... ....|++|.+...... ..+.+.+|++.+.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4678999999999999886321 2378999999755433 567899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCC-CCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 569 MPNGTLSNFLFHEGQR-PGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
+++++|.+++...... +++..+..++.|++.||+|||+. +++|+||||+||+++ .++.++|+|||++....
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~-----~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVG-----ENLVVKISDFGLSRDLY 154 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEc-----cCCeEEEcccCCceecc
Confidence 9999999999765444 89999999999999999999999 999999999999998 77899999999998765
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
...........++..|+|||.+.+..++.++||||+|+++|+|++ |+.||........ .........
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~------------~~~~~~~~~ 222 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV------------LEYLKKGYR 222 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH------------HHHHhcCCC
Confidence 442222212336789999999988889999999999999999998 7788764321110 011111110
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
. ........++.+++.+|++.||++|||+.|+++.|
T Consensus 223 ~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 L---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 00111456788899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=305.60 Aligned_cols=201 Identities=21% Similarity=0.322 Sum_probs=162.2
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec--CCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--EDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lV~e~~~~ 571 (788)
.+||+|+||+||+|..........||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 5799999999999987654566789999886532 23467789999999999999999998853 5678999999864
Q ss_pred CCHhHhhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 572 GTLSNFLFHE--------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 572 gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||+.... ..++.+||+|||++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~-~~~~~~kl~DfG~a 159 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG-PERGRVKIADMGFA 159 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCC-CCCCcEEEeeccce
Confidence 777776321 23478889999999999999999999 999999999999995321 15678999999999
Q ss_pred cccCCCCCc--ccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccc
Q 047157 644 KLLNKDQTR--TDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSR 701 (788)
Q Consensus 644 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~ 701 (788)
+........ ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876443221 2233567899999999876 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.22 Aligned_cols=267 Identities=23% Similarity=0.283 Sum_probs=198.1
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.+.||+|+||.||+|... .++..||+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSK--LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEc--CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 4666789999999999999876 566789999886432 2234467789999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|++ ++|.+++......+++..+..++.||++||.|||+. +|+|+||||+||+++ .++.+||+|||++....
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~-----~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLIN-----ERGELKLADFGLARAKS 155 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEEC-----CCCcEEECcCcchhccC
Confidence 997 599999877667789999999999999999999999 999999999999998 77899999999987643
Q ss_pred CCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHHhhc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISCMLS 723 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 723 (788)
.... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+........+ ....+.....
T Consensus 156 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 156 IPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 3221 1223456889999998865 457889999999999999999999997654322111000000 0000000000
Q ss_pred c-cccccccCCCCCcc------cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 724 R-NLQVLVSHDPEVLS------DLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 724 ~-~~~~l~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. .....- .+.... .......+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYN--YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccc--cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 000000 000000 0112346778999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=302.66 Aligned_cols=270 Identities=23% Similarity=0.272 Sum_probs=202.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|++|.||+|... .++..|++|.+.... ....+.+.+|+.++++++||||+++++++..+...++|+|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDR--ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred ceEEeecccCCCcEEEEEEEC--CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 567789999999999999886 557789999986543 3445688999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+ +++|.+++......+++.++..++.||++||.|||+. +++|+||||+||+++ .++.++|+|||++....
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~-----~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLIS-----ADGVLKIADFGLARLFS 150 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEc-----CCCcEEEeeeeeccccc
Confidence 99 9999999977667789999999999999999999998 999999999999998 78899999999998765
Q ss_pred CCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHHhhc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISCMLS 723 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 723 (788)
...........++..|+|||.+.+. .++.++||||+|+++|||++|+.+|......+......... ....+....+
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 4432223345688899999988654 46899999999999999999988776543211100000000 0000000000
Q ss_pred -ccccccccC-CCC-Ccc--cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 724 -RNLQVLVSH-DPE-VLS--DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 724 -~~~~~l~~~-~~~-~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
......... ... ... ..+..+.+.+++.+||+.||++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000 000 01224778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=297.64 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=199.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc----------hHHHHHHHHHHHHHhcC-CCccccceEeeEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD----------IEKTNEEFMTELKIIGR-THHKNLVRLLGFCSE 558 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~ 558 (788)
|.+.+.||+|+||.||+|..... .+..+++|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNN-GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCC-CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 45568899999999999998631 4568999987422 23344567889988865 799999999999999
Q ss_pred CCeEEEEEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEeccCCCCCCCc
Q 047157 559 EDKRLLVYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDLKTLDTNYM 634 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~~~~~ 634 (788)
++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ . +++|+||+|+||+++ .++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~-----~~~~ 152 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLG-----EDDK 152 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEEC-----CCCc
Confidence 9999999999999999998743 34568899999999999999999996 5 899999999999998 7889
Q ss_pred EEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH
Q 047157 635 AKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 635 ~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 714 (788)
+||+|||.+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 153 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~--------- 221 (269)
T cd08528 153 VTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--------- 221 (269)
T ss_pred EEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---------
Confidence 9999999998754433 22345688899999999988899999999999999999999999864321110
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
. ........... ........+.+++.+||+.||++||++.||.++++
T Consensus 222 --~-~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 --A-TKIVEAVYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --H-HHHhhccCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 00111111100 01123456788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.43 Aligned_cols=267 Identities=22% Similarity=0.255 Sum_probs=198.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchH-----HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-----KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
|.+.+.||+|++|.||+|... .++..|++|.+..... .....+..|++++++++|+||+++++++.+.+..++
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDK--ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred ceeeeeeeeccccEEEEEEEC--CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 456688999999999999876 5567999999865432 234567889999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+ +++|.+++......+++..+..++.||++||.|||++ +|+|+||||+||+++ .++.+||+|||++.
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~-----~~~~~~l~dfg~~~ 150 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIA-----SDGVLKLADFGLAR 150 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEc-----CCCCEEEccceeee
Confidence 99999 9999999976555789999999999999999999999 999999999999998 78899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHH
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISC 720 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 720 (788)
........ .....++..|+|||.+.+ ..++.++||||||+++|||++|..+|......+......... ....+..
T Consensus 151 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 151 SFGSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred eccCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 76543221 122345778999998854 467899999999999999999987776543211110000000 0000000
Q ss_pred hhcccccccccCCCCCc-----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVL-----SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...+........... ........+.+++.+||+.||++|||++||+++
T Consensus 230 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 --VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred --cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000 011235678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.37 Aligned_cols=241 Identities=26% Similarity=0.294 Sum_probs=186.1
Q ss_pred ccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCC---CccccceEeeEEecCCeEEEEEecC
Q 047157 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRT---HHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 496 lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
||+|+||+||+|... .++..||+|.+.+... .....+..|..++.+. +||||+++++.+.+.+..++||||+
T Consensus 1 lG~G~~g~Vy~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKK--DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEEC--CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 699999999999876 6677999999865321 2233455666666654 6999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++.+. ..+++..+..++.||++||+|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~-----~~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 79 SGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLD-----ATGHIALCDFGLSKANLTD 149 (330)
T ss_pred CCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEEC-----CCCCEEEecCCcCcCCCCC
Confidence 999999988654 5688999999999999999999999 999999999999998 7789999999998754322
Q ss_pred CCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
.. ......||..|+|||.+.+. .++.++|||||||++|||++|+.||......+. ......+...
T Consensus 150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------------~~~i~~~~~~- 215 (330)
T cd05586 150 NK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------------YRNIAFGKVR- 215 (330)
T ss_pred CC-CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------------HHHHHcCCCC-
Confidence 21 22345689999999998754 489999999999999999999999975432111 0111111110
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC----CHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP----SMKKVIH 769 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~evl~ 769 (788)
+ + .......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~----~----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 F----P----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred C----C----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 0 011245667899999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=295.31 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=199.6
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEec-CCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-EDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lV~ 566 (788)
|.+.+.||+|++|.||++... .++..+++|.+.... ....+.+.+|++++++++|||++++++.+.. +...++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHR--TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEc--CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 567789999999999999886 556689999986432 3445678899999999999999999998764 44679999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++... ...+++.++..++.|++.||.+||+. +|+|+||||+||+++ .++.++|+|||++..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~-----~~~~~~l~df~~~~~ 151 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLT-----RTNIIKVGDLGIARV 151 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEe-----cCCcEEEecccceEE
Confidence 999999999999764 44589999999999999999999999 999999999999998 788999999999986
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... ......+++.|+|||.+.+..++.++||||||+++++|++|+.||....... ... ....+.
T Consensus 152 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-----------~~~-~~~~~~ 218 (257)
T cd08223 152 LENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-----------LVY-RIIEGK 218 (257)
T ss_pred ecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----------HHH-HHHhcC
Confidence 643322 2233567889999999999999999999999999999999999986432111 000 011111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... ........+.+++.+|++.||++||++.+++++
T Consensus 219 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 LPP---------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCC---------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 110 112344678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=303.51 Aligned_cols=245 Identities=27% Similarity=0.394 Sum_probs=197.3
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGT 573 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 573 (788)
..||+|+||.||++... .++..|+||.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++++
T Consensus 28 ~~lg~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 28 IKIGEGSTGIVCIATEK--HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hcccCCCCeEEEEEEEC--CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 56899999999999876 5667899999876656667789999999999999999999999999999999999999999
Q ss_pred HhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcc
Q 047157 574 LSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653 (788)
Q Consensus 574 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 653 (788)
|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.++|+|||++........ .
T Consensus 106 L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~-----~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 106 LTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLT-----SDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEc-----CCCCEEEccCcchhhcccccc-c
Confidence 9998843 3578899999999999999999999 999999999999998 778999999999876543222 1
Q ss_pred cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCC
Q 047157 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD 733 (788)
Q Consensus 654 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 733 (788)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||........ . ..... ....
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~-----~~~~~-~~~~----- 236 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-------M-----RRIRD-NLPP----- 236 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------H-----HHHHh-cCCC-----
Confidence 2234678899999999888999999999999999999999999965321110 0 00000 0000
Q ss_pred CCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 734 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...........+.+++.+||+.||++|||++|+++.
T Consensus 237 -~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 237 -RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011111234467788899999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=298.48 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=197.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---------HHHHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---------EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
+.+.+.||+|++|.||+|... ..+..+++|.+.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNA--SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred ccccceeecCCCeEEEEEEec--CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 345678999999999999876 556789999775432 123367889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++ +++.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~-----~~~~~~l~df 150 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVD-----NKGGIKISDF 150 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEc-----CCCCEEeccc
Confidence 999999999999999999654 5678888999999999999999998 999999999999998 7889999999
Q ss_pred CCccccCCCCCc-----ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH
Q 047157 641 GISKLLNKDQTR-----TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 641 g~a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
|.+......... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------- 220 (267)
T cd06628 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---------- 220 (267)
T ss_pred CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH----------
Confidence 999876532111 11234578899999999988899999999999999999999999975321110
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
... ..... .+.. +....+.+.+++.+||+.||.+||++.||++
T Consensus 221 -~~~-~~~~~-------~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 -IFK-IGENA-------SPEI--PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -HHH-HhccC-------CCcC--CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 00000 0111 1123466788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.61 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=200.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|...+.||.|+||.||+|... ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDN--RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEc--cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3455678999999999999876 567789999886432 4456788999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++.. ..+++.++..++.|++.||.|||+. +++|+||+|+||+++ .++.++|+|||++....
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~-----~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLS-----EQGDVKLADFGVAGQLT 152 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEc-----CCCCEEEcccccceecc
Confidence 9999999999854 4578889999999999999999998 999999999999998 77889999999997664
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ......
T Consensus 153 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------------~~~~~~--- 216 (277)
T cd06640 153 DTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------------FLIPKN--- 216 (277)
T ss_pred CCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------------hhhhcC---
Confidence 3321 122345788899999998889999999999999999999999998653211100 000000
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+ ..........+.+++.+||+.+|++||+++++++.
T Consensus 217 -----~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 -----NP-PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -----CC-CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00 11122345678899999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=312.56 Aligned_cols=267 Identities=21% Similarity=0.244 Sum_probs=195.5
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------ 559 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 559 (788)
..|.+.+.||+|+||.||++... ..+..||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDA--ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEEC--CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 35677789999999999999876 566789999986532 33456788999999999999999999987543
Q ss_pred CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~-----~~~~~kL~D 169 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK-----SDCTLKILD 169 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEEC-----CCCcEEEEe
Confidence 357999999965 7777663 3477888999999999999999999 999999999999998 788999999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh----hHH
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV----LSD 715 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~ 715 (788)
||+++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||...+..+........ ...
T Consensus 170 fG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 170 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred CCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99998654322 122356899999999999999999999999999999999999999765432211100000 000
Q ss_pred H-------HHHHhhc-cccc-----ccccC---CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 716 W-------VISCMLS-RNLQ-----VLVSH---DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 716 ~-------~~~~~~~-~~~~-----~l~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+ ....... .... .+... .............+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000000 0000 00000 00000011123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=304.96 Aligned_cols=251 Identities=25% Similarity=0.285 Sum_probs=200.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|++|+||++... ..+..+++|.+..... ...+.+.+|++++++++||||+++++.+.+....++||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLK--GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred eEEeeeecCCccEEEEEEEEc--CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 556788999999999999886 5677999998865432 24567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+.+++|.+++... ...+++..+..++.||+.||+|||+. +++|+||||+||+++ .++.++|+|||++..
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~-----~~~~~~l~dfg~~~~ 152 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLH-----ESGHIMLSDFDLSKQ 152 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEc-----CCCCEEEeecchhhc
Confidence 999999999998653 35688999999999999999999998 999999999999998 778999999999875
Q ss_pred cCCCCCc----------------------------ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCC
Q 047157 646 LNKDQTR----------------------------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHI 697 (788)
Q Consensus 646 ~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~ 697 (788)
....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 232 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence 5322110 111245788999999999889999999999999999999999999
Q ss_pred CccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC----HHHHHHH
Q 047157 698 ELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS----MKKVIHM 770 (788)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~~ 770 (788)
........ + .... ...............+.+++.+||+.||++||| ++|++..
T Consensus 233 ~~~~~~~~-------~-----~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 233 KGSNRDET-------F-----SNIL--------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCchHHH-------H-----HHHh--------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 75432111 0 0000 111111111124577889999999999999999 7777763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=302.04 Aligned_cols=269 Identities=22% Similarity=0.263 Sum_probs=195.2
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|++|.||+|... .++..|++|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNK--KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred ceEeeEecccCceEEEEEEEC--CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 456788999999999999876 567789999886432 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 568 LMPNGTLSNFLFHE--GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 568 ~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|++ ++|.+++... +..+++..+..++.||+.||.|||++ +|+|+||||+||+++ .++.+||+|||++..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~-----~~~~~~l~dfg~~~~ 150 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLID-----NKGVIKLADFGLARA 150 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEc-----CCCcEEECcccceee
Confidence 997 6888888543 25688999999999999999999999 999999999999998 788999999999876
Q ss_pred cCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH---HHHHHHh
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS---DWVISCM 721 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 721 (788)
...... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||................. .-.+...
T Consensus 151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 151 FGIPVR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred cCCCcc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 543221 12233567899999988654 578999999999999999999999975432111000000000 0000000
Q ss_pred h-cccccccccCCCCC---cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 722 L-SRNLQVLVSHDPEV---LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 722 ~-~~~~~~l~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. .............. ........++.+++.+||+.||++|||+++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00000000000000 0001124567789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=298.33 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=202.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.+.+.||+|++|.||++... ..+..+++|.+.... ....+++.+|++++++++||||+++++.+...+..++|+||
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHR--PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEc--CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 445678999999999999886 567789999886553 34567889999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
+++++|.+++......++...+..++.|++.||+|||+ . +++|+||||+||+++ .++.++|+|||.+....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~-----~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVN-----SRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEEC-----CCCCEEEeecccchhhH
Confidence 99999999997665778899999999999999999999 7 999999999999998 77899999999987653
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
..... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...+.. .....
T Consensus 153 ~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~~---- 218 (265)
T cd06605 153 NSLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD------GIFELL-QYIVN---- 218 (265)
T ss_pred HHHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc------cHHHHH-HHHhc----
Confidence 32211 15678899999999998999999999999999999999999965421100 000111 00111
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..............+.+++..||..||++|||+.+++.+
T Consensus 219 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 219 ----EPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ----CCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111111111245668899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=332.32 Aligned_cols=261 Identities=22% Similarity=0.305 Sum_probs=199.0
Q ss_pred HHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEec--C
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--E 559 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 559 (788)
+.....|.+.+.||+|+||+||++... ..+..+++|.+... .......+..|+.++++++||||+++++++.+ .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk--~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHK--RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEEC--CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 334456778899999999999999887 56778999987643 23445688999999999999999999998854 4
Q ss_pred CeEEEEEecCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccC----CceEecCCCCCcEEeccCC----
Q 047157 560 DKRLLVYELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECE----TQIIHCDIKPQNVLLDLKT---- 628 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~----~~ivH~dlkp~NIll~~~~---- 628 (788)
...+|||||+++++|.++|... ...+++..++.|+.||+.||.|||+... .+||||||||+||||+...
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5789999999999999998642 3568999999999999999999998521 2599999999999996321
Q ss_pred --------CCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCC
Q 047157 629 --------LDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN--VPVTTKVDVFSFGVMLLEIICGRRHIE 698 (788)
Q Consensus 629 --------~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltg~~p~~ 698 (788)
......+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||||++|+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 11345699999999986643221 223568999999999854 458899999999999999999999996
Q ss_pred ccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 699 LSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...... ... ..+... +.. ........+.+|+..||+.+|.+||++.|++.
T Consensus 245 ~~~~~~----------qli-~~lk~~---------p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANNFS----------QLI-SELKRG---------PDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCcHH----------HHH-HHHhcC---------CCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 432111 101 111110 000 00112456888999999999999999999984
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=308.04 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=211.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
..+...||.|+||.||+++.+ .++...|-|.+........++++-|++||....||+||++++.|..++.++|+.|||
T Consensus 34 WeIiGELGDGAFGKVyKA~nk--et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNK--ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcc--cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 455678999999999999887 777778889998888888899999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
.||-.+..+..-++.+.+.++.-++.|++.||.|||++ +|||||||..|||++ -+|.++|+|||.+......
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~T-----ldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLT-----LDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEE-----ecCcEeeecccccccchhH
Confidence 99999999988889999999999999999999999999 999999999999999 8889999999998754322
Q ss_pred CCcccccccCCccccCcccc-----cCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 650 QTRTDTNMRGTMGYVAPEWL-----RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
......+.||+.|||||+. +..+|+.++||||||++|.||.-+.+|-...+.. ..+.. +
T Consensus 184 -~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-------RVllK-----i--- 247 (1187)
T KOG0579|consen 184 -RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLK-----I--- 247 (1187)
T ss_pred -HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-------HHHHH-----H---
Confidence 2223457899999999976 5678999999999999999999999886432110 01111 0
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.-...|....+......+.+++.+||..||..||++.+++++
T Consensus 248 ----aKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 248 ----AKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ----hhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 011244455566778889999999999999999999999864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=321.67 Aligned_cols=270 Identities=18% Similarity=0.238 Sum_probs=189.2
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC------ccccceEeeEEecC-C
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH------HKNLVRLLGFCSEE-D 560 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~-~ 560 (788)
..|.+.++||+|+||+||+|.+. ..+..||||+++... ...+.+..|+++++.++ |++++++++++..+ .
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDR--KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEc--CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 45677899999999999999886 567789999986432 22334455666665554 55689999988764 5
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEeccCCC----------
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDLKTL---------- 629 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~---------- 629 (788)
..++|||++ +++|.+++.+. ..+++..+..|+.||+.||.|||+ . +|+||||||+|||++..+.
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccccccc
Confidence 788999988 77888888654 568899999999999999999997 5 8999999999999974321
Q ss_pred -CCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccccc
Q 047157 630 -DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEE 708 (788)
Q Consensus 630 -~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~ 708 (788)
.+...+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 0123599999998764322 22346789999999999999999999999999999999999999976543221111
Q ss_pred chhhh----HHHHHH--------Hhhc-ccccccccC-------CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 047157 709 VDIVL----SDWVIS--------CMLS-RNLQVLVSH-------DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768 (788)
Q Consensus 709 ~~~~~----~~~~~~--------~~~~-~~~~~l~~~-------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 768 (788)
....+ ..|... .... ..+...... .............+.+|+.+||+.||++|||++|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 00000 001000 0000 000000000 000000111235678999999999999999999999
Q ss_pred H
Q 047157 769 H 769 (788)
Q Consensus 769 ~ 769 (788)
+
T Consensus 437 ~ 437 (467)
T PTZ00284 437 T 437 (467)
T ss_pred c
Confidence 7
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.71 Aligned_cols=246 Identities=31% Similarity=0.510 Sum_probs=195.6
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..+.+.+.||+|+||.||++.. .+..+++|.+.... ..+.+.+|+.++++++||||+++++++... ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~----~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY----TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc----CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 4567789999999999999864 45579999886542 346788999999999999999999998654 5799999
Q ss_pred cCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+++++|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++ .++.+||+|||.+...
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~-----~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVS-----EDGVAKVSDFGLARVG 150 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEc-----CCCcEEECCCccceec
Confidence 999999999997553 3578999999999999999999998 999999999999998 7789999999998754
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.... .....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ......+.
T Consensus 151 ~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------------~~~~~~~~ 214 (254)
T cd05083 151 SMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV------------KECVEKGY 214 (254)
T ss_pred cccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH------------HHHHhCCC
Confidence 3221 12234567999999988899999999999999999997 8999865432111 01111110
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
. +. ......+.+.+++.+||+.+|++||+++++++.|++
T Consensus 215 -~------~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -R------ME--PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -C------CC--CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 00 011234677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.44 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=190.4
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc-----hHHHHHHHHHHHHHhcCCCccccceEeeEEec--CCeE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-----IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--EDKR 562 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 562 (788)
+...+.||+|+||.||+|... .++..+++|.+... ..+..+.+.+|+.++++++||||+++++++.+ ....
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDV--DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred ccccceecCCCCEEEEEEEEc--CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 455689999999999999876 56778999987532 12344678899999999999999999998865 3578
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++++||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++ .++.+||+|||+
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~-----~~~~~~l~dfg~ 152 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRD-----SAGNVKLGDFGA 152 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEC-----CCCCEEEccCCC
Confidence 8999999999999999654 4578889999999999999999998 999999999999998 778999999999
Q ss_pred ccccCCCCC--cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 643 SKLLNKDQT--RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 643 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
+........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-----------~~~~ 221 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----------IFKI 221 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----------HHHH
Confidence 876543211 111234578899999999988899999999999999999999999964321110 0000
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..... .+.. +....+.+.+++ +||..+|++||+++||++
T Consensus 222 ~~~~~-------~~~~--~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ATQPT-------NPQL--PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcCCC-------CCCC--chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00000 0111 111223344455 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=300.06 Aligned_cols=269 Identities=22% Similarity=0.283 Sum_probs=198.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|++|.||+|..+ .++..|++|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNR--ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred eeeeeeecccCCeEEEEEEEC--CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 556788999999999999886 567799999886432 2334568899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|..++.. ...+++..+..++.||+.||.|||+. +++|+||||+||+++ .++.+||+|||++....
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~-----~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILIT-----KQGQIKLCDFGFARILT 151 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEc-----CCCcEEECccccceecC
Confidence 9999888877644 34689999999999999999999998 999999999999998 77899999999998765
Q ss_pred CCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH---HHHhhc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV---ISCMLS 723 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 723 (788)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...........+. ......
T Consensus 152 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 152 GPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred CCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 4322 1223456788999999865 5678999999999999999999999975432211110000000000 000000
Q ss_pred cc-ccccccCCCCCcccH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 724 RN-LQVLVSHDPEVLSDL-----ERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 724 ~~-~~~l~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. ...+..+.+...... .....+.+++.+||+.||++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 000000111111111 124668899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=302.67 Aligned_cols=245 Identities=22% Similarity=0.346 Sum_probs=197.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGT 573 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 573 (788)
..||+|+||.||++... ..+..|++|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++
T Consensus 27 ~~ig~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 27 IKIGEGSTGIVCIAREK--HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhcCCCCceeEEEEEEc--CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 47999999999999876 5567899999865545556778899999999999999999999999999999999999999
Q ss_pred HhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcc
Q 047157 574 LSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653 (788)
Q Consensus 574 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 653 (788)
|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++ .++.+||+|||++........ .
T Consensus 105 L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~-----~~~~~kL~dfg~~~~~~~~~~-~ 173 (297)
T cd06659 105 LTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLT-----LDGRVKLSDFGFCAQISKDVP-K 173 (297)
T ss_pred HHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEc-----cCCcEEEeechhHhhcccccc-c
Confidence 9998743 4678999999999999999999999 999999999999998 788999999999875543222 1
Q ss_pred cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCC
Q 047157 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD 733 (788)
Q Consensus 654 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 733 (788)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||......+.. . ...... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--------~----~~~~~~-------~ 234 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--------K----RLRDSP-------P 234 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------H----HHhccC-------C
Confidence 22356889999999999889999999999999999999999999643211100 0 000000 0
Q ss_pred CCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 734 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+...........+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 235 PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000111223567789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.16 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=199.9
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|+||.||++... .++..+++|.+... .....+.+.+|++++++++||||+++++.+..++..++|+|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRK--ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred ceEEEEecccCceEEEEEEEc--CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 556789999999999999886 56778999988643 23446789999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+++++|.+++... ...+++..+..++.|++.+|.|||++ +++|+||+|+||+++. .+..+||+|||.+...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~----~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDK----HKMVVKIGDFGISKIL 152 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC----CCCEEEEccCCCceec
Confidence 99999999999764 34578999999999999999999999 9999999999999972 3456899999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ... ......
T Consensus 153 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-----------~~~-~~~~~~ 218 (256)
T cd08220 153 SSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL-----------VLK-IMSGTF 218 (256)
T ss_pred CCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH-----------HHH-HHhcCC
Confidence 43322 1234578899999999988899999999999999999999999865422110 000 111111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..+ .......+.+++.+||+.||++|||++|++++
T Consensus 219 ~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 API---------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCC---------CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111 11234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.58 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=193.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEe-----cCCeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCS-----EEDKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~-----~~~~~ 562 (788)
+|.+.+.||+|+||.||++... ..+..+++|.+... ......+.+|+.+++++ +||||+++++++. .++..
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~--~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNK--KNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEEC--CCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 4556688999999999999886 56678999987643 22345778899999999 6999999999874 44578
Q ss_pred EEEEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 563 LLVYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
++||||+++++|.+++.. ....+++..+..++.|+++||.|||+. +|+||||||+||+++ .++.+||+|
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~-----~~~~~kl~d 167 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLT-----TEGGVKLVD 167 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEEC-----CCCCEEEcc
Confidence 999999999999998753 335678899999999999999999998 999999999999998 777899999
Q ss_pred cCCccccCCCCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 714 (788)
||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||........ ..
T Consensus 168 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~~ 239 (286)
T cd06638 168 FGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LF 239 (286)
T ss_pred CCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------Hh
Confidence 999886543221 122346889999999875 34578899999999999999999999864321110 00
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
. ..... .+...........+.+++.+||+.||++|||+.||++.+
T Consensus 240 ~-----~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 K-----IPRNP-------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred h-----ccccC-------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 00000 000001111234688899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.98 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=205.5
Q ss_pred cccccccccccceEEEEEEec-cCcceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 491 GFSKLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.+.|+||+|.||.|++|.+.. .++...||||.++.+... ...+|++|+.+|.+|+|||++++||+..+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 446899999999999999874 344568999999876543 67899999999999999999999999887 788999999
Q ss_pred CCCCCHhHhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 569 MPNGTLSNFLFH-EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 569 ~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
++.|+|.+.|++ ....+-......++.|||.|+.||..+ +.|||||..+|+|+. ....+||+|||+.+.+.
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNllla-----sprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLA-----SPRTVKICDFGLMRALG 263 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheec-----ccceeeeecccceeccC
Confidence 999999999987 455677888889999999999999999 999999999999998 67799999999999876
Q ss_pred CCCCc-cc-ccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 648 KDQTR-TD-TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 648 ~~~~~-~~-~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..... .+ ....-...|+|||.++..+++.++|||+|||+||||++ |..||-+.......
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL------------------ 325 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL------------------ 325 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH------------------
Confidence 54332 22 22334668999999999999999999999999999997 66888765432211
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..++............+++.++++.||..+|++|||+..|.+
T Consensus 326 ---~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 326 ---KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ---HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 112223333344556788999999999999999999999974
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.68 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=196.1
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecc--c--chHHHHHHHHHHHHHhcCCCccccceEeeEEecCCe--EEE
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLE--K--DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK--RLL 564 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~--~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~l 564 (788)
+|.++||+|+|-+||+|.+. .++..||=-.++ + ..+...++|..|+++|+.|+||||+++++...+... .-+
T Consensus 43 k~~evLGrGafKtVYka~De--~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDE--EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred ehhhhcccccceeeeecccc--ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 34578999999999999986 667676644332 1 124456899999999999999999999998877554 789
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+|.+..|+|..|+.+. ++.+...+..|++||++||.|||++ .|+|||||||-+||+|+ ..-+.|||+|+|+|.
T Consensus 121 iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFin----G~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVN----GNLGEVKIGDLGLAT 194 (632)
T ss_pred eeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEc----CCcCceeecchhHHH
Confidence 99999999999999655 6788899999999999999999996 67999999999999998 367899999999999
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.+..... ....|||.|||||... ..|++.+||||||+.++||+|+..||.-...... +.....++
T Consensus 195 l~r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-----------IYKKV~SG 259 (632)
T KOG0584|consen 195 LLRKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-----------IYKKVTSG 259 (632)
T ss_pred Hhhcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-----------HHHHHHcC
Confidence 8765433 2368999999999987 6899999999999999999999999964422111 11222222
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
....-+.. . .-.++.++|..||.. .++|||+.|+|.
T Consensus 260 iKP~sl~k-------V-~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 260 IKPAALSK-------V-KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CCHHHhhc-------c-CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 22222111 0 124567889999998 999999999995
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=302.81 Aligned_cols=269 Identities=19% Similarity=0.225 Sum_probs=195.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|+||.||+|... .++..+++|.+.... ......+.+|++++++++||||+++++++.+....++|+|
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~--~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNR--ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred ceeEEEecccCCeEEEEEEEC--CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 456788999999999999886 567789999886432 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|++ ++|.+++......+++..+..++.||++||.|||++ +|+|+||||+||+++ .++.+||+|||++....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~-----~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLIN-----KNGELKLADFGLARAFG 150 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEc-----CCCcEEECccchhhccC
Confidence 996 588888876666789999999999999999999999 999999999999998 77899999999998654
Q ss_pred CCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCcccccccc-ccchhhh---HHHHHHHhh
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES-EEVDIVL---SDWVISCML 722 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~---~~~~~~~~~ 722 (788)
.... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+......... ....... ....+....
T Consensus 151 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 151 IPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh
Confidence 3221 12234568899999988664 4789999999999999999999986433211100 0000000 000000000
Q ss_pred cccccccccCCCCCc----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVL----SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...-........... ......+.+.+++.+||+.||.+|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000000000 001234577889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=296.92 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=196.9
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.+.+.||+|+||.||++... ..+..+|+|.+... .......+.+|++++++++||||+++++.+...+..++||||
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHR--PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEc--CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 556789999999999999886 56779999988653 234456889999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 569 MPNGTLSNFLFHE--GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 569 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
+++++|..++... ...+++..+..++.||+.||.|||+. .+|+|+||||+||+++ .++.+||+|||++...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~-----~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVN-----GNGQVKLCDFGVSGNL 153 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEEC-----CCCCEEEeecCCcccc
Confidence 9999999988653 23689999999999999999999963 2899999999999998 7789999999998765
Q ss_pred CCCCCcccccccCCccccCcccccCC------CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNV------PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
..... ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ . . ....
T Consensus 154 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-------~-~-~~~~ 221 (286)
T cd06622 154 VASLA---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-------F-A-QLSA 221 (286)
T ss_pred cCCcc---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-------H-H-HHHH
Confidence 33221 224578899999998544 358899999999999999999999964321110 0 0 0000
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... .+. ........+.+++.+||+.+|++||++++++..
T Consensus 222 ~~~~~-------~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 IVDGD-------PPT--LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HhhcC-------CCC--CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 01110 011 112245677889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=292.58 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=200.4
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|+||.||++... .++..+++|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSK--EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred ceEEEEeccCCceEEEEEEEc--CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 556789999999999999876 56678999988643 23445688999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+++++|.+++... ...+++.++..++.|++.||.|||++ +++|+||+|+||+++ .+..++|+|||.+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~-----~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLT-----KDGTIKLGDFGIARVL 151 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc-----CCCCEEEeeccceeec
Confidence 99999999998654 34578899999999999999999998 999999999999998 7788999999999865
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
...... .....++..|+|||.+.+..++.++||||||+++++|++|+.||......+ .... ...+..
T Consensus 152 ~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----------~~~~-~~~~~~ 218 (256)
T cd08218 152 NSTVEL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-----------LVLK-IIRGSY 218 (256)
T ss_pred Ccchhh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-----------HHHH-HhcCCC
Confidence 432221 123457889999999998899999999999999999999999986432111 1111 111111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. . ........+.+++.+||+.+|++||++.+|+++
T Consensus 219 ~-------~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 P-------P--VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred C-------C--CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 0 111234568889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.62 Aligned_cols=249 Identities=25% Similarity=0.344 Sum_probs=195.9
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch------HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI------EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
+...+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~---~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLT---NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred ccccceEeccCCeEEEEEEE---cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence 44567899999999999976 356689999875321 233457889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+|+||+++++|.+++.+. ..+++..+..++.|++.||+|||+. +|+|+||+|+||+++ .++.++|+|||++
T Consensus 79 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~-----~~~~~~l~dfg~~ 149 (265)
T cd06631 79 IFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLM-----PNGIIKLIDFGCA 149 (265)
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEEC-----CCCeEEeccchhh
Confidence 999999999999999654 4578889999999999999999998 999999999999998 7889999999998
Q ss_pred cccCCCC-----CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 644 KLLNKDQ-----TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 644 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
....... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..... ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----------~~ 219 (265)
T cd06631 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM----------FY 219 (265)
T ss_pred HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH----------HH
Confidence 7643211 11122346788999999999889999999999999999999999999643211100 00
Q ss_pred HHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 719 SCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
........ +. ......+.+.+++.+||+.+|++||++.|+++
T Consensus 220 ~~~~~~~~-------~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 220 IGAHRGLM-------PR--LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhhccCCC-------CC--CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 00 11123466788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=308.56 Aligned_cols=266 Identities=23% Similarity=0.287 Sum_probs=193.4
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------ 559 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 559 (788)
..|.+.+.||+|+||.||+|... .++..||||.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDT--RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhheecccCCCeEEEEEEEC--CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 34666789999999999999876 567799999986532 22345678999999999999999999987543
Q ss_pred CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
...++++|++ +++|.+++. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~-----~~~~~kl~D 161 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVN-----EDCELRILD 161 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEEC-----CCCCEEEcC
Confidence 4578999988 789988874 34688999999999999999999999 999999999999998 788999999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh---hHH
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV---LSD 715 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~ 715 (788)
||++...... .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||............... ...
T Consensus 162 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 162 FGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999865432 223468999999999876 57899999999999999999999999754321110000000 000
Q ss_pred HHHHHhhcccccccccCCCCCcc-c-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLS-D-----LERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~-~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..............+...+.... . ....+.+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000000000000 0 0112346789999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=289.99 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=204.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
|...+.||+|++|.||++... .++..+++|++........+.+.+|++.+++++|||++++++++......++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHK--RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEEC--CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 345688999999999999886 466789999997765556778999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++......+++..+..++.|++.||.|||+. +++|+||+|+||+++ +++.++|+|||.+......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~-----~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLT-----SDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEc-----cCCeEEEeecccccccccc
Confidence 99999999977656789999999999999999999998 999999999999998 7889999999999876544
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... . ......
T Consensus 152 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----------~-~~~~~~---- 213 (253)
T cd05122 152 KA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-----------F-KIATNG---- 213 (253)
T ss_pred cc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-----------H-HHHhcC----
Confidence 32 23456788999999998888999999999999999999999998654211100 0 000010
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+...........+.+++.+||+.||++|||+.|++++
T Consensus 214 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 214 ---PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---CCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111111224678899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=292.34 Aligned_cols=251 Identities=29% Similarity=0.410 Sum_probs=200.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchH--HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|...+.||+|+||.||+|... .++..+++|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNL--DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred ceeeeEeecCCCcEEEEEEEC--CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 556789999999999999875 5667899999865443 367789999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++ .++.+||+|||.+....
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~-----~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 80 YCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLD-----HNGVIKLGDFGCAVKLK 150 (264)
T ss_pred cCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC-----CCCCEEEcccccccccC
Confidence 99999999998654 4578889999999999999999999 999999999999998 78899999999998765
Q ss_pred CCCCcccc---cccCCccccCcccccCCC---CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 648 KDQTRTDT---NMRGTMGYVAPEWLRNVP---VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 648 ~~~~~~~~---~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
........ ...++..|+|||.+.+.. ++.++||||||+++||+++|+.||....... .. ... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-------~~---~~~-~ 219 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-------QI---MFH-V 219 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-------HH---HHH-H
Confidence 43322211 345788999999998766 8899999999999999999999996432100 00 000 0
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
... ..+...........+.+++.+||+.+|++|||++|++.
T Consensus 220 ~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 GAG-------HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hcC-------CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 11111112223456778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.08 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=199.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEec--CCeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--EDKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lV 565 (788)
|.+.+.||.|+||.||++... .++..+++|.+... .....+++.+|++++++++||||+++++++.. ....+++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRK--SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred ceeeeeeccCCCeEEEEeeec--CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 456688999999999999876 56678999988642 24455678899999999999999999997754 4568999
Q ss_pred EecCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhh-----hccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 566 YELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLH-----EECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH-----~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
|||+++++|.+++... ...+++..++.++.||+.||.||| +. +++|+||||+||+++ .++.+||
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~-----~~~~~kl 151 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLD-----ANNNVKL 151 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEe-----cCCCEEE
Confidence 9999999999998653 457899999999999999999999 66 999999999999998 7889999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ..
T Consensus 152 ~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~--- 219 (265)
T cd08217 152 GDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--------LA--- 219 (265)
T ss_pred ecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--------HH---
Confidence 999999876543321 223467899999999998889999999999999999999999997543111 11
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.....+.... ........+.+++.+|++.+|++||++++|+++
T Consensus 220 -~~~~~~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 220 -SKIKEGKFRR---------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -HHHhcCCCCC---------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111111111 112334678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=294.34 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=197.0
Q ss_pred cccccccccccceEEEEEEecc-Ccceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCC------e
Q 047157 491 GFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED------K 561 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~ 561 (788)
.+.+.||+|+||.||+|..... ..+..||||.+.... ....+++.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 4567899999999999987632 356789999886542 345677899999999999999999999886532 2
Q ss_pred EEEEEecCCCCCHhHhhhcc-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 562 RLLVYELMPNGTLSNFLFHE-----GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
.++++||+++++|.+++... ...+++.....++.||+.||+|||+. +|+||||||+||+++ .++.+|
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~-----~~~~~k 153 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLN-----ENMTVC 153 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEc-----CCCCEE
Confidence 47899999999999887432 22468889999999999999999998 999999999999998 788999
Q ss_pred EeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhH
Q 047157 637 ISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 714 (788)
|+|||.+......... ......++..|++||.+....++.++||||||+++|||++ |+.||......+ ..
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--------~~ 225 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--------IY 225 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--------HH
Confidence 9999999866432211 1122345678999999998889999999999999999999 888886432211 11
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
.+. .... . ..........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 226 ~~~----~~~~--~-------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 226 NYL----IKGN--R-------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHH----HcCC--c-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 0000 0 001112346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=318.42 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=210.4
Q ss_pred ccccccccccceEEEEEEeccCc--ceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 492 FSKLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 492 ~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
-.++||+|+||+||+|.+-.++. +.+||+|.+.... .+..+++..|+-+|.+++||||++++++|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 35789999999999999875433 4578999886543 455679999999999999999999999998776 8899999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
|+.|+|.++++.++..+..+..+.|..|||+||.|||++ .++||||..+|||+. .-..+||.|||+++.+..
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVk-----sP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVK-----SPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeec-----CCCeEEEEecchhhccCc
Confidence 999999999999888999999999999999999999999 999999999999998 667899999999999876
Q ss_pred CCCcccc-cccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 649 DQTRTDT-NMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 649 ~~~~~~~-~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
+...... ...-.+.|||-|.+....++.++|||||||++||++| |..|+++....+.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------------------- 909 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------------------- 909 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh---------------------
Confidence 6544322 2233567999999999999999999999999999997 8899887654332
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.+++....+...+......+..++.+||..|++.||+++++...+.+..
T Consensus 910 ~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 910 PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 2222222333334445567778889999999999999999998886654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=301.94 Aligned_cols=270 Identities=22% Similarity=0.298 Sum_probs=198.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
+|.+.++||+|+||.||+|... .++..+|+|.+.... ....+.+.+|+++++.++||||+++++++..++..++|+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHK--ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEEC--CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 3566789999999999999886 567789999876432 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.++.... ..+++..+..++.||+.||+|||+. +++|+||+|+||+++ +++.++|+|||++...
T Consensus 80 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~-----~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 80 EFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVS-----QSGVVKLCDFGFARTL 150 (286)
T ss_pred ecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEC-----CCCcEEEEeeeeeeec
Confidence 999999998876443 4589999999999999999999998 999999999999998 7889999999998865
Q ss_pred CCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh---hHHHHHHHhh
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV---LSDWVISCML 722 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 722 (788)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ +.........
T Consensus 151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 151 AAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred cCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 44332 2223457889999998865 45788999999999999999999998654321110000000 0000000000
Q ss_pred cccc-cccccCCCCCcc-----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 SRNL-QVLVSHDPEVLS-----DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 ~~~~-~~l~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.... .....+...... .......+.+++.+||+.+|++||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 000000000000 01234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=296.52 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=198.0
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
.+.||+|++|.||++... ..+..+++|.+........+.+.+|+.++++++||||+++++++...+..++|+||++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~ 101 (285)
T cd06648 24 FVKIGEGSTGIVCIATDK--STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101 (285)
T ss_pred ceEeccCCCeEEEEEEEC--CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence 468999999999999876 556789999887555555677899999999999999999999999999999999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||+|+||+++ .++.++|+|||.+.........
T Consensus 102 ~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~-----~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 102 ALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLT-----SDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEc-----CCCcEEEcccccchhhccCCcc
Confidence 99999865 4688899999999999999999999 999999999999998 7889999999988765433221
Q ss_pred ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccC
Q 047157 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSH 732 (788)
Q Consensus 653 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 732 (788)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||........ . .......
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-----------~-~~~~~~~------- 231 (285)
T cd06648 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----------M-KRIRDNL------- 231 (285)
T ss_pred -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-----------H-HHHHhcC-------
Confidence 2234578899999999888899999999999999999999999864321110 0 0011110
Q ss_pred CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 733 DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 733 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.+...........+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 232 PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0011111123457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.07 Aligned_cols=271 Identities=20% Similarity=0.233 Sum_probs=201.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|++|.||+|... .++..|++|.+.... ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNK--ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeC--CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 3567789999999999999886 567799999886432 334578899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||++++.|..+.. ....+++..+..++.||+.||.|||+. +++|+||+|+||+++ .++.+||+|||++...
T Consensus 80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~-----~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 80 EYVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVS-----ESGVLKLCDFGFARAL 150 (288)
T ss_pred ecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEC-----CCCCEEEEeeeccccc
Confidence 9999877766554 345689999999999999999999999 999999999999998 7889999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh----HHHHHHHh
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL----SDWVISCM 721 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 721 (788)
............++..|+|||++.+. .++.++||||||+++|+|++|+.||......+......... ........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 55443233345678899999999887 88999999999999999999999987542211100000000 00000000
Q ss_pred hcccccccccCCCCCc------ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVL------SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
........--...... ........+.+++.+||+.+|++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000000000000 011125678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=293.60 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=196.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch----------HHHHHHHHHHHHHhcCCCccccceEeeEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI----------EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE 559 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 559 (788)
|...+.||+|+||.||+|... .++..+|+|.++... ....+.+.+|++++++++||||+++++++...
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNV--TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred eeecceecccCceEEEEEeec--CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 345678999999999999876 567789999875321 11235688899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
+..++|+||+++++|.+++... ..+++..+..++.||+.||.|||++ +++|+||+|+||+++ .++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~-----~~~~~~l~d 151 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVD-----ADGICKISD 151 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEc-----CCCeEEEee
Confidence 9999999999999999999665 5678899999999999999999998 999999999999998 788999999
Q ss_pred cCCccccCCCCCc-ccccccCCccccCcccccCCC--CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 640 FGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVP--VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 640 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
||++......... ......++..|+|||.+.... ++.++|+||||+++||+++|..||......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----------- 220 (272)
T cd06629 152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA----------- 220 (272)
T ss_pred ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-----------
Confidence 9999865432211 123346788999999987654 88999999999999999999999853321110
Q ss_pred HHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... .......+ ...........+.+++..||+.||++|||+++|+++
T Consensus 221 ~~~~~-~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 221 MFKLG-NKRSAPPI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHhh-ccccCCcC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000 00000000 000111235678889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=292.52 Aligned_cols=247 Identities=27% Similarity=0.368 Sum_probs=197.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch-----HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-----EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
|...+.||+|++|.||+|... .++..|++|.+.... .+..+.+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNL--DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred ccccceeeecCCceEEEEEEc--CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 445688999999999999886 466789999886432 3356789999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+||+++++|.+++.+. ..+++..+..++.||+.||+|||+. +|+|+||+|+||+++ .++.+||+|||.+.
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~-----~~~~~kl~d~~~~~ 150 (258)
T cd06632 80 FLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVD-----TNGVVKLADFGMAK 150 (258)
T ss_pred EEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC-----CCCCEEEccCccce
Confidence 99999999999999654 4578899999999999999999999 999999999999998 77899999999988
Q ss_pred ccCCCCCcccccccCCccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVP-VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
...... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....... ........
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-----------~~~~~~~~ 217 (258)
T cd06632 151 QVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-----------AVFKIGRS 217 (258)
T ss_pred eccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-----------HHHHHHhc
Confidence 654333 223356788999999987766 8999999999999999999999986542110 00000000
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..... ......+.+.+++.+||+.+|++||+++++++
T Consensus 218 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KELPP---------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCCC---------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00000 01122456778999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.09 Aligned_cols=254 Identities=22% Similarity=0.244 Sum_probs=198.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|+||.||++... ..+..|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHK--ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred ceEeeEeecCCCeeEEEEEEC--CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 556789999999999999886 667789999886543 234467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++ .++.+||+|||+++..
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~-----~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLIT-----SMGHIKLTDFGLSKIG 151 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEEC-----CCCCEEEeeCCCcccc
Confidence 999999999999655 4678889999999999999999998 999999999999998 7889999999998642
Q ss_pred CCCC--------------CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh
Q 047157 647 NKDQ--------------TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 647 ~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 712 (788)
.... ........++..|+|||.+....++.++||||||+++|||++|+.||......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~------- 224 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------- 224 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------
Confidence 1100 0011124578889999999888999999999999999999999999965422110
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
.......... .+. ........+.+++.+||+.||++||++.++.+.|+.
T Consensus 225 -----~~~~~~~~~~-----~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 225 -----FGQVISDDIE-----WPE--GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -----HHHHHhcccC-----CCC--ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0111111000 000 011234567889999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.73 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=198.1
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch------HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI------EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
|...+.||+|++|.||++... .++..+++|.+.... ....+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~--~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDV--KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred ccccceecCcCceEEEEEEEc--CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 345678999999999999875 567789999886432 234578899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC-CcEEEeecCC
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN-YMAKISDFGI 642 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~-~~~kL~Dfg~ 642 (788)
+|+||+++++|.+++.+. ..+++..+..++.||+.||.|||++ +++|+||+|+||+++ .+ ..+||+|||.
T Consensus 80 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~-----~~~~~~~l~dfg~ 150 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLID-----STGQRLRIADFGA 150 (268)
T ss_pred EEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc-----CCCCEEEEccccc
Confidence 999999999999998654 4678899999999999999999999 999999999999997 44 4699999999
Q ss_pred ccccCCCCCc---ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHH
Q 047157 643 SKLLNKDQTR---TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 643 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
+......... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||......... .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--------~~~~~ 222 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--------ALIFK 222 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--------HHHHH
Confidence 9876543211 122345788999999998888999999999999999999999998643221100 00000
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.... ......+......+.+++.+||+.+|++||++.|++.
T Consensus 223 -~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 -IASA--------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -Hhcc--------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000 0001112234567888999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=298.16 Aligned_cols=246 Identities=25% Similarity=0.321 Sum_probs=196.4
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc---hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|+||+||+|... ..+..|++|.+... .....+++.+|+++++.++||||+++++++.+.+..++|+
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDV--RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhheeecCCCCeEEEEEEEc--CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 566688999999999999876 56678999988532 2344567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||++ ++|.+++......+++..+..++.||+.||.|||+. +|+|+||+|+||+++ .++.+||+|||++...
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~-----~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLT-----EPGTVKLADFGSASLV 165 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEC-----CCCCEEEeecCcceec
Confidence 9996 678777765556789999999999999999999998 999999999999998 7889999999998765
Q ss_pred CCCCCcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
... ....++..|+|||.+. ...++.++||||||+++|||++|+.||........ ... ...
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----------~~~-~~~ 228 (307)
T cd06607 166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------LYH-IAQ 228 (307)
T ss_pred CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----------HHH-Hhc
Confidence 322 2245778999999874 45688999999999999999999999865421110 000 000
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
. .+.........+.+.+++.+||+.||++||++.+|+.+.
T Consensus 229 ~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 229 N--------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred C--------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 011111223456789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=297.18 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=206.4
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..|.+.+.||+|+||.||++... .++..+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDV--ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEc--CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 35566789999999999999875 4566899999865555556788999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++.+ ..+++..+..++.|++.||.|||++ +++|+||||+||+++ .++.+||+|||++....
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~-----~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLG-----MDGSVKLTDFGFCAQIT 166 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEc-----CCCCEEEccCcceeccc
Confidence 9999999999854 3578889999999999999999999 999999999999998 77899999999887654
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
.... ......+++.|+|||.+....++.++||||||+++|++++|+.||........... ..
T Consensus 167 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-----------~~------ 228 (293)
T cd06647 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----------IA------ 228 (293)
T ss_pred cccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-----------hh------
Confidence 3322 22234678899999999888899999999999999999999999975432111000 00
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCcC-CCCCCC
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTLE-VGMPPL 782 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~-~~~pp~ 782 (788)
....+...........+.+++.+||+.+|++||++.+++.+ ++...+ ...||+
T Consensus 229 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~ 284 (293)
T cd06647 229 --TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPL 284 (293)
T ss_pred --cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccch
Confidence 00011111112234567789999999999999999999976 333332 445554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=291.68 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=193.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc-----hHHHHHHHHHHHHHhcCCCccccceEeeEEecC--CeE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-----IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DKR 562 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 562 (788)
+.+.+.||+|+||.||+|... .++..|++|.+... .....+.+.+|++++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDA--DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred ceEeeEEecCCceEEEEEEEc--CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 456789999999999999876 66779999987532 123456788999999999999999999988763 467
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++ .++.++|+|||+
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~-----~~~~~~l~Dfg~ 152 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRD-----SVGNVKLGDFGA 152 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEec-----CCCCEEECcCcc
Confidence 8999999999999998654 4578888999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCC--cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 643 SKLLNKDQT--RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 643 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
+........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----------~~~~ 221 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-----------IFKI 221 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-----------HHHH
Confidence 886543211 112234578899999999888899999999999999999999999964311110 0000
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... ......+......+.+++.+|+. +|++||+++||+++
T Consensus 222 ~~~---------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 222 ATQ---------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hcC---------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 000 00111122344567778888884 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=291.97 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=201.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.+.||.|+||+||+|... .++..+++|.+.... ....+.+.+|++.++.++|+||+++++.+...+..++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICL--PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEc--CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 3567789999999999999876 566789999886432 3356789999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 568 LMPNGTLSNFLFHE--GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 568 ~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
++++++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||+|+||+++ +++.++|+|||++..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~-----~~~~~~l~df~~~~~ 151 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLG-----EDGSVKIADFGVSAS 151 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEc-----CCCCEEEcccchHHH
Confidence 99999999999654 24678999999999999999999998 999999999999998 778899999999886
Q ss_pred cCCCCCc---ccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 646 LNKDQTR---TDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 646 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+...... ......++..|+|||.+... .++.++|+||||+++|||++|+.||........ .... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-------~~~~----~ 220 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-------LMLT----L 220 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-------HHHH----h
Confidence 6543222 12334678899999998776 789999999999999999999999965422110 0000 0
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... ... ...........+.+++..||+.||++||++++++++
T Consensus 221 -~~~~~-~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 221 -QNDPP-SLE---TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -cCCCC-CcC---CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 000 000011335678899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=298.10 Aligned_cols=254 Identities=25% Similarity=0.297 Sum_probs=199.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc---hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.+...+.||+|+||.||++... .++..+++|.+... .....+.+.+|++++++++|||++++++++.+++..++|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDV--RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEc--CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 3455678999999999999876 56678999988643 234456788999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||++ |+|.+.+......+++.++..++.||+.||.|||+. +|+|+||+|+||+++ .++.+||+|||++..
T Consensus 104 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~-----~~~~~kl~dfg~~~~ 174 (317)
T cd06635 104 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLT-----EPGQVKLADFGSASI 174 (317)
T ss_pred EeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEEC-----CCCCEEEecCCCccc
Confidence 99996 588888766667789999999999999999999999 999999999999998 778999999998875
Q ss_pred cCCCCCcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
.... ....++..|+|||++. ...++.++||||||+++|||++|+.||........ . ....
T Consensus 175 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~-----~~~~ 237 (317)
T cd06635 175 ASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------L-----YHIA 237 (317)
T ss_pred cCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-------H-----HHHH
Confidence 4322 2345788999999873 45788999999999999999999999864321110 0 0000
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVG 778 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 778 (788)
.... ...........+.+++.+||+.+|++||++.+|++.+.-....+
T Consensus 238 ~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 238 QNES--------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred hccC--------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 0000 00111223456788999999999999999999998765444333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=320.12 Aligned_cols=200 Identities=23% Similarity=0.344 Sum_probs=159.5
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeee------------------eeecccchHHHHHHHHHHHHHhcCCCccc
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIA------------------VKKLEKDIEKTNEEFMTELKIIGRTHHKN 548 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~va------------------vK~l~~~~~~~~~~~~~E~~~l~~l~hpn 548 (788)
...|.+.+.||+|+||+||++..+.... ...+ .|.+.. .......+.+|++++++++|||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTE-EAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccch-hhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 4568888999999999999987652211 1111 111111 1234557889999999999999
Q ss_pred cceEeeEEecCCeEEEEEecCCCCCHhHhhhccC----CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEe
Q 047157 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEG----QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLL 624 (788)
Q Consensus 549 iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 624 (788)
|+++++++.+.+..++|+|++. ++|.+++.... .......+..++.||+.||.|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999984 57777764331 2234566778999999999999999 99999999999999
Q ss_pred ccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCC
Q 047157 625 DLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHI 697 (788)
Q Consensus 625 ~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~ 697 (788)
+ .++.+||+|||++..+............|+..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 301 ~-----~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 301 N-----CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred C-----CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 8 7889999999999876544333333467899999999999999999999999999999999988643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.62 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=201.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcC--CCccccceEeeEEecCC----eE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR--THHKNLVRLLGFCSEED----KR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~----~~ 562 (788)
+..+.+.||+|.||.||+|.++ +..||||++... .++.+.+|.++.+. |+|+||+.+++.-..++ .+
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr----Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR----GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred eeEEEEEecCccccceeecccc----CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3345688999999999999985 558999999754 34567788888874 69999999998754433 68
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc-----cCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE-----CETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
+||++|.+.|||.|||.. ..++....++++..+|.||+|||.. .+|.|.|||||.+|||+. .++...|
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-----kn~~C~I 357 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-----KNGTCCI 357 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-----cCCcEEE
Confidence 999999999999999955 5788999999999999999999953 578999999999999998 8999999
Q ss_pred eecCCccccCCCCCc---ccccccCCccccCcccccCC----CCC--ccCcchhhHHHHHHHHhC----------CCCCC
Q 047157 638 SDFGISKLLNKDQTR---TDTNMRGTMGYVAPEWLRNV----PVT--TKVDVFSFGVMLLEIICG----------RRHIE 698 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~s--~k~DVwSlGvil~elltg----------~~p~~ 698 (788)
+|+|+|......... .....+||-+|||||++... .+. ..+||||||.++||+... +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999877554322 23347899999999998543 122 359999999999999742 34554
Q ss_pred ccccccccccchhhhHHHHHHHhhcccc-cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 699 LSRVEEESEEVDIVLSDWVISCMLSRNL-QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
..-..+... +.+..-.. +.+--.-+......+.+..+.++++.||..+|+.|-|+-.|.+.|.++.+.
T Consensus 438 d~Vp~DPs~-----------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 438 DVVPSDPSF-----------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred cCCCCCCCH-----------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 322221111 11111111 111112344556778899999999999999999999999999999877643
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=296.25 Aligned_cols=243 Identities=26% Similarity=0.284 Sum_probs=198.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|+||.||++... ..+..+++|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHK--GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEc--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 567789999999999999886 567789999886532 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..++...+..++.||+.||.|||+. +|+|+||+|+||+++ .++.+||+|||++...
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~-----~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLD-----SDGYIKITDFGFAKRV 151 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEC-----CCCCEEEeeCCCcccc
Confidence 999999999998665 5688999999999999999999998 999999999999998 7789999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
... .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||....... ........
T Consensus 152 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------~~~~~~~~-- 213 (290)
T cd05580 152 KGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------------IYEKILEG-- 213 (290)
T ss_pred CCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------------HHHHHhcC--
Confidence 443 223467899999999988889999999999999999999999996543111 00001111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIH 769 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 769 (788)
.+... ......+.+++.+||+.||.+|| +++|+++
T Consensus 214 ------~~~~~--~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 ------KVRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ------CccCC--ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11111 11245677899999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=294.19 Aligned_cols=251 Identities=26% Similarity=0.362 Sum_probs=197.1
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCC------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED------ 560 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~------ 560 (788)
..|.+.+.||+|++|.||+|..+ ..+..+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHK--KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hheeheeeecCCCCeEEEEEEEC--CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 34667789999999999999886 5567899998875533 346789999999999 7999999999996644
Q ss_pred eEEEEEecCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 561 KRLLVYELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
..++||||+++++|.+++... +..+++..+..++.|++.||.|||+. +++|+||+|+||+++ .++.+||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~-----~~~~~~l 154 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLT-----KNAEVKL 154 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEc-----cCCeEEE
Confidence 489999999999999998643 36789999999999999999999999 999999999999998 7789999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-----VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 712 (788)
+|||++........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||........
T Consensus 155 ~d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------- 226 (275)
T cd06608 155 VDFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------- 226 (275)
T ss_pred CCCccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-------
Confidence 99999876543222 2223567889999998753 3567899999999999999999999964311110
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.. ..... ..+.........+.+.+++.+||+.||++|||++++++
T Consensus 227 ~~-----~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 227 LF-----KIPRN-------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HH-----Hhhcc-------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 01111 01111222235567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.58 Aligned_cols=257 Identities=27% Similarity=0.367 Sum_probs=198.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecC--CeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lV~ 566 (788)
+.+.+.||.|++|.||++... ..+..+++|.+.... .....++.+|++++++++||||+++++++.+. ...++||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLK--NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred eEEEEEeccCCceEEEEEEEC--CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 445688999999999999986 567789999887433 34567889999999999999999999988653 4789999
Q ss_pred ecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 567 ELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 567 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
||+++++|.+++.. ....++...+..++.||+.||+|||+. +++|+||+|+||+++ .++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~-----~~~~~~l~dfg~~ 152 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLT-----RKGQVKLCDFGVS 152 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEe-----cCCeEEEeecccc
Confidence 99999999988743 345678899999999999999999998 999999999999998 7778999999998
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
........ ....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .......+. ..
T Consensus 153 ~~~~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~----~~ 222 (287)
T cd06621 153 GELVNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL---GPIELLSYI----VN 222 (287)
T ss_pred cccccccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC---ChHHHHHHH----hc
Confidence 76533221 134567889999999998999999999999999999999999975532100 011111111 11
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.....+. ..+ .......+.+.+++.+||+.+|++|||+.||++
T Consensus 223 ~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 223 MPNPELK-DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCchhhc-cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111110 011 111224567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=294.88 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=194.2
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEec------CC
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSE------ED 560 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~------~~ 560 (788)
..+.+.+.||+|+||.||+|... ..+..+++|.+.... ....++..|+.++.++ +||||+++++++.. .+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHV--KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEc--CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 34556689999999999999886 566789999886543 3345788999999988 79999999999853 46
Q ss_pred eEEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 561 KRLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
..+++|||+++++|.+++... ...+++..+..++.||+.||.|||+. +|+|+||||+||+++ .++.++|+|
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~-----~~~~~~l~d 164 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLT-----ENAEVKLVD 164 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC-----CCCCEEEee
Confidence 789999999999999998653 34578888899999999999999999 999999999999998 778899999
Q ss_pred cCCccccCCCCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 714 (788)
||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||..........
T Consensus 165 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------- 236 (282)
T cd06636 165 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------- 236 (282)
T ss_pred Ccchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-------
Confidence 999876532221 122356888999999875 3567889999999999999999999996432111000
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. .... .............+.+++.+||+.||.+||++.|+++
T Consensus 237 ----~-~~~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ----L-IPRN--------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----h-HhhC--------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0000 0001111123467889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.04 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=204.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..|.+.+.||+|.|+.|.+|.+. .++..||||.+++.. ......+.+|+++|+.++|||||+++.+.+....+|+|
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~--~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHI--LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cceeeeeeeccceeEEEEeeEec--CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34566789999999999999998 667799999997654 23334588999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+.+|.+.+++.+.++..+ .....++.|+.+|++|||++ .|+|||||++||||+ .+.++||+|||++..
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~-----~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLD-----ENMNIKIADFGFSTF 204 (596)
T ss_pred EEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccc-----cccceeeecccccee
Confidence 999999999999987755555 88889999999999999999 999999999999999 888999999999998
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVT-TKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
+.... .....+|++.|.|||++.+.++. +++|+||+|++||.|+.|..||++....+.....
T Consensus 205 ~~~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv--------------- 267 (596)
T KOG0586|consen 205 FDYGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV--------------- 267 (596)
T ss_pred ecccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---------------
Confidence 76433 33457899999999999988775 7999999999999999999999976544332211
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+... .. .+.-...++.++++++|-.+|.+|++++++++.
T Consensus 268 -l~gk----~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 268 -LRGK----YR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -eeee----ec--ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 0000 00 111123456678889999999999999999863
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=295.89 Aligned_cols=250 Identities=27% Similarity=0.343 Sum_probs=193.4
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecC-----CeEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE-----DKRL 563 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-----~~~~ 563 (788)
|.+.+.||+|+||.||++... .++..+++|.+.... .....+.+|+.++.++ +|||++++++++... +..+
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~--~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNK--KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred eEEEEEeecCCCeEEEEEEEC--CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 455689999999999999876 567789999886532 2345678899999988 899999999998653 3589
Q ss_pred EEEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 564 LVYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
+|+||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||+++ .++.+||+||
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~-----~~~~~kl~df 172 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLT-----TEGGVKLVDF 172 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEc-----CCCCEEEeec
Confidence 99999999999998853 345688999999999999999999998 999999999999998 7788999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCC-----CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-----PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
|++......... .....++..|+|||.+... .++.++||||||+++|||++|+.||........ +..
T Consensus 173 g~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-------~~~ 244 (291)
T cd06639 173 GVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-------LFK 244 (291)
T ss_pred ccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-------HHH
Confidence 998865432211 1234578899999987543 368899999999999999999999864321110 000
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...... +...........+.+++.+||+.+|++||++.|++++
T Consensus 245 -----~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 -----IPRNPP-------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----HhcCCC-------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 001100 0111112234568889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=297.29 Aligned_cols=269 Identities=22% Similarity=0.302 Sum_probs=194.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchH-HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.+.||+|++|.||+|..+ .++..|++|.+..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSK--LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEc--CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 4566789999999999999876 5667899999864332 223456789999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++ +|.+++......+++..+..++.|++.||.|||+. +|+|+||||+||+++ .++.+||+|||++....
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~-----~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLIS-----ERGELKLADFGLARAKS 154 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEc-----CCCCEEECccccccccC
Confidence 9974 99999877666789999999999999999999999 999999999999998 77899999999987543
Q ss_pred CCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCcccccccc-ccchhh---hHHHHHHHhh
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES-EEVDIV---LSDWVISCML 722 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~---~~~~~~~~~~ 722 (788)
.... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......... ...... .....+....
T Consensus 155 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 155 VPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 2111 1122346788999998865 45889999999999999999999999654311000 000000 0000000000
Q ss_pred c-cccccc----ccCCC--CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 723 S-RNLQVL----VSHDP--EVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 723 ~-~~~~~l----~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. ...... ....+ ...........+.+++.+||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000000 00000 00001111256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=293.01 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=197.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCC---ccccceEeeEEecCCeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTH---HKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lV 565 (788)
|.+.+.||+|+||.||+|... ..+..+++|.+.... ....+++.+|++++++++ |||++++++++..+...++|
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHV--PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhheeccCCceEEEEEEc--CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 455678999999999999986 566799999886432 344567889999999886 99999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+|+||+|+||+++ .++.++|+|||.+..
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~-----~~~~~~l~dfg~~~~ 150 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVT-----NTGNVKLCDFGVAAL 150 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEc-----CCCCEEEccCCceee
Confidence 999999999999854 3688999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ......
T Consensus 151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~------------~~~~~~ 217 (277)
T cd06917 151 LNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM------------MLIPKS 217 (277)
T ss_pred cCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh------------hccccC
Confidence 654332 2233468889999998865 45789999999999999999999999654221100 000000
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+...........+.+++.+||+.||++||++.|++++
T Consensus 218 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 218 --------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00001111134578889999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=291.11 Aligned_cols=252 Identities=28% Similarity=0.377 Sum_probs=203.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchH-HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.+.+.||+|++|.||++... ..+..+++|++..... ...+.+.+|++.+.+++|+||+++++++...+..++|+||
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~--~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHK--PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEc--CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 456789999999999999887 5677999999876543 4567899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
+++++|.+++... ..+++..++.++.|+++||.|||+ . +++|+||+|+||+++ .++.++|+|||.+....
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~-----~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLIN-----SKGEVKIADFGISKVLE 151 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEEC-----CCCCEEEccCccceecc
Confidence 9999999999655 668999999999999999999999 8 999999999999998 78899999999998765
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
...... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...... .......
T Consensus 152 ~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-----~~~~~~----~~~~~~~- 220 (264)
T cd06623 152 NTLDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----FFELMQ----AICDGPP- 220 (264)
T ss_pred cCCCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC-----HHHHHH----HHhcCCC-
Confidence 433221 23457889999999998899999999999999999999999996543200 000111 1111110
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.........+.+.+++.+||+.+|++||+++|++++
T Consensus 221 -------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 -------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 001111145678889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=296.09 Aligned_cols=270 Identities=21% Similarity=0.234 Sum_probs=197.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC--CeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 564 (788)
.|.+.+.||+|+||.||+|... .++..+++|.++... ......+.+|+.++.+++||||+++++++... +..++
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDK--KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEEC--CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4566789999999999999886 567789999886433 22334677899999999999999999998877 89999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+||++ ++|.+++......+++..+..++.||+.||.|||++ +++|+||||+||+++ .++.+||+|||++.
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~-----~~~~~~l~d~g~~~ 154 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLN-----NRGILKICDFGLAR 154 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEEC-----CCCcEEEeecCcee
Confidence 999997 599998876666789999999999999999999999 999999999999998 77899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHH
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISC 720 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 720 (788)
....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||................ ....+..
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 155 EYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred eccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 7654321 11224567889999988654 46899999999999999999999997553322111100000 0000000
Q ss_pred hhc------ccccccccCCCCC-cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLS------RNLQVLVSHDPEV-LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~------~~~~~l~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... ............. .......+.+.+++..||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 0000000000000 0000124567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=291.39 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=199.1
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
..+.+.+.||+|+||.||+|... ..+..+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDN--RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEEC--CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 34556788999999999999875 566799999876432 344567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++ .++.++|+|||++..+
T Consensus 82 e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~-----~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 82 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLS-----EHGEVKLADFGVAGQL 151 (277)
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEEC-----CCCCEEEeecccceec
Confidence 99999999999853 4678999999999999999999998 999999999999998 7788999999998765
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... . . ........
T Consensus 152 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~---~-~~~~~~~~ 218 (277)
T cd06641 152 TDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------V---L-FLIPKNNP 218 (277)
T ss_pred ccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------H---H-HHHhcCCC
Confidence 43221 1223457889999999988889999999999999999999999986432111 0 0 00111100
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+. ........+.+++.+||+.+|++||++++++++
T Consensus 219 -------~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 -------PT--LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -------CC--CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 011234567789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=293.11 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=201.2
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
+.+.+.||+|++|.||+|... ..+..+++|.+..... ..+.+.+|++.+++++|+||+++++.+...+..++|+||+
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 97 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDR--ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97 (286)
T ss_pred chHhHhccCCCCeEEEEEEEc--cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence 445578999999999999886 4567899999876544 5677889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++......+++..+..++.|++.||.|||+. +|+|+||+|+||+++ .++.++|+|||.+......
T Consensus 98 ~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~-----~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 98 DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLS-----KDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEc-----CCCCEEECccchhhhhccc
Confidence 99999999977655789999999999999999999998 999999999999998 7789999999988765432
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .. .......
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-------~~-----~~~~~~~--- 233 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-------LF-----LITTKGI--- 233 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-------HH-----HHHhcCC---
Confidence 21 11234577899999999888899999999999999999999999864322110 00 0000000
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+...........+.+++.+||+.+|.+||++.+|+++
T Consensus 234 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 234 ----PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111111234678889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=292.68 Aligned_cols=266 Identities=19% Similarity=0.188 Sum_probs=194.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCC-ccccceEeeEEecC--CeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEE--DKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lV 565 (788)
|.+.+.||+|+||.||+|... .++..+|+|.+.... ........+|+.++.++. ||||+++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~--~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR--KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEc--CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 346688999999999999876 566789999886542 222334557888998885 99999999999887 889999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+||++ ++|.+++......+++..+..++.||+.||.|||+. +++||||+|+||+++ . +.+||+|||++..
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~-----~-~~~kl~dfg~~~~ 148 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIK-----D-DILKLADFGSCRG 148 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEc-----C-CCeEEEecccccc
Confidence 99996 588888876656789999999999999999999999 999999999999998 5 8999999999987
Q ss_pred cCCCCCcccccccCCccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh----hhHHHHHHH
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLR-NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI----VLSDWVISC 720 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~ 720 (788)
....... ....++..|+|||.+. +..++.++|||||||++|||++|+.||...+..+....... ....+ ...
T Consensus 149 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 225 (282)
T cd07831 149 IYSKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKK 225 (282)
T ss_pred cccCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHh
Confidence 6433221 2245788999999764 45678999999999999999999999976432211000000 00000 000
Q ss_pred hhcccccccccCCCCC----cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEV----LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...........+.... .........+.+++.+||+.+|++||+++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000000 0011235788999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=290.14 Aligned_cols=247 Identities=28% Similarity=0.309 Sum_probs=199.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
|.+.+.||+|+||.||++... .++..+++|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKR--DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred ceEEEEeccCCCceEEEEEEc--cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 566789999999999999876 567789999987543 245678999999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.||++||.|||+. +++|+||+|+||+++ .++.++|+|||.+...
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~-----~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLD-----EQGHVHITDFNIATKV 150 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEc-----CCCCEEEeeccccccc
Confidence 999999999999655 5788999999999999999999998 999999999999998 7889999999998876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ..........
T Consensus 151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~--- 216 (258)
T cd05578 151 TPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---------RDQIRAKQET--- 216 (258)
T ss_pred CCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---------HHHHHHHhcc---
Confidence 4432 1223567889999999988889999999999999999999999997553210 0111111110
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH--HHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM--KKVI 768 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~evl 768 (788)
............+.+++.+||+.||.+||++ +|++
T Consensus 217 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0001111234678899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=293.28 Aligned_cols=269 Identities=23% Similarity=0.253 Sum_probs=199.0
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC--CeEEEEE
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DKRLLVY 566 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lV~ 566 (788)
.+.+.||+|++|.||+|... ..+..+++|.+.... ....+.+.+|++++++++|||++++++++... +..++|+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNK--KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred eeeEEeccCCCeEEEEEEEC--CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 45688999999999999886 566789999997653 33456788999999999999999999999888 8999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++ +|.+++......+++..++.++.||+.||+|||+. +++|+||+|+||+++ +++.+||+|||++...
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~-----~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILIN-----NDGVLKLADFGLARPY 150 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEc-----CCCCEEEccccceeec
Confidence 99974 89998876656789999999999999999999998 999999999999998 7889999999999876
Q ss_pred CCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH---HHHHHHhh
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS---DWVISCML 722 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 722 (788)
............++..|+|||.+.+ ..++.++||||||+++|||++|+.||................. ...+....
T Consensus 151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 5543222333456788999998764 4678999999999999999999999975432211110000000 00000000
Q ss_pred cccccccccCCCCCcc----cH-H-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLS----DL-E-RFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~----~~-~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.-.............. .. . ....+.+++.+||+.+|.+||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000000000 00 1 25678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=293.56 Aligned_cols=269 Identities=21% Similarity=0.239 Sum_probs=193.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.+.||+|+||.||+|... ..+..+++|.+.... ......+.+|++++++++|+||+++++++..++..++|+|
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISR--INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEc--CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 3566789999999999999886 556689999986543 2233467789999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+. ++|.+++......+.+..+..++.||+.||.|||+. +|+|+||||+||+++ .++.+||+|||++....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~-----~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLIS-----YLGELKLADFGLARAKS 154 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEc-----CCCcEEEeccccccccC
Confidence 995 678777765556678888889999999999999999 999999999999998 77899999999987643
Q ss_pred CCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh-----hHH-HHHHH
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV-----LSD-WVISC 720 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-----~~~-~~~~~ 720 (788)
.... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||............... ... +....
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 155 IPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 3221 11234568899999998754 5788999999999999999999999754321100000000 000 00000
Q ss_pred hhcccccccccCCCCC-----cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEV-----LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
................ .........+.+++.+|++.||++|||++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 001112356778899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=288.91 Aligned_cols=244 Identities=29% Similarity=0.342 Sum_probs=192.1
Q ss_pred ccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 496 lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
||+|+||+||++... .++..+++|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||++++
T Consensus 1 lg~g~~g~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVK--ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEc--CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 689999999999876 567789999886432 223456678999999999999999999999999999999999999
Q ss_pred CHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC
Q 047157 573 TLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651 (788)
Q Consensus 573 sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~ 651 (788)
+|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++ .++.+||+|||.+.......
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~-----~~~~~~l~dfg~~~~~~~~~- 149 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLD-----DHGNVRISDLGLAVELKGGK- 149 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEC-----CCCCEEEccCcchhhhccCC-
Confidence 9999997654 3688999999999999999999999 999999999999998 77899999999987654321
Q ss_pred cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccccc
Q 047157 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVS 731 (788)
Q Consensus 652 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 731 (788)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... . . ......
T Consensus 150 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~----~----~~~~~~---- 212 (277)
T cd05577 150 -KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE----E----L----KRRTLE---- 212 (277)
T ss_pred -ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH----H----H----Hhcccc----
Confidence 1123457789999999988889999999999999999999999996543211000 0 0 000000
Q ss_pred CCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 047157 732 HDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIH 769 (788)
Q Consensus 732 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 769 (788)
.... ........+.+++.+||+.||++|| ++.++++
T Consensus 213 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 213 MAVE--YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cccc--CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0000 0111245678899999999999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=290.15 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=196.9
Q ss_pred ccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 496 lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
||+|+||.||++... .++..+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++|+||++++
T Consensus 1 lg~g~~~~vy~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEEC--CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999886 5577999999865432 45668899999999999999999999999999999999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC-
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT- 651 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~- 651 (788)
+|.+++.+.+ .+++..+..++.||++||+|||+. +++|+||+|+||+++ .++.++|+|||++........
T Consensus 79 ~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~-----~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 79 DLASLLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILID-----SNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEc-----CCCCEEEEecccchhcccCccc
Confidence 9999996653 689999999999999999999999 999999999999998 788999999999876533211
Q ss_pred ------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 652 ------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 652 ------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.......++..|+|||.......+.++||||||+++|||++|+.||......+. . .......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----------~-~~~~~~~ 217 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----------F-QNILNGK 217 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-----------H-HHHhcCC
Confidence 122334578899999999888899999999999999999999999965432110 0 1111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
............+.+++.+||+.+|++|||+.++.+.|+
T Consensus 218 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 --------IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --------cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 011111112567789999999999999999977766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.86 Aligned_cols=244 Identities=24% Similarity=0.354 Sum_probs=196.3
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGT 573 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 573 (788)
.+||+|+||.||++... .++..|++|++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVK--SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEc--CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 67999999999999886 6677999999865555566789999999999999999999999999999999999999999
Q ss_pred HhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcc
Q 047157 574 LSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653 (788)
Q Consensus 574 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 653 (788)
|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++ .++.++|+|||++........ .
T Consensus 104 L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~-----~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 104 LTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLT-----HDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC-----CCCCEEEcccccceecccccc-c
Confidence 9998743 3578899999999999999999999 999999999999998 778899999999876543221 1
Q ss_pred cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCC
Q 047157 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD 733 (788)
Q Consensus 654 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 733 (788)
.....++..|+|||.+.+..++.++||||+|+++|+|++|..||........ ..... ......+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--------~~~~~-----~~~~~~~--- 236 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------MKMIR-----DNLPPKL--- 236 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHH-----hhCCccc---
Confidence 2234578899999999888899999999999999999999999875322110 00000 0000000
Q ss_pred CCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 734 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.........+.+++.+||+.||.+||++.++++
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 237 ---KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ---CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 001122345678899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.72 Aligned_cols=267 Identities=22% Similarity=0.241 Sum_probs=195.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecC------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------ 559 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 559 (788)
..|...+.||+|+||.||++... .++..||+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDT--VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEEC--CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45667789999999999999886 56779999998643 233445778899999999999999999988643
Q ss_pred CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
...++||||+. ++|.+.+... ++...+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~-----~~~~~kL~D 161 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK-----SDCTLKILD 161 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEC-----CCCCEEEcc
Confidence 35799999995 5888877432 78889999999999999999999 999999999999998 788999999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccch-------hh
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD-------IV 712 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~-------~~ 712 (788)
||++........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+......... ..
T Consensus 162 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 162 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred CccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999986543222 223457889999999999999999999999999999999999997543221110000 00
Q ss_pred hHH----HHHHHhhccc------ccccccCCC----CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 713 LSD----WVISCMLSRN------LQVLVSHDP----EVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 713 ~~~----~~~~~~~~~~------~~~l~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+.. .......... +..+..... ...........+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000000 000000000 000011335667899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.03 Aligned_cols=284 Identities=22% Similarity=0.285 Sum_probs=213.6
Q ss_pred CHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecC
Q 047157 481 TFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE 559 (788)
Q Consensus 481 ~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 559 (788)
+++++-+.| .+.||+|+|+.|-.++.. .++.++|||++++.....+.++.+|++++... .|+||+++++||+++
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i--~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSI--QTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeee--ccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 456665544 478999999999988776 67889999999998888889999999999988 599999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
...|||||-|.||+|..++.++ +.+++.++.++.++|+.||.|||.+ +|.||||||+|||-.... .-.-+||+|
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn--~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPN--KVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCC--CcCceeeec
Confidence 9999999999999999999655 6789999999999999999999999 999999999999986433 456799999
Q ss_pred cCCccccCC--CC----CcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCcccccccc--
Q 047157 640 FGISKLLNK--DQ----TRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES-- 706 (788)
Q Consensus 640 fg~a~~~~~--~~----~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~-- 706 (788)
|.+..-+.. +. .......+|+..|||||+.. ...|+.+.|.||||||||-|++|..||.+....+-.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 988764422 11 22233567899999999863 346889999999999999999999999865432211
Q ss_pred -ccchhhhHHHHHHHhhcccccccccCCCCCcc-c-HHHHHHHHHHHhHccCCCCCCCCCHHHHHH-----HhhcCcCCC
Q 047157 707 -EEVDIVLSDWVISCMLSRNLQVLVSHDPEVLS-D-LERFERMAMVGLWCNHPDPNLRPSMKKVIH-----MLEGTLEVG 778 (788)
Q Consensus 707 -~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~-----~L~~~~~~~ 778 (788)
.+....-.......+.++.. +... + .....+..+++...+-.||.+|-++.+++. +......++
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkY--------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp 374 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKY--------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP 374 (463)
T ss_pred CCCccHHHHHHHHHHHhccCC--------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC
Confidence 11111111112222222211 1111 0 123456667788888899999999999987 223334555
Q ss_pred CCCCC
Q 047157 779 MPPLL 783 (788)
Q Consensus 779 ~pp~p 783 (788)
.|+..
T Consensus 375 tp~v~ 379 (463)
T KOG0607|consen 375 TPQVL 379 (463)
T ss_pred CCccc
Confidence 55543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.76 Aligned_cols=270 Identities=24% Similarity=0.245 Sum_probs=195.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchH--HHHHHHHHHHHHhcCCCccccceEeeEEecC--CeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--KTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 564 (788)
.|.+.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDT--TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEEC--CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4566789999999999999886 5677899998864322 2233567899999999999999999998765 56899
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+. ++|.+++......+++.++..++.||+.||.|||+. +++||||||+||+++ .++.+||+|||++.
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~-----~~~~~kL~dfg~~~ 156 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLT-----DKGCLKIADFGLAR 156 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC-----CCCCEEECccceee
Confidence 999996 589888876667789999999999999999999999 999999999999998 77899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHH
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISC 720 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 720 (788)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... ....+..
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 157 TYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred ecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 7654321 1122345778999999865 567899999999999999999999997543222111000000 0000000
Q ss_pred hhcccccccccCCCCCccc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
................... ....+.+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000000000000 1124567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.22 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=190.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHH-hcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKI-IGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
+.+.+.||+|+||.||++... .++..||+|+++... ......+..|+.+ ++.++||||+++++++..++..++|||
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHV--PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred ceEEEEecccCCeEEEEEEEc--CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 456788999999999999886 667899999887543 2334456667665 566789999999999999999999999
Q ss_pred cCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 568 LMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 568 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|++ ++|.+++.. .+..+++..++.++.||+.||.|||++ .+++||||||+||+++ .++.+||+|||++.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~-----~~~~~kl~dfg~~~ 152 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLIN-----RNGQVKLCDFGISG 152 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEEC-----CCCCEEEeeccccc
Confidence 996 688887754 235679999999999999999999974 2799999999999998 78899999999988
Q ss_pred ccCCCCCcccccccCCccccCcccccC----CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRN----VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
...... ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... ..+ ...
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~----~~~ 220 (283)
T cd06617 153 YLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF------QQL----KQV 220 (283)
T ss_pred cccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH------HHH----HHH
Confidence 654321 1122457889999998864 456889999999999999999999986421100 000 000
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.... ..........+.+.+++.+||+.+|++||+++++++
T Consensus 221 -~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 221 -VEEP--------SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -HhcC--------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000011123467889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=286.87 Aligned_cols=243 Identities=24% Similarity=0.282 Sum_probs=194.5
Q ss_pred ccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 496 lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
||.|++|.||++... ..+..+++|.+.... ....+.+.+|++++++++||||+++++.+.+++..++|+||++++
T Consensus 1 lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVK--SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEEC--CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 689999999999986 557799999886432 234568999999999999999999999999999999999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
+|.+++.+. ..+++..+..++.||+.||.|||++ +++|+||+|+||+++ .++.++|+|||.+.......
T Consensus 79 ~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~-----~~~~~~l~df~~~~~~~~~~-- 147 (262)
T cd05572 79 ELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLD-----SNGYVKLVDFGFAKKLKSGQ-- 147 (262)
T ss_pred cHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEc-----CCCCEEEeeCCcccccCccc--
Confidence 999999654 4578899999999999999999998 999999999999998 78899999999998765432
Q ss_pred ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccC
Q 047157 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSH 732 (788)
Q Consensus 653 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 732 (788)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .... ......
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~-~~~~~~-------- 209 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---------MEIY-NDILKG-------- 209 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---------HHHH-HHHhcc--------
Confidence 1223467889999999988889999999999999999999999997553210 0000 001100
Q ss_pred CCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 047157 733 DPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIH 769 (788)
Q Consensus 733 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 769 (788)
......+......+.+++.+||+.||++||+ ++|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0000111112567889999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.78 Aligned_cols=208 Identities=21% Similarity=0.322 Sum_probs=168.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecC--CeEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DKRLL 564 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 564 (788)
|.+.+.||+|++|.||+|.......+..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 45678899999999999998732267799999987633 34456778899999999999999999999888 88999
Q ss_pred EEecCCCCCHhHhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 565 VYELMPNGTLSNFLFHE----GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
||||+++ +|.+++... ...++...+..++.||+.||.|||+. +|+||||||+||+++.++ ..++.+||+||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~-~~~~~~kl~Df 156 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEG-PERGVVKIGDL 156 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCC-CccceEEECCC
Confidence 9999975 676666322 23678899999999999999999999 999999999999998321 12889999999
Q ss_pred CCccccCCCCC--cccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCcccc
Q 047157 641 GISKLLNKDQT--RTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRV 702 (788)
Q Consensus 641 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~ 702 (788)
|++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99987643322 11223457889999998765 4578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=293.98 Aligned_cols=268 Identities=24% Similarity=0.291 Sum_probs=194.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|...+.||.|++|.||+|+.. .++..|+||.+.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNK--LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred ceeeeeecCCCceEEEEEEEC--CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 455688999999999999886 566789999886432 2234578899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+. ++|.+++... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++ .++.+||+|||++...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~-----~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLIN-----TEGAIKLADFGLARAF 150 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC-----CCCCEEEeeccchhhc
Confidence 995 6898888653 35678999999999999999999998 999999999999998 7889999999998765
Q ss_pred CCCCCcccccccCCccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHHhh
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVP-VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISCML 722 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 722 (788)
..... ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||......+......... ....++...
T Consensus 151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 151 GVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 43221 112234678899999886644 6889999999999999999999997543221110000000 000000000
Q ss_pred -----cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 -----SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 -----~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
............... .......+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000000 00123456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=271.07 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=198.7
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEecCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
...||.|.-|.|++..++ .++..+|||.+.+.. .+..++++..+.++.+-+ +|.||+.+|+|..+...++.||.|
T Consensus 97 l~dlGsGtcG~V~k~~~r--s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFR--STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred HHhhcCCCccceEEEEEc--ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 467999999999999987 778899999997543 556678889998887664 899999999999999999999998
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
..-++.++..-...+++..+-++...++.||.||.++ .+|+|||+||+|||+| +.+++||+|||++-.+....
T Consensus 174 s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlD-----e~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 174 STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLD-----ERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEc-----cCCCEEeecccccceeeccc
Confidence 4466777766667788888889999999999999987 4999999999999999 89999999999998765433
Q ss_pred CcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 651 TRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
..+...|.+.|||||.+. ...|+-++||||||+.|+||.||+.||.+...+-. +...+.+.
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-----------~ltkvln~--- 310 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-----------VLTKVLNE--- 310 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-----------HHHHHHhc---
Confidence 233457889999999985 34688899999999999999999999987543211 11111111
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..|...........+.+++..||+.|+.+||...+++++
T Consensus 311 ----ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 ----EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ----CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 122222233366788899999999999999999998764
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.22 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=198.1
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|+||.||++..+ ..+..+++|.+.... ....+.+.+|++++++++|+||+++++.+.+....++|+|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAK--SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred ceEEEEecCCCcceEEEEEEc--CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 456788999999999999987 566789999886532 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC-CcEEEeecCCccc
Q 047157 568 LMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN-YMAKISDFGISKL 645 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~-~~~kL~Dfg~a~~ 645 (788)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++ ++ ..+||+|||.+..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~-----~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLS-----KNGMVAKLGDFGIARQ 151 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEc-----CCCCeEEecccccchh
Confidence 999999999986543 3578999999999999999999998 999999999999998 44 4579999999887
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... ......+++.|+|||.+.+..++.++||||||++++||++|+.||......+ ...... ...
T Consensus 152 ~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----------~~~~~~-~~~ 218 (257)
T cd08225 152 LNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----------LVLKIC-QGY 218 (257)
T ss_pred ccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----------HHHHHh-ccc
Confidence 643322 1223457889999999988889999999999999999999999986442111 111111 111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.... .......+.+++.+||+.+|++|||+.|+++.
T Consensus 219 ~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 219 FAPI---------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCC---------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1100 11223568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.24 Aligned_cols=271 Identities=20% Similarity=0.261 Sum_probs=193.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCC------
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED------ 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 560 (788)
.|.+.+.||+|+||.||+|... .++..||||.+.... ......+.+|++++++++||||+++++++...+
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~--~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHK--KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred heEEEEEeecCCCEEEEEEEEC--CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4667789999999999999876 567799999885432 222345678999999999999999999987654
Q ss_pred --eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 561 --KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 561 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
..++||||+. ++|.+++......+++.++..++.||+.||.|||++ +++|+||||+||+++ .++.+||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~-----~~~~~kl~ 161 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILIT-----KDGILKLA 161 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEC-----CCCcEEEC
Confidence 4599999996 588888866656789999999999999999999999 999999999999998 78899999
Q ss_pred ecCCccccCCCCCc---ccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh-
Q 047157 639 DFGISKLLNKDQTR---TDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL- 713 (788)
Q Consensus 639 Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~- 713 (788)
|||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||................
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999866432211 12234567889999988654 47889999999999999999999987543221100000000
Q ss_pred --HHHHHHHhhcccc-cccccCC-C-----CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 714 --SDWVISCMLSRNL-QVLVSHD-P-----EVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 714 --~~~~~~~~~~~~~-~~l~~~~-~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
....++....... ..+.... . ...........+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000000000 0000000 0 000000112456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.76 Aligned_cols=268 Identities=23% Similarity=0.250 Sum_probs=195.2
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.+.+.||.|++|.||+|... .++..|++|++.... ....+.+.+|++++++++||||+++++++.+++..+++|||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDK--LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred chheEecCCCCeEEEEEEEc--CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 45678999999999999886 567789999886443 23345788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 569 MPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 569 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
++ ++|.+++.... ..+++..+..++.|+++||.|||++ +++|+||+|+||+++ .++.++|+|||++....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~-----~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLID-----REGALKLADFGLARAFG 150 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEc-----CCCcEEEeecccccccC
Confidence 95 68999886543 4689999999999999999999998 999999999999998 77899999999997654
Q ss_pred CCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh---hHHHHHHH--h
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV---LSDWVISC--M 721 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~--~ 721 (788)
.... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............... .....+.. .
T Consensus 151 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 151 VPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred CCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 3221 11223467889999987654 5789999999999999999999999754322110000000 00000000 0
Q ss_pred hcccccccccCCCCC--cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 722 LSRNLQVLVSHDPEV--LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.......+....... .........+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000000 0011223578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=288.65 Aligned_cols=243 Identities=23% Similarity=0.269 Sum_probs=186.2
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHH---hcCCCccccceEeeEEecCCeEEEEEec
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKI---IGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~---l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.||+|+||.||++... .++..+|+|.+.... ......+.+|..+ +...+||||+.+++.+..++..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEEC--CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999876 567799999886432 1222334444433 3345799999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+|||++ .++.++|+|||++.....
T Consensus 79 ~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~-----~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 79 MNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLD-----EHGHVRISDLGLACDFSK 149 (279)
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEEC-----CCCCEEEccCCcceeccc
Confidence 9999999988654 4689999999999999999999999 999999999999998 778999999999875533
Q ss_pred CCCcccccccCCccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLR-NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
.. .....++..|+|||.+. +..++.++||||||+++|||++|+.||......... .... ....
T Consensus 150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~----~~~~---- 213 (279)
T cd05633 150 KK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDR----MTLT---- 213 (279)
T ss_pred cC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-----HHHH----Hhhc----
Confidence 22 12346899999999886 456899999999999999999999999754221100 0000 0000
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
... ..+.....++.+++..||+.||++|| +++|++++
T Consensus 214 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 ----VNV--ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----CCc--CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000 01122346778899999999999999 69999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=273.30 Aligned_cols=290 Identities=19% Similarity=0.258 Sum_probs=207.2
Q ss_pred hhcccccccccccceEEEEEEeccCcc--eeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEec-CCeEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQ--IEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-EDKRL 563 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~--~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~ 563 (788)
.|+....||+|.||.||+|.-+..... +.+|||+++... ........+|+.+++.++||||+.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 356678899999999999976654553 389999997542 2233456799999999999999999998877 78999
Q ss_pred EEEecCCCCCHhHhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 564 LVYELMPNGTLSNFLFH----EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
+++||.+. +|...++. ..+.++...+..|+.||+.|+.|||++ -|+||||||.|||+..++. +.+.|||+|
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgp-erG~VKIaD 179 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGP-ERGRVKIAD 179 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCC-ccCeeEeec
Confidence 99999965 78887743 235678888999999999999999999 9999999999999985553 469999999
Q ss_pred cCCccccCCCCCc--ccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccc-cchhhhHH
Q 047157 640 FGISKLLNKDQTR--TDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESE-EVDIVLSD 715 (788)
Q Consensus 640 fg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~ 715 (788)
||+++.+...... ....++-|..|+|||.+.+. .||++.|||+.|||+.||+|-++.|.+....-... ..+....+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999988654322 22235668999999998765 68999999999999999999998887653322211 11111112
Q ss_pred HHHHHhhc---ccccccccCCCCCc-----------cc---HH-------HHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 716 WVISCMLS---RNLQVLVSHDPEVL-----------SD---LE-------RFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 716 ~~~~~~~~---~~~~~l~~~~~~~~-----------~~---~~-------~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
.+...+-. .....+ ...|+.. .+ .. ......+|+..+|+.||.+|.|+++.++..
T Consensus 260 rIf~vLG~Pt~~~Wp~l-kk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDL-KKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhh-hhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 12221111 011111 0111110 00 00 012366788899999999999999988754
Q ss_pred hcCcCCCCCCCCCC
Q 047157 772 EGTLEVGMPPLLHD 785 (788)
Q Consensus 772 ~~~~~~~~pp~p~~ 785 (788)
- -.+.+.||.|.+
T Consensus 339 y-F~~d~lpp~pt~ 351 (438)
T KOG0666|consen 339 Y-FTEDPLPPLPTS 351 (438)
T ss_pred c-cccCCCCCCccc
Confidence 1 234556666654
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.10 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=196.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
|.+.+.||+|++|.||+|... .++..|++|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNR--TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred ceEeeeeccCCceEEEEEEEC--CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 456789999999999999886 567799999886543 22345678899999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 569 MPNGTLSNFLFHEG--QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 569 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
+++ +|.+++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++ +++.++|+|||++...
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~-----~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLIN-----KRGELKLADFGLARAF 150 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEC-----CCCcEEEeecchhhhh
Confidence 985 8888886543 4579999999999999999999998 999999999999998 7889999999999765
Q ss_pred CCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHHhh
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISCML 722 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 722 (788)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+......... ..-.+..+.
T Consensus 151 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 151 GIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred cCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 33221 1123456788999998865 356889999999999999999999997654322111100000 000000000
Q ss_pred cccccccccCCCCCcc------cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLS------DLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
....+....+.... .......+.+++.+|++.||.+||+++|+++
T Consensus 230 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 --QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred --cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111000000000 0122456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.94 Aligned_cols=268 Identities=22% Similarity=0.258 Sum_probs=200.5
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccchH--HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.+.+.||+|++|.||++... .++..+++|.+..... .....+.+|++++++++|+||+++++++..++..++|+||
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDK--LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred ccceeeecCCCceEEEEEcC--CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 45678999999999999876 5677899998865432 3456788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++ +|.+++......+++..+..++.||+.||.|||+. +|+|+||||+||+++ .++.+||+|||.+.....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~-----~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLIN-----TEGVLKLADFGLARSFGS 150 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEEC-----CCCcEEEeeeeeeEecCC
Confidence 975 88888877667889999999999999999999999 999999999999998 778999999999987654
Q ss_pred CCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH---HHHHHHhhc-
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS---DWVISCMLS- 723 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~- 723 (788)
.. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+........+. ...+.....
T Consensus 151 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 151 PV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred Cc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 43 122234577889999998776 789999999999999999999999976543221110000000 000000000
Q ss_pred --ccccccccCCCCCc--ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 724 --RNLQVLVSHDPEVL--SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 724 --~~~~~l~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.............. ........+.+++..||+.||.+||++++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000000000 012345788999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=283.14 Aligned_cols=247 Identities=26% Similarity=0.340 Sum_probs=201.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|+||.||++... .++..+++|.+.... ......+.+|++++++++||||+++++++.+....++|+|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRL--SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred ceEeeeecCCCceeEEEEEEC--CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 456788999999999999876 566789999886432 3445678899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 568 LMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 568 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+++++|.+++.+. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++ .++.+||+|||++.
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~-----~~~~~kl~d~g~~~ 151 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLV-----ANDLVKIGDLGISK 151 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEe-----cCCcEEEeeccchh
Confidence 99999999998652 35678999999999999999999999 999999999999998 67889999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||......+. . ......
T Consensus 152 ~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--------~----~~~~~~ 216 (256)
T cd08530 152 VLKKNM---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--------R----YKVQRG 216 (256)
T ss_pred hhccCC---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------H----HHHhcC
Confidence 765441 1224578899999999999999999999999999999999999975432110 0 011111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.... ........+.+++.+|++.+|++||++.|+++.
T Consensus 217 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111 112445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=291.22 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=195.7
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc---hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
.++...+.||+|+||.||+|+.. .++..+++|.+... .....+++.+|+++++.++|+|++++++++......++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDV--RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEc--CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34555678999999999999886 56678999987532 23445678899999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+||+. ++|.+++......+++.++..++.|++.||.|||+. +++||||+|+||+++ .++.+||+|||++.
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~-----~~~~~kl~dfg~~~ 163 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLS-----EPGLVKLGDFGSAS 163 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEEC-----CCCcEEECCcccce
Confidence 999996 688888766566789999999999999999999998 999999999999998 77899999999987
Q ss_pred ccCCCCCcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
..... ....++..|+|||.+. ...++.++||||||+++|||++|+.||......+. .. ..
T Consensus 164 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----------~~-~~ 226 (308)
T cd06634 164 IMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------LY-HI 226 (308)
T ss_pred eecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-----------HH-HH
Confidence 65432 2345788999999874 35678899999999999999999999864321110 00 00
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
..... +. .........+.+++.+||+.+|++||+++++++.-
T Consensus 227 ~~~~~-------~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 227 AQNES-------PA-LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred hhcCC-------CC-cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00000 00 01113345678899999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=280.45 Aligned_cols=251 Identities=28% Similarity=0.367 Sum_probs=202.4
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC--CeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lV 565 (788)
+...+.||+|++|.||+|... .++..|++|.+.... ....+.+.+|++++++++||||+++++.+.+. ...++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDK--DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred ceeeeEeeecCceEEEEEEEC--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 345688999999999999886 567789999886544 24567899999999999999999999999988 899999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+||+++++|.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++ .++.++|+|||.+..
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~-----~~~~~~l~d~~~~~~ 150 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVD-----SDGVVKLADFGCAKR 150 (260)
T ss_pred EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEc-----CCCCEEEcccccEEe
Confidence 99999999999997654 889999999999999999999998 999999999999998 778999999999987
Q ss_pred cCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
....... ......++..|+|||.+.....+.++||||||+++|+|++|+.||...... ...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~~~~~ 220 (260)
T cd06606 151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----------MAALYKIGSSG 220 (260)
T ss_pred cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----------HHHHHhccccC
Confidence 6554321 122356788999999998888999999999999999999999999764300 00000000000
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. +. ........+.+++.+|++.||++||++.|+++.
T Consensus 221 ~~-------~~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 EP-------PE--IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CC-------cC--CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00 01 111225678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=290.31 Aligned_cols=265 Identities=23% Similarity=0.255 Sum_probs=196.5
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCC----
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED---- 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 560 (788)
...|.+.+.||+|+||.||+|..+ .++..|++|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDK--DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEEC--CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 445667789999999999999986 556789999986432 223456788999999999999999999987654
Q ss_pred ------eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCc
Q 047157 561 ------KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM 634 (788)
Q Consensus 561 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~ 634 (788)
..++|+||+++ +|..++......+++..+..++.||+.||+|||+. +|+|+||||+||+++ +++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~-----~~~~ 154 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLN-----NKGQ 154 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC-----CCCc
Confidence 78999999976 77777766556789999999999999999999999 999999999999998 7889
Q ss_pred EEEeecCCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh
Q 047157 635 AKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL 713 (788)
Q Consensus 635 ~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 713 (788)
+||+|||.+...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~----- 229 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL----- 229 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----
Confidence 9999999998765433222223345778999998864 4578999999999999999999999975422111000
Q ss_pred HHHHHHHhhc---ccccccc--------cCCCCCc-----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 714 SDWVISCMLS---RNLQVLV--------SHDPEVL-----SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 714 ~~~~~~~~~~---~~~~~l~--------~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
....... .....+. +...... ........+.+++..||+.||++||+++++++.
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 230 ---ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ---HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 0000000 0000000 000124578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=282.94 Aligned_cols=249 Identities=28% Similarity=0.404 Sum_probs=202.9
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|+||.||++... .++..+++|.+.... ....+.+.+|++++++++|||++++++.+...+..++|+|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRK--SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEc--CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 456688999999999999986 566789999987543 3556788999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 568 LMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 568 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
++++++|.+++... ...+++..+..++.+++.||.|||+. +++|+||+|+||+++ .++.++|+|||.+.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~-----~~~~~~l~d~~~~~ 151 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLT-----SNGLVKLGDFGISK 151 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEc-----CCCcEEECCcccee
Confidence 99999999999765 37789999999999999999999999 999999999999998 77899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
....... ......+++.|+|||.+.+..++.++||||+|+++++|++|+.||....... .. ......
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----------~~-~~~~~~ 218 (258)
T cd08215 152 VLSSTVD-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----------LA-LKILKG 218 (258)
T ss_pred ecccCcc-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-----------HH-HHHhcC
Confidence 7654431 2223467889999999988899999999999999999999999986543111 01 111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
....+ + ......+.+++.+||+.+|++|||++|+++.
T Consensus 219 ~~~~~----~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 219 QYPPI----P-----SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCC----C-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111 1 1234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=283.31 Aligned_cols=245 Identities=23% Similarity=0.226 Sum_probs=188.9
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHh-cCCCccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKII-GRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
+.||+|+||.||+|... ..+..||+|.+.... ......+..|..++ ...+||||+++++++..++..++|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKR--STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEec--CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 56899999999999886 566789999986532 22233445555544 4558999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||+|+||+++ .++.+||+|||++.....
T Consensus 80 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~-----~~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 80 NGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLID-----QTGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEC-----CCCcEEEeecccceeccc-
Confidence 999999998654 4678899999999999999999998 999999999999998 778999999999875432
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.....++..|+|||.+.+..++.++||||||+++|||++|..||........ ..........
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------------~~~~~~~~~~-- 211 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------------FDNILSRRIN-- 211 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------------HHHHHhcccC--
Confidence 2234578899999999888899999999999999999999999965422110 0111111100
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
............+.+++.+||+.||++||++.++.+.|.
T Consensus 212 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 212 ----WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ----CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 000001123467889999999999999998876655553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=289.48 Aligned_cols=251 Identities=26% Similarity=0.353 Sum_probs=191.1
Q ss_pred ccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEecC
Q 047157 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 492 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
+.++||+|+||.||++... .++..+|+|.+.... ......+.+|+.++.++. ||||+++++++..+...+++|||+
T Consensus 8 ~~~~lg~G~~g~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHK--PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred HHHHhCCCCceEEEEEEEC--CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 4578999999999999886 567799999886432 344567889999999996 999999999999999999999998
Q ss_pred CCCCHhHhh---hc-cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 570 PNGTLSNFL---FH-EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 570 ~~gsL~~~l---~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+ ++|.++. .. ....+++..+..++.|++.||+|||+. .+|+||||||+||+++ .++.+||+|||++..
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~-----~~~~~kl~dfg~~~~ 157 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLD-----RNGNIKLCDFGISGQ 157 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEc-----cCCcEEEeecchhHH
Confidence 6 4555443 22 235689999999999999999999963 2899999999999998 778899999999876
Q ss_pred cCCCCCcccccccCCccccCcccccCC---CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNV---PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
...... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...... ...
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~-~~~ 224 (288)
T cd06616 158 LVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------VFDQLT-QVV 224 (288)
T ss_pred hccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------HHHHHh-hhc
Confidence 543221 1233578899999998765 689999999999999999999999964320 000000 000
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
......+ ...........+.+++.+||+.||++|||+++|++.
T Consensus 225 ~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 KGDPPIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCCCcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 001112345678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=293.90 Aligned_cols=266 Identities=18% Similarity=0.205 Sum_probs=191.6
Q ss_pred cccccc--ccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 494 KLVGTG--SSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G--~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
+.||+| +|++||++.+. ..+..||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT--PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEc--CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 456666 89999999876 56779999988642 2344578899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 570 PNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 570 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
.+++|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.++++||+.+.....
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~-----~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILIS-----GDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEe-----CCCcEEEechHHHhhhhc
Confidence 999999998654 34578899999999999999999998 999999999999998 778999999986543322
Q ss_pred CCCcc------cccccCCccccCcccccCC--CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh---------
Q 047157 649 DQTRT------DTNMRGTMGYVAPEWLRNV--PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI--------- 711 (788)
Q Consensus 649 ~~~~~------~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~--------- 711 (788)
..... .....++..|+|||++.+. .++.++||||||+++|||++|+.||..............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI 233 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence 11110 0112345679999998763 478999999999999999999999975432111000000
Q ss_pred hhHHHHHHH-------hh----cccc-----cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 712 VLSDWVISC-------ML----SRNL-----QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 712 ~~~~~~~~~-------~~----~~~~-----~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
......... .. +... ...................+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000000 00 0000 0000001111112345677899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=280.62 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=200.4
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchH--HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|++|.||++... ..+..+++|.+..... ...+.+.+|++++.+++|||++++++++.+.+..++|+|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNL--ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEc--CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 456789999999999999876 5667899999876543 456789999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++ .++.++|+|||.+....
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~-----~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTT-----KDGVVKLADFGVATKLN 150 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEC-----CCCCEEEeccccceecC
Confidence 99999999998655 5789999999999999999999998 999999999999998 67899999999998765
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
..... .....++..|+|||...+..++.++||||+|+++|+|++|+.||........ . + . ......
T Consensus 151 ~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-------~--~--~-~~~~~~- 216 (254)
T cd06627 151 DVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-------L--F--R-IVQDDH- 216 (254)
T ss_pred CCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-------H--H--H-HhccCC-
Confidence 43321 2234678899999999888889999999999999999999999864321100 0 0 0 000000
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
+. ......+.+.+++.+||+.+|++|||+.+++.
T Consensus 217 ------~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 ------PP--LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ------CC--CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00 01122456788999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=286.91 Aligned_cols=258 Identities=24% Similarity=0.258 Sum_probs=198.8
Q ss_pred hcccccccccccceEEEEEEecc-Ccceeeeeeecccch----HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 563 (788)
|.+.+.||+|++|.||++..... ..+..++||.+.+.. ....+.+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 45678999999999999986532 355689999886432 23345788999999999 6999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++++|.+++... ..+++..+..++.|++++|.|||+. +++|+||+|+||+++ .++.++|+|||++
T Consensus 82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~-----~~~~~~l~dfg~~ 152 (288)
T cd05583 82 LILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLD-----SEGHVVLTDFGLS 152 (288)
T ss_pred EEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEEC-----CCCCEEEEECccc
Confidence 999999999999998654 4678889999999999999999998 999999999999998 7788999999998
Q ss_pred cccCCCCCcccccccCCccccCcccccCCC--CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVP--VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
...............++..|+|||.+.+.. .+.++||||||+++|||++|..||........ ....... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~-~ 224 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-------QSEISRR-I 224 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-------HHHHHHH-H
Confidence 876544333333356788999999987655 78899999999999999999999864321110 0010000 0
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
.. ..+.. .......+.+++.+||+.||++|||+.++.+.|+-.
T Consensus 225 ~~--------~~~~~--~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 225 LK--------SKPPF--PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred Hc--------cCCCC--CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 01111 111234567889999999999999998888777543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=290.71 Aligned_cols=261 Identities=23% Similarity=0.263 Sum_probs=191.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCe-----
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDK----- 561 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~----- 561 (788)
|.+.+.||+|+||.||+|... .++..|++|.+.... ....+.+.+|+.++++++ ||||+++++++...+.
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~--~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDK--NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred ceEeeEecccCCeEEEEEEEC--CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 556789999999999999886 567799999876432 223457888999999995 6999999999877665
Q ss_pred EEEEEecCCCCCHhHhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCC-CCcEE
Q 047157 562 RLLVYELMPNGTLSNFLFHE----GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT-NYMAK 636 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~-~~~~k 636 (788)
.++||||+++ +|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+||+++ . ++.+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~-----~~~~~~k 151 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVD-----KQKGLLK 151 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEe-----cCCCeEE
Confidence 8999999985 888887543 24579999999999999999999999 999999999999998 5 78999
Q ss_pred EeecCCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH
Q 047157 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
|+|||++......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||......+....
T Consensus 152 l~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~------- 223 (295)
T cd07837 152 IADLGLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH------- 223 (295)
T ss_pred EeecccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------
Confidence 9999998765332111 122346788999998865 4578999999999999999999999975432211100
Q ss_pred HHHHHhhccc---------ccccccC---CCCCcc--cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 716 WVISCMLSRN---------LQVLVSH---DPEVLS--DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 716 ~~~~~~~~~~---------~~~l~~~---~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. ....... ....... .+.... ......++.+++.+||+.||++||+++|++.+
T Consensus 224 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 224 IF-KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HH-HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0000000 0000000 000000 01234668889999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=294.17 Aligned_cols=273 Identities=23% Similarity=0.299 Sum_probs=196.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecC-----CeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE-----DKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 562 (788)
.|.+.++||+|+||.||+|... .++..||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHK--PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEc--CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4667789999999999999886 567799999986422 33456788999999999999999999987554 357
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++|+||++ ++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 84 ~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~-----~~~~~kl~dfg~ 152 (336)
T cd07849 84 YIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLN-----TNCDLKICDFGL 152 (336)
T ss_pred EEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEC-----CCCCEEECcccc
Confidence 99999996 48887773 34688999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCc--ccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh----HH
Q 047157 643 SKLLNKDQTR--TDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL----SD 715 (788)
Q Consensus 643 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~ 715 (788)
+......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...............+ .+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 8865432211 1123467889999998754 568899999999999999999999996543211100000000 00
Q ss_pred HHHHHhhcccccccccCCCCC-cc-----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCc
Q 047157 716 WVISCMLSRNLQVLVSHDPEV-LS-----DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTL 775 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~-~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~ 775 (788)
. ............+...+.. .. ......++.+++.+||+.||++|||+.|++++ ++...
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 233 D-LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred H-HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 0000000000000000000 00 01124568899999999999999999999986 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=281.73 Aligned_cols=250 Identities=22% Similarity=0.263 Sum_probs=194.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc-----hHHHHHHHHHHHHHhcCCCccccceEeeEEecC--Ce
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-----IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DK 561 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 561 (788)
.|.+.+.||+|+||.||+|... .++..+++|.+... .....+.+.+|++++++++||||+++++++.+. ..
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDA--DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEc--CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 3567789999999999999876 56778999987421 234456889999999999999999999998664 46
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++|+||+++++|.+++... ..+++.....++.||+.||.|||+. +++|+||||+||+++ .++.++|+|||
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~-----~~~~~~l~dfg 151 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRD-----SAGNVKLGDFG 151 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc-----CCCCEEECccc
Confidence 88999999999999998654 3478888999999999999999999 999999999999998 77889999999
Q ss_pred CccccCCCCC--cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHH
Q 047157 642 ISKLLNKDQT--RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 642 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
++........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------~~~ 220 (264)
T cd06653 152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-----------IFK 220 (264)
T ss_pred cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-----------HHH
Confidence 9986543211 111234578899999999988899999999999999999999999964311110 000
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... .......+....+.+.+++.+|++ +|..||++.+++.+
T Consensus 221 ~~~---------~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 221 IAT---------QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHc---------CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 000 001111122344668889999998 57999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=287.39 Aligned_cols=243 Identities=26% Similarity=0.342 Sum_probs=192.2
Q ss_pred ccccccccccceEEEEEEeccCcceeeeeeecccc---hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 492 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
..+.||+|+||+||+|... .++..|++|.+... .....+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 25 ~~~~lg~g~~g~v~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNS--HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred cceeeccCCCeEEEEEEEC--CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 3467999999999999876 56778999988643 233446788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+. ++|.+++......+++.++..++.||+.||.|||+. +++|+||+|+||+++ .++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~-----~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLT-----EPGQVKLADFGSASKSSP 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEEC-----CCCCEEEeecCCCcccCC
Confidence 95 578888866666789999999999999999999998 999999999999998 778999999998864322
Q ss_pred CCCcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.....++..|+|||.+. ...++.++||||||+++|||++|..||........ ..... ...
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-----------~~~~~-~~~ 236 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------LYHIA-QND 236 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----------HHHHH-hcC
Confidence 12346788999999974 45688999999999999999999999865421110 00000 000
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. +. .........+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~-------~~-~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 S-------PT-LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C-------CC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 0111223457789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=294.05 Aligned_cols=270 Identities=23% Similarity=0.291 Sum_probs=195.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCC-CccccceEeeEEecC--CeE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE--DKR 562 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~ 562 (788)
..|.+.+.||+|+||.||+|... .++..+++|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDR--RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEc--CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 45667789999999999999876 56678999988542 233445677899999999 999999999988653 468
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||++ ++|.+++... .+++..+..++.||+.||.|||+. +|+|+||||+||+++ .++.+||+|||+
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~-----~~~~~kl~d~g~ 153 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLN-----SDCRVKLADFGL 153 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc-----CCCcEEEeeccc
Confidence 99999997 5999888554 778889999999999999999998 999999999999998 888999999999
Q ss_pred ccccCCCCC----cccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---H
Q 047157 643 SKLLNKDQT----RTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---S 714 (788)
Q Consensus 643 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~ 714 (788)
+........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+......... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 986643322 12233567889999998754 567899999999999999999999997543322111000000 0
Q ss_pred HHHHHHhhccccccccc----CCCCC--cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 715 DWVISCMLSRNLQVLVS----HDPEV--LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~----~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.-....+.......++. ..... .........+.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000000 00000 0001134678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=290.02 Aligned_cols=262 Identities=23% Similarity=0.264 Sum_probs=192.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|++|+||+|... .++..|++|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDR--VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEec--CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 3566789999999999999876 567789999886432 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||++ ++|.+++.... ...++..+..++.||+.||+|||++ +++|+||+|+||+++. .+..+||+|||++..
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~----~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDR----RTNALKLADFGLARA 152 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEEC----CCCEEEEcccccccc
Confidence 9996 57887775433 3357888889999999999999999 9999999999999972 345799999999976
Q ss_pred cCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.... ........
T Consensus 153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~--------~~~~~~~~ 223 (294)
T PLN00009 153 FGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK--------IFRILGTP 223 (294)
T ss_pred cCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHHHhCCC
Confidence 543211 1123456789999998865 4578999999999999999999999975432111000 00000000
Q ss_pred ---------cccccccCCCCCc------ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 725 ---------NLQVLVSHDPEVL------SDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 725 ---------~~~~l~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.+.......+... ......+++.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000000000 01122456788999999999999999999986
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=285.79 Aligned_cols=260 Identities=23% Similarity=0.270 Sum_probs=192.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCC---CccccceEeeEEecCCe---
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRT---HHKNLVRLLGFCSEEDK--- 561 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~--- 561 (788)
|.+.+.||+|+||.||+|..+ .++..+++|.+.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL--NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEEC--CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 345688999999999999986 457799999986332 22334566787776555 69999999999988776
Q ss_pred --EEEEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 562 --RLLVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 562 --~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
.+++|||++ ++|.+++.... ..+++..+..++.|+++||.|||+. +++|+||+|+||+++ .++.+||+
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~-----~~~~~~l~ 149 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVT-----SDGQVKIA 149 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEc-----cCCCEEEe
Confidence 999999997 48988886543 3689999999999999999999998 999999999999998 77899999
Q ss_pred ecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
|||.+......... ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+... ....
T Consensus 150 dfg~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~-------~~~~ 220 (287)
T cd07838 150 DFGLARIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD-------KIFD 220 (287)
T ss_pred ccCcceeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH-------HHHH
Confidence 99999876443221 22346888999999999899999999999999999999999987543221110 0000
Q ss_pred HHhhcccc---------cccccCCCCCc---ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 719 SCMLSRNL---------QVLVSHDPEVL---SDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 719 ~~~~~~~~---------~~l~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
........ ........... ........+.+++.+||+.||++||+++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 00000000000 01133467788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=285.31 Aligned_cols=268 Identities=23% Similarity=0.303 Sum_probs=196.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchH-HHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+.+.||+|++|+||+|+.. .++..|+||++..... .......+|+..+++++ ||||+++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK--ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEEC--CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 346788999999999999986 5667899999865432 22334567999999998 9999999999999999999999
Q ss_pred cCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+ +++|.+++.... ..+++..+..++.|++.+|.|||++ +++|+||+|+||+++ .++.++|+|||.+...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~-----~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVS-----GPEVVKIADFGLAREI 149 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEc-----CCCCEEEeecccceec
Confidence 99 889999886653 5779999999999999999999998 999999999999998 7889999999999865
Q ss_pred CCCCCcccccccCCccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh-----hhHHHHHHH
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLR-NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI-----VLSDWVISC 720 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~-----~~~~~~~~~ 720 (788)
..... .....++..|+|||.+. ...++.++||||||++++||++|+.||......+....... ....|....
T Consensus 150 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07830 150 RSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227 (283)
T ss_pred cCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence 43222 12245788999999874 45678999999999999999999999975533221110000 000011010
Q ss_pred hhcccccccccCCCCC-ccc--HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEV-LSD--LERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~-~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.........+...... ... ......+.+++.+||+.||++|||++|++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0111111110000000 000 0113678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=287.64 Aligned_cols=265 Identities=18% Similarity=0.194 Sum_probs=184.6
Q ss_pred HHHHHhhcccccccccccceEEEEEEeccCc-ceeeeeeecccchHHH-----------HHHHHHHHHHhcCCCccccce
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDT-QIEIAVKKLEKDIEKT-----------NEEFMTELKIIGRTHHKNLVR 551 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~ 551 (788)
++....|.+.++||+|+||+||+|....... ...+++|......... ......+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3444567788999999999999998763211 3455666432211110 112234445566789999999
Q ss_pred EeeEEecCC----eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccC
Q 047157 552 LLGFCSEED----KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK 627 (788)
Q Consensus 552 ~~~~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 627 (788)
+++.+.... ..++++|++. .++.+.+... ...++..+..++.|++.||.|||++ +|+||||||+|||++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~-- 160 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD-- 160 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc--
Confidence 998765443 4467888764 4666665432 3456788899999999999999998 999999999999998
Q ss_pred CCCCCCcEEEeecCCccccCCCCC------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccc
Q 047157 628 TLDTNYMAKISDFGISKLLNKDQT------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSR 701 (788)
Q Consensus 628 ~~~~~~~~kL~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~ 701 (788)
.++.++|+|||+++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 161 ---~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 161 ---GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred ---CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 778899999999986643211 11123468999999999999999999999999999999999999997652
Q ss_pred cccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 702 VEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
..... ......++. .....+.. .. ....+.+.+++..|++.+|++||++.++++.|+
T Consensus 238 ~~~~~--~~~~~~~~~-~~~~~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 238 HNGNL--IHAAKCDFI-KRLHEGKI--------KI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred cchHH--HHHhHHHHH-HHhhhhhh--------cc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 21110 000001111 11111110 00 012466888999999999999999999998874
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=288.19 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=193.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.+.+.+.||+|++|.||+|... .++..||||.+.... .....++..|+.++.+. .||||+++++++.+....++||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFK--KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred hheeeeEeeccCCeEEEEEEEC--CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3556789999999999999886 557799999986532 33445677788777666 4999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||++ ++|.+++......+++..+..++.||+.||+|||+. .+|+||||+|+||+++ .++.+||+|||++..+
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~-----~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLD-----ASGNVKLCDFGISGRL 165 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEc-----CCCCEEECccccchhc
Confidence 9985 578887766556789999999999999999999973 2899999999999998 7889999999998765
Q ss_pred CCCCCcccccccCCccccCcccccCCC----CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVP----VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
...... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... +.... ..
T Consensus 166 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------~~~~~-~~ 232 (296)
T cd06618 166 VDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----------EVLTK-IL 232 (296)
T ss_pred cCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH----------HHHHH-Hh
Confidence 432222 2235678999999987553 7889999999999999999999996431110 00000 11
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
..... .........+++.+++.+||+.||++||++++++++-
T Consensus 233 ~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 233 QEEPP-------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred cCCCC-------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 11100 0001112345688899999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=295.43 Aligned_cols=274 Identities=22% Similarity=0.264 Sum_probs=197.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecC-----Ce
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE-----DK 561 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 561 (788)
.|.+.+.||+|+||+||++... .++..|+||.+... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNS--ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEec--CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3556789999999999999876 67779999988643 233345677899999999999999999988654 35
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++|+||+. ++|.+++... ..+++..+..++.||+.||.|||++ +++|+||||+||+++ .++.+||+|||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~-----~~~~~kL~Dfg 153 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLN-----ANCDLKICDFG 153 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc-----CCCCEEECcCc
Confidence 799999995 6898888544 5689999999999999999999999 999999999999998 77899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHH
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWV 717 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~ 717 (788)
++....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||................ ..-.
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 154 LARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred cccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 998764332 12223457889999998764 468899999999999999999999997543211000000000 0000
Q ss_pred HHHhhcccccccccC---CCCCc---ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCc
Q 047157 718 ISCMLSRNLQVLVSH---DPEVL---SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTL 775 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~---~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~ 775 (788)
............+.. .+... ........+.+++.+||+.||++|||++|+++. ++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000000000000 00000 011234668899999999999999999999987 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=294.69 Aligned_cols=274 Identities=22% Similarity=0.265 Sum_probs=203.1
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCC-----eE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED-----KR 562 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~ 562 (788)
|.+.+.||+|++|.||+|... ..+..+++|.+.... ....+.+.+|+++++.++||||+++++++...+ ..
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDK--RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeC--CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 566789999999999999876 557789999887543 445568899999999999999999999988775 78
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||++ ++|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++ .++.++|+|||+
T Consensus 80 ~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~-----~~~~~~L~dfg~ 149 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVN-----SNCDLKICDFGL 149 (330)
T ss_pred EEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc-----CCCCEEEcccCc
Confidence 99999997 5898888554 4789999999999999999999999 999999999999998 778999999999
Q ss_pred ccccCCCCC--cccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH---
Q 047157 643 SKLLNKDQT--RTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW--- 716 (788)
Q Consensus 643 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--- 716 (788)
+........ .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+............
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229 (330)
T ss_pred eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence 987654431 122334578899999999887 88999999999999999999999997654322111000000000
Q ss_pred HHHHhhcccccccccCCCCC-cc-----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCc
Q 047157 717 VISCMLSRNLQVLVSHDPEV-LS-----DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTL 775 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~-~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~ 775 (788)
.+...........+...... .. .......+.+++.+||+.+|++|||+++++++ +++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000000000000000 00 01134567899999999999999999999985 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=294.58 Aligned_cols=271 Identities=22% Similarity=0.287 Sum_probs=196.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEec----CCe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE----EDK 561 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 561 (788)
..|.+.+.||+|++|.||+|... .++..|++|++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT--RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc--CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 34566789999999999999876 567799999986542 2345677889999999999999999998753 356
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++|+||+. ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~-----~~~~~kl~dfg 152 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVN-----EDCELRIGDFG 152 (334)
T ss_pred EEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc-----CCCcEEecccc
Confidence 899999995 6898888544 4589999999999999999999998 999999999999998 78899999999
Q ss_pred CccccCCCCCc---ccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---H
Q 047157 642 ISKLLNKDQTR---TDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---S 714 (788)
Q Consensus 642 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~ 714 (788)
++......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............+ .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 99765432221 1123467889999998865 468899999999999999999999996543221100000000 0
Q ss_pred HHHHHHhhcccccccccCCC-CCcc-----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 715 DWVISCMLSRNLQVLVSHDP-EVLS-----DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~-~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...........+.......+ .... .....+.+.+++.+||+.||++|||+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000111110000 0000 01235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=266.42 Aligned_cols=251 Identities=24% Similarity=0.263 Sum_probs=197.1
Q ss_pred hccc-ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEec----CCeEE
Q 047157 490 KGFS-KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSE----EDKRL 563 (788)
Q Consensus 490 ~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~~~~~ 563 (788)
|.++ ++||-|-.|.|..+.++ .+++..|+|.+.... ..++|+++.-+. .|||||.++++++. ...+.
T Consensus 63 Y~is~qvLG~GinGkV~~C~~k--~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 63 YSISWQVLGAGINGKVVQCVHK--RTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred heehhhhhccccCCceEEEEec--cchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 4444 78999999999999887 788899999997542 334777765555 69999999998754 45778
Q ss_pred EEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 564 LVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
+|||.|+||.|...+.+++ ..+++.++..|++||+.|+.|||+. +|.||||||+|+|..... .+-.+||+|||+
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~--~na~lKLtDfGF 210 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTS--PNAPLKLTDFGF 210 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCC--CCcceEeccccc
Confidence 9999999999999997764 4579999999999999999999999 999999999999998655 778899999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
|+.-... ......+-|+.|.|||++...+|+...|+||+||++|-|++|-+||........... ....+.
T Consensus 211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg--------Mk~rI~ 280 (400)
T KOG0604|consen 211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--------MKRRIR 280 (400)
T ss_pred ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh--------HHhHhh
Confidence 9975432 233456789999999999999999999999999999999999999975422111110 111111
Q ss_pred cccccccccCCCCCccc--HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSD--LERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+ .-+...+ ....+...++|+.+|..+|.+|.|++|+++.
T Consensus 281 ~g--------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 281 TG--------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cc--------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11 1111111 1345677789999999999999999999864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=285.95 Aligned_cols=261 Identities=17% Similarity=0.163 Sum_probs=186.9
Q ss_pred ccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCCHhHh
Q 047157 500 SSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNF 577 (788)
Q Consensus 500 ~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~ 577 (788)
+++.||.+... .++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.++
T Consensus 12 ~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHK--PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEec--CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence 33445555444 46779999998654 345567899999999999999999999999999999999999999999999
Q ss_pred hhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC-----
Q 047157 578 LFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT----- 651 (788)
Q Consensus 578 l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~----- 651 (788)
+... ...+++..+..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||.+........
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~-----~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLS-----GDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEe-----cCCceEEecCccceeecccccccccc
Confidence 9754 34678889999999999999999999 999999999999998 778999999998875532211
Q ss_pred -cccccccCCccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccc-hhhhHHHHH---HHhhcc
Q 047157 652 -RTDTNMRGTMGYVAPEWLRN--VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEV-DIVLSDWVI---SCMLSR 724 (788)
Q Consensus 652 -~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~ 724 (788)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||............ ......+.. ......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 11122456778999999865 35889999999999999999999999754221100000 000000000 000000
Q ss_pred cccc----c----ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQV----L----VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~----l----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.... . ...............++.+++.+||+.||++|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 0 00001111122334678899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=322.17 Aligned_cols=247 Identities=29% Similarity=0.427 Sum_probs=196.4
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
..||.|.||.||.|... +++...|+|.+.... ....+.+.+|+.++..|+|||+|+++|+-.+++..+|.||||++
T Consensus 1241 ~~Ig~G~fG~VYtavN~--~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNL--DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred cccCCcceeeeEEeecC--CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhcc
Confidence 57999999999999887 788899999875432 34456788999999999999999999999999999999999999
Q ss_pred CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC
Q 047157 572 GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651 (788)
Q Consensus 572 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~ 651 (788)
|+|.+++.+. +..++.....+..|++.|++|||++ +||||||||.||+++ .++.+|++|||.|..+.....
T Consensus 1319 GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld-----~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1319 GSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLD-----FNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred CcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeee-----cCCcEEeecccceeEecCchh
Confidence 9999999543 4455555666889999999999999 999999999999999 788999999999998865531
Q ss_pred ---cccccccCCccccCcccccCC---CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 652 ---RTDTNMRGTMGYVAPEWLRNV---PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 652 ---~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.......||+.|||||++.+. ...-++||||+||++.||+||++||...+.+ |+.-..
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------------~aIMy~---- 1453 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------------WAIMYH---- 1453 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------------hHHHhH----
Confidence 122346799999999999654 3456899999999999999999999754211 111110
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
.-..+.|+... ....+-.+++..||+.||+.|.++.|++++=
T Consensus 1454 --V~~gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1454 --VAAGHKPQIPE--RLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred --HhccCCCCCch--hhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 01111222222 2445567889999999999999999888754
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=291.29 Aligned_cols=269 Identities=21% Similarity=0.291 Sum_probs=193.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC------Ce
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------DK 561 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~ 561 (788)
|...+.||+|+||.||+|... .++..||+|++.... ......+.+|++++++++||||+++++++... ..
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDK--RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeC--CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 445689999999999999876 567799999886432 23345688999999999999999999998654 34
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++|+||+.. +|..++ +..+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||
T Consensus 95 ~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~-----~~~~~kL~dfg 162 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVN-----EDCELKILDFG 162 (342)
T ss_pred EEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC-----CCCCEEEeeCC
Confidence 6999999964 776655 24578899999999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh----hhHHH
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI----VLSDW 716 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~ 716 (788)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ....
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 237 (342)
T cd07879 163 LARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE- 237 (342)
T ss_pred CCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH-
Confidence 98764322 123456888999999866 4688999999999999999999999975432111000000 0000
Q ss_pred HHHHhhcccccccccCCCCCcc-c-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCcCC
Q 047157 717 VISCMLSRNLQVLVSHDPEVLS-D-----LERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTLEV 777 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~-~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~ 777 (788)
.................+.... . ......+.+++.+||+.||++||+++|++.+ +++..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000000000000000000000 0 0123567899999999999999999999954 6665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=285.24 Aligned_cols=267 Identities=24% Similarity=0.271 Sum_probs=198.7
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.+.+.||+|++|.||+|+.. .++..+++|.+.... ....+.+..|++++++++|+||+++++++.+.+..++|+||
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDK--KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred eeehcccccCcceEEEeeec--CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 34578999999999999886 567799999987643 33456788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
++ ++|.+++......+++..+..++.|++.||.|||++ +|+|+||+|+||+++ .++.+||+|||.+.....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~-----~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILIN-----RDGVLKLADFGLARAFGI 150 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEc-----CCCCEEEecCCcccccCC
Confidence 97 599999976656789999999999999999999999 999999999999998 788999999999987644
Q ss_pred CCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHHhhcc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISCMLSR 724 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 724 (788)
... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+......... ....+......
T Consensus 151 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 151 PLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred Ccc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 322 12223456789999998766 88999999999999999999999997653221111000000 00000000000
Q ss_pred c-ccccccCCCCCc---ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 725 N-LQVLVSHDPEVL---SDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 725 ~-~~~l~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. ............ ........+.+++.+||+.||++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 000000000000 00112457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=281.58 Aligned_cols=243 Identities=24% Similarity=0.285 Sum_probs=186.3
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHH---HHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTEL---KIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~---~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.||+|+||.||++... .+++.||+|.+.... ......+..|. +.++..+||+|+++++++.+.+..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEe--cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 4899999999999876 567799999886532 11122333443 344456899999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++ .++.+||+|||++.....
T Consensus 79 ~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~-----~~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 79 MNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLD-----EHGHVRISDLGLACDFSK 149 (278)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEEC-----CCCCEEEccCcCccccCc
Confidence 9999999988543 5689999999999999999999998 999999999999998 778999999999876533
Q ss_pred CCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
... ....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||.......... .......
T Consensus 150 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---------~~~~~~~---- 213 (278)
T cd05606 150 KKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---------IDRMTLT---- 213 (278)
T ss_pred cCC---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---------HHHHhhc----
Confidence 221 234688999999998754 68999999999999999999999997542211100 0000000
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
..+... ......+.+++.+|++.+|++|| ++.+++++
T Consensus 214 ----~~~~~~--~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 214 ----MAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ----cCCCCC--CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 011111 11246788899999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=308.83 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=184.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecC-------------
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------------- 559 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------------- 559 (788)
++||+||||.||+++.+ -+++.+|||++... .......+.+|+.++++|+|||||+++....+.
T Consensus 485 ~lLGkGGFG~VvkVRNK--lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~ 562 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNK--LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASD 562 (1351)
T ss_pred HHhcCCCCceEEEEeec--ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccc
Confidence 68999999999999887 67789999999754 344556789999999999999999987642000
Q ss_pred --------------------------------------------------------------------------------
Q 047157 560 -------------------------------------------------------------------------------- 559 (788)
Q Consensus 560 -------------------------------------------------------------------------------- 559 (788)
T Consensus 563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~ 642 (1351)
T KOG1035|consen 563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL 642 (1351)
T ss_pred hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence
Q ss_pred --------------------------CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceE
Q 047157 560 --------------------------DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613 (788)
Q Consensus 560 --------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 613 (788)
..+||-||||+..+|.+++..+...-.....++++++|++||+|+|++ +||
T Consensus 643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giI 719 (1351)
T KOG1035|consen 643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GII 719 (1351)
T ss_pred CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---cee
Confidence 125789999999888888865533225677899999999999999999 999
Q ss_pred ecCCCCCcEEeccCCCCCCCcEEEeecCCccccC-----------------CCCCcccccccCCccccCcccccCC---C
Q 047157 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN-----------------KDQTRTDTNMRGTMGYVAPEWLRNV---P 673 (788)
Q Consensus 614 H~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~ 673 (788)
||||||.||+++ ++..|||+|||+|.... .......+...||.-|+|||++.+. +
T Consensus 720 HRDLKP~NIFLd-----~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 720 HRDLKPRNIFLD-----SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred eccCCcceeEEc-----CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 999999999999 88899999999998721 0111134557899999999999655 4
Q ss_pred CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHc
Q 047157 674 VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWC 753 (788)
Q Consensus 674 ~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~c 753 (788)
|+.|+|+|||||||+||+. ||...- ++. .+...++.+.+... .. ...+....=.+++.+|
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsM-----ERa------~iL~~LR~g~iP~~-----~~-f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSM-----ERA------SILTNLRKGSIPEP-----AD-FFDPEHPEEASLIRWL 854 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchH-----HHH------HHHHhcccCCCCCC-----cc-cccccchHHHHHHHHH
Confidence 9999999999999999985 454321 100 01111222222211 00 1122233445789999
Q ss_pred cCCCCCCCCCHHHHHH
Q 047157 754 NHPDPNLRPSMKKVIH 769 (788)
Q Consensus 754 l~~dP~~RPt~~evl~ 769 (788)
++.||.+||||.|++.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=282.20 Aligned_cols=248 Identities=28% Similarity=0.341 Sum_probs=201.8
Q ss_pred ccccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 492 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.-++||+|+||.||-++.+ .+++.+|.|++.+... +.....++|-.+|.+++.+.||.+--.|+..+.+++|+..
T Consensus 189 ~~RvlGkGGFGEV~acqvr--aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl 266 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVR--ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL 266 (591)
T ss_pred eeEEEecccccceeEEEEe--cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence 3479999999999999887 8888999999976542 3345678999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 569 MPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 569 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|.||+|.-+|.+.+ ..+++....-++.+|+-||.+||.. .||.|||||+|||+| +.++++|+|+|+|..+.
T Consensus 267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLD-----d~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLD-----DHGHVRISDLGLAVEIP 338 (591)
T ss_pred ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeec-----cCCCeEeeccceEEecC
Confidence 99999999997764 4678888999999999999999999 999999999999999 99999999999999876
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
...... ..+||.+|||||++.+..|+...|.||+||+||||+.|+.||.........++.+
T Consensus 339 ~g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd----------------- 399 (591)
T KOG0986|consen 339 EGKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD----------------- 399 (591)
T ss_pred CCCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH-----------------
Confidence 554432 3489999999999999999999999999999999999999998653322211111
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIH 769 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 769 (788)
..+..++. ..+....+++..+....|+.||++|. .+.+|.+
T Consensus 400 rr~~~~~~-ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 400 RRTLEDPE-EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred HHHhcchh-hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 11111111 11234456667777788999999996 4456654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=296.55 Aligned_cols=201 Identities=28% Similarity=0.436 Sum_probs=173.4
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCC------eEEEE
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED------KRLLV 565 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~lV 565 (788)
.+.||+|+||.||+|+++ .++..||||.+.... ....+...+|+++|++++|||||+++++-++.. ...+|
T Consensus 18 ~e~LG~Ga~g~V~rgrnk--etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNK--ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred hhhhcCCccceeeeeccc--ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 578999999999999887 788999999987643 334567889999999999999999999865543 56899
Q ss_pred EecCCCCCHhHhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 566 YELMPNGTLSNFLFHE--GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
||||.+|+|+..|.+. ...+++.+.+.++.++..||.|||++ +|+||||||.||++-... +.....||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Ge-dgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGE-DGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecC-CCceEEeeeccccc
Confidence 9999999999999754 34689999999999999999999999 999999999999995332 13456899999999
Q ss_pred cccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSR 701 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~ 701 (788)
+.+..+. ......||..|.+||.+.. +.|+..+|.|||||++|+.+||..||....
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9886655 5566899999999999984 889999999999999999999999997653
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=282.95 Aligned_cols=254 Identities=25% Similarity=0.284 Sum_probs=195.4
Q ss_pred hcccccccccccceEEEEEEec-cCcceeeeeeecccch----HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 563 (788)
|.+.+.||+|+||.||++.... ..++..||+|.+.... ....+.+.+|++++.++ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 4567899999999999998742 1356789999986532 22346788999999999 5999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+|+||+++++|.+++... ..+++..+..++.||+.||.|||+. +++||||+|+|||++ .++.+||+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~-----~~~~~kl~dfg~~ 152 (290)
T cd05613 82 LILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLD-----SNGHVVLTDFGLS 152 (290)
T ss_pred EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEC-----CCCCEEEeeCccc
Confidence 999999999999999654 4578888899999999999999998 999999999999998 7789999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCC--CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNV--PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
...............++..|+|||.+... .++.++||||||+++|+|++|+.||........ .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~~~~~~~~ 225 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-------QAEISRRIL 225 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-------HHHHHHHhh
Confidence 87644333333345688899999998653 467899999999999999999999864321110 011111110
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
. ..+.. .......+.+++.+||+.||++|| ++++++.+
T Consensus 226 ~---------~~~~~--~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 226 K---------SEPPY--PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred c---------cCCCC--CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 00000 111345677899999999999997 77777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=278.37 Aligned_cols=240 Identities=20% Similarity=0.233 Sum_probs=183.7
Q ss_pred ccccc--ccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEe
Q 047157 491 GFSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 491 ~~~~~--lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.+.+. ||+|+||.||++..+ .++..+++|.+........ |+.....+ +||||+++++.+...+..++|||
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~--~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHK--PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred ccccceeecCCCceEEEEEEEc--CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 34444 599999999999876 5677899998864321111 22222212 79999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCC-cEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNY-MAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~-~~kL~Dfg~a~~~ 646 (788)
|+++++|.+++... ..+++.++..++.||++||.|||+. +++||||||+||+++ .++ .++|+|||++...
T Consensus 90 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~-----~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 90 YIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYD-----RAKDRIYLCDYGLCKII 160 (267)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEe-----CCCCeEEEecCccceec
Confidence 99999999999655 3789999999999999999999999 999999999999998 555 8999999998765
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
.... ...++..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+.... .
T Consensus 161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~--~--- 224 (267)
T PHA03390 161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE------LDLESLLKRQ--Q--- 224 (267)
T ss_pred CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch------hhHHHHHHhh--c---
Confidence 4322 2357889999999999899999999999999999999999997432211 1111111100 0
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-HHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-MKKVIH 769 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 769 (788)
.... ........+.+++.+||+.||.+||+ ++|+++
T Consensus 225 -----~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 -----KKLP--FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----ccCC--cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 01134567888999999999999996 588874
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=284.93 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=199.4
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV 565 (788)
|.+.+.||+|+||.||++... .++..+++|.+.... ....+.+.+|++++++++ ||||+++++++.+.+..++|
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEK--ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred ceEeeeecCCCceEEEEEEEc--CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 566789999999999999886 567789999886532 334567889999999998 99999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||++++++|.+++.+. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++ .++.++|+|||++..
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~-----~~~~~~l~df~~~~~ 151 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLD-----KDMHIKITDFGTAKV 151 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEEC-----CCCCEEecCCccccc
Confidence 9999999999999655 4689999999999999999999998 999999999999998 788999999999987
Q ss_pred cCCCCC-------------------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccc
Q 047157 646 LNKDQT-------------------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES 706 (788)
Q Consensus 646 ~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~ 706 (788)
...... .......++..|+|||.+....++.++||||||++++++++|+.||.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-- 229 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-- 229 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--
Confidence 644322 12223457889999999988889999999999999999999999997553111
Q ss_pred ccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH----HHHHH
Q 047157 707 EEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM----KKVIH 769 (788)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~evl~ 769 (788)
.. ...... .........+.+.+++.+||+.+|++||++ +++++
T Consensus 230 -----~~-----~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 -----TF-----QKILKL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -----HH-----HHHHhc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 000000 000111225678899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=289.27 Aligned_cols=269 Identities=23% Similarity=0.237 Sum_probs=192.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchH--HHHHHHHHHHHHhcCCCccccceEeeEEecCC-----
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--KTNEEFMTELKIIGRTHHKNLVRLLGFCSEED----- 560 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 560 (788)
..|.+.+.||+|+||.||+|... .++..+++|.+..... .....+.+|++++++++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQI--KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEEC--CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 34667789999999999999876 5667899998864322 22346678999999999999999999875433
Q ss_pred ---eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 561 ---KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 561 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
..++|+||+.+ +|...+......+++..+..++.||++||.|||++ +|+|+||||+||+++ .++.+||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~-----~~~~~~l 156 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILID-----NQGILKI 156 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC-----CCCCEEE
Confidence 46999999864 77777766666789999999999999999999999 999999999999998 7889999
Q ss_pred eecCCccccCCCCCc----------ccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCcccccccc
Q 047157 638 SDFGISKLLNKDQTR----------TDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES 706 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~ 706 (788)
+|||++......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999865432211 1122356788999998765 45889999999999999999999999754332111
Q ss_pred ccchhh---hHHHHHHHhhccccccccc--CCCCCccc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 707 EEVDIV---LSDWVISCMLSRNLQVLVS--HDPEVLSD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 707 ~~~~~~---~~~~~~~~~~~~~~~~l~~--~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...... .....+... ..+..... ........ ....+.+.+++.+||+.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 HLIFKLCGTPTEETWPGW--RSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHhCCCChhhchhh--hhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 100000 000000000 00000000 00000000 112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=291.22 Aligned_cols=260 Identities=23% Similarity=0.253 Sum_probs=192.7
Q ss_pred ccccccccccceEEEEEEeccCcceeeeeeecccchHHH--------------HHHHHHHHHHhcCCCccccceEeeEEe
Q 047157 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT--------------NEEFMTELKIIGRTHHKNLVRLLGFCS 557 (788)
Q Consensus 492 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~~~~~~~ 557 (788)
+.+.||+|+||+||+|... ..+..||||.+....... ...+.+|++++++++||||+++++++.
T Consensus 13 ~~~~ig~G~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 90 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDT--LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV 90 (335)
T ss_pred hhhcccCCCceeEEEEEEC--CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe
Confidence 3467999999999999876 567789999886432211 125789999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 558 EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 558 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
.++..++||||++ ++|.+++... ..+++.....++.|++.||.|||+. +|+|+||+|+||+++ .++.+||
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~-----~~~~~kl 160 (335)
T PTZ00024 91 EGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFIN-----SKGICKI 160 (335)
T ss_pred cCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEEC-----CCCCEEE
Confidence 9999999999996 6899888543 5688899999999999999999998 999999999999998 7789999
Q ss_pred eecCCccccCCCC-------------CcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccc
Q 047157 638 SDFGISKLLNKDQ-------------TRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVE 703 (788)
Q Consensus 638 ~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~ 703 (788)
+|||++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999997654111 1111223467889999998764 4689999999999999999999999755322
Q ss_pred cccccchhhhHHHHHHHhhccc---cc---------ccccCCCCCcc--cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 704 EESEEVDIVLSDWVISCMLSRN---LQ---------VLVSHDPEVLS--DLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~---~~---------~l~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
+... .+........ .. ......+.... .......+.+++..||+.+|++|||++|++.
T Consensus 241 ~~~~--------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLG--------RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHH--------HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1110 0100000000 00 00000000000 0112456889999999999999999999997
Q ss_pred Hh
Q 047157 770 ML 771 (788)
Q Consensus 770 ~L 771 (788)
+-
T Consensus 313 ~~ 314 (335)
T PTZ00024 313 HE 314 (335)
T ss_pred Cc
Confidence 43
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=270.57 Aligned_cols=258 Identities=26% Similarity=0.334 Sum_probs=199.3
Q ss_pred CcccCHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEee
Q 047157 477 FREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLG 554 (788)
Q Consensus 477 ~~~~~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~ 554 (788)
...|+-++|+.. ..||.|+||+|++-.++ ..++..|||+++... ...+++++.|.+...+- +.||||+++|
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk--~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHK--PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcC--ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 455666665543 57999999999998887 788899999998655 36677889999866554 7999999999
Q ss_pred EEecCCeEEEEEecCCCCCHhHhhh----ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCC
Q 047157 555 FCSEEDKRLLVYELMPNGTLSNFLF----HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD 630 (788)
Q Consensus 555 ~~~~~~~~~lV~e~~~~gsL~~~l~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 630 (788)
.+..++..++-||.| ..||+.+-. -....+++...-.|....++||.||.+. ..|||||+||+|||++
T Consensus 131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILld----- 202 (361)
T KOG1006|consen 131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLD----- 202 (361)
T ss_pred hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEe-----
Confidence 999999999999999 457765542 1345678888888999999999999976 5899999999999999
Q ss_pred CCCcEEEeecCCccccCCCCCcccccccCCccccCccccc--CCCCCccCcchhhHHHHHHHHhCCCCCCcccccccccc
Q 047157 631 TNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR--NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEE 708 (788)
Q Consensus 631 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~ 708 (788)
..+.+||+|||++-.+.... ..+.-.|...|||||.+. +..|+-++||||||++|||+.||+.|+...+..-
T Consensus 203 r~G~vKLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf---- 276 (361)
T KOG1006|consen 203 RHGDVKLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF---- 276 (361)
T ss_pred cCCCEeeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH----
Confidence 88899999999997664322 233446888999999984 3358899999999999999999999997653210
Q ss_pred chhhhHHHHHHHhhcccccccccCCCCCccc---HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 709 VDIVLSDWVISCMLSRNLQVLVSHDPEVLSD---LERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.+ + .....++ .|....+ .+....+..++..|+-.|..+||...++++
T Consensus 277 -----eq-l-~~Vv~gd-------pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 277 -----EQ-L-CQVVIGD-------PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -----HH-H-HHHHcCC-------CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 00 0 0111121 2222222 346678889999999999999999998765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=308.06 Aligned_cols=257 Identities=24% Similarity=0.236 Sum_probs=210.9
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCe
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 561 (788)
+....+.+.++||+|+||.|..++++ .++..+|+|++.+.. ......|..|-.+|..-+.+-|++++-.|+++++
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k--~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHK--STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEee--ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 34456677899999999999999887 788899999998632 3344678899999998899999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
+|+|||||+||+|-.++.+.. ++++..+.-++..|..||.-||+. |+|||||||+||||| ..|++||+|||
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld-----~~GHikLADFG 220 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLD-----KSGHIKLADFG 220 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEec-----ccCcEeeccch
Confidence 999999999999999997776 788888888999999999999999 999999999999999 89999999999
Q ss_pred CccccCCCCCcccccccCCccccCccccc----C-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLR----N-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
.+..+..++.-.....+|||.|++||++. + +.|.+.+|.||+||++|||+.|..||...+..+....+
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI------- 293 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI------- 293 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH-------
Confidence 99999888777777789999999999984 3 57899999999999999999999999865433322111
Q ss_pred HHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC---HHHHHHHh
Q 047157 717 VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS---MKKVIHML 771 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~L 771 (788)
+.. ... ...+.+...+++..+||...+. +|+.|-. ++++..+-
T Consensus 294 ----m~h---k~~----l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 294 ----MNH---KES----LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred ----hch---hhh----cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 111 111 1112233456677777777764 7889988 88888653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=309.21 Aligned_cols=262 Identities=24% Similarity=0.390 Sum_probs=208.4
Q ss_pred HHHHhhcccccccccccceEEEEEEeccC-----cceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEe
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKD-----TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCS 557 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 557 (788)
+....-.+.+.||+|.||.|++|...... ....||||.++... ....+.+..|+++|+.+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 33344456679999999999999866322 25689999997543 34567899999999998 6999999999999
Q ss_pred cCCeEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 558 EEDKRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 558 ~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
.++..++|+||+..|+|.++|++++ ..+.....+.++.|||.|++||++. ++|||||..+||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 9999999999999999999998776 3478889999999999999999999 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCCccccccc--CCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCc
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR--GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIEL 699 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~ 699 (788)
|+. .+..+||+|||+++.............. -...|||||.+....|+.|+|||||||+||||++ |..|+..
T Consensus 450 Li~-----~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 450 LIT-----KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred Eec-----CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 998 8889999999999976554444322222 2456999999999999999999999999999997 6678765
Q ss_pred cccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
.... .+ +...+.++ -....+....+++.++++.||+.+|++||+..|+++.|+..
T Consensus 525 ~~~~----------~~-l~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 525 IPPT----------EE-LLEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCcH----------HH-HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 2100 01 11122222 12222333466788999999999999999999999999874
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=278.66 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=191.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc-----hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-----IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
|.+.+.||+|+||.||++.... ....+++|.++.. ......++..|+.++++++||||+++++++.+....++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKK--AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred ceeeeeecCCCCceEEEEEecC--CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 5667899999999999998763 2333444443321 12233467789999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 565 VYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
|+||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++ . ..+||+|||
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~-----~-~~~~l~d~g 150 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLK-----N-NLLKIGDFG 150 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEee-----c-CCEeecccC
Confidence 9999999999998854 345689999999999999999999998 999999999999996 3 469999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .. ...
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----------~~-~~~ 217 (260)
T cd08222 151 VSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-----------VV-LRI 217 (260)
T ss_pred ceeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----------HH-HHH
Confidence 9876543222 2223457889999999988889999999999999999999999986432111 00 001
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..+.. +. .+......+.+++.+||+.||++||++.|+++.
T Consensus 218 ~~~~~-------~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 218 VEGPT-------PS--LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HcCCC-------CC--CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11110 11 122345678889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=284.98 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=199.3
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
++||+|.||+||-|+++ .+++.||||.+.+.. .+....+++|+.+|++++||.||.+.-.|+..+..++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hR--ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHR--KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceec--ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 78999999999999998 788899999997643 44567899999999999999999999999999999999999966
Q ss_pred CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC
Q 047157 572 GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651 (788)
Q Consensus 572 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~ 651 (788)
.=|+-.|..+..++++..-.-++.||+.||.|||.+ +|+|+||||+|||+.... .-.++||+|||+|+++.....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~--~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASAS--PFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCC--CCCceeeccccceeecchhhh
Confidence 666666667778888888888999999999999999 999999999999997443 567899999999999875443
Q ss_pred cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccccc
Q 047157 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVS 731 (788)
Q Consensus 652 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 731 (788)
. ...+||+.|+|||+++++.|...-|+||.|||+|--+.|..||....... .. +.. .-+.
T Consensus 723 R--rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQ------------IQN----AaFM 782 (888)
T KOG4236|consen 723 R--RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQ------------IQN----AAFM 782 (888)
T ss_pred h--hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HH------------hhc----cccc
Confidence 3 34689999999999999999999999999999999999999996431110 00 000 0000
Q ss_pred CCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 732 HDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 732 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..+... .+.....+++|...||..-.+|.|...-+.
T Consensus 783 yPp~PW--~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 783 YPPNPW--SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cCCCch--hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 111111 133456778888888888888888876554
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=289.34 Aligned_cols=269 Identities=20% Similarity=0.248 Sum_probs=192.6
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecC--------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE-------- 559 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-------- 559 (788)
..|.+.+.||.|+||.||+|... .++..|++|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~--~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDS--DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEEC--CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 34667789999999999999886 66779999988765555667888999999999999999999876543
Q ss_pred ------CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCC
Q 047157 560 ------DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNY 633 (788)
Q Consensus 560 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~ 633 (788)
...++|+||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||+++. .+.
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~----~~~ 152 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINT----EDL 152 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcC----CCc
Confidence 35789999997 589888743 3578899999999999999999998 9999999999999972 456
Q ss_pred cEEEeecCCccccCCCCCc--ccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccch
Q 047157 634 MAKISDFGISKLLNKDQTR--TDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD 710 (788)
Q Consensus 634 ~~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~ 710 (788)
.+||+|||.+..+...... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+......
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7899999999765432211 1122356888999997644 568889999999999999999999997543221110000
Q ss_pred h----hhHHHHHHHhhcccccccccCCCCCccc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 711 I----VLSDWVISCMLSRNLQVLVSHDPEVLSD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 711 ~----~~~~~~~~~~~~~~~~~l~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. .... ....................... .....++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREE-DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChH-HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 0000 00000000000000000000000 112356788999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=285.57 Aligned_cols=268 Identities=23% Similarity=0.293 Sum_probs=194.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCC------
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED------ 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 560 (788)
.|.+.+.||+|+||.||++... .++..||||++... .....+.+.+|++++++++||||+++++++..+.
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDR--RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEEC--CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 4556789999999999999876 56778999988542 2334457889999999999999999999987654
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+||+++ .++.+||+||
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~-----~~~~~kl~df 162 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVN-----EDCELKILDF 162 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc-----CCCCEEEeec
Confidence 458999998 7799888753 4688999999999999999999998 999999999999998 7789999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccch----hhhHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD----IVLSD 715 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~----~~~~~ 715 (788)
|++....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............. .....
T Consensus 163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9998654321 23456889999998865 458899999999999999999999997543211100000 00000
Q ss_pred HHHHHhhcccccccccCCCCCcc------cHHHHHHHHHHHhHccCCCCCCCCCHHHHH--HHhhcC
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLS------DLERFERMAMVGLWCNHPDPNLRPSMKKVI--HMLEGT 774 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl--~~L~~~ 774 (788)
+ ................+.... .......+.+++.+|++.||++|||+.+++ ..++..
T Consensus 239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 239 F-VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred H-HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0 000000000111100000000 012234578999999999999999999999 344443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=273.15 Aligned_cols=237 Identities=30% Similarity=0.324 Sum_probs=191.2
Q ss_pred ccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 496 lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
||+|+||.||++... ..+..+++|.+..... .....+..|++++++++||||+++++.+..++..++||||++++
T Consensus 1 lg~G~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKK--DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEEC--CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 689999999999886 5567899998865432 24568899999999999999999999999999999999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
+|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++ .++.++|+|||++....... .
T Consensus 79 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~-----~~~~~~l~d~~~~~~~~~~~-~ 148 (250)
T cd05123 79 ELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLD-----ADGHIKLTDFGLAKELSSEG-S 148 (250)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEc-----CCCcEEEeecCcceecccCC-C
Confidence 999999655 3678999999999999999999998 999999999999998 77899999999998764432 1
Q ss_pred ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccC
Q 047157 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSH 732 (788)
Q Consensus 653 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 732 (788)
......++..|+|||...+...+.++|+||||+++|+|++|+.||....... .. ......
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~----~~~~~~-------- 208 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--------IY----EKILKD-------- 208 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HH----HHHhcC--------
Confidence 2233567889999999988889999999999999999999999996542211 00 001110
Q ss_pred CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 047157 733 DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKK 766 (788)
Q Consensus 733 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 766 (788)
... .+......+.+++.+||..||++||++.+
T Consensus 209 ~~~--~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 209 PLR--FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCC--CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 011 11111466788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=273.42 Aligned_cols=281 Identities=19% Similarity=0.263 Sum_probs=211.0
Q ss_pred ccCHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-c-c----ccceE
Q 047157 479 EFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-H-K----NLVRL 552 (788)
Q Consensus 479 ~~~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-p----niv~~ 552 (788)
.+...+.....|.+...+|+|.||.|-++.+. ..+..||||+++.. ....+..+-|+++++++. + | -+|++
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~--~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDR--ETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeec--CCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 34555666777888899999999999999887 44779999999764 556677788999999994 2 2 27888
Q ss_pred eeEEecCCeEEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCC---
Q 047157 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT--- 628 (788)
Q Consensus 553 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~--- 628 (788)
.++|+-.++.+||+|.+ |-|+.++|..+ -..++...+..|+.|++++++|||+. +++|-||||+|||+....
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence 89999999999999998 77999999764 34678999999999999999999999 999999999999994211
Q ss_pred ------------CCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC
Q 047157 629 ------------LDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696 (788)
Q Consensus 629 ------------~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p 696 (788)
...+..+||+|||.|....... ...+.|..|.|||++.+-.++.++||||+||||.|+.+|...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 1235679999999998754443 345779999999999999999999999999999999999999
Q ss_pred CCccccccccccchhhhHHHHHHHh---------hccccc-----------ccccCC-C---CCcccHHHHHHHHHHHhH
Q 047157 697 IELSRVEEESEEVDIVLSDWVISCM---------LSRNLQ-----------VLVSHD-P---EVLSDLERFERMAMVGLW 752 (788)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~-----------~l~~~~-~---~~~~~~~~~~~l~~l~~~ 752 (788)
|...+..+.....+..+.......+ ..+.+. ...+.. + .......+..+|++|+..
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 9876533321111111111100000 001111 000000 0 011233556789999999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 047157 753 CNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 753 cl~~dP~~RPt~~evl~~ 770 (788)
||..||.+|+|+.|++++
T Consensus 389 mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSH 406 (415)
T ss_pred HHccCccccccHHHHhcC
Confidence 999999999999999863
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=281.77 Aligned_cols=269 Identities=22% Similarity=0.254 Sum_probs=191.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCC-CccccceEeeEEec----CCeE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSE----EDKR 562 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~~~~ 562 (788)
|.+.+.||+|+||.||++.......+..+|+|.+.... ....+.+.+|+++++++ +||||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 45678999999999999998743337789999886432 23356788999999999 59999999987543 2457
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++++|++. ++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||+
T Consensus 82 ~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~-----~~~~~kl~Dfg~ 151 (332)
T cd07857 82 YLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVN-----ADCELKICDFGL 151 (332)
T ss_pred EEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEc-----CCCCEEeCcCCC
Confidence 88899885 689888854 35688999999999999999999999 999999999999998 778999999999
Q ss_pred ccccCCCCCc---ccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh----H
Q 047157 643 SKLLNKDQTR---TDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL----S 714 (788)
Q Consensus 643 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~ 714 (788)
+......... ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...............+ .
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9865432211 1223468899999998765 568999999999999999999999997643221110000000 0
Q ss_pred HHHHHHhhccccccccc---CCCCCc---ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 715 DWVISCMLSRNLQVLVS---HDPEVL---SDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~---~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
+. .............. ..+... ........+.+++.+||+.||++|||+.|++.
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ET-LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HH-HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 00000000000000 000000 00012356888999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=287.11 Aligned_cols=264 Identities=23% Similarity=0.304 Sum_probs=194.1
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCe-----
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK----- 561 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----- 561 (788)
.|.+.+.||+|++|.||+|... .++..|++|.+... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDT--KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred ceEEEEEeccCCceEEEEEEEC--CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 3556789999999999999886 56778999988643 23344677889999999999999999998866554
Q ss_pred -EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 562 -RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 562 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+|+||||+||+++ .++.+||+||
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~-----~~~~~kL~df 162 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVN-----EDCELKILDF 162 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEC-----CCCCEEEccc
Confidence 89999998 6799998854 4689999999999999999999998 999999999999998 7789999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh---hHHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV---LSDW 716 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~ 716 (788)
|++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ..+-
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 999865432 223457888999998865 46789999999999999999999999754322111000000 0000
Q ss_pred HHHHhhcccccccccCCCCCc-cc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 717 VISCMLSRNLQVLVSHDPEVL-SD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~-~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
............++...+... .. ......+.+++.+||+.||++|||+.||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000011110000000 00 012467889999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=281.17 Aligned_cols=264 Identities=22% Similarity=0.238 Sum_probs=192.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEec-CCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-EDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lV 565 (788)
.|.+.+.||+|+||.||++... .++..|++|++.... ....+.+.+|++++++++||||+++++++.. ....++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQ--LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ceEEEEeecccCCeEEEEEEEC--CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 3556789999999999999876 567789999875422 2345678899999999999999999998865 5678999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+||+ +++|.+++.. ..++...+..++.||+.||.|||+. +|+|+||+|+||+++ .++.+||+|||.+..
T Consensus 89 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~-----~~~~~~l~dfg~~~~ 157 (328)
T cd07856 89 TELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILIN-----ENCDLKICDFGLARI 157 (328)
T ss_pred eehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeEC-----CCCCEEeCccccccc
Confidence 9998 5689888753 3567788889999999999999999 999999999999998 778999999999875
Q ss_pred cCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh----hhHHHHHHH
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI----VLSDWVISC 720 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~ 720 (788)
..... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............. ...++.. .
T Consensus 158 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~ 232 (328)
T cd07856 158 QDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN-T 232 (328)
T ss_pred cCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH-h
Confidence 43221 22456788999998765 5789999999999999999999999965432110000000 0000000 0
Q ss_pred hhcccccccccCCC-CCccc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDP-EVLSD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~-~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
........++.... ..... ......+.+++.+||+.+|++|||+++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 00000 0123678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=285.65 Aligned_cols=240 Identities=25% Similarity=0.277 Sum_probs=191.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+...+|.|+|+.|-.+.+. .+.+..++|++.+... +-.+|+.++.+. +||||+++.+.+.+..+.|+|||
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~--~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESS--PTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred hhccccccCCCCccceeeeecc--ccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 3556677999999999999887 6777899999976522 234677666655 79999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
.+.++-|.+.+..... .. ..+..|+.+|+.|+.|||++ +||||||||+|||++ .+.++++|+|||.++...
T Consensus 397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~----~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLD----GSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeec----CCCCcEEEEEechhhhCc
Confidence 9999988887755422 22 67778999999999999999 999999999999994 177899999999999876
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
.. ....+-|..|.|||++....+++++|+||||++||+|++|+.||........ +...+..+...
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-----------i~~~i~~~~~s 532 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-----------IHTRIQMPKFS 532 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-----------HHHhhcCCccc
Confidence 65 2233568899999999999999999999999999999999999986543310 11111111111
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
....+...+|+.+||+.||.+||+|.++..+
T Consensus 533 ------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------------cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 3345677889999999999999999998753
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=284.59 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=190.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC------C
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------D 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 560 (788)
.|.+.+.||+|+||.||++... .++..||+|++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDT--KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEc--CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 3445688999999999999876 567799999986532 23346788999999999999999999988543 3
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..+++++++ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+||+++ .++.+||+||
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~-----~~~~~kl~df 164 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVN-----EDCELKILDF 164 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEc-----CCCCEEEecc
Confidence 467888887 7899888743 3588999999999999999999999 999999999999998 7789999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh---hhHHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI---VLSDW 716 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~ 716 (788)
|++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .....
T Consensus 165 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 165 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred ccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 998764322 123457889999998866 5688999999999999999999999965432111000000 00000
Q ss_pred HHHHhhcccccccc---cCCCCCcc---cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLSRNLQVLV---SHDPEVLS---DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~~~~~~l~---~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..........+..+ ...+.... .......+.+++.+|++.||.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000000000 00000000 00124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=268.63 Aligned_cols=221 Identities=22% Similarity=0.150 Sum_probs=175.7
Q ss_pred cccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCCHhHhh
Q 047157 499 GSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL 578 (788)
Q Consensus 499 G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l 578 (788)
|.++.||++... .++..+|+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~--~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDT--RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEc--cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999887 677799999987643 2234555555567999999999999999999999999999999998
Q ss_pred hccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCccccccc
Q 047157 579 FHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR 658 (788)
Q Consensus 579 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 658 (788)
.+. ..+++..+..++.|++.||.|||++ +|+||||||+||+++ .++.++|+|||.+....... ....
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~-----~~~~~~l~df~~~~~~~~~~----~~~~ 143 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLD-----DRGHIQLTYFSRWSEVEDSC----DGEA 143 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEc-----CCCCEEEecccchhcccccc----ccCC
Confidence 654 4588999999999999999999998 999999999999998 77889999999876554321 1234
Q ss_pred CCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcc
Q 047157 659 GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLS 738 (788)
Q Consensus 659 gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 738 (788)
++..|+|||.+.+..++.++||||+|+++|||++|+.|+........ . ......
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------------~----~~~~~~ 197 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------------T----HTTLNI 197 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------------c----ccccCC
Confidence 56789999999888899999999999999999999988753211000 0 000000
Q ss_pred cHHHHHHHHHHHhHccCCCCCCCCCHH
Q 047157 739 DLERFERMAMVGLWCNHPDPNLRPSMK 765 (788)
Q Consensus 739 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ 765 (788)
+......+.+++.+|++.||++||++.
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 111245678899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=240.33 Aligned_cols=201 Identities=25% Similarity=0.392 Sum_probs=170.3
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
.++||+|.||+||+|+.+ ++.+.||+|+++-+ .+..-....+|+-+++.++|.|||+++++...++...+|+|||
T Consensus 7 mekigegtygtvfkarn~--~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c- 83 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNR--ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC- 83 (292)
T ss_pred HHhhcCCcceeeEecccC--CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-
Confidence 367999999999999876 78889999988643 3344456789999999999999999999999999999999999
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
..+|..+...-...++.+....++.|+++||.|+|++ ++.||||||+|.||+ .++..||+|||+++.++-.-
T Consensus 84 dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin-----~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 84 DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLIN-----RNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEec-----cCCcEEecccchhhhcCCce
Confidence 4588888877778889999999999999999999999 999999999999998 89999999999999776443
Q ss_pred CcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHh-CCCCCCccccccc
Q 047157 651 TRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEE 705 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~ 705 (788)
.. ....+-|..|.+|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+..++
T Consensus 156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 22 2233558899999998765 57899999999999999985 6666666554443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=261.26 Aligned_cols=245 Identities=26% Similarity=0.300 Sum_probs=194.9
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.++||+|.||.|-+++-+ .+++.+|+|++++.. .+....-..|-++|+..+||.+..+--.|+..+.+++|||
T Consensus 171 dfLKvLGkGTFGKVIL~rEK--at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREK--ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hHHHHhcCCccceEEEEeec--ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 45689999999999998766 788899999998764 2334456678899999999999999889999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|..||.|.-+|.+. +.+++....-+-..|+.||.|||++ +||.||||.+|.|+| .++++||+|||+++.--
T Consensus 249 yanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLD-----kDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 249 YANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLD-----KDGHIKITDFGLCKEEI 319 (516)
T ss_pred EccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhC---Ceeeeechhhhheec-----cCCceEeeecccchhcc
Confidence 99999999988554 5566666667888999999999999 999999999999999 89999999999998643
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
... .....++||+.|+|||++....|..+.|.|.+||++|||++|+.||...+.+.. .+ .+.-.+
T Consensus 320 ~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL--------Fe----LIl~ed-- 384 (516)
T KOG0690|consen 320 KYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL--------FE----LILMED-- 384 (516)
T ss_pred ccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH--------HH----HHHhhh--
Confidence 332 334568999999999999999999999999999999999999999976533221 11 111111
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIH 769 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 769 (788)
... +.....+...|+...|..||.+|. .++||.+
T Consensus 385 ------~kF--Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 385 ------LKF--PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ------ccC--CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 111 111223445667778899999994 4666654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=268.85 Aligned_cols=261 Identities=24% Similarity=0.324 Sum_probs=196.9
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeec--ccch-----HHHHHHHHHHHHHhcCCCccccceEeeEEe-
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKL--EKDI-----EKTNEEFMTELKIIGRTHHKNLVRLLGFCS- 557 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l--~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~- 557 (788)
....|-+.++||+|||+.||++.+- ..++.||||+- .+.. ....+...+|.++.+.|.||.||++|+++.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl--~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDL--TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhccc--chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3444555688999999999999876 56678888864 2222 223456788999999999999999999985
Q ss_pred cCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 558 EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 558 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
+.+..+-|+|||+|.+|+-||... +.+++.++..|+.||+.||.||.+. +++|||-||||.|||+-... ..+.+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gt--acGeIKI 614 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGT--ACGEIKI 614 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCc--ccceeEe
Confidence 456788999999999999999654 6789999999999999999999996 77999999999999997544 6789999
Q ss_pred eecCCccccCCCCCc------ccccccCCccccCcccccC----CCCCccCcchhhHHHHHHHHhCCCCCCccccccccc
Q 047157 638 SDFGISKLLNKDQTR------TDTNMRGTMGYVAPEWLRN----VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESE 707 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~ 707 (788)
.|||+++++..+... ......||..|++||.+.- .+++.|+||||.|||+|..+.|+.||........
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-- 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-- 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--
Confidence 999999998655433 2345679999999998742 3578899999999999999999999975422111
Q ss_pred cchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 047157 708 EVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768 (788)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 768 (788)
.+..-. .+.... ...........+...+|++||+..-++|....++.
T Consensus 693 ----ILqeNT--IlkAtE--------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ----ILQENT--ILKATE--------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ----HHhhhc--hhccee--------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 000000 000000 11111112234556788999999999998877765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=300.66 Aligned_cols=145 Identities=28% Similarity=0.324 Sum_probs=128.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.++||+|+||+||+|... ..+..||||++.... ......+..|+.++..++||||+++++++...+..+||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~--~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKK--NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEEC--CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 3566789999999999999886 567799999986432 33456788999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|||+.+++|.+++... ..+++..++.|+.||+.||.|||.+ +|+||||||+|||++ .++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~-----~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLIS-----NEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEc-----CCCCEEEEeCCCCc
Confidence 9999999999998654 4578888999999999999999998 999999999999998 77899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=267.83 Aligned_cols=245 Identities=27% Similarity=0.340 Sum_probs=195.5
Q ss_pred HHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecC
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE 559 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 559 (788)
.|.....+|..+||+|+||.|.++.-+ ++...+|||+++++. .+..+.-+.|-++|... +-|.+++++.+|+.-
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerk--gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERK--GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeeccc--CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 355566789999999999999999766 777799999998764 22334456788888776 578999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
+.+|+||||+.||+|--++++-+ ++.+..+.-++..||-||-+||++ +|+.||||.+||++| .++++||+|
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd-----~eGHiKi~D 493 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLD-----SEGHIKIAD 493 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEec-----cCCceEeee
Confidence 99999999999999988886653 455566778999999999999999 999999999999999 889999999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHH
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
||+++.---+. .....++||+.|+|||++...+|...+|.|||||+||||+.|+.||++.+..+.- .
T Consensus 494 FGmcKEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF------------~ 560 (683)
T KOG0696|consen 494 FGMCKENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------------Q 560 (683)
T ss_pred cccccccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH------------H
Confidence 99998543222 2334589999999999999999999999999999999999999999987543321 1
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP 762 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 762 (788)
.+.+. ....+-....+.+.+....|...|.+|.
T Consensus 561 aI~eh----------nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 561 AIMEH----------NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHc----------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11111 1112223345667778888888999884
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=279.95 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=203.2
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEe-----cCCeEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCS-----EEDKRL 563 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~-----~~~~~~ 563 (788)
..|.++||+|.+|.||+++.. .+++..|+|++.-. ....+++..|.++++.+ +|||++.+++++. .++.++
T Consensus 21 ~ei~evig~Gtygkv~k~k~~--~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHV--KTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred cEEEEEEeeccceeEEEEeee--ecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 456789999999999999888 55556677766543 34556788899999888 6999999999884 356899
Q ss_pred EEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 564 LVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
||||||.+||..+++..- +.++.|..+..|++.+++||.|||.. .++|||||-.|||++ .++.+||.|||+
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT-----~e~~VKLvDFGv 169 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLT-----ENAEVKLVDFGV 169 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEe-----ccCcEEEeeeee
Confidence 999999999999999643 67889999999999999999999999 999999999999999 889999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRN-----VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
+..+...... .....||+.|||||++.. ..|+..+|+||||++..||.-|.+|+........
T Consensus 170 SaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------------ 236 (953)
T KOG0587|consen 170 SAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------------ 236 (953)
T ss_pred eeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------------
Confidence 9877543322 234679999999999843 3577899999999999999999999854311110
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+...-.+.|.........+++.++|..||..|-++||++.+++++
T Consensus 237 -------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 -------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 0111222455566677889999999999999999999999988753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=259.00 Aligned_cols=238 Identities=29% Similarity=0.363 Sum_probs=192.0
Q ss_pred ccceEEEEEEeccCcceeeeeeecccchHHH-HHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCCHhHhh
Q 047157 500 SSGKVYRGILRLKDTQIEIAVKKLEKDIEKT-NEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL 578 (788)
Q Consensus 500 ~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l 578 (788)
+||.||+|... .++..+++|.+....... .+.+.+|++.+++++|+||+++++++......++++|++++++|.+++
T Consensus 1 ~~g~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDK--KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEEC--CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999886 556789999987654433 678999999999999999999999999999999999999999999998
Q ss_pred hccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCccccccc
Q 047157 579 FHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR 658 (788)
Q Consensus 579 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 658 (788)
..... +++..++.++.+++++|.|||+. +++|+||+|+||+++ .++.++|+|||.+....... ......
T Consensus 79 ~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~-----~~~~~~l~d~~~~~~~~~~~--~~~~~~ 147 (244)
T smart00220 79 KKRGR-LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLD-----EDGHVKLADFGLARQLDPGG--LLTTFV 147 (244)
T ss_pred HhccC-CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEEC-----CCCcEEEccccceeeecccc--cccccc
Confidence 65433 88999999999999999999999 999999999999998 77899999999998765432 223356
Q ss_pred CCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcc
Q 047157 659 GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLS 738 (788)
Q Consensus 659 gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 738 (788)
++..|+|||.+....++.++||||||+++++|++|..||....... ... ....... .....
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-------~~~----~~~~~~~--------~~~~~ 208 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-------ELF----KKIGKPK--------PPFPP 208 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-------HHH----HHHhccC--------CCCcc
Confidence 7889999999998889999999999999999999999986531110 000 1111100 00000
Q ss_pred cHH-HHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 739 DLE-RFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 739 ~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
... ....+.+++.+|+..+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 000 3467888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-31 Score=253.64 Aligned_cols=267 Identities=21% Similarity=0.308 Sum_probs=194.2
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeeccc--chHHHHHHHHHHHHHhcCCCccccceEeeEEec--------CCeE
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--------EDKR 562 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------~~~~ 562 (788)
..+||+|.||.||+|+.+ .+++.||+|+.-- .....-....+|+.+|..+.|+|++.+++.|.. ....
T Consensus 22 ~~kigqGtfgeVFkAr~~--n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSK--NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred HHhcCCchHHHHHHHhhc--CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 357999999999999876 6677788886532 222233456799999999999999999998843 2358
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
|+|+.+|+. +|..+|.....+++..++.+++.++..||.|+|.. .|+|||+||.|+||+ .++.+||+|||+
T Consensus 100 ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt-----~dgilklADFGl 170 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLIT-----KDGILKLADFGL 170 (376)
T ss_pred eeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEc-----CCceEEeecccc
Confidence 999999965 88999977778899999999999999999999999 999999999999999 889999999999
Q ss_pred ccccCCCCC---cccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH---
Q 047157 643 SKLLNKDQT---RTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD--- 715 (788)
Q Consensus 643 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--- 715 (788)
++.+..... ...++.+-|..|++||.+.+ ..++++.|||..|||+.||.++.+.+.+.........+......
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987643322 22345566999999998865 57999999999999999999999988766443322111111100
Q ss_pred HHHHHhhcccccccccCC--CCC--cccHHH------HHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 716 WVISCMLSRNLQVLVSHD--PEV--LSDLER------FERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~--~~~--~~~~~~------~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
-+|+....-.+-.-+... ++. ..-.+. -.+.++|+..++..||.+|+++.+++.+
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 011111110010011000 000 000111 1356788889999999999999998864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=237.16 Aligned_cols=196 Identities=29% Similarity=0.389 Sum_probs=165.8
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEecCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
.+.||+|++|.|-+-++. .++...|+|++.... .+..++..+|+.+..+. .+|.+|+++|....+...++.||.|
T Consensus 51 i~elGrGayG~vekmrh~--~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M- 127 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHI--QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM- 127 (282)
T ss_pred hhhhcCCccchhhheeec--cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-
Confidence 367999999999888776 788899999997543 45567888999887765 7999999999999999999999999
Q ss_pred CCCHhHhhh---ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 571 NGTLSNFLF---HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 571 ~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
..||+.+-. +.+...++..+-+|+..+++||.|||++ ..++|||+||+||||+ ..+++|++|||++-.+.
T Consensus 128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn-----~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILIN-----YDGQVKICDFGISGYLV 200 (282)
T ss_pred hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEc-----cCCcEEEcccccceeeh
Confidence 567776653 4677889999999999999999999998 6899999999999999 88999999999998765
Q ss_pred CCCCcccccccCCccccCccccc----CCCCCccCcchhhHHHHHHHHhCCCCCCcc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLR----NVPVTTKVDVFSFGVMLLEIICGRRHIELS 700 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~s~k~DVwSlGvil~elltg~~p~~~~ 700 (788)
..-. .+...|...|||||.+. ...|+-|+||||||+.+.||.+++.|++..
T Consensus 201 dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 201 DSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 4322 22245777899999884 347899999999999999999999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=288.22 Aligned_cols=266 Identities=19% Similarity=0.138 Sum_probs=168.5
Q ss_pred HhhcccccccccccceEEEEEEeccCc----ceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeE------Ee
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDT----QIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF------CS 557 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~------~~ 557 (788)
..|.+.++||+|+||.||+|.+. .+ +..||+|++..... .+....| .+....+.++..++.. ..
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~--~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLV--NKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEc--CCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 34667799999999999999986 44 67899998764321 1111111 1112222222222211 24
Q ss_pred cCCeEEEEEecCCCCCHhHhhhccCCCC-------------------CHHHHHHHHHHHHHHHHHhhhccCCceEecCCC
Q 047157 558 EEDKRLLVYELMPNGTLSNFLFHEGQRP-------------------GWVQRVEIALGVARGLLYLHEECETQIIHCDIK 618 (788)
Q Consensus 558 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlk 618 (788)
.+...++|+||+++++|.+++....... ....+..++.||+.||.|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 5678999999999999999986542111 1234567999999999999998 99999999
Q ss_pred CCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCC----------------------CCCc
Q 047157 619 PQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV----------------------PVTT 676 (788)
Q Consensus 619 p~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ 676 (788)
|+|||++. .++.+||+|||+++.+............+++.|+|||.+... .++.
T Consensus 283 P~NILl~~----~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 283 PQNIIFSE----GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred HHHEEEeC----CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 99999972 357899999999987654444444456789999999965322 2345
Q ss_pred cCcchhhHHHHHHHHhCCCCCCcccccc--ccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHcc
Q 047157 677 KVDVFSFGVMLLEIICGRRHIELSRVEE--ESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCN 754 (788)
Q Consensus 677 k~DVwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl 754 (788)
++|||||||+||||+++..++....... ...........|... .......-+....+ ..........+|+.+||
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~--~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL--VEPRASPDLRRGFE--VLDLDGGAGWELLKSMM 434 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh--hccccchhhhhhhh--hccccchHHHHHHHHHc
Confidence 6799999999999999776653221000 000000111111110 00000000000000 00001224558999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 047157 755 HPDPNLRPSMKKVIHM 770 (788)
Q Consensus 755 ~~dP~~RPt~~evl~~ 770 (788)
+.||++|||++|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=257.29 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=201.4
Q ss_pred hcccccccccccceEEEEEEeccC---cceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEec-CCeEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKD---TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-EDKRLL 564 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 564 (788)
...+.++-+|.||.||+|+++..+ +.+.|.+|.++... +-....+..|...+..+.|||+..+.+++.+ .+..++
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence 344567899999999999887433 34568888886543 3345678899999999999999999998855 557789
Q ss_pred EEecCCCCCHhHhhhc-------cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 565 VYELMPNGTLSNFLFH-------EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
+|.++.-|+|..+|.. ..+..+..+...++.|++.|++|||.+ +|||.||..+|.+|| +..++||
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId-----d~LqVkl 437 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID-----DQLQVKL 437 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh-----hheeEEe
Confidence 9999999999999962 123456778889999999999999999 999999999999999 8899999
Q ss_pred eecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHH
Q 047157 638 SDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
+|-.+++.+-+.... ...+......||+||.+.+..|+.++|||||||++|||+| |+.|+...++.+.
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm---------- 507 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM---------- 507 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH----------
Confidence 999999876443322 2222334678999999999999999999999999999997 7888864433221
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
...+...-+...+.+.++++..++..||..+|++||+.+|++.-|.+
T Consensus 508 -----------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 -----------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -----------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11111223334455678899999999999999999999999998864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=280.49 Aligned_cols=244 Identities=30% Similarity=0.448 Sum_probs=186.2
Q ss_pred ccccccccce-EEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGK-VYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~-Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
+++|.|+.|+ ||+|.. .+++||||++-.. ......+|+..|+.- +|||||++++.-.++...||..|.| .
T Consensus 515 eilG~Gs~Gt~Vf~G~y----e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY----EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred HHcccCCCCcEEEEEee----CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 6789998875 699987 3569999998533 344567899999877 6999999999999999999999999 6
Q ss_pred CCHhHhhhccCCCC---CHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 572 GTLSNFLFHEGQRP---GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 572 gsL~~~l~~~~~~~---~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
.+|.+++....... .....+.++.|++.||+|||+. +||||||||+||||+.........++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 79999997641111 1134567899999999999998 99999999999999854333557899999999998865
Q ss_pred CCCcc--cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhC-CCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 649 DQTRT--DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG-RRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 649 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
+.... .....||-+|+|||++....-+.++||||+||++|+.++| .+||...-..+.. +..+.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------------Il~~~ 729 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------------ILTGN 729 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------------hhcCc
Confidence 54332 3456799999999999988888899999999999999987 8999754211100 00010
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. .+. ......+. +..+||.+|+++||..||++.+|+.
T Consensus 730 ~-~L~----~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 Y-TLV----HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred c-cee----eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 000 00011111 6788999999999999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=275.50 Aligned_cols=264 Identities=18% Similarity=0.220 Sum_probs=178.0
Q ss_pred hhcccccccccccceEEEEEEec--------------cCcceeeeeeecccchHHHHHHHH--------------HHHHH
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRL--------------KDTQIEIAVKKLEKDIEKTNEEFM--------------TELKI 540 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~--------------~~~~~~vavK~l~~~~~~~~~~~~--------------~E~~~ 540 (788)
.+.+.++||+|+||+||+|.... ...+..||||++........++|. .|+..
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 45667899999999999997521 133457999998654433333333 46666
Q ss_pred hcCCCcccc-----ceEeeEEec--------CCeEEEEEecCCCCCHhHhhhccC-----------------------CC
Q 047157 541 IGRTHHKNL-----VRLLGFCSE--------EDKRLLVYELMPNGTLSNFLFHEG-----------------------QR 584 (788)
Q Consensus 541 l~~l~hpni-----v~~~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~ 584 (788)
+.+++|.++ ++++++|.. .+..+|||||+++++|.++++... ..
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 666766544 677777643 356899999999999999986421 12
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCcccc
Q 047157 585 PGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664 (788)
Q Consensus 585 ~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~ 664 (788)
+++..+..++.|++.+|.|||+. +|+||||||+|||++ .++.+||+|||++...............+++.|+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~-----~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVT-----VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEEC-----CCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 35677889999999999999998 999999999999998 7789999999999765433222222233578999
Q ss_pred CcccccCCCC----------------------CccCcchhhHHHHHHHHhCCC-CCCcccccccc-ccchhhhHHHHHHH
Q 047157 665 APEWLRNVPV----------------------TTKVDVFSFGVMLLEIICGRR-HIELSRVEEES-EEVDIVLSDWVISC 720 (788)
Q Consensus 665 aPE~~~~~~~----------------------s~k~DVwSlGvil~elltg~~-p~~~~~~~~~~-~~~~~~~~~~~~~~ 720 (788)
|||.+..... ..+.||||+||++|+|++|.. |+......... ......+..|..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-- 455 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-- 455 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence 9998753221 235799999999999999875 66432111110 001111111111
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCC---CCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDP---NLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~~ 770 (788)
.... ...........+...+++.++|..+| .+|+|++|++++
T Consensus 456 ~~~~--------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQ--------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hccc--------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1000 11111112234567788888998765 789999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=245.41 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=194.5
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEE
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.+.++||+|+|+.|.++.++ .+.+.+|+|++++..- +...-...|-.+..+. +||.+|-++.+|+.+..+++|.
T Consensus 253 ~ll~vigrgsyakvl~~~~~--~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLK--KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred eeeeeecCcchhhhhheehc--ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 34689999999999999887 7778999999876532 2233445666676665 7999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|+|--+++.. ++++++.+.-+...|+-||.|||++ |||.||||.+|||+| ..+++||+|+|+++.-
T Consensus 331 eyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlld-----aeghikltdygmcke~ 401 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLD-----AEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEc-----cCCceeecccchhhcC
Confidence 999999998777544 5677777777888999999999999 999999999999999 8899999999999865
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
-.+.. ....++||+.|+|||++++..|....|.|+|||+++||+.|+.||+...... .+....++....+.+..+
T Consensus 402 l~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n----~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 402 LGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN----PDMNTEDYLFQVILEKQI 476 (593)
T ss_pred CCCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC----cccchhHHHHHHHhhhcc
Confidence 43332 3456899999999999999999999999999999999999999998654332 223344555555554433
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP 762 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 762 (788)
+-.. ....+...+++.-|+.||.+|.
T Consensus 477 ripr----------slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 RIPR----------SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccc----------eeehhhHHHHHHhhcCCcHHhc
Confidence 2211 1122344567778899999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=264.12 Aligned_cols=244 Identities=21% Similarity=0.240 Sum_probs=195.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
..||-|+||.|=++..+ ......|+|.+++.. ....+.+..|-.+|...+.|.||++|-.|.+....|++||-|-
T Consensus 426 aTLGvGgFGRVELV~~~--~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVN--SQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhcccCccceEEEEEec--ccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 46999999999998876 333358899886542 4556788999999999999999999999999999999999999
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
||.|...|+++ ..++..+..-++..+.+|++|||.+ +||.|||||+|.+++ .++-+||.|||+|+.+....
T Consensus 504 GGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd-----~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 504 GGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLD-----NRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred Cchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeec-----cCCceEEeehhhHHHhccCC
Confidence 99999999766 4566666677888899999999999 999999999999999 88899999999999886544
Q ss_pred CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccc
Q 047157 651 TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 730 (788)
. .-+++||+.|.|||++.++..+.++|.||||+++|||++|.+||...+.......+-..+..+
T Consensus 575 K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-------------- 638 (732)
T KOG0614|consen 575 K--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-------------- 638 (732)
T ss_pred c--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------------
Confidence 3 335899999999999999999999999999999999999999998765432211110000000
Q ss_pred cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 047157 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIHM 770 (788)
Q Consensus 731 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 770 (788)
..+........+++++.+..+|.+|.- +.+|.++
T Consensus 639 ------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 ------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 001123445667888888899999975 6666654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-30 Score=245.39 Aligned_cols=267 Identities=22% Similarity=0.296 Sum_probs=196.1
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHH--HHHHHHHHHHHhcCCCccccceEeeEEecCC-----eEEEE
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK--TNEEFMTELKIIGRTHHKNLVRLLGFCSEED-----KRLLV 565 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~lV 565 (788)
.+.||.|+||.||.+.+. .+++.|++|++...... ..+.+.+|+++|..++|.|++..+++.+-.. ++|++
T Consensus 58 DRPIGYGAFGVVWsVTDP--RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDP--RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCcccccceeEEEeccCC--CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 367999999999999877 67889999998765433 3468889999999999999999988875543 56888
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+|.| ..+|...+.. .+.++...+.-++.||++||+|||+. +|.||||||.|.|++ .+..+||+|||+++.
T Consensus 136 TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVN-----SNCvLKICDFGLARv 205 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVN-----SNCILKICDFGLART 205 (449)
T ss_pred HHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEec-----cCceEEecccccccc
Confidence 8988 4577776643 35677788888999999999999999 999999999999998 899999999999998
Q ss_pred cCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh---
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM--- 721 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 721 (788)
-..+....++..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+..|......+..+.+...+.....+.+
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 877777777766778999999999765 6899999999999999999998888765443322111100000000000
Q ss_pred hcccccccccCCCC-----C----cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 722 LSRNLQVLVSHDPE-----V----LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 722 ~~~~~~~l~~~~~~-----~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
-++....++...+. . ......-.+.+.+...++.+||.+|.+.++.+..+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00100011111110 0 01112223445677779999999999999998776
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=256.96 Aligned_cols=203 Identities=26% Similarity=0.325 Sum_probs=170.8
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
.+.||-|+||.|.++.-. ++...+|+|.+++... ......+.|-.||...+.+-||+++-.|++.+.+|+||||+
T Consensus 634 ik~iGvGAFGeV~Lv~Kv--DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYI 711 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKV--DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 711 (1034)
T ss_pred EeeecccccceeEEEeec--chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEecc
Confidence 367999999999998765 6777999999987542 33456788999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC-
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK- 648 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~- 648 (788)
+||++-.+|.+. ..+++..+..++..+..|+++.|.. |+|||||||+||||| .++++||+|||++.-+.-
T Consensus 712 PGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILID-----rdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 712 PGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILID-----RDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred CCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEc-----cCCceeeeeccccccceec
Confidence 999999999766 3456666667778899999999998 999999999999999 889999999999875420
Q ss_pred ---------CCC-------------------------------cccccccCCccccCcccccCCCCCccCcchhhHHHHH
Q 047157 649 ---------DQT-------------------------------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLL 688 (788)
Q Consensus 649 ---------~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ 688 (788)
+.. ......+||+.|+|||++....++..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 000 0011246999999999999999999999999999999
Q ss_pred HHHhCCCCCCcccccccc
Q 047157 689 EIICGRRHIELSRVEEES 706 (788)
Q Consensus 689 elltg~~p~~~~~~~~~~ 706 (788)
||+.|+.||-.....+..
T Consensus 863 em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HHhhCCCCccCCCCCcce
Confidence 999999999876555443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=228.33 Aligned_cols=265 Identities=17% Similarity=0.226 Sum_probs=193.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCC--eEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEED--KRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~--~~~l 564 (788)
..|.+.+++|+|.|+.||.|... .+...++||.++.. ..+.+.+|+.+|..|. ||||++++++..+.. ...|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~--~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINI--TNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred chHHHHHHHcCccHhhHhccccc--CCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 34667789999999999999876 55668999998743 4567889999999996 999999999987644 5679
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+||+.+.+...+. ..++...+..++.+++.||.|+|+. ||+|||+||.|++||. ....++|+|+|+|.
T Consensus 113 iFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh----~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDH----ELRKLRLIDWGLAE 181 (338)
T ss_pred HhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeech----hhceeeeeecchHh
Confidence 99999998877665 4567778888999999999999999 9999999999999994 56789999999999
Q ss_pred ccCCCCCcccccccCCccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCccccc-cccccchhhh-----HHHH
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLR-NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVE-EESEEVDIVL-----SDWV 717 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~-----~~~~ 717 (788)
...+..... ..+.+..|.-||.+. ...|+..-|+|||||+|..|+..+.||...... ++.-.+...+ ..++
T Consensus 182 FYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 182 FYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 876544332 235677899999884 456889999999999999999999998643221 1111111111 0111
Q ss_pred HH--HhhcccccccccCCCCC--------cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 718 IS--CMLSRNLQVLVSHDPEV--------LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 718 ~~--~~~~~~~~~l~~~~~~~--------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. ...++.+..+++..... ....-...+.++++...|..|-.+|||++|.+.+
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00 00112222222111110 0011123567888889999999999999998863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=232.37 Aligned_cols=212 Identities=34% Similarity=0.543 Sum_probs=183.1
Q ss_pred ccccccceEEEEEEeccCcceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCCH
Q 047157 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTL 574 (788)
Q Consensus 496 lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL 574 (788)
||+|.+|.||++... ..+..+++|.+...... ..+.+.+|++.+++++|++|+++++++......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDK--KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEec--CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999885 45778999998765432 456899999999999999999999999999999999999999999
Q ss_pred hHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCC-CCcEEEeecCCccccCCCCCcc
Q 047157 575 SNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT-NYMAKISDFGISKLLNKDQTRT 653 (788)
Q Consensus 575 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~-~~~~kL~Dfg~a~~~~~~~~~~ 653 (788)
.+++......+++..+..++.+++++|.+||+. +++|+||+|.||+++ . +..++|+|||.+........ .
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~-----~~~~~~~l~d~~~~~~~~~~~~-~ 149 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLD-----SDNGKVKLADFGLSKLLTSDKS-L 149 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEe-----CCCCcEEEecCCceEEccCCcc-h
Confidence 999966545688999999999999999999999 999999999999998 5 68999999999987654321 1
Q ss_pred cccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccC
Q 047157 654 DTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSH 732 (788)
Q Consensus 654 ~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 732 (788)
.....+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2234567889999999877 888999999999999999
Q ss_pred CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 733 DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 733 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
..+.+++..|++.||++||++.++++.+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3566788889999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=256.35 Aligned_cols=195 Identities=26% Similarity=0.384 Sum_probs=166.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchH--------HHHHHHHHHHHHhcCCC---ccccceEeeEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--------KTNEEFMTELKIIGRTH---HKNLVRLLGFCSE 558 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~ 558 (788)
|...+.+|.|+||.|+.++++ .+...|+||.+.+..- ...-.+-.|+++|..++ |+||++++++|++
T Consensus 563 yttlq~lG~GAyGkV~lai~K--~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHK--ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ceeeeeccccccceEEEeeec--ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 444578999999999999998 5577999999876431 11123567999999997 9999999999999
Q ss_pred CCeEEEEEecC-CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 559 EDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 559 ~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
++.+||+||-. ++-+|.+++.. ...+++.+...|++|++.|+++||++ +|||||||-+||.++ .++-+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd-----~~g~~kl 711 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVD-----SNGFVKL 711 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEe-----cCCeEEE
Confidence 99999999974 46789999954 46788999999999999999999999 999999999999999 8999999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCC
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT-TKVDVFSFGVMLLEIICGRRHIE 698 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltg~~p~~ 698 (788)
+|||.+....... ...++||..|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 712 idfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999998765433 3347899999999999998875 56899999999999999988875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=242.14 Aligned_cols=284 Identities=23% Similarity=0.273 Sum_probs=206.8
Q ss_pred CcccCHHHHHH-HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-----c---c
Q 047157 477 FREFTFQELQE-ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-----H---K 547 (788)
Q Consensus 477 ~~~~~~~~l~~-~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---p 547 (788)
.......+... +.|.+.++||-|-|++||++.+. ...+.||+|+.+.. +...+..+.||++|++++ | .
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDt--q~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDT--QNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred CceeeccccccCceEEEEEeccccccceeEEEeec--cCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 44555556666 78889999999999999999987 77789999998754 455667889999999873 3 3
Q ss_pred ccceEeeEEec----CCeEEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 548 NLVRLLGFCSE----EDKRLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 548 niv~~~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
.||++++.|.. +.++++|+|++ |.+|..+|... -+.++...+.+|++||+.||.|||..| +|||-||||+||
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv 219 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV 219 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence 69999999965 55899999999 77888888654 456899999999999999999999986 999999999999
Q ss_pred EeccCC--------------------------------------------------------------------------
Q 047157 623 LLDLKT-------------------------------------------------------------------------- 628 (788)
Q Consensus 623 ll~~~~-------------------------------------------------------------------------- 628 (788)
|+....
T Consensus 220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~ 299 (590)
T KOG1290|consen 220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN 299 (590)
T ss_pred eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence 991100
Q ss_pred --------------------------------------------------------------------------------
Q 047157 629 -------------------------------------------------------------------------------- 628 (788)
Q Consensus 629 -------------------------------------------------------------------------------- 628 (788)
T Consensus 300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~ 379 (590)
T KOG1290|consen 300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL 379 (590)
T ss_pred ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence
Q ss_pred -------CCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccc
Q 047157 629 -------LDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSR 701 (788)
Q Consensus 629 -------~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~ 701 (788)
...+.++||+|||-|.-.....+ .-..|..|+|||++.+..|++.+||||++|+++||+||...|+...
T Consensus 380 v~p~~~~~~~di~vKIaDlGNACW~~khFT----~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhs 455 (590)
T KOG1290|consen 380 VNPDIPLPECDIRVKIADLGNACWVHKHFT----EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHS 455 (590)
T ss_pred cCCCCCCCccceeEEEeeccchhhhhhhhc----hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCC
Confidence 00012356666666655433322 2246788999999999999999999999999999999999998765
Q ss_pred cccccccch-hh-----hHHHHHHHhhccc-ccccccCC--------CCC-----------cccHHHHHHHHHHHhHccC
Q 047157 702 VEEESEEVD-IV-----LSDWVISCMLSRN-LQVLVSHD--------PEV-----------LSDLERFERMAMVGLWCNH 755 (788)
Q Consensus 702 ~~~~~~~~~-~~-----~~~~~~~~~~~~~-~~~l~~~~--------~~~-----------~~~~~~~~~l~~l~~~cl~ 755 (788)
.+......+ +. +..........+. -++++... +.. .-..+...++.+++.-||+
T Consensus 456 G~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe 535 (590)
T KOG1290|consen 456 GENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE 535 (590)
T ss_pred CCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence 544322221 11 1111111111111 11122111 111 1134667889999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 047157 756 PDPNLRPSMKKVIHM 770 (788)
Q Consensus 756 ~dP~~RPt~~evl~~ 770 (788)
.+|++||||.+.+++
T Consensus 536 f~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 536 FDPEKRPTAAQCLKH 550 (590)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999853
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=249.71 Aligned_cols=281 Identities=18% Similarity=0.230 Sum_probs=212.5
Q ss_pred CCcccCHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC------cccc
Q 047157 476 NFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH------HKNL 549 (788)
Q Consensus 476 ~~~~~~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------hpni 549 (788)
+...+.+.|+....|.+....|+|-|++|..|... ..+..||||++... +-..+.=+.|+++|++|+ --|+
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~--~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQ--ARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeecccc--CCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 45667888999999999999999999999999887 45559999999865 556677789999999995 3579
Q ss_pred ceEeeEEecCCeEEEEEecCCCCCHhHhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccC
Q 047157 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQ--RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK 627 (788)
Q Consensus 550 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 627 (788)
++++-.|...+++|||+|-+ ..+|.++|.+-++ .+....+..++.|+..||..|... +|+|.||||+|||++.
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE- 571 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE- 571 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc-
Confidence 99999999999999999987 5699999977654 456778889999999999999998 9999999999999983
Q ss_pred CCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccc
Q 047157 628 TLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESE 707 (788)
Q Consensus 628 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~ 707 (788)
....+||+|||.|.......... ..-+.-|.|||++.+.+|+...|+||.||.||||.||+..|.+........
T Consensus 572 ---~k~iLKLCDfGSA~~~~eneitP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 572 ---SKNILKLCDFGSASFASENEITP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred ---CcceeeeccCccccccccccccH---HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 56789999999998765433221 223456999999999999999999999999999999999998764332111
Q ss_pred cc---------hhhhHHHHHHHhhc----------------------------ccccccccCCCCCc-ccHHHHHHHHHH
Q 047157 708 EV---------DIVLSDWVISCMLS----------------------------RNLQVLVSHDPEVL-SDLERFERMAMV 749 (788)
Q Consensus 708 ~~---------~~~~~~~~~~~~~~----------------------------~~~~~l~~~~~~~~-~~~~~~~~l~~l 749 (788)
.. .+.-...+.....+ ..+...+....... .+.....+|.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 00 00000000000000 00000011111111 234567789999
Q ss_pred HhHccCCCCCCCCCHHHHHHH
Q 047157 750 GLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 750 ~~~cl~~dP~~RPt~~evl~~ 770 (788)
+..|+..||++|.|..++|.+
T Consensus 726 Ldkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHhccChhhcCCHHHHhcC
Confidence 999999999999999998864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=234.02 Aligned_cols=260 Identities=23% Similarity=0.269 Sum_probs=187.9
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC------CeEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------DKRLLV 565 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~lV 565 (788)
+.++.|.- .|..+.+. -.+.+||+|++.... ....++..+|...+..++|+||++++.++.-. .+.|+|
T Consensus 23 ~p~~~g~~-~v~~a~D~--v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v 99 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQ--VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV 99 (369)
T ss_pred cccCCCCc-eEEecchh--hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence 44666766 55555444 456689999875432 33456778999999999999999999998543 367999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+| ..+|.+.+. ..++-..+..|+.|++.|++|||+. +|+||||||+||++. .+..+||.|||+++.
T Consensus 100 ~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~-----~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 100 MELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVN-----SDCTLKILDFGLART 167 (369)
T ss_pred HHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceec-----chhheeeccchhhcc
Confidence 9999 568888875 3456677889999999999999999 999999999999998 889999999999986
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh-----------hhH
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI-----------VLS 714 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~-----------~~~ 714 (788)
-... ...+....|..|.|||++.+..+.+.+||||+||++.||++|+-.|.+....++...... .+.
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 5443 345567788999999999988899999999999999999999998876543322211100 000
Q ss_pred HHHHHHhhc------ccccccccC---CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 715 DWVISCMLS------RNLQVLVSH---DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 715 ~~~~~~~~~------~~~~~l~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.-+...... -....++.. ......+......+.+++.+||-.||++|.++++++++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111111100 000011000 00111112234567789999999999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=228.01 Aligned_cols=199 Identities=31% Similarity=0.508 Sum_probs=172.3
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
.+.+.||+|++|.||++... .++..+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDK--GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred ceeeEeecCCCeEEEEEEEc--CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 45678999999999999886 45678999999765544 6778999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++++|.+++......+++..+..++.+++.+|.+||+. +++|+||+|+||+++ .+..++|+|||.+......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~-----~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLG-----MDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc-----CCCCEEEeeCceeeEecCc
Confidence 99999999966533378999999999999999999999 999999999999998 6789999999999876544
Q ss_pred CCcccccccCCccccCcccc-cCCCCCccCcchhhHHHHHHHHhCCCCCCc
Q 047157 650 QTRTDTNMRGTMGYVAPEWL-RNVPVTTKVDVFSFGVMLLEIICGRRHIEL 699 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~elltg~~p~~~ 699 (788)
.........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 31122334577889999998 677888899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=220.23 Aligned_cols=252 Identities=19% Similarity=0.285 Sum_probs=186.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeE-EecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGF-CSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~-~~~~~~~~lV~ 566 (788)
.|.+.+.||+|.||.+.++.++ ..+..+++|.+.+. ....++|.+|..----| .|.||+.-|++ |+..+..++++
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr--~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHR--QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhHHHHhcccceeeEEeeecc--CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4677899999999999999987 77889999998765 44567899998765555 58999988874 67788889999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||++.|+|.+-+.. ..+.+....+++.|++.||.|+|++ ++||||||.+||||-.. +..++||+|||..+..
T Consensus 102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~---df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDA---DFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecC---CccEEEeeeccccccc
Confidence 99999999988744 4567778889999999999999999 99999999999999643 4559999999998865
Q ss_pred CCCCCcccccccCCccccCcccccCC-----CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNV-----PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+..-. ...-+..|.|||..... ...+.+|||.||+++|.++||+.||+.....+ ...|-+..+
T Consensus 174 g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d--------~~Y~~~~~w 241 (378)
T KOG1345|consen 174 GTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD--------KPYWEWEQW 241 (378)
T ss_pred Cceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC--------chHHHHHHH
Confidence 43221 12345679999977432 35678999999999999999999997432211 122333333
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..+....+. ... ....++++++.++-+.++|++|=-..++.+
T Consensus 242 ~~rk~~~~P----~~F--~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 242 LKRKNPALP----KKF--NPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred hcccCccCc----hhh--cccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 322222111 110 112355666777889999999944444443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-26 Score=246.82 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=200.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
|.+...+|.|.||.||+++.+ ..+...|+|.++-......+-+.+|+-+++..+||||+.+++-+...+..++.|||+
T Consensus 17 yellqrvgsgTygdvyKaRd~--~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDK--RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred hhheeeecCCcccchhhhccc--ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 344578999999999999887 667788999888776677778889999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
.+|+|.+.-+ -...+++.++....+..++||+|||+. +=+|||||-.|||++ +.+.+||+|||.+..+...
T Consensus 95 gggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanillt-----d~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 95 GGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLT-----DEGDVKLADFGVSAQITAT 165 (829)
T ss_pred CCCcccceee-ecccchhHHHHHHHhhhhccchhhhcC---Ccccccccccceeec-----ccCceeecccCchhhhhhh
Confidence 9999998764 346788899999999999999999999 889999999999998 8899999999998876432
Q ss_pred CCcccccccCCccccCcccc---cCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWL---RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
-. ....+.||+.|||||+. +.+.|..++|||++|+...|+---+.|...... ..+...+.....
T Consensus 166 i~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------------mr~l~LmTkS~~ 232 (829)
T KOG0576|consen 166 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------------MRALFLMTKSGF 232 (829)
T ss_pred hh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------------HHHHHHhhccCC
Confidence 22 23457899999999987 566789999999999999999877665432100 001111111111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..+.........+.+.++++.|+..+|++|||++.++.
T Consensus 233 -----qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 -----QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -----CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 12334444566778888999999999999999987654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=229.47 Aligned_cols=198 Identities=23% Similarity=0.355 Sum_probs=163.1
Q ss_pred hcccccccccccceEEEEEEecc-CcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e 567 (788)
+...++||.|.|++||++.+... .....||+|.+.... .-.++.+|++.|..+ .|.||+++.+++..++...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 44468899999999999988741 256689999986543 234688999999998 59999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|++.....++. ..++..++..+++.++.||.++|.+ |||||||||+|+|.+. ....-.|.|||+|....
T Consensus 116 ~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~----~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 116 YFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNR----RTQRGVLVDFGLAQRYD 184 (418)
T ss_pred ccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccc----ccCCceEEechhHHHHH
Confidence 99999999888 4466888999999999999999999 9999999999999984 44677899999998210
Q ss_pred C-------------CC------------------------------CcccccccCCccccCcccccC-CCCCccCcchhh
Q 047157 648 K-------------DQ------------------------------TRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSF 683 (788)
Q Consensus 648 ~-------------~~------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSl 683 (788)
. .. ........||++|.|||++.. ...++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 0 00 001123469999999999865 457889999999
Q ss_pred HHHHHHHHhCCCCCCcc
Q 047157 684 GVMLLEIICGRRHIELS 700 (788)
Q Consensus 684 Gvil~elltg~~p~~~~ 700 (788)
|||++-+++++.||...
T Consensus 265 GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKA 281 (418)
T ss_pred cceeehhhccccccccC
Confidence 99999999999999654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=266.70 Aligned_cols=201 Identities=20% Similarity=0.278 Sum_probs=142.6
Q ss_pred CCCc-cccceEeeEE-------ecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEe
Q 047157 543 RTHH-KNLVRLLGFC-------SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIH 614 (788)
Q Consensus 543 ~l~h-pniv~~~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH 614 (788)
.++| +||++++++| .+.+..++++|++ +++|.++|......+++.+++.++.||++||.|||++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 4456 6888888877 2334567888987 6699999976666789999999999999999999999 9999
Q ss_pred cCCCCCcEEeccCC--------------CCCCCcEEEeecCCccccCCCCC---------------cccccccCCccccC
Q 047157 615 CDIKPQNVLLDLKT--------------LDTNYMAKISDFGISKLLNKDQT---------------RTDTNMRGTMGYVA 665 (788)
Q Consensus 615 ~dlkp~NIll~~~~--------------~~~~~~~kL~Dfg~a~~~~~~~~---------------~~~~~~~gt~~y~a 665 (788)
|||||+||||+..+ ...+..+||+|||+++....... .......||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996211 01345677777777764321000 00111357888999
Q ss_pred cccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHH
Q 047157 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFER 745 (788)
Q Consensus 666 PE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 745 (788)
||++.+..++.++|||||||+||||++|..|+..... ...... ... + .+. ......+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~-----~~~----~--~~~---~~~~~~~ 240 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLR-----HRV----L--PPQ---ILLNWPK 240 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHH-----Hhh----c--Chh---hhhcCHH
Confidence 9999999999999999999999999998887642210 000000 000 0 000 0111234
Q ss_pred HHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 746 MAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 746 l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...++.+||++||.+||+|.||+++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhc
Confidence 5678889999999999999999863
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=191.33 Aligned_cols=106 Identities=29% Similarity=0.558 Sum_probs=93.7
Q ss_pred CCCeeecCCCeEEEeeeecCCCc-eEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeCCCcEEEEeccc-
Q 047157 38 SNTSWLSPSGDFAFGFYSLFGGL-YLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSGA- 115 (788)
Q Consensus 38 ~~~~~vS~~g~F~lGFf~~~~~~-~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~~~~~~~~~s~~- 115 (788)
.+++|+|++|.|++|||++.... .+.+|||.+++ +++||+||++.|....++|.|..||+|+|.|.+|.+.|.+.+.
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~ 84 (116)
T cd00028 6 SGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR 84 (116)
T ss_pred CCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccC
Confidence 34789999999999999998776 99999999887 8999999999997777899999999999999888765544432
Q ss_pred ---ccccccCCCCcEEEEecCCceeecccCCC
Q 047157 116 ---ASLALMQNDGNFVLKNANSAVVWDSFDFP 144 (788)
Q Consensus 116 ---~~~a~LldsGNlVl~~~~~~~lWqSFD~P 144 (788)
..+++|+|+|||||++.++.++|||||||
T Consensus 85 ~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 85 VNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred CCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 34689999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-25 Score=194.82 Aligned_cols=99 Identities=41% Similarity=0.670 Sum_probs=67.8
Q ss_pred CCeEEEEecCCCCCC---CCcEEEEecCCceEEEeCCCcEEEEe-cc-----cccccccCCCCcEEEEecCCceeecccC
Q 047157 72 EKTLVWAADRDSPAE---AGSKITLTNDGKLLLTYFNGSVQQIY-SG-----AASLALMQNDGNFVLKNANSAVVWDSFD 142 (788)
Q Consensus 72 ~~tvVWvANr~~p~~---~~s~l~l~~~G~L~l~~~~~~~~~~~-s~-----~~~~a~LldsGNlVl~~~~~~~lWqSFD 142 (788)
++||||+|||++|+. ...+|.|..||||+|.+.+++..|.. .+ ....|.|+|+|||||++..+.++|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 479999999999993 34789999999999999887764443 21 1467999999999999999999999999
Q ss_pred CCCCcccCCccccCCCe------EEeecCCCCCCC
Q 047157 143 FPTDTILPGQVLLTGKK------LYSNSRGTADYS 171 (788)
Q Consensus 143 ~PtDtllpg~~l~~g~~------l~s~~~~~~dps 171 (788)
|||||+||||+|+.|.. +.+ |++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~s-w~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTS-WSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEE-EESS----
T ss_pred CCccEEEeccCcccCCCccccceEEe-ECCCCCCC
Confidence 99999999999987553 344 47888886
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=206.30 Aligned_cols=166 Identities=21% Similarity=0.206 Sum_probs=126.1
Q ss_pred CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC
Q 047157 572 GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651 (788)
Q Consensus 572 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~ 651 (788)
|+|.+++...+..+++.+++.++.||+.||.|||++ + ||+|||++ .++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~-----~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLT-----WDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEc-----Cccceee--ccceEeecccc-
Confidence 689999987677899999999999999999999998 4 99999998 7888999 99988654322
Q ss_pred cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccccc
Q 047157 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVS 731 (788)
Q Consensus 652 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 731 (788)
..|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.... .....
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------~~~~~~~-~~~~~-------- 123 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS------AILEILL-NGMPA-------- 123 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc------HHHHHHH-HHhcc--------
Confidence 257899999999999999999999999999999999999986432111 0011111 00000
Q ss_pred CCCCC-cccHHHH--HHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 732 HDPEV-LSDLERF--ERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 732 ~~~~~-~~~~~~~--~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
..+.. ....... .++.+++.+||+.||++||++.|+++++...
T Consensus 124 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 124 DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00110 1111222 2689999999999999999999999988643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=185.03 Aligned_cols=105 Identities=29% Similarity=0.534 Sum_probs=92.9
Q ss_pred CCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeCCCcEEEEeccc--
Q 047157 38 SNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSGA-- 115 (788)
Q Consensus 38 ~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~~~~~~~~~s~~-- 115 (788)
.+++|+|++|.|++|||.+.....+.+|||++.+ +++||+|||+.|+..++.|.|..||+|+|.+.+|.+.|...+.
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~ 84 (114)
T smart00108 6 SGQTLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGA 84 (114)
T ss_pred CCCEEecCCCcEeeeccccCCCCCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccCC
Confidence 4578999999999999999877899999999987 8999999999999777899999999999999888765544433
Q ss_pred --ccccccCCCCcEEEEecCCceeecccCC
Q 047157 116 --ASLALMQNDGNFVLKNANSAVVWDSFDF 143 (788)
Q Consensus 116 --~~~a~LldsGNlVl~~~~~~~lWqSFD~ 143 (788)
..+++|+|+|||||++..+.++||||||
T Consensus 85 ~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 85 NGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred CCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 3478999999999999999999999997
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-22 Score=210.69 Aligned_cols=173 Identities=19% Similarity=0.154 Sum_probs=131.3
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc-----hHHHHHHHHHHHHHhcCCCccccce-EeeEEecCCe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-----IEKTNEEFMTELKIIGRTHHKNLVR-LLGFCSEEDK 561 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~hpniv~-~~~~~~~~~~ 561 (788)
..|.+.+.||+|+||+||+|.+... ++..+|||++... .....+.+.+|++++++++|+|+++ +++ .+.
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~ 92 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGD-PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGK 92 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCC-CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCC
Confidence 3467789999999999999987521 4556899986532 1234567999999999999999985 443 246
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCC-CCCcEEeccCCCCCCCcEEEeec
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDI-KPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dl-kp~NIll~~~~~~~~~~~kL~Df 640 (788)
.++||||+++++|... ... . ...++.|++++|.|||++ +|+|||| ||+|||++ .++.+||+||
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~-----~~~~ikLiDF 156 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG-----PDGEAAVIDF 156 (365)
T ss_pred cEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc-----CCCCEEEEEC
Confidence 7999999999999732 111 1 146789999999999999 9999999 99999998 6778999999
Q ss_pred CCccccCCCCCcc-------cccccCCccccCcccccCCC------CCccCcch
Q 047157 641 GISKLLNKDQTRT-------DTNMRGTMGYVAPEWLRNVP------VTTKVDVF 681 (788)
Q Consensus 641 g~a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~s~k~DVw 681 (788)
|+++.+....... .....+++.|+|||.+...+ .+..+|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999775543211 13466888999999985432 33446666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=207.85 Aligned_cols=265 Identities=21% Similarity=0.254 Sum_probs=192.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCc----cccceEeeEE-ecCCeEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHH----KNLVRLLGFC-SEEDKRL 563 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----pniv~~~~~~-~~~~~~~ 563 (788)
.|.+.++||+|+||.||.+...... ...+|+|............+..|..++..+.+ +++.++++.. ..+...+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~-~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK-NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC-CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 5677899999999999999876333 45788887765433322367788888888863 6899999988 5778899
Q ss_pred EEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 564 LVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
+||+.+ |.+|.++..... +.++..+.+.|+.|++.+|.+||+. |++||||||+|+++..........+.|.|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999998 889999886554 7899999999999999999999999 99999999999999843211236799999999
Q ss_pred cc--ccCCCCC------cc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh
Q 047157 643 SK--LLNKDQT------RT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL 713 (788)
Q Consensus 643 a~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 713 (788)
++ ....... .. .....||..|+++....+.+.+.+.|+||++.++.|++.|..||.......... ..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~----~~ 249 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS----KF 249 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH----HH
Confidence 98 3322111 11 234569999999999999999999999999999999999999996543221111 00
Q ss_pred HHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 714 SDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 714 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
....... .... ........+.++...+-..+..++|....+...|+...
T Consensus 250 ~~~~~~~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 250 EKDPRKL--------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHhhhh--------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 0100000 0000 00111233444444455578999999999998886554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=195.23 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=185.2
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeeccc--chHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
++..+|...-.|..|+|++. + ..+++|++.- -.....++|..|.-.|+.+.||||+.+++.|.......++..|
T Consensus 193 nl~tkl~e~hsgelwrgrwq--g--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ--G--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhccCCCccccccccc--C--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 34567888899999999985 2 2566666642 2344456888999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe--ecCCccc
Q 047157 569 MPNGTLSNFLFHEGQ-RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS--DFGISKL 645 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~--Dfg~a~~ 645 (788)
|+.|+|...|+.... ..+..+..+++.+|++|++|||+. .+-|..--|....+++| ++.+++|+ |--++
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmid-----edltarismad~kfs-- 340 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMID-----EDLTARISMADTKFS-- 340 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEec-----chhhhheecccceee--
Confidence 999999999976533 347788899999999999999996 33344456889999999 77777764 22111
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCC---ccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVT---TKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
.......-.+.||+||.++.++-+ .++|+|||.++||||.|...||......+...+..
T Consensus 341 ------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------ 402 (448)
T KOG0195|consen 341 ------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------ 402 (448)
T ss_pred ------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------------
Confidence 111223346889999999877654 47999999999999999999997654433221110
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
+ .......+......+.+++.-|+.+||.+||.+..|+-.||++.
T Consensus 403 ---l-----eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 ---L-----EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---h-----ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0 01122223344566778888899999999999999999998764
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=173.28 Aligned_cols=107 Identities=27% Similarity=0.653 Sum_probs=85.0
Q ss_pred cccCcccccceeeeecc---ceeEEEEecCCcceEEEEeeccCCCCceEEEEEEeCCccEEEEEeecCCCCceeEEeecc
Q 047157 198 WYTGTVTLNNVSLIFNQ---SAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAV 274 (788)
Q Consensus 198 w~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~ld~~G~l~~~~w~~~~~~~W~~~~~~p 274 (788)
|++|+|++..++.+..+ ..+.+.|..+.++.+..+. ..+.+.++|++||.+|+++++.|.+ ..+.|..+|++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~---~~~~s~~~r~~ld~~G~l~~~~w~~-~~~~W~~~~~~p 76 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYS---LSNSSVLSRLVLDSDGQLQRYIWNE-STQSWSVFWSAP 76 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEe---cCCCceEEEEEEeeeeEEEEEEEec-CCCcEEEEEEec
Confidence 78888888777665543 3445556666655554432 2346789999999999999999976 468899999999
Q ss_pred ccccccCCCCCCCcccccCCCCCcccCCCCCCccCC
Q 047157 275 NDPCIVNCICGVYGMCTSSDNETVTCNCIPGYTPLN 310 (788)
Q Consensus 275 ~~~C~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~~~ 310 (788)
.|+||+|+.||+||+|+. +..|.|+||+||+|++
T Consensus 77 ~d~Cd~y~~CG~~g~C~~--~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 77 KDQCDVYGFCGPNGICNS--NNSPKCSCLPGFEPKN 110 (110)
T ss_pred ccCCCCccccCCccEeCC--CCCCceECCCCcCCCc
Confidence 999999999999999964 5678899999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.6e-21 Score=188.78 Aligned_cols=207 Identities=20% Similarity=0.269 Sum_probs=179.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|++.++||.|.||.++.|..- -++++||||.-...+ ...++..|.+..+.| ..+.|..++-|-.++.+-.||+|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl--~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNL--YNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeeccccc--ccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4667899999999999999876 567799999865433 234667888888887 47999999999899999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
.+ |.||+++..-.+++++.+++..+|.|++.-++|+|++ .+|.|||||+|+||..........+.|+|||+|+...
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 98 8999999988899999999999999999999999999 9999999999999987776677889999999999876
Q ss_pred CCCCc------ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccc
Q 047157 648 KDQTR------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVE 703 (788)
Q Consensus 648 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~ 703 (788)
...+. ......||.+||+--...+.+.+.+.|+-|||-++.+.|-|..||.+....
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 54432 234467999999999999999999999999999999999999999876443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7e-21 Score=181.70 Aligned_cols=209 Identities=22% Similarity=0.313 Sum_probs=177.0
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCc-cccceEeeEEecCCeEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHH-KNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~ 563 (788)
|....|.+.++||.|+||.+|.|... ..+..||||.-+... ...++.-|..+...|+| ..|+.+..+..+...-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i--~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISI--TSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeec--cCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 44556788899999999999999887 677899999876543 23467788899988865 77888888899999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+|||.. |.+|+++..-..+.++..+.+-++-|++.-++|+|.+ +++||||||+|+|..-.. ....+.|+|||++
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgr--h~~kl~LIDFGLa 161 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGR--HCNKLYLIDFGLA 161 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeecccc--ccceEEEEeccch
Confidence 999998 8999999977788999999999999999999999999 999999999999997443 4568999999999
Q ss_pred cccCCCCC------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccc
Q 047157 644 KLLNKDQT------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVE 703 (788)
Q Consensus 644 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~ 703 (788)
+......+ ....+..||..|.+--...+...+.+.|+-|+|.+|..+.-|..||++....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 97743322 2234567999999998888888899999999999999999999999876443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=222.60 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=184.5
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeec-----ccchHH-HHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKL-----EKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l-----~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.+++|.|++|.|+...... .....+.|.. ...... ....+..|+-+-..++|||++..+..+.+.....-+|
T Consensus 323 ~~~~g~ga~g~~~~~~~~~--~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRS--DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred cceeeecccCceEEEEecC--CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4689999999777766542 2222233322 111111 1223677888888999999998888887777777779
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++ +|..++... ..+...++..++.|++.|+.|||+. +|.|||||++|+++. .++.+||+|||.+..+
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~-----~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVT-----ENGILKIIDFGAASVF 470 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEe-----cCCceEEeecCcceee
Confidence 99999 999998544 4678888899999999999999999 999999999999998 8889999999999877
Q ss_pred CCCCC---cccccccCCccccCcccccCCCCCc-cCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 647 NKDQT---RTDTNMRGTMGYVAPEWLRNVPVTT-KVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 647 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~-k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
..... ......+|+..|+|||.+.+.+|.+ ..||||.|+++..|++|+.||......+..... ..
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-----------~~ 539 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-----------NN 539 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-----------hc
Confidence 55443 3445678999999999999999987 599999999999999999999765433321100 00
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...-.... ............+...++.+||+.||.+|.|+++|++
T Consensus 540 ~~~~~~~~--~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 540 YSDQRNIF--EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccccc--cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000000 0000011233456678999999999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-19 Score=191.94 Aligned_cols=259 Identities=28% Similarity=0.381 Sum_probs=194.1
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHH---HHHHHHHHHHHhcCCCcc-ccceEeeEEecCCeEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK---TNEEFMTELKIIGRTHHK-NLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lV 565 (788)
+.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+++......+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence 445678999999999999874 57888888654432 467899999999999988 799999999887788999
Q ss_pred EecCCCCCHhHhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCC-cEEEeecCC
Q 047157 566 YELMPNGTLSNFLFHEG--QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNY-MAKISDFGI 642 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~-~~kL~Dfg~ 642 (788)
++++.+++|.+++.... ..+.......++.|++.++.|+|.. +++|||+||+||+++ ... .++++|||.
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~-----~~~~~~~l~dfg~ 148 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLD-----RDGRVVKLIDFGL 148 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeec-----CCCCeEEEeccCc
Confidence 99999999997775544 2688899999999999999999999 999999999999998 555 799999999
Q ss_pred ccccCCCCCc-----ccccccCCccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH
Q 047157 643 SKLLNKDQTR-----TDTNMRGTMGYVAPEWLRN---VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 643 a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 714 (788)
+......... ......++..|+|||.+.+ ...+...|+||+|++++++++|..||....... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~--------~~ 220 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS--------AT 220 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc--------cH
Confidence 9865443322 2345779999999999987 678899999999999999999999976543210 00
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
................ ..............+.+++..++..+|..|.++.+....
T Consensus 221 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 221 SQTLKIILELPTPSLA-SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHhcCCcccc-cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0011111111100000 000000002223567778888999999999999887764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=195.38 Aligned_cols=217 Identities=24% Similarity=0.424 Sum_probs=166.1
Q ss_pred hcCCCccccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCce-EecCCCC
Q 047157 541 IGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQI-IHCDIKP 619 (788)
Q Consensus 541 l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~i-vH~dlkp 619 (788)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+......+++.....++++|+.||.|||.. +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 4678999999999999999999999999999999999988888899999999999999999999987 55 9999999
Q ss_pred CcEEeccCCCCCCCcEEEeecCCccccCCC-CCcccccccCCccccCcccccCC-------CCCccCcchhhHHHHHHHH
Q 047157 620 QNVLLDLKTLDTNYMAKISDFGISKLLNKD-QTRTDTNMRGTMGYVAPEWLRNV-------PVTTKVDVFSFGVMLLEII 691 (788)
Q Consensus 620 ~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~s~k~DVwSlGvil~ell 691 (788)
.|.++| ....+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|++
T Consensus 78 ~nClvd-----~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 78 SNCLVD-----SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred ccceee-----eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 999999 9999999999998876431 11111112234579999998653 2577899999999999999
Q ss_pred hCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 692 CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 692 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
+.+.||.......... .+...+ .. .....+ +|......+..+.+..++..||..+|++||++++|-..+
T Consensus 153 ~r~~~~~~~~~~~~~~----eii~~~----~~-~~~~~~--rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPD----EIILRV----KK-GGSNPF--RPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred hccCccccccccCChH----HHHHHH----Hh-cCCCCc--CcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 9999998643322210 111111 11 111111 122221224445788999999999999999999999988
Q ss_pred hcCcC
Q 047157 772 EGTLE 776 (788)
Q Consensus 772 ~~~~~ 776 (788)
+.+..
T Consensus 222 ~~~~~ 226 (484)
T KOG1023|consen 222 LTINK 226 (484)
T ss_pred hhhcc
Confidence 76654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=178.05 Aligned_cols=175 Identities=13% Similarity=0.122 Sum_probs=133.0
Q ss_pred HHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHH---H------HHHHHHHhcCCCccccceE
Q 047157 482 FQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNE---E------FMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 482 ~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~hpniv~~ 552 (788)
.+++....|+..++||.|+||.||+... +...+++|.+........+ . +.+|++.+.+++|++|..+
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 3456677888889999999999998543 3447999999644322222 2 6899999999999999999
Q ss_pred eeEEecC--------CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEe
Q 047157 553 LGFCSEE--------DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLL 624 (788)
Q Consensus 553 ~~~~~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 624 (788)
.+++... ...+|||||++|.+|.++.. .+. ....+++.+|..||+. +++|||+||+||++
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 9886543 35789999999999988741 222 3456999999999999 99999999999999
Q ss_pred ccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHH
Q 047157 625 DLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691 (788)
Q Consensus 625 ~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ell 691 (788)
+ +++ ++|+|||.......+.... .+.....+..++|+|+||+.+..+.
T Consensus 169 ~-----~~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 S-----KNG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred e-----CCC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 8 566 9999999887543221111 1334445667999999999887664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-20 Score=209.84 Aligned_cols=251 Identities=21% Similarity=0.217 Sum_probs=175.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHH---HHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTN---EEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
.+.+.+.||++.|=+|.++++. .| .|+||++-+.. .-.. ++-..|++ ...++|||.+.+.-+...+...||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~---eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR---EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC---Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHH
Confidence 3556789999999999999874 55 47788774433 2222 23334444 556689999999888778888889
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|-+|.. -+|.|.|..+ ..+...+...|+.|++.||..+|.. +|+|||||.+||||+ .-.-+.|+||..-+
T Consensus 99 vRqyvk-hnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiT-----SWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 99 VRQYVK-HNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILIT-----SWNWLYLTDFASFK 168 (1431)
T ss_pred HHHHHh-hhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEe-----eechhhhhcccccC
Confidence 888884 4888877333 4567778888999999999999999 999999999999998 77789999998765
Q ss_pred cc--CCCCCcccc----cccCCccccCcccccC----------CC-CCccCcchhhHHHHHHHHh-CCCCCCcccccccc
Q 047157 645 LL--NKDQTRTDT----NMRGTMGYVAPEWLRN----------VP-VTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEES 706 (788)
Q Consensus 645 ~~--~~~~~~~~~----~~~gt~~y~aPE~~~~----------~~-~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~ 706 (788)
.. ..+...... +...-..|+|||.+.. .. .+++.||||+||++.||++ |++||+....-.-.
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr 248 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYR 248 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHh
Confidence 32 222221111 1223347999998743 12 6789999999999999987 57778654221111
Q ss_pred ccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 707 EEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
... .... +.++. .-+...+.++++.|++.||++|.++++.++.-.+..
T Consensus 249 ~~~-~~~~------------e~~Le--------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 249 SGN-ADDP------------EQLLE--------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred ccC-ccCH------------HHHHH--------hCcCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 100 0000 00000 001125677889999999999999999999866643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-18 Score=170.15 Aligned_cols=140 Identities=17% Similarity=0.144 Sum_probs=106.7
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHH--H------------------------HHHHHHHHHHhcCCCc
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK--T------------------------NEEFMTELKIIGRTHH 546 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~h 546 (788)
...||+|++|.||+|... ++..||||.++..... . ......|++.+.++.|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~---~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05147 2 NGCISTGKEANVYHATTA---NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT 78 (190)
T ss_pred CCccccccceEEEEEECC---CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 357999999999999874 5679999998654211 0 1123459999999988
Q ss_pred cccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHh-hhccCCceEecCCCCCcEEec
Q 047157 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYL-HEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 547 pniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~~~~ivH~dlkp~NIll~ 625 (788)
+++.....+.. ...+|||||+++++|...... ...++......++.|++.+|.+| |+. +|+||||||+|||++
T Consensus 79 ~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 79 AGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 77644333222 223899999998877655322 35678889999999999999999 687 999999999999996
Q ss_pred cCCCCCCCcEEEeecCCccccC
Q 047157 626 LKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
+ +.++|+|||++....
T Consensus 153 -----~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -----D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred -----C-CcEEEEEccccccCC
Confidence 2 579999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-18 Score=172.67 Aligned_cols=228 Identities=22% Similarity=0.274 Sum_probs=147.3
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeeccc---chHHHHHHHHHHHHHhcCCC----------ccccceEeeEEe--
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK---DIEKTNEEFMTELKIIGRTH----------HKNLVRLLGFCS-- 557 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~----------hpniv~~~~~~~-- 557 (788)
.+.||.|+++.||.+++. .+++++++|.... ......+++++|.-....+. |-.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~--~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDV--ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEETTEEEEEEEET--TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred ccccccCCceEEEEEEEc--cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 578999999999999987 7788999997642 22345667777776555543 222332233221
Q ss_pred -------cC---C-----eEEEEEecCCCCCHhHhhh---ccCCC---CCHHHHHHHHHHHHHHHHHhhhccCCceEecC
Q 047157 558 -------EE---D-----KRLLVYELMPNGTLSNFLF---HEGQR---PGWVQRVEIALGVARGLLYLHEECETQIIHCD 616 (788)
Q Consensus 558 -------~~---~-----~~~lV~e~~~~gsL~~~l~---~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~d 616 (788)
.. . ..+++|+-+ .++|.+++. ..... +....++.+..|+++.+++||.. |++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 11 1 235677777 668887753 22222 34556677889999999999999 999999
Q ss_pred CCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccC--------CCCCccCcchhhHHHHH
Q 047157 617 IKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN--------VPVTTKVDVFSFGVMLL 688 (788)
Q Consensus 617 lkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DVwSlGvil~ 688 (788)
|+|+|++++ .++.++|+||+.....+..... ...+..|.|||.... ..++.+.|.|++|+++|
T Consensus 171 i~~~nfll~-----~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 171 IKPENFLLD-----QDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp -SGGGEEE------TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred cceeeEEEc-----CCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 999999999 8899999999887765432221 234578999997633 35788999999999999
Q ss_pred HHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCC
Q 047157 689 EIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLR 761 (788)
Q Consensus 689 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 761 (788)
.|.+++.||........... .+ . ... +.++.+..||..+|+.||.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~--------------------~f----~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW--------------------DF----S-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG--------------------GG----T-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccccc--------------------cc----h-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999986633221110 00 0 111 456778889999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=160.72 Aligned_cols=184 Identities=14% Similarity=0.053 Sum_probs=136.6
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHH----HHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEe
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK----TNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e 567 (788)
...|++|+||+||.+. ..+.+++.+.+.....- ....+.+|+++|++|+ |+++++++++ +..+++||
T Consensus 7 ~~~l~~~~f~~v~~~~----~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 7 NEPLKSDTFGRILLVR----GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ceeecCCCcceEEEee----cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4679999999999653 34557777777654321 1235889999999995 5889999886 45699999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCC-CCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDI-KPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dl-kp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+.|.+|.+.+.. ....++.|++++|.++|++ +|+|||| ||+|||++ .++.++|+|||++...
T Consensus 79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~-----~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQ-----EDGSPAVIDFQLAVRG 142 (218)
T ss_pred eecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEc-----CCCCEEEEECCCceec
Confidence 9999998754311 1235788999999999999 9999999 79999998 6778999999999865
Q ss_pred CCCCCc----c--------cccccCCccccCcccccCC-CCC-ccCcchhhHHHHHHHHhCCCCCCcc
Q 047157 647 NKDQTR----T--------DTNMRGTMGYVAPEWLRNV-PVT-TKVDVFSFGVMLLEIICGRRHIELS 700 (788)
Q Consensus 647 ~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~k~DVwSlGvil~elltg~~p~~~~ 700 (788)
...... . ..-...++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+....
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 543321 0 0112356778888754321 333 5678889999999999999876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=168.26 Aligned_cols=200 Identities=22% Similarity=0.248 Sum_probs=141.7
Q ss_pred CccccceEeeEEec---------------------------CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHH
Q 047157 545 HHKNLVRLLGFCSE---------------------------EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGV 597 (788)
Q Consensus 545 ~hpniv~~~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi 597 (788)
+|||||++.++|.+ ....|+||..+ ..+|.+++..+ ..+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC--CCchHHHHHHHHHH
Confidence 68888888877632 23578999887 45999999654 45566677789999
Q ss_pred HHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC-----CcccccccCCccccCcccccCC
Q 047157 598 ARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ-----TRTDTNMRGTMGYVAPEWLRNV 672 (788)
Q Consensus 598 ~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~ 672 (788)
++|+.|||.+ +|.|||+|.+|||+..++ +......|+|||++---.... ........|...-||||+....
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~Eldd-D~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDD-DEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecC-CCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999 999999999999997553 255678999999986543321 2223345688889999998543
Q ss_pred C-----C-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHH
Q 047157 673 P-----V-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERM 746 (788)
Q Consensus 673 ~-----~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l 746 (788)
+ . -.|+|.|+.|.+.||+++...||........ .... +.+..+..+.+ .....+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L------~~r~-----Yqe~qLPalp~---------~vpp~~ 486 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL------DTRT-----YQESQLPALPS---------RVPPVA 486 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee------chhh-----hhhhhCCCCcc---------cCChHH
Confidence 2 1 2589999999999999999999976321110 1101 12222222221 123456
Q ss_pred HHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 747 AMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 747 ~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
.+++...|+.||++|++..-....|
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHH
Confidence 6788889999999999987655544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=161.53 Aligned_cols=141 Identities=17% Similarity=0.127 Sum_probs=108.4
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHH--------------------------HHHHHHHHHHHhcCCCc
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK--------------------------TNEEFMTELKIIGRTHH 546 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~h 546 (788)
.+.||+|++|.||+|... ++..||||.++..... ....+..|.+.+.++.|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~---~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05145 2 NGCISTGKEANVYHARTG---DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE 78 (190)
T ss_pred CceeecCCCcEEEEEEcC---CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence 367999999999999874 5779999998754210 01234678999999999
Q ss_pred cccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEec
Q 047157 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 547 pniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~ 625 (788)
+++.....+... ..+|||||++++++...... ...++......++.|++.+|.+||+ . +|+||||||+||+++
T Consensus 79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 987544443332 24899999998865443222 2456778889999999999999999 8 999999999999995
Q ss_pred cCCCCCCCcEEEeecCCccccCC
Q 047157 626 LKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
++.++|+|||++.....
T Consensus 153 ------~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 ------DGKPYIIDVSQAVELDH 169 (190)
T ss_pred ------CCCEEEEEcccceecCC
Confidence 35799999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=162.15 Aligned_cols=138 Identities=20% Similarity=0.258 Sum_probs=105.8
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-----CccccceEeeEEecCC---eEE-
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-----HHKNLVRLLGFCSEED---KRL- 563 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~---~~~- 563 (788)
.++||+|+|+.||. ++ ..... +||++........+.+.+|+.+++.+ .||||++++++++++. ..+
T Consensus 7 ~~~LG~G~~~~Vy~--hp--~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HP--EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CC--CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 36899999999995 43 33433 68877654344567899999999999 5799999999998864 333
Q ss_pred EEEec--CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHH-HHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 564 LVYEL--MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGL-LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 564 lV~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL-~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
+|+|| +++++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++..+ ..+..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~-~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRIS-ESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccC-CCCCcEEEEEC
Confidence 78999 5579999999553 34444 35678888777 999999 999999999999997433 13458999995
Q ss_pred CCc
Q 047157 641 GIS 643 (788)
Q Consensus 641 g~a 643 (788)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.1e-18 Score=183.59 Aligned_cols=189 Identities=29% Similarity=0.285 Sum_probs=152.7
Q ss_pred cccccccceEEEEEEe-ccCcceeeeeeecccchHH--HHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEecCC
Q 047157 495 LVGTGSSGKVYRGILR-LKDTQIEIAVKKLEKDIEK--TNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~-~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
++|+|.||.|+++.-. ..+.+..+|+|.+.+.... .......|..++...+ ||.++++.-.++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3789999999875321 2244556788877654311 1124556778888886 9999999999999999999999999
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
+|.|...+.+. ..........+...++-+++++|+. +|+|||+|++||+++ .+|++++.|||+++..-...
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld-----~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLL-----LEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeec-----ccCccccCCchhhhHhHhhh
Confidence 99999888655 3344555556667789999999999 999999999999999 88999999999998764433
Q ss_pred CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCc
Q 047157 651 TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIEL 699 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~ 699 (788)
.. +||..|||||++. ....++|-||||++.+||++|..||..
T Consensus 152 ~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 IA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 22 7899999999998 578899999999999999999999976
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.9e-17 Score=189.66 Aligned_cols=204 Identities=23% Similarity=0.207 Sum_probs=158.3
Q ss_pred HHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC---ccccceEeeEEecC
Q 047157 483 QELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH---HKNLVRLLGFCSEE 559 (788)
Q Consensus 483 ~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~ 559 (788)
-++....+.+.+.||+|+||+||.|... ++..||+|.-+.... =+|.--.+++.||+ -+-|+++...+.-.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~---~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHS---NGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecC---CCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3455556677899999999999999885 488999998653321 11222223334443 23455555556667
Q ss_pred CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCC--CCCcEEE
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD--TNYMAKI 637 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~--~~~~~kL 637 (788)
+.-+||+||.+.|+|.+++. ..+.+++.....++.|+++-+++||.. +|||+||||+|+||..+... +...++|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 78899999999999999996 557789999999999999999999999 99999999999999654322 3557999
Q ss_pred eecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC
Q 047157 638 SDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p 696 (788)
+|||.+..+.--... ......+|-.+--+|...+++++..+|.|.+..+++-||.|+..
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999999866432222 33446778899999999999999999999999999999999853
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.6e-17 Score=171.51 Aligned_cols=121 Identities=28% Similarity=0.513 Sum_probs=106.2
Q ss_pred eEEEEEecCCCCCHhHhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 561 KRLLVYELMPNGTLSNFLFHE--GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
..||.|+++...+|.++|..+ ....++...+.++.|++.|+.| + +.+|+|+||.||+.. .+..+||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~-----~d~q~kIg 398 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFS-----DDDQLKIG 398 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccc-----cchhhhhh
Confidence 578999999999999999543 4566888999999999999999 5 899999999999997 67789999
Q ss_pred ecCCccccCCCC-----CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh
Q 047157 639 DFGISKLLNKDQ-----TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC 692 (788)
Q Consensus 639 Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 692 (788)
|||+........ ....+...||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 999998776554 223455679999999999999999999999999999999997
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-15 Score=154.71 Aligned_cols=142 Identities=18% Similarity=0.231 Sum_probs=107.9
Q ss_pred hcccccccccccceEEEEE-EeccCcceeeeeeecccchH------------------------HHHHHHHHHHHHhcCC
Q 047157 490 KGFSKLVGTGSSGKVYRGI-LRLKDTQIEIAVKKLEKDIE------------------------KTNEEFMTELKIIGRT 544 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~-~~~~~~~~~vavK~l~~~~~------------------------~~~~~~~~E~~~l~~l 544 (788)
+.+.+.||+|++|.||+|. .. .++..||+|.+..... .....+..|++.+.++
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~--~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFD--GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred HHhCCeeccCcceeEEEEEecC--CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4566899999999999998 33 4677999998864321 0123467899999999
Q ss_pred Ccc--ccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCc-eEecCCCCCc
Q 047157 545 HHK--NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ-IIHCDIKPQN 621 (788)
Q Consensus 545 ~hp--niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~-ivH~dlkp~N 621 (788)
.+. .+++++++ ...++||||+++.+|....... ..........++.||+.+|.+||+. + |+||||||+|
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 753 34455543 2358999999998887665332 3445566778999999999999999 9 9999999999
Q ss_pred EEeccCCCCCCCcEEEeecCCccccC
Q 047157 622 VLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 622 Ill~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~------~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH------DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE------CCCEEEEEChhhhccC
Confidence 9996 3579999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.7e-15 Score=150.38 Aligned_cols=134 Identities=21% Similarity=0.348 Sum_probs=109.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch--------HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--------EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
+.||+|++|.||+|.. .+..+++|...... ......+.+|++++..++|++|+....++...+..++|
T Consensus 2 ~~l~~G~~~~vy~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEE
Confidence 5789999999999976 33467778654221 11234678899999999999988777777777888999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||++|++|.+++.... . .+..++.+++.+|.+||+. +++|+|++|+|||++ ++.++|+|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~------~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS------GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE------CCCEEEEECCcccC
Confidence 99999999999985432 1 7788999999999999999 999999999999996 35799999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.3e-15 Score=146.53 Aligned_cols=137 Identities=15% Similarity=0.170 Sum_probs=106.3
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchH----------------------HHHHHHHHHHHHhcCCCcc
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE----------------------KTNEEFMTELKIIGRTHHK 547 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~hp 547 (788)
+.+.+.||+|+||.||++... ++..||||.+..... .....+..|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP---DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred hhcCCccccCcceEEEEEEcC---CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 666789999999999999763 577999997643210 1112367788888888877
Q ss_pred --ccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 548 --NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 548 --niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
.+++.++. ...++||||+++++|...... .....++.+++.++.++|+. +|+|+||||+||+++
T Consensus 94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 44555442 355899999999999876421 23457889999999999998 999999999999998
Q ss_pred cCCCCCCCcEEEeecCCccccCC
Q 047157 626 LKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
.++.++|+|||++.....
T Consensus 160 -----~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 -----DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred -----CCCcEEEEECCccccCCC
Confidence 778999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.4e-15 Score=168.79 Aligned_cols=135 Identities=17% Similarity=0.263 Sum_probs=107.0
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeeccc--c----hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--D----IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~--~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
...++||+|+||+||+|.+. .....+.++..+. . .....+++.+|++++.+++|++++....++.+....++
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred CccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34688999999999999875 2222222211111 0 11223578899999999999999988888777778899
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++. ....++.+++++|.+||+. +++||||||+|||++ ++.++|+|||+++
T Consensus 414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl~------~~~~~liDFGla~ 475 (535)
T PRK09605 414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIVR------DDRLYLIDFGLGK 475 (535)
T ss_pred EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEEE------CCcEEEEeCcccc
Confidence 999999999999884 3567999999999999999 999999999999994 4579999999997
Q ss_pred c
Q 047157 645 L 645 (788)
Q Consensus 645 ~ 645 (788)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=7e-15 Score=146.86 Aligned_cols=130 Identities=18% Similarity=0.337 Sum_probs=103.4
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccch--------HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--------EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.||+|++|.||+|... +..+++|...... ....+++.+|++++..++|+++.....++...+..++||
T Consensus 1 ~ig~G~~~~vy~~~~~----~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL----GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeecC----CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEE
Confidence 4899999999999852 3578888753211 112356789999999999887665555555667789999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++..... .++.+++.+|.+||+. +++|+|++|+||+++ ++.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~------~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR------DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE------CCcEEEEECCCCcC
Confidence 99999999998744311 7899999999999999 999999999999996 45799999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=9e-16 Score=174.59 Aligned_cols=203 Identities=26% Similarity=0.299 Sum_probs=137.3
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
.+.|..|+||.||..+++ .+.+..|+|+ .++.- +.+- ++.....|.+| |
T Consensus 88 IklisngAygavylvrh~--~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHK--ETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred eEeeccCCCCceeeeecc--ccccchhhcc-cccch-----hhhc--cccccCCccee---------------------c
Confidence 578999999999999886 6677888843 32211 1110 33333444433 3
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC--
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ-- 650 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~-- 650 (788)
+-...+...+. ++. +++.+++|||+. +|+|||+||+|.+|+ .-+++|+.|||+.+......
T Consensus 137 Dc~tllk~~g~-lPv--------dmvla~Eylh~y---givhrdlkpdnllIT-----~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 137 DCATLLKNIGP-LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLIT-----SMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred hhhhhcccCCC-Ccc--------hhhHHhHhhccC---CeecCCCCCCcceee-----ecccccccchhhhhhhhhhccc
Confidence 33333432222 221 237899999999 999999999999998 88899999999987542100
Q ss_pred ------------CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 651 ------------TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 651 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
.......+||+.|+|||++....|...+|.|++|+|+||.+.|+.||.+...++... ..+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg-------~vi- 271 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG-------QVI- 271 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh-------hhh-
Confidence 011234689999999999999999999999999999999999999998875544211 111
Q ss_pred HHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC
Q 047157 719 SCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP 762 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 762 (788)
...+.. ++. +.....+..+++.+.|+.+|..|-
T Consensus 272 ----sd~i~w-----pE~--dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 ----SDDIEW-----PEE--DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----hhhccc-----ccc--CcCCCHHHHHHHHHHHHhChHhhc
Confidence 111000 000 222344566788889999999995
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.6e-15 Score=171.74 Aligned_cols=254 Identities=24% Similarity=0.276 Sum_probs=186.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~ 566 (788)
+++.+.||+|+|+.|-..... ......+++|.+.... ....+.+..|..+-..+. |+|++++++...+.+..+++.
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~-~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNS-RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred ccccccccccccchhhhhhhc-CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 455677999999999877654 2344567777775442 333445566787777786 999999999999999999999
Q ss_pred ecCCCCCHhHhh-hccCCCCCHHHHHHHHHHHHHHHHHhh-hccCCceEecCCCCCcEEeccCCCCCCC-cEEEeecCCc
Q 047157 567 ELMPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLH-EECETQIIHCDIKPQNVLLDLKTLDTNY-MAKISDFGIS 643 (788)
Q Consensus 567 e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~~ivH~dlkp~NIll~~~~~~~~~-~~kL~Dfg~a 643 (788)
|+..++++.+.+ .......+....-.++.|+..++.|+| .. ++.|+||||+|.+++ ..+ ..+++|||+|
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~-----~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLD-----ESGSALKIADFGLA 172 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhc-----cCCCcccCCCchhh
Confidence 999999999988 444335566667779999999999999 77 999999999999998 666 8999999999
Q ss_pred cccCC--CCCcccccccC-CccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHH
Q 047157 644 KLLNK--DQTRTDTNMRG-TMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 644 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
..... ..........| ++.|+|||...+. ...+..|+||.|+++..+++|..|+.......... ..|...
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------~~~~~~ 246 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------SSWKSN 246 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------eeeccc
Confidence 98766 23333344667 9999999999874 45678999999999999999999997654332110 011000
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. . ......-........++...++..+|+.|.+.+++..
T Consensus 247 ~---~--------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 247 K---G--------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c---c--------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 0 0000011112234556677788899999999888753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-13 Score=128.78 Aligned_cols=134 Identities=20% Similarity=0.213 Sum_probs=112.3
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCc--cccceEeeEEecCCeEEEEEecCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHH--KNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
.+.||+|.++.||++... . ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||++
T Consensus 3 ~~~i~~g~~~~v~~~~~~---~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTK---D-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred ceecccccccceEEEEec---C-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 367899999999999874 2 5789998865433 5678899999999976 589999999888889999999998
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+..+..+ +......++.+++++|++||.....+++|+|++|+||+++ +...++++|||.+..
T Consensus 77 g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-----~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-----DGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-----CCcEEEEEecccccC
Confidence 8777654 4566678899999999999986445799999999999998 567899999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.4e-13 Score=135.84 Aligned_cols=134 Identities=14% Similarity=0.207 Sum_probs=101.7
Q ss_pred cccc-ccccceEEEEEEeccCcceeeeeeecccch-------------HHHHHHHHHHHHHhcCCCcccc--ceEeeEEe
Q 047157 494 KLVG-TGSSGKVYRGILRLKDTQIEIAVKKLEKDI-------------EKTNEEFMTELKIIGRTHHKNL--VRLLGFCS 557 (788)
Q Consensus 494 ~~lg-~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~ 557 (788)
..|| .|+.|+||.+... +..++||.+.... ......+.+|++++.+++|++| ++.+++..
T Consensus 37 ~~lg~~~g~gtv~~v~~~----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred ceeecCCCCccEEEEEeC----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 4677 8889999988663 4478888774311 1223567889999999998875 67777654
Q ss_pred cCC----eEEEEEecCCC-CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC
Q 047157 558 EED----KRLLVYELMPN-GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632 (788)
Q Consensus 558 ~~~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~ 632 (788)
... ..++|+|++++ .+|.+++... .++.. .+.+|+.+|.+||+. +|+|+||||+|||++ .+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~-----~~ 178 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLD-----PD 178 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEc-----CC
Confidence 332 23599999997 6999888542 33432 367899999999999 999999999999998 56
Q ss_pred CcEEEeecCCccc
Q 047157 633 YMAKISDFGISKL 645 (788)
Q Consensus 633 ~~~kL~Dfg~a~~ 645 (788)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 6899999998875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.6e-13 Score=133.03 Aligned_cols=136 Identities=17% Similarity=0.189 Sum_probs=94.1
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHH--HHHH----------------------HHHHHHHhcCCCcc-
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK--TNEE----------------------FMTELKIIGRTHHK- 547 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~hp- 547 (788)
.+.||+|+||+||+|... ++..||||.+...... .... ...|.+.+.++.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~---~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 78 (187)
T cd05119 2 GGPIGTGKEADVYLALDG---DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG 78 (187)
T ss_pred CcccccccceeEEEEECC---CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence 467999999999999864 5668999987643211 1111 13455555555433
Q ss_pred -ccceEeeEEecCCeEEEEEecCCCCCHhHh-hhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEe
Q 047157 548 -NLVRLLGFCSEEDKRLLVYELMPNGTLSNF-LFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLL 624 (788)
Q Consensus 548 -niv~~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll 624 (788)
.+.+.++. ...++||||++++.+... +..... . .....++.+++.++.++|. . +|+|+||||+||++
T Consensus 79 ~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~--~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 79 VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL--L-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CCCCceEec----CCCEEEEEEeCCCCccChhhhhhhh--c-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 24444443 245899999998543221 111101 1 5667899999999999999 7 99999999999999
Q ss_pred ccCCCCCCCcEEEeecCCccccC
Q 047157 625 DLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 625 ~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
+ ++.++|+|||.+....
T Consensus 149 ~------~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D------DGKVYIIDVPQAVEID 165 (187)
T ss_pred E------CCcEEEEECccccccc
Confidence 6 4579999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.8e-12 Score=130.12 Aligned_cols=149 Identities=21% Similarity=0.340 Sum_probs=112.8
Q ss_pred hcCCCccccceEeeEEec-----CCeEEEEEecCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCce
Q 047157 541 IGRTHHKNLVRLLGFCSE-----EDKRLLVYELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQI 612 (788)
Q Consensus 541 l~~l~hpniv~~~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~i 612 (788)
|-++-|.|||+++.|..+ ..+..++.|||..|+|..+|++. +..+....-.+++.||+.||.|||+ |.+.|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence 344579999999988754 34678999999999999999653 4567777888999999999999999 58899
Q ss_pred EecCCCCCcEEeccCCCCCCCcEEEeecCCcccc---CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHH
Q 047157 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL---NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLE 689 (788)
Q Consensus 613 vH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~e 689 (788)
+|+++..+.|++. .++-+|+.--.-...- ............+-++|.+||.=.....+.++|||+||+..+|
T Consensus 200 ihgnlTc~tifiq-----~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQ-----HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccCCcchhheeec-----CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 9999999999998 6666666421111100 0001111222346789999998877788889999999999999
Q ss_pred HHhCCC
Q 047157 690 IICGRR 695 (788)
Q Consensus 690 lltg~~ 695 (788)
|..+..
T Consensus 275 mailEi 280 (458)
T KOG1266|consen 275 MAILEI 280 (458)
T ss_pred HHHhee
Confidence 988764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.8e-12 Score=141.62 Aligned_cols=256 Identities=20% Similarity=0.212 Sum_probs=185.5
Q ss_pred HHHHHHhhcccccccc--cccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCC-CccccceEeeEEe
Q 047157 483 QELQEATKGFSKLVGT--GSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRT-HHKNLVRLLGFCS 557 (788)
Q Consensus 483 ~~l~~~t~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 557 (788)
.+.......+.+.+|. |.+|.||.+..........+|+|+-+... ......=.+|+....++ .|+|.++.+...+
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 4455566667788999 99999999987333667788888743222 23333344666666666 4999999999999
Q ss_pred cCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHH----HHHHhhhccCCceEecCCCCCcEEeccCCCCCC-
Q 047157 558 EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVAR----GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN- 632 (788)
Q Consensus 558 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~----aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~- 632 (788)
..+..++-+|++ +.+|..+.......++....+.++.+..+ ||.++|.. +++|-|+||.||++. .+
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~-----~~~ 259 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTT-----SDW 259 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecc-----ccc
Confidence 999999999998 57898888777777888888899999999 99999999 999999999999998 66
Q ss_pred CcEEEeecCCccccCCCCCc----ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccccc
Q 047157 633 YMAKISDFGISKLLNKDQTR----TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEE 708 (788)
Q Consensus 633 ~~~kL~Dfg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~ 708 (788)
...+++|||+...+...... ......+...|++||..++ -++.+.|||++|.++.+..++..+...........
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~- 337 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ- 337 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-
Confidence 78999999999887654321 1122357788999998865 67889999999999999999877654331111100
Q ss_pred chhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 709 VDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
....-+ ..........++..++..|++.+|-.|++.+.++.
T Consensus 338 ------------~r~~~i--------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ------------LRQGYI--------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------------cccccC--------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000000 00000011123333777899999999999887764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.4e-11 Score=135.16 Aligned_cols=141 Identities=25% Similarity=0.251 Sum_probs=97.1
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHH----------------------------------------HH
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN----------------------------------------EE 533 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~ 533 (788)
+.||.|++|.||+|+++ +++.||||+.+....... -+
T Consensus 123 ~plasaSigQVh~A~l~---~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld 199 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV---DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD 199 (437)
T ss_pred cceeeeehhheEEEEec---CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence 56999999999999985 567999998754321100 02
Q ss_pred HHHHHHHhcCC----CccccceEeeEE-ecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHH-HHHHhhhc
Q 047157 534 FMTELKIIGRT----HHKNLVRLLGFC-SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVAR-GLLYLHEE 607 (788)
Q Consensus 534 ~~~E~~~l~~l----~hpniv~~~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~-aL~~LH~~ 607 (788)
|.+|.+.+.++ +|.+-+.+-.++ ......+|||||++|++|.++........ .+..++.+++. .+..+|..
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 44455555544 233223332333 22445799999999999998764322222 23456666666 46788888
Q ss_pred cCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 608 ~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++|+|+||.||+++ .++.++|+|||++..+..
T Consensus 277 ---g~~H~D~hPgNilv~-----~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVL-----KDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEEC-----CCCcEEEEeCCCeeECCH
Confidence 999999999999998 778999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.9e-10 Score=125.45 Aligned_cols=165 Identities=16% Similarity=0.219 Sum_probs=125.8
Q ss_pred CcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHH
Q 047157 513 DTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVE 592 (788)
Q Consensus 513 ~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~ 592 (788)
..+.+|.|+..+...........+.++.|+.++||||+++++..+.+...|||+|.+ ..|..++.+.+ ......
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~~ 108 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVCL 108 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHHH
Confidence 455678888776655545566778899999999999999999999999999999987 36777774433 556667
Q ss_pred HHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCC
Q 047157 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672 (788)
Q Consensus 593 i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 672 (788)
.+.||+.||.|||+.+ +++|++|..+.|+++ ..+..||++|.++........ ......--..|..|+.+...
T Consensus 109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn-----~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVN-----ESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHhccC--CeeeccEeeeeEEEc-----CCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 8899999999998653 899999999999999 889999999998865432221 11111222346677655332
Q ss_pred CCCccCcchhhHHHHHHHHhC
Q 047157 673 PVTTKVDVFSFGVMLLEIICG 693 (788)
Q Consensus 673 ~~s~k~DVwSlGvil~elltg 693 (788)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999998
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.6e-11 Score=96.49 Aligned_cols=59 Identities=19% Similarity=0.220 Sum_probs=48.7
Q ss_pred ceeEeeeccccccccccccccccccCCHHHHHHHhhccccccccccc----CCceeecccccccc
Q 047157 334 NFTVEVMDDAGFLFDNFADLARVSNVDVEGCRKAVMDDCYSLGASLV----GSTCVKTRMPLLNA 394 (788)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~----~~~C~~w~~~L~~~ 394 (788)
.++|.+++++++|+.....+. .+.++++|+..||+||+|.||+|. +++|++|.++|+|+
T Consensus 4 ~d~F~~l~~~~~p~~~~~~~~--~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDNAIVD--SSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CCEEEEECCeeCCCCcceeee--cCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 458999999999876432221 458999999999999999999996 48999999999885
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.04 E-value=6e-10 Score=108.01 Aligned_cols=130 Identities=19% Similarity=0.151 Sum_probs=94.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcccc-ceEeeEEecCCeEEEEEecCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL-VRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lV~e~~~~g 572 (788)
+.|+.|..+.||++... +..+++|....... ....+.+|+++++.+.+.++ ++++.+.. ...++|||++++.
T Consensus 4 ~~l~~G~~~~vy~~~~~----~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~ 76 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA----NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS 76 (170)
T ss_pred eecCCcccCceEEEEEC----CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence 56788999999998753 55899998765422 22346788999988865544 45555433 3457999999998
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC--ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
++.+.. .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 77 ~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~------~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD------DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE------CCeEEEEecccccC
Confidence 876430 111345678999999999982 22369999999999996 24689999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.2e-10 Score=126.49 Aligned_cols=142 Identities=22% Similarity=0.225 Sum_probs=89.3
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHH----------------------------------HHH------H
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK----------------------------------TNE------E 533 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~----------------------------------~~~------~ 533 (788)
+.||+|++|.||+|+++ ++++.||||+.+....+ ..+ +
T Consensus 125 ~PlasaSiaQVh~A~l~--~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD 202 (537)
T PRK04750 125 KPLASASIAQVHFARLK--DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELD 202 (537)
T ss_pred hhhcCCCccEEEEEEEC--CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhC
Confidence 57999999999999986 44789999998643211 111 2
Q ss_pred HHHHHHHhcCCC----ccccceEeeEEec-CCeEEEEEecCCCCCHhHhh--hccCC---CCCHHHHHHHHHHHHHHHHH
Q 047157 534 FMTELKIIGRTH----HKNLVRLLGFCSE-EDKRLLVYELMPNGTLSNFL--FHEGQ---RPGWVQRVEIALGVARGLLY 603 (788)
Q Consensus 534 ~~~E~~~l~~l~----hpniv~~~~~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~~---~~~~~~~~~i~~qi~~aL~~ 603 (788)
+.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++. ...+. .+.......++.|+
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi------ 276 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV------ 276 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH------
Confidence 333444333332 3333333333332 45678999999999998753 22211 12222223333443
Q ss_pred hhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 604 LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+.. |++|+|+||.||+++.++. ..+.++++|||+...+..
T Consensus 277 -f~~---GffHaDpHPGNIlv~~~g~-~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -FRD---GFFHADMHPGNIFVSYDPP-ENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -HhC---CeeeCCCChHHeEEecCCC-CCCeEEEEecceEEECCH
Confidence 334 9999999999999983321 234899999999987754
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.5e-10 Score=94.96 Aligned_cols=72 Identities=18% Similarity=0.236 Sum_probs=58.0
Q ss_pred ceeEeeeccccccccccccccccccCCHHHHHHHhhccccccccccc--CCceeeccccccccccccccCCceeEEeec
Q 047157 334 NFTVEVMDDAGFLFDNFADLARVSNVDVEGCRKAVMDDCYSLGASLV--GSTCVKTRMPLLNARKSASTKGMKAIIKVP 410 (788)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~w~~~L~~~~~~~~~~~~~~~ik~~ 410 (788)
.+.|..++++.+++..+ .. .+.++++|++.||+||+|.||+|. +++|++|..++.+.+.. ...+.++|||++
T Consensus 11 ~~~f~~~~~~~~~~~~~---~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~-~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNAS---AI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSL-SSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchh---hh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEee-cCCCcEEEEEeC
Confidence 45788888888886543 22 567899999999999999999996 58999999999987764 334578999974
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.4e-10 Score=123.07 Aligned_cols=246 Identities=20% Similarity=0.205 Sum_probs=166.9
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHH--HHHHHHHhcCC-CccccceEeeEEecCCeEEEEEe
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE--FMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e 567 (788)
++...||.|.|+.|+.... ...++..+++|.+.+.......+ -..|+.+...+ .|.++++...........|+-.|
T Consensus 268 ~~v~~i~~~~~~~~~~~~~-r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSK-RPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred ceeEEccCCccccceeeee-cCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 4457899999999998873 33456688999886554322222 23455555555 58888888777777777889999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|++++++...+ .-...++...++++..|++.++.++|+. .++|+|+||+||++.. ..+.-++.|||....+.
T Consensus 347 ~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~----~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 347 FCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISN----DGFFSKLGDFGCWTRLA 418 (524)
T ss_pred hhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeecc----chhhhhccccccccccc
Confidence 99999887666 2234567778889999999999999998 9999999999999972 22788999999986432
Q ss_pred CCCCcccccccCCccc-cCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 648 KDQTRTDTNMRGTMGY-VAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
-... .....+..| .+|+......+-.+.|++|||.-+.|.+++...-+...... .+..+..
T Consensus 419 ~~~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---------------~i~~~~~ 480 (524)
T KOG0601|consen 419 FSSG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---------------TIRSGDT 480 (524)
T ss_pred eecc---cccccccccccchhhccccccccccccccccccccccccCcccCcccccce---------------eeecccc
Confidence 1111 111123334 35666677788899999999999999999875432211000 0000100
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
+..... ..++..+..-+..+++..||.+.+...+.+-
T Consensus 481 -------p~~~~~---~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 481 -------PNLPGL---KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -------cCCCch---HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111111 1444556666889999999999888766543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.2e-09 Score=102.93 Aligned_cols=140 Identities=15% Similarity=0.129 Sum_probs=98.5
Q ss_pred ccccccccceEEEEEEeccC----cceeeeeeecccch----------------------HHHHHHHH----HHHHHhcC
Q 047157 494 KLVGTGSSGKVYRGILRLKD----TQIEIAVKKLEKDI----------------------EKTNEEFM----TELKIIGR 543 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~l~~~~----------------------~~~~~~~~----~E~~~l~~ 543 (788)
..||.|.=+.||.|...... .+..+|||..+... ....+.+. +|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754210 24689999764211 01122333 89999998
Q ss_pred CC--ccccceEeeEEecCCeEEEEEecCCCCCHhH-hhhccCCCCCHHHHHHHHHHHHHHHHHh-hhccCCceEecCCCC
Q 047157 544 TH--HKNLVRLLGFCSEEDKRLLVYELMPNGTLSN-FLFHEGQRPGWVQRVEIALGVARGLLYL-HEECETQIIHCDIKP 619 (788)
Q Consensus 544 l~--hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~~~~ivH~dlkp 619 (788)
+. .-++++.+++ ...+|||||+.+..+.. .+.+ ..++..+...+..+++.+|..| |.. +|+|+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 85 3567777765 56789999997654322 2211 2344455667889999999999 788 999999999
Q ss_pred CcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 620 QNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 620 ~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
.||+++ ++.+.|+|||.+.....
T Consensus 154 ~NIL~~------~~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWH------DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEE------CCcEEEEECCCceeCCC
Confidence 999995 35799999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.2e-09 Score=98.42 Aligned_cols=144 Identities=19% Similarity=0.287 Sum_probs=105.5
Q ss_pred cccccccccceEEEEEEeccCcceeeeee-ecccc-------hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVK-KLEKD-------IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK-~l~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
...|-||+=+.|+++... ++...|| +..+. ..-..++..+|.+.+.+++--.|.--.-++.+...-.|
T Consensus 12 l~likQGAEArv~~~~~~----Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS----GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred ceeeeccceeeEeeeccC----CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence 357889999999999763 3344444 33221 12345678899999988865454444445666777789
Q ss_pred EEecCCC-CCHhHhhhccCCCCCHHHH-HHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 565 VYELMPN-GTLSNFLFHEGQRPGWVQR-VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 565 V~e~~~~-gsL~~~l~~~~~~~~~~~~-~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
+|||.++ .++.+++...-........ ..++..|-+.+.-||.. +|+|+||..+||++..++ ....+.|+|||+
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~--~~~~~~lIdfgl 162 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDG--NQITPILIDFGL 162 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCC--CcCceEEEeecc
Confidence 9999976 4788888665443333333 78899999999999999 999999999999998655 566779999999
Q ss_pred ccc
Q 047157 643 SKL 645 (788)
Q Consensus 643 a~~ 645 (788)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 864
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.1e-10 Score=91.50 Aligned_cols=64 Identities=11% Similarity=0.060 Sum_probs=50.6
Q ss_pred eEeeeccccccccccccccccccCCHHHHHHHhhc---cccccccccc--CCceeeccccc-cccccccccCCceeEEe
Q 047157 336 TVEVMDDAGFLFDNFADLARVSNVDVEGCRKAVMD---DCYSLGASLV--GSTCVKTRMPL-LNARKSASTKGMKAIIK 408 (788)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~--~~~C~~w~~~L-~~~~~~~~~~~~~~~ik 408 (788)
.|.++.++..|+. ...+++||+++|++ ||+|.||+|. +.+|++|.++| +|+++... .|.++|+|
T Consensus 10 ~fl~~~~~klpd~--------~~~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~-~g~~Ly~r 79 (80)
T cd00129 10 TTLIKIALKIKTT--------KANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFS-HGFDLYEN 79 (80)
T ss_pred eEEEeecccCCcc--------cccCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccC-CCceeEeE
Confidence 3455555555543 34789999999999 9999999994 46999999999 99988754 47889987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.7e-09 Score=104.94 Aligned_cols=144 Identities=16% Similarity=0.239 Sum_probs=108.2
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchH-HHHHHHHHHHHHhcCCCc--cccceEeeEEecCC---eEEEEEe
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHH--KNLVRLLGFCSEED---KRLLVYE 567 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~---~~~lV~e 567 (788)
+.|+.|..+.||++... ++..+++|....... .....+..|.++++.+++ .++++++.+..... ..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~---~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG---GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec---CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 46889999999998764 345888998765322 134578899999999865 45677888776543 5689999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcc---------------------------------------
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC--------------------------------------- 608 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------- 608 (788)
|+++.++.+.+.. ..++......++.+++++|..||+..
T Consensus 81 ~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 81 RVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9999988776532 34677777888889999999998521
Q ss_pred --------------CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 609 --------------ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 609 --------------~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
...++|+|++|.||+++.. .+..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~---~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD---EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC---CCcEEEEEecccccc
Confidence 2468999999999999821 145689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.2e-08 Score=95.94 Aligned_cols=131 Identities=21% Similarity=0.330 Sum_probs=96.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeee-cccch-------HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKK-LEKDI-------EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~-l~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..+.+|+=+.+|.+.+. +..+++|. +.+.- .-..++-.+|..++.+++--.|..-+=+..+.+...|+
T Consensus 2 ~~i~~GAEa~i~~~~~~----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeecc----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEE
Confidence 35788999999988653 22344442 22111 11234677899999888654444434445577788899
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||.+|..|.+++... ...++..+-..+.-||.. +|+|+||.++||++. +..+.++|||++..
T Consensus 78 me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~------~~~i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILS------GGRIYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEe------CCcEEEEECCcccc
Confidence 9999999999988544 256788888899999999 999999999999995 44599999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.3e-08 Score=103.34 Aligned_cols=168 Identities=19% Similarity=0.267 Sum_probs=126.9
Q ss_pred cceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEe----cCCeEEEEEecCCC-CCHh
Q 047157 501 SGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCS----EEDKRLLVYELMPN-GTLS 575 (788)
Q Consensus 501 ~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~~lV~e~~~~-gsL~ 575 (788)
-.+.|++... -++..+++|++.............-++.++++.|+|+|++.+++. .+..+++||+|.++ ++|.
T Consensus 289 ~~Ttyk~~s~--~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSN--VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeec--cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3678888876 566689999995433222223345577889999999999999886 35578999999985 5777
Q ss_pred Hhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 576 NFLFHE--------------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 576 ~~l~~~--------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
++-+.. +...++..+|.++.|+..||.++|+. |..-+-|.+.+||++ .+.+++|+..|
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~-----G~~RIriS~C~ 438 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVT-----GKMRIRISGCG 438 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEee-----CcceEEEeccc
Confidence 765432 23456889999999999999999999 999999999999998 67789998888
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p 696 (788)
....+..+.. |-+. --.+-|.=.||.+++.|.||...
T Consensus 439 i~Dvl~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 439 IMDVLQEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ceeeecCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 7766544331 1111 12367888999999999999754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.6e-07 Score=96.61 Aligned_cols=260 Identities=12% Similarity=0.118 Sum_probs=152.3
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEE------ecC-CeEEE
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFC------SEE-DKRLL 564 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~------~~~-~~~~l 564 (788)
++.||+|+-+.+|..- .-..-+-|+..........+.. +.|... .||-+..-+.+= .++ ...-+
T Consensus 16 gr~LgqGgea~ly~l~-----e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 16 GRPLGQGGEADLYTLG-----EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CccccCCccceeeecc-----hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 4679999999999542 1112334555444333332222 223333 566544322221 122 23567
Q ss_pred EEecCCCCC-HhHhhhc-----cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 565 VYELMPNGT-LSNFLFH-----EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 565 V~e~~~~gs-L~~~l~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
.|..+++.. ...++.. .-...+|...++.++.++.+.+.||+. |.+-+|+.++|+|+. ++..+.|.
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVs-----d~~~V~LV 159 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVS-----DDSKVVLV 159 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeee-----cCceEEEE
Confidence 787776542 2222211 112358999999999999999999999 999999999999998 88899999
Q ss_pred ecCCccccCCCCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhC-CCCCCccccccccccc---
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICG-RRHIELSRVEEESEEV--- 709 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg-~~p~~~~~~~~~~~~~--- 709 (788)
|-..-....++ ....-.+|...|.+||... +..-++..|.|.||+++++++.| ++||.+..........
T Consensus 160 dsDsfqi~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 160 DSDSFQINANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred cccceeeccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 86554433221 1122346888999999764 44567889999999999999987 8999765322111100
Q ss_pred hhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCC--CCCCCCCHHHHHHHhhcC
Q 047157 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHP--DPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPt~~evl~~L~~~ 774 (788)
++....++. ..+-+.-....+....-.-....+..+..+|+.. ++.-|||++..+..|..+
T Consensus 238 ~Ia~g~f~y----a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 238 DIAHGRFAY----ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hhhcceeee----chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 111111100 0011111111122211111223344455567653 356899999998888654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.6e-09 Score=120.83 Aligned_cols=193 Identities=22% Similarity=0.245 Sum_probs=132.1
Q ss_pred CccccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEe
Q 047157 545 HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLL 624 (788)
Q Consensus 545 ~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 624 (788)
+||-+++..--+......+||++|..+++|...|+..+..-... ....+..+..++++||.. .+.|+|++|.|+|+
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saep-aRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEP-ARSPILERVQSLESLHSS---LRKHRDLKPDSLLI 937 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCccccc-ccchhHHHHhhhhccccc---hhhcccccccchhh
Confidence 34555544444455678899999999999999987665332223 334555678899999998 79999999999999
Q ss_pred ccCCCCCCCcEEEeecCCccccC---------------------CC---------CCcccccccCCccccCcccccCCCC
Q 047157 625 DLKTLDTNYMAKISDFGISKLLN---------------------KD---------QTRTDTNMRGTMGYVAPEWLRNVPV 674 (788)
Q Consensus 625 ~~~~~~~~~~~kL~Dfg~a~~~~---------------------~~---------~~~~~~~~~gt~~y~aPE~~~~~~~ 674 (788)
. .++..+++||+...... .. .........+|+.|.+||...+...
T Consensus 938 ~-----~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h 1012 (1205)
T KOG0606|consen 938 A-----YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH 1012 (1205)
T ss_pred c-----ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC
Confidence 7 78899999998433221 00 0011233568999999999999999
Q ss_pred CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHcc
Q 047157 675 TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCN 754 (788)
Q Consensus 675 s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl 754 (788)
...+|.|+.|++++|.++|..||.....+..- ..+..+.... +. ...+...+..+++...+
T Consensus 1013 gs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f------------~ni~~~~~~~-----p~--g~~~~s~~aq~~~~~ll 1073 (1205)
T KOG0606|consen 1013 GSAADWWSSGVCLFEVLTGIPPFNAETPQQIF------------ENILNRDIPW-----PE--GPEEGSYEAQDLINRLL 1073 (1205)
T ss_pred CCcchhhhhhhhhhhhhcCCCCCCCcchhhhh------------hccccCCCCC-----CC--CccccChhhhhhhhhhh
Confidence 99999999999999999999999765432211 1111111111 11 11222334455666778
Q ss_pred CCCCCCCCCHH
Q 047157 755 HPDPNLRPSMK 765 (788)
Q Consensus 755 ~~dP~~RPt~~ 765 (788)
..+|.+|-.|.
T Consensus 1074 ~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1074 TEEPTQRLGAK 1084 (1205)
T ss_pred ccCchhccCcc
Confidence 88999997776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.2e-07 Score=94.05 Aligned_cols=138 Identities=15% Similarity=0.090 Sum_probs=96.2
Q ss_pred cceEEEEEEeccCcceeeeeeecccchH-HHHH----------HHHHHHHHhcCCCccc--cceEeeEEec-----CCeE
Q 047157 501 SGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNE----------EFMTELKIIGRTHHKN--LVRLLGFCSE-----EDKR 562 (788)
Q Consensus 501 ~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~----------~~~~E~~~l~~l~hpn--iv~~~~~~~~-----~~~~ 562 (788)
...|++..+ .++.+.||+...... ...+ .+.+|.+.+.++...+ .++.+++.+. ....
T Consensus 35 ~rrvvr~~~----~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s 110 (268)
T PRK15123 35 GRRTLRFEL----AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTS 110 (268)
T ss_pred CceEEEEEE----CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcccee
Confidence 334556554 345788886643221 1111 3778998888875333 3455555543 2357
Q ss_pred EEEEecCCCC-CHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccC--CCCCCCcEEEe
Q 047157 563 LLVYELMPNG-TLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK--TLDTNYMAKIS 638 (788)
Q Consensus 563 ~lV~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~--~~~~~~~~kL~ 638 (788)
+||+|++++. +|.+++... ....+...+..++.+++..+.-||.. ||+|+|++++|||++.. ...+...+.|+
T Consensus 111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 8999999886 899988532 23455667778999999999999999 99999999999999741 00135789999
Q ss_pred ecCCccc
Q 047157 639 DFGISKL 645 (788)
Q Consensus 639 Dfg~a~~ 645 (788)
||+.+..
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9998863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=2e-07 Score=90.87 Aligned_cols=126 Identities=21% Similarity=0.230 Sum_probs=79.5
Q ss_pred eEEEEEEeccCcceeeeeeecccch--------------------------HHHHHHHHHHHHHhcCCCcc--ccceEee
Q 047157 503 KVYRGILRLKDTQIEIAVKKLEKDI--------------------------EKTNEEFMTELKIIGRTHHK--NLVRLLG 554 (788)
Q Consensus 503 ~Vy~~~~~~~~~~~~vavK~l~~~~--------------------------~~~~~~~~~E~~~l~~l~hp--niv~~~~ 554 (788)
.||.|.. ..+..+|||..+... ........+|.+.|.++..- +++++++
T Consensus 1 ~Vy~~~~---~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~ 77 (188)
T PF01163_consen 1 DVYHAID---PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD 77 (188)
T ss_dssp EEEEEEE---CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred CEEEEEC---CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence 3788876 356688998753210 11234578899999999754 5777776
Q ss_pred EEecCCeEEEEEecCC--CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHH-hhhccCCceEecCCCCCcEEeccCCCCC
Q 047157 555 FCSEEDKRLLVYELMP--NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLY-LHEECETQIIHCDIKPQNVLLDLKTLDT 631 (788)
Q Consensus 555 ~~~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~-LH~~~~~~ivH~dlkp~NIll~~~~~~~ 631 (788)
+- ...|||||++ +..+..+.... ++......++.+++..+.. +|.. +|+|+||.+.||+++ +
T Consensus 78 ~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~-----~ 142 (188)
T PF01163_consen 78 YN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVD-----D 142 (188)
T ss_dssp EE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEE-----T
T ss_pred Ee----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEee-----c
Confidence 53 3479999998 65554433211 1123345677778885555 5677 999999999999997 4
Q ss_pred CCcEEEeecCCccccC
Q 047157 632 NYMAKISDFGISKLLN 647 (788)
Q Consensus 632 ~~~~kL~Dfg~a~~~~ 647 (788)
+ .+.|+|||.+....
T Consensus 143 ~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 143 G-KVYIIDFGQAVDSS 157 (188)
T ss_dssp T-CEEE--GTTEEETT
T ss_pred c-eEEEEecCcceecC
Confidence 4 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.8e-07 Score=88.29 Aligned_cols=108 Identities=22% Similarity=0.309 Sum_probs=84.3
Q ss_pred HHHHHHHHHhcCCCc--cccceEeeEEecCC----eEEEEEecCCCC-CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHh
Q 047157 532 EEFMTELKIIGRTHH--KNLVRLLGFCSEED----KRLLVYELMPNG-TLSNFLFHEGQRPGWVQRVEIALGVARGLLYL 604 (788)
Q Consensus 532 ~~~~~E~~~l~~l~h--pniv~~~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L 604 (788)
....+|...+.+|.. -..++.+++.+... ..+||+|++++. +|.+++..... .+......++.++++.++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 467788888877753 34566777765532 458999999874 89999865323 56667788999999999999
Q ss_pred hhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 605 H~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|+. +|+|+|+++.|||++.+. ....+.|+||+.+..
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~--~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDD--GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCC--CceeEEEEcchhcee
Confidence 999 999999999999998443 445899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=8.1e-08 Score=106.86 Aligned_cols=151 Identities=21% Similarity=0.268 Sum_probs=101.2
Q ss_pred HHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcc--------cccccCCccccC
Q 047157 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT--------DTNMRGTMGYVA 665 (788)
Q Consensus 594 ~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~--------~~~~~gt~~y~a 665 (788)
+.+++.||.|+|.. .++||++|.|++|.++ ..+..||+.|+.+.......... ..-......|.|
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~n-----a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a 177 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVN-----ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA 177 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeec-----cCcceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence 34556999999987 6899999999999998 88899999999887654421111 011234567999
Q ss_pred cccccCCCCCccCcchhhHHHHHHHH-hCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHH
Q 047157 666 PEWLRNVPVTTKVDVFSFGVMLLEII-CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFE 744 (788)
Q Consensus 666 PE~~~~~~~s~k~DVwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 744 (788)
||++.....++++|+||+|+++|.+. .|+.-+.......... ... ...+. .......+.+.
T Consensus 178 pE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~----------~~~-~~~~~-------~~~~~s~~~p~ 239 (700)
T KOG2137|consen 178 PEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS----------FSR-NLLNA-------GAFGYSNNLPS 239 (700)
T ss_pred chhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh----------hhh-ccccc-------ccccccccCcH
Confidence 99999988899999999999999999 5555554332111100 000 00000 01111123345
Q ss_pred HHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 745 RMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 745 ~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
++.+=+.+++..++..||++.++..
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhc
Confidence 5666666788999999998777643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.2e-06 Score=83.88 Aligned_cols=136 Identities=15% Similarity=0.157 Sum_probs=95.1
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch----------------------HHHHHHHHHHHHHhcCCCcc
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI----------------------EKTNEEFMTELKIIGRTHHK 547 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~----------------------~~~~~~~~~E~~~l~~l~hp 547 (788)
+.++..||-|.=+.||.|... .+.+++||.=+... .-......+|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~---~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP---KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred HhhccccccCccceEEEEECC---CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 345688999999999999874 56688888532110 11234567899999988654
Q ss_pred --ccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 548 --NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 548 --niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
.+++.+++ +...+|||+.++-.|...- ++....-.++..|++-+..+-.. ||||+|+.+-||+++
T Consensus 170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 67776654 5668999999987665432 12223334444455544444455 999999999999999
Q ss_pred cCCCCCCCcEEEeecCCcccc
Q 047157 626 LKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
+++.+.++||-.+...
T Consensus 237 -----~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 -----EDGDIVVIDWPQAVPI 252 (304)
T ss_pred -----cCCCEEEEeCcccccC
Confidence 8889999999766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=9e-06 Score=79.76 Aligned_cols=138 Identities=14% Similarity=0.114 Sum_probs=101.3
Q ss_pred cccccceEEEEEEeccCcceeeeeeecccch------HHHHHHHHHHHHHhcCCCcc--ccceEeeEEe-c----CCeEE
Q 047157 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKDI------EKTNEEFMTELKIIGRTHHK--NLVRLLGFCS-E----EDKRL 563 (788)
Q Consensus 497 g~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~-~----~~~~~ 563 (788)
++||-+.|+...+. +. .+-+|+-+... +-....|.+|...+.+|..- .+++.. ++. . ...-+
T Consensus 27 ~rgG~SgV~r~~~~---g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 27 RRNGMSGVQCVERN---GK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred CCCCcceEEEEEeC---Cc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 67999999987663 22 68888775221 23457899999999988532 345555 332 1 12468
Q ss_pred EEEecCCC-CCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 564 LVYELMPN-GTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 564 lV~e~~~~-gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
||+|-+++ .+|.+++.+.. .+++...+..++.+++..++-||+. ++.|+|+-+.||+++.. ....++++||.
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~---g~~~v~lIDlE 175 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTE---GKAEAGFLDLE 175 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCC---CCeeEEEEEhh
Confidence 99997753 58988885532 3567778889999999999999999 99999999999999732 23459999998
Q ss_pred Cccc
Q 047157 642 ISKL 645 (788)
Q Consensus 642 ~a~~ 645 (788)
-++.
T Consensus 176 k~r~ 179 (216)
T PRK09902 176 KSRR 179 (216)
T ss_pred ccch
Confidence 7653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.2e-05 Score=90.14 Aligned_cols=140 Identities=21% Similarity=0.254 Sum_probs=89.3
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHH----------------------------------------HHH
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT----------------------------------------NEE 533 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~ 533 (788)
+-|+.++-|.||+|+++ +++.||||+.+....+. +-+
T Consensus 131 ~PiAsASIaQVH~A~L~---sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD 207 (517)
T COG0661 131 EPIASASIAQVHRAVLK---SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD 207 (517)
T ss_pred CchhhhhHhhheeEEec---CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence 56899999999999995 57899999875432110 011
Q ss_pred HHHHHHHhcCCC-----ccccceEeeEEe-cCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHH-HHHhhh
Q 047157 534 FMTELKIIGRTH-----HKNLVRLLGFCS-EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARG-LLYLHE 606 (788)
Q Consensus 534 ~~~E~~~l~~l~-----hpniv~~~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~a-L~~LH~ 606 (788)
+.+|..-+.+++ .|+ +++=.++. -.....|+|||++|-.+.+....+....+...+ +..++++ +..+-.
T Consensus 208 y~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~i---a~~~~~~f~~q~~~ 283 (517)
T COG0661 208 YRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKEL---AELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHH---HHHHHHHHHHHHHh
Confidence 333444443331 222 22222232 245678999999999999886444344443332 2222221 111222
Q ss_pred ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 607 ~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
. +++|.|.+|.||+++ .++++.+.|||+...+..
T Consensus 284 d---gffHaDpHpGNi~v~-----~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 D---GFFHADPHPGNILVR-----SDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred c---CccccCCCccceEEe-----cCCcEEEEcCcceecCCH
Confidence 3 899999999999998 788999999999887653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.00 E-value=9.2e-05 Score=73.01 Aligned_cols=141 Identities=13% Similarity=0.117 Sum_probs=88.5
Q ss_pred HHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHH---------HHHHHHhcCCC---ccccc
Q 047157 483 QELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---------MTELKIIGRTH---HKNLV 550 (788)
Q Consensus 483 ~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~---hpniv 550 (788)
+++....+...+++-......|.+-.. ++..+.+|..+......++.| .+++..+.+++ --...
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei----~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~ 101 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI----DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA 101 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE----CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence 445555666667777777777776654 345788887765433222222 22333333332 22222
Q ss_pred eEeeEE-----ecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 551 RLLGFC-----SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 551 ~~~~~~-----~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
.++.+. .-....+++|||++|..|.++.. ++. .++..|.+++.-||+. |++|+|.+|.|++++
T Consensus 102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS 169 (229)
T ss_pred cceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence 222222 22345578999999988876541 111 3556677889999999 999999999999996
Q ss_pred cCCCCCCCcEEEeecCCccc
Q 047157 626 LKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+..++++||+..+.
T Consensus 170 ------~~~i~iID~~~k~~ 183 (229)
T PF06176_consen 170 ------NNGIRIIDTQGKRM 183 (229)
T ss_pred ------CCcEEEEECccccc
Confidence 34599999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.1e-06 Score=94.55 Aligned_cols=182 Identities=17% Similarity=0.117 Sum_probs=130.6
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccc-cceEeeEEecCCeEEEEEecCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN-LVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
+-++++++++++|.+.. .+. .+..+.+... ....-++++|.+++||| .++.++-++.+...+++++++..+
T Consensus 248 h~fvK~altknpKkRpt--aek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPT--AEK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHhcCCCccCCC--hhh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 44678999999987543 222 2334444322 45567889999999999 677777777788899999999876
Q ss_pred -CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC
Q 047157 573 -TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651 (788)
Q Consensus 573 -sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~ 651 (788)
+-..........+...+...+.+.-.++|++||+. .=+|+| ||+. .+...|..||+....+.+..
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~------s~~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILG------SEEEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccc------cccccccccccCCcccCccc-
Confidence 22222211122334445556777778899999986 558888 8886 45678999999988776543
Q ss_pred cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCC
Q 047157 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIE 698 (788)
Q Consensus 652 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~ 698 (788)
......+++.++|||......+..+-|+|++|+---++.-|..|-.
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3344678999999999999999999999999987777776666543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.97 E-value=7.8e-05 Score=75.61 Aligned_cols=72 Identities=15% Similarity=0.241 Sum_probs=52.8
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccc--cceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN--LVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
..||+|..+.||+. . +..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~-----~-~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----K-TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe-----c-CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 56899999999973 1 2256677765432 2345688999998886433 57788888888888999999988
Q ss_pred CC
Q 047157 572 GT 573 (788)
Q Consensus 572 gs 573 (788)
..
T Consensus 79 ~~ 80 (226)
T TIGR02172 79 KR 80 (226)
T ss_pred cc
Confidence 63
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=8.7e-05 Score=83.09 Aligned_cols=145 Identities=18% Similarity=0.214 Sum_probs=92.5
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHH-------------------------------HHH------HHHH
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK-------------------------------TNE------EFMT 536 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-------------------------------~~~------~~~~ 536 (788)
+.||.-+.|.||+|+++ +++.||||+-+....+ ..+ +|.+
T Consensus 167 ~piaaASlaQVhrA~L~---~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK---NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred chhhhcchhheEEEEec---CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 56999999999999996 4779999986533211 111 2334
Q ss_pred HHHHhcC----CCccc------cceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh
Q 047157 537 ELKIIGR----THHKN------LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606 (788)
Q Consensus 537 E~~~l~~----l~hpn------iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 606 (788)
|.+-..+ +.|-+ |++++-- -.....|+||||+|..+.+.-.-....++...+..-+.++. ++.
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~-----~~q 316 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY-----LEQ 316 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH-----HHH
Confidence 4433332 23444 3333322 23467899999999988877544444555554433333222 221
Q ss_pred ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 607 ~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
.-..|++|+|-+|.||+++... ..+..+.+-|||+...+...
T Consensus 317 If~~GffHaDPHPGNilv~~~~-~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNP-EGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCC-CCCccEEEEcccccccccHH
Confidence 1223899999999999998543 25788999999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00013 Score=72.75 Aligned_cols=136 Identities=17% Similarity=0.170 Sum_probs=88.3
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccchHHHH------------------------HHHHHHHHHhcCCC--ccc
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN------------------------EEFMTELKIIGRTH--HKN 548 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~------------------------~~~~~E~~~l~~l~--hpn 548 (788)
.|+.|.=+.||+|.. ..+..+|||+......... .-..+|..-|.++. +-.
T Consensus 55 ~istGKEA~Vy~a~~---~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 55 CISTGKEANVYLAET---GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eecCCcceEEEeecc---CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 577888899999875 4677999998854321111 01245666666652 344
Q ss_pred cceEeeEEecCCeEEEEEecCCCCCH-hHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEecc
Q 047157 549 LVRLLGFCSEEDKRLLVYELMPNGTL-SNFLFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDL 626 (788)
Q Consensus 549 iv~~~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~ 626 (788)
+++-+++. .-.|||||+....+ .-.|. ...+...+...+..++++.+.-|-. . ++||+||..-|||+.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~- 201 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEA---GLVHGDLSEYNILVH- 201 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhc---CcccccchhhheEEE-
Confidence 44555443 34699999864311 11111 1122233556677788888887776 5 999999999999994
Q ss_pred CCCCCCCcEEEeecCCccccCC
Q 047157 627 KTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 627 ~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
++.+.|+|++.+....+
T Consensus 202 -----~~~p~iID~~QaV~~~h 218 (268)
T COG1718 202 -----DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred -----CCeEEEEECccccccCC
Confidence 56899999999886543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00015 Score=74.65 Aligned_cols=75 Identities=16% Similarity=0.183 Sum_probs=52.4
Q ss_pred cccccc-ceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEecCCCCC
Q 047157 496 VGTGSS-GKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYELMPNGT 573 (788)
Q Consensus 496 lg~G~~-g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~~~~gs 573 (788)
|..|.. ..||+.... +..+.+|...... ...+.+|+++++.+. +--+++++++....+..++|||+++|.+
T Consensus 6 ~~~g~~~~~v~~~~~~----~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 6 VTEGQSGATVYRLDGK----NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred cCCCCCcCeEEEEcCC----CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 444555 788987542 2478888876542 335667888887773 4456788888777777899999999988
Q ss_pred HhHh
Q 047157 574 LSNF 577 (788)
Q Consensus 574 L~~~ 577 (788)
|...
T Consensus 79 l~~~ 82 (244)
T cd05150 79 AAAL 82 (244)
T ss_pred HhHh
Confidence 7644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00029 Score=69.35 Aligned_cols=131 Identities=19% Similarity=0.301 Sum_probs=89.6
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch----------------HHHHHHHHHHHHHhcCCC------ccccce
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI----------------EKTNEEFMTELKIIGRTH------HKNLVR 551 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------hpniv~ 551 (788)
..||+|+.-.||. ++ ......||+..... ....++..+|+.-...+. +.+|.+
T Consensus 7 ~~i~~G~~R~cy~--HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred cccccCCCceEEE--CC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 5799999999995 33 23356677765443 122455566665554444 889999
Q ss_pred EeeEEecCCeEEEEEecCCC------CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 552 LLGFCSEEDKRLLVYELMPN------GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 552 ~~~~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
++|+.+++...-+|+|.+.+ .+|.+++.+. .++. .+...+-+-..||-+. .|+.+||+|.||++.
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 99999999999999998643 3688888443 3433 2333444555677777 899999999999998
Q ss_pred cCCCCCCCcEEEee
Q 047157 626 LKTLDTNYMAKISD 639 (788)
Q Consensus 626 ~~~~~~~~~~kL~D 639 (788)
.... ....+.|+|
T Consensus 153 ~~~~-~~~~lvlID 165 (199)
T PF10707_consen 153 RRDS-GEFRLVLID 165 (199)
T ss_pred ecCC-CceEEEEEe
Confidence 5541 223677877
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00011 Score=71.90 Aligned_cols=102 Identities=24% Similarity=0.296 Sum_probs=80.9
Q ss_pred HHHHHhcCCCc-cccceEeeEEecCCeEEEEEecCCCCCHhHhhh--ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCce
Q 047157 536 TELKIIGRTHH-KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLF--HEGQRPGWVQRVEIALGVARGLLYLHEECETQI 612 (788)
Q Consensus 536 ~E~~~l~~l~h-pniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~i 612 (788)
+|.-+++.+++ +++++++|+|- .++|.||...+++...-. ..-...+|..|.+|+.++++.+.+|+......+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57778888865 69999999993 378999998776542210 011246899999999999999999998655468
Q ss_pred EecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 613 vH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
.-.|++++|+-++ +++++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~-----~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVN-----DDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEe-----CCCcEEEEechhcchh
Confidence 8899999999998 7889999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.69 E-value=6.2e-05 Score=62.15 Aligned_cols=69 Identities=14% Similarity=0.156 Sum_probs=47.9
Q ss_pred eEeeeccccccccccccccccccCCHHHHHHHhhc-cccccccccc--CCceeecc-ccccccccccccCCceeEEe
Q 047157 336 TVEVMDDAGFLFDNFADLARVSNVDVEGCRKAVMD-DCYSLGASLV--GSTCVKTR-MPLLNARKSASTKGMKAIIK 408 (788)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~--~~~C~~w~-~~L~~~~~~~~~~~~~~~ik 408 (788)
.|..++++.++.... ......++++|++.|++ +|+|.|+.|. +++|.+|. .++.+.+... ..+.++|.|
T Consensus 5 ~f~~~~~~~l~~~~~---~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~~~~-~~~~~~y~~ 77 (78)
T smart00473 5 CFVRLPNTKLPGFSR---IVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDARLFP-SGGVDLYEK 77 (78)
T ss_pred eeEEecCccCCCCcc---eeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccceecc-cCCceeEEe
Confidence 466667766653222 11345789999999999 9999999996 68999999 7777776322 223445543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00022 Score=63.86 Aligned_cols=82 Identities=30% Similarity=0.467 Sum_probs=55.1
Q ss_pred EEEecCCceEEEeCC-CcEEEEeccc-----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEeec
Q 047157 91 ITLTNDGKLLLTYFN-GSVQQIYSGA-----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNS 164 (788)
Q Consensus 91 l~l~~~G~L~l~~~~-~~~~~~~s~~-----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~~ 164 (788)
+....||+||+.... +...|..++. ...+.|.++|||||++.++.++|+|=. .
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t---~------------------ 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNT---T------------------ 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecc---c------------------
Confidence 344578999998764 2444433332 135788899999999999999999811 0
Q ss_pred CCCCCCCCCceEEeeccCCcceeeecccCCCCCccc
Q 047157 165 RGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYT 200 (788)
Q Consensus 165 ~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~ 200 (788)
...|.+.+.|+.+|+++++.. .....|.+
T Consensus 83 -----~~~~~~~~~L~ddGnlvl~~~--~~~~~W~S 111 (114)
T smart00108 83 -----GANGNYVLVLLDDGNLVIYDS--DGNFLWQS 111 (114)
T ss_pred -----CCCCceEEEEeCCCCEEEECC--CCCEEeCC
Confidence 124678899999999876532 23346655
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00048 Score=70.14 Aligned_cols=77 Identities=19% Similarity=0.292 Sum_probs=55.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcc--ccceEeeEEec---CCeEEEEEec
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHK--NLVRLLGFCSE---EDKRLLVYEL 568 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~---~~~~~lV~e~ 568 (788)
+.|+.|..+.||+.... + ..+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|++
T Consensus 3 ~~l~~G~~n~~~~v~~~---~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD---D-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEESSSSEEEEEEET---T-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEEC---C-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 56888999999998763 3 38889987654 4556777888888877433 35677765433 3357899999
Q ss_pred CCCCCHhH
Q 047157 569 MPNGTLSN 576 (788)
Q Consensus 569 ~~~gsL~~ 576 (788)
+++..+..
T Consensus 77 i~g~~~~~ 84 (239)
T PF01636_consen 77 IPGRPLDD 84 (239)
T ss_dssp ESSEEHHH
T ss_pred eccccccc
Confidence 99988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00021 Score=64.22 Aligned_cols=81 Identities=31% Similarity=0.444 Sum_probs=54.6
Q ss_pred Eec-CCceEEEeCCC-cEEEEeccc-----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEeecC
Q 047157 93 LTN-DGKLLLTYFNG-SVQQIYSGA-----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSR 165 (788)
Q Consensus 93 l~~-~G~L~l~~~~~-~~~~~~s~~-----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~~~ 165 (788)
... +|+||+.+... +..|..++. ...+.|.++|||||.+.++.++|||=-
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~----------------------- 82 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNT----------------------- 82 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecc-----------------------
Confidence 344 89999987542 444433332 235788899999999999999999821
Q ss_pred CCCCCCCCceEEeeccCCcceeeecccCCCCCcccC
Q 047157 166 GTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTG 201 (788)
Q Consensus 166 ~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~ 201 (788)
.. +.+.+.+.|+.+|++.++... ....|.+.
T Consensus 83 -~~--~~~~~~~~L~ddGnlvl~~~~--~~~~W~Sf 113 (116)
T cd00028 83 -TR--VNGNYVLVLLDDGNLVLYDSD--GNFLWQSF 113 (116)
T ss_pred -cC--CCCceEEEEeCCCCEEEECCC--CCEEEcCC
Confidence 00 247788999999998865432 34467553
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00087 Score=81.40 Aligned_cols=81 Identities=10% Similarity=0.212 Sum_probs=55.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCC-cccc--ceEeeEEecC---CeEEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTH-HKNL--VRLLGFCSEE---DKRLLVY 566 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-hpni--v~~~~~~~~~---~~~~lV~ 566 (788)
+.++.|.+..+|+...........+++|+..... ......+.+|.++++.+. |+++ ++++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5678899999998766422212356666654321 122356789999999985 6665 8888888764 4678999
Q ss_pred ecCCCCCH
Q 047157 567 ELMPNGTL 574 (788)
Q Consensus 567 e~~~~gsL 574 (788)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99988653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0012 Score=64.54 Aligned_cols=134 Identities=25% Similarity=0.364 Sum_probs=93.7
Q ss_pred CCcccCHHHHHHHhhccccccccccc-ceEEEEEEeccCcceeeeeeeccc-----------chH----------HHHHH
Q 047157 476 NFREFTFQELQEATKGFSKLVGTGSS-GKVYRGILRLKDTQIEIAVKKLEK-----------DIE----------KTNEE 533 (788)
Q Consensus 476 ~~~~~~~~~l~~~t~~~~~~lg~G~~-g~Vy~~~~~~~~~~~~vavK~l~~-----------~~~----------~~~~~ 533 (788)
.+..|+... ....+.+.||.|.- |.||++... +..+|+|.... ... .....
T Consensus 28 KL~~F~~h~---~~I~flefLg~g~~~~~V~kv~I~----g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 28 KLEPFTHHG---DDIEFLEFLGHGSHDGYVFKVEID----GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CcCCcCCCC---CcEeeeeecCCCCceeEEEEEEEC----CeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 455666622 56677899999999 999999883 45999998321 000 12346
Q ss_pred HHHHHHHhcCCC---cccc--ceEeeEEecC------------------CeEEEEEecCCCCCHhHhhhccCCCCCHHHH
Q 047157 534 FMTELKIIGRTH---HKNL--VRLLGFCSEE------------------DKRLLVYELMPNGTLSNFLFHEGQRPGWVQR 590 (788)
Q Consensus 534 ~~~E~~~l~~l~---hpni--v~~~~~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~ 590 (788)
|..|.+...+|+ +.++ |+++||..-. ....||.||++... .+ .
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~----~ 166 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL----Q 166 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc----c
Confidence 889999988884 4466 8999987211 12357888775432 11 1
Q ss_pred HHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 591 VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 591 ~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
..-+.+|.+-|..+|.. +|+-+|+++.|..= -||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~~----------G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKL---GIVPRDVKPRNYRG----------GKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHC---CeeeccCccccccC----------CEEEecccC
Confidence 23456777888889998 99999999999872 489999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00083 Score=63.37 Aligned_cols=127 Identities=21% Similarity=0.263 Sum_probs=86.6
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcccc-ceEeeEEecCCeEEEEEecCCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL-VRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lV~e~~~~ 571 (788)
.+.|++|.+|.||++.+. +..+|+|.-+.+. ....+..|.++|..+.--++ .+++.+-.+ .+.|||..|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~----~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR----GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhcccccEEEEeecc----CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 578999999999999874 3488888876543 35678899999998876655 345544322 355999998
Q ss_pred CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCC-C-CcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 572 GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIK-P-QNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 572 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlk-p-~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
..|.+.-... +-. -...+++.---|... ||-|+.|. | .||++ .+..+.|+||..|...
T Consensus 97 ~~L~~~~~~~----~rk----~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv------~~~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIGG----DRK----HLLRVLEKAYKLDRL---GIEHGELSRPWKNVLV------NDRDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhcc----cHH----HHHHHHHHHHHHHHh---ccchhhhcCCceeEEe------cCCcEEEEEccchhhc
Confidence 8887765221 122 233444443334444 89999887 3 45665 4458999999998743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0013 Score=67.32 Aligned_cols=73 Identities=15% Similarity=0.167 Sum_probs=44.3
Q ss_pred ccccccccc-eEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcc---ccceEeeEEecCC---eEEEEE
Q 047157 494 KLVGTGSSG-KVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHK---NLVRLLGFCSEED---KRLLVY 566 (788)
Q Consensus 494 ~~lg~G~~g-~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~~~~---~~~lV~ 566 (788)
+.|+.|+.. .||+. + ..+++|..... .....+.+|.+++..+... -+.++++.....+ ..+++|
T Consensus 3 ~~~~~gG~~n~vy~~-----~--~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL-----G--DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc-----C--CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 346666665 58864 1 14566765432 2244788899988877532 3455555443322 348899
Q ss_pred ecCCCCCHh
Q 047157 567 ELMPNGTLS 575 (788)
Q Consensus 567 e~~~~gsL~ 575 (788)
|+++|.++.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0017 Score=77.10 Aligned_cols=197 Identities=21% Similarity=0.181 Sum_probs=129.8
Q ss_pred HHHHHHHHhcCCCccccceEeeEEecCCeEE----EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcc
Q 047157 533 EFMTELKIIGRTHHKNLVRLLGFCSEEDKRL----LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608 (788)
Q Consensus 533 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 608 (788)
....|+..+.++.|+|++.++.|-.++...- +..|++..-++...+.+. ...+......+..++..||+|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 3455777788889999999999876544332 445778888888777554 4567777788899999999999997
Q ss_pred CCceEecCCCCC---cEEeccCCCCCCCcEEEe--ecCCccccCCCCCcccccccCCccccCcccccCCCCCcc--Ccch
Q 047157 609 ETQIIHCDIKPQ---NVLLDLKTLDTNYMAKIS--DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTK--VDVF 681 (788)
Q Consensus 609 ~~~ivH~dlkp~---NIll~~~~~~~~~~~kL~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k--~DVw 681 (788)
...|.-+..+ +.-.+ ..+.+.++ ||+....+....... .......+.+||.......+.+ .|+|
T Consensus 306 --~l~~v~L~~s~~~~~~~~-----~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVD-----GEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred --ccceeEEecccccccccC-----ccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHH
Confidence 4444444333 22222 45566666 888877654332221 1223456788888776655544 7999
Q ss_pred hhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCC
Q 047157 682 SFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLR 761 (788)
Q Consensus 682 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 761 (788)
.+|.++..+..|..+-...... ..+++. .. ...+.+....|+..++++|
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~~-----------------------~~~l~~----~~----~~~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAVP-----------------------VSLLDV----LS----TSELLDALPKCLDEDSEER 425 (1351)
T ss_pred HHHHHHhhhhhcCcccccccch-----------------------hhhhcc----cc----chhhhhhhhhhcchhhhhc
Confidence 9999999999887654322100 000000 00 0034456667999999999
Q ss_pred CCHHHHHHHh
Q 047157 762 PSMKKVIHML 771 (788)
Q Consensus 762 Pt~~evl~~L 771 (788)
+++.+++.+.
T Consensus 426 l~~~~ll~~~ 435 (1351)
T KOG1035|consen 426 LSALELLTHP 435 (1351)
T ss_pred cchhhhhhch
Confidence 9999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0038 Score=63.81 Aligned_cols=75 Identities=23% Similarity=0.234 Sum_probs=45.7
Q ss_pred ccccccccceEEEEEEeccC-cceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
+.|..|-...+|+.... . .+..+++|........ .-...+|+.+++.+. +.-.+++++.... .+||||++|
T Consensus 4 ~~l~gG~tN~~~~v~~~--~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNK--EDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcC--CCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCC
Confidence 45677778899987642 1 2457888876543221 123346888888774 3334555554332 479999998
Q ss_pred CCHh
Q 047157 572 GTLS 575 (788)
Q Consensus 572 gsL~ 575 (788)
.++.
T Consensus 77 ~~l~ 80 (235)
T cd05157 77 RTLE 80 (235)
T ss_pred CcCC
Confidence 7653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.011 Score=62.70 Aligned_cols=75 Identities=7% Similarity=-0.023 Sum_probs=53.4
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCc---cccceEeeEEec---CCeEEEEEe
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHH---KNLVRLLGFCSE---EDKRLLVYE 567 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~---~~~~~lV~e 567 (788)
+.||.|..+.||+.... ++ .+.+|..+.. .....+..|.+.++.+.. ..++++++++.. .+..+||||
T Consensus 20 ~~i~~G~~~~vy~~~~~---~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 20 ECISEQPYAALWALYDS---QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eecCCccceeEEEEEcC---CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 57999999999987542 23 4566664321 123477889998888742 468889988754 366899999
Q ss_pred cCCCCCH
Q 047157 568 LMPNGTL 574 (788)
Q Consensus 568 ~~~~gsL 574 (788)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.005 Score=54.95 Aligned_cols=97 Identities=25% Similarity=0.384 Sum_probs=57.2
Q ss_pred CeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEec-CCCCCCCCcEEEEecCCceEEEeCCCcEEEEeccccc-
Q 047157 40 TSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAAD-RDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSGAAS- 117 (788)
Q Consensus 40 ~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvAN-r~~p~~~~s~l~l~~~G~L~l~~~~~~~~~~~s~~~~- 117 (788)
+++.+.+|.+.|-|-.-|+ |-| |+ ...++||.++ ........+.+.|..+|||||.|.++++.|.+ ....
T Consensus 12 ~p~~~~s~~~~L~l~~dGn----Lvl-~~--~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~S-f~~pt 83 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN----LVL-YD--SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQS-FDYPT 83 (114)
T ss_dssp EEEEECETTEEEEEETTSE----EEE-EE--TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEES-TTSSS
T ss_pred cccccccccccceECCCCe----EEE-Ec--CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEee-cCCCc
Confidence 3454545778777765332 222 22 2367799994 33333356789999999999999777653322 3322
Q ss_pred --ccccCC--CCcEEEEecCCceeecccCCCC
Q 047157 118 --LALMQN--DGNFVLKNANSAVVWDSFDFPT 145 (788)
Q Consensus 118 --~a~Lld--sGNlVl~~~~~~~lWqSFD~Pt 145 (788)
....++ .||++ ......+.|.|=+.|+
T Consensus 84 dt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 84 DTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp -EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred cEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 233334 78888 7777889999977774
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.011 Score=64.65 Aligned_cols=76 Identities=14% Similarity=0.143 Sum_probs=52.3
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccc-------hHHHHHHHHHHHHHhcCCC---ccccceEeeEEecCCeEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-------IEKTNEEFMTELKIIGRTH---HKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~ 563 (788)
+.||.|.+..||++... ++++.|+||.-... ..-..+++..|.+.|..+. ..++++++.+ +.+..+
T Consensus 32 ~elggGn~N~VyrV~~~--~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDT--EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeC--CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 57899999999999874 33357899974311 1123456677888777652 3467788876 445678
Q ss_pred EEEecCCCCC
Q 047157 564 LVYELMPNGT 573 (788)
Q Consensus 564 lV~e~~~~gs 573 (788)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999987643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.005 Score=63.87 Aligned_cols=136 Identities=13% Similarity=0.117 Sum_probs=74.1
Q ss_pred ccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcccc-ceEeeEEecCCeEEEEEecCCCCCH
Q 047157 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL-VRLLGFCSEEDKRLLVYELMPNGTL 574 (788)
Q Consensus 496 lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lV~e~~~~gsL 574 (788)
+..|-...+|+... .+..+++|..........-...+|.++++.+....+ ++++.... .++|+||++|..+
T Consensus 4 ~~~G~tn~~y~~~~----~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIEH----PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEEe----CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence 45677788997753 344677887644322211134678888887753323 44554432 3689999998765
Q ss_pred hHh--------------h---hcc---CCCCCHHHH-HHHHHHH---------HHHHHHhhhc-----cCCceEecCCCC
Q 047157 575 SNF--------------L---FHE---GQRPGWVQR-VEIALGV---------ARGLLYLHEE-----CETQIIHCDIKP 619 (788)
Q Consensus 575 ~~~--------------l---~~~---~~~~~~~~~-~~i~~qi---------~~aL~~LH~~-----~~~~ivH~dlkp 619 (788)
... + +.. ...++.... ..+..++ ...+..+... ....++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 421 1 111 111121111 1111111 1111112111 123689999999
Q ss_pred CcEEeccCCCCCCCcEEEeecCCccc
Q 047157 620 QNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 620 ~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
.||+++ +++ +.|+||..+..
T Consensus 156 ~Nil~~-----~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVT-----PQG-LKLIDWEYASD 175 (256)
T ss_pred CcEEEe-----CCC-CEEEeccccCc
Confidence 999997 444 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.013 Score=62.39 Aligned_cols=76 Identities=20% Similarity=0.285 Sum_probs=45.3
Q ss_pred cccccccceEEEEEEec----cCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccc-cceEeeEEecCCeEEEEEecC
Q 047157 495 LVGTGSSGKVYRGILRL----KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN-LVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lV~e~~ 569 (788)
.|..|-...+|+..... +..+..+++|...... .......+|.+++..+.... ..++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 45556667888876531 0124578888865432 22234567877777774322 3456665542 3589998
Q ss_pred CCCCHh
Q 047157 570 PNGTLS 575 (788)
Q Consensus 570 ~~gsL~ 575 (788)
+|..+.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.022 Score=60.39 Aligned_cols=140 Identities=18% Similarity=0.231 Sum_probs=80.6
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcc--ccceEeeE------EecCCeEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHK--NLVRLLGF------CSEEDKRLLV 565 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~------~~~~~~~~lV 565 (788)
+.|..|....+|+.... ++ .+++|..... ....+..|++++..+.+. .+++++.. ....+..++|
T Consensus 20 ~~i~~G~~n~~y~v~~~---~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 20 EGISAGIENTNYFVTTD---SG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred ecccCccccceEEEEeC---CC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 45777877899987542 33 6788877642 234566777777776432 24444432 2334567899
Q ss_pred EecCCCCCHhH----h-------h---hcc--C--------CCCCHHHHH----------HHHHHHHHHHHHhhh----c
Q 047157 566 YELMPNGTLSN----F-------L---FHE--G--------QRPGWVQRV----------EIALGVARGLLYLHE----E 607 (788)
Q Consensus 566 ~e~~~~gsL~~----~-------l---~~~--~--------~~~~~~~~~----------~i~~qi~~aL~~LH~----~ 607 (788)
+++++|..+.. . + +.. + ....|.... .....+..++.++.. .
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99999876532 0 1 100 0 001111110 011123334444443 1
Q ss_pred cCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 608 ~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
...+++|+|+.|.||+++ ++..+.|+||+.+..
T Consensus 173 ~~~~l~HgD~~~~Nil~~-----~~~~~~iIDfe~a~~ 205 (296)
T cd05153 173 LPRGVIHADLFRDNVLFD-----GDELSGVIDFYFACT 205 (296)
T ss_pred CCCcCCccCcCcccEEEe-----CCceEEEeehhhhcC
Confidence 234799999999999998 555568999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.077 Score=56.96 Aligned_cols=32 Identities=25% Similarity=0.390 Sum_probs=26.2
Q ss_pred CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 609 ~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
..+++|+|++|.||+++ .+...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~-----~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFE-----GDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEE-----CCceEEEEecccccC
Confidence 45899999999999997 444558999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.033 Score=59.54 Aligned_cols=140 Identities=19% Similarity=0.273 Sum_probs=76.9
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcc--ccceEeeE------EecCCeEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHK--NLVRLLGF------CSEEDKRLLV 565 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~------~~~~~~~~lV 565 (788)
+.++.|....+|+... +++ .+++|....... .+.+..|.+++..|... .+++++.. ....+..+++
T Consensus 28 ~~~~~G~~n~~y~v~t---~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT---DVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred cccCCccccceEEEEe---CCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 4567777789998754 233 566776644211 23344566666555321 23444432 1224567899
Q ss_pred EecCCCCCHh-----------Hhh---hccCC-----------CCCHHHHH------------HHHHHHHHHHHHhhh--
Q 047157 566 YELMPNGTLS-----------NFL---FHEGQ-----------RPGWVQRV------------EIALGVARGLLYLHE-- 606 (788)
Q Consensus 566 ~e~~~~gsL~-----------~~l---~~~~~-----------~~~~~~~~------------~i~~qi~~aL~~LH~-- 606 (788)
+||++|..+. ..+ +.... ...|.... .....+.+.++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 9999885532 111 11000 01111110 011123334555532
Q ss_pred --ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 607 --ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 607 --~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
....+++|+|+++.||+++ ++....|+||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~-----~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFD-----GDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEE-----CCceEEEeeccccc
Confidence 2345899999999999998 55566899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.042 Score=59.56 Aligned_cols=142 Identities=16% Similarity=0.169 Sum_probs=79.0
Q ss_pred cccccccceEEEEEEecc--CcceeeeeeecccchHHHHHHHHHHHHHhcCCCcccc-ceEeeEEecCCeEEEEEecCCC
Q 047157 495 LVGTGSSGKVYRGILRLK--DTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL-VRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lV~e~~~~ 571 (788)
.|..|-.-.+|+...... ..+..+++|.......... .-.+|..+++.+..-++ .++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 344577778898765321 1235788887755432222 22578888887754333 4566665432 57999887
Q ss_pred CCHhHh-----------------hhccC----CCC-CHHHHHHHHHH-----------------HHHHHHHhh----h-c
Q 047157 572 GTLSNF-----------------LFHEG----QRP-GWVQRVEIALG-----------------VARGLLYLH----E-E 607 (788)
Q Consensus 572 gsL~~~-----------------l~~~~----~~~-~~~~~~~i~~q-----------------i~~aL~~LH----~-~ 607 (788)
.+|... +++.. ... .+..+..+..+ +...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 01111 001 12222222211 111122221 1 1
Q ss_pred cCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 608 ~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
....++|+|+++.||+++. .+..+.|+||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~----~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDE----ETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeC----CCCcEEEEeehhccc
Confidence 2347899999999999972 246799999988864
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.0065 Score=49.42 Aligned_cols=34 Identities=18% Similarity=0.203 Sum_probs=28.8
Q ss_pred ccCCHHHHHHHhhccccccccccc--CCceeecccc
Q 047157 357 SNVDVEGCRKAVMDDCYSLGASLV--GSTCVKTRMP 390 (788)
Q Consensus 357 ~~~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~w~~~ 390 (788)
...+.++|+..|+.||.|.|+.|. .+.|+++...
T Consensus 23 ~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~ 58 (73)
T cd01100 23 FASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE 58 (73)
T ss_pred ecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence 356899999999999999999985 4789888763
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.0091 Score=61.75 Aligned_cols=135 Identities=12% Similarity=0.106 Sum_probs=87.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc--h-------H-------------HHHHHHHHHHHHhcCCC-c
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--I-------E-------------KTNEEFMTELKIIGRTH-H 546 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~-------~-------------~~~~~~~~E~~~l~~l~-h 546 (788)
+.+.++||-|.=+.||.+.. ..+.+.++|.=+-. + . -.+-...+|...|+.|. |
T Consensus 94 ~svGnqIGVGKESDIY~v~d---~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD---EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhccccccccccceEEEec---CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 34568999999999999977 45667777742110 0 0 01123457788887774 2
Q ss_pred -cccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 547 -KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 547 -pniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
--+++.++ .+..++|||++.+-.|...-+ ..+..++. ..+..-+.-|-.+ |+||+|..--||+++
T Consensus 171 gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly---~~lm~~Iv~la~~---GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 171 GFPVPKPID----HNRHCVVMELVDGYPLRQVRH----VEDPPTLY---DDLMGLIVRLANH---GLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCCccc----ccceeeHHHhhcccceeeeee----cCChHHHH---HHHHHHHHHHHHc---CceecccchheeEEe
Confidence 22444444 346689999998888765431 22233332 3333334445555 999999999999998
Q ss_pred cCCCCCCCcEEEeecCCcccc
Q 047157 626 LKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
++..++++||=.....
T Consensus 237 -----dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 -----DDDKIVVIDFPQMVST 252 (465)
T ss_pred -----cCCCEEEeechHhhcc
Confidence 7889999999765544
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.0031 Score=76.70 Aligned_cols=159 Identities=12% Similarity=-0.024 Sum_probs=112.2
Q ss_pred HHHHHHHHhcCCCccccceEeeEEe--cCCeEEEEEecCCCCCHhHhhhccCCC---CCHHHHHHHHHHHHHHHHHhhhc
Q 047157 533 EFMTELKIIGRTHHKNLVRLLGFCS--EEDKRLLVYELMPNGTLSNFLFHEGQR---PGWVQRVEIALGVARGLLYLHEE 607 (788)
Q Consensus 533 ~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~ 607 (788)
....|...++...|+++.....-.. +..+.+.+++|+..|.+.+.+.+.... ++..-+.....+...+..-+|..
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3344444555568988877655443 234668899999999999998654322 22222333333335555555554
Q ss_pred cC--CceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHH
Q 047157 608 CE--TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGV 685 (788)
Q Consensus 608 ~~--~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGv 685 (788)
.+ .-.+|++||+-|.+|. .+.++|++++|+.+...+. ........+++.|+.|++...-+++.++|+|..|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIV-----tny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIV-----TNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred ccCCccchhhhhhhhcccee-----cCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 22 2368999999999998 8889999999999943332 22233456788899999999889999999999999
Q ss_pred HHHHHHhCCCCC
Q 047157 686 MLLEIICGRRHI 697 (788)
Q Consensus 686 il~elltg~~p~ 697 (788)
.+|+..-|..+|
T Consensus 1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHhcccHHH
Confidence 999998887766
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.099 Score=54.77 Aligned_cols=31 Identities=26% Similarity=0.546 Sum_probs=24.9
Q ss_pred CceEecCCCCCcEEeccCCCCCCCc-EEEeecCCccc
Q 047157 610 TQIIHCDIKPQNVLLDLKTLDTNYM-AKISDFGISKL 645 (788)
Q Consensus 610 ~~ivH~dlkp~NIll~~~~~~~~~~-~kL~Dfg~a~~ 645 (788)
..++|+|++|.||+++ +++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~-----~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILID-----EDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEe-----CCCCEEEEECcHhccc
Confidence 3589999999999997 4333 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.12 Score=54.39 Aligned_cols=72 Identities=17% Similarity=0.204 Sum_probs=44.5
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC---CccccceEeeEEecCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT---HHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
+.++.|.-..+|+.. ..+..+.||.-... ....|..|.+-|+.| .--.+++++++....+..+||+||++
T Consensus 23 ~~v~GG~i~~a~~~~----~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD----TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEE--SSSSEEEEEE----TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred EecCCCChhheEEEE----CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 567888889999764 45558889987632 234566777777666 34568889998887778899999987
Q ss_pred CC
Q 047157 571 NG 572 (788)
Q Consensus 571 ~g 572 (788)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 66
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.14 Score=54.20 Aligned_cols=122 Identities=20% Similarity=0.260 Sum_probs=73.2
Q ss_pred ceeeeeeecc-cchHHHHHHHHHHHHHhcCCCc--cccceEeeEEecCC--eEEEEEecCCCCCHhHhhhccCCCCCHHH
Q 047157 515 QIEIAVKKLE-KDIEKTNEEFMTELKIIGRTHH--KNLVRLLGFCSEED--KRLLVYELMPNGTLSNFLFHEGQRPGWVQ 589 (788)
Q Consensus 515 ~~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~~~~~~ 589 (788)
+++.++.+-. ...........+|.++++.+.- .-..+.++.|.++. ..+.||+|++|..+.+.+... ...
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~----~~~- 122 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE----SLG- 122 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc----cch-
Confidence 4456666221 1223344556678888877643 33456677777766 679999999885433322111 000
Q ss_pred HHHHH-HHHHHHHHHhhh--------------------------------------------------c-----cCCceE
Q 047157 590 RVEIA-LGVARGLLYLHE--------------------------------------------------E-----CETQII 613 (788)
Q Consensus 590 ~~~i~-~qi~~aL~~LH~--------------------------------------------------~-----~~~~iv 613 (788)
.+++ ..+++.|+-||+ + ..+.++
T Consensus 123 -~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lv 201 (321)
T COG3173 123 -RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLV 201 (321)
T ss_pred -HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceee
Confidence 1111 244444444443 2 124799
Q ss_pred ecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 614 H~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+|+++.||+++ +...+-+.||+++..-.
T Consensus 202 HGD~~~gNlii~-----~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 202 HGDYRPGNLIID-----PGRPTGVLDWELATLGD 230 (321)
T ss_pred eCCcccCCEEEe-----CCCeeEEEeccccccCC
Confidence 999999999998 44458899999987643
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.047 Score=60.00 Aligned_cols=49 Identities=18% Similarity=0.337 Sum_probs=37.6
Q ss_pred HHHHHHHHHhcCCCccccceEeeEEecCC-eEEEEEecCCCCCHhHhhhcc
Q 047157 532 EEFMTELKIIGRTHHKNLVRLLGFCSEED-KRLLVYELMPNGTLSNFLFHE 581 (788)
Q Consensus 532 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~ 581 (788)
.++.-....++.+.|+|+...+++..... ...+|+|++ +.||++.+...
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 34556677888889999999999876543 467889998 77999888544
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.1 Score=55.25 Aligned_cols=141 Identities=18% Similarity=0.180 Sum_probs=89.6
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch-------------------------HHHHH-HHHHHHHHhcCCCcc
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-------------------------EKTNE-EFMTELKIIGRTHHK 547 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-------------------------~~~~~-~~~~E~~~l~~l~hp 547 (788)
..|..|.=+-||.+.- ..+..+|||+++... ....+ -..+|++-|.+|+.-
T Consensus 150 GCiSTGKEANVYHat~---~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 150 GCISTGKEANVYHATE---EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccCccceeEeeec---CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4578899999999876 355679999874211 11111 134677777777544
Q ss_pred ccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccC
Q 047157 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK 627 (788)
Q Consensus 548 niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 627 (788)
.|.----+. -....|||+|+....- -.=.-+...++...+..+-.|++.-+.-|-+.| ++||.||.--|+|+
T Consensus 227 GIP~PePIl--Lk~hVLVM~FlGrdgw-~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly--- 298 (520)
T KOG2270|consen 227 GIPCPEPIL--LKNHVLVMEFLGRDGW-AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY--- 298 (520)
T ss_pred CCCCCCcee--eecceEeeeeccCCCC-cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE---
Confidence 332111000 0134689999853211 110011234555567777788888888887765 89999999999999
Q ss_pred CCCCCCcEEEeecCCccccCC
Q 047157 628 TLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 628 ~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
.++.+.|+|-+.+.....
T Consensus 299 ---hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 299 ---HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred ---ECCEEEEEEccccccCCC
Confidence 578999999988776543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.16 Score=54.47 Aligned_cols=80 Identities=18% Similarity=0.128 Sum_probs=49.0
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccch-------HHHHHHHHHHHHHhcCCC--cc-ccceEeeEEecCCeEEE
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-------EKTNEEFMTELKIIGRTH--HK-NLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~--hp-niv~~~~~~~~~~~~~l 564 (788)
.||-|....||++... +.+..|+||.-.... +-..++..-|.+.|+... -| .+++++.+ +.+...+
T Consensus 2 EigdGnlN~VfrV~~~--~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQ--EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcC--CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccccee
Confidence 5799999999999863 333578898653211 222345556777776543 23 45566543 5556679
Q ss_pred EEecCCCC-CHhHhh
Q 047157 565 VYELMPNG-TLSNFL 578 (788)
Q Consensus 565 V~e~~~~g-sL~~~l 578 (788)
|||+++.. .|++.|
T Consensus 78 vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 78 VMEDLSHHKIARKGL 92 (370)
T ss_pred hHhhCccchHHHHHH
Confidence 99998543 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.075 Score=53.25 Aligned_cols=30 Identities=27% Similarity=0.492 Sum_probs=20.8
Q ss_pred ceEecCCCCCcEEe-ccCCCCCCCcEEEeecCCccc
Q 047157 611 QIIHCDIKPQNVLL-DLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 611 ~ivH~dlkp~NIll-~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
.++|+|+.+.|||+ + .++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~-----~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINN-----KDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETS-----SSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEecc-----CCCeEEEecHHHHhh
Confidence 68999999999999 4 778999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.22 Score=53.71 Aligned_cols=76 Identities=13% Similarity=0.258 Sum_probs=43.9
Q ss_pred ccccccccceEEEEEEeccC-cceeeeeeecccchHHHHHHHHHHHHHhcCCCcccc-ceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL-VRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lV~e~~~~ 571 (788)
+.|..|-.-.+|+....... ....|.+|........ .-.-.+|..+++.+..-++ +++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 34444666778887654211 1236778876543221 1223578888887754444 4666665322 58999877
Q ss_pred CCH
Q 047157 572 GTL 574 (788)
Q Consensus 572 gsL 574 (788)
..|
T Consensus 95 ~~l 97 (330)
T PLN02421 95 RTL 97 (330)
T ss_pred CCC
Confidence 665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 788 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-31 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-23 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-23 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-23 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-22 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-22 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-20 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-19 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 788 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-116 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-105 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-102 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-68 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-65 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-64 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-63 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-63 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-58 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-57 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 7e-57 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-56 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-55 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-54 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-48 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-47 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-47 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-47 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-42 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-40 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-39 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-39 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-39 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-39 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-38 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-38 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-38 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-38 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-37 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-37 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-37 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-37 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-37 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 8e-37 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 9e-37 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-36 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-36 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-36 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-36 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-36 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 8e-36 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-36 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-35 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-35 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-35 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-35 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-35 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-35 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-35 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-35 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-35 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 7e-35 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 9e-35 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 9e-35 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-34 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-34 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-34 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-34 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-34 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-33 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-33 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-33 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-33 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 5e-33 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 8e-33 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 9e-33 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-32 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-32 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-32 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-32 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-32 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 6e-32 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-32 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-32 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-32 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-32 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 9e-32 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 9e-32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-31 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-31 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-31 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 7e-30 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 8e-30 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-29 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-29 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-29 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-29 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-29 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-29 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-29 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-29 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-29 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-29 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 4e-29 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-29 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 6e-29 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-29 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-28 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-28 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-28 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-28 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-28 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 6e-28 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-28 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-27 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-27 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-27 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-27 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-27 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-27 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-27 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-27 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-27 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 6e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-27 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 6e-27 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-27 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 9e-27 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-27 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-26 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-26 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-26 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-26 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-26 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-26 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-26 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-26 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-26 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-26 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-26 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-26 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-26 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 6e-26 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 7e-26 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-26 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 9e-26 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 9e-26 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-25 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 5e-25 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 8e-25 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-25 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-24 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-24 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-24 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-24 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-24 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-24 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-24 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 8e-24 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-23 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-23 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-23 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-23 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-23 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 6e-23 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 8e-23 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 9e-23 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-22 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-22 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-22 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 9e-22 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 4e-21 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-21 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 5e-21 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-21 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 7e-21 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 8e-21 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 8e-21 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-20 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-20 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-20 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-20 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-20 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-20 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 4e-20 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 6e-20 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-20 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 5e-19 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 8e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-17 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-17 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-17 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-17 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-17 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-17 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-17 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-17 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-17 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 9e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 9e-17 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 8e-16 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 2e-06 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-15 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-15 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-15 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 8e-15 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 9e-15 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-14 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-14 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-14 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-14 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-13 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-13 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-13 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-13 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 7e-13 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-12 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-12 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-12 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-12 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-12 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-12 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 8e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-11 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-10 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-11 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-11 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-11 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-11 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 1e-10 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 5e-07 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-10 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-10 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 5e-10 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 1e-06 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 8e-10 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 1e-06 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 1e-09 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 3e-07 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 2e-09 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 7e-05 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 3e-09 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 4e-07 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 4e-09 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 9e-08 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 4e-05 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 1e-08 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 8e-08 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-08 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 7e-08 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 1e-07 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-07 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 7e-07 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 4e-06 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 3e-05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 7e-07 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-06 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 7e-06 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 2e-05 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 9e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-06 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-05 | |
| 2vse_A | 841 | MTX holotoxin, mosquitocidal toxin; ADP-ribosyltra | 5e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 352 bits (906), Expect = e-116
Identities = 122/315 (38%), Positives = 183/315 (58%), Gaps = 25/315 (7%)
Query: 469 DPNSMEINFREFTFQELQEATKGFSK--LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD 526
DP + F+ +ELQ A+ FS ++G G GKVY+G RL D +AVK+L+++
Sbjct: 9 DPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKG--RLADGT-LVAVKRLKEE 65
Query: 527 IEKTNE-EFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP 585
+ E +F TE+++I H+NL+RL GFC +RLLVY M NG++++ L +
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR--ERPE 123
Query: 586 G-----WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640
W +R IALG ARGL YLH+ C+ +IIH D+K N+LLD + A + DF
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD-----EEFEAVVGDF 178
Query: 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELS 700
G++KL++ T T +RGT+G++APE+L + K DVF +GVMLLE+I G+R +L+
Sbjct: 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238
Query: 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLS--DLERFERMAMVGLWCNHPDP 758
R+ + D++L DWV + + L+ LV D ++ E E++ V L C P
Sbjct: 239 RLANDD---DVMLLDWVKGLLKEKKLEALV--DVDLQGNYKDEEVEQLIQVALLCTQSSP 293
Query: 759 NLRPSMKKVIHMLEG 773
RP M +V+ MLEG
Sbjct: 294 MERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-105
Identities = 110/316 (34%), Positives = 162/316 (51%), Gaps = 26/316 (8%)
Query: 470 PNSMEINFREFTFQELQEATKGFSK--LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI 527
+ +L+EAT F L+G G GKVY+G+LR D ++A+K+ +
Sbjct: 19 SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR--DGA-KVALKRRTPES 75
Query: 528 EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPG- 586
+ EEF TE++ + H +LV L+GFC E ++ +L+Y+ M NG L L+
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 587 --WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
W QR+EI +G ARGL YLH IIH D+K N+L LD N++ KI+DFGISK
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINIL-----LDENFVPKITDFGISK 187
Query: 645 L-LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVE 703
DQT T ++GT+GY+ PE+ +T K DV+SFGV+L E++C R I S
Sbjct: 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247
Query: 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLS--DLERFERMAMVGLWCNHPDPNLR 761
E + L++W + + L+ +V DP + E + + C R
Sbjct: 248 EM-----VNLAEWAVESHNNGQLEQIV--DPNLADKIRPESLRKFGDTAVKCLALSSEDR 300
Query: 762 PSMKKVIHMLEGTLEV 777
PSM V+ LE L +
Sbjct: 301 PSMGDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-102
Identities = 109/323 (33%), Positives = 158/323 (48%), Gaps = 41/323 (12%)
Query: 469 DPNSMEINFREFTFQELQEATKGFSK--------LVGTGSSGKVYRGILRLKDTQIEIAV 520
+ F F+F EL+ T F + +G G G VY+G + + +AV
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---NNT-TVAV 59
Query: 521 KKLEKDIEKT----NEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSN 576
KKL ++ T ++F E+K++ + H+NLV LLGF S+ D LVY MPNG+L +
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 577 FLFHEGQRPG--WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM 634
L P W R +IA G A G+ +LHE IH DIK N+L LD +
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL-----LDEAFT 171
Query: 635 AKISDFGISKLL-NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
AKISDFG+++ QT + + GT Y+APE LR +T K D++SFGV+LLEII G
Sbjct: 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230
Query: 694 RRHIELSRVEEESEEVDIVLSDWVISCMLS-RNLQVLVSHDPEVLSD--LERFERMAMVG 750
++ R E + L D + ++ + D + ++D E M V
Sbjct: 231 LPAVDEHR-EPQL------LLDIKEEIEDEEKTIEDYI--DKK-MNDADSTSVEAMYSVA 280
Query: 751 LWCNHPDPNLRPSMKKVIHMLEG 773
C H N RP +KKV +L+
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-68
Identities = 67/320 (20%), Positives = 119/320 (37%), Gaps = 42/320 (13%)
Query: 478 REFTFQELQEATKGFS--KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFM 535
+ + L + ++ G G V++ L +AVK +K + +
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL----NEYVAVKIFPIQ-DKQSWQNE 66
Query: 536 TELKIIGRTHHKNLVRLLGFCSEEDK----RLLVYELMPNGTLSNFLFHEGQRPGWVQRV 591
E+ + H+N+++ +G L+ G+LS+FL W +
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELC 124
Query: 592 EIALGVARGLLYLHEECETQ-------IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
IA +ARGL YLHE+ I H DIK +NVLL N A I+DFG++
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-----NNLTACIADFGLAL 179
Query: 645 LLNKDQTRTDTNMR-GTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIE 698
++ DT+ + GT Y+APE L ++D+++ G++L E+
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT--- 236
Query: 699 LSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD------PEVLSDLERFERMAMVGLW 752
+ +E + + + ++Q +V H + +
Sbjct: 237 --AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 753 CNHPDPNLRPSMKKVIHMLE 772
C D R S V +
Sbjct: 295 CWDHDAEARLSAGCVGERIT 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 4e-65
Identities = 79/302 (26%), Positives = 135/302 (44%), Gaps = 49/302 (16%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
I+++E +E+ VG G+ G V + R ++A+K++E E +
Sbjct: 4 MIDYKEIEVEEV----------VGRGAFGVVCKAKWR----AKDVAIKQIES--ESERKA 47
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPG--WVQRV 591
F+ EL+ + R +H N+V+L G C + LV E G+L N L P +
Sbjct: 48 FIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM 105
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651
L ++G+ YLH +IH D+KP N+LL + KI DFG + D
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV----AGGTVLKICDFGTAC----DIQ 157
Query: 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI 711
TN +G+ ++APE + K DVFS+G++L E+I R+ + +I
Sbjct: 158 THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-----------EI 206
Query: 712 VLSDWVISCMLSRNLQ-VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770
+ I + + L+ + P+ + L M W DP+ RPSM++++ +
Sbjct: 207 GGPAFRIMWAVHNGTRPPLIKNLPKPIESL-------MTRCW--SKDPSQRPSMEEIVKI 257
Query: 771 LE 772
+
Sbjct: 258 MT 259
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 5e-64
Identities = 76/322 (23%), Positives = 142/322 (44%), Gaps = 53/322 (16%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKL--EKDIEKTN 531
+I + + +E +G GS G V+R ++AVK L + +
Sbjct: 33 DIPWCDLNIKEK----------IGAGSFGTVHRAEWH----GSDVAVKILMEQDFHAERV 78
Query: 532 EEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP--GWVQ 589
EF+ E+ I+ R H N+V +G ++ +V E + G+L L G R +
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 590 RVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649
R+ +A VA+G+ YLH I+H ++K N+L+D Y K+ DFG+S+L
Sbjct: 139 RLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVD-----KKYTVKVCDFGLSRLKAST 192
Query: 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR---RHIELSRVEEES 706
+ + GT ++APE LR+ P K DV+SFGV+L E+ + ++ ++
Sbjct: 193 FL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----- 246
Query: 707 EEVDIVLSDWVISCMLSRNLQVLVSHD-PEVLSDLERFERMAMVGLWCNHPDPNLRPSMK 765
V++ + + ++ + + ++ + + G W +P RPS
Sbjct: 247 ----------VVAAVGFKCKRLEIPRNLNPQVAAI-------IEGCW--TNEPWKRPSFA 287
Query: 766 KVIHMLEGTLEVGMPPLLHDQM 787
++ +L ++ +PP +
Sbjct: 288 TIMDLLRPLIKSAVPPPNRSDL 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-63
Identities = 88/310 (28%), Positives = 136/310 (43%), Gaps = 54/310 (17%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKL----EKDIEK 529
EI+F E T +E+ +G G GKVYR E+AVK ++DI +
Sbjct: 3 EIDFAELTLEEI----------IGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQ 48
Query: 530 TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQ 589
T E E K+ H N++ L G C +E LV E G L+ L G+R
Sbjct: 49 TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDI 106
Query: 590 RVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD---LKTLDTNYMAKISDFGISKLL 646
V A+ +ARG+ YLH+E IIH D+K N+L+ +N + KI+DFG+++
Sbjct: 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166
Query: 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR---RHIELSRVE 703
++ + G ++APE +R + DV+S+GV+L E++ G R I+
Sbjct: 167 HRTTKMSAA---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-- 221
Query: 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHD-PEVLSDLERFERMAMVGLWCNHPDPNLRP 762
V + L + + PE + L M W +PDP+ RP
Sbjct: 222 -------------VAYGVAMNKLALPIPSTCPEPFAKL-------MEDCW--NPDPHSRP 259
Query: 763 SMKKVIHMLE 772
S ++ L
Sbjct: 260 SFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-63
Identities = 65/312 (20%), Positives = 124/312 (39%), Gaps = 54/312 (17%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKL-------EKD 526
+ E +++ +G G G V++G L + +A+K L E +
Sbjct: 15 TLADNEIEYEKQ----------IGKGGFGLVHKGRLVKDKS--VVAIKSLILGDSEGETE 62
Query: 527 IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPG 586
+ + +EF E+ I+ +H N+V+L G +V E +P G L + L +
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIK 120
Query: 587 WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646
W ++ + L +A G+ Y+ I+H D++ N+ L + AK++DFG+S
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS--- 176
Query: 647 NKDQTRTDTNMRGTMGYVAPEWL--RNVPVTTKVDVFSFGVMLLEIICGR---RHIELSR 701
+ + + + G ++APE + T K D +SF ++L I+ G +
Sbjct: 177 -QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 702 VEEESEEVDIVLSDWVISCMLSRNLQVLVSHD-PEVLSDLERFERMAMVGLWCNHPDPNL 760
+ I+ + L+ + D P L ++ + W DP
Sbjct: 236 I-------------KFINMIREEGLRPTIPEDCPPRLRNV-------IELCW--SGDPKK 273
Query: 761 RPSMKKVIHMLE 772
RP ++ L
Sbjct: 274 RPHFSYIVKELS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-58
Identities = 71/322 (22%), Positives = 123/322 (38%), Gaps = 72/322 (22%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
+ E+ +G G G+ + R +T + +K+L + E+T
Sbjct: 6 IFRPSDLIHGEV----------LGKGCFGQAIKVTHR--ETGEVMVMKELIRFDEETQRT 53
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI 593
F+ E+K++ H N+++ +G ++ + + E + GTL + + W QRV
Sbjct: 54 FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF 113
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653
A +A G+ YLH IIH D+ N L+ N ++DFG+++L+ ++T+
Sbjct: 114 AKDIASGMAYLHSM---NIIHRDLNSHNCLVR-----ENKNVVVADFGLARLMVDEKTQP 165
Query: 654 D-------------TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELS 700
+ + G ++APE + KVDVFSFG++L EII
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN----- 220
Query: 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVG---------- 750
L R + + ++ F
Sbjct: 221 ----------------ADPDYLPRTMDFGL--------NVRGFLDRYCPPNCPPSFFPIT 256
Query: 751 LWCNHPDPNLRPSMKKVIHMLE 772
+ C DP RPS K+ H LE
Sbjct: 257 VRCCDLDPEKRPSFVKLEHWLE 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-57
Identities = 67/310 (21%), Positives = 117/310 (37%), Gaps = 60/310 (19%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKL--EKDIEKTN 531
I+F++ F + SG++++G + +I VK L + +
Sbjct: 6 GIDFKQLNFLTK----------LNENHSGELWKGRWQ----GNDIVVKVLKVRDWSTRKS 51
Query: 532 EEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL--VYELMPNGTLSNFLFHEGQRPG--W 587
+F E + H N++ +LG C + MP G+L N L HEG
Sbjct: 52 RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQ 110
Query: 588 VQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647
Q V+ AL +ARG+ +LH E I + ++V+ +D + A+IS +
Sbjct: 111 SQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVM-----IDEDMTARISMADVKF--- 161
Query: 648 KDQTRTDTNMRGTMGYVAPEWLRNVP---VTTKVDVFSFGVMLLEIICGRR-HIELSRVE 703
+ +VAPE L+ P D++SF V+L E++ +LS +E
Sbjct: 162 ---SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME 218
Query: 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHD-PEVLSDLERFERMAMVGLWCNHPDPNLRP 762
+ + L+ + +S L M + DP RP
Sbjct: 219 -------------IGMKVALEGLRPTIPPGISPHVSKL-------MKICM--NEDPAKRP 256
Query: 763 SMKKVIHMLE 772
++ +LE
Sbjct: 257 KFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 7e-57
Identities = 64/317 (20%), Positives = 117/317 (36%), Gaps = 65/317 (20%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKL--EKDIEKTN 531
+I F + EL +G G G+VY G E+A++ + E+D E
Sbjct: 29 DIPFEQLEIGEL----------IGKGRFGQVYHGRWH-----GEVAIRLIDIERDNEDQL 73
Query: 532 EEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV 591
+ F E+ +T H+N+V +G C ++ L TL + + +
Sbjct: 74 KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR 133
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK--- 648
+IA + +G+ YLH + I+H D+K +NV D + I+DFG+ +
Sbjct: 134 QIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNGKV------VITDFGLFSISGVLQA 184
Query: 649 -DQTRTDTNMRGTMGYVAPEWLRNV---------PVTTKVDVFSFGVMLLEIICGR---R 695
+ G + ++APE +R + P + DVF+ G + E+ +
Sbjct: 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244
Query: 696 HIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNH 755
+ W + + + + E+ L C
Sbjct: 245 TQPAEAII------------WQMGTGM-KPNLSQIGMGKEISDILLF----------CWA 281
Query: 756 PDPNLRPSMKKVIHMLE 772
+ RP+ K++ MLE
Sbjct: 282 FEQEERPTFTKLMDMLE 298
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-56
Identities = 74/339 (21%), Positives = 117/339 (34%), Gaps = 61/339 (17%)
Query: 468 FDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI 527
+ ++ EL +G G G VY+G L + +AVK
Sbjct: 3 AAASEPSLDLDNLKLLEL----------IGRGRYGAVYKGSLD----ERPVAVKVFSFAN 48
Query: 528 EKTNEEFMTELKI--IGRTHHKNLVRLLGFCSE-----EDKRLLVYELMPNGTLSNFLFH 580
+ F+ E I + H N+ R + + LLV E PNG+L +L
Sbjct: 49 RQ---NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL 105
Query: 581 EGQRPGWVQRVEIALGVARGLLYLHEE------CETQIIHCDIKPQNVLLDLKTLDTNYM 634
WV +A V RGL YLH E + I H D+ +NVL + +
Sbjct: 106 --HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL-----VKNDGT 158
Query: 635 AKISDFGISKLL-------NKDQTRTDTNMRGTMGYVAPEWLRNV-------PVTTKVDV 680
ISDFG+S L ++ + GT+ Y+APE L +VD+
Sbjct: 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218
Query: 681 FSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD------- 733
++ G++ EI E E + V + ++QVLVS +
Sbjct: 219 YALGLIYWEIFMRC---TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP 275
Query: 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
+ + C D R + + +
Sbjct: 276 EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-54
Identities = 66/307 (21%), Positives = 134/307 (43%), Gaps = 50/307 (16%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKL--EKDIEKTN 531
EI + T + +G+GS G VY+G ++AVK L +
Sbjct: 20 EIPDGQITVGQR----------IGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQL 64
Query: 532 EEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV 591
+ F E+ ++ +T H N++ +G+ + + +V + +L + L + + +
Sbjct: 65 QAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLI 123
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ- 650
+IA ARG+ YLH + IIH D+K N+ L + KI DFG++ ++
Sbjct: 124 DIARQTARGMDYLHAK---SIIHRDLKSNNIF-----LHEDNTVKIGDFGLATEKSRWSG 175
Query: 651 TRTDTNMRGTMGYVAPEWLRN---VPVTTKVDVFSFGVMLLEIICGRR-HIELSRVEEES 706
+ + G++ ++APE +R P + + DV++FG++L E++ G+ + ++ ++
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-- 233
Query: 707 EEVDIVLSDWVISCMLSRNLQVLVSHD-PEVLSDLERFERMAMVGLWCNHPDPNLRPSMK 765
I+ ++ V + P+ + L M C + RPS
Sbjct: 234 ----II---EMVGRGSLSPDLSKVRSNCPKRMKRL-----M----AECLKKKRDERPSFP 277
Query: 766 KVIHMLE 772
+++ +E
Sbjct: 278 RILAEIE 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 2e-47
Identities = 64/323 (19%), Positives = 115/323 (35%), Gaps = 52/323 (16%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
++ + +G G G+V+ G R ++AVK E+ +
Sbjct: 33 RTIAKQIQMVKQ----------IGKGRYGEVWMGKWR----GEKVAVKVF-FTTEEASWF 77
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKR----LLVYELMPNGTLSNFLFHEGQRPGWVQ 589
TE+ H+N++ + + L+ + NG+L ++L +
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKS 135
Query: 590 RVEIALGVARGLLYLHEECETQ-----IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
+++A GL +LH E + I H D+K +N+L + N I+D G++
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL-----VKKNGTCCIADLGLAV 190
Query: 645 LLNKDQTRTDTNM---RGTMGYVAPEWL------RNVPVTTKVDVFSFGVMLLEIICGRR 695
D D GT Y+ PE L + D++SFG++L E+
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR-- 248
Query: 696 HIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD------PEVLSDLERFERMAMV 749
EE + D V S +++ +V P S E +M +
Sbjct: 249 ----CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKL 304
Query: 750 GLWCNHPDPNLRPSMKKVIHMLE 772
C +P R + +V L
Sbjct: 305 MTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 63/305 (20%), Positives = 116/305 (38%), Gaps = 42/305 (13%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+ VG G G+V+RG + +AVK ++ + TEL H+N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ----GENVAVKIF-SSRDEKSWFRETELYNTVMLRHENILG 66
Query: 552 LLGFCSEEDKR----LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
+ L+ G+L ++L + V + I L +A GL +LH E
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 608 CETQ-----IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNM---RG 659
I H D+K +N+L + N I+D G++ + ++ + D G
Sbjct: 125 IFGTQGKPAIAHRDLKSKNIL-----VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 660 TMGYVAPEWLRNVPVTT------KVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL 713
T Y+APE L +VD+++FG++L E+ E+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR------MVSNGIVEDYKPPF 233
Query: 714 SDWVISCMLSRNLQVLVSHD------PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKV 767
D V + +++ +V D P +A + C + +P+ R + ++
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 768 IHMLE 772
L
Sbjct: 294 KKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 63/307 (20%), Positives = 115/307 (37%), Gaps = 46/307 (14%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+ +G G G+V+RG R E+AVK E+ + E+ H+N++
Sbjct: 46 LQESIGKGRFGEVWRGKWR----GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILG 100
Query: 552 LLGFCSEEDKR----LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
+ ++++ LV + +G+L ++L +++AL A GL +LH E
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 608 CETQ-----IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNM---RG 659
I H D+K +N+L + N I+D G++ + D G
Sbjct: 159 IVGTQGKPAIAHRDLKSKNIL-----VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 660 TMGYVAPEWLRN------VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL 713
T Y+APE L + + D+++ G++ EI + E+ +
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR------CSIGGIHEDYQLPY 267
Query: 714 SDWVISCMLSRNLQVLVSHD------PEVLSDLERFERMA--MVGLWCNHPDPNLRPSMK 765
D V S ++ +V P E MA M W + + R +
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW--YANGAARLTAL 325
Query: 766 KVIHMLE 772
++ L
Sbjct: 326 RIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-42
Identities = 76/365 (20%), Positives = 130/365 (35%), Gaps = 100/365 (27%)
Query: 439 FSAICALLSGVAAIYYSPAARGLIKR-----RNYFDPNSMEINFREFTFQELQEATKGFS 493
F +I L+ + + L K+ + +N +
Sbjct: 75 FPSIPLLID-----HLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLG---------- 119
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRL 552
+ +G G+ G+V+ G LR +T + AVK + + +F+ E +I+ + H N+VRL
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLV--AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQI 612
+G C+++ +V EL+ G FL EG R +++ A G+ YL +
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV-----APE 667
IH D+ +N L + + KISDFG+S+ G + V APE
Sbjct: 235 IHRDLAARNCL-----VTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAPE 285
Query: 668 WLRNVPVTTKVDVFSFGVMLLEII-CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726
L +++ DV+SFG++L E G
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGAS------------------------------- 314
Query: 727 QVLVSHDP-------EVLSDLERFERMA------------MVGLWCNHPDPNLRPSMKKV 767
P + +E+ R+ M C +P RPS +
Sbjct: 315 -------PYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM--EQCWAYEPGQRPSFSTI 365
Query: 768 IHMLE 772
L+
Sbjct: 366 YQELQ 370
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-40
Identities = 81/337 (24%), Positives = 135/337 (40%), Gaps = 60/337 (17%)
Query: 453 YYSPAARGLIKRRNYFDPNSMEINFREFTFQ----ELQEATKGFSKLVGTGSSGKVYRGI 508
++S A GLI +Y P + + E++ +G G G+VY G
Sbjct: 181 HHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEG- 239
Query: 509 LRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568
K + +AVK L K+ EEF+ E ++ H NLV+LLG C+ E ++ E
Sbjct: 240 -VWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297
Query: 569 MPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK 627
M G L ++L Q V + +A ++ + YL ++ IH ++ +N L
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCL---- 350
Query: 628 TLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVML 687
+ N++ K++DFG+S+L+ D + + + APE L + K DV++FGV+L
Sbjct: 351 -VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409
Query: 688 LEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA 747
EI + +D +V LE+ RM
Sbjct: 410 WEIA--------TYGMSPYPGID----------------------LSQVYELLEKDYRME 439
Query: 748 ------------MVGLWCNHPDPNLRPSMKKVIHMLE 772
M C +P+ RPS ++ E
Sbjct: 440 RPEGCPEKVYELM--RACWQWNPSDRPSFAEIHQAFE 474
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 66/299 (22%), Positives = 126/299 (42%), Gaps = 43/299 (14%)
Query: 492 FSKLVGTGSSGKVYRGILRL--KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL 549
F + +G G+ G V +T +AVKKL+ E+ +F E++I+ H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 550 VRLLGFCSEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
V+ G C +R L+ E +P G+L ++L +R ++ ++ + +G+ YL +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL--NKDQTRTDTNMRGTMGYVA 665
+ IH D+ +N+L ++ KI DFG++K+L +K+ + + + A
Sbjct: 134 ---RYIHRDLATRNIL-----VENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725
PE L + DV+SFGV+L E+ + M+ +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELF--------------TYIEKSKSPPAEFMRMIGND 231
Query: 726 LQVLVSHDPEVLSDLERFERMA------------MVGLWCNHPDPNLRPSMKKVIHMLE 772
Q + ++ L+ R+ M W + + N RPS + + ++
Sbjct: 232 KQGQMIV-FHLIELLKNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 67/330 (20%), Positives = 127/330 (38%), Gaps = 59/330 (17%)
Query: 463 KRRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRL--KDTQIEIAV 520
K DP R + +G G GKV +T ++AV
Sbjct: 8 KPATEVDPT--HFEKRFLKRI----------RDLGEGHFGKVELCRYDPEGDNTGEQVAV 55
Query: 521 KKL-EKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR--LLVYELMPNGTLSNF 577
K L + + E++I+ +H+N+V+ G C+E+ L+ E +P+G+L +
Sbjct: 56 KSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY 115
Query: 578 LFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637
L + Q+++ A+ + +G+ YL Q +H D+ +NVL +++ + KI
Sbjct: 116 LPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVL-----VESEHQVKI 167
Query: 638 SDFGISKLL--NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII-CGR 694
DFG++K + +K+ + + + APE L DV+SFGV L E++
Sbjct: 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227
Query: 695 RHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA------- 747
+ + ++ +++ L+ +R+
Sbjct: 228 SDSSPMALFLKMIGPTH----GQMT-------------VTRLVNTLKEGKRLPCPPNCPD 270
Query: 748 -----MVGLWCNHPDPNLRPSMKKVIHMLE 772
M W P+ R S + +I E
Sbjct: 271 EVYQLMRKCW--EFQPSNRTSFQNLIEGFE 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 70/330 (21%), Positives = 136/330 (41%), Gaps = 43/330 (13%)
Query: 461 LIKRRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRL--KDTQIEI 518
+ N + +M F + + +E F + +G G+ G V +T +
Sbjct: 14 IPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV 73
Query: 519 AVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR--LLVYELMPNGTLSN 576
AVKKL+ E+ +F E++I+ H N+V+ G C +R L+ E +P G+L +
Sbjct: 74 AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133
Query: 577 FLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636
+L +R ++ ++ + +G+ YL + + IH D+ +N+L ++ K
Sbjct: 134 YLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNIL-----VENENRVK 185
Query: 637 ISDFGISKLL--NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
I DFG++K+L +K+ + + + APE L + DV+SFGV+L E+
Sbjct: 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF--- 242
Query: 695 RHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA------- 747
+ M+ + Q + ++ L+ R+
Sbjct: 243 -----------TYIEKSKSPPAEFMRMIGNDKQGQMIV-FHLIELLKNNGRLPRPDGCPD 290
Query: 748 -----MVGLWCNHPDPNLRPSMKKVIHMLE 772
M W + + N RPS + + ++
Sbjct: 291 EIYMIMTECW--NNNVNQRPSFRDLALRVD 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-39
Identities = 67/301 (22%), Positives = 120/301 (39%), Gaps = 48/301 (15%)
Query: 492 FSKLVGTGSSGKVYRGILRL--KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL 549
+ +G G+ G V +T +AVK+L+ +F E++I+ H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 550 VRLLGFCSEEDKR--LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
V+ G ++ LV E +P+G L +FL R + + + + +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL--NKDQTRTDTNMRGTMGYVA 665
+ +H D+ +N+L +++ KI+DFG++KLL +KD + + + A
Sbjct: 147 ---RCVHRDLAARNIL-----VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEII--CGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723
PE L + + + DV+SFGV+L E+ C + + V +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA--------- 249
Query: 724 RNLQVLVSHDPEVLSDLERFERMA------------MVGLWCNHPDPNLRPSMKKVIHML 771
+L LE +R+ M W P P RPS + L
Sbjct: 250 ---------LSRLLELLEEGQRLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQL 298
Query: 772 E 772
+
Sbjct: 299 D 299
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-38
Identities = 81/335 (24%), Positives = 133/335 (39%), Gaps = 61/335 (18%)
Query: 453 YYSPAARGLIKRRNYFDPNSMEINFREFTFQ-ELQEATKGFSKLVGTGSSGKVYRGILRL 511
YYS A GL R P S E+ + +G G G+V+ G
Sbjct: 148 YYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN- 206
Query: 512 KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPN 571
+A+K L K + E F+ E +++ + H+ LV+L SEE +V E M
Sbjct: 207 --GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSK 262
Query: 572 GTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD 630
G+L +FL G+ Q V++A +A G+ Y+ +H D++ N+L+
Sbjct: 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG----- 314
Query: 631 TNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
N + K++DFG+++L+ ++ + + + APE T K DV+SFG++L E+
Sbjct: 315 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 691 I-CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA-- 747
GR + + EVL +ER RM
Sbjct: 375 TTKGRVPY------------------PGMV-------------NREVLDQVERGYRMPCP 403
Query: 748 ----------MVGLWCNHPDPNLRPSMKKVIHMLE 772
M C +P RP+ + + LE
Sbjct: 404 PECPESLHDLM--CQCWRKEPEERPTFEYLQAFLE 436
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 1e-38
Identities = 81/335 (24%), Positives = 133/335 (39%), Gaps = 61/335 (18%)
Query: 453 YYSPAARGLIKRRNYFDPNSMEINFREFTFQ-ELQEATKGFSKLVGTGSSGKVYRGILRL 511
YYS A GL R P S E+ + +G G G+V+ G
Sbjct: 231 YYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN- 289
Query: 512 KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPN 571
+A+K L K + E F+ E +++ + H+ LV+L SEE +V E M
Sbjct: 290 --GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSK 345
Query: 572 GTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD 630
G+L +FL G+ Q V++A +A G+ Y+ +H D++ N+L+
Sbjct: 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG----- 397
Query: 631 TNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
N + K++DFG+++L+ ++ + + + APE T K DV+SFG++L E+
Sbjct: 398 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 691 I-CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA-- 747
GR + + EVL +ER RM
Sbjct: 458 TTKGRVPY------------------PGMV-------------NREVLDQVERGYRMPCP 486
Query: 748 ----------MVGLWCNHPDPNLRPSMKKVIHMLE 772
M C +P RP+ + + LE
Sbjct: 487 PECPESLHDLM--CQCWRKEPEERPTFEYLQAFLE 519
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-38
Identities = 77/342 (22%), Positives = 139/342 (40%), Gaps = 65/342 (19%)
Query: 453 YYSPAARGLIKRRNYFDPNSME---INFREFTFQELQEATKGFSKLVGTGSSGKVYRGIL 509
++ YF +FT E+ + K++G G G+VY+G+L
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSDPNQAVLKFT-TEIHPSCVTRQKVIGAGEFGEVYKGML 65
Query: 510 RLKDTQIEI--AVKKL-EKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566
+ + E+ A+K L EK +F+ E I+G+ H N++RL G S+ +++
Sbjct: 66 KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 125
Query: 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDL 626
E M NG L FL + +Q V + G+A G+ YL +H D+ +N+L
Sbjct: 126 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNIL--- 179
Query: 627 KTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV---APEWLRNVPVTTKVDVFSF 683
+++N + K+SDFG+S++L +D G + APE + T+ DV+SF
Sbjct: 180 --VNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 236
Query: 684 GVMLLEII-CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLER 742
G+++ E++ G R + + EV+ +
Sbjct: 237 GIVMWEVMTYGERPYW----------------EL---------------SNHEVMKAIND 265
Query: 743 FERMA------------MVGLWCNHPDPNLRPSMKKVIHMLE 772
R+ M + C + RP ++ +L+
Sbjct: 266 GFRLPTPMDCPSAIYQLM--MQCWQQERARRPKFADIVSILD 305
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 64/317 (20%), Positives = 115/317 (36%), Gaps = 73/317 (23%)
Query: 482 FQELQEATKGFSKLVGTGSSGKVYRGILRLKD-----TQIEIAVKKLEKDIEKTNEEFMT 536
F +++ F++ +G G+ K+++G+ R + E+ +K L+K +E F
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 537 ELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALG 596
++ + HK+LV G C D+ +LV E + G+L +L + ++E+A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 597 VARGLLYLHEECETQIIHCDIKPQNVLL---DLKTLDTNYMAKISDFGISKLLNKDQTRT 653
+A + +L E +IH ++ +N+LL + + K+SD GIS +
Sbjct: 122 LAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--- 175
Query: 654 DTNMRGTMGY------VAPEWLRNVPV-TTKVDVFSFGVMLLEII-CGRRHIELSRVEEE 705
V PE + N D +SFG L EI G +
Sbjct: 176 --------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK---------- 217
Query: 706 SEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA----------MVGLWCNH 755
LS L E ++ +
Sbjct: 218 ------PLSAL---------------DSQRKLQFYEDRHQLPAPKAAELANLINNCM--D 254
Query: 756 PDPNLRPSMKKVIHMLE 772
+P+ RPS + +I L
Sbjct: 255 YEPDHRPSFRAIIRDLN 271
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-37
Identities = 68/299 (22%), Positives = 128/299 (42%), Gaps = 61/299 (20%)
Query: 492 FSKLVGTGSSGKVYRGILRL--KDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKN 548
K++G+G+ G VY+G+ + +I +A+K+L + K N+E + E ++ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+ RLLG C L+ +LMP G L +++ G + + +A+G+ YL +
Sbjct: 79 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV---A 665
++H D+ +NVL + T KI+DFG++KLL ++ G + A
Sbjct: 138 ---LVHRDLAARNVL-----VKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMA 187
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEII-CGRR-HIELSRVEEESEEVDIVLSDWVISCMLS 723
E + + T + DV+S+GV + E++ G + + +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------------------- 224
Query: 724 RNLQVLVSHDPEVLSDLERFERMA----------MVGLWCNHPDPNLRPSMKKVIHMLE 772
E+ S LE+ ER+ M+ C D + RP +++I
Sbjct: 225 ---------ASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 85/356 (23%), Positives = 145/356 (40%), Gaps = 86/356 (24%)
Query: 446 LSGVAAIYYSPAARGLIKRRNYFDPNSMEINF-REFTFQELQEATKGFSKLVGTGSSGKV 504
+ P + + Y +P +F RE + K++G+G SG+V
Sbjct: 11 RENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIH-----IEKIIGSGDSGEV 65
Query: 505 YRGILRLKD-TQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562
G LR+ + +A+K L+ E+ +F++E I+G+ H N++RL G +
Sbjct: 66 CYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125
Query: 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622
++V E M NG+L FL + +Q V + GV G+ YL + +H D+ +NV
Sbjct: 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNV 182
Query: 623 LLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG------TMGYVAPEWLRNVPVTT 676
L +D+N + K+SDFG+S++L D T G T APE + ++
Sbjct: 183 L-----VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAFRTFSS 233
Query: 677 KVDVFSFGVMLLEII-CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDP- 734
DV+SFGV++ E++ G R P
Sbjct: 234 ASDVWSFGVVMWEVLAYGER--------------------------------------PY 255
Query: 735 ------EVLSDLERFERMA------------MVGLWCNHPDPNLRPSMKKVIHMLE 772
+V+S +E R+ M+ W H D RP +++ +L+
Sbjct: 256 WNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCW--HKDRAQRPRFSQIVSVLD 309
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-37
Identities = 80/336 (23%), Positives = 145/336 (43%), Gaps = 66/336 (19%)
Query: 456 PAARGLIKRRNYFDPNSMEINF-REFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKD- 513
P R + + DP F +E + K+VG G G+V G L+L
Sbjct: 17 PGLRTFVDPHTFEDPTQTVHEFAKELDATNIS-----IDKVVGAGEFGEVCSGRLKLPSK 71
Query: 514 TQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572
+I +A+K L+ EK +F+ E I+G+ H N++RL G ++ ++V E M NG
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENG 131
Query: 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632
+L +FL + +Q V + G+A G+ YL + +H D+ +N+L +++N
Sbjct: 132 SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNIL-----INSN 183
Query: 633 YMAKISDFGISKLLNKDQTRTDTNMRGTMGYV---APEWLRNVPVTTKVDVFSFGVMLLE 689
+ K+SDFG+ ++L +D RG + +PE + T+ DV+S+G++L E
Sbjct: 184 LVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 690 II-CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA- 747
++ G R + + +V+ ++ R+
Sbjct: 243 VMSYGERPYW----------------EM---------------SNQDVIKAVDEGYRLPP 271
Query: 748 -----------MVGLWCNHPDPNLRPSMKKVIHMLE 772
M L C D N RP ++++ +L+
Sbjct: 272 PMDCPAALYQLM--LDCWQKDRNNRPKFEQIVSILD 305
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 70/340 (20%), Positives = 125/340 (36%), Gaps = 59/340 (17%)
Query: 453 YYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRL- 511
++ G ++ + + R + +G G GKV
Sbjct: 6 HHHHHHHGALEVLFQGPGDPTVFHKRYLKKI----------RDLGEGHFGKVSLYCYDPT 55
Query: 512 -KDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR--LLVYE 567
T +AVK L + + E+ I+ +H+++++ G C + LV E
Sbjct: 56 NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115
Query: 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK 627
+P G+L ++L G Q + A + G+ YLH + IH D+ +NVL
Sbjct: 116 YVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVL---- 166
Query: 628 TLDTNYMAKISDFGISKLL--NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGV 685
LD + + KI DFG++K + + R + + + APE L+ DV+SFGV
Sbjct: 167 -LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGV 225
Query: 686 MLLEII-CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFE 744
L E++ E + ++ + LER E
Sbjct: 226 TLYELLTHCDSSQSPPTKFLELIGIAQ----GQMT-------------VLRLTELLERGE 268
Query: 745 RMA------------MVGLWCNHPDPNLRPSMKKVIHMLE 772
R+ M W + + RP+ + +I +L+
Sbjct: 269 RLPRPDKCPAEVYHLMKNCW--ETEASFRPTFENLIPILK 306
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-37
Identities = 73/344 (21%), Positives = 138/344 (40%), Gaps = 80/344 (23%)
Query: 453 YYSPAARGLIKRRNYFDPNSM----------EINFREFTFQELQEATKGFSKLVGTGSSG 502
+Y GL ++ + +S EI + K +G G G
Sbjct: 153 HYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLE----------KKLGAGQFG 202
Query: 503 KVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562
+V+ ++AVK + K + E F+ E ++ H LV+L ++E
Sbjct: 203 EVWMATYN---KHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE-PI 257
Query: 563 LLVYELMPNGTLSNFLF-HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQN 621
++ E M G+L +FL EG + + ++ + +A G+ ++ + IH D++ N
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAAN 314
Query: 622 VLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVF 681
+L + + + KI+DFG+++++ ++ + + + APE + T K DV+
Sbjct: 315 IL-----VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 682 SFGVMLLEII-CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDL 740
SFG++L+EI+ GR +S +PEV+ L
Sbjct: 370 SFGILLMEIVTYGRIPY------------------PGMS-------------NPEVIRAL 398
Query: 741 ERFERMA------------MVGLWCNHPDPNLRPSMKKVIHMLE 772
ER RM M + C P RP+ + + +L+
Sbjct: 399 ERGYRMPRPENCPEELYNIM--MRCWKNRPEERPTFEYIQSVLD 440
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 72/319 (22%), Positives = 127/319 (39%), Gaps = 82/319 (25%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
E+ E T K +G+G G V G + Q ++AVK + K+ + +E
Sbjct: 4 ELKREEITLL----------KELGSGQFGVVKLGKWK---GQYDVAVKMI-KEGSMSEDE 49
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI 593
F E + + + H LV+ G CS+E +V E + NG L N+L G+ Q +E+
Sbjct: 50 FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653
V G+ +L Q IH D+ +N L +D + K+SDFG+++ + DQ +
Sbjct: 110 CYDVCEGMAFLESH---QFIHRDLAARNCL-----VDRDLCVKVSDFGMTRYVLDDQYVS 161
Query: 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII-CGRRHIELSRVEEESEEVDIV 712
+ + + APE ++K DV++FG+++ E+ G+
Sbjct: 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM----------------- 204
Query: 713 LSDWVISCMLSRNLQVLVSHDP-------EVLSDLERFERMA------------MVGLWC 753
P EV+ + + R+ M C
Sbjct: 205 ---------------------PYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM--YSC 241
Query: 754 NHPDPNLRPSMKKVIHMLE 772
H P RP+ ++++ +E
Sbjct: 242 WHELPEKRPTFQQLLSSIE 260
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-37
Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 60/293 (20%)
Query: 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
G G+ G V +G+ R++ QI++A+K L++ + EE M E +I+ + + +VRL+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
C E +LV E+ G L FL + + E+ V+ G+ YL E+ +H
Sbjct: 79 CQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHR 134
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM--GYVAPEWLRNVP 673
D+ +NVL L + AKISDFG+SK L D + G + APE +
Sbjct: 135 DLAARNVL-----LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 674 VTTKVDVFSFGVMLLEII-CGRR-HIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVS 731
+++ DV+S+GV + E + G++ + ++
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMK------------------------------- 218
Query: 732 HDPEVLSDLERFERMA------------MVGLWCNHPDPNLRPSMKKVIHMLE 772
PEV++ +E+ +RM M W RP V +
Sbjct: 219 -GPEVMAFIEQGKRMECPPECPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 268
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 61/303 (20%)
Query: 492 FSKLVGTGSSGKVYRGILRL--KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKN 548
K++G+G G V++G+ + +I + +K +E ++ + + IG H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+VRLLG C LV + +P G+L + + G + + +A+G+ YL E
Sbjct: 77 IVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH- 134
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV---A 665
++H ++ +NVL L + +++DFG++ LL D + + A
Sbjct: 135 --GMVHRNLAARNVL-----LKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMA 185
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEII-CGRR-HIELSRVEEESEEVDIVLSDWVISCMLS 723
E + T + DV+S+GV + E++ G + L
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR----------------------- 222
Query: 724 RNLQVLVSHDPEVLSDLERFERMA----------MVGLWCNHPDPNLRPSMKKVIHMLEG 773
EV LE+ ER+A MV + C D N+RP+ K++ +
Sbjct: 223 ---------LAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 273
Query: 774 TLE 776
Sbjct: 274 MAR 276
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 73/326 (22%), Positives = 131/326 (40%), Gaps = 82/326 (25%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
I+ E TF + +G+G G V+ G + ++A+K + ++ + E+
Sbjct: 4 VIDPSELTFV----------QEIGSGQFGLVHLGYWL---NKDKVAIKTI-REGAMSEED 49
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI 593
F+ E +++ + H LV+L G C E+ LV E M +G LS++L + + +
Sbjct: 50 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM 109
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653
L V G+ YL E +IH D+ +N L + N + K+SDFG+++ + DQ +
Sbjct: 110 CLDVCEGMAYLEEA---CVIHRDLAARNCL-----VGENQVIKVSDFGMTRFVLDDQYTS 161
Query: 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII-CGRRHIELSRVEEESEEVDIV 712
T + + + +PE ++K DV+SFGV++ E+ G+
Sbjct: 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI----------------- 204
Query: 713 LSDWVISCMLSRNLQVLVSHDP-------EVLSDLERFERMA------------MVGLWC 753
P EV+ D+ R+ M W
Sbjct: 205 ---------------------PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW- 242
Query: 754 NHPDPNLRPSMKKVIHMLEGTLEVGM 779
P RP+ +++ L E G+
Sbjct: 243 -RERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-36
Identities = 65/329 (19%), Positives = 115/329 (34%), Gaps = 67/329 (20%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT--NE-EFMTELKIIGRTHHKN 548
++G G+ G + R ++AVK++ + E + + E H N
Sbjct: 28 PKDVLGHGAEGTIVY---RGMFDNRDVAVKRILPECFSFADREVQLLRESD-----EHPN 79
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
++R + + + EL TL ++ + ++ + + GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL- 137
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ--TRTDTNMRGTMGYVAP 666
I+H D+KP N+L+ + A ISDFG+ K L + + + GT G++AP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 667 EWLR---NVPVTTKVDVFSFGVMLLEIICGRRH-----------IELSRVEEESEEVDIV 712
E L T VD+FS G + +I H I L + +
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 713 LSDWV---ISCMLSRN-------LQVLVSH-------------------------DPEVL 737
I M++ + VL H D ++
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVL-KHPFFWSLEKQLQFFQDVSDRIEKESLDGPIV 314
Query: 738 SDLERFERMAMVGLWCNHPDPNLRPSMKK 766
LER R + W + L+ ++K
Sbjct: 315 KQLERGGRAVVKMDWRENITVPLQTDLRK 343
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 24/227 (10%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTN 531
++ + T ++ K +G+G+ G V +G ++K +AVK L+ +
Sbjct: 12 YLDRKLLTLED---------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 62
Query: 532 EEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV 591
+E + E ++ + + +VR++G C E +LV E+ G L+ +L + + +
Sbjct: 63 DELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL-QQNRHVKDKNII 120
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651
E+ V+ G+ YL E +H D+ +NVL L T + AKISDFG+SK L D+
Sbjct: 121 ELVHQVSMGMKYLEES---NFVHRDLAARNVL-----LVTQHYAKISDFGLSKALRADEN 172
Query: 652 RTDTNMRGTM--GYVAPEWLRNVPVTTKVDVFSFGVMLLEII-CGRR 695
G + APE + ++K DV+SFGV++ E G++
Sbjct: 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+G G G+VY G K + +AVK L K+ EEF+ E ++ H NLV+
Sbjct: 17 MKHKLGGGQYGEVYEG--VWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
LLG C+ E ++ E M G L ++L Q V + +A ++ + YL ++
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--- 130
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
IH D+ +N L + N++ K++DFG+S+L+ D + + + APE L
Sbjct: 131 NFIHRDLAARNCL-----VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 671 NVPVTTKVDVFSFGVMLLEII 691
+ K DV++FGV+L EI
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIA 206
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 28/214 (13%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVK--KLEKDIEKTNEEFMTELKIIGRTHHKNL 549
F +G GS VY+G+ +T +E+A + K + + F E +++ H N+
Sbjct: 30 FDIEIGRGSFKTVYKGLD--TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 550 VRLLGFC---SEEDKRLLVY-ELMPNGTLSNFL-----FHEGQRPGWVQRVEIALGVARG 600
VR + K +++ ELM +GTL +L W +++ +G
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKG 141
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT 660
L +LH IIH D+K N+ + KI D G++ L + + GT
Sbjct: 142 LQFLHT-RTPPIIHRDLKCDNIFITGP----TGSVKIGDLGLATLKRASFAKA---VIGT 193
Query: 661 MGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
++APE VDV++FG+ +LE+
Sbjct: 194 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 226
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 67/297 (22%), Positives = 132/297 (44%), Gaps = 57/297 (19%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEI--AVKKLEKD-IEKTNEEFMTELKIIGRTHHKN 548
K++G+G+ G VY+G+ + +++I A+K+L + K N+E + E ++ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+ RLLG C L+ +LMP G L +++ G + + +A+G+ YL +
Sbjct: 79 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ-TRTDTNMRGTMGYVAPE 667
++H D+ +NVL + T KI+DFG++KLL ++ + + ++A E
Sbjct: 138 ---LVHRDLAARNVL-----VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 668 WLRNVPVTTKVDVFSFGVMLLEII-CGRR-HIELSRVEEESEEVDIVLSDWVISCMLSRN 725
+ + T + DV+S+GV + E++ G + + +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------------------------- 224
Query: 726 LQVLVSHDPEVLSDLERFERMA----------MVGLWCNHPDPNLRPSMKKVIHMLE 772
E+ S LE+ ER+ M+ + C D + RP +++I
Sbjct: 225 -------ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 62/223 (27%), Positives = 111/223 (49%), Gaps = 23/223 (10%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
EI+ ++ TF K +GTG G V G R Q ++A+K + K+ + +E
Sbjct: 20 EIDPKDLTFL----------KELGTGQFGVVKYGKWR---GQYDVAIKMI-KEGSMSEDE 65
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI 593
F+ E K++ H+ LV+L G C+++ ++ E M NG L N+L R Q +E+
Sbjct: 66 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653
V + YL + Q +H D+ +N L ++ + K+SDFG+S+ + D+ +
Sbjct: 126 CKDVCEAMEYLESK---QFLHRDLAARNCL-----VNDQGVVKVSDFGLSRYVLDDEYTS 177
Query: 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII-CGRR 695
+ + + PE L ++K D+++FGV++ EI G+
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 65/300 (21%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQ-IEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNL 549
++++G G G+VY G+ + I +AVK +KD E+FM+E I+ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
V+L+G EE ++ EL P G L ++L + V +L + + + YL
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV---AP 666
+H DI +N+L + + K+ DFG+S+ + + T + +P
Sbjct: 133 -NCVHRDIAVRNIL-----VASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSP 183
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEII-CGRR-HIELSRVEEESEEVDIVLSDWVISCMLSR 724
E + TT DV+ F V + EI+ G++ L
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE------------------------ 219
Query: 725 NLQVLVSHDPEVLSDLERFERMA------------MVGLWCNHPDPNLRPSMKKVIHMLE 772
+ +V+ LE+ +R+ M W DP+ RP +++ L
Sbjct: 220 --------NKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCW--DYDPSDRPRFTELVCSLS 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-35
Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 59/297 (19%)
Query: 492 FSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNL 549
+ +G G G V++GI + + +A+K + + E+F+ E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
V+L+G +E ++ EL G L +FL + A ++ L YL +
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-- 510
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+ +H DI +NVL + +N K+ DFG+S+ + + + + ++APE +
Sbjct: 511 -RFVHRDIAARNVL-----VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 670 RNVPVTTKVDVFSFGVMLLEII-CGRR-HIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
T+ DV+ FGV + EI+ G + +
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------------------------- 597
Query: 728 VLVSHDPEVLSDLERFERMA------------MVGLWCNHPDPNLRPSMKKVIHMLE 772
+ +V+ +E ER+ M C DP+ RP ++ L
Sbjct: 598 -----NNDVIGRIENGERLPMPPNCPPTLYSLM--TKCWAYDPSRRPRFTELKAQLS 647
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQ-IEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNL 549
+ +G G G V++GI + + +A+K + + E+F+ E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
V+L+G +E ++ EL G L +FL + A ++ L YL +
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+ +H DI +NVL + +N K+ DFG+S+ + + + + ++APE +
Sbjct: 136 -RFVHRDIAARNVL-----VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 189
Query: 670 RNVPVTTKVDVFSFGVMLLEII 691
T+ DV+ FGV + EI+
Sbjct: 190 NFRRFTSASDVWMFGVCMWEIL 211
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 16/216 (7%)
Query: 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR 543
E E ++G G+ G VY G Q+ IA+K++ + + ++ E+ +
Sbjct: 20 EYDENGDR--VVLGKGTYGIVYAGRD--LSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 75
Query: 544 THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV--EIALGVARGL 601
HKN+V+ LG SE + E +P G+LS L + ++ + GL
Sbjct: 76 LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
YLH+ QI+H DIK NVL++ + + KISDFG SK L T+T GT+
Sbjct: 136 KYLHDN---QIVHRDIKGDNVLINTY----SGVLKISDFGTSKRLAGINPCTET-FTGTL 187
Query: 662 GYVAPEWLRNVPV--TTKVDVFSFGVMLLEIICGRR 695
Y+APE + P D++S G ++E+ G+
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-35
Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 43/254 (16%)
Query: 453 YYSPAARGLIKR-------------RNYFDPNSMEINFREFTFQELQEATKGFSKLVGTG 499
+Y+ A GL R ++ F + +N +E + +G G
Sbjct: 155 HYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLL----------QTIGKG 204
Query: 500 SSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE 559
G V G R +AVK ++ D T + F+ E ++ + H NLV+LLG EE
Sbjct: 205 EFGDVMLGDYRGNK----VAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 560 DKRL-LVYELMPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDI 617
L +V E M G+L ++L G ++ +L V + YL +H D+
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDL 315
Query: 618 KPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTK 677
+NVL + + +AK+SDFG L K+ + T + + + APE LR +TK
Sbjct: 316 AARNVL-----VSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 678 VDVFSFGVMLLEII 691
DV+SFG++L EI
Sbjct: 367 SDVWSFGILLWEIY 380
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-35
Identities = 77/323 (23%), Positives = 134/323 (41%), Gaps = 64/323 (19%)
Query: 467 YFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD 526
+ DP ++ + F + +L G G+ G V +G+ R++ QI++A+K L++
Sbjct: 319 FSDPEELK---DKKLFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQG 374
Query: 527 -IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP 585
+ EE M E +I+ + + +VRL+G C E +LV E+ G L FL + +
Sbjct: 375 TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI 433
Query: 586 GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645
E+ V+ G+ YL E+ +H ++ +NVL L + AKISDFG+SK
Sbjct: 434 PVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVL-----LVNRHYAKISDFGLSKA 485
Query: 646 LNKDQTRTDTNMRGTMGY--VAPEWLRNVPVTTKVDVFSFGVMLLEII-CGRR-HIELSR 701
L D + G APE + +++ DV+S+GV + E + G++ + ++
Sbjct: 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK- 544
Query: 702 VEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA------------MV 749
PEV++ +E+ +RM M
Sbjct: 545 -------------------------------GPEVMAFIEQGKRMECPPECPPELYALM- 572
Query: 750 GLWCNHPDPNLRPSMKKVIHMLE 772
C RP V +
Sbjct: 573 -SDCWIYKWEDRPDFLTVEQRMR 594
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 492 FSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNL 549
F++++G G G VY G L D +I AVK L + +F+TE I+ H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 550 VRLLGFCSEEDK-RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+ LLG C + L+V M +G L NF+ +E P + L VA+G+ YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA--- 145
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV---A 665
+ +H D+ +N + LD + K++DFG+++ + + + N G V A
Sbjct: 146 SKKFVHRDLAARNCM-----LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEII 691
E L+ TTK DV+SFGV+L E++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 59/206 (28%), Positives = 83/206 (40%), Gaps = 19/206 (9%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
VG GS G+V+R K T + AVKK+ +E E EL +V L
Sbjct: 64 PRVGRGSFGEVHRMKD--KQTGFQCAVKKV--RLEVFRVE---ELVACAGLSSPRIVPLY 116
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
G E + EL+ G+L + G P GL YLH +I+
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY-YLGQALEGLEYLHTR---RIL 172
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN----MRGTMGYVAPEWL 669
H D+K NVLL A + DFG + L D + GT ++APE +
Sbjct: 173 HGDVKADNVLLSSDGSR----AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 670 RNVPVTTKVDVFSFGVMLLEIICGRR 695
P KVD++S M+L ++ G
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-35
Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 36/293 (12%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE-FMTELKIIGRTHHKNLV 550
+ +GTG G V R +DT ++A+K+ +++ N E + E++I+ + +H N+V
Sbjct: 18 MKERLGTGGFGYVLRW--IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 551 RLL------GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGL 601
+ D LL E G L +L ++ + ++ I ++ L
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSAL 134
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
YLHE +IIH D+KP+N++L + KI D G +K L GT+
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIH--KIIDLGYAKEL-DQGELCTE-FVGTL 187
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR-------HIELSRVEEESEEVDIVLS 714
Y+APE L T VD +SFG + E I G R ++ E IV+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 715 DWVISCMLSRNLQVLVSHDPEVLSDLER--FERMAMVGLWCNHPDPNLRPSMK 765
D + + ++ +H +L+ + M M R +
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW-------HQRQRGTDP 293
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 15/206 (7%)
Query: 492 FSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHK 547
+ +G GS G V RG + +AVK L+ D+ + ++F+ E+ + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
NL+RL G +V EL P G+L + L A+ VA G+ YL +
Sbjct: 82 NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY--VA 665
+ IH D+ +N+L L T + KI DFG+ + L ++ + + A
Sbjct: 141 ---RFIHRDLAARNLL-----LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEII 691
PE L+ + D + FGV L E+
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-35
Identities = 67/245 (27%), Positives = 112/245 (45%), Gaps = 16/245 (6%)
Query: 453 YYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLK 512
Y A + + +P ++ + F++++G G G VY G L
Sbjct: 56 LYFQGANTVHIDLSALNPELVQ-AVQHVV-IGPSSLIVHFNEVIGRGHFGCVYHGTLLDN 113
Query: 513 D-TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK-RLLVYELM 569
D +I AVK L + +F+TE I+ H N++ LLG C + L+V M
Sbjct: 114 DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173
Query: 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL 629
+G L NF+ +E P + L VA+G+ +L + +H D+ +N + L
Sbjct: 174 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCM-----L 225
Query: 630 DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV---APEWLRNVPVTTKVDVFSFGVM 686
D + K++DFG+++ + + + N G V A E L+ TTK DV+SFGV+
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 285
Query: 687 LLEII 691
L E++
Sbjct: 286 LWELM 290
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 492 FSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNL 549
+++G G G VY G + +I+ A+K L + + E F+ E ++ +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 550 VRLLGFCSEED-KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+ L+G + ++ M +G L F+ + P + L VARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV---A 665
E + +H D+ +N + LD ++ K++DFG+++ + + + R V A
Sbjct: 142 EQKFVHRDLAARNCM-----LDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEII 691
E L+ TTK DV+SFGV+L E++
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 71/296 (23%), Positives = 127/296 (42%), Gaps = 62/296 (20%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+ +G G G+V+ G ++AVK L K + + F+ E ++ + H+ LVR
Sbjct: 17 LVERLGAGQFGEVWMGYYN---GHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
L ++E ++ E M NG+L +FL G + + +++A +A G+ ++ E
Sbjct: 73 LYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
IH D++ N+L + KI+DFG+++L+ ++ + + + APE +
Sbjct: 129 NYIHRDLRAANIL-----VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 671 NVPVTTKVDVFSFGVMLLEII-CGRR-HIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728
T K DV+SFG++L EI+ GR + ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------------------------- 215
Query: 729 LVSHDPEVLSDLERFERMA------------MVGLWCNHPDPNLRPSMKKVIHMLE 772
+PEV+ +LER RM M C P RP+ + +LE
Sbjct: 216 ----NPEVIQNLERGYRMVRPDNCPEELYQLM--RLCWKERPEDRPTFDYLRSVLE 265
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 76/299 (25%), Positives = 123/299 (41%), Gaps = 50/299 (16%)
Query: 492 FSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHK 547
+ +G G+ G+VY G + + +++AVK L E E+ +F+ E II + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFL------FHEGQRPGWVQRVEIALGVARGL 601
N+VR +G + R ++ ELM G L +FL + + + +A +A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
YL E IH DI +N LL +AKI DFG++ +D R +G
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCP--GPGRVAKIGDFGMA----RDIYRASYYRKGGC 204
Query: 662 GYV-----APEWLRNVPVTTKVDVFSFGVMLLEII-CGRR-HIELSRVEEESEEV-DIVL 713
+ PE T+K D +SFGV+L EI G + S ++EV + V
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFVT 259
Query: 714 SDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
S + P+ + M C P RP+ ++ +E
Sbjct: 260 SGGRMDP-------------PKNCPG-PVYRIM----TQCWQHQPEDRPNFAIILERIE 300
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-34
Identities = 74/307 (24%), Positives = 119/307 (38%), Gaps = 63/307 (20%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLV 550
K++G GSSG V + +AVK++ D + + E+K++ + H N++
Sbjct: 19 SEKILGYGSSGTVV---FQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVI 72
Query: 551 RLLGFCSEEDKRL--LVYELMPNGTLSNFLFHEGQRPGWVQRV------EIALGVARGLL 602
R +CSE R + EL N L + + + ++ + +A G+
Sbjct: 73 RY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 603 YLHEECETQIIHCDIKPQNVLLDLK--------TLDTNYMAKISDFGISKLLNKDQTRTD 654
+LH +IIH D+KPQN+L+ T N ISDFG+ K L+ Q+
Sbjct: 130 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 655 TNMR---GTMGYVAPEWLRNV-------PVTTKVDVFSFGVMLLEIICGRRHIELSRVEE 704
TN+ GT G+ APE L +T +D+FS G + I+ +H +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 705 ESE----EVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNL 760
ES + + L L+S DP
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ--------------------MIDHDPLK 286
Query: 761 RPSMKKV 767
RP+ KV
Sbjct: 287 RPTAMKV 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 51/299 (17%), Positives = 101/299 (33%), Gaps = 42/299 (14%)
Query: 492 FSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN 548
L+G G+ +VY + + +K + ++ + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWV----QRVEIALGVARGLLYL 604
++ ++ +LV EL GTL N + P V + A+ + + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMA------KISDFGISKLLNK-DQTRTDTNM 657
H+ +IIH DIKP N +L L+ + + D G S + + T
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 658 RGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717
T G+ E L N P ++D F + ++ G ++++ E
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMKVKNEGGE----------CK 294
Query: 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776
+ R ++ ++ F M N PD + PS+ + L+ +
Sbjct: 295 PEGLFRR------LPHLDMWNEF--FHVML------NIPDCHHLPSLDLLRQKLKKVFQ 339
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTN--EEFMTELKIIGRTHHKNLV 550
+ +G G G VY R K ++ +A+K L K +EK + E++I H N++
Sbjct: 15 RPLGKGKFGNVYLA--REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
RL G+ + + L+ E P GT+ L + I +A L Y H +
Sbjct: 73 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHSK--- 128
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
++IH DIKP+N+LL + KI+DFG S +R + GT+ Y+ PE +
Sbjct: 129 RVIHRDIKPENLLLG-----SAGELKIADFGWSVHA--PSSRRTD-LCGTLDYLPPEMIE 180
Query: 671 NVPVTTKVDVFSFGVMLLEIICGR 694
KVD++S GV+ E + G+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 60/297 (20%), Positives = 120/297 (40%), Gaps = 63/297 (21%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+L+G+G G+V++ + + +K+ ++ NE+ E+K + + H N+V
Sbjct: 17 ELIGSGGFGQVFKA--KHRIDGKTYVIKR----VKYNNEKAEREVKALAKLDHVNIVHYN 70
Query: 554 GFCSEEDKRL----------------LVYELMPNGTLSNFLFHEGQRPGWVQRVEIA--- 594
G D + E GTL ++ E +R + +V
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELF 128
Query: 595 LGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD 654
+ +G+ Y+H + ++I+ D+KP N+ L KI DFG+ L D RT
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLV-----DTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 655 TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714
+ +GT+ Y++PE + + +VD+++ G++L E++ E+ + L
Sbjct: 181 S--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------AFETSKFFTDLR 232
Query: 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771
D +IS + + + L+ P RP+ +++ L
Sbjct: 233 DGIISDIFDKKEKTLLQ--------------------KLLSKKPEDRPNTSEILRTL 269
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHK 547
+ +G G+ G+VY G + + +++AVK L E E+ +F+ E II + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFL------FHEGQRPGWVQRVEIALGVARGL 601
N+VR +G + R ++ ELM G L +FL + + + +A +A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
YL E IH DI +N LL +AKI DFG++ +D R +G
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCP--GPGRVAKIGDFGMA----RDIYRAGYYRKGGC 245
Query: 662 GYV-----APEWLRNVPVTTKVDVFSFGVMLLEII 691
+ PE T+K D +SFGV+L EI
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLV 550
S ++G G++ V+RG R K T A+K + + M E +++ + +HKN+V
Sbjct: 13 LSDILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 551 RLLGFCSEEDKRL--LVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLH 605
+L E R L+ E P G+L L E + E + V G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
E I+H +IKP N++ + D + K++DFG ++ L D+ + GT Y+
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGE-DGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLH 183
Query: 666 PEWLRNVPVTT--------KVDVFSFGVMLLEIICGR 694
P+ + VD++S GV G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+ +G G G V G R ++AVK ++ D T + F+ E ++ + H NLV+
Sbjct: 25 LLQTIGKGEFGDVMLGDYR----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQ 78
Query: 552 LLGFCSEEDKRL-LVYELMPNGTLSNFL-FHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
LLG EE L +V E M G+L ++L G ++ +L V + YL
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 136
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+H D+ +NVL + + +AK+SDFG L K+ + T + + + APE L
Sbjct: 137 -NFVHRDLAARNVL-----VSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEAL 186
Query: 670 RNVPVTTKVDVFSFGVMLLEII 691
R +TK DV+SFG++L EI
Sbjct: 187 REKKFSTKSDVWSFGILLWEIY 208
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 68/303 (22%), Positives = 105/303 (34%), Gaps = 49/303 (16%)
Query: 468 FDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI 527
+DP+ E F++ +FQ L +G GS G+V++ R K+ AVK+
Sbjct: 46 YDPSRPESFFQQ-SFQRL--------SRLGHGSYGEVFKV--RSKEDGRLYAVKRSMSPF 94
Query: 528 EKTNE--EFMTELKIIGR-THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQR 584
+ + E+ + H VRL E L EL +L G
Sbjct: 95 RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGAS 153
Query: 585 PGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
Q L +LH + ++H D+KP N+ L K+ DFG+
Sbjct: 154 LPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIF-----LGPRGRCKLGDFGLLV 205
Query: 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEE 704
L G Y+APE L+ T DVFS G+ +LE+ C E
Sbjct: 206 ELGTAGAGEV--QEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMEL--PHGGEG 260
Query: 705 ESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM 764
+ L + LS L+ ++ PDP LR +
Sbjct: 261 WQQLRQGYLPP-EFTAGLSSELRSVLV--------------------MMLEPDPKLRATA 299
Query: 765 KKV 767
+ +
Sbjct: 300 EAL 302
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTN--EEFMTELKIIGRTHHKNLV 550
+ +G G G VY R K + +A+K L K +EK + E++I H N++
Sbjct: 20 RPLGKGKFGNVYLA--REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
R+ + + + L+ E P G L L G+ + +A L Y HE
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCHER--- 133
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
++IH DIKP+N+L+ KI+DFG S R T M GT+ Y+ PE +
Sbjct: 134 KVIHRDIKPENLLMGY-----KGELKIADFGWSVH--APSLRRRT-MCGTLDYLPPEMIE 185
Query: 671 NVPVTTKVDVFSFGVMLLEIICGR 694
KVD++ GV+ E + G
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-33
Identities = 65/318 (20%), Positives = 119/318 (37%), Gaps = 65/318 (20%)
Query: 470 PNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-- 527
+ +++ FQ +++ + + +G GS GK + + + +K++
Sbjct: 8 SSGVDLGTENLYFQSMEKYVRL--QKIGEGSFGKAILV--KSTEDGRQYVIKEINISRMS 63
Query: 528 EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL-------FH 580
K EE E+ ++ H N+V+ E +V + G L + F
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 581 EGQRPGW-VQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639
E Q W VQ + L ++H+ +I+H DIK QN+ L + ++ D
Sbjct: 124 EDQILDWFVQ-------ICLALKHVHDR---KILHRDIKSQNIFLT-----KDGTVQLGD 168
Query: 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR---- 695
FGI+++LN GT Y++PE N P K D+++ G +L E+ +
Sbjct: 169 FGIARVLNSTVELARA-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227
Query: 696 --HIELSRVEEESEEVDIVLSDW-VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLW 752
L I+ + +S S +L+ LVS
Sbjct: 228 GSMKNLVL--------KIISGSFPPVSLHYSYDLRSLVS--------------------Q 259
Query: 753 CNHPDPNLRPSMKKVIHM 770
+P RPS+ ++
Sbjct: 260 LFKRNPRDRPSVNSILEK 277
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 77/310 (24%), Positives = 140/310 (45%), Gaps = 56/310 (18%)
Query: 492 FSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHK 547
S+ +G GS G VY G+ + + + +A+K + + + EF+ E ++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFL---------FHEGQRPGWVQRVEIALGVA 598
++VRLLG S+ L++ ELM G L ++L P + +++A +A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR 658
G+ YL+ + +H D+ +N + + ++ KI DFG+++ + TD +
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCM-----VAEDFTVKIGDFGMTRDIY----ETDYYRK 196
Query: 659 GTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEII--CGRRHIELSRVEEESEEV-D 710
G G + +PE L++ TT DV+SFGV+L EI + + LS +E+V
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----NEQVLR 251
Query: 711 IVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770
V+ ++ P+ D FE M M C +P +RPS ++I
Sbjct: 252 FVMEGGLLDK-------------PDNCPD-MLFELMRM----CWQYNPKMRPSFLEIISS 293
Query: 771 LEGTLEVGMP 780
++ +E G
Sbjct: 294 IKEEMEPGFR 303
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 47/217 (21%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNL-- 549
K +G+G S KV++ L + + A+K + + +T + + E+ + + +
Sbjct: 34 KQIGSGGSSKVFQV---LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
+RL + + +V E N L+++L + W ++ + + +H+
Sbjct: 91 IRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQH-- 146
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEW 668
I+H D+KP N L+ + M K+ DFGI+ + D T + GT+ Y+ PE
Sbjct: 147 -GIVHSDLKPANFLIV------DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 669 LRNVP-----------VTTKVDVFSFGVMLLEIICGR 694
++++ ++ K DV+S G +L + G+
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 59/286 (20%), Positives = 116/286 (40%), Gaps = 41/286 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQI----EIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL 549
K +G G +VYR L D ++ + L + + + E+ ++ + +H N+
Sbjct: 38 KKIGRGQFSEVYRA-ACLLDGVPVALKKVQIFDLMDAKAR--ADCIKEIDLLKQLNHPNV 94
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIA---LGVARGLLYLHE 606
++ E+++ +V EL G LS + H ++ + + + + L ++H
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
+++H DIKP NV + + K+ D G+ + + T + + GT Y++P
Sbjct: 155 R---RVMHRDIKPANVFIT-----ATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSP 205
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW--VISCMLSR 724
E + K D++S G +L E+ + ++ S I D+ + S S
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265
Query: 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770
L+ LV+ C +PDP RP + V +
Sbjct: 266 ELRQLVN--------------------MCINPDPEKRPDVTYVYDV 291
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 492 FSKLVGTGSSGKVYRGI---LRLKDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGR-THH 546
F K +G G+ GKV L +D +++AVK L E M+ELKI+ H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL-------------FHEGQRPGWVQRVEI 593
+N+V LLG C+ L++ E G L NFL +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653
+ VA+G+ +L + IH D+ +NVL L ++AKI DFG+++ + D
Sbjct: 170 SSQVAQGMAFLASK---NCIHRDVAARNVL-----LTNGHVAKIGDFGLARDIMND---- 217
Query: 654 DTNMRGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEII 691
+ + APE + + T + DV+S+G++L EI
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 58/317 (18%), Positives = 106/317 (33%), Gaps = 68/317 (21%)
Query: 470 PNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDI 527
M+ + F EL + +G+G G V++ + A+K+
Sbjct: 2 AMGMKSRYTT-EFHEL--------EKIGSGEFGSVFKC--VKRLDGCIYAIKRSKKPLAG 50
Query: 528 EKTNEEFMTELKIIGR-THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPG 586
+ + E+ H ++VR +E+D L+ E G+L++ + +
Sbjct: 51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS 110
Query: 587 WVQRVEIA---LGVARGLLYLHEECETQIIHCDIKPQNVLLD--------------LKTL 629
+ + E+ L V RGL Y+H ++H DIKP N+ +
Sbjct: 111 YFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167
Query: 630 DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE-WLRNVPVTTKVDVFSFGVMLL 688
M KI D G ++ Q G ++A E N K D+F+ + ++
Sbjct: 168 SNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVV 222
Query: 689 EIICGRRHIELSRVEEESEEVDIVLSDWV--ISCMLSRNLQVLVSHDPEVLSDLERFERM 746
+ ++ + + I +LS+ L+
Sbjct: 223 CAAGAE------PLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLK--------------- 261
Query: 747 AMVGLWCNHPDPNLRPS 763
HPDP RPS
Sbjct: 262 -----VMIHPDPERRPS 273
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 492 FSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKN 548
K++G G G V G L+ +D T +++AVK ++ D ++ EEF++E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 549 LVRLLGFCSEED-----KRLLVYELMPNGTLSNFL-----FHEGQRPGWVQRVEIALGVA 598
++RLLG C E K +++ M G L +L + ++ + +A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL-NKDQTRTDTN- 656
G+ YL +H D+ +N + L + ++DFG+SK + + D R
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCM-----LRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 657 ------MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII 691
+ A E L + T+K DV++FGV + EI
Sbjct: 210 KMPVKWI-------AIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 74/350 (21%), Positives = 129/350 (36%), Gaps = 94/350 (26%)
Query: 467 YFDPNSMEINF-REFTFQELQEATKGFSKLVGTGSSGKVYRGILR---LKDTQIEIAVKK 522
+P +++ +G G+ GKV+ + ++ +AVK
Sbjct: 24 IENPQYFSDACVHHIKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA 78
Query: 523 LEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL---- 578
L++ E ++F E +++ H+++VR G C+E L+V+E M +G L+ FL
Sbjct: 79 LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138
Query: 579 ----------FHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT 628
G Q + +A VA G++YL +H D+ +N L
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCL----- 190
Query: 629 LDTNYMAKISDFGISKLL-NKDQTRTDTN-------MRGTMGYVAPEWLRNVPVTTKVDV 680
+ + KI DFG+S+ + + D R M PE + TT+ DV
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM-------PPESILYRKFTTESDV 243
Query: 681 FSFGVMLLEII-CGRR-HIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLS 738
+SFGV+L EI G++ +LS + E +
Sbjct: 244 WSFGVVLWEIFTYGKQPWYQLS--------------------------------NTEAID 271
Query: 739 DLERFERMA------------MVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776
+ + + M G W +P R S+K V L+ +
Sbjct: 272 CITQGRELERPRACPPEVYAIMRGCW--QREPQQRHSIKDVHARLQALAQ 319
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-32
Identities = 53/261 (20%), Positives = 112/261 (42%), Gaps = 43/261 (16%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNL-- 549
K +G+G S KV++ L + + A+K + + +T + + E+ + + +
Sbjct: 62 KQIGSGGSSKVFQV---LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
+RL + + +V E N L+++L + W ++ + + +H+
Sbjct: 119 IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQH-- 174
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEW 668
I+H D+KP N L+ + M K+ DFGI+ + D T + G + Y+ PE
Sbjct: 175 -GIVHSDLKPANFLIV------DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 669 LRNVP-----------VTTKVDVFSFGVMLLEIICGR---RHIE-----LSRVEEESEEV 709
++++ ++ K DV+S G +L + G+ + I L + + + E+
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 710 DI--VLSDW---VISCMLSRN 725
+ + V+ C L R+
Sbjct: 288 EFPDIPEKDLQDVLKCCLKRD 308
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 44/252 (17%)
Query: 462 IKRRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVK 521
+P+ + + +++ F ++G G+ G+V + ++ +++ A+K
Sbjct: 6 HHHHGKNNPDPTI--YPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIK 58
Query: 522 KLEKDI-EKTNEEFMTELKIIGR-THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL- 578
++++ + + +F EL+++ + HH N++ LLG C L E P+G L +FL
Sbjct: 59 RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118
Query: 579 --------------FHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLL 624
Q + A VARG+ YL ++ Q IH D+ +N+L
Sbjct: 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL- 174
Query: 625 DLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV-----APEWLRNVPVTTKVD 679
+ NY+AKI+DFG+S+ + ++ TMG + A E L TT D
Sbjct: 175 ----VGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD 223
Query: 680 VFSFGVMLLEII 691
V+S+GV+L EI+
Sbjct: 224 VWSYGVLLWEIV 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-32
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 21/216 (9%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLV 550
S ++G G++ V+RG R K T A+K + + M E +++ + +HKN+V
Sbjct: 13 LSDILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 551 RLLGFCSEEDKRL--LVYELMPNGTLSNFLFHEGQRPGWVQRV--EIALGVARGLLYLHE 606
+L E R L+ E P G+L L G + + V G+ +L E
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
I+H +IKP N++ + D + K++DFG ++ L D+ + GT Y+ P
Sbjct: 131 N---GIVHRNIKPGNIMRVIGE-DGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHP 184
Query: 667 EWLRNVPVTT--------KVDVFSFGVMLLEIICGR 694
+ + VD++S GV G
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 48/217 (22%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIG--RTHHKNL 549
K +G+G S KV++ L + + A+K + + +T + + E+ + + H +
Sbjct: 15 KQIGSGGSSKVFQV---LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
+RL + + +V E N L+++L + W ++ + + +H+
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQH-- 127
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEW 668
I+H D+KP N L+ + M K+ DFGI+ + D T + GT+ Y+ PE
Sbjct: 128 -GIVHSDLKPANFLIV------DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 669 LRNVP-----------VTTKVDVFSFGVMLLEIICGR 694
++++ ++ K DV+S G +L + G+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 31/219 (14%)
Query: 492 FSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKN 548
+++G G G V L+ +D + +++AVK L+ DI EEF+ E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 549 LVRLLGFCSEEDKR------LLVYELMPNGTLSNFL-----FHEGQRPGWVQRVEIALGV 597
+ +L+G + +++ M +G L FL V + +
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 598 ARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNM 657
A G+ YL IH D+ +N + L + ++DFG+S+ + D
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCM-----LAEDMTVCVADFGLSRKIY----SGDYYR 194
Query: 658 RGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEII 691
+G + A E L + T DV++FGV + EI+
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 70/321 (21%), Positives = 127/321 (39%), Gaps = 89/321 (27%)
Query: 492 FSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN 548
+ +G G+ GKV+ ++ +AVK L+ ++F E +++ H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFL---------------FHEGQRPGWVQRVEI 593
+V+ G C + D ++V+E M +G L+ FL G Q + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL-NKDQTR 652
A +A G++YL + +H D+ +N L + N + KI DFG+S+ + + D R
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCL-----VGANLLVKIGDFGMSRDVYSTDYYR 190
Query: 653 TDTN-------MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII-CGRR-HIELSRVE 703
+ M PE + TT+ DV+SFGV+L EI G++ +LS
Sbjct: 191 VGGHTMLPIRWM-------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--- 240
Query: 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA------------MVGL 751
+ EV+ + + + M+G
Sbjct: 241 -----------------------------NTEVIECITQGRVLERPRVCPKEVYDVMLGC 271
Query: 752 WCNHPDPNLRPSMKKVIHMLE 772
W +P R ++K++ +L
Sbjct: 272 W--QREPQQRLNIKEIYKILH 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVR 551
+GTGS G+ + R K + K+L+ E + ++E+ ++ H N+VR
Sbjct: 12 YTIGTGSYGRCQKI--RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 552 LLG-FCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWV---QRVEIALGVARGLLYLHE 606
+ L +V E G L++ + + ++ + + + L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 607 ECET--QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
+ ++H D+KP NV LD K+ DFG++++LN D + T + GT Y+
Sbjct: 130 RSDGGHTVLHRDLKPANVFLD-----GKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICGRR 695
+PE + + K D++S G +L E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 73/333 (21%), Positives = 119/333 (35%), Gaps = 100/333 (30%)
Query: 492 FSKLVGTGSSGKVYRGI---LRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKI---IGRT 544
F K +G G+ GKV L D + +AVK L+ E M+ELK+ +G
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 545 HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL-------FHEGQRPGWVQR------- 590
H N+V LLG C+ L++ E G L NFL P ++
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 591 ---VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647
+ + VA+G+ +L IH D+ +N+L L + KI DFG+++ +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL-----LTHGRITKICDFGLARDIK 196
Query: 648 KDQTRTDTNMRGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEII-------CGRR 695
D + + APE + N T + DV+S+G+ L E+ G
Sbjct: 197 ND----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-- 250
Query: 696 HIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA-------- 747
+ D + ++ RM
Sbjct: 251 ----------------------------------MPVDSKFYKMIKEGFRMLSPEHAPAE 276
Query: 748 ----MVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776
M W DP RP+ K+++ ++E +
Sbjct: 277 MYDIMKTCW--DADPLKRPTFKQIVQLIEKQIS 307
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 63/319 (19%), Positives = 111/319 (34%), Gaps = 84/319 (26%)
Query: 492 FSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKL-EKDIEKTNEEFMTELKIIGRTHHK 547
F + +G GKVY+G L + +A+K L +K EEF E + R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFL---------------FHEGQRPGWVQRVE 592
N+V LLG +++ +++ +G L FL V
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL-NKDQT 651
+ +A G+ YL ++H D+ +NVL + KISD G+ + + D
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVL-----VYDKLNVKISDLGLFREVYAADYY 184
Query: 652 RTDTN----MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEII--CGRRHIELSRVEEE 705
+ N +R APE + + D++S+GV+L E+ + + S
Sbjct: 185 KLLGNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----- 235
Query: 706 SEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA------------MVGLWC 753
+ +V+ + + + M+ W
Sbjct: 236 ---------------------------NQDVVEMIRNRQVLPCPDDCPAWVYALMIECW- 267
Query: 754 NHPDPNLRPSMKKVIHMLE 772
+ P+ RP K + L
Sbjct: 268 -NEFPSRRPRFKDIHSRLR 285
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQI--EIAVKKLEKDIEKTNEEFMT----ELKIIGRTHHK 547
+G G VY +DT + ++A+K + + EE + E+ + H+
Sbjct: 17 DKLGGGGMSTVYLA----EDTILNIKVAIKAIFIPP-REKEETLKRFEREVHNSSQLSHQ 71
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
N+V ++ E+D LV E + TLS ++ + + G+ + H+
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR-GTMGYVAP 666
+I+H DIKPQN+L+D +N KI DFGI+K L+ + + T TN GT+ Y +P
Sbjct: 131 ---RIVHRDIKPQNILID-----SNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSP 181
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICGRR 695
E + D++S G++L E++ G
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 65/340 (19%), Positives = 119/340 (35%), Gaps = 63/340 (18%)
Query: 453 YYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLK 512
++ + G + YF + + I+ + + F + +G G V
Sbjct: 6 HHHHHSSG--RENLYFQGHMVIIDNKHYLFI----------QKLGEGGFSYVDLV--EGL 51
Query: 513 DTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR----LLVYEL 568
A+K++ ++ EE E + +H N++RL+ +C E L+
Sbjct: 52 HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111
Query: 569 MPNGTLSNFLFHEGQRPGWVQRVEIA---LGVARGLLYLHEECETQIIHCDIKPQNVLLD 625
GTL N + + ++ +I LG+ RGL +H H D+KP N+L
Sbjct: 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNIL-- 166
Query: 626 LKTLDTNYMAKISDFGISKLLNKDQTRT--------DTNMRGTMGYVAPEWL---RNVPV 674
L + D G + R T+ Y APE + +
Sbjct: 167 ---LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI 223
Query: 675 TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI--SCMLSRNLQVLVSH 732
+ DV+S G +L ++ G ++ + +S + V + I S S L L++
Sbjct: 224 DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-AVQNQLSIPQSPRHSSALWQLLN- 281
Query: 733 DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
DP+ RP + ++ LE
Sbjct: 282 -------------------SMMTVDPHQRPHIPLLLSQLE 302
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-29
Identities = 68/302 (22%), Positives = 121/302 (40%), Gaps = 51/302 (16%)
Query: 422 KKKNNFNSRLLLKIGFIFSAICALLSGVAAIYYSPAARGLIKRRNYFDPNSMEINFREFT 481
++ + + F+ + ++ YF ++ E
Sbjct: 5 HHHHHHDYDIPTTENLYFNGMGYYHH-----HHHHDYDIPTTENLYFQGMLAGVSEYELP 59
Query: 482 FQ---ELQEATKGFSKLVGTGSSGKVYRGILR-----LKDTQIEIAVKKL-EKDIEKTNE 532
EL K +G G+ G+V + ++AVK L EK
Sbjct: 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 119
Query: 533 EFMTELKI---IGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL----------- 578
+ ++E+++ IG+ HKN++ LLG C+++ ++ E G L +L
Sbjct: 120 DLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 579 FHEGQRPGWV----QRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM 634
++ P V A VARG+ YL + + IH D+ +NVL + + +
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL-----VTEDNV 229
Query: 635 AKISDFGISKLLNKDQTRTDTNMRGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLE 689
KI+DFG+++ ++ D + T G + APE L + T + DV+SFGV+L E
Sbjct: 230 MKIADFGLARDIHHI----DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 285
Query: 690 II 691
I
Sbjct: 286 IF 287
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 73/331 (22%), Positives = 124/331 (37%), Gaps = 97/331 (29%)
Query: 492 FSKLVGTGSSGKVYRGILR-----LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGR-T 544
K +G G G+V + +AVK L+ D EK + ++E++++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 545 HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL---------------FHEGQRPGWVQ 589
HKN++ LLG C+++ ++ E G L +L ++ +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 590 RVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649
V +ARG+ YL + + IH D+ +NVL + N + KI+DFG+++ +N
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVL-----VTENNVMKIADFGLARDINNI 256
Query: 650 QTRTDTNMRGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEII-------CGRRHI 697
D + T G + APE L + T + DV+SFGV++ EI G
Sbjct: 257 ----DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV- 311
Query: 698 ELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA---------- 747
E+ L+ RM
Sbjct: 312 ------------------------------------EELFKLLKEGHRMDKPANCTNELY 335
Query: 748 --MVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776
M C H P+ RP+ K+++ L+ L
Sbjct: 336 MMM--RDCWHAVPSQRPTFKQLVEDLDRILT 364
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
F +++G+G+ +V+ + T A+K ++K + E+ ++ + H+N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQ--RLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR--------VEIALGVARGLLY 603
L LV +L+ G L + + ++R + V + Y
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDRI---------LERGVYTEKDASLVIQQVLSAVKY 121
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
LHE I+H D+KP+N+L T + N I+DFG+SK+ T GT GY
Sbjct: 122 LHEN---GIVHRDLKPENLLY--LTPEENSKIMITDFGLSKMEQNGIMST---ACGTPGY 173
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
VAPE L P + VD +S GV+ ++CG
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 47/225 (20%), Positives = 96/225 (42%), Gaps = 36/225 (16%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLE-KDIEKTNEEFMTELKIIGRTHHKNLVRL 552
+ +G G G V+ + K A+K++ + E E+ M E+K + + H +VR
Sbjct: 11 QCLGRGGFGVVFEA--KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 553 LGFCSEED---------KRLLVY---ELMPNGTLSNFLFH--EGQRPGWVQRVEIALGVA 598
E++ ++ +Y +L L +++ + + I L +A
Sbjct: 69 FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR 658
+ +LH + ++H D+KP N+ + + K+ DFG+ +++D+
Sbjct: 129 EAVEFLHSK---GLMHRDLKPSNIFFT-----MDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 659 -----------GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC 692
GT Y++PE + + KVD+FS G++L E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 492 FSKLVGTGSSGKVYRGILR-----LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGR-T 544
K +G G+ G+V + +AVK L+ D EK + ++E++++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 545 HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL---------------FHEGQRPGWVQ 589
HKN++ LLG C+++ ++ E G L +L ++ +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 590 RVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649
V +ARG+ YL + + IH D+ +NVL + N + KI+DFG+++ +N
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVL-----VTENNVMKIADFGLARDINNI 210
Query: 650 QTRTDTNMRGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEII 691
D + T G + APE L + T + DV+SFGV++ EI
Sbjct: 211 ----DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 71/338 (21%), Positives = 116/338 (34%), Gaps = 105/338 (31%)
Query: 492 FSKLVGTGSSGKVYRGI---LRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKI---IGRT 544
F K++G+G+ GKV + I++AVK L++ E M+ELK+ +G
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS- 107
Query: 545 HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL----------------------FHEG 582
H+N+V LLG C+ L++E G L N+L +
Sbjct: 108 -HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 583 QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642
+ + A VA+G+ +L + +H D+ +NVL+ + KI DFG+
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVT-----HGKVVKICDFGL 218
Query: 643 SKLLNKDQTRTDTNMRGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEII------ 691
++ + D + + APE L T K DV+S+G++L EI
Sbjct: 219 ARDIMSD----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
Query: 692 -CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA--- 747
G + D ++ +M
Sbjct: 275 YPG------------------------------------IPVDANFYKLIQNGFKMDQPF 298
Query: 748 ---------MVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776
M W D RPS + L L
Sbjct: 299 YATEEIYIIMQSCW--AFDSRKRPSFPNLTSFLGCQLA 334
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 62/297 (20%), Positives = 104/297 (35%), Gaps = 51/297 (17%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVK-----KLEKDIEKTNEEFMTELKIIGRTHH 546
+++G G V R I ++T + AVK K + E+ E I H
Sbjct: 28 LCEVIGKGPFSVVRRCIN--RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGW---VQRVEIALGVARGLLY 603
++V LL S + +V+E M L + + L Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
H+ IIH D+KP VLL K + + K+ FG++ L + GT +
Sbjct: 146 CHDN---NIIHRDVKPHCVLLASK--ENSAPVKLGGFGVAIQLGESGLVA-GGRVGTPHF 199
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICGR-----------RHIELSRVEEESEEVDIV 712
+APE ++ P VDV+ GV+L ++ G I + + + +
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHI 259
Query: 713 LSDW---VISCMLSRN-------LQVL-------------VSHDPEVLSDLERFERM 746
S+ ++ ML + + L H PE + L +F
Sbjct: 260 -SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNAR 315
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 56/232 (24%), Positives = 108/232 (46%), Gaps = 44/232 (18%)
Query: 492 FSKLVGTGSSGKVYRGI---LRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHK 547
K +G G GKV + L+ + +AVK L+++ + ++E ++ + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFL-----------------------FHEGQR 584
++++L G CS++ LL+ E G+L FL + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 585 PGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
+ A +++G+ YL E +++H D+ +N+L + KISDFG+S+
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNIL-----VAEGRKMKISDFGLSR 198
Query: 645 LLNKDQTRTDTNMRGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEII 691
+ ++ D+ ++ + G + A E L + TT+ DV+SFGV+L EI+
Sbjct: 199 DVYEE----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G G+SG VY T E+A+++ L++ +K E + E+ ++ + N+V L
Sbjct: 28 IGQGASGTVYTA--MDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNPNIVNYL 83
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEECET 610
D+ +V E + G+L++ + + +IA + L +LH
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
Q+IH DIK N+L L + K++DFG + +Q++ T M GT ++APE +
Sbjct: 136 QVIHRDIKSDNIL-----LGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT 189
Query: 671 NVPVTTKVDVFSFGVMLLEIICG 693
KVD++S G+M +E+I G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 74/330 (22%), Positives = 120/330 (36%), Gaps = 95/330 (28%)
Query: 492 FSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGR-THH 546
K +G G+ G+V T +AVK L++ + M+ELKI+ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 547 KNLVRLLGFCSEEDK-RLLVYELMPNGTLSNFL---------------FHEGQRPGWVQR 590
N+V LLG C++ +++ E G LS +L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 591 VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650
+ + VA+G+ +L + IH D+ +N+L L + KI DFG+++ + KD
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNIL-----LSEKNVVKICDFGLARDIYKD- 201
Query: 651 TRTDTNMRGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEII-------CGRRHIE 698
+R + APE + + T + DV+SFGV+L EI G
Sbjct: 202 ---PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG----- 253
Query: 699 LSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA----------- 747
V D E L+ RM
Sbjct: 254 -------------------------------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 282
Query: 748 -MVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776
M+ W H +P+ RP+ +++ L L+
Sbjct: 283 TMLDCW--HGEPSQRPTFSELVEHLGNLLQ 310
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 60/296 (20%), Positives = 120/296 (40%), Gaps = 36/296 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRL 552
+G G+ G V++ K + + +A K + +I + + EL+++ + +V
Sbjct: 39 SELGAGNGGVVFKV--SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 96
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQI 612
G + + + E M G+L L G+ P + +++ V +GL YL E+ +I
Sbjct: 97 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSIAVIKGLTYLREKH--KI 153
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
+H D+KP N+L++ + K+ DFG+S L + GT Y++PE L+
Sbjct: 154 MHRDVKPSNILVN-----SRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGT 205
Query: 673 PVTTKVDVFSFGVMLLEIICGR--RHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730
+ + D++S G+ L+E+ GR ++ E + + L
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 731 SHDPEVLSDLERFERMAMV----------GLW----------CNHPDPNLRPSMKK 766
+ + FE + + G++ C +P R +K+
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G GS+G V R K + ++AVK ++ ++ E E+ I+ H N+V +
Sbjct: 53 IGEGSTGIVCLA--REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEECETQI 612
++ ++ E + G L++ + + +IA V + L YLH + +
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQ---GV 162
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
IH DIK ++L L + K+SDFG ++KD + + + GT ++APE +
Sbjct: 163 IHRDIKSDSIL-----LTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRS 216
Query: 673 PVTTKVDVFSFGVMLLEIICG 693
T+VD++S G+M++E++ G
Sbjct: 217 LYATEVDIWSLGIMVIEMVDG 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-29
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 30/232 (12%)
Query: 477 FREFTFQELQEATKG---FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNE 532
F ++ + E Q + +++G G G+V+ ++K T A KKL K ++K
Sbjct: 171 FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF--ACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 533 EFMT--ELKIIGRTHHKNLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGW-- 587
E KI+ + H + +V L + E L LV +M G + +++ +
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 588 VQRV-----EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642
R +I G L +LH+ II+ D+KP+NVLLD D +ISD G+
Sbjct: 288 EPRAIFYTAQIVSG----LEHLHQR---NIIYRDLKPENVLLD----DDGN-VRISDLGL 335
Query: 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
+ L QT+T GT G++APE L VD F+ GV L E+I R
Sbjct: 336 AVELKAGQTKTKG-YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 50/233 (21%), Positives = 92/233 (39%), Gaps = 50/233 (21%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
++G G+ G+V + R A+KK+ E+ ++E+ ++ +H+ +VR
Sbjct: 12 AVLGQGAFGQVVKA--RNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 554 GFCSEEDKRL-------------LVYELMPNGTLS------NFLFHEGQRPGWVQRVEIA 594
E + + E NGTL N + + +I
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QIL 126
Query: 595 LGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD 654
++ Y+H + IIH D+KP N+ +D + KI DFG++K +++
Sbjct: 127 EALS----YIHSQ---GIIHRDLKPMNIF-----IDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 655 TNMR-------------GTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICG 693
+ + GT YVA E L K+D++S G++ E+I
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTN--EEFMTELKIIGRTHHKNLV 550
L+G GS VYR T +E+A+K ++K + K + E+KI + H +++
Sbjct: 17 NLLGKGSFAGVYRA--ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIA---LGVARGLLYLHEE 607
L + + + LV E+ NG ++ +L R E + G+LYLH
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
I+H D+ N+LL N KI+DFG++ L + T + GT Y++PE
Sbjct: 132 ---GILHRDLTLSNLLLT-----RNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGR 694
+ DV+S G M ++ GR
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 44/232 (18%)
Query: 492 FSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHK 547
+ + +G G+ G+V++ + +AVK L+++ +F E ++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFL-----------------------FHEGQR 584
N+V+LLG C+ L++E M G L+ FL
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 585 PGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
+++ IA VA G+ YL E + +H D+ +N L + N + KI+DFG+S
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL-----VGENMVVKIADFGLS- 221
Query: 645 LLNKDQTRTDTNMRGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEII 691
++ D + PE + TT+ DV+++GV+L EI
Sbjct: 222 ---RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 42/228 (18%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-------DIEKTNEEFMT---------- 536
+ + G K+ + A+KK EK D K+N + ++
Sbjct: 37 RTLNQGKFNKIILC----EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92
Query: 537 ELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALG 596
EL+II ++ + G + D+ ++YE M N ++ F + I +
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF-VLDKNYTCFIPIQ 151
Query: 597 VAR--------GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648
V + Y+H E I H D+KP N+L +D N K+SDFG S+ +
Sbjct: 152 VIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNIL-----MDKNGRVKLSDFGESEYMVD 204
Query: 649 DQTRTDTNMRGTMGYVAPEWLRNVPVT--TKVDVFSFGVMLLEIICGR 694
+ + RGT ++ PE+ N KVD++S G+ L +
Sbjct: 205 KKIKG---SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTN--EEFMTELKIIGRTHHKNLV 550
+ +G G K + DT+ A K + K + K + E+ E+ I H+++V
Sbjct: 47 RFLGKGGFAKCFEI--SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
GF + D +V EL +L R + G YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLHRN--- 160
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
++IH D+K N+ L+ + KI DFG++ + D R + GT Y+APE L
Sbjct: 161 RVIHRDLKLGNLFLN-----EDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLS 214
Query: 671 NVPVTTKVDVFSFGVMLLEIICGR 694
+ +VDV+S G ++ ++ G+
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTN--EEFMTELKIIGRTHHKNLV 550
+ +G G K + DT+ A K + K + K + E+ E+ I H+++V
Sbjct: 21 RFLGKGGFAKCFEI--SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIA---LGVARGLLYLHEE 607
GF + D +V EL +L +R + E + G YLH
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
++IH D+K N+ L+ + KI DFG++ + D R + GT Y+APE
Sbjct: 135 ---RVIHRDLKLGNLFLN-----EDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 185
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGR 694
L + +VDV+S G ++ ++ G+
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 61/252 (24%), Positives = 90/252 (35%), Gaps = 57/252 (22%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVK-----KLEKDIEKTNEEFMTELKIIGRTHH 546
+G GS G V I T+ A+K K+ + K E TE++++ + HH
Sbjct: 30 LKGAIGQGSYGVVRVAIE--NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALG---------- 596
N+ RL +E LV EL G L + L +++
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 597 -----------------------------VARGLLYLHEECETQIIHCDIKPQNVLLDLK 627
+ L YLH + I H DIKP+N L
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFST- 203
Query: 628 TLDTNYMAKISDFGISKLLNKDQTRTDTNMR---GTMGYVAPEWLRNV--PVTTKVDVFS 682
+ ++ K+ DFG+SK K M GT +VAPE L K D +S
Sbjct: 204 --NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 683 FGVMLLEIICGR 694
GV+L ++ G
Sbjct: 262 AGVLLHLLLMGA 273
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 25/242 (10%)
Query: 463 KRRNYFDPNSMEINFREFTFQELQEATKG--FSKLVGTGSSGKVYRGILRLKDTQIEIAV 520
R N + ++ F + ++ K +G+G+ G+V K T +E A+
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRD--KVTHVERAI 67
Query: 521 KKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTL---- 574
K + K +N + + E+ ++ H N+++L F ++ LV E G L
Sbjct: 68 KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI 127
Query: 575 -SNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNY 633
F+E V I V G+ YLH+ I+H D+KP+N+LL+ K + +
Sbjct: 128 IHRMKFNE------VDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESK--EKDA 176
Query: 634 MAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
+ KI DFG+S + + + GT Y+APE LR K DV+S GV+L ++ G
Sbjct: 177 LIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233
Query: 694 RR 695
Sbjct: 234 YP 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEE--FMTELKIIGRTHHKN 548
F K++G GS V + R T E A+K LEK I K N+ E ++ R H
Sbjct: 34 FGKILGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLH 605
V+L +++K NG L ++ G R EI L YLH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA----LEYLH 147
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN-MRGTMGYV 664
+ IIH D+KP+N+LL+ + +I+DFG +K+L+ + + N GT YV
Sbjct: 148 GK---GIIHRDLKPENILLN-----EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
+PE L D+++ G ++ +++ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 36/271 (13%), Positives = 73/271 (26%), Gaps = 63/271 (23%)
Query: 470 PNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK---- 525
+ + +G ++G ++T V
Sbjct: 57 NTGQPFRVESELGERPRTLVRG--TVLGQEDPYAYLEA--TDQETGESFEVHVPYFTERP 112
Query: 526 ---DIEKTNEE---------------------FMTELKIIGRTHHKNLVRLLGFCSEED- 560
I++ EE F+ ++ K ++R+ +
Sbjct: 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 172
Query: 561 -KRLLVYELM--PNGTLSNFLFHEGQRPG---WVQRVEIALGVARGLLYLHEECETQIIH 614
R +Y M T L R+++ L V R L LH ++H
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH 229
Query: 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL----- 669
++P +++ LD ++ F + G+ PE
Sbjct: 230 TYLRPVDIV-----LDQRGGVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRAT 279
Query: 670 ------RNVPVTTKVDVFSFGVMLLEIICGR 694
R +T D ++ G+++ I C
Sbjct: 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+G G++ VYR + K TQ A+K L+K ++K + TE+ ++ R H N+++
Sbjct: 57 VESELGRGATSIVYRC--KQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIK 112
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR--------VEIALGVARGLLY 603
L + LV EL+ G L + + V++ + + + Y
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRI---------VEKGYYSERDAADAVKQILEAVAY 163
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
LHE I+H D+KP+N+L T + KI+DFG+SK++ + GT GY
Sbjct: 164 LHEN---GIVHRDLKPENLLY--ATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGY 216
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
APE LR +VD++S G++ ++CG
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNL 549
+ +G G+ V R + K T +E A K + + ++ E +I + H N+
Sbjct: 10 VKEELGKGAFSVVRRCVH--KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV--------EIALGVARGL 601
VRL EE LV++L+ G L + V R + +
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDI---------VAREFYSEADASHCIQQILESI 118
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
Y H I+H ++KP+N+LL K K++DFG++ +N + GT
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAA--VKLADFGLAIEVNDSEAWHG--FAGTP 171
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
GY++PE L+ P + VD+++ GV+L ++ G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 73/238 (30%), Positives = 116/238 (48%), Gaps = 32/238 (13%)
Query: 471 NSMEIN-FREFTFQELQEATKG---FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD 526
+S+ N F ++ + E Q TK +++G G G+V +++ T A KKLEK
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVC--ACQVRATGKMYACKKLEKK 220
Query: 527 -IEKTNEEFMT--ELKIIGRTHHKNLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEG 582
I+K E M E +I+ + + + +V L + E L LV LM G L ++H G
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 583 QRPGWVQRV-----EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637
Q R EI G L LH E +I++ D+KP+N+LLD D + +I
Sbjct: 280 QAGFPEARAVFYAAEICCG----LEDLHRE---RIVYRDLKPENILLD----DHGH-IRI 327
Query: 638 SDFGISK-LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
SD G++ + + GT+GY+APE ++N T D ++ G +L E+I G+
Sbjct: 328 SDLGLAVHVPEGQTIKG---RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNL 549
++G GS G+V + + TQ E AVK + K K + E++++ + H N+
Sbjct: 26 IVCMLGKGSFGEVLKCKD--RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTL-----SNFLFHEGQRPGWVQRVEIALGVARGLL-- 602
++L + +V EL G L F E A + + +
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD----------AARIIKQVFSG 133
Query: 603 --YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT 660
Y+H+ I+H D+KP+N+LL+ K + + KI DFG+S ++ D GT
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESK--EKDCDIKIIDFGLSTCFQQNTKMKD--RIGT 186
Query: 661 MGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR 695
Y+APE LR K DV+S GV+L ++ G
Sbjct: 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKN 548
+++G GS G+V K T E AVK + K + E + E++++ + H N
Sbjct: 30 GQRVLGKGSFGEVILCKD--KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTL-----SNFLFHEGQRPGWVQRVEIALGVARGLLY 603
+++L F ++ LV E+ G L S F E V I V G+ Y
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE------VDAARIIRQVLSGITY 141
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
+H+ +I+H D+KP+N+LL+ K + +I DFG+S + D GT Y
Sbjct: 142 MHKN---KIVHRDLKPENLLLESK--SKDANIRIIDFGLSTHFEASKKMKD--KIGTAYY 194
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
+APE L K DV+S GV+L ++ G
Sbjct: 195 IAPEVLHG-TYDEKCDVWSTGVILYILLSGC 224
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE-FMTELKIIGRTHHKNLV 550
F + +G+G+ G V+ + + +E +K + KD + E E++++ H N++
Sbjct: 26 FKRKLGSGAFGDVHLV--EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEE 607
++ + +V E G L + R + +A + L Y H +
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
++H D+KP+N+L + KI DFG+++L D+ T+ GT Y+APE
Sbjct: 144 ---HVVHKDLKPENILFQDT--SPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPE 196
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICG 693
+ VT K D++S GV++ ++ G
Sbjct: 197 VFKR-DVTFKCDIWSAGVVMYFLLTG 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIE--IAVKKLEKDIEKTNEEFMT----ELKIIGRTHHK 547
+LVG G G VY +DT E +A+K + + + ++ F T E + GR
Sbjct: 40 RLVGRGGMGDVYEA----EDTVRERIVALKLMSETL-SSDPVFRTRMQREARTAGRLQEP 94
Query: 548 NLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQR-VEIALGVARGLLYLH 605
++V + F E D +L + L+ L+ L +G R V I + L H
Sbjct: 95 HVVPIHDF-GEIDGQLYVDMRLINGVDLAAMLRRQGPLA--PPRAVAIVRQIGSALDAAH 151
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR-GTMGYV 664
H D+KP+N+L+ + A + DFGI+ D+ T GT+ Y+
Sbjct: 152 AA---GATHRDVKPENILVS-----ADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYM 202
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICGRR 695
APE T + D+++ +L E + G
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTE-----LKIIGRTHHK 547
+++G G G+VY R DT A+K L+K I+ E + L ++
Sbjct: 195 RIIGRGGFGEVY--GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 548 NLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLY 603
+V + + +L + +LM G L L G R EI LG L +
Sbjct: 253 FIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEH 307
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
+H +++ D+KP N+LLD + ++ +ISD G++ +K + GT GY
Sbjct: 308 MHNR---FVVYRDLKPANILLD----EHGHV-RISDLGLACDFSKKKPHA---SVGTHGY 356
Query: 664 VAPEWL-RNVPVTTKVDVFSFGVMLLEIICGR 694
+APE L + V + D FS G ML +++ G
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLL 553
+G G+ G V + R + +AVK++ + + + + +L I RT V
Sbjct: 15 LGRGAYGVVEKM--RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVE---IALGVARGLLYLHEECET 610
G E + ELM + +L F + + IA+ + + L +LH +
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--L 129
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS-KLLNKDQTRTDTNMRGTMGYVAPE-- 667
+IH D+KP NVL ++ K+ DFGIS L++ D G Y+APE
Sbjct: 130 SVIHRDVKPSNVL-----INALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERI 181
Query: 668 --WLRNVPVTTKVDVFSFGVMLLEIICGR 694
L + K D++S G+ ++E+ R
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 28/237 (11%), Positives = 62/237 (26%), Gaps = 50/237 (21%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN---EEFMTELKIIGRTHHKNLV 550
+ + G V+ R + + A+K E + E R ++
Sbjct: 68 EPLRVGDRSVVFLV--RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 551 RLLGFC----------------------SEEDKR----LLVYELM-----PNGTLSNFLF 579
++D LL+ + +F++
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185
Query: 580 HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639
G + + + R L + ++H P N+ + + + D
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLF-----IMPDGRLMLGD 237
Query: 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWL--RNVPVTTKVDVFSFGVMLLEIICGR 694
K TR + Y E+L T ++ + G+ + + C
Sbjct: 238 VSALW---KVGTRGPA-SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGF 555
+G G+ GKVY+ + K+T A K +E E+ E+++ E++I+ H +V+LLG
Sbjct: 27 LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEECETQI 612
+ K ++ E P G + + + +I + + L +LH + +I
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE----- 667
IH D+K NVL + +++DFG+S K + D+ GT ++APE
Sbjct: 139 IHRDLKAGNVL-----MTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCE 192
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICG 693
+++ P K D++S G+ L+E+
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLL 553
+G G+ G V + K + +AVK++ + EK ++ + +L ++ R+ +V+
Sbjct: 30 IGRGAYGSVNKM--VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVE------IALGVARGLLYLHEE 607
G E + ELM + + F + + I L + L +L E
Sbjct: 88 GALFREGDCWICMELM-STSFDKFYKYVYSVLD--DVIPEEILGKITLATVKALNHLKEN 144
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
+IIH DIKP N+L LD + K+ DFGIS L + T G Y+APE
Sbjct: 145 --LKIIHRDIKPSNIL-----LDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPE 195
Query: 668 ----WLRNVPVTTKVDVFSFGVMLLEIICGR 694
+ DV+S G+ L E+ GR
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 68/300 (22%), Positives = 115/300 (38%), Gaps = 64/300 (21%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNL 549
+ +G G+ V R + K T +E A K + + ++ E +I + H N+
Sbjct: 33 VKEELGKGAFSVVRRCVH--KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV--------EIALGVARGL 601
VRL EE LV++L+ G L + V R + +
Sbjct: 91 VRLHDSIQEESFHYLVFDLVTGGELFEDI---------VAREFYSEADASHCIQQILESI 141
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
Y H I+H ++KP+N+LL K K++DFG++ +N + GT
Sbjct: 142 AYCHSN---GIVHRNLKPENLLLASKAKGAA--VKLADFGLAIEVNDSEAWHG--FAGTP 194
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR------------RHIELSRVEEESEEV 709
GY++PE L+ P + VD+++ GV+L ++ G I+ + S E
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 254
Query: 710 DIVLSDWV---ISCMLSRN-------LQVL-------------VSHDPEVLSDLERFERM 746
D V + I ML+ N Q L H + + L++F
Sbjct: 255 DTV-TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNAR 313
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 26/214 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQI--EIAVKKLEKDIEKTNEEFMT----ELKIIGRTHHK 547
+++G G +V+ +D + ++AVK L D+ + F E + +H
Sbjct: 18 EILGFGGMSEVHLA----RDLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHP 72
Query: 548 NLVRLLGFCSEEDKRL----LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLY 603
+V + E +V E + TL + + H + +E+ + L +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNF 131
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD-QTRTDTNMR-GTM 661
H+ IIH D+KP N+++ K+ DFGI++ + + T T GT
Sbjct: 132 SHQ---NGIIHRDVKPANIMIS-----ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR 695
Y++PE R V + DV+S G +L E++ G
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+ +G+G+ G V+R + K T K + E+ I+ + HH L+
Sbjct: 55 ILEELGSGAFGVVHRCVE--KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
L ++ + +L+ E + G L + + E + + + GL ++HE
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---S 169
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
I+H DIKP+N++ + K + KI DFG++ LN D+ T + APE +
Sbjct: 170 IVHLDIKPENIMCETKKASS---VKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDR 224
Query: 672 VPVTTKVDVFSFGV---MLLEIICG 693
PV D+++ GV +LL G
Sbjct: 225 EPVGFYTDMWAIGVLGYVLL---SG 246
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 65/300 (21%), Positives = 112/300 (37%), Gaps = 63/300 (21%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE--FMTELKIIGRTHHKNL 549
+ +G G+ V R + E A + + E +I H N+
Sbjct: 15 LFEELGKGAFSVVRRCVK--VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR--------VEIALGVARGL 601
VRL SEE L+++L+ G L + V R + +
Sbjct: 73 VRLHDSISEEGHHYLIFDLVTGGELFEDI---------VAREYYSEADASHCIQQILEAV 123
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
L+ H+ ++H ++KP+N+LL K K++DFG++ + +Q GT
Sbjct: 124 LHCHQM---GVVHRNLKPENLLLASK--LKGAAVKLADFGLAIEVEGEQQAWFG-FAGTP 177
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR------------RHIELSRVEEESEEV 709
GY++PE LR P VD+++ GV+L ++ G + I+ + S E
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237
Query: 710 DIVLSDWV---ISCMLSRN-------LQVL-------------VSHDPEVLSDLERFERM 746
D V + I+ ML+ N + L H E + L++F
Sbjct: 238 DTV-TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNAR 296
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-------------DIEKTNEEFMTEL 538
+ +G+G+ G+V + K+ E A+K ++K +IEK +EE E+
Sbjct: 40 KVRKLGSGAYGEVLLC--KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 539 KIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR--VEIALG 596
++ H N+++L ++ LV E G L + + + + I
Sbjct: 98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD---ECDAANIMKQ 154
Query: 597 VARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN 656
+ G+ YLH+ I+H DIKP+N+LL+ K ++ KI DFG+S +KD D
Sbjct: 155 ILSGICYLHKH---NIVHRDIKPENILLENK--NSLLNIKIVDFGLSSFFSKDYKLRD-- 207
Query: 657 MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR 695
GT Y+APE L+ K DV+S GV++ ++CG
Sbjct: 208 RLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL 549
F L +G GS G VY+ K+T +A+K++ +E +E + E+ I+ + ++
Sbjct: 31 FDVLEKLGEGSYGSVYKA--IHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHV 86
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHE 606
V+ G + +V E G++S+ + R + EIA +GL YLH
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
+ IH DIK N+LL+ T AK++DFG++ L + +T + GT ++AP
Sbjct: 144 M---RKIHRDIKAGNILLN-----TEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAP 194
Query: 667 EWLRNVPVTTKVDVFSFGVMLLEIICG 693
E ++ + D++S G+ +E+ G
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 61/250 (24%), Positives = 105/250 (42%), Gaps = 44/250 (17%)
Query: 469 DPNSMEINFREFTFQELQEATKGF------SKLVGTGSSGKVYRGILRLKDTQIEIAVKK 522
+ F + T + K SK +G+G+ G+V + T ++A++
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFE--RKTCKKVAIRI 167
Query: 523 LEKD--------IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTL 574
+ K TE++I+ + +H ++++ F + + +V ELM G L
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL 226
Query: 575 SNFLFHEGQRPGWVQRV--------EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDL 626
+ + V + + YLHE IIH D+KP+NVLL
Sbjct: 227 FDKV---------VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSS 274
Query: 627 KTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPV---TTKVDVFSF 683
+ + + + KI+DFG SK+L + + GT Y+APE L +V VD +S
Sbjct: 275 Q--EEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 684 GVMLLEIICG 693
GV+L + G
Sbjct: 331 GVILFICLSG 340
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNL 549
++G GS G+V + + TQ E AVK + K K + E++++ + H N+
Sbjct: 26 IVCMLGKGSFGEVLKCKD--RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTL-----SNFLFHEGQRPGWVQRVEIALGVARGLLYL 604
++L + +V EL G L F E I V G+ Y+
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE------HDAARIIKQVFSGITYM 137
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
H+ I+H D+KP+N+LL+ K + + KI DFG+S ++ D GT Y+
Sbjct: 138 HKH---NIVHRDLKPENILLESK--EKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYI 190
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICG 693
APE LR K DV+S GV+L ++ G
Sbjct: 191 APEVLRG-TYDEKCDVWSAGVILYILLSG 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN---EEFMTELKIIGRTHHKNLVRL 552
+G GS G+V++GI TQ +A+K + D+E+ E+ E+ ++ + + +
Sbjct: 30 IGKGSFGEVFKGID--NRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEECE 609
G ++ K ++ E + G+ + L PG + +IA + +GL YLH E
Sbjct: 86 YGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE-- 138
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+ IH DIK NVLL + K++DFG++ L Q + +T GT ++APE +
Sbjct: 139 -KKIHRDIKAANVLLS-----EHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 191
Query: 670 RNVPVTTKVDVFSFGVMLLEIICG 693
+ +K D++S G+ +E+ G
Sbjct: 192 KQSAYDSKADIWSLGITAIELARG 215
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 10/202 (4%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+ +GTG+ G V+R + T A K + E E E++ + H LV
Sbjct: 161 IHEELGTGAFGVVHRVTE--RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
L ++++ +++YE M G L + E + + VE V +GL ++HE
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
+H D+KP+N++ K + K+ DFG++ L+ Q+ GT + APE
Sbjct: 276 YVHLDLKPENIMFTTKRSNE---LKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEG 330
Query: 672 VPVTTKVDVFSFGVMLLEIICG 693
PV D++S GV+ ++ G
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSG 352
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 17/205 (8%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+G GS G+V K T+I A KK+ K + + F E++I+ H N++R
Sbjct: 13 LENTIGRGSWGEVKIA--VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQ---RPGWVQRVEIALGVARGLLYLHEEC 608
L + LV EL G L + H+ I V + Y H+
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES----DAARIMKDVLSAVAYCHKL- 125
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
+ H D+KP+N L + K+ DFG++ + GT YV+P+
Sbjct: 126 --NVAHRDLKPENFLFLTD--SPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQV 179
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICG 693
L + D +S GVM+ ++CG
Sbjct: 180 LEG-LYGPECDEWSAGVMMYVLLCG 203
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 49/216 (22%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLV 550
++++G G G+V++ T +++A K ++ K EE E+ ++ + H NL+
Sbjct: 92 SKTEILGGGRFGQVHKCEE--TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 551 RLLGFCSEEDKRLLVYELMPNGTL------SNFLFHEGQRPGWVQRVEIALGVAR----G 600
+L ++ +LV E + G L ++ E + + G
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD----------TILFMKQICEG 199
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT 660
+ ++H+ I+H D+KP+N+L + KI DFG+++ + GT
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQ---IKIIDFGLARRYKPREKLKV--NFGT 251
Query: 661 MGYVAPEWLRNVPVTTKVDVFSFGV---MLLEIICG 693
++APE + V+ D++S GV MLL G
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL---SG 284
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 37/217 (17%)
Query: 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGR-THHKNL 549
SK +G G V + I K T E A K L+K + E + E+ ++ +
Sbjct: 34 SKELGRGKFAVVRQCIS--KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALG----------VAR 599
+ L + +L+ E G + + + + + +
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLC---------LPELAEMVSENDVIRLIKQILE 142
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG 659
G+ YLH+ I+H D+KPQN+LL ++ KI DFG+S+ + + + G
Sbjct: 143 GVYYLHQN---NIVHLDLKPQNILLS--SIYPLGDIKIVDFGMSRKIGHACELRE--IMG 195
Query: 660 TMGYVAPEWLRNVPVTTKVDVFSFGV---MLLEIICG 693
T Y+APE L P+TT D+++ G+ MLL
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLL---TH 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK------DIEKTNEEFMTELKIIGRTH 545
+ +G+G V + K T +E A K ++K EE E+ I+ +
Sbjct: 16 IGEELGSGQFAIVKKCRE--KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 546 HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQ---RPGWVQRVEIALGVARGLL 602
H N++ L +L+ EL+ G L +FL + + + G+
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE----EATSFIKQILDGVN 129
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
YLH + +I H D+KP+N++L K + K+ DFG++ + + + GT
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIP-IPHIKLIDFGLAHEIEDGVEFKN--IFGTPE 183
Query: 663 YVAPEWLRNVPVTTKVDVFSFGV---MLLEIICG 693
+VAPE + P+ + D++S GV +LL G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILL---SG 214
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 45/226 (19%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK---------DIEKTNEEFMTELKIIG 542
+++G G S V R I K T E AVK ++ ++++ E + E+ I+
Sbjct: 21 PKEILGRGVSSVVRRCIH--KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 543 R-THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV--------EI 593
+ + H N+++L LV++LM G L ++L ++V +I
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---------TEKVTLSEKETRKI 129
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653
+ + LH+ I+H D+KP+N+L LD + K++DFG S L+ +
Sbjct: 130 MRALLEVICALHKL---NIVHRDLKPENIL-----LDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 654 DTNMRGTMGYVAPEWLRNVPVTT------KVDVFSFGVMLLEIICG 693
+ + GT Y+APE + +VD++S GV++ ++ G
Sbjct: 182 E--VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK------DIEKTNEEFMTELKIIGRTH 545
+ +G+G V + R K T E A K ++K + EE E+ I+
Sbjct: 9 MGEELGSGQFAIVRKC--RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 546 HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI-ALGVAR----G 600
H N++ L + +L+ EL+ G L +FL + E A + G
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT------EDEATQFLKQILDG 120
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT 660
+ YLH + +I H D+KP+N++L K + + K+ DFGI+ + + + GT
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRI-KLIDFGIAHKIEAGNEFKN--IFGT 174
Query: 661 MGYVAPEWLRNVPVTTKVDVFSFGV---MLLEIICG 693
+VAPE + P+ + D++S GV +LL G
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILL---SG 207
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-26
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR-THHKNLV 550
+ +G GS R I K T +E AVK I+K+ + E++I+ R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIH--KATNMEFAVKI----IDKSKRDPTEEIEILLRYGQHPNII 79
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV--------EIALGVARGLL 602
L + +V ELM G L + + +++ + + + +
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKI---------LRQKFFSEREASAVLFTITKTVE 130
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
YLH + ++H D+KP N+L ++ + + +I DFG +K L + T T
Sbjct: 131 YLHAQ---GVVHRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAENGLLMT-PCYTAN 185
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
+VAPE L D++S GV+L ++ G
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 7e-26
Identities = 49/348 (14%), Positives = 84/348 (24%), Gaps = 86/348 (24%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-------DIEKTNEEFMTELKIIGRTHH 546
++G ++T V I++ EE + + G +
Sbjct: 84 TVLGQEDPYAYLEA--TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 141
Query: 547 KNLVRLLGFCSEEDK-----------------------RLLVYELM--PNGTLSNFLFHE 581
K L F D R +Y M T L
Sbjct: 142 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 201
Query: 582 GQRPG---WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638
R+++ L V R L LH ++H ++P +++LD ++
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLD-----QRGGVFLT 253
Query: 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICG 693
F A L +T D ++ G+ + I C
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 694 R-----------RHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLER 742
+ + V ++ L E
Sbjct: 314 DLPNTDDAALGGSEWIFRSCKNIPQPV----RA-LLEGFLRY--------PKE------- 353
Query: 743 FERM----AMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPPLLHDQ 786
+R+ AM L ++ E T E G PP Q
Sbjct: 354 -DRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQ 400
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 40/205 (19%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
++ +G G G V+R + ++ K ++ E+ I+ H+N++
Sbjct: 9 IAEDLGRGEFGIVHRCVE--TSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
L ++ ++++E + + + + V V L +LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---N 122
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
I H DI+P+N++ + + KI +FG ++ L + Y APE ++
Sbjct: 123 IGHFDIRPENIIYQTRR---SSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQH 177
Query: 672 VPVTTKVDVFSFGV---MLLEIICG 693
V+T D++S G +LL G
Sbjct: 178 DVVSTATDMWSLGTLVYVLL---SG 199
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN------EEFMTELKIIGRTH 545
+ +G+G V + K T +E A K ++K + + EE E+ I+ +
Sbjct: 16 IGEELGSGQFAIVKKCRE--KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 546 HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQ---RPGWVQRVEIALGVARGLL 602
H N++ L +L+ EL+ G L +FL + + + G+
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE----EATSFIKQILDGVN 129
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
YLH + +I H D+KP+N++L K + ++ K+ DFG++ + + + GT
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHI-KLIDFGLAHEIEDGVEFKN--IFGTPE 183
Query: 663 YVAPEWLRNVPVTTKVDVFSFGV---MLLEIICG 693
+VAPE + P+ + D++S GV +LL G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILL---SG 214
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEF--MTELKIIGRTHHKN 548
+ +G GS GKV I++ DT+ A+K + K + NE EL+I+ H
Sbjct: 19 ILRAIGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLH 605
LV L +E+ +V +L+ G L L ++ E+ + L YL
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA----LDYLQ 132
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+ +IIH D+KP N+L LD + I+DF I+ +L +T+ T M GT Y+A
Sbjct: 133 NQ---RIIHRDMKPDNIL-----LDEHGHVHITDFNIAAML-PRETQITT-MAGTKPYMA 182
Query: 666 PEWLRNVPV---TTKVDVFSFGVMLLEIICGRR 695
PE + + VD +S GV E++ GRR
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTH-HKNLVRLL 553
+G+G+ G+V++ R + T IAVK++ + ++ N+ + +L ++ ++H +V+
Sbjct: 33 MGSGTCGQVWKM--RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
G + ELM ++ + + + L YL E+ +I
Sbjct: 91 GTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVI 147
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE-----W 668
H D+KP N+L LD K+ DFGIS L + G Y+APE
Sbjct: 148 HRDVKPSNIL-----LDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICGR 694
+ DV+S G+ L+E+ G+
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 38/221 (17%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--------DIEKTNEEFMTELKIIGR 543
SK +G+G+ G+V + T ++A+K + K TE++I+ +
Sbjct: 14 MSKTLGSGACGEVKLAFE--RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 544 THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV--------EIAL 595
+H ++++ F + + +V ELM G L + + V
Sbjct: 72 LNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV---------VGNKRLKEATCKLYFY 121
Query: 596 GVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDT 655
+ + YLHE IIH D+KP+NVLL + D KI+DFG SK+L +
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSLMRTL 176
Query: 656 NMRGTMGYVAPEWLRNV---PVTTKVDVFSFGVMLLEIICG 693
GT Y+APE L +V VD +S GV+L + G
Sbjct: 177 C--GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-25
Identities = 53/299 (17%), Positives = 99/299 (33%), Gaps = 64/299 (21%)
Query: 495 LVGTGSSGKVYRGI-LRLKDTQIEIAVKKLEKDIEKTNEEFMT----ELKIIGRTHHKNL 549
+ G G +Y + + + +K L + + E E + + H ++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPV--VLKGL---VHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 550 VRLLGFCSEEDKRL-----LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYL 604
V++ F D+ +V E + +L GQ+ + + L + L YL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYL 198
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR-GTMGY 663
H +++ D+KP+N++L T K+ D G + GT G+
Sbjct: 199 HSI---GLVYNDLKPENIML------TEEQLKLIDLGAVSRI------NSFGYLYGTPGF 243
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723
APE +R P T D+++ G L +
Sbjct: 244 QAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN------------------------- 277
Query: 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-SMKKVIHMLEGTLEVGMPP 781
V PE L+ ++ + PDP R + +++ L G L +
Sbjct: 278 ---GRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQ 333
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 44/225 (19%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--------DIEKTNEEFMTELKIIGR 543
++G G S V R + + T E AVK +E +E+ E E I+ +
Sbjct: 98 PKDVIGRGVSSVVRRCVH--RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 544 -THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV--------EIA 594
H +++ L+ LV++LM G L ++L ++V I
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---------TEKVALSEKETRSIM 206
Query: 595 LGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD 654
+ + +LH I+H D+KP+N+L LD N ++SDFG S L + +
Sbjct: 207 RSLLEAVSFLHAN---NIVHRDLKPENIL-----LDDNMQIRLSDFGFSCHLEPGEKLRE 258
Query: 655 TNMRGTMGYVAPEWLRNVPVTT------KVDVFSFGVMLLEIICG 693
+ GT GY+APE L+ T +VD+++ GV+L ++ G
Sbjct: 259 --LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK------DIEKTNEEFMTELKIIGRTH 545
+ +G+G V + R K T ++ A K ++K + E+ E+ I+
Sbjct: 15 TGEELGSGQFAVVKKC--REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 546 HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI-ALGVAR----G 600
H N++ L + +L+ EL+ G L +FL + E A + G
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT------EEEATEFLKQILNG 126
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT 660
+ YLH QI H D+KP+N++L + + + KI DFG++ ++ + + GT
Sbjct: 127 VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRI-KIIDFGLAHKIDFGNEFKN--IFGT 180
Query: 661 MGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
+VAPE + P+ + D++S GV+ ++ G
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 38/217 (17%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
K++G GS G VY+ +L D+ +A+KK+ +D N EL+I+ + H N+VRL
Sbjct: 60 KVIGNGSFGVVYQA--KLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIVRLR 113
Query: 554 G-FCSEEDKRL-----LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGV---ARGLLYL 604
F S +K+ LV + +P T+ H + + + + L + R L Y+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
H I H DIKPQN+LLD T + K+ DFG +K L + + Y+
Sbjct: 173 HSF---GICHRDIKPQNLLLDPDT----AVLKLCDFGSAKQLVRGEPNVS--------YI 217
Query: 665 ------APEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
APE + T+ +DV+S G +L E++ G+
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR-THHKNLVR 551
K +G GS + + K + AVK + K +E E+ + H N+V+
Sbjct: 16 DKPLGEGSFSICRKCVH--KKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVK 70
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGW---VQRVEIALGVARGLLYLHEEC 608
L ++ LV EL+ G L F ++ + I + + ++H+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDV- 125
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
++H D+KP+N+L + N KI DFG ++L D T T+ Y APE
Sbjct: 126 --GVVHRDLKPENLLF--TDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPEL 180
Query: 669 LRNVPVTTKVDVFSFGVMLLEIICG 693
L D++S GV+L ++ G
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSG 205
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 46/225 (20%), Positives = 87/225 (38%), Gaps = 32/225 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR-THHKNLVRL 552
+++ G VY + + E A+K+L + E+ N + E+ + + + H N+V+
Sbjct: 34 RVLAEGGFAFVYEA--QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 553 LGFCSEEDKR--------LLVYELMPNGTLSNFLFHEGQRPGWVQRV-EIALGVARGLLY 603
S + LL+ EL + E + P V +I R + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT---------- 653
+H + IIH D+K +N+L L K+ DFG + ++ +
Sbjct: 152 MHR-QKPPIIHRDLKVENLL-----LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 654 -DTNMRGTMGYVAPE---WLRNVPVTTKVDVFSFGVMLLEIICGR 694
+ T Y PE N P+ K D+++ G +L + +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 39/217 (17%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
K++G GS G V++ +L ++ E+A+KK+ +D N EL+I+ H N+V L
Sbjct: 46 KVIGNGSFGVVFQA--KLVESD-EVAIKKVLQDKRFKN----RELQIMRIVKHPNVVDLK 98
Query: 554 G-FCSEEDKRL-----LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGV---ARGLLYL 604
F S DK+ LV E +P T+ H + + + I L + R L Y+
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
H I H DIKPQN+LLD + + K+ DFG +K+L + Y+
Sbjct: 158 HSI---GICHRDIKPQNLLLDPPS----GVLKLIDFGSAKILIAGEPNVS--------YI 202
Query: 665 ------APEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
APE + TT +D++S G ++ E++ G+
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
++ G G+ G V G + K T + +A+KK+ +D N E ++ + HH N+V+L
Sbjct: 29 RMAGQGTFGTVQLG--KEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQ 85
Query: 554 ------GFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGV---ARGLLY 603
G D L +V E +P+ TL + +R + I + + R +
Sbjct: 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
LH + H DIKP NVL++ K+ DFG +K L+ + Y
Sbjct: 145 LHLPS-VNVCHRDIKPHNVLVNEADGTL----KLCDFGSAKKLSPSEPNVA--------Y 191
Query: 664 V------APEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
+ APE + TT VD++S G + E++ G
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN---EEFMTELKIIGRTHHKNLVRL 552
+G+G++ V + ++A+K++ ++EK +E + E++ + + HH N+V
Sbjct: 23 IGSGATAVVQAAYC--APKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV----EIAL---GVARGLLYLH 605
+D+ LV +L+ G++ + + H + V IA V GL YLH
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM-G-- 662
+ IH D+K N+LL + +I+DFG+S L T +R T G
Sbjct: 139 KN---GQIHRDVKAGNILLG-----EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 663 -YVAPEWL-RNVPVTTKVDVFSFGVMLLEIICGR 694
++APE + + K D++SFG+ +E+ G
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 35/234 (14%)
Query: 479 EFTFQELQEATKGFSKL--VGTGSSGKVYRGILRLKDTQIEIAVK--KLEKDIEKTNEEF 534
E L++ F + VG G+ G+VY+G R T A+K + D E EE
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVTGDEE---EEI 67
Query: 535 MTELKIIGRT-HHKNLVRLLG------FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGW 587
E+ ++ + HH+N+ G +D+ LV E G++++ + + +
Sbjct: 68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNT 125
Query: 588 VQRVEIAL---GVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
++ IA + RGL +LH+ ++IH DIK QNVL L N K+ DFG+S
Sbjct: 126 LKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVL-----LTENAEVKLVDFGVSA 177
Query: 645 LLNKDQTRTDTNMRGTMGYVAPE-----WLRNVPVTTKVDVFSFGVMLLEIICG 693
L++ R +T GT ++APE + K D++S G+ +E+ G
Sbjct: 178 QLDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR-THHKNLVRL 552
++G G+ +V I T E AVK +EK E++++ + H+N++ L
Sbjct: 19 DVLGEGAHARVQTCIN--LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGW---VQRVEIALGVARGLLYLHEECE 609
+ F EED+ LV+E M G++ + ++ + VA L +LH +
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK-- 130
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR------GTMGY 663
I H D+KP+N+L + + KI DF + + + + + G+ Y
Sbjct: 131 -GIAHRDLKPENILC--EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 664 VAPEWLRNVPVTTK-----VDVFSFGVMLLEIICG 693
+APE + D++S GV+L ++ G
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKN 548
+ KL+G G+ GKV +++ K T A+K L+K++ +E +TE +++ + H
Sbjct: 152 YLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 549 LVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYL 604
L L + + RL V E G L L E R EI L YL
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LDYL 264
Query: 605 HEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
H E +++ D+K +N++LD + KI+DFG+ K KD T GT Y+
Sbjct: 265 HSEKN--VVYRDLKLENLMLD-----KDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 316
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
APE L + VD + GV++ E++CGR
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 38/211 (18%), Positives = 71/211 (33%), Gaps = 25/211 (11%)
Query: 497 GTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHKNLVRLLG 554
G V R K T + V++ LE + EL + +H N+V
Sbjct: 36 GFEDLMTVNLA--RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93
Query: 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEECETQ 611
+++ +V M G+ + + + + IA GV + L Y+H
Sbjct: 94 TFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYIHHM---G 148
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV------A 665
+H +K ++L + + +S + + R V +
Sbjct: 149 YVHRSVKASHIL-----ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 666 PEWLR--NVPVTTKVDVFSFGVMLLEIICGR 694
PE L+ K D++S G+ E+ G
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEE--FMTELKIIGRTHHKN 548
K +GTGS G+V +++ K++ A+K L+K + K + + E +I+ +
Sbjct: 45 RIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR---VEIALGVARGLLYLH 605
LV+L + +V E + G + + L G+ R +I L YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+I+ D+KP+N+L+D Y+ +++DFG +K + + RT T + GT +A
Sbjct: 159 SL---DLIYRDLKPENLLID----QQGYI-QVTDFGFAK---RVKGRTWT-LCGTPEALA 206
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
PE + + VD ++ GV++ E+ G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 6e-23
Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEE--FMTELKIIGRTHHKN 548
+ +GTGS G+V+ ++R + A+K L+K+ + + + E ++ H
Sbjct: 10 ILRTLGTGSFGRVH--LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLH 605
++R+ G + + ++ + + G L + L + P V + E+ L L YLH
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEYLH 123
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+ II+ D+KP+N+LLD ++ KI+DFG +K T T + GT Y+A
Sbjct: 124 SK---DIIYRDLKPENILLD----KNGHI-KITDFGFAK---YVPDVTYT-LCGTPDYIA 171
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
PE + P +D +SFG+++ E++ G
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-23
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKN 548
+ KL+G G+ GKV ++R K T A+K L K++ +E +TE +++ T H
Sbjct: 9 YLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 549 LVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRV-----EIALGVARGLL 602
L L + + RL V E G L L E +R EI L
Sbjct: 67 LTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGAEIVSA----LE 119
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
YLH +++ DIK +N++LD + KI+DFG+ K D T GT
Sbjct: 120 YLHSR---DVVYRDIKLENLMLD-----KDGHIKITDFGLCKEGISDGATMKT-FCGTPE 170
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y+APE L + VD + GV++ E++CGR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 496 VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGRTHHKNLVRL 552
+G GS G VY R +A+KK+ +++NE++ + E++ + + H N ++
Sbjct: 62 IGHGSFGAVYFA--RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIAL---GVARGLLYLHEECE 609
G E LV E H+ +Q VEIA G +GL YLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHSH-- 173
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE-- 667
+IH D+K N+L L + K+ DFG + ++ + GT ++APE
Sbjct: 174 -NMIHRDVKAGNIL-----LSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVI 222
Query: 668 -WLRNVPVTTKVDVFSFGVMLLEIICG 693
+ KVDV+S G+ +E+
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 27/210 (12%)
Query: 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRL 552
+++G G +GKV + T + A+K L K +E + G ++V +
Sbjct: 34 KQVLGLGVNGKVLECFH--RRTGQKCALKLLYD-SPKARQEVDHHWQASG---GPHIVCI 87
Query: 553 LGFCSEEDKR----LLVYELMPNGTLSNFLFHEGQRPGWVQRVE-----IALGVARGLLY 603
L L++ E M G L F Q G E I + + +
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
LH I H D+KP+N+L K + + + K++DFG +K ++ +T T Y
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSK--EKDAVLKLTDFGFAKETTQNALQT---PCYTPYY 195
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
VAPE L D++S GV++ ++CG
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 6e-22
Identities = 45/262 (17%), Positives = 96/262 (36%), Gaps = 48/262 (18%)
Query: 524 EKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQ 583
+ +++ + KN V L S + + +L L +++ +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRR 155
Query: 584 RPGWVQRVEIALGVAR----GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639
+ + L + + +LH + ++H D+KP N+ + + K+ D
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFT-----MDDVVKVGD 207
Query: 640 FGISKLLNKDQTRTDTNMR-----------GTMGYVAPEWLRNVPVTTKVDVFSFGVMLL 688
FG+ +++D+ GT Y++PE + + KVD+FS G++L
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 689 EIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAM 748
E++ E +++D + RNL+ P + + ++ + M
Sbjct: 268 ELLYS---------FSTQMERVRIITD--V-----RNLKF-----PLLFTQ--KYPQEHM 304
Query: 749 VGLWCNHPDPNLRPSMKKVIHM 770
+ P P RP +I
Sbjct: 305 MVQDMLSPSPTERPEATDIIEN 326
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-22
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
S+++G G +GKV + K TQ + A+K L+ K E + ++VR
Sbjct: 66 TSQVLGLGINGKVLQIFN--KRTQEKFALKMLQD-CPKARREVELHWRASQ---CPHIVR 119
Query: 552 LLGFC----SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVE-----IALGVARGLL 602
++ + L+V E + G L F Q G E I + +
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
YLH I H D+KP+N+L K + K++DFG +K + T T
Sbjct: 176 YLHSI---NIAHRDVKPENLLYTSKRPNAIL--KLTDFGFAKETTSHNSLTT--PCYTPY 228
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
YVAPE L D++S GV++ ++CG
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 9e-22
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 492 FSKLVGTGSSGKVY--RGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHK 547
K++G GS GKV+ + I D + A+K L+K + E I+ +H
Sbjct: 28 LLKVLGQGSFGKVFLVKKI-SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 548 NLVRLLGFCS--EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV-----EIALGVARG 600
+V+L + E K L+ + + G L L E + V E+AL
Sbjct: 87 FIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT--EEDVKFYLAELALA---- 138
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT 660
L +LH II+ D+KP+N+LLD K++DFG+SK + + + GT
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLD-----EEGHIKLTDFGLSKESIDHEKKAYS-FCGT 189
Query: 661 MGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
+ Y+APE + T D +SFGV++ E++ G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRL 552
+ +G G+ G+V + T+ +AVK ++ E E+ I +H+N+V+
Sbjct: 13 QTLGEGAYGEVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLHEECE 609
G E + + L E G L + + + P + ++ GV YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI-- 124
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR---GTMGYVAP 666
I H DIKP+N+L LD KISDFG++ + + + GT+ YVAP
Sbjct: 125 -GITHRDIKPENLL-----LDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAP 176
Query: 667 EWLRNVPVT-TKVDVFSFGVMLLEIICGR 694
E L+ VDV+S G++L ++ G
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 41/221 (18%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTE-----------LKIIG 542
L+G G G V+ G ++++A+K + + + L +G
Sbjct: 37 PLLGKGGFGTVFAG--HRLTDRLQVAIKVIPR--NRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 543 RTH-HKNLVRLLGFCSEEDKRLLVYEL-MPNGTLSNFLFHEGQ------RPGWVQRVEIA 594
H ++RLL + ++ +LV E +P L +++ +G R + Q
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ----- 147
Query: 595 LGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD 654
V + + H ++H DIK +N+L+DL+ K+ DFG LL D+ TD
Sbjct: 148 --VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA----KLIDFGSGALL-HDEPYTD 197
Query: 655 TNMRGTMGYVAPEWLRNVPVT-TKVDVFSFGVMLLEIICGR 694
+ GT Y PEW+ V+S G++L +++CG
Sbjct: 198 FD--GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 39/271 (14%)
Query: 444 ALLSGVAAIYYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEATKG-----FSKLVGT 498
LL + ++ A L + + D + + E L+E K++G
Sbjct: 16 PLLDLLLGVHQELGASELAQDKYVAD----FLQWAEPIVVRLKEVRLQRDDFEILKVIGR 71
Query: 499 GSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEE--FMTELKIIGRTHHKNLVRLLGF 555
G+ +V ++++K T A+K + K + K E F E ++ + + +L F
Sbjct: 72 GAFSEVA--VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-F 128
Query: 556 CSEEDKRL-LVYELMPNGTLSNFLFHEGQR--PGWVQ--RVEIALGVARGLLYLHEECET 610
+++ L LV E G L L G+R + EI + + +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVHRL--- 181
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
+H DIKP N+LLD +++DFG L D T GT Y++PE L+
Sbjct: 182 GYVHRDIKPDNILLD-----RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 671 NVPVTTK-------VDVFSFGVMLLEIICGR 694
V D ++ GV E+ G+
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 5e-21
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGR-THHK 547
F ++G GS GKV + K T AVK L+KD+ +++ M E +++
Sbjct: 345 FLMVLGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 548 NLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLY 603
L +L C + RL V E + G L + G+ EIA+G L +
Sbjct: 403 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFF 457
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
L + II+ D+K NV+LD + KI+DFG+ K D T T GT Y
Sbjct: 458 LQSK---GIIYRDLKLDNVMLD-----SEGHIKIADFGMCKENIWDGVTTKT-FCGTPDY 508
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
+APE + P VD ++FGV+L E++ G+
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 6e-21
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 34/217 (15%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEE--FMTELKIIGRTHHKNLV 550
K++G G+ G+V +++LK+ A+K L K + K E F E ++ K +
Sbjct: 80 KVIGRGAFGEVA--VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 551 RLLGFCSEEDKRL-LVYELMPNGTLSNFLFH----EGQRPGWVQRV---EIALGVARGLL 602
L + ++D L LV + G L L E + P + R E+ + +
Sbjct: 138 TLH-YAFQDDNNLYLVMDYYVGGDL---LTLLSKFEDRLPEEMARFYLAEMVIA----ID 189
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
+H+ +H DIKP N+L+D N +++DFG L +D T + GT
Sbjct: 190 SVHQL---HYVHRDIKPDNILMD-----MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 663 YVAPEWLRNVPVTTK-----VDVFSFGVMLLEIICGR 694
Y++PE L+ + D +S GV + E++ G
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-21
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 45/222 (20%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMT-----ELKIIGRTHHK 547
L+G+G G VY G + +A+K +EKD I E E+ ++ +
Sbjct: 49 PLLGSGGFGSVYSG--IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 548 --NLVRLLGFCSEEDKRLLVYEL-MPNGTLSNFLFHEGQRPGWVQRVEIALGVAR----- 599
++RLL + D +L+ E P L +F+ +R + +AR
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---------TERGALQEELARSFFWQ 157
Query: 600 ---GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN 656
+ + H ++H DIK +N+L+DL + K+ DFG LL DT
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL----KLIDFGSGALL------KDTV 204
Query: 657 MR---GTMGYVAPEWLRNVPVT-TKVDVFSFGVMLLEIICGR 694
GT Y PEW+R V+S G++L +++CG
Sbjct: 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGR-THHK 547
+++G GS KV ++RLK T A+K ++K++ +E+ TE + + ++H
Sbjct: 13 LLRVIGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 548 NLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGW--VQRV-----EIALGVAR 599
LV L C + + RL V E + G L QR + EI+L
Sbjct: 71 FLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLA--- 122
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG 659
L YLHE II+ D+K NVLLD + K++D+G+ K + T T G
Sbjct: 123 -LNYLHER---GIIYRDLKLDNVLLD-----SEGHIKLTDYGMCKEGLRPGDTTST-FCG 172
Query: 660 TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
T Y+APE LR VD ++ GV++ E++ GR
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 8e-21
Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 43/267 (16%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGR-THHK 547
+++G GS KV ++RLK T A++ ++K++ +E+ TE + + ++H
Sbjct: 56 LLRVIGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 548 NLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGW--VQRV-----EIALGVAR 599
LV L C + + RL V E + G L QR + EI+L
Sbjct: 114 FLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLA--- 165
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG 659
L YLHE II+ D+K NVLLD + K++D+G+ K + T T G
Sbjct: 166 -LNYLHER---GIIYRDLKLDNVLLD-----SEGHIKLTDYGMCKEGLRPGDTTST-FCG 215
Query: 660 TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR----RHIELSRVEEESEEV---DIV 712
T Y+APE LR VD ++ GV++ E++ GR ++ +E+ I+
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275
Query: 713 LSDWVISCMLSRN----LQVLVSHDPE 735
I LS L+ ++ DP+
Sbjct: 276 EKQIRIPRSLSVKAASVLKSFLNKDPK 302
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 492 FSKLVGTGSSGKVY--RGILRLKDTQIEIAVKKLEKD--IEKTNEEF--MTELKIIGRTH 545
+++G G GKV+ R + +T A+K L+K + + E I+
Sbjct: 21 LLRVLGKGGYGKVFQVRKV-TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 546 HKNLVRLLGFCS--EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV-----EIALGVA 598
H +V L + K L+ E + G L L EG EI++
Sbjct: 80 HPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFM--EDTACFYLAEISMA-- 133
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR 658
L +LH++ II+ D+KP+N++L+ K++DFG+ K D T T T
Sbjct: 134 --LGHLHQK---GIIYRDLKPENIMLN-----HQGHVKLTDFGLCKESIHDGTVTHT-FC 182
Query: 659 GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
GT+ Y+APE L VD +S G ++ +++ G
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK-DIEKTNEE--FMTELKIIGRTHHKNLV 550
K++G G+ G+V ++R K T+ A+K L K ++ K ++ F E I+ + +V
Sbjct: 75 KVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 551 RLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVAR--------GL 601
+L + ++D+ L +V E MP G L + + ++ AR L
Sbjct: 133 QLF-YAFQDDRYLYMVMEYMPGGDL----VN------LMSNYDVPEKWARFYTAEVVLAL 181
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
+H IH D+KP N+LLD + K++DFG +NK+ GT
Sbjct: 182 DAIHS---MGFIHRDVKPDNMLLD-----KSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 662 GYVAPEWLRNVPVTTK----VDVFSFGVMLLEIICGR 694
Y++PE L++ D +S GV L E++ G
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGR-THHK 547
F ++G GS GKV + K T AVK L+KD+ +++ M E +++
Sbjct: 24 FLMVLGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 548 NLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRV-----EIALGVARGL 601
L +L C + RL V E + G L + G+ EIA+G L
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK--EPHAVFYAAEIAIG----L 134
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
+L + II+ D+K NV+LD + KI+DFG+ K D T T GT
Sbjct: 135 FFLQSK---GIIYRDLKLDNVMLD-----SEGHIKIADFGMCKENIWDGVTTKT-FCGTP 185
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y+APE + P VD ++FGV+L E++ G+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRL 552
+ +G G+ G+V + T+ +AVK ++ E E+ I +H+N+V+
Sbjct: 13 QTLGEGAYGEVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLHEECE 609
G E + + L E G L + + + P + ++ GV YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI-- 124
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR---GTMGYVAP 666
I H DIKP+N+L LD KISDFG++ + + + GT+ YVAP
Sbjct: 125 -GITHRDIKPENLL-----LDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAP 176
Query: 667 EWLRNVPVT-TKVDVFSFGVMLLEIICGR 694
E L+ VDV+S G++L ++ G
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEE-FMTELKIIGRTHHKNLVR 551
K +G G+ KV L T E+A+K ++K + T+ + E++I+ +H N+V+
Sbjct: 21 KTIGKGNFAKVKLARHIL--TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLHEEC 608
L E L+ E G + ++L G+ R +I V Y H++
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCHQKR 134
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPE 667
I+H D+K +N+L LD + KI+DFG S G Y APE
Sbjct: 135 ---IVHRDLKAENLL-----LDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPE 183
Query: 668 WLRNVPVT-TKVDVFSFGVMLLEIICGR 694
+ +VDV+S GV+L ++ G
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 35/218 (16%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD----IEKTNEEFMTELKIIGRTHHKNL 549
L+G GS GKV +T AVK L+K I E++++ R HKN+
Sbjct: 11 DLLGEGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 550 VRLLGFCSEEDKR--LLVYELMPNGTLSNFLFH---EGQRPGWVQR---VEIALGVARGL 601
++L+ E+K+ +V E G + E + P ++ G+
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE--- 123
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR--- 658
YLH + I+H DIKP N+L L T KIS G+++ L D R
Sbjct: 124 -YLHSQG---IVHKDIKPGNLL-----LTTGGTLKISALGVAEAL--HPFAADDTCRTSQ 172
Query: 659 GTMGYVAPEWLRNVPV--TTKVDVFSFGVMLLEIICGR 694
G+ + PE + KVD++S GV L I G
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGR-THHK 547
F +++G GS GKV + R+K+T AVK L+KD+ +++ MTE +I+ +H
Sbjct: 27 FIRVLGKGSFGKVM--LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 548 NLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRV-----EIALGVARGL 601
L +L C + RL V E + G L + + R EI L
Sbjct: 85 FLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAEIISA----L 137
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
++LH++ II+ D+K NVLLD K++DFG+ K + T T GT
Sbjct: 138 MFLHDK---GIIYRDLKLDNVLLD-----HEGHCKLADFGMCKEGICNGVTTAT-FCGTP 188
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y+APE L+ + VD ++ GV+L E++CG
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 69/222 (31%), Positives = 99/222 (44%), Gaps = 46/222 (20%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEF--MTELKIIGR-THHK 547
F K++G GS GKV + R K ++ AVK L+K I K EE M+E ++ + H
Sbjct: 42 FLKVIGKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 548 NLVRLLGFCS--EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV-------------E 592
LV L S DK V + + G L +H +QR E
Sbjct: 100 FLVGL--HFSFQTADKLYFVLDYINGGEL---FYH-------LQRERCFLEPRARFYAAE 147
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
IA L YLH I++ D+KP+N+LLD + ++DFG+ K + +
Sbjct: 148 IASA----LGYLHSL---NIVYRDLKPENILLD-----SQGHIVLTDFGLCKENIEHNST 195
Query: 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
T T GT Y+APE L P VD + G +L E++ G
Sbjct: 196 TST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF---MTELKIIGR-THHK 547
K++G GS GKV+ + K T A+K L+KD+ +++ M E +++ H
Sbjct: 21 LHKMLGKGSFGKVF--LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 548 NLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRV-----EIALGVARGL 601
L + + + L V E + G L + + + R EI LG L
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD--LSRATFYAAEIILG----L 131
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
+LH + I++ D+K N+LLD + KI+DFG+ K +T+T GT
Sbjct: 132 QFLHSK---GIVYRDLKLDNILLD-----KDGHIKIADFGMCKENMLGDAKTNT-FCGTP 182
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y+APE L VD +SFGV+L E++ G+
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 55/249 (22%), Positives = 94/249 (37%), Gaps = 70/249 (28%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
K +GTGS G V ++ A+KK+ +D N E L I+ H N+++L+
Sbjct: 13 KTLGTGSFGIVCEV--FDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLV 66
Query: 554 -GFCSEEDKRL-------------------------------------LVYELMPNGTLS 575
F + D+ ++ E +P+ TL
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 576 NFLFHEGQRPGWVQRVEIALGV---ARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632
L + + I++ + R + ++H I H DIKPQN+L++ K
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNT-- 180
Query: 633 YMAKISDFGISKLLNKDQTRTDTNMRGTMGYV------APEWLRNVPV-TTKVDVFSFGV 685
K+ DFG +K L + Y+ APE + T +D++S G
Sbjct: 181 --LKLCDFGSAKKLIPSEPSVA--------YICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 686 MLLEIICGR 694
+ E+I G+
Sbjct: 231 VFGELILGK 239
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT----------ELKIIGR 543
+G+G+ G V+ K+ E+ VK ++K EK E+ E+ I+ R
Sbjct: 30 SPLGSGAFGFVWTA--VDKEKNKEVVVKFIKK--EKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 544 THHKNLVRLLGFCSEEDKRLLVYELMPNGT-LSNFLFHEGQRPGWVQRV---EIALGVAR 599
H N++++L + LV E +G L F+ + + ++ V
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG- 144
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRG 659
YL + IIH DIK +N++ + ++ K+ DFG + L + + T G
Sbjct: 145 ---YLRLKD---IIHRDIKDENIV-----IAEDFTIKLIDFGSAAYLERGK-LFYTFC-G 191
Query: 660 TMGYVAPEWLRNVPVT-TKVDVFSFGVMLLEIICGR 694
T+ Y APE L P +++++S GV L ++
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 8e-19
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTN--EEFMTELKIIGRTHHKNLV 550
+G G+ GKV G + T ++AVK L + I + + E++ + H +++
Sbjct: 17 DTLGVGTFGKVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLHEE 607
+L S +V E + G L +++ G+ R +I V Y H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCHRH 130
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAP 666
++H D+KP+NVL LD + AKI+DFG+S +++ + RT G+ Y AP
Sbjct: 131 M---VVHRDLKPENVL-----LDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAP 179
Query: 667 EWLRNVPVT-TKVDVFSFGVMLLEIICGR 694
E + +VD++S GV+L ++CG
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 26/206 (12%), Positives = 54/206 (26%), Gaps = 48/206 (23%)
Query: 495 LVGTGSSGKVYRGILRLKDTQI--EIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNL 549
G + ++ DT + ++A+ ++ + +E ++ + R +
Sbjct: 38 FHGGVPPLQFWQA----LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
R+L L+V E + G+L P V + +A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL 669
+ P V +S G L +
Sbjct: 149 -GVALSIDHPSRVR-------------VSIDGDVVL-------------AYPATMP---- 177
Query: 670 RNVPVTTKVDVFSFGVMLLEIICGRR 695
+ D+ G L ++ R
Sbjct: 178 ---DANPQDDIRGIGASLYALLVNRW 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 56/206 (27%), Positives = 82/206 (39%), Gaps = 21/206 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
K +G+G+ G R K T+ +AVK +E+ +E E+ H N+VR
Sbjct: 26 KDIGSGNFGVARLM--RDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFK 82
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLHEECET 610
++ E G L + + G+ R ++ GV+ Y H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YCHSM--- 135
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWL 669
QI H D+K +N LLD KI DFG SK ++ GT Y+APE L
Sbjct: 136 QICHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVL 189
Query: 670 RNVPVT-TKVDVFSFGVMLLEIICGR 694
DV+S GV L ++ G
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTN--EEFMTELKIIGRTHHKNLV 550
+G G+ GKV G L T ++AVK L + I + + E++ + H +++
Sbjct: 22 DTLGVGTFGKVKVGKHEL--TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLHEE 607
+L S +V E + G L +++ G+ R +I GV Y H
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCHRH 135
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAP 666
++H D+KP+NVL LD + AKI+DFG+S +++ + RT G+ Y AP
Sbjct: 136 M---VVHRDLKPENVL-----LDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAP 184
Query: 667 EWLRNVPVT-TKVDVFSFGVMLLEIICGR 694
E + +VD++S GV+L ++CG
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 492 FSKLVGTGSSGKVY--RGILRLKDTQIEIAVKKLEKD--IEKTN--EEFMTELKIIGRT- 544
K++GTG+ GKV+ R I DT A+K L+K ++K E TE +++
Sbjct: 58 LLKVLGTGAYGKVFLVRKI-SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 545 HHKNLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRV-----EIALGVA 598
LV L + + + +L L+ + + G L L + V EI L
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFT--EHEVQIYVGEIVLA-- 171
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR 658
L +LH+ II+ DIK +N+LLD +N ++DFG+SK D+T +
Sbjct: 172 --LEHLHKL---GIIYRDIKLENILLD-----SNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 659 GTMGYVAPEWLRNVPV--TTKVDVFSFGVMLLEIICGR 694
GT+ Y+AP+ +R VD +S GV++ E++ G
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 55/236 (23%), Positives = 89/236 (37%), Gaps = 52/236 (22%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMT---------------- 536
+G GS G V ++ A+K L K + +
Sbjct: 19 DEIGKGSYGVVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 537 ---------ELKIIGRTHHKNLVRLLG--FCSEEDKRLLVYELMPNGTLSNFLFH----E 581
E+ I+ + H N+V+L+ ED +V+EL+ G + E
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 582 GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641
Q + Q ++ G+ YLH + +IIH DIKP N+L + + KI+DFG
Sbjct: 137 DQARFYFQ--DLIKGIE----YLHYQ---KIIHRDIKPSNLL-----VGEDGHIKIADFG 182
Query: 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT---TKVDVFSFGVMLLEIICGR 694
+S GT ++APE L +DV++ GV L + G+
Sbjct: 183 VSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHK 547
+ K+ +G GS G V++ R +DT +A+KK + + + + E++++ + H
Sbjct: 5 YEKIGKIGEGSYGVVFKC--RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFL--FHEGQRPGWVQRVEIALGVARGLLYLH 605
NLV LL + + LV+E + T+ + L + G V+ I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKS--ITWQTLQAVNFCH 119
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+ IH D+KP+N+L + + + K+ DFG ++LL + + T Y +
Sbjct: 120 KH---NCIHRDVKPENIL-----ITKHSVIKLCDFGFARLLT-GPSDYYDDEVATRWYRS 170
Query: 666 PEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
PE L VDV++ G + E++ G
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 30/239 (12%)
Query: 463 KRRNYFDPNSMEINFREF-TFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVK 521
+ D + + F+ ++ L LVG GS G V + R KDT +A+K
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENL--------GLVGEGSYGMVMKC--RNKDTGRIVAIK 56
Query: 522 KLEKDIEKTNEEFMT--ELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL- 578
K + + + + E+K++ + H+NLV LL C ++ + LV+E + + T+ + L
Sbjct: 57 KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE 115
Query: 579 -FHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK-TLDTNYMAK 636
F G VQ+ + G+ + H IIH DIKP+N+L+ + K
Sbjct: 116 LFPNGLDYQVVQK--YLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVV------K 164
Query: 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL-RNVPVTTKVDVFSFGVMLLEIICGR 694
+ DFG ++ L + T Y APE L +V VDV++ G ++ E+ G
Sbjct: 165 LCDFGFARTLA-APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 51/240 (21%), Positives = 100/240 (41%), Gaps = 27/240 (11%)
Query: 473 MEINFREFTFQELQEATKGFSKL---VGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IE 528
M+ +F+ E + F VG G+ G VY+ + + A+K++E I
Sbjct: 3 MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 62
Query: 529 KTNEEFMTELKIIGRTHHKNLVRLLG-FCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPG 586
+ + L+ + H N++ L F S D+++ L+++ + L + +
Sbjct: 63 MSACREIALLREL---KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKA 118
Query: 587 WVQRVEIALGVA--------RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638
+ V++ G+ G+ YLH ++H D+KP N+L+ KI+
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVM-GEGPERGRVKIA 174
Query: 639 DFGISKLLNKDQTRTDTNMRG---TMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
D G ++L N + ++ T Y APE L T +D+++ G + E++
Sbjct: 175 DMGFARLFNSP-LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 50/224 (22%), Positives = 92/224 (41%), Gaps = 39/224 (17%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKII-----------G 542
+ +G G V+ + +A+K + + + E E+K++
Sbjct: 25 RKLGWGHFSTVWLA--KDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 543 RTHHKNLVRLLG---FCSEEDKRL-LVYELM-PNGTLSNFLFHEGQRPGWVQRV-EIALG 596
++++LL + +V+E++ N L + R + V +I+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKKYEHRGIPLIYVKQISKQ 139
Query: 597 VARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMA-KISDFGISKLLNKD-----Q 650
+ GL Y+H C IIH DIKP+NVL+++ N + KI+D G + ++ Q
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 651 TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
TR Y +PE L P D++S ++ E+I G
Sbjct: 198 TRE---------YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT-----ELKIIGRTHHKN 548
+ +G GS GKV TQ ++A+K + + + + M E+ + H +
Sbjct: 15 ETLGEGSFGKVKLA--THYKTQQKVALKFISR--QLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV---EIALGVARGLLYLH 605
+++L + ++V E G L +++ + + R +I + Y H
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH 125
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYV 664
I+H D+KP+N+L LD N KI+DFG+S ++ +T G+ Y
Sbjct: 126 RHK---IVHRDLKPENLL-----LDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 174
Query: 665 APEWLRNVPVT-TKVDVFSFGVMLLEIICGR 694
APE + +VDV+S G++L ++ GR
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 46/209 (22%), Positives = 91/209 (43%), Gaps = 15/209 (7%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHK 547
+ ++ +G G+ G+VY+ T +A+K+ LE + E + E+ ++ H+
Sbjct: 36 YRRITKLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQ-RPGWVQRVEIALGVARGLLYLHE 606
N++ L + L++E N L ++ ++ + G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKS--FLYQLINGVNFCHS 150
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAP 666
+ +H D+KPQN+LL + + KI DFG+++ R T+ T+ Y P
Sbjct: 151 R---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEIITLWYRPP 206
Query: 667 EWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
E L +T VD++S + E++
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.4 bits (189), Expect = 8e-16
Identities = 42/287 (14%), Positives = 82/287 (28%), Gaps = 33/287 (11%)
Query: 18 YGLHGQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYL----LGIWFDKIPEK 73
+G + + +++AG LSP+ F G L + +W +
Sbjct: 7 IPFNGVGTSVLPAYQTLSAGQ--YLLSPNQRFKLLLQGD-GNLVIQDNGATVWVANEQQP 63
Query: 74 TLVWAADRDSPA-----EAGSKITLTNDGKLLLTYFNGSVQQIYSGAASLALMQNDGNFV 128
R+ A + + N + + ++Q+DGN V
Sbjct: 64 FSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIV 123
Query: 129 LKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLS 188
L ++ + + +L G +L Y G L Q DGNLV
Sbjct: 124 LVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV----YGAGASKLVFQGDGNLVA- 178
Query: 189 AYHFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDY-YHRAT 247
Y W GT V +F + + + ++ + T +
Sbjct: 179 -YGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWH------SHTGGHASAVLR 231
Query: 248 IDGHGNFQQFAYHKST---SSRWTRVWRAVNDPCIVNCICGVYGMCT 291
+ +G+ + + +R +N + T
Sbjct: 232 LQANGSIA--ILDEKPVWARFGFQPTYRH---IRKINPDQKPIDIWT 273
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.3 bits (116), Expect = 2e-06
Identities = 19/163 (11%), Positives = 34/163 (20%), Gaps = 11/163 (6%)
Query: 134 SAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFA 193
T + Q L G+ L S + + L +Q DGNLV+
Sbjct: 3 GRTRIPFNGVGTSVLPAYQTLSAGQYLLSPN--------QRFKLLLQGDGNLVIQDNGAT 54
Query: 194 DPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGN 253
W + ++ D + D
Sbjct: 55 ---VWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNR 111
Query: 254 FQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNE 296
+ P I + + + +E
Sbjct: 112 THLVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSE 154
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 46/258 (17%), Positives = 91/258 (35%), Gaps = 67/258 (25%)
Query: 461 LIKRRNYFDPNSMEINFREFTFQELQEATKGFSKL--VGTGSSGKVYRGILRLKDTQIEI 518
+ R Y+D S + + + + +G G +V+ I ++
Sbjct: 16 THRPREYWDYESHVVEW---------GNQDDYQLVRKLGRGKYSEVFEAINI--TNNEKV 64
Query: 519 AVKKLEKDIEKTNEEFMTELKIIGR-THHKNLVRLLG-FCSEEDKR--LLVYELMPN--- 571
VK L+ +K + E+KI+ N++ L + L+ +
Sbjct: 65 VVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK 121
Query: 572 ---GTLSN----FLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLL 624
TL++ F +E + + L Y H I+H D+KP NV++
Sbjct: 122 QLYQTLTDYDIRFYMYE---------------ILKALDYCHSM---GIMHRDVKPHNVMI 163
Query: 625 DLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV------APEWLRNVPV-TTK 677
D + ++ D+G+++ + Q V PE L + +
Sbjct: 164 DHEHRKL----RLIDWGLAEFYHPGQEYN--------VRVASRYFKGPELLVDYQMYDYS 211
Query: 678 VDVFSFGVMLLEIICGRR 695
+D++S G ML +I +
Sbjct: 212 LDMWSLGCMLASMIFRKE 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKK--LEKDIEKTNEEFMTELKIIGRTHHK 547
+ KL +G G+ G V++ + ++T +A+K+ L+ D E + E+ ++ HK
Sbjct: 4 YEKLEKIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQR--PGWVQRVEIALGVARGLLYLH 605
N+VRL + K LV+E L + P V+ + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKS--FLFQLLKGLGFCH 118
Query: 606 EECETQIIHCDIKPQNVLLDLK-TLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
++H D+KPQN+L++ L K+++FG+++ R + T+ Y
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGEL------KLANFGLARAFG-IPVRCYSAEVVTLWYR 168
Query: 665 APEWLRNVPV-TTKVDVFSFGVMLLEIICGRR 695
P+ L + +T +D++S G + E+ R
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVR 551
K +G+G+ G V + +A+KKL + + EL ++ +HKN++
Sbjct: 31 KPIGSGAQGIVCAAYDA--ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 552 LLG-FCSEEDKRL-----LVYELMP---NGTLSNFLFHEGQRPGWVQRVEIALGVARGLL 602
LL F ++ +V ELM + L HE Q + G+
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ-------MLCGIK 141
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
+LH IIH D+KP N+++ ++ KI DFG+++ T T
Sbjct: 142 HLHS---AGIIHRDLKPSNIVVK-----SDCTLKILDFGLARTAGTSFMMTPY--VVTRY 191
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y APE + + VD++S G ++ E+I G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 8e-15
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEI-AVKK--LEKDIEKTNEEFMTELKIIGRTHH 546
+ L +G G+ G VY+ ++ E A+KK LEK+ E + E+ I+ H
Sbjct: 4 YHGLEKIGEGTYGVVYKA----QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
N+V+L + + +LV+E + L L V L + G+ Y H+
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 607 ECETQIIHCDIKPQNVLLDLK-TLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+++H D+KPQN+L++ + L KI+DFG+++ R T+ T+ Y A
Sbjct: 119 R---RVLHRDLKPQNLLINREGEL------KIADFGLARAFG-IPVRKYTHEIVTLWYRA 168
Query: 666 PEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
P+ L +T +D++S G + E++ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEI-AVKK--LEKDIEKTNEEFMTELKIIGRTHH 546
+ KL VG G+ G VY+ KD+Q I A+K+ L+ + E + E+ ++ HH
Sbjct: 23 YQKLEKVGEGTYGVVYKA----KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 547 KNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQR--PGWVQRVEIALGVARGLLYL 604
N+V L+ E LV+E M L L ++ + RG+ +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKI--YLYQLLRGVAHC 135
Query: 605 HEECETQIIHCDIKPQNVLLDLK-TLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
H+ +I+H D+KPQN+L++ L K++DFG+++ R+ T+ T+ Y
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGAL------KLADFGLARAFG-IPVRSYTHEVVTLWY 185
Query: 664 VAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
AP+ L +T VD++S G + E+I G+
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 27/215 (12%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF-MT---ELKIIGRTH 545
F +L +G G+ VY+G K T + +A+K+++ D E E T E+ ++
Sbjct: 7 FKQLEKLGNGTYATVYKG--LNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELK 61
Query: 546 HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFL--FHEGQRPGWVQRVEIALGVA---RG 600
H+N+VRL E+K LV+E M N L ++ G P ++ + +G
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 601 LLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGT 660
L + HE +I+H D+KPQN+L++ + K+ DFG+++ T ++ T
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQ-----LKLGDFGLARAFG-IPVNTFSSEVVT 171
Query: 661 MGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
+ Y AP+ L +T +D++S G +L E+I G+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE-----FMTELKIIGRT 544
+ KL +G G+ VY+G + K T +A+K++ + +EE + E+ ++
Sbjct: 4 YIKLDKLGEGTYATVYKG--KSKLTDNLVALKEIRLE----HEEGAPCTAIREVSLLKDL 57
Query: 545 HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQR--PGWVQRVEIALGVARGLL 602
H N+V L E LV+E + L +L G V+ L RGL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL--LRGLA 114
Query: 603 YLHEECETQIIHCDIKPQNVLLDLK-TLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
Y H + +++H D+KPQN+L++ + L K++DFG+++ + T+T N T+
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGEL------KLADFGLARAKS-IPTKTYDNEVVTL 164
Query: 662 GYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
Y P+ L +T++D++ G + E+ GR
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE---FMT--ELKIIGRT 544
+ KL +G G VY+ R K+T +A+KK++ ++ E+K++
Sbjct: 12 YEKLDFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 545 HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQR--PGWVQRVEIALGVARGLL 602
H N++ LL + LV++ M L + P ++ L +GL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKA--YMLMTLQGLE 126
Query: 603 YLHEECETQIIHCDIKPQNVLLDLK-TLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
YLH+ I+H D+KP N+LLD L K++DFG++K R T+ T
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVL------KLADFGLAKSFG-SPNRAYTHQVVTR 176
Query: 662 GYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
Y APE L + VD+++ G +L E++
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 49/212 (23%), Positives = 83/212 (39%), Gaps = 49/212 (23%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR-THHKNLV 550
S+++G G +GKV + K TQ + A+K L+ + E+++ R + ++V
Sbjct: 22 TSQVLGLGINGKVLQIFN--KRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIV 74
Query: 551 RLLGFC----SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVE-----IALGVARGL 601
R++ + L+V E + G L F Q G E I + +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
YLH I H D+KP+N+L K + K++DFG
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAIL--KLTDFGF------------------- 166
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
A E D++S GV++ ++CG
Sbjct: 167 ---AKETTGE-KYDKSCDMWSLGVIMYILLCG 194
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 8e-14
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVR 551
K +G+G+ G V + +A+KKL + + EL ++ +HKN++
Sbjct: 68 KPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 552 LL-----GFCSEEDKRL-LVYELMP---NGTLSNFLFHEGQRPGWVQRVEIALGVARGLL 602
LL EE + + LV ELM + L HE Q + G+
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ-------MLCGIK 178
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
+LH IIH D+KP N+++ ++ KI DFG+++ T T
Sbjct: 179 HLHS---AGIIHRDLKPSNIVVK-----SDCTLKILDFGLARTAGTSFMMTPY--VVTRY 228
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y APE + + VD++S G ++ E++ +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 50/239 (20%), Positives = 85/239 (35%), Gaps = 73/239 (30%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT-----------ELKIIG 542
+ + +GS G V G+ I +A+K++ + + E++++
Sbjct: 28 RFISSGSYGAVCAGVDS---EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84
Query: 543 RTHHKNLVRLLG----FCSEEDKRL-LVYELM----------PNGTLSN-----FLFHEG 582
HH N++ L F +L LV ELM +S F++H
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH-- 142
Query: 583 QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642
+ GL LHE ++H D+ P N+L L N I DF +
Sbjct: 143 --------------ILLGLHVLHE---AGVVHRDLHPGNIL-----LADNNDITICDFNL 180
Query: 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLR-------NVPVTTKVDVFSFGVMLLEIICGR 694
++ D +T YV W R T VD++S G ++ E+ +
Sbjct: 181 AREDTADANKTH--------YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 43/227 (18%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF-MT---ELKIIGRTH 545
+ KL +G G+ G+V++ R + T ++A+KK+ + EK E F +T E+KI+
Sbjct: 19 YEKLAKIGQGTFGEVFKA--RHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 546 HKNLVRLLGFCSEEDKRL--------LVYELMPN---GTLSN--FLFHEGQRPGWVQRVE 592
H+N+V L+ C + LV++ + G LSN F + +Q +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML- 133
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLK-TLDTNYMAKISDFGISKLLN---K 648
GL Y+H +I+H D+K NVL+ L K++DFG+++ +
Sbjct: 134 -----LNGLYYIHRN---KILHRDMKAANVLITRDGVL------KLADFGLARAFSLAKN 179
Query: 649 DQTRTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
Q TN T+ Y PE L +D++ G ++ E+
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 52/229 (22%), Positives = 91/229 (39%), Gaps = 64/229 (27%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVR 551
+ VG+G+ G V + T ++A+KKL + + EL+++ H+N++
Sbjct: 31 QPVGSGAYGAVCSAVDG--RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 552 LLG-FCSEEDKRL-----LVYELMP--------NGTLSN-----FLFHEGQRPGWVQRVE 592
LL F +E LV M + L ++
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ------------ 136
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
+ +GL Y+H IIH D+KP N+ ++ + KI DFG+++ + + T
Sbjct: 137 ----MLKGLRYIHA---AGIIHRDLKPGNLA-----VNEDCELKILDFGLARQADSEMT- 183
Query: 653 TDTNMRGTMGYVAPEWLR-------NVPVTTKVDVFSFGVMLLEIICGR 694
GYV W R + T VD++S G ++ E+I G+
Sbjct: 184 ---------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 47/219 (21%), Positives = 86/219 (39%), Gaps = 45/219 (20%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVR 551
VG+G+ G V I + + ++A+KKL + + EL ++ H+N++
Sbjct: 30 THVGSGAYGSVCSAIDK--RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 552 LL-----GFCSEEDKRL-LVYELMP---NGTLSNFLFHEGQRPGWVQRVEIALGVARGLL 602
LL LV M + E + Q + +GL
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ-------MLKGLK 140
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
Y+H ++H D+KP N+ ++ + KI DFG+++ + + T G
Sbjct: 141 YIHS---AGVVHRDLKPGNLA-----VNEDCELKILDFGLARHADAEMT----------G 182
Query: 663 YVAPEWLR-------NVPVTTKVDVFSFGVMLLEIICGR 694
YV W R + VD++S G ++ E++ G+
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 54/226 (23%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT----ELKIIGRTHHKNL 549
+G G+ G V ++ +A+KK+ ++ + E+KI+ R H+N+
Sbjct: 33 SYIGEGAYGMVCSAYD--NLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHENI 87
Query: 550 VRLLGF----CSEEDKRL-LVYELMP--------NGTLSN-----FLFHEGQRPGWVQRV 591
+ + E+ K + +V +LM LSN FL+
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ----------- 136
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651
+ RGL Y+H ++H D+KP N+L L+T KI DFG++++ + D
Sbjct: 137 -----ILRGLKYIHS---ANVLHRDLKPSNLL-----LNTTCDLKICDFGLARVADPDHD 183
Query: 652 RTD--TNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
T T T Y APE + N T +D++S G +L E++ R
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 51/221 (23%), Positives = 99/221 (44%), Gaps = 47/221 (21%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKII------GRTHHK 547
K++G GS G+V + K +A+K + ++ ++ + + E++I+ + +
Sbjct: 103 KVIGKGSFGQVVKAY-DHK-VHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 548 NLVRLLGF-------CSEEDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRV-EIALGVA 598
N++ +L C + +EL+ N L + + + V + A +
Sbjct: 160 NVIHMLENFTFRNHIC-------MTFELLSMN--LYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD-----QTRT 653
+ L LH+ +IIHCD+KP+N+L LK + + K+ DFG S ++ Q+R
Sbjct: 211 QCLDALHKN---RIIHCDLKPENIL--LKQQGRSGI-KVIDFGSSCYEHQRVYTYIQSRF 264
Query: 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y APE + +D++S G +L E++ G
Sbjct: 265 ---------YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 51/235 (21%), Positives = 97/235 (41%), Gaps = 63/235 (26%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT----ELKIIGRTHHKNL 549
K +G G +G V+ + D +A+KK I T+ + + E+KII R H N+
Sbjct: 17 KPLGCGGNGLVFSAVDN--DCDKRVAIKK----IVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 550 VRLLGFCSEEDKRL--------------LVYELMP--------NGTLSN-----FLFHEG 582
V++ +L +V E M G L F++
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY--- 127
Query: 583 QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642
Q + RGL Y+H ++H D+KP N+ ++ + + + KI DFG+
Sbjct: 128 ------Q-------LLRGLKYIHS---ANVLHRDLKPANLFINTE----DLVLKIGDFGL 167
Query: 643 SKLLNKDQTRTD--TNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
+++++ + + T Y +P L + T +D+++ G + E++ G+
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF-MT---E---LKIIG 542
+ + +G G+ GKV++ LK+ +A+K++ + E ++ E L+ +
Sbjct: 13 YECVAEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLE 69
Query: 543 RTHHKNLVRLL----GFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEI---A 594
H N+VRL ++ + +L LV+E + L+ +L + V I
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMM 126
Query: 595 LGVARGLLYLHEECETQIIHCDIKPQNVLLDLK-TLDTNYMAKISDFGISKLLNKDQTRT 653
+ RGL +LH ++H D+KPQN+L+ + K++DFG++++
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI------KLADFGLARI--YSFQMA 175
Query: 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
T++ T+ Y APE L T VD++S G + E+ +
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 50/221 (22%), Positives = 93/221 (42%), Gaps = 33/221 (14%)
Query: 492 FSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFM--------TELKII 541
+ + +G G+ G VY+ R + +A+K + + L+ +
Sbjct: 11 YEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 542 GRTHHKNLVRLL----GFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRPGWVQRVEI--- 593
H N+VRL+ ++ + ++ LV+E + L +L + P + I
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDL 125
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653
RGL +LH I+H D+KP+N+L+ K++DFG++++
Sbjct: 126 MRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG-----TVKLADFGLARI--YSYQMA 175
Query: 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
T + T+ Y APE L T VD++S G + E+ +
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 45/221 (20%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKII------GRTHHK 547
L+G GS G+V + R Q +A+K + K+ + + E++++
Sbjct: 60 SLIGKGSFGQVVKAYDR--VEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 548 NLVRLLGF-------CSEEDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRV-EIALGVA 598
+V L C LV+E++ N L + L + R + + A +
Sbjct: 117 YIVHLKRHFMFRNHLC-------LVFEMLSYN--LYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD-----QTRT 653
LL+L E IIHCD+KP+N+LL KI DFG S L + Q+R
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF 223
Query: 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y +PE L +P +D++S G +L+E+ G
Sbjct: 224 ---------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 46/220 (20%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVR 551
VG+G+ G V T + +AVKKL + + T EL+++ H+N++
Sbjct: 35 SPVGSGAYGSVCAAFDT--KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 552 LL-----GFCSEEDKRL-LVYELMP----NGTLSNFLFHEGQRPGWVQRVEIALGVARGL 601
LL EE + LV LM N L + + Q + RGL
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-------ILRGL 145
Query: 602 LYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661
Y+H IIH D+KP N+ ++ + KI DFG+++ + T
Sbjct: 146 KYIHS---ADIIHRDLKPSNLA-----VNEDCELKILDFGLARHTADEMT---------- 187
Query: 662 GYVAPEWLR-------NVPVTTKVDVFSFGVMLLEIICGR 694
GYVA W R + VD++S G ++ E++ GR
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 51/234 (21%), Positives = 94/234 (40%), Gaps = 63/234 (26%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL-----EKDIEKTNEEFMTELKIIGRTHHKN 548
L+G G+ G V + T +A+KK+ +T + E+KI+ H+N
Sbjct: 17 SLLGEGAYGVVCSATHK--PTGEIVAIKKIEPFDKPLFALRT----LREIKILKHFKHEN 70
Query: 549 LVRLLGF----CSEEDKRL-LVYELMP--------NGTLSN-----FLFHEGQRPGWVQR 590
++ + E + ++ ELM LS+ F++ Q
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY---------Q- 120
Query: 591 VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL--NK 648
R + LH + +IH D+KP N+L +++N K+ DFG+++++ +
Sbjct: 121 ------TLRAVKVLHG---SNVIHRDLKPSNLL-----INSNCDLKVCDFGLARIIDESA 166
Query: 649 DQTRTDTNMRGTM-GYV------APEWLRNVPV-TTKVDVFSFGVMLLEIICGR 694
T + M +V APE + + +DV+S G +L E+ R
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 46/203 (22%), Positives = 77/203 (37%), Gaps = 60/203 (29%)
Query: 591 VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650
+ + VA+G+ +L + IH D+ +N+LL + KI DFG+++ + KD
Sbjct: 196 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLS-----EKNVVKICDFGLARDIYKD- 246
Query: 651 TRTDTNMRGTMGYV-----APEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEE 705
+R + APE + + T + DV+SFGV+L EI
Sbjct: 247 ---PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------------- 288
Query: 706 SEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA------------MVGLWC 753
L + V D E L+ RM M+ W
Sbjct: 289 --------------FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW- 333
Query: 754 NHPDPNLRPSMKKVIHMLEGTLE 776
H +P+ RP+ +++ L L+
Sbjct: 334 -HGEPSQRPTFSELVEHLGNLLQ 355
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 492 FSKLVGTGSSGKVYRGI---LRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKI-IGRTHH 546
K +G G+ G+V + T +AVK L++ + M+ELKI I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 547 KNLVRLLGFCSEEDKRLLV-YELMPNGTLSNFL 578
N+V LLG C++ L+V E G LS +L
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 49/245 (20%), Positives = 91/245 (37%), Gaps = 69/245 (28%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVR 551
L+G GS G VY + +T+ +A+KK+ + E + E+ I+ R ++R
Sbjct: 32 HLIGRGSYGYVYLAYDK--NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIR 89
Query: 552 LLGFCSEEDKRL-----LVYELMP---------NGTLSN-----FLFHEGQRPGWVQRVE 592
L +D +V E+ L+ L++
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN------------ 137
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
+ G ++HE + IIH D+KP N L L+ + K+ DFG+++ +N ++
Sbjct: 138 ----LLLGENFIHE---SGIIHRDLKPANCL-----LNQDCSVKVCDFGLARTINSEKDT 185
Query: 653 TDTNMRGTM---------------GYV------APEWLRNVPV-TTKVDVFSFGVMLLEI 690
N +V APE + T +D++S G + E+
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 691 ICGRR 695
+ +
Sbjct: 246 LNMLQ 250
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 50/246 (20%), Positives = 92/246 (37%), Gaps = 74/246 (30%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT--ELKIIGRTHHKNLVR 551
L+GTGS G V + + +A+KK+ + E + E+ I+ R +H ++V+
Sbjct: 59 HLIGTGSYGHVCEAYDK--LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVK 116
Query: 552 LLGFC----SEEDKRL-LVYELMP---------NGTLSN-----FLFHEGQRPGWVQRVE 592
+L E+ L +V E+ L+ L+
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY---------N--- 164
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS--------- 643
+ G+ Y+H I+H D+KP N L ++ + K+ DFG++
Sbjct: 165 ----LLVGVKYVHS---AGILHRDLKPANCL-----VNQDCSVKVCDFGLARTVDYPENG 212
Query: 644 ----------KLLNKDQTRTDTNMRGTM-GYV------APEWLRNVPV-TTKVDVFSFGV 685
+N N++ + G+V APE + T +DV+S G
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 686 MLLEII 691
+ E++
Sbjct: 273 IFAELL 278
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 49/234 (20%), Positives = 89/234 (38%), Gaps = 57/234 (24%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKII------GRTHHK 547
+G G+ GKV L + ++A+K + +++ K E E+ ++ + +
Sbjct: 25 GNLGEGTFGKVVE-CLDHARGKSQVALKII-RNVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 548 NLVRLLGF-------CSEEDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRV-EIALGVA 598
V + + C + +EL+ N FL +P + V +A +
Sbjct: 83 LCVLMSDWFNFHGHMC-------IAFELLGKN--TFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMA--------------KISDFGISK 644
L +LHE Q+ H D+KP+N+L +T Y +++DFG +
Sbjct: 134 HALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 645 LLNKD-----QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
++ TR Y PE + + DV+S G +L E G
Sbjct: 191 FDHEHHTTIVATRH---------YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 40/179 (22%), Positives = 64/179 (35%), Gaps = 56/179 (31%)
Query: 564 LVYELMPNG-TLSNFL--FHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQ 620
+V+E++ G L ++ + P + +I V +GL YLH +C +IIH DIKP+
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLDYLHTKC--RIIHTDIKPE 176
Query: 621 NVLLDLKTLDTNYMA--------------------------------------------K 636
N+LL + +A K
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR 695
I+D G + ++K T T Y + E L T D++S M E+ G
Sbjct: 237 IADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-10
Identities = 27/146 (18%), Positives = 42/146 (28%), Gaps = 35/146 (23%)
Query: 62 LLGIWFDKIPEKTLVWAADRDSPAEAGS-KITLTNDGKLLLTYFNGSV---QQIYSGAAS 117
+ D + L + + + D L+L N + G
Sbjct: 4 IFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGC 63
Query: 118 LALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTL 177
A++Q DG V+ + VW S A G+Y L
Sbjct: 64 RAVLQPDGVLVVITNENVTVWQS-------------------------PVAG-KAGHYVL 97
Query: 178 EMQADGNLVLSAYHFADPGYWYTGTV 203
+Q D N+V+ W T TV
Sbjct: 98 VLQPDRNVVIY-----GDALWATQTV 118
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 5e-07
Identities = 19/86 (22%), Positives = 31/86 (36%), Gaps = 5/86 (5%)
Query: 146 DTILPGQVLLT-GKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVT 204
+ I Q + L++ + T Y MQ D NLVL Y + W T T
Sbjct: 2 NIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVL--YD-NNNPIWATNTGG 58
Query: 205 L-NNVSLIFNQSAFMYLINSTGDNIF 229
L N + + +I + ++
Sbjct: 59 LGNGCRAVLQPDGVLVVITNENVTVW 84
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 69/242 (28%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT----ELKIIGR-THHKN 548
K +G G+ G V++ I + T +AVKK+ + N E+ I+ + H+N
Sbjct: 15 KKLGKGAYGIVWKSID--RRTGEVVAVKKIFDAFQ--NSTDAQRTFREIMILTELSGHEN 70
Query: 549 LVRLLG-FCSEEDKRL-LVYELMP--------NGTLSN-----FLFHEGQRPGWVQRVEI 593
+V LL ++ D+ + LV++ M L ++ Q
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY---------Q---- 117
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653
+ + + YLH ++H D+KP N+L L+ K++DFG+S+ + T
Sbjct: 118 ---LIKVIKYLHS---GGLLHRDMKPSNIL-----LNAECHVKVADFGLSRSFVNIRRVT 166
Query: 654 DTNMRGTM--------------GYV------APEWLRNVPV-TTKVDVFSFGVMLLEIIC 692
+ YV APE L T +D++S G +L EI+C
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 693 GR 694
G+
Sbjct: 227 GK 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 2e-10
Identities = 53/357 (14%), Positives = 113/357 (31%), Gaps = 97/357 (27%)
Query: 468 FDPNSMEINFRE------------FTFQELQEATKG-FSK-----LVGTGSS-GKVYR-- 506
F+ + +++ F +++Q+ K SK ++ + + R
Sbjct: 9 FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLF 68
Query: 507 GILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566
L K ++ V+K +++ + N +F+ I +++ + + + D+
Sbjct: 69 WTLLSKQEEM---VQKFVEEVLRINYKFLMS-PIKTEQRQPSMMTRM-YIEQRDR----- 118
Query: 567 ELMPNGTLSNFLFHEGQ--RPGWVQRVEIALGVARGLLYLHEECETQIIH----CDIKP- 619
L+++ Q V R++ L + + LL L + +I K
Sbjct: 119 -----------LYNDNQVFAKYNVSRLQPYLKLRQALLELRPA-KNVLIDGVLGSG-KTW 165
Query: 620 --QNVLLDLKTLDTNYMAKISDFGIS--KLLNKDQTRTDTNMRGTMGY-VAPEWLRNV-- 672
+V L K DF I L N + T M + Y + P W
Sbjct: 166 VALDVCLSYKVQCKM------DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 673 PVTTKVDVFSFGVMLLEIICGRRHIE-LSRVEEESEEVDIVLSD----WVI-----SC-- 720
K+ + S L ++ + + L +VL + SC
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCL-----------LVLLNVQNAKAWNAFNLSCKI 268
Query: 721 -MLSRNLQVL-------VSHDP--EVLSDLERFERMAMVGLWCNHPDPNLRPSMKKV 767
+ +R QV +H L E +++ + + +L +
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT 325
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 6e-05
Identities = 89/625 (14%), Positives = 178/625 (28%), Gaps = 201/625 (32%)
Query: 4 KRIVP---CVLTLILKFYGLHGQTSPNISL-GSSITAGSNTSWLSPSGDFAFGFYSLF-G 58
K V L L L + + N+ + G GS +W++ ++
Sbjct: 128 KYNVSRLQPYLKLRQALLEL--RPAKNVLIDG---VLGSGKTWVALDVCLSYKVQCKMDF 182
Query: 59 GLYLLGIWFDKIPE------KTLVWAADRD--SPAEAGSKITL-TNDGKLLLTYFNGSVQ 109
++ L + PE + L++ D + S ++ S I L + + L
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL--LKS 240
Query: 110 QIYSGAASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPG-QVLLTGKKLYSNSRGTA 168
+ Y L VL N +A W++F+ ++LLT + +
Sbjct: 241 KPY--ENCL--------LVLLNVQNAKAWNAFNL-------SCKILLT-----TRFKQVT 278
Query: 169 DYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTLNNVSLIFNQSAFM-YLINSTGDN 227
D+ + T ++L++ S+ L+
Sbjct: 279 DFLSAATTTH------------------------ISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 228 IFRLTRNVMT--PTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICG 285
L R V+T P + I + + W W+ VN + I
Sbjct: 315 PQDLPREVLTTNP----RRLSII-A-------ESIRDGLATWDN-WKHVNCDKLTTII-- 359
Query: 286 VYGMCTSSDNETVTCNCIPGYTPLNPSDVSEGCHPETVVNYCAETSSKNFTVEVMDDAGF 345
L P++ + + +V
Sbjct: 360 --ESS---------------LNVLEPAEYRK--------MF------DRLSV-------- 380
Query: 346 LFDNFAD-----LARV-SNVDVEGCRKAVMDDCYSLGASLVGSTCVKTRMPLLNARKSAS 399
F A L+ + +V V++ + L+ + S
Sbjct: 381 -FPPSAHIPTILLSLIWFDVIKSDVMV-VVNKLHKYS--------------LVEKQPKES 424
Query: 400 TKGMKAI-IKVPTKMSN-PSNH-------EGKKKNNFNSRLLLKI-GFIFSAICALLSGV 449
T + +I +++ K+ N + H K + + + + + +S I G
Sbjct: 425 TISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHI-----G- 478
Query: 450 AAIYYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGIL 509
++ L + + F +F F L+ K+ ++ IL
Sbjct: 479 ---HH------LKNIEHPERMTLFRMVFLDFRF--LE------QKIRHDSTAWNASGSIL 521
Query: 510 R-LKDTQIEIAVKKLEK---DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565
L+ +K + D + E + + +NL+ + LL
Sbjct: 522 NTLQQ------LKFYKPYICDNDPKYERLVNAILDFLPKIEENLIC------SKYTDLLR 569
Query: 566 YELMPNGTLSNFLFHEGQRPGWVQR 590
LM +F E + VQR
Sbjct: 570 IALMAE---DEAIFEEAHKQ--VQR 589
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 49/239 (20%), Positives = 92/239 (38%), Gaps = 63/239 (26%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR-----THHKN 548
+ +G G+ G+V D + AVK + ++I+K E I+ + ++ N
Sbjct: 41 RKMGDGTFGRVLLCQHI--DNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 549 LVRLLGF-------CSEEDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRV-EIALGVAR 599
+V+ G C L++E + P+ L + ++ + + + +
Sbjct: 98 IVKYHGKFMYYDHMC-------LIFEPLGPS--LYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 600 GLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMA--------------------KISD 639
L YL + + H D+KP+N+LLD + + + K+ D
Sbjct: 149 ALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 640 FGISKLLNKD-----QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
FG + + TR Y APE + N+ D++SFG +L E+ G
Sbjct: 206 FGCATFKSDYHGSIINTRQ---------YRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 49/234 (20%), Positives = 94/234 (40%), Gaps = 57/234 (24%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKII------GRTHHK 547
+G G+ GKV I K +AVK + K++++ E +E++++
Sbjct: 20 DTLGEGAFGKVVECI-DHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 548 NLVRLLGF-------CSEEDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRV-EIALGVA 598
V++L + C +V+EL+ + +F+ G P + + ++A +
Sbjct: 78 RCVQMLEWFEHHGHIC-------IVFELLGLS--TYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMA--------------KISDFGISK 644
+ + +LH ++ H D+KP+N+L Y K+ DFG +
Sbjct: 129 KSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 645 LLNKD-----QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG 693
++ TR Y APE + + + DV+S G +L+E G
Sbjct: 186 YDDEHHSTLVSTRH---------YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 5e-10
Identities = 20/113 (17%), Positives = 36/113 (31%), Gaps = 31/113 (27%)
Query: 90 KITLTNDGKLLLTYFNGSVQQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDFPTDTIL 149
+ + +D L+L N +G + + G V+KN + + VW
Sbjct: 24 DLVMQDDCNLVLYNGNWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWK---------- 73
Query: 150 PGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202
S ++ GNY + DG LV+ + P +
Sbjct: 74 ------------SGAQS----VKGNYAAVVHPDGRLVV--F---GPSVFKIDP 105
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 25/113 (22%), Positives = 40/113 (35%), Gaps = 21/113 (18%)
Query: 143 FPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202
T+ +L GQ L T L G++ L MQ D NLVL Y+ G W + T
Sbjct: 1 LGTNYLLSGQTLDTEGHL----------KNGDFDLVMQDDCNLVL--YN----GNWQSNT 44
Query: 203 VTLN-NVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNF 254
+ L + + N G +++ + + A + G
Sbjct: 45 ANNGRDCKLTLTDYGELVIKNGDGSTVWKSG----AQSVKGNYAAVVHPDGRL 93
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 8e-10
Identities = 23/100 (23%), Positives = 40/100 (40%), Gaps = 13/100 (13%)
Query: 109 QQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTA 168
+ + +G +MQ D N VL + + + W + D + G + + R
Sbjct: 14 EFLNNGRYVF-IMQEDCNLVLYDVDKPI-WATNTGGLDRRCHLSMQSDGNLVVYSPRNNP 71
Query: 169 DYST------GNYTLEMQADGNLVLSAYHFADPGYWYTGT 202
+++ GNY +Q D N+V+ Y W TGT
Sbjct: 72 IWASNTGGENGNYVCVLQKDRNVVI--Y---GTARWATGT 106
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 24/110 (21%), Positives = 38/110 (34%), Gaps = 18/110 (16%)
Query: 146 DTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTL 205
+ + G+ L G+ L + G Y MQ D NLVL Y P W T T L
Sbjct: 2 NILYSGETLSPGEFL----------NNGRYVFIMQEDCNLVL--YDVDKP-IWATNTGGL 48
Query: 206 N-NVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNF 254
+ L + + + + I+ T E+ + + N
Sbjct: 49 DRRCHLSMQSDGNLVVYSPRNNPIWASN----TGGENGNYVCVLQKDRNV 94
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 1e-09
Identities = 20/116 (17%), Positives = 39/116 (33%), Gaps = 34/116 (29%)
Query: 90 KITLTNDGKLLLTYFNG---SVQQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDFPTD 146
++ + D +L + G+ + N+GN V+ + ++ V+W +
Sbjct: 23 RLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQT------ 76
Query: 147 TILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202
T +Y L +Q D N+V+ P W TG+
Sbjct: 77 -------------------KTNG-KEDHYVLVLQQDRNVVIY-----GPVVWATGS 107
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-07
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 13/84 (15%)
Query: 146 DTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTL 205
+++ L TG L +Y L MQ D N VL W + T L
Sbjct: 2 NSLSSPNSLFTGHSLEVG---------PSYRLIMQGDCNFVLYDSGKP---VWASNTGGL 49
Query: 206 -NNVSLIFNQSAFMYLINSTGDNI 228
+ L + + + + + + I
Sbjct: 50 GSGCRLTLHNNGNLVIYDQSNRVI 73
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 2e-09
Identities = 24/124 (19%), Positives = 37/124 (29%), Gaps = 21/124 (16%)
Query: 145 TDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVT 204
+D + G L TG L G Y +Q D NLVL Y + W +GT
Sbjct: 1 SDRLNSGHQLDTGGSLAE----------GGYLFIIQNDCNLVL--YDN-NRAVWASGTNG 47
Query: 205 LN-NVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKST 263
L + + + + T + + N Y S
Sbjct: 48 KASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGN-----YYLILQRDRNVVI--YDNSN 100
Query: 264 SSRW 267
++ W
Sbjct: 101 NAIW 104
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-05
Identities = 13/67 (19%), Positives = 31/67 (46%), Gaps = 4/67 (5%)
Query: 77 WAADRDSPAEAGSKITLTNDGKLLLTYFNGSV---QQIYSGAASLALMQNDGNFVLKNAN 133
WA+ + A +G + + NDG L++ + ++ ++Q D N V+ + +
Sbjct: 41 WASGTNGKA-SGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS 99
Query: 134 SAVVWDS 140
+ +W +
Sbjct: 100 NNAIWAT 106
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 3e-09
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 33/116 (28%)
Query: 89 SKITLTNDGKLLLTYFNGSVQQ--IYSGAASLALMQNDGNFVLKNANSAVVWDSFDFPTD 146
++ + D L+L Q +G + + G ++K+ + +W
Sbjct: 26 HQLVMQGDCNLVLYGGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIW-------- 77
Query: 147 TILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202
S S G Y L +Q DG V+ Y P + T +
Sbjct: 78 --------------SSRSSS----KQGEYVLILQDDGFGVI--Y---GPAIFETSS 110
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-07
Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 15/90 (16%)
Query: 140 SFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWY 199
+ F + + GQVL +L + N+ L MQ D NLVL + W
Sbjct: 1 NIPFTNNLLFSGQVLYGDGRLTA----------KNHQLVMQGDCNLVLYGGKY----GWQ 46
Query: 200 TGTVTLN-NVSLIFNQSAFMYLINSTGDNI 228
+ T + L N + + + I
Sbjct: 47 SNTHGNGEHCFLRLNHKGELIIKDDDFKTI 76
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-09
Identities = 31/125 (24%), Positives = 45/125 (36%), Gaps = 35/125 (28%)
Query: 82 DSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSG----AASLALMQNDGNFVLKNANSAVV 137
S + D L+L + SV +G A++Q+DGNFV+ +A +
Sbjct: 14 QSLDVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSL 73
Query: 138 WDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGY 197
W S + GNY L +Q DGN+V+ Y
Sbjct: 74 WASH--------------------------SVRGNGNYVLVLQEDGNVVI--Y---GSDI 102
Query: 198 WYTGT 202
W TGT
Sbjct: 103 WSTGT 107
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 9e-08
Identities = 18/111 (16%), Positives = 35/111 (31%), Gaps = 19/111 (17%)
Query: 146 DTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTL 205
+ + G+ L G+ L Y MQ D NLVL + W + T L
Sbjct: 2 NLLTNGEGLYAGQSLDV----------EPYHFIMQEDCNLVL---YDHSTSVWASNTGIL 48
Query: 206 --NNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNF 254
+ + ++ G +++ + + + + GN
Sbjct: 49 GKKGCKAVLQSDGNFVVYDAEGRSLWAS----HSVRGNGNYVLVLQEDGNV 95
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 18/75 (24%), Positives = 32/75 (42%), Gaps = 7/75 (9%)
Query: 73 KTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQ---QIYSGAASLAL-MQNDGNFV 128
T VWA++ + G K L +DG ++ G G + L +Q DGN V
Sbjct: 37 STSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVV 96
Query: 129 LKNANSAVVWDSFDF 143
+ ++ +W + +
Sbjct: 97 IYGSD---IWSTGTY 108
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 18/119 (15%), Positives = 33/119 (27%), Gaps = 38/119 (31%)
Query: 90 KITLTNDGKLLLTYFNGSVQQIYS------GAASLALMQNDGNFVLKNANSAVVWDSFDF 143
+ + +D L+L ++ G + + G + + V+ S
Sbjct: 27 SLVMRDDCNLVL-TKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVS--- 82
Query: 144 PTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202
T G+Y L +Q +G V+ Y P W T
Sbjct: 83 ----------------------NT-VGQEGDYVLILQINGQAVV--Y---GPAVWSTAA 113
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 8e-08
Identities = 15/87 (17%), Positives = 33/87 (37%), Gaps = 12/87 (13%)
Query: 143 FPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202
+ + QV+ +L + +Y+L M+ D NLVL+ + W +GT
Sbjct: 4 RVRNVLFSSQVMYDNAQLAT----------RDYSLVMRDDCNLVLTKGSKTNI-VWESGT 52
Query: 203 VTL-NNVSLIFNQSAFMYLINSTGDNI 228
+ + S + + + + +
Sbjct: 53 SGRGQHCFMRLGHSGELDITDDRLNTV 79
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 44/213 (20%), Positives = 86/213 (40%), Gaps = 25/213 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE---FMTELKIIGRTHH-KNL 549
K +G G+ G++ G T +A+K +E E + + +
Sbjct: 15 KKIGCGNFGELRLGKN--LYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGI 67
Query: 550 VRLLGFCSEEDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRV-EIALGVARGLLYLHEE 607
++ F +V EL+ P+ L + LF R ++ V IA+ + + Y+H +
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGPS--LED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT------RTDTNMRGTM 661
+I+ D+KP+N L+ T + I DF ++K +T R ++ GT
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y++ + + D+ + G M + + G
Sbjct: 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-08
Identities = 22/106 (20%), Positives = 33/106 (31%), Gaps = 13/106 (12%)
Query: 109 QQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTA 168
+ +GA +L +QN N V + W S + +L G + +
Sbjct: 15 HSLQAGAYTLT-IQNKCNLVKYQNGRQI-WASNTDRRGSGCRLTLLSDGNLVIYDHNNND 72
Query: 169 ------DYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTLNNV 208
G Y L +Q DG V+ P W G V
Sbjct: 73 VWGSACWGDNGKYALVLQKDGRFVIY-----GPVLWSLGPNGCRRV 113
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-07
Identities = 18/110 (16%), Positives = 34/110 (30%), Gaps = 18/110 (16%)
Query: 146 DTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTL 205
+ +L GQ L L + G YTL +Q NLV W + T
Sbjct: 3 NVLLSGQTLHADHSLQA----------GAYTLTIQNKCNLVKYQNGRQ---IWASNTDRR 49
Query: 206 N-NVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNF 254
L + + + ++++ ++ + + G F
Sbjct: 50 GSGCRLTLLSDGNLVIYDHNNNDVWG----SACWGDNGKYALVLQKDGRF 95
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 1e-07
Identities = 34/218 (15%), Positives = 55/218 (25%), Gaps = 61/218 (27%)
Query: 480 FTFQELQEATKGFSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKL--------EKDIEK 529
F T+ + +G G G+V++ I +A+K + +K
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTI----ADHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 530 TNEEFMTE---------LKIIGRTHHKNLVRLLGFC------------------------ 556
T EE + E L + + L
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 557 ------SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
++D+ +V E G + I + L
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181
Query: 611 QIIHCDIKPQNVLLD---LKTLDTNYMAKISDFGISKL 645
+ H D+ NVLL LK L K S L
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL 219
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 7e-07
Identities = 23/139 (16%), Positives = 41/139 (29%), Gaps = 34/139 (24%)
Query: 66 WFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQ---IYSGAASLALMQ 122
+ + + S + ++++ D L+L + V G A++Q
Sbjct: 129 YSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQ 188
Query: 123 NDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQAD 182
+G + + VW S + S G Y +Q D
Sbjct: 189 PNGRMDVLTNQNIAVWTSGN--------------------------SRSAGRYVFVLQPD 222
Query: 183 GNLVLSAYHFADPGYWYTG 201
NL + Y W TG
Sbjct: 223 RNLAI--Y---GGALWTTG 236
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 4e-06
Identities = 16/164 (9%), Positives = 35/164 (21%), Gaps = 17/164 (10%)
Query: 144 PTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTV 203
+ Q L + L ++ MQ+D NLVL + W + T
Sbjct: 7 LSHEGSHPQTLHAAQSLEL----------SSFRFTMQSDCNLVL--FDSDVR-VWASNTA 53
Query: 204 TLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKST 263
+ + ++ + + T + + +
Sbjct: 54 GATGCRAVLQSDGLLVILTAQNTIRWS----SGTKGSIGNYVLVLQPDRTVTIYGPGLWD 109
Query: 264 SSRWTRVWRAVNDPCIVNCICGVYGMCTSSDNETVTCNCIPGYT 307
S + V + + Y
Sbjct: 110 SGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYR 153
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 3e-05
Identities = 35/190 (18%), Positives = 58/190 (30%), Gaps = 34/190 (17%)
Query: 65 IWFDKIPEKTLVWAADRDSPAEAGS-KITLTNDGKLLLTYFNGSV--QQIYSGAASLALM 121
I F E + E S + T+ +D L+L + V A++
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 122 QNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQA 181
Q+DG V+ A + + W S S GNY L +Q
Sbjct: 63 QSDGLLVILTAQNTIRWSS--------------------------GTKGSIGNYVLVLQP 96
Query: 182 DGNLVLSAYHFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTED 241
D + + D G G+V + N N ++ +Y ++ L
Sbjct: 97 DRTVTIYGPGLWDSGTSNKGSVVVAN-----NGNSILYSTQGNDNHPQTLHATQSLQLSP 151
Query: 242 YYHRATIDGH 251
Y D +
Sbjct: 152 YRLSMETDCN 161
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 26/175 (14%), Positives = 56/175 (32%), Gaps = 37/175 (21%)
Query: 494 KLVGTGSSGKVYRGI------LRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHK 547
+ G +Y + + ++K ++ + E R
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKDGRLFNEQNFFQRAAKP 102
Query: 548 NLV---------------RLLGFCSEEDK-RLLVYELM-PNGTLSNFLFHEGQRPGWVQR 590
V +GF +DK R LV + + L + L + +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS--LQSALDVSPKHVLSERS 160
Query: 591 V-EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
V ++A + L +LHE +H ++ +N+ +D + +A +G +
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLA---GYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 43/213 (20%), Positives = 80/213 (37%), Gaps = 25/213 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT---ELKIIGRTHHKNLV 550
+ +G GS G ++ G ++A+K E + E + +
Sbjct: 16 RRIGEGSFGVIFEGTN--LLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 551 -RLLGFCSEEDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRV-EIALGVARGLLYLHEE 607
+ F E +LV +L+ P+ L + L R V+ V A + + +HE+
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPS--LED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT------RTDTNMRGTM 661
+++ DIKP N L+ M + DFG+ K T R N+ GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 662 GYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
Y++ + + D+ + G + + + G
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 7e-06
Identities = 20/117 (17%), Positives = 30/117 (25%), Gaps = 34/117 (29%)
Query: 90 KITLTNDGKLLLTYFNGSV---QQIYSGAASLALMQNDGNFVLKNANS-AVVWDSFDFPT 145
+ D L+L Y G + N G + +ANS VW
Sbjct: 23 AFVMQGDCNLVL-YNEAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVY----- 76
Query: 146 DTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202
+ GNY + D ++ + Y P W T
Sbjct: 77 ---------------PRSVNT----VRGNYAATLGPDQHVTI--Y---GPAIWSTPA 109
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-05
Identities = 20/103 (19%), Positives = 42/103 (40%), Gaps = 10/103 (9%)
Query: 153 VLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTLN-NVSLI 211
VLLTG ++++++ S + MQ D NLVL + + G + + T + +L
Sbjct: 4 VLLTGDVIHTDNQ----LSYESAAFVMQGDCNLVL----YNEAGGFQSNTHGRGVDCTLR 55
Query: 212 FNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNF 254
N + + ++ + + T + AT+ +
Sbjct: 56 LNNRGQLEIHSANSNTPVWVYPR-SVNTVRGNYAATLGPDQHV 97
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 50/239 (20%), Positives = 82/239 (34%), Gaps = 62/239 (25%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKI---------IGRT 544
K +G+G G +Y K + V K+E + N +ELK I +
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY---QENGPLFSELKFYQRVAKKDCIKKW 99
Query: 545 HHKNLVRLLGF----------CSEEDKRLLVYELM---------PNGTLSNFLFHEGQRP 585
+ + LG R +V E + NGT
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFK---------- 149
Query: 586 GWVQRVEIALGVARGLL----YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641
L + +L Y+HE +H DIK N+LL K D Y+A D+G
Sbjct: 150 -----KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLA---DYG 198
Query: 642 ISKLLNKDQT------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
+S + GT+ + + + + V ++ + DV G +L +CG+
Sbjct: 199 LSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 39/231 (16%), Positives = 78/231 (33%), Gaps = 43/231 (18%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKI---------IGRT 544
+G G G +Y + + K N TELK I +
Sbjct: 41 LPIGQGGFGCIYLAD-MNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 545 HHKNLVRLLGFCS----------EEDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRVEI 593
++ LG + R ++ + + L ++ + + V
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQK-IYEANAKRFSRKTV-- 154
Query: 594 ALGVARGLL----YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649
L ++ +L Y+HE +H DIK N+LL+ K D Y+ D+G++ +
Sbjct: 155 -LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLV---DYGLAYRYCPE 207
Query: 650 QT------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
GT+ + + + V + + D+ G +++ + G
Sbjct: 208 GVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT---E---LKIIGRTHHK 547
+ +G+GS G++Y G T E+A+K +E + E +I+
Sbjct: 13 RKIGSGSFGEIYLGTN--IQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQGGTG- 64
Query: 548 NLVRLLGFCSEEDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRV-EIALGVARGLLYLH 605
+ + F E D +LV +L+ P+ L + LF+ R ++ V +A + + ++H
Sbjct: 65 -IPNVRWFGVEGDYNVLVMDLLGPS--LED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT------RTDTNMRG 659
+ +H DIKP N L+ L I DFG++K T R + N+ G
Sbjct: 121 SKS---FLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 660 TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
T Y + + + + D+ S G +L+ + G
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 31/215 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMT---E---LKIIGRTHHK 547
+ +G+GS G +Y G E+A+K +E + E K++
Sbjct: 15 RKIGSGSFGDIYLGTD--IAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVG- 66
Query: 548 NLVRLLGFCSEEDKRLLVYELM-PNGTLSNFLFHEGQRPGWVQRV-EIALGVARGLLYLH 605
+ + +E D ++V EL+ P+ L + LF+ R ++ V +A + + Y+H
Sbjct: 67 -IPTIRWCGAEGDYNVMVMELLGPS--LED-LFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT------RTDTNMRG 659
IH D+KP N L+ L + I DFG++K +T R + N+ G
Sbjct: 123 S---KNFIHRDVKPDNFLMGLG--KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 660 TMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
T Y + + + + D+ S G +L+ G
Sbjct: 178 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2vse_A MTX holotoxin, mosquitocidal toxin; ADP-ribosyltransferase, lectin, ricin-B-like domain; 2.5A {Lysinibacillus sphaericus} PDB: 2vsa_A Length = 841 | Back alignment and structure |
|---|
Score = 42.7 bits (99), Expect = 5e-04
Identities = 28/226 (12%), Positives = 62/226 (27%), Gaps = 25/226 (11%)
Query: 76 VWAADRDSPAEAGSKITLTNDGKLLLTYFNGSVQQIYSGAASLALMQNDGNFVLKNANSA 135
++ ++ G + L + + NG + + + + + +KN
Sbjct: 222 ENHSEGNNMDSKGFILDLDYNQDFDMFAPNGEIPNNNLLNNNSLNVIQNSEYQIKNKKDR 281
Query: 136 VVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTA-------DYSTGNYTLEMQADGNLVLS 188
+ + D G + + Y N D Y + + L+LS
Sbjct: 282 NIVVTLDSDYG----GSPV----ESYKNFGFENQKWNIKYDSKKNAYKIYNRETPTLLLS 333
Query: 189 AYHFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTE--DYYHRA 246
+ G + S NQ + I + ++ RN+ P++ D
Sbjct: 334 WNSNSSNG---EQVIRGYTESGSNNQ---YWTIEKNVNGFYKF-RNLSDPSKILDLKDGN 386
Query: 247 TIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPCIVNCICGVYGMCTS 292
T++ + + S+S W
Sbjct: 387 TLNK-TPLVVSSENSSSSQEWLIEKTNYQTVKDGTYQVSSKLNENK 431
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 788 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.81 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.73 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.67 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.66 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.51 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.4 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.38 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.35 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.34 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.33 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.22 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.99 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.9 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.9 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.85 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.8 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.78 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.71 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.63 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.61 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.38 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.37 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.24 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.22 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.1 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.07 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.01 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.85 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.83 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.56 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.38 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.0 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.85 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.44 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.41 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.23 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.74 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.7 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.66 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.26 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.51 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.92 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.62 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.76 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=435.46 Aligned_cols=262 Identities=25% Similarity=0.428 Sum_probs=213.5
Q ss_pred HHHhhcccccccccccceEEEEEEec---cCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
....+.+.++||+|+||+||+|.+.. ..++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 34456678999999999999998752 235678999999877777788999999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhcc------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCC
Q 047157 563 LLVYELMPNGTLSNFLFHE------------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD 630 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 630 (788)
+||||||++|+|.++|... ...+++.+++.|+.||++||.|||++ +|+||||||+|||++
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~----- 162 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG----- 162 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEEC-----
Confidence 9999999999999999653 24689999999999999999999999 999999999999998
Q ss_pred CCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcccccccccc
Q 047157 631 TNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEE 708 (788)
Q Consensus 631 ~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~ 708 (788)
.++.+||+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||......+
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---- 238 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---- 238 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----
T ss_pred CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence 8889999999999876443322 2233568999999999999999999999999999999998 899997643221
Q ss_pred chhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 709 VDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
+...+..+.... . +...++++.+|+.+||+.||++|||++||++.|+++..
T Consensus 239 --------~~~~i~~~~~~~----~-----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 239 --------VIECITQGRVLQ----R-----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp --------HHHHHHHTCCCC----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHHHHcCCCCC----C-----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111221111 1 11234578899999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=437.40 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=207.0
Q ss_pred hhcccccccccccceEEEEEEec---cCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
...+.++||+|+||+||+|.++. ..++..||||+++.......++|.+|+++|++++|||||+++++|.+.+..+||
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 44567899999999999998752 235678999999877777788999999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCC
Q 047157 566 YELMPNGTLSNFLFHEG--------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT 631 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~ 631 (788)
||||++|+|.+++.+.. ..+++.+++.|+.||++||+|||++ +||||||||+||||+ .
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~-----~ 193 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG-----Q 193 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE-----T
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC-----C
Confidence 99999999999996542 3589999999999999999999998 999999999999999 8
Q ss_pred CCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccc
Q 047157 632 NYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEV 709 (788)
Q Consensus 632 ~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 709 (788)
++.+||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+.
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---- 269 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---- 269 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH----
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH----
Confidence 89999999999987644332 23344679999999999999999999999999999999999 8999976432211
Q ss_pred hhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
...+..+. .+. .+...++++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 270 --------~~~i~~g~-------~~~--~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 --------IDCITQGR-------ELE--RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --------HHHHHHTC-------CCC--CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------HHHHHcCC-------CCC--CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11111111 011 1112346788999999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=434.31 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=213.1
Q ss_pred HHHHHHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEec
Q 047157 483 QELQEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE 558 (788)
Q Consensus 483 ~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 558 (788)
.|+...+.+|.++||+|+||+||+|.+.. ...++.||||+++... ....++|.+|+.++++++|||||+++|+|.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 34445567889999999999999998742 2356789999996543 3446789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEE
Q 047157 559 EDKRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVL 623 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 623 (788)
++..+||||||++|+|.++|.... ..+++..++.|+.|||+||.|||++ +||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 999999999999999999996432 3578999999999999999999999 9999999999999
Q ss_pred eccCCCCCCCcEEEeecCCccccCCCC-CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccc
Q 047157 624 LDLKTLDTNYMAKISDFGISKLLNKDQ-TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSR 701 (788)
Q Consensus 624 l~~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~ 701 (788)
|+ +++.+||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||....
T Consensus 178 l~-----~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 178 VY-----DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp EC-----GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred EC-----CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 99 88899999999998764332 223345679999999999999999999999999999999998 899997653
Q ss_pred cccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 702 VEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
..+ +...+..+.... .+...+..+.+|+.+||+.||++||||+||+++|+...
T Consensus 253 ~~~------------~~~~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 253 NQD------------VVEMIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHH------------HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHH------------HHHHHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 221 111122221111 11223467889999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=425.82 Aligned_cols=264 Identities=24% Similarity=0.381 Sum_probs=202.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeeccc--chHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK--DIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...+.++||+|+||+||+|++. . .||||.++. ......+.|.+|++++++++|||||++++++.+ +..+|||
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~---~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWH---G--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESS---S--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEEC---C--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3456789999999999999763 2 588888753 234566789999999999999999999998865 5689999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|||++|+|.++|......+++.++..|+.|||+||+|||++ +||||||||+||||+ .++.+||+|||+|+..
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~-----~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLH-----EGLTVKIGDFGLATVK 182 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEE-----TTEEEEECCCSSCBC-
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEEC-----CCCcEEEeeccCceec
Confidence 99999999999987777899999999999999999999998 999999999999999 8899999999999876
Q ss_pred CCCC-CcccccccCCccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 647 NKDQ-TRTDTNMRGTMGYVAPEWLRN---VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 647 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
.... ........||+.|||||++.+ .+++.++|||||||+||||+||+.||........ ......
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-----------~~~~~~ 251 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-----------IIFMVG 251 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----------HHHHHH
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-----------HHHHHh
Confidence 5432 223345689999999999863 4689999999999999999999999975422110 111111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCCCCCCC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPPLL 783 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~pp~p 783 (788)
.+... +.+. ......++.+.+|+.+||+.||++||||.||+++|+.+. -+.|+.+
T Consensus 252 ~~~~~----p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~-~~lpk~~ 306 (307)
T 3omv_A 252 RGYAS----PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ-HSLPKIN 306 (307)
T ss_dssp TTCCC----CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH-TTCCC--
T ss_pred cCCCC----CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh-ccCCCCC
Confidence 11100 0000 011123467888999999999999999999999997653 3455543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=424.16 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=208.2
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
|.+.++||+|+||+||+|.++ .+++.||||++........+.+.+|+++|++++|||||++++++.+++..||||||+
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVR--SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cEEeEEeecCcCeEEEEEEEC--CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 666789999999999999987 678899999997665555667899999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++|+|.+++.+ ..+++..+..++.||+.||.|||++ +|+||||||+||||+ .++.+||+|||+++.+...
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~-----~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLT-----HDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTCCEEECCCTTCEECCSS
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEC-----CCCCEEEecCcCceecCCC
Confidence 99999999965 4689999999999999999999999 999999999999998 8889999999999877544
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 729 (788)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+. . ..+....
T Consensus 224 ~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--------~----~~i~~~~---- 286 (346)
T 4fih_A 224 VP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------M----KMIRDNL---- 286 (346)
T ss_dssp SC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------H----HHHHHSS----
T ss_pred CC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--------H----HHHHcCC----
Confidence 33 23457899999999999999999999999999999999999999975432211 0 1111110
Q ss_pred ccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 730 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+.........+++.+|+.+||+.||++|||++|++++
T Consensus 287 ---~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 287 ---PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp ---CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111122334678889999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=419.83 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=201.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.++||+|+||+||+|+++ .+++.||||++... .....+.+.+|++++++++|||||++++++.+++..||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKST--EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CEEEEEEC------CEEEEEET--TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEEC--CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4777899999999999999887 67789999998643 2445678999999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++|+|.++|...+ ..+++.++..|+.||+.||.|||++ +|+||||||+||||+ .++.+||+|||+|+.
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~-----~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLT-----KDGTVQLGDFGIARV 174 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEEC-----TTCCEEECSTTEESC
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEEC-----CCCCEEEccccccee
Confidence 9999999999997553 4578999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
+..... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+. ......+.
T Consensus 175 ~~~~~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------------~~~i~~~~ 241 (350)
T 4b9d_A 175 LNSTVE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------------VLKIISGS 241 (350)
T ss_dssp CCHHHH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------------HHHHHHTC
T ss_pred ecCCcc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------------HHHHHcCC
Confidence 643211 22346799999999999999999999999999999999999999976532211 11111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...+ ......++.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~---------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 242 FPPV---------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC---------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 1123456888999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=407.87 Aligned_cols=247 Identities=24% Similarity=0.342 Sum_probs=197.7
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEec----CCeEEE
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE----EDKRLL 564 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~l 564 (788)
.+.++||+|+||+||+|.+. .++..||+|.+... .....+.|.+|++++++++|||||++++++.+ ++..+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDT--ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC--CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 56678999999999999887 67789999998643 24456789999999999999999999999865 346899
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ--IIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
|||||++|+|.+++.+. ..+++..+..++.||+.||+|||++ + |+||||||+||||+. .++.+||+|||+
T Consensus 107 vmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~----~~g~vKl~DFGl 178 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITG----PTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESS----TTSCEEECCTTG
T ss_pred EEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEEC----CCCCEEEEeCcC
Confidence 99999999999999654 5789999999999999999999998 6 999999999999971 367999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
|+..... .....+||+.|||||++.+ +++.++|||||||+||||+||+.||........ ......
T Consensus 179 a~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-----------~~~~i~ 243 (290)
T 3fpq_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----------IYRRVT 243 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----------HHHHHT
T ss_pred CEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-----------HHHHHH
Confidence 9864332 2334689999999999875 699999999999999999999999964321110 111111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+..... .+.....++.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 244 SGVKPAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTCCCGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCCCC--------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111100 011123467889999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=415.72 Aligned_cols=250 Identities=24% Similarity=0.213 Sum_probs=201.6
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
+.+.++||+|+||+||+|+++ .++..||||+++.... ..+|+.++++++|||||++++++.+++..||||||+
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~--~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDK--QTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred eEeCcEeccCCCeEEEEEEEC--CCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 456688999999999999987 6778999999975422 247999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCC-cEEEeecCCccccCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNY-MAKISDFGISKLLNK 648 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~-~~kL~Dfg~a~~~~~ 648 (788)
++|+|.+++.+. ..+++..+..++.||+.||.|||++ +||||||||+||||+ .++ .+||+|||+|+.+..
T Consensus 133 ~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~-----~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 133 EGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLS-----SDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEC-----TTSCCEEECCCTTCEEC--
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEe-----CCCCEEEEeeCCCCeEccC
Confidence 999999999765 5689999999999999999999999 999999999999998 555 699999999997754
Q ss_pred CCCc----ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 649 DQTR----TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 649 ~~~~----~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.... .....+||+.|||||++.+..++.++|||||||++|||++|+.||......+... . +...
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--------~----i~~~ 271 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL--------K----IASE 271 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH--------H----HHHS
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH--------H----HHcC
Confidence 3321 1233679999999999999999999999999999999999999997653322110 0 0111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
... + ..........+.+++.+||+.||++|||+.|+++.|...
T Consensus 272 ~~~-~------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 272 PPP-I------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp CCG-G------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-c------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 000 0 001112345678899999999999999999999988654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=412.94 Aligned_cols=247 Identities=22% Similarity=0.295 Sum_probs=207.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.++||+|+||+||+|+.+ .+++.||||.+.+.. ....+.+.+|+++|++++|||||++++++++++..|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~--~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEecccCeEEEEEEEC--CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4788899999999999999887 678899999997542 33456899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|+.
T Consensus 111 mEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~-----~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLN-----EDMHIQITDFGTAKV 181 (311)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTSCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEc-----CCCCEEEEEcCCcee
Confidence 9999999999999765 5689999999999999999999999 999999999999998 888999999999998
Q ss_pred cCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
+..... ......+||+.|||||++.+..++.++||||+||++|||++|+.||...+..+. ...+...
T Consensus 182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------------~~~i~~~ 249 (311)
T 4aw0_A 182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI------------FAKIIKL 249 (311)
T ss_dssp CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHT
T ss_pred cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------------HHHHHcC
Confidence 754433 233457899999999999999999999999999999999999999976532211 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 768 (788)
.. ... ....+++.+|+.+||+.||++|||++|++
T Consensus 250 ~~--------~~p--~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 250 EY--------DFP--EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CC--------CCC--TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CC--------CCC--cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11 110 11245678899999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=425.55 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=208.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.++||+|+||+||+|.++ .+++.||||++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVR--SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hcEeeeEeccCcCcEEEEEEEC--CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 3667789999999999999987 67889999999765555566789999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
|++|+|.+++.. ..+++.++..++.||+.||+|||++ +||||||||+||||+ .++.+||+|||+|+.+..
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~-----~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLT-----HDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEEC-----TTCCEEECCCTTCEECCS
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEc-----CCCCEEEecCccceECCC
Confidence 999999999964 3589999999999999999999999 999999999999998 788999999999987754
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+. . ..+....
T Consensus 300 ~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--------~----~~i~~~~--- 363 (423)
T 4fie_A 300 EVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------M----KMIRDNL--- 363 (423)
T ss_dssp SCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------H----HHHHHSC---
T ss_pred CCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--------H----HHHHcCC---
Confidence 432 23457899999999999999999999999999999999999999975432211 0 1111110
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+...........+.+|+.+||+.||++|||++|++++
T Consensus 364 ----~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 364 ----PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ----CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111111234577889999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=410.35 Aligned_cols=272 Identities=21% Similarity=0.259 Sum_probs=202.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCC----eEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED----KRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l 564 (788)
++.+.++||+|+||+||+|.+ .+..||||++..... ....+..|+..+.+++|||||++++++.+++ ..+|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~----~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE----TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE----CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 356678999999999999987 356899999975432 2233456777778899999999999997654 5799
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc-----cCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE-----CETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
||||+++|+|.++|... .+++..+.+++.|+++||+|||++ +.++|+||||||+||||+ .++.+||+|
T Consensus 79 V~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-----~~~~~Ki~D 151 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-----KNGTCCIAD 151 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-----TTSCEEECC
T ss_pred EecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-----CCCCEEEEe
Confidence 99999999999999653 689999999999999999999976 245899999999999998 889999999
Q ss_pred cCCccccCCCCCc---ccccccCCccccCcccccCC------CCCccCcchhhHHHHHHHHhCCCCCCcccccccccc--
Q 047157 640 FGISKLLNKDQTR---TDTNMRGTMGYVAPEWLRNV------PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEE-- 708 (788)
Q Consensus 640 fg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~-- 708 (788)
||+++........ ......||+.|||||++.+. .++.++|||||||+||||+||+.|+......+....
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~ 231 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence 9999876543322 12345799999999998654 477899999999999999999888754322111000
Q ss_pred --chhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 709 --VDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 709 --~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
....... .........++.- -+......+..+.+.+|+.+||+.||++||||.||+++|+++.+
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~rp~---~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 232 VPSDPSVEE-MRKVVCEQKLRPN---IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SCSSCCHHH-HHHHHTTSCCCCC---CCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccchHHH-HHHHHhcccCCCC---CCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0000111 1111111111100 11222234567788999999999999999999999999987654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=419.65 Aligned_cols=265 Identities=27% Similarity=0.388 Sum_probs=212.6
Q ss_pred HHHHHhhcccccccccccceEEEEEEecc---Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCc-cccceEeeEEec
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHH-KNLVRLLGFCSE 558 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~ 558 (788)
|+....+.+.++||+|+||+||+|.+... ...+.||||.+.... ....+.|.+|+++|.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 34556778889999999999999998632 234689999996543 3456789999999999965 999999999966
Q ss_pred -CCeEEEEEecCCCCCHhHhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 559 -EDKRLLVYELMPNGTLSNFLFHE---------------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 559 -~~~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
++..+||||||++|+|.++|+.. ...+++..++.++.|||+||.|||++ +||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence 45789999999999999999653 23478999999999999999999999 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcc
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELS 700 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~ 700 (788)
|++ .++.+||+|||+|+.+...... ......||+.|||||++.+..++.++|||||||+||||+| |+.||...
T Consensus 217 Ll~-----~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 217 LLS-----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp EEC-----GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred eeC-----CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 998 8889999999999977554333 3344678999999999999999999999999999999998 89999764
Q ss_pred ccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
...+. +...+..+.. +. .+....+++.+++.+||+.||++|||++||+++|+++++
T Consensus 292 ~~~~~-----------~~~~i~~g~~-------~~--~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 292 KIDEE-----------FCRRLKEGTR-------MR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCSHH-----------HHHHHHHTCC-------CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHH-----------HHHHHHcCCC-------CC--CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 32111 1111111110 11 111234568889999999999999999999999988764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=398.00 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=190.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||+||+|..+ .+++.||||.+.+.. ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHT--TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECT--TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 5788899999999999999876 677899999986543 33456799999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+ +|+|.+++.+. ..+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.
T Consensus 92 mEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~-----~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLD-----EHLNVKIADFGLSNI 161 (275)
T ss_dssp EECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEEC-----TTCCEEECCSSCC--
T ss_pred EeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEEC-----CCCCEEEeecCCCee
Confidence 9999 68999999665 5689999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..... ......||+.|||||++.+..+ +.++||||+||++|||++|+.||...+..+. ......+
T Consensus 162 ~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~------------~~~i~~~ 227 (275)
T 3hyh_A 162 MTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL------------FKNISNG 227 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHT
T ss_pred cCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH------------HHHHHcC
Confidence 64332 2234689999999999998886 5799999999999999999999975432111 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.. ... ....+++.+++.+||+.||++|||++|+++
T Consensus 228 ~~--------~~p--~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 VY--------TLP--KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CC--------CCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC--------CCC--CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 100 112356788999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=403.64 Aligned_cols=249 Identities=25% Similarity=0.267 Sum_probs=196.7
Q ss_pred hhcccccccccccceEEEEEEec-cCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||+||+|+... ..+++.||||.+++.. ......+.+|++++++++|||||++++++.+++..|||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47888999999999999998753 3457789999986532 22334688999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++.+. ..+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.
T Consensus 105 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~-----~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLD-----EEGHIKLTDFGLSKE 175 (304)
T ss_dssp ECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEEC-----TTSCEEEESSEEEEC
T ss_pred EEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEc-----CCCCEEeccccccee
Confidence 9999999999999765 5689999999999999999999999 999999999999998 888999999999986
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... .....+||+.|||||++.+..++.++|||||||++|||++|+.||...+..+. ........
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------------~~~i~~~~ 242 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------------MTMILKAK 242 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHCC
T ss_pred ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH------------HHHHHcCC
Confidence 543322 23346899999999999999999999999999999999999999976532221 11111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 769 (788)
. .. +.....++.+|+.+||+.||++||| ++|+++
T Consensus 243 ~--------~~--p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 L--------GM--PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C--------CC--CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C--------CC--CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 11 1112456788999999999999998 467775
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=390.37 Aligned_cols=248 Identities=21% Similarity=0.343 Sum_probs=187.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCC-------
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED------- 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------- 560 (788)
.|.+.+.||+|+||+||+|..+ .++..||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNK--VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEET--TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEEC--CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4777899999999999999886 677899999986543 445578999999999999999999999986544
Q ss_pred -----eEEEEEecCCCCCHhHhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCC
Q 047157 561 -----KRLLVYELMPNGTLSNFLFHEGQ--RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNY 633 (788)
Q Consensus 561 -----~~~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~ 633 (788)
..|+||||+++|+|.+++..... ..++..++.++.||+.||+|||++ +|+||||||+|||++ .++
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~-----~~~ 155 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFT-----MDD 155 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEEC-----CCC
Confidence 36999999999999999976533 345677889999999999999999 999999999999998 788
Q ss_pred cEEEeecCCccccCCCCCc-----------ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccc
Q 047157 634 MAKISDFGISKLLNKDQTR-----------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRV 702 (788)
Q Consensus 634 ~~kL~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~ 702 (788)
.+||+|||+|+.+...... .....+||+.|||||++.+..++.++|||||||++|||++ ||.....
T Consensus 156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~ 232 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME 232 (299)
T ss_dssp CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence 9999999999877543221 1233579999999999999999999999999999999996 7753210
Q ss_pred ccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 703 EEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. .. ............ ........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~----------~~-~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 R----------VR-TLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H----------HH-HHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----------HH-HHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00 001111111110 11223345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=384.83 Aligned_cols=262 Identities=21% Similarity=0.285 Sum_probs=201.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEec------CC
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE------ED 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 560 (788)
.|.+.++||+|+||+||+|.++ .+++.||||++.... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~--~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRR--LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CeEEEEEEecccCeEEEEEEEC--CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4777899999999999999987 678899999996532 3445678899999999999999999998753 46
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..||||||++ |+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~-----~~~~~Ki~DF 202 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVN-----ENCELKIGDF 202 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC-----TTCCEEECCC
T ss_pred EEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccC-----CCCCEEEeec
Confidence 7899999995 6899999654 5789999999999999999999999 999999999999998 8889999999
Q ss_pred CCccccCCCC---CcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 641 GISKLLNKDQ---TRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 641 g~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
|+++.+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+....
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~-------- 274 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL-------- 274 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH--------
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH--------
Confidence 9998764322 2233457899999999998775 569999999999999999999999986543221111
Q ss_pred HHHHhhccc-----------ccccccCCC-CCcccH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLSRN-----------LQVLVSHDP-EVLSDL-----ERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~~~-----------~~~l~~~~~-~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+........ ....+...+ ...... ....++.+|+.+||+.||++|||++|++++
T Consensus 275 I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 275 IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 000000000 000111 123567899999999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=379.02 Aligned_cols=199 Identities=22% Similarity=0.338 Sum_probs=168.9
Q ss_pred hhcccccccccccceEEEEEEecc-CcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.++||+|+||+||+|+.+.+ ..++.||||.+.... ...++.+|+++|+.+ +||||+++++++.+.+..++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 477889999999999999987632 457799999886543 345678999999988 6999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|+|.+++ +.+++.++..++.||+.||+|||++ +|+||||||+|||++. +.+.+||+|||+|+..
T Consensus 100 E~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~----~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 100 PYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNR----RLKKYALVDFGLAQGT 168 (361)
T ss_dssp ECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEET----TTTEEEECCCTTCEEC
T ss_pred eCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeC----CCCeEEECcCCCCccc
Confidence 999999999998 3588999999999999999999999 9999999999999982 3378999999999865
Q ss_pred CCCCC---------------------------cccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCC
Q 047157 647 NKDQT---------------------------RTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIE 698 (788)
Q Consensus 647 ~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~ 698 (788)
..... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 43211 112335799999999999775 58999999999999999999999996
Q ss_pred cc
Q 047157 699 LS 700 (788)
Q Consensus 699 ~~ 700 (788)
..
T Consensus 249 ~~ 250 (361)
T 4f9c_A 249 KA 250 (361)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=402.89 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=211.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||.||+|..+ .++..||+|.+........+.+.+|+++|+.++|||||++++++.+.+..+|||||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~--~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTER--ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccEEEEEEeeccCeEEEEEEEC--CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4778899999999999999887 67889999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
|++|+|.++|......+++.++..++.||+.||.|||++ +|+||||||+|||++.+ ..+.+||+|||+++.+..
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~---~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTK---RSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSS---SCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCC---CCCCEEEeeccceeEccC
Confidence 999999999977767899999999999999999999999 99999999999999732 347899999999998754
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... ....+||+.|||||++.+..++.++|||||||++|||++|+.||......+.. ..+......
T Consensus 310 ~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~------------~~i~~~~~~- 374 (573)
T 3uto_A 310 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWN- 374 (573)
T ss_dssp TSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------------HHHHTTCCC-
T ss_pred CCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------------HHHHhCCCC-
Confidence 432 23467999999999999999999999999999999999999999765332211 111111100
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..........+.+.+|+.+||+.||++|||++|++++
T Consensus 375 -----~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 375 -----MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -----CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001111224567889999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=370.20 Aligned_cols=289 Identities=40% Similarity=0.720 Sum_probs=239.0
Q ss_pred CCcccCHHHHHHHhhcc--cccccccccceEEEEEEeccCcceeeeeeecccchH-HHHHHHHHHHHHhcCCCccccceE
Q 047157 476 NFREFTFQELQEATKGF--SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-KTNEEFMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 476 ~~~~~~~~~l~~~t~~~--~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~hpniv~~ 552 (788)
..+.+++.++...+.++ .+.||+|+||.||+|.. .++..||||++..... .....+.+|++++++++||||+++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL---ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC---SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEe---cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 45678888888776655 58999999999999975 3567999999875432 223368999999999999999999
Q ss_pred eeEEecCCeEEEEEecCCCCCHhHhhhccC---CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC
Q 047157 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEG---QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL 629 (788)
Q Consensus 553 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 629 (788)
++++.+.+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++..+|+||||||+|||++
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~---- 168 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD---- 168 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC----
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC----
Confidence 999999999999999999999999997643 3489999999999999999999998777999999999999998
Q ss_pred CCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccc
Q 047157 630 DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEV 709 (788)
Q Consensus 630 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~ 709 (788)
.++.+||+|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..
T Consensus 169 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~ 244 (326)
T 3uim_A 169 -EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN---DD 244 (326)
T ss_dssp -TTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT---TS
T ss_pred -CCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc---cc
Confidence 78899999999998776555555555679999999999988899999999999999999999999997433221 12
Q ss_pred hhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.....++.........+..+.+............+.+.+++.+||+.||++|||++||+++|++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred chhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 233445555555555666666666666667788899999999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=393.52 Aligned_cols=248 Identities=24% Similarity=0.273 Sum_probs=199.1
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch------HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI------EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
.|.+.++||+|+||+||+|+.+ .++..||||++.+.. .........++++++.++|||||++++++.+.+..
T Consensus 190 df~i~k~LG~G~fG~V~la~~~--~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HeEEEEEEecccCeEEEEEEEC--CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 3667799999999999999887 778899999996532 11122334457788889999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
||||||++||+|.++|.+. ..+++..+..++.||+.||.|||++ +||||||||+||||+ .++++||+|||+
T Consensus 268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld-----~~G~vKL~DFGl 338 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLD-----EHGHVRISDLGL 338 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEEC-----TTSCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEe-----CCCCEEecccce
Confidence 9999999999999999765 5689999999999999999999999 999999999999999 889999999999
Q ss_pred ccccCCCCCcccccccCCccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLR-NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
|+.+.... ....+||+.|||||++. +..|+.++|||||||++|||++|+.||......... .+ ....
T Consensus 339 A~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-----~i----~~~i 406 (689)
T 3v5w_A 339 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EI----DRMT 406 (689)
T ss_dssp CEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-----HH----HHHH
T ss_pred eeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-----HH----HHhh
Confidence 98765433 23468999999999996 457999999999999999999999999764322110 00 0111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 769 (788)
.... +.. +.....++.+|+.+||+.||++|++ ++||++
T Consensus 407 ~~~~--------~~~--p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 407 LTMA--------VEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHCC--------CCC--CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred cCCC--------CCC--CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111 111 1122456788999999999999998 788875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.63 Aligned_cols=273 Identities=36% Similarity=0.616 Sum_probs=226.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
|.+.+.||+|+||+||+|.+ .++..||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 117 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVL---RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEEC---TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred cCccceeecCCCeeEEEEEE---CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence 44568899999999999986 356799999987666666788999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccC---CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 570 PNGTLSNFLFHEG---QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 570 ~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++...
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~-----~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLD-----ENFVPKITDFGISKKG 189 (321)
T ss_dssp TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEEC-----TTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEEC-----CCCCEEEeeccccccc
Confidence 9999999996543 3589999999999999999999999 999999999999998 7889999999999865
Q ss_pred CCCC-CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 647 NKDQ-TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 647 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ....|.........
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV-----NLAEWAVESHNNGQ 264 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC-----CHHHHTHHHHTTTC
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH-----HHHHHhhhcccccc
Confidence 4322 22223356899999999998889999999999999999999999999765433221 22334444444555
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCC
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVG 778 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 778 (788)
+...++.........+..+.+.+++.+||+.||++|||++||+++|+.++...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 55555555555556778889999999999999999999999999999876544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=360.65 Aligned_cols=260 Identities=26% Similarity=0.390 Sum_probs=212.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..+.+.++||+|+||+||+|.+. .++..||+|.+........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHR--ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET--TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEEC--CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 34667899999999999999886 6677999999877667778899999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++......+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~-----~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVR-----ENKNVVVADFGLARLMV 159 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEC-----TTSCEEECCCTTCEECC
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEEC-----CCCCEEEeecccceecc
Confidence 9999999999988778899999999999999999999999 999999999999998 78899999999998764
Q ss_pred CCCCcc-------------cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH
Q 047157 648 KDQTRT-------------DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 648 ~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 714 (788)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+............ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--~~~ 237 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--NVR 237 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--CHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--hhh
Confidence 432211 11457899999999999999999999999999999999999998754332211111 111
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
..... . . .......+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 238 ~~~~~-~----~------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 238 GFLDR-Y----C------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHHH-T----C------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccc-c----C------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11000 0 0 00112457789999999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=360.41 Aligned_cols=265 Identities=27% Similarity=0.431 Sum_probs=200.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..|.+.+.||+|+||+||+|.. .+..||||.+.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 4567789999999999999976 35689999986443 44557899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 566 YELMPNGTLSNFLFHEGQ--RPGWVQRVEIALGVARGLLYLHEECETQ--IIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
|||+++++|.+++..... .+++..++.++.||+.||+|||++ + |+||||||+|||++ .++.+||+|||
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~-----~~~~~kL~Dfg 184 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVD-----KKYTVKVCDFG 184 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEEC-----TTCCEEECCCC
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEe-----CCCcEEECCCC
Confidence 999999999999976532 389999999999999999999998 8 99999999999998 78899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. . ...
T Consensus 185 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~--------~---~~~ 252 (309)
T 3p86_A 185 LSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV--------A---AVG 252 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--------H---HHH
T ss_pred CCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------H---HHH
Confidence 9986543221 223457899999999999999999999999999999999999999754322110 0 000
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCCCCCCCCC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPPLLHD 785 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~pp~p~~ 785 (788)
... ............+.+++.+||+.||++|||++|+++.|+.+.....||.++.
T Consensus 253 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~~ 307 (309)
T 3p86_A 253 FKC---------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307 (309)
T ss_dssp HSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---------
T ss_pred hcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCcc
Confidence 000 0001111233568889999999999999999999999999988777766554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=362.65 Aligned_cols=265 Identities=28% Similarity=0.483 Sum_probs=212.9
Q ss_pred HHHHhhcccccccccccceEEEEEEeccC-cceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
+....|.+.+.||+|+||+||+|.+...+ .+..||||.+... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34456777899999999999999986322 3456999999754 345567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~-----~~~~~kl~Dfg~ 197 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVD-----SNLVCKVSDFGL 197 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTCCEEECCCSS
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEC-----CCCCEEECCCCc
Confidence 999999999999999987777899999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHH
Q 047157 643 SKLLNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 643 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
+......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ..
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------------~~ 265 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV------------IS 265 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------------HH
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH------------HH
Confidence 9876543322 2223446778999999998899999999999999999999 9999965432211 01
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCC
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVG 778 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 778 (788)
..... ............+.+++.+||+.||++|||++||+++|+.+...+
T Consensus 266 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 266 SVEEG---------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHcC---------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 11111 011111223467888999999999999999999999999876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.05 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=206.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||+||+|... .++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDV--ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBT--TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceeeeeeeccCCCeEEEEEEEC--CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4666789999999999999875 66779999998766555677889999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.....
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~-----~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLG-----MDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEC-----CCCCEEEeeCCCceecCC
Confidence 9999999999654 588999999999999999999999 999999999999998 788999999999987654
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .......
T Consensus 169 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----------~~~~~~~---- 232 (297)
T 3fxz_A 169 EQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----------YLIATNG---- 232 (297)
T ss_dssp TTCC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----------HHHHHHC----
T ss_pred cccc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhCC----
Confidence 3332 23467999999999999999999999999999999999999999754321110 0000000
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+...........+.+++.+||+.||++|||++|++++
T Consensus 233 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 233 ----TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ----SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111122334568889999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=361.66 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=210.8
Q ss_pred HhhcccccccccccceEEEEEEec-----cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCC
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRL-----KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED 560 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 560 (788)
..|.+.+.||+|+||.||+|.... ...+..||||.+.... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 456778999999999999998752 2345689999997543 44567899999999999 8999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 9999999999999999997643 3478999999999999999999999 999999999999998
Q ss_pred cCCCCCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccc
Q 047157 626 LKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVE 703 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~ 703 (788)
.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 238 -----~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 238 -----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp -----TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred -----CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 788999999999987654332 22233557889999999999999999999999999999999 99999764322
Q ss_pred cccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
+.. .....+.. ...+......+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 313 ~~~------------~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 ELF------------KLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GHH------------HHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH------------HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 110 11111110 01111234578889999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=349.35 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=212.9
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
....|.+.+.||+|+||.||+|... ++..||+|.+.... ...+++.+|++++.+++||||+++++++.+.+..++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK---GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec---CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 3456778899999999999999774 56689999987543 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++...+..+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~-----~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVD-----RDLCVKVSDFGMTRY 153 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEEC-----TTCCEEECCTTCEEE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEEC-----CCCCEEEccCcccee
Confidence 999999999999987767799999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ......
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------------~~~~~~ 221 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------------LKVSQG 221 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------------HHHHTT
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------------HHHHcC
Confidence 76554444444566788999999999899999999999999999999 99999754322110 001111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
. ....+....+.+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 222 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 222 H---------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp C---------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred C---------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0 0000111235688899999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=352.24 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=213.1
Q ss_pred CCcccCHHHHHHHhhc------------ccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcC
Q 047157 476 NFREFTFQELQEATKG------------FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR 543 (788)
Q Consensus 476 ~~~~~~~~~l~~~t~~------------~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~ 543 (788)
....++++++..++.. ..+.||+|+||.||+|... .++..||||.+........+.+.+|+.++++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK--HSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC--CCCcEEEEEEEeccchhHHHHHHHHHHHHHh
Confidence 3456888888887743 3468999999999999886 5677999999976656667789999999999
Q ss_pred CCccccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEE
Q 047157 544 THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVL 623 (788)
Q Consensus 544 l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 623 (788)
++||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999999853 4689999999999999999999999 9999999999999
Q ss_pred eccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccc
Q 047157 624 LDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVE 703 (788)
Q Consensus 624 l~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~ 703 (788)
++ .++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 174 l~-----~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~ 247 (321)
T 2c30_A 174 LT-----LDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247 (321)
T ss_dssp EC-----TTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred EC-----CCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 98 7889999999999876543322 23467999999999999999999999999999999999999999754221
Q ss_pred cccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. ........ .+...........+.+++.+||+.||++|||++|+++.
T Consensus 248 ~~------------~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QA------------MKRLRDSP-------PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HH------------HHHHHHSS-------CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH------------HHHHhcCC-------CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 01111110 11111112234567889999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.88 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=210.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..|.+.+.||+|+||+||+|... .+..||+|++.... ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEec---CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 45677899999999999999874 45679999987543 234678999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++......+++..++.++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||++....
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~-----~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVG-----ENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----GGGCEEECCTTGGGGBC
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEc-----CCCCEEecccccccccc
Confidence 9999999999987777899999999999999999999999 999999999999998 77899999999998765
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~------------~~~~~~~~- 224 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------------VEDISTGF- 224 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------------HHHHHTTC-
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH------------HHHHhcCc-
Confidence 433333334556788999999998999999999999999999999 9999975432211 01111110
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
....+......+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 225 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 --------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0001111245688899999999999999999999999887643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=358.95 Aligned_cols=274 Identities=23% Similarity=0.370 Sum_probs=211.0
Q ss_pred HHHHhhcccccccccccceEEEEEEe--ccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec--CC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--ED 560 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~ 560 (788)
+....|.+.+.||+|+||+||++.+. ...++..||||++........+.+.+|++++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 34456778899999999999999853 235678999999987777777889999999999999999999999855 35
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~-----~~~~~kl~Df 158 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVE-----NENRVKIGDF 158 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE-----ETTEEEECCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEc-----CCCeEEEccC
Confidence 68999999999999999987767799999999999999999999999 999999999999998 7789999999
Q ss_pred CCccccCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccc----ccchhhhH
Q 047157 641 GISKLLNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES----EEVDIVLS 714 (788)
Q Consensus 641 g~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~----~~~~~~~~ 714 (788)
|++......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+......... ........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 999876543321 222345677899999999999999999999999999999999998654321100 00000001
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.......... ..........+.+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 239 ~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 239 FHLIELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111111111 111112233467889999999999999999999999998764
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=345.41 Aligned_cols=225 Identities=21% Similarity=0.336 Sum_probs=177.1
Q ss_pred CcCCCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCC-----CcEEEEecC
Q 047157 22 GQTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEA-----GSKITLTND 96 (788)
Q Consensus 22 ~~~~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~-----~s~l~l~~~ 96 (788)
+++.++|++|++|+++ ++||||+|+||||||.+ +++|| |+ +.+ |||+||||+|+.+ +++|+|+.|
T Consensus 11 ~~~~~~l~~g~~l~~~--~~l~S~~g~F~lgf~~~--~~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~ 80 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAG--QYLLSPNQRFKLLLQGD--GNLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY 80 (276)
T ss_dssp CTTSSEECTTEEBCTT--CEEECTTSSEEEEECTT--SCEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred cccCCEecCCCEecCC--CEEEcCCCcEEEEEECC--CCeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence 4667999999999864 79999999999999943 36777 77 777 9999999999976 678999999
Q ss_pred CceEE--EeCCCcEEEEeccc---------ccccccCCCCcEEEEecCCceeecccCCCCCcccCCcc----ccCCCeEE
Q 047157 97 GKLLL--TYFNGSVQQIYSGA---------ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQV----LLTGKKLY 161 (788)
Q Consensus 97 G~L~l--~~~~~~~~~~~s~~---------~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~----l~~g~~l~ 161 (788)
|+|+| .|.+|++.|..+.. .++|+|+|+|||||++ +.+|||| |||||+||||+ |.+|.+|
T Consensus 81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L- 155 (276)
T 3m7h_A 81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL- 155 (276)
T ss_dssp ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE-
T ss_pred CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc-
Confidence 99999 77777775544322 2479999999999998 7899999 99999999999 7778776
Q ss_pred eecCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCcccccceeeeeccceeEEEEecCCcceEEEEeeccCCCCc
Q 047157 162 SNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTED 241 (788)
Q Consensus 162 s~~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (788)
++..||++|.|+++|+++|++.+ +......||+++++......+.++..+.+.+++.++..+ ..+... . .
T Consensus 156 ---~S~~dps~G~fsl~l~~dGnlvL--y~~~~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~v-WsS~t~--~--~ 225 (276)
T 3m7h_A 156 ---VQGVVYGAGASKLVFQGDGNLVA--YGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVL-WHSHTG--G--H 225 (276)
T ss_dssp ---CTTCEEEETTEEEEECTTSCEEE--ECTTSSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEE-EECSCT--T--C
T ss_pred ---ccCCCCCCceEEEeecCCceEEE--EeCCCeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEE-EEecCC--C--C
Confidence 45789999999999999997654 444456799999887654556677777777776655322 222211 1 1
Q ss_pred eEEEEEEeCCccEEEEEeecCCCCceeEEeeccc
Q 047157 242 YYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVN 275 (788)
Q Consensus 242 ~~~rl~ld~~G~l~~~~w~~~~~~~W~~~~~~p~ 275 (788)
..+|++|+.||++++|.| . ..|..++.+|+
T Consensus 226 ~~~rl~Ld~dGnLvly~~-~---~~Wqsf~~~P~ 255 (276)
T 3m7h_A 226 ASAVLRLQANGSIAILDE-K---PVWARFGFQPT 255 (276)
T ss_dssp TTCEEEECTTSCEEEEEE-E---EEEESSSCCTT
T ss_pred CCEEEEEcCCccEEEEcC-C---CeEEccCccCC
Confidence 237999999999999998 1 45888777775
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=347.17 Aligned_cols=263 Identities=23% Similarity=0.325 Sum_probs=206.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc---hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..|.+.+.||+|+||.||++... ..+..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDT--ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET--TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEEC--CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 35677899999999999999876 66779999987432 24556789999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 89 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~-----~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILID-----SNKTLKIFDFGIAK 159 (294)
T ss_dssp EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTSCEEECCCSSST
T ss_pred EEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC-----CCCCEEEEeCCCcc
Confidence 99999999999999655 4689999999999999999999999 999999999999998 78899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..............||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... ..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----------~~~~~-~~ 227 (294)
T 4eqm_A 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-----------AIKHI-QD 227 (294)
T ss_dssp TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-----------HHHHH-SS
T ss_pred ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----------HHHHh-hc
Confidence 7755444444456789999999999999999999999999999999999999976532111 00111 11
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHhhcCcCCC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-SMKKVIHMLEGTLEVG 778 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~~~ 778 (788)
....... .......+.+.+++.+||+.||++|| +++++.+.|+..+.-.
T Consensus 228 ~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 228 SVPNVTT-----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCCCHHH-----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred cCCCcch-----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 1110000 00112345688899999999999998 9999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.43 Aligned_cols=247 Identities=22% Similarity=0.320 Sum_probs=204.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||.||+|.+. .++..||||++... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHI--LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4667799999999999999886 67779999998654 2445678899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~-----~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLD-----ADMNIKIADFGFSNEF 164 (328)
T ss_dssp CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTSCEEECSTTCCGGG
T ss_pred ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEc-----CCCCEEEeeccCceec
Confidence 999999999999665 5688999999999999999999999 999999999999998 7889999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVT-TKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.... ......||+.|+|||++.+..++ +++||||||+++|||++|+.||......+. ......+.
T Consensus 165 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------------~~~i~~~~ 230 (328)
T 3fe3_A 165 TVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL------------RERVLRGK 230 (328)
T ss_dssp SSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHCC
T ss_pred CCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH------------HHHHHhCC
Confidence 5432 23446799999999999888775 799999999999999999999976532211 11111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. . +......+.+++.+||+.||++|||++|++++
T Consensus 231 ~~--------~--p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 YR--------I--PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CC--------C--CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC--------C--CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10 0 11123567789999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=353.75 Aligned_cols=273 Identities=23% Similarity=0.280 Sum_probs=207.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCC----eEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED----KRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~ 563 (788)
..|.+.++||+|+||+||+|... +..||||++.... .....+..|+.++++++||||+++++++.+.. ..+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL----NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhchhhheecccCceEEEEEEEC----CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34667799999999999999763 5699999997543 33445667999999999999999999998744 479
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc-------cCCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE-------CETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-------~~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
+||||+++|+|.+++... .+++..++.++.||+.||.|||+. +..+|+||||||+|||++ .++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~-----~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-----NNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC-----TTCCEE
T ss_pred EEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC-----CCCeEE
Confidence 999999999999999653 589999999999999999999985 234899999999999998 788999
Q ss_pred EeecCCccccCCCCCc-ccccccCCccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccc-
Q 047157 637 ISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRN-----VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEV- 709 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~- 709 (788)
|+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999876543322 2233578999999999976 45677899999999999999999999764332211100
Q ss_pred ----hhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 710 ----DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 710 ----~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
......+. ........... ...........+.+.+++.+||+.||++|||++||++.|+++.+
T Consensus 252 ~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 252 EIGQHPSLEDMQ-EVVVHKKKRPV---LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHCSSCCHHHHH-HHHTTSCCCCC---CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccCCchhhhh-hhhhcccCCCC---ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00011111 11111111110 11111233456779999999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=364.48 Aligned_cols=262 Identities=27% Similarity=0.480 Sum_probs=200.4
Q ss_pred HHHHhhcccccccccccceEEEEEEecc-Ccceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
+....+.+.+.||+|+||.||+|.+... ..+..||||.+... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 3345677789999999999999987522 34668999998754 344567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++++|.+++...+..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~-----~~~~~kl~Dfg~ 193 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILIN-----SNLVCKVSDFGL 193 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTCCEEECCC--
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEc-----CCCCEEECcCcc
Confidence 999999999999999987777899999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCcc--cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHH
Q 047157 643 SKLLNKDQTRT--DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 643 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
+.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. . .
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--------~----~ 261 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------I----K 261 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--------H----H
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--------H----H
Confidence 98765433221 112335678999999999999999999999999999998 9999965432111 0 1
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
....+. ...........+.+++.+||+.||++||+++||+++|+++.
T Consensus 262 ~i~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 262 AVDEGY---------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HHHTTE---------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCC---------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 111110 00111123467889999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=375.68 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=213.4
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
....+.+.+.||+|+||.||+|.+. ..+..||||.+.... ...++|.+|++++++++||||+++++++.+.+..++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEG--GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEc--CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3445777899999999999999986 567799999997643 3457899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 566 YELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~-----~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVG-----ENHLVKVADFGLSR 366 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----GGGCEEECCTTCEE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEC-----CCCcEEEeecccce
Confidence 9999999999999764 35689999999999999999999999 999999999999998 78899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
..............++..|+|||.+....++.++||||||+++|||++ |+.||......+. .. .+..
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--------~~----~~~~ 434 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------YE----LLEK 434 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--------HH----HHHT
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--------HH----HHHc
Confidence 775443333334456789999999998899999999999999999999 9999976532211 01 1111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
. ..........+.+.+|+.+||+.||++|||+++|++.|+.+..
T Consensus 435 ~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 D---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0 1111112234678889999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=366.84 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=208.5
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
..+.+.+.||+|+||.||+|.+. .++..||||.+.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLR--ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET--TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEe--cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 45667899999999999999986 567799999987543 344567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++...+..+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~-----~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVT-----EKNVLKISDFGMSREE 263 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTCCEEECCGGGCEEC
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEc-----CCCcEEECcCCCceec
Confidence 99999999999987767789999999999999999999999 999999999999998 7889999999999865
Q ss_pred CCCCCccc-ccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 647 NKDQTRTD-TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 647 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
........ ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ......+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~------------~~~~~~~ 331 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT------------REFVEKG 331 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH------------HHHHHTT
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------------HHHHHcC
Confidence 43221111 11235678999999998899999999999999999998 9999975432111 0111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
. ....+....+.+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 332 ~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 332 G---------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 0 00111123456788999999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=347.87 Aligned_cols=259 Identities=22% Similarity=0.346 Sum_probs=198.0
Q ss_pred HHhhcccccccccccceEEEEEEecc-Ccceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
...|.+.+.||+|+||.||+|.+... ..+..||+|.+... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 45677889999999999999988632 23567999998653 3445678999999999999999999999984 567899
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~-----~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS-----SNDCVKLGDFGLSR 164 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE-----ETTEEEECC-----
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEEC-----CCCCEEECcccccc
Confidence 9999999999999987767799999999999999999999999 999999999999998 77899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
..............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~------------~~i~~ 232 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI------------GRIEN 232 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------------HHHHT
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH------------HHHHc
Confidence 765543333334456789999999998899999999999999999996 99999764322110 01111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
..... ........+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 233 ~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 233 GERLP---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11000 11123456788999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=341.83 Aligned_cols=280 Identities=37% Similarity=0.573 Sum_probs=223.3
Q ss_pred CCcccCHHHHHHHhhccc--------ccccccccceEEEEEEeccCcceeeeeeecccc----hHHHHHHHHHHHHHhcC
Q 047157 476 NFREFTFQELQEATKGFS--------KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD----IEKTNEEFMTELKIIGR 543 (788)
Q Consensus 476 ~~~~~~~~~l~~~t~~~~--------~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~ 543 (788)
....|++.++.+++.+|. +.||+|+||.||+|.. .+..||||.+... .....+.+.+|++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~ 86 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence 567899999999999886 4599999999999975 3568999988643 23456789999999999
Q ss_pred CCccccceEeeEEecCCeEEEEEecCCCCCHhHhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCc
Q 047157 544 THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHE--GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQN 621 (788)
Q Consensus 544 l~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~N 621 (788)
++||||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 99999999999999999999999999999999998643 35689999999999999999999999 99999999999
Q ss_pred EEeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcc
Q 047157 622 VLLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELS 700 (788)
Q Consensus 622 Ill~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~ 700 (788)
|+++ .++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...
T Consensus 164 ili~-----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~ 237 (307)
T 2nru_A 164 ILLD-----EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH 237 (307)
T ss_dssp EEEC-----TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred EEEc-----CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence 9998 7889999999999876543322 2334578999999998875 5889999999999999999999999765
Q ss_pred ccccccccchhhhHHHHHHH-hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 701 RVEEESEEVDIVLSDWVISC-MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
........ +.... .....+...+.... ........+.+.+++.+||+.||++|||+++|+++|+++..
T Consensus 238 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 238 REPQLLLD-------IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BSSSBTTH-------HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cchHHHHH-------HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 43221111 11000 01111222222211 12345667889999999999999999999999999988653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=346.92 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=206.9
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...|.+.+.||+|+||.||++.+. ++..||+|.+..... ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET---TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc---CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 445677899999999999999874 566899999975432 3467899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++...
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~-----~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVN-----DQGVVKVSDFGLSRYV 170 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEEC-----TTSCEEECSTTGGGGB
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEc-----CCCCEEEccccccccc
Confidence 99999999999987667799999999999999999999999 999999999999998 7889999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .......
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------------~~~~~~~ 238 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------------EHIAQGL 238 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------------HHHHTTC
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------------HHHhccc
Confidence 5433333334456788999999998899999999999999999998 99999754322110 1111110
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.........+.+.+++.+||+.||++|||++|++++|+++.
T Consensus 239 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 239 ---------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 00011112356888999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.17 Aligned_cols=253 Identities=16% Similarity=0.187 Sum_probs=206.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||+||++... .++..+|+|.+... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~--~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVET--SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ceEeeeEEecCCCeEEEEEEEC--CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4677899999999999999886 67789999998754 33456788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++.. .++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~---~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTR---RSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSS---SCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccC---CCCCEEEEECCCCeECCC
Confidence 999999999977767899999999999999999999999 99999999999999831 268999999999987654
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+.. .........
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------------~~i~~~~~~- 221 (321)
T 1tki_A 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII------------ENIMNAEYT- 221 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------------HHHHHTCCC-
T ss_pred CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH------------HHHHcCCCC-
Confidence 332 23456899999999999988999999999999999999999999764322110 111111100
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...........++.+++.+||+.||++|||+.|++++
T Consensus 222 -----~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 222 -----FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000001224578899999999999999999999973
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=348.99 Aligned_cols=248 Identities=26% Similarity=0.297 Sum_probs=204.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||+||++..+ .++..||+|.+.+.. ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4667899999999999999886 677899999997542 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~-----~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLD-----KDGHIKITDFGLCKE 154 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC-----TTSCEEECCCTTCBC
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEEC-----CCCCEEEeeccchhh
Confidence 9999999999998654 5688999999999999999999999 999999999999998 788999999999986
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........
T Consensus 155 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------------~~~i~~~~ 221 (337)
T 1o6l_A 155 GISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------------FELILMEE 221 (337)
T ss_dssp SCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHCC
T ss_pred cccCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH------------HHHHHcCC
Confidence 433222 23346799999999999999999999999999999999999999975432111 11111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
. .. +......+.+++.+||+.||++|| +++||+++
T Consensus 222 ~--------~~--p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 I--------RF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C--------CC--CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C--------CC--CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1 00 112245678899999999999999 89999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=354.41 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=202.7
Q ss_pred HHhhcccccccccccceEEEEEEeccCc--ceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
...|.+.+.||+|+||+||+|.+...+. ..+||+|.+.... ....+++.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 4457778999999999999998763222 2356888875432 345678999999999999999999999998765 78
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+|+||+++|+|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~-----~~~~~kl~Dfg~a 164 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVK-----TPQHVKITDFGLA 164 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE-----ETTEEEECCTTHH
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEEC-----CCCCEEEccCcce
Confidence 99999999999999988778899999999999999999999999 999999999999998 7789999999999
Q ss_pred cccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHh
Q 047157 644 KLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 644 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. ..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------~~----~~ 232 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------SS----IL 232 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------HH----HH
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--------HH----HH
Confidence 876543322 2223456889999999999999999999999999999999 9999976532221 01 01
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
... ............+.+++.+||+.||++|||++|++++|+.+.
T Consensus 233 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 233 EKG---------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HTT---------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111 011111123456888999999999999999999999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=359.87 Aligned_cols=263 Identities=26% Similarity=0.378 Sum_probs=208.5
Q ss_pred HHhhcccccccccccceEEEEEEec---cCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
...+.+.+.||+|+||+||+|.+.. ...+..||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4567788999999999999998642 245678999998643 344556889999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccC------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 563 LLVYELMPNGTLSNFLFHEG------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++..+ .+..+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~--~~~~~k 224 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG--PGRVAK 224 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS--TTCCEE
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCC--CCceEE
Confidence 99999999999999997543 4588999999999999999999999 999999999999998443 445699
Q ss_pred EeecCCccccCCCC-CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhH
Q 047157 637 ISDFGISKLLNKDQ-TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 637 L~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 714 (788)
|+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--------- 295 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------- 295 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---------
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---------
Confidence 99999997553221 122233567899999999999999999999999999999998 9999976432211
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
......... ..........+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 296 ---~~~i~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 296 ---LEFVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ---HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111111110 0011122456788999999999999999999999997654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=346.00 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=214.0
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
+....+.+.+.||+|+||+||+|.+. ..+..||+|.+... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEG--GGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEec--CCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 44556778899999999999999986 66789999998754 3345788999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 565 VYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
||||+++++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~-----~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVG-----ENHLVKVADFGLS 158 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEEC-----GGGCEEECCCCGG
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEc-----CCCCEEEccCccc
Confidence 99999999999999764 35589999999999999999999999 999999999999998 7789999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... . ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~--------~----~~~ 226 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--------E----LLE 226 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--------H----HHH
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--------H----HHh
Confidence 8776555444444567889999999998899999999999999999999 99999764322110 0 010
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.. ..........+.+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 227 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 227 KD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc---------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 00 011111123467889999999999999999999999998654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=349.26 Aligned_cols=267 Identities=24% Similarity=0.363 Sum_probs=205.9
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCc-----ceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDT-----QIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE 559 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 559 (788)
+....|.+.+.||+|+||+||+|.....+. ...||+|.+........+.+.+|++++++++||||+++++++.+.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 344567788999999999999998873322 257999999877667778899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC---CCCCcEE
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL---DTNYMAK 636 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---~~~~~~k 636 (788)
+..++||||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++.... .....+|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999987766699999999999999999999999 9999999999999983221 0111299
Q ss_pred EeecCCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH
Q 047157 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
|+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+........ ...
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-------~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-------KLQ 229 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHH
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-------HHH
Confidence 9999998754322 22457889999999987 7799999999999999999996655432211100 000
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCCCCC
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPP 781 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~pp 781 (788)
.......... .....+.+++.+||+.||++|||++|+++.|+++.....++
T Consensus 230 ---~~~~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 230 ---FYEDRHQLPA------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp ---HHHTTCCCCC------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred ---HhhccCCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 0000000000 01235678999999999999999999999999988755444
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=343.58 Aligned_cols=276 Identities=21% Similarity=0.269 Sum_probs=210.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCC--eEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED--KRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lV 565 (788)
.|.+.++||+|+||+||+|... .++..||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHK--KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEEC--CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4667899999999999999886 567799999987543 334567889999999999999999999988765 78999
Q ss_pred EecCCCCCHhHhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 566 YELMPNGTLSNFLFHEGQ--RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
|||+++++|.+++..... .+++..++.++.||+.||.|||++ +|+||||||+|||+.... ...+.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~-~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGE-DGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECT-TSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccC-CCCceEEEccCCCc
Confidence 999999999999976433 389999999999999999999999 999999999999982111 16778999999999
Q ss_pred cccCCCCCcccccccCCccccCccccc--------CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLR--------NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
........ .....||+.|+|||++. +..++.++||||||+++|||++|+.||........... ....
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~ 238 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE---VMYK 238 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH---HHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH---HHHH
Confidence 87654332 22356899999999986 57889999999999999999999999975432221111 1111
Q ss_pred HHHHHhhcccccccc-----------cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 716 WVISCMLSRNLQVLV-----------SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.............. ...............+.+++.+||+.||++|||++|+++......-
T Consensus 239 -~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 239 -IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp -HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred -HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 11111111111000 0011112345667788999999999999999999999999976543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=358.79 Aligned_cols=263 Identities=27% Similarity=0.398 Sum_probs=208.8
Q ss_pred HHHhhcccccccccccceEEEEEEe---ccCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCC
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED 560 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 560 (788)
....|.+.+.||+|+||.||+|.+. ...++..||||++.... ....+.+.+|++++.++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 3456777899999999999999864 23566799999997543 34457899999999999 7999999999998755
Q ss_pred -eEEEEEecCCCCCHhHhhhccCC--------------------------------------------------------
Q 047157 561 -KRLLVYELMPNGTLSNFLFHEGQ-------------------------------------------------------- 583 (788)
Q Consensus 561 -~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 583 (788)
..++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 48999999999999999976432
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC-cc
Q 047157 584 ---------RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT-RT 653 (788)
Q Consensus 584 ---------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~ 653 (788)
.+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++........ ..
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~-----~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS-----EKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----GGGCEEECCCGGGSCTTSCTTCEE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEc-----CCCcEEEEeccceeeecccccchh
Confidence 178999999999999999999999 999999999999998 778999999999987644332 22
Q ss_pred cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccccccC
Q 047157 654 DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSH 732 (788)
Q Consensus 654 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 732 (788)
.....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ............
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----------~~~~~~~~~~~~---- 316 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----------FCRRLKEGTRMR---- 316 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----------HHHHHHHTCCCC----
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-----------HHHHHHcCCCCC----
Confidence 334568899999999999999999999999999999998 9999976432211 011111111000
Q ss_pred CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 733 DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 733 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
........+.+++..||+.||++|||++||+++|+++++
T Consensus 317 -----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 317 -----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 011123568889999999999999999999999987653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=353.47 Aligned_cols=254 Identities=20% Similarity=0.271 Sum_probs=208.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||.||+|... .++..||+|.+..........+.+|++++++++||||+++++++.+....++||||
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEK--ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceEEEEEEecCCCEEEEEEEEC--CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4777899999999999999886 66779999999776555667899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++.. ..+.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~---~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETK---KASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESST---TCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecC---CCCceEEEecccceecCC
Confidence 999999999977767889999999999999999999999 99999999999999732 346799999999987654
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. . .........
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--------~----~~i~~~~~~- 268 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--------L----QNVKRCDWE- 268 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------H----HHHHHCCCC-
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--------H----HHHHhCCCC-
Confidence 332 2234689999999999999999999999999999999999999976432111 0 011111100
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. ... ........+.+++.+||+.||++|||++|++++
T Consensus 269 ~---~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 F---DED--AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp C---CSS--TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C---Ccc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 000 011234567899999999999999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=351.93 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=205.1
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchH-----HHHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-----KTNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
....|.+.+.||+|+||+||+|... .++..||||.+..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINR--ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEEeeEEeeCCCEEEEEEEEC--CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3456888999999999999999886 6677999999864321 13567899999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 561 KRLLVYELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
..++||||+++++|.+++... +..+++..+..++.||+.||.|||++ +|+||||||+|||++.+. ....+||
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~--~~~~vkl 174 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKE--NSAPVKL 174 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSS--TTCCEEE
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCC--CCCcEEE
Confidence 999999999999999888543 34589999999999999999999999 999999999999998433 3456999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .
T Consensus 175 ~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------------~ 240 (351)
T 3c0i_A 175 GGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-------------L 240 (351)
T ss_dssp CCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-------------H
T ss_pred ecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-------------H
Confidence 99999987654322 223457999999999999999999999999999999999999999754210 0
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
........... .+ .......+.+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~i~~~~~~~----~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 241 FEGIIKGKYKM----NP--RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHTCCCC----CH--HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCCC----Cc--cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111111000 00 000112457888999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=357.50 Aligned_cols=257 Identities=20% Similarity=0.250 Sum_probs=206.3
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
...|.+.+.||+|+||+||++... .++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~--~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKV--LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEET--TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEEC--CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 456888899999999999999886 677899999886432 3455678999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++|+|.+.+... ..+++..+..++.||+.||.|||++ +|+||||||+|||++... .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~--~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKL--KGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSS--TTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccC--CCCcEEEccCceeE
Confidence 99999999999999665 5689999999999999999999999 999999999999998543 45789999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+. ......+
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~------------~~~i~~~ 228 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL------------YQQIKAG 228 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------------HHHHHHT
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH------------HHHHHhC
Confidence 7654332 22346799999999999999999999999999999999999999975432111 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... .+ ......+.+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~---~~---~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 229 AYDFP---SP---EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCCCC---TT---TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCC---cc---ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11100 00 001224567889999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=356.98 Aligned_cols=264 Identities=28% Similarity=0.413 Sum_probs=213.1
Q ss_pred HHHHHhhcccccccccccceEEEEEEecc-----Ccceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEE
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLK-----DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFC 556 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 556 (788)
++....+.+.+.||+|+||+||+|..... ..+..||||++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 34445677889999999999999987521 234579999986543 44557899999999999 899999999999
Q ss_pred ecCCeEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCc
Q 047157 557 SEEDKRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQN 621 (788)
Q Consensus 557 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~N 621 (788)
.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 99999999999999999999997653 3589999999999999999999999 99999999999
Q ss_pred EEeccCCCCCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCc
Q 047157 622 VLLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIEL 699 (788)
Q Consensus 622 Ill~~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~ 699 (788)
||++ .++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 222 Ill~-----~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 222 VLVT-----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp EEEC-----TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEEc-----CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998 788999999999987654332 22333567889999999999999999999999999999999 9999975
Q ss_pred cccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
....+ ........... .........+.+++.+||+.||++|||++||++.|+++..
T Consensus 297 ~~~~~------------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 297 VPVEE------------LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp CCHHH------------HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH------------HHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 43221 11111111100 0111234568889999999999999999999999988764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=347.74 Aligned_cols=254 Identities=21% Similarity=0.285 Sum_probs=203.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHH------HHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK------TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
.|.+.+.||+|+||+||++... .++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEeeEEeeCcCEEEEEEEEC--CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4677899999999999999886 66779999998754321 356889999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++..+. ....+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~-~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNI-PIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTS-SSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCC-CccCEEEEecCC
Confidence 9999999999999999654 5689999999999999999999999 9999999999999973210 123799999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+.. ..+.
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~------------~~i~ 231 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------ANIT 231 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------------HHHH
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH------------HHHH
Confidence 98765432 223457999999999999999999999999999999999999999764322110 0111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..... ..........+.+.+++..||+.||++|||++|+++
T Consensus 232 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 AVSYD------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCC------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11000 000000112456788999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=368.77 Aligned_cols=257 Identities=22% Similarity=0.421 Sum_probs=208.1
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...+.+.+.||+|+||.||+|.+. .+..||||.+.... ...+.+.+|++++++++||||+++++++. .+..++||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN---KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET---TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC---CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 445677899999999999999884 45689999997543 34678999999999999999999999986 56789999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~-----~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS-----ASLVCKIADFGLARV 333 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEEC-----TTCCEEECSTTGGGG
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEC-----CCCcEEEeeCCCceE
Confidence 999999999999754 24678899999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.............++..|+|||.+....++.++||||||+++|||++ |+.||......+. . ..+..+
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~--------~----~~i~~~ 401 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--------I----RALERG 401 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--------H----HHHHHT
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH--------H----HHHHcC
Confidence 64432222233456788999999998899999999999999999999 9999975432111 0 111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
. ....+....+.+.+++.+||+.||++|||+++|++.|+.+...
T Consensus 402 ~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 402 Y---------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred C---------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0 0001112346788999999999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=339.13 Aligned_cols=258 Identities=24% Similarity=0.409 Sum_probs=203.2
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHH-------HHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK-------TNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
..|.+.+.||+|+||+||+|.+. .++..||+|.+...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLV--KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEET--TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred ccceehhccccCCceeEEEEEEc--CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 45677899999999999999886 56779999988543211 1167899999999999999999999987665
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ--IIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
++||||+++++|.+++......+++..++.++.|++.||.|||++ + |+||||||+|||++..+......+||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999999988878899999999999999999999998 8 999999999999984332233449999
Q ss_pred ecCCccccCCCCCcccccccCCccccCcccc--cCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWL--RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
|||++..... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||........ ....
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~- 240 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI------KFIN- 240 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH------HHHH-
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH------HHHH-
Confidence 9999985433 22345789999999998 455678999999999999999999999975432211 0001
Q ss_pred HHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 717 VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
......... .........+.+++.+||+.||++|||++|+++.|+++
T Consensus 241 ---~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 ---MIREEGLRP--------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---HHHHSCCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---HHhccCCCC--------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 011111111 11112345788999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=350.40 Aligned_cols=262 Identities=26% Similarity=0.381 Sum_probs=210.9
Q ss_pred HHhhcccccccccccceEEEEEEecc---Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
...|.+.+.||+|+||.||+|..... ..+..||||.+.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 34567789999999999999998632 345789999997543 44567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCC
Q 047157 563 LLVYELMPNGTLSNFLFHEG-----------------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKP 619 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp 619 (788)
++||||+++++|.+++.... ..+++.+++.++.||++||.|||++ +|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCc
Confidence 99999999999999997642 5689999999999999999999999 999999999
Q ss_pred CcEEeccCCCCCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCC
Q 047157 620 QNVLLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHI 697 (788)
Q Consensus 620 ~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~ 697 (788)
+|||++ .++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 203 ~NIl~~-----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 203 RNCLVG-----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp GGEEEC-----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ceEEEC-----CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999998 788999999999986543221 22233567889999999998899999999999999999999 99999
Q ss_pred CccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 698 ELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
......+ .......+..... .......+.+++.+||+.||++|||+.+|+++|+++.+-
T Consensus 278 ~~~~~~~------------~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 278 YGMAHEE------------VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTSCHHH------------HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCChHH------------HHHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 7543211 1111111111111 112345688899999999999999999999999987653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=350.25 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=206.8
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
...|.+.+.||+|+||.||++... .++..||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHK--TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEEC--CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 456888899999999999999886 66779999998643 23455788999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++... .+..+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~--~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKA--KGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSS--TTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCC--CCCCEEEeecCcce
Confidence 99999999999998654 5689999999999999999999999 999999999999998433 34579999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+. ......+
T Consensus 180 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------~~~i~~~ 245 (362)
T 2bdw_A 180 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------------YAQIKAG 245 (362)
T ss_dssp CCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHT
T ss_pred EecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------------HHHHHhC
Confidence 7653322 2346799999999999999999999999999999999999999975432111 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.... ...........+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 246 AYDY------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCCC------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCC------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1100 000011224567889999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.45 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=211.1
Q ss_pred HHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
...|.+.+.||+|+||.||+|.... ...+..||||.+.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 4457778999999999999998742 2345789999987543 44567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCC
Q 047157 563 LLVYELMPNGTLSNFLFHEG-----------------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKP 619 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp 619 (788)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 99999999999999997643 2378999999999999999999999 999999999
Q ss_pred CcEEeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCC
Q 047157 620 QNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHI 697 (788)
Q Consensus 620 ~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~ 697 (788)
+||+++ .++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 179 ~NIli~-----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 179 RNILVA-----EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp GGEEEE-----TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred heEEEc-----CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999998 7889999999999876543322 2233457888999999999899999999999999999999 99999
Q ss_pred CccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 698 ELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
......... ........ ........+.+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 254 ~~~~~~~~~------------~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 254 PGIPPERLF------------NLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp TTCCGGGHH------------HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHH------------HHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 765322110 11111110 01111234678899999999999999999999999987653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=348.37 Aligned_cols=274 Identities=22% Similarity=0.340 Sum_probs=211.1
Q ss_pred HHHHHhhcccccccccccceEEEEEEe--ccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecC-
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE- 559 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 559 (788)
.+....+.+.+.||+|+||.||+|.+. ....+..||+|.+.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 344555778899999999999999853 23567899999987443 33457889999999999999999999999876
Q ss_pred -CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 560 -DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 560 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
+..++||||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~-----~~~~~kl~ 168 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE-----SEHQVKIG 168 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE-----ETTEEEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEc-----CCCCEEEC
Confidence 678999999999999999977777899999999999999999999999 999999999999998 77899999
Q ss_pred ecCCccccCCCCC--cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccc----ccchhh
Q 047157 639 DFGISKLLNKDQT--RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES----EEVDIV 712 (788)
Q Consensus 639 Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~----~~~~~~ 712 (788)
|||++........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+......... ......
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence 9999987755432 2233456788899999999999999999999999999999999987533111000 000000
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
. .......... ..........+.+.+++.+||+.||++|||++|+++.|+.++
T Consensus 249 ~-~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 249 V-TRLVNTLKEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp H-HHHHHHHHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-HHHHHHHhcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0 0011111111 111111223467889999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=351.50 Aligned_cols=249 Identities=22% Similarity=0.270 Sum_probs=199.6
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
.+.||+|+||.||+|... .++..||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEET--ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEET--TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEc--CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 468999999999999886 667799999998766666788999999999999999999999999999999999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
+|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++.. .++.+||+|||++........
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~---~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNR---DAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEET---TTTEEEECCCSSCEECCTTCB-
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecC---CCCcEEEEeCCCceecCCccc-
Confidence 99999977767789999999999999999999999 99999999999999421 567899999999987654332
Q ss_pred ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccC
Q 047157 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSH 732 (788)
Q Consensus 653 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 732 (788)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. + ..+.....
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~-----~~i~~~~~------ 305 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-------L-----NNILACRW------ 305 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------H-----HHHHHTCC------
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------H-----HHHHhccC------
Confidence 2234689999999999999999999999999999999999999976532211 0 00111100
Q ss_pred CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 733 DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 733 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...........+.+.+++.+||+.||++|||++|+++
T Consensus 306 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000001123467889999999999999999999987
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=339.33 Aligned_cols=267 Identities=17% Similarity=0.203 Sum_probs=211.3
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~ 566 (788)
..|.+.+.||+|+||.||+|... .++..||||.+.... ..+.+.+|+++++++ +|+|++++++++.+....++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNL--LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET--TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEEC--CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 34677899999999999999876 677899999886432 234678899999999 7999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+ +++|.+++...+..+++..+..++.||+.||.|||++ +|+||||||+|||++.++......+||+|||++...
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 9999999987777899999999999999999999999 999999999999998443224455999999999876
Q ss_pred CCCCCc------ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 647 NKDQTR------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 647 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........... . ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~----~-~~~~~~ 236 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK----Y-ERIGEK 236 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH----H-HHHHHH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH----H-HHHHhh
Confidence 543321 23346799999999999999999999999999999999999999986432211110 0 001010
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
........+. ....+.+.+++.+||+.||++|||+++|++.|+++.+
T Consensus 237 ~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 237 KQSTPLRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHHSCHHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCccHHHHH---------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 1011111110 0124578889999999999999999999999988754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.00 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=209.6
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..|.+.+.||+|+||.||++... ++..||+|.+..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEec---CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 45677899999999999999874 456899999976432 34678999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++....
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~-----~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVG-----ENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEEC-----GGGCEEECCTTGGGGBC
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEC-----CCCCEEEcccccccccc
Confidence 9999999999987777889999999999999999999999 999999999999998 77899999999998764
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ........
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------------~~~i~~~~- 222 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------------VEDISTGF- 222 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------------HHHHHTTC-
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------------HHHHhcCC-
Confidence 432222333456788999999998899999999999999999999 8999975432111 01111110
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
. ...+......+.+++.+||+.||++|||++|++++|+++.+
T Consensus 223 ~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 223 R--------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c--------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 00011224567889999999999999999999999988654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=365.49 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=204.3
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...+.+.+.||+|+||.||+|.+. .+..||||.+.... ...++|.+|++++++++||||+++++++.+ +..++||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN---GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEEC---CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 345677899999999999999885 34579999997543 235689999999999999999999999876 6789999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++|+|.+++... +..+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~-----~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG-----ENLVCKVADFGLARL 329 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----GGGCEEECCCCTTC-
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEC-----CCCCEEECCCcccee
Confidence 999999999999753 35689999999999999999999999 999999999999998 778999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ......+
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------------~~~i~~~ 397 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------------LDQVERG 397 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------------HHHHHTT
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH------------HHHHHcC
Confidence 65433333333456789999999998899999999999999999999 9999975432111 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCCCCC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPP 781 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~pp 781 (788)
. ....+....+.+.+++.+||+.||++|||+++|++.|+.+.....|.
T Consensus 398 ~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 398 Y---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred C---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 0 00111123467888999999999999999999999999987654443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.78 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=205.3
Q ss_pred HhhcccccccccccceEEEEEEec-cCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..|.+.+.||+|+||+||+|.... ...+..||+|.+... .....+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 456678999999999999998763 234567999998754 34456789999999999999999999999865 456899
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++......+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~-----~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVA-----SPECVKLGDFGLSRY 162 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEE-----ETTEEEECCCCGGGC
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEC-----CCCcEEeCccCCCcc
Confidence 999999999999987777799999999999999999999999 999999999999998 778999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--------~~~----~~~~ 230 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--------IGV----LEKG 230 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--------HHH----HHHT
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--------HHH----HhcC
Confidence 65544333344567889999999998899999999999999999998 9999975432211 010 1111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
... .......+.+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 231 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 231 DRL---------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 000 001112356888999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=344.92 Aligned_cols=257 Identities=22% Similarity=0.291 Sum_probs=204.6
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchH------HHHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE------KTNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
...|.+.+.||+|+||.||++... .++..||+|.+..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEET--TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccceEeceEEeeCCCeEEEEEEEC--CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 356788899999999999999886 6677999998865432 13578899999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++..+. ....+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~-~~~~~kl~Df 162 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNV-PKPRIKIIDF 162 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSS-SSCCEEECCC
T ss_pred EEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCC-CCCCEEEEEC
Confidence 999999999999999999654 5689999999999999999999999 9999999999999983221 2238999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+.. ..
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------------~~ 228 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------AN 228 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------------HH
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------------HH
Confidence 99987653322 23457899999999999999999999999999999999999999754321110 00
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
....... ............+.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 229 VSAVNYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHTCCC------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhcCCC------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 0000001123567889999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.23 Aligned_cols=261 Identities=21% Similarity=0.319 Sum_probs=197.4
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcC--CCccccceEeeEEec----CC
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR--THHKNLVRLLGFCSE----ED 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~----~~ 560 (788)
...|.+.+.||+|+||+||+|.. ++..||||++.... .+.+..|.+++.. ++||||+++++++.. ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW----QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE----TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE----CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 34577789999999999999976 46689999986542 3444555555554 899999999998654 34
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhh--------hccCCceEecCCCCCcEEeccCCCCCC
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH--------EECETQIIHCDIKPQNVLLDLKTLDTN 632 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivH~dlkp~NIll~~~~~~~~ 632 (788)
..++||||+++++|.+++.. ..+++..++.++.||+.||.||| +. +|+||||||+|||++ .+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~-----~~ 149 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVK-----KN 149 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEEC-----TT
T ss_pred eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEc-----CC
Confidence 68999999999999999943 46899999999999999999999 76 999999999999998 78
Q ss_pred CcEEEeecCCccccCCCCCcc---cccccCCccccCcccccCC------CCCccCcchhhHHHHHHHHhC----------
Q 047157 633 YMAKISDFGISKLLNKDQTRT---DTNMRGTMGYVAPEWLRNV------PVTTKVDVFSFGVMLLEIICG---------- 693 (788)
Q Consensus 633 ~~~kL~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltg---------- 693 (788)
+.+||+|||++.......... .....||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 899999999998664433221 2234789999999999876 566799999999999999999
Q ss_pred CCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 694 RRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 694 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
+.||......... ..... ......... ...+...........+.+++.+||+.||++|||++||++.|++
T Consensus 230 ~~pf~~~~~~~~~------~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 230 KPPFYDVVPNDPS------FEDMR-KVVCVDQQR---PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CCTTTTTSCSSCC------HHHHH-HHHTTSCCC---CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccCCCCcc------hhhhh-HHHhccCCC---CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 7777543221111 01111 111100000 0011111233567889999999999999999999999999986
Q ss_pred C
Q 047157 774 T 774 (788)
Q Consensus 774 ~ 774 (788)
+
T Consensus 300 i 300 (301)
T 3q4u_A 300 I 300 (301)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=345.01 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=201.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||+|.+. .++..||+|.+..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHY--KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4677899999999999999886 6777999999875432 2245789999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+ +|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~-----~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLD-----DNLNVKIADFGLSNI 157 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEEC-----TTCCEEECCSSCTBT
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEc-----CCCCEEEEEecccee
Confidence 9999 78999988655 5689999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... .....||+.|+|||.+.+..+ ++++||||||+++|+|++|+.||............
T Consensus 158 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------------- 220 (336)
T 3h4j_B 158 MTDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------------- 220 (336)
T ss_dssp TTTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------
T ss_pred ccCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------
Confidence 654322 234579999999999988776 68999999999999999999999764322211110
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... ..+......+.+++.+||+.||.+|||++|+++.
T Consensus 221 -----~~~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 221 -----NSCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -----CSSCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -----HcCCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00000 0111224567889999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.20 Aligned_cols=273 Identities=23% Similarity=0.306 Sum_probs=214.3
Q ss_pred HHhhcccccccccccceEEEEEEe--ccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEe--cCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCS--EEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~ 562 (788)
...|.+.+.||+|+||.||++.+. ....+..||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 356778899999999999999853 23567799999998776777788999999999999999999999886 45678
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~-----~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVE-----SEAHVKIADFGL 173 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE-----ETTEEEECCGGG
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEEC-----CCCCEEEccccc
Confidence 999999999999999977666799999999999999999999999 999999999999998 778999999999
Q ss_pred ccccCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccccc---chhhhHHHH
Q 047157 643 SKLLNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEE---VDIVLSDWV 717 (788)
Q Consensus 643 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~---~~~~~~~~~ 717 (788)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........... .........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 9876543322 22335678889999999998999999999999999999999999875432211000 000000001
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
...... ...........+.+.+++.+||+.||++|||++|++++|+.+..
T Consensus 254 ~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 254 LELLEE---------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHhhc---------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111 11111122335678899999999999999999999999988753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=352.36 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=199.9
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED 560 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 560 (788)
+....|.+.++||+|+||+||+|..+ .++..||||.+.+.. ....+.+.+|.+++..+ +||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVK--ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEc--CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 33445777899999999999999886 667799999997542 33456788999999988 7999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~-----~~g~ikL~DF 168 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLD-----HEGHCKLADF 168 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC-----TTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEEC-----CCCCEEEccc
Confidence 999999999999999999655 5689999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
|+++...... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...
T Consensus 169 G~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------------~~~ 235 (353)
T 3txo_A 169 GMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------------FEA 235 (353)
T ss_dssp TTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHH
T ss_pred cceeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------------HHH
Confidence 9998643322 223346799999999999999999999999999999999999999976532211 111
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH------HHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM------KKVIH 769 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 769 (788)
+..... .. +......+.+++.+||+.||++||++ +|+++
T Consensus 236 i~~~~~--------~~--p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 236 ILNDEV--------VY--PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHCCC--------CC--CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHcCCC--------CC--CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111111 00 11123567889999999999999998 77775
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=344.53 Aligned_cols=264 Identities=17% Similarity=0.191 Sum_probs=206.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.+.||+|+||+||+|... .++..||||.+.... ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNL--YTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEET--TTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CeEEEEEeeccCCceEEEEEEC--CCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4667799999999999999876 677899999986532 234678999999999 99999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+ +++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++.........+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 9999999987677899999999999999999999999 9999999999999983321122239999999998764
Q ss_pred CCCCc------ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 648 KDQTR------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 648 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............ .. .....
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~----~~-i~~~~ 236 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY----QK-IGDTK 236 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH----HH-HHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH----HH-HHhhh
Confidence 43321 123467999999999999999999999999999999999999999865322211100 00 00000
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.......+. ...+ ++.+++..||+.||.+||++++|++.|+++.
T Consensus 237 ~~~~~~~~~---------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 237 RATPIEVLC---------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHSCHHHHT---------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCCHHHHh---------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000000000 0012 7888999999999999999999999997553
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=341.31 Aligned_cols=254 Identities=22% Similarity=0.231 Sum_probs=200.4
Q ss_pred cCHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCC-CccccceEeeEE
Q 047157 480 FTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRT-HHKNLVRLLGFC 556 (788)
Q Consensus 480 ~~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 556 (788)
....++....|.+.++||+|+||+||+|... .++..||||++... .......+..|+..+.++ +||||+++++++
T Consensus 49 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSK--EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp TSSSCHHHHHEEEEEEEEEETTEEEEEEEET--TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCccchhhhheeeeheeccCCCeEEEEEEEC--CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 3445666778888999999999999999886 56779999987543 233344556666666555 899999999999
Q ss_pred ecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 557 SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 557 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
.+++..++||||+ +++|.+++...+..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+|
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~-----~~~~~k 197 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLG-----PRGRCK 197 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----GGGCEE
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEC-----CCCCEE
Confidence 9999999999999 7799999988777899999999999999999999999 999999999999998 788999
Q ss_pred EeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
|+|||++........ .....||+.|+|||++.+ .++.++||||||+++|||++|..|+......
T Consensus 198 l~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~------------- 261 (311)
T 3p1a_A 198 LGDFGLLVELGTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW------------- 261 (311)
T ss_dssp ECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-------------
T ss_pred EccceeeeecccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------------
Confidence 999999987644322 234568999999999876 7999999999999999999998776543111
Q ss_pred HHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..+........ ......+.+.+++.+||+.||++|||++|++++
T Consensus 262 --~~~~~~~~~~~--------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 262 --QQLRQGYLPPE--------FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp --HHHTTTCCCHH--------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHhccCCCcc--------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 01111111000 011224678899999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.30 Aligned_cols=263 Identities=27% Similarity=0.404 Sum_probs=208.9
Q ss_pred HHHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCC
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED 560 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 560 (788)
....|.+.+.||+|+||.||+|.+.. ...+..||||.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 34567788999999999999998742 3456789999987542 33456899999999999 8999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccCC----------------------CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCC
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQ----------------------RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIK 618 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlk 618 (788)
..++||||+++++|.+++..... .+++..++.++.||+.||.|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999976543 368999999999999999999999 99999999
Q ss_pred CCcEEeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCC
Q 047157 619 PQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRH 696 (788)
Q Consensus 619 p~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p 696 (788)
|+|||++ .++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 200 p~NIll~-----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 200 ARNVLVT-----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp GGGEEEE-----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred hhhEEEc-----CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999998 7889999999999876543322 2233557889999999998899999999999999999998 9999
Q ss_pred CCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 697 IELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
|........ .. ...... . ....+....+.+.+++.+||+.||++|||+.||+++|+.++.
T Consensus 275 ~~~~~~~~~-------~~----~~~~~~-~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 275 YPGIPVDAN-------FY----KLIQNG-F--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp STTCCCSHH-------HH----HHHHTT-C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cccCCcHHH-------HH----HHHhcC-C--------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 976432111 00 111111 0 001111224678889999999999999999999999988664
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=358.01 Aligned_cols=255 Identities=20% Similarity=0.217 Sum_probs=205.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.+.+.++||+|+||+||+|..+ .++..||+|++.+... ...+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLK--NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred heEEEEEEEeCCCEEEEEEEEc--CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 4566789999999999999886 6678999999975322 1223488999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++.+....+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~-----~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMD-----MNGHIRLADFGSCLK 224 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEc-----CCCCEEEcchhhhhh
Confidence 999999999999987667899999999999999999999999 999999999999998 888999999999987
Q ss_pred cCCCCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
.............||+.|+|||++. ...++.++|||||||++|||++|+.||......+.... +...
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~--------i~~~ 296 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK--------IMNH 296 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------HHTH
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHh--------hhhc
Confidence 7655554445578999999999986 56789999999999999999999999976533221110 0000
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNL--RPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 770 (788)
.....+ +... ....+.+.+|+.+||+.+|++ ||+++|++++
T Consensus 297 ~~~~~~-------p~~~--~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERFQF-------PTQV--TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHCCC-------CSSC--CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccccC-------Cccc--ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 000000 1100 012356778999999888888 9999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=350.95 Aligned_cols=257 Identities=24% Similarity=0.337 Sum_probs=201.2
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 563 (788)
..|.+.++||+|+||+||+++.+ .++..||+|++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~--~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLK--KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 34677899999999999999886 677899999997643 22334678899999876 8999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 130 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~-----~~g~ikL~DFGla 200 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLD-----SEGHIKLTDYGMC 200 (396)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC-----TTSCEEECCCTTC
T ss_pred EEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEC-----CCCCEEEeeccee
Confidence 999999999999999654 5689999999999999999999999 999999999999998 8889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
+...... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... ...........
T Consensus 201 ~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~---~~~~~~~~i~~ 276 (396)
T 4dc2_A 201 KEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN---TEDYLFQVILE 276 (396)
T ss_dssp BCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C---CHHHHHHHHHH
T ss_pred eecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh---hHHHHHHHHhc
Confidence 8633222 2234468999999999999999999999999999999999999999754322111100 11111111211
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH------HHHHH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM------KKVIH 769 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 769 (788)
... ... ......+.+++.+||+.||++||++ +||++
T Consensus 277 ~~~--------~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 277 KQI--------RIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp CCC--------CCC--TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ccc--------CCC--CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 111 111 1124567889999999999999995 56665
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=339.97 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=207.6
Q ss_pred hhcccc-cccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSK-LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.+.+.+ .||+|+||.||+|.+.....+..||||.+.... ....+.+.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344444 899999999999987655677889999997642 44567899999999999999999999999 556789999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~-----~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLV-----NRHYAKISDFGLSKAL 160 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEE-----ETTEEEECCCTTCEEC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEc-----CCCCEEECcccceeee
Confidence 99999999999987777899999999999999999999999 999999999999998 7789999999999877
Q ss_pred CCCCCcc--cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 647 NKDQTRT--DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 647 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. . .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------~----~~i~~ 228 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--------M----AFIEQ 228 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--------H----HHHHT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--------H----HHHhc
Confidence 5433221 223456889999999998899999999999999999998 9999975432111 0 11111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.... ..+......+.+++..||+.||++||++.|++++|+.+..
T Consensus 229 ~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 229 GKRM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcC---------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1100 0111234678889999999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=338.24 Aligned_cols=258 Identities=30% Similarity=0.436 Sum_probs=193.2
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchH----HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE----KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
..|.+.+.||+|+||.||+|.+. +..||||.+..... ...+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred hheeeeeeeccCCCeEEEEEEEc----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 34667899999999999999863 56899999865432 23467899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC---CCCCcEEEeec
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL---DTNYMAKISDF 640 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---~~~~~~kL~Df 640 (788)
+||||+++++|.+++. ...+++..++.++.|++.||.|||++...+|+||||||+|||++.... ..++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999999984 357899999999999999999999982122999999999999984221 02678999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
|++........ ....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ...
T Consensus 161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----------~~~- 225 (271)
T 3dtc_A 161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-----------AYG- 225 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----------HHH-
T ss_pred Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------HHh-
Confidence 99986543322 234689999999999999999999999999999999999999975432111 000
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
...... .........+.+.+++.+||+.||++|||++|++++|+++
T Consensus 226 ~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 VAMNKL--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHTSCC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hhcCCC--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111110 1111122345788899999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=339.15 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=194.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchH--------------------------HHHHHHHHHHHHhc
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--------------------------KTNEEFMTELKIIG 542 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 542 (788)
.|.+.+.||+|+||.||+|... .++..||||.+..... ...+.+.+|+++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNE--NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEET--TTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ceEEEeEEeecCCEEEEEEEEC--CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4677899999999999999876 6778999999865421 12356889999999
Q ss_pred CCCccccceEeeEEec--CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCC
Q 047157 543 RTHHKNLVRLLGFCSE--EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQ 620 (788)
Q Consensus 543 ~l~hpniv~~~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 620 (788)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.||+.||.|||++ +|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 9999999999999986 568999999999999988763 35789999999999999999999999 9999999999
Q ss_pred cEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCC---CCccCcchhhHHHHHHHHhCCCCC
Q 047157 621 NVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVP---VTTKVDVFSFGVMLLEIICGRRHI 697 (788)
Q Consensus 621 NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltg~~p~ 697 (788)
|||++ .++.+||+|||++........ ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||
T Consensus 167 Nil~~-----~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 167 NLLVG-----EDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp GEEEC-----TTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred HEEEC-----CCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 99998 788999999999987654322 223457899999999997665 478899999999999999999999
Q ss_pred CccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 698 ELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
....... . .......... ........+.+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~--------~----~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDERIMC--------L----HSKIKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCSSHHH--------H----HHHHHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccHHH--------H----HHHHhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 7542211 0 0111111110 0111122456788999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=347.13 Aligned_cols=260 Identities=27% Similarity=0.484 Sum_probs=202.9
Q ss_pred HHhhcccccccccccceEEEEEEeccC--cceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKD--TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
...+.+.+.||+|+||+||+|.....+ .+..||||.+.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 345566789999999999999886322 24569999987542 445568999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~-----~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVN-----SNLVCKVSDFGLS 194 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTCCEEECCCCC-
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEEC-----CCCcEEECCCCcc
Confidence 99999999999999987777899999999999999999999999 999999999999998 7889999999999
Q ss_pred cccCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHH
Q 047157 644 KLLNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 644 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------------~~~~ 262 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------VMKA 262 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------------HHHH
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------------HHHH
Confidence 876543221 1222346788999999999999999999999999999999 999996542211 0111
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
...+. ...........+.+++.+||+.||++||++.+++++|+++.
T Consensus 263 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 263 INDGF---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp HHTTC---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHCCC---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11110 00111123456888999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=342.46 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=199.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||+||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDS---QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEET---TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hhHhhhhccCCCCeEEEEEEEC---CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4667799999999999999874 46799999986443 233567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||++ ++|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~-----~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLIN-----SDGALKLADFGLARAF 169 (311)
T ss_dssp ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTCCEEECCCTTCEET
T ss_pred cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEEC-----CCCCEEEccCcCceec
Confidence 9997 488888877777799999999999999999999999 999999999999998 7789999999999876
Q ss_pred CCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
..... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.... .........
T Consensus 170 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------i~~~~~~~~ 240 (311)
T 3niz_A 170 GIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK--------IFSILGTPN 240 (311)
T ss_dssp TSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH--------HHHHHCCCC
T ss_pred CCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH--------HHHHHCCCC
Confidence 43322 2233568999999999876 5689999999999999999999999976543221110 111000000
Q ss_pred c---c-------------ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 L---Q-------------VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~---~-------------~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. . ......+.........+++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0 000000000000112357789999999999999999999987
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=344.63 Aligned_cols=252 Identities=25% Similarity=0.321 Sum_probs=200.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.+.||+|+||+||+|... .++..||||.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNR--VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hceeeeEEecCCCEEEEEEEEC--CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 4667899999999999999886 567799999986433 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..+.
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~-----~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLD-----ERDNLKISDFGLATVFR 156 (323)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTCCEEECCCTTCEECE
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEe-----CCCCEEEEEeeccceec
Confidence 99999999998543 5689999999999999999999999 999999999999998 77899999999998664
Q ss_pred CCCC-cccccccCCccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 648 KDQT-RTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 648 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+. ..
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~-----~~- 224 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWK-----EK- 224 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH------HHHHHH-----TT-
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHh-----cc-
Confidence 3222 22334679999999999987765 7899999999999999999999976432211 111110 00
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.............+.+++.+||+.||++|||++|+++.
T Consensus 225 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 -------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00001111234567789999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.51 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=203.9
Q ss_pred hcccccccccccceEEEEEEecc-Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE-EEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR-LLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-~lV~ 566 (788)
+...++||+|+||+||+|.+... .....+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 34458899999999999987532 234479999987533 34567899999999999999999999999876655 9999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+.+++|.+++......+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++...
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~-----~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLD-----ESFTVKVADFGLARDI 174 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----TTCCEEECCTTSSCTT
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEc-----CCCcEEeCcCCCcccc
Confidence 99999999999988778889999999999999999999999 999999999999998 7889999999999865
Q ss_pred CCCC---CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 647 NKDQ---TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 647 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
.... ........+++.|+|||.+.+..++.++||||||+++|||++|..|+....... ..... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-------~~~~~----~~~ 243 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-------DLTHF----LAQ 243 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-------GHHHH----HHT
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-------HHHHH----hhc
Confidence 4322 112233567889999999999999999999999999999999666653321111 01110 111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.. .........+.+.+++.+||+.||++|||++++++.|+++.
T Consensus 244 ~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 244 GR---------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 00111122456888999999999999999999999998765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=343.74 Aligned_cols=263 Identities=27% Similarity=0.441 Sum_probs=212.0
Q ss_pred HHHhhcccccccccccceEEEEEEe---ccCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCC
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED 560 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 560 (788)
....|.+.+.||+|+||.||+|... ....+..||||.+.... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 3456778899999999999999863 23567799999987543 34457899999999999 9999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccCC-----------------CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEE
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQ-----------------RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVL 623 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 623 (788)
..++||||+++++|.+++..... .+++..++.++.||+.||.|||++ +|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999976543 489999999999999999999999 9999999999999
Q ss_pred eccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccc
Q 047157 624 LDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSR 701 (788)
Q Consensus 624 l~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~ 701 (788)
++ .++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 ~~-----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 178 LT-----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EE-----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred Ec-----CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 98 7889999999999877554332 2233457789999999999999999999999999999999 999997543
Q ss_pred cccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 702 VEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.... .... .... ... .........+.+++.+||+.||++|||++|++++|+++..
T Consensus 253 ~~~~-------~~~~----~~~~-~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 253 VDSK-------FYKM----IKEG-FRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp SSHH-------HHHH----HHHT-CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhH-------HHHH----hccC-CCC--------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 2111 1110 1110 010 0111234578889999999999999999999999987653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.09 Aligned_cols=244 Identities=27% Similarity=0.320 Sum_probs=202.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||++... .++..||+|.+.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSR--HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 4677899999999999999886 677899999997543 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~-----~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLD-----KNGHIKITDFGFAKY 155 (318)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEEC-----TTSCEEECCCSSCEE
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEc-----CCCCEEEeecCccee
Confidence 9999999999999654 5688999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ........
T Consensus 156 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------------~~~i~~~~ 219 (318)
T 1fot_A 156 VPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------------YEKILNAE 219 (318)
T ss_dssp CSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------------HHHHHHCC
T ss_pred cCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------------HHHHHhCC
Confidence 5432 2345799999999999999999999999999999999999999975432111 01111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 769 (788)
. .. +......+.+++.+||+.||++|| +++|+++
T Consensus 220 ~--------~~--p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 L--------RF--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp C--------CC--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C--------CC--CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1 00 011235678899999999999999 8999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.27 Aligned_cols=264 Identities=18% Similarity=0.227 Sum_probs=199.7
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..|.+.+.||+|+||.||++... .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDT--VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEET--TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEc--CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35777899999999999999876 567899999987543 3345789999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++.
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~-----~~~~~kl~Dfg~~~ 182 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVS-----ADDFAYLVDFGIAS 182 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTSCEEECSCCC--
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEc-----CCCCEEEecCccCc
Confidence 99999999999999654 5689999999999999999999999 999999999999998 77899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..............+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ...... .
T Consensus 183 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------------~~~~~~-~ 249 (309)
T 2h34_A 183 ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV------------MGAHIN-Q 249 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH------------HHHHHH-S
T ss_pred cccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH------------HHHHhc-c
Confidence 765543333344578999999999999999999999999999999999999997643210 000111 1
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHhhcCcCCCCCC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-SMKKVIHMLEGTLEVGMPP 781 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~~~~pp 781 (788)
...... .........+.+++.+||+.||++|| +++++++.|+..+....+.
T Consensus 250 ~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 250 AIPRPS------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp CCCCGG------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred CCCCcc------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 111000 00112234677899999999999999 9999999999887655443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=353.97 Aligned_cols=255 Identities=21% Similarity=0.197 Sum_probs=204.5
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..+.+.++||+|+||.||++..+ .+++.||||++.+.. ....+.+.+|..++..++||||+++++++.+.+..++
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~--~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMK--QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 34566789999999999999886 677899999997532 2233458899999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++|+|.+++.+.+..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++++||+|||+++
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld-----~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLD-----RCGHIRLADFGSCL 210 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEECCCTTCE
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeec-----CCCCEEEeechhhe
Confidence 9999999999999987767899999999999999999999999 999999999999998 88899999999998
Q ss_pred ccCCCCCcccccccCCccccCccccc-------CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLR-------NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
..............||+.|+|||++. ...++.++|||||||++|||++|+.||......+.... +
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~--------i 282 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK--------I 282 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------H
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH--------H
Confidence 77655443444568999999999987 45789999999999999999999999976532221100 0
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCC---CCHHHHHHH
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLR---PSMKKVIHM 770 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl~~ 770 (788)
......... +. .......++.+++.+||+ +|++| |+++||+++
T Consensus 283 ~~~~~~~~~-------p~--~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 283 VHYKEHLSL-------PL--VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HTHHHHCCC-------C------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HhcccCcCC-------Cc--cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000000000 00 011224577889999999 99998 699999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.31 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=183.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||+|... .++..||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESI--HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEc--cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4667789999999999999876 5677999999865432 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~-----~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLT-----RNMNIKIADFGLATQ 161 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEEC-----TTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc-----CCCCEEEEeecceee
Confidence 999999999999987767889999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....
T Consensus 162 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------------- 223 (278)
T 3cok_A 162 LKMPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----------------- 223 (278)
T ss_dssp CC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------
T ss_pred ccCCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-----------------
Confidence 6433221 2235689999999999998999999999999999999999999976432211100
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
....... .+......+.+++.+||+.||++|||++++++
T Consensus 224 ---~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 224 ---VVLADYE--MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CCSSCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---HhhcccC--CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0000000 11122456788999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=344.33 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=193.5
Q ss_pred HHhhcccccccccccceEEEEEEeccCc-ceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE-
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDT-QIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR- 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~- 562 (788)
...|.+.+.||+|+||+||+|.+...+. ...||||.+... .....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3457788999999999999998763221 137999998754 244567899999999999999999999999887655
Q ss_pred -----EEEEecCCCCCHhHhhhccC-----CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC
Q 047157 563 -----LLVYELMPNGTLSNFLFHEG-----QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632 (788)
Q Consensus 563 -----~lV~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~ 632 (788)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++ .+
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~-----~~ 173 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLA-----ED 173 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----TT
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEc-----CC
Confidence 99999999999999995432 2589999999999999999999999 999999999999998 78
Q ss_pred CcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccch
Q 047157 633 YMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVD 710 (788)
Q Consensus 633 ~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 710 (788)
+.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---- 249 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---- 249 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH----
Confidence 8999999999987644322 22223456788999999999999999999999999999999 89999764322210
Q ss_pred hhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 711 IVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
....... .........+.+.+++.+||+.||++|||+.++++.|++++.
T Consensus 250 --------~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 250 --------NYLIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp --------HHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111111 001111234578899999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=349.08 Aligned_cols=277 Identities=14% Similarity=0.168 Sum_probs=205.6
Q ss_pred Hhhccccccccc--ccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTG--SSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G--~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
..|.+.++||+| +||+||+|... .++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYK--PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEc--CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 357778999999 99999999986 677899999987543 445678889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 564 LVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
+||||+++++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||.
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~-----~~~~~kl~dfg~ 174 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILIS-----VDGKVYLSGLRS 174 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTCCEEECCGGG
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc-----CCCCEEEccccc
Confidence 999999999999999654 35689999999999999999999999 999999999999998 788999999998
Q ss_pred ccccCCCCC------cccccccCCccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh-h
Q 047157 643 SKLLNKDQT------RTDTNMRGTMGYVAPEWLRN--VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV-L 713 (788)
Q Consensus 643 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-~ 713 (788)
+........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 875432211 11223468899999999987 67999999999999999999999999764332211110000 0
Q ss_pred HHHHHH------H--------hhcccccccccC---------CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 714 SDWVIS------C--------MLSRNLQVLVSH---------DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 714 ~~~~~~------~--------~~~~~~~~l~~~---------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...... . .....+...+.. .+...........+.+|+.+||+.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 0 000000000000 00000112234568899999999999999999999965
Q ss_pred --hhcC
Q 047157 771 --LEGT 774 (788)
Q Consensus 771 --L~~~ 774 (788)
++++
T Consensus 335 p~f~~~ 340 (389)
T 3gni_B 335 SFFKQI 340 (389)
T ss_dssp GGGGGC
T ss_pred HHHHHH
Confidence 4443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=359.40 Aligned_cols=250 Identities=29% Similarity=0.406 Sum_probs=202.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCC-eEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED-KRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lV~ 566 (788)
..+.+.+.||+|+||.||+|.+. +..||||.++... ..+.|.+|++++++++||||+++++++.+.+ ..++||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~----~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET----TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec----CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 44667789999999999999873 4589999997643 4568999999999999999999999987665 799999
Q ss_pred ecCCCCCHhHhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHEGQ-RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++|+|.+++...+. .+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~-----~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVS-----EDNVAKVSDFGLTKE 338 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC-----TTSCEEECCCTTCEE
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEC-----CCCCEEEeeCCCccc
Confidence 99999999999987654 369999999999999999999999 999999999999998 788999999999985
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .....+
T Consensus 339 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~------------~~i~~~ 402 (450)
T 1k9a_A 339 ASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------------PRVEKG 402 (450)
T ss_dssp CC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH------------HHHHTT
T ss_pred ccccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------HHHHcC
Confidence 43221 12356889999999999999999999999999999998 99999754322110 111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
. ....+......+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 403 ~---------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 403 Y---------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0 001111234678889999999999999999999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=349.86 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=196.0
Q ss_pred hcccccccccccceEEEEEEecc-Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEec-CCeEEEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-EDKRLLVY 566 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lV~ 566 (788)
+.+.++||+|+||+||+|..... .....||+|.+.... ....+++.+|+.++++++||||+++++++.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 45668999999999999987633 234578999886532 3456789999999999999999999998754 56789999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++......+++..++.++.||++||.|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~-----~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLD-----EKFTVKVADFGLARDM 242 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTCCEEECCC------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEEC-----CCCCEEEeeccccccc
Confidence 99999999999987777889999999999999999999999 999999999999998 7889999999999866
Q ss_pred CCCCCc---ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 647 NKDQTR---TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 647 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. ... ..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--------~~~----~~ 310 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--------TVY----LL 310 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--------HHH----HH
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--------HHH----HH
Confidence 433211 1223457788999999999999999999999999999999 6677754422111 000 11
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.+.. ...+......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 311 ~~~~---------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 311 QGRR---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1110 0011122456888999999999999999999999998765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.76 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=202.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 564 (788)
.|.+.+.||+|+||.||++..+ .++..||+|.+.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLK--KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred heEEEEEEEecCCeEEEEEEEC--CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 4677899999999999999886 677899999997542 34456788999999887 89999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~-----~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLD-----SEGHIKLTDYGMCK 158 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC-----TTSCEEECCGGGCB
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEC-----CCCCEEEEeccccc
Confidence 99999999999999654 5689999999999999999999999 999999999999998 78899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........... .............
T Consensus 159 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~~~~~~i~~~ 234 (345)
T 3a8x_A 159 EGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---NTEDYLFQVILEK 234 (345)
T ss_dssp CSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------CHHHHHHHHHHC
T ss_pred cccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc---ccHHHHHHHHHcC
Confidence 643222 223346799999999999999999999999999999999999999975322111000 0011111111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH------HHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM------KKVIH 769 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 769 (788)
.. .. +......+.+++.+||+.||++||++ +|+++
T Consensus 235 ~~--------~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 235 QI--------RI--PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CC--------CC--CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CC--------CC--CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11 11 11234567889999999999999995 67665
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.32 Aligned_cols=260 Identities=21% Similarity=0.253 Sum_probs=204.1
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEe----cCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCS----EEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~~ 563 (788)
..|.+.+.||+|+||.||++... .++..||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGL--HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEET--TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEec--CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 34677899999999999999886 567799999987666667788999999999999999999999986 344789
Q ss_pred EEEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 564 LVYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
+||||+++++|.+++.. .+..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~-----~~~~~kl~df 178 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLG-----DEGQPVLMDL 178 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTSCEEECCC
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc-----CCCCEEEEec
Confidence 99999999999999965 356789999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCCCc--------ccccccCCccccCcccccCCC---CCccCcchhhHHHHHHHHhCCCCCCccccccccccc
Q 047157 641 GISKLLNKDQTR--------TDTNMRGTMGYVAPEWLRNVP---VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEV 709 (788)
Q Consensus 641 g~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~ 709 (788)
|++......... ......|++.|+|||.+.... ++.++||||||+++|||++|+.||.........
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--- 255 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--- 255 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---
Confidence 998765321111 011235789999999987543 789999999999999999999999643211100
Q ss_pred hhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
... .... . ............+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 256 ---~~~----~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 256 ---VAL----AVQN-Q--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ---HHH----HHHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ---hhH----Hhhc-c--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 0000 0 0001111234578889999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=344.50 Aligned_cols=272 Identities=15% Similarity=0.171 Sum_probs=204.2
Q ss_pred HHhhcccccccccccceEEEEEEeccC---cceeeeeeecccchHHH-----------HHHHHHHHHHhcCCCccccceE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKD---TQIEIAVKKLEKDIEKT-----------NEEFMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~ 552 (788)
...|.+.+.||+|+||.||+|.+.... .+..||||.+....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 346778899999999999999886322 24689999986543211 1234556677888999999999
Q ss_pred eeEEecC----CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCC
Q 047157 553 LGFCSEE----DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT 628 (788)
Q Consensus 553 ~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 628 (788)
++++... ...+|||||+ +++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++..
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~- 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK- 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS-
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC-
Confidence 9998764 4589999999 9999999988777899999999999999999999999 99999999999999732
Q ss_pred CCCCCcEEEeecCCccccCCCCCc------ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccc
Q 047157 629 LDTNYMAKISDFGISKLLNKDQTR------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRV 702 (788)
Q Consensus 629 ~~~~~~~kL~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~ 702 (788)
.++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 189 --~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 189 --NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp --CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred --CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 4678999999999876433211 11234599999999999999999999999999999999999999975322
Q ss_pred ccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 703 EEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
... ........ ....+..+++.... ....++++.+++..||+.||++||++++|++.|++++.
T Consensus 267 ~~~-------~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 267 DPK-------YVRDSKIR-YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp CHH-------HHHHHHHH-HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHH-------HHHHHHHH-hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 111 00000000 01111111111000 01124567889999999999999999999999987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.75 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=200.2
Q ss_pred hhcccccccccccceEEEEEEeccCc--ceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||+||+|.+...+. ...|++|.+.... ....+.+.+|+.++++++||||+++++++. ++..++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 46677899999999999999863222 2247778775432 223356778999999999999999999986 4668999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~-----~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLK-----SPSQVQVADFGVADL 164 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEES-----SSSCEEECSCSGGGG
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEEC-----CCCeEEECCCCcccc
Confidence 999999999999977666788999999999999999999999 999999999999998 788999999999997
Q ss_pred cCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 646 LNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 646 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~----~~~~ 232 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--------PD----LLEK 232 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--------HH----HHHT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--------HH----HHHc
Confidence 7544322 2334567889999999998999999999999999999999 9999976432211 01 1111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.... .........+.+++.+||+.||++|||++|++++|+.+.
T Consensus 233 ~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 233 GERL---------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TCBC---------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCC---------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1000 000112234677899999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.18 Aligned_cols=250 Identities=26% Similarity=0.343 Sum_probs=202.3
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..|.+.+.||+|+||.||++... .++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~--~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKN--DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45677899999999999999886 677799999986543 2345678899999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 93 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~-----~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLD-----EHGHVHITDFNIAA 163 (384)
T ss_dssp EECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEC-----CCCCEEEeccceee
Confidence 99999999999999654 5689999999999999999999999 999999999999998 88899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRN---VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||......... . .....
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--------~-~~~~~ 232 (384)
T 4fr4_A 164 MLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK--------E-IVHTF 232 (384)
T ss_dssp ECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH--------H-HHHHH
T ss_pred eccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH--------H-HHHHH
Confidence 765332 2334679999999999864 45899999999999999999999999754322110 0 00111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-HHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-MKKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 769 (788)
..... . .+......+.+++.+||+.||++||+ +++|++
T Consensus 233 ~~~~~--------~--~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 ETTVV--------T--YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHCCC--------C--CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hhccc--------C--CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11100 0 01122457888999999999999998 777765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=344.19 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=199.9
Q ss_pred HhhcccccccccccceEEEEEEeccCc--ceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..|.+.++||+|+||+||+|.+...+. ..+|++|.+... .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 456778999999999999999863222 224577776433 2345678999999999999999999999998765 789
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|+|++++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~-----~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVK-----TPQHVKITDFGLAK 165 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE-----ETTEEEECCTTC--
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEc-----CCCCEEEccCccee
Confidence 9999999999999988778899999999999999999999999 999999999999998 77899999999998
Q ss_pred ccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 645 LLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 645 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. . ...
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--------~----~~~ 233 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------S----ILE 233 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--------H----HHH
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH--------H----HHH
Confidence 76443222 2223456788999999999999999999999999999999 99999765332210 1 011
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.. ............+.+++.+||+.||++|||++|+++.|+++..
T Consensus 234 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 KG---------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred cC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 0111111234567889999999999999999999999987754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=354.64 Aligned_cols=252 Identities=23% Similarity=0.245 Sum_probs=203.1
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.++||+|+||+||+|..+ .++..||+|++.+... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~--~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHK--STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEcCCCEEEEEEEEC--CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4666789999999999999886 6678999999875321 2234578999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 148 ~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~-----~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD-----KSGHLKLADFGTCMK 217 (410)
T ss_dssp ECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeEC-----CCCCEEEeccceeEe
Confidence 999999999999965 3588999999999999999999999 999999999999998 888999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCC----CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVP----VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
.............||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+... .+
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------------~i 285 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------------KI 285 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------------HH
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH------------HH
Confidence 7655444444578999999999997665 7899999999999999999999997653222110 01
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNL--RPSMKKVIHM 770 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 770 (788)
...... +. .+. .......+.+|+.+||+.+|.+ ||+++||+++
T Consensus 286 ~~~~~~-~~--~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 286 MNHKNS-LT--FPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HTHHHH-CC--CCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred Hhcccc-cc--CCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000000 00 000 0112356788999999999988 9999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=330.52 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=205.2
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...|.+.+.||+|+||.||+|... .++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQK--GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeC--CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 345778899999999999999886 667789999997766566778999999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||++..+. .++.+||+|||++...
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~--~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 86 ELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDS--PDSPLKLIDFGLAARF 159 (277)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS--TTCCEEECCCTTCEEC
T ss_pred eccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCC--CCCcEEEEecccceec
Confidence 999999999998654 5689999999999999999999999 999999999999994222 7789999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
..... .....+|+.|+|||.+.+. ++.++||||||+++|||++|+.||......+. .........
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------------~~~~~~~~~ 224 (277)
T 3f3z_A 160 KPGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV------------MLKIREGTF 224 (277)
T ss_dssp CTTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHCCC
T ss_pred cCccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH------------HHHHHhCCC
Confidence 54332 2335689999999998764 89999999999999999999999976432211 011111110
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.. .........+.+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 TF------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CC------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00000022467888999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.65 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=196.5
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCC------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED------ 560 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 560 (788)
..|.+.+.||+|+||.||+|.+. .++..||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNK--VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEET--TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEc--CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 45777899999999999999886 567799999986433 345678999999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEecCCCCCHhHhhhccCC--CCCH
Q 047157 561 ---------------------------------------------------KRLLVYELMPNGTLSNFLFHEGQ--RPGW 587 (788)
Q Consensus 561 ---------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~--~~~~ 587 (788)
..++||||+++++|.+++..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999976532 3466
Q ss_pred HHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC-----------ccccc
Q 047157 588 VQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT-----------RTDTN 656 (788)
Q Consensus 588 ~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~-----------~~~~~ 656 (788)
..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++........ .....
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~-----~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFT-----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEe-----CCCCEEEeecCcccccccchhhccccccccccccccc
Confidence 77899999999999999999 999999999999998 778999999999987754421 12233
Q ss_pred ccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCC
Q 047157 657 MRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEV 736 (788)
Q Consensus 657 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 736 (788)
..||+.|+|||.+.+..++.++||||||+++|||++|..|+.... . ...........
T Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------------~-~~~~~~~~~~~--------- 292 (332)
T 3qd2_B 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------------R-IITDVRNLKFP--------- 292 (332)
T ss_dssp CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------------H-HHHHHHTTCCC---------
T ss_pred cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------------H-HHHHhhccCCC---------
Confidence 569999999999999999999999999999999999877643210 0 00001111100
Q ss_pred cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 737 LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 737 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.........+.+++.+||+.||++|||++|++++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 1122344567889999999999999999999873
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=345.16 Aligned_cols=271 Identities=24% Similarity=0.352 Sum_probs=207.4
Q ss_pred hcccccccccccceEEEEEEe--ccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEec--CCeEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--EDKRLL 564 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 564 (788)
+.+.+.||+|+||+||++.+. ...++..||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 367799999999999998764 22467799999997543 3456789999999999999999999999987 467899
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++... .+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~-----~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLD-----NDRLVKIGDFGLAK 182 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTCCEEECCGGGCE
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEc-----CCCCEEECCccccc
Confidence 99999999999999654 489999999999999999999999 999999999999998 78899999999998
Q ss_pred ccCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 645 LLNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 645 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||........... ..........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~--- 258 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI-GIAQGQMTVL--- 258 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-CSCCHHHHHH---
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh-cccccchhHH---
Confidence 77544321 22335678889999999998999999999999999999999999875422110000 0000000000
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.+...+...............+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 259 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 259 --RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp --HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 0011111111111122334678899999999999999999999999988764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=346.49 Aligned_cols=249 Identities=25% Similarity=0.324 Sum_probs=202.5
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 562 (788)
...|.+.+.||+|+||.||+|..+ .+++.||||.+.+.. ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFK--KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEET--TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 345677899999999999999886 677899999997643 23456778899999876 899999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~-----~~g~vkL~DFG~ 164 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLD-----KDGHIKIADFGM 164 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC-----TTSCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEEC-----CCCCEEEeEChh
Confidence 9999999999999999654 4688999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+.
T Consensus 165 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------------~~~i~ 231 (345)
T 1xjd_A 165 CKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------------FHSIR 231 (345)
T ss_dssp CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHH
T ss_pred hhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH------------HHHHH
Confidence 986432222 23346799999999999999999999999999999999999999976432211 01111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMK-KVIH 769 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 769 (788)
... +.. +......+.+++.+||+.||++||++. ||++
T Consensus 232 ~~~--------~~~--p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 232 MDN--------PFY--PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HCC--------CCC--CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred hCC--------CCC--CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111 110 011235678899999999999999998 7653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=331.75 Aligned_cols=263 Identities=20% Similarity=0.245 Sum_probs=200.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||+||+|... .++..||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNR--ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEEC--CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 3667789999999999999886 667799999986432 344578889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++ +|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~-----~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLIN-----RNGELKLANFGLARAF 151 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEECCCTTCEEC
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc-----CCCCEEEeecccceec
Confidence 99975 67677766667899999999999999999999999 999999999999998 7889999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc-
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVP-VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR- 724 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 724 (788)
..... ......+|+.|+|||.+.+.. ++.++||||||+++|||++|..|+........ .+ ..........
T Consensus 152 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~------~~-~~i~~~~~~~~ 223 (292)
T 3o0g_A 152 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD------QL-KRIFRLLGTPT 223 (292)
T ss_dssp CSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH------HH-HHHHHHHCCCC
T ss_pred CCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH------HH-HHHHHHhCCCC
Confidence 43322 223457899999999997765 79999999999999999999988643321110 00 1111111000
Q ss_pred --cc---cccccCC---------CCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 --NL---QVLVSHD---------PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 --~~---~~l~~~~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. ....... ............+.+++.+||+.||++|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000000 0000011234567889999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.25 Aligned_cols=254 Identities=24% Similarity=0.238 Sum_probs=192.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||+||++... .++..||||.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDK--LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEET--TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEeccCCCEEEEEEEEC--CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 4777899999999999999886 677799999997543 2345688999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.. ....+||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~---~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSS---SSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCC---CCceEEEeecCccccccc
Confidence 9999999999654 4689999999999999999999999 99999999999999721 233599999999975432
Q ss_pred CCCcccccccCCccccCcccccCCCCCcc-CcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTK-VDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
.. ......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.......... ... ......
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------~~~-~~~~~~--- 237 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-------KTI-QRILSV--- 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH-------HHH-HHHHTT---
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH-------HHH-HHHhcC---
Confidence 22 2233568999999999988887665 899999999999999999997643221110 000 111111
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.............+.+++.+||+.||++|||++|++++
T Consensus 238 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 -----KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -----CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -----CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111111224567889999999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.43 Aligned_cols=250 Identities=27% Similarity=0.327 Sum_probs=203.7
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 562 (788)
...|.+.+.||+|+||.||+|... .++..||+|.+.+.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERK--GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET--TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 345777899999999999999886 677899999997643 23456788999999988 899999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~-----~~g~vkL~DFG~ 167 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLD-----SEGHIKIADFGM 167 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC-----TTSCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEc-----CCCcEEEEeCCc
Confidence 9999999999999999654 4689999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+.
T Consensus 168 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------------~~~i~ 234 (353)
T 2i0e_A 168 CKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------------FQSIM 234 (353)
T ss_dssp CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHH
T ss_pred ccccccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH------------HHHHH
Confidence 986432222 23346799999999999999999999999999999999999999976432111 11111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIHM 770 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 770 (788)
.... .. +......+.+++.+||+.||++||+ ++||+++
T Consensus 235 ~~~~--------~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 EHNV--------AY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HCCC--------CC--CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred hCCC--------CC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 11 1123456788999999999999995 5777754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=343.65 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=195.6
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCe---
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK--- 561 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--- 561 (788)
..|.+.+.||+|+||.||++.+. .++..||||.+.... ....+.+.+|++++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDL--RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred CcEEEEEEEccCCCEEEEEEEEC--CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 35677899999999999999886 677899999986542 3445688999999999999999999999876543
Q ss_pred -EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 562 -RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 562 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~-----~~~~~kl~Df 160 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMIS-----ATNAVKVMDF 160 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-----TTSCEEECCC
T ss_pred ccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEc-----CCCCEEEeec
Confidence 49999999999999999655 4689999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 641 GISKLLNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 641 g~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
|++......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ..
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----------~~ 229 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----------AY 229 (311)
T ss_dssp SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----------HH
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----------HH
Confidence 999876543221 22335689999999999999999999999999999999999999976432211 11
Q ss_pred HHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHH-HHhhcCc
Q 047157 719 SCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI-HMLEGTL 775 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl-~~L~~~~ 775 (788)
.......... ..........+.+++.+||+.||++||++.+++ +.|....
T Consensus 230 ~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 230 QHVREDPIPP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHCCCCCH-------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHhcCCCCCc-------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1111110000 000111345678899999999999999665544 5555443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.47 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=201.5
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc---hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..|...+.||+|+||+||+|... .++..||||++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV--RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEc--cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 44677789999999999999876 67789999998643 24445689999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||++ |+|.+++......+++..+..++.||++||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~-----~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLS-----EPGLVKLGDFGSAS 202 (348)
T ss_dssp EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEE-----TTTEEEECCCTTCB
T ss_pred EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEC-----CCCCEEEeeccCce
Confidence 999997 688888876667899999999999999999999999 999999999999998 78899999999998
Q ss_pred ccCCCCCcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
..... ....||+.|+|||++. ...++.++||||||+++|||++|+.||........ ... .
T Consensus 203 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----------~~~-~ 265 (348)
T 1u5q_A 203 IMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------LYH-I 265 (348)
T ss_dssp SSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----------HHH-H
T ss_pred ecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----------HHH-H
Confidence 65432 2356899999999984 56789999999999999999999999965422110 001 1
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
........ ......+.+.+++.+||+.||++|||+++++++
T Consensus 266 ~~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 266 AQNESPAL--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHSCCCCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HhcCCCCC--------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111111 111224567889999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.10 Aligned_cols=245 Identities=21% Similarity=0.221 Sum_probs=203.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||++... .++..||+|.+.+.. ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEEC--CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4667799999999999999886 667799999986543 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~-----~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLID-----QQGYIQVTDFGFAKR 190 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEECCCTTCEE
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEEC-----CCCCEEEccccccee
Confidence 9999999999999765 4689999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..+.
T Consensus 191 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------------~~~i~~~~ 254 (350)
T 1rdq_E 191 VKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------------YEKIVSGK 254 (350)
T ss_dssp CSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHCC
T ss_pred ccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH------------HHHHHcCC
Confidence 6432 2345789999999999999999999999999999999999999975432111 11111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 770 (788)
.. . +......+.+++.+||+.||++||+ ++||+++
T Consensus 255 ~~--------~--p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 VR--------F--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CC--------C--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC--------C--CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 10 0 1122456788999999999999998 8888763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=333.80 Aligned_cols=263 Identities=24% Similarity=0.417 Sum_probs=196.6
Q ss_pred HHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCe
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 561 (788)
|+....|.+.+.||+|+||+||+|... + .||+|.+... .....+.+.+|++++++++||||+++++++ ....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~----~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH----G-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS----S-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc----C-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 445566788899999999999999753 2 4888887533 345567899999999999999999999965 5567
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++||||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~-----~~~~~kl~Dfg 165 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLH-----EDNTVKIGDFG 165 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE-----TTTEEEECCCC
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC-----CCCCEEEccce
Confidence 8999999999999999987778899999999999999999999999 999999999999998 77899999999
Q ss_pred CccccCCCC-CcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 642 ISKLLNKDQ-TRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 642 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
++....... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+. .
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----------~ 234 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-----------I 234 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-----------H
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-----------H
Confidence 998654322 22233456899999999986 66788999999999999999999999975422111 1
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.............. .......+.+.+++.+||+.||++|||++|++++|+++.+
T Consensus 235 ~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 235 IEMVGRGSLSPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHTSCCCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHhcccccCcchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111111111100 0011234678899999999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=338.30 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=206.6
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...|.+.+.||+|+||.||+|... .+..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc---CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 346778899999999999999874 55689999986543 235688999999999999999999999864 5689999
Q ss_pred ecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~-----~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS-----DTLSCKIADFGLARL 158 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTSCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEc-----CCCCEEECCCccccc
Confidence 9999999999996542 3689999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------------~~~~~~~ 226 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------------IQNLERG 226 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------------HHHHHTT
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH------------HHHHhcc
Confidence 75544333334557789999999998899999999999999999999 8999975432111 0111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
. .........+.+.+++.+||+.||++|||++++++.|+++..
T Consensus 227 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 227 Y---------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c---------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 0 000111234678889999999999999999999999987653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=368.40 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=202.7
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCCC
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGT 573 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~gs 573 (788)
.||+|+||.||+|.++....+..||||.++... ....+++.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 799999999999998766677789999997643 3456789999999999999999999999976 56899999999999
Q ss_pred HhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcc
Q 047157 574 LSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT 653 (788)
Q Consensus 574 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 653 (788)
|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.........
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~-----~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLV-----NRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE-----ETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEc-----CCCcEEEeeccCcccccCCCcee
Confidence 9999987777899999999999999999999999 999999999999998 77899999999998765433221
Q ss_pred --cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccccc
Q 047157 654 --DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730 (788)
Q Consensus 654 --~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 730 (788)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+..+.
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~------------~~~i~~~~----- 556 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------------MAFIEQGK----- 556 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH------------HHHHHTTC-----
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH------------HHHHHcCC-----
Confidence 122345688999999998999999999999999999998 9999976432211 11111111
Q ss_pred cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 731 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
....+......+.+++..||+.||++||++++|++.|+.+.
T Consensus 557 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 557 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01111223467889999999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.59 Aligned_cols=259 Identities=28% Similarity=0.454 Sum_probs=201.9
Q ss_pred hhcccccccccccceEEEEEEecc-Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEe-cCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCS-EEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lV 565 (788)
.|.+.++||+|+||+||+|.+... .....+|+|.+.... ....+.+.+|+.++++++||||+++++++. .++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 356678999999999999987532 334568999886533 445678999999999999999999999864 55688999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~-----~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLD-----EKFTVKVADFGLARD 177 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----TTCCEEECSCGGGCC
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEC-----CCCCEEECccccccc
Confidence 999999999999987777889999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCC---cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhC-CCCCCccccccccccchhhhHHHHHHHh
Q 047157 646 LNKDQT---RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICG-RRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 646 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||......+. .. ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--------~~----~~ 245 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--------TV----YL 245 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--------HH----HH
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--------HH----HH
Confidence 644322 122335577889999999999999999999999999999995 455543322111 00 01
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
..... ..........+.+++.+||+.||++|||++|+++.|+++..
T Consensus 246 ~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 246 LQGRR---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11100 00011123568889999999999999999999999988754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.31 Aligned_cols=253 Identities=27% Similarity=0.431 Sum_probs=194.2
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..+.+.+.||+|+||+||+|... +..||||.+... ...+.+.+|++++++++||||+++++++.+ ..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR----AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET----TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC----CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 45667899999999999999863 468999998753 345789999999999999999999998874 4799999
Q ss_pred cCCCCCHhHhhhccCC--CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCc-EEEeecCCcc
Q 047157 568 LMPNGTLSNFLFHEGQ--RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM-AKISDFGISK 644 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~-~kL~Dfg~a~ 644 (788)
|+++++|.+++..... .+++..++.++.||++||.|||+.+..+|+||||||+|||++ .++. +||+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~-----~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV-----AGGTVLKICDFGTAC 154 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE-----TTTTEEEECCCCC--
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe-----CCCCEEEEccccccc
Confidence 9999999999976543 468899999999999999999993323999999999999998 5554 8999999997
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... ....
T Consensus 155 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------~~~~~-~~~~ 220 (307)
T 2eva_A 155 DIQTHM----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---------RIMWA-VHNG 220 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---------HHHHH-HHTT
T ss_pred cccccc----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---------HHHHH-HhcC
Confidence 654322 234689999999999999999999999999999999999999974321110 00000 1111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
..... .......+.+++.+||+.||++|||++|++++|+.+..
T Consensus 221 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 221 TRPPL---------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCCCC---------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CCCCc---------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11223567889999999999999999999999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.27 Aligned_cols=264 Identities=28% Similarity=0.419 Sum_probs=210.5
Q ss_pred HHHHHhhcccccccccccceEEEEEEec-----cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEE
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRL-----KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFC 556 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 556 (788)
++....|.+.+.||+|+||.||+|.... ...+..||||.+.... ....+.+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 3445677888999999999999998752 1345689999997543 44567899999999999 899999999999
Q ss_pred ecCCeEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCc
Q 047157 557 SEEDKRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQN 621 (788)
Q Consensus 557 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~N 621 (788)
.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 99999999999999999999997643 2478999999999999999999999 99999999999
Q ss_pred EEeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCc
Q 047157 622 VLLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIEL 699 (788)
Q Consensus 622 Ill~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~ 699 (788)
||++ .++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 188 Ill~-----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 188 VLVT-----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp EEEC-----TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEEc-----CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 9998 7889999999999876543322 2233456788999999988899999999999999999999 9999975
Q ss_pred cccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
....+. ........... ........+.+++.+||+.||++|||++|+++.|+++..
T Consensus 263 ~~~~~~------------~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 263 IPVEEL------------FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp CCHHHH------------HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHH------------HHHHhcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 432111 01111111000 111234568889999999999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=340.49 Aligned_cols=261 Identities=21% Similarity=0.244 Sum_probs=184.1
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEecCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
+.||+|+||+||++.+. .++..||||.+... ....+.+|+.+++++. ||||+++++++.+....++||||++++
T Consensus 17 ~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK--KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEET--TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEEC--CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 78999999999999886 66779999999754 3456778999999996 999999999999999999999999999
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCc
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 652 (788)
+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++ ....+||+|||++........
T Consensus 92 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~--~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 92 ELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDEN--DNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp BHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC------CEEEECCCTTCEECCC----
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCC--CcccEEEeccccceecCCCCC-
Confidence 999999664 5789999999999999999999999 999999999999997332 344899999999986544322
Q ss_pred ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccC
Q 047157 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSH 732 (788)
Q Consensus 653 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 732 (788)
......+|+.|+|||++.+..++.++||||||+++|||++|+.||............ .........+...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-----~~~~~~i~~~~~~----- 234 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA-----VEIMKKIKKGDFS----- 234 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH-----HHHHHHHTTTCCC-----
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH-----HHHHHHHHcCCCC-----
Confidence 223456899999999999999999999999999999999999999765332111110 0111111111110
Q ss_pred CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCcCC
Q 047157 733 DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTLEV 777 (788)
Q Consensus 733 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~ 777 (788)
..........+.+.+++.+||+.||++|||++|++++ +++....
T Consensus 235 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 235 -FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp -CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred -CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 0000011235678899999999999999999999854 4443333
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=337.76 Aligned_cols=261 Identities=23% Similarity=0.291 Sum_probs=197.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||+||+|.. ..+..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN---NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE---TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred cchhhhhcccCCCEEEEEEEc---CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 366778999999999999987 356689999886432 223467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++ +|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~-----~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLIN-----REGELKIADFGLARAF 150 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTSCEEECCTTHHHHH
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc-----CCCCEEEeECcccccc
Confidence 99975 99999977767889999999999999999999999 999999999999998 7889999999999865
Q ss_pred CCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc-
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR- 724 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 724 (788)
..... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+... . ........
T Consensus 151 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-------~-~~~~~~~~~ 221 (288)
T 1ob3_A 151 GIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM-------R-IFRILGTPN 221 (288)
T ss_dssp CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------H-HHHHHCCCC
T ss_pred Ccccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------H-HHHHHCCCC
Confidence 43221 2233468999999999875 458999999999999999999999997643221110 0 00100000
Q ss_pred --c---ccccccCCCCC---------cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 --N---LQVLVSHDPEV---------LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 --~---~~~l~~~~~~~---------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. ...+....+.. .......+.+.+++.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00000000000 0001234567899999999999999999999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=337.33 Aligned_cols=274 Identities=23% Similarity=0.293 Sum_probs=203.5
Q ss_pred HHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcC--CCccccceEeeEEecC
Q 047157 482 FQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR--THHKNLVRLLGFCSEE 559 (788)
Q Consensus 482 ~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~ 559 (788)
..+.....|.+.+.||+|+||.||+|... +..||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR----GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET----TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC----CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 34555678889999999999999999863 6789999986542 2334445555544 5999999999999877
Q ss_pred ----CeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCceEecCCCCCcEEeccCCCC
Q 047157 560 ----DKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC-----ETQIIHCDIKPQNVLLDLKTLD 630 (788)
Q Consensus 560 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~ 630 (788)
...++||||+++++|.+++... .+++..++.++.|++.||.|||++. ..+|+||||||+|||++
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~----- 176 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----- 176 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC-----
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC-----
Confidence 7899999999999999999543 6899999999999999999999752 34899999999999998
Q ss_pred CCCcEEEeecCCccccCCCCCcc---cccccCCccccCcccccCCCCCcc------CcchhhHHHHHHHHhC--------
Q 047157 631 TNYMAKISDFGISKLLNKDQTRT---DTNMRGTMGYVAPEWLRNVPVTTK------VDVFSFGVMLLEIICG-------- 693 (788)
Q Consensus 631 ~~~~~kL~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k------~DVwSlGvil~elltg-------- 693 (788)
.++.+||+|||++.......... .....||+.|+|||++.+...+.+ +||||||+++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 78899999999997664433221 224578999999999987766665 9999999999999999
Q ss_pred --CCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 694 --RRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 694 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
+.||......... ... ......... .....+.........+++.+++.+||+.||++|||+.||+++|
T Consensus 257 ~~~~p~~~~~~~~~~------~~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPS------YED-MREIVCIKK---LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp CCCCTTTTTSCSSCC------HHH-HHHHHTTSC---CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cccccHhhhcCCCCc------hhh-hHHHHhhhc---cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 5555432211110 000 111111111 1111112222346778899999999999999999999999999
Q ss_pred hcCcCCCC
Q 047157 772 EGTLEVGM 779 (788)
Q Consensus 772 ~~~~~~~~ 779 (788)
+++.+...
T Consensus 327 ~~l~~~~~ 334 (337)
T 3mdy_A 327 AKMSESQD 334 (337)
T ss_dssp HHHHHTTT
T ss_pred HHHHhhcc
Confidence 98775443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=340.69 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=203.6
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV 565 (788)
..|.+.+.||+|+||.||+|.....+....+++|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 4577889999999999999998744444456999886532 34456789999999999 899999999999999999999
Q ss_pred EecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCC
Q 047157 566 YELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD 630 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 630 (788)
|||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~----- 176 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG----- 176 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc-----
Confidence 99999999999996543 4689999999999999999999999 999999999999998
Q ss_pred CCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccc
Q 047157 631 TNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEV 709 (788)
Q Consensus 631 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 709 (788)
.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---- 250 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---- 250 (327)
T ss_dssp GGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----
T ss_pred CCCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH----
Confidence 77899999999987433211 1223456789999999998889999999999999999998 9999975432111
Q ss_pred hhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
........ ...........+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 251 --------~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 251 --------YEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp --------HHHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111110 001111234568889999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.86 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=198.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
..|.+.+.||+|+||+||++... .++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER--SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEc--cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 46788899999999999999876 667789999986543 234578899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 567 ELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 567 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
||+++++|.+++... +..+++..+..++.||+.||.|||++ +|+||||||+||+++... .++.+||+|||++
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~--~~~~~kl~Dfg~a 174 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTS--PHSPIKIIDFGLA 174 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSS--TTCCEEECCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCC--CCCCEEEEeeecc
Confidence 999999999998543 46789999999999999999999999 999999999999996432 5678999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
........ .....+++.|+|||.+. ..++.++||||||+++|||++|+.||......+... .. ....
T Consensus 175 ~~~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~--------~~--~~~~ 241 (285)
T 3is5_A 175 ELFKSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ--------KA--TYKE 241 (285)
T ss_dssp CC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HH--HHCC
T ss_pred eecCCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh--------hh--ccCC
Confidence 87644322 23456899999999886 478999999999999999999999997653221110 00 0000
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.... .. .....+.+.+++.+||+.||++|||++||++
T Consensus 242 ~~~~------~~---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNYA------VE---CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCC------C-----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccc------cc---cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 0012356778999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.13 Aligned_cols=261 Identities=24% Similarity=0.420 Sum_probs=209.1
Q ss_pred HHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
...|.+.+.||+|+||.||+|.... ...+..||+|.+.... ......+.+|++++++++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 4557788999999999999998752 2346789999986543 34456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccC---------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCC
Q 047157 563 LLVYELMPNGTLSNFLFHEG---------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNY 633 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~ 633 (788)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||+++ .++
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~-----~~~ 175 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA-----EDF 175 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC-----TTC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc-----CCC
Confidence 99999999999999996532 4568999999999999999999999 999999999999998 788
Q ss_pred cEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchh
Q 047157 634 MAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDI 711 (788)
Q Consensus 634 ~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 711 (788)
.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------ 249 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------ 249 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH------
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH------
Confidence 9999999999865433221 2223456889999999998899999999999999999999 8899875432111
Q ss_pred hhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 712 VLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 712 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
........... ........+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 250 ------~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 ------LRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------HHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111111 011234567889999999999999999999999988754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=334.33 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=205.3
Q ss_pred Hhhcccc-cccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSK-LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..|.+.+ .||+|+||+||+|.+.....+..||||.+.... ....+++.+|++++++++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 3455666 899999999999987666777899999987543 33467899999999999999999999999 5677899
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++.
T Consensus 95 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~-----~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLV-----TQHYAKISDFGLSK 165 (291)
T ss_dssp EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE-----ETTEEEECCCTTCE
T ss_pred EEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEe-----CCCcEEEccCCcce
Confidence 99999999999999664 5689999999999999999999999 999999999999998 77899999999998
Q ss_pred ccCCCCCcc--cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHh
Q 047157 645 LLNKDQTRT--DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 645 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------------~~~~ 233 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------------TAML 233 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------------HHHH
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH------------HHHH
Confidence 765443322 222346788999999998889999999999999999999 9999976432111 1111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
...... .........+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 234 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 234 EKGERM---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111100 011123467888999999999999999999999998765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=346.54 Aligned_cols=273 Identities=23% Similarity=0.371 Sum_probs=212.2
Q ss_pred HHHhhcccccccccccceEEEEEEe--ccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCC--e
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILR--LKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED--K 561 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~ 561 (788)
....+.+.+.||+|+||.||++... ...++..||||++........+.+.+|++++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 3455778899999999999999853 23567899999998766667788999999999999999999999987654 7
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++||||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~-----~~~~~kL~Dfg 190 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVE-----NENRVKIGDFG 190 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEE-----ETTEEEECCCT
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEc-----CCCcEEEecCc
Confidence 8999999999999999988777799999999999999999999999 999999999999998 77899999999
Q ss_pred CccccCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccc----ccchhhhHH
Q 047157 642 ISKLLNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES----EEVDIVLSD 715 (788)
Q Consensus 642 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~----~~~~~~~~~ 715 (788)
++......... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 99877544322 122345677899999999888999999999999999999999988643211000 000000000
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
......... ...........++.+++.+||+.||++|||++||++.|+.+.
T Consensus 271 ~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 271 HLIELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhhcC---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111 111111223467888999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.01 Aligned_cols=262 Identities=25% Similarity=0.359 Sum_probs=189.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.+.||+|+||+||+|... .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNK--TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp -------------CEEEEEECS--SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ceeEeeEECCCCCEEEEEEEEC--CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4667789999999999999876 667899999986543 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhcc-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 568 LMPNGTLSNFLFHE-----GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 568 ~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
|++ ++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~-----~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLIN-----KRGQLKLGDFGL 154 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTCCEEECCCSS
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEc-----CCCCEEECcCcc
Confidence 997 5999988643 24588999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+... ......
T Consensus 155 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--------~i~~~~ 225 (317)
T 2pmi_A 155 ARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK--------LIFDIM 225 (317)
T ss_dssp CEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--------HHHHHH
T ss_pred ceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--------HHHHHh
Confidence 987643322 2233568999999999876 468999999999999999999999997653322110 011100
Q ss_pred hcc---c---cccccc------CC-CCCc-------ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 722 LSR---N---LQVLVS------HD-PEVL-------SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 722 ~~~---~---~~~l~~------~~-~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... . ...+.. .. +... ........+.+++.+||+.||++|||++|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 0 000000 00 0000 000123578899999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=353.73 Aligned_cols=247 Identities=26% Similarity=0.299 Sum_probs=193.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||++... .++..||||.+.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEK--ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred HcEEeEEEeeCcCEEEEEEEEc--CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4677899999999999999886 677899999997542 33446778999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|||+++++|.+++... ..+++..+..++.||+.||+|||+ + +|+||||||+|||++ .++.+||+|||+++
T Consensus 227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~-----~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLD-----KDGHIKITDFGLCK 297 (446)
T ss_dssp ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEEC-----SSSCEEECCCCCCC
T ss_pred EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEEC-----CCCCEEEccCCCce
Confidence 9999999999999654 578999999999999999999998 7 999999999999998 78899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .......
T Consensus 298 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------------~~~i~~~ 364 (446)
T 4ejn_A 298 EGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------------FELILME 364 (446)
T ss_dssp TTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHC
T ss_pred eccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------------HHHHHhC
Confidence 6433222 23346799999999999999999999999999999999999999975432211 0111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIH 769 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 769 (788)
... . +......+.+++.+||+.||++|| +++|+++
T Consensus 365 ~~~--------~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 EIR--------F--PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCC--------C--CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCC--------C--CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 110 0 011235678899999999999999 9999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=337.23 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=198.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc---hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||+|... .++..||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACL--LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEET--TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEc--CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 5778899999999999999876 56779999988642 245567899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 566 YELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
|||+++++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~-----~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFIT-----ATGVVKLGDLGL 182 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTSCEEECCC--
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEc-----CCCCEEEEeccc
Confidence 999999999999864 356689999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||....... .... ....
T Consensus 183 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~~-~~~~ 251 (310)
T 2wqm_A 183 GRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---------YSLC-KKIE 251 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH---------HHHH-HHHH
T ss_pred eeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH---------HHHH-HHhh
Confidence 986643322 1223568999999999999999999999999999999999999996542111 0000 1111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVG 778 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 778 (788)
....... ......+.+.+++.+||+.||++|||+++|++.|+++.+..
T Consensus 252 ~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 252 QCDYPPL--------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp TTCSCCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccCCCC--------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1111111 01123456888999999999999999999999999886543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=367.49 Aligned_cols=262 Identities=25% Similarity=0.409 Sum_probs=210.0
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
+....+.+.++||+|+||.||+|.+. ....||||.+.... ...++|.+|+++|++++||||+++++++.+ +..+|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWN---GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET---TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cchhhhhhheecccCCCeEEEEEEEC---CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 33455677899999999999999885 34579999997543 235689999999999999999999999876 67899
Q ss_pred EEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 565 VYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
||||+++|+|.+++... +..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~-----~~~~~kl~DFG~a 410 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG-----ENLVCKVADFGLA 410 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----GGGCEEECCTTST
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEc-----CCCcEEEcccccc
Confidence 99999999999999753 35689999999999999999999999 999999999999998 7789999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+..............++..|+|||.+....++.++||||||+++|||++ |+.||......+. ...+.
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~------------~~~i~ 478 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------------LDQVE 478 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH------------HHHHH
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------------HHHHH
Confidence 8765332222233456788999999998899999999999999999999 8999975432111 11111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCCCC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMP 780 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p 780 (788)
.+. .........+.+.+|+.+||+.||++|||+++|+++|+.+.....|
T Consensus 479 ~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 479 RGY---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 110 0011112345788899999999999999999999999998765443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=349.73 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=204.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||+|.+. .++..||||.+..... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHE--LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEET--TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4667899999999999999886 5778999999975432 2356789999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 95 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~-----~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLD-----AHMNAKIADFGLSNM 165 (476)
T ss_dssp EECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEC-----TTCCEEECCCSSCEE
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEe-----cCCCeEEEeccchhh
Confidence 9999999999999654 5689999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ......+
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------------~~~i~~~ 231 (476)
T 2y94_A 166 MSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL------------FKKICDG 231 (476)
T ss_dssp CCTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH------------HHHHHTT
T ss_pred cccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH------------HHHHhcC
Confidence 654322 234579999999999988765 6899999999999999999999975432111 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH--Hhhc
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH--MLEG 773 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~ 773 (788)
... .+. .....+.+++.+||+.||++|||++|+++ .+.+
T Consensus 232 ~~~-----~p~-----~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 232 IFY-----TPQ-----YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp CCC-----CCT-----TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred CcC-----CCc-----cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 110 011 12346788999999999999999999997 4544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.00 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=201.6
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecC--CeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE--DKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 563 (788)
..|.+.+.||+|+||.||+|.+. +..||||.+... .....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 35677899999999999999873 568999988643 245567899999999999999999999999887 7889
Q ss_pred EEEecCCCCCHhHhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 564 LVYELMPNGTLSNFLFHEGQ-RPGWVQRVEIALGVARGLLYLHEECETQ--IIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
+||||+++++|.+++..... .+++..++.++.||+.||.|||++ + |+||||||+||+++ .++.++|+||
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~-----~~~~~~l~~~ 157 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMID-----EDMTARISMA 157 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEEC-----TTSCEEEEGG
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEc-----CCcceeEEec
Confidence 99999999999999976543 589999999999999999999998 7 99999999999998 7888999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCc---cCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTT---KVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
|++..... ....+|+.|+|||.+.+...+. ++||||||+++|||++|+.||........ .
T Consensus 158 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----------~ 220 (271)
T 3kmu_A 158 DVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-----------G 220 (271)
T ss_dssp GSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-----------H
T ss_pred cceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-----------H
Confidence 88764322 2346789999999998765554 79999999999999999999975432111 0
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
........ . ..........+.+++..||+.||++|||++|+++.|+++.+
T Consensus 221 ~~~~~~~~-~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 221 MKVALEGL-R--------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHSCC-C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHhcCC-C--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01111110 0 01111234568889999999999999999999999987653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=334.70 Aligned_cols=265 Identities=20% Similarity=0.294 Sum_probs=204.7
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEE-ecCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFC-SEEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lV~ 566 (788)
..|.+.+.||+|+||+||+|... .++..||||.+.... ..+.+.+|++++++++|++++..+..+ .+.+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDI--AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEET--TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEc--CCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45778899999999999999876 677899999865432 234678899999999888877666655 6778889999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+ +++|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++... .++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~--~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGK--KGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGG--GTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccC--CCCeEEEecCccceec
Confidence 999 9999999987677899999999999999999999999 999999999999993211 6788999999999876
Q ss_pred CCCCC------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 647 NKDQT------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 647 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||............. . ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~-~~~~ 233 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----R-ISEK 233 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH----H-HHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh----h-hhcc
Confidence 54332 12234678999999999999999999999999999999999999997653322211111 0 0000
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
........+. ....+.+.+++.+||+.||++|||+++|++.|+++..
T Consensus 234 ~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 234 KMSTPIEVLC---------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHSCHHHHT---------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cccchhhhhh---------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0000000000 0123578899999999999999999999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.14 Aligned_cols=265 Identities=21% Similarity=0.269 Sum_probs=197.5
Q ss_pred hcc-cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEe
Q 047157 490 KGF-SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e 567 (788)
|.+ .+.||+|+||+||+|... .++..||||.+........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINL--ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECS--SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEecCceecCCceEEEEEEEEc--CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 445 368999999999999875 56779999999766555677899999999885 79999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++..+ ....+||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~--~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPN--QVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSS--SSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCC--CcCceEEEEccCccccc
Confidence 99999999999665 5688999999999999999999999 999999999999998332 23359999999998654
Q ss_pred CCCC------cccccccCCccccCcccccC-----CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh---hh
Q 047157 648 KDQT------RTDTNMRGTMGYVAPEWLRN-----VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI---VL 713 (788)
Q Consensus 648 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~---~~ 713 (788)
.... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 11223468999999999865 5688999999999999999999999976533221100000 00
Q ss_pred HHHHHHHhhcccccccccCCCCCccc--HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 714 SDWVISCMLSRNLQVLVSHDPEVLSD--LERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 714 ~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
............. ..... ......+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGKY--------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCc--------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0001111111111 10000 1124568899999999999999999999984
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=329.03 Aligned_cols=253 Identities=21% Similarity=0.304 Sum_probs=203.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||.||+|... .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHK--TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhcCcCCeEEEEEEEc--CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4677899999999999999886 667799999986542 345578889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.+. ....+||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~--~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKA--KGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSS--TTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCC--CCCcEEEeeceeeEEc
Confidence 999999999988655 5689999999999999999999999 999999999999998433 3456999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
..... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ .........
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------~~~~~~~~~ 224 (284)
T 3kk8_A 159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------------YAQIKAGAY 224 (284)
T ss_dssp CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHTCC
T ss_pred ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH------------HHHHHhccc
Confidence 54322 2345789999999999999999999999999999999999999975432211 011111111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
... .+ ......+.+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~---~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 DYP---SP---EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCC---TT---TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCC---ch---hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 100 00 00122356788999999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=329.72 Aligned_cols=246 Identities=25% Similarity=0.366 Sum_probs=199.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||+||+|... .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREK--QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cEEEeeEEecCCCeEEEEEEEc--cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4667799999999999999886 667789999986533 22356789999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~-----~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLG-----SAGELKIADFGWSVH 158 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEEC-----TTSCEEECSCCEESC
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEc-----CCCCEEEEecccccc
Confidence 9999999999999655 5688999999999999999999998 999999999999998 788999999999865
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+.. .......
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------------~~~~~~~ 223 (279)
T 3fdn_A 159 APSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------------KRISRVE 223 (279)
T ss_dssp C-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------------HHHHHTC
T ss_pred CCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH------------HHHHhCC
Confidence 43322 23356899999999999999999999999999999999999999754322110 0011100
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. . .+....+.+.+++.+||+.||++|||++|++++
T Consensus 224 ~--------~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 F--------T--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp C--------C--CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred C--------C--CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0 011123567789999999999999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.69 Aligned_cols=270 Identities=16% Similarity=0.211 Sum_probs=198.9
Q ss_pred HHHHhhcccccccccccceEEEEEEec-cCcceeeeeeecccchHH-----------HHHHHHHHHHHhcCCCccccceE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDIEK-----------TNEEFMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~ 552 (788)
+....|.+.+.||+|+||.||+|.... ...+..+|+|........ ..+.+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 334557788999999999999999862 125678999988654211 12346788899999999999999
Q ss_pred eeEEec----CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCC
Q 047157 553 LGFCSE----EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT 628 (788)
Q Consensus 553 ~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 628 (788)
++++.. ....++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~--- 185 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG--- 185 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE---
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc---
Confidence 999987 77899999999 999999997654 789999999999999999999999 999999999999998
Q ss_pred CCCCC--cEEEeecCCccccCCCCC------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcc
Q 047157 629 LDTNY--MAKISDFGISKLLNKDQT------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELS 700 (788)
Q Consensus 629 ~~~~~--~~kL~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~ 700 (788)
.++ .+||+|||+++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 186 --~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 186 --YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp --SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred --cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 444 999999999987643221 1123457899999999999999999999999999999999999999643
Q ss_pred ccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
...... ... ....... .+...+.. ........+.+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 264 ~~~~~~------~~~-~~~~~~~-~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 264 LKDPVA------VQT-AKTNLLD-ELPQSVLK---WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TTCHHH------HHH-HHHHHHH-TTTHHHHH---HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccccHH------HHH-HHHhhcc-cccHHHHh---hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111100 000 0000000 00000000 0000023457888999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=343.11 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=188.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||+||+|... .++..||||.+.... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQK--GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEeeEEeeCCCEEEEEEEEC--CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4667799999999999999886 567789999997543 346788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++... .++.+||+|||++.....
T Consensus 130 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~--~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPA--PDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSS--TTCCEEECCCC-------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCC--CCCCEEEccCccccccCc
Confidence 9999999999654 5689999999999999999999999 999999999999997322 478999999999986643
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .............
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----------~~~~~i~~~~~~~ 270 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----------FMFRRILNCEYYF 270 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----------HHHHHHHTTCCCC
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----------HHHHHHHhCCCcc
Confidence 22 2234578999999999999999999999999999999999999996542211 0111111111110
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. .........+.+++.+||+.||++|||+.|++++
T Consensus 271 -~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 -IS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -CT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0011234567889999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=329.51 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=208.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..|.+.+.||+|+||.||+|... .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREK--QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEc--CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 45777899999999999999886 667799999986542 2234678999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++.
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~-----~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMG-----YKGELKIADFGWSV 162 (284)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEEC-----TTCCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEc-----CCCCEEEecccccc
Confidence 99999999999999665 4688999999999999999999999 999999999999998 77899999999987
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. .......
T Consensus 163 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------~~~~~~~ 227 (284)
T 2vgo_A 163 HAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------------HRRIVNV 227 (284)
T ss_dssp ECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------------HHHHHTT
T ss_pred cCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------------HHHHhcc
Confidence 654322 2335689999999999999999999999999999999999999975432111 0111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH--HhhcCcCCCCCCC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH--MLEGTLEVGMPPL 782 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~~~pp~ 782 (788)
. ... +......+.+++.+||+.||++|||++|+++ .+........||.
T Consensus 228 ~--------~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~ 277 (284)
T 2vgo_A 228 D--------LKF--PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277 (284)
T ss_dssp C--------CCC--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCC
T ss_pred c--------cCC--CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCc
Confidence 1 000 1112356788999999999999999999996 4554444444443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=340.66 Aligned_cols=258 Identities=26% Similarity=0.253 Sum_probs=198.1
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch-----HHHHHHHHHHHHHhcCCCccccceEeeEEecCCe
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-----EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 561 (788)
...|.+.+.||+|+||+||+|... .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIEN--QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhheeecceeeecCCeEEEEEEEC--CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 356788899999999999999876 667799999886542 3455789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhcc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 047157 562 RLLVYELMPNGTLSNFLFHE---------------------------------------GQRPGWVQRVEIALGVARGLL 602 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~aL~ 602 (788)
.++||||+++++|.+++... ...+++..+..++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999998421 111256778889999999999
Q ss_pred HhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC---CcccccccCCccccCcccccC--CCCCcc
Q 047157 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ---TRTDTNMRGTMGYVAPEWLRN--VPVTTK 677 (788)
Q Consensus 603 ~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~s~k 677 (788)
|||++ +|+||||||+|||++.+ ....+||+|||++..+.... ........||+.|+|||.+.+ ..++.+
T Consensus 183 ~LH~~---~ivH~Dlkp~NIll~~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 183 YLHNQ---GICHRDIKPENFLFSTN---KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHT---TEECCCCCGGGEEESCS---SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHC---CccccCCChhhEEEecC---CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999 99999999999999721 23489999999998654322 122344678999999999865 678999
Q ss_pred CcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCC
Q 047157 678 VDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPD 757 (788)
Q Consensus 678 ~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~d 757 (788)
+||||||+++|||++|+.||......+.. ......... ............+.+++.+||+.|
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~------------~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTI------------SQVLNKKLC------FENPNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHH------------HHHHHCCCC------TTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHH------------HHHHhcccc------cCCcccccCCHHHHHHHHHHcCCC
Confidence 99999999999999999999754322110 011111100 000111123457888999999999
Q ss_pred CCCCCCHHHHHHH
Q 047157 758 PNLRPSMKKVIHM 770 (788)
Q Consensus 758 P~~RPt~~evl~~ 770 (788)
|++|||+.|+++.
T Consensus 319 p~~Rps~~~~l~h 331 (345)
T 3hko_A 319 VDERFDAMRALQH 331 (345)
T ss_dssp TTTSCCHHHHHHS
T ss_pred hhHCCCHHHHhcC
Confidence 9999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.52 Aligned_cols=263 Identities=27% Similarity=0.406 Sum_probs=208.0
Q ss_pred HHHHhhcccccccccccceEEEEEEeccC---cceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKD---TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE 559 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 559 (788)
+....+.+.+.||+|+||.||+|.....+ ....||+|.+.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 33456777899999999999999876321 22479999986543 34567899999999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhcc-------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEecc
Q 047157 560 DKRLLVYELMPNGTLSNFLFHE-------------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDL 626 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 626 (788)
+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~- 198 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT- 198 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE-
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC-
Confidence 9999999999999999999653 24578999999999999999999999 999999999999998
Q ss_pred CCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcccccc
Q 047157 627 KTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEE 704 (788)
Q Consensus 627 ~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~ 704 (788)
.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 199 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 199 ----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp ----GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred ----CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 7889999999999866443322 2233456789999999998899999999999999999998 899997542211
Q ss_pred ccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 705 ESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
. .... .... .. ...+....+.+.+++.+||+.||++|||++||+++|+.+.
T Consensus 275 ~-------~~~~----~~~~-~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 275 K-------FYKL----VKDG-YQ--------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp H-------HHHH----HHHT-CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-------HHHH----HhcC-CC--------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 0 1111 1111 00 0001112456788999999999999999999999998653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=338.90 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=200.9
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchH--------HHHHHHHHHHHHhcCCCccccceEeeEEec
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--------KTNEEFMTELKIIGRTHHKNLVRLLGFCSE 558 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 558 (788)
...|.+.+.||+|+||+||+|... .++..||||.+..... ...+.+.+|++++++++||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDK--EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEET--TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccceEEEeEEEecCCEEEEEEEEC--CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 456778899999999999999876 6778999999865421 133467789999999999999999999999
Q ss_pred CCeEEEEEecCCCC-CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 559 EDKRLLVYELMPNG-TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 559 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
.+..++||||+.+| +|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~-----~~~~~kL 171 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIA-----EDFTIKL 171 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTSCEEE
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEc-----CCCcEEE
Confidence 99999999999777 999998654 5689999999999999999999999 999999999999998 7889999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......
T Consensus 172 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------ 237 (335)
T 3dls_A 172 IDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------ 237 (335)
T ss_dssp CCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------
T ss_pred eecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------
Confidence 99999987654332 233568999999999988777 789999999999999999999996431100
Q ss_pred HHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... .+ ....+.+.+++.+||+.||++|||++|+++.
T Consensus 238 ----------~~~~~-~~-----~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----------EAAIH-PP-----YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------TTCCC-CS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------hhccC-CC-----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01 1123567889999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=336.01 Aligned_cols=257 Identities=22% Similarity=0.291 Sum_probs=204.2
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHH------HHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK------TNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
...|.+.+.||+|+||.||++... .++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccEEEeeEeeecCCEEEEEEEEC--CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 456888899999999999999886 66779999998654321 3578999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++..+. ....+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~-~~~~~kl~Df 163 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNI-PIPHIKLIDF 163 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTS-SSCCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCC-CcCCEEEccC
Confidence 999999999999999999653 5688999999999999999999999 9999999999999982210 1127999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
|++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+.. ..
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------------~~ 229 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------AN 229 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------------HH
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH------------HH
Confidence 99987654322 23456899999999999999999999999999999999999999754321110 00
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...... ...........+.+.+++.+||+.||++|||++|++++
T Consensus 230 i~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 230 ITSVSY------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHTTCC------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHhccc------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111000 00000001123567889999999999999999999873
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=334.24 Aligned_cols=266 Identities=23% Similarity=0.268 Sum_probs=197.6
Q ss_pred HHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch-----HHHHHHHHHHHHHhcCC---CccccceEeeE
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-----EKTNEEFMTELKIIGRT---HHKNLVRLLGF 555 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l---~hpniv~~~~~ 555 (788)
++....|.+.+.||+|+||+||+|... .++..||||.+.... ......+.+|+++++++ +||||++++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDP--HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECT--TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEEC--CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 344567888899999999999999875 667799999986432 11224556777777666 49999999999
Q ss_pred EecCC-----eEEEEEecCCCCCHhHhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC
Q 047157 556 CSEED-----KRLLVYELMPNGTLSNFLFHEGQ-RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL 629 (788)
Q Consensus 556 ~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 629 (788)
+.... ..++||||+. ++|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~---- 154 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVT---- 154 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEEC----
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEc----
Confidence 97765 5799999996 599999976543 489999999999999999999999 999999999999998
Q ss_pred CCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccc
Q 047157 630 DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEV 709 (788)
Q Consensus 630 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~ 709 (788)
.++.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...
T Consensus 155 -~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-- 229 (308)
T 3g33_A 155 -SGGTVKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG-- 229 (308)
T ss_dssp -TTSCEEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH--
T ss_pred -CCCCEEEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence 788999999999987643322 234578999999999999999999999999999999999999997653322111
Q ss_pred hhhhHHHHHHHhhc---cccccccc-----CCCCCccc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 710 DIVLSDWVISCMLS---RNLQVLVS-----HDPEVLSD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 710 ~~~~~~~~~~~~~~---~~~~~l~~-----~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
........ ........ ........ .+..+.+.+++.+||+.||++|||+.|++++
T Consensus 230 ------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 230 ------KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp ------HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 01111100 00000000 00000000 1234678899999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=343.51 Aligned_cols=245 Identities=27% Similarity=0.316 Sum_probs=190.7
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHH-hcCCCccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKI-IGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
..|.+.+.||+|+||.||++..+ .++..||||.+.+.. ....+.+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~--~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHK--AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEET--TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEc--CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 35677899999999999999886 677799999997543 2334566778776 57789999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 116 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~-----~~g~ikL~DFG~a 186 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLD-----SQGHIVLTDFGLC 186 (373)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTSCEEECCCCBC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEC-----CCCCEEEeeCccc
Confidence 999999999999999654 5678889999999999999999999 999999999999998 7889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..
T Consensus 187 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------------~~~i~~ 253 (373)
T 2r5t_A 187 KENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------------YDNILN 253 (373)
T ss_dssp GGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH------------HHHHHH
T ss_pred cccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------------HHHHHh
Confidence 8643222 223346799999999999999999999999999999999999999976432211 111111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKK 766 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 766 (788)
..+ ... ......+.+++.+||+.||++||++.+
T Consensus 254 ~~~--------~~~--~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 254 KPL--------QLK--PNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp SCC--------CCC--SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ccc--------CCC--CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 111 110 112356788999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=335.26 Aligned_cols=270 Identities=21% Similarity=0.259 Sum_probs=199.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||+||+|... .++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNR--DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeC--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 4667799999999999999886 667799999875432 344577889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||++...
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~-----~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILIT-----KHSVIKLCDFGFARLL 152 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEECCCTTCEEC
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEc-----CCCCEEEeeCCCchhc
Confidence 999999999887543 5689999999999999999999999 999999999999998 7889999999999876
Q ss_pred CCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh----hHHHHHHHh
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV----LSDWVISCM 721 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~ 721 (788)
...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+........ .........
T Consensus 153 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 153 TGPSDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp C-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred cCcccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 533222 233568999999999875 67899999999999999999999999765433221110000 000000000
Q ss_pred hcccccccccCCCCCccc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..........+.+..... ......+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000001111111111111 1234568899999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=334.03 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=198.6
Q ss_pred HHHhhcccccccccccceEEEEEEecc-Ccceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCC--
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED-- 560 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 560 (788)
....|.+.+.||+|+||.||+|..... ..+..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 345677789999999999999987632 35668999998643 2445578999999999999999999999997755
Q ss_pred ---eEEEEEecCCCCCHhHhhhc-----cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC
Q 047157 561 ---KRLLVYELMPNGTLSNFLFH-----EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632 (788)
Q Consensus 561 ---~~~lV~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~ 632 (788)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||+++ .+
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~-----~~ 183 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLR-----DD 183 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEEC-----TT
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEc-----CC
Confidence 35999999999999999843 345689999999999999999999999 999999999999998 78
Q ss_pred CcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccch
Q 047157 633 YMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVD 710 (788)
Q Consensus 633 ~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 710 (788)
+.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----- 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----- 258 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----
Confidence 8999999999987644322 12233457889999999999999999999999999999999 8889875432211
Q ss_pred hhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 711 IVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.. ........ .........+.+++.+||+.||++|||+++++++|+++.+
T Consensus 259 ---~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 259 ---YD----YLLHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ---HH----HHHTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HH----HHHcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01 11111100 1111234578889999999999999999999999987653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.06 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=208.4
Q ss_pred HHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCC-
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEED- 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~- 560 (788)
...|.+.+.||+|+||+||+|.... ..++..||||.+.... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 4567778999999999999998642 3466799999987543 34456899999999999 7999999999987755
Q ss_pred eEEEEEecCCCCCHhHhhhccCCC---------------CCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQR---------------PGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
..++||||+++++|.+++...... +++..++.++.||+.||.|||++ +|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC
Confidence 589999999999999999765432 78999999999999999999999 999999999999998
Q ss_pred cCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccc
Q 047157 626 LKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVE 703 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~ 703 (788)
.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 183 -----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 183 -----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp -----GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred -----CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 7789999999999876543322 2234567889999999999999999999999999999998 99999754321
Q ss_pred cccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.. . ........... ........+.+++.+||+.||++|||++||+++|+.+++
T Consensus 258 ~~-------~----~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 258 EE-------F----CRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HH-------H----HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-------H----HHHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11 0 01111111000 011123567889999999999999999999999987653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=344.57 Aligned_cols=274 Identities=22% Similarity=0.268 Sum_probs=203.7
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-----ccccceEeeEEecC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-----HKNLVRLLGFCSEE 559 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~~ 559 (788)
+....|.+.++||+|+||+||+|... .++..||||.+... ....+.+..|+++++.++ ||||+++++++...
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHI--DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred EecCEEEEEEEEcccCCeEEEEEEEC--CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 44456777899999999999999886 56779999998753 344556778998888875 99999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC---------
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL--------- 629 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--------- 629 (788)
+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++....
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhc
Confidence 9999999999 999999997653 4589999999999999999999999 9999999999999973110
Q ss_pred -----------CCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCC
Q 047157 630 -----------DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIE 698 (788)
Q Consensus 630 -----------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~ 698 (788)
..++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 036789999999998654322 34578999999999999999999999999999999999999997
Q ss_pred ccccccccccchhh---hHHHHHHHhhcccccccccC------CCCCcccHH---------------HHHHHHHHHhHcc
Q 047157 699 LSRVEEESEEVDIV---LSDWVISCMLSRNLQVLVSH------DPEVLSDLE---------------RFERMAMVGLWCN 754 (788)
Q Consensus 699 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~------~~~~~~~~~---------------~~~~l~~l~~~cl 754 (788)
.....+........ .................+.. -+....... ..+.+.+++.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 65332211100000 00000000000000000000 011111110 1256789999999
Q ss_pred CCCCCCCCCHHHHHH
Q 047157 755 HPDPNLRPSMKKVIH 769 (788)
Q Consensus 755 ~~dP~~RPt~~evl~ 769 (788)
+.||++|||++|+++
T Consensus 341 ~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 341 QIDPTLRPSPAELLK 355 (360)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=366.94 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=200.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
++||+|+||.||+|.+.....+..||||+++... ....+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 5799999999999988766777899999997543 3446789999999999999999999999965 568899999999
Q ss_pred CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC
Q 047157 572 GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651 (788)
Q Consensus 572 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~ 651 (788)
|+|.+++... ..+++..++.|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~-----~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLV-----TQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE-----ETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEe-----CCCCEEEEEcCCccccccCcc
Confidence 9999999644 6789999999999999999999999 999999999999998 778999999999987654332
Q ss_pred c--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 652 R--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 652 ~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
. ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+..+..
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~------------~~~i~~~~~-- 590 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------------TAMLEKGER-- 590 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------------HHHHHTTCC--
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------------HHHHHcCCC--
Confidence 1 2223456788999999999999999999999999999998 9999976532211 111111110
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
...+......+.+++..||+.||++|||+++|++.|+..
T Consensus 591 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011112346788999999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=332.26 Aligned_cols=264 Identities=19% Similarity=0.290 Sum_probs=205.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEE-ecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFC-SEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lV~e 567 (788)
.|.+.+.||+|+||.||+|... .++..||||.+.... ..+.+.+|++++++++|++++..+.++ .+.+..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDI--AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEEccCCCeEEEEEEEc--CCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4667799999999999999876 677899999886543 234688999999999988876666555 66778899999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+ +++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++... .++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~--~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGK--KGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGG--GTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCC--CCCeEEEeeCCCccccc
Confidence 99 9999999986677899999999999999999999999 999999999999994222 66789999999998765
Q ss_pred CCCCc------ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 648 KDQTR------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 648 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............. . .....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~-~~~~~ 234 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----R-ISEKK 234 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH----H-HHHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh----h-hcccc
Confidence 43321 1234678999999999999999999999999999999999999998643322111110 0 00100
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.......+. ....+.+.+++.+||+.||++|||+++|++.|+.+..
T Consensus 235 ~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 235 MSTPIEVLC---------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHSCHHHHT---------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cCCchHHHH---------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 000000000 1123568889999999999999999999999987654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.87 Aligned_cols=277 Identities=21% Similarity=0.262 Sum_probs=210.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCC--eEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED--KRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lV 565 (788)
.|.+.++||+|+||+||+|.+. .++..||||.+.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHK--KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred ceEEEEEEEcCCCeEEEEEEEC--CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4667899999999999999886 667799999987543 334567889999999999999999999998755 78999
Q ss_pred EecCCCCCHhHhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 566 YELMPNGTLSNFLFHEG--QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
|||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+.... ..++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~-~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGE-DGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECT-TSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecC-CCceeEEEecCCCc
Confidence 99999999999997543 2389999999999999999999999 999999999999982111 16678999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccC--------CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRN--------VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... .+..
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~---~~~~ 238 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE---VMYK 238 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH---HHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH---HHHH
Confidence 8764432 2234578999999999865 5778899999999999999999999975432211110 0100
Q ss_pred HHHHHhhcccccccc-----------cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 716 WVISCMLSRNLQVLV-----------SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
.............. ...............+.+++.+||+.||++||++.|+++.++.+++.
T Consensus 239 -~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 -IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp -HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred -HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00000000000000 00111122356677888999999999999999999999999887654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=333.00 Aligned_cols=260 Identities=24% Similarity=0.341 Sum_probs=199.4
Q ss_pred HhhcccccccccccceEEEEEEecc-Ccceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
..|.+.+.||+|+||+||+|.+... +....||||.+.... ....+.+.+|++++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 4577789999999999999987532 344579999986542 345678999999999999999999999998765 88
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+|+||+++++|.+++......+++..+..++.||+.||.|||++ +|+|+||||+||+++ .++.+||+|||++
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~-----~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLA-----TRDLVKIGDFGLM 168 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEE-----ETTEEEECCCTTC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEc-----CCCCEEEcccccc
Confidence 99999999999999987667789999999999999999999999 999999999999998 7789999999999
Q ss_pred cccCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHH
Q 047157 644 KLLNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 644 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----------~-~~ 236 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----------L-HK 236 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------H-HH
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-----------H-HH
Confidence 876543322 1223457788999999998889999999999999999999 9999975432111 0 01
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
..... ..........+.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 237 ~~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 237 IDKEG--------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHTSC--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHccC--------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11110 0011112234678899999999999999999999999987654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=336.68 Aligned_cols=252 Identities=23% Similarity=0.244 Sum_probs=193.7
Q ss_pred HHhhcccccccccccceEEEEEEec-cCcceeeeeeecccch----HHHHHHHHHHHHHhcCCCccccceEeeEEecCCe
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 561 (788)
...|.+.+.||+|+||.||++.... ..++..||+|.+.+.. ......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 3457788999999999999998742 2467799999987542 2334568899999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~-----~~~~~kl~Dfg 166 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLN-----HQGHVKLTDFG 166 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEEC-----TTSCEEECCCS
T ss_pred EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEEC-----CCCcEEEEeCC
Confidence 99999999999999999654 4678899999999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ....
T Consensus 167 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------------~~~i 233 (327)
T 3a62_A 167 LCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------------IDKI 233 (327)
T ss_dssp CC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------------HHHH
T ss_pred cccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------------HHHH
Confidence 9976433222 22345789999999999999999999999999999999999999976432111 0111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
..... .. +......+.+++.+||+.||++|| +++|++++
T Consensus 234 ~~~~~--------~~--p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 234 LKCKL--------NL--PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHTCC--------CC--CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HhCCC--------CC--CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11110 00 011245678899999999999999 78888763
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.67 Aligned_cols=253 Identities=25% Similarity=0.319 Sum_probs=203.1
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
..|.+.+.||+|+||.||+|... .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNR--VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEEC--CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 45778899999999999999886 567799999986433 344578899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+|+||||+||+++ .++.+||+|||.+...
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~-----~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLD-----ERDNLKISDFGLATVF 155 (276)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTCCEEECCCTTCEEC
T ss_pred EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEc-----cCCCEEEeeCCCcccc
Confidence 999999999998543 5689999999999999999999999 999999999999998 7789999999999865
Q ss_pred CCCCC-cccccccCCccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 647 NKDQT-RTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 647 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..... .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-----~~~ 224 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDW-----KEK 224 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHH-----HTT
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHh-----hhc
Confidence 43221 12234578999999999987765 7899999999999999999999976432111 11111 000
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. ............+.+++.+||+.||++|||++|++++
T Consensus 225 ~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 225 K--------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp C--------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0 0000111234567889999999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=327.13 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=203.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||++... .++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDA--DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEEC--CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4667799999999999999886 667789999886542 34567889999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~-----~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLN-----EDLEVKIGDFGLATK 164 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEc-----CCCCEEEEeccCcee
Confidence 9999999999988654 5689999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ........
T Consensus 165 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------------~~~~~~~~ 231 (294)
T 2rku_A 165 VEYDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------------YLRIKKNE 231 (294)
T ss_dssp CCSTTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------------HHHHHTTC
T ss_pred cccCccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------------HHHHhhcc
Confidence 6533222 2335689999999999998999999999999999999999999976432111 00111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. . ........+.+++.+||+.||++|||++|+++.
T Consensus 232 ~--------~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 Y--------S--IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp C--------C--CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred C--------C--CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0 011123567889999999999999999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.55 Aligned_cols=265 Identities=26% Similarity=0.383 Sum_probs=204.7
Q ss_pred HHHHhhcccccccccccceEEEEEEe---ccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
+....|.+.+.||+|+||.||+|... ....+..||||.+... ......++.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34556788899999999999999853 1245668999998643 3445668899999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccC------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCc
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM 634 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~ 634 (788)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++..+ ....
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~--~~~~ 181 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG--PGRV 181 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS--TTCC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCC--Ccce
Confidence 9999999999999999997653 3478999999999999999999999 999999999999998443 4557
Q ss_pred EEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhh
Q 047157 635 AKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 635 ~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 712 (788)
+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------- 253 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------- 253 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--------
Confidence 99999999975533221 22233567889999999998899999999999999999998 999997542211
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
. ........... ........+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 254 ~----~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 254 V----LEFVTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp H----HHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 0 11111111000 01122456788999999999999999999999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=339.89 Aligned_cols=256 Identities=22% Similarity=0.283 Sum_probs=200.4
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV 565 (788)
...|.+.+.||+|+||.||++..+ .++..||||.+.+... ...+|++++.++ +||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK--ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 346778899999999999999886 6778999999976432 234688888877 799999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+.... .....+||+|||++..
T Consensus 95 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~-~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDES-GNPESIRICDFGFAKQ 169 (342)
T ss_dssp ECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSS-CSGGGEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCC-CCcCeEEEEECCCccc
Confidence 9999999999999654 5689999999999999999999999 999999999999985321 1234699999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......+..+.
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---------~~~~~~i~~~~ 239 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---------EEILARIGSGK 239 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---------HHHHHHHHHCC
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---------HHHHHHHccCC
Confidence 654332 22345789999999999888899999999999999999999999975321110 00111111121
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
... .........+.+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 240 FSL------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCC------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccc------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 00001123456788999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=341.82 Aligned_cols=204 Identities=27% Similarity=0.407 Sum_probs=164.0
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCC--
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEED-- 560 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~-- 560 (788)
....|.+.+.||+|+||.||+|.+. .++..||||++... .....+.+.+|+.++.++. ||||+++++++...+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDR--RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEET--TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEEC--CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3456778899999999999999886 66779999988543 2445567889999999997 999999999997544
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||++ ++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~-----~~~~~kl~DF 153 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLN-----AECHVKVADF 153 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTCCEEECCC
T ss_pred EEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEc-----CCCCEEecCC
Confidence 7899999997 689998865 4688999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCC--------------------CcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCc
Q 047157 641 GISKLLNKDQ--------------------TRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIEL 699 (788)
Q Consensus 641 g~a~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~ 699 (788)
|+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 9998653211 112234579999999999876 6789999999999999999999999986
Q ss_pred ccc
Q 047157 700 SRV 702 (788)
Q Consensus 700 ~~~ 702 (788)
.+.
T Consensus 234 ~~~ 236 (388)
T 3oz6_A 234 SST 236 (388)
T ss_dssp SSH
T ss_pred CCH
Confidence 543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=338.73 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=188.1
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEe--------c
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCS--------E 558 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--------~ 558 (788)
..|.+.++||+|+||.||+|.+. .++..||||++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDV--GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEET--TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEEC--CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 35677899999999999999886 567799999987766667788999999999996 999999999983 3
Q ss_pred CCeEEEEEecCCCCCHhHhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCcEEeccCCCCCCCc
Q 047157 559 EDKRLLVYELMPNGTLSNFLFH--EGQRPGWVQRVEIALGVARGLLYLHEECETQ--IIHCDIKPQNVLLDLKTLDTNYM 634 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~~~~ 634 (788)
....++||||+. |+|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~-----~~~~ 176 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLS-----NQGT 176 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEEC-----TTSC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEEC-----CCCC
Confidence 446899999995 799998864 345689999999999999999999998 7 99999999999998 7789
Q ss_pred EEEeecCCccccCCCCCcc-----------cccccCCccccCcccc---cCCCCCccCcchhhHHHHHHHHhCCCCCCcc
Q 047157 635 AKISDFGISKLLNKDQTRT-----------DTNMRGTMGYVAPEWL---RNVPVTTKVDVFSFGVMLLEIICGRRHIELS 700 (788)
Q Consensus 635 ~kL~Dfg~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~k~DVwSlGvil~elltg~~p~~~~ 700 (788)
+||+|||++.......... .....+|+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998765432211 1134589999999998 5677899999999999999999999999653
Q ss_pred ccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
...... ..... ..........+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 257 ~~~~~~----------------~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 257 AKLRIV----------------NGKYS--------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------------------CC--------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHhh----------------cCccc--------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 221100 00000 00001112346779999999999999999999999987754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=354.67 Aligned_cols=253 Identities=28% Similarity=0.322 Sum_probs=205.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..+.+.++||+|+||.||+|... .++..||+|.+.+.. ......+.+|++++++++||||+++++++.+.+..++
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~--~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 34666789999999999999886 677899999996542 2334678899999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 565 VYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
||||+++|+|.+++...+ ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld-----~~g~vKL~DFGla 333 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLD-----DHGHIRISDLGLA 333 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTSCEEECCCTTC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEe-----CCCCeEEEecccc
Confidence 999999999999997653 3589999999999999999999999 999999999999998 7889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+ ......
T Consensus 334 ~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~----~i----~~~i~~ 403 (576)
T 2acx_A 334 VHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EV----ERLVKE 403 (576)
T ss_dssp EECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH----HH----HHHHHH
T ss_pred eecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH----HH----HHHhhc
Confidence 87654322 234579999999999999999999999999999999999999997643211110 01 111111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
.. ... .......+.+++.+||+.||++|| +++||+++
T Consensus 404 ~~--------~~~--p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 VP--------EEY--SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CC--------CCC--CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cc--------ccC--CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 10 000 112245778899999999999999 78999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=332.75 Aligned_cols=273 Identities=21% Similarity=0.291 Sum_probs=210.3
Q ss_pred CcccCHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcC--CCccccceEee
Q 047157 477 FREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR--THHKNLVRLLG 554 (788)
Q Consensus 477 ~~~~~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~ 554 (788)
...+...+.....|.+.+.||+|+||.||+|.. .+..||||.+... ..+.+.+|.+++.. ++||||+++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE----TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE----cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 344555667778899999999999999999986 3668999998654 24567788888876 79999999999
Q ss_pred EEecCC----eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhh--------hccCCceEecCCCCCcE
Q 047157 555 FCSEED----KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH--------EECETQIIHCDIKPQNV 622 (788)
Q Consensus 555 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivH~dlkp~NI 622 (788)
++.... ..++||||+++++|.+++.+ ..+++..++.++.||+.||.||| +. +|+||||||+||
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI 178 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI 178 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence 998876 78999999999999999965 36899999999999999999999 66 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCCc---ccccccCCccccCcccccCC------CCCccCcchhhHHHHHHHHhC
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQTR---TDTNMRGTMGYVAPEWLRNV------PVTTKVDVFSFGVMLLEIICG 693 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltg 693 (788)
|++ .++.+||+|||++......... ......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 179 ll~-----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 179 LVK-----KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp EEC-----TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEC-----CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 998 7789999999999876543322 22345789999999998765 344789999999999999999
Q ss_pred ----------CCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC
Q 047157 694 ----------RRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS 763 (788)
Q Consensus 694 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 763 (788)
+.||......... ... ............. .+......+..+.+.+++.+||+.||++|||
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~------~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPS------VEE-MRKVVCEQKLRPN---IPNRWQSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCC------HHH-HHHHHTTSCCCCC---CCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred cCcCCcccccccCccccCcCccc------HHH-HHHHHHHHHhCCC---CcccccchhHHHHHHHHHHHHhccChhhCCC
Confidence 6677543221110 011 1111111111100 1111123466778999999999999999999
Q ss_pred HHHHHHHhhcCcC
Q 047157 764 MKKVIHMLEGTLE 776 (788)
Q Consensus 764 ~~evl~~L~~~~~ 776 (788)
++||+++|+.+.+
T Consensus 324 ~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 324 ALRIKKTLSQLSQ 336 (342)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999987654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=350.47 Aligned_cols=266 Identities=21% Similarity=0.246 Sum_probs=194.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecC------C
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------D 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 560 (788)
.|.+.+.||+|+||+||+|... .++..||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDA--VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEET--TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CeEEEEEeecCCCeEEEEEEEC--CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 3667789999999999999886 66789999999754 344567889999999999999999999999654 4
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~-----~~~~~kl~DF 208 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK-----SDCTLKILDF 208 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTSCEEECCC
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEe-----CCCCEEEEEE
Confidence 67999999976 4666653 3488999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh----H--
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL----S-- 714 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~-- 714 (788)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+........+ .
T Consensus 209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 209 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred EeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9998764432 2334678999999999999999999999999999999999999998754322211100000 0
Q ss_pred -----HHHHHHhhcc-c-----ccccccC---CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 715 -----DWVISCMLSR-N-----LQVLVSH---DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 715 -----~~~~~~~~~~-~-----~~~l~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.......... . +...+.. .............+.+|+.+||+.||++|||++|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0 0000000 00000111235678999999999999999999999974
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.74 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=205.5
Q ss_pred HHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec----
Q 047157 483 QELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE---- 558 (788)
Q Consensus 483 ~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 558 (788)
.......|.+.+.||+|+||.||+|... .++..||+|.+.... +.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHR--IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEET--TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred cchhccccceeeeeccCCceEEEEEEEc--CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 3455667888899999999999999886 567799999987543 346689999999999999999998854
Q ss_pred ------------CCeEEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 559 ------------EDKRLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 559 ------------~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
....++||||+++++|.+++... ...+++..++.++.||+.||.|||++ +|+|+||||+||+++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 44589999999999999999654 45789999999999999999999999 999999999999998
Q ss_pred cCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccc
Q 047157 626 LKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEE 705 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~ 705 (788)
.++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 157 -----~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 225 (284)
T 2a19_B 157 -----DTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---- 225 (284)
T ss_dssp -----ETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----
T ss_pred -----CCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----
Confidence 778999999999987654332 233568999999999999999999999999999999999998874211
Q ss_pred cccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 706 SEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
. .........+.. .....+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 226 ---------~-~~~~~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 226 ---------K-FFTDLRDGIISD------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ---------H-HHHHHHTTCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ---------H-HHHHhhcccccc------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0 011111111111 1234577899999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=343.22 Aligned_cols=270 Identities=21% Similarity=0.329 Sum_probs=203.2
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
...|.+.+.||+|+||+||++... .++..||+|.+... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHK--PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEEC--CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 345677789999999999999886 66779999998754 344567899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++..+..++.||+.||.|||++ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 110 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~-----~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVN-----SRGEIKLCDFGVSGQ 181 (360)
T ss_dssp ECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEEC-----TTCCEEECCCCCCHH
T ss_pred EECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEEC-----CCCCEEEEECCCCcc
Confidence 9999999999999655 4688999999999999999999983 1799999999999998 778999999999875
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh------------
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL------------ 713 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------------ 713 (788)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.........
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 182 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred cccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 4321 1223578999999999999999999999999999999999999997653322110000000
Q ss_pred ------HHHHHHHhhc----ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 714 ------SDWVISCMLS----RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 714 ------~~~~~~~~~~----~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..+....... ..+...................+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000 0000000011111111123456889999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.50 Aligned_cols=260 Identities=25% Similarity=0.312 Sum_probs=204.8
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...|.+.+.||+|+||.||++... .++..||+|.+........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQR--LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEEC--CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 456788899999999999999886 567799999997665555667899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||++.... .++.+||+|||++...
T Consensus 86 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~--~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 86 QLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPE--ENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSS--TTCCEEBCSCSTTCCC
T ss_pred EcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCC--CCCCEEEccCCcceec
Confidence 999999999998654 4688999999999999999999999 999999999999994222 6789999999999764
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .........
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------~~~i~~~~~ 224 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL------------FEKIKEGYY 224 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------------HHHHHHCCC
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------------HHHHHcCCC
Confidence 332 12234689999999999999999999999999999999999999975422110 111111111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH--HhhcCc
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH--MLEGTL 775 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~ 775 (788)
. . ...........+.+++.+||+.||++|||++|+++ .+++..
T Consensus 225 ~-~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 225 E-F-----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp C-C-----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred C-C-----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 0 0 00001123456888999999999999999999996 455443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.80 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=203.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||++... .++..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDA--DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4667799999999999999886 667789999986542 34567889999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-----~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLN-----EDLEVKIGDFGLATK 190 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC-----TTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEc-----CCCCEEEeeccCcee
Confidence 9999999999988654 5689999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
....... .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+. ........
T Consensus 191 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------~~~~~~~~ 257 (335)
T 2owb_A 191 VEYDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------------YLRIKKNE 257 (335)
T ss_dssp CCSTTCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------------HHHHHHTC
T ss_pred cccCccc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------------HHHHhcCC
Confidence 6533222 2335689999999999999999999999999999999999999975432111 00011111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.. . .......+.+++.+||+.||++|||++|+++
T Consensus 258 ~~--------~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 YS--------I--PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CC--------C--CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CC--------C--CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 0112346778999999999999999999997
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.69 Aligned_cols=274 Identities=24% Similarity=0.316 Sum_probs=196.3
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec-----CCeE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-----EDKR 562 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~ 562 (788)
..|.+.+.||+|+||.||+|.. .+..||||++...... ......|+..+..++||||+++++.+.. ....
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL----DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE----TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred HHhheeeecccCCCeEEEEEEE----CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3466779999999999999965 4579999998754322 1222344445566899999999985532 3367
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcc------CCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC------ETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
++||||+++|+|.+++... ..++..++.++.||+.||.|||+.+ .++|+||||||+|||++ .++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~-----~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-----NDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC-----TTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc-----CCCcEE
Confidence 8999999999999999654 3488999999999999999999863 33899999999999998 778999
Q ss_pred EeecCCccccCCCCC-------cccccccCCccccCcccccC-------CCCCccCcchhhHHHHHHHHhCCCCCCcccc
Q 047157 637 ISDFGISKLLNKDQT-------RTDTNMRGTMGYVAPEWLRN-------VPVTTKVDVFSFGVMLLEIICGRRHIELSRV 702 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwSlGvil~elltg~~p~~~~~~ 702 (788)
|+|||++..+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 12224569999999999976 4677899999999999999999877654322
Q ss_pred ccccccch-------hhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 703 EEESEEVD-------IVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 703 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
........ ...... ............+ .............+.+++.+||+.||++|||++||++.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDM-QVLVSREKQRPKF--PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHH-HHHHTTSCCCCCC--CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHH-HhhhcccccCCCC--CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 21111000 000010 0111111111110 1111223345678999999999999999999999999998876
Q ss_pred C
Q 047157 776 E 776 (788)
Q Consensus 776 ~ 776 (788)
.
T Consensus 318 ~ 318 (336)
T 3g2f_A 318 M 318 (336)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.23 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=196.8
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEec----CCeEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE----EDKRL 563 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 563 (788)
+.+.+.||+|+||+||+|... .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~--~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDT--ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeeccCCCCeEEEEeEec--CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 456788999999999999886 677789999886432 4456789999999999999999999998865 45689
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ--IIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++ + |+||||||+|||++. .++.+||+|||
T Consensus 106 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~----~~~~~kl~Dfg 177 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITG----PTGSVKIGDLG 177 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESS----TTSCEEECCTT
T ss_pred EEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEEC----CCCCEEEeeCC
Confidence 999999999999999654 5688999999999999999999998 7 999999999999962 56789999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
++....... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........ .....
T Consensus 178 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----------~~~~~ 242 (290)
T 1t4h_A 178 LATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----------IYRRV 242 (290)
T ss_dssp GGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----------HHHHH
T ss_pred Ccccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----------HHHHH
Confidence 997654332 223568999999998874 589999999999999999999999965322110 01111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
........ ........+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 243 TSGVKPAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTTCCCGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccCCccc--------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111100 111123568889999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=337.02 Aligned_cols=266 Identities=19% Similarity=0.235 Sum_probs=193.3
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..|.+.++||+|+||+||+|... .++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDT--VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEEC--CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 35777899999999999999876 677899999986443 23345788999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||++ ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++..+....+.+||+|||++..
T Consensus 112 ~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 99997 5999998655 4689999999999999999999999 99999999999999643323566799999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+... . ........
T Consensus 187 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------~-~~~~~~~~ 257 (329)
T 3gbz_A 187 FGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF-------K-IFEVLGLP 257 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------H-HHHHHCCC
T ss_pred cCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH-------H-HHHHhCCC
Confidence 643322 22335679999999999774 58999999999999999999999997653221110 0 00000000
Q ss_pred ---cc------cccccCCCCCc-ccH------HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 725 ---NL------QVLVSHDPEVL-SDL------ERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 725 ---~~------~~l~~~~~~~~-~~~------~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.. .......+... ... ...+.+.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 00000000000 000 12367789999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=330.59 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=200.9
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
.....|.+.+.||+|+||.||+|... .++..||+|.+.... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHK--ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEET--TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEEC--CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34456777899999999999999886 567799999987532 34678899999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++......+++..+..++.||+.||.|||+. +|+|+||||+||+++ .++.+||+|||++.
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~-----~~~~~kl~dfg~~~ 173 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLN-----TEGHAKLADFGVAG 173 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTCCEEECCCTTCE
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEEC-----CCCCEEEeecccch
Confidence 9999999999999976677899999999999999999999999 999999999999998 77899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ ... ....
T Consensus 174 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------~~~-~~~~ 240 (314)
T 3com_A 174 QLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----------IFM-IPTN 240 (314)
T ss_dssp ECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----------HHH-HHHS
T ss_pred hhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-----------HHH-HhcC
Confidence 7644322 22335689999999999999999999999999999999999999975422110 000 0000
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. .+...........+.+++.+||+.||++|||+.++++
T Consensus 241 ~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 241 P-------PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp C-------CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-------CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 0111111223457888999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.18 Aligned_cols=256 Identities=24% Similarity=0.309 Sum_probs=201.3
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchH------HHHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE------KTNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
...|.+.+.||+|+||.||++... .++..||+|.+..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQK--GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhHHhhcccCceEEEEEEEc--CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 456888899999999999999886 5677999998865321 13578899999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.... ....+||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~-~~~~~kl~df 156 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNV-PNPRIKLIDF 156 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSS-SSCCEEECCC
T ss_pred eEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCC-CCCceEEEec
Confidence 999999999999999999654 5689999999999999999999999 9999999999999983221 2348999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
|++........ .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+.. ..
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------------~~ 222 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL------------TN 222 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------------HH
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH------------HH
Confidence 99987644322 23356899999999999999999999999999999999999999764321110 00
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...... ...........+.+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 223 ISAVNY------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHTTCC------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hHhccc------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000000 0000000122456888999999999999999999997
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=341.37 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=189.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhc-CCCccccceEeeEEec----CCeEEEEEec
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIG-RTHHKNLVRLLGFCSE----EDKRLLVYEL 568 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~----~~~~~lV~e~ 568 (788)
++||+|+||+||++.+. .++..||||++... ..+.+|++++. ..+||||+++++++.. ....+|||||
T Consensus 68 ~~LG~G~~g~V~~~~~~--~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNK--RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp EEEEEETTEEEEEEEET--TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ceeeeccCeEEEEEEEC--CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 68999999999999886 67789999998643 34567888764 4589999999998865 5678999999
Q ss_pred CCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 569 MPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 569 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++... .++.+||+|||+++...
T Consensus 141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~--~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKR--PNAILKLTDFGFAKETT 215 (400)
T ss_dssp CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSS--TTCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCC--CCccEEEEecccccccC
Confidence 99999999997653 4689999999999999999999999 999999999999998432 37899999999998654
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. ....+...
T Consensus 216 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~----~i~~~~~~ 285 (400)
T 1nxk_A 216 SHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KT----RIRMGQYE 285 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH----HH----HHHHTCCC
T ss_pred CCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH----HH----HHHcCccc
Confidence 322 223457899999999999999999999999999999999999999765332211110 00 01111110
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. ..+ ......+.+.+|+.+||+.||++|||++|++++
T Consensus 286 ~---~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 F---PNP---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C---CTT---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C---CCc---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000 001234568889999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.04 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=191.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCc--cccceEeeEEecCCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHH--KNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~l 564 (788)
.|.+.+.||+|+||.||++.. .++..||||++... .....+.+.+|++++.+++| |||+++++++.+++..++
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLN---EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEEC---TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred EEEEEEEEecCCCeEEEEEEe---CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 466789999999999999976 35668999988643 34455789999999999976 999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||| +.+++|.+++... ..+++.++..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||++.
T Consensus 87 v~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~------~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV------DGMLKLIDFGIAN 155 (343)
T ss_dssp EEC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE------TTEEEECCCSSSC
T ss_pred EEe-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE------CCcEEEeeccccc
Confidence 999 5688999999764 5788999999999999999999999 999999999999995 3579999999998
Q ss_pred ccCCCCCc-ccccccCCccccCcccccC-----------CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh
Q 047157 645 LLNKDQTR-TDTNMRGTMGYVAPEWLRN-----------VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 645 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 712 (788)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------- 227 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------- 227 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--------
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH--------
Confidence 76543322 2234679999999999864 678999999999999999999999996431110
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... .... ......+......+.+++.+||+.||++|||+.|++++
T Consensus 228 --~~~~~-~~~~--------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 228 --SKLHA-IIDP--------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --HHHHH-HHCT--------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHH-HhcC--------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 00000 1111 11111111113467889999999999999999999865
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=336.58 Aligned_cols=257 Identities=19% Similarity=0.151 Sum_probs=198.8
Q ss_pred HhhcccccccccccceEEEEEEe---ccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC---ccccceEeeEEecCCe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILR---LKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH---HKNLVRLLGFCSEEDK 561 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~ 561 (788)
..|.+.++||+|+||+||+|... ....+..||||.+.... ..++..|++++.+++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 45667789999999999999531 12567799999997653 345666666666665 9999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCC------CCC
Q 047157 562 RLLVYELMPNGTLSNFLFH----EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT------LDT 631 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~------~~~ 631 (788)
.++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++... ...
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999964 346789999999999999999999999 999999999999998310 012
Q ss_pred CCcEEEeecCCccccCCC-CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccch
Q 047157 632 NYMAKISDFGISKLLNKD-QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD 710 (788)
Q Consensus 632 ~~~~kL~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~ 710 (788)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----
Confidence 789999999999765322 222334567999999999999999999999999999999999999999644221110
Q ss_pred hhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCC-CCHHHHHHHhhcCcC
Q 047157 711 IVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLR-PSMKKVIHMLEGTLE 776 (788)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~evl~~L~~~~~ 776 (788)
+...+. .. ...+.+.+++..|++.+|.+| |+++++.+.|++.++
T Consensus 295 ---------------~~~~~~----~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 ---------------PEGLFR----RL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ---------------ECSCCT----TC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------------echhcc----cc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 001110 11 123456678888999999999 688888888876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=350.62 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=200.4
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
...|.+.+.||+|+||+||+|... .++..||+|.+.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDK--VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEET--TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEEC--CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 456888899999999999999886 667799999987543 2335678999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++... .+..+||+|||++.
T Consensus 114 v~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~--~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKE--KDALIKIVDFGLSA 187 (494)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSS--TTCCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCC--CCCcEEEEECCCCe
Confidence 99999999999988655 5688999999999999999999999 999999999999997433 45679999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
....... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||......+. .......
T Consensus 188 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------------~~~i~~~ 252 (494)
T 3lij_A 188 VFENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI------------LRKVEKG 252 (494)
T ss_dssp ECBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHT
T ss_pred ECCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH------------HHHHHhC
Confidence 7654322 23457999999999986 4699999999999999999999999976532211 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.... ...........+.+++.+||+.||++|||++|++++
T Consensus 253 ~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 253 KYTF------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCCC------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCC------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1100 000001224567889999999999999999999853
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=349.60 Aligned_cols=256 Identities=25% Similarity=0.328 Sum_probs=205.3
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
....|.+.++||+|+||+||++... .++..||||.+.... ......+.+|++++++++||||+++++++.+....+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDR--ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEET--TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEEC--CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 3467888999999999999999886 667799999986432 234568899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++... .++.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~--~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKE--KDCDIKIIDFGLS 171 (486)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSS--TTCCEEECSCSCT
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCC--CCCCEEEEECCcC
Confidence 999999999999988655 5689999999999999999999999 999999999999997433 5678999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+. ......
T Consensus 172 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------------~~~i~~ 236 (486)
T 3mwu_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------------LKRVET 236 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHH
T ss_pred eECCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------------HHHHHh
Confidence 87644322 234578999999999976 599999999999999999999999976532211 011111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+... ............+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 GKYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp TCCC------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCC------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 0001111234567899999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=343.41 Aligned_cols=258 Identities=26% Similarity=0.353 Sum_probs=194.1
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch--------HHHHHHHHHHHHHhcCCCccccceEeeEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--------EKTNEEFMTELKIIGRTHHKNLVRLLGFC 556 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 556 (788)
.....|.+.+.||+|+||+||+|... .++..||||.+.... ......+.+|++++++++||||+++++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFER--KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEEC--CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34556888899999999999999886 667799999986532 11223578999999999999999999998
Q ss_pred ecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 557 SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 557 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
.. +..++||||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++..+ .+..+|
T Consensus 210 ~~-~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~--~~~~~k 282 (419)
T 3i6u_A 210 DA-EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE--EDCLIK 282 (419)
T ss_dssp ES-SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS--SSCCEE
T ss_pred ec-CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC--CcceEE
Confidence 54 5689999999999999998654 5689999999999999999999999 999999999999997433 456799
Q ss_pred EeecCCccccCCCCCcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh
Q 047157 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL 713 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 713 (788)
|+|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ +
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~ 353 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------L 353 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-------H
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-------H
Confidence 99999998765332 223467899999999985 36788999999999999999999999975422211 0
Q ss_pred HHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 714 SDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 714 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. .......... + .......+.+.+++.+||+.||++|||++|++++
T Consensus 354 ~~----~i~~~~~~~~----~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 354 KD----QITSGKYNFI----P--EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HH----HHHTTCCCCC----H--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HH----HHhcCCCCCC----c--hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0111110000 0 0001224678899999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=341.60 Aligned_cols=249 Identities=21% Similarity=0.335 Sum_probs=192.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCC--ccccceEeeEEecCCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTH--HKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~l 564 (788)
.|.+.+.||+|+||.||++... .+..||||.+... .....+.+.+|++++.+++ ||||+++++++...+..++
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcC---CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3677799999999999999864 3678999988643 3455678999999999996 5999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||| +.+++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||++.
T Consensus 134 v~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~------~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV------DGMLKLIDFGIAN 202 (390)
T ss_dssp EEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES------SSCEEECCCSSSC
T ss_pred EEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE------CCeEEEEecCccc
Confidence 999 5688999999765 4778889999999999999999999 999999999999995 3689999999998
Q ss_pred ccCCCCCc-ccccccCCccccCcccccC-----------CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh
Q 047157 645 LLNKDQTR-TDTNMRGTMGYVAPEWLRN-----------VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 645 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 712 (788)
.+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------- 274 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------- 274 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--------
Confidence 76543322 2334679999999999865 468899999999999999999999996432110
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... ........ ....+......+.+++.+||+.||++|||+.|++++
T Consensus 275 --~~~-~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 275 --SKL-HAIIDPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HHH-HHHHCTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHH-HHHhCccc--------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 000 01111110 000011113567889999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=326.31 Aligned_cols=248 Identities=28% Similarity=0.404 Sum_probs=195.1
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCCC
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
..+||+|+||.||+|... .++..||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDL--SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp BCEEEECSSSEEEEEEET--TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred cEEEeecCcEEEEEEEEC--CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 358999999999999886 667799999997765666778999999999999999999999999999999999999999
Q ss_pred CHhHhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 573 TLSNFLFHEG--QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 573 sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
+|.+++.... ...++..+..++.||+.||.|||++ +|+|+||||+||+++. .++.+||+|||++.......
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~----~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINT----YSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET----TTCCEEECCTTTCEESCC--
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEEC----CCCCEEEeecccccccCCCC
Confidence 9999997653 3457888999999999999999999 9999999999999982 27899999999998764322
Q ss_pred CcccccccCCccccCcccccCCC--CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 651 TRTDTNMRGTMGYVAPEWLRNVP--VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
. ......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||........ .... ... ..
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~---~~~-~~---- 242 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA------AMFK---VGM-FK---- 242 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH------HHHH---HHH-HC----
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH------HHHh---hcc-cc----
Confidence 1 123456899999999987643 88999999999999999999999964321110 0000 000 00
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..+.. .......+.+++.+||+.||++|||++|+++
T Consensus 243 ---~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 ---VHPEI--PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---CCCCC--CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---ccccc--cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00111 1123456788999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.33 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=197.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHH-HHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK-TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.+.||+|+||+||+|... .++..||+|.+...... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSK--LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEEC--CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 4667789999999999999886 56779999998654322 12245679999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|++ ++|.+++...+..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~-----~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLIN-----ERGELKLADFGLARAKS 151 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEEC-----TTCCEEECSSSEEECC-
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEEC-----CCCCEEEccCccccccc
Confidence 997 599999988777899999999999999999999999 999999999999998 77899999999998654
Q ss_pred CCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc--
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR-- 724 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 724 (788)
.... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+... .........
T Consensus 152 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--------~i~~~~~~~~~ 222 (324)
T 3mtl_A 152 IPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH--------FIFRILGTPTE 222 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--------HHHHHHCCCCT
T ss_pred CCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHHHHhCCCCh
Confidence 3222 2233567999999999876 578999999999999999999999997654322111 011100000
Q ss_pred -ccccccc---------CCCCCc----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH--HhhcC
Q 047157 725 -NLQVLVS---------HDPEVL----SDLERFERMAMVGLWCNHPDPNLRPSMKKVIH--MLEGT 774 (788)
Q Consensus 725 -~~~~l~~---------~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~ 774 (788)
....... ...... ........+.+++.+||+.||++|||++|+++ .+.++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0000000 000000 00122356789999999999999999999987 34444
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.53 Aligned_cols=249 Identities=29% Similarity=0.408 Sum_probs=194.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecC-CeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE-DKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lV~ 566 (788)
..|.+.+.||+|+||+||++.. .+..||||.+.... ..+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY----RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE----TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhceEEeEEecCCCceEEEEEE----cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 4567789999999999999976 35689999987543 456789999999999999999999987554 4789999
Q ss_pred ecCCCCCHhHhhhccCC-CCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHEGQ-RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++++|.+++..... .+++..++.++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~-----~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVS-----EDNVAKVSDFGLTKE 166 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----TTSCEEECCCCC---
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEe-----CCCcEEEeecccccc
Confidence 99999999999965532 378899999999999999999999 999999999999998 788999999999886
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ......
T Consensus 167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------------~~~~~~ 230 (278)
T 1byg_A 167 ASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------------PRVEKG 230 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH------------HHHTTT
T ss_pred ccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------HHHhcC
Confidence 54322 22356889999999998899999999999999999998 99999754322110 111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
. ...........+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 231 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 231 Y---------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 0 00111123467888999999999999999999999998764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=347.05 Aligned_cols=239 Identities=15% Similarity=0.126 Sum_probs=186.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc---hHHHHHHHHHHH---HHhcCCCccccceEe-------eE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTEL---KIIGRTHHKNLVRLL-------GF 555 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~hpniv~~~-------~~ 555 (788)
.|.+.+.||+|+||+||+|... .++..||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQ--ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC---CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred eEEEcceeecCCCEEEEEEEEC--CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 3556789999999999999875 56779999998632 344567889999 566667899999998 66
Q ss_pred EecCCe-----------------EEEEEecCCCCCHhHhhhccCCC------CCHHHHHHHHHHHHHHHHHhhhccCCce
Q 047157 556 CSEEDK-----------------RLLVYELMPNGTLSNFLFHEGQR------PGWVQRVEIALGVARGLLYLHEECETQI 612 (788)
Q Consensus 556 ~~~~~~-----------------~~lV~e~~~~gsL~~~l~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~~~~~i 612 (788)
+.+.+. .++||||+ +|+|.+++...+.. +++..++.|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665532 78999999 68999999754322 23688889999999999999999 99
Q ss_pred EecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCC-----------CCCccCcch
Q 047157 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-----------PVTTKVDVF 681 (788)
Q Consensus 613 vH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DVw 681 (788)
+||||||+|||++ .++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||
T Consensus 228 vHrDikp~NIll~-----~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 228 VHTYLRPVDIVLD-----QRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp ECSCCCGGGEEEC-----TTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred ecCCCCHHHEEEc-----CCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 9999999999998 778999999999986432 2234567 999999999887 899999999
Q ss_pred hhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCC
Q 047157 682 SFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLR 761 (788)
Q Consensus 682 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 761 (788)
|||+++|||++|+.||.......... .+..... ...+.+.+++.+||+.||++|
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~~~--------------------~~~~~~~------~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGGSE--------------------WIFRSCK------NIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CCSG--------------------GGGSSCC------CCCHHHHHHHHHHTCSSGGGC
T ss_pred HHHHHHHHHHHCCCCCcccccccchh--------------------hhhhhcc------CCCHHHHHHHHHHcCCCchhC
Confidence 99999999999999997543222111 1111000 123567889999999999999
Q ss_pred CCHHHHHH
Q 047157 762 PSMKKVIH 769 (788)
Q Consensus 762 Pt~~evl~ 769 (788)
||+.|+++
T Consensus 352 pt~~e~l~ 359 (377)
T 3byv_A 352 LLPLQAME 359 (377)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=333.30 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=199.2
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..|.+.+.||+|+||.||+|... .++..||+|.+........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNK--ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEET--TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEc--CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 35677899999999999999886 5677999999877666667889999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++......+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||++....
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~-----~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMT-----LEGDIRLADFGVSAKNL 168 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC-----TTSCEEECCCHHHHHHH
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEC-----CCCCEEEEECCCCcccc
Confidence 9999999999987677899999999999999999999999 999999999999998 77899999999875432
Q ss_pred CCCCcccccccCCccccCcccc-----cCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWL-----RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
... .......|++.|+|||++ ....++.++||||||+++|||++|+.||........ ... ..
T Consensus 169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------~~~-~~ 235 (302)
T 2j7t_A 169 KTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----------LLK-IA 235 (302)
T ss_dssp HHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----------HHH-HH
T ss_pred ccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----------HHH-Hh
Confidence 111 111234689999999998 466789999999999999999999999975432110 000 11
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
... .+...........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 236 KSD-------PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HSC-------CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccC-------CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111 1111112233456888999999999999999999976
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.38 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=183.5
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
...|.+.+.||+|+||.||+|... .++..||||.+.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCA--PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEEC--CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 345667899999999999999875 566799999986543 33456788999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhc-------cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 566 YELMPNGTLSNFLFH-------EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
|||+++++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||+++ .++.+||+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~-----~~~~~kl~ 163 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLG-----EDGSVQIA 163 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC-----TTCCEEEC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEc-----CCCCEEEE
Confidence 999999999999864 245689999999999999999999999 999999999999998 78899999
Q ss_pred ecCCccccCCCCC----cccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh
Q 047157 639 DFGISKLLNKDQT----RTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL 713 (788)
Q Consensus 639 Dfg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 713 (788)
|||++........ .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------- 236 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------- 236 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-------
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-------
Confidence 9999876643221 11233568999999999875 56899999999999999999999999764322110
Q ss_pred HHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 714 SDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 714 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.. .........................+.+++.+||+.||++|||++|+++
T Consensus 237 ----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 237 ----ML-TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ----HH-HHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HH-HhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 0011100000000000001122356788999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=345.97 Aligned_cols=193 Identities=24% Similarity=0.372 Sum_probs=153.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEec-----CCe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-----EDK 561 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 561 (788)
.|.+.++||+|+||+||+|.+. .++..||||++... .....+++.+|++++++++||||+++++++.. ...
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDK--LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TEEECCC-------CEEEEEEC--C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CeEEeeEeeecCCeEEEEEEEC--CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4677899999999999999887 66779999988653 23455789999999999999999999999843 357
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~-----~~~~~kl~DFG 201 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVN-----QDCSVKVCDFG 201 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC-----TTCCEEECCCT
T ss_pred EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEEC-----CCCCEeecccc
Confidence 89999998 57899988544 6789999999999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCCC--------------------------cccccccCCccccCcccc-cCCCCCccCcchhhHHHHHHHHhC
Q 047157 642 ISKLLNKDQT--------------------------RTDTNMRGTMGYVAPEWL-RNVPVTTKVDVFSFGVMLLEIICG 693 (788)
Q Consensus 642 ~a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~elltg 693 (788)
+++....... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 9987643221 122345789999999976 566799999999999999999993
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=332.53 Aligned_cols=261 Identities=21% Similarity=0.259 Sum_probs=202.8
Q ss_pred HHHHHHhhccc-ccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCC-CccccceEeeEEec
Q 047157 483 QELQEATKGFS-KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSE 558 (788)
Q Consensus 483 ~~l~~~t~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 558 (788)
.+.....|.+. +.||+|+||.||+|... .++..||+|.+.... ......+.+|+.++.++ +||||+++++++.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISK--STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEEC--CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 34444556665 89999999999999886 667799999986543 23457889999999998 57999999999999
Q ss_pred CCeEEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 559 EDKRLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++... .++.+||
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~--~~~~~kL 175 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIY--PLGDIKI 175 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBT--TBCCEEE
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCC--CCCcEEE
Confidence 99999999999999999998643 46789999999999999999999999 999999999999998322 3689999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+...
T Consensus 176 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---------- 243 (327)
T 3lm5_A 176 VDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL---------- 243 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------
T ss_pred eeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH----------
Confidence 99999987653322 233578999999999999999999999999999999999999997643221100
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
........ ..........+.+.+++.+||+.||++|||++|++++
T Consensus 244 --~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 244 --NISQVNVD------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --HHHHTCCC------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --HHHhcccc------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00000000 0001111234567889999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=329.85 Aligned_cols=253 Identities=20% Similarity=0.279 Sum_probs=201.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEe--cCCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCS--EEDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l 564 (788)
.|.+.+.||+|+||.||++... .++..||+|.+... .....+.+.+|++++++++||||+++++++. .....++
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRK--SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred heeeehhccCCCCcEEEEEEEC--CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4667799999999999999886 56779999998643 2445678999999999999999999999874 4678999
Q ss_pred EEecCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCc-----eEecCCCCCcEEeccCCCCCCCcEE
Q 047157 565 VYELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQ-----IIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
||||+++++|.+++... ...+++..++.++.||+.||.|||++ + |+||||||+||+++ .++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~-----~~~~~k 156 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLD-----GKQNVK 156 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEEC-----SSSCEE
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEc-----CCCCEE
Confidence 99999999999999653 34589999999999999999999998 7 99999999999998 788999
Q ss_pred EeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
|+|||++......... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 157 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------ 223 (279)
T 2w5a_A 157 LGDFGLARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------------ 223 (279)
T ss_dssp ECCCCHHHHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------------
T ss_pred EecCchheeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH------------
Confidence 9999999876443221 223468999999999999899999999999999999999999997643211
Q ss_pred HHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 717 VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
.......+....+ .......+.+++.+||+.||++|||++||++.+..
T Consensus 224 ~~~~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 224 LAGKIREGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHHHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHhhcccccC---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0111111111111 11234578889999999999999999999987744
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.92 Aligned_cols=269 Identities=23% Similarity=0.322 Sum_probs=198.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||.||+|... .++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNK--DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEET--TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEEC--CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4677799999999999999886 667799999885432 344567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 104 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~-----~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 104 EFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVS-----QSGVVKLCDFGFARTL 174 (331)
T ss_dssp ECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTSCEEECCCTTC---
T ss_pred ecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEc-----CCCcEEEEeCCCceee
Confidence 99999999887644 35689999999999999999999999 999999999999998 7789999999999866
Q ss_pred CCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHHHHHHh-
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDWVISCM- 721 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~- 721 (788)
..... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+......... ........
T Consensus 175 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 175 AAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred cCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 44322 22335689999999999775 78999999999999999999999997654322111000000 00000000
Q ss_pred hcccccccccCCCCCccc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..........+....... ....+.+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000011110011111111 123567889999999999999999999886
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.42 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=200.2
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEec-------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE------- 558 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------- 558 (788)
..|.+.+.||+|+||+||+|... .++..||||++.... ......+.+|++++++++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHR--KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEET--TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cceeEEEEEecCCCcEEEEEEEC--CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 35777899999999999999886 667799999885432 2234577899999999999999999999877
Q ss_pred -CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 559 -EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 559 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
.+..++||||+++ +|.+.+......+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~-----~~~~~kl 165 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLIT-----RDGVLKL 165 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEc-----CCCCEEE
Confidence 4568999999975 88888877767899999999999999999999999 999999999999998 7889999
Q ss_pred eecCCccccCCCC---CcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh
Q 047157 638 SDFGISKLLNKDQ---TRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL 713 (788)
Q Consensus 638 ~Dfg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 713 (788)
+|||++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..........
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------ 239 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA------ 239 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH------
Confidence 9999998764322 222334578999999998876 468999999999999999999999998653322111
Q ss_pred HHHHHHHhhc---ccccc--------cccC-CCCCcccHH------HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 714 SDWVISCMLS---RNLQV--------LVSH-DPEVLSDLE------RFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 714 ~~~~~~~~~~---~~~~~--------l~~~-~~~~~~~~~------~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
........ ..... .+.. ......... ....+.+|+.+||+.||++|||++|++++
T Consensus 240 --~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 240 --LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp --HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000 00000 0000 000000111 13457899999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=340.78 Aligned_cols=264 Identities=14% Similarity=0.163 Sum_probs=202.6
Q ss_pred HhhcccccccccccceEEEEEEeccC------cceeeeeeecccchHHHHHHHHHHHHHhcCCCccccce----------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKD------TQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR---------- 551 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~---------- 551 (788)
..|.+.+.||+|+||.||+|...... .+..||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 35677899999999999999986321 3679999998754 46779999999999999987
Q ss_pred -----EeeEEec-CCeEEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEe
Q 047157 552 -----LLGFCSE-EDKRLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLL 624 (788)
Q Consensus 552 -----~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 624 (788)
+++++.. +...++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 6677765 77899999999 99999999764 46789999999999999999999999 99999999999999
Q ss_pred ccCCCCCCC--cEEEeecCCccccCCCCCc------ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC
Q 047157 625 DLKTLDTNY--MAKISDFGISKLLNKDQTR------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696 (788)
Q Consensus 625 ~~~~~~~~~--~~kL~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p 696 (788)
+ .++ .+||+|||++..+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus 193 ~-----~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 193 D-----PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp E-----TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred c-----CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 8 666 8999999999876533211 12335789999999999999999999999999999999999999
Q ss_pred CCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 697 IELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
|........ ....... .. ......+...... .....+.+.+++.+||+.||++|||+++|+++|+++..
T Consensus 268 f~~~~~~~~------~~~~~~~-~~-~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 268 WTNCLPNTE------DIMKQKQ-KF-VDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TGGGTTCHH------HHHHHHH-HH-HHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cccCCcCHH------HHHHHHH-hc-cCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 976431110 0111110 01 1111111111100 01123678889999999999999999999999987753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=348.71 Aligned_cols=252 Identities=25% Similarity=0.301 Sum_probs=202.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchH---HHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE---KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.+.+.++||+|+||.||++..+ .++..||+|++.+... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~--~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMK--ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEC--CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 4555688999999999999886 6778999999975432 2346788999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 566 YELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
|||+++|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~-----~~g~vkL~DFGl 335 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLD-----DDGNVRISDLGL 335 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTSCEEECCCTT
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEe-----CCCCEEEeecce
Confidence 9999999999998654 34689999999999999999999999 999999999999998 888999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+..+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . ......
T Consensus 336 a~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~-------~-~~~~i~ 406 (543)
T 3c4z_A 336 AVELKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-------E-LKQRVL 406 (543)
T ss_dssp CEECCTTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH-------H-HHHHHH
T ss_pred eeeccCCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH-------H-HHHHHh
Confidence 9876543322 233579999999999999999999999999999999999999997643211100 0 111111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM-----KKVIH 769 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 769 (788)
.... .. +......+.+++.+||+.||++||++ ++|++
T Consensus 407 ~~~~--------~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 407 EQAV--------TY--PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HCCC--------CC--CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred hccc--------CC--CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1111 00 11224567889999999999999975 66664
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=351.64 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=206.4
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
....|.+.++||+|+||.||++... .++..||||.+.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDK--ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEEC--CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3457888899999999999999886 677799999986432 33467889999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+.+++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++... .++.+||+|||+
T Consensus 102 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~--~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKS--KDANIRIIDFGL 175 (484)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS--TTCCEEECCTTH
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCC--CCCcEEEEeeee
Confidence 9999999999999998654 5689999999999999999999999 999999999999996433 678999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+. ...+.
T Consensus 176 a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------------~~~i~ 240 (484)
T 3nyv_A 176 STHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI------------LKKVE 240 (484)
T ss_dssp HHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHH
T ss_pred eEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH------------HHHHH
Confidence 987654332 233568999999999876 699999999999999999999999976532211 01111
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.+... ..........+.+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 241 KGKYT------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HCCCC------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCC------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 11111 001111123466888999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=324.22 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=198.5
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 563 (788)
...|.+.+.||+|+||+||+|... .++..||+|.+... ......++.+|+..+.++ +||||+++++++.+.+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR--LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEc--CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 456778899999999999999886 56779999998753 234456788999999998 9999999999999999999
Q ss_pred EEEecCCCCCHhHhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC-----------
Q 047157 564 LVYELMPNGTLSNFLFHE---GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL----------- 629 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~----------- 629 (788)
+||||+++++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++..+.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999654 25689999999999999999999999 9999999999999974321
Q ss_pred ---CCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccc
Q 047157 630 ---DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEE 705 (788)
Q Consensus 630 ---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~ 705 (788)
.....+||+|||.+....... ...|++.|+|||.+.+. .+++++||||||+++|||++|..++.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 034579999999998765432 23589999999999765 667899999999999999999987643311
Q ss_pred cccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 706 SEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...........+ + ......+.+++.+||+.||++|||+.|++++
T Consensus 237 ------------~~~~~~~~~~~~----~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ------------WHEIRQGRLPRI----P-----QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ------------HHHHHTTCCCCC----S-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------------HHHHHcCCCCCC----C-----cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 011111111111 0 1123567889999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.50 Aligned_cols=251 Identities=11% Similarity=0.026 Sum_probs=180.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHH---HHhcCCCccccceEe-------eEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTEL---KIIGRTHHKNLVRLL-------GFC 556 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~---~~l~~l~hpniv~~~-------~~~ 556 (788)
|.+.+.||+|+||+||+|.+. .++..||||++.... ....+.+.+|+ +.++. +||||++++ +++
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDV--ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeccCCCCEEEEEEEEC--CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 556789999999999999886 667899999997643 34456777885 45555 799988755 444
Q ss_pred ecC-----------------CeEEEEEecCCCCCHhHhhhccCCCCCHHHH------HHHHHHHHHHHHHhhhccCCceE
Q 047157 557 SEE-----------------DKRLLVYELMPNGTLSNFLFHEGQRPGWVQR------VEIALGVARGLLYLHEECETQII 613 (788)
Q Consensus 557 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~qi~~aL~~LH~~~~~~iv 613 (788)
... ...++||||++ ++|.+++...+..+++..+ +.++.||+.||+|||++ +|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 332 34799999998 8999999765455565666 78889999999999999 999
Q ss_pred ecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccC--CCCCccCcchhhHHHHHHHH
Q 047157 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN--VPVTTKVDVFSFGVMLLEII 691 (788)
Q Consensus 614 H~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~ell 691 (788)
||||||+|||++ .++.+||+|||+++...... ....+++.|+|||++.+ ..++.++||||||+++|||+
T Consensus 217 HrDikp~NIll~-----~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 217 HGHFTPDNLFIM-----PDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp ETTCSGGGEEEC-----TTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEEC-----CCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 999999999998 78899999999998654221 13456799999999987 78999999999999999999
Q ss_pred hCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 692 CGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 692 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
+|+.||............. ....................+.+.+++.+||+.||++|||+.|+++
T Consensus 288 tg~~Pf~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWKR-------------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCTTCCCB-------------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCcccccchhh-------------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999997653221110000 0000000001111111123467888999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=360.62 Aligned_cols=250 Identities=27% Similarity=0.327 Sum_probs=204.4
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCe
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 561 (788)
....|.+.++||+|+||.||+|... .++..||||++.+.. ....+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERK--GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEES--SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEEC--CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 3345677799999999999999887 677789999997542 23446788899999987 79999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.||||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||||+ .++.+||+|||
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~-----~~g~ikL~DFG 487 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLD-----SEGHIKIADFG 487 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEEC-----SSSCEEECCCT
T ss_pred EEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEc-----CCCcEEEeecc
Confidence 99999999999999999765 4689999999999999999999999 999999999999998 88899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+. ...+
T Consensus 488 la~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~------------~~~i 554 (674)
T 3pfq_A 488 MCKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------------FQSI 554 (674)
T ss_dssp TCEECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHH
T ss_pred eeeccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH------------HHHH
Confidence 9986433222 23456899999999999999999999999999999999999999976532211 1111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM-----KKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 769 (788)
.... +.. +.....++.+|+..||+.||++||++ +||++
T Consensus 555 ~~~~--------~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 555 MEHN--------VAY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HSSC--------CCC--CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HhCC--------CCC--CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111 111 11234578889999999999999997 77765
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=363.04 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=206.9
Q ss_pred HHHHhhcccccccccccceEEEEEEecc-Ccceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
+....+.+.+.||+|+||.||+|.+... .....||||.+... .....+.+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3345677889999999999999988632 34568999988653 3445578999999999999999999999985 4568
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++|+|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~-----~~~~vkL~DFG~ 537 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS-----SNDCVKLGDFGL 537 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE-----ETTEEEECCCCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEe-----CCCCEEEEecCC
Confidence 999999999999999987767789999999999999999999999 999999999999998 778999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. ....
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~------------~~~i 605 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------------IGRI 605 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------------HHHH
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH------------HHHH
Confidence 98775544333334557789999999998899999999999999999997 9999975432211 0111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
..+.... ........+.+++.+||+.||++|||+.||++.|+.++
T Consensus 606 ~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 606 ENGERLP---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCC---------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111000 11123457888999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=336.22 Aligned_cols=270 Identities=23% Similarity=0.284 Sum_probs=196.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCC------
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED------ 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 560 (788)
.|.+.+.||+|+||.||+|... .++..||||++... .....+++.+|+++++.++||||+++++++...+
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDG--RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SEEEEEEC------CEEEEEET--TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred eEEEeEEeeecCCeEEEEEEEC--CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4667789999999999999886 67779999998543 2445678899999999999999999999997653
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~-----~~~~~kl~Df 172 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVN-----EDCELKILDF 172 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTCCEEECCC
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEc-----CCCCEEEEee
Confidence 469999999 8899999865 4688999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDW 716 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~ 716 (788)
|+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+......... ...
T Consensus 173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999875432 234578999999999877 689999999999999999999999998654322111100000 000
Q ss_pred HHHHhhcccccccccCCC----CC--cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCc
Q 047157 717 VISCMLSRNLQVLVSHDP----EV--LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTL 775 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~----~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~ 775 (788)
....+........+...+ .. .........+.+++.+||+.||++|||++|++++ +++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000000000000000000 00 0011224568889999999999999999999984 55543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.81 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=202.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.+.||+|+||.||+|... .++..||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDN--RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHhhhhcccCCeEEEEEEEC--CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3666789999999999999876 567799999986443 3446789999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++.. ..+++..+..++.||+.||.|||++ +|+|+||||+||+++ .++.+||+|||++....
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~-----~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLS-----EHGEVKLADFGVAGQLT 170 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEECCCTTCEECB
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEEC-----CCCCEEEeecccceecC
Confidence 9999999999854 4689999999999999999999999 999999999999998 77899999999998765
Q ss_pred CCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . .........
T Consensus 171 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~----~~~~~~~~~ 237 (303)
T 3a7i_A 171 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--------L----FLIPKNNPP 237 (303)
T ss_dssp TTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------H----HHHHHSCCC
T ss_pred cccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--------H----HHhhcCCCC
Confidence 4322 22345789999999999999999999999999999999999999975422110 0 011111111
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+ .......+.+++..||+.||++|||++|++++
T Consensus 238 ~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 TL---------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CC---------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CC---------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 11123567889999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=321.40 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=193.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||+|... .++..||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQ--LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEEC--CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 4667799999999999999886 567799999986543 23356889999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+|+||||+||+++ .++.+||+|||++..
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~-----~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLD-----AHMNAKIADFGLSNM 160 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEEC-----TTSCEEECCCCGGGC
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEEC-----CCCCEEEeecccccc
Confidence 9999999999999655 4688999999999999999999999 999999999999998 778999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
...... .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||........ .......
T Consensus 161 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------------~~~~~~~ 226 (276)
T 2h6d_A 161 MSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL------------FKKIRGG 226 (276)
T ss_dssp CCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHC
T ss_pred cCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------------HHHhhcC
Confidence 654322 223468899999999987765 6899999999999999999999975422110 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... .+ ......+.+++.+||+.||++|||++|++++
T Consensus 227 ~~~-----~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 VFY-----IP-----EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCC-----CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ccc-----Cc-----hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 100 01 1123567889999999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=343.69 Aligned_cols=263 Identities=19% Similarity=0.281 Sum_probs=205.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCc-cccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHH-KNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.++||+|+||.||+|.+. .++..||||++.... ...++.+|+++++.++| ++|..+..++.+.+..+||||
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEET--TTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEEC--CCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4667899999999999999876 567799999876432 23457889999999976 566667777788889999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+ +++|.+++......+++..++.|+.||+.||.|||++ +|+||||||+||||+... .++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~--~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGG--GTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCC--CCCeEEEEeCCcceecc
Confidence 99 9999999987777899999999999999999999999 999999999999994221 67899999999998765
Q ss_pred CCCCc------ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 648 KDQTR------TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 648 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
..... ......||+.|+|||.+.+..++.++||||||++||||++|+.||............ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-----~~i~~~~ 232 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-----EKISEKK 232 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH-----HHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH-----HHHhhcc
Confidence 43321 122567999999999999999999999999999999999999999765332211111 0011111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
....+..+.. ...+++.+++..||+.||++||++++|+++|+.+.
T Consensus 233 ~~~~~~~l~~---------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 233 VATSIEALCR---------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHSCHHHHHT---------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccccHHHHhc---------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1111111111 12457889999999999999999999999998763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.84 Aligned_cols=257 Identities=26% Similarity=0.296 Sum_probs=202.1
Q ss_pred HhhcccccccccccceEEEEEEec-cCcceeeeeeecccch----HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 561 (788)
..|.+.+.||+|+||.||++.... ..++..||||++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 357778999999999999998742 2467799999986432 22345677899999999 69999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~-----~~~~~kl~DfG 204 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLD-----SNGHVVLTDFG 204 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTSCEEESCSS
T ss_pred EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC-----CCCcEEEeeCC
Confidence 99999999999999999655 4688999999999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHH
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRN--VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
+++..............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... ... .
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-------~~~-~ 276 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-------EIS-R 276 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-------HHH-H
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH-------HHH-H
Confidence 998765444444445679999999999975 457899999999999999999999997543221110 000 0
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHh
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHML 771 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~L 771 (788)
..... .+.. .......+.+++.+||+.||++|| +++|++++.
T Consensus 277 ~~~~~--------~~~~--~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 277 RILKS--------EPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHC--------CCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHhcc--------CCCC--CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 01000 1111 112235677899999999999999 999998765
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=348.55 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=200.5
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchH-------------HHHHHHHHHHHHhcCCCccccceEee
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-------------KTNEEFMTELKIIGRTHHKNLVRLLG 554 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~~~~ 554 (788)
..|.+.++||+|+||+||+|... .++..||+|.+..... ...+.+.+|++++++++||||+++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEK--NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEET--TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cceEEEeEecccCCeEEEEEEEC--CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45777899999999999999886 6677999999865321 33567899999999999999999999
Q ss_pred EEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCc
Q 047157 555 FCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM 634 (788)
Q Consensus 555 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~ 634 (788)
++.+....++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++..+ ....
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~--~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKN--SLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTT--CCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCC--CCcc
Confidence 999999999999999999999998655 5689999999999999999999999 999999999999998432 3347
Q ss_pred EEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH
Q 047157 635 AKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714 (788)
Q Consensus 635 ~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 714 (788)
+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+..
T Consensus 188 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------- 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII-------- 256 (504)
T ss_dssp EEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------
T ss_pred EEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--------
Confidence 99999999987654322 234579999999999874 6899999999999999999999999765322111
Q ss_pred HHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 715 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.....+.... ...........+.+++.+||+.||.+|||++|++++
T Consensus 257 ----~~i~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 257 ----KKVEKGKYYF------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ----HHHHHCCCCC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHHcCCCCC------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111111100 000001124568899999999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=332.40 Aligned_cols=264 Identities=21% Similarity=0.254 Sum_probs=199.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHH-----HHHHHHHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK-----TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
..|.+.+.||+|+||.||+|... .++..||||.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDK--NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECS--SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred cccEEEeEEeecCCEEEEEEEEC--CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 45677899999999999999876 56779999998643221 124688999999999999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+++ +|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~-----~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLD-----ENGVLKLADFGL 158 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTCCEEECCCGG
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEc-----CCCCEEEEeccc
Confidence 999999976 89999877767788999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+........ ......+|+.|+|||.+.+. .++.++||||||+++|||++|..||......+.. .. .....
T Consensus 159 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~-------~~-i~~~~ 229 (346)
T 1ua2_A 159 AKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL-------TR-IFETL 229 (346)
T ss_dssp GSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HH-HHHHH
T ss_pred ceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-------HH-HHHHc
Confidence 987643322 22345789999999998654 5889999999999999999999998765322111 01 11111
Q ss_pred hcc---cccc------cccCCCCCccc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHh
Q 047157 722 LSR---NLQV------LVSHDPEVLSD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771 (788)
Q Consensus 722 ~~~---~~~~------l~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 771 (788)
... .... .+......... ......+.+++.+||+.||++|||++|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 0000 00000000000 12236788999999999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.58 Aligned_cols=264 Identities=17% Similarity=0.204 Sum_probs=198.1
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEec--CCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSE--EDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~l 564 (788)
..|.+.+.||+|+||+||+|... .++..||||.+... ..+.+.+|++++++++ ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINI--TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEEC--CCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 45777899999999999999886 66779999998743 2467889999999997 9999999999987 668899
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCC-cEEEeecCCc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNY-MAKISDFGIS 643 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~-~~kL~Dfg~a 643 (788)
||||+++++|.+++. .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++ .+||+|||++
T Consensus 111 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~-----~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMID-----HEHRKLRLIDWGLA 178 (330)
T ss_dssp EEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEE-----TTTTEEEECCCTTC
T ss_pred EEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEc-----CCCCEEEEEeCCCc
Confidence 999999999999983 478899999999999999999999 999999999999998 444 8999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCcccccccc-ccchhhh-HHHHHHH
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES-EEVDIVL-SDWVISC 720 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~-~~~~~~~ 720 (788)
........ .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ......+ .......
T Consensus 179 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 179 EFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp EECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred eEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 87654332 233568999999999876 67899999999999999999999999543221100 0000000 0000000
Q ss_pred hhccc------ccccccC--------CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 721 MLSRN------LQVLVSH--------DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 721 ~~~~~------~~~l~~~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... ....... .............+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 0000000 00001111235678899999999999999999999873
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=340.62 Aligned_cols=198 Identities=23% Similarity=0.342 Sum_probs=169.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC------CccccceEeeEEecCCeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT------HHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~~~ 562 (788)
.|.+.++||+|+||+||+|... .++..||||++... ....+.+.+|+++++.+ +|+||+++++++...+..
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~--~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDH--KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEET--TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cEEEEEEcccCccEEEEEEEEC--CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4677899999999999999886 66789999999764 33445667777777665 678999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCc--EEEee
Q 047157 563 LLVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM--AKISD 639 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~--~kL~D 639 (788)
++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++. +||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~-----~~~~~~vkL~D 245 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLK-----QQGRSGIKVID 245 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEES-----STTSCCEEECC
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEc-----cCCCcceEEee
Confidence 99999995 69999987654 4589999999999999999999999 999999999999998 5544 99999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccc
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRV 702 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~ 702 (788)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 246 FG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 246 FGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9999764332 2235789999999999999999999999999999999999999976543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=327.28 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=201.6
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch--------HHHHHHHHHHHHHhcCC-CccccceEeeEEe
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--------EKTNEEFMTELKIIGRT-HHKNLVRLLGFCS 557 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 557 (788)
...|.+.+.||+|+||.||+|.+. .++..||||.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHR--ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhcccceEEecCCCEEEEEEEEC--CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 355777799999999999999886 567799999875432 23356788999999998 7999999999999
Q ss_pred cCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 558 EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 558 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
.....++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+|||++ .++.+||
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~-----~~~~ikl 241 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLD-----DNMQIRL 241 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTCCEEE
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC-----CCCCEEE
Confidence 999999999999999999999654 5689999999999999999999999 999999999999998 7889999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccC------CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN------VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI 711 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 711 (788)
+|||++..+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 242 ~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------- 312 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------- 312 (365)
T ss_dssp CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred EecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-------
Confidence 99999987654322 234678999999999853 368899999999999999999999996542111
Q ss_pred hhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 712 VLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 712 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... .......... ..........+.+++.+||+.||++|||++|++++
T Consensus 313 -~~~----~i~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 -MLR----MIMEGQYQFS------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -HHH----HHHHTCCCCC------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHH----HHHhCCCCCC------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 1111111000 00000123567889999999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.05 Aligned_cols=252 Identities=22% Similarity=0.249 Sum_probs=185.6
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
...|.+.+.||+|+||+||++... .++..||+|++.... ....+.+.++...++.++||||+++++++.+++..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHV--PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEec--CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 345677899999999999999886 677899999986542 2333445555566888999999999999999999999
Q ss_pred EEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 565 VYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
||||++ ++|.+++.. ....+++..+..++.||+.||.|||++ .+|+||||||+||+++ .++.+||+|||
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~-----~~~~~kl~Dfg 155 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLIN-----ALGQVKMCDFG 155 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEEC-----TTCCEEBCCC-
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEEC-----CCCCEEEeecC
Confidence 999997 588887754 456789999999999999999999984 3899999999999998 77899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccc----cCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWL----RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
++........ .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ ..
T Consensus 156 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~---- 223 (290)
T 3fme_A 156 ISGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ------QL---- 223 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH------HH----
T ss_pred Cccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH------HH----
Confidence 9987644322 2234689999999996 566789999999999999999999999974321110 00
Q ss_pred HHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 718 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..... ... ...........+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 224 KQVVE-EPS--------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHH-SCC--------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhc-cCC--------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00111 110 11111123456888999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.25 Aligned_cols=249 Identities=26% Similarity=0.302 Sum_probs=195.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch----HHHHHHHHHHHHHhcCCCccccceEeeEE--ecCCeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRTHHKNLVRLLGFC--SEEDKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~~ 562 (788)
.|.+.+.||+|+||.||++... .++..||+|.+.... ....+.+.+|++++++++||||+++++++ .+....
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDS--ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBT--TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ceeEeeEEecCCCeEEEEEEEC--CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4677899999999999999875 667799999987543 23457899999999999999999999998 445688
Q ss_pred EEEEecCCCCCHhHhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 563 LLVYELMPNGTLSNFLFH-EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
++||||++++ |.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+|||
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~-----~~~~~kl~dfg 154 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLT-----TGGTLKISALG 154 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTCCEEECCCT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEc-----CCCcEEeeccc
Confidence 9999999876 7777654 345789999999999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCC-CcccccccCCccccCcccccCCC--CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 642 ISKLLNKDQ-TRTDTNMRGTMGYVAPEWLRNVP--VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 642 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
++....... ........|++.|+|||.+.+.. .+.++||||||+++|||++|+.||......+. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------~ 222 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL------------F 222 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------------H
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH------------H
Confidence 998765322 22223456899999999987644 47899999999999999999999975432111 0
Q ss_pred HHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 719 SCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
......... . .......+.+++.+||+.||++|||++|++++
T Consensus 223 ~~i~~~~~~--------~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 223 ENIGKGSYA--------I--PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHCCCC--------C--CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHhcCCCC--------C--CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111110 0 01123567789999999999999999999964
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.12 Aligned_cols=205 Identities=20% Similarity=0.308 Sum_probs=156.2
Q ss_pred hcc-cccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEe--cCCeEEEEE
Q 047157 490 KGF-SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCS--EEDKRLLVY 566 (788)
Q Consensus 490 ~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lV~ 566 (788)
|.+ .++||+|+||+||+|..+....+..||||++.... ..+.+.+|++++++++||||+++++++. .....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 46899999999999998654567799999997542 2346789999999999999999999994 477899999
Q ss_pred ecCCCCCHhHhhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 567 ELMPNGTLSNFLFHE--------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 567 e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
||++ ++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||+.... ..++.+||+
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~-~~~~~~kl~ 174 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG-PERGRVKIA 174 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSS-TTTTCEEEC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCC-CCCCcEEEE
Confidence 9996 5888777422 22489999999999999999999999 999999999999994221 167899999
Q ss_pred ecCCccccCCCCC--cccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccc
Q 047157 639 DFGISKLLNKDQT--RTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSR 701 (788)
Q Consensus 639 Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~ 701 (788)
|||++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987654321 22234678999999999877 458999999999999999999999997653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=336.73 Aligned_cols=198 Identities=25% Similarity=0.364 Sum_probs=166.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecC-----Ce
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE-----DK 561 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 561 (788)
.|.+.+.||+|+||.||+|... .++..||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDK--NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CEEEEEEEeecCCEEEEEEEEC--CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 5777899999999999999886 67789999998653 234557899999999999999999999999766 57
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.++||||++ ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~-----~~~~~kL~DFG 174 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLN-----QDCSVKVCDFG 174 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTCCEEECCCT
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEEC-----CCCCEEEccCC
Confidence 899999986 5999998543 5689999999999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCCCc---------------------ccccccCCccccCcccc-cCCCCCccCcchhhHHHHHHHHhCCCCCC
Q 047157 642 ISKLLNKDQTR---------------------TDTNMRGTMGYVAPEWL-RNVPVTTKVDVFSFGVMLLEIICGRRHIE 698 (788)
Q Consensus 642 ~a~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~elltg~~p~~ 698 (788)
+++........ ......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 99876543211 22456789999999986 56679999999999999999998655553
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=326.76 Aligned_cols=273 Identities=21% Similarity=0.281 Sum_probs=202.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccc------cceEeeEEecCCe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN------LVRLLGFCSEEDK 561 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~~~~~~ 561 (788)
..|.+.+.||+|+||+||+|.... .++..||||.+... ....+.+.+|+++++.++|++ ++++++++.+.+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHK-AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecC-CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 467788999999999999998732 45679999999754 344567889999998887665 9999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCC----------
Q 047157 562 RLLVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLD---------- 630 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~---------- 630 (788)
.++||||+ +++|.+++...+ ..+++..+..++.||+.||+|||++ +|+||||||+|||++.....
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 899999997654 3678999999999999999999999 99999999999999832100
Q ss_pred ----CCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCcccccccc
Q 047157 631 ----TNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES 706 (788)
Q Consensus 631 ----~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~ 706 (788)
.++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 0568999999999865432 22357899999999999999999999999999999999999999765432211
Q ss_pred ccchhhh---HHHHHHHhhccccc------------------ccccC-CCCCcccHHHHHHHHHHHhHccCCCCCCCCCH
Q 047157 707 EEVDIVL---SDWVISCMLSRNLQ------------------VLVSH-DPEVLSDLERFERMAMVGLWCNHPDPNLRPSM 764 (788)
Q Consensus 707 ~~~~~~~---~~~~~~~~~~~~~~------------------~l~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 764 (788)
....... .............. ..... ...........+.+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 1000000 00000000000000 00000 00011123456788999999999999999999
Q ss_pred HHHHHH
Q 047157 765 KKVIHM 770 (788)
Q Consensus 765 ~evl~~ 770 (788)
+|++++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=338.02 Aligned_cols=279 Identities=22% Similarity=0.253 Sum_probs=205.1
Q ss_pred cCHHHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC--------ccccce
Q 047157 480 FTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH--------HKNLVR 551 (788)
Q Consensus 480 ~~~~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------hpniv~ 551 (788)
+...++....|.+.++||+|+||+||+|... .++..||||++... ....+.+.+|++++++++ |+||++
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDI--QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEec--CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 3334444567888899999999999999876 67789999999754 445677889999999885 888999
Q ss_pred EeeEEe----cCCeEEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEecc
Q 047157 552 LLGFCS----EEDKRLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDL 626 (788)
Q Consensus 552 ~~~~~~----~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 626 (788)
+++++. .....++||||+ +++|.+.+... ...+++..+..++.||+.||.|||+++ +|+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~ 182 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV 182 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence 999987 566899999999 55666665443 467899999999999999999999852 7999999999999983
Q ss_pred CC--------------------------------------------CCCCCcEEEeecCCccccCCCCCcccccccCCcc
Q 047157 627 KT--------------------------------------------LDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662 (788)
Q Consensus 627 ~~--------------------------------------------~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~ 662 (788)
.+ ......+||+|||++...... .....||+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~ 258 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQ 258 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCc
Confidence 21 001137999999999876533 233568999
Q ss_pred ccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh--------ccc---------
Q 047157 663 YVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML--------SRN--------- 725 (788)
Q Consensus 663 y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~--------- 725 (788)
|+|||++.+..++.++|||||||++|||++|+.||......+....... ......... ...
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH--IALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHH--HHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHH--HHHHHHhcCCCChHHhhcccccccccCCc
Confidence 9999999999999999999999999999999999986543322111110 000000000 000
Q ss_pred --ccccccCCC---------CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 726 --LQVLVSHDP---------EVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 726 --~~~l~~~~~---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+..+....+ ...........+.+|+.+||+.||++|||++|++++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000000 011234566789999999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.55 Aligned_cols=266 Identities=21% Similarity=0.240 Sum_probs=191.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCC------
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED------ 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 560 (788)
.|.+.+.||+|+||.||+|... .++..||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDA--ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred heeEeeeeEecCCEEEEEEEEC--CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4667789999999999999876 66789999998653 2445578889999999999999999999997655
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||++ ++|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~-----~~~~~kl~Df 171 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK-----SDCTLKILDF 171 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTSCEEECCC
T ss_pred ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEc-----CCCCEEEEEe
Confidence 7899999997 47888874 3588999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh---------
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI--------- 711 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~--------- 711 (788)
|++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.......
T Consensus 172 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 172 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp CC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred eccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998654322 22345789999999999999999999999999999999999999976543221100000
Q ss_pred --hhHHHHHHHhhc-cc-----ccccccC---CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 712 --VLSDWVISCMLS-RN-----LQVLVSH---DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 712 --~~~~~~~~~~~~-~~-----~~~l~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.+.......... .. +...... .............+.+|+.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 00 0000000 00001112335678999999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=328.14 Aligned_cols=257 Identities=28% Similarity=0.371 Sum_probs=197.7
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch--------HHHHHHHHHHHHHhcCCCccccceEeeEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--------EKTNEEFMTELKIIGRTHHKNLVRLLGFC 556 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 556 (788)
.....|.+.+.||+|+||.||+|... .++..||||.+.... ......+.+|++++++++||||+++++++
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFER--KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEc--CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 34567888999999999999999886 667899999986432 12234688999999999999999999998
Q ss_pred ecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 557 SEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 557 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
..++ .++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++..+ .+..+|
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~--~~~~~k 157 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE--EDCLIK 157 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS--SSCCEE
T ss_pred cCCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCC--CCCeEE
Confidence 7665 89999999999999998643 5789999999999999999999999 999999999999998432 345699
Q ss_pred EeecCCccccCCCCCcccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh
Q 047157 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL 713 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 713 (788)
|+|||++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||........ +
T Consensus 158 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~ 228 (322)
T 2ycf_A 158 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------L 228 (322)
T ss_dssp ECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-------H
T ss_pred EccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-------H
Confidence 99999998764322 122356899999999973 56789999999999999999999999975432211 1
Q ss_pred HHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 714 SDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 714 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
... ...+..... +. ......+.+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~----~~~~~~~~~----~~--~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 229 KDQ----ITSGKYNFI----PE--VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHH----HHHTCCCCC----HH--HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHH----HHhCccccC----ch--hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 010 111110000 00 00122467889999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.42 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=201.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---------HHHHHHHHHHHHHhcCCC-ccccceEeeEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---------EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSE 558 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 558 (788)
.|.+.+.||+|+||.||+|... .++..||||.+.... ....+.+.+|+++++++. ||||+++++++.+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHK--PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEEc--CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4667789999999999999886 677899999986432 234567889999999995 9999999999999
Q ss_pred CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 559 EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+|+||||+||+++ .++.+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~-----~~~~~kl~ 166 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLD-----DDMNIKLT 166 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTCCEEEC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEc-----CCCcEEEe
Confidence 99999999999999999999654 5689999999999999999999999 999999999999998 78899999
Q ss_pred ecCCccccCCCCCcccccccCCccccCccccc------CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR------NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 712 (788)
|||++........ .....+++.|+|||.+. ...++.++||||||+++|||++|+.||........
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------- 237 (298)
T 1phk_A 167 DFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------- 237 (298)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------
T ss_pred cccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-------
Confidence 9999987654322 23356899999999885 45688999999999999999999999965422110
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
........... ...........+.+++.+||+.||++|||+.|+++
T Consensus 238 -----~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 -----LRMIMSGNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -----HHHHHHTCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----HHHHhcCCccc------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 01111111110 00111123467889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.82 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=192.9
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec---------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--------- 558 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------- 558 (788)
..|.+.+.||+|+||.||+|... .++..||||.+... ....+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNA--LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEc--CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 45777899999999999999876 56779999999654 4456789999999999999999999998755
Q ss_pred ----CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCc
Q 047157 559 ----EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM 634 (788)
Q Consensus 559 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~ 634 (788)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~-----~~~~ 154 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFID-----ESRN 154 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTSC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEc-----CCCC
Confidence 3578999999999999999987767788899999999999999999999 999999999999998 7889
Q ss_pred EEEeecCCccccCCCC-------------CcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCcc
Q 047157 635 AKISDFGISKLLNKDQ-------------TRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELS 700 (788)
Q Consensus 635 ~kL~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~ 700 (788)
+||+|||++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 9999999998764321 1122345689999999999764 78999999999999999998 55322
Q ss_pred ccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.... . .......... .............+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~----------~-~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 MERV----------N-ILKKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHH----------H-HHHHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhHH----------H-HHHhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1000 0 0011111100 00011112334567889999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.61 Aligned_cols=258 Identities=25% Similarity=0.333 Sum_probs=205.3
Q ss_pred HHHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCC
Q 047157 483 QELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED 560 (788)
Q Consensus 483 ~~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 560 (788)
+......|.+.+.||+|+||.||+|... .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDR--ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEc--CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 4455667888999999999999999886 567799999986432 234678899999999999999999999999999
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++|+||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+|+||||+||+++..+ .+..+||+||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~--~~~~~kL~Df 168 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKE--KDCDIKIIDF 168 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS--TTCCEEECST
T ss_pred eEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCC--CcccEEEecc
Confidence 999999999999999988654 4689999999999999999999999 999999999999997433 4568999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
|++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+. ...
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------------~~~ 233 (287)
T 2wei_A 169 GLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------------LKR 233 (287)
T ss_dssp TGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHH
T ss_pred CcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH------------HHH
Confidence 99987644322 123457889999999876 489999999999999999999999976432111 111
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...+.... ...........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 234 VETGKYAF------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHCCCCC------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCC------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 11111110 00001122456888999999999999999999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=328.91 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=200.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHH-----------------HHHHHHHHHHhcCCCccccce
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKT-----------------NEEFMTELKIIGRTHHKNLVR 551 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~hpniv~ 551 (788)
.|.+.+.||+|+||.||+|.. ++..||||.+....... .+.+.+|++++++++||||++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ceEEEEEEcCCCCeEEEEEEc----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 467789999999999999987 56799999987543221 178999999999999999999
Q ss_pred EeeEEecCCeEEEEEecCCCCCHhHh------hhcc-CCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEE
Q 047157 552 LLGFCSEEDKRLLVYELMPNGTLSNF------LFHE-GQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVL 623 (788)
Q Consensus 552 ~~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIl 623 (788)
+++++.+.+..++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ + +|+||||||+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 99999999999999999999999998 5442 5678999999999999999999998 8 9999999999999
Q ss_pred eccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCC-CCCc-cCcchhhHHHHHHHHhCCCCCCccc
Q 047157 624 LDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTT-KVDVFSFGVMLLEIICGRRHIELSR 701 (788)
Q Consensus 624 l~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-k~DVwSlGvil~elltg~~p~~~~~ 701 (788)
++ .++.+||+|||.+...... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||....
T Consensus 185 ~~-----~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 185 MD-----KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EC-----TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ec-----CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98 7889999999999876443 23345789999999999877 6666 9999999999999999999997643
Q ss_pred cccccccchhhhHHHHHHHhhccccccccc------CC---CCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 702 VEEESEEVDIVLSDWVISCMLSRNLQVLVS------HD---PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~------~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.... ............... .. ............+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~-----------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SLVE-----------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSHH-----------HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHHH-----------HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2110 011111111110000 00 000001223467889999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.89 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=182.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecC------C
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------D 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 560 (788)
.|.+.+.||+|+||.||+|... .++..||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDT--KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TEEEEEECC----CCEEEEEET--TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEeeEEeecCCeEEEEEEEC--CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4667789999999999999876 67789999998653 234567888999999999999999999998654 5
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++|+|++ +++|.+++.. ..+++..+..++.||++||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~-----~~~~~kL~DF 176 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVN-----EDCELKILDF 176 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTCCEEECC-
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEEC-----CCCCEEEeec
Confidence 679999999 7899998854 5689999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH---HH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS---DW 716 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~ 716 (788)
|+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+........+. .-
T Consensus 177 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 177 GLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999865432 234578999999999876 6889999999999999999999999976543221111000000 00
Q ss_pred HHHHhhcccccccccCCCCCc-ccH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLSRNLQVLVSHDPEVL-SDL-----ERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~-~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.............+...+... ... .....+.+|+.+||+.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000000000000000 000 123567899999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=336.83 Aligned_cols=264 Identities=21% Similarity=0.233 Sum_probs=193.7
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec---------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--------- 558 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------- 558 (788)
..|.+.+.||+|+||+||+|... .++..||||++..... ...+|+++++.++||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~--~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDI--ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEET--TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred ceEEEEEEEEeccCEEEEEEEEC--CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 45777899999999999999886 6778999999865432 23479999999999999999999843
Q ss_pred -----------------------------CCeEEEEEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhh
Q 047157 559 -----------------------------EDKRLLVYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHE 606 (788)
Q Consensus 559 -----------------------------~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~ 606 (788)
....++||||++ ++|.+.+.. .+..+++..+..++.||++||.|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 334889999998 588877753 45678999999999999999999999
Q ss_pred ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHH
Q 047157 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGV 685 (788)
Q Consensus 607 ~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGv 685 (788)
+ +|+||||||+|||++. .++.+||+|||++........ .....+|+.|+|||.+.+. .++.++||||+|+
T Consensus 160 ~---gi~H~Dikp~Nil~~~----~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 160 L---GICHRDIKPQNLLVNS----KDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp T---TEECSCCCGGGEEEET----TTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred C---cCccCccCHHHEEEcC----CCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 9 9999999999999972 467899999999987644332 2335689999999998765 5899999999999
Q ss_pred HHHHHHhCCCCCCccccccccccchhhh----HHHHHHHhhcccccccccCCCCCc-----ccHHHHHHHHHHHhHccCC
Q 047157 686 MLLEIICGRRHIELSRVEEESEEVDIVL----SDWVISCMLSRNLQVLVSHDPEVL-----SDLERFERMAMVGLWCNHP 756 (788)
Q Consensus 686 il~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~~~-----~~~~~~~~l~~l~~~cl~~ 756 (788)
++|||++|+.||......+........+ .+... .. ........-+..... ........+.+|+.+||+.
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMI-RM-NPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH-HH-CTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH-Hh-CcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999998654322111100000 00000 00 000000000000000 0112345688999999999
Q ss_pred CCCCCCCHHHHHH
Q 047157 757 DPNLRPSMKKVIH 769 (788)
Q Consensus 757 dP~~RPt~~evl~ 769 (788)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=330.40 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=197.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..|.+.+.||+|+||.||+|... . .+++|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~---~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWH---G--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEES---S--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred HHeEEeeEeccCCceEEEEEEEc---C--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 34667799999999999999874 2 48888875432 23345678899999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|.+++...+..+++..++.++.||+.||.|||++ +|+||||||+||+++ ++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~------~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD------NGKVVITDFGLFSI 178 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC--------CCEECCCSCCC-
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe------CCCEEEeecCCccc
Confidence 999999999999987767789999999999999999999999 999999999999996 35899999999876
Q ss_pred cCCCC----CcccccccCCccccCcccccC---------CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh
Q 047157 646 LNKDQ----TRTDTNMRGTMGYVAPEWLRN---------VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 646 ~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 712 (788)
..... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||........
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------- 251 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------- 251 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-------
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------
Confidence 53211 112223458899999999864 4578899999999999999999999975432211
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
............. .......+.+++.+||+.||++|||+++++++|+.+...
T Consensus 252 -----~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 252 -----IWQMGTGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -----HHHHHTTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -----HHHhccCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 0111111111110 011234577899999999999999999999999988754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=320.72 Aligned_cols=269 Identities=20% Similarity=0.262 Sum_probs=193.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEe-----------
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCS----------- 557 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----------- 557 (788)
.|.+.+.||+|+||.||+|... .++..||+|.+........+.+.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDN--DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TEEEEEECC-----CEEEEEET--TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred ceeEEEEeccCCCeEEEEEEEC--CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4667789999999999999886 667899999987766667788999999999999999999999873
Q ss_pred ---cCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCc
Q 047157 558 ---EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM 634 (788)
Q Consensus 558 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~ 634 (788)
+....++||||++ ++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++. .++.
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~----~~~~ 159 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINT----EDLV 159 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEET----TTTE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcC----CCCe
Confidence 4468899999997 699999853 4688999999999999999999999 9999999999999972 4568
Q ss_pred EEEeecCCccccCCCCC--cccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh
Q 047157 635 AKISDFGISKLLNKDQT--RTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI 711 (788)
Q Consensus 635 ~kL~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 711 (788)
+||+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.......
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999987643221 12233457889999998865 6789999999999999999999999976543221110000
Q ss_pred hh---HHHHHHHhhcccccccccC---CCCCc---ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 712 VL---SDWVISCMLSRNLQVLVSH---DPEVL---SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 712 ~~---~~~~~~~~~~~~~~~l~~~---~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.. .......... .+...+.. .+... ........+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00 0000000000 00000000 00000 001234678899999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.86 Aligned_cols=269 Identities=21% Similarity=0.280 Sum_probs=199.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecC-----CeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE-----DKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 562 (788)
.|.+.+.||+|+||.||+|... .++..||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDN--LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cEEEEEEeecCCCeEEEEEEEC--CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4677899999999999999876 677899999986433 44457889999999999999999999998654 468
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||++ ++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~-----~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLN-----TTCDLKICDFGL 174 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTCCEEECCCTT
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEEC-----CCCCEEEEeCcc
Confidence 99999997 599998854 3689999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCc--ccccccCCccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH---HH
Q 047157 643 SKLLNKDQTR--TDTNMRGTMGYVAPEWLR-NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS---DW 716 (788)
Q Consensus 643 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~ 716 (788)
+......... ......||+.|+|||++. ...++.++||||||+++|||++|+.||......+........+. ..
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9876543222 123457899999999865 44589999999999999999999999976543322111100000 00
Q ss_pred HHHHhhcccccccccCCC-CCccc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLSRNLQVLVSHDP-EVLSD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~-~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.................+ ..... ......+.+++.+||+.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000000 00000 1123568899999999999999999999973
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.27 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=191.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEec------CCe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSE------EDK 561 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~------~~~ 561 (788)
.|.+.+.||+|+||.||+|... .++..||||.+.... ...+.+.+|+.+++++ +||||+++++++.. .+.
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHV--KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred cEEEEEEeccCCCEEEEEEEEC--CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 4566799999999999999886 567799999986542 3346788999999998 79999999999976 568
Q ss_pred EEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 562 RLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||++ +|+|+||||+||+++ .++.+||+||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~-----~~~~~kl~Df 173 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT-----ENAEVKLVDF 173 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC-----TTCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEc-----CCCCEEEeeC
Confidence 89999999999999999754 35688999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 715 (788)
|++........ ......|++.|+|||++. +..++.++||||||+++|+|++|+.||........
T Consensus 174 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------- 242 (326)
T 2x7f_A 174 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---------- 242 (326)
T ss_dssp TTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------
T ss_pred cCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH----------
Confidence 99987643221 122356899999999986 56789999999999999999999999965422110
Q ss_pred HHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 716 WVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.. .........+ ........+.+++.+||+.||++|||++|+++
T Consensus 243 -~~-~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 -LF-LIPRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -HH-HHHHSCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HH-HhhcCccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 0111111111 01122456788999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=339.43 Aligned_cols=265 Identities=26% Similarity=0.256 Sum_probs=192.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecC------CeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE------DKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~ 562 (788)
.|.+.++||+|+||.||+|.+. .++..||||++..... ...+|++++++++||||+++++++... ...
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEEC--CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 3566789999999999999886 5677999999865422 234799999999999999999988432 236
Q ss_pred EEEEecCCCCCHhHhhh---ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 563 LLVYELMPNGTLSNFLF---HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
++||||+++ +|.+.+. .....+++..+..++.||++||.|||++ +|+||||||+|||++. +...+||+|
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~----~~~~~kl~D 200 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDP----DTAVLKLCD 200 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEET----TTTEEEECC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeC----CCCeEEecc
Confidence 799999975 6666554 3456789999999999999999999999 9999999999999982 335789999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH---
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD--- 715 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--- 715 (788)
||+++.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+........+..
T Consensus 201 FG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 201 FGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp CTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred chhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999987644322 2335789999999998764 7999999999999999999999999865432211110000000
Q ss_pred HHHHHhhcccccccccCCCCCc-----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 716 WVISCMLSRNLQVLVSHDPEVL-----SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 716 ~~~~~~~~~~~~~l~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
-.+... ........-+..... .......++.+|+.+||+.||++|||+.|++++
T Consensus 279 ~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 279 EQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000000 111111100000000 011224678899999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.95 Aligned_cols=202 Identities=26% Similarity=0.361 Sum_probs=170.2
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-cc-----ccceEeeEEecCCe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HK-----NLVRLLGFCSEEDK 561 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~~~~~~~~~~~ 561 (788)
..|.+.+.||+|+||+||+|... .++..||||++... ....+++..|+++++.++ |+ +|+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDR--VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET--TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeEEEEEEEeecCCEEEEEEEEc--CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 45677899999999999999886 66789999999754 334566778888887774 44 59999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 562 RLLVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
.++||||++ ++|.+++.... ..+++..+..++.||+.||.|||.+ ..+|+||||||+|||++.. .++.+||+||
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~---~~~~~kL~DF 205 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNP---KRSAIKIVDF 205 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESST---TSCCEEECCC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecC---CCCcEEEEec
Confidence 999999996 59999997654 5689999999999999999999952 2389999999999999521 4678999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccc
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSR 701 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~ 701 (788)
|++...... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999876432 223578999999999999999999999999999999999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=325.12 Aligned_cols=271 Identities=20% Similarity=0.262 Sum_probs=200.7
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccc------cceEeeEEecCC
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN------LVRLLGFCSEED 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~~~~~ 560 (788)
...|.+.+.||+|+||+||+|.... .++..||+|.+... ....+.+.+|++++++++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHA-RGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecC-CCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3467788999999999999998752 23368999999754 345567889999999987766 899999999999
Q ss_pred eEEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC----------
Q 047157 561 KRLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL---------- 629 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---------- 629 (788)
..++||||+ +++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++....
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 66777776554 35689999999999999999999999 9999999999999942210
Q ss_pred ----CCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccc
Q 047157 630 ----DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEE 705 (788)
Q Consensus 630 ----~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~ 705 (788)
..++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 157889999999998644322 335789999999999999999999999999999999999999976533221
Q ss_pred cccchhhh---HHHHHHHhhcccccccccC---------------------CCCCcccHHHHHHHHHHHhHccCCCCCCC
Q 047157 706 SEEVDIVL---SDWVISCMLSRNLQVLVSH---------------------DPEVLSDLERFERMAMVGLWCNHPDPNLR 761 (788)
Q Consensus 706 ~~~~~~~~---~~~~~~~~~~~~~~~l~~~---------------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 761 (788)
........ ........... ...... .............+.+|+.+||+.||++|
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQ--KYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCG--GGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHcCCCcHHHhhhccch--hhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 11000000 00000000000 000000 00011122445678899999999999999
Q ss_pred CCHHHHHH
Q 047157 762 PSMKKVIH 769 (788)
Q Consensus 762 Pt~~evl~ 769 (788)
||++|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.86 Aligned_cols=268 Identities=21% Similarity=0.238 Sum_probs=191.7
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch-----------HHHHHHHHHHHHHhcCCCccccceEeeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-----------EKTNEEFMTELKIIGRTHHKNLVRLLGFC 556 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-----------~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 556 (788)
..|.+.+.||+|+||.||+|... .+..||||++.... ....+.+.+|++++++++||||+++++++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDS---EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECT---TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred cceEEeEEeccCCCEEEEEEECC---CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34556799999999999999874 47799999885422 22347899999999999999999999998
Q ss_pred ec-----CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCC
Q 047157 557 SE-----EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT 631 (788)
Q Consensus 557 ~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~ 631 (788)
.. ....++||||++ ++|.+++......+++..+..++.||+.||.|||++ +|+||||||+|||++ .
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~-----~ 169 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA-----D 169 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----T
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc-----C
Confidence 43 346899999997 689998877777899999999999999999999999 999999999999998 7
Q ss_pred CCcEEEeecCCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccch
Q 047157 632 NYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD 710 (788)
Q Consensus 632 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~ 710 (788)
++.+||+|||++........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+......
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 88999999999985443222 233568899999999876 678999999999999999999999997654322111000
Q ss_pred hhh----HHHHHHHhhcccc----cccccCCCCCc---ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 711 IVL----SDWVISCMLSRNL----QVLVSHDPEVL---SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 711 ~~~----~~~~~~~~~~~~~----~~l~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
... .... ........ .......+... ........+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 248 EVVGTPKIEDV-VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHCCCCHHHH-HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHcCCCChHHh-hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000 0000 00000000 00000000000 011224568899999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=323.13 Aligned_cols=262 Identities=23% Similarity=0.263 Sum_probs=175.6
Q ss_pred hhccc-ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec----CCeEE
Q 047157 489 TKGFS-KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE----EDKRL 563 (788)
Q Consensus 489 t~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 563 (788)
.|.+. ++||+|+||+||+|... .++..||||++.... ...+++ ...++.++||||+++++++.. ....+
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHR--RTGQKCALKLLYDSP-KARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEESSH-HHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEEC--CCCCEEEEEEecCcH-HHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 35553 57999999999999886 667799999986542 222222 233456699999999999876 45689
Q ss_pred EEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 564 LVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++..+ .++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~--~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKE--KDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSS--TTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecC--CCceEEEecccc
Confidence 9999999999999997654 4689999999999999999999999 999999999999998433 456799999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+....... .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............. ....
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------~~~~ 246 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--------RRIR 246 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--------Hhhh
Confidence 98654322 223567999999999998899999999999999999999999997543222111000 0000
Q ss_pred cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH--HhhcCcCCC
Q 047157 723 SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH--MLEGTLEVG 778 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~~ 778 (788)
.... .............+.+++.+||+.||++|||++|+++ .+.+....+
T Consensus 247 ~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 247 LGQY------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred cccc------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence 0000 0000001123456788999999999999999999997 445443333
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.33 Aligned_cols=279 Identities=21% Similarity=0.282 Sum_probs=203.9
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-----------ccccceEeeE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-----------HKNLVRLLGF 555 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~ 555 (788)
...|.+.+.||+|+||+||+|... .++..||||.+... ....+.+.+|++++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDM--VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEec--CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 456778899999999999999876 66789999999754 334567888999988876 8999999999
Q ss_pred EecCC----eEEEEEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCC-
Q 047157 556 CSEED----KRLLVYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL- 629 (788)
Q Consensus 556 ~~~~~----~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~- 629 (788)
+...+ ..++|||++ +++|.+++... ...+++..+..++.||+.||.|||++ .+|+||||||+|||++..+.
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCC
Confidence 87654 789999999 89999999764 34589999999999999999999984 28999999999999963221
Q ss_pred CCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccc
Q 047157 630 DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEV 709 (788)
Q Consensus 630 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~ 709 (788)
...+.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 14558999999999876432 22346899999999999999999999999999999999999999865422211111
Q ss_pred hhhhHHHHHHHhh------------------cc-cccccccCC---------CCCcccHHHHHHHHHHHhHccCCCCCCC
Q 047157 710 DIVLSDWVISCML------------------SR-NLQVLVSHD---------PEVLSDLERFERMAMVGLWCNHPDPNLR 761 (788)
Q Consensus 710 ~~~~~~~~~~~~~------------------~~-~~~~l~~~~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~R 761 (788)
. .+.... .... .. ......... ..........+.+.+|+.+||+.||++|
T Consensus 248 ~-~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 248 D-HIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp H-HHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred H-HHHHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 0 000000 0000 00 000000000 0011234567789999999999999999
Q ss_pred CCHHHHHH--HhhcCcCC
Q 047157 762 PSMKKVIH--MLEGTLEV 777 (788)
Q Consensus 762 Pt~~evl~--~L~~~~~~ 777 (788)
||++|+++ .+.+....
T Consensus 326 pt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp BCHHHHHTCGGGTTCTTC
T ss_pred CCHHHHhhChhhhcccCc
Confidence 99999997 45554443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=322.54 Aligned_cols=264 Identities=20% Similarity=0.262 Sum_probs=194.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeE----
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKR---- 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~---- 562 (788)
.|.+.+.||+|+||+||+|... .++..||||++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDK--RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cEEEEeEEecCCCeEEEEEEEC--CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4666789999999999999886 67789999998653 244467889999999999999999999999877655
Q ss_pred --EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 563 --LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 563 --~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~-----~~~~~kL~Df 188 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVN-----EDCELKILDF 188 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTCCEEECST
T ss_pred eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEEC-----CCCCEEEEec
Confidence 99999997 68888773 4489999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDW 716 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~ 716 (788)
|++...... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... ...
T Consensus 189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 999865432 233568999999999877 789999999999999999999999997653222111000000 000
Q ss_pred HHHHhhccc----ccccccCCCCCcc--cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLSRN----LQVLVSHDPEVLS--DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~~~----~~~l~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
......... ...+......... .......+.+|+.+||+.||++|||++|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000 0000000000000 01224678899999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.02 Aligned_cols=276 Identities=21% Similarity=0.238 Sum_probs=187.2
Q ss_pred HHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCe----
Q 047157 486 QEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK---- 561 (788)
Q Consensus 486 ~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---- 561 (788)
....|.+.+.||+|+||+||+|... .++..||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEK--STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHTTEEEC----------CEEEEET--TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hccceEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 3345777899999999999999886 567799999886542 233456678888888999999999999865333
Q ss_pred ---EEEEEecCCCCCHhHhhh---ccCCCCCHHHHHHHHHHHHHHHHHhh--hccCCceEecCCCCCcEEeccCCCCCCC
Q 047157 562 ---RLLVYELMPNGTLSNFLF---HEGQRPGWVQRVEIALGVARGLLYLH--EECETQIIHCDIKPQNVLLDLKTLDTNY 633 (788)
Q Consensus 562 ---~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~~ivH~dlkp~NIll~~~~~~~~~ 633 (788)
.++||||+++ +|.+.+. .....+++..+..++.||+.||.||| ++ +|+||||||+|||++. .++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~----~~~ 169 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE----ADG 169 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET----TTT
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC----CCC
Confidence 7899999976 5544443 24567889999999999999999999 77 9999999999999981 278
Q ss_pred cEEEeecCCccccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh
Q 047157 634 MAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 634 ~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 712 (788)
.+||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...............
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 999999999987654332 2345689999999998654 4899999999999999999999999765432211110000
Q ss_pred h---HHHHHHHhhcccc-cccccCCCC------CcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcC
Q 047157 713 L---SDWVISCMLSRNL-QVLVSHDPE------VLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGT 774 (788)
Q Consensus 713 ~---~~~~~~~~~~~~~-~~l~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~ 774 (788)
. ............. ......... ..........+.+|+.+||+.||++|||+.|++++ +++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 0 0000000000000 000000000 00011235678999999999999999999999974 4444
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=329.37 Aligned_cols=269 Identities=24% Similarity=0.239 Sum_probs=191.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCC------eE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED------KR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~ 562 (788)
.|.+.++||+|+||+||+|.+. .++ .+|+|++..... ...+|+++++.++||||+++++++.... ..
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~--~~~-~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLV--ESD-EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEET--TTE-EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEEC--CCC-eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4677899999999999999885 344 588888754322 2236999999999999999999985433 37
Q ss_pred EEEEecCCCCCHhHhhh--ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 563 LLVYELMPNGTLSNFLF--HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
++||||++++.+..... .....+++..+..++.||++||+|||++ +|+||||||+|||++. .++.+||+||
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~----~~~~~kL~DF 186 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDP----PSGVLKLIDF 186 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEET----TTTEEEECCC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcC----CCCcEEEeeC
Confidence 89999998754443332 2356789999999999999999999999 9999999999999972 4678999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH---HH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS---DW 716 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~ 716 (788)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+........+. ..
T Consensus 187 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 187 GSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp TTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99987644332 2345689999999998664 589999999999999999999999986543221111000000 00
Q ss_pred HHHHhhcccccccccCCCCCc-----ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcC
Q 047157 717 VISCMLSRNLQVLVSHDPEVL-----SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGT 774 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~ 774 (788)
...... .......-+..... ........+.+|+.+||+.||++|||+.|++++ ++++
T Consensus 265 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 265 QIKTMN-PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHC-GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHhhC-hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 000000 00000000000000 011134578899999999999999999999975 4444
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.76 Aligned_cols=261 Identities=20% Similarity=0.248 Sum_probs=197.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecC-----CeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE-----DKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 562 (788)
.|.+.+.||+|+||.||+|... .++..||||.+... .......+.+|++++++++||||+++++++... ...
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHK--PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ceEEeeEEcCCCCeEEEEEEEC--CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4667799999999999999886 66789999998643 244556788999999999999999999987654 678
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+. ++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~-----~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLIN-----SNCDLKVCDFGL 158 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC-----TTCCEEECCCTT
T ss_pred EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEc-----CCCcEEEEeccc
Confidence 99999996 689998865 4689999999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCc---------ccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh
Q 047157 643 SKLLNKDQTR---------TDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 643 a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 712 (788)
+......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..........
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----- 233 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL----- 233 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-----
Confidence 9876532211 1223568999999998754 778999999999999999999999997653221100
Q ss_pred hHHHHHHHhhccc------------ccccccCCCCCc-c-----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 713 LSDWVISCMLSRN------------LQVLVSHDPEVL-S-----DLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 713 ~~~~~~~~~~~~~------------~~~l~~~~~~~~-~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.......... ....+...+... . .......+.+++.+||+.||++|||++|++++
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 234 ---LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp ---HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 000000000000 0 01234567899999999999999999999973
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.53 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=194.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCe-----
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK----- 561 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----- 561 (788)
.|.+.+.||+|+||.||+|... .++..||||.+... .....+.+.+|+.++++++||||+++++++.....
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDK--RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred eEEEeeeEecCCCeEEEEEEEC--CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4666789999999999999886 67789999998653 23445788999999999999999999999987654
Q ss_pred -EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 562 -RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 562 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+||+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~-----~~~~~kl~Df 170 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVN-----EDCELKILDF 170 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEEC-----TTCCEEECST
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeEC-----CCCcEEEeec
Confidence 499999997 68888773 3589999999999999999999999 999999999999998 7889999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh----HH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL----SD 715 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~ 715 (788)
|++...... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... ..
T Consensus 171 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 171 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp TCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred ccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999865432 223568999999999876 678999999999999999999999997654321110000000 00
Q ss_pred HHHHHhhccc----ccccccC-CCCC-cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 716 WVISCMLSRN----LQVLVSH-DPEV-LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 716 ~~~~~~~~~~----~~~l~~~-~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
+ ........ +..+... .... .........+.+++.+||+.||++|||++|++++
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 F-VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp H-HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred H-HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00000000 0000000 0000 0011235678899999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.05 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=176.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHH-HhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELK-IIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||.||+|... .++..||||.+.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHK--PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEET--TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhehheeccCCCEEEEEEEEc--CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 3556789999999999999886 567899999986542 334455666666 778889999999999999999999999
Q ss_pred ecCCCCCHhHhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 567 ELMPNGTLSNFLFH----EGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 567 e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
||+++ +|.+++.. ....+++..+..++.|++.||.|||+. .+|+||||||+|||++ .++.+||+|||+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~-----~~~~~kl~Dfg~ 172 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLD-----RSGNIKLCDFGI 172 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEE-----TTTEEEECCCSS
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEc-----CCCCEEEccCCC
Confidence 99975 88877753 256789999999999999999999984 3899999999999998 788999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccc----cCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWL----RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
+........ .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||.........
T Consensus 173 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------------ 238 (327)
T 3aln_A 173 SGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------------ 238 (327)
T ss_dssp SCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------
T ss_pred ceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------------
Confidence 987643322 2234689999999998 4667899999999999999999999999753211000
Q ss_pred HHhhcccccccccCC-C--CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 719 SCMLSRNLQVLVSHD-P--EVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~-~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
+....... + ...........+.+++.+||+.||++|||+.||++
T Consensus 239 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 239 -------LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00011100 0 00011123457888999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=321.51 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=196.4
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchH--HHHHHHHHHHHHhcCC---CccccceEeeEEe-----
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--KTNEEFMTELKIIGRT---HHKNLVRLLGFCS----- 557 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~~~----- 557 (788)
..|.+.+.||+|+||.||+|.... .++..||+|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hceeeeeeecccccEEEEEEEecC-CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 346778999999999999998742 3567899998864321 1223456777776655 8999999999987
Q ss_pred cCCeEEEEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEE
Q 047157 558 EEDKRLLVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636 (788)
Q Consensus 558 ~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~k 636 (788)
.....++||||++ ++|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+||+++ .++.+|
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~-----~~~~~k 160 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVT-----SSGQIK 160 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTCCEE
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEc-----CCCCEE
Confidence 5668899999997 69999997653 4589999999999999999999999 999999999999998 788999
Q ss_pred EeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..
T Consensus 161 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------~~ 230 (326)
T 1blx_A 161 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--------GK 230 (326)
T ss_dssp ECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--------HH
T ss_pred EecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--------HH
Confidence 99999998654322 223457899999999999999999999999999999999999999765322111 00
Q ss_pred HHHHhhc---ccccc-------cccC---CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLS---RNLQV-------LVSH---DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~---~~~~~-------l~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
....... ..... .... .+.........+.+.+++.+||+.||++|||+.|++++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1110000 00000 0000 00000011234567889999999999999999999963
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.20 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=190.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCC--ccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTH--HKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~ 563 (788)
..|.+.+.||+|+||.||++... .+..||||.+... .....+.+.+|++++.+++ ||||+++++++.+.+..+
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC---CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 34667799999999999999874 4668999998543 3445678999999999997 599999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||| +.+++|.+++... ..+++..+..++.||++||.|||++ +|+||||||+|||++ + +.+||+|||++
T Consensus 105 lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-----~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-----D-GMLKLIDFGIA 173 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-----T-TEEEECCCSSS
T ss_pred EEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-----C-CeEEEeecccc
Confidence 9999 5688999999754 5688999999999999999999999 999999999999996 3 68999999999
Q ss_pred cccCCCCCc-ccccccCCccccCcccccC-----------CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh
Q 047157 644 KLLNKDQTR-TDTNMRGTMGYVAPEWLRN-----------VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI 711 (788)
Q Consensus 644 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 711 (788)
......... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------- 246 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------- 246 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-------
Confidence 876543322 2233568999999999865 478889999999999999999999996432110
Q ss_pred hhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 712 VLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 712 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... ...... .........+.+.+++.+||+.||++|||++|+++.
T Consensus 247 ---~~~~~-~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 ---SKLHA-IIDPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---HHHHH-HHCTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHH-HHhccc--------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 00000 111110 000011113567889999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.67 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=178.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.+.||+|+||.||+|... .++..||||.+.... ....+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFR--KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GEEEEEEC------CEEEEEET--TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred cccccceeeecCCeeEEEEEEe--cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 4566789999999999999886 567799999986542 223334455556788889999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+ ++.+..+.......+++..+..++.||+.||.|||+ . +|+|+||||+||+++ .++.+||+|||++..
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~-----~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLD-----ERGQIKLCDFGISGR 174 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEEC-----TTSCEEECCCTTC--
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEEC-----CCCCEEEEECCCchh
Confidence 999 566666665556778999999999999999999998 5 899999999999998 788999999999976
Q ss_pred cCCCCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
...... .....+++.|+|||.+. ...++.++||||||+++|||++|+.||....... .. . ..
T Consensus 175 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~---~-~~ 241 (318)
T 2dyl_A 175 LVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-------EV---L-TK 241 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HH---H-HH
T ss_pred ccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-------HH---H-HH
Confidence 543322 22346899999999984 5578899999999999999999999997532110 00 0 11
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
....... ...........+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 242 VLQEEPP-------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHSCCC-------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HhccCCC-------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111100 01111123456788999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.92 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=186.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.+.+.++||+|+||+|+.... .++..||||++..... ..+.+|+++++++ +||||+++++++.+....++|||
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~---~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGM---FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEE---SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEEEEE---eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 355568999999999664333 4567899999864322 2356899999988 79999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+. ++|.+++...........++.++.||+.||.|||++ +|+||||||+|||++..+......+||+|||++....
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 996 699999977665566666788999999999999999 9999999999999964332245678999999998765
Q ss_pred CCCC--cccccccCCccccCccccc---CCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHh
Q 047157 648 KDQT--RTDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 648 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
.... .......||+.|+|||++. ...++.++|||||||++|||++ |..||........ ....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~------------~~~~ 242 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA------------NILL 242 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH------------HHHT
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH------------HHHh
Confidence 4321 2233467999999999997 4577889999999999999999 8899854321110 0000
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..... ............+.+++.+||+.||++|||++||++
T Consensus 243 ~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 GACSL-------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCCCC-------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCc-------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00000 011112234456788999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=327.99 Aligned_cols=251 Identities=27% Similarity=0.355 Sum_probs=185.0
Q ss_pred ccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEEecCC
Q 047157 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 492 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
..++||+|+||+||.+.. .++..||||++.... .+.+.+|++++.++ +||||+++++++.+.+..++||||+.
T Consensus 19 ~~~~LG~G~~g~V~~~~~---~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGS---FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEEECSTTCEEEEEE---SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred ccCeEeeCCCeEEEEEEE---ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 457899999999986543 457799999986542 34678899999876 89999999999999999999999995
Q ss_pred CCCHhHhhhccCCCC------CHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCC--------CCCCCcEE
Q 047157 571 NGTLSNFLFHEGQRP------GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKT--------LDTNYMAK 636 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~------~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~--------~~~~~~~k 636 (788)
|+|.+++....... .+..++.++.||+.||.|||++ +|+||||||+|||++..+ ...+..+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996543221 2334578999999999999999 999999999999997321 01456899
Q ss_pred EeecCCccccCCCCCc---ccccccCCccccCcccccC-------CCCCccCcchhhHHHHHHHHh-CCCCCCccccccc
Q 047157 637 ISDFGISKLLNKDQTR---TDTNMRGTMGYVAPEWLRN-------VPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEE 705 (788)
Q Consensus 637 L~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~ 705 (788)
|+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999977543322 1234579999999999865 678999999999999999999 999996432111
Q ss_pred cccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 706 SEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.. ....... . .............++.+++.+||+.||++|||+.||++
T Consensus 248 --------~~-----i~~~~~~-~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --------SN-----IIRGIFS-L--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --------HH-----HHHTCCC-C--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HH-----HhcCCCC-c--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00 0001000 0 11122234456678999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=319.56 Aligned_cols=243 Identities=24% Similarity=0.403 Sum_probs=196.7
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchH------HHHHHHHHHHHHhcCCC--ccccceEeeEEec
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE------KTNEEFMTELKIIGRTH--HKNLVRLLGFCSE 558 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~ 558 (788)
...|.+.+.||+|+||.||+|... .++..||||.+..... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEET--TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred cCceEEEEEEeeCCCeEEEEEEEC--CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 345777899999999999999876 6678999999865432 12245678999999885 5999999999999
Q ss_pred CCeEEEEEecCCC-CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 559 EDKRLLVYELMPN-GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 559 ~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
.+..++|+|++.+ ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++. .++.+||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~----~~~~~kL 191 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDL----NRGELKL 191 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET----TTTEEEE
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeC----CCCCEEE
Confidence 9999999999976 8999999654 5688999999999999999999999 9999999999999972 4578999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHH
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDW 716 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 716 (788)
+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 192 ~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------------- 255 (320)
T 3a99_A 192 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------- 255 (320)
T ss_dssp CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------------
T ss_pred eeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------------
Confidence 9999998765332 233568999999999977665 68899999999999999999999643110
Q ss_pred HHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 717 VISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 717 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... .. .....+.+.+++.+||+.||++|||++||++.
T Consensus 256 -----~~~~~--~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 -----IRGQV--FF--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -----HHCCC--CC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----hcccc--cc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00 01123567889999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.02 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=189.8
Q ss_pred HHHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchH------HHHHHHHHHHHHhcCC----CccccceEe
Q 047157 484 ELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE------KTNEEFMTELKIIGRT----HHKNLVRLL 553 (788)
Q Consensus 484 ~l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~hpniv~~~ 553 (788)
+.....|.+.+.||+|+||.||+|... .++..||||.+..... .....+.+|+.++.++ +||||++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRL--TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECT--TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEc--cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 344567888899999999999999775 5677999999865432 1233456788888887 899999999
Q ss_pred eEEecCCeEEEEEec-CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC
Q 047157 554 GFCSEEDKRLLVYEL-MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632 (788)
Q Consensus 554 ~~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~ 632 (788)
+++.+.+..++|+|+ +.+++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||+++. .+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~----~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDL----RR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEET----TT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeC----CC
Confidence 999999999999999 7899999999764 4689999999999999999999999 9999999999999972 46
Q ss_pred CcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCC-ccCcchhhHHHHHHHHhCCCCCCccccccccccchh
Q 047157 633 YMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVT-TKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI 711 (788)
Q Consensus 633 ~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 711 (788)
+.+||+|||++....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||......
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------- 245 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------- 245 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--------
Confidence 789999999998765432 2345689999999998776664 5899999999999999999999643110
Q ss_pred hhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 712 VLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 712 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
..... . ........+.+++.+||+.||++|||++|++++
T Consensus 246 ----------~~~~~--------~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 ----------LEAEL--------H--FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----------HHTCC--------C--CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------hhhcc--------C--CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0 001123567889999999999999999999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=338.56 Aligned_cols=278 Identities=24% Similarity=0.267 Sum_probs=202.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEec------CC
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE------ED 560 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 560 (788)
..|.+.+.||+|+||+||+|.+. .++..||||.+... .....+.+.+|++++++++||||+++++++.. .+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~--~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQ--DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCT--TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEEC--CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 45778899999999999999875 66779999998654 34556789999999999999999999998765 67
Q ss_pred eEEEEEecCCCCCHhHhhhccC--CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG--QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+. +|+||||||+||+++..+ ....+||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g--~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGP--QRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCS--SSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCC--CceeEEEc
Confidence 7899999999999999997643 2578889999999999999999999 999999999999998433 34459999
Q ss_pred ecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||............... ....
T Consensus 167 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~--~~~~ 242 (676)
T 3qa8_A 167 DLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE--KSNE 242 (676)
T ss_dssp SCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-------
T ss_pred ccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc--ccch
Confidence 9999987654332 23457899999999999999999999999999999999999999754211100000000 0000
Q ss_pred HHhhcccccccc--cCC--CCCcccHHHHHHHHHHHhHccCCCCCCCCCHHH-----HHHHhhcCcC
Q 047157 719 SCMLSRNLQVLV--SHD--PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKK-----VIHMLEGTLE 776 (788)
Q Consensus 719 ~~~~~~~~~~l~--~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e-----vl~~L~~~~~ 776 (788)
...........+ ... ............+.+++.+||+.||++|||++| ..+.++.++.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000000000000 000 001112235678899999999999999999977 3445544443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=340.30 Aligned_cols=240 Identities=21% Similarity=0.312 Sum_probs=192.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCe-----
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK----- 561 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----- 561 (788)
..|.+.+.||+|+||.||+|.+.. .++..||||.+... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRN-VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGG-GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcC-CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 457788999999999999998852 14678999988543 34556788999999999999999999999987665
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.+|||||+++++|.+++.. .+++.+++.++.||+.||.|||++ +|+||||||+|||++ .+ .+||+|||
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~-----~~-~~kl~DFG 226 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLT-----EE-QLKLIDLG 226 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----SS-CEEECCCT
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEe-----CC-cEEEEecc
Confidence 7999999999999987743 689999999999999999999999 999999999999997 43 89999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
++...... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||........
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------- 284 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------- 284 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------
T ss_pred cchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------
Confidence 99876443 3456899999999987654 8899999999999999999888764311100
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHhhcC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-SMKKVIHMLEGT 774 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~ 774 (788)
+...........+.+++.+||+.||++|| +++++.+.|.+.
T Consensus 285 ------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ------------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 01111122345688899999999999999 566676766554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.16 Aligned_cols=231 Identities=12% Similarity=0.125 Sum_probs=183.4
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
...|.+.+.||+|+||.||+|... ..+..||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDT--ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEET--TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEec--CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 345778899999999999999886 667899999997542 344578999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++++|.+++... ....++..++.||+.||.|||++ +|+||||||+|||++ .++.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~-----~~g~~kl~~~~-- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVS-----IDGDVVLAYPA-- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEE-----TTSCEEECSCC--
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEc-----CCCCEEEEecc--
Confidence 999999999999999432 45567889999999999999999 999999999999998 78889997443
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
|++ +++.++||||||+++|||++|+.||.............
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------------- 215 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------------- 215 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-------------
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-------------
Confidence 333 36889999999999999999999998654322110000
Q ss_pred ccccccccCCCCC--cccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 724 RNLQVLVSHDPEV--LSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 724 ~~~~~l~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
..+...+.. .......+.+.+++.+||+.||++| |+.|+++.|+.+..
T Consensus 216 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 216 ----RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp ----BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ----HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000000000 0001224568889999999999999 99999999987654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=297.54 Aligned_cols=241 Identities=22% Similarity=0.301 Sum_probs=181.9
Q ss_pred hccc-ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHh-cCCCccccceEeeEEec----CCeEE
Q 047157 490 KGFS-KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKII-GRTHHKNLVRLLGFCSE----EDKRL 563 (788)
Q Consensus 490 ~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~----~~~~~ 563 (788)
|.+. +.||+|+||.||++... .++..||+|.+... ..+.+|++++ +.++||||+++++++.. ....+
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNK--RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEc--CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 4444 78999999999999886 66779999998653 3456788887 55699999999999876 67889
Q ss_pred EEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 564 LVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++... .++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~--~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKR--PNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS--TTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCC--CCCcEEEecccc
Confidence 9999999999999997653 4689999999999999999999999 999999999999998432 378899999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML 722 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (788)
+.... +..++.++||||||+++|||++|+.||...........
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------------- 209 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------------- 209 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--------------
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--------------
Confidence 86432 23567899999999999999999999975432211100
Q ss_pred cccccccccCCCCCccc--HHHHHHHHHHHhHccCCCCCCCCCHHHHHH--HhhcCcCCCCCC
Q 047157 723 SRNLQVLVSHDPEVLSD--LERFERMAMVGLWCNHPDPNLRPSMKKVIH--MLEGTLEVGMPP 781 (788)
Q Consensus 723 ~~~~~~l~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~~~pp 781 (788)
............... ......+.+++.+||+.||++|||++|+++ .+.+....+.+|
T Consensus 210 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~ 270 (299)
T 3m2w_A 210 --MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270 (299)
T ss_dssp --SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred --HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence 000000000110000 123567889999999999999999999997 344444433333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=314.76 Aligned_cols=237 Identities=15% Similarity=0.095 Sum_probs=176.4
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCc-cccce---------Ee----
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHH-KNLVR---------LL---- 553 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-pniv~---------~~---- 553 (788)
...++||+|+||+||+|.+. .++..||||++.... ....+.+.+|+.+++.++| +|... ..
T Consensus 81 ~~~~~LG~G~fG~Vy~a~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 81 VRGTVLGQEDPYAYLEATDQ--ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEETTEEEEEEEET--TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred EEecccccCCCEEEEEEEec--CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 34578999999999999986 667799999887332 2235678999999999977 32111 11
Q ss_pred --------eEEec-----CCeEEEEEecCCCCCHhHhhh------ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEe
Q 047157 554 --------GFCSE-----EDKRLLVYELMPNGTLSNFLF------HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIH 614 (788)
Q Consensus 554 --------~~~~~-----~~~~~lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH 614 (788)
.++.. ....+++|+++ +++|.+++. ..+..+++..++.++.||++||+|||++ +|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 11111 12456777765 689999884 2244567889999999999999999999 9999
Q ss_pred cCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccc----------cCCCCCccCcchhhH
Q 047157 615 CDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL----------RNVPVTTKVDVFSFG 684 (788)
Q Consensus 615 ~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~k~DVwSlG 684 (788)
|||||+|||++ .++.+||+|||+++..... .....| +.|+|||++ ....++.++||||||
T Consensus 235 rDiKp~NILl~-----~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 235 TYLRPVDIVLD-----QRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp SCCCGGGEEEC-----TTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred CCcccceEEEe-----cCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 99999999998 7788999999998865432 334567 999999999 666788999999999
Q ss_pred HHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCH
Q 047157 685 VMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM 764 (788)
Q Consensus 685 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 764 (788)
|++|||++|+.||......+... ..+.... ...+.+.+++.+||+.||++|||+
T Consensus 305 vil~elltg~~Pf~~~~~~~~~~--------------------~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGGSE--------------------WIFRSCK------NIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCSG--------------------GGGSSCC------CCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHCCCCCCCcchhhhHH--------------------HHHhhcc------cCCHHHHHHHHHHccCChhhCcCH
Confidence 99999999999997653322111 1111111 113568889999999999999997
Q ss_pred HHHHH
Q 047157 765 KKVIH 769 (788)
Q Consensus 765 ~evl~ 769 (788)
.|+++
T Consensus 359 ~~~l~ 363 (413)
T 3dzo_A 359 LQAME 363 (413)
T ss_dssp HHHTT
T ss_pred HHHHh
Confidence 77643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-33 Score=304.19 Aligned_cols=249 Identities=14% Similarity=0.110 Sum_probs=181.2
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccch--------HHHHHHHHHHHHHhcCCC---------cc
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--------EKTNEEFMTELKIIGRTH---------HK 547 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------hp 547 (788)
+....|.+.+.||+|+||+||+|+. ++..||||++.... ....+.+.+|+++++.++ ||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred cccccchheeeecccCceEEEEEEe----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 3356678889999999999999986 45799999997542 223367788888887775 66
Q ss_pred ccceEeeE-----------------Eec-------------CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHH
Q 047157 548 NLVRLLGF-----------------CSE-------------EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGV 597 (788)
Q Consensus 548 niv~~~~~-----------------~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi 597 (788)
||+++.++ +.+ .+..++||||+++|++.+.+.+ ..+++..+..++.||
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQL 170 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHH
Confidence 66666554 333 6789999999999977766633 567999999999999
Q ss_pred HHHHHHhh-hccCCceEecCCCCCcEEeccCCC---------------CCCCcEEEeecCCccccCCCCCcccccccCCc
Q 047157 598 ARGLLYLH-EECETQIIHCDIKPQNVLLDLKTL---------------DTNYMAKISDFGISKLLNKDQTRTDTNMRGTM 661 (788)
Q Consensus 598 ~~aL~~LH-~~~~~~ivH~dlkp~NIll~~~~~---------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~ 661 (788)
+.||.||| ++ +|+||||||+|||++..+. .....+||+|||+++..... ...||+
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence 99999999 88 9999999999999983210 01128999999999876432 347899
Q ss_pred cccCcccccCCCCCccCcchhhHHH-HHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccH
Q 047157 662 GYVAPEWLRNVPVTTKVDVFSFGVM-LLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDL 740 (788)
Q Consensus 662 ~y~aPE~~~~~~~s~k~DVwSlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 740 (788)
.|+|||++.+.. +.++||||++++ .+++++|..||..... ............ ............
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-----------~~~~~~~~~~~~---~~~~~~~~~~~~ 306 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-----------LHYLTDKMLKQM---TFKTKCNTPAMK 306 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-----------HHHHHHHHHHTC---CCSSCCCSHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh-----------hhHHHHhhhhhh---ccCcccchhhhh
Confidence 999999998766 899999998776 7888899998843100 000111111000 000111111233
Q ss_pred HHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 047157 741 ERFERMAMVGLWCNHPDPNLRPSMKKVI 768 (788)
Q Consensus 741 ~~~~~l~~l~~~cl~~dP~~RPt~~evl 768 (788)
...+++.+|+.+||+.| |++|++
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHH
Confidence 56778999999999866 999988
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=271.42 Aligned_cols=206 Identities=19% Similarity=0.249 Sum_probs=147.9
Q ss_pred cCCCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEE
Q 047157 23 QTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLT 102 (788)
Q Consensus 23 ~~~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~ 102 (788)
+..++|++|++|+++ ++| ++|.|+|||+.+++. . +|.. +|+||+|||+.| .++.|+|..||||||.
T Consensus 6 ~~~~~i~~g~~L~~g--~~l--~~g~f~l~f~~~gnl----~-ly~~---~~~vW~an~~~~--~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAA--QSL--ELSSFRFTMQSDCNL----V-LFDS---DVRVWASNTAGA--TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTT--CEE--CSTTEEEEECTTSCE----E-EEES---SSEEECCCCCSC--SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCC--CEE--EcCCEEEEECCCCcE----E-EEEC---CEEEEECCCCCC--CCeEEEEcCCCcEEEE
Confidence 566899999999975 577 599999999865442 2 3432 799999999998 6678999999999999
Q ss_pred eCCCcEEEEeccc------ccccccCCCCcEEEEecCCceeecccCCCCCcc----------cCCccccCCC-eEEeecC
Q 047157 103 YFNGSVQQIYSGA------ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTI----------LPGQVLLTGK-KLYSNSR 165 (788)
Q Consensus 103 ~~~~~~~~~~s~~------~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtl----------lpg~~l~~g~-~l~s~~~ 165 (788)
|.+|++ +|+++ ...|+|+|+|||||+++ ++||||||||||+ +|||+++.+. .| .
T Consensus 72 d~~~~~--vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L----~ 142 (236)
T 1dlp_A 72 TAQNTI--RWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTL----H 142 (236)
T ss_dssp CTTTCC--SCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEE----C
T ss_pred cCCCcE--EEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceE----E
Confidence 988876 34432 13689999999999964 8999999998766 5555554432 23 2
Q ss_pred CCCCCCCCceEEeeccCCcceeeecccCCCCCcccCccccc-ceeeeeccceeEEEEecCCcceEEEEeeccCCCCceEE
Q 047157 166 GTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTLN-NVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYH 244 (788)
Q Consensus 166 ~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (788)
+..||++|.|++.++++|++. ++... ..||+++++... .....+...+.++++..+++.++... .. ... ..+
T Consensus 143 s~~d~s~G~~~l~l~~dG~Lv--L~~~~-~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~-~~--~~~-~~~ 215 (236)
T 1dlp_A 143 ATQSLQLSPYRLSMETDCNLV--LFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSG-NS--RSA-GRY 215 (236)
T ss_dssp SSCCCBCSSCEEEEETTTEEE--EEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECC-CC--CSS-SCC
T ss_pred cCcEeecCcEEEEECCCCcEE--EEcCC-EeEEeCCCcCCCCceEEEECCCCcEEEEeCCCcEEEEeC-CC--CCC-CCE
Confidence 478999999999999999654 34433 479999987532 12234555666666665544333222 11 112 357
Q ss_pred EEEEeCCccEEEEE
Q 047157 245 RATIDGHGNFQQFA 258 (788)
Q Consensus 245 rl~ld~~G~l~~~~ 258 (788)
|++||.||++++|.
T Consensus 216 rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 216 VFVLQPDRNLAIYG 229 (236)
T ss_dssp EEEECSSSCEEEEC
T ss_pred EEEEcCCCcEEEeC
Confidence 99999999999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-28 Score=280.89 Aligned_cols=186 Identities=19% Similarity=0.137 Sum_probs=129.3
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccc----------hHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEE
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD----------IEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 563 (788)
..+.|++|.+..++.. -.+..+++|.+.+. .+...++|.+|+++|+++ +|+||+++++++++++..|
T Consensus 241 ~~~~~~~~~h~~~rr~--~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRY--FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp C-C--------CCEEE--EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred ccccCCcccccccccc--cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 3455666655554433 34567888887543 234456899999999999 7999999999999999999
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
|||||++|++|.++|... ..++.. +|+.||+.||+|||++ +||||||||+|||++ .++.+||+|||++
T Consensus 319 LVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~-----~dg~vKL~DFGlA 386 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVD-----ARQHARLIDFGSI 386 (569)
T ss_dssp EEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEEC-----TTSCEEECCCTTE
T ss_pred EEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEEC-----CCCCEEEeecccC
Confidence 999999999999999765 445543 5889999999999999 999999999999998 8889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p 696 (788)
+........ ....+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 387 r~~~~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 387 VTTPQDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ESCC---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eeCCCCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 876544332 234679999999999976 467789999999999888765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=248.40 Aligned_cols=182 Identities=16% Similarity=0.231 Sum_probs=143.1
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccch--------HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--------EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
.++||+|+||.||++.. .+..+++|+..... ....+++.+|++++++++||||+++..++...+..+|
T Consensus 341 ~~~LG~G~fg~Vy~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp -------CCEEEEEEEC----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCEEeeCCCEEEEEEEE----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 46899999999999943 34567777643211 1224568999999999999999966666667778899
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++++|.+++.. +..++.||++||.|||++ +|+||||||+|||++ . .+||+|||+++
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~-----~--~~kL~DFGla~ 477 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFD-----K--DLYIIDFGLGK 477 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEES-----S--SEEECCCTTCE
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEEC-----C--eEEEEECccCE
Confidence 9999999999999955 568999999999999999 999999999999997 4 89999999999
Q ss_pred ccCCCCCcc------cccccCCccccCcccccC--CCCCccCcchhhHHHHHHHHhCCCCC
Q 047157 645 LLNKDQTRT------DTNMRGTMGYVAPEWLRN--VPVTTKVDVFSFGVMLLEIICGRRHI 697 (788)
Q Consensus 645 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltg~~p~ 697 (788)
......... .....||+.|+|||++.. ..|+.+.|+|+..+-..+-+.++.++
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 875432211 234679999999999976 57888999999999998888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=196.07 Aligned_cols=143 Identities=17% Similarity=0.119 Sum_probs=113.7
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccchH------------------HHHHHHHHHHHHhcCCCccccceE
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE------------------KTNEEFMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~hpniv~~ 552 (788)
.+.+.||+|+||.||+|.. .++..||+|.++.... .....+.+|++++++++ | +++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~---~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS---EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE---TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EecCEeccCCCceEEEEEe---CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3458999999999999987 4677999999864321 23567899999999998 4 566
Q ss_pred eeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC
Q 047157 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632 (788)
Q Consensus 553 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~ 632 (788)
.+++.. +..++||||+++++|.+ +.. .....++.||+.||.|||++ +|+||||||+|||++ +
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~------~ 228 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS------E 228 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE------T
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE------C
Confidence 665543 55699999999999998 421 12346999999999999999 999999999999996 4
Q ss_pred CcEEEeecCCccccCCCCCcccccccCCccccCcccccC
Q 047157 633 YMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671 (788)
Q Consensus 633 ~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 671 (788)
+.+||+|||++.. +..++|||++..
T Consensus 229 ~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 229 EGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred CcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 5899999999974 345789998753
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.73 E-value=2.3e-17 Score=147.39 Aligned_cols=104 Identities=17% Similarity=0.263 Sum_probs=85.0
Q ss_pred cCCCccCCCCceecCCCCeee--cCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceE
Q 047157 23 QTSPNISLGSSITAGSNTSWL--SPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLL 100 (788)
Q Consensus 23 ~~~~~i~~~~~l~~~~~~~~v--S~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~ 100 (788)
+..++|.+|++|.++ ++|+ |++|.|+|+|+++++ . +||++ +++||+|||+.| ..++.++|..|||||
T Consensus 6 ~~~~~l~~g~~L~~g--~~l~~~S~~g~~~L~~~~dgn--l---vly~~---~~~vW~sn~~~~-~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHAT--ESLEILFGTHVYRFIMQTDCN--L---VLYDN---NNPIWATNTGGL-GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETT--CEEEEEETTEEEEEEECTTSC--E---EEEET---TEEEEECCCTTS-CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCC--CEEEEeCCCCCEEEEEecCCC--E---EEEEC---CEEEEeCCCccC-CCceEEEEccCCEEE
Confidence 456789999999976 5899 999999999998664 2 58875 799999999877 345789999999999
Q ss_pred EEeCCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecc
Q 047157 101 LTYFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDS 140 (788)
Q Consensus 101 l~~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqS 140 (788)
|.|.++++.|.+.+. ...++|+|+|||||++ .++|||
T Consensus 75 l~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 999888765443332 2368999999999998 389998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.5e-17 Score=144.34 Aligned_cols=106 Identities=22% Similarity=0.348 Sum_probs=84.9
Q ss_pred CCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeC
Q 047157 25 SPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYF 104 (788)
Q Consensus 25 ~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~ 104 (788)
+|+|..|+.|..+ ++|+ ++|.|+|+|+..++ . |||+ ..++||+||++.|. .++.+.|..||||||.|.
T Consensus 1 ~d~l~~g~~L~~g--~~l~-~~~~~~l~~~~dGn--l---vl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTG--HSLE-VGPSYRLIMQGDCN--F---VLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTT--CEEE-ETTTEEEEECTTSC--E---EEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCC--CEEE-ECCCEEEEEcCCCc--E---EEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEEEECC
Confidence 4789999999865 6899 99999999987654 2 6776 37999999998763 457899999999999998
Q ss_pred CCcEEEEecccc----cccccCCCCcEEEEecCCceeecccCCCC
Q 047157 105 NGSVQQIYSGAA----SLALMQNDGNFVLKNANSAVVWDSFDFPT 145 (788)
Q Consensus 105 ~~~~~~~~s~~~----~~a~LldsGNlVl~~~~~~~lWqSFD~Pt 145 (788)
++++.|.+.+.. ..++|+|+|||||++. .+||||+||.
T Consensus 69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 887654433322 2688999999999975 8999999984
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=5e-18 Score=175.40 Aligned_cols=136 Identities=18% Similarity=0.171 Sum_probs=104.0
Q ss_pred cccccccccccceEEEEEEeccCccee--eeeeecccchH------------------------HHHHHHHHHHHHhcCC
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIE--IAVKKLEKDIE------------------------KTNEEFMTELKIIGRT 544 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~--vavK~l~~~~~------------------------~~~~~~~~E~~~l~~l 544 (788)
.+.+.||+|+||.||+|... .++.. ||||.++.... .....+.+|++++.++
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~--~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGV--FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEE--ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEc--CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 45688999999999999874 34557 99998643211 1124688999999999
Q ss_pred Ccccc--ceEeeEEecCCeEEEEEecCCC-C----CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhh-hccCCceEecC
Q 047157 545 HHKNL--VRLLGFCSEEDKRLLVYELMPN-G----TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH-EECETQIIHCD 616 (788)
Q Consensus 545 ~hpni--v~~~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~~ivH~d 616 (788)
+|+++ +.++++ +..+|||||+.+ | +|.++... .++..+..++.||+.+|.||| +. +|+|||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 88864 444443 356899999942 3 67766532 123456789999999999999 88 999999
Q ss_pred CCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 617 IKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 617 lkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|||+|||++ . .++|+|||++...
T Consensus 197 lkp~NILl~-----~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYI-----D--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEES-----S--SEEECCCTTCEET
T ss_pred CCHHHEEEc-----C--cEEEEECcccccC
Confidence 999999997 4 8999999999764
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2.3e-16 Score=140.47 Aligned_cols=106 Identities=20% Similarity=0.333 Sum_probs=83.8
Q ss_pred CCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeC
Q 047157 25 SPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYF 104 (788)
Q Consensus 25 ~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~ 104 (788)
.|+|.+||+|..+ ++|+ +|.|+|+|++.++ .. +|+ ..++||+||++.|. .++.|.|..+|||||.|.
T Consensus 2 ~dtl~~gq~L~~g--~~L~--~g~~~L~~~~dgn--lv---ly~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHAD--HSLQ--AGAYTLTIQNKCN--LV---KYQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETT--EEEE--ETTEEEEECTTSC--EE---EEE---TTEEEEECSCTTSC-SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCC--CEEE--CCCEEEEEcCCCc--EE---EEe---CCEEEEeCCCCCCC-CceEEEECCCCcEEEECC
Confidence 4789999999965 6788 8999999986553 32 354 48999999999884 457899999999999998
Q ss_pred CCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCC
Q 047157 105 NGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTD 146 (788)
Q Consensus 105 ~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtD 146 (788)
+++..|.+... ...++|+|+|||||++. ++||||.++..
T Consensus 69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 77764433222 23689999999999964 89999998765
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-16 Score=137.57 Aligned_cols=100 Identities=18% Similarity=0.332 Sum_probs=80.8
Q ss_pred CccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeCC
Q 047157 26 PNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFN 105 (788)
Q Consensus 26 ~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~~ 105 (788)
++|.+||.|.++ ++|+| |.|.|.|...++ |.++. ..++||+|||+.|..+++.|+|..||||||.|.+
T Consensus 2 n~L~~g~~L~~g--~~L~s--g~y~l~~q~DgN----Lvly~----~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 2 NILDNNEGLYAG--QSLDV--EPYHFIMQDDCN----LVLYD----HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CEECTTEEECTT--CEEEE--TTEEEEECTTSC----EEEEE----TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEEcCC--CEEEE--CCEEEEECCCCe----EEEEE----CCEEEEEecCCCCCCccEEEEEeCCccEEEECCC
Confidence 568899999865 67888 889999875543 44543 3689999999999988899999999999999999
Q ss_pred CcEEEEeccc----ccccccCCCCcEEEEecCCceeecc
Q 047157 106 GSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDS 140 (788)
Q Consensus 106 ~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqS 140 (788)
++..|.+++. ..+|+|+|+|||||++. .+|||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 8875544332 24689999999999964 69998
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.8e-16 Score=138.49 Aligned_cols=106 Identities=19% Similarity=0.379 Sum_probs=83.3
Q ss_pred CCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeC
Q 047157 25 SPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYF 104 (788)
Q Consensus 25 ~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~ 104 (788)
+|+|.+||.|+.+ ++| ++|.|+|+|+.+++- +||++ +++||+||++.+ ..++.+.|..+|||||.|
T Consensus 1 tdtl~~gq~L~~g--~~L--~~~~~~L~~~~dgnl-----vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTG--GSL--AEGGYLFIIQNDCNL-----VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTT--CEE--EETTEEEEECTTSCE-----EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCC--CEE--eCCCEEEEEcCCCcE-----EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEEEEc-
Confidence 4789999999865 577 589999999987652 35665 699999999764 345689999999999999
Q ss_pred CCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCC
Q 047157 105 NGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFP 144 (788)
Q Consensus 105 ~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~P 144 (788)
++.+.|.+.+. .-.++|+++|||||++..+.++||||+|.
T Consensus 67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 66554332222 23688999999999997788999999985
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=3.8e-15 Score=159.83 Aligned_cols=141 Identities=11% Similarity=0.104 Sum_probs=96.1
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchH--------------HHHH--------HHHHHHHHhcCCCcc
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE--------------KTNE--------EFMTELKIIGRTHHK 547 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~--------------~~~~--------~~~~E~~~l~~l~hp 547 (788)
|.+.+.||+|++|.||+|.. ..+..||||+++.... .... ...+|...|.++.+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d---~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD---EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC---TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEecCEeeeCCceEEEEEEC---CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 56778999999999999986 3577999997642110 0011 123455666666444
Q ss_pred ccc--eEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 548 NLV--RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 548 niv--~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
++. ..+++ ...+|||||+++++|.++... .....++.||+.+|.+||+. +||||||||.|||++
T Consensus 174 gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 174 GFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp TCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 332 22221 123799999999888765421 12346889999999999998 999999999999998
Q ss_pred cCCCCC-----CCcEEEeecCCccccC
Q 047157 626 LKTLDT-----NYMAKISDFGISKLLN 647 (788)
Q Consensus 626 ~~~~~~-----~~~~kL~Dfg~a~~~~ 647 (788)
.++... ...+.|+||+.+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 432100 1148999999887644
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=4.7e-14 Score=124.10 Aligned_cols=99 Identities=16% Similarity=0.339 Sum_probs=77.3
Q ss_pred CccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeCC
Q 047157 26 PNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFN 105 (788)
Q Consensus 26 ~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~~ 105 (788)
.+|.+||.|..+ ++|+ +|.|+|+|+..++ ..| |+. .++||+||++.+ ..++.|.|..||||||.|.+
T Consensus 2 ntL~~gq~L~~g--~~L~--~g~~~L~~q~dGn--Lvl---y~~---~~~vW~snt~~~-~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 2 NILYSGETLSPG--EFLN--NGRYVFIMQEDCN--LVL---YDV---DKPIWATNTGGL-DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CEEETTEEECTT--CEEE--ETTEEEEECTTSC--EEE---EET---TEEEEECCCTTS-SSSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEeCCC--CEEE--CCCEEEEEcCCCc--EEE---EeC---CEEEEECCcccC-CCCEEEEEeCCCCEEEECCC
Confidence 478899999865 5776 7999999976654 333 554 589999999876 34578999999999999988
Q ss_pred CcEEEEeccc----ccccccCCCCcEEEEecCCceeecc
Q 047157 106 GSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDS 140 (788)
Q Consensus 106 ~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqS 140 (788)
+++.|.+.+. ..+|+|+|+|||||+++ .+|||
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s 104 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWAT 104 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeC
Confidence 8765433332 24689999999999985 89998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.40 E-value=8.6e-13 Score=115.97 Aligned_cols=100 Identities=11% Similarity=0.157 Sum_probs=74.6
Q ss_pred CCCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEe
Q 047157 24 TSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTY 103 (788)
Q Consensus 24 ~~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~ 103 (788)
+.|+|.+||.|..+ ++|+| |.|.|-| +..++ |.+ |.. ++||++|++.. ..++.+.|..||||||.|
T Consensus 5 ~~dtL~~gq~L~~g--~~L~s--g~~~L~~-q~dGn---Lvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 5 TNNLLFSGQVLYGD--GRLTA--KNHQLVM-QGDCN---LVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp BTTEEETTCEEETT--EEEEC--SSCEEEE-CTTSC---EEE-ECS----SSCEECCCTTS-SSSCEEEECTTSCEEEEC
T ss_pred ccCEECCCCEecCC--CEEEe--CCEEEEE-cCCCe---EEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCcEEEEe
Confidence 56899999999965 68998 4588855 43333 333 654 48999999863 234689999999999999
Q ss_pred CCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecc
Q 047157 104 FNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDS 140 (788)
Q Consensus 104 ~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqS 140 (788)
.++++.|.+.+. ..+|+|+|+|||||++ ..+|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 888765443331 1468999999999998 489987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.9e-13 Score=117.68 Aligned_cols=86 Identities=21% Similarity=0.371 Sum_probs=66.4
Q ss_pred CCCcEEEEecCCceEEEeCCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEE
Q 047157 86 EAGSKITLTNDGKLLLTYFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLY 161 (788)
Q Consensus 86 ~~~s~l~l~~~G~L~l~~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~ 161 (788)
+...+|.+..||||+|.+ ++++.|..++. ...++|+|+|||||++.++.++||||.
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t------------------- 78 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT------------------- 78 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC-------------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC-------------------
Confidence 345789999999999998 45554443332 246899999999999999999999993
Q ss_pred eecCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCcc
Q 047157 162 SNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTV 203 (788)
Q Consensus 162 s~~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~~ 203 (788)
++++|.|++.|+++|++.++ .. .||.+++.
T Consensus 79 -------~~~~g~~~l~l~~dGnlvl~--~~---~~W~S~~~ 108 (110)
T 3a0c_A 79 -------NGKEDHYVLVLQQDRNVVIY--GP---VVWATGSG 108 (110)
T ss_dssp -------CCSSSCCEEEECTTSCEEEE--CS---EEEECSCC
T ss_pred -------CCCCCCEEEEEeCCccEEEE--CC---CEecCCCc
Confidence 45569999999999986653 22 59988653
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.35 E-value=6.3e-12 Score=111.11 Aligned_cols=103 Identities=13% Similarity=0.185 Sum_probs=77.6
Q ss_pred CCCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEe
Q 047157 24 TSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTY 103 (788)
Q Consensus 24 ~~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~ 103 (788)
+.++|.+||.|..+ ++|. +|.|.|-|...++ |.++..+ ..++||++|+..+- .++.+.|..+|||||.|
T Consensus 5 ~~~tL~~gq~L~~g--~~L~--~g~~~L~~q~dGN----LvL~~~~--~~~~vWssnt~~~~-~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 5 VRNVLFSSQVMYDN--AQLA--TRDYSLVMRDDCN----LVLTKGS--KTNIVWESGTSGRG-QHCFMRLGHSGELDITD 73 (113)
T ss_dssp CSSEEETTCEEETT--CEEE--ETTEEEEECTTSC----EEEEETT--TTEEEEECCCTTSC-SSCEEEECTTSCEEEEC
T ss_pred cCCEeCCCCEECCC--CEeE--cCCEEEEEcCCCE----EEEEECC--CCEEEEECCcccCC-cCEEEEEeCCCcEEEEC
Confidence 56789999999865 5676 4889988864433 4444321 47899999998763 35689999999999999
Q ss_pred CCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecc
Q 047157 104 FNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDS 140 (788)
Q Consensus 104 ~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqS 140 (788)
.++++.|.+++. ..+|+|+|+|||||++ ..+|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 888764443332 1468999999999997 689997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.34 E-value=2.8e-12 Score=113.44 Aligned_cols=88 Identities=31% Similarity=0.430 Sum_probs=68.0
Q ss_pred CcEEEEecCCceEEEeCCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEee
Q 047157 88 GSKITLTNDGKLLLTYFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSN 163 (788)
Q Consensus 88 ~s~l~l~~~G~L~l~~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~ 163 (788)
..+|.+..||||+|.+. +++.|..++. ..+++|+++|||||++ ++.++||||+
T Consensus 20 ~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~--------------------- 76 (112)
T 1xd5_A 20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT--------------------- 76 (112)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC---------------------
T ss_pred CEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc---------------------
Confidence 45899999999999886 5554443332 2478999999999999 8889999994
Q ss_pred cCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCcccc
Q 047157 164 SRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTL 205 (788)
Q Consensus 164 ~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~~~~ 205 (788)
||++|.|++.|+++|++.+ +......||.++++.+
T Consensus 77 -----~~~~g~~~l~l~~dGnlvl--~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -----NRQNGNYYLILQRDRNVVI--YDNSNNAIWATHTNVG 111 (112)
T ss_dssp -----CCSCCCCEEEECTTSCEEE--ECTTSCEEEECCCCCC
T ss_pred -----cCCCCCEEEEEeCCCcEEE--ECCCCceEEECCCccC
Confidence 3456899999999998655 3334457999988754
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.33 E-value=4e-12 Score=113.34 Aligned_cols=82 Identities=26% Similarity=0.359 Sum_probs=64.7
Q ss_pred cEEEEecCCceEEEeCCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEeec
Q 047157 89 SKITLTNDGKLLLTYFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNS 164 (788)
Q Consensus 89 s~l~l~~~G~L~l~~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~~ 164 (788)
.+|.+..||||+|.+. +++.|..++. ...++|+|+|||||+|.++.++||||.
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~~---------------------- 88 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV---------------------- 88 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCCC----------------------
Confidence 4788899999999886 5554443332 247899999999999999999999993
Q ss_pred CCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCc
Q 047157 165 RGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202 (788)
Q Consensus 165 ~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~ 202 (788)
||++|.|++.++++|++.++ . ..||.+++
T Consensus 89 ----~~~~g~~~l~l~~~Gnlvl~--~---~~~W~Sg~ 117 (119)
T 1b2p_A 89 ----AGKAGHYVLVLQPDRNVVIY--G---DALWATQT 117 (119)
T ss_dssp ----CCCSSCEEEEECTTSCEEEE--E---SEEEECCC
T ss_pred ----CCCCCCEEEEEECCCcEEEE--C---ccEeCCCC
Confidence 45679999999999986553 2 26998875
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.1e-11 Score=108.71 Aligned_cols=104 Identities=19% Similarity=0.314 Sum_probs=77.1
Q ss_pred CCCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEe
Q 047157 24 TSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTY 103 (788)
Q Consensus 24 ~~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~ 103 (788)
+.++|.+||.|..+ ++| .+|.|.|.|...++--. |.. +|.+|+..+ ..++.|+|..||||||.|
T Consensus 2 ~~dtL~~gq~L~~g--~~L--~~g~~~L~~q~dGNLvl-----~~~------~Wssnt~~~-~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 2 GTNYLLSGQTLDTE--GHL--KNGDFDLVMQDDCNLVL-----YNG------NWQSNTANN-GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCSEEETTCEECTT--CEE--EETTEEEEECTTSCEEE-----ETT------TEECCCTTS-CSSCEEEECTTSCEEEEC
T ss_pred ccCCcCCCCCcCCC--CEe--ECCCEEEEEecCCeEEE-----EeC------eEEcCCCCC-CCcEEEEEcCCCeEEEEe
Confidence 46789999999865 567 57999999865443212 332 699998765 345789999999999999
Q ss_pred CCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCCcccCC
Q 047157 104 FNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPG 151 (788)
Q Consensus 104 ~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg 151 (788)
.+++..|..++. ..+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 888765433332 2468999999999997 689998 555554
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.6e-11 Score=107.72 Aligned_cols=87 Identities=25% Similarity=0.370 Sum_probs=67.1
Q ss_pred CCcEEEEecCCceEEEeCCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEe
Q 047157 87 AGSKITLTNDGKLLLTYFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYS 162 (788)
Q Consensus 87 ~~s~l~l~~~G~L~l~~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s 162 (788)
....|.+..||||+|.+ .+++.|..++. ...++|+++|||||++.++.++|||||+|
T Consensus 20 g~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~------------------ 80 (115)
T 2dpf_A 20 GAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG------------------ 80 (115)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCC------------------
Confidence 34578888999999987 45554443332 24688999999999998889999999973
Q ss_pred ecCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCcccc
Q 047157 163 NSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTL 205 (788)
Q Consensus 163 ~~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~~~~ 205 (788)
++|.|++.++++|++.++ .. .||.+++|..
T Consensus 81 --------~~g~~~l~l~~dGnlvl~--~~---~~W~S~~~~~ 110 (115)
T 2dpf_A 81 --------DNGKYALVLQKDGRFVIY--GP---VLWSLGPNGC 110 (115)
T ss_dssp --------SSSCCEEEECTTSCEEEE--CS---EEECSSTTCB
T ss_pred --------CCCCEEEEEeCCCeEEEE--CC---CEEECCCCCC
Confidence 358899999999986653 22 6999988754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=2.5e-10 Score=117.74 Aligned_cols=140 Identities=16% Similarity=0.070 Sum_probs=107.5
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEec
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
+.+...++.|+.+.||++.. .+..+++|............+.+|+++++.+. |..++++++++.+.+..++|||+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~----~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVG----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp SEEEECCSCCSSSEEEEEEC----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ceeEeeccCCCCCeEEEEEC----CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 55567788888899998853 24589999886532222346788999998884 67888999999998999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcc----------------------------------------
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC---------------------------------------- 608 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------- 608 (788)
++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 92 i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999876421 1223468889999999999810
Q ss_pred ----------------CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 609 ----------------ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 609 ----------------~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
...++|+|++|.||+++ +...+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-----~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-----DGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-----TTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-----CCcEEEEEEchhcc
Confidence 13699999999999997 55556799998775
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.99 E-value=6.8e-10 Score=97.55 Aligned_cols=99 Identities=14% Similarity=0.258 Sum_probs=72.5
Q ss_pred CCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeC
Q 047157 25 SPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYF 104 (788)
Q Consensus 25 ~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~ 104 (788)
.++|.+||.|..+ ++| .+|.|.|-|...++ .-| |.. .. ||.+|+..+ ..++.+.|..+|||||.|.
T Consensus 2 ~~~l~~gq~L~~g--~~L--~~g~~~L~~q~dGn--Lvl---~~~---~~-vW~snt~~~-~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTD--NQL--SYESAAFVMQGDCN--LVL---YNE---AG-GFQSNTHGR-GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTT--CEE--EETTEEEEECTTSC--EEE---ECS---SC-CEECCCTTS-CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCC--CEE--ecCCEEEEEccCCe--EEE---ECC---CC-EEECCcccC-CcCEEEEEcCCCcEEEEeC
Confidence 4689999999865 566 37899999854432 222 443 23 999999876 3357899999999999998
Q ss_pred CCcE-EEEeccc------ccccccCCCCcEEEEecCCceeecc
Q 047157 105 NGSV-QQIYSGA------ASLALMQNDGNFVLKNANSAVVWDS 140 (788)
Q Consensus 105 ~~~~-~~~~s~~------~~~a~LldsGNlVl~~~~~~~lWqS 140 (788)
+++. .|.+.+. ..+++|+++|||||++ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 7754 4433321 2368999999999997 689997
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=6.5e-09 Score=106.89 Aligned_cols=109 Identities=16% Similarity=0.318 Sum_probs=80.2
Q ss_pred cCCCccCCCCc----eecCCCCeeecCCCeEEEeeeecC---CCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEec
Q 047157 23 QTSPNISLGSS----ITAGSNTSWLSPSGDFAFGFYSLF---GGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTN 95 (788)
Q Consensus 23 ~~~~~i~~~~~----l~~~~~~~~vS~~g~F~lGFf~~~---~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~ 95 (788)
..+||+.+|+. |..+ ++|+|+ ..++.|+|+.. .+..+| |++ ..+++|.+++..+-. ..+.+..
T Consensus 134 ~ptdtlLpg~~~~~~l~~g--~~L~S~-~dps~G~fsl~l~~dGnlvL---y~~--~~~~yW~Sgt~~~~~--~~l~l~~ 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPG--SELVQG-VVYGAGASKLVFQGDGNLVA---YGP--NGAATWNAGTQGKGA--VRAVFQG 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECSS--EEECTT-CEEEETTEEEEECTTSCEEE---ECT--TSSEEEECCCTTTTC--CEEEECT
T ss_pred ccccccccccccccccccC--cccccC-CCCCCceEEEeecCCceEEE---EeC--CCeEEEECCCCCCcc--EEEEEcC
Confidence 56788999998 7643 567664 57788877652 333443 332 268999999987632 6889999
Q ss_pred CCceEEEeCCCcEEEEeccc---ccccccCCCCcEEEEecCCceeecccCC
Q 047157 96 DGKLLLTYFNGSVQQIYSGA---ASLALMQNDGNFVLKNANSAVVWDSFDF 143 (788)
Q Consensus 96 ~G~L~l~~~~~~~~~~~s~~---~~~a~LldsGNlVl~~~~~~~lWqSFD~ 143 (788)
+|+|++.|.++...|...+. ...++|+++|||||++. +.+||||||
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 99999999877554433221 35789999999999986 689999997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.90 E-value=3.1e-09 Score=93.71 Aligned_cols=89 Identities=18% Similarity=0.312 Sum_probs=64.4
Q ss_pred CCCCC-CCcEEEEecCCceEEEeCC-CcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCcccc
Q 047157 82 DSPAE-AGSKITLTNDGKLLLTYFN-GSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLL 155 (788)
Q Consensus 82 ~~p~~-~~s~l~l~~~G~L~l~~~~-~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~ 155 (788)
+.|+. ....|.+..||||||.+.+ ++..|..++. ...++|+++|||||++.++.++|||-.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~------------ 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTV------------ 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCC------------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCc------------
Confidence 34443 3458999999999999873 6655544332 2468999999999999988999998321
Q ss_pred CCCeEEeecCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccC
Q 047157 156 TGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTG 201 (788)
Q Consensus 156 ~g~~l~s~~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~ 201 (788)
. ..|.|.+.++.+|++.++. ...|.++
T Consensus 86 -------------~-~~~~~~~~L~~dGnlvly~-----~~~W~s~ 112 (113)
T 3mez_B 86 -------------G-QEGDYVLILQINGQAVVYG-----PAVWSTA 112 (113)
T ss_dssp -------------C-SSSCCEEEECTTSCEEEEC-----SEEEESC
T ss_pred -------------C-CCCCEEEEEcCCceEEEec-----CCEecCC
Confidence 0 1256899999999988753 4578765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.85 E-value=2.9e-09 Score=109.39 Aligned_cols=128 Identities=16% Similarity=0.115 Sum_probs=94.1
Q ss_pred cccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccc--cceEeeEEecCCeEEEEEecCCCCCH
Q 047157 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN--LVRLLGFCSEEDKRLLVYELMPNGTL 574 (788)
Q Consensus 497 g~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lV~e~~~~gsL 574 (788)
+.|..+.||++.. .++..+++|..... ....+.+|+++++.+.+.+ +++++++...++..++||||++|.+|
T Consensus 29 ~gg~~~~v~~~~~---~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 29 IGCSDAAVFRLSA---QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp CTTSSCEEEEEEC---TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCCCceEEEEec---CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 4556699999854 34557899987543 2245678888888885434 56789988888889999999999888
Q ss_pred hHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcc----------------------------------------------
Q 047157 575 SNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC---------------------------------------------- 608 (788)
Q Consensus 575 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------------- 608 (788)
. .. ..+ ...++.++++.|..||+..
T Consensus 103 ~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 103 L--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp T--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred C--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 4 21 111 2357788888888888742
Q ss_pred ---------CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 609 ---------ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 609 ---------~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
...++|+|++|.||+++ ++..+.|+||+.+.
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~-----~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVE-----NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEE-----TTEEEEECCCTTCE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEE-----CCcEEEEEcchhcc
Confidence 12399999999999997 55566799999875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.80 E-value=1.1e-08 Score=89.91 Aligned_cols=84 Identities=21% Similarity=0.332 Sum_probs=62.2
Q ss_pred CcEEEEecCCceEEEeCCCcEEEEeccc----ccccccCCCCcEEEEecCCc-eeecccCCCCCcccCCccccCCCeEEe
Q 047157 88 GSKITLTNDGKLLLTYFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSA-VVWDSFDFPTDTILPGQVLLTGKKLYS 162 (788)
Q Consensus 88 ~s~l~l~~~G~L~l~~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~-~lWqSFD~PtDtllpg~~l~~g~~l~s 162 (788)
...|.+..||||||.+.++ .|..++. ...++|+++|||||++.++. ++|||.-+
T Consensus 21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------------- 79 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------------- 79 (111)
T ss_dssp TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-------------------
T ss_pred CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-------------------
Confidence 4589999999999998766 3333332 24688999999999998776 59999621
Q ss_pred ecCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCc
Q 047157 163 NSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202 (788)
Q Consensus 163 ~~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~ 202 (788)
.....|.|.+.++.+|++.++. +.+|.+++
T Consensus 80 -----~~~~~~~~~l~Lq~dGNlvly~-----~~~W~s~t 109 (111)
T 3mez_A 80 -----VNTVRGNYAATLGPDQHVTIYG-----PAIWSTPA 109 (111)
T ss_dssp -----CCCCSSCCEEEECTTSCEEEEC-----SEEEECCC
T ss_pred -----cCCCCcCEEEEECCCCeEEEec-----cCEEccCC
Confidence 0113478999999999988763 56898765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.78 E-value=1.9e-08 Score=108.73 Aligned_cols=142 Identities=14% Similarity=0.214 Sum_probs=103.2
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecc--cch-HHHHHHHHHHHHHhcCCC--ccccceEeeEEecC---CeEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLE--KDI-EKTNEEFMTELKIIGRTH--HKNLVRLLGFCSEE---DKRLLV 565 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~---~~~~lV 565 (788)
+.|+.|.++.||+.... + ..+++|+.. ... ......+.+|.++++.+. +..+++++.++.+. +..++|
T Consensus 44 ~~l~~G~sn~~y~v~~~---~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP---G-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EECCC-CCSCEEEEECS---S-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred EEcCCcccceEEEEEEC---C-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 57899999999987653 2 467788775 321 123456788999998886 45688999988776 458999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcc-------------------------------------
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC------------------------------------- 608 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------------------------------------- 608 (788)
|||++|..+.+.. -..++..++..++.++++.|+.||...
T Consensus 120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999998875422 134677888899999999999999731
Q ss_pred ------------------CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 609 ------------------ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 609 ------------------~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
...++|+|+++.|||++.++ ...+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~---~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE---PRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS---SCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC---CcEEEEECcccccc
Confidence 25799999999999998321 12368999998874
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=5.8e-08 Score=84.99 Aligned_cols=84 Identities=26% Similarity=0.355 Sum_probs=62.2
Q ss_pred CCcEEEEecCCceEEEeCCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEe
Q 047157 87 AGSKITLTNDGKLLLTYFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYS 162 (788)
Q Consensus 87 ~~s~l~l~~~G~L~l~~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s 162 (788)
....|.+..||||+|.+. +++.|..++. ...+.|+++|||||++.++.++|||....
T Consensus 19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------ 79 (109)
T 3dzw_A 19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------ 79 (109)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC------------------
Confidence 346899999999999886 5554443332 24679999999999999889999985211
Q ss_pred ecCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCc
Q 047157 163 NSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202 (788)
Q Consensus 163 ~~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~ 202 (788)
..+.|.+.++.+|++.++. ...|.+++
T Consensus 80 --------~~~~~~~~L~ddGNlvly~-----~~~W~s~t 106 (109)
T 3dzw_A 80 --------ENGNYVCVLQKDRNVVIYG-----TARWATGT 106 (109)
T ss_dssp --------SSSCEEEEECTTSCEEEEE-----SCCCCCCC
T ss_pred --------CCCCEEEEEeCCCEEEEEC-----CCEEeCCC
Confidence 1256889999999988653 25787765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.63 E-value=8.8e-09 Score=108.60 Aligned_cols=184 Identities=17% Similarity=0.208 Sum_probs=120.4
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCC-Cccc--cceEeeEEecCC---eEEEEEe
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRT-HHKN--LVRLLGFCSEED---KRLLVYE 567 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~hpn--iv~~~~~~~~~~---~~~lV~e 567 (788)
+.++.|....||+.. ..+++|..... .....+.+|.++++.+ .+.. +.+++......+ ..|+|||
T Consensus 26 ~~~~~G~~n~v~~v~-------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST-------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC-------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 457889999999751 35778876532 3456788999999877 3332 455655544333 3488999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE---------------------------------------- 607 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------------------------------------- 607 (788)
+++|.+|.+... ..++..++..++.++++.|+.||..
T Consensus 97 ~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 97 KIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred ccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 999988875432 2456777788888999999888861
Q ss_pred ---------------cCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccc---cCcccc
Q 047157 608 ---------------CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY---VAPEWL 669 (788)
Q Consensus 608 ---------------~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y---~aPE~~ 669 (788)
..+.++|+|++|.||+++.+ ....+.|+||+.+........... .... ..|+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~---~~~~~~~iD~~~~~~~~~~~Dl~~-----~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE---KNTICGIIDFGDAAISDPDNDFIS-----LMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT---TTEEEEECCCTTCEEECTTHHHHT-----TCCTTTSCCHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCC---CCCEEEEEeCCCCccCChHHHHHH-----HHhhccccCHHHH
Confidence 11458999999999999821 145688999998875422111000 0011 222221
Q ss_pred cC-----CC---------CCccCcchhhHHHHHHHHhCCCCC
Q 047157 670 RN-----VP---------VTTKVDVFSFGVMLLEIICGRRHI 697 (788)
Q Consensus 670 ~~-----~~---------~s~k~DVwSlGvil~elltg~~p~ 697 (788)
.. .. .....+.|+++.++|.+.+|..+|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 10 00 112258999999999999998765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.61 E-value=9e-08 Score=83.78 Aligned_cols=81 Identities=20% Similarity=0.329 Sum_probs=59.4
Q ss_pred CcEEEEecCCceEEEeCCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEee
Q 047157 88 GSKITLTNDGKLLLTYFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSN 163 (788)
Q Consensus 88 ~s~l~l~~~G~L~l~~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~ 163 (788)
+..|.+..||||+|.+. +..|..++. ...++|+++|||||++.++.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~------------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS------------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC-------------------
Confidence 46889999999999875 343433332 13688999999999999899999994210
Q ss_pred cCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccC
Q 047157 164 SRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTG 201 (788)
Q Consensus 164 ~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~ 201 (788)
..|.|.+.++.+|++.++. +..|.++
T Consensus 84 -------~~~~~~~~L~~dGNlvly~-----~~~W~t~ 109 (110)
T 3r0e_B 84 -------KQGEYVLILQDDGFGVIYG-----PAIFETS 109 (110)
T ss_dssp -------SSSCCEEEECTTSCEEEEC-----SEEEESC
T ss_pred -------CCCCEEEEEcCCccEEEec-----CCEecCC
Confidence 1356889999999988753 3567765
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.38 E-value=1e-06 Score=76.93 Aligned_cols=94 Identities=27% Similarity=0.415 Sum_probs=67.7
Q ss_pred CCcccCCccccCCCeEEeecCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCcccc-cceeeeeccceeEEEEec
Q 047157 145 TDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTL-NNVSLIFNQSAFMYLINS 223 (788)
Q Consensus 145 tDtllpg~~l~~g~~l~s~~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~~~~-~~~~~~~~~~~~~~~~~~ 223 (788)
+|||+|||.|..|..|. .|.|.|.|+.+|++.++. .||.+.+... .+..+.+..++.+++++.
T Consensus 3 ~dtL~~gq~L~~g~~L~----------~g~~~L~~q~dGNLvl~~------~~Wssnt~~~~~~~~l~l~~dGnLvl~d~ 66 (109)
T 3r0e_A 3 TNYLLSGQTLDTEGHLK----------NGDFDLVMQDDCNLVLYN------GNWQSNTANNGRDCKLTLTDYGELVIKNG 66 (109)
T ss_dssp CSEEETTCEECTTCEEE----------ETTEEEEECTTSCEEEET------TTEECCCTTSCSSCEEEECTTSCEEEECT
T ss_pred cCCcCCCCCcCCCCEeE----------CCCEEEEEecCCeEEEEe------CeEEcCCCCCCCcEEEEEcCCCeEEEEeC
Confidence 69999999999999882 399999999999988742 3898766532 235567777888888766
Q ss_pred CCcceEEEEeeccCCCCceEEEEEEeCCccEEEEE
Q 047157 224 TGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQFA 258 (788)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~rl~ld~~G~l~~~~ 258 (788)
++..+. ... ........|++|+.||++++|.
T Consensus 67 ~~~~vW--ss~--t~~~~~~~~~~L~~dGNlvly~ 97 (109)
T 3r0e_A 67 DGSTVW--KSG--AQSVKGNYAAVVHPDGRLVVFG 97 (109)
T ss_dssp TSCEEE--ECC--CCCSSSCCEEEEETTTEEEEEC
T ss_pred CCCEEE--cCC--CcCCCcCEEEEEcCCCeEEEEe
Confidence 554222 111 1112335689999999999984
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.37 E-value=1.3e-06 Score=87.90 Aligned_cols=74 Identities=27% Similarity=0.345 Sum_probs=54.7
Q ss_pred CcEEEEecCCceEEEeCCCcEEEEeccc---ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEeec
Q 047157 88 GSKITLTNDGKLLLTYFNGSVQQIYSGA---ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNS 164 (788)
Q Consensus 88 ~s~l~l~~~G~L~l~~~~~~~~~~~s~~---~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~~ 164 (788)
..+|.+..+|||+|.+. ++++|..++. ...+.|.++|||||+|.++.++|+|+++.
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~-------------------- 85 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG-------------------- 85 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC--------------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc--------------------
Confidence 34677777899998875 5555544442 34788999999999999999999998641
Q ss_pred CCCCCCCCCceEEeeccCCcceee
Q 047157 165 RGTADYSTGNYTLEMQADGNLVLS 188 (788)
Q Consensus 165 ~~~~dps~G~~~~~~~~~g~~~~~ 188 (788)
++|.|.+.|+.+|+++++
T Consensus 86 ------~~~~~~~~l~d~Gnlvl~ 103 (236)
T 1dlp_A 86 ------SIGNYVLVLQPDRTVTIY 103 (236)
T ss_dssp ------CSSCCEEEECSSSCEEEE
T ss_pred ------cCCcEEEEEeCCCCEEEe
Confidence 135677788888887664
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.22 E-value=4.5e-06 Score=72.16 Aligned_cols=73 Identities=27% Similarity=0.497 Sum_probs=55.2
Q ss_pred cEEEEecCCceEEEeCCCcEEEEeccc-----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEee
Q 047157 89 SKITLTNDGKLLLTYFNGSVQQIYSGA-----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSN 163 (788)
Q Consensus 89 s~l~l~~~G~L~l~~~~~~~~~~~s~~-----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~ 163 (788)
-+|.+-.||||||.+. +++.|.+++. ...+.|.++|||||.|.++.++|+|-.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t--------------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS--------------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC---------------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC---------------------
Confidence 4788889999999974 4455544442 245789999999999999999998721
Q ss_pred cCCCCCCCCCceEEeeccCCcceee
Q 047157 164 SRGTADYSTGNYTLEMQADGNLVLS 188 (788)
Q Consensus 164 ~~~~~dps~G~~~~~~~~~g~~~~~ 188 (788)
....|.+.+.|+.+|++.++
T Consensus 79 -----~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 -----TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp -----CCCSSCEEEEECTTSCEEEE
T ss_pred -----CCCCCCEEEEEeCCCeEEEE
Confidence 01246788999999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=9e-06 Score=83.67 Aligned_cols=134 Identities=19% Similarity=0.179 Sum_probs=95.3
Q ss_pred ccccccc-eEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEecCCCCC
Q 047157 496 VGTGSSG-KVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYELMPNGT 573 (788)
Q Consensus 496 lg~G~~g-~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~~~~gs 573 (788)
+..|..+ .||+.... ..+..+.+|.-... ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus 32 ~~~G~S~~~v~rl~~~--~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGK--PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECC--TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEec--CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 4445444 68876543 45557888876543 3456778888887773 4447889999999999999999999988
Q ss_pred HhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcc---------------------------------------------
Q 047157 574 LSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC--------------------------------------------- 608 (788)
Q Consensus 574 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------------- 608 (788)
+.+..... ......+..++++.|..||...
T Consensus 107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 87765321 1223456677777777777521
Q ss_pred ----------CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 609 ----------ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 609 ----------~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
.+.++|+|+.+.||+++ +...+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~-----~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFD-----EGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEE-----TTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEE-----CCeEEEEEECcccc
Confidence 12379999999999998 55667799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=2.4e-05 Score=82.10 Aligned_cols=138 Identities=15% Similarity=0.163 Sum_probs=94.0
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcc---ccceEeeEEe-cCCeEEEEEecC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHK---NLVRLLGFCS-EEDKRLLVYELM 569 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~-~~~~~~lV~e~~ 569 (788)
+.++.|....||+. +..+++|.... ......+.+|.++|+.+.+. .+.+++.+.. ..+..++|||++
T Consensus 25 ~~l~~G~~n~v~~v-------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE-------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eecCCCcceeEEEE-------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 45778888899976 23577777532 33456788999999988642 3667777764 455678999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE------------------------------------------ 607 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~------------------------------------------ 607 (788)
+|.+|.+... ..++..+...++.++++.|+.||+.
T Consensus 96 ~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 96 QGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 9988876321 1234455556666666666666642
Q ss_pred ---------------cCCceEecCCCCCcEEeccCCCCCCCc-EEEeecCCccc
Q 047157 608 ---------------CETQIIHCDIKPQNVLLDLKTLDTNYM-AKISDFGISKL 645 (788)
Q Consensus 608 ---------------~~~~ivH~dlkp~NIll~~~~~~~~~~-~kL~Dfg~a~~ 645 (788)
..+.++|+|++|.||+++... .++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~--~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS--RQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC--SSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC--CCCceEEEEehhhcCC
Confidence 223579999999999998311 1344 58999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=2e-05 Score=84.60 Aligned_cols=83 Identities=10% Similarity=0.028 Sum_probs=54.5
Q ss_pred ccc-cccccceEEEEEEec--cC--cceeeeeeecccch---HHHHHHHHHHHHHhcCCC-c--cccceEeeEEecC---
Q 047157 494 KLV-GTGSSGKVYRGILRL--KD--TQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTH-H--KNLVRLLGFCSEE--- 559 (788)
Q Consensus 494 ~~l-g~G~~g~Vy~~~~~~--~~--~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~--- 559 (788)
+.| +.|....+|+..... ++ .+..+++|...... ......+.+|..+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 788889999876520 00 14578888765432 001245678888888774 3 3577888887665
Q ss_pred CeEEEEEecCCCCCHhH
Q 047157 560 DKRLLVYELMPNGTLSN 576 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~ 576 (788)
...++|||+++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00013 Score=79.43 Aligned_cols=75 Identities=13% Similarity=0.097 Sum_probs=47.3
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchH-------HHHHHHHHHHHHhcCCC---ccccceEeeEEecCCeEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE-------KTNEEFMTELKIIGRTH---HKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~ 563 (788)
+.||.|..+.||++... ..+..++||....... ....++..|.++++.+. ...+++++.+ +.+..+
T Consensus 36 ~~lg~G~~n~vyrv~~~--~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQ--EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EECCSSSSEEEEEEEC------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EECCCCceEEEEEEEEC--CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 57899999999998654 3345788997542211 12235667888887663 2345566654 344568
Q ss_pred EEEecCCCC
Q 047157 564 LVYELMPNG 572 (788)
Q Consensus 564 lV~e~~~~g 572 (788)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00094 Score=70.81 Aligned_cols=138 Identities=14% Similarity=0.153 Sum_probs=76.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCc--cccceEee------EEecCCeEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHH--KNLVRLLG------FCSEEDKRLLV 565 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~------~~~~~~~~~lV 565 (788)
+.|+.|....||+... .++ .+++|+..... ..+..|.++++.|.. -.+++++. +....+..++|
T Consensus 38 ~~l~gG~~n~~~~v~~---~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT---DSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EECC----CEEEEEEE---TTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeccccccCcEEEEEe---CCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 3466677889998865 334 58888886532 223344454444421 12333332 12346678999
Q ss_pred EecCCCCCHh-----------Hhh---hc--cCC-----------CCCHHHH----------------------------
Q 047157 566 YELMPNGTLS-----------NFL---FH--EGQ-----------RPGWVQR---------------------------- 590 (788)
Q Consensus 566 ~e~~~~gsL~-----------~~l---~~--~~~-----------~~~~~~~---------------------------- 590 (788)
|||++|..+. ..| +. ... ...|...
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986542 111 11 000 0123211
Q ss_pred ---HHHHHHHHHHHHHhhh----------ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 591 ---VEIALGVARGLLYLHE----------ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 591 ---~~i~~qi~~aL~~LH~----------~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
..+..++..++.+|+. .....++|+|+++.|||++ .+..+.|+||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~-----~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLG-----ENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEEC-----GGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEe-----CCCcEEEEehhhcc
Confidence 0111223446666763 1345899999999999997 55689999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0047 Score=64.47 Aligned_cols=74 Identities=14% Similarity=0.126 Sum_probs=57.5
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC---ccccceEeeEEecCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH---HKNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
+.|+.|....+|+... .+..+++|..... ....+..|.+.|+.|. ...+++++.+....+..++|||+++
T Consensus 42 ~~l~gG~~n~~y~v~~----~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND----EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEECCSSSSEEEEEES----SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred EEeCCccceeeeEEEE----CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 4688999999998753 3447888876543 2456788988888774 3668899999888889999999999
Q ss_pred CCCH
Q 047157 571 NGTL 574 (788)
Q Consensus 571 ~gsL 574 (788)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0025 Score=69.91 Aligned_cols=79 Identities=10% Similarity=-0.009 Sum_probs=46.0
Q ss_pred CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCC---CCCccCcchhhHH
Q 047157 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV---PVTTKVDVFSFGV 685 (788)
Q Consensus 609 ~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwSlGv 685 (788)
...++|+|++|.|||++ .+. ++|+||+.+..-.........-..-...|.+|+..... .-....++.+...
T Consensus 231 ~~~liHGDl~~~Nil~~-----~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVT-----QDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIE 304 (420)
T ss_dssp CCEEECSCCSGGGEEEC-----SSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEe-----CCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHH
Confidence 45899999999999997 443 99999998875322111100000001245666554311 1112345567777
Q ss_pred HHHHHHhC
Q 047157 686 MLLEIICG 693 (788)
Q Consensus 686 il~elltg 693 (788)
.+|+...+
T Consensus 305 ~~~~~y~~ 312 (420)
T 2pyw_A 305 QTWNLFNK 312 (420)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 78877654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0019 Score=66.86 Aligned_cols=74 Identities=19% Similarity=0.166 Sum_probs=51.6
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-c--cccceEeeEEecCCeEEEEEecCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-H--KNLVRLLGFCSEEDKRLLVYELMP 570 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~~~~~lV~e~~~ 570 (788)
+.+|.|..+.||+... .++..+.+|+...........|..|.+.|+.|. . --+++++++. ..++|||+++
T Consensus 21 ~~~g~G~~~~vyrv~l---~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~ 93 (288)
T 3f7w_A 21 AERGHSHRWHLYRVEL---ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD 93 (288)
T ss_dssp EEEEEETTEEEEEEEE---TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred EecCCCCCeEEEEEEE---CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence 5689999999999987 456689999875443333445778888887773 2 2355666542 2378999988
Q ss_pred CCCH
Q 047157 571 NGTL 574 (788)
Q Consensus 571 ~gsL 574 (788)
.+..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.44 E-value=0.019 Score=55.60 Aligned_cols=104 Identities=12% Similarity=-0.031 Sum_probs=68.2
Q ss_pred CCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCC
Q 047157 571 NGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650 (788)
Q Consensus 571 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~ 650 (788)
.-+|.+.|...+.+++++++|.++.|.+.+|.-+-.+. .-..+=+.|..|++. .+|.|.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~-----~dG~V~f~~-~~s~------ 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVW-----RDGAVTLAP-AADD------ 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEE-----TTSCEEECC-C---------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEe-----cCCceeccc-cccc------
Confidence 34899999999999999999999999999987762210 111333456888887 777777654 1110
Q ss_pred CcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCC
Q 047157 651 TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696 (788)
Q Consensus 651 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p 696 (788)
.....+.|||... ...+.+.=|||||++||.-+--..|
T Consensus 98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123577888763 3456788999999999999865443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0058 Score=65.63 Aligned_cols=146 Identities=16% Similarity=0.140 Sum_probs=80.3
Q ss_pred ccccccccceEEEEEEec-----cCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEe
Q 047157 494 KLVGTGSSGKVYRGILRL-----KDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e 567 (788)
+.|..|-...+|+..... ...+..+.+|+.... ......+.+|.++++.+. +.-..++++++.++ +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 456667788889876531 112357888876332 223445668988888774 33346777776542 9999
Q ss_pred cCCCCCHhHh--------------h---hcc----CCCCC--HHHHHHHHHHHHH-------------------HHHHhh
Q 047157 568 LMPNGTLSNF--------------L---FHE----GQRPG--WVQRVEIALGVAR-------------------GLLYLH 605 (788)
Q Consensus 568 ~~~~gsL~~~--------------l---~~~----~~~~~--~~~~~~i~~qi~~-------------------aL~~LH 605 (788)
|++|.+|..- | +.. ++... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9987655311 1 111 11222 3444444443321 123332
Q ss_pred hc-----cCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 606 EE-----CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 606 ~~-----~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+. ....++|+|+.+.||+++.+. .....+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~-~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEP-ENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC----CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCC-CccCcEEEEecccCCc
Confidence 21 234789999999999998321 0136899999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0046 Score=67.84 Aligned_cols=75 Identities=16% Similarity=0.173 Sum_probs=47.8
Q ss_pred ccccccccceEEEEEEecc-----CcceeeeeeecccchHHHHHHHHHHHHHhcCCCccc-cceEeeEEecCCeEEEEEe
Q 047157 494 KLVGTGSSGKVYRGILRLK-----DTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN-LVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lV~e 567 (788)
+.|+.|....+|+...... ..+..+++|+.... .....+..|..+++.+...+ .+++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 4677788899999876421 12357888887431 11134557888888775333 3677776543 28999
Q ss_pred cCCCCCH
Q 047157 568 LMPNGTL 574 (788)
Q Consensus 568 ~~~~gsL 574 (788)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0067 Score=63.61 Aligned_cols=140 Identities=14% Similarity=0.153 Sum_probs=74.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccc--cceEeeE------EecCCeEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN--LVRLLGF------CSEEDKRLLV 565 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~------~~~~~~~~lV 565 (788)
+.|+.|....+|+.... ++ .+++|...... ..+.+..|+.++..+.... +++++.. ....+..+++
T Consensus 28 ~~i~~G~~n~~~~v~~~---~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT---KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEECC---EEEEEEEES---SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eccCCCcccceEEEEeC---Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 45677888899988653 33 67788776521 1234456666666553211 3333321 1234567899
Q ss_pred EecCCCCCHhH-----------h---hhcc----CCC----C---CHHHHHH------------HHHHHHHHHHHhhhc-
Q 047157 566 YELMPNGTLSN-----------F---LFHE----GQR----P---GWVQRVE------------IALGVARGLLYLHEE- 607 (788)
Q Consensus 566 ~e~~~~gsL~~-----------~---l~~~----~~~----~---~~~~~~~------------i~~qi~~aL~~LH~~- 607 (788)
+++++|..+.. . ++.. ... . .|...+. +...+.+.+..++..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99998865421 0 1110 000 1 1222110 001134445555432
Q ss_pred ---cCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 608 ---CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 608 ---~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
....++|+|+++.|||++ ++..+.|+||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~-----~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFL-----GDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEE-----TTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEe-----CCceEEEecchhcc
Confidence 234799999999999997 55455799998775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0077 Score=62.55 Aligned_cols=70 Identities=13% Similarity=0.086 Sum_probs=41.2
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcccc-ceEeeEEecCCeEEEEEecC-CC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL-VRLLGFCSEEDKRLLVYELM-PN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lV~e~~-~~ 571 (788)
+.|+.|....+|+. ..+++|........ .....+|..+++.+....+ .+++++. .+.-++|+||+ ++
T Consensus 24 ~~l~gG~tN~~~~~--------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 24 LERLGGLTNLVFRA--------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp EEEESCSSEEEEEE--------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eEcCCcccccccee--------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 56788888999987 25777776543211 1122457777766642222 5666543 33457899999 66
Q ss_pred CCH
Q 047157 572 GTL 574 (788)
Q Consensus 572 gsL 574 (788)
.+|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.74 E-value=0.019 Score=61.54 Aligned_cols=76 Identities=12% Similarity=0.166 Sum_probs=42.4
Q ss_pred ccccccccceEEEEEEeccC------cceeeeeeecccchHHHHHHHHHHHHHhcCCCccc-cceEeeEEecCCeEEEEE
Q 047157 494 KLVGTGSSGKVYRGILRLKD------TQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKN-LVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lV~ 566 (788)
+.|+.|....+|+....... .+..+++|+........ .....|.++++.+...+ .+++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 45677888899988764100 12477888765432211 12356777777764333 45676554 2 26899
Q ss_pred ecCCCCCH
Q 047157 567 ELMPNGTL 574 (788)
Q Consensus 567 e~~~~gsL 574 (788)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.03 Score=58.98 Aligned_cols=36 Identities=25% Similarity=0.243 Sum_probs=27.3
Q ss_pred CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 609 ~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
...++|+|+.+.||+++.+.. ....+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~-~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPERE-GLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSC-GGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcC-CCCCeEEEeCCCcCc
Confidence 358999999999999973110 025789999998875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.021 Score=62.99 Aligned_cols=74 Identities=15% Similarity=0.130 Sum_probs=44.7
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcccc-ceEeeEEecCCeEEEEEecCCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL-VRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lV~e~~~~g 572 (788)
+.|+.|-...+|+.... +.+..+++|+........ -....|..++..|...++ +++++.+. + .+|+||++|.
T Consensus 114 ~~lsgG~tN~~y~v~~~--~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 114 QIINGGITNILIKVKDM--SKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEECC--CEEEEEEEET--TTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEcCCCeEeEEEEEEEC--CCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 56778888999998763 223578888764322111 112478888887754444 67777763 2 2599999875
Q ss_pred CH
Q 047157 573 TL 574 (788)
Q Consensus 573 sL 574 (788)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.62 E-value=0.024 Score=59.48 Aligned_cols=75 Identities=11% Similarity=0.125 Sum_probs=43.9
Q ss_pred cccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcc--ccceEeeE-----EecCCeEEEEEe
Q 047157 495 LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHK--NLVRLLGF-----CSEEDKRLLVYE 567 (788)
Q Consensus 495 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~-----~~~~~~~~lV~e 567 (788)
.++ |....||+... .++..+++|...... .....+..|..++..+... .+++++.. ....+..++|+|
T Consensus 33 ~l~-g~~n~~y~v~~---~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD---EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEC-CSSSEEEEECC---TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred eec-CcccceEEEEc---CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 455 77788997643 234478889875321 1234555677776665321 23444432 223456688999
Q ss_pred cCCCCCH
Q 047157 568 LMPNGTL 574 (788)
Q Consensus 568 ~~~~gsL 574 (788)
+++|..+
T Consensus 108 ~i~G~~~ 114 (328)
T 1zyl_A 108 SVGGRQF 114 (328)
T ss_dssp CCCCEEC
T ss_pred ecCCCCC
Confidence 9987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.26 E-value=0.18 Score=53.17 Aligned_cols=32 Identities=28% Similarity=0.341 Sum_probs=27.0
Q ss_pred CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 609 ~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
...++|+|+.+.||+++ +++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~-----~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVG-----NEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEEC-----GGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEe-----CCCeEEEEECCCCee
Confidence 35799999999999997 556799999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.51 E-value=0.16 Score=55.20 Aligned_cols=76 Identities=12% Similarity=0.084 Sum_probs=45.1
Q ss_pred ccccccccceEEEEEEeccCc-----ceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEe
Q 047157 494 KLVGTGSSGKVYRGILRLKDT-----QIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e 567 (788)
+.|..|-...+|+........ +..+++|+....... .-...+|.++++.+. +.-..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 456677788899887642111 357888876443211 112346777777764 333456665442 278999
Q ss_pred cCCCCCH
Q 047157 568 LMPNGTL 574 (788)
Q Consensus 568 ~~~~gsL 574 (788)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.92 E-value=1.8 Score=41.68 Aligned_cols=115 Identities=9% Similarity=0.150 Sum_probs=79.6
Q ss_pred CccccceEeeEEecCCeEEEEEecCCCC-CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEE
Q 047157 545 HHKNLVRLLGFCSEEDKRLLVYELMPNG-TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVL 623 (788)
Q Consensus 545 ~hpniv~~~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 623 (788)
.||+++.. .+-.+++...+.|+.-+.+ ++.. + +..+...+++++.+|+....+++.+ +|--|+|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEE
Confidence 68888876 5666777777777765422 3332 3 4567889999999999988777654 78899999999
Q ss_pred eccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCC
Q 047157 624 LDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIE 698 (788)
Q Consensus 624 l~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~ 698 (788)
++ .++.+++.--|+-..+ +|.- .+...=.-.+=+++..++.++..|+
T Consensus 112 f~-----~~~~p~i~~RGik~~l------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FT-----RDGLPIAKTRGLQNVV------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EC-----TTSCEEESCCEETTTB------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred Ec-----CCCCEEEEEccCccCC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99 8889999876654332 2221 1111112245678888999988875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.62 E-value=3 Score=40.26 Aligned_cols=115 Identities=10% Similarity=0.123 Sum_probs=77.6
Q ss_pred CccccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHH-HhhhccCCceEecCCCCCcEE
Q 047157 545 HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLL-YLHEECETQIIHCDIKPQNVL 623 (788)
Q Consensus 545 ~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~-~LH~~~~~~ivH~dlkp~NIl 623 (788)
.||++ -..+-.+++...+.++.-+++.=...+ +..+...+++++.+|+.... +++.+ +|--|+|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEE
Confidence 57887 344457778888888876443322233 45788899999999998888 77654 78899999999
Q ss_pred eccCCCCCCCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCC
Q 047157 624 LDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIE 698 (788)
Q Consensus 624 l~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~ 698 (788)
++ .++.+++.-.|+-.. ++|.-+.. .-=.-++=+++..++.++..|+
T Consensus 117 f~-----~~~~p~i~hRGi~~~------------------lpP~e~~e-----e~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FN-----RALEPFFLHVGVKES------------------LPPDEWDD-----ERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EC-----TTCCEEESCCEETTT------------------BSSCSCCH-----HHHHHHHHHHHHHHTTCSSCHH
T ss_pred Ee-----CCCcEEEEEcCCccc------------------CCCCCCCH-----HHHHHHHHHHHHHHHcCCCCHH
Confidence 98 888999987665433 33332111 1112245567778888877764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.76 E-value=0.55 Score=50.61 Aligned_cols=35 Identities=23% Similarity=0.185 Sum_probs=26.4
Q ss_pred ceEecCCCCCcEEeccCCC-CCCCcEEEeecCCccc
Q 047157 611 QIIHCDIKPQNVLLDLKTL-DTNYMAKISDFGISKL 645 (788)
Q Consensus 611 ~ivH~dlkp~NIll~~~~~-~~~~~~kL~Dfg~a~~ 645 (788)
.++|+|+.+.|||+..... .+...++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 4679999999999953211 1456799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 788 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-17 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-16 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-10 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 5e-16 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-11 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-05 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 5e-11 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 6e-10 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-09 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-07 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-08 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 6e-08 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-64
Identities = 62/303 (20%), Positives = 131/303 (43%), Gaps = 42/303 (13%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
EI + T + +G+GS G VY+G + + + + + +
Sbjct: 4 EIPDGQITVGQR----------IGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQA 50
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEI 593
F E+ ++ +T H N++ +G+ + +V + +L + L + ++ ++I
Sbjct: 51 FKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 109
Query: 594 ALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ-TR 652
A A+G+ YLH + IIH D+K N+ L + KI DFG++ + ++ +
Sbjct: 110 ARQTAQGMDYLHAKS---IIHRDLKSNNIF-----LHEDLTVKIGDFGLATVKSRWSGSH 161
Query: 653 TDTNMRGTMGYVAPEWLR---NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEV 709
+ G++ ++APE +R P + + DV++FG++L E++ G+ ++
Sbjct: 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---- 217
Query: 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769
+ V LS +L + S+ P+ + L C + RP +++
Sbjct: 218 ---IIFMVGRGYLSPDLSKVRSNCPKAMKRL---------MAECLKKKRDERPLFPQILA 265
Query: 770 MLE 772
+E
Sbjct: 266 SIE 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 1e-62
Identities = 73/329 (22%), Positives = 149/329 (45%), Gaps = 54/329 (16%)
Query: 465 RNYFDPNSMEINFREFTFQELQEATKGFS-----------KLVGTGSSGKVYRGILRL-K 512
+ + DP FTF++ EA + F+ +++G G G+V G L+L
Sbjct: 1 KIFIDP---------FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG 51
Query: 513 DTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPN 571
+I +A+K L+ EK +F++E I+G+ H N++ L G ++ +++ E M N
Sbjct: 52 KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN 111
Query: 572 GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT 631
G+L +FL + +Q V + G+A G+ YL + +H D+ +N+L +++
Sbjct: 112 GSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNIL-----VNS 163
Query: 632 NYMAKISDFGISKLLNKDQT----RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVML 687
N + K+SDFG+S+ L D + + + + + APE ++ T+ DV+S+G+++
Sbjct: 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223
Query: 688 LEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMA 747
E++ ++ + + D + ++ +
Sbjct: 224 WEVMSYGERPYWDMTNQD--------------------VINAIEQDYRLPPPMDCPSALH 263
Query: 748 MVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776
+ L C D N RP ++++ L+ +
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 5e-62
Identities = 68/287 (23%), Positives = 128/287 (44%), Gaps = 32/287 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVR 551
F + +G+G G V+ G + ++A+K + + + E+F+ E +++ + H LV+
Sbjct: 9 FVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
L G C E+ LV+E M +G LS++L + + + L V G+ YL E C
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
+IH D+ +N L + N + K+SDFG+++ + DQ + T + + + +PE
Sbjct: 122 VIHRDLAARNCL-----VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 672 VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVS 731
++K DV+SFGV++ E+ + +R E ++
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------------VVEDISTGFRL 221
Query: 732 HDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVG 778
+ P + S + + C P RP+ +++ L E G
Sbjct: 222 YKPRLAS-----THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-61
Identities = 64/300 (21%), Positives = 122/300 (40%), Gaps = 44/300 (14%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
E+ E +G G G+V+ G ++AVK L++ + +
Sbjct: 9 EVPRETLKLVER----------LGAGQFGEVWMGYYN---GHTKVAVKSLKQG-SMSPDA 54
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLF-HEGQRPGWVQRVE 592
F+ E ++ + H+ LVRL ++ ++ E M NG+L +FL G + + ++
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
+A +A G+ ++ E IH D++ N+L+ KI+DFG+++L+ ++
Sbjct: 114 MAAQIAEGMAFIEERN---YIHRDLRAANILVS-----DTLSCKIADFGLARLIEDNEYT 165
Query: 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712
+ + + APE + T K DV+SFG++L EI+ R E
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 218
Query: 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
++ + P+ E + + C P RP+ + +LE
Sbjct: 219 --------VIQNLERGYRMVRPDNCP-----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 7e-61
Identities = 69/298 (23%), Positives = 129/298 (43%), Gaps = 42/298 (14%)
Query: 475 INFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEF 534
I+ ++ TF K +GTG G V G R Q ++A+K +++ + +EF
Sbjct: 1 IDPKDLTFL----------KELGTGQFGVVKYGKWR---GQYDVAIKMIKEG-SMSEDEF 46
Query: 535 MTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIA 594
+ E K++ H+ LV+L G C+++ ++ E M NG L N+L R Q +E+
Sbjct: 47 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106
Query: 595 LGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD 654
V + YL + +H D+ +N L ++ + K+SDFG+S+ + D+ +
Sbjct: 107 KDVCEAMEYLESKQ---FLHRDLAARNCL-----VNDQGVVKVSDFGLSRYVLDDEYTSS 158
Query: 655 TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714
+ + + PE L ++K D+++FGV++ EI + E
Sbjct: 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------- 209
Query: 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
Q L + P + S E++ + C H + RP+ K ++ +
Sbjct: 210 ------TAEHIAQGLRLYRPHLAS-----EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 5e-58
Identities = 73/304 (24%), Positives = 132/304 (43%), Gaps = 42/304 (13%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
E+ + T + +G G G+VY G K + +AVK L++D EE
Sbjct: 13 EMERTDITMKHK----------LGGGQYGEVYEG--VWKKYSLTVAVKTLKED-TMEVEE 59
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRP-GWVQRVE 592
F+ E ++ H NLV+LLG C+ E ++ E M G L ++L ++ V +
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
+A ++ + YL ++ IH D+ +N L+ N++ K++DFG+S+L+ D
Sbjct: 120 MATQISSAMEYLEKKN---FIHRDLAARNCLVG-----ENHLVKVADFGLSRLMTGDTYT 171
Query: 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712
+ + + APE L + K DV++FGV+L EI + S+ +++
Sbjct: 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVYELL 229
Query: 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
D+ + PE E++ + C +P+ RPS ++ E
Sbjct: 230 EKDYRMER-------------PEGCP-----EKVYELMRACWQWNPSDRPSFAEIHQAFE 271
Query: 773 GTLE 776
+
Sbjct: 272 TMFQ 275
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 9e-58
Identities = 78/301 (25%), Positives = 126/301 (41%), Gaps = 50/301 (16%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
+N +E + +G G G V G R ++AVK ++ D T +
Sbjct: 3 ALNMKELKLLQT----------IGKGEFGDVMLGDYR----GNKVAVKCIKND--ATAQA 46
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHEGQRP-GWVQRV 591
F+ E ++ + H NLV+LLG EE L +V E M G+L ++L G+ G +
Sbjct: 47 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 106
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651
+ +L V + YL +H D+ +NVL+ + +AK+SDFG++K + Q
Sbjct: 107 KFSLDVCEAMEYLEGNN---FVHRDLAARNVLVS-----EDNVAKVSDFGLTKEASSTQD 158
Query: 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI 711
+ + + APE LR +TK DV+SFG++L EI R D+
Sbjct: 159 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-----YPRIPLKDV 209
Query: 712 VLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771
V +V + + + V C H D +RPS ++ L
Sbjct: 210 V-------------PRVEKGYKMDAPDGCP--PAVYEVMKNCWHLDAAMRPSFLQLREQL 254
Query: 772 E 772
E
Sbjct: 255 E 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-57
Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 34/291 (11%)
Query: 492 FSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDIEKTN-EEFMTELKIIGRTHHKNL 549
F++++G G G VY G L D +I AVK L + + +F+TE I+ H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 550 VRLLGFCSE-EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
+ LLG C E L+V M +G L NF+ +E P + L VA+G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNM---RGTMGYVA 665
+ +H D+ +N +LD + K++DFG+++ + + + N + + ++A
Sbjct: 148 SKKFVHRDLAARNCMLD-----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725
E L+ TTK DV+SFGV+L E++ + +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------------ITVYL 247
Query: 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776
LQ PE D + V L C HP +RPS +++ +
Sbjct: 248 LQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-57
Identities = 62/297 (20%), Positives = 118/297 (39%), Gaps = 36/297 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRL 552
+G G+ G V++ K + + +A K + +I + + EL+++ + +V
Sbjct: 12 SELGAGNGGVVFKV--SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQI 612
G + + + E M G+L L G+ P ++++ V +GL YL E+ +I
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-EQILGKVSIAVIKGLTYLREKH--KI 126
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV 672
+H D+KP N+L +++ K+ DFG+S L + GT Y++PE L+
Sbjct: 127 MHRDVKPSNIL-----VNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGT 178
Query: 673 PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL------------------- 713
+ + D++S G+ L+E+ GR I +E +
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 714 ---SDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKV 767
D + L +V+ P L C +P R +K++
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-57
Identities = 69/309 (22%), Positives = 124/309 (40%), Gaps = 44/309 (14%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE 533
EI + +G G G+V+ G T +A+K L+ + E
Sbjct: 13 EIPRESLRLE----------VKLGQGCFGEVWMG--TWNGTT-RVAIKTLKPG-TMSPEA 58
Query: 534 FMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPG-WVQRVE 592
F+ E +++ + H+ LV+L SE + +V E M G+L +FL E + Q V+
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117
Query: 593 IALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR 652
+A +A G+ Y+ +H D++ N+L+ N + K++DFG+++L+ ++
Sbjct: 118 MAAQIASGMAYVERMN---YVHRDLRAANILVG-----ENLVCKVADFGLARLIEDNEYT 169
Query: 653 TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712
+ + + APE T K DV+SFG++L E+ R V E
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------- 222
Query: 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
+L + + P E + + C +P RP+ + + LE
Sbjct: 223 --------VLDQVERGYRMPCPPECP-----ESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
Query: 773 GTLEVGMPP 781
P
Sbjct: 270 DYFTSTEPQ 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-56
Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 32/279 (11%)
Query: 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN-EEFMTELKIIGRTHHKNLVRLLGF 555
G G+ G V +G+ R++ QI++A+K L++ EK + EE M E +I+ + + +VRL+G
Sbjct: 18 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77
Query: 556 CSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHC 615
C + + +LV E+ G L FL + + E+ V+ G+ YL E+ +H
Sbjct: 78 C-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHR 133
Query: 616 DIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT--RTDTNMRGTMGYVAPEWLRNVP 673
D+ +NVL L + AKISDFG+SK L D + + + + + APE +
Sbjct: 134 DLAARNVL-----LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 674 VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD 733
+++ DV+S+GV + E + + E +++ Q
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------------VMAFIEQGKRMEC 233
Query: 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
P + + C RP V +
Sbjct: 234 PPECP-----PELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 3e-56
Identities = 64/298 (21%), Positives = 121/298 (40%), Gaps = 32/298 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+ +G G G+V+RG K E+AVK E+ + E+ H+N++ +
Sbjct: 9 ESIGKGRFGEVWRG----KWRGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFI 63
Query: 554 GFCSEED----KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC- 608
++++ + LV + +G+L ++L +++AL A GL +LH E
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 609 ----ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD---TNMRGTM 661
+ I H D+K +N+L+ N I+D G++ + D + GT
Sbjct: 122 GTQGKPAIAHRDLKSKNILVK-----KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 662 GYVAPEWL------RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD 715
Y+APE L ++ + D+++ G++ EI + + + D+V SD
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQLPYYDLVPSD 235
Query: 716 WVISCMLSRNL-QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
+ M Q L + P E MA + C + + R + ++ L
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-56
Identities = 72/304 (23%), Positives = 127/304 (41%), Gaps = 43/304 (14%)
Query: 473 MEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN- 531
+ ++ + T ++ K +G+G+ G V +G ++K +AVK L+ +
Sbjct: 1 VYLDRKLLTLED---------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 51
Query: 532 -EEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR 590
+E + E ++ + + +VR++G C E + +LV E+ G L+ +L
Sbjct: 52 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVK-DKNI 109
Query: 591 VEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQ 650
+E+ V+ G+ YL E +H D+ +NVLL T + AKISDFG+SK L D+
Sbjct: 110 IELVHQVSMGMKYLEESN---FVHRDLAARNVLLV-----TQHYAKISDFGLSKALRADE 161
Query: 651 T--RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEE 708
+ T+ + + + APE + ++K DV+SFGV++ E + E
Sbjct: 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--- 218
Query: 709 VDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
V + + + P + DL C D RP V
Sbjct: 219 --------VTAMLEKGERMGCPAGCPREMYDL---------MNLCWTYDVENRPGFAAVE 261
Query: 769 HMLE 772
L
Sbjct: 262 LRLR 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-55
Identities = 76/335 (22%), Positives = 128/335 (38%), Gaps = 56/335 (16%)
Query: 466 NYFDPNSMEINFR-EFTFQELQEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVK 521
Y DP + + + EF L F K +G G+ GKV D + +AVK
Sbjct: 5 VYIDPTQLPYDHKWEFPRNRLS-----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 59
Query: 522 KLEKD-IEKTNEEFMTELKIIGR-THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLF 579
L+ E M+ELK++ +H N+V LLG C+ L++ E G L NFL
Sbjct: 60 MLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119
Query: 580 HEGQRPG-----------------WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622
+ + + VA+G+ +L + IH D+ +N+
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176
Query: 623 LLDLKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVF 681
L L + KI DFG+++ + D N R + ++APE + N T + DV+
Sbjct: 177 L-----LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 682 SFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLE 741
S+G+ L E+ + ++ +LS
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDS-------------------KFYKMIKEGFRMLSPEH 272
Query: 742 RFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776
M + C DP RP+ K+++ ++E +
Sbjct: 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-55
Identities = 76/338 (22%), Positives = 139/338 (41%), Gaps = 61/338 (18%)
Query: 467 YFDPNSMEINFR-EFTFQELQEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKK 522
Y D E + + EF + L+ F K++G+G+ GKV I++AVK
Sbjct: 20 YVDFREYEYDLKWEFPRENLE-----FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM 74
Query: 523 LEKDIEKTN-EEFMTELKIIGR-THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFH 580
L++ + + E M+ELK++ + H+N+V LLG C+ L++E G L N+L
Sbjct: 75 LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134
Query: 581 EGQRPG----------------------WVQRVEIALGVARGLLYLHEECETQIIHCDIK 618
+ ++ + + A VA+G+ +L + +H D+
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191
Query: 619 PQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTK 677
+NVL + + KI DFG+++ + D N R + ++APE L T K
Sbjct: 192 ARNVL-----VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 678 VDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVL 737
DV+S+G++L EI + + ++ ++ + + + P
Sbjct: 247 SDVWSYGILLWEIFSLGVNP-YPGIPVDANFYKLIQNGFKMDQ-------------PFYA 292
Query: 738 SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775
+ E + ++ C D RPS + L L
Sbjct: 293 T-----EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 6e-55
Identities = 71/311 (22%), Positives = 139/311 (44%), Gaps = 43/311 (13%)
Query: 472 SMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQ--IEIAVKKLEKD-IE 528
+ EI+ T Q K++G G G+VY+G+L+ + + +A+K L+ E
Sbjct: 1 TTEIHPSCVTRQ----------KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE 50
Query: 529 KTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWV 588
K +F+ E I+G+ H N++RL G S+ +++ E M NG L FL + +
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 110
Query: 589 QRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648
Q V + G+A G+ YL +H D+ +N+L +++N + K+SDFG+S++L
Sbjct: 111 QLVGMLRGIAAGMKYLANMN---YVHRDLAARNIL-----VNSNLVCKVSDFGLSRVLED 162
Query: 649 DQ--TRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES 706
D T T + + + + APE + T+ DV+SFG+++ E++ E
Sbjct: 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE- 221
Query: 707 EEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKK 766
+ ++ + + ++ + + + C + RP
Sbjct: 222 -------------------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262
Query: 767 VIHMLEGTLEV 777
++ +L+ +
Sbjct: 263 IVSILDKLIRA 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 3e-54
Identities = 71/313 (22%), Positives = 124/313 (39%), Gaps = 56/313 (17%)
Query: 492 FSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHK 547
+ + +G G+ G+V++ + +AVK L+++ +F E ++ +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPG--------------------- 586
N+V+LLG C+ L++E M G L+ FL
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 587 --WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644
+++ IA VA G+ YL E +H D+ +N L + N + KI+DFG+S+
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCL-----VGENMVVKIADFGLSR 188
Query: 645 LL-NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVE 703
+ + D + D N + ++ PE + TT+ DV+++GV+L EI
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS 763
EE VI + N+ + P L +L C P RPS
Sbjct: 249 EE-----------VIYYVRDGNILACPENCPLELYNL---------MRLCWSKLPADRPS 288
Query: 764 MKKVIHMLEGTLE 776
+ +L+ E
Sbjct: 289 FCSIHRILQRMCE 301
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-54
Identities = 62/282 (21%), Positives = 114/282 (40%), Gaps = 37/282 (13%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+G G+ GKVY+ + K+T + A K ++ E+ E++M E+ I+ H N+V+LL
Sbjct: 18 GELGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
E+ ++ E G + + + Q + L YLH+ +II
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KII 132
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWL---- 669
H D+K N+L + K++DFG+S + R D+ GT ++APE +
Sbjct: 133 HRDLKAGNIL-----FTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCET 186
Query: 670 -RNVPVTTKVDVFSFGVMLLEIICGRR-HIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
++ P K DV+S G+ L+E+ H EL+ + + S N +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246
Query: 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769
+ C + + R + +++
Sbjct: 247 DFLKK--------------------CLEKNVDARWTTSQLLQ 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 5e-54
Identities = 60/284 (21%), Positives = 107/284 (37%), Gaps = 37/284 (13%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNL 549
F +G GS VY+G +T +E+A +L+ + + F E +++ H N+
Sbjct: 13 FDIEIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 550 VRLLGFCSEEDKR----LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH 605
VR K +LV ELM +GTL +L + + +GL +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
IIH D+K N+ + KI D G++ L + + GT ++A
Sbjct: 130 TRTP-PIIHRDLKCDNIFIT----GPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMA 181
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725
PE VDV++FG+ +LE+ + ++
Sbjct: 182 PEMYEE-KYDESVDVYAFGMCMLEMATSEY-------------------PYSECQNAAQI 221
Query: 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769
+ + S D + + C + + R S+K +++
Sbjct: 222 YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 4e-53
Identities = 67/308 (21%), Positives = 117/308 (37%), Gaps = 51/308 (16%)
Query: 469 DPNSMEINFREFTFQELQEATKGFSKL--VGTGSSGKVYRGILRLKDTQIEIAVKKLEKD 526
DP+ E+ F++ + K FS L +G GS G VY R +A+KK+
Sbjct: 1 DPDVAELFFKD-------DPEKLFSDLREIGHGSFGAVYFA--RDVRNSEVVAIKKMSYS 51
Query: 527 IEKTNE---EFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQ 583
+++NE + + E++ + + H N ++ G E LV E H+
Sbjct: 52 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP 111
Query: 584 RPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643
V+ + G +GL YLH +IH D+K N+L L + K+ DFG +
Sbjct: 112 LQ-EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNIL-----LSEPGLVKLGDFGSA 162
Query: 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNV---PVTTKVDVFSFGVMLLEIICGRRHIELS 700
++ + GT ++APE + + KVDV+S G+ +E+ + +
Sbjct: 163 SIMAPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
Query: 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNL 760
+ S + S S + V C P
Sbjct: 218 NAMSALYHIAQNESPALQSGHWSEYFRNFVD--------------------SCLQKIPQD 257
Query: 761 RPSMKKVI 768
RP+ + ++
Sbjct: 258 RPTSEVLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 5e-53
Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 44/294 (14%)
Query: 478 REFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEF 534
R++ ++ + + +G G G VY R K ++ +A+K L K +
Sbjct: 1 RQWALEDFE-----IGRPLGKGKFGNVYLA--REKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 535 MTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIA 594
E++I H N++RL G+ + + L+ E P GT+ L + +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATYI 112
Query: 595 LGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD 654
+A L Y H + ++IH DIKP+N+L L + KI+DFG S + T
Sbjct: 113 TELANALSYCHSK---RVIHRDIKPENLL-----LGSAGELKIADFGWSVHAPSSRRTT- 163
Query: 655 TNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS 714
+ GT+ Y+ PE + KVD++S GV+ E + G+ E + +E + I
Sbjct: 164 --LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR--ISRV 219
Query: 715 DWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
++ ++ + L+S +P+ RP +++V+
Sbjct: 220 EFTFPDFVTEGARDLIS--------------------RLLKHNPSQRPMLREVL 253
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 7e-53
Identities = 52/284 (18%), Positives = 107/284 (37%), Gaps = 38/284 (13%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVR 551
+GTGS G+ + R K + K+L+ E + ++E+ ++ H N+VR
Sbjct: 10 YTIGTGSYGRCQKI--RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 552 LLGFCSEEDKRL--LVYELMPNGTLSNFLFHEGQRPG---WVQRVEIALGVARGLLYLHE 606
+ +V E G L++ + + + + + L H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 607 --ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYV 664
+ ++H D+KP NV LD K+ DFG++++LN D + GT Y+
Sbjct: 128 RSDGGHTVLHRDLKPANVF-----LDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYM 181
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724
+PE + + K D++S G +L E+ +E + +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------------LAGKIREG 229
Query: 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
+ + + L+++ + RPS+++++
Sbjct: 230 KFRRIPYRYSDELNEIIT---------RMLNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-52
Identities = 76/320 (23%), Positives = 133/320 (41%), Gaps = 57/320 (17%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN-E 532
+++ + FQ++ +G G+ G+V + ++ +++ A+K++++ K +
Sbjct: 6 VLDWNDIKFQDV----------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 533 EFMTELKIIGR-THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHE---------- 581
+F EL+++ + HH N++ LLG C L E P+G L +FL
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 582 -----GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAK 636
Q + A VARG+ YL ++ Q IH D+ +N+L+ NY+AK
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG-----ENYVAK 167
Query: 637 ISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRH 696
I+DFG+S+ +T R + ++A E L TT DV+S+GV+L EI+
Sbjct: 168 IADFGLSRGQEVYVKKT--MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 697 IELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHP 756
E + + Q P D + + C
Sbjct: 226 PYCGMTCAE---------------LYEKLPQGYRLEKPLNCDD-----EVYDLMRQCWRE 265
Query: 757 DPNLRPSMKKVIHMLEGTLE 776
P RPS +++ L LE
Sbjct: 266 KPYERPSFAQILVSLNRMLE 285
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-52
Identities = 63/283 (22%), Positives = 128/283 (45%), Gaps = 33/283 (11%)
Query: 494 KLVGTGSSGKVYRGILRL--KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLV 550
K++G+G+ G VY+G+ + +I +A+K+L + K N+E + E ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
RLLG C +L + +LMP G L +++ G + + +A+G+ YL +
Sbjct: 75 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--- 130
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN-MRGTMGYVAPEWL 669
+++H D+ +NVL+ T KI+DFG++KLL ++ + + ++A E +
Sbjct: 131 RLVHRDLAARNVLVK-----TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 670 RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVL 729
+ T + DV+S+GV + E++ S + S +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKGE 230
Query: 730 VSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
P + + + M+ + C D + RP +++I
Sbjct: 231 RLPQPPICT-----IDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-52
Identities = 64/305 (20%), Positives = 117/305 (38%), Gaps = 41/305 (13%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILR-LKDTQIEIAVKKLEKDI-EKTN 531
EI + +G G G V++GI ++ + +A+K + +
Sbjct: 3 EIQRERIELG----------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR 52
Query: 532 EEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRV 591
E+F+ E + + H ++V+L+G E+ ++ EL G L +FL +
Sbjct: 53 EKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI 111
Query: 592 EIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651
A ++ L YL + +H DI +NVL+ +N K+ DFG+S+ +
Sbjct: 112 LYAYQLSTALAYLESKR---FVHRDIAARNVLVS-----SNDCVKLGDFGLSRYMEDSTY 163
Query: 652 RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI 711
+ + + ++APE + T+ DV+ FGV + EI+ +
Sbjct: 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------ 217
Query: 712 VLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHML 771
VI + + + + P L L C DP+ RP ++ L
Sbjct: 218 -----VIGRIENGERLPMPPNCPPTLYSL---------MTKCWAYDPSRRPRFTELKAQL 263
Query: 772 EGTLE 776
LE
Sbjct: 264 STILE 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 66/277 (23%), Positives = 114/277 (41%), Gaps = 33/277 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRL 552
+ +G G+ G+V + T+ +AVK ++ E E+ I +H+N+V+
Sbjct: 11 QTLGEGAYGEVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQI 612
G E + + L E G L + + + P + G++YLH I
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 613 IHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD-QTRTDTNMRGTMGYVAPEWLRN 671
H DIKP+N+L LD KISDFG++ + + + R M GT+ YVAPE L+
Sbjct: 125 THRDIKPENLL-----LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 672 VPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730
VDV+S G++L ++ G ++ + SDW + +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI- 232
Query: 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKV 767
D L+ L + +P+ R ++ +
Sbjct: 233 --DSAPLALLHK----------ILVENPSARITIPDI 257
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (453), Expect = 1e-50
Identities = 63/275 (22%), Positives = 113/275 (41%), Gaps = 28/275 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+ +GTG+ G V+R + T A K + E E E++ + H LV L
Sbjct: 32 EELGTGAFGVVHRV--TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
++++ +++YE M G L + E + + VE V +GL ++HE +
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVP 673
H D+KP+N++ + K+ DFG++ L+ Q+ T GT + APE P
Sbjct: 147 HLDLKPENIMFT---TKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKP 201
Query: 674 VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD 733
V D++S GV+ ++ G +E + + S + + S
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNMDDSAF 249
Query: 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
+ D + F R DPN R ++ + +
Sbjct: 250 SGISEDGKDFIR------KLLLADPNTRMTIHQAL 278
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-50
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 36/286 (12%)
Query: 494 KLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNL 549
+ +G GS G V RG + +AVK L+ D+ + ++F+ E+ + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 550 VRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECE 609
+RL G +V EL P G+L + L A+ VA G+ YL +
Sbjct: 74 IRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR- 131
Query: 610 TQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL--NKDQTRTDTNMRGTMGYVAPE 667
IH D+ +N+LL T + KI DFG+ + L N D + + + APE
Sbjct: 132 --FIHRDLAARNLLLA-----TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
L+ + D + FGV L E+ + + + +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------------------IL 224
Query: 728 VLVSHDPEVLSDLERF-ERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
+ + E L E + + V + C P RP+ + L
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-50
Identities = 75/341 (21%), Positives = 146/341 (42%), Gaps = 60/341 (17%)
Query: 453 YYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRL- 511
Y+S A + + P+ E+ + T + +G GS G VY G+ +
Sbjct: 3 YFSAA--------DVYVPDEWEVAREKITMS----------RELGQGSFGMVYEGVAKGV 44
Query: 512 --KDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568
+ + +A+K + + + EF+ E ++ + ++VRLLG S+ L++ EL
Sbjct: 45 VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104
Query: 569 MPNGTLSNFLFHEGQR---------PGWVQRVEIALGVARGLLYLHEECETQIIHCDIKP 619
M G L ++L P + +++A +A G+ YL+ + +H D+
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 161
Query: 620 QNVLLDLKTLDTNYMAKISDFGISKLLNK-DQTRTDTNMRGTMGYVAPEWLRNVPVTTKV 678
+N + + ++ KI DFG+++ + + D R + +++PE L++ TT
Sbjct: 162 RNCM-----VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 216
Query: 679 DVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLS 738
DV+SFGV+L EI E+ V+ ++ L + P++L
Sbjct: 217 DVWSFGVVLWEIATLAEQPYQGLSNEQ-----------VLRFVMEGGLLDKPDNCPDMLF 265
Query: 739 DLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGM 779
+L C +P +RPS ++I ++ +E G
Sbjct: 266 EL---------MRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 60/275 (21%), Positives = 112/275 (40%), Gaps = 32/275 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+ +G G+SG VY T E+A++++ + E + E+ ++ + N+V L
Sbjct: 26 EKIGQGASGTVYTA--MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
D+ +V E + G+L++ + Q + + L +LH Q+I
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSN---QVI 138
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVP 673
H DIK N+L L + K++DFG + +Q++ + M GT ++APE +
Sbjct: 139 HRDIKSDNIL-----LGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA 192
Query: 674 VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD 733
KVD++S G+M +E+I G E + ++ ++ L
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRALYLIATNGTPELQNPEKL------- 242
Query: 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
+ D C D R S K+++
Sbjct: 243 SAIFRDFLN---------RCLDMDVEKRGSAKELL 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (436), Expect = 3e-48
Identities = 57/275 (20%), Positives = 104/275 (37%), Gaps = 28/275 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+ +G+G+ G V+R K T K + E+ I+ + HH L+ L
Sbjct: 35 EELGSGAFGVVHRC--VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
++ + +L+ E + G L + + E + + + GL ++HE I+
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIV 149
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVP 673
H DIKP+N++ + KI DFG++ LN D+ T + APE + P
Sbjct: 150 HLDIKPENIMCE---TKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREP 204
Query: 674 VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD 733
V D+++ GV+ ++ G E D+ V C + S
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFA--------GEDDLETLQNVKRCDWEFDEDAFSSVS 256
Query: 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
PE ++ +P R ++ +
Sbjct: 257 PEAKDFIKN----------LLQKEPRKRLTVHDAL 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 70/331 (21%), Positives = 124/331 (37%), Gaps = 59/331 (17%)
Query: 468 FDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLE 524
+D + E K +G G+ G+V T +AVK L+
Sbjct: 3 YDASKWEFPRDRLKLG----------KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 52
Query: 525 KD-IEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRL-LVYELMPNGTLSNFLFHE 581
+ + M+ELKI+ HH N+V LLG C++ L ++ E G LS +L +
Sbjct: 53 EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 112
Query: 582 GQRP---------------GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDL 626
+ + VA+G+ +L + IH D+ +N+LL
Sbjct: 113 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS- 168
Query: 627 KTLDTNYMAKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGV 685
+ KI DFG+++ + KD + R + ++APE + + T + DV+SFGV
Sbjct: 169 ----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224
Query: 686 MLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFER 745
+L EI + + + + + +
Sbjct: 225 LLWEIFSLGASP----------YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT----- 269
Query: 746 MAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776
L C H +P+ RP+ +++ L L+
Sbjct: 270 ----MLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 72/327 (22%), Positives = 129/327 (39%), Gaps = 61/327 (18%)
Query: 474 EINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILR-----LKDTQIEIAVKKLEKD-I 527
E+ K +G G+ G+V + ++AVK L+ D
Sbjct: 9 ELPRDRLVLG----------KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 528 EKTNEEFMTELKIIGR-THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPG 586
EK + ++E++++ HKN++ LLG C+++ ++ E G L +L
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 587 ---------------WVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT 631
V A VARG+ YL + + IH D+ +NVL+
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT-----E 170
Query: 632 NYMAKISDFGISKLLNKDQTRTDT-NMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEI 690
+ + KI+DFG+++ ++ T N R + ++APE L + T + DV+SFGV+L EI
Sbjct: 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230
Query: 691 ICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVG 750
EE + + P + + M+
Sbjct: 231 FTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT-----NELYMMM 270
Query: 751 LWCNHPDPNLRPSMKKVIHMLEGTLEV 777
C H P+ RP+ K+++ L+ + +
Sbjct: 271 RDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 2e-46
Identities = 65/279 (23%), Positives = 113/279 (40%), Gaps = 29/279 (10%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLV 550
F ++GTG+ +V K TQ +A+K + K +E E+ ++ + H N+V
Sbjct: 13 FRDVLGTGAFSEVILA--EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
L L+ +L+ G L + + +G + V + YLH+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT-ERDASRLIFQVLDAVKYLHDLG-- 127
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
I+H D+KP+N+L LD + ISDFG+SK+ + + GT GYVAPE L
Sbjct: 128 -IVHRDLKPENLLYYS--LDEDSKIMISDFGLSKMEDPGSVLST--ACGTPGYVAPEVLA 182
Query: 671 NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730
P + VD +S GV+ ++CG + + +L +
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------------LFEQILKAEYEFDS 230
Query: 731 SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769
+ ++ + F R DP R + ++ +
Sbjct: 231 PYWDDISDSAKDFIR------HLMEKDPEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-46
Identities = 56/285 (19%), Positives = 99/285 (34%), Gaps = 37/285 (12%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD---IEKTNEEFMTELKIIGRTHHKN 548
F K++G GS V R T E A+K LEK E E ++ R H
Sbjct: 12 FGKILGEGSFSTVVLA--RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
V+L +++K NG L ++ G A + L
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYLH 125
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTN-MRGTMGYVAPE 667
IIH D+KP+N+L L+ + +I+DFG +K+L+ + + N GT YV+PE
Sbjct: 126 GKGIIHRDLKPENIL-----LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
L D+++ G ++ +++ G + + ++
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----------------IFQKIIK 224
Query: 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
+ + + L D R +++
Sbjct: 225 LEYDFPEKFFPKARDL----VEKLLV--LDATKRLGCEEMEGYGP 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-44
Identities = 42/274 (15%), Positives = 94/274 (34%), Gaps = 29/274 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+ +G G G V+R ++ K ++ E+ I+ H+N++ L
Sbjct: 11 EDLGRGEFGIVHRC--VETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLH 67
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
++ ++++E + + + + V V L +LH I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVP 673
H DI+P+N++ + KI +FG ++ L + Y APE ++
Sbjct: 125 HFDIRPENIIYQ---TRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179
Query: 674 VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHD 733
V+T D++S G ++ ++ G ++ +I +++
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQ------------IIENIMNAEYTFDEEAF 227
Query: 734 PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKV 767
E+ + F + R + +
Sbjct: 228 KEISIEAMDFVD------RLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (389), Expect = 1e-42
Identities = 56/289 (19%), Positives = 105/289 (36%), Gaps = 39/289 (13%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLV 550
+++G G +V+ R ++AVK L D+ F E + +H +V
Sbjct: 13 EILGFGGMSEVHLA--RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 551 RLLGFCSEEDKRL----LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE 606
+ E +V E + TL + + EG + +E+ + L + H+
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT-PKRAIEVIADACQALNFSHQ 129
Query: 607 ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD--TNMRGTMGYV 664
IIH D+KP N+++ K+ DFGI++ + + GT Y+
Sbjct: 130 NG---IIHRDVKPANIMIS-----ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 665 APEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724
+PE R V + DV+S G +L E++ G V +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------------VAYQHVRE 229
Query: 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-SMKKVIHMLE 772
+ + + +DL+ A+ +P R + ++ L
Sbjct: 230 DPIPPSARHEGLSADLDAVVLKAL------AKNPENRYQTAAEMRADLV 272
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (389), Expect = 2e-42
Identities = 40/285 (14%), Positives = 95/285 (33%), Gaps = 27/285 (9%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+ +G GS G ++ G ++A+K + + E + + +
Sbjct: 11 RRIGEGSFGVIFEG--TNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
+ +E ++ + +L + L G++ A + + +HE+ ++
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 123
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD------TNMRGTMGYVAPE 667
+ DIKP N L+ M + DFG+ K T+ N+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
+ + D+ + G + + + G + + ++ + + S L+
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-----ERIGEKKQSTPLR 238
Query: 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
L + PE + + + P + +
Sbjct: 239 ELCAGFPEEFYKYMH---------YARNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 32/282 (11%)
Query: 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRL 552
S+++G G +GKV + K TQ + A+K L +D K E + ++VR+
Sbjct: 17 SQVLGLGINGKVLQI--FNKRTQEKFALKML-QDCPKARREVELHWRAS---QCPHIVRI 70
Query: 553 LGFC----SEEDKRLLVYELMPNGTLSNFLFHEGQRP-GWVQRVEIALGVARGLLYLHEE 607
+ + L+V E + G L + + G + + EI + + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
I H D+KP+N+L + N + K++DFG +K + T T YVAPE
Sbjct: 131 ---NIAHRDVKPENLLYT--SKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPE 183
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
L D++S GV++ ++CG + +S + + + +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY--------SNHGLAISPGMKTRIRMGQYE 235
Query: 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769
EV +++ R +P R ++ + ++
Sbjct: 236 FPNPEWSEVSEEVKMLIR------NLLKTEPTQRMTITEFMN 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 3e-42
Identities = 47/285 (16%), Positives = 103/285 (36%), Gaps = 29/285 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+ +G+GS G +Y G E+A+K ++ + + E KI + +
Sbjct: 13 RKIGSGSFGDIYLG--TDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 554 GFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQII 613
+C E ++ + +L + ++ + +A + + Y+H + I
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFI 125
Query: 614 HCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTD------TNMRGTMGYVAPE 667
H D+KP N L+ L + I DFG++K +T N+ GT Y +
Sbjct: 126 HRDVKPDNFLMGLG--KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
+ + + D+ S G +L+ G + + + ++ + + +S ++
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-----ERISEKKMSTPIE 238
Query: 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772
VL P + +C + +P + +
Sbjct: 239 VLCKGYPSEFATYLN---------FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 154 bits (389), Expect = 1e-41
Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 40/280 (14%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNE------EFMTELKIIGRTH 545
+++G G G+VY R DT A+K L+K K + L ++
Sbjct: 8 VHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 546 HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH 605
+V + DK + +LM G L L + A + GL ++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
+++ D+KP N+L LD + +ISD G++ +K + GT GY+A
Sbjct: 125 NRF---VVYRDLKPANIL-----LDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMA 173
Query: 666 PEWL-RNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724
PE L + V + D FS G ML +++ G + +++ E + L+
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---------IDRMTLTM 224
Query: 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSM 764
+++ S PE+ S LE D N R
Sbjct: 225 AVELPDSFSPELRSLLEG----------LLQRDVNRRLGC 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 62/282 (21%), Positives = 115/282 (40%), Gaps = 33/282 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN------EEFMTELKIIGRTHHK 547
+ +G+G V + R K T ++ A K ++K K++ E+ E+ I+ H
Sbjct: 16 EELGSGQFAVVKKC--REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
N++ L + +L+ EL+ G L +F E + + E + G+ YLH
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
I H D+KP+N++L + KI DFG++ ++ N+ GT +VAPE
Sbjct: 133 Q---IAHFDLKPENIMLLDRN-VPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPE 186
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
+ P+ + D++S GV+ ++ G +E L+
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----------------TLANVSA 230
Query: 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769
V + E S+ + + L DP R +++ +
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIRRLLV--KDPKKRMTIQDSLQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 63/281 (22%), Positives = 105/281 (37%), Gaps = 38/281 (13%)
Query: 492 FSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE---FMTELKIIGRT-HHK 547
K++G GS GKV+ K T A+K L+KD+ +++ M E +++ H
Sbjct: 6 LHKMLGKGSFGKVFLA--EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
L + ++ V E + G L + + + A + GL +L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-LSRATFYAAEIILGLQFL--- 119
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
I++ D+K N+LLD + KI+DFG+ K + GT Y+APE
Sbjct: 120 HSKGIVYRDLKLDNILLD-----KDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPE 173
Query: 668 WLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727
L VD +SFGV+L E++ G+ EE + + N
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------------LFHSIRMDNPF 221
Query: 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
+ E L + +P R ++ I
Sbjct: 222 YPRWLEKEAKDLLVK----------LFVREPEKRLGVRGDI 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (379), Expect = 4e-41
Identities = 60/291 (20%), Positives = 117/291 (40%), Gaps = 47/291 (16%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEK---------DIEKTNEEFMTELKIIGRT 544
+++G G S V R K T E AVK ++ ++++ E + E+ I+ +
Sbjct: 9 EILGRGVSSVVRRC--IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 545 H-HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLY 603
H N+++L LV++LM G L ++L E + +I + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICA 125
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
LH+ I+H D+KP+N+L LD + K++DFG S L+ + + GT Y
Sbjct: 126 LHKLN---IVHRDLKPENIL-----LDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSY 175
Query: 664 VAPEWLR------NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717
+APE + + +VD++S GV++ ++ G + +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------------M 223
Query: 718 ISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
+ ++S N Q + ++ P R + ++ +
Sbjct: 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVS------RFLVVQPQKRYTAEEAL 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 63/298 (21%), Positives = 110/298 (36%), Gaps = 42/298 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-----IEKTNEEFMTELKIIGRTHHKN 548
+G G VY+ R K+T +A+KK++ + N + E+K++ H N
Sbjct: 4 DFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 549 LVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC 608
++ LL + LV++ M + L +GL YLH+
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEW 668
I+H D+KP N+LLD N + K++DFG++K T+ T Y APE
Sbjct: 121 ---ILHRDLKPNNLLLD-----ENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPEL 171
Query: 669 LRNV-PVTTKVDVFSFGVMLLEIICGR---------------RHIELSRVEEESEEVDIV 712
L VD+++ G +L E++ + EE+ ++ +
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770
L + S + L DL + +P R + + + M
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---------GLFLFNPCARITATQALKM 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (380), Expect = 6e-41
Identities = 64/249 (25%), Positives = 114/249 (45%), Gaps = 24/249 (9%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLV 550
+ +GTGS G+V+ R + A+K L+K+I K E E ++ H ++
Sbjct: 10 RTLGTGSFGRVHLI--RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
R+ G + + ++ + + G L + L + P V + A V L YLH +
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLHSKD-- 124
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
II+ D+KP+N+L LD N KI+DFG +K + + GT Y+APE +
Sbjct: 125 -IIYRDLKPENIL-----LDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVS 174
Query: 671 NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQVLV 730
P +D +SFG+++ E++ G S + E+ I+ ++ + +++ L+
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--ILNAELRFPPFFNEDVKDLL 232
Query: 731 SH----DPE 735
S D
Sbjct: 233 SRLITRDLS 241
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 60/284 (21%), Positives = 103/284 (36%), Gaps = 49/284 (17%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE------FMTELKIIGR--TH 545
L+G+G G VY G + +A+K +EKD E E+ ++ + +
Sbjct: 10 PLLGSGGFGSVYSG--IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 546 HKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH 605
++RLL + D +L+ E E V + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 126
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
++H DIK +N+L+DL K+ DFG LL T+ GT Y
Sbjct: 127 --HNCGVLHRDIKDENILIDLN----RGELKLIDFGSGALLKDTVY---TDFDGTRVYSP 177
Query: 666 PEWLRNVPVTTK-VDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724
PEW+R + V+S G++L +++CG E + +I+ +S
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------HDEEIIRGQVFFRQRVSS 229
Query: 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
Q L+ WC P+ RP+ +++
Sbjct: 230 ECQHLIR--------------------WCLALRPSDRPTFEEIQ 253
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-39
Identities = 66/308 (21%), Positives = 113/308 (36%), Gaps = 39/308 (12%)
Query: 478 REFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTE 537
+E ++ + K++G GS G VY+ +L D+ +A+KK+ +D E
Sbjct: 18 QEVSYTDT--------KVIGNGSFGVVYQA--KLCDSGELVAIKKVLQD----KRFKNRE 63
Query: 538 LKIIGRTHHKNLVRLLGFCSEEDKR------LLVYELMPNGTLSNFLFH--EGQRPGWVQ 589
L+I+ + H N+VRL F ++ LV + +P + Q +
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 590 RVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649
+ R L Y+H I H DIKPQN+LLD + K+ DFG +K L +
Sbjct: 124 VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRG 176
Query: 650 QTRTDTNMRGTMGYVAP-EWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEE 708
+ Y AP T+ +DV+S G +L E++ G+ ++ E
Sbjct: 177 EPNVSYICS--RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 709 VDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVG-------LWCNHPDPNLR 761
+ VL + N P++ + P R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 762 PSMKKVIH 769
+ +
Sbjct: 295 LTPLEACA 302
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (357), Expect = 3e-38
Identities = 55/284 (19%), Positives = 110/284 (38%), Gaps = 21/284 (7%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL--EKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+ +G G+ G VY+ A+KK+ EK+ E + E+ I+ H N+V+
Sbjct: 8 EKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
L + + +LV+E + EG V L + G+ Y H+
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE-SVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
++H D+KPQN+L++ KI+DFG+++ + + + +
Sbjct: 121 VLHRDLKPQNLLIN-----REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 672 VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL-----SDWVISCMLSRNL 726
+T +D++S G + E++ G ++ + +L +W L +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 727 QVLVSHDPEVLSDLERFERMAMVGL--WCNHPDPNLRPSMKKVI 768
++P + + + L DPN R + K+ +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-38
Identities = 63/299 (21%), Positives = 119/299 (39%), Gaps = 44/299 (14%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL-----EKDIEKTNEEFMTELKIIGRTHHKN 548
+G G+ GKV++ LK+ +A+K++ E+ + + + L+ + H N
Sbjct: 13 AEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71
Query: 549 LVRLLGFCS-----EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLY 603
+VRL C+ E K LV+E + + ++ + RGL +
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGY 663
LH ++H D+KPQN+L+ ++ K++DFG++++ + T ++ T+ Y
Sbjct: 132 LHSHR---VVHRDLKPQNILVT-----SSGQIKLADFGLARIYSFQMALT--SVVVTLWY 181
Query: 664 VAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR--------------HIELSRVEEESEEV 709
APE L T VD++S G + E+ + + EE
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 710 DIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768
D+ L ++ ++ V+ E+ DL C +P R S +
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---------KCLTFNPAKRISAYSAL 291
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 57/290 (19%), Positives = 109/290 (37%), Gaps = 25/290 (8%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN-EEFMTELKIIGRTHHKNLVRL 552
+G G+ G V ++ +A+KK+ +T + + E+KI+ R H+N++ +
Sbjct: 14 SYIGEGAYGMVCSA--YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 71
Query: 553 LGFCSEEDKRLLVYELMPNGTLSNFLFH--EGQRPGWVQRVEIALGVARGLLYLHEECET 610
+ + + L+ + Q + RGL Y+H
Sbjct: 72 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA--- 128
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR--TDTNMRGTMGYVAPEW 668
++H D+KP N+L L+T KI DFG++++ + D T T Y APE
Sbjct: 129 NVLHRDLKPSNLL-----LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 669 LRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL-----SDWVISCML 722
+ N T +D++S G +L E++ R ++ + +L D L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 723 SRNLQVLVSHDPEVLSDLERFERMAMVGL----WCNHPDPNLRPSMKKVI 768
+L + F L +P+ R +++ +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 58/285 (20%), Positives = 103/285 (36%), Gaps = 19/285 (6%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVR 551
+ +G G+ G VY+ R K T +A+KK+ D E + E+ ++ +H N+V+
Sbjct: 8 EKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
LL E+K LV+E + + +GL + H
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
++H D+KPQN+L ++T K++DFG+++ + L
Sbjct: 123 VLHRDLKPQNLL-----INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 672 VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL-----SDWVISCMLSRNL 726
+T VD++S G + E++ R ++ + L W +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 727 QVLVSHDPEVLSDLERFERMAMVGL--WCNHPDPNLRPSMKKVIH 769
+ S + L H DPN R S K +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-35
Identities = 58/206 (28%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEE---FMTELKIIGRTHHKNLV 550
KL+G G+ GKV R K T A+K L K++ +E +TE +++ T H L
Sbjct: 11 KLLGKGTFGKVILV--REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 551 RLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECET 610
L D+ V E G L L R A + L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 611 QIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLR 670
+++ DIK +N++LD + KI+DFG+ K D GT Y+APE L
Sbjct: 125 DVVYRDIKLENLMLD-----KDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLE 178
Query: 671 NVPVTTKVDVFSFGVMLLEIICGRRH 696
+ VD + GV++ E++CGR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 47/286 (16%), Positives = 104/286 (36%), Gaps = 21/286 (7%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVR 551
+ +G G+ G V++ + ++T +A+K++ D E + E+ ++ HKN+VR
Sbjct: 8 EKIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 552 LLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ 611
L + K LV+E + + G + + + + L L
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 612 IIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN 671
++H D+KPQN+L ++ N K+++FG+++ +
Sbjct: 122 VLHRDLKPQNLL-----INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 672 VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEES----EEVDIVLSDWVISCMLSRNLQ 727
+T +D++S G + E+ R + ++ + ++ M
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 728 VLVSHDPEVLSDLERFERMAMVGL----WCNHPDPNLRPSMKKVIH 769
P S + ++ G +P R S ++ +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-33
Identities = 54/298 (18%), Positives = 111/298 (37%), Gaps = 35/298 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKL--EKDIEKTNEEFMTELKIIGRTHHKNLVR 551
+G G+ G+V++ R + T ++A+KK+ E + E + E+KI+ H+N+V
Sbjct: 16 AKIGQGTFGEVFKA--RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 552 LLGFCSEEDKR--------LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLY 603
L+ C + LV++ + + EI + L
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS----EIKRVMQMLLNG 129
Query: 604 LHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR---GT 660
L+ +I+H D+K NVL + + + K++DFG+++ + + T
Sbjct: 130 LYYIHRNKILHRDMKAANVL-----ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 661 MGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRR-------HIELSRVEEESEEVDIV 712
+ Y PE L +D++ G ++ E+ +L+ + + +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVG---LWCNHPDPNLRPSMKKV 767
+ V + L L+++ +V L+ + R DP R
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 8e-33
Identities = 62/314 (19%), Positives = 122/314 (38%), Gaps = 41/314 (13%)
Query: 480 FTFQELQEATKGFS------KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTN 531
F QE+ + + VG+G+ G V T ++A+KKL + E
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSA--VDGRTGAKVAIKKLYRPFQSELFA 61
Query: 532 EEFMTELKIIGRTHHKNLVRLLGFCSEEDKR------LLVYELMPNGTLSNFLFHEGQRP 585
+ EL+++ H+N++ LL + ++ LV M + ++
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKL 118
Query: 586 GWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645
G + + + +GL Y+H IIH D+KP N+ ++ + KI DFG+++
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLA-----VNEDCELKILDFGLARQ 170
Query: 646 LNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGR---RHIELSR 701
+ + T T Y APE + N + T VD++S G ++ E+I G+ + +
Sbjct: 171 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
Query: 702 VEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSD--LERFERMAMVGL----WCNH 755
+E +V + + S + + PE+ + + +
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 286
Query: 756 PDPNLRPSMKKVIH 769
D R + + +
Sbjct: 287 LDAEQRVTAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (315), Expect = 5e-32
Identities = 54/246 (21%), Positives = 101/246 (41%), Gaps = 30/246 (12%)
Query: 453 YYSPAARGLIKRRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLK 512
+ + A +K+ N+ +++ F + K +GTGS G+V + K
Sbjct: 18 FLAKAKEDFLKKWETPSQNTAQLD----QFDRI--------KTLGTGSFGRVMLV--KHK 63
Query: 513 DTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569
++ A+K L+K K E + E +I+ + LV+L + +V E +
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTL 629
G + + L G+ A + YLH +I+ D+KP+N+L +
Sbjct: 124 AGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLL-----I 174
Query: 630 DTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLE 689
D +++DFG + K + GT +APE + + VD ++ GV++ E
Sbjct: 175 DQQGYIQVTDFGFA----KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 690 IICGRR 695
+ G
Sbjct: 231 MAAGYP 236
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 494 KLVGTGSSGKVYRGI-LRLKDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGR-THHK 547
K++GTG+ GKV+ + DT A+K L+K KT E TE +++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 548 NLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE 607
LV L E K L+ + + G L L + E+ + V +L L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH----EVQIYVGEIVLALEHL 145
Query: 608 CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPE 667
+ II+ DIK +N+L LD+N ++DFG+SK D+T + GT+ Y+AP+
Sbjct: 146 HKLGIIYRDIKLENIL-----LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 668 WLR--NVPVTTKVDVFSFGVMLLEIICGRR 695
+R + VD +S GV++ E++ G
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (303), Expect = 1e-30
Identities = 53/325 (16%), Positives = 106/325 (32%), Gaps = 45/325 (13%)
Query: 463 KRRNYFDPNSMEINFREFTFQELQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKK 522
+ R Y+D S + + +L + +G G +V+ ++ VK
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLV-------RKLGRGKYSEVFEA--INITNNEKVVVKI 67
Query: 523 LEKDIEKTNEEFMTELKIIGR-THHKNLVRLLGFCSEEDKRL--LVYELMPNGTLSNFLF 579
L+ +K + E+KI+ N++ L + R LV+E + N
Sbjct: 68 LKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY- 123
Query: 580 HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639
Q + + L Y H I+H D+KP NV++D + + ++ D
Sbjct: 124 ---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHE----HRKLRLID 173
Query: 640 FGISKLLNKDQTRTDTNMRGTMGYVAPE-WLRNVPVTTKVDVFSFGVMLLEIICGRRHIE 698
+G+++ + Q + + PE + +D++S G ML +I +
Sbjct: 174 WGLAEFYHPGQEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231
Query: 699 LSRVEEESEEVDI------VLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLW 752
+ L D++ + + + ERF L
Sbjct: 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 291
Query: 753 ----------CNHPDPNLRPSMKKV 767
D R + ++
Sbjct: 292 SPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-29
Identities = 48/209 (22%), Positives = 83/209 (39%), Gaps = 24/209 (11%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN--EEFMTELKIIGRTHHKNLVR 551
K +G+G+ G V +A+KKL + + + EL ++ +HKN++
Sbjct: 23 KPIGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 552 LLGFCS------EEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLH 605
LL + E LV ELM + + + G+ +LH
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH 136
Query: 606 EECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA 665
IIH D+KP N + ++ KI DFG+++ T T Y A
Sbjct: 137 SAG---IIHRDLKPSN-----IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRA 186
Query: 666 PEWLRNVPVTTKVDVFSFGVMLLEIICGR 694
PE + + VD++S G ++ E++ +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-28
Identities = 59/311 (18%), Positives = 109/311 (35%), Gaps = 33/311 (10%)
Query: 479 EFTFQELQEATKGFS------KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTN- 531
F QEL + VG+G+ G V T + +AVKKL + +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIH 60
Query: 532 -EEFMTELKIIGRTHHKNLVRLLGFCSEEDK---RLLVYELMPNGTLSNFLFHEGQRPGW 587
+ EL+++ H+N++ LL + VY + + Q+
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 588 VQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647
+ + RGL Y+H IIH D+KP N+ ++ + KI DFG+++ +
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLA-----VNEDCELKILDFGLARHTD 172
Query: 648 KDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR-------HIELS 700
+ T + L + VD++S G ++ E++ GR +L
Sbjct: 173 DEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
Query: 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGL--WCNHPDP 758
+ L + S +Q L +++ V L D
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289
Query: 759 NLRPSMKKVIH 769
+ R + + +
Sbjct: 290 DKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 3e-28
Identities = 47/241 (19%), Positives = 92/241 (38%), Gaps = 25/241 (10%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLL 553
+ +G G V+ + +A+K + D + E E+K++ R + + +
Sbjct: 19 RKLGWGHFSTVWLA--KDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 554 GFCSEEDKRLLVY---------------ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVA 598
+ +LL + E++ L+ +E + + +I+ +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 599 RGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMR 658
GL Y+H C IIH DIKP+NVL+++ + + I+ L N
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIV----DSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 659 -GTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717
T Y +PE L P D++S ++ E+I G E +++ D +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 718 I 718
+
Sbjct: 250 L 250
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.1 bits (189), Expect = 8e-17
Identities = 33/207 (15%), Positives = 59/207 (28%), Gaps = 32/207 (15%)
Query: 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI----------EKTNEEFMTELKIIGR 543
KL+G G V+ E VK + + + F R
Sbjct: 6 KLMGEGKESAVFNCYSE---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 544 THHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQR-VEIALGVARGLL 602
+ L +L G + Y N L + + V+ E+ + +
Sbjct: 63 NEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVA 117
Query: 603 YLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQTRTDTNMRGTMG 662
+ I+H D+ NVL+ I DF S + ++ R
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVS------EEGIWIIDFPQSVEVGEEGWREILERDVR-- 166
Query: 663 YVAPEWLRNVPVTTKVDVFSFGVMLLE 689
+ T+ D+ S +L+
Sbjct: 167 -NIITYFSR-TYRTEKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 73.8 bits (181), Expect = 2e-16
Identities = 22/140 (15%), Positives = 38/140 (27%), Gaps = 35/140 (25%)
Query: 65 IWFDKIPEKTLVWAADRDSPAEAGS-KITLTNDGKLLLTYFNGSV---QQIYSGAASLAL 120
I + + ++++ D L+L + V G A+
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71
Query: 121 MQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQ 180
+Q +G + + VW S + S G Y +Q
Sbjct: 72 LQPNGRMDVLTNQNIAVWTSGN--------------------------SRSAGRYVFVLQ 105
Query: 181 ADGNLVLSAYHFADPGYWYT 200
D NL + Y W T
Sbjct: 106 PDRNLAI--Y---GGALWTT 120
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 56.5 bits (136), Expect = 2e-10
Identities = 17/130 (13%), Positives = 38/130 (29%), Gaps = 20/130 (15%)
Query: 125 GNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGN 184
G+ V+ N +++++ + Q L + L Y L M+ D N
Sbjct: 1 GSVVVANNGNSILYSTQGNDN----HPQTLHATQSL----------QLSPYRLSMETDCN 46
Query: 185 LVLSAYHFADPGYWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYH 244
LVL + D + + + M ++ + ++ +
Sbjct: 47 LVL--FDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSG----NSRSAGRY 100
Query: 245 RATIDGHGNF 254
+ N
Sbjct: 101 VFVLQPDRNL 110
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 72.7 bits (178), Expect = 5e-16
Identities = 30/141 (21%), Positives = 46/141 (32%), Gaps = 34/141 (24%)
Query: 65 IWFDKIPEKTLVWAADRDSPAEAGS-KITLTNDGKLLLTYFNGSV--QQIYSGAASLALM 121
I F E + E S + T+ +D L+L + V A++
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 122 QNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQA 181
Q+DG V+ A + + W S S GNY L +Q
Sbjct: 63 QSDGLLVILTAQNTIRWSSG--------------------------TKGSIGNYVLVLQP 96
Query: 182 DGNLVLSAYHFADPGYWYTGT 202
D + + PG W +GT
Sbjct: 97 DRTVTIY-----GPGLWDSGT 112
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 58.4 bits (141), Expect = 3e-11
Identities = 20/111 (18%), Positives = 40/111 (36%), Gaps = 12/111 (10%)
Query: 38 SNTSWLSPSGDFAFGFYSL-FGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTND 96
+N L Y L ++ T VWA++ + G K L +D
Sbjct: 5 TNGEGLYAGQSLDVEPYHFIMQEDCNLVLY----DHSTSVWASNTGILGKKGCKAVLQSD 60
Query: 97 GKLLLTYFNG----SVQQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDF 143
G ++ G + + + ++Q DGN V+ ++ +W + +
Sbjct: 61 GNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 43.0 bits (101), Expect = 1e-05
Identities = 18/111 (16%), Positives = 35/111 (31%), Gaps = 19/111 (17%)
Query: 146 DTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTL 205
+ + G+ L G+ L Y MQ D NLVL + W + T L
Sbjct: 2 NLLTNGEGLYAGQSL----------DVEPYHFIMQEDCNLVLYDH---STSVWASNTGIL 48
Query: 206 NNV--SLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNF 254
+ + ++ G +++ + + + + GN
Sbjct: 49 GKKGCKAVLQSDGNFVVYDAEGRSLWA----SHSVRGNGNYVLVLQEDGNV 95
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 58.5 bits (141), Expect = 5e-11
Identities = 24/122 (19%), Positives = 45/122 (36%), Gaps = 16/122 (13%)
Query: 89 SKITLTNDGKLLLTYFNGSVQQIYSGAASLALMQNDGNFVLKNANSAVVW-DSFDFPTDT 147
SK N ++L + S++ ++ +MQ D N VL + N+ + ++
Sbjct: 6 SKQPDDNHPQIL--HATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGC 63
Query: 148 ILPGQVLLTGKKLYSNSRGTADYSTG------NYTLEMQADGNLVLSAYHFADPGYWYTG 201
Q G + + + + +Y L +Q D N+V+ W T
Sbjct: 64 RAVLQP--DGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY-----GDALWATQ 116
Query: 202 TV 203
TV
Sbjct: 117 TV 118
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.4 bits (133), Expect = 6e-10
Identities = 16/118 (13%), Positives = 32/118 (27%), Gaps = 18/118 (15%)
Query: 137 VWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPG 196
D L++ + T Y MQ D NLVL Y +P
Sbjct: 6 SKQPDDNHPQI------------LHATESLEILFGTHVYRFIMQTDCNLVL--YDNNNPI 51
Query: 197 YWYTGTVTLNNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNF 254
+ N + + +I + +++ + ++ + N
Sbjct: 52 WATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP----VAGKAGHYVLVLQPDRNV 105
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 53.6 bits (128), Expect = 2e-09
Identities = 24/124 (19%), Positives = 40/124 (32%), Gaps = 21/124 (16%)
Query: 145 TDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVT 204
+D + G L TG L G Y +Q D NLVL + A W +GT
Sbjct: 1 SDRLNSGHQLDTGGSLAE----------GGYLFIIQNDCNLVLYDNNRA---VWASGTNG 47
Query: 205 LNNVS-LIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKST 263
+ L + + + + T ++ + + N Y S
Sbjct: 48 KASGCVLKMQNDGNLVIYSGSRAIWAS-----NTNRQNGNYYLILQRDRNVVI--YDNSN 100
Query: 264 SSRW 267
++ W
Sbjct: 101 NAIW 104
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 47.9 bits (113), Expect = 2e-07
Identities = 19/122 (15%), Positives = 48/122 (39%), Gaps = 16/122 (13%)
Query: 28 ISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEA 87
++ G + G + + G + F + L ++ + VWA+ + A +
Sbjct: 4 LNSGHQLDTGGSLA----EGGYLFIIQNDCN----LVLYDNNRA----VWASGTNGKA-S 50
Query: 88 GSKITLTNDGKLLLTYFNGSV---QQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDFP 144
G + + NDG L++ + ++ ++Q D N V+ + ++ +W +
Sbjct: 51 GCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110
Query: 145 TD 146
+
Sbjct: 111 GN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 50.8 bits (121), Expect = 2e-08
Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 16/109 (14%)
Query: 146 DTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTL 205
+ + G+ L TG+ L + G++ MQ D NLVL Y P +
Sbjct: 2 NILYSGETLSTGEFL----------NYGSFVFIMQEDCNLVL--YDVDKPIWATNTGGLS 49
Query: 206 NNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNF 254
+ L + + N + I+ T ++ + + N
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWA----SNTGGQNGNYVCILQKDRNV 94
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 49.2 bits (117), Expect = 6e-08
Identities = 22/103 (21%), Positives = 34/103 (33%), Gaps = 15/103 (14%)
Query: 109 QQIYSGAASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQ-------VLLTGKKLY 161
+ + G+ MQ D N VL + + + W + V+
Sbjct: 14 EFLNYGSFVFI-MQEDCNLVLYDVDKPI-WATNTGGLSRSCFLSMQTDGNLVVYNPSNKP 71
Query: 162 SNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVT 204
+ T GNY +Q D N+V+ W TGT T
Sbjct: 72 IWASNTG-GQNGNYVCILQKDRNVVIY-----GTDRWATGTHT 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 36.5 bits (84), Expect = 0.002
Identities = 15/109 (13%), Positives = 32/109 (29%), Gaps = 19/109 (17%)
Query: 42 WLSPSGDFAFGFYSLF----GGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDG 97
LS +G + L L +WA + + +++ DG
Sbjct: 9 TLSTGEFLNYGSFVFIMQEDCNLVLYD-------VDKPIWATNTGGLS-RSCFLSMQTDG 60
Query: 98 KLLL----TYFNGSVQQIYSGAASLALMQNDGNFVLKNANSAVVWDSFD 142
L++ + + ++Q D N V+ + W +
Sbjct: 61 NLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATGT 106
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 788 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.71 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.62 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.59 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.58 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.41 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.15 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.78 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.71 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.51 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.5 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.41 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.38 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.01 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.44 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.73 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.97 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.53 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 86.94 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 81.73 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.07 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-49 Score=415.07 Aligned_cols=270 Identities=27% Similarity=0.499 Sum_probs=206.7
Q ss_pred cccCHHHHHHHhhcc-----------cccccccccceEEEEEEeccC-cceeeeeeecccc-hHHHHHHHHHHHHHhcCC
Q 047157 478 REFTFQELQEATKGF-----------SKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKD-IEKTNEEFMTELKIIGRT 544 (788)
Q Consensus 478 ~~~~~~~l~~~t~~~-----------~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l 544 (788)
..++|+++.+++..| .++||+|+||+||+|.++..+ ....||||.+... .....++|.+|+++|+++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 345666666655444 468999999999999986332 3346899988653 345567899999999999
Q ss_pred CccccceEeeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEe
Q 047157 545 HHKNLVRLLGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLL 624 (788)
Q Consensus 545 ~hpniv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 624 (788)
+|||||++++++.+++..++||||+++|+|.+++......+++.+++.++.||++||.|||++ +|+||||||+||||
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 999999999999999999999999999999999988777899999999999999999999999 99999999999999
Q ss_pred ccCCCCCCCcEEEeecCCccccCCCCCcc----cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCc
Q 047157 625 DLKTLDTNYMAKISDFGISKLLNKDQTRT----DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIEL 699 (788)
Q Consensus 625 ~~~~~~~~~~~kL~Dfg~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~ 699 (788)
+ .++.+||+|||+++.+....... .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 162 ~-----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 162 N-----SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp C-----TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred C-----CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 8 88899999999998765433221 122457899999999999999999999999999999998 8999975
Q ss_pred cccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
....+. . ..+..+ .....+....+.+.+|+.+||+.||++||||+||++.|+++++
T Consensus 237 ~~~~~~--------~----~~i~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 237 MTNQDV--------I----NAIEQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCHHHH--------H----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHHH--------H----HHHHcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 432211 1 111111 1111122345678899999999999999999999999988754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=408.25 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=198.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.+.+.++||+|+||+||+|.+. ++..||||+++... ...++|.+|++++++++||||++++|++.+++..++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET---TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEEC---CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 3567789999999999999874 45689999997643 3456899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++|+|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++....
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~-----~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVG-----ENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEEC-----GGGCEEECSCC-------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeec-----CCCCeEecccchheeccC
Confidence 999999999988778899999999999999999999999 999999999999999 788999999999987765
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCC-CCCccccccccccchhhhHHHHHHHhhccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR-HIELSRVEEESEEVDIVLSDWVISCMLSRNLQ 727 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (788)
..........||+.|+|||++.+..++.++|||||||++|||+|+.. |+......+ ... ....+..
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--------~~~----~i~~~~~- 220 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVE----DISTGFR- 220 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--------HHH----HHHHTCC-
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--------HHH----HHHhcCC-
Confidence 54444445678999999999999999999999999999999999654 444322111 111 1111100
Q ss_pred ccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 728 VLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 728 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
. ..+ ....+++.+++.+||+.||++||||+||+++|+++.+
T Consensus 221 -~--~~p-----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 221 -L--YKP-----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -C--CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -C--CCc-----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 0 011 1223578899999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-49 Score=412.13 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=214.9
Q ss_pred HHHHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
+....+.+.++||+|+||+||+|.++ .++..||||+++... ...++|.+|++++++++|||||++++++.+++..++
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEG--GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEEC--CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 44456778899999999999999987 677899999997553 345689999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 565 VYELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
||||+++|+|.+++... ...+++..+..++.||++||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~-----~~~~~Kl~DFG~a 162 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVG-----ENHLVKVADFGLS 162 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----GGGCEEECCCCCT
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEEC-----CCCcEEEccccce
Confidence 99999999999999754 45789999999999999999999999 999999999999998 7889999999999
Q ss_pred cccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 644 KLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 644 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
+..............|++.|+|||++.+..++.++|||||||++|||++|..|+....... . .......
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-------~----~~~~i~~ 231 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------Q----VYELLEK 231 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------H----HHHHHHT
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-------H----HHHHHhc
Confidence 9876655555555668999999999999999999999999999999999877764332111 0 1111111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
+ ..........+++.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 232 ~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 232 D---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred C---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 0111111234678899999999999999999999999987653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=396.85 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=205.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||+||+|+.+ .++..||+|.+.+.. ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREK--QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEEC--CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 3778899999999999999986 677899999986432 23456789999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++.+. ..+++..+..++.||++||+|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~-----~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLG-----SAGELKIADFGWSVH 155 (263)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTSCEEECCCCSCSC
T ss_pred EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---Ceeeeeeccccceec-----CCCCEeecccceeee
Confidence 9999999999999654 5689999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ........
T Consensus 156 ~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------------~~~i~~~~ 220 (263)
T d2j4za1 156 APSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------------YKRISRVE 220 (263)
T ss_dssp CCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------------HHHHHTTC
T ss_pred cCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH------------HHHHHcCC
Confidence 65432 2346799999999999999999999999999999999999999976432211 11111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
+.. +....+++.+++.+||+.||++|||++|+++
T Consensus 221 --------~~~--p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 --------FTF--PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --------CCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCC--CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 110 1112456788999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=400.67 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=206.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.++||+|+||+||+|..+ .++..||||++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~--~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDV--ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBT--TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEecCcCcEEEEEEEC--CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 3667789999999999999876 66789999999766555667899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++|+|.+++.+ ..+++.++..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.+..
T Consensus 99 ~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~-----~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLG-----MDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTCCEEECCCTTCEECCS
T ss_pred cCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEEC-----CCCcEeeccchhheeecc
Confidence 999999998855 3689999999999999999999999 999999999999998 778999999999987754
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ........
T Consensus 169 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----------~~~~~~~~---- 232 (293)
T d1yhwa1 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----------LYLIATNG---- 232 (293)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----------HHHHHHHC----
T ss_pred ccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-----------HHHHHhCC----
Confidence 332 23446799999999999999999999999999999999999999975432111 00001110
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.+.........+.+.+++.+||+.||++|||++|+++
T Consensus 233 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 233 ----TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ----SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111112223467888999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=395.19 Aligned_cols=252 Identities=26% Similarity=0.422 Sum_probs=211.9
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecC
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELM 569 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~ 569 (788)
+.+.++||+|+||+||+|+++ ++..||||.++... ...++|.+|++++++++||||+++++++.+++..++||||+
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEET---TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred CEEeEEEecCCCeEEEEEEEC---CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 457789999999999999974 56689999997643 34568999999999999999999999999999999999999
Q ss_pred CCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCC
Q 047157 570 PNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKD 649 (788)
Q Consensus 570 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~ 649 (788)
++|+|.+++......+++..+++++.||++||.|||++ +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~-----~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVN-----DQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEEC-----TTCCEEECCCSSCCBCSSS
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEc-----CCCcEEECcchhheeccCC
Confidence 99999999888778899999999999999999999999 999999999999998 7889999999999877655
Q ss_pred CCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 650 QTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 650 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
.........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+. ...+..+.
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~------------~~~i~~~~--- 218 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------------AEHIAQGL--- 218 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------------HHHHHTTC---
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH------------HHHHHhCC---
Confidence 5444555678999999999999999999999999999999998 8999976532221 11111111
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
....+....+++.+++.+||+.||++|||++||+++|..+
T Consensus 219 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 ------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 0011112335788999999999999999999999999653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=397.84 Aligned_cols=251 Identities=25% Similarity=0.302 Sum_probs=201.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.|.+.++||+|+||+||+|+++ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+++..+||||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNR--VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 3677899999999999999987 667899999986543 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|+...
T Consensus 84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~-----~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLD-----ERDNLKISDFGLATVFR 154 (271)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC-----TTCCEEECCCTTCEECE
T ss_pred ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEEC-----CCCCEEEccchhheeec
Confidence 9999999999954 35789999999999999999999999 999999999999998 77899999999999765
Q ss_pred CCCC-cccccccCCccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 648 KDQT-RTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 648 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ .... ....
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~~-----~~~~- 222 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSD-----WKEK- 222 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH------HHHH-----HHTT-
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH------HHHH-----HhcC-
Confidence 4332 23345689999999999988876 5789999999999999999999975432111 0000 0000
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...........+++.+|+.+||+.||++|||++|+++
T Consensus 223 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 -------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001111122456778999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=402.81 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=205.8
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
...+.+.+.||+|+||+||+|.++ ++..||||+++... ...+.|.+|++++++++|||||++++++.+ +..++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC---CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 345677899999999999999974 55689999997543 345689999999999999999999998855 5679999
Q ss_pred ecCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 567 ELMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 567 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
||+++|+|.+++... ...+++..++.|+.||++||.|||++ +|+||||||+||||+ .++.+||+|||+++.
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~-----~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS-----DTLSCKIADFGLARL 158 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTSCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeee-----cccceeeccccceEE
Confidence 999999999988544 34689999999999999999999999 999999999999998 888999999999998
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
+............||+.|+|||++.+..++.++|||||||++|||+||..|+....... . .......+.
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-------~----~~~~i~~~~ 227 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------E----VIQNLERGY 227 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------H----HHHHHHTTC
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-------H----HHHHHHhcC
Confidence 76655545555678999999999999999999999999999999999766654321110 0 111111110
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
....+....+++.+|+.+||+.||++||||+||+++|+..
T Consensus 228 ---------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 228 ---------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 0011112345688999999999999999999999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=400.85 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=206.4
Q ss_pred hcccc-cccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 490 KGFSK-LVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 490 ~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
+.+.+ +||+|+||+||+|.++..+++..||||.++... ....++|.+|+++|++++|||||++++++.+ +..+||||
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE 88 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 88 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence 33445 499999999999988766667789999986543 4456789999999999999999999999865 46899999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++|+|.+++......+++..+..++.||++||.|||++ +|+||||||+|||++ .++.+||+|||+++.+.
T Consensus 89 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~-----~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 89 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLV-----NRHYAKISDFGLSKALG 160 (285)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEE-----ETTEEEECCCTTCEECT
T ss_pred eCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeec-----cCCceeeccchhhhccc
Confidence 9999999999877777899999999999999999999999 999999999999998 78899999999999775
Q ss_pred CCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 648 KDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 648 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+. ...+..+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~------------~~~i~~~ 228 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------------MAFIEQG 228 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH------------HHHHHTT
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH------------HHHHHcC
Confidence 54332 2234568999999999999999999999999999999998 8999975432111 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
.. +. .+...++++.+|+.+||+.||++|||+.+|++.|+..
T Consensus 229 ~~-------~~--~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 229 KR-------ME--CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CC-------CC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-------CC--CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 11 1112346788999999999999999999999988753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=403.66 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=207.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||+||+|.++ .++..||||+++.......+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNK--ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CeEEeEEEeeCCCcEEEEEEEC--CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 3667889999999999999887 67789999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++|+|.+++.+....+++.++..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.....
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~-----~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFT-----LDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEECCCTTCEECHH
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeEC-----CCCCEEEEechhhhccCC
Confidence 999999999877777899999999999999999999999 999999999999998 788999999999976532
Q ss_pred CCCcccccccCCccccCccccc-----CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLR-----NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. .....
T Consensus 163 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------------~~i~~ 229 (288)
T d2jfla1 163 TI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------------LKIAK 229 (288)
T ss_dssp HH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------------HHHHH
T ss_pred Cc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------------HHHHc
Confidence 21 1223467999999999983 556899999999999999999999999765322210 00111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.. .+.........+++.+|+.+||+.||++|||++|+++
T Consensus 230 ~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 SE-------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SC-------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC-------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1111112234567889999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=397.75 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=201.6
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
..+.+.++||+|+||+||+|+++ + .||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~----~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH----G-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS----S-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC----C-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34567789999999999999753 2 5999988643 34556789999999999999999999998754 568999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++...+..+++..+..++.||++||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~-----~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLH-----EDLTVKIGDFGLATV 153 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE-----TTSSEEECCCCCSCC
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEc-----CCCCEEEccccceee
Confidence 999999999999987777899999999999999999999999 999999999999998 888999999999987
Q ss_pred cCCCCC-cccccccCCccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 646 LNKDQT-RTDTNMRGTMGYVAPEWLRN---VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 646 ~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ .........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-------~~~~~~~~~ 226 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------IIFMVGRGY 226 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-------HHHHHHHTS
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-------HHHHHhcCC
Confidence 654332 23345679999999999864 3589999999999999999999999975422111 111111111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
....... .....++.+.+|+.+||+.||++|||++||+++|+.+.+
T Consensus 227 ~~p~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 227 LSPDLSK---------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCCCGGG---------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcchh---------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111111 111234678889999999999999999999999987653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=401.49 Aligned_cols=261 Identities=25% Similarity=0.462 Sum_probs=203.3
Q ss_pred hhcccccccccccceEEEEEEeccC--cceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKD--TQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.+.+.++||+|+||+||+|.++... ....||||++.... ....++|.+|++++++++|||||+++|++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 4556789999999999999987432 23579999986433 44556899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+.+++|.+++......+++.++..++.||+.||.|||++ +|+||||||+||||+ .++.+||+|||+++.
T Consensus 88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~-----~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVN-----SNLVCKVSDFGLSRV 159 (283)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTCCEEECCCCC---
T ss_pred EEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEEC-----CCCeEEEcccchhhc
Confidence 999999999999988878899999999999999999999999 999999999999998 888999999999987
Q ss_pred cCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 646 LNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 646 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|..|+....... . +...+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-------~----~~~~i~~ 228 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------E----VMKAIND 228 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H----HHHHHHT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-------H----HHHHHhc
Confidence 6543322 2233568999999999999999999999999999999999776654321110 0 1111111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCC
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEV 777 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 777 (788)
+. ....+...+.++.+|+.+||+.||++||||.||+++|+++.+.
T Consensus 229 ~~---------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 229 GF---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TC---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cC---------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11 1111122346788999999999999999999999999887653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=396.27 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=201.2
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEecCCC
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYELMPN 571 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~~~~ 571 (788)
++||+|+||+||+|.++....++.||||+++... ....++|.+|++++++++|||||+++++|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 5799999999999998766677899999986432 3445789999999999999999999999965 457899999999
Q ss_pred CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCCCCC
Q 047157 572 GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNKDQT 651 (788)
Q Consensus 572 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~ 651 (788)
|+|.+++.+. ..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~-----~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLV-----TQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE-----ETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhccc-----ccCcccccchhhhhhcccccc
Confidence 9999998654 5689999999999999999999999 999999999999998 788999999999987654433
Q ss_pred cc--cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 652 RT--DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 652 ~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
.. .....||+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ +...+..+..
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~------------~~~~i~~~~~-- 228 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------------VTAMLEKGER-- 228 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------------HHHHHHTTCC--
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH------------HHHHHHcCCC--
Confidence 22 234568999999999999999999999999999999998 899997543211 1111111111
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhc
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEG 773 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 773 (788)
+. .+...++++.+|+.+||+.||++|||+++|+++|+.
T Consensus 229 -----~~--~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 -----MG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -----CC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CC--CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11 111234678899999999999999999999998865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=390.67 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=197.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEec----CCeEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE----EDKRL 563 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 563 (788)
+++.++||+|+||+||+|.+. .++..||+|.+... .....+.+.+|++++++++|||||++++++.+ ....+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~--~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDT--ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEEC--CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 356678999999999999886 67779999998654 24456789999999999999999999999865 34689
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCc--eEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQ--IIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
+||||+++|+|.+++.+. ..+++..+..++.||++||+|||++ + |+||||||+|||++. +++.+||+|||
T Consensus 89 ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~----~~~~~Kl~DFG 160 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITG----PTGSVKIGDLG 160 (270)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESS----TTSCEEECCTT
T ss_pred EEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeC----CCCCEEEeecC
Confidence 999999999999999654 5689999999999999999999998 6 999999999999961 46789999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+++...... .....||+.|+|||++.+ +++.++|||||||++|||++|+.||........ .....
T Consensus 161 la~~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----------~~~~i 225 (270)
T d1t4ha_ 161 LATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----------IYRRV 225 (270)
T ss_dssp GGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----------HHHHH
T ss_pred cceeccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----------HHHHH
Confidence 998654332 234679999999999876 699999999999999999999999964321110 11111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..+..... .+....+++.+|+.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 226 TSGVKPAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTTCCCGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HcCCCCcc--------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111110 11112345788999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=393.40 Aligned_cols=252 Identities=20% Similarity=0.303 Sum_probs=193.4
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEec--CCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE--EDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 564 (788)
.|.+.+.||+|+||+||+|+.+ .+++.||||.+... .....+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRK--SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hCEEeEEEecCCCeEEEEEEEC--CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 4677899999999999999886 66779999998644 24456789999999999999999999999865 456899
Q ss_pred EEecCCCCCHhHhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 565 VYELMPNGTLSNFLFH---EGQRPGWVQRVEIALGVARGLLYLHEEC--ETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~--~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
||||+++|+|.+++.+ ....+++..++.++.||+.||.|||++. ..+|+||||||+|||++ .++.+||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-----~~~~vkl~D 157 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-----GKQNVKLGD 157 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-----TTSCEEECC
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-----CCCcEEEee
Confidence 9999999999999864 3567899999999999999999999871 12499999999999998 788999999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHH
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+ ...
T Consensus 158 FG~a~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------------~~~ 224 (269)
T d2java1 158 FGLARILNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------------LAG 224 (269)
T ss_dssp HHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------------HHH
T ss_pred ccceeecccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------------HHH
Confidence 9999887543322 234679999999999999999999999999999999999999997543221 111
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.+..+....+ +....+++.+|+.+||+.||++|||++|+++
T Consensus 225 ~i~~~~~~~~---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 225 KIREGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1222222111 1123457888999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=406.65 Aligned_cols=269 Identities=23% Similarity=0.328 Sum_probs=205.2
Q ss_pred HHhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
...|.+.++||+|+||+||+|... .++..||+|+++... ....+.+.+|+.+|++++|||||+++++|.+.+..++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHK--PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEET--TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEEC--CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 445777899999999999999886 678899999986542 34457899999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||+ + +|+||||||+|||++ .++.+||+|||+|+
T Consensus 83 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~-----~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVN-----SRGEIKLCDFGVSG 153 (322)
T ss_dssp EECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEEC-----TTCCEEECCCCCCH
T ss_pred EEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeEC-----CCCCEEEeeCCCcc
Confidence 9999999999999765 468999999999999999999997 5 799999999999998 78899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh-hHHHH------
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV-LSDWV------ 717 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~------ 717 (788)
...... .....||+.|+|||++.+.+++.++||||+||++|||++|+.||......+........ .....
T Consensus 154 ~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 154 QLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHHHHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred ccCCCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 654322 23468999999999999999999999999999999999999999765432211000000 00000
Q ss_pred -------HHHhh----cc----cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 718 -------ISCML----SR----NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 718 -------~~~~~----~~----~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
..... .. .........+..........++.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000 00 000000001111111122456888999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=397.18 Aligned_cols=264 Identities=25% Similarity=0.383 Sum_probs=205.2
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
..+.+.+.||+|+||+||+|.++ ++..||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~---~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN---GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC---CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 45788899999999999999885 34579999997543 345789999999999999999999999854 56899999
Q ss_pred cCCCCCHhHhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHE-GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+++|+|..++... ...+++.+++.++.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+++..
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~-----~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG-----ENLVCKVADFGLARLI 163 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----GGGCEEECCCCTTC--
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEEC-----CCCcEEEcccchhhhc
Confidence 99999999998654 35689999999999999999999999 999999999999998 7889999999999877
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
............||+.|+|||++....++.++||||||+++|||++|..|+....... ... ..+..+.
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-------~~~----~~i~~~~- 231 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVL----DQVERGY- 231 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHH----HHHHTTC-
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-------HHH----HHHHhcC-
Confidence 5554444455678999999999999999999999999999999999877665432111 011 1111111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcCCCCCCCCC
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLEVGMPPLLH 784 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~pp~p~ 784 (788)
.+ .......+++.+++.+||+.||++||||++|+++|+.......|+.+|
T Consensus 232 ------~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 232 ------RM--PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp ------CC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred ------CC--CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 00 111123457889999999999999999999999999877655565444
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=396.75 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=201.9
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||+||+|..+ .+++.||||.+.+.. ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLAREL--ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 4778899999999999999886 667799999987532 23456799999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 87 mEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~-----~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLN-----EDMHIQITDFGTAKV 157 (288)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTSCEEECCCTTCEE
T ss_pred EEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccC-----CCceEEeccccccee
Confidence 9999999999998655 5689999999999999999999999 999999999999998 788999999999997
Q ss_pred cCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 646 LNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 646 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. .......
T Consensus 158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------------~~~i~~~ 225 (288)
T d1uu3a_ 158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------------FQKIIKL 225 (288)
T ss_dssp CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHTT
T ss_pred cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH------------HHHHHcC
Confidence 7544322 23346799999999999999999999999999999999999999976432211 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVI 768 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 768 (788)
.. .. +....+++.+|+.+||+.||++|||++|++
T Consensus 226 ~~--------~~--p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 226 EY--------DF--PEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CC--------CC--CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CC--------CC--CccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11 11 112245678899999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-46 Score=400.86 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=211.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.++||+|+||+||+|+.+ .++..||||++........+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTER--ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CeEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5788899999999999999886 67889999999876666678899999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++|+|.+++.+....+++..+..++.||+.||.|||++ +|+||||||+|||++.+ .++.+||+|||+++.+..
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~---~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTK---RSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESST---TSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccC---CCCeEEEeecchheeccc
Confidence 999999999977767899999999999999999999999 99999999999999632 457899999999987654
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ........
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------------~~i~~~~~-- 242 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDW-- 242 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------------HHHHHTCC--
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH------------HHHHhCCC--
Confidence 332 23467899999999999999999999999999999999999999765322111 11111110
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...........+.+.+|+.+||+.||++|||++|++++
T Consensus 243 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 ----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111111234567889999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-46 Score=400.08 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=212.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||+||+|... .++..||||++........+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEK--ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4778899999999999999886 66789999999876666677889999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++|+|.+++...+..+++.++..|+.||+.||.|||++ +|+||||||+|||++.. .++.+||+|||++..+..
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~---~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETK---KASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESST---TCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccccccccccc---CCCeEEEeecccceecCC
Confidence 999999999877777899999999999999999999999 99999999999999732 457899999999998765
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+......
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------------~~~i~~~~~~- 246 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------------LQNVKRCDWE- 246 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------------HHHHHHCCCC-
T ss_pred CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------------HHHHHhCCCC-
Confidence 432 2345789999999999999999999999999999999999999976532211 0111111111
Q ss_pred cccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhc
Q 047157 729 LVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEG 773 (788)
Q Consensus 729 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~ 773 (788)
...........++.+|+.+||+.||++|||++|++++ +++
T Consensus 247 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 247 -----FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp -----CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred -----CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0001111234567889999999999999999999874 544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=403.22 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=205.3
Q ss_pred HHhhcccccccccccceEEEEEEecc---Ccceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecCCe
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 561 (788)
...+.+.++||+|+||+||+|++... .....||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 34577889999999999999998632 223579999886432 34456789999999988 89999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccC----------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCC
Q 047157 562 RLLVYELMPNGTLSNFLFHEG----------------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKP 619 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp 619 (788)
.++||||+++|+|.++|.... ..+++..++.++.||++||+|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 999999999999999996543 2478899999999999999999999 999999999
Q ss_pred CcEEeccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCC
Q 047157 620 QNVLLDLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHI 697 (788)
Q Consensus 620 ~NIll~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~ 697 (788)
+|||++ .++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 193 ~Nill~-----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 193 RNVLVT-----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp GGEEEE-----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred hccccc-----cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999998 8889999999999876544332 2334568999999999999999999999999999999997 89999
Q ss_pred CccccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhh
Q 047157 698 ELSRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLE 772 (788)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 772 (788)
........ +.. ....+ .....+....+++.+|+.+||+.||++|||++||+++|.
T Consensus 268 ~~~~~~~~-------~~~----~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDAN-------FYK----LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHH-------HHH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHH-------HHH----HHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 75432211 111 11111 011111123467889999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-46 Score=394.28 Aligned_cols=255 Identities=23% Similarity=0.304 Sum_probs=191.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
..|.+.++||+|+||+||+|..+ .+++.||||.+.... ....+.+.+|++++++++||||+++++++.+++..||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDK--RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEET--TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEEC--CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34778899999999999999886 667799999987543 334467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+.... +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~--~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLD--EDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS--TTCCEEECCC------
T ss_pred eccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccC--CCceEEEeccceeEEc
Confidence 999999999999654 5789999999999999999999999 999999999999996432 5789999999999866
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
..... .....||+.|+|||++.+..+++++|||||||++|||++|+.||......+. .........
T Consensus 161 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------------~~~i~~~~~ 226 (307)
T d1a06a_ 161 DPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------------FEQILKAEY 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------------HHHHHTTCC
T ss_pred cCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH------------HHHHhccCC
Confidence 43322 2346799999999999999999999999999999999999999975432211 111111111
Q ss_pred cccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 727 QVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 727 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
. ..........+.+.+++.+||+.||++|||++|++++
T Consensus 227 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 E------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp C------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 0001111234568889999999999999999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=391.20 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=199.8
Q ss_pred HHhhcccccccccccceEEEEEEecc-Ccceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
...|.+.+.||+|+||.||+|++... .....||||.++... ....+.+.+|++++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 34577889999999999999988633 334679999986433 445678999999999999999999999985 467899
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++|+|.+++......+++..++.++.||++||.|||++ +|+||||||+||+++ .++.+||+|||+++
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~-----~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS-----SNDCVKLGDFGLSR 156 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE-----ETTEEEECC-----
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---Ceeccccchhheeec-----CCCcEEEccchhhe
Confidence 9999999999999887777899999999999999999999999 999999999999998 78899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
..............||+.|+|||.+.+..++.++|||||||++|||++ |..||......+.. .....
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~------------~~i~~ 224 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI------------GRIEN 224 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------------HHHHT
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH------------HHHHc
Confidence 776544444455678999999999999999999999999999999998 88898765332211 11111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
+.... .+...++.+.+|+.+||+.||++|||++||++.|+.++
T Consensus 225 ~~~~~---------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 225 GERLP---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC---------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11111 11123467889999999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-46 Score=392.08 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=201.3
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
..|...+.||+|+||+||+|+.. .++..||||++.... ....+.+.+|++++++++|||||++++++.+++..++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDV--RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET--TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEEC--CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 34677789999999999999886 678899999986432 3445679999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++|+|..++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 93 v~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~-----~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLS-----EPGLVKLGDFGSAS 163 (309)
T ss_dssp EEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEE-----TTTEEEECCCTTCB
T ss_pred EEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEC-----CCCCEEEeeccccc
Confidence 9999999999776644 46789999999999999999999999 999999999999998 88899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccC---CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRN---VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
..... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. . ...
T Consensus 164 ~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----------~-~~i 226 (309)
T d1u5ra_ 164 IMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------L-YHI 226 (309)
T ss_dssp SSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----------H-HHH
T ss_pred ccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-----------H-HHH
Confidence 65432 23579999999999853 4689999999999999999999999975422111 0 011
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
.......+ ......+.+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 227 AQNESPAL--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHSCCCCC--------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhCCCCCC--------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111111 11123467888999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=388.15 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=207.0
Q ss_pred cccccccccccceEEEEEEeccC-cceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEec-CCeEEEEEe
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKD-TQIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-EDKRLLVYE 567 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lV~e 567 (788)
+|.++||+|+||+||+|.+.... ....||||+++.. .....++|.+|++++++++||||++++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 45688999999999999986432 3457999998643 35556889999999999999999999999865 568999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+++++|.+++.......++..++.++.|++.||.|||+. +|+||||||+|||++ +++.+||+|||+++...
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~-----~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLD-----EKFTVKVADFGLARDMY 181 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----TTCCEEECSSGGGCCTT
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeEC-----CCCCEEEecccchhhcc
Confidence 9999999999988878889999999999999999999999 999999999999998 88899999999998765
Q ss_pred CCCCc---ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 648 KDQTR---TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 648 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
..... ......||+.|+|||.+....++.++||||||+++|||++|+.||........ .... ...+
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-------~~~~----i~~g 250 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVY----LLQG 250 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHH----HHTT
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-------HHHH----HHcC
Confidence 43322 22345689999999999999999999999999999999999888864321110 1111 1111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.. +. .+....+.+.+|+.+||+.||++||||.||+++|+++..
T Consensus 251 ~~-------~~--~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 251 RR-------LL--QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CC-------CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-------CC--CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 10 00 111224568899999999999999999999999988764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-45 Score=386.65 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=208.9
Q ss_pred hhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 564 (788)
.+.+.+.||+|+||+||+|+.+. ..++..||||++.... ....++|.+|++++++++||||+++++++.+.+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 46678999999999999999863 2355789999986543 4456789999999999999999999999999999999
Q ss_pred EEecCCCCCHhHhhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCc
Q 047157 565 VYELMPNGTLSNFLFHEG-----------------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQN 621 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~N 621 (788)
||||+++|+|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence 999999999999996432 2478899999999999999999999 99999999999
Q ss_pred EEeccCCCCCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCC-CCCCc
Q 047157 622 VLLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR-RHIEL 699 (788)
Q Consensus 622 Ill~~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~-~p~~~ 699 (788)
||++ .++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++|. .||..
T Consensus 171 ILld-----~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 171 CLVG-----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp EEEC-----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred eEEC-----CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 9999 788999999999986644322 2233467889999999999999999999999999999999996 56655
Q ss_pred cccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 700 SRVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
....+. ...+.++..... +...+.++.+|+.+||+.||++||||.||+++|+++++
T Consensus 246 ~~~~e~------------~~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 246 MAHEEV------------IYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp SCHHHH------------HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCHHHH------------HHHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 422211 111222221111 11223568899999999999999999999999998864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=383.95 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=199.4
Q ss_pred HhhcccccccccccceEEEEEEecc-Ccceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLK-DTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
..+.+.+.||+|+||+||+|.+... +....||||++.... .+..++|.+|++++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 3467789999999999999987633 345689999986532 3445789999999999999999999999966 4678
Q ss_pred EEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCc
Q 047157 564 LVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGIS 643 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a 643 (788)
+||||+++|+|.+++......+++..++.++.||++||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~-----~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLA-----TRDLVKIGDFGLM 158 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEE-----ETTEEEECCCTTC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccc-----cccceeeccchhh
Confidence 99999999999999887777899999999999999999999999 999999999999999 7789999999999
Q ss_pred cccCCCCCc--ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHH
Q 047157 644 KLLNKDQTR--TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 644 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
+........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+. . ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-----------~-~~ 226 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----------L-HK 226 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------H-HH
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-----------H-HH
Confidence 987554332 2233567889999999999999999999999999999998 8999975432221 1 11
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
+..... ........+..+.+|+.+||+.||++|||++||++.|++.
T Consensus 227 i~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 227 IDKEGE--------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHTSCC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCCC--------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111110 0111112235688999999999999999999999999763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=383.34 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=205.7
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch------HHHHHHHHHHHHHhcCCCccccceEeeEEecCCe
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI------EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDK 561 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 561 (788)
..|.+.+.||+|+||+||+|..+ .++..||||.+.+.. ....+.+.+|++++++++|||||++++++.+.+.
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~--~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCEEEeEEEecCCCeEEEEEEEC--CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 35778899999999999999886 677899999986432 1235789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.+|||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++..+. ....+||+|||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~-~~~~vkl~DfG 162 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNV-PKPRIKIIDFG 162 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSS-SSCCEEECCCT
T ss_pred EEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCC-cccceEecchh
Confidence 99999999999999999665 4789999999999999999999999 9999999999999984331 23469999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ...
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------------~~i 228 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------ANV 228 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------------HHH
T ss_pred hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH------------HHH
Confidence 9987654322 23457899999999999999999999999999999999999999765322210 111
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...... ............+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 229 SAVNYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HTTCCC------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhcCCC------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111100 000001122456788999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=386.46 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=204.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc-hHHHHHHHHHHHHHhcCC-CccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD-IEKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.+.+.++||+|+||+||+|.++..+....||||++... .....++|.+|+++|+++ +||||+++++++.+++..++||
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 45667899999999999999985555557899988643 344566899999999998 7999999999999999999999
Q ss_pred ecCCCCCHhHhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCC
Q 047157 567 ELMPNGTLSNFLFHE---------------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDT 631 (788)
Q Consensus 567 e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~ 631 (788)
||+++|+|.++|+.. ...+++..+..++.||++||.|||++ +|+||||||+|||++ .
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~-----~ 162 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG-----E 162 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----G
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc-----C
Confidence 999999999999643 36789999999999999999999999 999999999999998 7
Q ss_pred CCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCC-CCCccccccccccch
Q 047157 632 NYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR-HIELSRVEEESEEVD 710 (788)
Q Consensus 632 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~-p~~~~~~~~~~~~~~ 710 (788)
++.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~------ 234 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------ 234 (309)
T ss_dssp GGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------
T ss_pred CCceEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH------
Confidence 88999999999986543222 223468999999999999999999999999999999999765 565432111
Q ss_pred hhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 711 IVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
....+..+. .+.. .....+++.+|+.+||+.||++||||+||++.|+++.+
T Consensus 235 ------~~~~i~~~~-------~~~~--~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 235 ------LYEKLPQGY-------RLEK--PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ------HHHHGGGTC-------CCCC--CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHhcC-------CCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111111 1111 11234678899999999999999999999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=383.28 Aligned_cols=248 Identities=26% Similarity=0.297 Sum_probs=205.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||+|+.+ .++..||||++++.. ....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~--~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 4777899999999999999886 677899999997543 23457789999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 84 ~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~-----~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLD-----KDGHIKITDFGLCKE 154 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC-----TTSCEEECCCTTCBC
T ss_pred eeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEec-----CCCCEEEeecccccc
Confidence 9999999999998665 5678889999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. ........
T Consensus 155 ~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------------~~~i~~~~ 221 (337)
T d1o6la_ 155 GISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------------FELILMEE 221 (337)
T ss_dssp SCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHCC
T ss_pred cccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH------------HHHHhcCC
Confidence 644332 23346899999999999999999999999999999999999999986543211 11111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 770 (788)
. .. +.....++.+|+.+||+.||++||+ ++|++++
T Consensus 222 ~--------~~--p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 I--------RF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C--------CC--CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C--------CC--CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1 11 1112456788999999999999995 8888863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=379.64 Aligned_cols=248 Identities=29% Similarity=0.412 Sum_probs=194.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec-CCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE-EDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lV~e 567 (788)
.+.+.+.||+|+||.||+|.++ +..||||++++. ...+.+.+|++++++++||||++++|++.+ .+..++|||
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEET----TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HeEEeEEEecCCCeEEEEEEEC----CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 4567899999999999999873 458999999764 345789999999999999999999999865 456899999
Q ss_pred cCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 568 LMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|+++|+|.+++.+.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~-----~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVS-----EDNVAKVSDFGLTKEA 153 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC-----TTSCEEECCCCC----
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheec-----CCCCEeecccccceec
Confidence 999999999997543 3589999999999999999999999 999999999999998 8889999999999865
Q ss_pred CCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.... ....++..|+|||++.+..+++++||||||+++|||+| |+.||......+. .. ....+.
T Consensus 154 ~~~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~--------~~----~i~~~~ 217 (262)
T d1byga_ 154 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------VP----RVEKGY 217 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--------HH----HHTTTC
T ss_pred CCCC----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH--------HH----HHHcCC
Confidence 4322 23467889999999999999999999999999999998 6777765432221 11 111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
.+.. +....+++.+|+.+||+.||++||||.||+++|+.+.
T Consensus 218 -------~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 218 -------KMDA--PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp -------CCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCC--CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111 1123357889999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=388.19 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=202.6
Q ss_pred hhcccccccccccceEEEEEEeccCc--ceeeeeeecccc-hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDT--QIEIAVKKLEKD-IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.++||+|+||+||+|.+...+. ..+||+|++... .....++|.+|++++++++|||||+++++|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 36778999999999999998863222 346899988643 344567899999999999999999999999875 56788
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
+|++.+++|.+++......+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~-----~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVK-----TPQHVKITDFGLAKL 160 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE-----ETTEEEECCCSHHHH
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeC-----CCCCeEeecccccee
Confidence 899999999999988888899999999999999999999999 999999999999998 788999999999997
Q ss_pred cCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCccccccccccchhhhHHHHHHHhhc
Q 047157 646 LNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRVEEESEEVDIVLSDWVISCMLS 723 (788)
Q Consensus 646 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 723 (788)
........ .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+. .. ....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--------~~----~i~~ 228 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------SS----ILEK 228 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--------HH----HHHH
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--------HH----HHHc
Confidence 75543332 233568999999999999999999999999999999998 7888875532221 11 1111
Q ss_pred ccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 724 RNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 724 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
+. .+ ..+....+.+.+|+.+||+.||++|||+.||+++|+.+
T Consensus 229 ~~-------~~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 229 GE-------RL--PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp TC-------CC--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-------CC--CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11 00 11112345688899999999999999999999988754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-44 Score=380.83 Aligned_cols=245 Identities=27% Similarity=0.317 Sum_probs=203.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||+||+|+.+ .+++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSR--HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HeEEEEEEecCcCcEEEEEEEC--CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 3778899999999999999886 667899999997543 23456889999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 83 mE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~-----~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLD-----KNGHIKITDFGFAKY 153 (316)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEEC-----TTSCEEECCCSSCEE
T ss_pred eeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEc-----CCCCEEEecCccceE
Confidence 9999999999988654 5678888889999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. ........
T Consensus 154 ~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------------~~~i~~~~ 217 (316)
T d1fota_ 154 VPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------------YEKILNAE 217 (316)
T ss_dssp CSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------------HHHHHHCC
T ss_pred eccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------------HHHHHcCC
Confidence 6533 2346899999999999999999999999999999999999999976432211 11111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIHM 770 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 770 (788)
. .. +....+.+.+++.+||+.||++|| |++|++++
T Consensus 218 ~--------~~--p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 L--------RF--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C--------CC--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--------CC--CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 00 111235678899999999999996 89999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=380.29 Aligned_cols=250 Identities=16% Similarity=0.201 Sum_probs=206.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYEL 568 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e~ 568 (788)
.|.+.+.||+|+||+||+|.++ .++..||||.++.... ....+.+|+++|++++||||+++++++.+++..||||||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~--~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVET--SSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEEC--CCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 3677899999999999999887 6778999999976533 345788999999999999999999999999999999999
Q ss_pred CCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccCC
Q 047157 569 MPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLNK 648 (788)
Q Consensus 569 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~~ 648 (788)
+++|+|.+++...+..+++.++..++.||+.||.|||++ +|+||||||+|||++.+ ....+||+|||++.....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~---~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTR---RSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSS---SCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCC---CceEEEEcccchhhcccc
Confidence 999999999987767899999999999999999999999 99999999999999732 345899999999987644
Q ss_pred CCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccccc
Q 047157 649 DQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNLQV 728 (788)
Q Consensus 649 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (788)
.. ......+++.|+|||.+.+..++.++||||+||++|||++|+.||......+. ........
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~------------~~~i~~~~--- 219 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------------IENIMNAE--- 219 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------------HHHHHHTC---
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH------------HHHHHhCC---
Confidence 32 22345789999999999999999999999999999999999999976532211 11111111
Q ss_pred cccCCCCCccc--HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 729 LVSHDPEVLSD--LERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 729 l~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
...... ....+++.+|+.+||+.||++|||++|+++
T Consensus 220 -----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 220 -----YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 100000 012456788999999999999999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=383.83 Aligned_cols=262 Identities=27% Similarity=0.380 Sum_probs=198.5
Q ss_pred HHhhcccccccccccceEEEEEEecc---Ccceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecC-C
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLK---DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE-D 560 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~ 560 (788)
...|.+.++||+|+||.||+|.+... ..++.||||++.... ....+.+.+|...+.++ +|+||+++++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 35677889999999999999998632 345689999986533 34456788888888776 789999999988664 4
Q ss_pred eEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLD 625 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 625 (788)
..++||||+++|+|.+++.... ..+++..+..++.||++||.|||++ +|+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 6899999999999999996532 3478999999999999999999999 999999999999998
Q ss_pred cCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCC-CCCCccccc
Q 047157 626 LKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR-RHIELSRVE 703 (788)
Q Consensus 626 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~-~p~~~~~~~ 703 (788)
.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|. .||......
T Consensus 169 -----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 169 -----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp -----GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred -----CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 7889999999999876544332 334467999999999999999999999999999999999875 567543221
Q ss_pred cccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 704 EESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
+. .......+.... .+....+++.+++.+||+.||++|||++||+++|+++++
T Consensus 244 ~~-----------~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EE-----------FCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HH-----------HHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-----------HHHHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 10 111111111111 111224568899999999999999999999999998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=376.34 Aligned_cols=271 Identities=21% Similarity=0.241 Sum_probs=201.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEecCC----eEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED----KRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l 564 (788)
++-+.+.||+|+||+||+|++ .+..||||+++.... .......|+..+.+++||||+++++++.+.+ ..++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~----~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW----RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE----TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE----CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 455678999999999999986 356999999865432 2223445666677889999999999997654 6799
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc-----cCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE-----CETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
||||+++|+|.+++.+. .+++..++.++.|++.||.|||+. ...+|+||||||+||||+ .++.+||+|
T Consensus 79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-----~~~~~Kl~D 151 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-----KNGTCCIAD 151 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-----TTSCEEECC
T ss_pred EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-----CCCCeEEEe
Confidence 99999999999999654 689999999999999999999973 134999999999999998 888999999
Q ss_pred cCCccccCCCCCc---ccccccCCccccCcccccCC------CCCccCcchhhHHHHHHHHhCCCCCCccccccccccch
Q 047157 640 FGISKLLNKDQTR---TDTNMRGTMGYVAPEWLRNV------PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVD 710 (788)
Q Consensus 640 fg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~ 710 (788)
||+++........ ......||+.|+|||++.+. .++.++|||||||+||||+||..|+.............
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence 9999876543322 22346799999999998754 36779999999999999999998875433222111000
Q ss_pred ---hhhHHHHHHHhhcccccccccCC-CCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 711 ---IVLSDWVISCMLSRNLQVLVSHD-PEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 711 ---~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
...............+ .+. +......+....+.+|+.+||+.||++|||+.||+++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0011111111111111 111 122223456677999999999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=380.27 Aligned_cols=261 Identities=28% Similarity=0.401 Sum_probs=206.3
Q ss_pred HHhhcccccccccccceEEEEEEecc-----Ccceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecC
Q 047157 487 EATKGFSKLVGTGSSGKVYRGILRLK-----DTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE 559 (788)
Q Consensus 487 ~~t~~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 559 (788)
...|.+.++||+|+||.||+|+.... .....||||++.... .....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 34567789999999999999987532 223579999997654 34457889999999888 899999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhccC---------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEe
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEG---------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLL 624 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 624 (788)
+..++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 99999999999999999996543 4579999999999999999999999 99999999999999
Q ss_pred ccCCCCCCCcEEEeecCCccccCCCCCc-ccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHh-CCCCCCcccc
Q 047157 625 DLKTLDTNYMAKISDFGISKLLNKDQTR-TDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIIC-GRRHIELSRV 702 (788)
Q Consensus 625 ~~~~~~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-g~~p~~~~~~ 702 (788)
+ .++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 169 ~-----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 T-----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp C-----TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred c-----CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 8 7889999999999977554332 2344678999999999999999999999999999999998 6788865432
Q ss_pred ccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 703 EEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
.. +...+..+.. + ..+....+++.+|+.+||+.||++|||+.||++.|++++.
T Consensus 244 ~~------------~~~~i~~~~~-------~--~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 EE------------LFKLLKEGHR-------M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH------------HHHHHHTTCC-------C--CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH------------HHHHHHcCCC-------C--CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11 1111111111 1 1111234578899999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-44 Score=374.64 Aligned_cols=257 Identities=20% Similarity=0.270 Sum_probs=200.1
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCC----e
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED----K 561 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~ 561 (788)
.|.+.+.||+|+||+||+|.+. .+++.||||.++... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDL--RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred eeEEeEEEeeCCCeEEEEEEEC--CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4778899999999999999886 678899999986432 345568999999999999999999999987654 4
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.||||||+++++|.+++... ..+++.++..++.||+.||.|||++ +|+||||||+|||++ .++..+|+|||
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~-----~~~~~~l~d~~ 156 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMIS-----ATNAVKVMDFG 156 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEE-----TTSCEEECCCT
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccC-----ccccceeehhh
Confidence 78999999999999988655 5689999999999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCCC--cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHH
Q 047157 642 ISKLLNKDQT--RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVIS 719 (788)
Q Consensus 642 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 719 (788)
.+........ .......||+.|+|||++.+..+++++|||||||++|||+||+.||......+. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----------~~~ 225 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----------AYQ 225 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----------HHH
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-----------HHH
Confidence 9876543322 233446799999999999999999999999999999999999999975432211 111
Q ss_pred HhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHhhcC
Q 047157 720 CMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-SMKKVIHMLEGT 774 (788)
Q Consensus 720 ~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~ 774 (788)
........ ........++++.+++.+||+.||++|| |++++++.|.++
T Consensus 226 ~~~~~~~~-------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 226 HVREDPIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHCCCCC-------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHhcCCCC-------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 11111110 0001112346788899999999999999 899999988764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.8e-44 Score=369.89 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=204.3
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---------HHHHHHHHHHHHHhcCCC-ccccceEeeEEec
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---------EKTNEEFMTELKIIGRTH-HKNLVRLLGFCSE 558 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 558 (788)
.|.+.+.||+|+||+||+|+.. .+++.||||++.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~--~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHK--PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cCEEceEEecCcCeEEEEEEEC--CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4677899999999999999876 677899999986432 234457899999999997 9999999999999
Q ss_pred CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEe
Q 047157 559 EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKIS 638 (788)
Q Consensus 559 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~ 638 (788)
++..||||||+++|+|.+++... ..+++.++..++.||++||+|||++ +|+||||||+|||++ .++.+||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~-----~~~~~kl~ 152 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLD-----DDMNIKLT 152 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----TTCCEEEC
T ss_pred CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEc-----CCCCeEEc
Confidence 99999999999999999999765 4689999999999999999999999 999999999999998 88899999
Q ss_pred ecCCccccCCCCCcccccccCCccccCcccccC------CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhh
Q 047157 639 DFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN------VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIV 712 (788)
Q Consensus 639 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 712 (788)
|||+++.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.
T Consensus 153 DFG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------- 223 (277)
T d1phka_ 153 DFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------- 223 (277)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------
T ss_pred cchheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-------
Confidence 9999987754332 234679999999999853 3578899999999999999999999976532211
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
......+... +.........+++.+++.+||+.||++|||++||+++
T Consensus 224 -----~~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 224 -----LRMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -----HHHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -----HHHHHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111111111 0111112334678899999999999999999999764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=379.54 Aligned_cols=260 Identities=24% Similarity=0.288 Sum_probs=202.7
Q ss_pred hhccc-ccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcC-CCccccceEeeEEec----CCeE
Q 047157 489 TKGFS-KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGR-THHKNLVRLLGFCSE----EDKR 562 (788)
Q Consensus 489 t~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~----~~~~ 562 (788)
.|.+. +.||+|+||+||+|.+. .++..||||++++. +.+.+|++++.+ .+||||+++++++.+ +...
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNK--RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEEC--CCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35554 56999999999999886 56779999998653 346689988765 489999999999865 4678
Q ss_pred EEEEecCCCCCHhHhhhccC-CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 563 LLVYELMPNGTLSNFLFHEG-QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
|+|||||++|+|.+++.+.+ ..+++.++..++.||+.||+|||++ +|+||||||+|||++... ..+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~--~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKR--PNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSS--TTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccc--ccccccccccc
Confidence 99999999999999997653 5689999999999999999999999 999999999999998443 46789999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
+++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||........... .
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~--------~---- 225 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--------M---- 225 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH--------H----
Confidence 9987654332 2346799999999999999999999999999999999999999976432221100 0
Q ss_pred hcccccccccCCCCCc--ccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCcCCC
Q 047157 722 LSRNLQVLVSHDPEVL--SDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTLEVG 778 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~~ 778 (788)
............ ......+++.+|+.+||+.||++|||+.|++++ +.+....+
T Consensus 226 ----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 282 (335)
T d2ozaa1 226 ----KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282 (335)
T ss_dssp ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSC
T ss_pred ----HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCC
Confidence 000111111111 112345678999999999999999999999984 54433333
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=381.80 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=210.7
Q ss_pred HHHHhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCC-CccccceEeeEEecC
Q 047157 485 LQEATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRT-HHKNLVRLLGFCSEE 559 (788)
Q Consensus 485 l~~~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 559 (788)
+....+.+.++||+|+||.||+|++.. ...+..||||+++... .....++.+|+.+++++ +|||||++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 344567788999999999999998753 3566799999997543 44556899999999998 699999999999999
Q ss_pred CeEEEEEecCCCCCHhHhhhccC-----------------CCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcE
Q 047157 560 DKRLLVYELMPNGTLSNFLFHEG-----------------QRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNV 622 (788)
Q Consensus 560 ~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 622 (788)
+..++||||+++|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999996542 2578999999999999999999999 999999999999
Q ss_pred EeccCCCCCCCcEEEeecCCccccCCCCC-cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCC-CCCcc
Q 047157 623 LLDLKTLDTNYMAKISDFGISKLLNKDQT-RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRR-HIELS 700 (788)
Q Consensus 623 ll~~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~-p~~~~ 700 (788)
|++ .++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+|+.. |+...
T Consensus 177 l~~-----~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 177 LLT-----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EEE-----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccc-----ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 998 788999999999997755433 23344678999999999999999999999999999999999554 45433
Q ss_pred ccccccccchhhhHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 701 RVEEESEEVDIVLSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
...+. +... ...+ .. ...+....+.+.+|+.+||+.||++||||+||+++|++.+
T Consensus 252 ~~~~~-------~~~~----i~~~-~~--------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 252 PVDSK-------FYKM----IKEG-FR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp CSSHH-------HHHH----HHHT-CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHH-------HHHH----HhcC-CC--------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 22110 1111 1111 11 1111123467889999999999999999999999998643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-43 Score=381.39 Aligned_cols=248 Identities=23% Similarity=0.281 Sum_probs=197.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHH---HHHHHHhcCCCccccceEeeEEecCCeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEF---MTELKIIGRTHHKNLVRLLGFCSEEDKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~---~~E~~~l~~l~hpniv~~~~~~~~~~~~ 562 (788)
.|.+.++||+|+||.||+|+.. .++..||||.+.+.. ......+ .+|+++++.++||||+++++++.+.+..
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~--~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hCeeeeEEecCCCeEEEEEEEC--CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 3677899999999999999886 677899999986432 1122233 4457788889999999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~-----~~g~iKl~DFGl 153 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLD-----EHGHVRISDLGL 153 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----SSSCEEECCCTT
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEc-----CCCcEEEeeece
Confidence 9999999999999999655 5678899999999999999999999 999999999999998 788999999999
Q ss_pred ccccCCCCCcccccccCCccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLR-NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
++.+.... .....||+.|+|||++. +..+++++|||||||++|||++|+.||......+.. . .....
T Consensus 154 a~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--------~-~~~~~ 221 (364)
T d1omwa3 154 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------E-IDRMT 221 (364)
T ss_dssp CEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--------H-HHHHS
T ss_pred eeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--------H-HHHhc
Confidence 98765432 23457999999999986 456899999999999999999999999765322210 0 00000
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPS-----MKKVIH 769 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 769 (788)
.. ..+.. +....+++.+|+.+||+.||++||| ++|+++
T Consensus 222 ~~--------~~~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 LT--------MAVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SS--------CCCCC--CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cc--------CCCCC--CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 01111 1123456788999999999999999 688875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=377.12 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=209.3
Q ss_pred HhhcccccccccccceEEEEEEec---cCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRL---KDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 563 (788)
..+.+.+.||+|+||+||+|.++. ...+..||||+++... ......|.+|++++++++||||+++++++..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 455678999999999999998752 1235689999997543 444567999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHhhhcc---------CCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCc
Q 047157 564 LVYELMPNGTLSNFLFHE---------GQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYM 634 (788)
Q Consensus 564 lV~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~ 634 (788)
+||||+++|+|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+|||++ .+++
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld-----~~~~ 171 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA-----EDFT 171 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC-----TTCC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeec-----CCce
Confidence 999999999999998542 13468999999999999999999999 999999999999998 8889
Q ss_pred EEEeecCCccccCCCCCcc-cccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCC-CCCCccccccccccchhh
Q 047157 635 AKISDFGISKLLNKDQTRT-DTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGR-RHIELSRVEEESEEVDIV 712 (788)
Q Consensus 635 ~kL~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~ 712 (788)
+||+|||+++.+....... .....+|+.|+|||.+.+..++.++||||||+++|||+||. .||......+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------- 243 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------- 243 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--------
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence 9999999998765443322 33356899999999999999999999999999999999985 5665432211
Q ss_pred hHHHHHHHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCcC
Q 047157 713 LSDWVISCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTLE 776 (788)
Q Consensus 713 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 776 (788)
....+.++..... .....+.+.+++.+||+.||++||||+||+++|++.++
T Consensus 244 ----~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 ----VLRFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ----HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----HHHHHHhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111122211111 11223578899999999999999999999999998765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-43 Score=380.02 Aligned_cols=244 Identities=21% Similarity=0.222 Sum_probs=203.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV 565 (788)
.|.+.+.||+|+||.||+|+++ .++..||||++.+.. ....+.+.+|+++|++++||||+++++++.+....++|
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~--~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEEC--CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 4677899999999999999886 677899999986532 23456789999999999999999999999999999999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++ +||||||||+|||++ .++.+||+|||+++.
T Consensus 120 ~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~-----~~g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLID-----QQGYIQVTDFGFAKR 190 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTSCEEECCCTTCEE
T ss_pred cccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccC-----CCCCEEeeeceeeee
Confidence 9999999999999665 4689999999999999999999999 999999999999998 788999999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhccc
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRN 725 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (788)
+... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........
T Consensus 191 ~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------------~~~i~~~~ 254 (350)
T d1rdqe_ 191 VKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------------YEKIVSGK 254 (350)
T ss_dssp CSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHCC
T ss_pred cccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH------------HHHHhcCC
Confidence 6533 2346799999999999999999999999999999999999999975432111 11111111
Q ss_pred ccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 047157 726 LQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIH 769 (788)
Q Consensus 726 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 769 (788)
. .. +......+.+++.+||+.||++|+ |++|+++
T Consensus 255 ~--------~~--p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 V--------RF--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C--------CC--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C--------CC--CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 11 112345678899999999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=376.73 Aligned_cols=247 Identities=25% Similarity=0.322 Sum_probs=201.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch---HHHHHHHHHHHHHhc-CCCccccceEeeEEecCCeEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI---EKTNEEFMTELKIIG-RTHHKNLVRLLGFCSEEDKRLL 564 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~l 564 (788)
.|.+.++||+|+||+||+|+++ .+++.||||++++.. ....+.+..|..++. .++||||+++++++.+++..|+
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~--~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFK--KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEET--TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEEC--CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 4678899999999999999887 678899999997542 233456677777765 6899999999999999999999
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 81 vmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~-----~~~~~kl~DFG~a~ 151 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLD-----KDGHIKIADFGMCK 151 (320)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC-----TTSCEEECCCTTCB
T ss_pred EEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeec-----CCCceeccccchhh
Confidence 99999999999999654 5678899999999999999999999 999999999999998 88899999999998
Q ss_pred ccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc
Q 047157 645 LLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR 724 (788)
Q Consensus 645 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 724 (788)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. .......
T Consensus 152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~------------~~~i~~~ 218 (320)
T d1xjda_ 152 ENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------------FHSIRMD 218 (320)
T ss_dssp CCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHC
T ss_pred hcccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH------------HHHHHcC
Confidence 6644332 23346799999999999999999999999999999999999999976532221 1111111
Q ss_pred cccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHH-HHHH
Q 047157 725 NLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMK-KVIH 769 (788)
Q Consensus 725 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 769 (788)
.+... .....++.+|+.+||+.||++|||+. |+++
T Consensus 219 --------~~~~p--~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 --------NPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --------CCCCC--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --------CCCCC--ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111 11245678999999999999999996 7764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=371.46 Aligned_cols=268 Identities=23% Similarity=0.270 Sum_probs=201.1
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.++||+|+||+||+|.+. .+++.||||+++... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNK--LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEEC--CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 4667799999999999999986 667799999986543 233568899999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+.++.+..........+++..+..++.||+.||.|||++ +||||||||+|||++ .++.+||+|||.++..
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~-----~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLIN-----TEGAIKLADFGLARAF 152 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTSCEEECSTTHHHHH
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeec-----ccCcceeccCCcceec
Confidence 99976545444445567799999999999999999999999 999999999999998 7789999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhh-c-
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVP-VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCML-S- 723 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~- 723 (788)
..... ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..+.... ....... .
T Consensus 153 ~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~-------i~~~~~~~~~ 224 (298)
T d1gz8a_ 153 GVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR-------IFRTLGTPDE 224 (298)
T ss_dssp CCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------HHHHHCCCCT
T ss_pred cCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH-------HHHhcCCCch
Confidence 54332 233457899999999876655 57899999999999999999999976532211100 0000000 0
Q ss_pred c---ccccc---ccCCCCC-ccc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcC
Q 047157 724 R---NLQVL---VSHDPEV-LSD-----LERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGT 774 (788)
Q Consensus 724 ~---~~~~l---~~~~~~~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~ 774 (788)
. ..... ....+.. ..+ ....+++.+|+.+||+.||++|||++|++++ ++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 00000 0000000 001 1223578889999999999999999999986 5443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=372.91 Aligned_cols=261 Identities=21% Similarity=0.262 Sum_probs=196.7
Q ss_pred cccccccccceEEEEEEeccCcceeeeeeecccchHH-----HHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEEe
Q 047157 493 SKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEK-----TNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 493 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~e 567 (788)
.++||+|+||+||+|.++ .+++.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 3 l~~lG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDK--NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEETTEEEEEEECS--SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred ceEeccCcCeEEEEEEEC--CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 368999999999999876 66779999998654321 23468899999999999999999999999999999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+.++++..+. .....+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++...
T Consensus 81 ~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~-----~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 81 FMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLD-----ENGVLKLADFGLAKSFG 151 (299)
T ss_dssp CCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTCCEEECCCGGGSTTT
T ss_pred hhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEec-----CCCccccccCccccccC
Confidence 99887766555 4456788899999999999999999999 999999999999998 88899999999998765
Q ss_pred CCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcccc
Q 047157 648 KDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSRNL 726 (788)
Q Consensus 648 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 726 (788)
..... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+... ...........
T Consensus 152 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~--------~i~~~~~~~~~ 222 (299)
T d1ua2a_ 152 SPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--------RIFETLGTPTE 222 (299)
T ss_dssp SCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------HHHHHHCCCCT
T ss_pred CCccc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH--------HHHHhcCCCCh
Confidence 44322 233578999999998864 467999999999999999999999997653322111 01111100000
Q ss_pred cc---c------ccCCCCCcccH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhc
Q 047157 727 QV---L------VSHDPEVLSDL-----ERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEG 773 (788)
Q Consensus 727 ~~---l------~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~ 773 (788)
.. . ........... ...+.+.+|+.+||+.||++|||++|++++ +.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00 0 00000000011 123678899999999999999999999974 654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-43 Score=363.94 Aligned_cols=241 Identities=24% Similarity=0.411 Sum_probs=194.8
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchH------HHHHHHHHHHHHhcCCC--ccccceEeeEEecCC
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIE------KTNEEFMTELKIIGRTH--HKNLVRLLGFCSEED 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~ 560 (788)
.|.+.++||+|+||+||+|+.. .++..||||.+.+... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred eEEEeEEEeeCCCeEEEEEEEC--CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 5778899999999999999886 6678999999864321 12234678999999886 899999999999999
Q ss_pred eEEEEEecCCC-CCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEee
Q 047157 561 KRLLVYELMPN-GTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISD 639 (788)
Q Consensus 561 ~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~D 639 (788)
..++||||+.+ +++.+++... ..+++.++..++.||+.||.|||++ +|+||||||+|||++. +.+.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~----~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDL----NRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEET----TTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEec----CCCeEEECc
Confidence 99999999976 5777777554 5789999999999999999999999 9999999999999972 346899999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccCCCC-CccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHH
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPV-TTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVI 718 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 718 (788)
||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 155 FG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------------- 215 (273)
T d1xwsa_ 155 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------------- 215 (273)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------
T ss_pred cccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----------------
Confidence 9999865432 2334679999999999987765 5779999999999999999999975311
Q ss_pred HHhhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 719 SCMLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
...... .+ .. ...+++.+++.+||+.||++|||++|++++
T Consensus 216 --i~~~~~--~~--~~------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 --IIRGQV--FF--RQ------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --HHHCCC--CC--SS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --Hhhccc--CC--CC------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000000 00 00 123567889999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=364.96 Aligned_cols=268 Identities=22% Similarity=0.273 Sum_probs=199.0
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCC---CccccceEeeEEec----
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRT---HHKNLVRLLGFCSE---- 558 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~---- 558 (788)
..|.+.++||+|+||+||+|++.. .+++.||||++.... ......+.+|+++++.| +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT-TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecccCeEEEEEEEEC-CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 357778999999999999998752 235689999986432 22233456777776655 79999999999853
Q ss_pred -CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 559 -EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 559 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
....+++|||++++.+..........+++..+..++.||+.||+|||++ +|+||||||+|||++ ..+.+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~-----~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVT-----SSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTCCEEE
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEc-----CCCCeee
Confidence 3478999999998887766666677889999999999999999999999 999999999999998 7889999
Q ss_pred eecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHH
Q 047157 638 SDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWV 717 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 717 (788)
+|||++...... .......||+.|+|||++.+.+++.++||||+||++|||++|+.||......+.... .
T Consensus 158 ~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~--------i 227 (305)
T d1blxa_ 158 ADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK--------I 227 (305)
T ss_dssp CSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--------H
T ss_pred cchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH--------H
Confidence 999998865432 233456899999999999999999999999999999999999999976543221110 0
Q ss_pred HHHhhcc---ccc-------ccc-cC--CCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcC
Q 047157 718 ISCMLSR---NLQ-------VLV-SH--DPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGT 774 (788)
Q Consensus 718 ~~~~~~~---~~~-------~l~-~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~ 774 (788)
....... ... ... .. .+.........+.+.+|+.+||+.||++|||++|++++ ++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0000000 000 000 00 00000011223567789999999999999999999874 5443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-41 Score=356.52 Aligned_cols=260 Identities=22% Similarity=0.255 Sum_probs=195.5
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|.+.++||+|+||+||+|+++ +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..++++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceeccEEecCCCcEEEEEEeC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 3567789999999999999874 55789999986542 334578999999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|++.++.+..+. .....+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||.+...
T Consensus 80 e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~-----~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 80 EHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLIN-----REGELKIADFGLARAF 150 (286)
T ss_dssp ECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTSCEEECCTTHHHHH
T ss_pred EeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEc-----CCCCEEecccccceec
Confidence 999776665554 5557899999999999999999999998 999999999999998 7889999999999876
Q ss_pred CCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc-
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR- 724 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 724 (788)
..... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.... ........
T Consensus 151 ~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~--------i~~~~~~~~ 221 (286)
T d1ob3a_ 151 GIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR--------IFRILGTPN 221 (286)
T ss_dssp CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--------HHHHHCCCC
T ss_pred ccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH--------HHHhhCCCC
Confidence 54322 2233468999999999865 4568999999999999999999999976432221110 00000000
Q ss_pred --c---cccccc---------CCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 725 --N---LQVLVS---------HDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 725 --~---~~~l~~---------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. ...... ..+.........+.+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 00000001122357789999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-40 Score=350.67 Aligned_cols=262 Identities=19% Similarity=0.256 Sum_probs=201.0
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcccc-ceEeeEEecCCeEEEEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL-VRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lV~e 567 (788)
.|.+.++||+|+||+||+|.+. .+++.||||.+.... ..+++..|++++++++|+|+ +.+.++..+.+..++|||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDI--AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEET--TTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEEC--CCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 4778899999999999999886 667899999876543 23467889999999987665 455566678889999999
Q ss_pred cCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccccC
Q 047157 568 LMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLLN 647 (788)
Q Consensus 568 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~~ 647 (788)
|+ +++|.+.+......+++..+..++.|++.||+|||++ +|+||||||+|||++..+ .+..+||+|||+++.+.
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~--~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGK--KGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGG--GTTCEEECCCSSCEECB
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccC--CCceeeeeccCcceecc
Confidence 99 6678777777778899999999999999999999999 999999999999987443 56689999999999775
Q ss_pred CCCC------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHh
Q 047157 648 KDQT------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCM 721 (788)
Q Consensus 648 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (788)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............. ... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~----~~~-~~~ 232 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----RIS-EKK 232 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH----HHH-HHH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH----Hhh-ccc
Confidence 4332 12334679999999999999999999999999999999999999997653322211110 000 000
Q ss_pred hcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcC
Q 047157 722 LSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGT 774 (788)
Q Consensus 722 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 774 (788)
.......+. ...++++.+++..||+.||++||+++++.+.|+.+
T Consensus 233 ~~~~~~~~~---------~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 233 MSTPIEVLC---------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHSCHHHHT---------TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred CCCChhHhc---------cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000011110 01235678899999999999999999998888765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-40 Score=348.02 Aligned_cols=266 Identities=17% Similarity=0.204 Sum_probs=208.8
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCc-cccceEeeEEecCCeEEEEE
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHH-KNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lV~ 566 (788)
..|.+.++||+|+||+||+|++. .+++.||||.+.... ..+.+.+|++.++.++| +|++.+++++.+....++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNL--LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET--TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 35778899999999999999986 667899999886532 23456788888888865 89999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
||+ +++|.+++...+..++...+..++.|++.||.|||++ +|+||||||+|||++.......+.+||+|||+++..
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999 7899999988778899999999999999999999999 999999999999997543335678999999999876
Q ss_pred CCCCC------cccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 647 NKDQT------RTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 647 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
..... .......||+.|+|||.+.+..+++++||||||+++|||++|+.||............ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-----~~i~~~ 231 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-----ERIGEK 231 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-----HHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-----HHHHhc
Confidence 53322 1233467999999999999999999999999999999999999999765332221110 001111
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHhhcCc
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHMLEGTL 775 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 775 (788)
........+.. ..++++.+++..|++.+|++||+++.+.+.|+++.
T Consensus 232 ~~~~~~~~l~~---------~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 232 KQSTPLRELCA---------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHSCHHHHTT---------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCCChHHhcC---------CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111111111 11356788888999999999999999988887654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-41 Score=360.32 Aligned_cols=270 Identities=25% Similarity=0.258 Sum_probs=195.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCccccceEeeEEec------CCeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNLVRLLGFCSE------EDKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 562 (788)
+|...++||+|+||+||+|++. .+++.||||++..... .+.+|+++|++++||||+++++++.. ....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEEC--CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 4566789999999999999987 6778999999975432 23479999999999999999999853 3357
Q ss_pred EEEEecCCCCCHhHhhh--ccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC-CcEEEee
Q 047157 563 LLVYELMPNGTLSNFLF--HEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN-YMAKISD 639 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~-~~~kL~D 639 (788)
+|||||++++.+..+.. .....+++..+..++.||+.||+|||++ +|+||||||+|||++ .+ ..+||+|
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~-----~~~~~~kl~D 166 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLD-----PDTAVLKLCD 166 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEEC-----TTTCCEEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEe-----cCCCceeEec
Confidence 89999998765444332 3456789999999999999999999999 999999999999998 44 4899999
Q ss_pred cCCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HH
Q 047157 640 FGISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SD 715 (788)
Q Consensus 640 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~ 715 (788)
||++........ .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+........+ ..
T Consensus 167 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 167 FGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 999987654332 234578999999998764 578999999999999999999999997654322111100000 00
Q ss_pred HHHHHhh----cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcC
Q 047157 716 WVISCML----SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGT 774 (788)
Q Consensus 716 ~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~ 774 (788)
..+.... ...+.................+++.+|+.+||+.||++|||++|++++ ++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000000 001111100000001111234568889999999999999999999963 5544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=356.19 Aligned_cols=271 Identities=23% Similarity=0.294 Sum_probs=195.2
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCC------
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED------ 560 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 560 (788)
.|.+.++||+|+||+||+|... .+++.||||+++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDG--RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SEEEEEEC------CEEEEEET--TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cEEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4667789999999999999886 66789999998743 2445678899999999999999999999997654
Q ss_pred eEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeec
Q 047157 561 KRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDF 640 (788)
Q Consensus 561 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Df 640 (788)
..++||||+ +.+|..++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~-----~~~~~kl~Df 165 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVN-----EDCELKILDF 165 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTCCEEECCC
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcc-----cccccccccc
Confidence 579999999 6677777643 4689999999999999999999999 999999999999998 8889999999
Q ss_pred CCccccCCCCCcccccccCCccccCcccccC-CCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh---HHH
Q 047157 641 GISKLLNKDQTRTDTNMRGTMGYVAPEWLRN-VPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL---SDW 716 (788)
Q Consensus 641 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~ 716 (788)
|+++...... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||................ ...
T Consensus 166 g~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 166 GLARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TTCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 9998764432 34578999999999876 457899999999999999999999997653322110000000 000
Q ss_pred HHHHhh-------cccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCcCC
Q 047157 717 VISCML-------SRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTLEV 777 (788)
Q Consensus 717 ~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~ 777 (788)
...... ...+......... .........+.+|+.+||+.||++|||++|++++ ++++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 000000 0000000000000 0011223467789999999999999999999985 7665543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=356.89 Aligned_cols=274 Identities=20% Similarity=0.271 Sum_probs=196.0
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch-HHHHHHHHHHHHHhcCCCccccceEeeEEecCC----eEEE
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEED----KRLL 564 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l 564 (788)
|.+.++||+|+||+||+|... .+++.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDN--VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp EEEEEECC---CCCEEEEEET--TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred eEEEEEEeeccCeEEEEEEEC--CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 667799999999999999876 677899999986543 445678899999999999999999999986543 2345
Q ss_pred EEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 565 VYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 565 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
+++++.+++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 88 l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~-----~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLN-----TTCDLKICDFGLAR 157 (345)
T ss_dssp EEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTCCEEECCCTTCE
T ss_pred EEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEEC-----CCCCEEEcccCcee
Confidence 55666799999999643 689999999999999999999999 999999999999998 78899999999998
Q ss_pred ccCCCCC--cccccccCCccccCccccc-CCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHH---HHH
Q 047157 645 LLNKDQT--RTDTNMRGTMGYVAPEWLR-NVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSD---WVI 718 (788)
Q Consensus 645 ~~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~ 718 (788)
....... .......||+.|+|||++. ...++.++||||+||++|||++|+.||......+........... ...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 7644322 2234467899999999984 456789999999999999999999999765332111100000000 000
Q ss_pred HHhhcccccccccCCC-CCcccH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH--hhcCc
Q 047157 719 SCMLSRNLQVLVSHDP-EVLSDL-----ERFERMAMVGLWCNHPDPNLRPSMKKVIHM--LEGTL 775 (788)
Q Consensus 719 ~~~~~~~~~~l~~~~~-~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~ 775 (788)
...............+ ....+. ....++.+|+.+||+.||++|||++|++++ |+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0000000000000000 000000 112467899999999999999999999985 55443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=352.00 Aligned_cols=264 Identities=19% Similarity=0.229 Sum_probs=194.3
Q ss_pred HhhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEec-------
Q 047157 488 ATKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE------- 558 (788)
Q Consensus 488 ~t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------- 558 (788)
..|.+.++||+|+||+||+|++. .+++.||||++.... ....+++.+|+++|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHR--KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCEEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 35677899999999999999886 677899999985432 3345678899999999999999999998855
Q ss_pred -CCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEE
Q 047157 559 -EDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKI 637 (788)
Q Consensus 559 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL 637 (788)
.+..++||||+.++.+... ......++...+..++.||+.||.|||++ +|+||||||+|||++ .++.+||
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~-----~~~~~kl 158 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLIT-----RDGVLKL 158 (318)
T ss_dssp ---CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC-----TTSCEEE
T ss_pred cCceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeec-----CCCcEEe
Confidence 3468999999987666544 45556788999999999999999999999 999999999999998 7889999
Q ss_pred eecCCccccCCCCCc---ccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhh
Q 047157 638 SDFGISKLLNKDQTR---TDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVL 713 (788)
Q Consensus 638 ~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 713 (788)
+|||++......... ......||+.|+|||.+.+. .+++++||||+||++|||++|+.||..........
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~------ 232 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA------ 232 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHH------
Confidence 999999876533221 22335799999999998755 68999999999999999999999997543221110
Q ss_pred HHHHHHHhhcc--c---------ccccccCCCCCccc-------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 714 SDWVISCMLSR--N---------LQVLVSHDPEVLSD-------LERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 714 ~~~~~~~~~~~--~---------~~~l~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
......... . ....+......... ......+++|+.+||+.||++|||++|++++
T Consensus 233 --~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 233 --LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp --HHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 010100000 0 00000000000111 1123467789999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=351.04 Aligned_cols=254 Identities=27% Similarity=0.301 Sum_probs=202.4
Q ss_pred hhcccccccccccceEEEEEEec-cCcceeeeeeecccch----HHHHHHHHHHHHHhcCCCc-cccceEeeEEecCCeE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRL-KDTQIEIAVKKLEKDI----EKTNEEFMTELKIIGRTHH-KNLVRLLGFCSEEDKR 562 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~ 562 (788)
.|.+.+.||+|+||+||+|.... ..+++.||||.+.+.. ....+.+.+|++++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 37888999999999999998753 3467899999986432 2334578899999999966 8999999999999999
Q ss_pred EEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCC
Q 047157 563 LLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGI 642 (788)
Q Consensus 563 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~ 642 (788)
++||||+.+++|.+++... ..+.+..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 105 ~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~-----~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLD-----SNGHVVLTDFGL 175 (322)
T ss_dssp EEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTSCEEESCSSE
T ss_pred eeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeec-----CCCCEEEeeccc
Confidence 9999999999999999665 4567788889999999999999999 999999999999998 778999999999
Q ss_pred ccccCCCCCcccccccCCccccCcccccCC--CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHH
Q 047157 643 SKLLNKDQTRTDTNMRGTMGYVAPEWLRNV--PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISC 720 (788)
Q Consensus 643 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 720 (788)
++.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+.... ....
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--------i~~~ 247 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--------ISRR 247 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--------HHHH
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHHh
Confidence 987755544444556799999999998654 478899999999999999999999976543322111 1111
Q ss_pred hhcccccccccCCCCCcccHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 047157 721 MLSRNLQVLVSHDPEVLSDLERFERMAMVGLWCNHPDPNLRP-----SMKKVIH 769 (788)
Q Consensus 721 ~~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 769 (788)
.... .+.. +....+++.+++.+||+.||++|| |++|+++
T Consensus 248 ~~~~--------~~~~--~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 ILKS--------EPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHC--------CCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cccC--------CCCC--cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1111 1111 112356788899999999999999 5899986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-40 Score=345.36 Aligned_cols=263 Identities=20% Similarity=0.234 Sum_probs=201.1
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccc--hHHHHHHHHHHHHHhcCCCccccceEeeEEecCCeEEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKD--IEKTNEEFMTELKIIGRTHHKNLVRLLGFCSEEDKRLLVY 566 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lV~ 566 (788)
.|++.++||+|+||+||+|++. .++..||||+++.. .....+++.+|+.+++.++||||+++++++.+....++|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNR--ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEEC--CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 3667799999999999999987 67779999998543 2445678999999999999999999999999999999999
Q ss_pred ecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcccc
Q 047157 567 ELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKLL 646 (788)
Q Consensus 567 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~~ 646 (788)
|++.+++|..++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||.+...
T Consensus 81 ~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~-----~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 81 EFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLIN-----RNGELKLANFGLARAF 151 (292)
T ss_dssp ECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC-----TTCCEEECCCTTCEEC
T ss_pred eeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccc-----cCCceeeeecchhhcc
Confidence 9999988887764 446788999999999999999999999 999999999999998 7789999999999876
Q ss_pred CCCCCcccccccCCccccCcccccCCC-CCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhHHHHHHHhhcc-
Q 047157 647 NKDQTRTDTNMRGTMGYVAPEWLRNVP-VTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLSDWVISCMLSR- 724 (788)
Q Consensus 647 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 724 (788)
...... .....++..|+|||.+.... ++.++|||||||++|||++|+.||......... . ..........
T Consensus 152 ~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~------~-~~~~~~~~~~~ 223 (292)
T d1unla_ 152 GIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ------L-KRIFRLLGTPT 223 (292)
T ss_dssp CSCCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH------H-HHHHHHHCCCC
T ss_pred cCCCcc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH------H-HHHHhhcCCCC
Confidence 544332 22345788899999987655 689999999999999999999997543211100 0 0010100000
Q ss_pred --cccc---cc---------cCCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 725 --NLQV---LV---------SHDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 725 --~~~~---l~---------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.... .. .............+.+.+|+.+||+.||++|||++||+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00 0000000111234567889999999999999999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-39 Score=347.08 Aligned_cols=263 Identities=17% Similarity=0.215 Sum_probs=196.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEec--CCeEEEE
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSE--EDKRLLV 565 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lV 565 (788)
.|.+.++||+|+||+||+|+.. .+++.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++|
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~--~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINI--TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 5788899999999999999886 678899999987542 457889999999995 9999999999874 4568999
Q ss_pred EecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCccc
Q 047157 566 YELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISKL 645 (788)
Q Consensus 566 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~~ 645 (788)
|||+++++|..+. +.+++..+..++.||+.||.|||++ +|+||||||+|||++. ++..+||+|||++..
T Consensus 111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~----~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDH----EHRKLRLIDWGLAEF 179 (328)
T ss_dssp EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET----TTTEEEECCGGGCEE
T ss_pred EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcC----CCCeeeeccccccee
Confidence 9999999998764 4689999999999999999999999 9999999999999982 344699999999987
Q ss_pred cCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccc-cchhhh-HHHHHHHhh
Q 047157 646 LNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESE-EVDIVL-SDWVISCML 722 (788)
Q Consensus 646 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~~~~~~ 722 (788)
...... .....+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||.......... .....+ .........
T Consensus 180 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 180 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred ccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 654332 2345789999999998765 57999999999999999999999997543221100 000000 000000000
Q ss_pred c------ccccccccCCC--------CCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 047157 723 S------RNLQVLVSHDP--------EVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIH 769 (788)
Q Consensus 723 ~------~~~~~l~~~~~--------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 769 (788)
. ........... .........+++.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00011110000 00111223456889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=348.72 Aligned_cols=265 Identities=21% Similarity=0.234 Sum_probs=189.7
Q ss_pred hcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEec------CCe
Q 047157 490 KGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSE------EDK 561 (788)
Q Consensus 490 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~ 561 (788)
|.+.++||+|+||+||+|.+. .++..||||++.... ....+++.+|+.++++++||||+++++++.. ...
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~--~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDA--VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp EEEEEECSCC--CEEEEEEET--TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred eEEEEEeecCcCeEEEEEEEC--CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 666789999999999999886 678899999997543 4445678999999999999999999999853 468
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.|+||||+.++.+. .+ ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+|++|||
T Consensus 97 ~~iv~Ey~~~~l~~-~~---~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~-----~~~~~kl~df~ 164 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VI---QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK-----SDCTLKILDFG 164 (355)
T ss_dssp EEEEEECCSEEHHH-HH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC-----TTCCEEECCCC
T ss_pred eEEEEeccchHHHH-hh---hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccc-----cccceeeechh
Confidence 89999999765554 43 24688999999999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh----------
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI---------- 711 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~---------- 711 (788)
+++...... ......+|+.|+|||++.+..+++++||||+||++|||++|+.||...+..........
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 988654432 22345789999999999999999999999999999999999999975532211100000
Q ss_pred -hhHHHHHHHhhccc------cccccc---CCCCCcccHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 047157 712 -VLSDWVISCMLSRN------LQVLVS---HDPEVLSDLERFERMAMVGLWCNHPDPNLRPSMKKVIHM 770 (788)
Q Consensus 712 -~~~~~~~~~~~~~~------~~~l~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 770 (788)
.............. ...... ..............+.+|+.+||+.||++|||++||+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000000 000000 011111233456788999999999999999999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-39 Score=345.80 Aligned_cols=272 Identities=20% Similarity=0.253 Sum_probs=195.6
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccch--HHHHHHHHHHHHHhcCCCccccceEeeEEecC-----Ce
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI--EKTNEEFMTELKIIGRTHHKNLVRLLGFCSEE-----DK 561 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 561 (788)
.|.+.++||+|+||+||+|+.. .+++.||||++++.. ....+++.+|+++|++++||||+++++++... ..
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDT--KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEET--TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CeEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 3667799999999999999886 678899999997543 34456789999999999999999999998643 34
Q ss_pred EEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCCCcEEEeecC
Q 047157 562 RLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFG 641 (788)
Q Consensus 562 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg 641 (788)
.+++++++.+|+|.+++.. +.+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~-----~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVN-----EDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC-----TTCCEEECCC-
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccc-----ccccccccccc
Confidence 4667778889999999854 4689999999999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCCCcccccccCCccccCcccccCC-CCCccCcchhhHHHHHHHHhCCCCCCccccccccccchhhhH---HHH
Q 047157 642 ISKLLNKDQTRTDTNMRGTMGYVAPEWLRNV-PVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDIVLS---DWV 717 (788)
Q Consensus 642 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~ 717 (788)
.+..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+............. ...
T Consensus 167 ~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 167 LARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp ---CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 9976532 22345788999999987665 568999999999999999999999976533221110000000 000
Q ss_pred HHHhhccccccccc---CCCCCcc---cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH--HhhcCcC
Q 047157 718 ISCMLSRNLQVLVS---HDPEVLS---DLERFERMAMVGLWCNHPDPNLRPSMKKVIH--MLEGTLE 776 (788)
Q Consensus 718 ~~~~~~~~~~~l~~---~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~ 776 (788)
.............. ..+.... .....+.+.+|+.+||+.||++|||++|+++ .+.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 00000000000000 0000000 0112356788999999999999999999998 4655443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-35 Score=316.78 Aligned_cols=284 Identities=21% Similarity=0.229 Sum_probs=195.7
Q ss_pred hhcccccccccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-----------ccccceEeeEEe
Q 047157 489 TKGFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-----------HKNLVRLLGFCS 557 (788)
Q Consensus 489 t~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~ 557 (788)
.|.+.++||+|+||+||+|+.. .+++.||||++++.. ...+.+.+|+.++++++ |+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~--~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDM--VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 4788899999999999999886 678899999997653 33457778888887765 578999998875
Q ss_pred c--CCeEEEEEecCCCCCHhHh--hhccCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCceEecCCCCCcEEeccCCC-CC
Q 047157 558 E--EDKRLLVYELMPNGTLSNF--LFHEGQRPGWVQRVEIALGVARGLLYLHE-ECETQIIHCDIKPQNVLLDLKTL-DT 631 (788)
Q Consensus 558 ~--~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~-~~ 631 (788)
. ....+++++++..+..... .......+++..+..++.||+.||+|||+ . +|+||||||+|||++..+. ..
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 4 4566677776655443222 23345677899999999999999999998 6 8999999999999974321 11
Q ss_pred CCcEEEeecCCccccCCCCCcccccccCCccccCcccccCCCCCccCcchhhHHHHHHHHhCCCCCCccccccccccchh
Q 047157 632 NYMAKISDFGISKLLNKDQTRTDTNMRGTMGYVAPEWLRNVPVTTKVDVFSFGVMLLEIICGRRHIELSRVEEESEEVDI 711 (788)
Q Consensus 632 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 711 (788)
...++|+|||.+....... ....||+.|+|||.+....++.++||||+||+++||++|+.||..............
T Consensus 168 ~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 2359999999998654322 345789999999999999999999999999999999999999975433211111100
Q ss_pred hhHHHHHHH-------h----------hcc-cccccccCC---------CCCcccHHHHHHHHHHHhHccCCCCCCCCCH
Q 047157 712 VLSDWVISC-------M----------LSR-NLQVLVSHD---------PEVLSDLERFERMAMVGLWCNHPDPNLRPSM 764 (788)
Q Consensus 712 ~~~~~~~~~-------~----------~~~-~~~~l~~~~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 764 (788)
+....... . ... ......... ............+.+|+.+||+.||++|||+
T Consensus 244 -~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 244 -IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp -HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred -HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 00000000 0 000 000000000 0111234566789999999999999999999
Q ss_pred HHHHHH--hhcCc---CCCCCCCC
Q 047157 765 KKVIHM--LEGTL---EVGMPPLL 783 (788)
Q Consensus 765 ~evl~~--L~~~~---~~~~pp~p 783 (788)
+|++++ +++.. ++..|+.+
T Consensus 323 ~e~L~Hp~f~~~~~~~~~~~p~~~ 346 (362)
T d1q8ya_ 323 GGLVNHPWLKDTLGMEEIRVPDRE 346 (362)
T ss_dssp HHHHTCGGGTTCTTCTTCCCTTSC
T ss_pred HHHhcCcccCCCCCcccCCCCCcc
Confidence 999985 65443 34444433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=8e-21 Score=184.70 Aligned_cols=163 Identities=17% Similarity=0.134 Sum_probs=119.0
Q ss_pred cccccccccccceEEEEEEeccCcceeeeeeecccch------------------HHHHHHHHHHHHHhcCCCccccceE
Q 047157 491 GFSKLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI------------------EKTNEEFMTELKIIGRTHHKNLVRL 552 (788)
Q Consensus 491 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~------------------~~~~~~~~~E~~~l~~l~hpniv~~ 552 (788)
.+.++||+|+||+||+|... ++..||||.++... ......+.+|...+.++.|++++..
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~---~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~ 79 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred hhCCEeeeCcceEEEEEECC---CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence 45789999999999999873 56799999764211 1122345678889999999999998
Q ss_pred eeEEecCCeEEEEEecCCCCCHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhccCCceEecCCCCCcEEeccCCCCCC
Q 047157 553 LGFCSEEDKRLLVYELMPNGTLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEECETQIIHCDIKPQNVLLDLKTLDTN 632 (788)
Q Consensus 553 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~~~ 632 (788)
+++.. .+++|||+++..+.++ +......++.|++++|.|||++ +|+||||||+|||++ ++
T Consensus 80 ~~~~~----~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~-----~~ 139 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-----EE 139 (191)
T ss_dssp EEEET----TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-----TT
T ss_pred EEecC----CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeee-----CC
Confidence 87632 3799999988665432 2334467899999999999999 999999999999997 33
Q ss_pred CcEEEeecCCccccCCCCCcccccccCCccccC------cccccCCCCCccCcchhhHHHH
Q 047157 633 YMAKISDFGISKLLNKDQTRTDTNMRGTMGYVA------PEWLRNVPVTTKVDVFSFGVML 687 (788)
Q Consensus 633 ~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~k~DVwSlGvil 687 (788)
.++|+|||.+.......... |.. .|. ..+.++.++|+||..--+
T Consensus 140 -~~~liDFG~a~~~~~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp -EEEECCCTTCEETTSTTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 48999999997654332211 111 111 135778899999986443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.71 E-value=1.7e-17 Score=144.92 Aligned_cols=108 Identities=19% Similarity=0.346 Sum_probs=85.6
Q ss_pred CCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeC
Q 047157 25 SPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYF 104 (788)
Q Consensus 25 ~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~ 104 (788)
+|+|.+||.|.++ ++|+ +|.|+|+|+..|+ |.+++ ..++||.||++.|. ..+.+.|..||+|+|.+.
T Consensus 1 tDtL~~gq~L~~g--~~l~--~g~~~l~~q~DGN----Lvly~----~~~~vW~s~~~~~~-~~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTG--GSLA--EGGYLFIIQNDCN----LVLYD----NNRAVWASGTNGKA-SGCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTT--CEEE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCTTSC-SSEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCC--CEEE--ECCEEEEEcCCCC----EEEEc----CCcEEEEccCccCC-CCcEEEEeccccEEEEec
Confidence 5889999999976 5787 4999999986654 44544 36899999998874 346899999999999986
Q ss_pred CCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCC
Q 047157 105 NGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTD 146 (788)
Q Consensus 105 ~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtD 146 (788)
++ ..|++++. ..+|+|+|+|||||++.++.++|||+.+|++
T Consensus 68 ~~-~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp TE-EEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred CC-eEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 43 33332221 2478999999999999999999999999985
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.62 E-value=6.4e-16 Score=133.36 Aligned_cols=103 Identities=21% Similarity=0.339 Sum_probs=81.9
Q ss_pred CccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeCC
Q 047157 26 PNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFN 105 (788)
Q Consensus 26 ~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~~ 105 (788)
++|.+|+.|.++ ++|+ +|.|.|+|...++ |.++. ..++||+||++.|...++.|.|..||+|+|.|.+
T Consensus 2 ~~L~~g~~L~~g--~~l~--~g~~~l~~q~dgn----Lvl~~----~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 2 NLLTNGEGLYAG--QSLD--VEPYHFIMQEDCN----LVLYD----HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CEEETTCEEETT--CEEE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS
T ss_pred CCccCCCEEeCC--CEEE--eCCEEEEecCCCe----EEEEe----CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC
Confidence 578899999976 5676 5889999976544 33432 3689999999999988899999999999999999
Q ss_pred CcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCC
Q 047157 106 GSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDF 143 (788)
Q Consensus 106 ~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~ 143 (788)
|++.|...++ ..+|+|+|+|||||+++ .+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 9876544332 23689999999999964 69999854
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.59 E-value=1.6e-15 Score=130.76 Aligned_cols=102 Identities=16% Similarity=0.251 Sum_probs=80.4
Q ss_pred CccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeCC
Q 047157 26 PNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFN 105 (788)
Q Consensus 26 ~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~~ 105 (788)
++|.+||.|.++ ++|+ +|.|.|.|+..|+ |.||. ..++||.||++.|- ..+.+.+..+|+|+|.+.+
T Consensus 2 ~~L~~g~~L~~G--~~l~--ng~~~l~~q~DGN----Lvly~----~~~~vW~s~~~~~~-~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 2 NILYSGETLSTG--EFLN--YGSFVFIMQEDCN----LVLYD----VDKPIWATNTGGLS-RSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CEEETTEEECTT--CEEE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCTTSC-SSCEEEECTTSCEEEECTT
T ss_pred CCccCCCEecCC--CEEE--cCCEEEEECCCCe----EEEEe----CCceeeEeCCCCCC-CccEEEEeccceEEEECCC
Confidence 568889999865 5674 6999999987765 55654 36889999998873 3568999999999999999
Q ss_pred CcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCC
Q 047157 106 GSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDF 143 (788)
Q Consensus 106 ~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~ 143 (788)
|+..|...+. ..+|+|+|+|||||++. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 9876544332 23689999999999964 58999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=1.2e-15 Score=133.75 Aligned_cols=98 Identities=17% Similarity=0.262 Sum_probs=78.4
Q ss_pred EEEeCCCCCCeEEEEecCCCCCCCCc-EEEEecCCceEEEeCCCcEEEEecc----cccccccCCCCcEEEEecCCceee
Q 047157 64 GIWFDKIPEKTLVWAADRDSPAEAGS-KITLTNDGKLLLTYFNGSVQQIYSG----AASLALMQNDGNFVLKNANSAVVW 138 (788)
Q Consensus 64 giw~~~~~~~tvVWvANr~~p~~~~s-~l~l~~~G~L~l~~~~~~~~~~~s~----~~~~a~LldsGNlVl~~~~~~~lW 138 (788)
-|||.++++++++|++|++.|+..+. +|.+..||||+|.+.++ ..|.+.+ ....+.|+++|||||++.++.++|
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~~~-~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDD-RVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBTTB-CCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecCCc-EEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 48999999999999999999996554 89999999999998644 3222222 124689999999999999999999
Q ss_pred cccCCCCCcccCCccccCCCeEEeecCCCCCCCCCceEEeeccCCcceee
Q 047157 139 DSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLS 188 (788)
Q Consensus 139 qSFD~PtDtllpg~~l~~g~~l~s~~~~~~dps~G~~~~~~~~~g~~~~~ 188 (788)
|||. +.++|.|.+.|++||++.++
T Consensus 90 ~S~t--------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN--------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC--------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC--------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9973 23568899999999998875
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.41 E-value=5.8e-14 Score=121.54 Aligned_cols=106 Identities=27% Similarity=0.382 Sum_probs=85.4
Q ss_pred EEeCCCCCCeEEEEecCCCCCCCCc-EEEEecCCceEEEeCCCcEEEEecc---cccccccCCCCcEEEEecCCceeecc
Q 047157 65 IWFDKIPEKTLVWAADRDSPAEAGS-KITLTNDGKLLLTYFNGSVQQIYSG---AASLALMQNDGNFVLKNANSAVVWDS 140 (788)
Q Consensus 65 iw~~~~~~~tvVWvANr~~p~~~~s-~l~l~~~G~L~l~~~~~~~~~~~s~---~~~~a~LldsGNlVl~~~~~~~lWqS 140 (788)
|||.-.+..+..|+.+.+.++.++. +|.+..||||||.+. +.+.|...+ ....+.|+++|||||++.++.++|||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 7888778888889999999997655 899999999999884 444443322 24678999999999999999999998
Q ss_pred cCCCCCcccCCccccCCCeEEeecCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCc
Q 047157 141 FDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202 (788)
Q Consensus 141 FD~PtDtllpg~~l~~g~~l~s~~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~ 202 (788)
+- +.++|.|.+.|++||++.++ ..++|.+++
T Consensus 82 ~t--------------------------~~~~g~y~l~Lq~DGNlvlY-----~~~~Wssgt 112 (115)
T d1dlpa1 82 GT--------------------------KGSIGNYVLVLQPDRTVTIY-----GPGLWDSGT 112 (115)
T ss_dssp CC--------------------------CCCSSCCEEEECSSSCEEEE-----CSEEEECSC
T ss_pred CC--------------------------CCCCCCEEEEECCCCcEEEe-----CCCeecCCC
Confidence 63 34579999999999998764 346898875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.15 E-value=5.3e-11 Score=103.37 Aligned_cols=99 Identities=18% Similarity=0.279 Sum_probs=73.6
Q ss_pred CccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEEeCC
Q 047157 26 PNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLTYFN 105 (788)
Q Consensus 26 ~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~~~~ 105 (788)
.++..+|+|. .++..|.|.|.|...|+ |-+ |+ ..++||.||+..+.. .+.|.|..||+|+|.|.+
T Consensus 15 ~~l~~~q~l~------~~~~~~~y~l~mQ~DGN----LVL-y~---~~~~vWssnt~~~~~-~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESLE------ILFGTHVYRFIMQTDCN----LVL-YD---NNNPIWATNTGGLGN-GCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEEE------EEETTEEEEEEECTTSC----EEE-EE---TTEEEEECCCTTSCS-SCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeEE------EecCCceEEEEECCCCc----EEE-EE---CCeEEEEecCCCCCc-ceEEEEEeCCCEEEECCC
Confidence 4566666553 47789999999877655 222 33 368999999987643 468999999999999999
Q ss_pred CcEEEEeccc----ccccccCCCCcEEEEecCCceeecccC
Q 047157 106 GSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFD 142 (788)
Q Consensus 106 ~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD 142 (788)
|...|...+. ..+++|+|+|||||++ ..+|||-.
T Consensus 80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp CCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred CcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 9875543332 2358899999999995 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.78 E-value=1.4e-09 Score=93.50 Aligned_cols=96 Identities=19% Similarity=0.320 Sum_probs=66.9
Q ss_pred cCCCccCCCCceecCCCCeeecCCCeEEEeeeecCCCceEEEEEeCCCCCCeEEEEecCCCCCCCCcEEEEecCCceEEE
Q 047157 23 QTSPNISLGSSITAGSNTSWLSPSGDFAFGFYSLFGGLYLLGIWFDKIPEKTLVWAADRDSPAEAGSKITLTNDGKLLLT 102 (788)
Q Consensus 23 ~~~~~i~~~~~l~~~~~~~~vS~~g~F~lGFf~~~~~~~y~giw~~~~~~~tvVWvANr~~p~~~~s~l~l~~~G~L~l~ 102 (788)
....++..+++|. +|.|.|.|...|+ |.++. ..++||.+|... ...+.+.|..+|||||.
T Consensus 12 ~~~~tl~~~~~l~----------~g~~~l~~q~DGN----LvL~~----~~~~vW~s~t~~--~~~~~l~l~~dGNLvl~ 71 (115)
T d1dlpa1 12 SHPQTLHAAQSLE----------LSSFRFTMQSDCN----LVLFD----SDVRVWASNTAG--ATGCRAVLQSDGLLVIL 71 (115)
T ss_dssp CSCSCCCTTCEEC----------STTEEEEECTTSC----EEEEE----SSSEEECCCCCS--CSCCBCCBCSSSCBCCB
T ss_pred CCcceecCCCcEE----------cCCEEEEECCCCe----EEEEc----CCeeEEEcccCC--CCceEEEEeccCCEEEE
Confidence 3334566666553 4679998876655 44543 357899999754 34568899999999999
Q ss_pred eCCCcEEEEeccc----ccccccCCCCcEEEEecCCceeeccc
Q 047157 103 YFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSF 141 (788)
Q Consensus 103 ~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSF 141 (788)
|.++++.|...++ .-+++|+++|||||++ ..+|+|-
T Consensus 72 d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---~~~Wssg 111 (115)
T d1dlpa1 72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSG 111 (115)
T ss_dssp CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---SEEEECS
T ss_pred ccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC---CCeecCC
Confidence 9888763322222 1258899999999995 4799984
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.71 E-value=1.1e-08 Score=88.71 Aligned_cols=110 Identities=20% Similarity=0.268 Sum_probs=73.8
Q ss_pred cccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEeecCCCCCCCCCceEEeeccCCcceeeecccCCCCCc
Q 047157 119 ALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYW 198 (788)
Q Consensus 119 a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw 198 (788)
++++++||+|+.+. +|+|.|++++.++|.|. .|.|+|.|+.+|++.++ . ....+|
T Consensus 3 ~v~~~~~n~il~~~------~~~~~~~~~l~~~q~l~----------------~g~y~L~~q~DGNLvL~--~-~~~~vW 57 (120)
T d1dlpa2 3 VVVANNGNSILYST------QGNDNHPQTLHATQSLQ----------------LSPYRLSMETDCNLVLF--D-RDDRVW 57 (120)
T ss_dssp CCCSSCCCEECCCC--------CCCCCCEECSSCCCB----------------CSSCEEEEETTTEEEEE--B-TTBCCS
T ss_pred EEEEeCCCeEEEcC------CCCCCcccEEcCCCeeE----------------cCCEEEEEcCCCcEEEe--c-CCcEEE
Confidence 45666666666543 77899999999999874 37899999999998764 2 345688
Q ss_pred ccCcccc-cceeeeeccceeEEEEecCCcceEEEEeeccCCCCceEEEEEEeCCccEEEE
Q 047157 199 YTGTVTL-NNVSLIFNQSAFMYLINSTGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQF 257 (788)
Q Consensus 199 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~ld~~G~l~~~ 257 (788)
.+..... ....+.+...|.+.+++.++..+... ....... .+|++|+.||++++|
T Consensus 58 ~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S---~t~~~~~-~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 58 STNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTS---GNSRSAG-RYVFVLQPDRNLAIY 113 (120)
T ss_dssp CCCCCSSCSSCEEEEETTTEEEEEETTTEEEEEC---CCCCSSS-CCEEEECSSSCEEEE
T ss_pred EEccccCCCcEEEEEeCCeeEEEEcCCCCEEEEe---CCCCCCC-cEEEEECCCCcEEEe
Confidence 7765433 23456677778887777665433222 1111122 348999999999998
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.51 E-value=2.2e-07 Score=79.57 Aligned_cols=110 Identities=20% Similarity=0.297 Sum_probs=76.0
Q ss_pred CCcccCCccccCCCeEEeecCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCcccc-cceeeeeccceeEEEEec
Q 047157 145 TDTILPGQVLLTGKKLYSNSRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGTVTL-NNVSLIFNQSAFMYLINS 223 (788)
Q Consensus 145 tDtllpg~~l~~g~~l~s~~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~~~~-~~~~~~~~~~~~~~~~~~ 223 (788)
||||+|||.|..|..+.+ |.|+|.|+.||++.++. ....+|.++.... .+..+++...+.+.+++.
T Consensus 1 tDtL~~gq~L~~g~~l~~----------g~~~l~~q~DGNLvly~---~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE----------GGYLFIIQNDCNLVLYD---NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE----------TTEEEEECTTSCEEEEE---TTEEEEECCCTTSCSSEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCCCEEEE----------CCEEEEEcCCCCEEEEc---CCcEEEEccCccCCCCcEEEEeccccEEEEec
Confidence 799999999999999853 99999999999987643 3346887765442 334567777888877764
Q ss_pred CCcceEEEEeeccCCCCceEEEEEEeCCccEEEEEeecCCCCceeEEeecccccc
Q 047157 224 TGDNIFRLTRNVMTPTEDYYHRATIDGHGNFQQFAYHKSTSSRWTRVWRAVNDPC 278 (788)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~rl~ld~~G~l~~~~w~~~~~~~W~~~~~~p~~~C 278 (788)
.. .+ ..... .......+++|+.||+|++|.- .....|+...+.|
T Consensus 68 ~~-~~--w~s~t--~~~~~~~~l~L~ddGNlvly~~------~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 68 SR-AI--WASNT--NRQNGNYYLILQRDRNVVIYDN------SNNAIWATHTNVG 111 (112)
T ss_dssp TE-EE--EECCC--CCSCCCCEEEECTTSCEEEECT------TSCEEEECCCCCC
T ss_pred CC-eE--EEEee--ccCCCceEEEEcCCCCEEEECC------CCcEEecCCCccC
Confidence 32 12 22111 1222346899999999999831 2346788776655
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.50 E-value=1.5e-07 Score=81.08 Aligned_cols=81 Identities=27% Similarity=0.393 Sum_probs=59.8
Q ss_pred EEEEecCCceEEEeCCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEeecC
Q 047157 90 KITLTNDGKLLLTYFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNSR 165 (788)
Q Consensus 90 ~l~l~~~G~L~l~~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~~~ 165 (788)
+|.+-.||||||.+.+ ...|...+. ...+.|.++|||||++.++.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~~-~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t----------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDNN-NPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV----------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEETT-EEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred EEEECCCCcEEEEECC-eEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC-----------------------
Confidence 6778899999998754 344433332 346889999999999999999998731
Q ss_pred CCCCCCCCceEEeeccCCcceeeecccCCCCCcccCc
Q 047157 166 GTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202 (788)
Q Consensus 166 ~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~ 202 (788)
.-+.|.|.+.|++||++.++. .+.|.+++
T Consensus 89 ---~~~~~~~~l~Lq~DGNlvlYg-----~~~W~S~T 117 (119)
T d1b2pa_ 89 ---AGKAGHYVLVLQPDRNVVIYG-----DALWATQT 117 (119)
T ss_dssp ---CCCSSCEEEEECTTSCEEEEE-----SEEEECCC
T ss_pred ---cCCCCceEEEEcCCCCEEEEC-----CCEeccCC
Confidence 113478899999999988752 34787765
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.41 E-value=4.5e-07 Score=76.95 Aligned_cols=82 Identities=32% Similarity=0.537 Sum_probs=59.7
Q ss_pred cEEEEecCCceEEEeCCCcEEEEeccc-----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEee
Q 047157 89 SKITLTNDGKLLLTYFNGSVQQIYSGA-----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSN 163 (788)
Q Consensus 89 s~l~l~~~G~L~l~~~~~~~~~~~s~~-----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~ 163 (788)
-.+.+-.||||+|.. ++.+.|..++. ...+.|.++|||||++.++.++|+|= |
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~-----t---------------- 78 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH-----S---------------- 78 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC-----C----------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe-----e----------------
Confidence 477888999999987 44454444432 24578999999999999999999981 1
Q ss_pred cCCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCc
Q 047157 164 SRGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202 (788)
Q Consensus 164 ~~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~ 202 (788)
..+.|.|.+.|+++|++.++ ....|.+++
T Consensus 79 -----~~~~~~~~l~L~ddGNlvly-----~~~~W~S~t 107 (109)
T d1kj1a_ 79 -----VRGNGNYVLVLQEDGNVVIY-----GSDIWSTGT 107 (109)
T ss_dssp -----CCCSSCCEEEECTTSCEEEE-----CCEEEECCC
T ss_pred -----ECCCCCEEEEEeCCCcEEEE-----CCCEecCCC
Confidence 11247789999999998865 234677654
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.38 E-value=6.4e-07 Score=75.91 Aligned_cols=82 Identities=29% Similarity=0.414 Sum_probs=59.5
Q ss_pred cEEEEecCCceEEEeCCCcEEEEeccc----ccccccCCCCcEEEEecCCceeecccCCCCCcccCCccccCCCeEEeec
Q 047157 89 SKITLTNDGKLLLTYFNGSVQQIYSGA----ASLALMQNDGNFVLKNANSAVVWDSFDFPTDTILPGQVLLTGKKLYSNS 164 (788)
Q Consensus 89 s~l~l~~~G~L~l~~~~~~~~~~~s~~----~~~a~LldsGNlVl~~~~~~~lWqSFD~PtDtllpg~~l~~g~~l~s~~ 164 (788)
-+|.+-.||||||.+. +.+.|...+. ...+.|.++|||||++.++.++|+|= |
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS~---t------------------- 77 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASN---T------------------- 77 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC---C-------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEcc---c-------------------
Confidence 4788889999999874 3443332222 24688999999999999999999871 1
Q ss_pred CCCCCCCCCceEEeeccCCcceeeecccCCCCCcccCc
Q 047157 165 RGTADYSTGNYTLEMQADGNLVLSAYHFADPGYWYTGT 202 (788)
Q Consensus 165 ~~~~dps~G~~~~~~~~~g~~~~~~~~~~~~~yw~~~~ 202 (788)
..+++.|.+.|+.+|++.++. .+.|.+++
T Consensus 78 ----~~~~~~~~l~L~ddGNlVly~-----~~~W~S~t 106 (108)
T d1jpca_ 78 ----GGQNGNYVCILQKDRNVVIYG-----TDRWATGT 106 (108)
T ss_dssp ----CCSCSCEEEEECTTSCEEEEE-----CCCCCCCC
T ss_pred ----cCCCCcEEEEEcCCCCEEEeC-----CCcccCCC
Confidence 113478889999999988752 24787754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.01 E-value=6.9e-06 Score=81.57 Aligned_cols=133 Identities=17% Similarity=0.107 Sum_probs=91.3
Q ss_pred cccccceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEecCCCCCHh
Q 047157 497 GTGSSGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYELMPNGTLS 575 (788)
Q Consensus 497 g~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e~~~~gsL~ 575 (788)
+.++.+.||+... ++..+.+|+...........+.+|...+..+. +--+.+++.+..+++..++||+++++.++.
T Consensus 23 ~G~s~~~v~rv~~----~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 23 EGMSPAKVYKLVG----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp CCCSSSEEEEEEC----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred CCCCCCcEEEEEe----CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccc
Confidence 3344578997642 34467788776554434445677887776653 444678888888889999999999998887
Q ss_pred HhhhccCCCCCHHHHHHHHHHHHHHHHHhhhcc-----------------------------------------------
Q 047157 576 NFLFHEGQRPGWVQRVEIALGVARGLLYLHEEC----------------------------------------------- 608 (788)
Q Consensus 576 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----------------------------------------------- 608 (788)
+..... .....++.++++.++.||+..
T Consensus 99 ~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (263)
T d1j7la_ 99 EEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp HHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred cccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHH
Confidence 654221 112335666777777777521
Q ss_pred ---------CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 609 ---------ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 609 ---------~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
...++|+|+.|.||+++ ++..+-|+||+.+.
T Consensus 173 ~l~~~~~~~~~~l~HgD~~~~Nil~~-----~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 173 FLKTEKPEEELVFSHGDLGDSNIFVK-----DGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHSCCCCCEEEECSCCCTTSEEEE-----TTEEEEECCCTTCE
T ss_pred HHHhcCCcCCcEEEEeeccCcceeec-----CCceEEEeechhcc
Confidence 12379999999999997 55556799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.44 E-value=0.00021 Score=70.03 Aligned_cols=129 Identities=16% Similarity=0.114 Sum_probs=82.5
Q ss_pred ccccc-cceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCC--ccccceEeeEEecCCeEEEEEecCCCC
Q 047157 496 VGTGS-SGKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH--HKNLVRLLGFCSEEDKRLLVYELMPNG 572 (788)
Q Consensus 496 lg~G~-~g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lV~e~~~~g 572 (788)
+..|. .+.||+... +.+..+.+|...... ...+..|...++.+. .-.+.+++.+..+++..++|||+++|.
T Consensus 18 ~~~G~s~~~v~r~~~---~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA---QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEEC---TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEe---CCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 34444 367898764 345567888765432 224566777776553 334678888888888999999999887
Q ss_pred CHhHhhhccCCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 047157 573 TLSNFLFHEGQRPGWVQRVEIALGVARGLLYLHEE--------------------------------------------- 607 (788)
Q Consensus 573 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------------------------------------------- 607 (788)
++.+.. ... ..++.++++.|+-||..
T Consensus 92 ~~~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 92 DLLSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp ETTTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 654321 111 12233444444445431
Q ss_pred ----------cCCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 608 ----------CETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 608 ----------~~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
....++|+|+.|.|||++ ++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~-----~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVE-----NGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEE-----TTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEe-----CCceEEEEEchhcc
Confidence 012489999999999997 55567799998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.73 E-value=0.0018 Score=67.59 Aligned_cols=76 Identities=13% Similarity=0.089 Sum_probs=46.1
Q ss_pred ccccccccceEEEEEEeccCcceeeeeeecccch-------HHHHHHHHHHHHHhcCCC---ccccceEeeEEecCCeEE
Q 047157 494 KLVGTGSSGKVYRGILRLKDTQIEIAVKKLEKDI-------EKTNEEFMTELKIIGRTH---HKNLVRLLGFCSEEDKRL 563 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~ 563 (788)
+.||.|....||+.... .++..++||.-.... .....+...|.+.|+.+. ...+++++.+ +.+..+
T Consensus 32 ~eig~G~~N~vfrV~~~--~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ--EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEeCCCceEeEEEEEeC--CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 57899999999998764 445678888543211 111233456777776552 2456677655 344567
Q ss_pred EEEecCCCCC
Q 047157 564 LVYELMPNGT 573 (788)
Q Consensus 564 lV~e~~~~gs 573 (788)
+|||++++..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.44 E-value=0.013 Score=60.82 Aligned_cols=75 Identities=17% Similarity=0.149 Sum_probs=47.5
Q ss_pred ccccccccceEEEEEEecc-----CcceeeeeeecccchHHHHHHHHHHHHHhcCCC-ccccceEeeEEecCCeEEEEEe
Q 047157 494 KLVGTGSSGKVYRGILRLK-----DTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTH-HKNLVRLLGFCSEEDKRLLVYE 567 (788)
Q Consensus 494 ~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lV~e 567 (788)
+.|+.|-.-.+|+...... .....|.+++... .. ......+|..+++.+. +.-.+++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5677788889999876521 1223455555432 22 2234557888888774 4334688888754 58899
Q ss_pred cCCCCCH
Q 047157 568 LMPNGTL 574 (788)
Q Consensus 568 ~~~~gsL 574 (788)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.97 E-value=0.037 Score=55.53 Aligned_cols=68 Identities=12% Similarity=0.139 Sum_probs=41.3
Q ss_pred ceEEEEEEeccCcceeeeeeecccchHHHHHHHHHHHHHhcCCCcccc-----ceEe--eEEecCCeEEEEEecCCCCC
Q 047157 502 GKVYRGILRLKDTQIEIAVKKLEKDIEKTNEEFMTELKIIGRTHHKNL-----VRLL--GFCSEEDKRLLVYELMPNGT 573 (788)
Q Consensus 502 g~Vy~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~--~~~~~~~~~~lV~e~~~~gs 573 (788)
-.||++.. .++..+++|..+.. ....+++..|...+..|....+ +..- ..+......+.++++++|..
T Consensus 36 N~vy~v~~---~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD---EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC---TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEc---CCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47998866 45668999987543 2234566778777766642222 1111 12345667888999987643
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.13 E-value=0.015 Score=35.84 Aligned_cols=32 Identities=34% Similarity=0.801 Sum_probs=26.2
Q ss_pred cccccCCCCCCCcccccCCCCCcccCCCCCCccC
Q 047157 276 DPCIVNCICGVYGMCTSSDNETVTCNCIPGYTPL 309 (788)
Q Consensus 276 ~~C~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~~ 309 (788)
|.|.+-..|| +|-|+.-. ....|.|-+||+|.
T Consensus 2 dECsignpCG-nGTCtNvi-GgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVI-GGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSS-SSCEEECS-SSEEECCSSSSCCC
T ss_pred CccccCCccC-Cceeeecc-cceEEeecCCcCCC
Confidence 7899999998 57897543 46679999999985
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.53 E-value=0.44 Score=46.81 Aligned_cols=31 Identities=23% Similarity=0.367 Sum_probs=26.5
Q ss_pred CCceEecCCCCCcEEeccCCCCCCCcEEEeecCCcc
Q 047157 609 ETQIIHCDIKPQNVLLDLKTLDTNYMAKISDFGISK 644 (788)
Q Consensus 609 ~~~ivH~dlkp~NIll~~~~~~~~~~~kL~Dfg~a~ 644 (788)
..++||+|+.++||+++ .+...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~-----~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFL-----GDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEE-----TTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcc-----cccceeEecccccc
Confidence 45899999999999998 66566899999875
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.94 E-value=0.1 Score=34.40 Aligned_cols=31 Identities=32% Similarity=0.827 Sum_probs=25.1
Q ss_pred ccccc-CCCCCCCcccccCCCCCcccCCCCCCc
Q 047157 276 DPCIV-NCICGVYGMCTSSDNETVTCNCIPGYT 307 (788)
Q Consensus 276 ~~C~~-~~~CG~~g~C~~~~~~~~~C~C~~GF~ 307 (788)
|+|.. ...|..+|.|... .....|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~-~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINT-LGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEEC-SSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECC-CCCEEeECCCCCc
Confidence 56765 5689999999864 4568999999997
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.73 E-value=0.37 Score=30.97 Aligned_cols=31 Identities=29% Similarity=0.741 Sum_probs=23.3
Q ss_pred cccccCCCCCCCcccccCCCCCcccCCCCCCcc
Q 047157 276 DPCIVNCICGVYGMCTSSDNETVTCNCIPGYTP 308 (788)
Q Consensus 276 ~~C~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~ 308 (788)
|.|. ..-|-..|.|... .....|.|++||+=
T Consensus 1 D~C~-~~PC~ngg~C~~~-~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDG-LGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCC-SSSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECC-CCCEEEECCCCCCc
Confidence 3555 4678889999754 45788999999973
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.07 E-value=0.48 Score=31.18 Aligned_cols=31 Identities=29% Similarity=0.578 Sum_probs=24.0
Q ss_pred cccccCCCCCCCcccccCCCCCcccCCCCCCcc
Q 047157 276 DPCIVNCICGVYGMCTSSDNETVTCNCIPGYTP 308 (788)
Q Consensus 276 ~~C~~~~~CG~~g~C~~~~~~~~~C~C~~GF~~ 308 (788)
|+|.... |+.++.|.... .+-.|.|++||+.
T Consensus 6 dEC~~~~-~~~~~~C~Nt~-Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 6 DECKEPD-VCKHGQCINTD-GSYRCECPFGYIL 36 (43)
T ss_dssp CSSSSTT-SCSSSCCCCCS-SCCCCCCCTTEEE
T ss_pred eccCCcC-CCCCCEeECCC-CCeEeECCCCccc
Confidence 7887554 55789998654 5788999999985
|